PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mondal, N; Sukumar, R				Mondal, Nandita; Sukumar, Raman			Fires in Seasonally Dry Tropical Forest: Testing the Varying Constraints Hypothesis across a Regional Rainfall Gradient	PLOS ONE			English	Article							WESTERN-GHATS; NORTHERN AUSTRALIA; DECIDUOUS FOREST; BURNT AREA; CLIMATE; VARIABILITY; ECOSYSTEMS; PATTERNS; SAVANNA; DRIVERS	The "varying constraints hypothesis" of fire in natural ecosystems postulates that the extent of fire in an ecosystem would differ according to the relative contribution of fuel load and fuel moisture available, factors that vary globally along a spatial gradient of climatic conditions. We examined if the globally widespread seasonally dry tropical forests (SDTFs) can be placed as a single entity in this framework by analyzing environmental influences on fire extent in a structurally diverse SDTF landscape in the Western Ghats of southern India, representative of similar forests in monsoonal south and southeast Asia. We used logistic regression to model fire extent with factors that represent fuel load and fuel moisture at two levels-the overall landscape and within four defined moisture regimes (between 700 and1700 mm yr(-1))-using a dataset of area burnt and seasonal rainfall from 1990 to 2010. The landscape scale model showed that the extent of fire in a given year within this SDTF is dependent on the combined interaction of seasonal rainfall and extent burnt the previous year. Within individual moisture regimes the relative contribution of these factors to the annual extent burnt varied-early dry season rainfall (i.e., fuel moisture) was the predominant factor in the wettest regime, while wet season rainfall (i.e., fuel load) had a large influence on fire extent in the driest regime. Thus, the diverse structural vegetation types associated with SDTFs across a wide range of rainfall regimes would have to be examined at finer regional or local scales to understand the specific environmental drivers of fire. Our results could be extended to investigating fire-climate relationships in STDFs of monsoonal Asia.	[Mondal, Nandita; Sukumar, Raman] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Sukumar, Raman] Indian Inst Sci, Divecha Ctr Climate Change, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Sukumar, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.; Sukumar, R (corresponding author), Indian Inst Sci, Divecha Ctr Climate Change, Bangalore 560012, Karnataka, India.	rsuku@ces.iisc.ernet.in	Raman, Sukumar/C-9809-2013		Ministry of Environment and Forests, Government of India, India; Ministry of Environment and Forests, Government of India	Ministry of Environment and Forests, Government of India, India; Ministry of Environment and Forests, Government of India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India)	This project was funded by the Ministry of Environment and Forests, Government of India, India (http://www.moef.nic.in) (grant recipient: RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ministry of Environment and Forests, Government of India, for funding this study; Tamil Nadu Forest Department for research permissions; Forest Department staff at Mudumalai for assistance with mapping of burnt areas in the study area; Researchers at CES and staff at the Mudumalai field station, especially C.M. Bharanaiah, R. Arumugam, H.S. Dattaraja and H.S. Suresh, for mapping fires at Mudumalai as well as building the rainfall database for the study area; Kavita Isvaran and Geetha Ramaswami advised us on statistical analysis.	Archibald S, 2010, GLOBAL ECOL BIOGEOGR, V19, P794, DOI 10.1111/j.1466-8238.2010.00568.x; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Chandler C., 1983, FIRE FORESTRY FOREST, V1; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; Cochrane Mark A., 2009, P25, DOI 10.1007/978-3-540-77381-8_2; Crawley M.J., 2007, R BOOK; Dattaraja HS, 2013, SPATIAL INTERPOLATIO; FAO, 2020, GLOBAL FOREST RESOUR; Giglio L, 2006, J GEOPHYS RES, V111, DOI DOI 10.1029/2005JG000142; Grau HR, 2001, GLOBAL ECOL BIOGEOGR, V10, P133, DOI 10.1046/j.1466-822x.2001.00220.x; Grau HR, 2000, J BIOGEOGR, V27, P1107, DOI 10.1046/j.1365-2699.2000.00488.x; Gunnell Y, 1997, INT J CLIMATOL, V17, P1169, DOI 10.1002/(SICI)1097-0088(199709)17:11<1169::AID-JOC189>3.0.CO;2-W; KARANTH KU, 1992, J TROP ECOL, V8, P21, DOI 10.1017/S0266467400006040; Kirkpatrick JB, 2011, J APPL ECOL, V48, P642, DOI 10.1111/j.1365-2664.2011.01962.x; Kodandapani N, 2004, CONSERV BIOL, V18, P1553, DOI 10.1111/j.1523-1739.2004.00433.x; Kodandapani N, 2008, FOREST ECOL MANAG, V256, P607, DOI 10.1016/j.foreco.2008.05.006; Koutsias N, 2013, INT J WILDLAND FIRE, V22, P493, DOI 10.1071/WF12003; Krawchuk MA, 2011, ECOLOGY, V92, P121, DOI 10.1890/09-1843.1; Leimgruber P., 2011, ECOLOGY CONSERVATION, P59; Meyn A, 2007, PROG PHYS GEOG, V31, P287, DOI 10.1177/0309133307079365; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Miller C, 2000, LANDSCAPE ECOL, V15, P145, DOI 10.1023/A:1008181313360; Mulqueeny CM, 2011, INT J WILDLAND FIRE, V20, P532, DOI 10.1071/WF08141; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Park S, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099699, 10.1371/journal.pone.0085264]; Pascal JP, 1986, REPORT NO HORS SERIE, V18, P88; Pascal JP, 1996, REPORT NO HORS SERIE, V21, P66; Pausas JG, 2007, GLOBAL ECOL BIOGEOGR, V16, P330, DOI 10.1111/j.1466-8238.2006.00283.x; Pausas JG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1074, DOI 10.1111/j.1466-8238.2012.00769.x; Price OE, 2012, J ENVIRON MANAGE, V113, P301, DOI 10.1016/j.jenvman.2012.08.042; PUYRAVAUD JP, 1995, CURR SCI INDIA, V68, P745; Pyne S, 1996, INTRO WILDLAND FIRE; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; Silori CS, 2001, BIODIVERS CONSERV, V10, P2181, DOI 10.1023/A:1013285910650; Spessa A, 2005, GLOBAL ECOL BIOGEOGR, V14, P439, DOI 10.1111/j.1466-822x.2005.00174.x; STOTT P, 1988, GEOGR J, V154, P337, DOI 10.2307/634607; STOTT P, 1986, J BIOGEOGR, V13, P345, DOI 10.2307/2845018; STOTT PA, 1990, ECOL STU AN, V84, P32; Sukumar R, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P551; Suresh H.S., 2011, ECOLOGY CONSERVATION, P37; Turco M, 2013, CLIMATIC CHANGE, V116, P665, DOI 10.1007/s10584-012-0505-6; VARMAN KS, 1995, J BIOSCIENCE, V20, P273, DOI 10.1007/BF02703274; Von Lengerke HJ., 1977, NILGIRIS WEATHER CLI; Williams RJ, 1999, AUST J ECOL, V24, P50, DOI 10.1046/j.1442-9993.1999.00946.x	47	16	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159691	10.1371/journal.pone.0159691	http://dx.doi.org/10.1371/journal.pone.0159691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441689	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000380797500123
J	Wang, T; He, QZ; Li, HB; Ding, J; Wen, P; Zhang, Q; Xiang, JJ; Li, Q; Xuan, LM; Kong, LY; Mao, Y; Zhu, YJ; Shen, JJ; Liang, B; Li, H				Wang, Ting; He, Quanze; Li, Haibo; Ding, Jie; Wen, Ping; Zhang, Qin; Xiang, Jingjing; Li, Qiong; Xuan, Liming; Kong, Lingyin; Mao, Yan; Zhu, Yijun; Shen, Jingjing; Liang, Bo; Li, Hong			An Optimized Method for Accurate Fetal Sex Prediction and Sex Chromosome Aneuploidy Detection in Non-Invasive Prenatal Testing	PLOS ONE			English	Article							MATERNAL PLASMA; DNA; XX	Massively parallel sequencing (MPS) combined with bioinformatic analysis has been widely applied to detect fetal chromosomal aneuploidies such as trisomy 21, 18, 13 and sex chromosome aneuploidies (SCAs) by sequencing cell-free fetal DNA (cffDNA) from maternal plasma, so-called non-invasive prenatal testing (NIPT). However, many technical challenges, such as dependency on correct fetal sex prediction, large variations of chromosome Y measurement and high sensitivity to random reads mapping, may result in higher false negative rate (FNR) and false positive rate (FPR) in fetal sex prediction as well as in SCAs detection. Here, we developed an optimized method to improve the accuracy of the current method by filtering out randomly mapped reads in six specific regions of the Y chromosome. The method reduces the FNR and FPR of fetal sex prediction from nearly 1% to 0.01% and 0.06%, respectively and works robustly under conditions of low fetal DNA concentration (1%) in testing and simulation of 92 samples. The optimized method was further confirmed by large scale testing (1590 samples), suggesting that it is reliable and robust enough for clinical testing.	[Wang, Ting; He, Quanze; Li, Haibo; Ding, Jie; Wen, Ping; Zhang, Qin; Xiang, Jingjing; Li, Qiong; Li, Hong] Nanjing Med Univ, Suzhou Hosp, Ctr Reprod & Genet, Suzhou 215002, Jiangsu, Peoples R China; [Liang, Bo] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Xuan, Liming; Kong, Lingyin; Mao, Yan; Zhu, Yijun; Shen, Jingjing] Basecare Med Device Co Ltd, Suzhou, Jiangsu, Peoples R China	Nanjing Medical University; Shanghai Jiao Tong University	Li, H (corresponding author), Nanjing Med Univ, Suzhou Hosp, Ctr Reprod & Genet, Suzhou 215002, Jiangsu, Peoples R China.; Liang, B (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China.	boliang880@sjtu.edu.cn; hongliszivf@163.com			Suzhou Key Medical Center [SZZX201505]; Clinical Medicine Science and Technology Projects of the Jiangsu province [BL2013019]; Jiangsu Provincial Health Department Scientific Research Project [Q201412]; Suzhou Science and Technology Support Program [SS201429]; Program of the Science and Technology Support Plan of Jiangsu Province [BE2013654]; National High-tech RD Program of China "863" [2012AA020403]	Suzhou Key Medical Center; Clinical Medicine Science and Technology Projects of the Jiangsu province; Jiangsu Provincial Health Department Scientific Research Project; Suzhou Science and Technology Support Program; Program of the Science and Technology Support Plan of Jiangsu Province; National High-tech RD Program of China "863"	This work is supported by Suzhou Key Medical Center (SZZX201505), Clinical Medicine Science and Technology Projects of the Jiangsu province (BL2013019), the Jiangsu Provincial Health Department Scientific Research Project (Q201412), the Suzhou Science and Technology Support Program (SS201429), The Program of the Science and Technology Support Plan of Jiangsu Province (BE2013654), and the National High-tech RD Program of China "863" (2012AA020403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the families for participating in this research project. This work is supported by Suzhou Key Medical Center (SZZX201505), Clinical Medicine Science and Technology Projects of the Jiangsu province (BL2013019), the Jiangsu Provincial Health Department Scientific Research Project (Q201412); the Suzhou Science and Technology Support Program (SS201429); The Program of the Science and Technology Support Plan of Jiangsu Province (BE2013654) and the National High-tech RD Program of China "863" (2012AA020403).	[Anonymous], 2015, Obstet Gynecol, V126, pe31, DOI 10.1097/AOG.0000000000001051; Chen EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021791; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chung GTY, 2005, CLIN CHEM, V51, P655, DOI 10.1373/clinchem.2004.042168; DEMARCHI M, 1976, CLIN GENET, V10, P265; Everest E, 2015, CASE REP PEDIAT, V2015, DOI 10.1155/2015/263253; FITZGERALD PH, 1979, CLIN GENET, V15, P89; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Pan XY, 2014, J MATERN-FETAL NEO M, V27, P1829, DOI 10.3109/14767058.2014.885942; Sparks A, 2012, AM J OBSTET GYNECOL, V206, pS314, DOI 10.1016/j.ajog.2011.10.725; Visootsak J, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-42; Visootsak J, 2009, DEV DISABIL RES REV, V15, P328, DOI 10.1002/ddrr.76; Yuan Y, 2013, CLIN CHEM, V59, P846, DOI 10.1373/clinchem.2012.196725	15	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159648	10.1371/journal.pone.0159648	http://dx.doi.org/10.1371/journal.pone.0159648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441628	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500111
J	Kalbitz, M; Karbach, M; Braumueller, S; Kellermann, P; Gebhard, F; Huber-Lang, M; Perl, M				Kalbitz, Miriam; Karbach, Michael; Braumueller, Sonja; Kellermann, Philipp; Gebhard, Florian; Huber-Lang, Markus; Perl, Mario			Role of Complement C5 in Experimental Blunt Chest Trauma-Induced Septic Acute Lung Injury (ALI)	PLOS ONE			English	Article							RESPIRATORY-DISTRESS SYNDROME; PULMONARY CONTUSION; INFLAMMATORY RESPONSE; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; CECAL LIGATION; MURINE MODEL; SEPSIS; RECEPTOR; APOPTOSIS	Background Severe blunt chest trauma is associated with high mortality. Sepsis represents a serious risk factor for mortality in acute respiratory distress syndrome (ARDS). In septic patients with ARDS complement activation products were found to be elevated in the plasma. In single models like LPS or trauma complement has been studied to some degree, however in clinically highly relevant double hit models such as the one used here little data is available. Here, we hypothesized that absence of C5 is correlated with a decreased inflammatory response in trauma induced septic acute lung injury. Methods 12 hrs after DH in mice the local and systemic cytokines and chemokines were quantified by multiplex bead array or ELISA, activated caspase-3 by western blot. Data were analyzed using one-way ANOVA followed by post-hoc Sidak's multiple comparison test (significance, p <= 0.05). Results In lung tissue interleukin (IL)-6, monocyte chemo attractant protein-1 (MCP-1) and granulocyte-colony stimulating factor (G-CSF) was elevated in both C5(-/-) mice and wildtype littermates (wt), whereas caspase-3 was reduced in lungs after DH in C5(-/-) mice. Systemically, reduced keratinocyte-derived chemokine (KC) levels were observed after DH in C5(-/-) compared to wt mice. Locally, lung myeloperoxidase (MPO), protein, IL-6, MCP-1 and G-CSF in brochoalveolar lavage fluid (BALF) were elevated after DH in C5(-/-) compared to wt. Conclusions In the complex but clinically relevant DH model the local and systemic inflammatory immune response features both, C5-dependent and C5-independent characteristics. Activation of caspase-3 in lung tissue after DH was C5-dependent whereas local inflammation in lung tissue was C5-independent.	[Kalbitz, Miriam; Karbach, Michael; Braumueller, Sonja; Kellermann, Philipp; Gebhard, Florian; Huber-Lang, Markus; Perl, Mario] Univ Ulm, Ctr Surg, Dept Traumatol Hand Plast & Reconstruct Surg, Ulm, Germany; [Perl, Mario] BG Trauma Ctr Murnau, Orthoped Trauma, Murnau, Germany	Ulm University	Kalbitz, M (corresponding author), Univ Ulm, Ctr Surg, Dept Traumatol Hand Plast & Reconstruct Surg, Ulm, Germany.	miriam.kalbitz@uniklinik-ulm.de	Huber-Lang, Markus/AAJ-2209-2020		Deutsche Forschungsgemeinschaft [KFO200, TP2, 823/3-2]; DFG [PE 908/2-1]; Centre of Musculoskeletal Research Ulm (Zmfu) research grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Centre of Musculoskeletal Research Ulm (Zmfu) research grant	This work was supported by Deutsche Forschungsgemeinschaft research grant KFO200 (TP2; 823/3-2) to M.H.-L., DFG PE 908/2-1 to M.P. and Centre of Musculoskeletal Research Ulm (Zmfu) research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Deutsche Forschungsgemeinschaft research grant KFO200 (TP2; 823/3-2) to M.H.-L., DFG PE 908/2-1 to M.P. and Centre of Musculoskeletal Research Ulm (Zmfu) research grant. We thank Sonja Braumueller and Anke Schulze for their technical assistance.	Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; Bosmann M, 2013, EUR J IMMUNOL, V43, P1907, DOI 10.1002/eji.201243075; Bosmann M, 2012, ADV EXP MED BIOL, V946, P147, DOI 10.1007/978-1-4614-0106-3_9; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Flierl MA, 2008, FASEB J, V22, P3483, DOI 10.1096/fj.08-110595; Flierl MA, 2008, SHOCK, V29, P25, DOI 10.1097/shk.0b013e3180556a0b; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Guo RF, 2006, J LEUKOCYTE BIOL, V80, P1575, DOI 10.1189/jlb.0106065; Guo RF, 2001, FASEB J, V15, pA941; Hopken U, 1996, EUR J IMMUNOL, V26, P1103, DOI 10.1002/eji.1830260522; Hoth JJ, 2007, SHOCK, V28, P447, DOI 10.1097/shk.0b013e318048801a; Hoth JJ, 2014, J TRAUMA ACUTE CARE, V76, P601, DOI 10.1097/TA.0000000000000129; Hoth JJ, 2009, SHOCK, V31, P376, DOI 10.1097/SHK.0b013e3181862279; Knoferl MW, 2004, SHOCK, V22, P51, DOI 10.1097/01.shk.0000127684.64611.5c; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; LANGLOIS PF, 1988, AM REV RESPIR DIS, V138, P368, DOI 10.1164/ajrccm/138.2.368; Laudes IJ, 2002, J IMMUNOL, V169, P5962, DOI 10.4049/jimmunol.169.10.5962; Lomas-Neira J, 2006, AM J PHYSIOL-LUNG C, V290, pL51, DOI 10.1152/ajplung.00028.2005; Lomas-Neira JL, 2004, J LEUKOCYTE BIOL, V76, P58, DOI 10.1189/jlb.1103541; Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com; PARSONS PE, 1985, AM REV RESPIR DIS, V132, P490; Perl M, 2005, AM J PATHOL, V167, P1545, DOI 10.1016/S0002-9440(10)61240-0; Perl M, 2005, CRIT CARE MED, V33, P1351, DOI 10.1097/01.CCM.0000166352.28018.A9; Perl M, 2007, AM J RESP CRIT CARE, V176, P591, DOI 10.1164/rccm.200611-1743OC; Perl M, 2012, SHOCK, V38, P98, DOI 10.1097/SHK.0b013e318254be6a; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; Riedemann NC, 2002, J IMMUNOL, V168, P1919, DOI 10.4049/jimmunol.168.4.1919; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; ROBBINS RA, 1987, AM REV RESPIR DIS, V135, P651; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shah CV, 2008, CRIT CARE MED, V36, P2309, DOI 10.1097/CCM.0b013e318180dc74; Short A, 1999, BRIT J PHARMACOL, V126, P551, DOI 10.1038/sj.bjp.0702338; STELLIN G, 1991, AM SURGEON, V57, P780; Sun L, 2009, FASEB J, V23, P3808, DOI 10.1096/fj.09-133694; Wang LY, 2010, CLIN IMMUNOL, V137, P157, DOI 10.1016/j.clim.2010.05.012; Weckbach S, 2013, J TRAUMA ACUTE CARE, V74, P792, DOI 10.1097/TA.0b013e31827a3655; Weckbach S, 2013, J TRAUMA ACUTE CARE, V74, P489, DOI 10.1097/TA.0b013e31827d5f1b	43	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159417	10.1371/journal.pone.0159417	http://dx.doi.org/10.1371/journal.pone.0159417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437704	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100045
J	Chao, TL; Wang, GZ; Wang, JM; Liu, ZH; Ji, ZB; Hou, L; Zhang, CL				Chao, Tianle; Wang, Guizhi; Wang, Jianmin; Liu, Zhaohua; Ji, Zhibin; Hou, Lei; Zhang, Chunlan			Identification and Classification of New Transcripts in Dorper and Small-Tailed Han Sheep Skeletal Muscle Transcriptomes	PLOS ONE			English	Article							NONCODING RNAS; MESSENGER-RNAS; ANNOTATION; REVEALS; DISCOVERY; DORSET; MODEL; SKIN	High-throughput mRNA sequencing enables the discovery of new transcripts and additional parts of incompletely annotated transcripts. Compared with the human and cow genomes, the reference annotation level of the sheep genome is still low. An investigation of new transcripts in sheep skeletal muscle will improve our understanding of muscle development. Therefore, applying high-throughput sequencing, two cDNA libraries from the biceps brachii of small-tailed Han sheep and Dorper sheep were constructed, and whole-transcriptome analysis was performed to determine the unknown transcript catalogue of this tissue. In this study, 40,129 transcripts were finally mapped to the sheep genome. Among them, 3,467 transcripts were determined to be unannotated in the current reference sheep genome and were defined as new transcripts. Based on protein-coding capacity prediction and comparative analysis of sequence similarity, 246 transcripts were classified as portions of unannotated genes or incompletely annotated genes. Another 1,520 transcripts were predicted with high confidence to be long non-coding RNAs. Our analysis also revealed 334 new transcripts that displayed specific expression in ruminants and uncovered a number of new transcripts without intergenus homology but with specific expression in sheep skeletal muscle. The results confirmed a complex transcript pattern of coding and non-coding RNA in sheep skeletal muscle. This study provided important information concerning the sheep genome and transcriptome annotation, which could provide a basis for further study.	[Chao, Tianle; Wang, Guizhi; Wang, Jianmin; Liu, Zhaohua; Ji, Zhibin; Hou, Lei] Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An 271018, Shandong, Peoples R China; [Zhang, Chunlan] Weifang Univ, Coll Biol & Agr Engn, Key Lab Biochem & Mol Biol Univ Shandong, Weifang 261061, Peoples R China	Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University; Weifang University	Wang, JM (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An 271018, Shandong, Peoples R China.	wangjm@sdau.edu.cn	WANG, Jianmin/M-2002-2016	WANG, Jianmin/0000-0001-5678-8202; tianle, chao/0000-0001-9721-0634	Shandong Provincial Modern Agriculture Industry Technology System [SDAIT-0901101]; National Key Technology Support Program [2015BAD03B05]	Shandong Provincial Modern Agriculture Industry Technology System; National Key Technology Support Program(National Key Technology R&D Program)	This work was financially supported by the Shandong Provincial Modern Agriculture Industry Technology System (no. SDAIT-0901101) and National Key Technology Support Program (2015BAD03B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Jianmin Wang for revising the language and for providing valuable comments on the manuscript. This work was financially supported by the Shandong Provincial Modern Agriculture Industry Technology System (no. SDAIT-0901101) and National Key Technology Support Program (2015BAD03B05).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cloete SWP, 2000, SMALL RUMINANT RES, V36, P119, DOI 10.1016/S0921-4488(99)00156-X; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Du L., 2011, ANIMAL GENETIC RESOU; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Jager M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-158; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Li TT, 2012, GENOMICS, V99, P292, DOI 10.1016/j.ygeno.2012.02.003; Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Miao XY, 2015, GENE, V562, P188, DOI 10.1016/j.gene.2015.02.070; Miao XY, 2015, MOL CELL ENDOCRINOL, V402, P32, DOI 10.1016/j.mce.2014.12.023; Miao XY, 2013, REPRODUCTION, V145, P587, DOI 10.1530/REP-12-0507; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Penagaricano F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1034; Qu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052275; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Trapnell C, 2012, NATURE PROTOCOLS, P7; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TU YR, 1989, SMALL TAILED HAN SHE; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weikard R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-789; Yang Q, 2013, CELL PROLIFERAT, V46, P654, DOI 10.1111/cpr.12076; Yue YJ, 2015, GENET MOL RES, V14, P1371, DOI 10.4238/2015.February.13.16; Zhang CU, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004509; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072686	37	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159638	10.1371/journal.pone.0159638	http://dx.doi.org/10.1371/journal.pone.0159638			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434270	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600078
J	Speake, C; Pichugin, A; Sahu, T; Malkov, V; Morrison, R; Pei, Y; Juompan, L; Milman, N; Zarling, S; Anderson, C; Wong-Madden, S; Wendler, J; Ishizuka, A; MacMillen, ZW; Garcia, V; Kappe, SHI; Krzych, U; Duffy, PE				Speake, Cate; Pichugin, Alexander; Sahu, Tejram; Malkov, Vlad; Morrison, Robert; Pei, Ying; Juompan, Laure; Milman, Neta; Zarling, Stasya; Anderson, Charles; Wong-Madden, Sharon; Wendler, Jason; Ishizuka, Andrew; MacMillen, Zachary W.; Garcia, Valentino; Kappe, Stefan H. I.; Krzych, Urszula; Duffy, Patrick E.			Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein	PLOS ONE			English	Article							PLASMODIUM-BERGHEI MALARIA; CD8+ T-CELLS; NAIVE ADULTS; PROTECTIVE IMMUNITY; STERILE IMMUNITY; EFFICACY; DNA; IMMUNIZATION; SPOROZOITES; PARASITES	Malaria vaccine development has been hampered by the limited availability of antigens identified through conventional discovery approaches, and improvements are needed to enhance the efficacy of the leading vaccine candidate RTS, S that targets the circumsporozoite protein (CSP) of the infective sporozoite. Here we report a transcriptome-based approach to identify novel pre-erythrocytic vaccine antigens that could potentially be used in combination with CSP. We hypothesized that stage-specific upregulated genes would enrich for protective vaccine targets, and used tiling microarray to identify P. falciparum genes transcribed at higher levels during liver stage versus sporozoite or blood stages of development. We prepared DNA vaccines for 21 genes using the predicted orthologues in P. yoelii and P. berghei and tested their efficacy using different delivery methods against pre-erythrocytic malaria in rodent models. In our primary screen using P. yoelii in BALB/c mice, we found that 16 antigens significantly reduced liver stage parasite burden. In our confirmatory screen using P. berghei in C57Bl/6 mice, we confirmed 6 antigens that were protective in both models. Two antigens, when combined with CSP, provided significantly greater protection than CSP alone in both models. Based on the observations reported here, transcriptional patterns of Plasmodium genes can be useful in identifying novel pre-erythrocytic antigens that induce protective immunity alone or in combination with CSP.	[Speake, Cate; Malkov, Vlad; Pei, Ying; Milman, Neta; Wendler, Jason; Ishizuka, Andrew; MacMillen, Zachary W.; Garcia, Valentino; Kappe, Stefan H. I.] Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA; [Pichugin, Alexander; Juompan, Laure; Zarling, Stasya; Krzych, Urszula] Walter Reed Army Inst Res, Dept Cellular Immunol, Silver Spring, MD USA; [Sahu, Tejram; Morrison, Robert; Anderson, Charles; Wong-Madden, Sharon; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Center for Infectious Disease Research; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Duffy, PE (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	duffype@niaid.nih.gov		Ishizuka, Andrew/0000-0002-3024-7536	PATH Malaria Vaccine Initiative; Intramural Research Program of NIAID, NIH; Military Infectious Diseases Research Program of Walter Reed Army Institute of Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001135] Funding Source: NIH RePORTER	PATH Malaria Vaccine Initiative; Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Military Infectious Diseases Research Program of Walter Reed Army Institute of Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded in part by the PATH Malaria Vaccine Initiative, by the Intramural Research Program of NIAID, NIH and the Military Infectious Diseases Research Program of Walter Reed Army Institute of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Aly ASI, 2011, MOL MICROBIOL, V79, P929, DOI 10.1111/j.1365-2958.2010.07497.x; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Bergmann-Leitner Elke S, 2013, Methods Mol Biol, V940, P269, DOI 10.1007/978-1-62703-110-3_21; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Cummings JF, 2010, VACCINE, V28, P5135, DOI 10.1016/j.vaccine.2009.08.046; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Francis SE, 2007, INFECT IMMUN, V75, P4838, DOI 10.1128/IAI.00635-07; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Guebre-Xabier M, 1999, EUR J IMMUNOL, V29, P3978, DOI 10.1002/(SICI)1521-4141(199912)29:12&lt;3978::AID-IMMU3978&gt;3.0.CO;2-0; Haddad D, 2004, INFECT IMMUN, V72, P1594, DOI 10.1128/IAI.72.3.1594-1602.2004; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hodgson SH, 2015, J INFECT DIS, V211, P1076, DOI 10.1093/infdis/jiu579; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishino T, 2009, CELL MICROBIOL, V11, P1329, DOI 10.1111/j.1462-5822.2009.01333.x; Kaiser K, 2003, J EXP MED, V197, P1045, DOI 10.1084/jem.20022100; Kester KE, 2014, VACCINE, V32, P6683, DOI 10.1016/j.vaccine.2014.06.033; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; Leitner WW, 1997, J IMMUNOL, V159, P6112; Limbach K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-65; Lumsden JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020775; MALIK A, 1991, P NATL ACAD SCI USA, V88, P3300, DOI 10.1073/pnas.88.8.3300; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mauduit M, 2010, INFECT IMMUN, V78, P2182, DOI 10.1128/IAI.01415-09; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Miller JL, 2012, INFECT IMMUN, V80, P1399, DOI 10.1128/IAI.05861-11; Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373; Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; OZAKI LS, 1984, J PARASITOL, V70, P831, DOI 10.2307/3281779; Raj DK, 2014, SCIENCE, V344, P871, DOI 10.1126/science.1254417; Richie TL, 2012, HUM VACC IMMUNOTHER, V8, P1564, DOI 10.4161/hv.22129; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Sinnis Photini, 2013, Methods Mol Biol, V923, P385; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsuji M, 2003, TRENDS PARASITOL, V19, P88, DOI 10.1016/S1471-4922(02)00053-3; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Vignali M, 2011, J CLIN INVEST, V121, P1119, DOI 10.1172/JCI43457; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; White MT, 2011, P ROY SOC B-BIOL SCI, V278, P1298, DOI 10.1098/rspb.2010.1697; Yoshida A, 2000, VACCINE, V18, P1725, DOI 10.1016/S0264-410X(99)00432-6	60	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159449	10.1371/journal.pone.0159449	http://dx.doi.org/10.1371/journal.pone.0159449			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434123	gold, Green Submitted, Green Published			2022-12-27	WOS:000380169600053
J	Aumann, TD; Raabus, M; Tomas, D; Prijanto, A; Churilov, L; Spitzer, NC; Horne, MK				Aumann, Tim D.; Raabus, Mai; Tomas, Doris; Prijanto, Agustinus; Churilov, Leonid; Spitzer, Nicholas C.; Horne, Malcolm K.			Differences in Number of Midbrain Dopamine Neurons Associated with Summer and Winter Photoperiods in Humans	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; SUBSTANTIA-NIGRA; CATECHOLAMINE DEPLETION; TYROSINE-HYDROXYLASE; PROGENITOR CELLS; PROLIFERATION; NEUROGENESIS; MODEL; AVAILABILITY	Recent evidence indicates the number of dopaminergic neurons in the adult rodent hypothalamus and midbrain is regulated by environmental cues, including photoperiod, and that this occurs via up-or down-regulation of expression of genes and proteins that are important for dopamine (DA) synthesis in extant neurons ('DA neurotransmitter switching'). If the same occurs in humans, it may have implications for neurological symptoms associated with DA imbalances. Here we tested whether there are differences in the number of tyrosine hydroxylase (TH, the rate-limiting enzyme in DA synthesis) and DA transporter (DAT) immunoreactive neurons in the midbrain of people who died in summer (long-day photoperiod, n = 5) versus winter (short-day photoperiod, n = 5). TH and DAT immunoreactivity in neurons and their processes was qualitatively higher in summer compared with winter. The density of TH immunopositive (TH+) neurons was significantly (similar to 6-fold) higher whereas the density of TH immunonegative (TH-) neurons was significantly (similar to 2.5-fold) lower in summer compared with winter. The density of total neurons (TH+ and TH- combined) was not different. The density of DAT+ neurons was similar to 2-fold higher whereas the density of DAT-neurons was similar to 2-fold lower in summer compared with winter, although these differences were not statistically significant. In contrast, midbrain nuclear volume, the density of supposed glia (small TH- cells), and the amount of TUNEL staining were the same in summer compared with winter. This study provides the first evidence of an association between environmental stimuli (photoperiod) and the number of midbrain DA neurons in humans, and suggests DA neurotransmitter switching underlies this association.	[Aumann, Tim D.; Raabus, Mai; Tomas, Doris; Prijanto, Agustinus; Churilov, Leonid; Horne, Malcolm K.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Spitzer, Nicholas C.] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Spitzer, Nicholas C.] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Spitzer, Nicholas C.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Aumann, TD (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.	taumann@unimelb.edu.au	Horne, Malcolm/AAL-5214-2020	Horne, Malcolm/0000-0001-9427-2100; Spitzer, Nicholas/0000-0002-3523-1103	MRC; Brain Foundation of Australia, a Crowd-funding project [34732]; National Health and Medical Research Council (NHMRC) of Australia [1022839]; Victorian Government's Operational Infrastructure Support Grant	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Brain Foundation of Australia, a Crowd-funding project; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Grant	Thank you to the donors, families and MRC-funded Edinburgh University Brain Bank for supply of the brain tissue. This study was supported by the Brain Foundation of Australia, a Crowd-funding project hosted by Pozible (http://www.pozible.com/project/34732), and the National Health and Medical Research Council (NHMRC) of Australia (project 1022839). The Florey Institute of Neuroscience and Mental Health is supported by the Victorian Government's Operational Infrastructure Support Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thank you to the brain tissue donors and their families; and to Chris-Anne McKenzie and staff at the Medical Research Council (MRC)-funded Edinburgh University Brain Bank. This study was supported by the Brain Foundation of Australia, a Crowd-funding project hosted by Pozible (http://www.pozible.com/project/34732), and the National Health and Medical Research Council (NHMRC) of Australia (project 1022839). The Florey Institute of Neuroscience and Mental Health is supported by the Victorian Government's Operational Infrastructure Support Grant.	Aponso PM, 2008, NEUROSCIENCE, V151, P1142, DOI 10.1016/j.neuroscience.2007.11.036; Aumann TD, 2008, EXP NEUROL, V213, P419, DOI 10.1016/j.expneurol.2008.07.005; Aumann TD, 2013, BRAIN BEHAV, V3, P617, DOI 10.1002/brb3.163; Aumann TD, 2011, J NEUROCHEM, V116, P646, DOI 10.1111/j.1471-4159.2010.07151.x; BREWERTON TD, 1988, PSYCHIAT RES, V23, P257, DOI 10.1016/0165-1781(88)90016-9; Callaway EM, 2015, J NEUROSCI, V35, P8979, DOI 10.1523/JNEUROSCI.0409-15.2015; CARLSSON A, 1980, ACTA PSYCHIAT SCAND, V61, P75, DOI 10.1111/acps.1980.61.s280.75; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Cooper O, 2004, J NEUROSCI, V24, P8924, DOI 10.1523/JNEUROSCI.2344-04.2004; Deats SP, 2015, NEUROSCI LETT, V602, P17, DOI 10.1016/j.neulet.2015.06.038; Dulcis D, 2013, SCIENCE, V340, P449, DOI 10.1126/science.1234152; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Eisenberg DP, 2010, J NEUROSCI, V30, P14691, DOI 10.1523/JNEUROSCI.1953-10.2010; Frielingsdorf H, 2004, P NATL ACAD SCI USA, V101, P10177, DOI 10.1073/pnas.0401229101; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; HARTIKAINEN P, 1991, J NEURAL TRANSM-GEN, V84, P103, DOI 10.1007/BF01249114; Kaasinen V, 2012, NEUROSCI LETT, V530, P80, DOI 10.1016/j.neulet.2012.09.047; KARSON CN, 1984, PSYCHIAT RES, V11, P111, DOI 10.1016/0165-1781(84)90094-5; Lam RW, 2001, NEUROPSYCHOPHARMACOL, V25, pS97, DOI 10.1016/S0893-133X(01)00337-2; Lie DC, 2002, J NEUROSCI, V22, P6639; Neumeister A, 1998, ARCH GEN PSYCHIAT, V55, P524, DOI 10.1001/archpsyc.55.6.524; Neumeister A, 2001, INT J NEUROPSYCHOPH, V4, P409, DOI 10.1017/S1461145701002644; Neumeister A, 2001, PSYCHOL MED, V31, P1467, DOI 10.1017/S003329170105434z; Pail G, 2011, NEUROPSYCHOBIOLOGY, V64, P152, DOI 10.1159/000328950; Romeo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01395; Shan XY, 2006, STEM CELLS, V24, P1280, DOI 10.1634/stemcells.2005-0487; Spitzer NC, 2015, NEURON, V86, P1131, DOI 10.1016/j.neuron.2015.05.028; Tomas D, 2015, JOVE-J VIS EXP, DOI 10.3791/52329; Tsai HY, 2011, PROG NEURO-PSYCHOPH, V35, P107, DOI 10.1016/j.pnpbp.2010.09.014; WOLINSKY E, 1983, J NEUROSCI, V3, P1495; Yoshimi K, 2005, ANN NEUROL, V58, P31, DOI 10.1002/ana.20506; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	32	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158847	10.1371/journal.pone.0158847	http://dx.doi.org/10.1371/journal.pone.0158847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428306	Green Published, gold			2022-12-27	WOS:000380169300022
J	Hu, G; Feeley, KJ; Yu, MJ				Hu, Guang; Feeley, Kenneth J.; Yu, Mingjian			Habitat Fragmentation Drives Plant Community Assembly Processes across Life Stages	PLOS ONE			English	Article							PHYLOGENETIC SIGNAL; SPECIES-DIVERSITY; COEXISTENCE; RICHNESS; PATTERNS; ISLANDS; EVOLUTIONARY; MECHANISMS; DISPERSAL; MORTALITY	Habitat fragmentation is one of the principal causes of biodiversity loss and hence understanding its impacts on community assembly and disassembly is an important topic in ecology. We studied the relationships between fragmentation and community assembly processes in the land-bridge island system of Thousand Island Lake in East China. We focused on the changes in species diversity and phylogenetic diversity that occurred between life stages of woody plants growing on these islands. The observed diversities were compared with the expected diversities from random null models to characterize assembly processes. Regression tree analysis was used to illustrate the relationships between island attributes and community assembly processes. We found that different assembly processes predominate in the seedlings-to-saplings life-stage transition (SS) vs. the saplings-to-trees transition (ST). Island area was the main attribute driving the assembly process in SS. In ST, island isolation was more important. Within a fragmented landscape, the factors driving community assembly processes were found to differ between life stage transitions. Environmental filtering had a strong effect on the seedlings-to-saplings life-stage transition. Habitat isolation and dispersal limitation influenced all plant life stages, but had a weaker effect on communities than area. These findings add to our understanding of the processes driving community assembly and species coexistence in the context of pervasive and widespread habitat loss and fragmentation.	[Hu, Guang; Yu, Mingjian] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Hu, Guang] Zhejiang Sci Tech Univ, Sch Civil Engn & Architecture, Dept Landscape Architecture, Hangzhou, Zhejiang, Peoples R China; [Feeley, Kenneth J.] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL USA; [Feeley, Kenneth J.] Fairchild Trop Bot Garden, Ctr Trop Plant Conservat, Coral Gables, FL USA	Zhejiang University; Zhejiang Sci-Tech University; State University System of Florida; Florida International University	Yu, MJ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	fishmj202@hotmail.com	Hu, Guang/AAF-1689-2020	Feeley, Kenneth/0000-0002-3618-1144	National Natural Science Foundation of China [31361123001, 31200413, 31210103908]; China Postdoctoral Science Foundation [2012M521162]; National Science Foundation [DEB-1342751, DEB-1342757]; Zhejiang Postdoctoral Science Foundation [Bsh1201034]; Open Fund of Zhejiang Provincial Top Key Discipline of Biology; Science Foundation of Zhejiang Sci-Tech University [13052168-Y]; 521 Talent Project of Zhejiang Sci-Tech University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science Foundation(National Science Foundation (NSF)); Zhejiang Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Open Fund of Zhejiang Provincial Top Key Discipline of Biology; Science Foundation of Zhejiang Sci-Tech University(Zhejiang Sci-Tech University); 521 Talent Project of Zhejiang Sci-Tech University(Zhejiang Sci-Tech University)	This work was funded by the National Natural Science Foundation of China (31361123001, 31200413, 31210103908), http://www.nsfc.gov.cn; the China Postdoctoral Science Foundation (2012M521162), http://www.chinapostdoctor.org.cn; the National Science Foundation (DEB-1342751, DEB-1342757), http://www.nsf.gov; the Zhejiang Postdoctoral Science Foundation (Bsh1201034), http://www.zjhrss.gov.cn; the Open Fund of Zhejiang Provincial Top Key Discipline of Biology (no grant number), http://sky.zstu.edu.cn/; the Science Foundation of Zhejiang Sci-Tech University (13052168-Y), http://www.zstu.edu.cn/; and the 521 Talent Project of Zhejiang Sci-Tech University (no grant number), http://www.zstu.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Borges PAV, 2009, ACTA OECOL, V35, P149, DOI 10.1016/j.actao.2008.09.003; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; Condit R., 1998, FIELD GUIDE LARGE FO; CONNELL J H, 1971, P298; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dodd ME, 1999, EVOLUTION, V53, P732, DOI [10.2307/2640713, 10.1111/j.1558-5646.1999.tb05367.x]; Editorial committee of development of Xin'an River Xin'an River Development Corporation., 2009, DEV XIN RIV; Editorial Committee of Flora of Zhejiang, 1993, FLOR ZHEJ; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gonzalez MA, 2010, J ECOL, V98, P137, DOI 10.1111/j.1365-2745.2009.01607.x; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043894; Hu G, 2011, LANDSCAPE ECOL, V26, P1405, DOI 10.1007/s10980-011-9662-7; HUBBELL SP, 1990, PHILOS T R SOC B, V330, P269, DOI 10.1098/rstb.1990.0198; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kembel S. W., 2011, PICANTE R TOOLS INTE; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Levin S, 2009, PRINCETON GUIDE ECOL, P438; Lomolino MV, 2000, ECOLOGY, V81, P1517, DOI 10.2307/177303; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Luo ZR, 2012, OIKOS, V121, P1239, DOI 10.1111/j.1600-0706.2011.20079.x; McCallum H, 2002, P ROY SOC B-BIOL SCI, V269, P2041, DOI 10.1098/rspb.2002.2079; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; Nathan R, 2004, J ECOL, V92, P733, DOI 10.1111/j.0022-0477.2004.00914.x; Norden N, 2012, ECOLOGY, V93, pS70, DOI 10.1890/10-2179.1; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Paine CET, 2007, ECOLOGY, V88, P3076, DOI 10.1890/06-1835.1; Perdomo G, 2012, PHILOS T R SOC B, V367, P3042, DOI 10.1098/rstb.2012.0241; Pillon Y, 2006, BIOL CONSERV, V129, P4, DOI 10.1016/j.biocon.2005.06.036; Qian H, 2014, J SYST EVOL, V52, P423, DOI 10.1111/jse.12086; Regetz J, 2009, ECOPD ECOLOGICALLY I; RICKLEFS RE, 1992, AM NAT, V139, P1305, DOI 10.1086/285388; Stoll P, 2005, ECOLOGY, V86, P3048, DOI 10.1890/04-1540; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Therneau T.M., 2011, RPART RECURSIVE PART; Tilman D., 1982, Monographs in Population Biology, pi; Wang YP, 2011, J BIOGEOGR, V38, P1330, DOI 10.1111/j.1365-2699.2011.02502.x; Wang YP, 2010, DIVERS DISTRIB, V16, P862, DOI 10.1111/j.1472-4642.2010.00682.x; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; Webb CO, 2006, ECOLOGY, V87, pS123, DOI 10.1890/0012-9658(2006)87[123:PSMSSA]2.0.CO;2; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yang DS, 2009, HORTSCIENCE, V44, P1377, DOI 10.21273/HORTSCI.44.5.1377; Yeager LA, 2011, OECOLOGIA, V167, P157, DOI 10.1007/s00442-011-1959-3; Yu MJ, 2012, J BIOGEOGR, V39, P1124, DOI 10.1111/j.1365-2699.2011.02676.x; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872; Zhen C, 2005, KEYS SEED PLANTS ZHE; ZOBEL M, 1992, OIKOS, V65, P314, DOI 10.2307/3545024	64	10	14	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159572	10.1371/journal.pone.0159572	http://dx.doi.org/10.1371/journal.pone.0159572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427960	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169300077
J	Wen, YP; Pu, XY; Zheng, W; Hu, G				Wen, Yanping; Pu, Xiaoying; Zheng, Wei; Hu, Guang			High Prevalence of Plasmid-Mediated Quinolone Resistance and IncQ Plasmids Carrying qnrS2 Gene in Bacteria from Rivers near Hospitals and Aquaculture in China	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; AEROMONAS SPP.; WASTE-WATER; KLEBSIELLA-PNEUMONIAE; BETA-LACTAMASES; DETERMINANTS; FISH	Effluents from hospital and aquaculture are considered important sources of quinolone resistance. However, little information is available on the impact of this effluent on nearby rivers. In this study, 188 ciprofloxacin-resistant bacterial isolates obtained from rivers near hospitals and aquaculture were screened for plasmid-mediated quinolone resistance (PMQR) genes. Species identification, antibiotic susceptibility testing, and PMQR gene transferability assessment were conducted for PMQR-positive bacteria. Representative qnrS2-encoding plasmids were subsequently sequenced using a primer-walking approach. In total, 44 isolates (23.4%) were positive for qnr genes (16 qnrB2, 3 qnrS1, and 25 qnrS2) and 32 isolates (17.0%) were positive for aac(60)-Ib-cr. Other PMQR genes were not detected. The qnrB2 and aac(60)-Ib-cr genes had a higher prevalence in aquaculture samples than in hospital samples, and were significantly associated with Enterobacteriaceae (p < 0.05). In contrast, the prevalence of qnrS2 was not site-related, but was significantly associated with Aeromonas spp. (p < 0.05). All PMQR isolates were resistant to three or more classes of antibiotics. Eleven qnrS2-harboring plasmids from Aeromonas spp., including a novel conjugative plasmid pHP18, were selected for sequencing. These plasmids were small in size (6,388-16,197 bp) and belonged to the IncQ or IncU plasmid family, with qnrS2 being part of a mobile insertion cassette. Taken together, our findings suggest that aquaculture is a possible source for aac(60)-Ib-cr and qnrB2 dissemination, and demonstrate the ubiquity of qnrS2 in aquatic environments. Finally, Aeromonas spp. served as vectors for qnrS2 with the help of IncQ-type plasmids.	[Wen, Yanping; Pu, Xiaoying; Zheng, Wei] Hangzhou Ctr Dis Control & Prevent, Microbiol Lab, Hangzhou, Zhejiang, Peoples R China; [Hu, Guang] Zhejiang Sci Tech Univ, Sch Civil Engn & Architecture, Dept Landscape Architecture, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Hu, G (corresponding author), Zhejiang Sci Tech Univ, Sch Civil Engn & Architecture, Dept Landscape Architecture, Hangzhou, Zhejiang, Peoples R China.	hug163@163.com	Hu, Guang/AAF-1689-2020	Hu, Guang/0000-0002-4390-6166	Hangzhou Municipal Bureau of Science and Technology [20140733Q01]; Health and Family Planning Commission of Zhejiang Province [2015KYA190]; Science Foundation of Zhejiang Sci-Tech University [13052168-Y]; 521 Talent Project of Zhejiang Sci-Tech University	Hangzhou Municipal Bureau of Science and Technology; Health and Family Planning Commission of Zhejiang Province; Science Foundation of Zhejiang Sci-Tech University(Zhejiang Sci-Tech University); 521 Talent Project of Zhejiang Sci-Tech University(Zhejiang Sci-Tech University)	This work was supported by Hangzhou Municipal Bureau of Science and Technology (no. 20140733Q01, http://www.hzst.gov.cn/) and the Health and Family Planning Commission of Zhejiang Province (no. 2015KYA190, http://www.zjwst.gov.cn/). Yanping Wen received the funding mentioned above. Science Foundation of Zhejiang Sci-Tech University (no. 13052168-Y, http://www.zstu.edu.cn), 521 Talent Project of Zhejiang Sci-Tech University (http://www.zstu.edu.cn). Guang Hu received the funding mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P47, DOI 10.1093/jac/dkr457; Alouache S, 2014, MICROB DRUG RESIST, V20, P30, DOI 10.1089/mdr.2012.0264; Bonemann G, 2006, ANTIMICROB AGENTS CH, V50, P3075, DOI 10.1128/AAC.00378-06; Briales A, 2012, INT J ANTIMICROB AG, V39, P431, DOI 10.1016/j.ijantimicag.2011.12.009; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; Chandran SP, 2014, J APPL MICROBIOL, V117, P984, DOI 10.1111/jam.12591; Chen X, 2012, ANTIMICROB AGENTS CH, V56, P3423, DOI 10.1128/AAC.06191-11; Chenia HY, 2016, INT J FOOD MICROBIOL, V231, P26, DOI 10.1016/j.ijfoodmicro.2016.04.030; Cisar CR, 2014, WATER ENVIRON RES, V86, P835, DOI 10.2175/106143014X14062131177917; Devarajan N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149211; Dobiasova H, 2016, ANTIMICROB AGENTS CH, V60, P653, DOI 10.1128/AAC.01773-15; Figueira V, 2011, WATER RES, V45, P5599, DOI 10.1016/j.watres.2011.08.021; Fortini D, 2011, J ANTIMICROB CHEMOTH, V66, P1269, DOI 10.1093/jac/dkr085; Galvin S, 2010, APPL ENVIRON MICROB, V76, P4772, DOI 10.1128/AEM.02898-09; Han JE, 2012, LETT APPL MICROBIOL, V55, P290, DOI 10.1111/j.1472-765X.2012.03293.x; Han JE, 2012, LETT APPL MICROBIOL, V54, P374, DOI 10.1111/j.1472-765X.2012.03208.x; Harnisz M, 2015, CHEMOSPHERE, V128, P134, DOI 10.1016/j.chemosphere.2015.01.035; Heuer OE, 2009, CLIN INFECT DIS, V49, P1248, DOI 10.1086/605667; Huddleston JR, 2013, SYST APPL MICROBIOL, V36, P224, DOI 10.1016/j.syapm.2013.01.004; Ishida Y, 2010, J VET MED SCI, V72, P727, DOI 10.1292/jvms.09-0538; Ito H, 2004, PLASMID, V51, P41, DOI 10.1016/j.plasmid.2003.10.001; Jacoby GA, 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiolspec.PLAS-0006-2013, 10.1128/microbiolspec.PLAS-0006.2013]; Jiang HX, 2012, J ANTIMICROB CHEMOTH, V67, P2350, DOI 10.1093/jac/dks250; Khajanchi BK, 2010, APPL ENVIRON MICROB, V76, P2313, DOI 10.1128/AEM.02535-09; Kulinska A, 2008, APPL ENVIRON MICROB, V74, P4119, DOI 10.1128/AEM.00229-08; Liu BT, 2011, J ANTIMICROB CHEMOTH, V66, P1638, DOI 10.1093/jac/dkr172; Loftie-Eaton W, 2012, PLASMID, V67, P15, DOI 10.1016/j.plasmid.2011.10.001; Loftie-Eaton W, 2010, J BACTERIOL, V192, P6182, DOI 10.1128/JB.00176-10; Majumdar T, 2011, PLASMID, V66, P79, DOI 10.1016/j.plasmid.2011.05.001; Martinez-Murcia AJ, 2011, SYST APPL MICROBIOL, V34, P189, DOI 10.1016/j.syapm.2010.11.014; Meyer R, 2009, PLASMID, V62, P57, DOI 10.1016/j.plasmid.2009.05.001; Naas T, 2013, J ANTIMICROB CHEMOTH, V68, P1757, DOI 10.1093/jac/dkt094; Pablos M, 2010, EUR J CLIN MICROBIOL, V29, P1163, DOI 10.1007/s10096-010-0982-3; Picao RC, 2013, DIAGN MICR INFEC DIS, V76, P80, DOI 10.1016/j.diagmicrobio.2013.02.001; Pico RC, 2008, J ANTIMICROB CHEMOTH, V62, P948, DOI 10.1093/jac/dkn341; Poirel L, 2005, J ANTIMICROB CHEMOTH, V56, P1118, DOI 10.1093/jac/dki371; Poirel Laurent, 2005, Antimicrob Agents Chemother, V49, P3523, DOI 10.1128/AAC.49.8.3523-3525.2005; Poirel L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00024; Rodriguez-Mozaz S, 2015, WATER RES, V69, P234, DOI 10.1016/j.watres.2014.11.021; Sanchez-Cespedes J, 2008, ANTIMICROB AGENTS CH, V52, P2990, DOI 10.1128/AAC.00287-08; Seo MR, 2010, CHEMOTHERAPY, V56, P46, DOI 10.1159/000290972; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tello A, 2012, ENVIRON HEALTH PERSP, V120, P1100, DOI 10.1289/ehp.1104650; Varela AR, 2016, SCI TOTAL ENVIRON, V542, P665, DOI 10.1016/j.scitotenv.2015.10.124; Varela AR, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv015; Vredenburg J, 2014, ENVIRON MICROBIOL, V16, P995, DOI 10.1111/1462-2920.12231; Xia RR, 2013, MICROB DRUG RESIST, V19, P446, DOI 10.1089/mdr.2012.0210; Yang HY, 2013, INT J ANTIMICROB AG, V42, P173, DOI 10.1016/j.ijantimicag.2013.04.026; Zhang R, 2012, MICROBES ENVIRON, V27, P158, DOI 10.1264/jsme2.ME11308; Zhao JY, 2012, MICROB ECOL, V64, P187, DOI 10.1007/s00248-012-0008-z	51	27	27	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159418	10.1371/journal.pone.0159418	http://dx.doi.org/10.1371/journal.pone.0159418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427763	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300064
J	Thomas, M; Lemaitre, M; Wilson, ML; Viboud, C; Yordanov, Y; Wackernagel, H; Carrat, F				Thomas, Maud; Lemaitre, Magali; Wilson, Mark L.; Viboud, Cecile; Yordanov, Youri; Wackernagel, Hans; Carrat, Fabrice			Applications of Extreme Value Theory in Public Health	PLOS ONE			English	Article								Objectives We present how Extreme Value Theory (EVT) can be used in public health to predict future extreme events. Methods We applied EVT to weekly rates of Pneumonia and Influenza (P&I) deaths over 1979-2011. We further explored the daily number of emergency department visits in a network of 37 hospitals over 2004-2014. Maxima of grouped consecutive observations were fitted to a generalized extreme value distribution. The distribution was used to estimate the probability of extreme values in specified time periods. Results An annual P&I death rate of 12 per 100,000 (the highest maximum observed) should be exceeded once over the next 30 years and each year, there should be a 3% risk that the P&I death rate will exceed this value. Over the past 10 years, the observed maximum increase in the daily number of visits from the same weekday between two consecutive weeks was 1133. We estimated at 0.37% the probability of exceeding a daily increase of 1000 on each month. Conclusion The EVT method can be applied to various topics in epidemiology thus contributing to public health planning for extreme events.	[Thomas, Maud] Chalmers Univ Technol Goteborg, Dept Math Stat, Gothenburg, Sweden; [Lemaitre, Magali; Carrat, Fabrice] Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ,UMR S 11, F-75012 Paris, France; [Lemaitre, Magali; Viboud, Cecile] NIH, Fogarty Int Ctr, Washington, DC USA; [Wilson, Mark L.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Yordanov, Youri] Hop St Antoine, AP HP, Serv Urgences, Paris, France; [Wackernagel, Hans] PSL Res Univ, MINES ParisTech, Geostat Grp, Ctr Geosci, Fontainebleau, France; [Carrat, Fabrice] St Antoine Hosp, AP HP, Publ Hlth Unit, F-75012 Paris, France	Chalmers University of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Michigan System; University of Michigan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Carrat, F (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ,UMR S 11, F-75012 Paris, France.; Carrat, F (corresponding author), St Antoine Hosp, AP HP, Publ Hlth Unit, F-75012 Paris, France.	fabrice.carrat@iplesp.upmc.fr	Carrat, Fabrice/AAU-8480-2020	Carrat, Fabrice/0000-0002-8672-7918; Thomas, Maud/0000-0003-1369-055X				Chen JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118521; Coles S., 2001, INTRO STAT MODELING; de Haan L., 1990, STAT NEERL, V44, P45, DOI 10.1111j.1467-9574.1990.tb01526.x////; Embrechts P., 1997, MODELLING EXTREMAL E, DOI 10.1007/978-3-642-33483-2; Guillou A, 2014, STAT MED, V33, P5015, DOI 10.1002/sim.6275; Josseran L, 2006, Euro Surveill, V11, P11, DOI 10.2807/esm.11.12.00668-en; Katz RW, 2002, ADV WATER RESOUR, V25, P1287, DOI 10.1016/S0309-1708(02)00056-8; Khan AS, 2014, LANCET, V384, P93, DOI 10.1016/S0140-6736(14)60260-9; Lee H. C., 2007, EXTREME VALUES ANAL; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944	10	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0159312	10.1371/journal.pone.0159312	http://dx.doi.org/10.1371/journal.pone.0159312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR1JR	27419853	Green Published, Green Submitted, gold			2022-12-27	WOS:000379662300011
J	Al Dhaheri, AS; Mohamad, MN; Jarrar, AH; Ohuma, EO; Ismail, LC; Al Meqbaali, FT; Souka, U; Shah, SM				Al Dhaheri, Ayesha S.; Mohamad, Maysm N.; Jarrar, Amjad H.; Ohuma, Eric O.; Ismail, Leila Cheikh; Al Meqbaali, Fatima T.; Souka, Usama; Shah, Syed M.			A Cross-Sectional Study of the Prevalence of Metabolic Syndrome among Young Female Emirati Adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OBESITY; DIETARY; DISEASE; GENDER; FAT	Introduction Metabolic syndrome (MetS) is a growing problem in the United Arab Emirates (UAE). Moreover, the prevalence of overweight and obesity is rapidly increasing in the UAE especially among young females. However, few studies have evaluated the prevalence of MetS among young female adults in the UAE. This study determined the prevalence of MetS in Emirati females aged 17-25 years and its relation to overweight and obesity. Methods In total, 555 Emirati female college students were enrolled in a cross-sectional study, conducted during 2013-2014 at United Arab Emirates University in Al Ain, UAE. Anthropometric measurements, blood pressure and biochemical measurements were collected. MetS was defined according to the harmonised International Diabetes Federation criteria. Results Of the 555 participants enrolled, 23.1% were overweight and 10.4% were classified as obese. The overall prevalence of MetS was 6.8%. MetS prevalence was highest among obese participants (34.5%), as compared with normal-weight (1.7%) and overweight (10.1%) participants. MetS was significantly associated with overweight (adjusted odds ratio [aOR] = 3.8, 95% confidence interval [CI]; 1.15-12.52) and obesity (aOR = 11.2, 95% CI; 3.1-40.9), as compared with normal-weight. Waist-hip ratio >= 0.8 (aOR = 3.04, 95% CI; 1.10-8.44) was significantly associated with MetS, as compared with waist-hip ratio <0.8. The odds of MetS were 22 fold higher in participants with glycated haemoglobin (HbA1c) >= 6.5% (aOR = 22.5, 95% CI; 6.37-79.42) compared to HbA1c < 6.5%. This difference was 9 fold higher when HbA1c between 5.6%-6.4% was compared to HbA1c < 5.6% (aOR = 8.9, 95% CI; 3.4-23.5). Conclusion The prevalence of MetS among obese Emirati female students was significantly higher than overweight and normal weight students. The high prevalence of MetS highlights the importance of regular screening and intervention programmes targeting weight reduction.	[Al Dhaheri, Ayesha S.; Mohamad, Maysm N.; Jarrar, Amjad H.; Al Meqbaali, Fatima T.; Souka, Usama] United Arab Emirates Univ, Coll Food & Agr, Nutr & Hlth Dept, Al Ain, U Arab Emirates; [Ohuma, Eric O.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Ohuma, Eric O.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Ismail, Leila Cheikh] Univ Oxford, Green Templeton Coll, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Ismail, Leila Cheikh] Univ Oxford, Green Templeton Coll, Oxford Maternal & Perinatal Hlth Inst, Oxford, England; [Shah, Syed M.] United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates	United Arab Emirates University; University of Oxford; University of Oxford; University of Oxford; University of Oxford; United Arab Emirates University	Al Dhaheri, AS (corresponding author), United Arab Emirates Univ, Coll Food & Agr, Nutr & Hlth Dept, Al Ain, U Arab Emirates.	ayesha_aldhaheri@uaeu.ac.ae	Mohamad, Maysm N./AAG-4203-2020; Mohamad, Maysm/W-4573-2019	Mohamad, Maysm N./0000-0002-6396-6625; Jarrar, Amjad/0000-0001-7185-6330; AL DHAHERI, AYESHA/0000-0002-7634-3531; Cheikh Ismail, Leila/0000-0003-3048-7481	United Arab Emirates University [CFA-31F038]	United Arab Emirates University	This study was supported by a research start-up grant from the United Arab Emirates University (CFA-31F038) and was given to ASA. The funding agent had no role with the study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.uaeu.ac.ae/en/; This study was supported by a research start-up grant from the United Arab Emirates University (CFA-31F038). The authors wish to thank Ms. Rahla Daneshi, Mr. Noura Alneyadi, Ms. Sara Alyousefi, Ms. Abeer Alwahedi, Ms. Moza Alkaabi, Ms. Haneen Ateya and Mr. Asma Numan for their help in recruiting study participants. We thank all UAEU female students who participated in this study.	Abolfotouh MA, 2012, INTERNATIONAL JOURNA, V2012; Ahmed HM, 2012, AM J CARDIOL, V109, P288, DOI 10.1016/j.amjcard.2011.08.042; Al-Daghri NM, 2010, EUR J CLIN INVEST, V40, P1063, DOI 10.1111/j.1365-2362.2010.02341.x; Al-Daghri NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012159; Al-Isa A, 2010, BRIT J NUTR, V103, P77, DOI 10.1017/S0007114509991425; Al-Kaabi Juma, 2009, Rev Diabet Stud, V6, P271, DOI 10.1900/RDS.2009.6.271; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alharbi NS, 2014, DIABETES RES CLIN PR, V106, pE30, DOI 10.1016/j.diabres.2014.08.019; ALNohair S, 2014, INT J HEALTH SCI-IJH, V8, P79, DOI 10.12816/0006074; Aounallah-Skhiri H, 2015, OBESITY FACTS S1, V8; Bhalavi Vijay, 2015, Indian J Community Med, V40, P43, DOI 10.4103/0970-0218.149270; Bowling JL, 2010, LABMEDICINE, V41, P398, DOI 10.1309/LM6T8D1LKQXVNCAC; de Freitas RWF, 2013, J CLIN NURS, V22, P1291, DOI 10.1111/jocn.12015; de Vries P.G., 1986, SAMPLING THEORY FORE, P31, DOI DOI 10.1007/978-3-642-71581-5_2; DIMAGNO EP, 1989, MAYO CLIN PROC, V64, P1226, DOI 10.1016/S0025-6196(12)61285-3; dong-il Kim, 2012, Journal of Obesity & Metabolic Syndrome, V21, P99, DOI 10.7570/kjo.2012.21.2.99; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Eapen V, 2010, J TROP PEDIATRICS, V56, P325, DOI 10.1093/tropej/fmp128; El Assaad MA, 2002, BLOOD PRESS MONIT, V7, P237, DOI 10.1097/00126097-200208000-00006; Elmagd MA, 2015, INT J PHYS ED SPORTS, V2, P92; Fernandes J, 2011, J AM COLL HEALTH, V59, P313, DOI 10.1080/07448481.2010.508084; Gibson RS, 2005, PRINCIPLES NUTR ASSE, P233; Gonzalez-Jimenez E, 2015, EUR J NUTR, V54, P589, DOI 10.1007/s00394-014-0740-x; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317; Jain J, 2015, J DIABETES METAB, V6, DOI 10.4172/2155-6156.1000503; Kant AK, 2015, INT J OBESITY, V39, P820, DOI 10.1038/ijo.2014.183; LOHMAN TG, 1981, HUM BIOL, V53, P181; Mabry RM, 2010, DIABETIC MED, V27, P593, DOI 10.1111/j.1464-5491.2010.02998.x; Malik Mahdi, 2008, Metabolic Syndrome and Related Disorders, V6, P177, DOI 10.1089/met.2008.0006; Mehairi AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056159; Musaiger AO, 2014, ENVIRON HEALTH PREV, V19, P207, DOI 10.1007/s12199-013-0377-z; Musaiger AO, 2014, APPETITE, V73, P197, DOI 10.1016/j.appet.2013.11.002; Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135; Organization WH, 2011, WAIST CIRCUMFERENCE; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Selmi S, 2015, AVICENNA, DOI 10.5339/avi.2015.2; Smitha F, 2011, INDIAN J PHARM PRACT, V4; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Subhedar R, 2014, INT J PHYSIOTHER RES, V2, P824, DOI DOI 10.16965/IJPR.2014.700; VANDERKOOY K, 1993, INT J OBESITY, V17, P187; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, WHO TECH REP SER, V959, P1; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Xu YQ, 2008, ACTA PAEDIATR, V97, P348, DOI 10.1111/j.1651-2227.2008.00665.x	46	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159378	10.1371/journal.pone.0159378	http://dx.doi.org/10.1371/journal.pone.0159378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414402	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500124
J	Brown, JL; Paris, S; Prado-Oviedo, NA; Meehan, CL; Hogan, JN; Morfeld, KA; Carlstead, K				Brown, Janine L.; Paris, Stephen; Prado-Oviedo, Natalia A.; Meehan, Cheryl L.; Hogan, Jennifer N.; Morfeld, Kari A.; Carlstead, Kathy			Reproductive Health Assessment of Female Elephants in North American Zoos and Association of Husbandry Practices with Reproductive Dysfunction in African Elephants (Loxodonta africana)	PLOS ONE			English	Article							POSTREPRODUCTIVE LIFE-SPAN; OVARIAN ACYCLICITY; ESTROUS-CYCLE; ENVIRONMENTAL ENRICHMENT; ASIAN ELEPHANTS; SOCIAL BONDS; HYPERPROLACTINEMIA; PROLACTIN; VARIABILITY; MAXIMUS	As part of a multi-institutional study of zoo elephant welfare, we evaluated female elephants managed by zoos accredited by the Association of Zoos and Aquariums and applied epidemiological methods to determine what factors in the zoo environment are associated with reproductive problems, including ovarian acyclicity and hyperprolactinemia. Bi-weekly blood samples were collected from 95 African (Loxodonta africana) and 75 Asian (Elephas maximus) (8-55 years of age) elephants over a 12-month period for analysis of serum progestogens and prolactin. Females were categorized as normal cycling (regular 13- to 17-week cycles), irregular cycling (cycles longer or shorter than normal) or acyclic (baseline progestogens, < 0.1 ng/ml throughout), and having Low/Normal (< 14 or 18 ng/ml) or High (>= 14 or 18 ng/ml) prolactin for Asian and African elephants, respectively. Rates of normal cycling, acyclicity and irregular cycling were 73.2, 22.5 and 4.2% for Asian, and 48.4, 37.9 and 13.7% for African elephants, respectively, all of which differed between species (P < 0.05). For African elephants, univariate assessment found that social isolation decreased and higher enrichment diversity increased the chance a female would cycle normally. The strongest multi-variable models included Age (positive) and Enrichment Diversity (negative) as important factors of acyclicity among African elephants. The Asian elephant data set was not robust enough to support multi-variable analyses of cyclicity status. Additionally, only 3% of Asian elephants were found to be hyperprolactinemic as compared to 28% of Africans, so predictive analyses of prolactin status were conducted on African elephants only. The strongest multi-variable model included Age (positive), Enrichment Diversity (negative), Alternate Feeding Methods (negative) and Social Group Contact (positive) as predictors of hyperprolactinemia. In summary, the incidence of ovarian cycle problems and hyperprolactinemia predominantly affects African elephants, and increases in social stability and feeding and enrichment diversity may have positive influences on hormone status.	[Brown, Janine L.; Paris, Stephen; Prado-Oviedo, Natalia A.; Morfeld, Kari A.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA; [Morfeld, Kari A.] Lincoln Childrens Zoo, Lincoln, NE USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Brown, JL (corresponding author), Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA.	brownjan@si.edu			Institute of Museum and Library Services [LG-25-10-0033-10]; Smithsonian National Zoological Park; Lincoln Children's Zoo; Honolulu Zoo; IMLS; AWARE Institute	Institute of Museum and Library Services; Smithsonian National Zoological Park(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Lincoln Children's Zoo; Honolulu Zoo; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. Employers provided financial support in the form of authors' salaries as follows: Smithsonian National Zoological Park (JLB, SP, NP-O, KM); Lincoln Children's Zoo (KM); Honolulu Zoo (KC). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2003, P R SOC LOND, V273, P513; ARON DC, 1995, WESTERN J MED, V162, P340; ASSIES J, 1992, PSYCHONEUROENDOCRINO, V17, P673, DOI 10.1016/0306-4530(92)90026-4; Bachelot A, 2007, REPRODUCTION, V133, P361, DOI 10.1530/REP-06-0299; Birkett PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038363; Brown JL, 2014, ADV EXP MED BIOL, V753, P135, DOI 10.1007/978-1-4939-0820-2_8; Brown JL, 1997, ZOO BIOL, V16, P149, DOI 10.1002/(SICI)1098-2361(1997)16:2<149::AID-ZOO5>3.0.CO;2-A; Brown JL, 1999, BIOL REPROD, V61, P1294, DOI 10.1095/biolreprod61.5.1294; BROWN JL, 1991, J ZOO WILDLIFE MED, V22, P49; Brown JL, 2000, ZOO BIOL, V19, P347, DOI 10.1002/1098-2361(2000)19:5&lt;347::AID-ZOO6&gt;3.0.CO;2-V; Brown JL, 1995, ZOO BIOL, V14, P555, DOI 10.1002/zoo.1430140608; Brown JL, 2004, GEN COMP ENDOCR, V136, P360, DOI 10.1016/j.ygcen.2004.01.013; Cacioppo JT, 2011, ANN NY ACAD SCI, V1231, P17, DOI 10.1111/j.1749-6632.2011.06028.x; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Capitanio JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110307; Capitanio JP, 2011, AM J PRIMATOL, V73, P507, DOI 10.1002/ajp.20870; CARLSTEAD K, 1994, ZOO BIOL, V13, P447, DOI 10.1002/zoo.1430130507; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Carlstead K, 2009, ZOO BIOL, V28, P589, DOI 10.1002/zoo.20289; Chamaille-Jammes S, 2008, J ANIM ECOL, V77, P135, DOI 10.1111/j.1365-2656.2007.01307.x; Chelini MOM, 2011, PHYSIOL BEHAV, V104, P948, DOI 10.1016/j.physbeh.2011.06.006; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; Cohen J., 2003, APPL MULTIPLE REGRES; Deis RP, 1989, J ENDOCRINOL, V110, P423; Dow TL, 2012, REPROD FERT DEVELOP, V24, P1019, DOI 10.1071/RD11302; Dow TL, 2011, ZOO BIOL, V30, P699, DOI 10.1002/zoo.20377; Dow TL, 2011, THERIOGENOLOGY, V75, P620, DOI 10.1016/j.theriogenology.2010.10.002; DRENT RH, 1980, ARDEA, V68, P225; Fanson KV, 2013, ANIM WELFARE, V22, P159, DOI 10.7120/09627286.22.2.159; Faust L., 2011, TECHNICAL REPORT ZOO; Fraser D, 2003, ANIM WELFARE, V12, P433; Frasor J, 2003, TRENDS ENDOCRIN MET, V14, P118, DOI 10.1016/S1043-2760(03)00030-4; Freeman EW, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot025; Freeman EW, 2011, BIOL CONSERV, V144, P2105, DOI 10.1016/j.biocon.2011.04.033; Freeman EW, 2009, AFR J ECOL, V47, P192, DOI 10.1111/j.1365-2028.2008.00957.x; Freeman EW, 2009, ZOO BIOL, V28, P1, DOI 10.1002/zoo.20187; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Garstang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108736; Gaskill BN, 2013, APPL ANIM BEHAV SCI, V143, P110, DOI 10.1016/j.applanim.2012.10.009; Glaeser SS, 2012, THERIOGENOLOGY, V78, P285, DOI 10.1016/j.theriogenology.2012.01.014; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; GOSDEN RG, 1987, HUM REPROD, V2, P617, DOI 10.1093/oxfordjournals.humrep.a136601; Gouveia A, 2004, BEHAV PROCESS, V67, P167, DOI 10.1016/j.beproc.2004.03.018; Greco BJ, 2016, PLOS ONE; Grynnerup AGA, 2012, ACTA OBSTET GYN SCAN, V91, P1252, DOI 10.1111/j.1600-0412.2012.01471.x; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Lahdenpera M, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0054-0; Marcondes FK, 2001, PHYSIOL BEHAV, V74, P435, DOI 10.1016/S0031-9384(01)00593-5; Matteri RL, 2000, BIOLOGY OF ANIMAL STRESS, P43, DOI 10.1079/9780851993591.0043; Meagher RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110589; Meehan CL, 2016, PLOS ONE; Mellen J, 2005, ZOO BIOL, V10, P95; Mellen J.D., 1998, 2 NATURE ENV ENRICHM, P329; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Morfeld KA, 2014, J ZOO WILDLIFE MED, V45, P569, DOI 10.1638/2013-0254R.1; Mouttham LL, 2011, ANIM REPROD SCI, V126, P115, DOI 10.1016/j.anireprosci.2011.04.006; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Nimon AJ, 2001, ANIM WELFARE, V10, P223; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; PIANKA ER, 1976, AM ZOOL, V16, P775; Prado-Oviedo NA, 2016, PLOS ONE; Prado-Oviedo NA, 2013, GEN COMP ENDOCR, V189, P7, DOI 10.1016/j.ygcen.2013.03.035; Proctor CM, 2010, ZOO BIOL, V29, P127, DOI 10.1002/zoo.20238; Rico C, 2009, BIOL REPROD, V80, P50, DOI 10.1095/biolreprod.108.072157; Roelfsema F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031305; Schuff KG, 2002, J CLIN INVEST, V110, P973, DOI 10.1172/JCI200215912; Serri O, 2003, CAN MED ASSOC J, V169, P575; Shepherdson D., 1994, P167; Shepherdson D.J., 1999, J ELEPHANT MANAGERS, V10, P69; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; SOBRINHO LG, 1984, OBSTET GYNECOL, V64, P465; Sobrinho Luis Goncalves, 2003, Pituitary, V6, P35, DOI 10.1023/A:1026229810876; Sonino N, 2004, EUR J ENDOCRINOL, V151, P61, DOI 10.1530/eje.0.1510061; Stansfield FJ, 2013, REPROD FERT DEVELOP, V25, P1165, DOI 10.1071/RD12296; Stoinski TS, 2000, ZOO BIOL, V19, P485, DOI 10.1002/1098-2361(2000)19:6&lt;485::AID-ZOO1&gt;3.0.CO;2-5; Torner L, 2002, STRESS, V5, P249, DOI 10.1080/1025389021000048638; Torre Daria La, 2007, Ther Clin Risk Manag, V3, P929; Vance EA, 2009, COMPUT MATH ORGAN TH, V15, P273, DOI 10.1007/s10588-008-9045-z; Wang C., 1981, DYNAMICS OVARIAN FUN, P61; Whitaker J, 2009, LAB ANIMAL, V38, P24, DOI 10.1038/laban0109-24; Wiedenmayer C, 1998, APPL ANIM BEHAV SCI, V56, P77, DOI 10.1016/S0168-1591(97)00091-9; Wielebnowski N, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P130; Wielebnowski NC, 2002, ZOO BIOL, V21, P77, DOI 10.1002/zoo.10005; Wielebnowski NC, 2002, ANIM CONSERV, V5, P291, DOI 10.1017/S1367943002004043; Wittemyer G, 2007, HORM BEHAV, V51, P346, DOI 10.1016/j.yhbeh.2006.12.013; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Yamamoto Y, 2010, J VET MED SCI, V72, P845, DOI 10.1292/jvms.09-0480; YUEN BH, 1992, CAN FAM PHYSICIAN, V38, P367; Zacur H.A., 1999, ENCY REPROD, V2, P725	92	35	37	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0145673	10.1371/journal.pone.0145673	http://dx.doi.org/10.1371/journal.pone.0145673			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416141	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500002
J	Fundament, T; Eldridge, PR; Green, AL; Whone, AL; Taylor, RS; Williams, AC; Schuepbach, WMM				Fundament, Tomasz; Eldridge, Paul R.; Green, Alexander L.; Whone, Alan L.; Taylor, Rod S.; Williams, Adrian C.; Schuepbach, W. M. Michael			Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; CARBIDOPA INTESTINAL GEL; OPEN-LABEL EXTENSION; 5-YEAR FOLLOW-UP; LONG-TERM; SUBTHALAMIC NUCLEUS; NONMOTOR SYMPTOMS; LEVODOPA INFUSION; ECONOMIC-IMPACT; MEDICAL THERAPY	Background Parkinson's disease (PD) is a debilitating illness associated with considerable impairment of quality of life and substantial costs to health care systems. Deep brain stimulation (DBS) is an established surgical treatment option for some patients with advanced PD. The EARLYSTIM trial has recently demonstrated its clinical benefit also in patients with early motor complications. We sought to evaluate the cost-effectiveness of DBS, compared to best medical therapy (BMT), among PD patients with early onset of motor complications, from a United Kingdom (UK) payer perspective. Methods We developed a Markov model to represent the progression of PD as rated using the Unified Parkinson's Disease Rating Scale (UPDRS) over time in patients with early PD. Evidence sources were a systematic review of clinical evidence; data from the EARLYSTIM study; and a UK Clinical Practice Research Datalink (CPRD) dataset including DBS patients. A mapping algorithm was developed to generate utility values based on UPDRS data for each intervention. The cost-effectiveness was expressed as the incremental cost per quality-adjusted life-year (QALY). One-way and probabilistic sensitivity analyses were undertaken to explore the effect of parameter uncertainty. Results Over a 15-year time horizon, DBS was predicted to lead to additional mean cost per patient of 26,799 pound compared with BMT (73,077 pound/patient versus 46,278 pound/patient) and an additional mean 1.35 QALYs (6.69 QALYs versus 5.35 QALYs), resulting in an incremental cost-effectiveness ratio of 19,887 pound per QALY gained with a 99% probability of DBS being cost-effective at a threshold of 30,000 pound/QALY. One-way sensitivity analyses suggested that the results were not significantly impacted by plausible changes in the input parameter values. Conclusion These results indicate that DBS is a cost-effective intervention in PD patients with early motor complications when compared with existing interventions, offering additional health benefits at acceptable incremental cost. This supports the extended use of DBS among patients with early onset of motor complications.	[Fundament, Tomasz] HTA Consulting, Krakow, Poland; [Eldridge, Paul R.] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England; [Eldridge, Paul R.] Univ Liverpool, Liverpool, Merseyside, England; [Green, Alexander L.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Whone, Alan L.] Southmead Hosp, Bristol Brain Ctr, Bristol, Avon, England; [Taylor, Rod S.] Univ Exeter, Sch Med, Exeter, Devon, England; [Williams, Adrian C.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Schuepbach, W. M. Michael] Univ Hosp Bern, Dept Neurol, Movement Disorders Ctr, Bern, Switzerland; [Schuepbach, W. M. Michael] Univ Bern, Bern, Switzerland; [Schuepbach, W. M. Michael] Univ Paris 06, AP HP, Ctr Invest Clin 9503, Inst Cerveau & Moelle Epiniere,Dept Neurol, Paris, France; [Schuepbach, W. M. Michael] CHU Pitie Salpetriere, INSERM, Paris, France	Walton Centre; University of Liverpool; University of Oxford; Southmead Hospital; University of Exeter; University of Birmingham; University of Bern; University Hospital of Bern; University of Bern; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Green, AL (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Oxford, England.	alex.green@nds.ox.ac.uk	Taylor, Rod/R-9581-2019; Whone, Alan/AAZ-4125-2020	Taylor, Rod/0000-0002-3043-6011; Whone, Alan/0000-0002-8931-4422	Medtronic; HTA Consulting; National Institute for Health Research [NF-SI-0514-10155] Funding Source: researchfish	Medtronic(Medtronic); HTA Consulting; National Institute for Health Research(National Institute for Health Research (NIHR))	Medtronic funded the development of the model, including consulting fees to physicians and health economic specialists, sponsored a medical writer and reviewed the manuscript. The funders provided input on the study design, decision to publish, and preparation of the manuscript. HTA Consulting provided support in the form of salaries for authors [TF], and staff resources to support evidence review and synthesis. They did not have any additional role in the study design and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alves G, 2005, NEUROLOGY, V65, P1436, DOI 10.1212/01.wnl.0000183359.50822.f2; [Anonymous], 2010, MEDTRONIC NEUROMODUL; Antonini A, 2008, NEURODEGENER DIS, V5, P244, DOI 10.1159/000113714; Antonini A, 2013, J NEURAL TRANSM, V120, P1553, DOI 10.1007/s00702-013-1026-9; Antonini A, 2015, PARKINSONISM RELAT D, V21, P231, DOI 10.1016/j.parkreldis.2014.12.012; Ashburn A, 2001, COMMUNITY DWELLING S, P277; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; British Medical Association and Royal Pharmaceutical Society of Great Britain, 2015, BRIT NATL FORMULARY; Brooks DJ, 2008, J NEURAL TRANSM, V115, P843, DOI 10.1007/s00702-008-0025-8; Caceres-Redondo MT, 2014, J NEUROL, V261, P561, DOI 10.1007/s00415-013-7235-1; Caro JJ, 2012, VALUE HEALTH, V15, P796, DOI 10.1016/j.jval.2012.06.012; Cheng KY, 2014, PARKINSONISM RELAT D, V20, P88, DOI 10.1016/j.parkreldis.2013.09.024; Contreras A, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/362572; Dams J, 2013, MOVEMENT DISORD, V28, P763, DOI 10.1002/mds.25407; Dams J, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-35; Dengler I, 2006, NERVENARZT, V77, P1204, DOI 10.1007/s00115-006-2150-7; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Dodel RC, 1998, PHARMACOECONOMICS, V14, P299, DOI 10.2165/00019053-199814030-00006; Drapier S, 2012, PARKINSONISM RELAT D, V18, P40, DOI 10.1016/j.parkreldis.2011.08.010; Duarte J, 2013, ACTA NEUROL SCAND, V127, P295, DOI 10.1111/ane.12003; Eggington S, 2013, 33 HLTH EC C SPAN HL; Eggington S, 2014, J NEUROL, V261, P106, DOI 10.1007/s00415-013-7148-z; Fasano A, 2010, BRAIN, V133, P2664, DOI 10.1093/brain/awq221; Fernandez HH, 2015, MOVEMENT DISORD, V30, P500, DOI 10.1002/mds.26123; Findley L, 2003, MOVEMENT DISORD, V18, P1139, DOI 10.1002/mds.10507; Forsaa EB, 2010, NEUROLOGY, V75, P1270, DOI 10.1212/WNL.0b013e3181f61311; Gazibara T, 2015, GERIATR GERONTOL INT, V15, P472, DOI 10.1111/ggi.12300; Gervais-Bernard H, 2009, J NEUROL, V256, P225, DOI 10.1007/s00415-009-0076-2; Hagell P, 2002, MOVEMENT DISORD, V17, P1213, DOI 10.1002/mds.10262; Honig H, 2009, MOVEMENT DISORD, V24, P1468, DOI 10.1002/mds.22596; Horstink M, 2006, EUR J NEUROL, V13, P1170, DOI 10.1111/j.1468-1331.2006.01547.x; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Kadastik-Eerme L, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0281-x; Karlsborg M, 2010, DAN MED BULL, V57; Kataoka H, 2011, EUR NEUROL, V66, P298, DOI 10.1159/000331635; Kent S, 2015, MED DECIS MAKING, P1; Keranen T, 2003, PARKINSONISM RELAT D, V9, P163, DOI 10.1016/S1353-8020(02)00097-4; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Kind P, 1999, WORKING PAPERS; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Latt MD, 2009, MOVEMENT DISORD, V24, P1280, DOI 10.1002/mds.22561; Leibson CL, 2006, MOVEMENT DISORD, V21, P446, DOI 10.1002/mds.20685; LeWitt PA, 2013, J NEURAL TRANSM, V120, P1069, DOI 10.1007/s00702-012-0925-5; Lindholm B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117018; Macleod AD, 2014, MOVEMENT DISORD, V29, P1615, DOI 10.1002/mds.25898; Marras C, 2005, NEUROLOGY, V64, P87, DOI 10.1212/01.WNL.0000148603.44618.19; Marras C, 2008, MOVEMENT DISORD, V23, P653, DOI 10.1002/mds.21853; Martinez-Martin P, 2014, EUR J NEUROL, V21, P519, DOI 10.1111/ene.12349; Martinez-Martin P, 2014, MODERN MICROSCOPY, P1; Matinolli M, 2011, ACTA NEUROL SCAND, V123, P193, DOI 10.1111/j.1600-0404.2010.01386.x; Maurel F, 2001, REV NEUROL-FRANCE, V157, P507; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; McCrone P, 2007, MOVEMENT DISORD, V22, P804, DOI 10.1002/mds.21360; McIntosh E, 2016, MOVEMENT DISORDERS O; Merola A, 2016, PARKINSONISM RELATED; Moro E, 2010, MOVEMENT DISORD, V25, P578, DOI 10.1002/mds.22735; Murphy A, 2013, EC EVALUATIONS HLTH; National Collaborating Centre for Chronic Conditions, 2006, PARK DIS NAT CLIN GU; National Institute for Health and Care Excellence, GUID METH TECHN APPR; National Institute for Health and Care Excellence, 2006, PARK DIS 20S DIAGN M; National Institute of Neurological Disorders and Stroke, 2011, WHAT IS PARK DIS; NHS England, 2015, NAT TAR PAYM SYST 20; Office for National Statistics, NAT LIF TABL UK; Olanow CW, 2014, LANCET NEUROL, V13, P141, DOI 10.1016/S1474-4422(13)70293-X; Ontario Medical Advisory Secretariat, 2005, DEEP BRAIN STIM PARK; Palhagen SE, 2012, ACTA NEUROL SCAND, V126, pe29, DOI 10.1111/j.1600-0404.2012.01689.x; Parashos SA, 2013, J PARKINSON DIS, V3, P515, DOI 10.3233/JPD-130249; Pechevis M, 2005, EUR J NEUROL, V12, P956, DOI 10.1111/j.1468-1331.2005.01096.x; Peretz C, 2014, PARKINSONISM RELAT D, V20, P69, DOI 10.1016/j.parkreldis.2013.09.020; Personal Social Services Research Unit (PSSRU), 2017, UNIT COSTS HLTH SOCI; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Quittenbam BH, 2004, PARKINSONISM RELAT D, V10, P129, DOI 10.1016/j.parkreldis.2003.12.001; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; Reinoso G, 2015, EUR J NEUROL, V22, P457, DOI 10.1111/ene.12476; Riazi A, 2003, J NEUROL NEUROSUR PS, V74, P710, DOI 10.1136/jnnp.74.6.710; Riedel O, 2008, J NEUROL, V255, P255, DOI 10.1007/s00415-008-0720-2; Rudzinska M, 2013, NEUROL NEUROCHIR POL, V47, P431, DOI 10.5114/ninp.2013.38223; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Schrag A, 2003, MOVEMENT DISORD, V18, P1250, DOI 10.1002/mds.10527; Schrag A, 2006, MOVEMENT DISORD, V21, P1839, DOI 10.1002/mds.21030; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Schupbach WMM, 2007, NEUROLOGY, V68, P267, DOI 10.1212/01.wnl.0000250253.03919.fb; Schupbach WMM, 2005, J NEUROL NEUROSUR PS, V76, P1640, DOI 10.1136/jnnp.2005.063206; Sensi M, 2014, J NEURAL TRANSM, V121, P633, DOI 10.1007/s00702-013-1153-3; Siebert U, 2012, VALUE HEALTH, V15, P812, DOI 10.1016/j.jval.2012.06.014; Skorvanek M, 2012, PARKINSONISM RELA S1, V18, pS21; Slevin JT, 2015, J PARKINSON DIS, V5, P165, DOI 10.3233/JPD-140456; SocialStyrelsen, 2016, NAT RIKTL VARD VID M; Spottke AE, 2005, PHARMACOECONOMICS, V23, P817, DOI 10.2165/00019053-200523080-00007; Valldeoriola F, 2007, MOVEMENT DISORD, V22, P2183, DOI 10.1002/mds.21652; Valldeoriola Francesc, 2013, J Med Econ, V16, P191, DOI 10.3111/13696998.2012.737392; Visser M, 2008, J NEUROL, V255, P1580, DOI 10.1007/s00415-008-0994-4; Voss TS, 2012, PARKINSONISM RELAT D, V18, P837, DOI 10.1016/j.parkreldis.2012.04.004; Vossius C, 2006, ACTA NEUROL SCAND, V113, P228, DOI 10.1111/j.1600-0404.2005.00574.x; Walleser Autiero S, 2014, INT SOC PHARMACOECON; Weaver F, 2009, AM MED; Weir S, 2016, INTERNAL REPORT; Wider C, 2008, PARKINSONISM RELAT D, V14, P114, DOI 10.1016/j.parkreldis.2007.06.012; Wielinski CL, 2005, MOVEMENT DISORD, V20, P410, DOI 10.1002/mds.20347; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4; Williams-Gray CH, 2013, J NEUROL NEUROSUR PS, V84, P1258, DOI 10.1136/jnnp-2013-305277; Winter Y, 2010, PARKINSONISM RELAT D, V16, P243, DOI 10.1016/j.parkreldis.2009.11.012; Wood BH, 2002, J NEUROL NEUROSUR PS, V72, P721, DOI 10.1136/jnnp.72.6.721; Woodford H, 2005, MOVEMENT DISORD, V20, P1104, DOI 10.1002/mds.20485; Zibetti M, 2011, MOVEMENT DISORD, V26, P2327, DOI 10.1002/mds.23903	105	19	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159340	10.1371/journal.pone.0159340	http://dx.doi.org/10.1371/journal.pone.0159340			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441637	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500056
J	Iqbal, ZM; Akbar, H; Hosseini, A; Forteguerri, EBR; Osorio, JS; Loor, JJ				Iqbal, Zeeshan Muhammad; Akbar, Haji; Hosseini, Afshin; Forteguerri, Elena Bichi Ruspoli; Osorio, Johan S.; Loor, Juan J.			Digital Cushion Fatty Acid Composition and Lipid Metabolism Gene Network Expression in Holstein Dairy Cows Fed a High-Energy Diet	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; MAMMARY EPITHELIAL-CELLS; TRANSCRIPTIONAL REGULATION; BOVINE CLAW; PREPARTUM; PERFORMANCE; LACTATION; NUTRITION; PERIOD; MEAL	The hoof digital cushion is a complex structure composed of adipose tissue beneath the distal phalanx, i.e. axial, middle and abaxial fat pad. The major role of these fat depots is dampening compression of the corium underneath the cushion. The study aimed to determine expression of target genes and fatty acid profiles in the hoof of non-pregnant dry Holstein cows fed low (CON) or high-energy (OVE) diets. The middle fat pad of the hoof digital cushion was collected soon after slaughter. Despite the lack of effect on expression of the transcription regulators SREBF1 and PPARG, the expression of the lipogenic enzymes ACACA, FASN, SCD, and DGAT2 was upregulated with OVE. Along with the upregulation of G6PD and IDH1, important for NADPH synthesis during lipogenesis, and the basal glucose transporter SLC2A1, these data indicated a pro-lipogenic response in the digital cushion with OVE. The expression of the lipid droplet-associated protein PLIN2 was upregulated while expression of lipolytic enzymes (ATGL, ABDH5, and LIPE) only tended to be upregulated with OVE. Therefore, OVE induced lipogenesis, lipid droplet formation, and lipolysis, albeit to different extents. Although concentration of monounsaturated fatty acids (MUFA) did not differ, among the polyunsaturated fatty acids (PUFA), the concentration of 20:5n3 was lower with OVE. Among the saturated fatty acids, 20:0 concentration was greater with OVE. Although data indicated that the hoof digital cushion metabolic transcriptome is responsive to higher-energy diets, this did not translate into marked differences in the fatty acid composition. The decrease in concentration of PUFA, which could contribute to synthesis of inflammatory molecules, in OVE-fed cows indicated that feeding higher-energy diets might be detrimental for the mediation of inflammation in digital cushion. This effect could be further exacerbated by physiologic and endocrine changes during the peripartal period that favor inflammation.	[Iqbal, Zeeshan Muhammad; Hosseini, Afshin; Loor, Juan J.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Iqbal, Zeeshan Muhammad; Hosseini, Afshin; Loor, Juan J.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Akbar, Haji] COMSATS Inst Informat Technol, Dept Biosci, Islamabad 44000, Pakistan; [Forteguerri, Elena Bichi Ruspoli] Univ Illinois, Vet Clin Med, Urbana, IL 61801 USA; [Osorio, Johan S.] South Dakota State Univ, Dept Dairy Sci, Brookings, SD 57007 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; COMSATS University Islamabad (CUI); University of Illinois System; University of Illinois Urbana-Champaign; South Dakota State University	Loor, JJ (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.; Loor, JJ (corresponding author), Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.; Osorio, JS (corresponding author), South Dakota State Univ, Dept Dairy Sci, Brookings, SD 57007 USA.	johan.osorio@sdstate.edu; jloor@illinois.edu	Osorio, Johan/J-3703-2019; Loor, Juan J./H-3760-2012	Osorio, Johan/0000-0001-6192-0917; Loor, Juan J./0000-0003-1586-4365	National Institute of Food and Agriculture (NIFA, Washington, DC) [ILLU-538-914]; University of Illinois Research Board	National Institute of Food and Agriculture (NIFA, Washington, DC); University of Illinois Research Board	The National Institute of Food and Agriculture (NIFA, Washington, DC; project ILLU-538-914) provided funds for the gene expression work, and the University of Illinois Research Board funded the animal study.	BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; Bauman DE, 2003, ANNU REV NUTR, V23, P203, DOI 10.1146/annurev.nutr.23.011702.073408; BIONAZ M, 2013, PPAR RES, DOI DOI 10.1155/2013/684159; Dann HM, 2006, J DAIRY SCI, V89, P3563, DOI 10.3168/jds.S0022-0302(06)72396-7; del Rincon JP, 2007, DIABETES, V56, P1638, DOI 10.2337/db06-0299; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; GREENOUGH PR, 1991, VET REC, V128, P11, DOI 10.1136/vr.128.1.11; Harvatine KJ, 2009, ANIMAL, V3, P40, DOI 10.1017/S1751731108003133; Hosseini A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142633; Janovick NA, 2011, J DAIRY SCI, V94, P1385, DOI 10.3168/jds.2010-3303; Ji P, 2012, J DAIRY SCI, V95, P4333, DOI 10.3168/jds.2011-5079; Kadegowda AKG, 2009, J DAIRY SCI, V92, P4276, DOI 10.3168/jds.2008-1932; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Koltes DA, 2011, J DAIRY SCI, V94, P1839, DOI 10.3168/jds.2010-3769; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Linden TC, 2009, J DAIRY SCI, V92, P2580, DOI [10.3168/jds.2008-1603, 10.3168/jds.2008-1827]; Ma L, 2012, J DAIRY SCI, V95, P3743, DOI 10.3168/jds.2011-5083; Mandell IB, 1997, J ANIM SCI, V75, P910; McNamara JP, 1995, J DAIRY SCI, V78, P2782, DOI 10.3168/jds.S0022-0302(95)76909-0; Moisa SJ, 2013, GENE REGUL SYST BIO, V7, P71, DOI 10.4137/GRSB.S11783; Laparra JM, 2015, BRIT J NUTR, V114, P1395, DOI 10.1017/S0007114515003153; Obert JC, 2007, J AGR FOOD CHEM, V55, P2062, DOI 10.1021/jf0617871; Ortinau Laura C, 2012, ISRN Endocrinol, V2012, P947323, DOI 10.5402/2012/947323; Raber M, 2004, VET J, V167, P258, DOI 10.1016/S1090-0233(03)00053-4; Raber M, 2006, VET J, V172, P173, DOI 10.1016/j.tvjl.2005.03.009; Rhoads RP, 2007, J ENDOCRINOL, V195, P49, DOI 10.1677/JOE-07-0068; Szefel J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/690692; Thering BJ, 2009, J DAIRY SCI, V92, P4290, DOI 10.3168/jds.2008-2000; Tomlinson DJ, 2004, J DAIRY SCI, V87, P797, DOI 10.3168/jds.S0022-0302(04)73223-3; Vailati-Riboni M, 2016, J DAIRY SCI, V99, P758, DOI 10.3168/jds.2015-10046; Vermunt JJ, 2007, VET J, V174, P219, DOI 10.1016/j.tvjl.2006.10.006; Weber M, 2016, J DAIRY SCI, V99, P1549, DOI 10.3168/jds.2015-10131; Yang A, 1999, LIPIDS, V34, P971, DOI 10.1007/s11745-999-0447-8; Yang G, 2012, J DAIRY SCI, V95, P5821, DOI 10.3168/jds.2011-4893	35	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159536	10.1371/journal.pone.0159536	http://dx.doi.org/10.1371/journal.pone.0159536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441691	gold, Green Published, Green Submitted			2022-12-27	WOS:000380797500090
J	Alhassan, RK; Nketiah-Amponsah, E; Spieker, N; Arhinful, DK; de Wit, TFR				Alhassan, Robert Kaba; Nketiah-Amponsah, Edward; Spieker, Nicole; Arhinful, Daniel Kojo; de Wit, Tobias F. Rinke			Assessing the Impact of Community Engagement Interventions on Health Worker Motivation and Experiences with Clients in Primary Health Facilities in Ghana: A Randomized Cluster Trial	PLOS ONE			English	Article							CARE QUALITY; SERVICES; PROGRAM; PERFORMANCE; RETENTION; MOZAMBIQUE; SECTOR; REGION; TRUST	Background Health worker density per 1000 population in Ghana is one of the lowest in the world estimated to be 2.3, below the global average of 9.3. Low health worker motivation induced by poor working conditions partly explain this challenge. Albeit the wage bill for public sector health workers is about 90% of domestic government expenditure on health in countries such as Ghana, staff motivation and performance output remain a challenge, suggesting the need to complement financial incentives with non-financial incentives through a community-based approach. In this study, a systematic community engagement (SCE) intervention was implemented to engage community groups in healthcare quality assessment to promote mutual collaboration between clients and healthcare providers, and enhance health worker motivation levels. SCE involves structured use of existing community groups and associations to assess healthcare quality in health facilities. Identified quality gaps are discussed with healthcare providers, improvements made and rewards given to best performing facilities for closing quality care gaps. Purpose To evaluate the effect of SCE interventions on health worker motivation and experiences with clients. Methods The study is a cluster randomized trial involving health workers in private (n = 38) and public (n = 26) primary healthcare facilities in two administrative regions in Ghana. Out of 324 clinical and non-clinical staff randomly interviewed at baseline, 234 (72%) were successfully followed at end-line and interviewed on workplace motivation factors and personal experiences with clients. Propensity score matching and difference-in-difference estimations were used to estimate treatment effect of the interventions on staff motivation. Results Intrinsic (non-financial) work incentives including cordiality with clients and perceived career prospects appeared to be prime sources of motivation for health staff interviewed in intervention health facilities while financial incentives were ranked lowest. Intervention health facilities that were assessed by female community groups (Coef. = 0.2720, p = 0.0118) and informal groups with organized leadership structures like Artisans (Coef. = 0.2268, p = 0.0368) associated positively with higher intrinsic motivation levels of staff. Conclusion Community-based approach to health worker motivation is a potential complementary strategy that needs policy deliberation to explore its prospects. Albeit financial incentives remain critical sources of staff motivation, innovative non-financial approaches like SCE should complement the latter.	[Alhassan, Robert Kaba] Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Alhassan, Robert Kaba; Arhinful, Daniel Kojo] Univ Ghana, Noguchi Mem Inst Med Res, Dept Epidemiol, Legon, Ghana; [Nketiah-Amponsah, Edward] Univ Ghana, Dept Econ, Legon, Ghana; [Spieker, Nicole; de Wit, Tobias F. Rinke] PharmAccess Fdn, Amsterdam, Netherlands	University of Amsterdam; University of Ghana; University of Ghana	Alhassan, RK (corresponding author), Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands.; Alhassan, RK (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Epidemiol, Legon, Ghana.	arkabason@gmail.com	Nketiah-Amponsah, Edward/S-9239-2019	Alhassan, Robert Kaba/0000-0003-4227-4854; Nketiah-Amponsah, Edward/0000-0002-9754-1983	Netherlands government through the Ministry of Foreign Affairs; Science for Global Development (WOTRO), Netherlands Organisation for Scientific Research (NWO); W07.45.104.00; Science for Global Development (WOTRO), Netherlands Organisation for Scientific Research (NWO), under the Global Health Policy and Systems Research (GHPHSR) programme [W07.45.104.00]; Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana Legon	Netherlands government through the Ministry of Foreign Affairs; Science for Global Development (WOTRO), Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); W07.45.104.00; Science for Global Development (WOTRO), Netherlands Organisation for Scientific Research (NWO), under the Global Health Policy and Systems Research (GHPHSR) programme; Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana Legon	The baseline data collection, design and implementation of interventions and follow-up surveys were funded by The Netherlands government through the Ministry of Foreign Affairs and the Science for Global Development (WOTRO) which is a division of the Netherlands Organisation for Scientific Research (NWO). The funding was given to carry out a four year randomized control trial in 64 primary healthcare facilities in two regions in Ghana. Local collaborating institution in Ghana is the Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana. The project funding number is: W07.45.104.00. Funders' website: www.nwo.nl/wotro.; This study was conducted with the financial support of The Netherlands government through the Ministry Foreign Affairs and the Science for Global Development (WOTRO) which is a division of the Netherlands Organisation for Scientific Research (NWO), under the Global Health Policy and Systems Research (GHPHSR) programme (Funding/grant number: W07.45.104.00). Funding recipient: Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana Legon.	Abbey M, 2014, INT HEALTH, V6, P99, DOI 10.1093/inthealth/ihu007; Agyepong IA, 2004, INT J HEALTH PLAN M, V19, P319, DOI 10.1002/hpm.770; Agyepong IA, 2014, HEALTH RES POLICY SY, V12, P1; Akobeng AK, 2005, ARCH DIS CHILD, V90, P840, DOI 10.1136/adc.2004.058222; Alhassan RK, 2015, PLOS ONE, V19, P1; Alhassan RK, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1438-y; Alhassan RK, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-37; [Anonymous], 2010, REP SEND GHAN BAL AC; [Anonymous], STATA TECHNICAL B; Antwi J, 2012, 69107 INT BANK REC D; Atinga RA, 2013, INT J SOC ECON, V40, P852, DOI 10.1108/IJSE-2011-0075; Audet CM, 2012, AJAR-AFR J AIDS RES, V11, P327, DOI 10.2989/16085906.2012.754832; Awoonor-Williams JK, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S3; Baatiema L, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-233; Bennett S, 1999, 1 ABT ASS INC PARTN; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Brugha R, 2015, INT J HEALTH POLICY, V4, P333, DOI 10.15171/ijhpm.2015.103; Buor D, 2004, HEALTH POLICY, V69, P375, DOI 10.1016/j.healthpol.2004.01.004; Caliendo M, 2005, 1588 U COL; Dil Y, 2012, J COMMUN HEALTH, V37, P1192, DOI 10.1007/s10900-012-9569-5; Dynes MM, 2014, J MIDWIFERY WOM HEAL, V59, pS32, DOI 10.1111/jmwh.12135; Frank T, 2012, LEARNING PAPERS SERI; Ghana Health Workers Observatory (GHWO), 2011, HUM RES HLTH COUNTR; Greenspan JA, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-52; Hernandez P, 2006, MEASURING EXPENDITUR; Jex M, 2015, ORG PSYCHOL SCI PRAC; Johnson JC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-300; Kallander K, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0657-6; Karakas B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126501; Kok MC, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0001-3; Kwansah J, 2012, HLTH POLICY PLANNING, V27, P1; Leuven E., 2003, STAT SOFTWARE COMPON; Lori JR, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-17; Manongi Rachel N, 2006, Hum Resour Health, V4, P6, DOI 10.1186/1478-4491-4-6; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Morgan MA., 2006, COMMUNITY ENGAGEMENT; National Health Insurance Authority (NHIA), 2012, ANN REPORT; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Okello DRO, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0007-5; Phillips JF, 2005, WORKING PAPER; Sakeah E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-340; Silvestri DM, 2014, B WORLD HEALTH ORGAN, V92, P750, DOI 10.2471/BLT.14.136051; Strachan DL, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0020-8; Takasugi T, 2012, PUBLIC HEALTH, V126, P839, DOI 10.1016/j.puhe.2012.06.005; Tindana PO, 2011, AM J PUBLIC HEALTH, V101, P1857, DOI 10.2105/AJPH.2011.300203; Turkson P K, 2009, Ghana Med J, V43, P65; UNDP Ghana/NDPC/GOG, 2012, UNDP GHAN NDPC GOG 2; Villa J., 2016, STAT SOFTWARE COMPON; WHO, 2006, WORK TOG HLTH WORLD; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; World Health Organization (WHO)/ Global Health Workforce Alliance (GHWA), 2007, COUNTR CAS STUD GHAN; World Health Organization (WHO)/ Global Health Workforce Alliance (GHWA), 2014, GLOB MESS	52	32	32	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158541	10.1371/journal.pone.0158541	http://dx.doi.org/10.1371/journal.pone.0158541			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27439012	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100012
J	Chen, YK; Wang, K; King, M; He, J; Ding, JX; Shi, Q; Wang, CJ; Li, PF				Chen, Yikai; Wang, Kai; King, Mark; He, Jie; Ding, Jianxun; Shi, Qin; Wang, Changjun; Li, Pingfan			Differences in Factors Affecting Various Crash Types with High Numbers of Fatalities and Injuries in China	PLOS ONE			English	Article							2-LANE RURAL ROADS; TRAFFIC ACCIDENTS; MODELS; SEVERITY; URBAN; TIME; FREEWAYS; INTERSECTIONS; MANAGEMENT; COLLISIONS	Objectives Road traffic crashes that involve very high numbers of fatalities and injuries arouse public concern wherever they occur. In China, there are two categories of such crashes: a crash that results in 10-30 fatalities, 50-100 serious injuries or a total cost of 50-100 million RMB ($US8-16m) is a "serious road traffic crash" (SRTC), while a crash that is even more severe or costly is a "particularly serious road traffic crash" (PSRTC). The aim of this study is to identify the main factors affecting different types of these crashes (single-vehicle, head-on, rear-end and side impact) with the ultimate goal of informing prevention activities and policies. Methods Detailed descriptions of the SRTCs and PSRTCs that occurred from 2007 to 2014 were collected from the database "In-depth Investigation and Analysis System for Major Road Traffic Crashes" (IIASMRTC), which is maintained by the Traffic Management Research Institute of the Ministry of Public Security of China (TMRI). 18 main risk factors, which were categorized into four areas (participant, vehicle, road and environment-related) were chosen as potential independent variables for the multinomial logistic regression analysis. Comparisons were made among the single-vehicle, head-on, rear-end and side impact crashes in terms of factors affecting crash occurrence. Findings Five risk factors were significant for the six multinomial logistic regression models, which were location, vertical alignment, roadside safety rating, driver distraction and overloading of cargo. It was indicated that intersections were more likely to have side impact SRTCs and PSRTCs, especially with poor visibility at night. Overloaded freight vehicles were more likely to be involved in a rear-end crash than other freight vehicles. Driver distraction is an important risk factor for head-on crashes, while vertical alignment and roadside safety rating are positively associated with single-vehicle crashes. Conclusion Based on the findings, promising measures were proposed to prevent each type of SRTC and PSRTC, which governmental or regulatory agencies could employ to plan strategies to reduce SRTCs and PSRTCs and support lifesaving policies.	[Chen, Yikai; Wang, Kai; Ding, Jianxun; Shi, Qin] Hefei Univ Technol, Sch Automot & Transportat Engn, Hefei, Anhui, Peoples R China; [Chen, Yikai; Wang, Changjun; Li, Pingfan] Minist Publ Secur, Traff Management Res Inst, Wuxi, Jiangsu, Peoples R China; [King, Mark] Queensland Univ Technol, Ctr Accid Res & Rd Safety Queensland, Brisbane, Qld, Australia; [He, Jie] Southeast Univ, Sch Transportat, Nanjing, Jiangsu, Peoples R China	Hefei University of Technology; Ministry of Public Security (China); Queensland University of Technology (QUT); Southeast University - China	Chen, YK (corresponding author), Hefei Univ Technol, Sch Automot & Transportat Engn, Hefei, Anhui, Peoples R China.; Chen, YK (corresponding author), Minist Publ Secur, Traff Management Res Inst, Wuxi, Jiangsu, Peoples R China.	yikaichen@hfut.edu.cn	King, Mark Johann/I-9852-2012; Ding, Jianxun/A-6155-2013; Chen, Yikai/U-4663-2019	King, Mark Johann/0000-0001-9895-7297; Ding, Jianxun/0000-0002-5232-8863; Chen, Yikai/0000-0002-3802-1144; chen, yi kai/0000-0002-4737-4371	National Natural Science Foundation of China [51305117]; Specialized Research Fund for the Doctoral Program of Higher Education [20130111120031, 20120092110044]; China Postdoctoral Science Foundation [2013M530230, 2014T70464]; Qing Lan Project of Jiangsu Province; key scientific and technical problems of Henan Province [152102310255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Qing Lan Project of Jiangsu Province; key scientific and technical problems of Henan Province	This work was supported by the National Natural Science Foundation of China, Grant No. 51305117 (http://www.nsfc.gov.cn/) to YKC, The Specialized Research Fund for the Doctoral Program of Higher Education, Grant No. 20130111120031 (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm) to YKC, The Specialized Research Fund for the Doctoral Program of Higher Education, Grant No. 20120092110044 (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm) to JH, China Postdoctoral Science Foundation, Grant Nos. 2013M530230 and 2014T70464 (http://jj.chinapostdoctor.org.cn/V1/Program2/Default.aspx) to YKC, The Qing Lan Project of Jiangsu Province (http://www.ec.js.edu.cn/) to JH and The 2015 key scientific and technical problems of Henan Province, Grant No. 152102310255 (http://www.hnkjt.gov.cn/) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab HT, 2001, TRANSPORT RES REC, P6, DOI 10.3141/1746-02; Amoros E, 2011, REPORTING SERIOUS RO; Basyouny K E, 2014, TRANSPORT RES REC, V2432, P65, DOI [10.3141/2432-08, DOI 10.3141/2432-08]; Belcher M., 2015, PRACTICAL ROAD SAFET; Bham GH, 2012, J TRANSP ENG, V138, P786, DOI 10.1061/(ASCE)TE.1943-5436.0000370; Chang LY, 2005, J SAFETY RES, V36, P365, DOI 10.1016/j.jsr.2005.06.013; Choi S, 2014, TRAFFIC INJ PREV, V15, P73, DOI 10.1080/15389588.2013.778989; Gauthier TD, 2001, ENVIRON FORENSICS, V2, P359, DOI 10.1006/enfo.2001.0061; Golob TF, 2004, TRANSPORT RES A-POL, V38, P53, DOI 10.1016/j.tra.2003.08.002; Haque M. M., 2010, TRANSPORT RES REC, V2194, P82, DOI DOI 10.3141/2194-10; Hossain M., 2010, 89 ANN M TRANSP RES; Jia J., 2014, STATISTICS-ABINGDON, VSix, P239; Jiang XM, 2013, TRAFFIC INJ PREV, V14, P544, DOI 10.1080/15389588.2012.731547; Jiang XG, 2015, TRAFFIC INJ PREV, V16, P289, DOI 10.1080/15389588.2014.936012; Jiang XG, 2010, ACCIDENT ANAL PREV, V42, P1352, DOI 10.1016/j.aap.2010.02.016; Kim DG, 2007, ACCIDENT ANAL PREV, V39, P125, DOI 10.1016/j.aap.2006.06.011; Larsen L, 2004, J HAZARD MATER, V111, P115, DOI 10.1016/j.jhazmat.2004.02.019; Neyens DM, 2007, ACCIDENT ANAL PREV, V39, P206, DOI 10.1016/j.aap.2006.07.004; Peng YC, 2012, TRANSPORT RES REC, P21, DOI 10.3141/2309-03; Qin X, 2006, ACCIDENT ANAL PREV, V38, P1071, DOI 10.1016/j.aap.2006.04.012; La QN, 2013, ACCIDENT ANAL PREV, V50, P451, DOI 10.1016/j.aap.2012.05.022; Rengarasu TM, 2009, TRANSPORT RES REC, P34, DOI 10.3141/2102-05; Schwab J. A, 2002, MULTINOMIAL LOGISTIC; Shariat-Mohaymany A, 2011, TRAFFIC INJ PREV, V12, P636, DOI 10.1080/15389588.2011.621472; Sonawane DB, 2011, INT J AUTO TECH-KOR, V12, P697, DOI 10.1007/s12239-011-0081-1; Starkweather J, MULTINOMIAL LOGISTIC; Sullivan EC, 2005, TRANSPORT RES REC, P114, DOI 10.3141/1908-14; Theofilatos A, 2012, TRAFFIC INJ PREV, V13, P458, DOI 10.1080/15389588.2012.661110; Traffic Management Bureau of Ministry of Public Security of China, 2007, ROAD TRAFF CRASH STA; Tulu GS, 2015, ACCIDENT ANAL PREV, V78, P118, DOI 10.1016/j.aap.2015.02.011; Wang YG, 2015, CENT EUR J PUBL HEAL, V23, P77, DOI 10.21101/cejph.a3931; World Health Organisation, 2018, NONC DIS COUNTR PROF; Xu CC, 2013, ACCIDENT ANAL PREV, V57, P30, DOI 10.1016/j.aap.2013.03.035; Yu RJ, 2014, IEEE T INTELL TRANSP, V15, P205, DOI 10.1109/TITS.2013.2276089; Yu RJ, 2013, ACCIDENT ANAL PREV, V50, P371, DOI 10.1016/j.aap.2012.05.011; Zhang WT, 2013, ADV COURSE STAT ANAL; Zhang XJ, 2013, IRAN J PUBLIC HEALTH, V42, P7; Zhu H, 2010, TRANSPORT RES REC, P88, DOI 10.3141/2147-11	38	8	8	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158559	10.1371/journal.pone.0158559	http://dx.doi.org/10.1371/journal.pone.0158559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27439113	Green Submitted, Green Published, gold			2022-12-27	WOS:000380170100013
J	Ippolito, JE; Brandenburg, MW; Ge, X; Crowley, JR; Kirmess, KM; Som, A; D'Avignon, DA; Arbeit, JM; Achilefu, S; Yarasheski, KE; Milbrandt, J				Ippolito, Joseph E.; Brandenburg, Matthew W.; Ge, Xia; Crowley, Jan R.; Kirmess, Kristopher M.; Som, Avik; D'Avignon, D. Andre; Arbeit, Jeffrey M.; Achilefu, Samuel; Yarasheski, Kevin E.; Milbrandt, Jeffrey			Extracellular pH Modulates Neuroendocrine Prostate Cancer Cell Metabolism and Susceptibility to the Mitochondrial Inhibitor Niclosamide	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BREAST-CANCER; ACIDIC PH; ACQUIRED-RESISTANCE; TUMOR-GROWTH; MICROENVIRONMENT; DIFFERENTIATION; EXPRESSION; METFORMIN; ONCOGENE	Neuroendocrine prostate cancer is a lethal variant of prostate cancer that is associated with castrate-resistant growth, metastasis, and mortality. The tumor environment of neuroendocrine prostate cancer is heterogeneous and characterized by hypoxia, necrosis, and numerous mitoses. Although acidic extracellular pH has been implicated in aggressive cancer features including metastasis and therapeutic resistance, its role in neuroendocrine prostate cancer physiology and metabolism has not yet been explored. We used the well-characterized PNEC cell line as a model to establish the effects of extracellular pH (pH 6.5, 7.4, and 8.5) on neuroendocrine prostate cancer cell metabolism. We discovered that alkalinization of extracellular pH converted cellular metabolism to a nutrient consumption-dependent state that was susceptible to glucose deprivation, glutamine deprivation, and 2-deoxyglucose (2-DG) mediated inhibition of glycolysis. Conversely, acidic pH shifted cellular metabolism toward an oxidative phosphorylation (OXPHOS)-dependent state that was susceptible to OXPHOS inhibition. Based upon this mechanistic knowledge of pH-dependent metabolism, we identified that the FDA-approved anti-helminthic niclosamide depolarized mitochondrial potential and depleted ATP levels in PNEC cells whose effects were enhanced in acidic pH. To further establish relevance of these findings, we tested the effects of extracellular pH on susceptibility to nutrient deprivation and OXPHOS inhibition in a cohort of castrate-resistant prostate cancer cell lines C4-2B, PC-3, and PC-3M. We discovered similar pH-dependent toxicity profiles among all cell lines with these treatments. These findings underscore a potential importance to acidic extracellular pH in the modulation of cell metabolism in tumors and development of an emerging paradigm that exploits the synergy of environment and therapeutic efficacy in cancer.	[Ippolito, Joseph E.; Brandenburg, Matthew W.; Ge, Xia; Som, Avik; Achilefu, Samuel] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA; [Ippolito, Joseph E.; Brandenburg, Matthew W.; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Crowley, Jan R.; Kirmess, Kristopher M.; Yarasheski, Kevin E.] Washington Univ, Biomed Mass Spectrometry Resource, Sch Med, St Louis, MO 63130 USA; [D'Avignon, D. Andre] Sanford Burnham Prebys Med Discovery Inst, Orlando, FL USA; [Arbeit, Jeffrey M.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Sanford Burnham Prebys Medical Discovery Institute; Washington University (WUSTL)	Ippolito, JE (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA.; Ippolito, JE (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	ippolitoj@wustl.edu	Yarasheski, Kevin/AAC-7450-2021; Achilefu, Samuel/AAC-2401-2019; Arbeit, Jeffrey/K-6920-2019	Yarasheski, Kevin/0000-0001-5436-2451; Achilefu, Samuel/0000-0002-3133-6717; Milbrandt, Jeffrey/0000-0002-5477-7689	Radiological Society of North America [RSD1345]; Prostate Cancer Foundation; NIH [P41-GM103422, P30-DK056341, P30-DK020579]; NATIONAL CANCER INSTITUTE [F30CA189435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK020579] Funding Source: NIH RePORTER	Radiological Society of North America; Prostate Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by a grant from the Radiological Society of North America (RSD1345; http://www.rsna.org), a Young Investigator Award from the Prostate Cancer Foundation (http://www.pcf.org), and NIH grants P41-GM103422, P30-DK056341, and P30-DK020579. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; Bailey KM, 2012, ADV PHARMACOL, V65, P63, DOI 10.1016/B978-0-12-397927-8.00004-X; Beltran H, 2014, CLIN CANCER RES, V20, P2846, DOI 10.1158/1078-0432.CCR-13-3309; Bental M, 1994, NMR PHYSL BIOMEDICIN; Blair H. C., 2007, V45, P539; Circu ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151718; Circu ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146931; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; De Luca A, 2015, ONCOTARGET, V6, P14777, DOI 10.18632/oncotarget.4401; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeLellis R A, 2001, Am J Clin Pathol, V115 Suppl, pS5; Denise C, 2015, ONCOTARGET, V6, P41706, DOI 10.18632/oncotarget.5991; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Epstein JI, 2014, AM J SURG PATHOL, V38, P756, DOI 10.1097/PAS.0000000000000208; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gillies Robert J, 2012, Eur J Radiol, V81 Suppl 1, pS48, DOI 10.1016/S0720-048X(12)70018-9; Goncalves RBR, 2002, MOL CELL BIOCHEM, V241, P69, DOI 10.1023/A:1020874626923; Hashim AI, 2011, CLIN EXP METASTAS, V28, P841, DOI 10.1007/s10585-011-9415-7; Hashim AI, 2011, NMR BIOMED, V24, P582, DOI 10.1002/nbm.1644; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Hu Y, 2004, P NATL ACAD SCI USA, V101, P5559, DOI 10.1073/pnas.0306988101; Ibrahim-Hashim A, 2012, J UROLOGY, V188, P624, DOI 10.1016/j.juro.2012.03.113; Ippolito JE, 2005, P NATL ACAD SCI USA, V102, P9901, DOI 10.1073/pnas.0500756102; Ippolito JE, 2006, P NATL ACAD SCI USA, V103, P12505, DOI 10.1073/pnas.0605207103; Ippolito JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088667; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Ismail AHR, 2002, PROSTATE, V51, P117, DOI 10.1002/pros.10066; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976; Kennedy KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075154; Khacho M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4550; Khanim FL, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.38; Lee JK, 2016, CANCER CELL, V29, P536, DOI 10.1016/j.ccell.2016.03.001; Leotlela PD, 2003, ENDOCR-RELAT CANCER, V10, P437, DOI 10.1677/erc.0.0100437; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; Li YH, 2014, CANCER LETT, V349, P8, DOI 10.1016/j.canlet.2014.04.003; Li ZG, 2013, INT J MOL SCI, V14, P20236, DOI 10.3390/ijms141020236; Liu C, 2016, ONCOTARGET; Marini C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19569; Mark R, 2000, AM J CLIN PATHOL, V113, P331; Martin NK, 2011, MATH BIOSCI, V230, P1, DOI 10.1016/j.mbs.2010.12.002; Menendez JA, 2005, J CELL BIOCHEM, V94, P1, DOI 10.1002/jcb.20310; Moellering RE, 2008, CLIN EXP METASTAS, V25, P411, DOI 10.1007/s10585-008-9145-7; Oliveras-Ferraros C, 2014, CELL CYCLE, V13, P1132, DOI 10.4161/cc.27982; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Pilon-Thomas S, 2016, CANCER RES, V76, P1381, DOI 10.1158/0008-5472.CAN-15-1743; Robey IF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-235; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; ROSS MH, 1951, J BIOL CHEM, V192, P561; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Scherbakov AM, 2016, IUBMB LIFE, V68, P281, DOI 10.1002/iub.1481; Schornack PA, 2003, NEOPLASIA, V5, P135, DOI 10.1016/S1476-5586(03)80005-2; Som A, 2015, NANOSCALE; Som A, 2016, NANOSCALE, V8, P12639, DOI 10.1039/c5nr06162h; Taniguchi K, 2016, BIOCHEM BIOPH RES CO, V473, P174, DOI 10.1016/j.bbrc.2016.03.074; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Tessem MB, 2008, MAGN RESON MED, V60, P510, DOI 10.1002/mrm.21694; Thews O, 2006, NEOPLASIA, V8, P143, DOI 10.1593/neo.05697; TISCHLER AS, 1977, NEW ENGL J MED, V296, P919; Vander Heiden MG, 1999, MOL CELL, V3, P159; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wafa LA, 2007, HUM PATHOL, V38, P161, DOI 10.1016/j.humpath.2006.07.003; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Wick MR, 2000, AM J CLIN PATHOL, V113, P331, DOI 10.1309/ETJ3-QBUK-13QD-J8FP; WICK MR, 2002, CURR DIAGN PATHOL, V8, P102, DOI DOI 10.1054/CDIP.2001.0102; Wojtkowiak JW, 2012, AUTOPHAGY, V8, P1688, DOI 10.4161/auto.21501; Wojtkowiak JW, 2012, CANCER RES, V72, P3938, DOI 10.1158/0008-5472.CAN-11-3881; Wojtkowiak JW, 2011, MOL PHARMACEUT, V8, P2032, DOI 10.1021/mp200292c; Yao CH, 2016, CELL CHEM BIOL, V23, P483, DOI 10.1016/j.chembiol.2016.03.007; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043	78	29	29	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159675	10.1371/journal.pone.0159675	http://dx.doi.org/10.1371/journal.pone.0159675			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438712	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100064
J	Li, C; Chen, ZX; Yang, H; Luo, FB; Chen, LH; Cai, HW; Li, YJ; You, GY; Long, D; Li, SF; Zhang, QP; Rao, L				Li, Chen; Chen, Zhongxiu; Yang, Hao; Luo, Fangbo; Chen, Lihong; Cai, Huawei; Li, Yajiao; You, Guiying; Long, Dan; Li, Shengfu; Zhang, Qiuping; Rao, Li			Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK Pathway	PLOS ONE			English	Article							MEK INHIBITOR SELUMETINIB; LAMIN A/C GENE; PHASE-II; SIGNALING PATHWAYS; SKELETAL-MUSCLE; KINASE; ARRY-142886; MELANOMA; SURVIVAL; MUTATION	Aims Although extracellular-regulated kinases (ERK) are a well-known central mediator in cardiac hypertrophy, no clinically available ERK antagonist has been tested for preventing cardiac hypertrophy. Selumetinib is a novel oral MEK inhibitor that is currently under Phase II and Phase III clinical investigation for advanced solid tumors. In this study, we investigated whether Selumetinib could inhibit the aberrant ERK activation of the heart in response to stress as well as prevent cardiac hypertrophy. Methods and Results In an in vitro model of PE-induced cardiac hypertrophy, Selumetinib significantly inhibited the ERK activation and prevented enlargement of cardiomyocytes or reactivation of certain fetal genes. In the pathologic cardiac hypertrophy model of ascending aortic constriction, Selumetinib provided significant ERK inhibition in the stressed heart but not in the other organs. This selective ERK inhibition prevented left ventricular (LV) wall thickening, LV mass increase, fetal gene reactivation and cardiac fibrosis. In another distinct physiologic cardiac hypertrophy model of a swimming rat, Selumetinib provided a similar anti-hypertrophy effect, except that no significant fetal gene reactivation or cardiac fibrosis was observed. Conclusions Selumetinib, a novel oral anti-cancer drug with good safety records in a number of Phase II clinical trials, can inhibit ERK activity in the heart and prevent cardiac hypertrophy. These promising results indicate that Selumetinib could potentially be used to treat cardiac hypertrophy. However, this hypothesis needs to be validated in human clinical trials.	[Li, Chen; Chen, Zhongxiu; Yang, Hao; Li, Yajiao; You, Guiying; Rao, Li] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China; [Luo, Fangbo] Community Hlth Ctr Shuangnan Wuhou Dist, Dept Rehabil, Chengdu, Sichuan, Peoples R China; [Chen, Lihong] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Biochem & Mol Biol, Chengdu, Sichuan, Peoples R China; [Cai, Huawei] Sichuan Univ, West China Hosp, Dept Nucl Med, Chengdu, Sichuan, Peoples R China; [Long, Dan; Li, Shengfu] Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, Chengdu, Sichuan, Peoples R China; [Zhang, Qiuping] Kings Coll London, British Heart Fdn, Cardiovasc Div, Ctr Res Excellence, London, England	Sichuan University; Sichuan University; Sichuan University; Sichuan University; University of London; King's College London; University College London	Rao, L (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China.	lrlz1989@163.com	Zhang, Qiuping/L-3522-2019	Zhang, Qiuping/0000-0002-4000-3957; Cai, Huawei/0000-0003-1341-8417	Natural Science Foundation of China [81300169, 81270289]; Science & Technology Pillar Program of Sichuan Province [2013SZ0082]; British Heart Foundation [PG/11/58/29004] Funding Source: researchfish	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Pillar Program of Sichuan Province; British Heart Foundation(British Heart Foundation)	This study was funded by grants from Natural Science Foundation of China (grant number 81300169 and 81270289), and Science & Technology Pillar Program of Sichuan Province (grant number 2013SZ0082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; Cai J, 2009, J CELL MOL MED, V13, P909, DOI 10.1111/j.1582-4934.2008.00620.x; Carvajal RD, 2014, JAMA-J AM MED ASSOC, V311, P2397, DOI 10.1001/jama.2014.6096; Catalanotti F, 2013, CLIN CANCER RES, V19, P2257, DOI 10.1158/1078-0432.CCR-12-3476; Farley J, 2013, LANCET ONCOL, V14, P134, DOI 10.1016/S1470-2045(12)70572-7; Ferguson BS, 2013, P NATL ACAD SCI USA, V110, P9806, DOI 10.1073/pnas.1301509110; Fremin C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-8; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Hayes DN, 2012, CLIN CANCER RES, V18, P2056, DOI 10.1158/1078-0432.CCR-11-0563; Hoffmann P, 1995, CARDIOVASC RES, V30, P889, DOI 10.1016/S0008-6363(95)00133-6; Hou JL, 2012, PHARMACOL THERAPEUT, V135, P337, DOI 10.1016/j.pharmthera.2012.06.006; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Jain N, 2014, CLIN CANCER RES, V20, P490, DOI 10.1158/1078-0432.CCR-13-1311; Kehat I, 2011, CIRC RES, V108, P176, DOI 10.1161/CIRCRESAHA.110.231514; Kehat I, 2010, ANN NY ACAD SCI, V1188, P96, DOI 10.1111/j.1749-6632.2009.05088.x; Kemi OJ, 2008, J CELL PHYSIOL, V214, P316, DOI 10.1002/jcp.21197; Liu YY, 2008, J IMMUNOL, V180, P7349, DOI 10.4049/jimmunol.180.11.7349; Lorenz K, 2009, INT J BIOCHEM CELL B, V41, P2351, DOI 10.1016/j.biocel.2009.08.002; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; MORDRET G, 1993, BIOL CELL, V79, P193, DOI 10.1016/0248-4900(93)90138-5; Muchir A, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-17; Muchir A, 2012, CARDIOVASC RES, V93, P311, DOI 10.1093/cvr/cvr301; Muiesan ML, 2004, HYPERTENSION, V43, P731, DOI 10.1161/01.HYP.0000121223.44837.de; Munzel F, 2005, CARDIOVASC RES, V68, P464, DOI 10.1016/j.cardiores.2005.06.020; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Prado CMM, 2012, BRIT J CANCER, V106, P1583, DOI 10.1038/bjc.2012.144; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Robert C, 2013, LANCET ONCOL, V14, P733, DOI 10.1016/S1470-2045(13)70237-7; Ruppert C, 2013, P NATL ACAD SCI USA, V110, P7440, DOI 10.1073/pnas.1221999110; Siu CW, 2012, AGING-US, V4, P803, DOI 10.18632/aging.100503; Vidal M, 2012, CARDIOVASC RES, V96, P255, DOI 10.1093/cvr/cvs249; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150	35	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159079	10.1371/journal.pone.0159079	http://dx.doi.org/10.1371/journal.pone.0159079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438013	Green Published, gold			2022-12-27	WOS:000380170100028
J	Cibelli, E; Xu, Y; Austerweil, JL; Griffiths, TL; Regier, T				Cibelli, Emily; Xu, Yang; Austerweil, Joseph L.; Griffiths, Thomas L.; Regier, Terry			The Sapir-Whorf Hypothesis and Probabilistic Inference: Evidence from the Domain of Color	PLOS ONE			English	Article							RIGHT VISUAL-FIELD; CATEGORICAL PERCEPTION; FACIAL EXPRESSIONS; PARTICULARS; LANGUAGE; ACCOUNT; MODEL	The Sapir-Whorf hypothesis holds that our thoughts are shaped by our native language, and that speakers of different languages therefore think differently. This hypothesis is controversial in part because it appears to deny the possibility of a universal groundwork for human cognition, and in part because some findings taken to support it have not reliably replicated. We argue that considering this hypothesis through the lens of probabilistic inference has the potential to resolve both issues, at least with respect to certain prominent findings in the domain of color cognition. We explore a probabilistic model that is grounded in a presumed universal perceptual color space and in language-specific categories over that space. The model predicts that categories will most clearly affect color memory when perceptual information is uncertain. In line with earlier studies, we show that this model accounts for language-consistent biases in color reconstruction from memory in English speakers, modulated by uncertainty. We also show, to our knowledge for the first time, that such a model accounts for influential existing data on cross-language differences in color discrimination from memory, both within and across categories. We suggest that these ideas may help to clarify the debate over the Sapir-Whorf hypothesis.	[Cibelli, Emily] Northwestern Univ, Dept Linguist, Evanston, IL 60208 USA; [Xu, Yang; Regier, Terry] Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA; [Xu, Yang; Griffiths, Thomas L.; Regier, Terry] Univ Calif Berkeley, Cognit Sci Program, Berkeley, CA 94720 USA; [Austerweil, Joseph L.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Griffiths, Thomas L.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA	Northwestern University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley	Regier, T (corresponding author), Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA.; Regier, T (corresponding author), Univ Calif Berkeley, Cognit Sci Program, Berkeley, CA 94720 USA.	terry.regier@berkeley.edu		Griffiths, Thomas/0000-0002-5138-7255; Austerweil, Joseph/0000-0002-1316-4691	National Science Foundation [DGE-1106400, SBE-1041707]; Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	National Science Foundation(National Science Foundation (NSF)); Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	This research was supported by the National Science Foundation (www.nsf.gov) under grants DGE-1106400 (EC) and SBE-1041707 (YX, TR). Publication was made possible in part by support from the Berkeley Research Impact Initiative (BRII) sponsored by the UC Berkeley Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae GY, 2015, J EXP PSYCHOL GEN, V144, P744, DOI 10.1037/xge0000076; Berlin B., 1969, BASIC COLOR TERMS TH; Brainard D.H., 2003, SCI COLOR, V2, P191, DOI DOI 10.1016/B978-044451251-2/50006-4; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown AM, 2011, J VISION, V11, DOI 10.1167/11.12.2; BROWN RW, 1954, J ABNORM SOC PSYCH, V49, P454, DOI 10.1037/h0057814; Drivonikou GV, 2007, P NATL ACAD SCI USA, V104, P1097, DOI 10.1073/pnas.0610132104; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Feldman NH, 2009, PSYCHOL REV, V116, P752, DOI 10.1037/a0017196; Gilbert AL, 2006, P NATL ACAD SCI USA, V103, P489, DOI 10.1073/pnas.0509868103; GOLDSTONE RL, 1995, PSYCHOL SCI, V6, P298, DOI 10.1111/j.1467-9280.1995.tb00514.x; Hanley JR, 2011, PSYCHON B REV, V18, P355, DOI 10.3758/s13423-010-0043-z; Hemmer P, 2015, P 37 ANN M COGN SCI, P896; Hemmer P, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00584; Hemmer P, 2009, TOP COGN SCI, V1, P189, DOI 10.1111/j.1756-8765.2008.01010.x; Holden MP, 2013, COGNITION, V128, P45, DOI 10.1016/j.cognition.2013.02.016; Hu ZH, 2014, PSYCHON B REV, V21, P1214, DOI 10.3758/s13423-014-0603-8; HUTTENLOCHER J, 1991, PSYCHOL REV, V98, P352, DOI 10.1037/0033-295X.98.3.352; Huttenlocher J, 2000, J EXP PSYCHOL GEN, V129, P220, DOI 10.1037//0096-3445.129.2.220; Jacobs RA, 2002, TRENDS COGN SCI, V6, P345, DOI 10.1016/S1364-6613(02)01948-4; Kay P, 2003, P NATL ACAD SCI USA, V100, P9085, DOI 10.1073/pnas.1532837100; KAY P, 1984, AM ANTHROPOL, V86, P65, DOI 10.1525/aa.1984.86.1.02a00050; Kay P., 2009, WORLD COLOR SURVEY; Kleiner M, 2007, PERCEPTION, V36, P14; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Luce R. D., 1963, HDB MATH PSYCHOL, V1, P103; Lupyan G, 2008, J EXP PSYCHOL GEN, V137, P348, DOI 10.1037/0096-3445.137.2.348; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Persaud K., 2014, P 36 ANN M COGN SCI, P1162; Regier T, 2007, P NATL ACAD SCI USA, V104, P1436, DOI 10.1073/pnas.0610341104; Roberson D, 2000, MEM COGNITION, V28, P977, DOI 10.3758/BF03209345; Roberson D, 2005, COGNITIVE PSYCHOL, V50, P378, DOI 10.1016/j.cogpsych.2004.10.001; Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369; Roberson D, 2008, COGNITION, V107, P752, DOI 10.1016/j.cognition.2007.09.001; Roberson D, 2007, MEM COGNITION, V35, P1814, DOI 10.3758/BF03193512; Sapir E, 1929, LANGUAGE, V5, P207, DOI 10.2307/409588; Whorf Benjamin., 1956, LANGUAGE THOUGHT REA; Winawer J, 2007, P NATL ACAD SCI USA, V104, P7780, DOI 10.1073/pnas.0701644104; Witzel C, 2011, J VISION, V11, DOI 10.1167/11.12.16; Wright O, 2015, Q J EXP PSYCHOL, V68, P745, DOI 10.1080/17470218.2014.966123; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; Yuille AL, 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	43	31	31	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158725	10.1371/journal.pone.0158725	http://dx.doi.org/10.1371/journal.pone.0158725			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DR8TG	27434643	Green Published, gold			2022-12-27	WOS:000380169600014
J	Lui, G; Wong, CK; Ip, M; Chu, YJ; Yung, IMH; Cheung, CSK; Zheng, L; Lam, JSY; Wong, KT; Sin, WWY; Choi, KW; Lee, N				Lui, Grace; Wong, Chun Kwok; Ip, Margaret; Chu, Yi Jun; Yung, Irene M. H.; Cheung, Catherine S. K.; Zheng, Lin; Lam, Judy S. Y.; Wong, Ka Tak; Sin, Winnie W. Y.; Choi, Kin Wing; Lee, Nelson			HMGB1/RAGE Signaling and Pro-Inflammatory Cytokine Responses in Non-HIV Adults with Active Pulmonary Tuberculosis	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MYCOBACTERIUM-TUBERCULOSIS; SOLUBLE RECEPTOR; ACTIVATION; SEVERITY; RAGE; SUSCEPTIBILITY; IMMUNOLOGY; SECRETION; RELEASE	Background We aimed to study the pathogenic roles of High-Mobility Group Box 1 (HMGB1) / Receptor-for-Advanced-Glycation-End-products (RAGE) signaling and pro-inflammatory cytokines in patients with active pulmonary tuberculosis (PTB). Methods A prospective study was conducted among non-HIV adults newly-diagnosed with active PTB at two acute-care hospitals (n = 80); age-and-sex matched asymptomatic individuals (tested for latent TB) were used for comparison (n = 45). Plasma concentrations of 8 cytokines/chemokines, HMGB1, soluble-RAGE, and transmembrane-RAGE expressed on monocytes/dendritic cells, were measured. Gene expression (mRNA) of HMGB1, RAGE, and inflammasome-NALP3 was quantified. Patients' PBMCs were stimulated with recombinant-HMGB1 and MTB-antigen (lipoarabinomannan) for cytokine induction ex vivo. Results In active PTB, plasma IL-8/CXCL8 [median(IQR), 6.0(3.6-15.1) vs 3.6(3.6-3.6) pg/ml, P<0.001] and IL-6 were elevated, which significantly correlated with mycobacterial load, extent of lung consolidation (r(s) + 0.509, P<0.001), severity-score (r(s) + 0.317, P = 0.004), and fever and hospitalization durations (r(s) + 0.407, P<0.001). IL-were independent predictors for respiratory failure, as well as for ICU admission/death. Gene expression of HMGB1, RAGE, and inflammasome-NALP3 were upregulated (1.2-2.8 fold). Transmembrane-RAGE was increased, whereas the decoy soluble-RAGE was significantly depleted. RAGE and HMGB1 gene expressions positively correlated with cytokine levels (IL-8/CXCL8, IL-6, sTNFR1) and clinico-/radiographical severity (e.g. extent of consolidation r(s) + 0.240, P = 0.034). Ex vivo, recombinant-HMGB1 potentiated cytokine release (e.g. TNF-alpha) when combined with lipoarabinomannan. Conclusion In patients with active PTB, HMGB1/RAGE signaling and pro-inflammatory cytokines may play important roles in pathogenesis and disease manifestations. Our clinico-immunological data can provide basis for the development of new strategies for disease monitoring, management and control.18 and sTNFR1 also increased. Plasma IL-8/CXCL8 (adjusted OR 1.12, 95% CI 1.02-1.23 per unit increase, P = 0.021) and HMGB1 (adjusted OR 1.42 per unit increase, 95% CI 1.08-1.87, P = 0.012) concentrations	[Lui, Grace; Yung, Irene M. H.; Cheung, Catherine S. K.; Lee, Nelson] Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Wong, Chun Kwok; Chu, Yi Jun] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Ip, Margaret; Zheng, Lin] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Lam, Judy S. Y.; Wong, Ka Tak] Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Sin, Winnie W. Y.; Choi, Kin Wing] Alice Ho Miu Ling Nethersole Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lee, Nelson] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Alice Ho Miu Ling Nethersole Hospital; Chinese University of Hong Kong	Lee, N (corresponding author), Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	leelsn@cuhk.edu.hk	Ip, Margaret/K-1096-2013; Wong, CK/H-3256-2016; Lee, Nelson/B-6418-2008; Lui, Grace/N-4498-2019; Lui, Chung Yan Grace/N-5178-2016; Cheung, Siu King/L-5665-2016	Ip, Margaret/0000-0003-1291-6537; Wong, CK/0000-0002-5637-8331; Lee, Nelson/0000-0002-0783-6607; Lui, Chung Yan Grace/0000-0001-5242-2967; Cheung, Siu King/0000-0002-3486-489X	Research Fund for the Control of Infectious Diseases [11100272]; Food and Health Bureau of the Hong Kong Special Administrative Region Government; Departmental research fund, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong	Research Fund for the Control of Infectious Diseases; Food and Health Bureau of the Hong Kong Special Administrative Region Government; Departmental research fund, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong	This work was supported jointly by the Research Fund for the Control of Infectious Diseases (ref. no. 11100272), Food and Health Bureau of the Hong Kong Special Administrative Region Government; and a Departmental research fund, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.	Abhimanyu, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145576; Alessandri AL, 2006, INFLAMM RES, V55, P528, DOI 10.1007/s00011-006-5136-9; Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Castiglioni A, 2011, CELL TISSUE RES, V343, P189, DOI 10.1007/s00441-010-1033-1; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144705; Dheda K, 2010, RESPIROLOGY, V15, P433, DOI 10.1111/j.1440-1843.2010.01739.x; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Ganachari M, 2012, GENES IMMUN, V13, P605, DOI 10.1038/gene.2012.39; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; Grover A, 2014, IMMUNOLOGY, V142, P111, DOI 10.1111/imm.12236; Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008459; Hernandez-Pando R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133200; Hofner P, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/53805; Iwamoto H, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-68; Johansson L, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00004; Kassa D, 2012, CLIN VACCINE IMMUNOL, V19, P1907, DOI 10.1128/CVI.00482-12; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Keyel PA, 2014, CYTOKINE, V69, P136, DOI 10.1016/j.cyto.2014.03.007; Kocsis AK, 2009, PANCREATOLOGY, V9, P383, DOI 10.1159/000181172; Krupa A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/124762; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; Lee N, 2013, INFLUENZA OTHER RESP, V7, P666, DOI 10.1111/irv.12109; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lui G, 2011, J INFECTION, V62, P440, DOI 10.1016/j.jinf.2011.04.011; Lui G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092077; Ma X, 2003, J INFECT DIS, V188, P349, DOI 10.1086/376559; Magrys A, 2013, IMMUNOL INVEST, V42, P49, DOI 10.3109/08820139.2012.723769; Masood KI, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-13; Momonaka H, 2014, BRAIN DEV-JPN, V36, P484, DOI 10.1016/j.braindev.2013.07.001; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Santilli F, 2009, CURR MED CHEM, V16, P940, DOI 10.2174/092986709787581888; Santucci N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026363; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sukkar MB, 2012, EUR RESPIR J, V39, P721, DOI 10.1183/09031936.00022011; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tuberculosis and Chest Services Centre for Health Protection Hong Kong SAR, 2006, TUBERCULOSIS MANUAL; van Zoelen MAD, 2012, MOL IMMUNOL, V52, P183, DOI 10.1016/j.molimm.2012.05.014; Verrall AJ, 2014, IMMUNOLOGY, V141, P506, DOI 10.1111/imm.12223; Wang GZ, 2014, EUR J PHARMACOL, V726, P27, DOI 10.1016/j.ejphar.2014.01.030; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180	52	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159132	10.1371/journal.pone.0159132	http://dx.doi.org/10.1371/journal.pone.0159132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434276	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600035
J	Pinilla-Vera, M; Xiong, ZY; Zhao, YT; Zhao, J; Donahoe, MP; Barge, S; Horne, WT; Kolls, JK; McVerry, BJ; Birukova, A; Tighe, RM; Foster, WM; Hollingsworth, J; Ray, A; Mallampalli, R; Ray, P; Lee, JS				Pinilla-Vera, Miguel; Xiong, Zeyu; Zhao, Yutong; Zhao, Jing; Donahoe, Michael P.; Barge, Suchitra; Horne, William T.; Kolls, Jay K.; McVerry, Bryan J.; Birukova, Anastasiya; Tighe, Robert M.; Foster, W. Michael; Hollingsworth, John; Ray, Anuradha; Mallampalli, Rama; Ray, Prabir; Lee, Janet S.			Full Spectrum of LPS Activation in Alveolar Macrophages of Healthy Volunteers by Whole Transcriptomic Profiling	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BACTERIAL PNEUMONIA; IN-VIVO; RECEPTOR; IL-10; EXPRESSION; TOLERANCE; CELLS; TRIF; LIPOPOLYSACCHARIDE	Despite recent advances in understanding macrophage activation, little is known regarding how human alveolar macrophages in health calibrate its transcriptional response to canonical TLR4 activation. In this study, we examined the full spectrum of LPS activation and determined whether the transcriptomic profile of human alveolar macrophages is distinguished by a TIR-domain-containing adapter-inducing interferon-beta (TRIF)-dominant type I interferon signature. Bronchoalveolar lavage macrophages were obtained from healthy volunteers, stimulated in the presence or absence of ultrapure LPS in vitro, and whole transcriptomic profiling was performed by RNA sequencing (RNA-Seq). LPS induced a robust type I interferon transcriptional response and Ingenuity Pathway Analysis predicted interferon regulatory factor (IRF) 7 as the top upstream regulator of 89 known gene targets. Ubiquitin-specific peptidase (USP)-18, a negative regulator of interferon alpha/beta responses, was among the top up-regulated genes in addition to IL10 and USP41, a novel gene with no known biological function but with high sequence homology to USP18. We determined whether IRF-7 and USP-18 can influence downstream macrophage effector cytokine production such as IL-10. We show that IRF-7 siRNA knockdown enhanced LPS-induced IL-10 production in human monocyte-derived macrophages, and USP-18 overexpression attenuated LPS-induced production of IL-10 in RAW264.7 cells. Quantitative PCR confirmed upregulation of USP18, USP41, IL10, and IRF7. An independent cohort confirmed LPS induction of USP41 and IL10 genes. These results suggest that IRF-7 and predicted downstream target USP18, both elements of a type I interferon gene signature identified by RNA-Seq, may serve to fine-tune early cytokine response by calibrating IL-10 production in human alveolar macrophages.	[Pinilla-Vera, Miguel; Xiong, Zeyu; Zhao, Yutong; Zhao, Jing; Donahoe, Michael P.; Barge, Suchitra; McVerry, Bryan J.; Ray, Anuradha; Ray, Prabir; Lee, Janet S.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Horne, William T.; Kolls, Jay K.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Birukova, Anastasiya; Tighe, Robert M.; Foster, W. Michael; Hollingsworth, John] Duke Univ, Dept Med, Durham, NC USA; [Hollingsworth, John] Ohio State Univ, Dept Med, Div Pulm & Crit Care Med, Columbus, OH USA; [Mallampalli, Rama] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA USA; [Zhao, Yutong; Zhao, Jing; Lee, Janet S.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; University System of Ohio; Ohio State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, JS (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.; Lee, JS (corresponding author), Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA.	leejs3@upmc.edu	McVerry, Bryan/AAS-7790-2021; Kolls, Jay/AAH-1829-2019	McVerry, Bryan/0000-0002-1175-4874; Kolls, Jay/0000-0001-5151-6304; Tighe, Robert/0000-0002-3465-9861; Pinilla-Vera, Miguel/0000-0002-2773-1570; Lee, Janet/0000-0002-6812-6043	Breathe Pennsylvania; National Institute of Health [R01 HL086884, R21AI119042, K08 HL105537, P01 HL114453]; Flight Attendant Medical Research Institute; Pilot Project Program in Hemostasis and Vascular Biology; Vascular Medicine Institute; Hemophilia Center of Western Pennsylvania; Institute for Transfusion Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114453, K08HL105537, R01HL081784, R01HL086884, R01HL098174, R01HL096376, R01HL097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016126, R01ES020350] Funding Source: NIH RePORTER	Breathe Pennsylvania; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; Pilot Project Program in Hemostasis and Vascular Biology; Vascular Medicine Institute; Hemophilia Center of Western Pennsylvania; Institute for Transfusion Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by Breathe Pennsylvania (JSL, MPD); National Institute of Health R01 HL086884 and R21AI119042 (JSL), K08 HL105537 (RMT), P01 HL114453 (RKM, PR); Flight Attendant Medical Research Institute (JSL); Pilot Project Program in Hemostasis and Vascular Biology, the Vascular Medicine Institute, the Hemophilia Center of Western Pennsylvania, Institute for Transfusion Medicine (JSL). The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Borzecka K, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/824919; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Doyle I, 2010, MOL IMMUNOL, V47, P1058, DOI 10.1016/j.molimm.2009.11.008; Fraziano M, 1999, AIDS RES HUM RETROV, V15, P869, DOI 10.1089/088922299310575; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Geisel J, 2007, J IMMUNOL, V179, P5811, DOI 10.4049/jimmunol.179.9.5811; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goubau D, 2009, EUR J IMMUNOL, V39, P527, DOI 10.1002/eji.200838832; GREENBERGER MJ, 1995, J IMMUNOL, V155, P722; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hoshino Y, 2004, J IMMUNOL, V172, P6251, DOI 10.4049/jimmunol.172.10.6251; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kaakoush NO, 2015, INFECT IMMUN, V83, P832, DOI 10.1128/IAI.03012-14; Kazeros A, 2008, AM J RESP CELL MOL, V39, P747, DOI 10.1165/rcmb.2007-0306OC; Ketscher L, 2015, P NATL ACAD SCI USA, V112, P1577, DOI 10.1073/pnas.1412881112; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; McDermott JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014673; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Njoroge JM, 2001, CYTOMETRY, V44, P38, DOI 10.1002/1097-0320(20010501)44:1<38::AID-CYTO1080>3.0.CO;2-T; Opalek Judy M, 2007, J Inflamm (Lond), V4, P19, DOI 10.1186/1476-9255-4-19; Owens BMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041050; Palmer SM, 2003, AM J RESP CRIT CARE; Pawaria S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1524; Poe SL, 2013, MUCOSAL IMMUNOL, V6, P189, DOI 10.1038/mi.2012.62; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Raben D, 2005, CLIN CANCER RES, V11, P795; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rigby RE, 2015, TRENDS IMMUNOL, V36, P179, DOI 10.1016/j.it.2015.02.001; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sethi S, 2002, GERIATRICS-US, V57, P56; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Umino T, 1999, EUR RESPIR J, V13, P894, DOI 10.1034/j.1399-3003.1999.13d33.x; West JB, 2013, AM J PHYSIOL-REG I, V304, pR171, DOI 10.1152/ajpregu.00444.2012; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224	59	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159329	10.1371/journal.pone.0159329	http://dx.doi.org/10.1371/journal.pone.0159329			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434537	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600047
J	Torigata, K; Daisuke, O; Mukai, S; Hatanaka, A; Ohka, F; Motooka, D; Nakamura, S; Ohkawa, Y; Yabuta, N; Kondo, Y; Nojima, H				Torigata, Kosuke; Daisuke, Okuzaki; Mukai, Satomi; Hatanaka, Akira; Ohka, Fumiharu; Motooka, Daisuke; Nakamura, Shota; Ohkawa, Yasuyuki; Yabuta, Norikazu; Kondo, Yutaka; Nojima, Hiroshi			LATS2 Positively Regulates Polycomb Repressive Complex 2	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; TUMOR-SUPPRESSOR; SELECTIVE-INHIBITION; HIPPO PATHWAY; HUMAN GENOME; STEM-CELLS; EZH2; PHOSPHORYLATION; APOPTOSIS; DIFFERENTIATION	LATS2, a pivotal Ser/Thr kinase of the Hippo pathway, plays important roles in many biological processes. LATS2 also function in Hippo-independent pathway, including mitosis, DNA damage response and epithelial to mesenchymal transition. However, the physiological relevance and molecular basis of these LATS2 functions remain obscure. To understand novel functions of LATS2, we constructed a LATS2 knockout HeLa-S3 cell line using TAL-effector nuclease (TALEN). Integrated omics profiling of this cell line revealed that LATS2 knockout caused genome-wide downregulation of Polycomb repressive complex 2 (PRC2) and H3K27me3. Cell-cycle analysis revealed that downregulation of PRC2 was not due to cell cycle aberrations caused by LATS2 knockout. Not LATS1, a homolog of LATS2, but LATS2 bound PRC2 on chromatin and phosphorylated it. LATS2 positively regulates histone methyltransferase activity of PRC2 and their expression at both the mRNA and protein levels. Our findings reveal a novel signal upstream of PRC2, and provide insight into the crucial role of LATS2 in coordinating the epigenome through regulation of PRC2.	[Torigata, Kosuke; Daisuke, Okuzaki; Mukai, Satomi; Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Dept Mol Genet, Microbial Dis Res Inst, Suita, Osaka, Japan; [Hatanaka, Akira; Ohka, Fumiharu; Kondo, Yutaka] Nagoya City Univ, Grad Sch Med Sci, Dept Epigen, Nagoya, Aichi, Japan; [Daisuke, Okuzaki; Nojima, Hiroshi] Osaka Univ, DNA Chip Dev Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka, Japan; [Motooka, Daisuke; Nakamura, Shota] Osaka Univ, Dept Infect Metagen, Genome Informat Res Ctr, Microbial Dis Res Inst, Suita, Osaka, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Dept Adv Med Initiat, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan	Osaka University; Nagoya City University; Osaka University; Osaka University; Kyushu University	Nojima, H (corresponding author), Osaka Univ, Dept Mol Genet, Microbial Dis Res Inst, Suita, Osaka, Japan.; Nojima, H (corresponding author), Osaka Univ, DNA Chip Dev Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka, Japan.	snj-0212@biken.osaka-u.ac.jp	Ohka, Fumiharu/A-3420-2016; Ohkawa, Yasuyuki/C-4087-2016; Nakamura, Shota/E-3033-2010; Okuzaki, Daisuke/AAN-5641-2020; Ohkawa, Yasuyuki/ABG-1839-2021	Ohkawa, Yasuyuki/0000-0001-6440-9954; Nakamura, Shota/0000-0003-2058-5942; Okuzaki, Daisuke/0000-0002-4552-783X; Ohkawa, Yasuyuki/0000-0001-6440-9954; Ohka, Fumiharu/0000-0002-5569-5626	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23370086, 22570185, 255951]; Project MEET, Osaka University Graduate School of Medicine	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project MEET, Osaka University Graduate School of Medicine	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Scientific Research B 23370086 [to HN], Scientific Research C 22570185 [to NY], and Research Fellowships for Young Scientists 255951 [to KT]) and by Project MEET, Osaka University Graduate School of Medicine (to DO).; We thank Dr. Patrick Hughes (Bioedit) for critically reading the manuscript. We also thank Dr. C. Oneyama, Dr. H. Fujii, and Dr. T. Fujita for valuable technical advice and discussions. This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Scientific Research B 23370086 [to HN], Scientific Research C 22570185 [to NY], and Research Fellowships for Young Scientists 255951 [to KT]), and by Project MEET, Osaka University Graduate School of Medicine (to DO).	Aylon Y, 2014, CELL DEATH DIFFER, V21, P624, DOI 10.1038/cdd.2013.188; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Aylon Y, 2010, GENE DEV, V24, P2420, DOI 10.1101/gad.1954410; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boulay G, 2011, BIOCHEM J, V434, P333, DOI 10.1042/BJ20100944; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cifuentes-Rojas C, 2014, MOL CELL, V55, P171, DOI 10.1016/j.molcel.2014.05.009; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kondo Y, 2014, J BIOCHEM, V156, P249, DOI 10.1093/jb/mvu054; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2013, CELL REP, V5, P1650, DOI 10.1016/j.celrep.2013.11.037; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Okada N, 2011, J CELL SCI, V124, P57, DOI 10.1242/jcs.072918; Parrish JZ, 2007, GENE DEV, V21, P956, DOI 10.1101/gad.1514507; Powzaniuk M, 2004, MOL ENDOCRINOL, V18, P2011, DOI 10.1210/me.2004-0065; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Qin H, 2012, HUM MOL GENET, V21, P2054, DOI 10.1093/hmg/dds023; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reuven N, 2013, CELL DEATH DIFFER, V20, P1330, DOI 10.1038/cdd.2013.83; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2013, J CELL SCI, V126, P4358, DOI 10.1242/jcs.125815; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Visser S, 2010, CELL CYCLE, V9, P3892, DOI 10.4161/cc.9.19.13386; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yabuta N, 2011, CELL CYCLE, V10, P2724, DOI 10.4161/cc.10.16.16873; Zeng XZ, 2011, CELL CYCLE, V10, P579, DOI 10.4161/cc.10.4.14722; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	54	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158562	10.1371/journal.pone.0158562	http://dx.doi.org/10.1371/journal.pone.0158562			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434182	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600010
J	Woodborne, S; Gandiwa, P; Hall, G; Patrut, A; Finch, J				Woodborne, Stephan; Gandiwa, Patience; Hall, Grant; Patrut, Adrian; Finch, Jemma			A Regional Stable Carbon Isotope Dendro-Climatology from the South African Summer Rainfall Area	PLOS ONE			English	Article							BAOBAB TREES ADANSONIA; ATMOSPHERIC CO2; RAINY-SEASON; DIGITATA L.; WATER-USE; VARIABILITY; RADIOCARBON; DELTA-C-13; RATIOS; MADAGASCAR	Carbon isotope analysis of four baobab (Adansonia digitata L.) trees from the Pafuri region of South Africa yielded a 1000-year proxy rainfall record. The Pafuri record age model was based on 17 radiocarbon dates, cross correlation of the climate record, and ring structures that were presumed to be annual for two of the trees. Here we present the analysis of five additional baobabs from the Mapungubwe region, approximately 200km west of Pafuri. The Mapungubwe chronology demonstrates that ring structures are not necessarily annually formed, and accordingly the Pafuri chronology is revised. Changes in intrinsic water-use efficiency indicate an active response by the trees to elevated atmospheric CO2, but this has little effect on the environmental signal. The revised Pafuri record, and the new Mapungubwe record correlate significantly with local rainfall. Both records confirm that the Medieval Warm Period was substantially wetter than present, and the Little Ice Age was the driest period in the last 1000 years. Although Mapungubwe is generally drier than Pafuri, both regions experience elevated rainfall peaking between AD 1570 and AD 1620 after which dry conditions persist in the Mapungubwe area until about AD 1840. Differences between the two records correlate with Agulhas Current sea-surface temperature variations suggesting east/west displacement of the temperate tropical trough system as an underlying mechanism. The Pafuri and Mapungubwe records are combined to provide a regional climate proxy record for the northern summer rainfall area of southern Africa.	[Woodborne, Stephan] iThemba LABS, Private Bag 11, ZA-2050 Johannesburg, South Africa; [Gandiwa, Patience; Finch, Jemma] Univ KwaZulu Natal, Discipline Geog, Sch Agr Earth & Environm Sci, Private Bag X01, ZA-3209 Pietermaritzburg, South Africa; [Woodborne, Stephan; Hall, Grant] Univ Pretoria, Mammal Res Inst, Private Bag X20, ZA-0028 Hatfield, South Africa; [Patrut, Adrian] Univ Babes Bolyai, Fac Chem, Arany Janos 11, Cluj Napoca 400028, Romania	National Research Foundation - South Africa; iThemba LABS; University of Kwazulu Natal; University of Pretoria; Babes Bolyai University from Cluj	Woodborne, S (corresponding author), iThemba LABS, Private Bag 11, ZA-2050 Johannesburg, South Africa.; Woodborne, S (corresponding author), Univ Pretoria, Mammal Res Inst, Private Bag X20, ZA-0028 Hatfield, South Africa.	Swoodborne@tlabs.ac.za	Finch, Jemma M./F-3739-2010; Patrut, Adrian/C-3566-2012; Hall, Grant/J-9886-2016	Finch, Jemma M./0000-0002-6678-6910; Patrut, Adrian/0000-0002-9862-6735; Hall, Grant/0000-0002-2164-4900	Romanian Ministry of National Education CNCS/UEFISCDI [PN-II-ID-PCE-2013-76]; African Origins Platform of the National Research Foundation of South Africa [82596]; National Research Foundation of South Africa [91042]	Romanian Ministry of National Education CNCS/UEFISCDI; African Origins Platform of the National Research Foundation of South Africa; National Research Foundation of South Africa(National Research Foundation - South Africa)	The radiocarbon dating of Luna and Shroda trees was funded by the Romanian Ministry of National Education CNCS/UEFISCDI under grant PN-II-ID-PCE-2013-76. Radiocarbon analyses on the LKA, LKB and MPC baobabs and fieldwork costs were supported wholly by the African Origins Platform of the National Research Foundation of South Africa (Grant Number 82596). Isotopic analyses were supported wholly by the National Research Foundation of South Africa (Grant Number 91042).	Abram NJ, 2007, NATURE, V445, P299, DOI 10.1038/nature05477; Abram NJ, 2014, NAT CLIM CHANGE, V4, P564, DOI [10.1038/nclimate2235, 10.1038/NCLIMATE2235]; CARTE AE, 1978, J APPL METEOROL, V17, P365, DOI 10.1175/1520-0450(1978)017<0365:VOHOTS>2.0.CO;2; Chapotin SM, 2006, PLANT CELL ENVIRON, V29, P1021, DOI 10.1111/j.1365-3040.2005.01456.x; Chapotin SM, 2006, NEW PHYTOL, V169, P549, DOI 10.1111/j.1469-8137.2005.01618.x; Cook C, 2004, CLIM RES, V26, P17, DOI 10.3354/cr026017; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Fauchereau N, 2009, CLIM DYNAM, V32, P575, DOI 10.1007/s00382-008-0426-2; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Hall G, 2008, CHEM GEOL, V247, P384, DOI 10.1016/j.chemgeo.2007.11.001; Hall G, 2009, HOLOCENE, V19, P251, DOI 10.1177/0959683608100569; HARRISON MSJ, 1984, J CLIMATOL, V4, P547, DOI 10.1002/joc.3370040510; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Hua Q, 2013, RADIOCARBON, V55, P2059, DOI 10.2458/azu_js_rc.v55i2.16177; Huffman TN, 2015, HOLOCENE; Lanzante JR, 1996, INT J CLIMATOL, V16, P1197, DOI 10.1002/(SICI)1097-0088(199611)16:11<1197::AID-JOC89>3.0.CO;2-L; Leavitt SW, 2010, SCI TOTAL ENVIRON, V408, P5244, DOI 10.1016/j.scitotenv.2010.07.057; Li JB, 2013, NAT CLIM CHANGE, V3, P822, DOI [10.1038/nclimate1936, 10.1038/NCLIMATE1936]; Loader NJ, 2013, HOLOCENE, V23, P1221, DOI 10.1177/0959683613486945; Loader NJ, 1997, CHEM GEOL, V136, P313, DOI 10.1016/S0009-2541(96)00133-7; Mader GN, 1979, S AFR GEOGR J, V61, P85; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; Neukom R, 2012, HOLOCENE, V22, P501, DOI 10.1177/0959683611427335; Norstrom E, 2005, S AFR J SCI, V101, P162; Patrut A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117193; Patrut A, 2011, ANN FOREST SCI, V68, P993, DOI 10.1007/s13595-011-0107-x; Patrut A, 2010, RADIOCARBON, V52, P727; Robertson I, 1997, J GEOPHYS RES-ATMOS, V102, P19507, DOI 10.1029/97JD01226; Robertson I, 2006, APPL GEOCHEM, V21, P1674, DOI 10.1016/j.apgeochem.2006.07.005; Usman MT, 2004, CLIM RES, V26, P199, DOI 10.3354/cr026199; Van den Bilcke N, 2013, S AFR J BOT, V88, P438, DOI 10.1016/j.sajb.2013.09.006; Vogel J., 1993, STABLE ISOTOPES PLAN, P26; Wang GA, 2012, ENVIRON SCI TECHNOL, V46, P8610, DOI 10.1021/es301323m; Weldeab S, 2013, CLIM PAST, V9, P2347, DOI 10.5194/cp-9-2347-2013; Woodborne S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124202; Zinke J, 2004, EARTH PLANET SC LETT, V228, P177, DOI 10.1016/j.epsl.2004.09.028; Zinke J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04393	38	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159361	10.1371/journal.pone.0159361	http://dx.doi.org/10.1371/journal.pone.0159361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427912	Green Submitted, gold, Green Published			2022-12-27	WOS:000380169300055
J	Breshears, LM; Gillman, AN; Stach, CS; Schlievert, PM; Peterson, ML				Breshears, Laura M.; Gillman, Aaron N.; Stach, Christopher S.; Schlievert, Patrick M.; Peterson, Marnie L.			Local Epidermal Growth Factor Receptor Signaling Mediates the Systemic Pathogenic Effects of Staphylococcus aureus Toxic Shock Syndrome	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; EX-VIVO; EPITHELIAL-CELLS; INFLAMMATION; MODEL; DISINTEGRIN; ACTIVATION; INFECTION; ADAM10; INJURY	Secreted factors of Staphylococcus aureus can activate host signaling from the epidermal growth factor receptor (EGFR). The superantigen toxic shock syndrome toxin-1 (TSST-1) contributes to mucosal cytokine production through a disintegrin and metalloproteinase (ADAM)-mediated shedding of EGFR ligands and subsequent EGFR activation. The secreted hemolysin, alpha-toxin, can also induce EGFR signaling and directly interacts with ADAM10, a sheddase of EGFR ligands. The current work explores the role of EGFR signaling in menstrual toxic shock syndrome (mTSS), a disease mediated by TSST-1. The data presented show that TSST-1 and alpha-toxin induce ADAM- and EGFR-dependent cytokine production from human vaginal epithelial cells. TSST-1 and alpha-toxin also induce cytokine production from an ex vivo porcine vaginal mucosa (PVM) model. EGFR signaling is responsible for the majority of IL-8 production from PVM in response to secreted toxins and live S. aureus. Finally, data are presented demonstrating that inhibition of EGFR signaling with the EGFR-specific tyrosine kinase inhibitor AG1478 significantly increases survival in a rabbit model of mTSS. These data indicate that EGFR signaling is critical for progression of an S. aureus exotoxin-mediated disease and may represent an attractive host target for therapeutics.	[Breshears, Laura M.; Gillman, Aaron N.; Peterson, Marnie L.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Stach, Christopher S.] Univ Minnesota, Coll Biol Sci, Inst Biotechnol, Minneapolis, MN USA; [Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa	Peterson, ML (corresponding author), Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA.	peter377@umn.edu		Schlievert, Patrick/0000-0001-8314-9369; Breshears, Laura/0000-0002-0997-1140; Gillman, Aaron/0000-0002-1210-0485	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI073366-03, R01AI074283]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI073366-03 (MP) and R01AI074283 (PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2013, J APPL MICROBIOL, V115, P679, DOI 10.1111/jam.12277; Anderson MJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00064; Anderson MJ, 2010, AM J INFECT CONTROL, V38, P826, DOI 10.1016/j.ajic.2010.06.022; Bajaj-Elliott M, 1998, J CLIN INVEST, V102, P1473, DOI 10.1172/JCI2792; Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; BLOMSTERHAUTAMAA DA, 1988, METHOD ENZYMOL, V165, P37; Bose JL, 2013, APPL ENVIRON MICROB, V79, P2218, DOI 10.1128/AEM.00136-13; Breshears LM, 2012, J BIOL CHEM, V287, P32578, DOI 10.1074/jbc.M112.352534; Brosnahan AJ, 2009, J IMMUNOL, V182, P2364, DOI 10.4049/jimmunol.0803283; Buret A, 1999, MICROBES INFECT, V1, P1139, DOI 10.1016/S1286-4579(99)00201-4; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Davis CC, 2014, TOXICOL APPL PHARM, V274, P240, DOI 10.1016/j.taap.2013.11.021; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lin YC, 2011, BIOCHEMISTRY-US, V50, P7157, DOI 10.1021/bi200435n; Liu DY, 2009, MOL THER, V17, P796, DOI 10.1038/mt.2009.18; MACDONALD KL, 1987, JAMA-J AM MED ASSOC, V257, P1053, DOI 10.1001/jama.257.8.1053; Mahipal A, 2014, CANCER CONTROL, V21, P74, DOI 10.1177/107327481402100111; Murray DL, 1996, INFECT IMMUN, V64, P371, DOI 10.1128/IAI.64.1.371-374.1996; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Parker D, 2012, SEMIN IMMUNOPATHOL, V34, P281, DOI 10.1007/s00281-011-0291-7; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Richter E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122089; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; Salgado-Pabon W, 2013, MBIO, V4, DOI 10.1128/mBio.00494-13; Schaefers MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032813; SCHLIEVERT PM, 1982, ANN INTERN MED, V96, P937, DOI 10.7326/0003-4819-96-6-937; SCHLIEVERT PM, 1981, J INFECT DIS, V143, P509, DOI 10.1093/infdis/143.4.509; Soong G, 2011, J BIOL CHEM, V286, P35891, DOI 10.1074/jbc.M111.295386; Sorensen OE, 2006, J CLIN INVEST, V116, P1878, DOI 10.1172/JCI28422; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Spaulding AR, 2012, VACCINE; Squier CA, 2008, J PHARM SCI-US, V97, P9, DOI 10.1002/jps.21077; Strandberg KL, 2010, J INFECT DIS, V202, P1690, DOI 10.1086/657156; Tang YW, 2010, J CLIN MICROBIOL, V48, P1974, DOI 10.1128/JCM.00224-10; Tran QT, 2012, PHYSIOL GENOMICS, V44, P455, DOI 10.1152/physiolgenomics.00176.2011; Wang WZY, 2012, CELL MOL IMMUNOL, V9, P131, DOI 10.1038/cmi.2011.65; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Xu XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028216	49	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158969	10.1371/journal.pone.0158969	http://dx.doi.org/10.1371/journal.pone.0158969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414801	gold, Green Submitted, Green Published			2022-12-27	WOS:000379579500054
J	Du, J; Wang, X; Dong, CH; Yang, JM; Yao, XJ				Du, Juan; Wang, Xue; Dong, Chun-Hai; Yang, Jian Ming; Yao, Xiao Jun			Computational Study of the Binding Mechanism of Actin-Depolymerizing Factor 1 with Actin in Arabidopsis thaliana	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; MOLECULAR-DYNAMICS SIMULATIONS; AMBER FORCE-FIELD; ADF/COFILIN FAMILY; PROTEIN-KINASE; YEAST COFILIN; FILAMENT; HOMOLOGY; COMPLEX; MODELS	Actin is a highly conserved protein. It plays important roles in cellular function and exists either in the monomeric (G-actin) or polymeric form (F-actin). Members of the actin-depolymerizing factor (ADF)/cofilin protein family bind to both G-actin and F-actin and play vital roles in actin dynamics by manipulating the rates of filament polymerization and depolymerization. It has been reported that the S6D and R98A/K100A mutants of actin-depolymerizing factor 1 (ADF1) in Arabidopsis thaliana decreased the binding affinity of ADF for the actin monomer. To investigate the binding mechanism and dynamic behavior of the ADF1-actin complex, we constructed a homology model of the AtADF1-actin complex based on the crystal structure of AtADF1 and the twinfilin C-terminal ADF-H domain in a complex with a mouse actin monomer. The model was then refined for subsequent molecular dynamics simulations. Increased binding energy of the mutated system was observed using the Molecular Mechanics Generalized Born Surface Area and Poisson-Boltzmann Surface Area (MM-GB/PBSA) methods. To determine the residues that make decisive contributions to the ADF1 actin-binding affinity, per-residue decomposition and computational alanine scanning analyses were performed, which provided more detailed information on the binding mechanism. Root-mean-square fluctuation and principal component analyses confirmed that the S6D and R98A/K100A mutants induced an increased conformational flexibility. The comprehensive molecular insight gained from this study is of great importance for understanding the binding mechanism of ADF1 and G-actin.	[Du, Juan; Wang, Xue; Dong, Chun-Hai; Yang, Jian Ming] Qingdao Agr Univ, Coll Life Sci, Key Lab Plant Biotechnol Shandong Prov, Qingdao, Peoples R China; [Yao, Xiao Jun] Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou, Peoples R China	Qingdao Agricultural University; Lanzhou University	Du, J (corresponding author), Qingdao Agr Univ, Coll Life Sci, Key Lab Plant Biotechnol Shandong Prov, Qingdao, Peoples R China.	dujuannx@126.com		Du, Juan/0000-0001-5993-4949	National Natural Science Foundation of China [31300599, 31571389, 21572242]; Talents of High Level Scientific Research Foundation of Qingdao Agricultural University [6631113318, 6631113326]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talents of High Level Scientific Research Foundation of Qingdao Agricultural University	This work was supported by the National Natural Science Foundation of China (grant numbers 31300599, 31571389 and 21572242), and the Talents of High Level Scientific Research Foundation (grant numbers 6631113318 and 6631113326) of Qingdao Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (grant numbers 31300599, 31571389 and 21572242), the Talents of High Level Scientific Research Foundation (grant numbers 6631113318 and 6631113326) of Qingdao Agricultural University.	Aalten DMFv, 1995, PROTEIN ENG, V8, P1129, DOI [10.1093/protein/8.11.1129, DOI 10.1093/PROTEIN/8.11.1129]; Allwood EG, 2002, PLANT CELL, V14, P2915, DOI 10.1105/tpc.005363; Allwood EG, 2001, FEBS LETT, V499, P97, DOI 10.1016/S0014-5793(01)02528-5; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; [Anonymous], BRYCE GROUP COMPUTIO; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bowman GD, 2000, PROTEINS, V41, P374, DOI 10.1002/1097-0134(20001115)41:3<374::AID-PROT90>3.0.CO;2-F; Carlier MF, 1998, CURR OPIN CELL BIOL, V10, P45, DOI 10.1016/S0955-0674(98)80085-9; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Dai K, 2011, BIOMOL NMR ASSIGN, V5, P249, DOI 10.1007/s12104-011-9311-8; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong CH, 2001, PLANT MOL BIOL, V45, P517, DOI 10.1023/A:1010687911374; Dong CH, 2013, PLANT CELL REP, V32, P1715, DOI 10.1007/s00299-013-1482-6; Dong CH, 2013, J INTEGR PLANT BIOL, V55, P250, DOI 10.1111/jipb.12015; Fan J, 2013, J MOL BIOL, V425, P1225, DOI 10.1016/j.jmb.2013.01.020; Fedorov AA, 1997, NAT STRUCT BIOL, V4, P366, DOI 10.1038/nsb0597-366; Feng Y, 2006, J PLANT PHYSIOL, V163, P69, DOI 10.1016/j.jplph.2005.01.015; Fogolari F, 2003, BIOPHYS J, V85, P159, DOI 10.1016/S0006-3495(03)74462-2; Genheden S, 2012, PROTEINS, V80, P1326, DOI 10.1002/prot.24029; Goroncy AK, 2009, PROTEIN SCI, V18, P2384, DOI 10.1002/pro.248; Gouda H, 2003, BIOPOLYMERS, V68, P16, DOI 10.1002/bip.10270; Hellman M, 2004, FEBS LETT, V576, P91, DOI 10.1016/j.febslet.2004.08.068; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Ivetac A, 2009, J MOL BIOL, V388, P644, DOI 10.1016/j.jmb.2009.03.037; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kandasamy MK, 2015, CYTOSKELETON, V72, P80, DOI 10.1002/cm.21198; Kato M, 2006, PROTEINS, V64, P829, DOI 10.1002/prot.21012; Kim JI, 2015, PHYS CHEM CHEM PHYS, V17, P8148, DOI 10.1039/c4cp06100d; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lee MR, 2000, PROTEINS, V39, P309, DOI 10.1002/(SICI)1097-0134(20000601)39:4<309::AID-PROT40>3.0.CO;2-S; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Maciver SK, 2002, GENOME BIOL, V3; Maiti S., 2013, ENCY BIOL CHEM, V2nd ed., P18, DOI [10.1016/B978-0-12-378630-2.00415-1, DOI 10.1016/B978-0-12-378630-2.00415-1]; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Pathak PP, 2010, J STRUCT BIOL, V172, P219, DOI 10.1016/j.jsb.2010.07.001; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Qu XL, 2013, PLANT CELL, V25, P1803, DOI 10.1105/tpc.113.110940; Roland J, 2008, BIOPHYS J, V94, P2082, DOI 10.1529/biophysj.107.121988; Ruzicka DR, 2007, PLANT J, V52, P460, DOI 10.1111/j.1365-313X.2007.03257.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sept D, 1999, J MOL BIOL, V294, P1181, DOI 10.1006/jmbi.1999.3332; Singh BK, 2011, J BIOL CHEM, V286, P28256, DOI 10.1074/jbc.M111.211730; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Smertenko AP, 1998, PLANT J, V14, P187, DOI 10.1046/j.1365-313X.1998.00107.x; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Su H, 2012, PLANT CELL, V24, P4539, DOI 10.1105/tpc.112.099358; Sun TT, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00512; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Wong DY, 2011, J MOL BIOL, V413, P97, DOI 10.1016/j.jmb.2011.08.039; Wriggers W, 1998, J MOL BIOL, V282, P921, DOI 10.1006/jmbi.1998.2048; Xue WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087077; Yadav R, 2011, J STRUCT BIOL, V176, P97, DOI 10.1016/j.jsb.2011.07.011	66	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159053	10.1371/journal.pone.0159053	http://dx.doi.org/10.1371/journal.pone.0159053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414648	Green Submitted, gold, Green Published			2022-12-27	WOS:000379579500065
J	Koster, R; Seow, TX; Dolan, RJ; Duzel, E				Koster, Raphael; Seow, Tricia X.; Dolan, Raymond J.; Duezel, Emrah			Stimulus Novelty Energizes Actions in the Absence of Explicit Reward	PLOS ONE			English	Article							RISK-TAKING; DOPAMINE; HIPPOCAMPAL; PERSONALITY; EXPLORATION; CURIOSITY; BEHAVIOR; DISSOCIATION; PREFERENCE; MECHANISM	Novelty seeking has been tied to impulsive choice and biased value based choice. It has been postulated that novel stimuli should trigger more vigorous approach and exploration. However, it is unclear whether stimulus novelty can enhance simple motor actions in the absence of explicit reward, a necessary condition for energizing approach and exploration in an entirely unfamiliar situation. In this study human subjects were cued to omit or perform actions in form of button presses by novel or familiar images. We found that subjects' motor actions were faster when cued by a novel compared to a familiar image. This facilitation by novelty was strongest when the delay between cue and action was short, consistent with a link between novelty and impulsive choices. The facilitation of reaction times by novelty was correlated across subjects with trait novelty seeking as measured in the Tridimensional Personality Questionnaire. However, this li between high novelty-seeking and action facilitation was driven by trials with a long delay between cue and action. This prolonged time window of energization following novelty could hint at a mechanistic underpinning of enhanced vigour for approach and exploration frequently postulated for novelty seeking humans. In conclusion, we show that stimulus novelty enhances the speed of a cued motor action. We suggest this is likely to reflect an adaptation to changing environments but may also provide a source of maladaptive choice and impulsive behaviour.	[Koster, Raphael; Seow, Tricia X.; Duezel, Emrah] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Koster, Raphael; Dolan, Raymond J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Duezel, Emrah] Univ Magdeburg, Inst Cognit Neurol & Dementia Res, D-39120 Magdeburg, Germany; [Duezel, Emrah] German Ctr Neurodegenerat Dis, D-39120 Magdeburg, Germany	University of London; University College London; University of London; University College London; Otto von Guericke University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Koster, R (corresponding author), UCL, Inst Cognit Neurosci, London WC1N 3AR, England.; Koster, R (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England.	raphael.koster.10@ucl.ac.uk	Duzel, Emrah/A-1794-2010	Seow, Tricia/0000-0002-5930-8929; Duzel, Emrah/0000-0002-0139-5388	UCL Grand Challenge Studentship in Biomedicine; Wellcome Trust [098362/Z/12/Z, 091593/Z/10/Z]; DFG [SFB 779]	UCL Grand Challenge Studentship in Biomedicine; Wellcome Trust(Wellcome Trust); DFG(German Research Foundation (DFG))	This work was supported by a UCL Grand Challenge Studentship in Biomedicine to RK, the Wellcome Trust (Senior Investigator Award 098362/Z/12/Z to RJD) and DFG grant SFB 779 (A07) supporting ED. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a UCL Grand Challenge Studentship in Biomedicine to RK, the Wellcome Trust (Senior Investigator Award 098362/Z/12/Z to RJD) and DFG grant SFB 779 (A07) supporting ED. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. The authors would like to thank Dorothea Hammerer for comments on a previous version of this manuscript.	Baranes AF, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00317; Beierholm U, 2013, NEUROPSYCHOPHARMACOL, V38, P1495, DOI 10.1038/npp.2013.48; Belin D, 2011, NEUROPSYCHOPHARMACOL, V36, P569, DOI 10.1038/npp.2010.188; BERLYNE DE, 1966, SCIENCE, V153, P25, DOI 10.1126/science.153.3731.25; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Bunzeck N, 2014, CEREB CORTEX, V24, P1351, DOI 10.1093/cercor/bhs420; Bunzeck N, 2011, J NEUROSCI, V31, P12816, DOI 10.1523/JNEUROSCI.0461-11.2011; Bunzeck N, 2010, HUM BRAIN MAPP, V31, P1380, DOI 10.1002/hbm.20939; BUTLER RA, 1954, J COMP PHYSIOL PSYCH, V47, P258, DOI 10.1037/h0054977; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Costa A, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/260896; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; DELINISTULA A, 1984, PHARMACOL BIOCHEM BE, V20, P613, DOI 10.1016/0091-3057(84)90312-5; DEsposito M, 2014, PSYCHOPHARMACOLOGY B; Donohew L, 2000, PERS INDIV DIFFER, V28, P1079, DOI 10.1016/S0191-8869(99)00158-0; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Duzel E, 2010, NEUROSCI BIOBEHAV R, V34, P660, DOI 10.1016/j.neubiorev.2009.08.006; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; GLANZER M, 1958, PSYCHOL BULL, V55, P302, DOI 10.1037/h0044731; Guitart-Masip M, 2014, TRENDS COGN SCI; Guitart-Masip M, 2012, P NATL ACAD SCI USA, V109, P7511, DOI 10.1073/pnas.1202229109; Guitart-Masip M, 2011, J COGNITIVE NEUROSCI, V23, P3933, DOI 10.1162/jocn_a_00090; Guitart-Masip M, 2011, J NEUROSCI, V31, P7867, DOI 10.1523/JNEUROSCI.6376-10.2011; Howard LR, 2011, J NEUROSCI, V31, P5253, DOI 10.1523/JNEUROSCI.6055-10.2011; Howard MO, 1997, J STUD ALCOHOL, V58, P48, DOI 10.15288/jsa.1997.58.48; Huys QJM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002028; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Insel N, 2008, BEHAV NEUROSCI, V122, P1328, DOI 10.1037/a0012928; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Koster R, 2015, CEREB CORTEX, V25, P4908, DOI 10.1093/cercor/bhv216; Krebs RM, 2011, J NEUROSCI, V31, P9752, DOI 10.1523/JNEUROSCI.0732-11.2011; Kumaran D, 2009, TRENDS COGN SCI, V13, P47, DOI 10.1016/j.tics.2008.11.004; Lemon N, 2012, CEREB CORTEX, V22, P2131, DOI 10.1093/cercor/bhr297; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; LOEWENSTEIN G, 1994, PSYCHOL BULL, V116, P75, DOI 10.1037/0033-2909.116.1.75; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Maass A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6547; Manohar SG, 2015, CURR BIOL, V25, P1707, DOI 10.1016/j.cub.2015.05.038; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Molander AC, 2011, PSYCHOPHARMACOLOGY, V215, P721, DOI 10.1007/s00213-011-2167-x; Murty VP, 2013, LEARN MEMORY, V20, P229, DOI 10.1101/lm.029728.112; Pluck Graham, 2011, Depress Res Treat, V2011, P893873, DOI 10.1155/2011/893873; Rangel-Gomez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066469; Rebec GV, 1998, ALCOHOL CLIN EXP RES, V22, P32, DOI 10.1111/j.1530-0277.1998.tb03614.x; Schonberg T, 2014, NAT NEUROSCI, V17, P625, DOI 10.1038/nn.3673; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Talmi D, 2008, J NEUROSCI, V28, P360, DOI 10.1523/JNEUROSCI.4028-07.2008; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; VANKOV A, 1995, EUR J NEUROSCI, V7, P1180, DOI 10.1111/j.1460-9568.1995.tb01108.x; Wills T A, 1994, J Subst Abuse, V6, P1, DOI 10.1016/S0899-3289(94)90039-6; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wittmann BC, 2008, NEURON, V58, P967, DOI 10.1016/j.neuron.2008.04.027; Zuckerman M, 2000, J PERS, V68, P999, DOI 10.1111/1467-6494.00124	59	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159120	10.1371/journal.pone.0159120	http://dx.doi.org/10.1371/journal.pone.0159120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27415631	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500081
J	Lutsey, PL; Norby, FL; Gottesman, RF; Mosley, T; MacLehose, RF; Punjabi, NM; Shahar, E; Jack, CR; Alonso, A				Lutsey, Pamela L.; Norby, Faye L.; Gottesman, Rebecca F.; Mosley, Thomas; MacLehose, Richard F.; Punjabi, Naresh M.; Shahar, Eyal; Jack, Clifford R., Jr.; Alonso, Alvaro			Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC)	PLOS ONE			English	Article							COGNITIVE-DECLINE; HEART HEALTH; CEREBROVASCULAR-DISEASE; INTERMITTENT HYPOXIA; STRUCTURAL-CHANGES; BLOOD-PRESSURE; OLDER WOMEN; DEMENTIA; IMPAIRMENT; STROKE	Background A growing body of literature has suggested that obstructive sleep apnea (OSA) and habitual short sleep duration are linked to poor cognitive function. Neuroimaging studies may provide insight into this relation. Objective We tested the hypotheses that OSA and habitual short sleep duration, measured at ages 54-73 years, would be associated with adverse brain morphology at ages 67-89 years. Methods Included in this analysis are 312 ARIC study participants who underwent in-home overnight polysomnography in 1996-1998 and brain MRI scans about 15 years later (2012-2013). Sleep apnea was quantified by the apnea-hypopnea index and categorized as moderate/ severe (>= 15.0 events/hour), mild (5.0-14.9 events/hour), or normal (<5.0 events/hour). Habitual sleep duration was categorized, in hours, as <7, 7 to <8, >= 8. MRI outcomes included number of infarcts (total, subcortical, and cortical) and white matter hyperintensity (WMH) and Alzheimer's disease signature region volumes. Multivariable adjusted logistic and linear regression models were used. All models incorporated inverse probability weighting, to adjust for potential selection bias. Results At the time of the sleep study participants were 61.7 (SD: 5.0) years old and 54% female; 19% had moderate/severe sleep apnea. MRI imaging took place 14.8 (SD: 1.0) years later, when participants were 76.5 (SD: 5.2) years old. In multivariable models which accounted for body mass index, neither OSA nor abnormal sleep duration were statistically significantly associated with odds of cerebral infarcts, WMH brain volumes or regional brain volumes. Conclusions In this community-based sample, mid-life OSA and habitually short sleep duration were not associated with later-life cerebral markers of vascular dementia and Alzheimer's disease. However, selection bias may have influenced our results and the modest sample size led to relatively imprecise associations.	[Lutsey, Pamela L.; Norby, Faye L.; MacLehose, Richard F.] Univ Minnesota, Minneapolis, MN 55455 USA; [Gottesman, Rebecca F.; Punjabi, Naresh M.] Johns Hopkins Univ, Baltimore, MD USA; [Mosley, Thomas] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Shahar, Eyal] Univ Arizona, Tucson, AZ USA; [Jack, Clifford R., Jr.] Mayo Clin, Rochester, MN USA; [Alonso, Alvaro] Emory Univ, Atlanta, GA 30322 USA	University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; University of Mississippi; University of Mississippi Medical Center; University of Arizona; Mayo Clinic; Emory University	Lutsey, PL (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	lutsey@umn.edu	Jack, Clifford R/F-2508-2010; Gottesman, Rebecca/ABA-8468-2020; Norby, Faye/FNA-7255-2022; Alonso, Alvaro/A-4917-2010; Punjabi, Naresh/EMH-1007-2022	Jack, Clifford R/0000-0001-7916-622X; Norby, Faye/0000-0002-1975-0405; Alonso, Alvaro/0000-0002-2225-8323; Lutsey, Pamela/0000-0002-1572-1340	National Heart, Lung, and Blood Institute [U01HL53934, U01HL64360, HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; NHLBI [R01-HL70825];  [R21 HL121412]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL096917, U01HL096812, U01HL096814, U01HL096902, U01HL096899] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The ARIC portion of the SHHS was supported by National Heart, Lung, and Blood Institute cooperative agreements U01HL53934 (University of Minnesota) and U01HL64360 (Johns Hopkins University). The ARIC is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). Neurocognitive data is collected by U01 HL096812, HL096814, HL096899, HL096902, HL096917 from the NHLBI and the National Institute of Neurological Disorders and Stroke, and with previous brain MRI examinations funded by R01-HL70825 from the NHLBI. This study was additionally supported by grant R21 HL121412 to Dr. Lutsey.	Alonso A, 2009, J NEUROL NEUROSUR PS, V80, P1194, DOI 10.1136/jnnp.2009.176818; Alzheimer's Association Report, 2015, ALZHEIMERS DEMENT, V11, P332; Amlander C, 2009, BASICS SLEEP GUIDE; Bliwise DL, 2002, J PSYCHOSOM RES, V53, P539, DOI 10.1016/S0022-3999(02)00436-1; Born J, 2012, PSYCHOL RES-PSYCH FO, V76, P192, DOI 10.1007/s00426-011-0335-6; Buratti L, 2014, J ALZHEIMERS DIS, V38, P445, DOI 10.3233/JAD-131046; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Durgan DJ, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000091; Eguchi K, 2005, AM J HYPERTENS, V18, P1489, DOI 10.1016/j.amjhyper.2005.05.032; Elias PK, 1997, DIABETES CARE, V20, P1388, DOI 10.2337/diacare.20.9.1388; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Gottesman RF, 2014, JAMA NEUROL, V71, P1218, DOI 10.1001/jamaneurol.2014.1646; Gottesman RF, 2014, AM J EPIDEMIOL, V179, P956, DOI 10.1093/aje/kwu020; Gottlieb DJ, 2004, NEUROLOGY, V63, P664, DOI 10.1212/01.WNL.0000134671.99649.32; Gregg EW, 2000, ARCH INTERN MED, V160, P174, DOI 10.1001/archinte.160.2.174; Harbison J, 2003, NEUROLOGY, V61, P959, DOI 10.1212/01.WNL.0000086818.57992.B8; Hernan MA, 2008, EPIDEMIOLOGY, V19, P448, DOI 10.1097/EDE.0b013e31816bbe14; INVESTIGATORS TA, 1989, AM J EPIDEMIOL, V129, P687; Jack CR, 2001, J MAGN RESON IMAGING, V14, P668, DOI 10.1002/jmri.10011; Joo EY, 2010, SLEEP, V33, P235, DOI 10.1093/sleep/33.2.235; Kadotani H, 2001, JAMA-J AM MED ASSOC, V285, P2888, DOI 10.1001/jama.285.22.2888; Kalaria RN, 2004, RESP PHYSIOL NEUROBI, V140, P53, DOI 10.1016/j.resp.2004.01.003; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kantarci K, 2009, NEUROLOGY, V72, P1519, DOI 10.1212/WNL.0b013e3181a2e864; Knopman DS, 2015, STROKE, V46, P433, DOI 10.1161/STROKEAHA.114.007847; Logroscino G, 2004, BMJ-BRIT MED J, V328, P548, DOI 10.1136/bmj.37977.495729.EE; Lutsey PL, 2015, SLEEP, V38, P877; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Munoz R, 2006, STROKE, V37, P2317, DOI 10.1161/01.STR.0000236560.15735.0f; Nair D, 2011, AM J RESP CRIT CARE, V184, P1305, DOI 10.1164/rccm.201107-1173OC; Nishibayashi M, 2008, J CLIN SLEEP MED, V4, P242; Ortman JM, 2014, AGING NATION OLDER P; Pathan SS, 2011, EUR J NEUROL, V18, P888, DOI 10.1111/j.1468-1331.2010.03340.x; Placidi F, 1998, J SLEEP RES, V7, P288, DOI 10.1046/j.1365-2869.1998.00120.x; Population Division Department of Economic and Social Affairs United Nations, 2013, WORLD POP AG 2013; Quan SF, 1997, SLEEP, V20, P1077; Rawlings AM, 2014, ANN INTERN MED, V161, P785, DOI 10.7326/M14-0737; Raz L, 2013, NEUROLOGY, V80, P911, DOI 10.1212/WNL.0b013e3182840c9f; Redline S, 1998, SLEEP, V21, P759; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Staessen JA, 2007, HYPERTENSION, V49, P389, DOI 10.1161/01.HYP.0000258151.00728.d8; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; Tung A, 2005, NEUROSCIENCE, V134, P721, DOI 10.1016/j.neuroscience.2005.06.008; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Weuve J, 2012, EPIDEMIOLOGY, V23, P119, DOI 10.1097/EDE.0b013e318230e861; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yaouhi K, 2009, J SLEEP RES, V18, P36, DOI 10.1111/j.1365-2869.2008.00705.x	52	23	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158758	10.1371/journal.pone.0158758	http://dx.doi.org/10.1371/journal.pone.0158758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415826	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500037
J	Nakas, CT; Schutz, N; Werners, M; Leichtle, AB				Nakas, Christos T.; Schutz, Narayan; Werners, Marcus; Leichtle, Alexander B.			Accuracy and Calibration of Computational Approaches for Inpatient Mortality Predictive Modeling	PLOS ONE			English	Article							HEALTH-CARE; BIG DATA; RISK; ANALYTICS	Electronic Health Record (EHR) data can be a key resource for decision-making support in clinical practice in the "big data" era. The complete database from early 2012 to late 2015 involving hospital admissions to Inselspital Bern, the largest Swiss University Hospital, was used in this study, involving over 100,000 admissions. Age, sex, and initial laboratory test results were the features/variables of interest for each admission, the outcome being inpatient mortality. Computational decision support systems were utilized for the calculation of the risk of inpatient mortality. We assessed the recently proposed Acute Laboratory Risk of Mortality Score (ALaRMS) model, and further built generalized linear models, generalized estimating equations, artificial neural networks, and decision tree systems for the predictive modeling of the risk of inpatient mortality. The Area Under the ROC Curve (AUC) for ALaRMS marginally corresponded to the anticipated accuracy (AUC = 0.858). Penalized logistic regression methodology provided a better result (AUC = 0.872). Decision tree and neural network-based methodology provided even higher predictive performance (up to AUC = 0.912 and 0.906, respectively). Additionally, decision tree-based methods can efficiently handle Electronic Health Record (EHR) data that have a significant amount of missing records (in up to >50% of the studied features) eliminating the need for imputation in order to have complete data. In conclusion, we show that statistical learning methodology can provide superior predictive performance in comparison to existing methods and can also be production ready. Statistical modeling procedures provided unbiased, well-calibrated models that can be efficient decision support tools for predicting inpatient mortality and assigning preventive measures.	[Nakas, Christos T.; Schutz, Narayan; Leichtle, Alexander B.] Univ Bern, Univ Hosp Bern, Ctr Lab Med, Univ Inst Clin Chem,Inselspital, Bern, Switzerland; [Nakas, Christos T.] Univ Thessaly, Lab Biometry, Volos, Greece; [Werners, Marcus] Univ Bern, Univ Hosp Bern, Cent Controlling Unit, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Thessaly; University of Bern; University Hospital of Bern	Leichtle, AB (corresponding author), Univ Bern, Univ Hosp Bern, Ctr Lab Med, Univ Inst Clin Chem,Inselspital, Bern, Switzerland.	alexander.leichtle@insel.ch	Leichtle, Alexander/C-7262-2011; Nakas, Christos T/F-3052-2011; PAN, ZEQIANG/X-6341-2018	Nakas, Christos T/0000-0003-4155-722X; Schutz, Narayan/0000-0001-5069-407X				Bates DW, 2014, HEALTH AFFAIR, V33, P1123, DOI 10.1377/hlthaff.2014.0041; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benitez JM, 2012, J STAT SOFT; Boef AGC, 2013, EPIDEMIOLOGY, V24, P937, DOI 10.1097/01.ede.0000434433.14388.a1; Elkan C, 2001, OBTAINING CALIBRATED; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Froom P, 2006, CLIN CHEM, V52, P325, DOI 10.1373/clinchem.2005.059030; Hardin JW, 2012, GEN ESTIMATING EQUAT; Hardison J E, 1979, N Engl J Med, V300, P193, DOI 10.1056/NEJM197901253000410; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Kuhn M, C50 C5 0 DECISION TR; Lee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127428; Leichtle A, 2015, LABORATORIUMSMEDIZIN, V39, P97, DOI 10.1515/labmed-2015-0033; Novack V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012184; Raghupathi W, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-3; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roski J, 2014, HEALTH AFFAIR, V33, P1115, DOI 10.1377/hlthaff.2014.0147; Smolin B, 2015, INT J CLIN PRACT, V69, P501, DOI 10.1111/ijcp.12564; Su YS, 2011, J STAT SOFTW, V45, P1; Tabak YP, 2007, MED CARE, V45, P789, DOI 10.1097/MLR.0b013e31803d3b41; Tabak YP, 2014, J AM MED INFORM ASSN, V21, P455, DOI 10.1136/amiajnl-2013-001790; Teich N, 2004, LANCET, V363, P1326, DOI 10.1016/S0140-6736(04)16015-7; Toga AW, 2015, J AM MED INFORM ASSN, V22, P1126, DOI 10.1093/jamia/ocv077; Wickham H., 2015, R PACKAGES ORGANIZE; Wickham H., 2018, GRAMMAR DATA MANIPUL; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Yuan M, 2005, J AM STAT ASSOC, V100, P1215, DOI 10.1198/016214505000000367	28	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159046	10.1371/journal.pone.0159046	http://dx.doi.org/10.1371/journal.pone.0159046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414408	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500064
J	Tang, X; Miao, QG; Yu, SS; Quan, YN				Tang, Xing; Miao, Qiguang; Yu, Shangshang; Quan, Yining			A Data-Based Approach to Discovering Multi-Topic Influential Leaders	PLOS ONE			English	Article							NETWORKS	Recently, increasing numbers of users have adopted microblogging services as their main information source. However, most of them find themselves drowning in the millions of posts produced by other users every day. To cope with this, identifying a set of the most influential people is paramount. Moreover, finding a set of related influential users to expand the coverage of one particular topic is required in real world scenarios. Most of the existing algorithms in this area focus on topology-related methods such as PageRank. These methods mine link structures to find the expected influential rank of users. However, because they ignore the interaction data, these methods turn out to be less effective in social networks. In reality, a variety of topics exist within the information diffusing through the network. Because they have different interests, users play different roles in the diffusion of information related to different topics. As a result, distinguishing influential leaders according to different topics is also worthy of research. In this paper, we propose a multi-topic influence diffusion model (MTID) based on traces acquired from historic information. We decompose the influential scores of users into two parts: the direct influence determined by information propagation along the link structure and indirect influence that extends beyond the restrictions of direct follower relationships. To model the network from a multi-topical viewpoint, we introduce topic pools, each of which represents a particular topic information source. Then, we extract the topic distributions from the traces of tweets, determining the influence propagation probability and content generation probability. In the network, we adopt multiple ground nodes representing topic pools to connect every user through bidirectional links. Based on this multi-topical view of the network, we further introduce the topic-dependent rank (TD-Rank) algorithm to identify the multi-topic influential users. Our algorithm not only effectively overcomes the shortages of PageRank but also effectively produces a measure of topic-related rank. Extensive experiments on a Weibo dataset show that our model is both effective and robust.	[Tang, Xing; Miao, Qiguang; Yu, Shangshang; Quan, Yining] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China	Xidian University	Miao, QG (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China.	qgmiao@126.com			National Natural Science Foundations of China [61472302, 61272280, U1404620, 41271447]; Open Projects Program of National Laboratory of Pattern Recognition [201600031]; Program for New Century Excellent Talents in University [NCET-12-0919]; Fundamental Research Funds for the Central Universities [K5051203020, K5051303018, JB150313, JB150317, BDY081422]; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund; Natural Science Foundation of Shaanxi Province [2010JM8027]; Creative Project of the Science and Technology State of xi'an [CXY1441(1)]; State Key Laboratory of Geo-information Engineering [SKLGIE2014-M-4-4]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Open Projects Program of National Laboratory of Pattern Recognition; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund; Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Creative Project of the Science and Technology State of xi'an; State Key Laboratory of Geo-information Engineering	The work was jointly supported by the National Natural Science Foundations of China under grant No. 61472302, 61272280, U1404620, and 41271447; The Open Projects Program of National Laboratory of Pattern Recognition (201600031); The Program for New Century Excellent Talents in University under grant No. NCET-12-0919; The Fundamental Research Funds for the Central Universities under grant No. K5051203020, K5051303018, JB150313, JB150317, and BDY081422; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase); Natural Science Foundation of Shaanxi Province, under grant No.2010JM8027; The Creative Project of the Science and Technology State of xi'an under grant No. CXY1441(1); and The State Key Laboratory of Geo-information Engineering under grant No. SKLGIE2014-M-4-4.	[Anonymous], 1999, PAGERANK CITATION RA; Bakshy E., 2011, P 4 ACM INT C WEB SE, P65, DOI DOI 10.1145/1935826.1935845; Barbieri N, 2013, KNOWL INF SYST, V37, P555, DOI 10.1007/s10115-013-0646-6; Benevenuto F., 2010, P COLLABORATION ELEC, VVolume 6, P12; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Brin S, 2012, COMPUT NETW, V56, P3825, DOI 10.1016/j.comnet.2012.10.007; Cha M., 2010, INT AAAI C WEB SOC M; Chen CY, 2014, SIGIR'14: PROCEEDINGS OF THE 37TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P1203, DOI 10.1145/2600428.2609545; Chen S, 2015, PROC VLDB ENDOW, V8, P666, DOI 10.14778/2735703.2735706; Cheng SQ, 2014, SIGIR'14: PROCEEDINGS OF THE 37TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P475, DOI 10.1145/2600428.2609592; Goyal A, 2011, PROC VLDB ENDOW, V5, P73, DOI 10.14778/2047485.2047492; Guille A, 2013, SIGMOD REC, V42, P17; Guo J, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P199; Kempe D, 2003, P 9 ACM SIGKDD INT C, V2003, P137, DOI DOI 10.1145/956750.956769; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Kolari P., 2006, P INT C WORLD WID WE, P22; Li Q, 2014, PHYSICA A, V404, P47, DOI 10.1016/j.physa.2014.02.041; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Richardson M., 2002, P 8 ACM SIGKDD INT C, P61, DOI DOI 10.1145/775047.775057; Shanahan JG, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P2323, DOI 10.1145/2783258.2789993; Su H, 2012, LEARNING DIVERSIFY E, P330; Wang Y, 2013, AAAI C ART INT; Weng J., 2010, P 3 ACM INT C WEB SE, P261, DOI [10.1145/1718487.1718520, DOI 10.1145/1718487.1718520]; Zhu T, 2014, INFORM SCIENCES, V278, P535, DOI 10.1016/j.ins.2014.03.070	25	15	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158855	10.1371/journal.pone.0158855	http://dx.doi.org/10.1371/journal.pone.0158855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415429	gold, Green Submitted, Green Published			2022-12-27	WOS:000379579500044
J	Watson, CV; Feng, J; Valentin-Blasini, L; Stanelle, R; Watson, CH				Watson, Christina Vaughan; Feng, June; Valentin-Blasini, Liza; Stanelle, Rayman; Watson, Clifford H.			Method for the Determination of Ammonia in Mainstream Cigarette Smoke Using Ion Chromatography	PLOS ONE			English	Article							TOBACCO; NICOTINE	Ammonia in mainstream smoke is present in both the particulate and vapor phases. The presence of ammonia in the cigarette filler material and smoke is of significance because of the potential role ammonia could have in raising the "smoke pH." An increased smoke pH could shift a fraction of total nicotine to free-base nicotine, which is reportedly more rapidly absorbed by the smoker. Methods measuring ammonia in smoke typically employ acid filled impingers to trap the smoke. We developed a fast, reliable method to measure ammonia in mainstream smoke without the use of costly and time consuming impingers to examine differences in ammonia delivery. The method uses both a Cambridge filter pad and a Tedlar bag to capture particulate and vapor phases of the smoke. We quantified ammonia levels in the mainstream smoke of 50 cigarette brands from 5 manufacturers. Ammonia levels ranged from approximately 1 mu g to 23 mu g per cigarette for ISO smoking conditions and 38 mu g to 67 mu g per cigarette for Canadian intense smoking conditions and statistically significance differences were observed between brands and manufacturers. Our findings suggest that ammonia levels vary by brand and are higher under Canadian intense smoking conditions.	[Watson, Christina Vaughan; Feng, June; Valentin-Blasini, Liza; Stanelle, Rayman; Watson, Clifford H.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Tobacco & Volatiles Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Watson, CV (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Tobacco & Volatiles Branch, Atlanta, GA 30333 USA.	cvaughan@cdc.gov						[Anonymous], 33082012 ISO; [Anonymous], 34021999 ISO; Ashley David L, 2009, Handb Exp Pharmacol, P437, DOI 10.1007/978-3-540-69248-5_15; Baker RR, 2004, FOOD CHEM TOXICOL, V42, pS3, DOI 10.1016/S0278-6915(03)00189-3; Callicutt CH, 2014, BEITR TABAKFORSCH, V22, P71; Counts ME, 2006, REGUL TOXICOL PHARM, V46, P225, DOI 10.1016/j.yrtph.2006.07.002; Food and Drug Administration, HARMF POT HARMF CONS; Hammond D, 2008, TOB CONTROL, V17, pI24, DOI 10.1136/tc.2008.024778; Hind JD, 1968, Patent, Patent No. [3,386,449, 3386449]; Huang Chorng B., 2003, Beitraege zur Tabakforschung International, V20, P389; Hundall CF, FREE NICOTINE AMMONI; JOHNSON R. W., 1989, INTRAPLATE VOLCANISM, P7; Mottier N, 2011, J AGR FOOD CHEM, V59, P92, DOI 10.1021/jf103772c; Rodgman A., 2008, CHEM COMPONENTS TOBA, DOI [10.1201/9781420078848, DOI 10.1201/9781420078848]; Seeman JI, 2007, CHEM RES TOXICOL, V20, P326, DOI 10.1021/tx600290v; Seligman RB, 1969, Patent, Patent No. [3,411,515, 3411515]; Stevenson T, 2008, AM J PUBLIC HEALTH, V98, P1184, DOI 10.2105/AJPH.2007.121657; Taylor JK, 1987, QUALITY ASSURANCE CH; Watson CV, 2015, REGUL TOXICOL PHARM, V72, P266, DOI 10.1016/j.yrtph.2015.04.019; World Health Organization, STAND OP PROC INT SM	20	3	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159126	10.1371/journal.pone.0159126	http://dx.doi.org/10.1371/journal.pone.0159126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415766	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500082
J	Balestrino, D; Quintana, M; Charbonnel, N; Forestier, C; Lartigue, C; Souweine, B				Balestrino, Damien; Quintana, Mercedes; Charbonnel, Nicolas; Forestier, Christiane; Lartigue, Claire; Souweine, Bertrand			Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; BLOOD-STREAM INFECTION; LOCK SOLUTIONS; STAPHYLOCOCCUS-AUREUS; CANDIDA-ALBICANS; HEMODIALYSIS CATHETERS; HEPARIN; BIOFILM; ERADICATION; PREVENTION	Background and Objectives Interdialytic lock solutions should maintain catheter patency and prevent catheter infections. We aimed to determine in which conditions injectable anticoagulant agents (IAAs) combined with ethanol are compatible and to assess the antibiofilm activity of the selected combination and its effects on dialysis catheters (DC). Methods The solubility and compatibility of unfractionated heparin (UFH), low molecular weight heparins (LMWHs), heparinoids and fondaparinux (50 to 2,500 U/mL) in 30 to 70% ethanol were determined by visual observation. The stability of enoxaparin in ethanol and the ethanol content were assessed by high performance liquid chromatography (HPLC) and titrimetric control, respectively. The bactericidal effect was determined on 24h-old biofilms embedded in silicone-DC. The integrity of polyurethane-DC immersed in anticoagulant-ethanol was assessed by gas chromatography-mass spectrometry (GC-MS) and compared with previously published results. Results The compatibility of IAAs and ethanol varied according to IAA type and concentration, and ethanol content. UFH in 40% ethanol was not compatible, whatever the UFH concentration used. Established limits of compatibility of enoxaparin, nadroparin, dalteparin and tinzaparin in 40% ethanol were 1350, 575, 307 and 207 U/ml, respectively, and up to 300 U/ml for danaparoid and 1 mg/mL for fondaparinux. Enoxaparin 400 U/mL in 40% ethanol (Enox/Eth) eradicated biofilm after 4 hours of exposure for Staphylococcus epidermidis, Pseudomonas aeruginosa and Candida albicans and after 24 hours for Klebsiella pneumoniae and S. aureus. Aliphatic carbonate and alcohol compounds were released by polyurethane-DC after Enox/Eth exposure, as after 40% ethanol or saline exposure. There was no significant difference between the amounts released after 30 minutes of exposure to Enox/Eth and 15 days to saline. Conclusions A 40% ethanol solution can be combined with all IAAs but UFH. Enox/Eth was effective as an anti-biofilm agent with minor impacts on DC integrity and could be a useful interdialytic lock solution.	[Balestrino, Damien; Forestier, Christiane; Souweine, Bertrand] Univ Auvergne, Clermont Univ, Lab Microorganismes Genome & Environm, UMR CNRS 6023, F-63000 Clermont Ferrand, France; [Balestrino, Damien; Charbonnel, Nicolas; Forestier, Christiane] Univ Auvergne, Fac Pharm, Bacteriol Lab, F-63001 Clermont Ferrand, France; [Quintana, Mercedes] Univ Auvergne, Fac Pharm, Lab Chim Analyt & Spectrometrie Masse, F-63001 Clermont Ferrand, France; [Quintana, Mercedes; Lartigue, Claire] IMTV, INSERM, UMR 990, F-63005 Clermont Ferrand, France; [Souweine, Bertrand] CHU Clermont Ferrand, Hop Gabriel Montpied, Reanimat Med, F-63000 Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand	Souweine, B (corresponding author), Univ Auvergne, Clermont Univ, Lab Microorganismes Genome & Environm, UMR CNRS 6023, F-63000 Clermont Ferrand, France.; Souweine, B (corresponding author), CHU Clermont Ferrand, Hop Gabriel Montpied, Reanimat Med, F-63000 Clermont Ferrand, France.	bsouweine@chu-clermontferrand.fr	quintana, mercedes/X-9609-2019; souweine, bertrand/HHR-8972-2022	quintana, mercedes/0000-0002-2069-907X; BALESTRINO, Damien/0000-0001-5378-0379	Auvergne FEDER (Fonds Europeen de Developpement Economique et Regional); Hemotech laboratories; Auvergne FEDER	Auvergne FEDER (Fonds Europeen de Developpement Economique et Regional); Hemotech laboratories; Auvergne FEDER(Region Auvergne-Rhone-Alpes)	This work was supported by a financial support from the Auvergne FEDER (Fonds Europeen de Developpement Economique et Regional) and a grant from Hemotech laboratories. DualCath (R) used in this study were specifically designed and provided by Hemotech, Ramonville, France.; This work was supported by a financial support from the Auvergne FEDER and a grant from Hemotech laboratories. The authors would like to thank Dr Helene Bargnoux for helpful discussions, Elsa Aigouy for her technical assistance, Damien Bouvier for determination of albumin concentrations and Jeffrey Watts for his help in preparing the manuscript.	[Anonymous], 2003, ICH REVISION, V2; [Anonymous], 2005, EUROPEAN PHARMACOPEI, V5.0, P1862; Balestrino D, 2009, NEPHROL DIAL TRANSPL, V24, P3204, DOI 10.1093/ndt/gfp187; Broom JK, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-146; Calvet L, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1533-2; Canaud B, 1999, NEPHROL DIAL TRANSPL, V14, P692, DOI 10.1093/ndt/14.3.692; Chauhan A, 2012, ANTIMICROB AGENTS CH, V56, P6310, DOI 10.1128/AAC.01606-12; Collins AJ, 2009, AM J KIDNEY DIS    S, V53, pS8; Crnich CJ, 2005, INFECT CONT HOSP EP, V26, P708, DOI 10.1086/502607; Davenport A, 2013, HEMODIAL INT, V17, pS28, DOI 10.1111/hdi.12086; Dixon JJ, 2012, NEPHROL DIAL TRANSPL, V27, P3575, DOI 10.1093/ndt/gfs081; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Guenu S, 2007, RAPID COMMUN MASS SP, V21, P229, DOI 10.1002/rcm.2837; Guyatt GH, 2012, CHEST, V141, p53S, DOI 10.1378/chest.11-2288; Ho G, 2013, AM J KIDNEY DIS, V61, P525, DOI 10.1053/j.ajkd.2012.09.015; Jain G, 2009, CLIN J AM SOC NEPHRO, V4, P1787, DOI 10.2215/CJN.03920609; Jaulmes P, 1958, CHIM ANAL, V40, P413; Perez-Granda MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091838; KANWAR YS, 1979, P NATL ACAD SCI USA, V76, P4493, DOI 10.1073/pnas.76.9.4493; Krishnasami Z, 2002, KIDNEY INT, V61, P1136, DOI 10.1046/j.1523-1755.2002.00201.x; Landry DL, 2010, CLIN J AM SOC NEPHRO, V5, P1799, DOI 10.2215/CJN.01270210; Lesens O, 2013, PRESENTED AT THE ICA, P952; Malo J, 2010, ASAIO J, V56, P42, DOI 10.1097/MAT.0b013e3181c84e61; Maya ID, 2010, CLIN J AM SOC NEPHRO, V5, P1458, DOI 10.2215/CJN.01230210; Mermel LA, 2014, J ANTIMICROB CHEMOTH, V69, P2611, DOI 10.1093/jac/dku182; Miceli MH, 2012, ANTIMICROB AGENTS CH, V56, P148, DOI 10.1128/AAC.05061-11; Moran JE, 2008, SEMIN DIALYSIS, V21, P490, DOI 10.1111/j.1525-139X.2008.00466.x; Msakni N, 2013, RAPID COMMUN MASS SP, V27, P2343, DOI 10.1002/rcm.6691; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Olsson JV, 2014, POLYM CHEM-UK, V5, P6651, DOI 10.1039/c4py00911h; Oncu S, 2014, CLIN NUTR, V33, P360, DOI 10.1016/j.clnu.2013.04.014; Peters BM, 2013, ANTIMICROB AGENTS CH, V57, P74, DOI 10.1128/AAC.01599-12; Polaschegg HD, 2005, ASAIO J, V51, P230, DOI 10.1097/01.MAT.0000159742.15560.93; Polkinghorne KR, 2002, AM J KIDNEY DIS, V40, P990, DOI 10.1053/ajkd.2002.36331; Qu Y, 2009, J MED MICROBIOL, V58, P442, DOI 10.1099/jmm.0.006387-0; Rane HS, 2012, ANTIMICROB AGENTS CH, V56, P4487, DOI 10.1128/AAC.00263-12; Rayner HC, 2010, SEMIN DIALYSIS, V23, P6, DOI 10.1111/j.1525-139X.2009.00675.x; Renal Data System, 2003, USRDS 2003 ANNUAL DA; Restrepo D, 2015, J PEDIATR SURG, V50, P472, DOI 10.1016/j.jpedsurg.2014.07.003; Sanders J, 2008, J ANTIMICROB CHEMOTH, V62, P809, DOI 10.1093/jac/dkn284; Saxena AK, 2002, PHARMACOTHERAPY, V22, P105, DOI 10.1592/phco.22.1.105.33507; Schilcher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084869; Shanks RMQ, 2005, INFECT IMMUN, V73, P4596, DOI 10.1128/IAI.73.8.4596-4606.2005; Shanks RMQ, 2006, NEPHROL DIAL TRANSPL, V21, P2247, DOI 10.1093/ndt/gfl170; Slobbe L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010840; Snaterse M, 2010, J HOSP INFECT, V75, P1, DOI 10.1016/j.jhin.2009.12.017; Souweine B, 2015, AM J RESP CRIT CARE, V191, P1024, DOI 10.1164/rccm.201408-1431OC; Speeckaert MM, 2013, NEPHROL DIAL TRANSPL, V28, P3090, DOI 10.1093/ndt/gft293; THORNTON DJ, 1983, BIOCHIM BIOPHYS ACTA, V757, P219, DOI 10.1016/0304-4165(83)90112-5; Volpi N, 1996, J CHROMATOGR B, V685, P27, DOI 10.1016/0378-4347(96)00154-5; Williams AW, 2012, CLIN J AM SOC NEPHRO, V7, P1664, DOI 10.2215/CJN.04970512	51	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159475	10.1371/journal.pone.0159475	http://dx.doi.org/10.1371/journal.pone.0159475			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441664	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500079
J	Coll-Bonfill, N; Peinado, VI; Pisano, MV; Parrizas, M; Blanco, I; Evers, M; Engelmann, JC; Garcia-Lucio, J; Tura-Ceide, O; Meister, G; Barbera, JA; Musri, MM				Coll-Bonfill, Nuria; Peinado, Victor I.; Pisano, Maria V.; Parrizas, Marcelina; Blanco, Isabel; Evers, Maurits; Engelmann, Julia C.; Garcia-Lucio, Jessica; Tura-Ceide, Olga; Meister, Gunter; Albert Barbera, Joan; Musri, Melina M.			Slug Is Increased in Vascular Remodeling and Induces a Smooth Muscle Cell Proliferative Phenotype	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; OBSTRUCTIVE PULMONARY-DISEASE; BREAST-CANCER CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; GROWTH-FACTOR; PROGENITOR CELLS; MILD COPD; MODULATION	Objective Previous studies have confirmed Slug as a key player in regulating phenotypic changes in several cell models, however, its role in smooth muscle cells (SMC) has never been assessed. The purpose of this study was to evaluate the expression of Slug during the phenotypic switch of SMC in vitro and throughout the development of vascular remodeling. Methods and Results Slug expression was decreased during both cell-to-cell contact and TGF beta 1 induced SMC differentiation. Tumor necrosis factor-alpha (TNF alpha), a known inductor of a proliferative/dedifferentiated SMC phenotype, induces the expression of Slug in SMC. Slug knockdown blocked TNF alpha-induced SMC phenotypic change and significantly reduced both SMC proliferation and migration, while its overexpression blocked the TGF beta 1-induced SMC differentiation and induced proliferation and migration. Genome-wide transcriptomic analysis showed that in SMC, Slug knockdown induced changes mainly in genes related to proliferation and migration, indicating that Slug controls these processes in SMC. Notably, Slug expression was significantly up-regulated in lungs of mice using a model of pulmonary hypertension-related vascular remodeling. Highly remodeled human pulmonary arteries also showed an increase of Slug expression compared to less remodeled arteries. Conclusions Slug emerges as a key transcription factor driving SMC towards a proliferative phenotype. The increased Slug expression observed in vivo in highly remodeled arteries of mice and human suggests a role of Slug in the pathogenesis of pulmonary vascular diseases.	[Coll-Bonfill, Nuria; Peinado, Victor I.; Blanco, Isabel; Garcia-Lucio, Jessica; Tura-Ceide, Olga; Albert Barbera, Joan; Musri, Melina M.] Univ Barcelona, Hosp Clin, Dept Pulm Med, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Peinado, Victor I.; Tura-Ceide, Olga; Albert Barbera, Joan] Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain; [Parrizas, Marcelina] CIBERDEM, IDIBAPS, Diabet & Obes Lab, Barcelona, Spain; [Evers, Maurits; Engelmann, Julia C.] Univ Regensburg, Inst Funct Genom, Regensburg, Germany; [Meister, Gunter] Univ Regensburg, Lab RNA Biol, Biochem Ctr Regensburg BZR, Regensburg, Germany; [Pisano, Maria V.; Musri, Melina M.] Univ Nacl Cordoba, INIMEC CONICET, Inst Invest Med Mercedes & Martin Ferreyra, Cordoba, Argentina	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Regensburg; University of Regensburg; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Musri, MM (corresponding author), Univ Barcelona, Hosp Clin, Dept Pulm Med, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.; Musri, MM (corresponding author), Univ Nacl Cordoba, INIMEC CONICET, Inst Invest Med Mercedes & Martin Ferreyra, Cordoba, Argentina.	mmusri@clinic.ub.es	Parrizas, Marcelina/AAS-3629-2021; Musri, Melina M/C-9078-2015; Evers, Maurits/A-9985-2016; Engelmann, Julia Catherine/AAF-5049-2021; Coll-Bonfill, Nuria/AAM-7251-2020; Tura-Ceide, Olga/D-6120-2014; Evers, Maurits/B-3672-2011	Musri, Melina M/0000-0002-9159-5497; Engelmann, Julia Catherine/0000-0002-4160-5474; Tura-Ceide, Olga/0000-0003-4334-9790; Parrizas, Marcelina/0000-0003-1296-8302; Peinado, Victor Ivo/0000-0001-9793-9433; Evers, Maurits/0000-0003-1252-7603	Instituto de Salud Carlos III (ISCIII) [FIS PI13/0083, FIS PS09/00536]; Sociedad Espanola de Pneumologia y Cirugia Toracica (SEPAR) [SEPAR-2009]; Sara Borrell contract from ISCIII; ISCIII; CONICET; Fundacion Contra la Hipertension Pulmonar (FCHP); Fondo Europeo de Desarrollo Regional (FEDER). Union Europea. Una manera de hacer Europa	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Sociedad Espanola de Pneumologia y Cirugia Toracica (SEPAR); Sara Borrell contract from ISCIII; ISCIII(Instituto de Salud Carlos III); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Contra la Hipertension Pulmonar (FCHP); Fondo Europeo de Desarrollo Regional (FEDER). Union Europea. Una manera de hacer Europa	This work was supported by the Instituto de Salud Carlos III (ISCIII), grants FIS PI13/0083 to VIP and FIS PS09/00536 to JAB, and the Sociedad Espanola de Pneumologia y Cirugia Toracica (SEPAR), grant SEPAR-2009 to MMM. MMM is recipient of a Sara Borrell contract from ISCIII. JGL is recipient of a Pre-doctoral contract from the ISCIII. MVP is recipient of a Post-doctoral contract from CONICET. This work was also funded by the Fundacion Contra la Hipertension Pulmonar (FCHP). "Cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER). Union Europea. Una manera de hacer Europa". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; Ali MS, 2013, J CEREBR BLOOD F MET, V33, P1564, DOI 10.1038/jcbfm.2013.109; Aomatsu K, 2012, INVEST OPHTH VIS SCI, V53, P751, DOI 10.1167/iovs.11-8222; BARATH P, 1990, AM J PATHOL, V137, P503; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Ciuclan L, 2011, AM J RESP CRIT CARE, V184, P1171, DOI 10.1164/rccm.201103-0412OC; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Coll-Bonfill N, 2016, PFLUG ARCH EUR J PHY, V468, P1071, DOI 10.1007/s00424-016-1821-x; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; Diez M, 2010, CARDIOVASC RES, V88, P502, DOI 10.1093/cvr/cvq236; Fang F, 2011, CIRC RES, V108, P797, DOI 10.1161/CIRCRESAHA.111.240655; Hannus M, 2014, NUCLEIC ACIDS RES, V42, P8049, DOI 10.1093/nar/gku480; Igura T, 1996, ARTERIOSCL THROM VAS, V16, P1524, DOI 10.1161/01.ATV.16.12.1524; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jang WG, 2004, PROTEOMICS, V4, P3383, DOI 10.1002/pmic.200400972; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mistry DS, 2014, STEM CELLS, V32, P3209, DOI 10.1002/stem.1809; Morales M, 2014, EMBO MOL MED, V6, P865, DOI 10.15252/emmm.201303675; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Murray SA, 2006, CELL CYCLE, V5, P2566, DOI 10.4161/cc.5.22.3502; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Owens Gary K, 2007, Novartis Found Symp, V283, P174; OWENS GK, 1995, PHYSIOL REV, V75, P487; Peinado VI, 1998, AM J PHYSIOL-LUNG C, V274, pL908, DOI 10.1152/ajplung.1998.274.6.L908; Perez-Mancera PA, 2006, CYTOGENET GENOME RES, V114, P24, DOI 10.1159/000091924; Pitsiou G, 2002, RESP MED, V96, P594, DOI 10.1053/rmed.2002.1322; Pizarro S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106163; Qiao LN, 2014, CIRCULATION, V129, P692, DOI 10.1161/CIRCULATIONAHA.113.003734; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Rieder F, 2011, AM J PATHOL, V179, P2660, DOI 10.1016/j.ajpath.2011.07.042; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Santos S, 2002, EUR RESPIR J, V19, P632, DOI 10.1183/09031936.02.00245902; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Scharadin TM, 2014, J INVEST DERMATOL, V134, P1811, DOI 10.1038/jid.2014.79; Schultz K, 2006, AM J PHYSIOL-HEART C, V290, pH2528, DOI 10.1152/ajpheart.01077.2005; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Shirley SH, 2010, MOL CARCINOGEN, V49, P851, DOI 10.1002/mc.20674; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soleimani VD, 2012, MOL CELL, V47, P457, DOI 10.1016/j.molcel.2012.05.046; Song J, 1998, TISSUE CELL, V30, P324, DOI 10.1016/S0040-8166(98)80045-1; Starke RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071954; Stenmark KR, 2006, PHYSIOLOGY, V21, P134, DOI 10.1152/physiol.00053.2005; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Stone MR, J CELL SCI 22, V15, P3999; Storci G, 2010, J CELL PHYSIOL, V225, P682, DOI 10.1002/jcp.22264; Takabatake N, 2000, AM J RESP CRIT CARE, V161, P1179, DOI 10.1164/ajrccm.161.4.9903022; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Torreggiani E, 2012, J CELL MOL MED, V16, P740, DOI 10.1111/j.1582-4934.2011.01352.x; Wang XB, 2011, J BIOL CHEM, V286, P41589, DOI 10.1074/jbc.M111.250878; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Zhou CH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2210	56	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159460	10.1371/journal.pone.0159460	http://dx.doi.org/10.1371/journal.pone.0159460			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441378	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500076
J	Pardo, MHS; Centurion, AM; Eustaquio, PSF; Santana, RHC; Bruschi, SM; Santana, MJ				Souza Pardo, Mario Henrique; Centurion, Adriana Molina; Franco Eustaquio, Paulo Sergio; Carlucci Santana, Regina Helena; Bruschi, Sarita Mazzini; Santana, Marcos Jose			Evaluating the Influence of the Client Behavior in Cloud Computing	PLOS ONE			English	Article							SIMULATION; MODELS	This paper proposes a novel approach for the implementation of simulation scenarios, providing a client entity for cloud computing systems. The client entity allows the creation of scenarios in which the client behavior has an influence on the simulation, making the results more realistic. The proposed client entity is based on several characteristics that affect the performance of a cloud computing system, including different modes of submission and their behavior when the waiting time between requests (think time) is considered. The proposed characterization of the client enables the sending of either individual requests or group of Web services to scenarios where the workload takes the form of bursts. The client entity is included in the CloudSim, a framework for modelling and simulation of cloud computing. Experimental results show the influence of the client behavior on the performance of the services executed in a cloud computing system.	[Souza Pardo, Mario Henrique; Centurion, Adriana Molina; Franco Eustaquio, Paulo Sergio; Carlucci Santana, Regina Helena; Bruschi, Sarita Mazzini; Santana, Marcos Jose] Univ Sao Paulo, Inst Math & Comp Sci, Sao Carlos, SP, Brazil	Universidade de Sao Paulo	Pardo, MHS (corresponding author), Univ Sao Paulo, Inst Math & Comp Sci, Sao Carlos, SP, Brazil.	mhpardo@icmc.usp.br	Bruschi, Sarita Mazzini/E-6607-2011	Bruschi, Sarita Mazzini/0000-0003-4011-8583; Pardo, Mario Henrique de Souza/0000-0001-8457-0753	Brazilian Foundation FAPESP; Brazilian Foundation CNPq; Brazilian Foundation CAPES	Brazilian Foundation FAPESP; Brazilian Foundation CNPq; Brazilian Foundation CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors acknowledge the financial support from the Brazilian Foundations FAPESP, CNPq and CAPES for the projects under development at the Distributed System and Concurrent Program Group of the Computer Systems Department at ICMC-USP.	Al-Roomi M, 2013, INT J GRID DISTRIB, V6, P93, DOI 10.14257/ijgdc.2013.6.5.09; Ali-Eldin A, 2014, INT CONF UTIL CLOUD, P566, DOI 10.1109/UCC.2014.87; Armbrust M., 2009, CLOUDS BERKELEY VIEW, P07; Belalem G, 2010, LECT NOTES COMPUT SC, V6377, P189, DOI 10.1007/978-3-642-16167-4_25; Beloglazov A, 2012, FUTURE GENER COMP SY, V28, P755, DOI 10.1016/j.future.2011.04.017; Bhatt TP, 2012, SURVEY VIRTUALIZATIO, V1, P1; Bohn R. B., 2011, Proceedings of the 2011 IEEE World Congress on Services (SERVICES 2011), P594, DOI 10.1109/SERVICES.2011.105; Bolch G., 2006, QUEUEING NETWORKS MA; Buyya Rajkumar, 2009, 2009 International Conference on High Performance Computing & Simulation (HPCS), P1, DOI 10.1109/HPCSIM.2009.5192685; Buyya R, 2010, ENERGY EFFICIENT MAN, P12; Buyya R, 2010, LECT NOTES COMPUT SC, V6081, P13; Calheiros R. N., 2009, ARXIV09032525, P9; Calheiros RN, 2011, SOFTWARE PRACT EXPER, V41, P23, DOI 10.1002/spe.995; Casale G, 2008, INT CONF QUANT EVAL, P83, DOI 10.1109/QEST.2008.33; Casale G, 2012, IEEE T SOFTWARE ENG, V38, P1040, DOI 10.1109/TSE.2011.87; Centurion AM, 2012, 30 S BRAS RED COMP S, P422; Chung L, 2013, J SYST SOFTWARE, V86, P2242, DOI 10.1016/j.jss.2012.10.028; de Souza Pardo MH, 2016, CLOUD BROKER APPROAC, P63; Ding S, 2014, KNOWL-BASED SYST, V56, P216, DOI 10.1016/j.knosys.2013.11.014; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; FISCHER W, 1993, PERFORM EVALUATION, V18, P149, DOI 10.1016/0166-5316(93)90035-S; Fittkau Florian, 2012, Service-Oriented and Cloud Computing. First European Conference, ESOCC 2012. Proceedings, P200, DOI 10.1007/978-3-642-33427-6_15; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Garg S. K., 2011, Proceedings of the 2011 IEEE 4th International Conference on Utility and Cloud Computing (UCC 2011), P105, DOI 10.1109/UCC.2011.24; Goutam D, 2014, 2014 FIFTH INTERNATIONAL CONFERENCE ON THE APPLICATIONS OF DIGITAL INFORMATION AND WEB TECHNOLOGIES (ICADIWT), P171, DOI 10.1109/ICADIWT.2014.6814666; Guerout T, 2013, SIMUL MODEL PRACT TH, V39, P76, DOI 10.1016/j.simpat.2013.04.007; GUSELLA R, 1991, IEEE J SEL AREA COMM, V9, P203, DOI 10.1109/49.68448; Jain R, 1990, ART COMPUTER SYSTEMS; Jeyarani R., 2010, Proceedings 2010 10th IEEE/ACM International Conference on Cluster, Cloud and Grid Computing (CCGrid), P585, DOI 10.1109/CCGRID.2010.94; Kathiravelu Pradeeban, 2014, 2014 22nd Annual IEEE International Symposium on Modeling, Analysis and Simulation of Computer and Telecommunication Systems (MASCOTS). Proceedings, P490, DOI 10.1109/MASCOTS.2014.70; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Ma JT, 2016, LECT NOTES ELECTR EN, V348, P829, DOI 10.1007/978-81-322-2580-5_75; Medina A, 2001, NINTH INTERNATIONAL SYMPOSIUM ON MODELING, ANALYSIS AND SIMULATION OF COMPUTER AND TELECOMMUNICATION SYSTEMS, PROCEEDINGS, P346, DOI 10.1109/MASCOT.2001.948886; MENASCE DA, 2001, CAPACITY PLANNING WE; Mondal B, 2012, PROC TECH, V4, P783, DOI 10.1016/j.protcy.2012.05.128; Ningfang Mi, 2010, Journal of Internet Services and Applications, V1, P117, DOI 10.1007/s13174-010-0012-9; Overman E, 2015, A MATLAB TUTORIAL; Pacini E, 2014, DYNAMIC SCHEDULING B, V14, P1; Perret Q, 2013, 2013 IEEE 27TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS (WAINA), P757, DOI 10.1109/WAINA.2013.194; Sa T. Teixeira, 2014, CLOUD COMPUT, P127, DOI DOI 10.1007/978-3-319-10530-76.; Shi YX, 2011, IEEE INT C CL COMP, P595, DOI 10.1109/CLUSTER.2011.63; Tan G, 2015, CLOUD RESOURCE SCHED, V2015, P189; Youssef A, 2013, PERF EV COMP TEL SYS	43	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158291	10.1371/journal.pone.0158291	http://dx.doi.org/10.1371/journal.pone.0158291			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441559	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500011
J	Li, LB; Deng, CW; Chen, S; Zhang, SL; Wu, ZY; Hu, CJ; Zhang, FC; Li, YZ				Li, Liubing; Deng, Chuiwen; Chen, Si; Zhang, Shulan; Wu, Ziyan; Hu, Chaojun; Zhang, Fengchun; Li, Yongzhe			Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis	PLOS ONE			English	Article							CITRULLINATED PEPTIDE ANTIBODIES; 2010 AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; CLASSIFICATION CRITERIA; CARP ANTIBODIES; CCP ANTIBODIES; AUTOIMMUNITY; SPECIFICITY; ARTHRALGIA; COMPLEMENT	Objective The anti-carbamylated protein (CarP) antibody is a novel biomarker that might help in the diagnosis of rheumatoid arthritis (RA). We aim to assess the diagnostic value of anti-CarP antibody for RA. Methods We systematically searched PubMed, Embase, the Cochrane Library, Web of Science, and Scopus for studies published by December 15, 2015. Studies in any language that evaluated the utility of the anti-CarP antibody in the diagnosis of RA in which healthy donors or patients without arthritis or arthralgia served as controls were included. Two investigators independently evaluated studies for inclusion, assessed study quality and abstracted data. A bivariate mixed-effects model was used to summarize the diagnostic indexes from 7 eligible studies. Results The pooled sensitivity, specificity, and positive and negative likelihood ratios for anti-CarP antibody were 42% (95% CI, 38% to 45%), 96% (95% CI, 95% to 97%), 10.2 (95% CI, 7.5 to 13.9), and 0.61 (95% CI, 0.57 to 0.65), respectively. The summary diagnostic odds ratio was 17 (95% CI, 12 to 24), and the area under summary receiver operator characteristic curve was 80% (95% CI, 77% to 84%). Conclusion Anti-CarP antibody has a moderate value in the diagnosis of RA with high specificity but relatively low sensitivity.	[Li, Liubing; Deng, Chuiwen; Chen, Si; Zhang, Shulan; Wu, Ziyan; Hu, Chaojun; Zhang, Fengchun; Li, Yongzhe] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China; [Li, Liubing; Deng, Chuiwen; Chen, Si; Zhang, Shulan; Wu, Ziyan; Hu, Chaojun; Zhang, Fengchun; Li, Yongzhe] Peking Union Med Coll, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing, Peoples R China; [Chen, Si] Capital Med Univ, Beijing Anzhen Hosp, Dept Clin Lab, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Li, YZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China.; Li, YZ (corresponding author), Peking Union Med Coll, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing, Peoples R China.	yongzhelipumch@126.com	zhang, shulan/AAS-6912-2020		Research Special Fund for Public Welfare Industry of Health [201202004]; National Natural Science Foundation of China [81172857, 81373188, 81302591]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2011AA02A113]; Key Projects in the National Science and Technology Pillar Program in the Twelfth Five-year Plan Period [2014BAI07B00]; Capital Health Research and Development of Special Fund [2014-1-4011]	Research Special Fund for Public Welfare Industry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); Key Projects in the National Science and Technology Pillar Program in the Twelfth Five-year Plan Period; Capital Health Research and Development of Special Fund	This research was funded by Research Special Fund for Public Welfare Industry of Health (NO. 201202004; FCZ); National Natural Science Foundation of China (NO. 81172857, 81373188, 81302591; http://www.nsfc.gov.cn/publish/portal1/; YZL); Chinese National High Technology Research and Development Program, Ministry of Science and Technology (NO. 2011AA02A113; http://www.most.gov.cn/eng/; YZL); Key Projects in the National Science and Technology Pillar Program in the Twelfth Five-year Plan Period (NO. 2014BAI07B00; http://www.most.gov.cn/eng/; YZL); Capital Health Research and Development of Special Fund (NO. 2014-1-4011; YZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajeganova S, 2017, ANN RHEUM DIS, V76, P112, DOI 10.1136/annrheumdis-2015-208870; Ajeganova S, 2015, NAT REV RHEUMATOL, V11, P9, DOI 10.1038/nrrheum.2014.194; Alessandri C, 2015, ANTICARBAMYLATED PRO; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bos WH, 2010, ANN RHEUM DIS, V69, P490, DOI 10.1136/ard.2008.105759; Brink M, 2014, ANTICARBAMYLATED PRO; Brink M, 2015, ANTICARBAMYLATED PRO; Caro-Oleas JL, 2008, CLIN EXP RHEUMATOL, V26, P461; Challener GJ, 2015, ANTICARBAMYLATED PRO; Chimenti MS, 2015, AUTOREACTIONS AUTOIM; Daha NA, 2011, MOL IMMUNOL, V48, P1656, DOI 10.1016/j.molimm.2011.04.024; Debaugnies F, 2013, SCAND J RHEUMATOL, V42, P108, DOI 10.3109/03009742.2012.723746; Fautrel B, 1987, ANN RHEUM DIS, V2012, P386, DOI DOI 10.1136/ANNRHEUMDIS-2011-; Funovits J, 2010, ANN RHEUM DIS, V69, P1589, DOI 10.1136/ard.2010.130310; Gan RW, 2015, J RHEUMATOL, V42, P572, DOI 10.3899/jrheum.140767; Hissink Muller PCE, 2013, ANTICARBAMYLATED PRO; Humphreys JH, 2015, ANTICARBAMYLATED PRO; Hunt L, 2014, ANTICARBAMYLATED PRO; Ioan-Facsinay A, 2008, ARTHRITIS RHEUM-US, V58, P3000, DOI 10.1002/art.23763; Janssen KM, 2015, RHEUMATOID ARTHRITIS; Jiang X, 2014, ANN RHEUM DIS, V73, P1761, DOI 10.1136/annrheumdis-2013-205109; Kay J, 2012, RHEUMATOLOGY, V51, P5, DOI 10.1093/rheumatology/kes279; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Montes A, 2014, SPANISH PATIENTS RHE; Neogi T, 2010, ARTHRITIS RHEUM-US, V62, P2582, DOI 10.1002/art.27580; Nielsen SF, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5244; NIENHUIS RL, 1964, ANN RHEUM DIS, V23, P302, DOI 10.1136/ard.23.4.302; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Qin X, 2011, RHEUMATOL INT, V31, P785, DOI 10.1007/s00296-009-1343-3; Riccieri V, 2014, ANTICARBAMYLATED PRO; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Senolt L, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-49; Shi J., 2011, PROC INT C WIRELESS, DOI [10.1109/WCSP.2011.6096958, DOI 10.1109/WCSP.2011.6096958]; Shi J, 2015, SPECIFICITY ANTICARB; Shi J, 2014, ANN RHEUM DIS, V73, P780, DOI 10.1136/annrheumdis-2013-204154; Shi J, 2014, AUTOIMMUN REV, V13, P225, DOI 10.1016/j.autrev.2013.10.008; Shi J, 2013, ARTHRITIS RHEUM-US, V65, P911, DOI 10.1002/art.37830; Shi J, 2013, ANN RHEUM DIS, V72, P148, DOI 10.1136/annrheumdis-2012-201559; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Szekanecz Z, 2013, IMMUNOL RES, V56, P439, DOI 10.1007/s12026-013-8425-8; Takasaki Yoshinari, 2004, Mod Rheumatol, V14, P367, DOI 10.1007/s10165-004-0325-2; Trouw LA, 2013, ANN RHEUM DIS, V72, P132, DOI 10.1136/annrheumdis-2012-202349; Trouw LA, 2009, ARTHRITIS RHEUM-US, V60, P1923, DOI 10.1002/art.24622; Trouw LA, 2012, AUTOIMMUN REV, V12, P318, DOI 10.1016/j.autrev.2012.05.007; van Venrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391, DOI 10.1038/nrrheum.2011.76; Vannini A, 2007, ANN RHEUM DIS, V66, P511, DOI 10.1136/ard.2006.058933; Verheul MK, 2015, ANTICARBAMYLATED PRO; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yee A, 2015, ANTICARP ANTIBODIES; YOUNG BJJ, 1979, BRIT MED J, V2, P97, DOI 10.1136/bmj.2.6182.97	50	32	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159000	10.1371/journal.pone.0159000	http://dx.doi.org/10.1371/journal.pone.0159000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437936	gold, Green Published, Green Submitted			2022-12-27	WOS:000380170100026
J	Liang, SL; Zhang, JC; Zhang, SH; Fu, XP				Liang, Shuli; Zhang, Junchen; Zhang, Shaohui; Fu, Xiangping			Epilepsy in Adults with Supratentorial Glioblastoma: Incidence and Influence Factors and Prophylaxis in 184 Patients	PLOS ONE			English	Article							BRAIN-TUMORS; SEIZURE; LEVETIRACETAM; PHENYTOIN; SURVIVAL; EXPRESSION; PHASE	Aim To analyze the incidence of epilepsy in adult patients with supratentorial glioblastoma, assess the factors influencing the development of epilepsy in these cases, and evaluate patients' response to antiepileptic drugs (AEDs) in a series of 184 patients. Methods We retrospectively analyzed the 184 adult patients diagnosed with supratentorial glioblastoma. All subjects were treated within our hospital and subsequently died between 2003 and 2013. The incidence of epilepsy was assessed before and after initial resection and reexamined every 2 months thereafter. We evaluated the efficacy of prophylactic AEDs in this patient population based on the gathered incidence data. Results Of 184 patients, 43 (23.37%) were diagnosed with epilepsy before their initial resection. The total incidence of epilepsy (both pre- and postoperative) was 68.48%. The prevalence of active epilepsy reached over 80% in patients with epilepsy and survival of greater than 13 months postoperatively. Patients with glioblastoma in the frontal and/or temporal lobes had a higher prevalence of epilepsy. In the 43 patients with preoperative epilepsy, total resection of glioblastoma resulted in significantly lower seizure frequency. Patients who received epilepsy prophylaxis with AEDs for at least 6 months had significantly fewer seizures and higher Karnofsky scores than those receiving AEDs for less than one month or not at all. Conclusion The incidence of epilepsy in adult patients with glioblastoma was high and responded poorly to AEDs in the short term. However, when taken for longer periods, AEDs can reduce the frequency of seizures in patients with glioblastoma.	[Liang, Shuli] Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing 100853, Peoples R China; [Liang, Shuli; Zhang, Shaohui; Fu, Xiangping] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Neurosurg, Beijing 100048, Peoples R China; [Zhang, Junchen] Jining Med Coll, Affiliated Hosp, Dept Neurosurg, Jining 272029, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Jining Medical University	Liang, SL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing 100853, Peoples R China.; Liang, SL (corresponding author), Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Neurosurg, Beijing 100048, Peoples R China.	liangsl_304@304.com	Liang, Shuli/GWC-5028-2022		Beijing Technology & Science New-star Training Project [2010B084]	Beijing Technology & Science New-star Training Project	This research was funded by Beijing Technology & Science New-star Training Project [2010B084].	Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bruna J, 2013, EXPERT REV CLIN PHAR, V6, P333, DOI [10.1586/ECP.13.12, 10.1586/ecp.13.12]; Chaichana KL, 2009, J NEUROSURG, V111, P282, DOI 10.3171/2009.2.JNS081132; Davis ME, 2011, CLIN J ONCOL NURS, V15, P291, DOI 10.1188/11.CJON.291-297; Experts Group of China Association Against Epilepsy, 2012, CHINESE J OF NEUROSU, V28, P751; Fountain NB, 2009, EPILEPSY CURR, V9, P71, DOI 10.1111/j.1535-7511.2009.01297.x; Glantz MJ, 2000, NEUROLOGY, V54, P1886, DOI 10.1212/WNL.54.10.1886; Klein M, 2003, ANN NEUROL, V54, P514, DOI 10.1002/ana.10712; Klimek M, 2010, CURR OPIN ANESTHESIO, V23, P564, DOI 10.1097/ACO.0b013e32833e14f2; Lee JW, 2014, EPILEPSY RES, V108, P843, DOI 10.1016/j.eplepsyres.2014.02.021; Liang SL, 2006, CHINESE J NEUROSURGI, V5, P524; Lim DA, 2009, J NEURO-ONCOL, V93, P349, DOI 10.1007/s11060-008-9781-4; Luyken C, 2003, EPILEPSIA, V44, P822, DOI 10.1046/j.1528-1157.2003.56102.x; Milligan TA, 2008, NEUROLOGY, V71, P665, DOI 10.1212/01.wnl.0000324624.52935.46; Pace A, 2013, J NEURO-ONCOL, V111, P83, DOI 10.1007/s11060-012-0993-2; Rosati A, 2013, NEURO-ONCOLOGY, V15, P618, DOI 10.1093/neuonc/nos338; Rosati A, 2009, J NEURO-ONCOL, V93, P319, DOI 10.1007/s11060-008-9794-z; Siomin V, 2005, J NEURO-ONCOL, V74, P211, DOI 10.1007/s11060-004-6912-4; Taphoorn MJB, 2010, ONCOLOGIST, V15, P618, DOI 10.1634/theoncologist.2009-0291; Tebo CC, 2014, J NEUROSURG, V120, P1415, DOI 10.3171/2014.1.JNS131694; Tremont-Lukats IW, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004424.pub2; van Breemen MSM, 2007, LANCET NEUROL, V6, P421, DOI 10.1016/S1474-4422(07)70103-5; Vecht CJ, 2014, ONCOLOGIST, V19, P751, DOI 10.1634/theoncologist.2014-0060; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yang ZJ, 2008, MED CLIN RES, V25, P2186	25	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158206	10.1371/journal.pone.0158206	http://dx.doi.org/10.1371/journal.pone.0158206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438472	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100008
J	Shanmugasundaram, U; Kovarova, M; Ho, PT; Schramm, N; Wahl, A; Parniak, MA; Garcia, JV				Shanmugasundaram, Uma; Kovarova, Martina; Ho, Phong T.; Schramm, Nathaniel; Wahl, Angela; Parniak, Michael A.; Garcia, J. Victor			Efficient Inhibition of HIV Replication in the Gastrointestinal and Female Reproductive Tracts of Humanized BLT Mice by EFdA	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITOR; T-CELL DEPLETION; IMMUNODEFICIENCY-VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; IMMUNE-RESPONSES; TYPE-1 INFECTION; POTENT ACTIVITY; IN-VIVO; CD4(+); TRANSMISSION	Background The nucleoside reverse transcriptase inhibitor (NRTI) 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) in preclinical development exhibits improved safety and antiviral activity profiles with minimal drug resistance compared to approved NRTIs. However, the systemic antiviral efficacy of EFdA has not been fully evaluated. In this study, we utilized bone marrow/liver/thymus (BLT) humanized mice to investigate the systemic effect of EFdA treatment on HIV replication and CD4+ T cell depletion in the peripheral blood (PB) and tissues. In particular, we performed a comprehensive analysis of the female reproductive tract (FRT) and gastrointestinal (GI) tract, major sites of transmission, viral replication, and CD4+ T cell depletion and where some current antiretroviral drugs have a sub-optimal effect. Results EFdA treatment resulted in reduction of HIV-RNA in PB to undetectable levels in the majority of treated mice by 3 weeks post-treatment. HIV-RNA levels in cervicovaginal lavage of EFdA-treated BLT mice also declined to undetectable levels demonstrating strong penetration of EFdA into the FRT. Our results also demonstrate a strong systemic suppression of HIV replication in all tissues analyzed. In particular, we observed more than a 2-log difference in HIV-RNA levels in the GI tract and FRT of EFdA-treated BLT mice compared to untreated HIV-infected control mice. In addition, HIV-RNA was also significantly lower in the lymph nodes, liver, lung, spleen of EFdA- treated BLT mice compared to untreated HIV-infected control mice. Furthermore, EFdA treatment prevented the depletion of CD4+ T cells in the PB, mucosal tissues and lymphoid tissues. Conclusion Our findings indicate that EFdA is highly effective in controlling viral replication and preserving CD4+ T cells in particular with high efficiency in the GI and FRT tract. Thus, EFdA represents a strong potential candidate for further development as a part of antiretroviral therapy regimens.	[Shanmugasundaram, Uma; Kovarova, Martina; Ho, Phong T.; Schramm, Nathaniel; Wahl, Angela; Garcia, J. Victor] Univ N Carolina, Sch Med, Div Infect Dis, Ctr AIDS Res, Chapel Hill, NC 27599 USA; [Parniak, Michael A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Garcia, JV (corresponding author), Univ N Carolina, Sch Med, Div Infect Dis, Ctr AIDS Res, Chapel Hill, NC 27599 USA.	victor_garcia@med.unc.edu		Kovarova, Martina/0000-0001-7152-1709	National Institutes of Health [AI073146, AI096138]; UNC Center for AIDS Research [P30 AI50410]; AIDS Research and Reagent Program [2708]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Center for AIDS Research; AIDS Research and Reagent Program	This work was supported by National Institutes of Health grants (AI073146 and AI096138) and the UNC Center for AIDS Research (P30 AI50410). The funders had no part in the study design, data collection/analysis, decision to publish, or preparation of the manuscript.; We thank I. Chen for providing pYK-JRCSF (cat# 2708) through the AIDS Research and Reagent Program. We also thank former and current members of the Garcia laboratory as well as the husbandry technicians at the UNC Division of Laboratory Animal Medicine who contributed to aspects of this work.	Anton PA, 2000, AIDS, V14, P1761, DOI 10.1097/00002030-200008180-00011; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bourry O, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-78; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Cohan D, 2005, AIDS, V19, P989, DOI 10.1097/01.aids.0000171417.84162.af; Cohen J, 2011, SCIENCE, V334, P1614, DOI 10.1126/science.334.6063.1614; Costiniuk CT, 2015, AIDS PATIENT CARE ST, V29, P55, DOI 10.1089/apc.2014.0173; Denton PW, 2012, MUCOSAL IMMUNOL, V5, P555, DOI 10.1038/mi.2012.31; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Denton PW, 2011, J VIROL, V85, P7582, DOI 10.1128/JVI.00537-11; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Edagwa BJ, 2014, CURR MED CHEM, V21, P4186, DOI 10.2174/0929867321666140826114135; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hattori S, 2009, ANTIMICROB AGENTS CH, V53, P3887, DOI 10.1128/AAC.00270-09; Hsu DC, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-29; Kantor R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093537; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; Kovarova M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005075; Krisko JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003242; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Long BR, 2012, J VIROL, V86, P3327, DOI 10.1128/JVI.06676-11; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Murphey-Corb M, 2012, ANTIMICROB AGENTS CH, V56, P4707, DOI 10.1128/AAC.00723-12; O'Connor JL, 2014, AIDS, V28, P919, DOI 10.1097/QAD.0000000000000165; Ohrui H, 2007, NUCLEOS NUCLEOT NUCL, V26, P1543, DOI 10.1080/15257770701545218; Olesen R, 2016, J CLIN INVEST, V126, P892, DOI 10.1172/JCI64212; Olesen R, 2011, J REPROD IMMUNOL, V88, P195, DOI 10.1016/j.jri.2010.11.005; Shanmugasundaram U, 2014, AM J REPROD IMMUNOL, V71, P95, DOI 10.1111/aji.12182; Stoddart CA, 2015, ANTIMICROB AGENTS CH, V59, P4190, DOI 10.1128/AAC.05036-14; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Veazey RS, 2003, J INFECT DIS, V187, P769, DOI 10.1086/368386; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Wahl A, 2015, J VIROL, V89, P10868, DOI 10.1128/JVI.01702-15; Wahl A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002732; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44; Zoufaly A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087160	40	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159517	10.1371/journal.pone.0159517	http://dx.doi.org/10.1371/journal.pone.0159517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438728	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100052
J	Hunt, J; Murrell, J; Knazovicky, D; Harris, J; Kelly, S; Knowles, TG; Lascelles, BDX				Hunt, James; Murrell, Jo; Knazovicky, David; Harris, John; Kelly, Sara; Knowles, Toby G.; Lascelles, B. Duncan X.			Alfaxalone Anaesthesia Facilitates Electrophysiological Recordings of Nociceptive Withdrawal Reflexes in Dogs (Canis familiaris)	PLOS ONE			English	Article							SPINAL-CORD; CENTRAL SENSITIZATION; OSTEOARTHRITIS PAIN; CONSCIOUS DOGS; RATE-INFUSION; ISOFLURANE; STIMULI; LIMB; ORGANIZATION; HEAT	Naturally occurring canine osteoarthritis represents a welfare issue for affected dogs (Canis familiaris), but is also considered very similar to human osteoarthritis and has therefore been proposed as a model of disease in humans. Central sensitisation is recognized in human osteoarthritis sufferers but identification in dogs is challenging. Electromyographic measurement of responses to nociceptive stimulation represents a potential means of investigating alterations in central nociceptive processing, and has been evaluated in conscious experimental dogs, but is likely to be aversive. Development of a suitable anaesthetic protocol in experimental dogs, which facilitated electrophysiological nociceptive withdrawal reflex assessment, may increase the acceptability of using the technique in owned dogs with naturally occurring osteoarthritis. Seven purpose bred male hound dogs underwent electromyographic recording sessions in each of three states: acepromazine sedation, alfaxalone sedation, and alfaxalone anaesthesia. Electromyographic responses to escalating mechanical and electrical, and repeated electrical, stimuli were recorded. Subsequently the integral of both early and late rectified responses was calculated. Natural logarithms of the integral values were analysed within and between the three states using multi level modeling. Alfaxalone increased nociceptive thresholds and decreased the magnitude of recorded responses, but characteristics of increasing responses with increasing stimulus magnitude were preserved. Behavioural signs of anxiety were noted in two out of seven dogs during recordings in the acepromazine sedated state. There were few significant differences in response magnitude or nociceptive threshold between the two alfaxalone states. Following acepromazine premedication, induction of anaesthesia with 1-2 mg kg(-1) alfaxalone, followed by a continuous rate infusion in the range 0.075-0.1 mg kg(-1) min(-1) produced suitable conditions to enable assessment of spinal nociceptive processing in dogs, without subjecting them to potentially aversive experiences. This methodology may be appropriate for obtaining electrophysiological nociceptive withdrawal reflex data in client-owned dogs with naturally occurring osteoarthritis.	[Hunt, James; Murrell, Jo; Knowles, Toby G.] Univ Bristol, Sch Vet Sci, Bristol, Avon, England; [Knazovicky, David; Lascelles, B. Duncan X.] North Carolina State Univ, Coll Vet Med, Comparat Pain Res Lab, Raleigh, NC 27695 USA; [Harris, John; Kelly, Sara] Univ Nottingham, Sch Biosci, Div Anim Sci, Sutton Bonington Campus, Loughborough, Leics, England; [Lascelles, B. Duncan X.] UNC Sch Dent, Ctr Pain Res & Innovat, Chapel Hill, NC 27599 USA; [Lascelles, B. Duncan X.] North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA; [Knazovicky, David] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA	University of Bristol; University of North Carolina; North Carolina State University; University of Nottingham; University of North Carolina; North Carolina State University; Oregon State University	Lascelles, BDX (corresponding author), North Carolina State Univ, Coll Vet Med, Comparat Pain Res Lab, Raleigh, NC 27695 USA.; Lascelles, BDX (corresponding author), UNC Sch Dent, Ctr Pain Res & Innovat, Chapel Hill, NC 27599 USA.; Lascelles, BDX (corresponding author), North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA.	dxlascel@ncsu.edu	Hunt, James/AAK-2854-2020; Knowles, Toby G/A-2026-2008	Knowles, Toby G/0000-0002-3845-0942; Lascelles, B. Duncan X./0000-0002-2950-9009; Harris, John/0000-0001-7815-5385	Comparative Pain Research Laboratory, North Carolina State University; BBSRC [BB/L00240X/1]; Biotechnology and Biological Sciences Research Council [BB/L00240X/1, BB/L001349/1] Funding Source: researchfish; BBSRC [BB/L001349/1] Funding Source: UKRI	Comparative Pain Research Laboratory, North Carolina State University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for the study was received from the Comparative Pain Research Laboratory, North Carolina State University. Travel and accommodation expenses for J. Hunt and JM, and salary costs of J. Hunt were met from BBSRC grant BB/L00240X/1, for which Zoetis is the Industry Partner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Z, 1996, PAIN, V68, P401, DOI 10.1016/S0304-3959(96)03199-5; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; Baron R, 2013, ANN NEUROL, V74, P630, DOI 10.1002/ana.24017; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Bergadano A, 2006, AM J VET RES, V67, P882, DOI 10.2460/ajvr.67.5.882; Bergadano A, 2007, AM J VET RES, V68, P899, DOI 10.2460/ajvr.68.8.899; Bergadano A, 2009, VET J, V182, P252, DOI 10.1016/j.tvjl.2008.06.003; Bergadano A, 2009, VET ANAESTH ANALG, V36, P261, DOI 10.1111/j.1467-2995.2009.00447.x; Briley JD, 2014, VET J, V199, P245, DOI 10.1016/j.tvjl.2013.10.025; Brydges NM, 2012, VET J, V193, P545, DOI 10.1016/j.tvjl.2012.01.019; CARSTENS E, 1993, J NEUROPHYSIOL, V70, P621, DOI 10.1152/jn.1993.70.2.621; Clarke RW, 2004, BRAIN RES REV, V46, P163, DOI 10.1016/j.brainresrev.2004.07.005; du Sert NP, 2014, BRIT J PHARMACOL, V171, P2951, DOI 10.1111/bph.12645; FANSELOW MS, 1986, ANN NY ACAD SCI, V467, P40, DOI 10.1111/j.1749-6632.1986.tb14617.x; Frahm KS, 2013, BMC NEUROSCI, V14, P1; Harris J, 2003, J PHYSIOL-LONDON, V546, P251, DOI 10.1113/jphysiol.2002.025023; Harris J, 2007, BRAIN RES, V1131, P106, DOI 10.1016/j.brainres.2006.11.003; Jennings EM, 2014, PROG NEUROBIOL, V121, P1, DOI 10.1016/j.pneurobio.2014.06.003; Jinks SL, 2003, ANESTHESIOLOGY, V98, P1128, DOI 10.1097/00000542-200305000-00015; Kelly S, 2013, OSTEOARTHR CARTILAGE, V21, P1327, DOI 10.1016/j.joca.2013.07.002; Kim J, 2007, ANESTH ANALG, V105, P1020, DOI 10.1213/01.ane.0000280483.17854.56; Knazovicky D, 2015, PEERJ, V3, DOI 10.7717/peerj.772; Lascelles BDX, 2008, J VET INTERN MED, V22, P53, DOI 10.1111/j.1939-1676.2007.0014.x; Lascelles BDX, 2002, J AM VET MED ASSOC, V221, P215, DOI 10.2460/javma.2002.221.215; Lervik A, 2012, VET ANAESTH ANALG, V39, P414, DOI 10.1111/j.1467-2995.2012.00713.x; MEYER RA, 1991, BRAIN RES, V561, P252, DOI 10.1016/0006-8993(91)91601-V; Moore SA, 2013, VET J, V197, P216, DOI 10.1016/j.tvjl.2012.11.003; Morch CD, 2011, MED BIOL ENG COMPUT, V49, P385, DOI 10.1007/s11517-010-0725-8; Nijland ML, 2010, PUBLIC HEALTH NUTR, V13, P102, DOI 10.1017/S136898000999022X; PETERSENFELIX S, 1995, BRIT J ANAESTH, V75, P55, DOI 10.1093/bja/75.1.55; Rasbash J, 2009, MLWIN VERSION 21; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; SCHOUENBORG J, 1994, NEWS PHYSIOL SCI, V9, P261; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Sorensen J, 1998, J RHEUMATOL, V25, P152; Spadavecchia C, 2006, AM J VET RES, V67, P762, DOI 10.2460/ajvr.67.5.762; Tomas A, 2014, VET SURG, V43, P542, DOI 10.1111/j.1532-950X.2014.12160.x; TORRING J, 1981, J NEUROL NEUROSUR PS, V44, P129, DOI 10.1136/jnnp.44.2.129; Vainio O, 2012, SCAND J PAIN, V3, P84, DOI 10.1016/j.sjpain.2011.11.007; Weerasinghe NS, 2014, EUR J PAIN, V18, P1199, DOI 10.1002/j.1532-2149.2014.00469.x; Williams MD, 2014, VET J, V199, P63, DOI 10.1016/j.tvjl.2013.11.003; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yeates J, 2014, J AWSELVA, V18, P9	44	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158990	10.1371/journal.pone.0158990	http://dx.doi.org/10.1371/journal.pone.0158990			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433936	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600028
J	Asselah, T; Moreno, C; Sarrazin, C; Gschwantler, M; Foster, GR; Craxi, A; Buggisch, P; Ryan, R; Lenz, O; Scott, J; Van Dooren, G; Lonjon-Domanec, I; Schlag, M; Buti, M				Asselah, Tarik; Moreno, Christophe; Sarrazin, Christoph; Gschwantler, Michael; Foster, Graham R.; Craxi, Antonio; Buggisch, Peter; Ryan, Robert; Lenz, Oliver; Scott, Jane; Van Dooren, Gino; Lonjon-Domanec, Isabelle; Schlag, Michael; Buti, Maria			An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)	PLOS ONE			English	Article							INTERFERON-ALPHA 2A; ANTIVIRAL THERAPY; PHASE-3 TRIAL; DOUBLE-BLIND; INFECTION; RIBAVIRIN; QUEST-1; SAFETY; RATES; SVR	Background Shortening duration of peginterferon-based HCV treatment reduces associated burden for patients. Primary objectives of this study were to assess the efficacy against the minimally acceptable response rate 12 weeks post-treatment (SVR12) and safety of simeprevir plus PR in treatment-naive HCV GT1 patients treated for 12 weeks. Additional objectives included the investigation of potential associations of rapid viral response and baseline factors with SVR12. Methods In this Phase III, open-label study in treatment-naive HCV GT1 patients with F0-F2 fibrosis, patients with HCV-RNA <25 IU/mL (detectable/undetectable) at Week 2, and undetectable HCV-RNA at Weeks 4 and 8, stopped all treatment at Week 12. All other patients continued PR for a further 12 weeks. Baseline factors significantly associated with SVR12 were identified through logistic regression. Results Of 163 patients who participated in the study, 123 (75%) qualified for 12-week treatment; of these, 81 (66%) achieved SVR12. Baseline factors positively associated with SVR12 rates in patients receiving the 12-week regimen were: IL28B CC genotype: (94% SVR12); HCV RNA <= 800,000 IU/mL (82%); F0-F1 fibrosis (74%). Among all 163 patients, 94% experienced >= 1 adverse event (AE), 4% a serious AE, and 2.5% discontinued due to an AE. Reduced impairment in patient-reported outcomes was observed in the 12-week vs > 12-week regimen. Conclusions Overall SVR12 rate (66%) was below the target of 80%, indicating that shortening of treatment with simeprevir plus PR to 12 weeks based on very early response is not effective. However, baseline factors associated with higher SVR12 rates were identified. Therefore, while Week 2 response alone is insufficient to predict efficacy, GT1 patients with favourable baseline factors may benefit from a shortened simeprevir plus PR regimen.	[Asselah, Tarik] Univ Paris Diderot, INSERM UMR 1149, Beaujon Hosp, Serv Hepatol, Paris, France; [Moreno, Christophe] Univ Libre Bruxelles, CUB Hop Erasme, Brussels, Belgium; [Sarrazin, Christoph] Johann Wolfgang Goethe Univ Hosp, Frankfurt, Germany; [Gschwantler, Michael] Wilhelminenspital Stadt Wien, Vienna, Austria; [Foster, Graham R.] Univ London, Barts Hlth, Queen Mary Hosp, London, England; [Craxi, Antonio] Univ Palermo, Palermo, Italy; [Buggisch, Peter] Inst Interdisciplinary Med, Hamburg, Germany; [Ryan, Robert] Janssen Res & Dev, Titusville, NJ USA; [Lenz, Oliver; Van Dooren, Gino] Janssen Infect Dis BVBA, Beerse, Belgium; [Scott, Jane] Janssen Global Serv, High Wycombe, Bucks, England; [Lonjon-Domanec, Isabelle] Janssen Pharmaceut, Paris, France; [Schlag, Michael] Janssen Cilag, Vienna, Austria; [Buti, Maria] Hosp Valle De Hebron, Barcelona, Spain; [Buti, Maria] Inst Carlos III, Ciberehd, Barcelona, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Libre de Bruxelles; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Wilhelminenspital; Barts Health NHS Trust; University of London; Queen Mary University London; University of Palermo; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Asselah, T (corresponding author), Univ Paris Diderot, INSERM UMR 1149, Beaujon Hosp, Serv Hepatol, Paris, France.	tarik.asselah@bjn.aphp.fr		Foster, Graham/0000-0002-3704-386X; Buti Ferret, Maria/0000-0002-0732-3078	Janssen Pharmaceuticals [HPC3014, NCT01846832]	Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	The study described in this manuscript (HPC3014; NCT01846832) was sponsored by Janssen Pharmaceuticals. The funder was involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Editorial support was provided by Ian Grieve (Medical Writer at Zoetic Science, an Ashfield Company, part of UDG Healthcare plc, Macclesfield, United Kingdom); this support was funded by Janssen Pharmaceuticals. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Asselah T, 2015, J VIRAL HEPATITIS, V22, P25; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; European Association for the Study of the Liver, 2015, EASL REC TREATM HEP; European Medicines Agency, 2014, OLYSIO SIM TABL SUMM; Everson GT, 2006, HEPATOLOGY, V44, P1675, DOI 10.1002/hep.21440; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Foster GR, 2014, J HEPATOL, V60, pS456, DOI 10.1016/S0168-8278(14)61287-3; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Hayashi N, 2014, J HEPATOL, V61, P219, DOI 10.1016/j.jhep.2014.04.004; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Lawitz E, 2014, HEPATOLOGY; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lenz O, 2015, J HEPATOL, V62, P1008, DOI 10.1016/j.jhep.2014.11.032; Lin CY, 2011, PLOS ONE, V30; Manns MP, 2015, J VIRAL HEPATITIS, V22, P366, DOI 10.1111/jvh.12346; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; Maylin S, 2008, GASTROENTEROLOGY, V135, P821, DOI 10.1053/j.gastro.2008.05.044; MCEWAN P, 2011, J HEPATOL S1, V54, pS461; Nelson DR, 2013, J HEPATOL, V58, pS362, DOI 10.1016/S0168-8278(13)60883-1; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Sarrazin C, 2015, REV ANTIVIRAL THERAP, V5, pA20; US Food and Drug Administration, 2014, OLYSIO SIM TABL PRES; Zeuzem S, 2009, J VIRAL HEPATITIS, V16, P75, DOI 10.1111/j.1365-2893.2008.01012.x	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158526	10.1371/journal.pone.0158526	http://dx.doi.org/10.1371/journal.pone.0158526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428331	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300011
J	Yan, R; Friemel, M; Aloisi, C; Huynen, M; Taylor, IA; Leimkuhler, S; Pastore, A				Yan, Robert; Friemel, Martin; Aloisi, Claudia; Huynen, Martijn; Taylor, Ian A.; Leimkuehler, Silke; Pastore, Annalisa			The Eukaryotic-Specific ISD11 Is a Complex-Orphan Protein with Ability to Bind the Prokaryotic IscS	PLOS ONE			English	Article							SULFUR CLUSTER FORMATION; CYSTEINE DESULFURASE; INTERACTING PROTEIN; BACTERIAL FRATAXIN; STATISTICAL-MODEL; BIOGENESIS; DEFICIENCY; FERREDOXIN; MECHANISM; MUTATION	The eukaryotic protein Isd11 is a chaperone that binds and stabilizes the central component of the essential metabolic pathway responsible for formation of iron-sulfur clusters in mitochondria, the desulfurase Nfs1. Little is known about the exact role of Isd11. Here, we show that human Isd11 (ISD11) is a helical protein which exists in solution as an equilibrium between monomer, dimeric and tetrameric species when in the absence of human Nfs1 (NFS1). We also show that, surprisingly, recombinant ISD11 expressed in E. coli co-purifies with the bacterial orthologue of NFS1, IscS. Binding is weak but specific suggesting that, despite the absence of Isd11 sequences in bacteria, there is enough conservation between the two desulfurases to retain a similar mode of interaction. This knowledge may inform us on the conservation of the mode of binding of Isd11 to the desulfurase. We used evolutionary evidence to suggest Isd11 residues involved in the interaction.	[Yan, Robert; Aloisi, Claudia; Pastore, Annalisa] Kings Coll London, Maurice Wohl Inst, 5 Cutcombe Rd, London SE5, England; [Friemel, Martin; Leimkuehler, Silke] Univ Potsdam, Dept Mol Enzymol, Inst Biochem & Biol, Karl Liebknecht Str 24-25, D-14476 Potsdam, Germany; [Huynen, Martijn] Radboud Univ Nijmegen, Med Ctr, CMBI 260, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Taylor, Ian A.] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England	University of Potsdam; Radboud University Nijmegen; Francis Crick Institute	Pastore, A (corresponding author), Kings Coll London, Maurice Wohl Inst, 5 Cutcombe Rd, London SE5, England.	Annalisa.1.Pastore@kcl.ac.uk	Yan, Robert/GYU-0395-2022; Huynen, Martijn A/A-1530-2014; Aloisi, Claudia/Z-1680-2018	Huynen, Martijn A/0000-0001-6189-5491; Leimkuhler, Silke/0000-0003-3238-2122; Aloisi, Claudia/0000-0002-2279-7757	MRC [U117584256]; EU (SARCOSI consortium); Deutsche Forschungsgemeinschaft (DFG) [LE1171/11-1]; MRC [MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887] Funding Source: researchfish; The Francis Crick Institute [10029, 10178] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU (SARCOSI consortium); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	The authors are indebted to the MRC NMR Centre and David Frith of LRI/NIMR Proteomics and Metabolomics Core Technology Platform (Francis Crick Institute) for technical support. This work was funded by MRC (Grant ref. U117584256) and EU (SARCOSI consortium) (AP), and by the Deutsche Forschungsgemeinschaft (DFG) grant LE1171/11-1 (SL).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Amela I, 2013, PROTEIN J, V32, P183, DOI 10.1007/s10930-013-9475-4; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Angerer H, 2013, BIOCHEM SOC T, V41, P1335, DOI 10.1042/BST20130116; Behshad E, 2004, BIOCHEMISTRY-US, V43, P12220, DOI 10.1021/bi049143e; Behshad E, 2009, BIOCHEMISTRY-US, V48, P12014, DOI 10.1021/bi802161u; Bridwell-Rabb J, 2012, BIOCHEMISTRY-US, V51, P2506, DOI 10.1021/bi201628j; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Feenstra KA, 2007, NUCLEIC ACIDS RES, V35, pW495, DOI 10.1093/nar/gkm406; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Fischer S, 2011, USING ORTHOMCL ASSIG, V35; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295; Maio N, 2014, CELL METAB, V19, P445, DOI 10.1016/j.cmet.2014.01.015; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Paris Z, 2010, J BIOL CHEM, V285, P22394, DOI 10.1074/jbc.M109.083774; Pastore A, 2013, J NEUROCHEM, V126, P43, DOI 10.1111/jnc.12220; Pastore C, 2006, STRUCTURE, V14, P857, DOI 10.1016/j.str.2006.02.010; Prischi F, 2010, PROTEIN EXPRES PURIF, V73, P161, DOI 10.1016/j.pep.2010.05.003; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Saha PP, 2015, J BIOL CHEM; Saha PP, 2014, J BIOL CHEM, V289, P10359, DOI 10.1074/jbc.M113.526665; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Terali K, 2013, BIOCHEM BIOPH RES CO, V440, P235, DOI 10.1016/j.bbrc.2013.09.039; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Webert H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6013; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yan R, 2015, BBA-PROTEINS PROTEOM, V1854, P1113, DOI 10.1016/j.bbapap.2015.02.002; Yan R, 2013, J BIOL CHEM, V288, P24777, DOI 10.1074/jbc.M113.480327; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	44	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0157895	10.1371/journal.pone.0157895	http://dx.doi.org/10.1371/journal.pone.0157895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427956	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169300006
J	Lee, G; Bucheli, DER; Madabhushi, A				Lee, George; Bucheli, David Edmundo Romo; Madabhushi, Anant			Adaptive Dimensionality Reduction with Semi-Supervision (AdDReSS): Classifying Multi-Attribute Biomedical Data	PLOS ONE			English	Article							FEATURE-SELECTION; CLASSIFICATION; GENE; REGRESSION; FEATURES	Medical diagnostics is often a multi-attribute problem, necessitating sophisticated tools for analyzing high-dimensional biomedical data. Mining this data often results in two crucial bottlenecks: 1) high dimensionality of features used to represent rich biological data and 2) small amounts of labelled training data due to the expense of consulting highly specific medical expertise necessary to assess each study. Currently, no approach that we are aware of has attempted to use active learning in the context of dimensionality reduction approaches for improving the construction of low dimensional representations. We present our novel methodology, AdDReSS (Adaptive Dimensionality Reduction with Semi-Supervision), to demonstrate that fewer labeled instances identified via AL in embedding space are needed for creating a more discriminative embedding representation compared to randomly selected instances. We tested our methodology on a wide variety of domains ranging from prostate gene expression, ovarian proteomic spectra, brain magnetic resonance imaging, and breast histopathology. Across these various high dimensional biomedical datasets with 100+ observations each and all parameters considered, the median classification accuracy across all experiments showed AdDReSS (88.7%) to outperform SSAGE, a SSDR method using random sampling (85.5%), and Graph Embedding (81.5%). Furthermore, we found that embeddings generated via AdDReSS achieved a mean 35.95% improvement in Raghavan efficiency, a measure of learning rate, over SSAGE. Our results demonstrate the value of AdDReSS to provide low dimensional representations of high dimensional biomedical data while achieving higher classification rates with fewer labelled examples as compared to without active learning.	[Lee, George; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Bucheli, David Edmundo Romo] Univ Nacl Colombia, CIM LAB Res Grp, Bogota, Colombia	Case Western Reserve University; Universidad Nacional de Colombia	Lee, G; Madabhushi, A (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	george.lee@case.edu; anant.madabhushi@case.edu	Madabhushi, Anant/AAG-2908-2019	Madabhushi, Anant/0000-0002-5741-0399; Lee, George/0000-0002-8705-9210	National Institutes of Health [K01ES026841]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK098503-02]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; DOD Prostate Cancer Idea Development Award; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant from the Cleveland Clinic; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University;  [R21CA167811-01];  [R21CA179327-01];  [R21CA195152-01];  [U24CA199374-01]; NATIONAL CANCER INSTITUTE [R21CA179327, R01CA202752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DOD Prostate Cancer Synergistic Idea Development Award; DOD Lung Cancer Idea Development New Investigator Award; DOD Prostate Cancer Idea Development Award; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant from the Cleveland Clinic; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	GL was supported by National Institutes of Health (K01ES026841). AM was supported by R21CA167811-01, R21CA179327-01, R21CA195152-01, U24CA199374-01; the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02; the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the DOD Lung Cancer Idea Development New Investigator Award (LC130463); the DOD Prostate Cancer Idea Development Award; the Ohio Third Frontier Technology development Grant; the CTSC Coulter Annual Pilot Grant; the Case Comprehensive Cancer Center Pilot Grant; the VelaSano Grant from the Cleveland Clinic; and the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baram Y, 2004, J MACH LEARN RES, V5, P255; Bellman R., 1961, ADAPTIVE CONTROL PRO; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Chang H, 2012, INT S BIOM IM; Chen YK, 2012, J BIOMED INFORM, V45, P265, DOI 10.1016/j.jbi.2011.11.003; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cox TFCMAA, 2001, MULTIDIMENSIONAL SCA; Dawson K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-195; Doyle S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-424; Duda R.O., 2000, PATTERN CLASSIFICATI; Freund Y, 1997, MACH LEARN, V28, P133, DOI 10.1023/A:1007330508534; Geurts P, 2005, BIOINFORMATICS, V21, P3138, DOI 10.1093/bioinformatics/bti494; Golugula A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-483; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Han YH, 2015, IEEE T NEUR NET LEAR, V26, P252, DOI 10.1109/TNNLS.2014.2314123; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Herlidou-Meme S, 2003, MAGN RESON IMAGING, V21, P989, DOI 10.1016/S0730-725X(03)00212-1; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Hou CP, 2011, LECT NOTES ARTIF INT, V6820, P91, DOI 10.1007/978-3-642-22589-5_10; Hoyle DC, 2008, J MACH LEARN RES, V9, P2733; Hsu W C, 2003, PRACTICAL GUIDE SUPP; Huang Y, 2012, IEEE T NEUR NET LEAR, V23, P519, DOI 10.1109/TNNLS.2011.2178037; HUGHES GF, 1968, IEEE T INFORM THEORY, V14, P55, DOI 10.1109/TIT.1968.1054102; Kwan RKS, 1999, IEEE T MED IMAGING, V18, P1085, DOI 10.1109/42.816072; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Lee G, 2008, IEEE ACM T COMPUT BI, V5, P368, DOI 10.1109/TCBB.2008.36; Lee G, 2010, LECT N BIOINFORMAT, V6282, P207, DOI 10.1007/978-3-642-16001-1_18; Liu MX, 2016, IEEE T CYBERNETICS, V46, P298, DOI 10.1109/TCYB.2015.2401733; Liu Y, 2004, J CHEM INF COMP SCI, V44, P1936, DOI 10.1021/ci049810a; Madabhushi A, 2005, LECT NOTES COMPUT SC, V3749, P729; Madabhushi A, 2011, COMPUT MED IMAG GRAP, V35, P506, DOI 10.1016/j.compmedimag.2011.01.008; Nilsson J, 2004, BIOINFORMATICS, V20, P874, DOI 10.1093/bioinformatics/btg496; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Qian B., 2010, AAAI; Raghavan H, 2006, J MACH LEARN RES, V7, P1655; Romo D, 2014, SPIE MED IMAGING; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Roux Ludovic, 2013, J Pathol Inform, V4, P8, DOI 10.4103/2153-3539.112693; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Schohn G., 2000, P 17 INT C MACH LEAR, P839; Scholkopf B, 1998, KERNEL PCA PATTERN R; Seung H. S., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P287, DOI 10.1145/130385.130417; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Shi XS, 2015, IEEE T IMAGE PROCESS, V24, P1341, DOI 10.1109/TIP.2015.2405474; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sugiyama M, 2010, MACH LEARN, V78, P35, DOI 10.1007/s10994-009-5125-7; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tong S, 2002, J MACH LEARN RES, V2, P45, DOI 10.1162/153244302760185243; Venna J, 2006, NEURAL NETWORKS, V19, P889, DOI 10.1016/j.neunet.2006.05.014; Verbeek JJ, 2006, PATTERN RECOGN, V39, P1864, DOI 10.1016/j.patcog.2006.04.011; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zha H., 2006, P INT C MACHINE LEAR, DOI [10.1145/1143844.1143978, DOI 10.1145/1143844.1143978]; Zhang D, 2007, SIAM INT C DAT MIN; Zhang L, 2011, IEEE T PATTERN ANAL; Zhao HT, 2006, NEUROCOMPUTING, V69, P2385, DOI 10.1016/j.neucom.2006.02.010; Zhao MB, 2012, PATTERN RECOGN, V45, P1482, DOI 10.1016/j.patcog.2011.10.008	59	2	2	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0159088	10.1371/journal.pone.0159088	http://dx.doi.org/10.1371/journal.pone.0159088			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27421116	Green Published, Green Submitted, gold			2022-12-27	WOS:000379662300009
J	Schaut, RG; Ridpath, JF; Sacco, RE				Schaut, Robert G.; Ridpath, Julia F.; Sacco, Randy E.			Bovine Viral Diarrhea Virus Type 2 Impairs Macrophage Responsiveness to Toll-Like Receptor Ligation with the Exception of Toll-Like Receptor 7	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; HEPATITIS-C VIRUS; INTERFERON REGULATORY FACTOR-3; MESSENGER-RNA EXPRESSION; IN-VITRO; PROTEASOMAL DEGRADATION; MUCOSAL DISEASE; ACUTE INFECTION; T-CELLS; BVDV	Bovine viral diarrhea virus (BVDV) is a member of the Flaviviridae family. BVDV isolates are classified into two biotypes based on the development of cytopathic (cp) or non-cytopathic (ncp) effects in epithelial cell culture. BVDV isolates are further separated into species, BVDV1 and 2, based on genetic differences. Symptoms of BVDV infection range from subclinical to severe, depending on strain virulence, and may involve multiple organ systems and induction of a generalized immunosuppression. During BVDV-induced immune suppression, macrophages, critical to innate immunity, may have altered pathogen recognition receptor (PRR) signaling, including signaling through toll-like receptors (TLRs). Comparison of BVDV 2 strains with different biotypes and virulence levels is valuable to determining if there are differences in host macrophage cellular responses between viral phenotypes. The current study demonstrates that cytopathic (cp), noncytopathic (ncp), high (hv) or low virulence (lv) BVDV2 infection of bovine monocyte-derived macrophages (MDMF) result in differential expression of pro-inflammatory cytokines compared to uninfected MDMF. A hallmark of cp BVDV2 infection is IL-6 production. In response to TLR2 or 4 ligation, as might be observed during secondary bacterial infection, cytokine secretion was markedly decreased in BVDV2-infected MDMF, compared to non-infected MDMF. Macrophages were hyporesponsive to viral TLR3 or TLR8 ligation. However, TLR7 stimulation of BVDV2-infected MDMF induced cytokine secretion, unlike results observed for other TLRs. Together, these data suggest that BVDV2 infection modulated mRNA responses and induced a suppression of proinflammatory cytokine protein responses to TLR ligation in MDMF with the exception of TLR7 ligation. It is likely that there are distinct differences in TLR pathways modulated following BVDV2 infection, which have implications for macrophage responses to secondary infections.	[Schaut, Robert G.; Sacco, Randy E.] Iowa State Univ, Immunobiol Grad Program, Ames, IA 50011 USA; [Schaut, Robert G.; Ridpath, Julia F.; Sacco, Randy E.] ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA	Iowa State University; United States Department of Agriculture (USDA)	Sacco, RE (corresponding author), Iowa State Univ, Immunobiol Grad Program, Ames, IA 50011 USA.; Sacco, RE (corresponding author), ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA.	randy.sacco@ars.usda.gov		Schaut, Robert G./0000-0003-2713-9013; Ridpath, Julia/0000-0001-7182-8161				Adler H, 1996, J VIROL, V70, P2650, DOI 10.1128/JVI.70.4.2650-2653.1996; AFFORD SC, 1992, J BIOL CHEM, V267, P21612; Ammari M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S9; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; ATLURU D, 1992, VET IMMUNOL IMMUNOP, V31, P49, DOI 10.1016/0165-2427(92)90086-6; Baigent SJ, 2002, J VIROL, V76, P8979, DOI 10.1128/JVI.76.18.8979-8988.2002; Baroth M, 2000, VIROLOGY, V278, P456, DOI 10.1006/viro.2000.0644; Bauermann FV, 2012, J VET DIAGN INVEST, V24, P253, DOI 10.1177/1040638711435144; Becher P, 2002, J VIROL, V76, P13069, DOI 10.1128/JVI.76.24.13069-13076.2002; Biasin M, 2010, J IMMUNOL, V184, P2710, DOI 10.4049/jimmunol.0902463; BROWN GB, 1991, AM J VET RES, V52, P381; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Buckwold VE, 2003, ANTIVIR RES, V60, P1, DOI 10.1016/S0166-3542(03)00174-8; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Chung H, 2011, J VIRAL HEPATITIS, V18, pE561, DOI 10.1111/j.1365-2893.2011.01478.x; de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215; Barros VED, 2009, REV INST MED TROP SP, V51, P141, DOI 10.1590/S0036-46652009000300004; DONIS RO, 1987, VIROLOGY, V158, P168, DOI 10.1016/0042-6822(87)90250-9; Duvel A, 2012, INNATE IMMUN-LONDON, V18, P886, DOI 10.1177/1753425912446954; Franchini M, 2006, VET IMMUNOL IMMUNOP, V110, P37, DOI 10.1016/j.vetimm.2005.09.002; Fulton RW, 2006, JAVMA-J AM VET MED A, V228, P578, DOI 10.2460/javma.228.4.578; Fulton RW, 2005, VET MICROBIOL, V111, P35, DOI 10.1016/j.vetmic.2005.10.002; Gibson A, 2011, J VIROL, V85, P3695, DOI 10.1128/JVI.02626-10; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Houe H, 2003, BIOLOGICALS, V31, P137, DOI 10.1016/S1045-1056(03)00030-7; JENSEN J, 1991, VET IMMUNOL IMMUNOP, V29, P251, DOI 10.1016/0165-2427(91)90018-8; KETELSEN AT, 1979, INFECT IMMUN, V25, P565, DOI 10.1128/IAI.25.2.565-568.1979; Kummerer BM, 2000, VET MICROBIOL, V77, P117, DOI 10.1016/S0378-1135(00)00268-6; Lambot M, 1998, J GEN VIROL, V79, P1745, DOI 10.1099/0022-1317-79-7-1745; Lee SR, 2008, COMP IMMUNOL MICROB, V31, P403, DOI 10.1016/j.cimid.2007.06.006; Liebler-Tenorio EM, 2004, J VET DIAGN INVEST, V16, P388, DOI 10.1177/104063870401600504; Liebler-Tenorio EM, 2003, BIOLOGICALS, V31, P119, DOI 10.1016/S1045-1056(03)00026-5; Liebler-Tenorio EM, 2003, J VET DIAGN INVEST, V15, P221, DOI 10.1177/104063870301500303; Liu BS, 2011, J LEUKOCYTE BIOL, V89, P981, DOI 10.1189/jlb.1210680; Liu L, 1999, CAN J VET RES, V63, P41; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; MING JE, 1990, CELL IMMUNOL, V130, P437, DOI 10.1016/0008-8749(90)90285-Y; Nelson CD, 2010, J DAIRY SCI, V93, P1041, DOI 10.3168/jds.2009-2663; OHMANN HB, 1988, VET PATHOL, V25, P304, DOI 10.1177/030098588802500409; OHMANN HB, 1987, J GEN VIROL, V68, P1971, DOI 10.1099/0022-1317-68-7-1971; Pedrera M, 2009, J GEN VIROL, V90, P2650, DOI 10.1099/vir.0.012021-0; Peterhans E, 2003, BIOLOGICALS, V31, P107, DOI 10.1016/S1045-1056(03)00024-1; Peterhans E, 2010, VET MICROBIOL, V142, P18, DOI 10.1016/j.vetmic.2009.09.038; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; QI FX, 1992, VIROLOGY, V189, P285, DOI 10.1016/0042-6822(92)90704-S; Raqib R, 1996, EUR J IMMUNOL, V26, P1130, DOI 10.1002/eji.1830260526; Rathinam VAK, 2010, J CLIN IMMUNOL, V30, P632, DOI 10.1007/s10875-010-9431-4; Re F, 1996, J EXP MED, V183, P1841, DOI 10.1084/jem.183.4.1841; RIDPATH JF, 1995, VIROLOGY, V212, P39, DOI 10.1006/viro.1995.1451; Ridpath JF, 2006, VIRUS RES, V118, P62, DOI 10.1016/j.virusres.2005.11.014; Ridpath JF, 2005, PREV VET MED, V72, P17, DOI 10.1016/j.prevetmed.2005.08.003; Ridpath J, 2010, VET CLIN N AM-FOOD A, V26, P335, DOI 10.1016/j.cvfa.2010.04.003; Rogez-Kreuz C, 2005, INT IMMUNOL, V17, P1047, DOI 10.1093/intimm/dxh285; ROTH JA, 1986, AM J VET RES, V47, P1139; ROTH JA, 1981, AM J VET RES, V42, P244; Ruzek MC, 1999, J IMMUNOL, V162, P3527; Schaut RG, 2015, VIRUS RES, V208, P44, DOI 10.1016/j.virusres.2015.05.017; SCHINDLER R, 1990, J BIOL CHEM, V265, P10232; Schweizer M, 2001, J VIROL, V75, P4692, DOI 10.1128/JVI.75.10.4692-4698.2001; Stott AW, 2010, VET J, V185, P138, DOI 10.1016/j.tvjl.2009.05.020; Taraktsoglou M, 2011, VET IMMUNOL IMMUNOP, V140, P130, DOI 10.1016/j.vetimm.2010.12.002; Tserel L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-642; Welsh M, 1995, VET IMMUNOL IMMUNOPA; Werling D, 2005, VET IMMUNOL IMMUNOP, V108, P157, DOI 10.1016/j.vetimm.2005.07.017; Wong KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036435; Wortham BW, 2012, J IMMUNOL, V188, P4468, DOI 10.4049/jimmunol.1102643; Yamane D, 2005, MICROBES INFECT, V7, P1482, DOI 10.1016/j.micinf.2005.05.006; Yonkers NL, 2007, J IMMUNOL, V178, P4436, DOI 10.4049/jimmunol.178.7.4436	69	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0159491	10.1371/journal.pone.0159491	http://dx.doi.org/10.1371/journal.pone.0159491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420479	Green Published, gold, Green Submitted			2022-12-27	WOS:000379662300014
J	Homa, J; Ortmann, W; Kolaczkowska, E				Homa, Joanna; Ortmann, Weronika; Kolaczkowska, Elzbieta			Conservative Mechanisms of Extracellular Trap Formation by Annelida Eisenia andrei: Serine Protease Activity Requirement	PLOS ONE			English	Article							NEUTROPHIL ELASTASE; INVERTEBRATE IMMUNITY; NUCLEAR-LOCALIZATION; NITRIC-OXIDE; CELL-DEATH; DNA TRAPS; EARTHWORM; RELEASE; CELOMOCYTES; AUTOPHAGY	Formation of extracellular traps (ETs) capturing and immobilizing pathogens is now a well-established defense mechanism added to the repertoire of vertebrate phagocytes. These ETs are composed of extracellular DNA (extDNA), histones and antimicrobial proteins. Formation of mouse and human ETs depends on enzymes (i) facilitating decondensation of chromatin by citrullination of histones, and (ii) serine proteases degrading histones. In invertebrates, initial reports revealed existence of ETs composed of extDNA and histones, and here we document for the first time that also coelomocytes, immunocompetent cells of an earthworm Eisenia andrei, cast ETs which successfully trap bacteria in a reactive oxygen species (ROS)-dependent and -independent manner. Importantly, the formation of ETs was observed not only when coelomocytes were studied ex vivo, but also in vivo, directly in the earthworm coelom. These ETs were composed of extDNA, heat shock proteins (HSP27) and H3 histones. Furthermore, the formation of E. andrei ETs depended on activity of serine proteases, including elastase-like activity. Moreover, ETs interconnected and hold together aggregating coelomocytes, a processes proceeding encapsulation. In conclusion, the study confirms ET formation by earthworms, and unravels mechanisms leading to ET formation and encapsulation in invertebrates.	[Homa, Joanna; Ortmann, Weronika; Kolaczkowska, Elzbieta] Jagiellonian Univ, Inst Zool, Dept Evolutionary Immunol, Gronostajowa 9, PL-30387 Krakow, Poland	Jagiellonian University	Homa, J (corresponding author), Jagiellonian Univ, Inst Zool, Dept Evolutionary Immunol, Gronostajowa 9, PL-30387 Krakow, Poland.	joanna.homa@uj.edu.pl	Homa, Joanna/AAL-8327-2020; Kolaczkowska, Elzbieta/AAC-1988-2021	Kolaczkowska, Elzbieta/0000-0002-3573-3584	National Science Centre of Poland [2014/15/B/NZ6/02519, Opus 8];  [K/ZDS/005405]	National Science Centre of Poland(National Science Centre, Poland); 	This study was supported by the National Science Centre of Poland (grant number 2014/15/B/NZ6/02519, Opus 8) and K/ZDS/005405 to Elzbieta Kolaczkowska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Science Centre of Poland (grant number 2014/15/B/NZ6/02519, Opus 8) and K/ZDS/005405.	Adamowicz A, 2005, TISSUE CELL, V37, P125, DOI 10.1016/j.tice.2004.11.002; Albini A, 2015, INT J NANOMED, V10, P6133, DOI 10.2147/IJN.S85275; Azevedo EPC, 2012, J BIOL CHEM, V287, P37206, DOI 10.1074/jbc.M112.369942; Bakshi S, 2014, APPL ENVIRON MICROB, V80, P4977, DOI 10.1128/AEM.00989-14; Bernard E, 2015, ECOTOX ENVIRON SAFE, V114, P273, DOI 10.1016/j.ecoenv.2014.04.024; Bilej M., 2010, EARTHWORM IMMUNITY, P66, DOI 10.1007/978-1-4419-8059-5_4; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Braian C, 2013, J INNATE IMMUN, V5, P591, DOI 10.1159/000348676; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bryantsev AL, 2007, EXP CELL RES, V313, P195, DOI 10.1016/j.yexcr.2006.10.004; Cho IH, 2004, J BIOCHEM MOL BIOL, V37, P199; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Cook SR, 2015, ISJ-INVERT SURVIV J, V12, P46; Cooper EL, 2002, BIOESSAYS, V24, P319, DOI 10.1002/bies.10077; Denis H, 2009, MOL CELL BIOL, V29, P4982, DOI 10.1128/MCB.00285-09; ELLIOTT JA, 1986, INFECT IMMUN, V51, P31, DOI 10.1128/IAI.51.1.31-36.1986; Engelmann P, 2005, DEV COMP IMMUNOL, V29, P599, DOI 10.1016/j.dci.2004.10.008; Engelmann P, 2004, CELL TISSUE RES, V316, P391, DOI 10.1007/s00441-004-0874-x; Falabella P, 2012, INSECT BIOCHEM MOLEC, V42, P203, DOI 10.1016/j.ibmb.2011.11.011; Farrera C, 2013, J IMMUNOL, V191, P2647, DOI 10.4049/jimmunol.1300436; Fierro IM, 1996, IMMUNOLOGY, V89, P295, DOI 10.1046/j.1365-2567.1996.d01-742.x; Fjosne TF, 2015, INNATE IMMUN-LONDON, V21, P161, DOI 10.1177/1753425914523056; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Golbach LA, 2015, J INNATE IMMUN, V7, P459, DOI 10.1159/000380764; Goldmann O, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00420; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Grimaldi A, 2012, ISJ-INVERT SURVIV J, V9, P153; Hara S, 2008, CLIN EXP PHARMACOL P, V35, P841, DOI 10.1111/j.1440-1681.2008.04921.x; Hirao A, 2009, APPL MICROBIOL BIOT, V84, P77, DOI 10.1007/s00253-009-1961-4; Homa J, 2016, J COMP PHYSIOL B, V186, P417, DOI 10.1007/s00360-016-0973-5; Homa J, 2008, DEV COMP IMMUNOL, V32, P9, DOI 10.1016/j.dci.2007.04.007; Homa J, 2013, J COMP PHYSIOL B, V183, P313, DOI 10.1007/s00360-012-0710-7; Kalac Yesim, 2002, Journal of Cell and Molecular Biology, V1, P7; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koiwai K, 2016, FISH SHELLFISH IMMUN, V52, P206, DOI 10.1016/j.fsi.2016.03.039; Kolaczkowska E, 2006, IMMUNOBIOLOGY, V211, P137, DOI 10.1016/j.imbio.2005.08.004; Kolaczkowska E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7673; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kolaczkowska E, 2009, J LEUKOCYTE BIOL, V85, P374, DOI 10.1189/jlb.0808460; Kurek A, 2007, EUR J SOIL BIOL, V43, pS121, DOI 10.1016/j.ejsobi.2007.08.051; Little TJ, 2005, NAT IMMUNOL, V6, P651, DOI 10.1038/ni1219; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Mena HA, 2016, J THROMB HAEMOST, V14, P397, DOI 10.1111/jth.13223; Mills CD, 2015, J INNATE IMMUN, V7, P443, DOI 10.1159/000380910; NAKAJIMA N, 1993, BIOSCI BIOTECH BIOCH, V57, P1726, DOI 10.1271/bbb.57.1726; Nakajima N, 2000, J BIOSCI BIOENG, V90, P174, DOI 10.1016/S1389-1723(00)80106-1; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Neeli I, 2009, J INNATE IMMUN, V1, P194, DOI 10.1159/000206974; Ng TH, 2015, DEV COMP IMMUNOL, V48, P229, DOI 10.1016/j.dci.2014.10.011; Pan R, APPL ENV SOIL SCI; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pascale M, 2014, DEV COMP IMMUNOL, V47, P129, DOI 10.1016/j.dci.2014.07.009; Pijanowski L, 2013, FISH SHELLFISH IMMUN, V34, P1244, DOI 10.1016/j.fsi.2013.02.010; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Poirier AC, 2014, J BIOL CHEM, V289, P24821, DOI 10.1074/jbc.M114.576546; Popovic M, 1998, GEN PHARMACOL, V30, P795, DOI 10.1016/S0306-3623(97)00014-1; Prochazkova P, 2006, J COMP PHYSIOL B, V176, P581, DOI 10.1007/s00360-006-0081-z; Pulze L, 2016, CLIN EXP IMMUNOL, V183, P469, DOI 10.1111/cei.12730; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Robb CT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5627; Rochael NC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18302; Rohrbach AS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00360; Sauter E, 2012, J ORTHOP RES, V30, P593, DOI 10.1002/jor.21552; Schorn T, 2015, CELL TISSUE RES, V359, P853, DOI 10.1007/s00441-014-2058-7; Skanta F, 2013, DEV COMP IMMUNOL, V41, P694, DOI 10.1016/j.dci.2013.08.009; Thakur S, 2015, EUR BIOPHYS J BIOPHY, V44, P337, DOI 10.1007/s00249-015-1027-8; Thomas MP, 2014, J IMMUNOL, V192, P5390, DOI 10.4049/jimmunol.1303296; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Tumminello RA, 2013, ISJ-INVERT SURVIV J, V10, P50; Ng TH, 2013, DEV COMP IMMUNOL, V41, P644, DOI 10.1016/j.dci.2013.06.014; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vorobjeva NV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1286, DOI 10.1134/S0006297914120025; Wada Y, 2006, CANCER SCI, V97, P1037, DOI 10.1111/j.1349-7006.2006.00278.x; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Zhang XZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10938; Zhao J, 2007, INT J BIOL MACROMOL, V40, P67, DOI 10.1016/j.ijbiomac.2006.05.007	80	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159031	10.1371/journal.pone.0159031	http://dx.doi.org/10.1371/journal.pone.0159031			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416067	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500061
J	Morfeld, KA; Meehan, CL; Hogan, JN; Brown, JL				Morfeld, Kari A.; Meehan, Cheryl L.; Hogan, Jennifer N.; Brown, Janine L.			Assessment of Body Condition in African (Loxodonta africana) and Asian (Elephas maximus) Elephants in North American Zoos and Management Practices Associated with High Body Condition Scores	PLOS ONE			English	Article							RISK-FACTORS; VETERINARY PRACTICES; PLASMA LEPTIN; DAIRY-COW; OBESITY; POPULATION; FAT; PREVALENCE; WEIGHT; HORSES	Obesity has a negative effect on health and welfare of many species, and has been speculated to be a problem for zoo elephants. To address this concern, we assessed the body condition of 240 elephants housed in North American zoos based on a set of standardized photographs using a 5-point Body Condition Score index (1 = thinnest; 5 = fattest). A multivariable regression analysis was then used to determine how demographic, management, housing, and social factors were associated with an elevated body condition score in 132 African (Loxodonta africana) and 108 Asian (Elephas maximus) elephants. The highest BCS of 5, suggestive of obesity, was observed in 34% of zoo elephants. In both species, the majority of elephants had elevated BCS, with 74% in the BCS 4 (40%) and 5 (34%) categories. Only 22% of elephants had BCS 3, and less than 5% of the population was assigned the lowest BCS categories (BCS 1 and 2). The strongest multi-variable model demonstrated that staff-directed walking exercise of 14 hours or more per week and highly unpredictable feeding schedules were associated with decreased risk of BCS 4 or 5, while increased diversity in feeding methods and being female was associated with increased risk of BCS 4 or 5. Our data suggest that high body condition is prevalent among North American zoo elephants, and management strategies that help prevent and mitigate obesity may lead to improvements in welfare of zoo elephants.	[Morfeld, Kari A.] Lincoln Childrens Zoo, Lincoln, NE USA; [Morfeld, Kari A.; Brown, Janine L.] Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Morfeld, KA (corresponding author), Lincoln Childrens Zoo, Lincoln, NE USA.; Morfeld, KA (corresponding author), Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA.	karimorfeld@yahoo.com			Institute of Museum and Library Services [LG-25-10-0033-10]; Smithsonian National Zoological Park; Lincoln Children's Zoo; IMLS; AWARE Institute	Institute of Museum and Library Services; Smithsonian National Zoological Park(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Lincoln Children's Zoo; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. Employers provided financial support in the form of authors' salaries as follows: Smithsonian National Zoological Park (JLB, KM); Lincoln Children's Zoo (KM). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; In addition, special thanks go to the AZA Elephant TAG and TAG Chair Martha Fischer for logistical support, Jackie Ogden for communications support, and Vistalogic, Inc. for technological support and software services. Thanks to the Lincoln Children's Zoo for dedicated laboratory space and support, and the Smithsonian National Zoological Park's Veterinary Pathology Laboratory for the triglyceride analyses.	Ange K, 2001, P NUTR ADV GROUP C, V4, P5; Brown JL, 2000, ZOO BIOL, V19, P347, DOI 10.1002/1098-2361(2000)19:5&lt;347::AID-ZOO6&gt;3.0.CO;2-V; Brown JL, 2004, GEN COMP ENDOCR, V136, P360, DOI 10.1016/j.ygcen.2004.01.013; Burkholder WJ, 2000, J AM VET MED ASSOC, V217, P650, DOI 10.2460/javma.2000.217.650; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Christie JL, 2006, CAN VET J, V47, P136; Clubb R, 2009, ANIM WELFARE, V18, P237; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cohen J., 2003, APPL MULTIPLE REGRES; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Cook RC, 2001, J WILDLIFE MANAGE, V65, P973, DOI 10.2307/3803046; DiPietro L, 1999, MED SCI SPORT EXER, V31, pS542, DOI 10.1097/00005768-199911001-00009; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; EDNEY ATB, 1986, VET REC, V118, P391, DOI 10.1136/vr.118.14.391; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Foreman J, 1998, EQUINE INTERNAL MED, P135; Frazier-Wood Alexis C, 2015, Curr Nutr Rep, V4, P82; Gallagher A. J., 2014, CONSERV PHYSIOL, V2, P1; Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; Giles SL, 2014, PEERJ, V2, DOI 10.7717/peerj.299; Greco BJ, 2016, PLOS ONE; Gustine DD, 2010, RANGIFER, V27, P249; GWINUP G, 1963, AM J CLIN NUTR, V13, P209, DOI 10.1093/ajcn/13.4.209; Hajian-Tilaki KO, 2007, OBES REV, V8, P3, DOI 10.1111/j.1467-789X.2006.00235.x; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Hatt J. -M., 2006, International Zoo Yearbook, V40, P88, DOI 10.1111/j.1748-1090.2006.00088.x; Hawn R, 2005, VET TECH, V26, P51; Hebebrand J, 2009, CHILD ADOL PSYCH CL, V18, P83, DOI 10.1016/j.chc.2008.07.006; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Holdgate MR, 2016, PLOS ONE; Holland JL, 1996, J ANIM SCI, V74, P1252; Hong Hye-Ryun, 2014, J Exerc Nutrition Biochem, V18, P277, DOI 10.5717/jenb.2014.18.3.277; Hu FB, 2003, LIPIDS, V38, P103, DOI 10.1007/s11745-003-1038-4; Garcia AI, 2015, ENDOCRINOL NUTR, V62, P130, DOI 10.1016/j.endonu.2014.11.007; Ishoika K, 2002, J VET MED SCI, V64, P39; Jakicic JM, 2002, J NUTR, V132, p3826S, DOI 10.1093/jn/132.12.3826S; Jenkins DJA, 1989, NEW ENGL J MED, V321, P919; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Laflamme D, 1997, CANINE PRACT, V22, P10; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lassen J, 2003, J DAIRY SCI, V86, P4123, DOI 10.3168/jds.S0022-0302(03)74026-0; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Li G, 2012, VET MED-RES REP, V3, P71, DOI 10.2147/VMRR.S34665; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]; Mazrier H, 2006, CAN VET J, V47, P883; McGreevy PD, 2005, VET REC, V156, P695, DOI 10.1136/vr.156.22.695; Meehan CL, 2016, PLOS ONE; Mellish JAE, 2004, J ZOO WILDLIFE MED, V35, P116, DOI 10.1638/03-028; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Morfeld KA, 2016, REPROD FERT DEVELOP, V28, P640, DOI 10.1071/RD14140; Morfeld KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093802; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; OTTO KL, 1991, J DAIRY SCI, V74, P852, DOI 10.3168/jds.S0022-0302(91)78234-9; Ozminkowski RJ, 2002, J OCCUP ENVIRON MED, V44, P21, DOI 10.1097/00043764-200201000-00005; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pena C, 2014, J VET MED SCI, V76, P1305, DOI 10.1292/jvms.13-0475; Phythian CJ, 2012, VET J, V193, P257, DOI 10.1016/j.tvjl.2011.12.006; POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6; Prado-Oviedo NA, 2016, PLOS ONE; Robinson D.S., 1970, COMPREHENSIVE BIOCH, P51; Rooney D, 1998, EQUINE INTERNAL MED, P216; Rothwell ES, 2011, ZOO BIOL, V30, P579, DOI 10.1002/zoo.20364; Sagawa MM, 2002, AM J VET RES, V63, P7, DOI 10.2460/AJVR.2002.63.7; Sargison ND, 2010, SMALL RUMINANT RES, V92, P2, DOI 10.1016/j.smallrumres.2010.04.019; Schroder UJ, 2006, J DAIRY SCI, V89, P1, DOI 10.3168/jds.S0022-0302(06)72064-1; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889; Stephenson TR, 1998, CAN J ZOOL, V76, P717, DOI 10.1139/cjz-76-4-717; Suagee JK, 2013, J VET INTERN MED, V27, P157, DOI 10.1111/jvim.12021; Taylor VJ, 1998, ZOO BIOL, V17, P311, DOI 10.1002/(SICI)1098-2361(1998)17:4&lt;311::AID-ZOO5&gt;3.0.CO;2-C; Thompson PD, 2013, PLOS ONE, V8; Wadha PS, 1986, AM J CLIN NUTR, V5, P551; WAGNER JJ, 1988, J ANIM SCI, V66, P603; Warren BS, 2011, BRIT J NUTR, V106, pS85, DOI 10.1017/S0007114511001814; Wemmer C, 2006, ZOO BIOL, V25, P187, DOI 10.1002/zoo.20099; WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6; Wyse CA, 2008, VET REC, V162, P590, DOI 10.1136/vr.162.18.590; Yamka R. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P282; YOUNG CM, 1972, J AM DIET ASSOC, V61, P391; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	87	63	65	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0155146	10.1371/journal.pone.0155146	http://dx.doi.org/10.1371/journal.pone.0155146			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415629	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500009
J	Riew, TR; Shin, YJ; Kim, HL; Cho, JM; Pak, HJ; Lee, MY				Riew, Tae-Ryong; Shin, Yoo-Jin; Kim, Hong Lim; Cho, Jeong Min; Pak, Ha-Jin; Lee, Mun-Yong			Spatiotemporal Progression of Microcalcification in the Hippocampal CA1 Region following Transient Forebrain Ischemia in Rats: An Ultrastructural Study	PLOS ONE			English	Article							DARK COMPACTED NEURONS; CALCIUM DEPOSITS; CEREBRAL-ISCHEMIA; HYPOXIA-ISCHEMIA; CELL-DEATH; ELECTRON-MICROSCOPY; GLOBAL-ISCHEMIA; BRAIN-INJURY; MITOCHONDRIA; CALCIFICATION	Calcification in areas of neuronal degeneration is a common finding in several neuropathological disorders including ischemic insults. Here, we performed a detailed examination of the onset and spatiotemporal profile of calcification in the CA1 region of the hippocampus, where neuronal death has been observed after transient forebrain ischemia. Histopathological examinations showed very little alizarin red staining in the CA1 pyramidal cell layer until day 28 after reperfusion, while prominent alizarin red staining was detected in CA1 dendritic subfields, particularly in the stratum radiatum, by 14 days after reperfusion. Electron microscopy using the osmium/potassium dichromate method and electron probe microanalysis revealed selective calcium deposits within the mitochondria of degenerating dendrites at as early as 7 days after reperfusion, with subsequent complete mineralization occurring throughout the dendrites, which then coalesced to form larger mineral conglomerates with the adjacent calcifying neurites by 14 days after reperfusion. Large calcifying deposits were frequently observed at 28 days after reperfusion, when they were closely associated with or completely engulfed by astrocytes. In contrast, no prominent calcification was observed in the somata of CA1 pyramidal neurons showing the characteristic features of necrotic cell death after ischemia, although what appeared to be calcified mitochondria were noted in some degenerated neurons that became dark and condensed. Thus, our data indicate that intrahippocampal calcification after ischemic insults initially occurs within the mitochondria of degenerating dendrites, which leads to the extensive calcification that is associated with ischemic injuries. These findings suggest that in degenerating neurons, the calcified mitochondria in the dendrites, rather than in the somata, may serve as the nidus for further calcium precipitation in the ischemic hippocampus.	[Riew, Tae-Ryong; Shin, Yoo-Jin; Cho, Jeong Min; Pak, Ha-Jin; Lee, Mun-Yong] Catholic Univ Korea, Coll Med, Cell Death Dis Res Ctr, Dept Anat,Catholic Neurosci Inst, Seoul 137701, South Korea; [Kim, Hong Lim] Catholic Univ Korea, Coll Med, Lab Electron Microscope, Integrat Res Support Ctr, Seoul 137701, South Korea	Catholic University of Korea; Catholic University of Korea	Lee, MY (corresponding author), Catholic Univ Korea, Coll Med, Cell Death Dis Res Ctr, Dept Anat,Catholic Neurosci Inst, Seoul 137701, South Korea.	munylee@catholic.ac.kr		Riew, Tae Ryong/0000-0001-7951-8176	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [NRF-2014R1A2A1A11050246]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF; http://www.nrf.re.kr) funded by the Ministry of Science, ICT and future Planning (NRF-2014R1A2A1A11050246). MYL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2014R1A2A1A11050246).	Agnew W F, 1979, Neurol Res, V1, P187; Bernal F, 2009, J NEUROSCI RES, V87, P1240, DOI 10.1002/jnr.21930; BONNEKOH P, 1992, ACTA NEUROPATHOL, V84, P400; Bueters T, 2008, EXP NEUROL, V209, P114, DOI 10.1016/j.expneurol.2007.09.005; Csordas A, 2003, ACTA NEUROPATHOL, V106, P37, DOI 10.1007/s00401-003-0694-1; Dubinsky JM, 2004, J BIOENERG BIOMEMBR, V36, P299, DOI 10.1023/B:JOBB.0000041757.68148.3c; DUX E, 1987, NEUROSCI LETT, V78, P295, DOI 10.1016/0304-3940(87)90376-4; Fairbanks SL, 2012, NEUROSCIENCE, V219, P183, DOI 10.1016/j.neuroscience.2012.05.048; Gallyas F, 2005, EXP BRAIN RES, V160, P473, DOI 10.1007/s00221-004-2037-4; Gallyas F, 2008, BRAIN RES, V1239, P207, DOI 10.1016/j.brainres.2008.08.069; Gayoso MJ, 2003, HISTOL HISTOPATHOL, V18, P855, DOI 10.14670/HH-18.855; GUTIERREZDIAZ JA, 1985, SURG NEUROL, V24, P67, DOI 10.1016/0090-3019(85)90067-9; Hasel P, 2015, BBA-MOL CELL RES, V1853, P2066, DOI 10.1016/j.bbamcr.2014.12.021; Herson PS, 2013, TRANSL STROKE RES, V4, P413, DOI 10.1007/s12975-012-0238-x; KATO H, 1995, BRAIN RES BULL, V38, P25, DOI 10.1016/0361-9230(95)00067-O; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kovesdi E, 2007, PROG BRAIN RES, V161, P81, DOI 10.1016/S0079-6123(06)61006-6; Kristian T, 2007, J NEUROCHEM, V102, P1346, DOI 10.1111/j.1471-4159.2007.04626.x; Lee MY, 1999, NEUROSCI LETT, V271, P81, DOI 10.1016/S0304-3940(99)00526-1; Liu FD, 2012, NEUROCHEM INT, V61, P1255, DOI 10.1016/j.neuint.2012.10.003; Luebke JI, 2010, BRAIN STRUCT FUNCT, V214, P181, DOI 10.1007/s00429-010-0244-2; Maetzler W, 2009, NEUROPATH APPL NEURO, V35, P165, DOI 10.1111/j.1365-2990.2008.00970.x; Maetzler W, 2010, AM J PATHOL, V177, P829, DOI 10.2353/ajpath.2010.090798; Mahy N, 1999, ACTA NEUROPATHOL, V98, P217, DOI 10.1007/s004010051072; Manwani B, 2013, EXP NEUROL, V249, P120, DOI 10.1016/j.expneurol.2013.08.011; Mazlo M, 2004, J NEUROCYTOL, V33, P557, DOI 10.1007/s11068-004-0517-5; Mori F, 2000, NEUROPATHOLOGY, V20, P210, DOI 10.1046/j.1440-1789.2000.00341.x; NITSCH C, 1992, ACTA NEUROPATHOL, V85, P55, DOI 10.1007/BF00304634; Ohta S, 1996, J CEREBR BLOOD F MET, V16, P915, DOI 10.1097/00004647-199609000-00015; Oliveira A, 2003, EXP NEUROL, V179, P127, DOI 10.1016/S0014-4886(02)00012-2; Pagnussat AD, 2007, J ANAT, V211, P589, DOI 10.1111/j.1469-7580.2007.00802.x; Park JM, 2012, J HISTOCHEM CYTOCHEM, V60, P550, DOI 10.1369/0022155412441707; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; PROBST W, 1986, HISTOCHEMISTRY, V85, P231, DOI 10.1007/BF00494809; Puka-Sundvall M, 2000, DEV BRAIN RES, V125, P31, DOI 10.1016/S0165-3806(00)00110-3; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Ramonet D, 2006, J NEUROSCI RES, V83, P147, DOI 10.1002/jnr.20711; Ramonet D, 2002, J PHYSIOLOGY-PARIS, V96, P307, DOI 10.1016/S0928-4257(02)00020-7; Riew TR, 2015, BRAIN RES, V1622, P430, DOI 10.1016/j.brainres.2015.06.048; Rodriguez MJ, 2004, J NEUROSCI RES, V77, P344, DOI 10.1002/jnr.20177; Rodriguez MJ, 2000, INT J DEV NEUROSCI, V18, P299, DOI 10.1016/S0736-5748(99)00098-2; Rodriguez MJ, 2001, NEUROBIOL DIS, V8, P59, DOI 10.1006/nbdi.2000.0332; Schafer M, 2014, CELL TISSUE RES, V357, P395, DOI 10.1007/s00441-014-1807-y; Sheldon RA, 2001, NEUROSCI LETT, V304, P165, DOI 10.1016/S0304-3940(01)01788-8; Shin YJ, 2012, J NEUROTRAUM, V29, P1530, DOI 10.1089/neu.2011.2078; SIMON RP, 1984, J CEREBR BLOOD F MET, V4, P350, DOI 10.1038/jcbfm.1984.52; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Winkelmann ER, 2006, ANAT EMBRYOL, V211, P423, DOI 10.1007/s00429-006-0095-z; Zeng YS, 2000, NEUROSCI RES, V37, P113, DOI 10.1016/S0168-0102(00)00107-3	50	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159229	10.1371/journal.pone.0159229	http://dx.doi.org/10.1371/journal.pone.0159229			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414398	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500100
J	Wortinger, LA; Endestad, T; Melinder, AMD; Oie, MG; Sevenius, A; Wyller, VB				Wortinger, Laura Anne; Endestad, Tor; Melinder, Annika Maria D.; Oie, Merete Glenne; Sevenius, Andre; Wyller, Vegard Bruun			Aberrant Resting-State Functional Connectivity in the Salience Network of Adolescent Chronic Fatigue Syndrome	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; BRAINS DEFAULT NETWORK; INSULAR CORTEX; PHYSIOLOGICAL CONDITION; PREFRONTAL CORTEX; WORKING-MEMORY; MODE NETWORKS; CHRONIC PAIN; STRESS; SCALE	Neural network investigations are currently absent in adolescent chronic fatigue syndrome (CFS). In this study, we examine whether the core intrinsic connectivity networks (ICNs) are altered in adolescent CFS patients. Eighteen adolescent patients with CFS and 18 aged matched healthy adolescent control subjects underwent resting-state functional magnetic resonance imaging (rfMRI). Data was analyzed using dual-regression independent components analysis, which is a data-driven approach for the identification of independent brain networks. Intrinsic connectivity was evaluated in the default mode network (DMN), salience network (SN), and central executive network (CEN). Associations between network characteristics and symptoms of CFS were also explored. Adolescent CFS patients displayed a significant decrease in SN functional connectivity to the right posterior insula compared to healthy comparison participants, which was related to fatigue symptoms. Additionally, there was an association between pain intensity and SN functional connectivity to the left middle insula and caudate that differed between adolescent patients and healthy comparison participants. Our findings of insula dysfunction and its association with fatigue severity and pain intensity in adolescent CFS demonstrate an aberration of the salience network which might play a role in CFS pathophysiology.	[Wortinger, Laura Anne; Wyller, Vegard Bruun] Akershus Univ Hosp, Dept Pediat, Nordbyhagen, Norway; [Wortinger, Laura Anne; Endestad, Tor; Oie, Merete Glenne; Sevenius, Andre] Univ Oslo, Dept Psychol, Oslo, Norway; [Melinder, Annika Maria D.] Univ Oslo, Dept Psychol, Cognit Dev Res Unit, Oslo, Norway; [Oie, Merete Glenne] Innlandet Hosp Trust, Res Dept, Lillehammer, Norway	University of Oslo; University of Oslo; University of Oslo; Innlandet Hospital Trust	Wortinger, LA (corresponding author), Akershus Univ Hosp, Dept Pediat, Nordbyhagen, Norway.; Wortinger, LA (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.	l.a.w.bakke@medisin.uio.no	Melinder, Annika/L-6782-2016	Melinder, Annika/0000-0001-7773-0579; Wortinger, Laura/0000-0003-2721-3172; Endestad, Tor/0000-0002-4403-6887; Nilsen, Andre/0000-0003-2084-6663	Norwegian Research Council [228874]; Health South-East Hospital Trust; University of Oslo	Norwegian Research Council(Research Council of NorwayEuropean Commission); Health South-East Hospital Trust; University of Oslo	Norwegian Research Council, http://www.forskningsradet.no/en (VBW, grant number 228874); Health South-East Hospital Trust, http://www.helse-sorost.no/fagfolk_/forskning_/forskningsmidler (VBW); and the University of Oslo, http://www.uio.no/english/ (VBW).	Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Beckmann C., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/S1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3, 10.1016/s1053-8119(09)71511-3]; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Boissoneault J, 2016, MAGN RESON IMAGING, V34, P603, DOI 10.1016/j.mri.2015.12.008; Brurberg KG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003973; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burkey AR, 1999, J NEUROSCI, V19, P4169; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Caseras X, 2008, PSYCHOL MED, V38, P941, DOI 10.1017/S0033291708003450; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chen TW, 2015, EUR J NEUROSCI, V41, P264, DOI 10.1111/ejn.12764; Connolly CG, 2013, BIOL PSYCHIAT, V74, P898, DOI 10.1016/j.biopsych.2013.05.036; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Crawley EM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000252; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2004, P NATL ACAD SCI USA, V101, P6333, DOI 10.1073/pnas.0401510101; Critchley HD, 2002, NEUROIMAGE, V16, P909, DOI 10.1006/nimg.2002.1147; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Gay CW, 2016, BRAIN CONNECT, V6, P48, DOI 10.1089/brain.2015.0366; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Goldstein DS, 2001, AUTONOMIC NERVOUS SY; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Haig-Ferguson A, 2009, ARCH DIS CHILD, V94, P757, DOI 10.1136/adc.2008.143032; Henckens MJAG, 2015, NEUROIMAGE, V105, P312, DOI 10.1016/j.neuroimage.2014.10.037; Hong JY, 2013, J NEUROSCI, V33, P11994, DOI 10.1523/JNEUROSCI.5733-12.2013; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Jason LA., 2006, J CHRON FATIGUE SYND, V13, P1, DOI DOI 10.1300/J092V13N02_01; Jolles DD, 2011, CEREB CORTEX, V21, P385, DOI 10.1093/cercor/bhq104; Kennedy G, 2010, PEDIATRICS, V125, pE1324, DOI 10.1542/peds.2009-2644; Kim BH, 2015, PSYCHIAT RES-NEUROIM, V234, P292, DOI 10.1016/j.pscychresns.2015.10.014; Klimas NG, 2012, BRAIN BEHAV IMMUN, V26, P1202, DOI 10.1016/j.bbi.2012.06.006; Lovick TA, 2008, NEUROSCI BIOBEHAV R, V32, P852, DOI 10.1016/j.neubiorev.2008.01.003; Menon V., 2015, BRAIN MAPPING ENCY R, V2, P597, DOI DOI 10.1016/B978-0-12-397025-1.00052-X; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Missen A, 2012, CHILD CARE HLTH DEV, V38, P505, DOI 10.1111/j.1365-2214.2011.01298.x; Moran LV, 2013, BIOL PSYCHIAT, V74, P467, DOI 10.1016/j.biopsych.2013.02.029; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; *NAT I HLTH CLIN E, 2007, NICE CLINICAL GUIDEL; National Institute for Health Care and Excellent (NICE), 2021, MAN ME CHRON FAT SYN; Nijhof SL, 2011, PEDIATRICS, V127, pE1169, DOI 10.1542/peds.2010-1147; Nijs J, 2012, EUR J CLIN INVEST, V42, P203, DOI 10.1111/j.1365-2362.2011.02575.x; Nisenbaum R, 2004, J PSYCHOSOM RES, V56, P171, DOI 10.1016/S0022-3999(03)00039-4; Pani L, 2000, MOL PSYCHIATR, V5, P14, DOI 10.1038/sj.mp.4000589; Papadopoulos AS, 2012, NAT REV ENDOCRINOL, V8, P22, DOI 10.1038/nrendo.2011.153; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raison CL, 2009, BRAIN BEHAV IMMUN, V23, P327, DOI 10.1016/j.bbi.2008.11.005; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Segal TY, 2005, J PEDIATR ENDOCR MET, V18, P295; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Spielberger CD, 1973, STAI MANUAL STAIT TR; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sulheim D, 2015, ARCH DIS CHILD, V100, P838, DOI 10.1136/archdischild-2014-306764; Sulheim D, 2014, JAMA PEDIATR, V168, P351, DOI 10.1001/jamapediatrics.2013.4647; Sullivan PF, 2005, PSYCHOL MED, V35, P1337, DOI 10.1017/S0033291705005210; Sund AM, 2001, EUR CHILD ADOLES PSY, V10, P222, DOI 10.1007/s007870170011; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Tanaka M, 2013, REV NEUROSCIENCE, V24, P617, DOI 10.1515/revneuro-2013-0035; Tanaka M, 2008, PSYCHOL REP, V103, P682, DOI 10.2466/PR0.103.3.682-690; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Wechsler D., 2007, NORWEGIAN MANUAL SUP; Weng SJ, 2010, BRAIN RES, V1313, P202, DOI 10.1016/j.brainres.2009.11.057; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; Winger A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005920; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wyller VB, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-5; Wyller VB, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-10; Wyller VB, 2008, ANN NONINVAS ELECTRO, V13, P67, DOI 10.1111/j.1542-474X.2007.00202.x; Wyller VB, 2007, PEDIATRICS, V120, pE129, DOI 10.1542/peds.2006-2759; Wyller VB, 2007, AM J CARDIOL, V99, P997, DOI 10.1016/j.amjcard.2006.10.067; Yuen GS, 2014, INT J GERIATR PSYCH, V29, P1116, DOI 10.1002/gps.4171	86	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159351	10.1371/journal.pone.0159351	http://dx.doi.org/10.1371/journal.pone.0159351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414048	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500123
J	Herbei, R; Rytel, AL; Lyons, WB; McKnight, DM; Jaros, C; Gooseff, MN; Priscu, JC				Herbei, Radu; Rytel, Alexander L.; Lyons, W. Berry; McKnight, Diane M.; Jaros, Christopher; Gooseff, Michael N.; Priscu, John C.			Hydrological Controls on Ecosystem Dynamics in Lake Fryxell, Antarctica	PLOS ONE			English	Article							MCMURDO DRY VALLEYS; WATER COLUMN; PHYTOPLANKTON; BONNEY	The McMurdo Dry Valleys constitute the largest ice free area of Antarctica. The area is a polar desert with an annual precipitation of similar to 3 cm water equivalent, but contains several lakes fed by glacial melt water streams that flow from four to twelve weeks of the year. Over the past similar to 20 years, data have been collected on the lakes located in Taylor Valley, Antarctica as part of the McMurdo Dry Valley Long-Term Ecological Research program (MCM-LTER). This work aims to understand the impact of climate variations on the biological processes in all the ecosystem types within Taylor Valley, including the lakes. These lakes are stratified, closed-basin systems and are perennially covered with ice. Each lake contains a variety of planktonic and benthic algae that require nutrients for photosynthesis and growth. The work presented here focuses on Lake Fryxell, one of the three main lakes of Taylor Valley; it is fed by thirteen melt-water streams. We use a functional regression approach to link the physical, chemical, and biological processes within the stream-lake system to evaluate the input of water and nutrients on the biological processes in the lakes. The technique has been shown previously to provide important insights into these Antarctic lacustrine systems where data acquisition is not temporally coherent. We use data on primary production (PPR) and chlorophyll-A (CHL) from Lake Fryxell as well as discharge observations from two streams flowing into the lake. Our findings show an association between both PPR, CHL and stream input.	[Herbei, Radu; Rytel, Alexander L.; Lyons, W. Berry] Ohio State Univ, Columbus, OH 43210 USA; [McKnight, Diane M.; Jaros, Christopher; Gooseff, Michael N.] Univ Colorado, Boulder, CO USA; [Priscu, John C.] Montana State Univ, Bozeman, MT USA; [Herbei, Radu] Ohio State Univ, Dept Stat, 1958 Neil Ave, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University of Colorado System; University of Colorado Boulder; Montana State University System; Montana State University Bozeman; University System of Ohio; Ohio State University	Herbei, R (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.	herbei@stat.osu.edu	Gooseff, Michael N/N-6087-2015	Gooseff, Michael N/0000-0003-4322-8315	NSF [OPP-9813061, ANT-0423595, ANT-1115245]	NSF(National Science Foundation (NSF))	This work was supported by the following NSF grants: OPP-9813061, ANT-0423595, and ANT-1115245. The grants were awarded to WBL, DMM, and JCP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JE, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2005JG000141; Doran PT, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD002045; Ebnet AF, 2005, ANN GLACIOL-SER, V40, P76, DOI 10.3189/172756405781813519; Foreman CM, 2004, AQUAT GEOCHEM, V10, P239, DOI 10.1007/s10498-004-2261-3; Fountain AG, 2010, INT J CLIMATOL, V30, P633, DOI 10.1002/joc.1933; Friedman J., 2015, PACKAGE GLASSO; Gooseff MN, 2011, GEOGR COMPASS, V5, DOI 10.1111/j.1749-8198.2011.00445.x; Herbei R, 2010, ECOL MODEL, V221, P1184, DOI 10.1016/j.ecolmodel.2009.12.015; Levy J, 2013, ANTARCT SCI, V25, P119, DOI 10.1017/S0954102012000727; LIZOTTE MP, 1992, J PHYCOL, V28, P179, DOI 10.1111/j.0022-3646.1992.00179.x; Lyons WB, 1998, ANTARCT SCI, V10, P247, DOI 10.1017/S0954102098000340; Lyons WB, 2016, SOURCE-TO-SINK FLUXES IN UNDISTURBED COLD ENVIRONMENTS, P260; McKnight DM, 1999, BIOSCIENCE, V49, P985, DOI 10.2307/1313732; Obryk MK, 2014, J GEOPHYS RES-BIOGEO, V119, P1879, DOI 10.1002/2014JG002672; PRISCU JC, 1995, FRESHWATER BIOL, V34, P215, DOI 10.1111/j.1365-2427.1995.tb00882.x; Priscu JC, 1999, BIOSCIENCE, V49, P997, DOI 10.2307/1313733; Ramsay J. O, 2006, FUNCTIONAL DATA ANAL; Roberts EC, 2004, POLAR BIOL, V27, P238, DOI 10.1007/s00300-003-0582-0; RUE H., 2005, GAUSSIAN MARKOV RAND	19	3	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159038	10.1371/journal.pone.0159038	http://dx.doi.org/10.1371/journal.pone.0159038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441705	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500036
J	Sabattini, S; Savini, F; Gallina, L; Scagliarini, A; Bassi, P; Bettini, G				Sabattini, Silvia; Savini, Federica; Gallina, Laura; Scagliarini, Alessandra; Bassi, Patrizia; Bettini, Giuliano			p16 Immunostaining of Canine Squamous Cell Carcinomas Is Not Associated with Papillomaviral DNA	PLOS ONE			English	Article							VIRAL PLAQUES; HEALTHY SKIN; LIFE-CYCLE; DOGS; EXPRESSION; SEQUENCES; CANCER; HEAD; OVEREXPRESSION; LESIONS	While papillomavirus (PVs) are an established cause of human cancer, few reports have supported a relationship between PV and canine squamous cell carcinomas (SCCs). Human oncogenic PVs lead to an increased expression of the p16 tumor suppressor protein, and the latter can be demonstrated immunohistochemically to support a likely causal relationship between tumor and PV infection. In the present study, archive samples of canine SCC from different anatomical locations were tested by polymerase chain reaction for the presence of PV DNA and by p16 immunohistochemistry. The aims were to investigate the relationship between p16 expression and presence of PV DNA, in order to assess the utility of p16 overexpression as a biomarker of PV infection in canine SCC. A total of 52 SCCs were included. Nine cases (17.3%) showed moderate p16 immunoreactivity, with no association with tumor degree of differentiation, histotype or mitotic activity. The canPVf/FAP64 primers amplified Canis familiaris PV-1 DNA from 3 out of 52 tumors (5.8%), one cutaneous, one oral and one tonsillar SCC. There was no association between PV presence and p16 immunostaining. These results do not support a significant role of PVs in the development of canine SCCs. Additionally, PV infection was apparently not the cause of the p16 immunostaining observed in a subset of canine SCCs. A better awareness of p16 level of expression and cellular function in canine cancer may help to define its diagnostic and prognostic role.	[Sabattini, Silvia; Bassi, Patrizia; Bettini, Giuliano] Univ Bologna, Dept Vet Med Sci, Div Pathol, Ozzano Dell Emilia, BO, Italy; [Savini, Federica; Gallina, Laura; Scagliarini, Alessandra] Univ Bologna, Dept Vet Med Sci, Div Virol, Ozzano Dell Emilia, BO, Italy	University of Bologna; University of Bologna	Bettini, G (corresponding author), Univ Bologna, Dept Vet Med Sci, Div Pathol, Ozzano Dell Emilia, BO, Italy.	giuliano.bettini@unibo.it	Sabattini, Silvia/AAN-3233-2020	Sabattini, Silvia/0000-0001-7005-2736; Bassi, Patrizia/0000-0002-1411-5007; Bettini, Giuliano/0000-0003-1857-7329; SCAGLIARINI, ALESSANDRA/0000-0003-1146-0101; , federica/0000-0003-3275-4029	University of Bologna (FARB-Finanziamenti di Ateneo alla ricerca di base)	University of Bologna (FARB-Finanziamenti di Ateneo alla ricerca di base)	This work was supported by grants from the University of Bologna (FARB-Finanziamenti di Ateneo alla ricerca di base). The funding source had no involvement in the study design or in the writing of the report.	Antonsson A, 2002, J VIROL, V76, P12537, DOI 10.1128/JVI.76.24.12537-12542.2002; Arifin MT, 2006, J NEURO-ONCOL, V77, P273, DOI 10.1007/s11060-005-9037-5; Boscolo-Rizzo P, 2016, CANCER TREAT REV, V42, P24, DOI 10.1016/j.ctrv.2015.10.009; BOSTOCK DE, 1984, VET REC, V114, P341, DOI 10.1136/vr.114.14.341; BREGMAN CL, 1987, VET PATHOL, V24, P477, DOI 10.1177/030098588702400602; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; FIRZLAFF JM, 1988, VIROLOGY, V164, P467, DOI 10.1016/0042-6822(88)90561-2; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Goldschmidt MH, 2006, J VIROL, V80, P6621, DOI 10.1128/JVI.02571-05; Gross TL, 2005, SKIN DISEASES OF THE DOG AND CAT: CLINICAL AND HISTOPATHOLOGIC DIAGNOSIS, 2ND EDITION, P562; Hauck ML., WITHROW MACEWENS SMA, V2013, P305, DOI DOI 10.1016/B978-1-4377-2362-5.00018-9; Lam AKY, 2008, PATHOLOGY, V40, P580, DOI 10.1080/00313020802320713; Lange CE, 2013, VET MICROBIOL, V162, P388, DOI 10.1016/j.vetmic.2012.10.012; Lange CE, 2012, J VIROL, V86, P10226, DOI 10.1128/JVI.01553-12; Lange CE, 2011, VET CLIN N AM-SMALL, V41, P1183, DOI 10.1016/j.cvsm.2011.08.003; Lange CE, 2011, J CLIN MICROBIOL, V49, P707, DOI 10.1128/JCM.02047-10; Little SE, 2006, GENOMICS, V87, P298, DOI 10.1016/j.ygeno.2005.09.019; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Luff J., 2015, GENOME ANNOUNC, V16, P3; Luff J, 2016, VET PATHOL; Luff JA, 2012, J VET DIAGN INVEST, V24, P576, DOI 10.1177/1040638712443360; MANOS MM, 1989, CANCER CEL, V7, P209; Mas A, 2011, J SMALL ANIM PRACT, V52, P359, DOI 10.1111/j.1748-5827.2011.01075.x; Mehanna H, 2016, HEAD NECK S1, V38; Mellett S, 2015, J SMALL ANIM PRACT, V56, P223, DOI 10.1111/jsap.12264; Meuten D.J., 2020, TUMORS DOMESTIC ANIM; Milde-Langosch K, 2001, BREAST CANCER RES TR, V67, P61, DOI 10.1023/A:1010623308275; Munday JS, 2013, NEW ZEAL VET J, V61, P234, DOI 10.1080/00480169.2012.731718; Munday JS, 2016, VET MICROBIOL, V182, P135, DOI 10.1016/j.vetmic.2015.11.015; Munday JS, 2015, VET J, V204, P223, DOI 10.1016/j.tvjl.2015.03.002; Munday JS, 2015, J VET DIAGN INVEST, V27, P221, DOI 10.1177/1040638714567191; Munday JS, 2014, VET J, V199, P340, DOI 10.1016/j.tvjl.2013.11.025; Munday JS, 2011, VET DERMATOL, V22, P104, DOI 10.1111/j.1365-3164.2010.00913.x; Munday JS, 2010, J VET DIAGN INVEST, V22, P946, DOI 10.1177/104063871002200615; Nasir L, 2013, VET MICROBIOL, V167, P159, DOI 10.1016/j.vetmic.2013.08.003; Nemec A, 2014, J COMP PATHOL, V150, P155, DOI 10.1016/j.jcpa.2013.07.007; Nemec A, 2012, J COMP PATHOL, V147, P111, DOI 10.1016/j.jcpa.2011.11.198; Ogawa T, 2004, J GEN VIROL, V85, P2191, DOI 10.1099/vir.0.80086-0; Peyton CL, 2001, J INFECT DIS, V183, P1554, DOI 10.1086/320696; Porcellato I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112833; Ralli M, 2016, J CANCER RES THER, V12, P232, DOI 10.4103/0973-1482.151447; Rector A, 2013, VIROLOGY, V445, P213, DOI 10.1016/j.virol.2013.05.007; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Teifke JP, 1998, VET MICROBIOL, V60, P119, DOI 10.1016/S0378-1135(98)00151-5; Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984; Waropastrakul S, 2012, VET DERMATOL, V23, P197, DOI 10.1111/j.1365-3164.2012.01043.x; WATRACH AM, 1970, J NATL CANCER I, V45, P915; Webb JL, 2009, COMPENDIUM, V31, P133; Wiggans KT, 2013, VET OPHTHALMOL, V16, P105, DOI 10.1111/j.1463-5224.2012.01062.x; Zaugg N, 2005, VET DERMATOL, V16, P290, DOI 10.1111/j.1365-3164.2005.00467.x	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159687	10.1371/journal.pone.0159687	http://dx.doi.org/10.1371/journal.pone.0159687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441555	gold, Green Published, Green Submitted			2022-12-27	WOS:000380797500121
J	Amelineau, F; Gremillet, D; Bonnet, D; Le Bot, T; Fort, J				Amelineau, Francoise; Gremillet, David; Bonnet, Delphine; Le Bot, Tangi; Fort, Jerme			Where to Forage in the Absence of Sea Ice? Bathymetry As a Key Factor for an Arctic Seabird	PLOS ONE			English	Article							AUKS ALLE-ALLE; CLIMATE-CHANGE; FEEDING ECOLOGY; ZOOPLANKTON; BEHAVIOR; DIET; ASSOCIATIONS; GREENLAND; DOVEKIES; STRATEGY	The earth is warming at an alarming rate, especially in the Arctic, where a marked decline in sea ice cover may have far-ranging consequences for endemic species. Little auks, endemic Arctic seabirds, are key bioindicators as they forage in the marginal ice zone and feed preferentially on lipid-rich Arctic copepods and ice-associated amphipods sensitive to the consequences of global warming. We tested how little auks cope with an ice-free foraging environment during the breeding season. To this end, we took advantage of natural variation in sea ice concentration along the east coast of Greenland. We compared foraging and diving behaviour, chick diet and growth and adult body condition between two years, in the presence versus nearby absence of sea ice in the vicinity of their breeding site. Moreover, we sampled zooplankton at sea when sea ice was absent to evaluate prey location and little auk dietary preferences. Little auks foraged in the same areas both years, irrespective of sea ice presence/concentration, and targeted the shelf break and the continental shelf. We confirmed that breeding little auks showed a clear preference for larger copepod species to feed their chick, but caught smaller copepods and nearly no ice-associated amphipod when sea ice was absent. Nevertheless, these dietary changes had no impact on chick growth and adult body condition. Our findings demonstrate the importance of bathymetry for profitable little auk foraging, whatever the sea-ice conditions. Our investigations, along with recent studies, also confirm more flexibility than previously predicted for this key species in a warming Arctic.	[Amelineau, Francoise; Gremillet, David; Le Bot, Tangi] Univ Montpellier 3, Univ Montpellier, EPHE, CNRS,CEFE UMR 5175, Montpellier, France; [Gremillet, David] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, Rondebosch, South Africa; [Bonnet, Delphine] Univ Montpellier, Lab MARBEC, Montpellier, France; [Fort, Jerme] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Fort, Jerme] Univ La Rochelle, CNRS, LIENSs, UMR 7266, La Rochelle, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Universite Paul-Valery; National Research Foundation - South Africa; University of Cape Town; Ifremer; Universite de Montpellier; Aarhus University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Amelineau, F (corresponding author), Univ Montpellier 3, Univ Montpellier, EPHE, CNRS,CEFE UMR 5175, Montpellier, France.	francoise.amelineau@gmail.com	Gremillet, David/W-1946-2018; Amelineau, Francoise/AAD-4833-2019; Fort, Jerome/F-1157-2016	Gremillet, David/0000-0002-7711-9398; Amelineau, Francoise/0000-0001-9723-5858; Fort, Jerome/0000-0002-0860-6707; BONNET, Delphine/0000-0002-2040-1800	French Polar Institute (IPEV); European Commission (Marie Curie IEF) [273061]; National Geographic Society - Global Exploration Fund Northern Europe [GEFNE-4112]; (European commission Marie Curie CIG) [631203]; French Polar Institute (ADACLIM program) [388]	French Polar Institute (IPEV); European Commission (Marie Curie IEF); National Geographic Society - Global Exploration Fund Northern Europe(National Geographic Society); (European commission Marie Curie CIG); French Polar Institute (ADACLIM program)	This study was co-funded by the French Polar Institute (IPEV (http://www.institut-polaire.fr) ADACLIM program no 388 to DG and JF), the European Commission (Marie Curie IEF to JF, Project 273061) and the the National Geographic Society - Global Exploration Fund Northern Europe (GEFNE-4112 to JF). This study also represents a contribution to the ARCTOX research project (European commission Marie Curie CIG, Project 631203 to JF).	Arndt CE, 2006, ADV MAR BIOL, V51, P197, DOI 10.1016/S0065-2881(06)51004-1; BANNASCH R, 1994, J EXP BIOL, V194, P83; Beaugrand G, 2009, GLOBAL CHANGE BIOL, V15, P1790, DOI 10.1111/j.1365-2486.2009.01848.x; Belkin IM, 2009, PROG OCEANOGR, V81, P223, DOI 10.1016/j.pocean.2009.04.015; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; BRADSTREET MSW, 1982, ARCTIC, V35, P126; Brown ZW, 2012, J AVIAN BIOL, V43, P215, DOI 10.1111/j.1600-048X.2012.05484.x; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Descamps S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065374; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dunbar MJ, 1963, CONS I POUR EXPLOR M, V4; Eamer J, 2013, LIFE LINKED ICE GUID; Egevang C, 2003, POLAR BIOL, V26, P8, DOI 10.1007/s00300-002-0448-x; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Fifield DA, 2009, ENV STUD RES FUNDS R, P183; Follestad A., 1990, Polar Research, V8, P23, DOI 10.1111/j.1751-8369.1990.tb00371.x; Fort J, 2013, DIVERS DISTRIB, V19, P1322, DOI 10.1111/ddi.12105; Fort J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041194; Fort J, 2010, MAR ECOL PROG SER, V414, P293, DOI 10.3354/meps08721; Fort J, 2010, BIOL LETTERS, V6, P682, DOI 10.1098/rsbl.2010.0082; Freeman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009236; Garzke J, 2015, OECOLOGIA, V177, P849, DOI 10.1007/s00442-014-3130-4; Gaston, 1998, THE AUKS ALCIDAE; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Gilg O, 2012, ANN NY ACAD SCI, V1249, P166, DOI 10.1111/j.1749-6632.2011.06412.x; Gremillet D, 2015, GLOBAL CHANGE BIOL, V21, P1116, DOI 10.1111/gcb.12811; Gremillet D, 2012, MAR ECOL PROG SER, V454, P197, DOI 10.3354/meps09590; Harding AMA, 2011, OECOLOGIA, V167, P49, DOI 10.1007/s00442-011-1971-7; Harding AMA, 2009, POLAR BIOL, V32, P785, DOI 10.1007/s00300-009-0581-x; Hargrave B, 1984, BIOLOGICAL OCEANOGRA; Hovinen JEH, 2014, ECOL EVOL, V4, P3127, DOI 10.1002/ece3.1160; Hovinen JEH, 2014, POLAR BIOL, V37, P665, DOI 10.1007/s00300-014-1466-1; Huettmann Falk, 2011, Marine Biodiversity, V41, P141, DOI 10.1007/s12526-011-0083-2; Hunt GL, 1997, ICES J MAR SCI, V54, P600; Hunt GL, 1998, MAR ECOL PROG SER, P167; Hyrenbach KD, 2006, FISH OCEANOGR, V15, P95, DOI 10.1111/j.1365-2419.2005.00350.x; Jakubas D, 2007, WATERBIRDS, V30, P421, DOI 10.1675/1524-4695(2007)030[0421:RODTCI]2.0.CO;2; Jakubas D, 2016, J EXP MAR BIOL ECOL, V475, P89, DOI 10.1016/j.jembe.2015.11.010; Jakubas D, 2014, J AVIAN BIOL, V45, P551, DOI 10.1111/jav.00303; Jakubas D, 2013, MAR ECOL PROG SER, V489, P263, DOI 10.3354/meps10414; Jakubas D, 2012, POLAR BIOL, V35, P73, DOI 10.1007/s00300-011-1034-x; Karnovsky N, 2010, MAR ECOL PROG SER, V415, P283, DOI 10.3354/meps08749; Karnovsky NJ, 2008, MAR ECOL PROG SER, V357, P291, DOI 10.3354/meps07295; Karnovsky NJ, 2003, MAR ECOL PROG SER, V253, P289, DOI 10.3354/meps253289; Kidawa D, 2012, POLAR BIOL, V35, P909, DOI 10.1007/s00300-011-1136-5; KINDER TH, 1983, ESTUAR COAST SHELF S, V16, P309, DOI 10.1016/0272-7714(83)90148-8; Klekowski R.Z., 1991, ATLAS MARINE FAUNA 1, V2; Kwasniewski S, 2010, PROG OCEANOGR, V87, P72, DOI 10.1016/j.pocean.2010.06.004; LONNE OJ, 1992, POLAR BIOL, V12, P685; Louzao M, 2009, MAR ECOL PROG SER, V391, P183, DOI 10.3354/meps08124; Lovvorn JR, 2009, ECOL APPL, V19, P1596, DOI 10.1890/08-1193.1; Mehlum F, 1997, POLAR BIOL, V18, P116, DOI 10.1007/s003000050166; Mosbech A, 2012, POLAR BIOL, V35, P305, DOI 10.1007/s00300-011-1064-4; Oksanen J., 2013, PACKAGE VEGAN, V2, P1; Pedersen CE, 2001, POLAR BIOL, V24, P53, DOI 10.1007/s003000000173; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinheiro J., 2019, NLME LINEAR NONLINEA; Polyak L, 2010, QUATERNARY SCI REV, V29, P1757, DOI 10.1016/j.quascirev.2010.02.010; Post E, 2013, SCIENCE, V341, P519, DOI 10.1126/science.1235225; Prop J, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00033; QGIS Development Team, 2015, QGIS GEOGR INF SYST; R Core Team, 2013, LANG ENV STAT COMP; Rose M, 1933, COPEPODES PELAGIQUES; Skov H, 2000, CONT SHELF RES, V20, P169, DOI 10.1016/S0278-4343(99)00067-9; Soreide JE, 2008, DEEP-SEA RES PT II, V55, P2225, DOI 10.1016/j.dsr2.2008.05.024; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; STEMPNIEWICZ L, 1993, POLAR RES, V12, P33, DOI 10.1111/j.1751-8369.1993.tb00420.x; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; STRAUSS RE, 1979, T AM FISH SOC, V108, P344, DOI 10.1577/1548-8659(1979)108<344:REFIEI>2.0.CO;2; Tamelander T, 2006, MAR ECOL PROG SER, V310, P33, DOI 10.3354/meps310033; Tencati JR, 1970, DTIC DOCUMENT; Van Hemert C, 2014, FRONT ECOL ENVIRON, V12, P548, DOI 10.1890/130291; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Welcker J, 2009, J AVIAN BIOL, V40, P388, DOI 10.1111/j.1600-048X.2008.04620.x; Yen PPW, 2004, J MARINE SYST, V50, P79, DOI 10.1016/j.jmarsys.2003.09.015; Zuur Alain F., 2009, P1	78	34	34	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0157764	10.1371/journal.pone.0157764	http://dx.doi.org/10.1371/journal.pone.0157764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438790	gold, Green Submitted, Green Published			2022-12-27	WOS:000380170100003
J	Gori, M; Simonelli, MC; Giannitelli, SM; Businaro, L; Trombetta, M; Rainer, A				Gori, Manuele; Simonelli, Maria Chiara; Giannitelli, Sara Maria; Businaro, Luca; Trombetta, Marcella; Rainer, Alberto			Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device	PLOS ONE			English	Article							LIPID-ACCUMULATION; CELL-CULTURE; RISK-FACTOR; HEPATOCYTE; TISSUE; ORGANS; ACID; STEATOSIS; PROGRESSION; MODEL	Background and Aim Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease worldwide, ranging from simple steatosis to nonalcoholic steatohepatitis, which may progress to cirrhosis, eventually leading to hepatocellular carcinoma (HCC). HCC ranks as the third highest cause of cancer-related death globally, requiring an early diagnosis of NAFLD as a potential risk factor. However, the molecular mechanisms underlying NAFLD are still under investigation. So far, many in vitro studies on NAFLD have been hampered by the limitations of 2D culture systems, in which cells rapidly lose tissue-specific functions. The present liver-on-a-chip approach aims at filling the gap between conventional in vitro models, often scarcely predictive of in vivo conditions, and animal models, potentially biased by their xenogeneic nature. Methods HepG2 cells were cultured into a microfluidically perfused device under free fatty acid (FFA) supplementation, namely palmitic and oleic acid, for 24h and 48h. The device mimicked the endothelial-parenchymal interface of a liver sinusoid, allowing the diffusion of nutrients and removal of waste products similar to the hepatic microvasculature. Assessment of intracellular lipid accumulation, cell viability/cytotoxicity and oxidative stress due to the FFA overload, was performed by high-content analysis methodologies using fluorescence-based functional probes. Results The chip enables gradual and lower intracellular lipid accumulation, higher hepatic cell viability and minimal oxidative stress in microfluidic dynamic vs. 2D static cultures, thus mimicking the chronic condition of steatosis observed in vivo more closely. Conclusions Overall, the liver-on-a-chip system provides a suitable culture microenvironment, representing a more reliable model compared to 2D cultures for investigating NAFLD pathogenesis. Hence, our system is amongst the first in vitro models of human NAFLD developed within a microfluidic device in a sinusoid-like fashion, endowing a more permissive tissue-like microenvironment for long-term culture of hepatic cells than conventional 2D static cultures.	[Gori, Manuele; Simonelli, Maria Chiara; Giannitelli, Sara Maria; Trombetta, Marcella; Rainer, Alberto] Tissue Engn Lab, Dept Engn, Univ Campus Biomed Roma, Rome, Italy; [Businaro, Luca; Rainer, Alberto] CNR, Inst Photon & Nanotechnol CNR IFN, Rome, Italy; [Businaro, Luca; Trombetta, Marcella; Rainer, Alberto] UCBM IFN Joint Lab Nanotechnol Life Sci, Rome, Italy	University Campus Bio-Medico - Rome Italy; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR)	Rainer, A (corresponding author), Tissue Engn Lab, Dept Engn, Univ Campus Biomed Roma, Rome, Italy.; Rainer, A (corresponding author), CNR, Inst Photon & Nanotechnol CNR IFN, Rome, Italy.; Rainer, A (corresponding author), UCBM IFN Joint Lab Nanotechnol Life Sci, Rome, Italy.	a.rainer@unicampus.it	Giannitelli, Sara Maria/AAC-1819-2019; Gori, Manuele/AAE-7052-2021; Rainer, Alberto/G-8588-2011; businaro, luca/F-9545-2012; Gori, Manuele/J-9184-2016	Giannitelli, Sara Maria/0000-0002-3616-5953; Rainer, Alberto/0000-0001-8971-551X; businaro, luca/0000-0002-5251-093X; Gori, Manuele/0000-0001-6957-2718; Trombetta, Marcella/0000-0002-1357-4885	Fondazione Umberto Veronesi Fellowship; Universita Campus Bio-Medico di Roma "Internal Grant Program"	Fondazione Umberto Veronesi Fellowship(Fondazione Umberto Veronesi); Universita Campus Bio-Medico di Roma "Internal Grant Program"	Support was provided by Fondazione Umberto Veronesi Fellowship to MG and Universita Campus Bio-Medico di Roma "Internal Grant Program" to AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Baudoin R, 2014, J PHARM SCI-US, V103, P706, DOI 10.1002/jps.23796; Baylin A, 2002, AM J CLIN NUTR, V76, P750, DOI 10.1093/ajcn/76.4.750; Beebe DJ, 2013, LAB CHIP, V13, P3447, DOI 10.1039/c3lc90080k; Benam KH, 2015, ANNU REV PATHOL-MECH, V10, P195, DOI 10.1146/annurev-pathol-012414-040418; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Bhise NS, 2014, J CONTROL RELEASE, V190, P82, DOI 10.1016/j.jconrel.2014.05.004; Chavez-Tapia NC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-20; Chen WB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/764981; CORLU A, 1991, J CELL BIOL, V115, P505, DOI 10.1083/jcb.115.2.505; Esch MB, 2015, LAB CHIP, V15, P2269, DOI 10.1039/c5lc00237k; Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4; Garcia-Canaveras J. C., 2015, ELECTROPHORESIS; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Gori M, 2014, J CELL PHYSIOL, V229, P1182, DOI 10.1002/jcp.24550; Gori M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/741465; Hamilton G, 2001, IN VITRO CELL DEV-AN, V37, P656; Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; LANDRY J, 1985, J CELL BIOL, V101, P914, DOI 10.1083/jcb.101.3.914; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lee J, 2013, ENZYME MICROB TECH, V53, P159, DOI 10.1016/j.enzmictec.2013.02.015; Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Luni C, 2014, CURR OPIN BIOTECH, V25, P45, DOI 10.1016/j.copbio.2013.08.015; Malaguarnera M, 2009, J MOL MED, V87, P679, DOI 10.1007/s00109-009-0464-1; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; No DY, 2015, LAB CHIP, V15, P3822, DOI 10.1039/c5lc00611b; Pamies D, 2014, EXP BIOL MED, V239, P1096, DOI 10.1177/1535370214537738; Perestrelo AR, 2015, SENSORS-BASEL, V15, P31142, DOI 10.3390/s151229848; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Schutte J, 2011, BIOMED MICRODEVICES, V13, P493, DOI 10.1007/s10544-011-9517-7; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Stoehr SA, 2003, HEPATOLOGY, V38, P1125, DOI 10.1053/jhep.2003.50418; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; van der Meer AD, 2012, INTEGR BIOL-UK, V4, P461, DOI 10.1039/c2ib00176d; Verhulsel M, 2014, BIOMATERIALS, V35, P1816, DOI 10.1016/j.biomaterials.2013.11.021; Vetelainen R, 2007, ANN SURG, V245, P20, DOI 10.1097/01.sla.0000225113.88433.cf; Wagner I, 2013, LAB CHIP, V13, P3538, DOI 10.1039/c3lc50234a; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yan E, 2007, NUTR REV, V65, P376, DOI [10.1301/nr.2007.aug.376-384, 10.1111/j.1753-4887.2007.tb00315.x]; Zhang C, 2009, LAB CHIP, V9, P3185, DOI 10.1039/b915147h; Zhang MY, 2008, BIOMED MICRODEVICES, V10, P117, DOI 10.1007/s10544-007-9116-9; Zinchenko YS, 2006, TISSUE ENG, V12, P751, DOI 10.1089/ten.2006.12.751	54	96	102	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159729	10.1371/journal.pone.0159729	http://dx.doi.org/10.1371/journal.pone.0159729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438262	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100071
J	Rodrigo, MB; Mojsiejczuk, LN; Torres, C; Sevic, I; Ledesma, MMGL; Perez, PS; Bouzas, MB; Galdame, O; Marciano, S; Fainboim, H; Flichman, DM; Campos, RH				Belen Rodrigo, Maria; Noelia Mojsiejczuk, Laura; Torres, Carolina; Sevic, Ina; Lopez Ledesma, Maria Mora Gonzalez; Soledad Perez, Paula; Belen Bouzas, Maria; Galdame, Omar; Marciano, Sebastian; Fainboim, Hugo; Martin Flichman, Diego; Hector Campos, Rodolfo			Analysis of the Molecular Evolution of Hepatitis B Virus Genotypes in Symptomatic Acute Infections in Argentina	PLOS ONE			English	Article							E-ANTIGEN; HISTORY	Hepatitis B virus (HBV) is a globally distributed human pathogen that leads to both self-limited and chronic infections. At least eight genotypes (A-H) with distinct geographical allocations and phylodynamic behaviors have been described. They differ substantially in many virological and probably some clinical parameters. The aim of this study was to analyze full-length HBV genome sequences from individuals with symptomatic acute HBV infections using phylogenetic and coalescent methods. The phylogenetic analysis resulted in the following subgenotype distribution: F1b (52.7%), A2 (18.2%), F4 (18.2%) and A1, B2, D3 and F2a 1.8% each. These results contrast with those previously reported from chronic infections, where subgenotypes F1b, F4, A2 and genotype D were evenly distributed. This differential distribution might be related to recent internal migrations and/or intrinsic biological features of each viral genotype that could impact on the probability of transmission. The coalescence analysis showed that after a diversification process started in the 80s, the current sequences of subgenotype F1b were grouped in at least four highly supported lineages, whereas subgenotype F4 revealed a more limited diversification pattern with most lineages without offspring in the present. In addition, the genetic characterization of the studied sequences showed that only two of them presented mutations of clinical relevance at S codifyng region and none at the polymerase catalytic domains. Finally, since the acute infections could be an expression of the genotypes currently being transmitted to new hosts, the predominance of subgenotype F1b might have epidemiological, as well as, clinical relevance due to its potential adverse disease outcome among the chronic cases.	[Belen Rodrigo, Maria; Noelia Mojsiejczuk, Laura; Torres, Carolina; Sevic, Ina; Lopez Ledesma, Maria Mora Gonzalez; Soledad Perez, Paula; Martin Flichman, Diego; Hector Campos, Rodolfo] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, Buenos Aires, DF, Argentina; [Belen Bouzas, Maria] Hosp Enfermedades Infecciosas F Muniz, Unidad Virol, Buenos Aires, DF, Argentina; [Galdame, Omar; Marciano, Sebastian] Hosp Italiano Buenos Aires, Unidad Hepatol, Buenos Aires, DF, Argentina; [Fainboim, Hugo] Hosp Enfermedades Infecciosas F Muniz, Unidad Hepatopatias Infecciosas, Buenos Aires, DF, Argentina	University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires	Campos, RH (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, Buenos Aires, DF, Argentina.	rcampos@ffyb.uba.ar	Sevic, Ina/ABF-2898-2021	Sevic, Ina/0000-0002-4920-5096; Gonzalez Lopez Ledesma, Maria Mora/0000-0002-2189-8388; Mojsiejczuk, Laura/0000-0001-7170-8880; Torres, Carolina/0000-0001-6786-8769; Rodrigo, Maria Belen/0000-0002-5741-2554	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP2012-11220110100215]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2011-0705]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; PIP2012-11220110100215), and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT; PICT2011-0705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hayashi K, 2008, J GASTROENTEROL, V43, P558, DOI 10.1007/s00535-008-2197-2; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; Kilpatrick AM, 2006, CONSERV BIOL, V20, P1224, DOI 10.1111/j.1523-1739.2006.00423.x; Kobayashi M, 2008, J MED VIROL, V80, P1880, DOI 10.1002/jmv.21309; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Livingston SE, 2007, GASTROENTEROLOGY, V133, P1452, DOI 10.1053/j.gastro.2007.08.010; Ledesma MMGL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121436; Mayerat C, 1999, J VIRAL HEPATITIS, V6, P299, DOI 10.1046/j.1365-2893.1999.00174.x; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Mizokami M, 1997, J MOL EVOL, V44, pS83, DOI 10.1007/PL00000061; Pezzano SC, 2011, CLIN MICROBIOL INFEC, V17, P223, DOI 10.1111/j.1469-0691.2010.03283.x; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sagnelli C, 2015, IMPACT VIRAL MOL DIV, V45, P137; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Sheldon J, 2006, J VIRAL HEPATITIS, V13, P427, DOI 10.1111/j.1365-2893.2005.00713.x; Shi WF, 2013, INFECT GENET EVOL, V16, P355, DOI 10.1016/j.meegid.2013.03.021; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Tong Shuping, 2005, Int J Med Sci, V2, P2; Torres C, 2013, VIROLOGY, V441, P40, DOI 10.1016/j.virol.2013.02.027; Torres C, 2011, MOL PHYLOGENET EVOL, V59, P114, DOI 10.1016/j.ympev.2011.01.010; Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037198; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	28	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159509	10.1371/journal.pone.0159509	http://dx.doi.org/10.1371/journal.pone.0159509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433800	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600060
J	Choe, DH; Park, H; Vo, C; Knyshov, A				Choe, Dong-Hwan; Park, Hoeun; Vo, Claudia; Knyshov, Alexander			Chemically Mediated Arrestment of the Bed Bug, Cimex lectularius, by Volatiles Associated with Exuviae of Conspecifics	PLOS ONE			English	Article							DORSAL ABDOMINAL GLANDS; ALARM PHEROMONE; AGGREGATION PHEROMONE; DEFENSIVE SECRETIONS; HEMIPTERA CIMICIDAE; HETEROPTERA; COMPONENTS; PENTATOMIDAE	Extracts of the exuviae (cast skins) of nymphal bed bugs (Cimex lectularius) were analyzed for volatile compounds that might contribute to arrestment of adult bed bugs. Four volatile aldehydes, (E)-2-hexenal, 4-oxo-(E)-2-hexenal, (E)-2-octenal, and 4-oxo-(E)-2-octenal were consistently detected in the headspace of freshly shed exuviae regardless of the developmental stages from which the exuviae were obtained. Quantification of the aldehydes in the solvent extracts of homogenized fresh, 45- or 99-d aged 5th instar exuviae indicated that the aldehydes are present in the exuviae and dissipate over time, through evaporation or degradation. Microscopic observation of the fifth instar exuviae indicated that the dorsal abdominal glands on the exuviae maintained their pocket-like structures with gland reservoirs, within which the aldehydes might be retained. Two-choice olfactometer studies with the volatiles from exuviae or a synthetic blend mimicking the volatiles indicated that adult bed bugs tend to settle close to sources of the aldehydes. Our results imply that the presence and accumulation of bed bug exuviae and the aldehydes volatilizing from the exuviae might mediate bed bugs' interaction with their microhabitats.	[Choe, Dong-Hwan; Knyshov, Alexander] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Park, Hoeun] Univ Calif Riverside, Dept Media & Cultural Studies, Riverside, CA 92521 USA; [Vo, Claudia] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Park, Hoeun] La Sierra Univ, Dept Biol, Riverside, CA USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Choe, DH (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	donghwan.choe@ucr.edu		Park, Hoeun/0000-0002-4608-548X	Early Career Chair in Urban Entomology fund; Academic Senate Regents Fellowship from University of California, Riverside	Early Career Chair in Urban Entomology fund; Academic Senate Regents Fellowship from University of California, Riverside	This research was funded in part by Early Career Chair in Urban Entomology fund and Academic Senate Regents Fellowship from University of California, Riverside. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH JR, 1991, J CHEM ECOL, V17, P2307, DOI 10.1007/BF00988010; Aldritch J. R., 1988, ACS SYM SER, P417; Analytical Software, 2008, STAT 9 US MAN; Benoit JB, 2009, J MED ENTOMOL, V46, P572, DOI 10.1603/033.046.0323; BORGES M, 1992, EXPERIENTIA, V48, P893, DOI 10.1007/BF02118429; COLLINS RP, 1968, ANN ENTOMOL SOC AM, V61, P1338, DOI 10.1093/aesa/61.5.1338; Domingue MJ, 2010, PHYSIOL ENTOMOL, V35, P203, DOI 10.1111/j.1365-3032.2010.00738.x; Eom IY, 2012, ANAL CHIM ACTA, V716, P2, DOI 10.1016/j.aca.2011.06.010; Feldlaufer MF, 2010, J MED ENTOMOL, V47, P140, DOI 10.1603/ME09210; Gries R, 2015, ANGEW CHEM INT EDIT, V54, P1135, DOI 10.1002/anie.201409890; Harraca V, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-121; Ho HY, 2006, ANN ENTOMOL SOC AM, V99, P859, DOI 10.1603/0013-8746(2006)99[859:VITDAG]2.0.CO;2; Hokeness K, 2014, CAN J MICROBIOL, V60, P1, DOI 10.1139/cjm-2013-0708; Inamdar AA, 2010, TOXICOL SCI, V117, P418, DOI 10.1093/toxsci/kfq222; Kemper H, 1936, Z KLEINTIERK PELZTIE, V12, P1; Kilpinen O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050981; Knckel MJ., 1886, ANN MAG NAT HIST, V18, P167, DOI [10.1080/00222938609459954, DOI 10.1080/00222938609459954]; LEVINSON HZ, 1974, NATURWISSENSCHAFTEN, V61, P684, DOI 10.1007/BF00606522; LEVINSON HZ, 1974, J INSECT PHYSIOL, V20, P1231, DOI 10.1016/0022-1910(74)90229-7; LEVINSON HZ, 1971, EXPERIENTIA, V27, P102, DOI 10.1007/BF02137766; Lewis VR, 2013, CALIF AGR, V67, P172, DOI 10.3733/ca.v067n03p172; Liedtke HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018156; Mendki MJ, 2014, J VECTOR DIS, V51, P224; Moreira JA, 2005, J CHEM ECOL, V31, P965, DOI 10.1007/s10886-004-1978-1; Noge K, 2015, J PESTIC SCI, V40, P143, DOI 10.1584/jpestics.J15-03; Noge K, 2012, BIOSCI BIOTECH BIOCH, V76, P1975, DOI 10.1271/bbb.120321; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; SCHILDKNECHT H, 1964, ANGEW CHEM INT EDIT, V3, P73, DOI 10.1002/anie.196400731; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Ulrich KR, 2016, PHYSIOL ENTOMOL, V41, P103, DOI 10.1111/phen.12129; Ulrich KR, 2015, BIOCONTROL, V60, P517, DOI 10.1007/s10526-015-9667-2; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Zar JH, 1999, BIOSTATISTICAL ANAL	33	5	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159520	10.1371/journal.pone.0159520	http://dx.doi.org/10.1371/journal.pone.0159520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434044	gold, Green Published			2022-12-27	WOS:000380169600063
J	Iglesias, M; Augustin, JJ; Alvarez, P; Santiuste, I; Postigo, J; Merino, J; Merino, R				Iglesias, Marcos; Jesus Augustin, Juan; Alvarez, Pilar; Santiuste, Ines; Postigo, Jorge; Merino, Jesus; Merino, Ramon			Selective Impairment of T(H)17-Differentiation and Protection against Autoimmune Arthritis after Overexpression of BCL2A1 in T Lymphocytes	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; PROMYELOCYTIC LEUKEMIA-CELLS; FAMILY MEMBER BIM; DEATH IN-VIVO; RETINOIC ACID; BCL-2 FAMILY; TRANSGENIC MICE; OUTER-MEMBRANE; IMMUNE-SYSTEM; B-CELLS	The inhibition of apoptotic cell death in T cells through the dysregulated expression of BCL2 family members has been associated with the protection against the development of different autoimmune diseases. However, multiple mechanisms were proposed to be responsible for such protective effect. The purpose of this study was to explore the effect of the T-cell overexpression of BCL2A1, an anti-apoptotic BCL2 family member without an effect on cell cycle progression, in the development of collagen-induced arthritis. Our results demonstrated an attenuated development of arthritis in these transgenic mice. The protective effect was unrelated to the suppressive activity of regulatory T cells but it was associated with a defective activation of p38 mitogen-activated protein kinase in CD4(+) cells after in vitro TCR stimulation. In addition, the in vitro and in vivo T(H)17 differentiation were impaired in BCL2A1 transgenic mice. Taken together, we demonstrated here a previously unknown role for BCL2A1 controlling the activation of CD4(+) cells and their differentiation into pathogenic proinflammatory T(H)17 cells and identified BCL2A1 as a potential target in the control of autoimmune/inflammatory diseases.	[Iglesias, Marcos; Jesus Augustin, Juan; Santiuste, Ines; Postigo, Jorge; Merino, Jesus; Merino, Ramon] IDIVAL Univ Cantabria, Dept Biol Mol, Santander, Spain; [Jesus Augustin, Juan; Alvarez, Pilar; Merino, Ramon] Univ Cantabria, Inst Biomed & Biotecnol Cantabria, Consejo Super Invest Cient, Santander, Spain; [Iglesias, Marcos] Johns Hopkins Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD USA; [Postigo, Jorge] Columbia Univ, Dept Med Sci, Columbia Ctr Translat Immunol, New York, NY USA; [Postigo, Jorge] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Johns Hopkins University; Johns Hopkins Medicine; Columbia University; Columbia University	Merino, J; Merino, R (corresponding author), IDIVAL Univ Cantabria, Dept Biol Mol, Santander, Spain.; Merino, R (corresponding author), Univ Cantabria, Inst Biomed & Biotecnol Cantabria, Consejo Super Invest Cient, Santander, Spain.	merinoj@unican.es; merinor@unican.es	Merino, Ramón/L-1310-2014	Merino, Ramón/0000-0002-5306-0635; Iglesias Lozano, Marcos/0000-0002-7523-5950	Spanish Ministerio de Economia y Competitividad [SAF2011-22463, SAF2014-55088-R, SAF2012-34059, IPT2011-1527-010000]; European Regional Development Fund; Fibrostatin SL	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund(European Commission); Fibrostatin SL	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad to RM (SAF2011-22463 and SAF2014-55088-R) and JM (SAF2012-34059), which were co-funded by the European Regional Development Fund. MI was partially supported by a grant from the Spanish Ministerio de Economia y Competitividad (IPT2011-1527-010000) associated with Fibrostatin SL.	AKAO Y, 1994, CANCER RES, V54, P2468; Andre JM, 2007, LUPUS, V16, P95, DOI 10.1177/0961203306075382; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Boldizsar F, 2010, ARTHRITIS RHEUM-US, V62, P2984, DOI 10.1002/art.27614; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chandraratna RAS, 2016, AM J TRANSL RES, V8, P1016; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Di Mitri D, 2015, IMMUNOLOGY, V146, P251, DOI 10.1111/imm.12497; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; FOSSATI L, 1995, EUR J IMMUNOL, V25, P166, DOI 10.1002/eji.1830250128; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Gonzalez J, 2003, BLOOD, V101, P2679, DOI 10.1182/blood-2002-04-1229; Greider C, 2002, ONCOGENE, V21, P7765, DOI 10.1038/sj.onc.1205928; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Iglesias M, 2013, ARTHRITIS RHEUM-US, V65, P343, DOI 10.1002/art.37778; Jing YK, 2001, BLOOD, V97, P264, DOI 10.1182/blood.V97.1.264; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kathania M, 2011, INT J BIOCHEM CELL B, V43, P573, DOI 10.1016/j.biocel.2010.12.014; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Korn T, 2014, ANNU REV IMMUNOL, V32, P121; Kovacs JR, 2012, CELL DEATH DIFFER, V19, P144, DOI 10.1038/cdd.2011.78; Lanave C, 2004, GENE, V333, P71, DOI 10.1016/j.gene.2004.02.017; Liu TX, 2000, BLOOD, V96, P1496, DOI 10.1182/blood.V96.4.1496.h8001496_1496_1504; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Ludwinski MW, 2009, J CLIN INVEST, V119, P1706, DOI 10.1172/JCI37619; Marquina R, 2004, J IMMUNOL, V172, P7177, DOI 10.4049/jimmunol.172.11.7177; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Olasz K, 2012, CLIN EXP IMMUNOL, V167, P346, DOI 10.1111/j.1365-2249.2011.04506.x; Postigo J, 2016, ARTHRITIS RHEUMATOL, V68, P1551, DOI 10.1002/art.39557; Postigo J, 2011, ARTHRITIS RHEUM-US, V63, P971, DOI 10.1002/art.30220; Rasooly R, 2005, J IMMUNOL, V175, P7916, DOI 10.4049/jimmunol.175.12.7916; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Sharabi A, 2010, J AUTOIMMUN, V34, P87, DOI 10.1016/j.jaut.2009.06.002; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Takeuchi H, 2013, J IMMUNOL, V191, P3725, DOI 10.4049/jimmunol.1300032; Verschelde C, 2006, CELL DEATH DIFFER, V13, P1213, DOI 10.1038/sj.cdd.4401814; Wen RR, 2003, J BIOL CHEM, V278, P43654, DOI 10.1074/jbc.M307318200; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Yanaba K, 2007, J IMMUNOL, V179, P1369, DOI 10.4049/jimmunol.179.2.1369; Yu Y, 2012, AM J BLOOD RES, V2, P77	53	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159714	10.1371/journal.pone.0159714	http://dx.doi.org/10.1371/journal.pone.0159714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433938	Green Published, gold			2022-12-27	WOS:000380169600083
J	Zhu, LC; Zhang, YH; Su, FC; Chen, L; Huang, T; Cai, YD				Zhu, Liucun; Zhang, Yu-Hang; Su, Fangchu; Chen, Lei; Huang, Tao; Cai, Yu-Dong			A Shortest-Path-Based Method for the Analysis and Prediction of Fruit-Related Genes in Arabidopsis thaliana	PLOS ONE			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE-2; AUXIN RESPONSE; CELL NUMBER; PROTEIN; NETWORK; EXPRESSION; RICE; PHOTOMORPHOGENESIS; INTERACTS; ENCODES	Biologically, fruits are defined as seed-bearing reproductive structures in angiosperms that develop from the ovary. The fertilization, development and maturation of fruits are crucial for plant reproduction and are precisely regulated by intrinsic genetic regulatory factors. In this study, we used Arabidopsis thaliana as a model organism and attempted to identify novel genes related to fruit-associated biological processes. Specifically, using validated genes, we applied a shortest-path-based method to identify several novel genes in a large network constructed using the protein-protein interactions observed in Arabidopsis thaliana. The described analyses indicate that several of the discovered genes are associated with fruit fertilization, development and maturation in Arabidopsis thaliana.	[Zhu, Liucun; Su, Fangchu; Cai, Yu-Dong] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China; [Zhang, Yu-Hang; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Maritime University	Cai, YD (corresponding author), Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China.; Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China.	tohuangtao@126.com; cai_yud@126.com	Zhang, Yu-Hang/AAQ-9012-2021; Chen, Lei/A-2275-2011; Zhang, Yu-Hang/O-9774-2015	Zhang, Yu-Hang/0000-0003-3825-0796; Chen, Lei/0000-0003-3068-1583; Zhang, Yu-Hang/0000-0003-3825-0796; zhu, liucun/0000-0002-8334-0216; cai, yudong/0000-0001-5664-7979	National Natural Science Foundation of China [31371335, 31501045]; Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) [2016245]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS)	This study was supported by the National Natural Science Foundation of China (31371335 and 31501045), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the National Natural Science Foundation of China (31371335 and 31501045), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245).	Adwy W, 2015, PLANT J, V84, P1231, DOI 10.1111/tpj.13084; Aloisi I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00155; Anand A, 2012, NEW PHYTOL, V195, P203, DOI 10.1111/j.1469-8137.2012.04133.x; Avraham S, 2008, NUCLEIC ACIDS RES, V36, pD449, DOI 10.1093/nar/gkm908; Bernhardt A, 2010, PLANTA, V232, P555, DOI 10.1007/s00425-010-1195-9; Bomblies K, 2010, PHILOS T R SOC B, V365, P1815, DOI 10.1098/rstb.2009.0304; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Chen L, 2016, MOL GENET GENOMICS, V291, P913, DOI 10.1007/s00438-015-1157-9; Chen L, 2016, CURR BIOINFORM, V11, P51, DOI 10.2174/1574893611666151119220024; Chen L, 2016, J BIOMOL STRUCT DYN, V34, P664, DOI 10.1080/07391102.2015.1042915; Chen L, 2015, MOL BIOSYST, V11, P2541, DOI 10.1039/c5mb00276a; Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096436; Chmielowska-Bak J, 2013, J PLANT PHYSIOL, V170, P1585, DOI 10.1016/j.jplph.2013.06.019; Chung K, 2011, PLANT CELL PHYSIOL, V52, P1657, DOI 10.1093/pcp/pcr099; Clemens S, 2001, Int J Occup Med Environ Health, V14, P235; Copetti D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1762-3; Egli B, 2010, PLANT PHYSIOL, V154, P1659, DOI 10.1104/pp.110.165027; El-Sharkawy I, 2014, PLANT MOL BIOL, V84, P399, DOI 10.1007/s11103-013-0139-8; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Ferrandiz C, 2002, J EXP BOT, V53, P2031, DOI 10.1093/jxb/erf082; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fujimori N, 2014, DNA REPAIR, V21, P171, DOI 10.1016/j.dnarep.2014.05.009; Gao LY, 2015, PLANT SCI, V235, P101, DOI 10.1016/j.plantsci.2015.03.007; Gao P, 2012, PROTEIN PEPTIDE LETT, V19, P910, DOI 10.2174/092986612802084528; Goins GD, 1997, J EXP BOT, V48, P1407, DOI 10.1093/jxb/48.7.1407; Gui TT, 2015, J COMPUT BIOL, V22, P63, DOI 10.1089/cmb.2014.0122; Guo M, 2011, PLANT SCI, V181, P1, DOI 10.1016/j.plantsci.2011.03.010; Ha S, 2014, CRIT REV BIOTECHNOL, V34, P16, DOI 10.3109/07388551.2013.783549; Hasse D, 2013, J BIOL CHEM, V288, P35333, DOI 10.1074/jbc.M113.509976; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066578; Im YJ, 2004, J MOL BIOL, V343, P659, DOI 10.1016/j.jmb.2004.08.054; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; Jiang CF, 2014, GENOME RES, V24, P1821, DOI 10.1101/gr.177659.114; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kinoshita T, 2008, SEMIN CELL DEV BIOL, V19, P574, DOI 10.1016/j.semcdb.2008.07.018; KUMARDE B, 1976, INT J VITAM NUTR RES, V46, P154; Kurepa J, 2009, PLANT PHYSIOL, V150, P178, DOI 10.1104/pp.109.135970; Lasky JR, 2012, MOL ECOL, V21, P5512, DOI 10.1111/j.1365-294X.2012.05709.x; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Li Bei, 2008, Weishengwu Xuebao, V48, P739; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li CJ, 2012, PLANT CELL ENVIRON, V35, P952, DOI 10.1111/j.1365-3040.2011.02464.x; Li ST, 2013, PLANT J, V76, P901, DOI 10.1111/tpj.12348; Liu FQ, 2004, PLANT CELL, V16, P5, DOI 10.1105/tpc.017772; Liu YS, 2017, IEEE ACM T COMPUT BI, V14, P905, DOI 10.1109/TCBB.2016.2550432; Malinova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112468; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Moon H, 2003, P NATL ACAD SCI USA, V100, P358, DOI 10.1073/pnas.252641899; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Oh S, 2013, J EXP BOT, V64, P5457, DOI 10.1093/jxb/ert308; Page DR, 2002, NAT REV GENET, V3, P124, DOI 10.1038/nrg730; Pautler M, 2015, PLANT CELL, V27, P104, DOI 10.1105/tpc.114.132506; Ramalingam J, 2003, MOL PLANT MICROBE IN, V16, P14, DOI 10.1094/MPMI.2003.16.1.14; Ravi M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6334; Robles P, 2005, INT J DEV BIOL, V49, P633, DOI 10.1387/ijdb.052020pr; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Ronceret A, 2008, PLANT J, V53, P776, DOI 10.1111/j.1365-313X.2007.03372.x; Sadanandom A, 2015, P NATL ACAD SCI USA, V112, P11108, DOI 10.1073/pnas.1415260112; Seo KI, 2014, PLANT CELL, V26, P695, DOI 10.1105/tpc.113.119974; Seong ES, 2007, BIOCHEM BIOPH RES CO, V363, P126, DOI 10.1016/j.bbrc.2007.08.147; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Shen Y, 2008, BMB REP, V41, P645, DOI 10.5483/BMBRep.2008.41.9.645; SNAPE JW, 1971, HEREDITY, V27, P299, DOI 10.1038/hdy.1971.91; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Sun XQ, 2014, GENE, V546, P408, DOI 10.1016/j.gene.2014.04.060; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Wang Q, 2012, PLANT PHYSIOL, V160, P1373, DOI 10.1104/pp.112.204339; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Ye WJ, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0479-6; Yu H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118966; Zarate X, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-32; Zhang J, 2016, NEUROCOMPUTING, V217, P63, DOI 10.1016/j.neucom.2015.09.136; Zimmermann S, 1999, J BIOL CHEM, V274, P17017, DOI 10.1074/jbc.274.24.17017; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024	75	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159519	10.1371/journal.pone.0159519	http://dx.doi.org/10.1371/journal.pone.0159519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434024	gold, Green Submitted, Green Published			2022-12-27	WOS:000380169600062
J	Bandyopadhyay, M; Bishop, CP; Bidwai, AP				Bandyopadhyay, Mohna; Bishop, Clifton P.; Bidwai, Ashok P.			The Conserved MAPK Site in E(spl)-M8, an Effector of Drosophila Notch Signaling, Controls Repressor Activity during Eye Development	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; OF-SPLIT COMPLEX; CELL-CYCLE PROGRESSION; CASEIN KINASE-II; EGF RECEPTOR; GENE-COMPLEX; LATERAL-INHIBITION; NEURAL DEVELOPMENT; PATTERN-FORMATION; BHLH PROTEINS	The specification of patterned R8 photoreceptors at the onset of eye development depends on timely inhibition of Atonal (Ato) by the Enhancer of split (E(spl) repressors. Repression of Ato by E(spl)-M8 requires the kinase CK2 and is inhibited by the phosphatase PP2A. The region targeted by CK2 harbors additional conserved Ser residues, raising the prospect of regulation via multi-site phosphorylation. Here we investigate one such motif that meets the consensus for modification by MAPK, a well-known effector of Epidermal Growth Factor Receptor (EGFR) signaling. Our studies reveal an important role for the predicted MAPK site of M8 during R8 birth. Ala/Asp mutations reveal that the CK2 and MAPK sites ensure that M8 repression of Ato and the R8 fate occurs in a timely manner and at a specific stage (stage-2/3) of the morphogenetic furrow (MF). M8 repression of Ato is mitigated by halved EGFR dosage, and this effect requires an intact MAPK site. Accordingly, variants with a phosphomimetic Asp at the MAPK site exhibit earlier (inappropriate) activity against Ato even at stage-1 of the MF, where a positive feedback-loop is necessary to raise Ato levels to a threshold sufficient for the R8 fate. Analysis of deletion variants reveals that both kinase sites (CK2 and MAPK) contribute to 'cis'-inhibition of M8. This key regulation by CK2 and MAPK is bypassed by the E(spl) D mutation encoding the truncated protein M8*, which potently inhibits Ato at stage-1 of R8 birth. We also provide evidence that PP2A likely targets the MAPK site. Thus multi-site phosphorylation controls timely onset of M8 repressor activity in the eye, a regulation that appears to be dispensable in the bristle. The high conservation of the CK2 and MAPK sites in the insect E(spl) proteins M7, M5 and M., and their mammalian homologue HES6, suggest that this mode of regulation may enable E(spl)/HES proteins to orchestrate repression by distinct tissue-specific mechanisms, and is likely to have broader applicability than has been previously recognized.	[Bandyopadhyay, Mohna; Bishop, Clifton P.; Bidwai, Ashok P.] West Virginia Univ, Dept Biol, Morgantown, WV 26506 USA	West Virginia University	Bidwai, AP (corresponding author), West Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	abidwai@wvu.edu		Bidwai, Ashok/0000-0002-4297-5629				Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Axelrod JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145pe38; Baker NE, 2004, DEV CELL, V7, P632, DOI 10.1016/j.devcel.2004.10.010; Baker NE, 1996, CURR BIOL, V6, P1290, DOI 10.1016/S0960-9822(02)70715-X; BAKER NE, 1992, DEV BIOL, V150, P381, DOI 10.1016/0012-1606(92)90250-K; BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; Baker RH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-354; Bandhakavi S, 2003, J BIOL CHEM, V278, P2829, DOI 10.1074/jbc.M206662200; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Belanger-Jasmin S, 2007, J NEUROCHEM, V103, P2022, DOI 10.1111/j.1471-4159.2007.04902.x; Bischof J, 2013, DEVELOPMENT, V140, P2434, DOI 10.1242/dev.088757; Blau J, 2003, NAT NEUROSCI, V6, P208, DOI 10.1038/nn0303-208; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bose A, 2006, MECH DEVELOP, V123, P649, DOI 10.1016/j.mod.2006.07.003; Bose A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101884; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bray SJ, 1997, PERSPECT DEV NEUROBI, V4, P313; Brent R, 1997, ANNU REV GENET, V31, P663, DOI 10.1146/annurev.genet.31.1.663; Brown NL, 1996, DEV BIOL, V179, P65, DOI 10.1006/dbio.1996.0241; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Cagan R, 2009, CURR TOP DEV BIOL, V89, P115, DOI 10.1016/S0070-2153(09)89005-4; CAMPOS AR, 1987, EMBO J, V6, P425, DOI 10.1002/j.1460-2075.1987.tb04772.x; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; deCelis JF, 1996, DEVELOPMENT, V122, P2719; DELIDAKIS C, 1991, GENETICS, V129, P803; Doherty D, 1997, DEVELOPMENT, V124, P3881; Dokucu ME, 1996, DEVELOPMENT, V122, P4139; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Filhol O, 2004, EMBO REP, V5, P351, DOI 10.1038/sj.embor.7400115; FISCHERVIZE JA, 1992, DEVELOPMENT, V115, P89; Freeman M, 1997, DEVELOPMENT, V124, P261; Gao XM, 2001, J CELL BIOL, V154, P1161, DOI 10.1083/jcb.200104058; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Gibert JM, 2003, INT J DEV BIOL, V47, P643; Giebel B, 1997, P NATL ACAD SCI USA, V94, P6250, DOI 10.1073/pnas.94.12.6250; Gomez-Skarmeta J, 2003, NAT REV NEUROSCI, V4, P587, DOI 10.1038/nrn1142; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Greenwald I, 2012, GENETICS, V191, P655, DOI 10.1534/genetics.112.141812; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Housden B, 2012, G3-GENES GENOM GENET, V2, P79, DOI 10.1534/g3.111.001321; Hsiung F, 2002, HUM MOL GENET, V11, P1207, DOI 10.1093/hmg/11.10.1207; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Jennings BH, 1999, MOL CELL BIOL, V19, P4600; Jimenez G, 1997, MOL CELL BIOL, V17, P4355, DOI 10.1128/MCB.17.8.4355; Jones C, 2006, GENETICS, V173, P793, DOI 10.1534/genetics.106.056762; Joshi M, 2006, DEV BIOL, V293, P64, DOI 10.1016/j.ydbio.2006.01.005; Kahali B, 2010, GENESIS, V48, P44, DOI 10.1002/dvg.20581; Kahali B, 2009, GENESIS, V47, P456, DOI 10.1002/dvg.20521; Karandikar UC, 2004, MECH DEVELOP, V121, P273, DOI 10.1016/j.mod.2004.01.008; Kavaler J, 1999, DEVELOPMENT, V126, P2261; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KNUST E, 1987, DEV BIOL, V122, P262, DOI 10.1016/0012-1606(87)90351-4; KNUST E, 1992, GENETICS, V132, P505; Kumar J, 1997, GENE DEV, V11, P2023, DOI 10.1101/gad.11.16.2023; Kumar JP, 2003, DEVELOPMENT, V130, P3703, DOI 10.1242/dev.00556; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Kumar JP, 2010, CURR TOP DEV BIOL, V93, P1, DOI [10.1016/B978-0-12-385044-7.00001-1, 10.1016/S0070-2153(10)93001-9]; KUNISCH M, 1994, P NATL ACAD SCI USA, V91, P10139, DOI 10.1073/pnas.91.21.10139; Kunttas-Tatli E, 2009, GENESIS, V47, P647, DOI 10.1002/dvg.20543; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; Ligoxygakis P, 1999, DEVELOPMENT, V126, P2205; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lubensky DK, 2011, P NATL ACAD SCI USA, V108, P11145, DOI 10.1073/pnas.1015302108; MAIER D, 1993, P NATL ACAD SCI USA, V90, P5464, DOI 10.1073/pnas.90.12.5464; Majot AT, 2015, ADV BIOCHEM HEALTH D, V12, P81, DOI 10.1007/978-3-319-14544-0_6; Mann RS, 2016, CELL, V164, P347, DOI 10.1016/j.cell.2016.01.010; Nagel AC, 1999, DEV BIOL, V208, P406, DOI 10.1006/dbio.1999.9203; Nagel AC, 2004, GENESIS, V39, P105, DOI 10.1002/gene.20033; Nagel AC, 1999, DEV GENET, V25, P168, DOI 10.1002/(SICI)1520-6408(1999)25:2<168::AID-DVG11>3.0.CO;2-0; Nakao K, 1996, NEURON, V16, P275, DOI 10.1016/S0896-6273(00)80046-X; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pepple KL, 2008, DEVELOPMENT, V135, P4071, DOI 10.1242/dev.028951; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Powell LM, 2004, MOL CELL BIOL, V24, P9517, DOI 10.1128/MCB.24.21.9517-9526.2004; PREISS A, 1988, EMBO J, V7, P3917, DOI 10.1002/j.1460-2075.1988.tb03278.x; Quan XJ, 2016, CELL, V164, P460, DOI 10.1016/j.cell.2015.12.048; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; SCHRONS H, 1992, GENETICS, V132, P481; SCHWEISGUTH F, 1995, DEVELOPMENT, V121, P1875; Schweisguth Francois, 1997, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V191, P55; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Simpson P, 1999, DEVELOPMENT, V126, P1349; Spencer SA, 1998, DEVELOPMENT, V125, P4777; Sun Y, 1998, DEVELOPMENT, V125, P3731; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; TATA F, 1995, MECH DEVELOP, V51, P305, DOI 10.1016/0925-4773(95)00377-0; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; TIETZE K, 1992, P NATL ACAD SCI USA, V89, P6152, DOI 10.1073/pnas.89.13.6152; Trott RL, 2001, J BIOL CHEM, V276, P2159, DOI 10.1074/jbc.M005996200; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Warren I, 2007, BIOESSAYS, V29, P300, DOI 10.1002/bies.20543; Welshons WJ, 1956, DROS INFORM SERV, V30, P157; White NM, 2000, DEVELOPMENT, V127, P1681; WOLFF T, 1991, DEVELOPMENT, V113, P841; WOLFF T, 1991, DEVELOPMENT, V113, P825; Wurmbach E, 2014, HEREDITAS, V151, P159, DOI 10.1111/hrd2.00065; Yang LH, 2003, DEV CELL, V4, P359, DOI 10.1016/S1534-5807(03)00059-5; Yang LH, 2001, DEVELOPMENT, V128, P1183; ZIEMER A, 1988, GENETICS, V119, P63	110	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159508	10.1371/journal.pone.0159508	http://dx.doi.org/10.1371/journal.pone.0159508			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428327	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300072
J	Cox, DTC; Gaston, KJ				Cox, Daniel T. C.; Gaston, Kevin J.			Urban Bird Feeding: Connecting People with Nature	PLOS ONE			English	Article							STRESS RECOVERY; WILD BIRDS; CONSERVATION; BIODIVERSITY; EXTINCTION; EXPERIENCE; ENVIRONMENTS; BENEFITS; ATTITUDE; CONTACT	At a time of unprecedented biodiversity loss, researchers are increasingly recognizing the broad range of benefits provided to humankind by nature. However, as people live more urbanized lifestyles there is a progressive disengagement with the natural world that diminishes these benefits and discourages positive environmental behaviour. The provision of food for garden birds is an increasing global phenomenon, and provides a readily accessible way for people to counter this trend. Yet despite its popularity, quite why people feed birds remains poorly understood. We explore three loosely defined motivations behind bird feeding: that it provides psychological benefits, is due to a concern about bird welfare, and/or is due to a more general orientation towards nature. We quantitatively surveyed households from urban towns in southern England to explore attitudes and actions towards garden bird feeding. Each household scored three Likert statements relating to each of the three motivations. We found that people who fed birds regularly felt more relaxed and connected to nature when they watched garden birds, and perceived that bird feeding is beneficial for bird welfare while investing time in minimising associated risks. Finally, feeding birds may be an expression of a wider orientation towards nature. Overall, we found that the feelings of being relaxed and connected to nature were the strongest drivers. As urban expansion continues both to threaten species conservation and to change peoples' relationship with the natural world, feeding birds may provide an important tool for engaging people with nature to the benefit of both people and conservation.	[Cox, Daniel T. C.; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, Cornwall, England	University of Exeter	Cox, DTC (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, Cornwall, England.	dan.t.cox@googlemail.com		Gaston, Kevin J./0000-0002-7235-7928; Cox, Daniel/0000-0003-1929-5438	Natural Environment Research Council [NE/J015237/1]; Fragments, Functions, Flows and Urban Ecosystem Services project; NERC [NE/J015237/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Fragments, Functions, Flows and Urban Ecosystem Services project; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Fragments, Functions, Flows and Urban Ecosystem Services project, Natural Environment Research Council grant NE/J015237/1.	Balmford A, 2006, CONSERV BIOL, V20, P692, DOI 10.1111/j.1523-1739.2006.00434.x; Barton K., 2015, MUMIN MULTIMODEL INF; Belaire JA, 2015, CONDOR, V117, P192, DOI 10.1650/CONDOR-14-128.1; Brock M, 2017, ENVIRON RESOUR ECON, V67, P127, DOI 10.1007/s10640-015-9979-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Capaldi CA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00976; Christensen RHB, ORDINAL REGRESSION M; Collado S, 2015, J ENVIRON PSYCHOL, V41, P65, DOI 10.1016/j.jenvp.2014.11.001; Cox DTC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141505; Davies ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039692; Eurostat, 2012, EUR FIG EUR YB; Fuller R. A., 2010, URBAN ECOL, P134, DOI [DOI 10.1017/CBO9780511778483.008, 10.1017/CBO9780511778483.008]; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Galbraith JA, 2015, P NATL ACAD SCI USA, V112, pE2648, DOI 10.1073/pnas.1501489112; Galbraith JA, 2014, BIOL CONSERV, V180, P64, DOI 10.1016/j.biocon.2014.09.038; Gaston KJ, 2007, BIODIVERS CONSERV, V16, P3227, DOI 10.1007/s10531-007-9174-6; Gauthier AH, 2003, RES AGING, V25, P247, DOI 10.1177/0164027503025003003; Green Ronda J., 2000, Pacific Conservation Biology, V6, P183; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Heiberger R.M., 2015, HH STAT ANAL DATA DI; Howard Peter, 2004, P55; Irvine KN, 2010, FUTURE CITY, V2, P215, DOI 10.1007/978-1-4020-8647-2_10; Ishigame Go, 2007, Ornithological Science, V6, P11, DOI 10.2326/1347-0558(2007)6[11:PAAOSA]2.0.CO;2; JIANG B, 2014, ENVIRON BEHAV, V48, P607, DOI DOI 10.1177/0013916514552321; Jones D, 2011, EMU, V111, pI, DOI 10.1071/MUv111n2_ED; Jones DN, 2008, J AVIAN BIOL, V39, P265, DOI 10.1111/j.0908-8857.2008.04271.x; Juster FT, 2004, CHANGING TIMES AM YO; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Lin BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087422; Louv R., 2005, LAST CHILD WOODS WHY; Martyn P, 2014, J CLEAN PRO IN PRESS, V1-10; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Nisbet EK, 2009, ENVIRON BEHAV, V41, P715, DOI 10.1177/0013916508318748; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; PYLE RM, 1977, HORTICULTURE, V55, P65; R Development Core Team, 2015, A LANGUAGE AND ENVIR; Ratcliffe E, 2013, J ENVIRON PSYCHOL, V36, P221, DOI 10.1016/j.jenvp.2013.08.004; Restall B, 2015, J ENVIRON MANAGE, V159, P264, DOI 10.1016/j.jenvman.2015.05.022; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Rollinson Daniel J., 2003, Corella, V27, P52; Royal Society for the Protection of Birds, 2007, 2007 FEED GARD BIRDS; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Scheibe S, 2013, PSYCHOL AGING, V28, P160, DOI 10.1037/a0030561; Shanahan DF, 2015, BIOSCIENCE, V65, P476, DOI 10.1093/biosci/biv032; Sigman A, 2012, ARCH DIS CHILD, V97, P935, DOI 10.1136/archdischild-2012-302196; Soga M, 2016, FRONT ECOL ENVIRON, V14, P94, DOI 10.1002/fee.1225; Soga M, 2015, LANDSCAPE URBAN PLAN, V143, P69, DOI 10.1016/j.landurbplan.2015.06.003; Tarrant MA, 2002, ENVIRON MANAGE, V30, P692, DOI 10.1007/s00267-002-2722-7; Tyrvainen L, 2014, J ENVIRON PSYCHOL, V38, P1, DOI 10.1016/j.jenvp.2013.12.005; U.S. Department of the Interior U.S. Fish and Wildlife Service & U.S. Department of Commerce U.S. Census Bureau, 2011, 2011 NAT SURV FISH H; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Weidensaul Scott, 2008, FEATHER BRIEF HIST A; Zelenski JM, 2014, ENVIRON BEHAV, V46, P3, DOI 10.1177/0013916512451901; Zhang WZ, 2014, BIOL CONSERV, V177, P109, DOI 10.1016/j.biocon.2014.06.011	57	81	83	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158717	10.1371/journal.pone.0158717	http://dx.doi.org/10.1371/journal.pone.0158717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27427988	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300019
J	Ma, K; Guo, L; Xu, AP; Cui, S; Wang, JH				Ma, Ke; Guo, Li; Xu, Aiping; Cui, Shan; Wang, Jin-Hui			Molecular Mechanism for Stress-Induced Depression Assessed by Sequencing miRNA and mRNA in Medial Prefrontal Cortex	PLOS ONE			English	Article							CHRONIC MILD STRESS; MAGNETIC-RESONANCE SPECTROSCOPY; GAMMA-AMINOBUTYRIC-ACID; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; BIPOLAR DISORDER; THERAPEUTIC TARGETS; INHIBITORY DEFICITS; MICRORNA EXPRESSION; GABAERGIC NEURONS	Background Major depression is a prevalent mood disorder. Chronic stress is presumably main etiology that leads to the neuron and synapse atrophies in the limbic system. However, the intermediate molecules from stresses to neuronal atrophy remain elusive, which we have studied in the medial prefrontal cortices from depression mice. Methods and Results The mice were treated by the chronic unpredictable mild stress (CUMS) until they expressed depression-like behaviors confirmed by the tests of sucrose preference, forced swimming and Y-maze. High-throughput sequencings of microRNA and mRNA in the medial prefrontal cortices were performed in CUMS-induced depression mice versus control mice to demonstrate the molecular profiles of major depression. In the medial prefrontal cortices of depression- like mice, the levels of mRNAs that translated the proteins for the GABAergic synapses, dopaminergic synapses, myelination, synaptic vesicle cycle and neuronal growth were down-regulated. miRNAs of regulating these mRNAs are upregulated. Conclusion The deteriorations of GABAergic and dopaminergic synapses as well as axonal growth are associated with CUMS-induced depression.	[Ma, Ke; Wang, Jin-Hui] Qingdao Univ, Sch Pharm, Qingdao, Shandong, Peoples R China; [Guo, Li; Cui, Shan; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China; [Guo, Li; Wang, Jin-Hui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Aiping; Wang, Jin-Hui] Univ Sci & Technol China, Coll Life Sci, Hefei, Anhui, Peoples R China	Qingdao University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, JH (corresponding author), Qingdao Univ, Sch Pharm, Qingdao, Shandong, Peoples R China.; Wang, JH (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China.; Wang, JH (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Wang, JH (corresponding author), Univ Sci & Technol China, Coll Life Sci, Hefei, Anhui, Peoples R China.	jhw@sun5.ibp.ac.cn			National Basic Research Program [2013CB531304]; Natural Science Foundation China [81471123]	National Basic Research Program(National Basic Research Program of China); Natural Science Foundation China(National Natural Science Foundation of China (NSFC))	This study is granted by the National Basic Research Program (2013CB531304) and Natural Science Foundation China (81471123) to JHW.	Afonso-Grunz F, 2015, CELL MOL LIFE SCI, V72, P3127, DOI 10.1007/s00018-015-1922-2; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bai M, 2014, PHYSIOL BEHAV, V129, P135, DOI 10.1016/j.physbeh.2014.02.035; Banasr M, 2011, CURR OPIN CELL BIOL, V23, P730, DOI 10.1016/j.ceb.2011.09.002; Barbash S, 2014, MOL BIOL EVOL, V31, P1237, DOI 10.1093/molbev/msu090; Beilharz TH, 2010, PROG MOL SUBCELL BIO, V50, P99, DOI 10.1007/978-3-642-03103-8_7; Bennett Paul, 2008, J Genet Couns, V17, P234, DOI 10.1007/s10897-007-9136-x; Berton O, 2012, SCIENCE, V338, P75, DOI 10.1126/science.1222940; Bhosale G, 2015, ANN NY ACAD SCI, V1350, P107, DOI 10.1111/nyas.12885; Biggar KK, 2011, J MOL CELL BIOL, V3, P167, DOI 10.1093/jmcb/mjq045; Booij L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0251; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P938, DOI 10.1016/j.bbrc.2006.06.003; Croarkin PE, 2011, NEUROSCI BIOBEHAV R, V35, P818, DOI 10.1016/j.neubiorev.2010.10.002; Crowley JJ, 2005, CURR PHARM DESIGN, V11, P157, DOI 10.2174/1381612053382278; Dalmay T, 2013, ESSAYS BIOCHEM, V54, P29, DOI [10.1042/BSE0540029, 10.1042/bse0540029]; Dalton VS, 2014, J AFFECT DISORDERS, V155, P1, DOI 10.1016/j.jad.2013.10.028; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; Dwivedi Y, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.175; Elhwuegi AS, 2004, PROG NEURO-PSYCHOPH, V28, P435, DOI 10.1016/j.pnpbp.2003.11.018; Elizalde N, 2008, PSYCHOPHARMACOLOGY, V199, P1, DOI 10.1007/s00213-007-1035-1; Elizalde N, 2010, J NEUROCHEM, V114, P1302, DOI 10.1111/j.1471-4159.2010.06854.x; Fatemi SH, 2013, TRANSL PSYCHIAT, V3, DOI [10.1038/tp.2013.64, 10.1038/tp.2013.46]; Friedlander MR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r57; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Garbett KA, 2015, BIOL PSYCHIAT, V77, P256, DOI 10.1016/j.biopsych.2014.05.015; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Hansen KF, 2013, NEUROPSYCH DIS TREAT, V9, P1011, DOI 10.2147/NDT.S34811; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; He J, 2016, P NATL ACAD SCI USA, V113, P584, DOI 10.1073/pnas.1521098113; He Y, 2012, DNA CELL BIOL, V31, P1499, DOI 10.1089/dna.2012.1660; Hill MN, 2012, NEUROSCI BIOBEHAV R, V36, P2085, DOI 10.1016/j.neubiorev.2012.07.001; Huang L, 2010, BIOCHEM BIOPH RES CO, V394, P709, DOI 10.1016/j.bbrc.2010.03.056; Iga JI, 2008, ANN MED, V40, P336, DOI 10.1080/07853890802082088; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Levinson AJ, 2010, BIOL PSYCHIAT, V67, P458, DOI 10.1016/j.biopsych.2009.09.025; Li JZ, 2013, P NATL ACAD SCI USA, V110, P9950, DOI 10.1073/pnas.1305814110; Lin E, 2016, PROG NEURO-PSYCHOPH, V64, P334, DOI 10.1016/j.pnpbp.2015.02.008; Lin LC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00110; Liu BB, 2015, PSYCHOPHARMACOLOGY, V232, P541, DOI 10.1007/s00213-014-3690-3; Lopez JP, 2014, NAT MED, V20, P764, DOI 10.1038/nm.3582; Lopizzo N, 2015, FRONT PSYCHIATRY, V6, DOI [10.3389/fpsyt.2015.0068, 10.3389/fpsyt.2015.00068]; Maheu M, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.11; Mehta D, 2010, CURR PSYCHIAT REP, V12, P135, DOI 10.1007/s11920-010-0100-3; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; O'Connor RM, 2012, MOL PSYCHIATR, V17, P359, DOI 10.1038/mp.2011.162; Opmeer EM, 2010, PROG NEUROBIOL, V92, P112, DOI 10.1016/j.pneurobio.2010.06.003; Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Plante DT, 2012, NEUROPSYCHOPHARMACOL, V37, P1548, DOI 10.1038/npp.2012.4; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Price RB, 2009, BIOL PSYCHIAT, V65, P792, DOI 10.1016/j.biopsych.2008.10.025; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Rajkowska G, 2015, J PSYCHIATR RES, V65, P53, DOI 10.1016/j.jpsychires.2015.04.010; Rohleder N, 2010, NEUROSCI BIOBEHAV R, V35, P104, DOI 10.1016/j.neubiorev.2009.12.003; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sandi C, 2015, NAT REV NEUROSCI, V16, P290, DOI 10.1038/nrn3918; Saus E, 2010, HUM MOL GENET, V19, P4017, DOI 10.1093/hmg/ddq316; Schweizer MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004326; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Smaili S, 2009, AN ACAD BRAS CIENC, V81, P467, DOI 10.1590/S0001-37652009000300011; Smalheiser NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086469; Smalheiser NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033201; Smalheiser NR, 2011, INT J NEUROPSYCHOPH, V14, P1315, DOI 10.1017/S1461145710001628; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Strekalova T, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-9; Tripp A, 2011, NEUROBIOL DIS, V42, P116, DOI 10.1016/j.nbd.2011.01.014; Urani A, 2005, NEUROSCI BIOBEHAV R, V29, P805, DOI 10.1016/j.neubiorev.2005.03.020; Veeraiah P, 2014, BIOL PSYCHIAT, V76, P231, DOI 10.1016/j.biopsych.2013.09.024; Wang J-H, 2015, BRAIN DISORDERS THER, V4, P1, DOI [10.4172/2168-975X.1000200, DOI 10.4172/2168-975X.1000200]; Whitton AE, 2015, CURR OPIN PSYCHIATR, V28, P7, DOI 10.1097/YCO.0000000000000122; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Wurtman RJ, 2005, METABOLISM, V54, P16, DOI 10.1016/j.metabol.2005.01.007; Xu AP, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv122; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zink M, 2009, NEUROCHEM RES, V34, P1584, DOI 10.1007/s11064-009-9947-2	82	58	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159093	10.1371/journal.pone.0159093	http://dx.doi.org/10.1371/journal.pone.0159093			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427907	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300035
J	Marshall, E; Rain-Taljaard, R; Tsepe, M; Monkwe, C; Hlatswayo, F; Tshabalala, S; Khela, S; Xulu, L; Xaba, D; Molomo, T; Malinga, T; Puren, A; Auvert, B				Marshall, Esaie; Rain-Taljaard, Reathe; Tsepe, Motlalepule; Monkwe, Cornelius; Hlatswayo, Florence; Tshabalala, Simphiwe; Khela, Simphiwe; Xulu, Lindo; Xaba, Dumazile; Molomo, Tebogo; Malinga, Thobile; Puren, Adrian; Auvert, Bertran			Sequential Cross-Sectional Surveys in Orange Farm, a Township of South Africa, Revealed a Constant Low Voluntary Medical Male Circumcision Uptake among Adults despite Demand Creation Campaigns and High Acceptability	PLOS ONE			English	Article							HIV PREVENTION; TRIAL; UGANDA; RAKAI; KNOWLEDGE; KENYA; MEN	Background WHO recommends a male circumcision (MC) prevalence rate higher than 80% to have a substantial impact on the HIV-AIDS epidemic in Eastern and Southern Africa. Orange Farm, a township in South Africa, has a free-for-service voluntary medical male circumcision (VMMC) clinic in operation since 2008. Following an intense campaign from 2008 to 2010, MC prevalence rate increased to 55.4% (ANRS-12126). Ongoing and past VMMC campaigns focused on youths, through school talks, and adults at a community level. The main objective of the study was to assess the change in MC prevalence rate among adults aged 18-19 and 18-49 years in the past 5 years. Methods A cross-sectional survey (ANRS-12285) was conducted among a random sample of 522 adult men in 2015. MC status and characteristics of participants were collected through a genital examination and a face-to-face questionnaire. Results MC prevalence rate among young adult men aged 18-19 years increased markedly from 61.2% (95%CI: 57.4% to 65.0%) in 2010 to 87.5% (76.0% to 94.6%) in 2015 (p<0.001). In the same period, among men aged 18-49 years, MC prevalence rate varied slightly from 55.4% (53.6% to 57.1%) to 56.7% (52.4% to 60.9%). In 2015, 84.9%(79.2% to 89.5%) of uncircumcised adult men reported that they were willing to be circumcised. However, we estimated that only 4.6% (11/237; 2.5% to 7.9%) of the uncircumcised men underwent circumcision in 2015, despite 117/185 (63.2%; 95%CI: 56.1% to 69.9%) who reported that they were definitely willing to become circumcised. Conclusions In Orange Farm, VMMC campaigns were successful among the youth and led to a sufficiently high MC prevalence rate to have a substantial impact in the future on the HIV-AIDS epidemic. However, despite high acceptability and a free VMMC service, VMMC campaigns since 2010 have failed to increase MC prevalence rate among adults to above 80%. These campaigns should be revisited.	[Marshall, Esaie; Auvert, Bertran] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Marshall, Esaie] Univ Burgundy, Fac Med, Res Unit 4184, Fac Med, Dijon, France; [Rain-Taljaard, Reathe; Tsepe, Motlalepule; Monkwe, Cornelius; Hlatswayo, Florence; Tshabalala, Simphiwe; Khela, Simphiwe; Xulu, Lindo; Xaba, Dumazile; Molomo, Tebogo; Malinga, Thobile] Progressus Res & Dev, Johannesburg, South Africa; [Puren, Adrian] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Johannesburg, South Africa; [Puren, Adrian] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Auvert, Bertran] Hop Ambroise Pare, AP HP, Boulogne, France; [Auvert, Bertran] Univ Versailles St Quentin, Fac Med, Versailles, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Bourgogne; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Auvert, B (corresponding author), INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France.; Auvert, B (corresponding author), Hop Ambroise Pare, AP HP, Boulogne, France.; Auvert, B (corresponding author), Univ Versailles St Quentin, Fac Med, Versailles, France.	bertran.auvert@uvsq.fr	Puren, Adrian/AAC-2065-2020; Puren, Adrian/W-1679-2018	Puren, Adrian/0000-0001-7531-4010; Puren, Adrian/0000-0001-7531-4010	French Agence Nationale de Recherches sur le Sida et les Hepatites Virales [12126, 12285]; Institut Universitaire de France; National Institute for Communicable Diseases; Progressus	French Agence Nationale de Recherches sur le Sida et les Hepatites Virales(ANRS); Institut Universitaire de France; National Institute for Communicable Diseases; Progressus	BA received funding (grant 12126 and 12285) from the French Agence Nationale de Recherches sur le Sida et les Hepatites Virales (www.anrs.fr). BA also received funding from the Institut Universitaire de France. AP received funding from the National Institute for Communicable Diseases. RRT received funding from Progressus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hatzold K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085051; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018299; Jones D, 2014, AIDS BEHAV, V18, P278, DOI 10.1007/s10461-013-0530-0; Kong XR, 2014, AIDS BEHAV, V18, P880, DOI 10.1007/s10461-014-0740-0; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; Liwen Vaughan, 2003, STAT METHODS INFORM; Lundahl B, 2009, J CLIN PSYCHOL, V65, P1232, DOI 10.1002/jclp.20638; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Miller WR, 2009, AM PSYCHOL, V64, P527, DOI 10.1037/a0016830; National Department of Health P, 2011, 2010 NAT ANT SENT HI, P50; R Development Core Team, 2005, R LANG ENV STAT COMP; Ssekubugu R, 2013, QUAL HEALTH RES, V23, P795, DOI 10.1177/1049732313482189; Thirumurthy H, 2014, JAMA-J AM MED ASSOC, V312, P703, DOI 10.1001/jama.2014.9087; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WESTERCAMP N, 2006, AIDS BEHAV; WHO/UNAIDS, 2011, JOINT STRAT ACT FRAM; WHO/UNAIDS, 2007, TECHN CONS MAL CIRC TECHN CONS MAL CIRC; WHO-UNAIDS, 2015, WHOHIV201521 WHOUNAI; WHO-UNAIDS, 2015, UNAIDS WORLD AIDS DA	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158675	10.1371/journal.pone.0158675	http://dx.doi.org/10.1371/journal.pone.0158675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27427957	Green Submitted, gold, Green Published			2022-12-27	WOS:000380169300017
J	Hansen, HH; Fabricius, K; Barkholt, P; Kongsbak-Wismann, P; Schlumberger, C; Jelsing, J; Terwel, D; Termont, A; Pyke, C; Knudsen, LB; Vrang, N				Hansen, Henrik H.; Fabricius, Katrine; Barkholt, Pernille; Kongsbak-Wismann, Pernille; Schlumberger, Chantal; Jelsing, Jacob; Terwel, Dick; Termont, Annelies; Pyke, Charles; Knudsen, Lotte Bjerre; Vrang, Niels			Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on beta-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease	PLOS ONE			English	Article							A-BETA; SYNAPTIC PLASTICITY; OBJECT RECOGNITION; COGNITIVE DEFICITS; BEHAVIORAL-CHANGES; MEMORY IMPAIRMENT; SPATIAL MEMORY; BODY-WEIGHT; FOOD-INTAKE; BRAIN	One of the major histopathological hallmarks of Alzheimer's disease (AD) is cerebral deposits of extracellular beta-amyloid peptides. Preclinical studies have pointed to glucagon-like peptide 1 (GLP-1) receptors as a potential novel target in the treatment of AD. GLP-1 receptor agonists, including exendin-4 and liraglutide, have been shown to promote plaque-lowering and mnemonic effects of in a number of experimental models of AD. Transgenic mouse models carrying genetic mutations of amyloid protein precursor (APP) and presenilin-1 (PS1) are commonly used to assess the pharmacodynamics of potential amyloidosis-lowering and pro-cognitive compounds. In this study, effects of long-term liraglutide treatment were therefore determined in two double APP/PS1 transgenic mouse models of Alzheimer's disease carrying different clinical APP/PS1 mutations, i.e. the 'London' (hAPP(Lon)/PS1(A246E)) and 'Swedish' mutation variant (hAPP(Swe)/PS1(Delta E9)) of APP, with co-expression of distinct PS1 variants. Liraglutide was administered in 5 month-old hAPPLon/PS1A246E mice for 3 months (100 or 500 ng/kg/day, s.c.), or 7 month-old hAPP(Swe)/PS1(Delta E9) mice for 5 months (500 ng/kg/day, s.c.). In both models, regional plaque load was quantified throughout the brain using stereological methods. Vehicle-dosed hAPP(Swe)/PS1(Delta E9) mice exhibited considerably higher cerebral plaque load than hAPPLon/PS1A246E control mice. Compared to vehicle-dosed transgenic controls, liraglutide treatment had no effect on the plaque levels in hAPP(Lon)/PS1(A246E) and hAPP(Swe)/PS1(Delta E9) mice. In conclusion, long-term liraglutide treatment exhibited no effect on cerebral plaque load in two transgenic mouse models of low-and high-grade amyloidosis, which suggests differential sensitivity to long-term liraglutide treatment in various transgenic mouse models mimicking distinct pathological hallmarks of AD.	[Hansen, Henrik H.; Fabricius, Katrine; Barkholt, Pernille; Kongsbak-Wismann, Pernille; Schlumberger, Chantal; Jelsing, Jacob; Vrang, Niels] Gubra, Agern Alle 1, DK-2970 Horsholm, Denmark; [Terwel, Dick; Termont, Annelies] ReMYND NV, Gaston Greenslaan 1, B-3001 Louvain, Belgium; [Pyke, Charles; Knudsen, Lotte Bjerre] Novo Nordisk AS, Diabet Res, DK-2760 Malov, Denmark	Novo Nordisk	Hansen, HH; Vrang, N (corresponding author), Gubra, Agern Alle 1, DK-2970 Horsholm, Denmark.	hbh@gubra.dk; niels@gubra.dk		Knudsen, Lotte Bjerre/0000-0002-2439-7116; Barkholt, Pernille/0000-0002-3603-2915	Novo Nordisk	Novo Nordisk(Novo Nordisk)	This study was carried out in collaboration with Novo Nordisk. Novo Nordisk funded the study, participated in the study design, data collection and analysis, as well as in decision to publish and preparation of the manuscript. The specific roles of the authors are articulated in the 'Author Contributions' section.	Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bilkei-Gorzo A, 2014, PHARMACOL THERAPEUT, V142, P244, DOI 10.1016/j.pharmthera.2013.12.009; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bomba M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.139; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Cai HY, 2014, NEUROSCIENCE, V277, P6, DOI 10.1016/j.neuroscience.2014.02.022; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; D'Amico M, 2010, EXP GERONTOL, V45, P202, DOI 10.1016/j.exger.2009.12.004; Dewachter I, 2000, J NEUROSCI, V20, P6452, DOI 10.1523/JNEUROSCI.20-17-06452.2000; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Easton A, 2013, PSYCHOPHARMACOLOGY, V230, P279, DOI 10.1007/s00213-013-3152-3; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Farr SA, 2000, BRAIN RES, V872, P242, DOI 10.1016/S0006-8993(00)02495-1; Flood JF, 1996, NEUROBIOL AGING, V17, P15, DOI 10.1016/0197-4580(95)02007-1; Gengler S, 2012, NEUROBIOL AGING, V33, P265, DOI 10.1016/j.neurobiolaging.2010.02.014; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Han WN, 2013, NEUROBIOL AGING, V34, P576, DOI 10.1016/j.neurobiolaging.2012.04.009; Hansen HH, 2016, BRAIN RES, V1634, P158, DOI 10.1016/j.brainres.2015.12.052; Hansen HH, 2015, J ALZHEIMERS DIS, V46, P877, DOI 10.3233/JAD-143090; Heppner KM, 2015, ENDOCRINOLOGY, V156, P255, DOI 10.1210/en.2014-1675; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kanoski SE, 2012, NEUROPHARMACOLOGY, V62, P1916, DOI 10.1016/j.neuropharm.2011.12.022; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Kastin AJ, 2002, J MOL NEUROSCI, V18, P7, DOI 10.1385/JMN:18:1-2:07; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Liu B, 2013, J NEUROSCI, V33, P7027, DOI 10.1523/JNEUROSCI.5924-12.2013; Long-Smith CM, 2013, NEUROMOL MED, V15, P102, DOI 10.1007/s12017-012-8199-5; Lund A, 2014, EUR J INTERN MED, V25, P407, DOI 10.1016/j.ejim.2014.03.005; Ma T, 2012, J NEUROSCI, V32, P13701, DOI 10.1523/JNEUROSCI.2107-12.2012; Mack CM, 2006, INT J OBESITY, V30, P1332, DOI 10.1038/sj.ijo.0803284; Manaye KF, 2007, AGE, V29, P87, DOI 10.1007/s11357-007-9035-y; McClean PL, 2015, BEHAV BRAIN RES, V293, P96, DOI 10.1016/j.bbr.2015.07.024; McClean PL, 2014, NEUROPHARMACOLOGY, V86, P241, DOI 10.1016/j.neuropharm.2014.07.015; McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Minkeviciene R, 2008, J NEUROCHEM, V105, P584, DOI 10.1111/j.1471-4159.2007.05147.x; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Morley JE, 2002, NEUROBIOL LEARN MEM, V78, P125, DOI 10.1006/nlme.2001.4047; Muhs A, 2007, P NATL ACAD SCI USA, V104, P9810, DOI 10.1073/pnas.0703137104; Orskov C, 1996, DIABETES, V45, P832, DOI 10.2337/diabetes.45.6.832; Park JH, 2006, J NEUROSCI, V26, P13279, DOI 10.1523/JNEUROSCI.4504-06.2006; Parthsarathy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058784; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Puzzo D, 2014, BIOCHEM PHARMACOL, V88, P450, DOI 10.1016/j.bcp.2014.01.011; Qin ZX, 2008, NEUROSCI LETT, V444, P217, DOI 10.1016/j.neulet.2008.08.047; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Scott L, 2012, NEUROBIOL AGING, V1481, pe1413; Secher A, 2014, J CLIN INVEST, V124, P4473, DOI 10.1172/JCI75276; Sisley S, 2014, J CLIN INVEST, V124, P2456, DOI 10.1172/JCI72434; Talbot K, 2014, NEURODEGENER DIS MAN, V4, P31, DOI [10.2217/NMT.13.73, 10.2217/nmt.13.73]; Tanghe A, 2010, INT J ALZHEIMERS DIS, P2010; Tatarkiewicz K, 2014, AM J PHYSIOL-REG I, V306, pR490, DOI 10.1152/ajpregu.00495.2013; van Groen T, 2006, NEUROBIOL DIS, V23, P653, DOI 10.1016/j.nbd.2006.05.010; Velmurugan K, 2012, J NEUROCHEM, V123, P919, DOI 10.1111/jnc.12036; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009	73	33	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0158205	10.1371/journal.pone.0158205	http://dx.doi.org/10.1371/journal.pone.0158205			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27421117	gold, Green Published, Green Submitted			2022-12-27	WOS:000379662300001
J	Avila, EE; Salaiza, N; Pulido, J; Rodriguez, MC; Diaz-Godinez, C; Laclette, JP; Becker, I; Carrero, JC				Avila, Eva E.; Salaiza, Norma; Pulido, Julieta; Rodriguez, Mayra C.; Diaz-Godinez, Cesar; Laclette, Juan P.; Becker, Ingeborg; Carrero, Julio C.			Entamoeba histolytica Trophozoites and Lipopeptidophosphoglycan Trigger Human Neutrophil Extracellular Traps	PLOS ONE			English	Article							AMEBIC LIVER-ABSCESS; INNATE IMMUNE-RESPONSE; HEPATIC AMEBIASIS; INTESTINAL AMEBIASIS; HUMAN CATHELICIDIN; ESCAPE; STREPTOCOCCUS; PATHOGENESIS; RESISTANCE; INFECTION	Neutrophil defense mechanisms include phagocytosis, degranulation and the formation of extracellular traps (NET). These networks of DNA are triggered by several immune and microbial factors, representing a defense strategy to prevent microbial spread by trapping/killing pathogens. This may be important against Entamoeba histolytica, since its large size hinders its phagocytosis. The aim of this study was to determine whether E. histolytica and their lipopeptidophosphoglycan (EhLPPG) induce the formation of NETs and the outcome of their interaction with the parasite. Our data show that live amoebae and EhLPPG, but not fixed trophozoites, induced NET formation in a time and dose dependent manner, starting at 5 min of co-incubation. Although immunofluorescence studies showed that the NETs contain cathelicidin LL-37 in close proximity to amoebae, the trophozoite growth was only affected when ethylene glycol tetra-acetic acid (EGTA) was present during contact with NETs, suggesting that the activity of enzymes requiring calcium, such as DNases, may be important for amoeba survival. In conclusion, E. histolytica trophozoites and EhLPPG induce in vitro formation of human NETs, which did not affect the parasite growth unless a chelating agent was present. These results suggest that NETs may be an important factor of the innate immune response during infection with E. histolytica.	[Avila, Eva E.; Pulido, Julieta; Rodriguez, Mayra C.] Univ Guanajuato, Dept Biol, Div Exact & Nat Sci, Guanajuato 36050, Mexico; [Salaiza, Norma; Becker, Ingeborg] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico; [Diaz-Godinez, Cesar; Laclette, Juan P.; Carrero, Julio C.] Univ Nacl Autonoma Mexico, Dept Immunol, Inst Invest Biomed, Mexico City 04510, DF, Mexico	Universidad de Guanajuato; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Becker, I (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico.; Carrero, JC (corresponding author), Univ Nacl Autonoma Mexico, Dept Immunol, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	ingeborg_becker@hotmail.com; carrero@unam.mx		Avila, Eva E./0000-0003-2011-688X; Carrero, Julio/0000-0003-1055-5774	CONACYT [167788, 182671]; DGAPA-UNAM-PAPIIT grant [IN213611]; Universidad de Guanajuato [977/2016]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM-PAPIIT grant; Universidad de Guanajuato	This work was funded by 1. CONACYT grant 167788, granted to JCC (http://www.conacyt.mx); 2. DGAPA-UNAM-PAPIIT grant IN213611, granted to JCC (http://dgapa.unam.mx); 3. CONACYT grant 182671, granted to EEA (http://www.conacyt.mx); and 4. Universidad de Guanajuato grant 977/2016, granted to EEA (www.ugto.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DSA, 2012, INFECT IMMUN, V80, P768, DOI 10.1128/IAI.05730-11; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Asgharpour A, 2005, INFECT IMMUN, V73, P4522, DOI 10.1128/IAI.73.8.4522-4529.2005; Baker VS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-41; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Burgess SL, 2014, MBIO, V5, DOI 10.1128/mBio.01817-14; CAMPOSRODRIGUEZ R, 1986, ARCH INVEST MED, V17, P353; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; de Buhr N, 2015, MICROBIOL-SGM, V161, P838, DOI 10.1099/mic.0.000040; Derre-Bobillot A, 2013, MOL MICROBIOL, V89, P518, DOI 10.1111/mmi.12295; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dickson-Gonzalez SM, 2009, SURG INFECT, V10, P91, DOI 10.1089/sur.2008.011; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Espinosa-Cantellano M, 2000, CLIN MICROBIOL REV, V13, P318, DOI 10.1128/CMR.13.2.318-331.2000; Estrada-Figueroa LA, 2011, PARASITE IMMUNOL, V33, P661, DOI 10.1111/j.1365-3024.2011.01333.x; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gabriel C, 2010, J IMMUNOL, V185, P4319, DOI 10.4049/jimmunol.1000893; Guimaraes-Costa AB, 2014, INFECT IMMUN, V82, P1732, DOI 10.1128/IAI.01232-13; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hahn S, 2013, SEMIN IMMUNOPATHOL, V35, P439, DOI 10.1007/s00281-013-0380-x; Hurrell BP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004929; ISIBASI A, 1982, ARCH INVEST MED, V13, P51; Jarillo-Luna RA, 2002, EXP PARASITOL, V101, P40, DOI 10.1016/S0014-4894(02)00021-8; Juneau RA, 2015, J INFECT DIS, V212, P316, DOI 10.1093/infdis/jiv031; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lotter H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000434; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maldonado-Bernal C, 2005, PARASITE IMMUNOL, V27, P127, DOI 10.1111/j.1365-3024.2005.00754.x; Morita C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103125; Naylor C, 2014, MBIO, V5, DOI 10.1128/mBio.02046-14; Olivos-Garcia A, 2007, EXP MOL PATHOL, V82, P310, DOI 10.1016/j.yexmp.2006.09.005; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Perez-Tamayo R, 2006, ARCH MED RES, V37, P203, DOI 10.1016/j.arcmed.2005.10.007; PEREZTAMAYO R, 1991, J PARASITOL, V77, P982, DOI 10.2307/3282753; PRATHAP K, 1970, AM J PATHOL, V60, P229; Quintanar-Quintanar ME, 2004, MED SCI MONITOR, V10, pBR317; Rico-Mata R, 2013, EXP PARASITOL, V133, P300, DOI 10.1016/j.exppara.2012.12.009; SALATA RA, 1986, J INFECT DIS, V154, P19, DOI 10.1093/infdis/154.1.19; Seper A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003614; Seydel KB, 1998, GASTROENTEROLOGY, V115, P1446, DOI 10.1016/S0016-5085(98)70023-X; Seydel KB, 1997, INFECT IMMUN, V65, P3951, DOI 10.1128/IAI.65.9.3951-3953.1997; Silva LMR, 2014, PARASITOL RES, V113, P2797, DOI 10.1007/s00436-014-3939-0; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Sousa-Rocha D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139569; Thammavongsa V, 2013, SCIENCE, V342, P863, DOI 10.1126/science.1242255; TSUTSUMI V, 1984, AM J PATHOL, V117, P81; TSUTSUMI V, 1988, AM J PATHOL, V130, P112; Velazquez C, 1998, PARASITE IMMUNOL, V20, P255, DOI 10.1046/j.1365-3024.1998.00128.x; Verkerke HP, 2012, SEMIN IMMUNOPATHOL, V34, P771, DOI 10.1007/s00281-012-0349-1; Vivanco-Cid H, 2007, PARASITE IMMUNOL, V29, P467, DOI 10.1111/j.1365-3024.2007.00963.x; Vorobjeva NV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1286, DOI 10.1134/S0006297914120025; WALSH JA, 1986, REV INFECT DIS, V8, P228; Yadav VP, 2009, FEBS J, V276, P7070, DOI 10.1111/j.1742-4658.2009.07419.x; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Zhu LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070363	61	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158979	10.1371/journal.pone.0158979	http://dx.doi.org/10.1371/journal.pone.0158979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415627	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500057
J	Ge, XP; Ritter, SY; Tsang, K; Shi, RR; Takei, K; Aliprantis, AO				Ge, Xianpeng; Ritter, Susan Y.; Tsang, Kelly; Shi, Ruirui; Takei, Kohtaro; Aliprantis, Antonios O.			Sex-Specific Protection of Osteoarthritis by Deleting Cartilage Acid Protein 1	PLOS ONE			English	Article							MURINE OSTEOARTHRITIS; EXTRACELLULAR-MATRIX; ALTERNATIVE CLEAVAGE; GAIT ANALYSIS; MOUSE MODELS; PATHOGENESIS; EXPRESSION; CYTOKINES; INTERLEUKIN-1-BETA; DESTABILIZATION	Cartilage acidic protein 1 (CRTAC1) was recently identified as an elevated protein in the synovial fluid of patients with osteoarthritis (OA) by a proteomic analysis. This gene is also upregulated in both human and mouse OA by transcriptomic analysis. The objective of this study was to characterize the expression and function of CRTAC1 in OA. Here, we first confirm the increase of CRTAC1 in cartilage biopsies from OA patients undergoing joint replacement by real-time PCR and immunohistochemistry. Furthermore, we report that proinflammatory cytokines interleukin-1beta and tumor necrosis factor alpha upregulate CRTAC1 expression in primary human articular chondrocytes and synovial fibroblasts. Genetic deletion of Crtac1 in mice significantly inhibited cartilage degradation, osteophyte formation and gait abnormalities of post-traumatic OA in female, but not male, animals undergoing the destabilization of medial meniscus (DMM) surgery. Taken together, CRTAC1 is upregulated in the osteoarthritic joint and directly induced in chondrocytes and synovial fibroblasts by pro-inflammatory cytokines. This molecule is necessary for the progression of OA in female mice after DMM surgery and thus represents a potential therapy for this prevalent disease, especially for women who demonstrate higher rates and more severe OA.	[Ge, Xianpeng; Ritter, Susan Y.; Tsang, Kelly; Aliprantis, Antonios O.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Ge, Xianpeng; Ritter, Susan Y.; Tsang, Kelly; Aliprantis, Antonios O.] Harvard Med Sch, Boston, MA 02115 USA; [Ge, Xianpeng; Shi, Ruirui] Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing, Peoples R China; [Shi, Ruirui] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA USA; [Takei, Kohtaro] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Mol Med Biosci Lab, Yokohama, Kanagawa, Japan; [Ge, Xianpeng] Yale Univ, Sch Med, Dept Orthopaed & Rehabil, New Haven, CT USA; [Aliprantis, Antonios O.] Merck Res Labs, 33 Ave Louis Pasteur, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Peking University; Harvard University; Harvard School of Dental Medicine; Yokohama City University; Yale University; Merck & Company	Aliprantis, AO (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Aliprantis, AO (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Aliprantis, AO (corresponding author), Merck Res Labs, 33 Ave Louis Pasteur, Boston, MA USA.	aaliprantis@partners.org	Ge, Xianpeng/H-7782-2019		NIH [R01AR060363]; Career Award for Medical Scientists from the Burroughs Wellcome Fund; National Natural Science Foundation of China [81100767]; Ministry of Education of China [2092808]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	The work was supported by NIH R01AR060363 (AOA) and a Career Award for Medical Scientists from the Burroughs Wellcome Fund (AOA). XG was fund by National Natural Science Foundation of China (project 81100767) and Ministry of Education of China (project 2092808).	Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Bateman JF, 2013, ARTHRITIS RHEUM-US, V65, P1547, DOI 10.1002/art.37900; Boyan BD, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-4; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Chambers MG, 1997, OSTEOARTHR CARTILAGE, V5, P301, DOI 10.1016/S1063-4584(97)80034-9; Clark AL, 2010, ARTHRITIS RHEUM-US, V62, P2973, DOI 10.1002/art.27624; Culley KL, 2015, METHODS MOL BIOL, V1226, P143, DOI 10.1007/978-1-4939-1619-1_12; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; Fang H, 2014, NAT REV RHEUMATOL, V10, P413, DOI 10.1038/nrrheum.2014.46; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Greenblatt MB, 2013, P NATL ACAD SCI USA, V110, P19914, DOI 10.1073/pnas.1320036110; Hinkle KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-25; Hui AY, 2012, WIRES SYST BIOL MED, V4, P15, DOI 10.1002/wsbm.157; Ijiri K, 2008, ARTHRITIS RHEUM-US, V58, P2075, DOI 10.1002/art.23504; Jacobs BY, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0456-x; Kaneko H, 2013, MATRIX BIOL, V32, P178, DOI 10.1016/j.matbio.2013.01.004; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kiener HP, 2006, AM J PATHOL, V168, P1486, DOI 10.2353/ajpath.2006.050999; Kim BJ, 2013, OSTEOARTHR CARTILAGE, V21, P2013, DOI 10.1016/j.joca.2013.09.012; Kim JH, 2015, P NATL ACAD SCI USA, V112, P9424, DOI 10.1073/pnas.1505700112; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Kurihara Y, 2014, MOL CELL NEUROSCI, V61, P211, DOI 10.1016/j.mcn.2014.07.001; Kurihara Y, 2012, BIOCHEM BIOPH RES CO, V418, P390, DOI 10.1016/j.bbrc.2012.01.033; Lee Y, 2012, J BONE MINER RES, V27, P1043, DOI 10.1002/jbmr.1561; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Maldonado M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/284873; Maleki-Fischbach M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3091; Malfait AM, 2016, OSTEOARTHR CARTILAGE, V24, P21, DOI 10.1016/j.joca.2015.09.010; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Melchiorri C, 1998, ARTHRITIS RHEUM-US, V41, P2165, DOI 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.3.CO;2-F; Murphy L, 2012, AM J NURS, V112, pS13, DOI 10.1097/01.NAJ.0000412646.80054.21; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Onuora Sarah, 2015, Nat Rev Rheumatol, V11, P504, DOI 10.1038/nrrheum.2015.107; Park Jae-Yeo, 2014, Evid Based Complement Alternat Med, V2014, P895272, DOI 10.1155/2014/895272; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Ritter SY, 2013, ARTHRITIS RHEUM-US, V65, P981, DOI 10.1002/art.37823; Roos EM, 2016, NAT REV RHEUMATOL, V12, P92, DOI 10.1038/nrrheum.2015.135; Ruan MZC, 2013, OSTEOARTHR CARTILAGE, V21, P1355, DOI 10.1016/j.joca.2013.06.016; Saha N, 1999, ARTHRITIS RHEUM, V42, P1577, DOI 10.1002/1529-0131(199908)42:8<1577::AID-ANR3>3.0.CO;2-Z; Sato Y, 2011, SCIENCE, V333, P769, DOI 10.1126/science.1204144; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Sharma AR, 2013, INT J MOL SCI, V14, P19805, DOI 10.3390/ijms141019805; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Steck E, 2001, BIOCHEM J, V353, P169, DOI 10.1042/0264-6021:3530169; Steck E, 2007, MATRIX BIOL, V26, P30, DOI 10.1016/j.matbio.2006.09.006; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; Vincelette J, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2331; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; Westacott CI, 2000, OSTEOARTHR CARTILAGE, V8, P213, DOI 10.1053/joca.1999.0292; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459	52	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159157	10.1371/journal.pone.0159157	http://dx.doi.org/10.1371/journal.pone.0159157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415616	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500093
J	Yang, Q; Lu, H; Song, XD; Li, SF; Wei, WB				Yang, Qiong; Lu, Hai; Song, Xudong; Li, Songfeng; Wei, Wenbin			iTRAQ-Based Proteomics Investigation of Aqueous Humor from Patients with Coats' Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL LASER PHOTOCOAGULATION; TRABECULAR MESHWORK; HUMAN LENS; IDENTIFICATION; PROTEINS; BEVACIZUMAB; BIOMARKERS; MANAGEMENT; RESISTANCE	Background Coats' disease is an uncommon form of retinal telangiectasis, and the identification of novel proteins that contribute to the development of Coats' disease is useful for improving treatment efficacy. Proteomic techniques have been used to study many eye diseases; however, few studies have used proteomics to study the development of Coats' disease. Methods Isobaric tagging for relative and absolute protein quantification (iTRAQ) was employed to screen differentially expressed proteins (DEPs) in the aqueous humor (AH) between stage 3A patients (n = 8), stage 3B patients (n = 14), stage 4 patients (n = 2) and control patients (n = 20). Differentially co-expressed proteins (DCPs) were present in all three stages of Coats' disease and were considered disease-specific proteins. These proteins were further analyzed using Gene Ontology (GO) functional annotations. Results A total of 819 proteins were identified in the AH, 222 of which were significantly differentially expressed (fold change > 2 and P < 0.05) in the samples from at least one stage of Coats' disease. Of the DEPs, 46 were found among all three stages of Coats' disease and the controls; therefore, they were considered Coats' disease-specific proteins (DCPs). A GO classification analysis indicated that the DCPs were closely related to structural molecule activity, cell adhesion molecule binding and receptor binding. Western blotting confirmed the expression levels of haptoglobin and apolipoprotein C-I were significantly up-regulated in Coats' disease. Conclusions The 46 Coats' disease-specific proteins may provide additional insights into the mechanism of Coats' disease and represent potential biomarkers for identifying individuals with Coats' disease.	[Yang, Qiong; Lu, Hai; Song, Xudong; Li, Songfeng; Wei, Wenbin] Capital Med Univ, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing 100730, Peoples R China	Capital Medical University	Wei, WB (corresponding author), Capital Med Univ, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing 100730, Peoples R China.	wbweitongren@163.com	wei, wei/HHR-8613-2022		Science & Technology Project of Beijing Municipal Science & Technology Commission [Z151100001615052]; National Natural Science Foundation of China [81570891, 81272981]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201307]; Beijing Natural Science Foundation [7151003]; Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau [2014-2-003]; Beijing Municipal Administration of Hospitals' Ascent Plan [DFL20150201]	Science & Technology Project of Beijing Municipal Science & Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau; Beijing Municipal Administration of Hospitals' Ascent Plan	This study was supported by the Science & Technology Project of Beijing Municipal Science & Technology Commission (code: Z151100001615052), the National Natural Science Foundation of China (No. 81570891), the Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (code: ZYLX201307), the National Natural Science Foundation of China (No. 81272981), the Beijing Natural Science Foundation (No. 7151003), the Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau (No. 2014-2-003) and the Beijing Municipal Administration of Hospitals' Ascent Plan (Code: DFL20150201).; This study was supported by the Science & Technology Project of Beijing Municipal Science & Technology Commission (code: Z151100001615052), the National Natural Science Foundation of China (No. 81570891), the Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (code: ZYLX201307), the National Natural Science Foundation of China (No. 81272981), the Beijing Natural Science Foundation (No. 7151003), the Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau (No. 2014-2-003) and the Beijing Municipal Administration of Hospitals' Ascent Plan (Code: DFL20150201). We also thank Dr. Xiang Jin from the Proteomics Center of Chinese Academy of Tropical Agricultural Sciences for kindly help on processing the iTRAQ data.	Ajaz MS, 1997, J BIOL CHEM, V272, P11250; Avery CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002322; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; Chan MP, 2008, BIOCHEMISTRY-US, V47, P11062, DOI 10.1021/bi8012438; Chatterjee A, 2014, J OCUL PHARMACOL TH, V30, P447, DOI 10.1089/jop.2014.0013; Chiang SY, 2012, J PROTEOMICS, V75, P2950, DOI 10.1016/j.jprot.2011.12.006; Crouch RK, 1996, PHOTOCHEM PHOTOBIOL, V64, P613, DOI 10.1111/j.1751-1097.1996.tb03114.x; Devi RR, 2008, MOL VIS, V14, P1157; Elsobky Sherif, 2014, World J Biol Chem, V5, P106, DOI 10.4331/wjbc.v5.i2.106; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Hadjistilianou T, 2012, CLIN EXP OPHTHALMOL, V40, pE8, DOI 10.1111/j.1442-9071.2011.02711.x; He YG, 2010, GRAEF ARCH CLIN EXP, V248, P1519, DOI 10.1007/s00417-010-1366-1; HELLER J, 1975, J BIOL CHEM, V250, P3613; Jin GZ, 2011, J PROTEOME RES, V10, P3418, DOI 10.1021/pr200482t; Kaul S, 2010, INDIAN J OPHTHALMOL, V58, P76, DOI 10.4103/0301-4738.58480; Kodama A, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-36; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Maatta M, 2005, J GLAUCOMA, V14, P64; Monteiro JP, 2015, PROTEOM CLIN APPL, V9, P187, DOI 10.1002/prca.201400133; Morris B, 2010, EYE, V24, P1797, DOI 10.1038/eye.2010.126; Muurling M, 2004, J LIPID RES, V45, P9, DOI 10.1194/jlr.M300240-JLR200; Ogata Masafumi, 2014, Tokai J Exp Clin Med, V39, P25; Ozcan Altan Atakan, 2004, International Ophthalmology, V25, P19, DOI 10.1023/B:INTE.0000018524.48581.79; RASK L, 1976, J BIOL CHEM, V251, P6360; RIDLEY ME, 1982, OPHTHALMOLOGY, V89, P1381; SEILER T, 1985, GRAEF ARCH CLIN EXP, V223, P88, DOI 10.1007/BF02150951; Shields JA, 2001, AM J OPHTHALMOL, V131, P561, DOI 10.1016/S0002-9394(00)00883-7; Shields JA, 2001, AM J OPHTHALMOL, V131, P572, DOI 10.1016/S0002-9394(01)00896-0; Skinner NEB, 2015, DIABETES THER, V6, P395, DOI 10.1007/s13300-015-0123-1; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; Tawara A, 2000, CURR EYE RES, V21, P934, DOI 10.1076/ceyr.21.6.934.6988; Theoulakis PE, 2012, KLIN MONATSBL AUGENH, V229, P447, DOI 10.1055/s-0031-1299216; To Chi-ho, 2002, Clin Exp Optom, V85, P335; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Wang KJ, 2011, HUM MUTAT, V32, pE2050, DOI 10.1002/humu.21436; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Xu DD, 2014, PROTEOMICS, V14, P322, DOI 10.1002/pmic.201300383; Yang Z, 2000, Zhonghua Xue Ye Xue Za Zhi, V21, P463; Zhang H, 2012, J OCUL PHARMACOL TH, V28, P397, DOI 10.1089/jop.2011.0168; [赵斌 Zhao Bin], 2003, [中华神经科杂志, Chinese Journal of Neurology], V36, P450; Zhao Q, 2014, ACTA OPHTHALMOL, V92, pE225, DOI 10.1111/aos.12158; Zhou HY, 2015, PROTEOM CLIN APPL, V9, P776, DOI 10.1002/prca.201400061; Zhu L, 2013, INVEST OPHTH VIS SCI, V54, P5675, DOI 10.1167/iovs.13-12050	44	18	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158611	10.1371/journal.pone.0158611	http://dx.doi.org/10.1371/journal.pone.0158611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416065	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500026
J	Zhang, HJ; Lamon, BD; Moran, G; Sun, T; Gotto, AM; Hajjar, DP				Zhang, Haijun; Lamon, Brian D.; Moran, George; Sun, Tao; Gotto, Antonio M., Jr.; Hajjar, David P.			Pitavastatin Differentially Modulates MicroRNA-Associated Cholesterol Transport Proteins in Macrophages	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR; EXPRESSION; EFFLUX; ATHEROSCLEROSIS; INDUCTION; STATINS; AGENTS; CELLS; ABCA1	There is emerging evidence identifying microRNAs (miRNAs) as mediators of statin-induced cholesterol efflux, notably through the ATP-binding cassette transporter A1 (ABCA1) in macrophages. The objective of this study was to assess the impact of an HMG-CoA reductase inhibitor, pitavastatin, on macrophage miRNAs in the presence and absence of oxidized-LDL, a hallmark of a pro-atherogenic milieu. Treatment of human THP-1 cells with pitavastatin prevented the oxLDL-mediated suppression of miR-33a, -33b and -758 mRNA in these cells, an effect which was not uniquely attributable to induction of SREBP2. Induction of ABCA1 mRNA and protein by oxLDL was inhibited (30%) by pitavastatin, while oxLDL or pitavastatin alone significantly induced and repressed ABCA1 expression, respectively. These findings are consistent with previous reports in macrophages. miRNA profiling was also performed using a miRNA array. We identified specific miRNAs which were up-regulated (122) and down-regulated (107) in THP-1 cells treated with oxLDL plus pitavastatin versus oxLDL alone, indicating distinct regulatory networks in these cells. Moreover, several of the differentially expressed miRNAs identified are functionally associated with cholesterol trafficking (six miRNAs in cells treated with oxLDL versus oxLDL plus pitavastatin). Our findings indicate that pitavastatin can differentially modulate miRNA in the presence of oxLDL; and, our results provide evidence that the net effect on cholesterol homeostasis is mediated by a network of miRNAs.	[Zhang, Haijun; Sun, Tao] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, 1300 York Ave, New York, NY 10065 USA; [Zhang, Haijun] Cornell Univ, Weill Med Coll, Dept Med Genet, 1300 York Ave, New York, NY 10065 USA; [Lamon, Brian D.; Moran, George; Hajjar, David P.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, 1300 York Ave, New York, NY 10065 USA; [Lamon, Brian D.; Moran, George; Hajjar, David P.] Cornell Univ, Weill Med Coll, Ctr Vasc Biol, 1300 York Ave, New York, NY 10065 USA; [Gotto, Antonio M., Jr.] Cornell Univ, Weill Med Coll, Dept Med, 1300 York Ave, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Hajjar, DP (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, 1300 York Ave, New York, NY 10065 USA.; Hajjar, DP (corresponding author), Cornell Univ, Weill Med Coll, Ctr Vasc Biol, 1300 York Ave, New York, NY 10065 USA.	dphajjar@med.cornell.edu	MIZEKA, PANU/A-3952-2017		KOWA Co, Ltd, Tokyo, Japan; NIH/NIMH [R01-MH083680-07]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083680] Funding Source: NIH RePORTER	KOWA Co, Ltd, Tokyo, Japan; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a sponsored research agreement with KOWA Co, Ltd, Tokyo, Japan, and in part, by an R01-MH083680-07 grant from the NIH/NIMH (T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a sponsored research agreement with KOWA Co, Ltd, Tokyo, Japan, and in part, by an R01-MH083680-08 grant from the NIH/NIMH (T.S.). Drs. David P. Hajjar and Antonio M. Gotto Jr. are consultants to KOWA Pharmaceuticals, Japan.	Argmann CA, 2005, J BIOL CHEM, V280, P22212, DOI 10.1074/jbc.M502761200; Cerda Alvaro, 2012, Drug Metabolism and Drug Interactions, V27, P101, DOI 10.1515/dmdi-2012-0007; Davignon J, 2012, BRIT J CLIN PHARMACO, V73, P518, DOI 10.1111/j.1365-2125.2011.04139.x; Geeraert B, 2007, J THROMB HAEMOST, V5, P2529, DOI 10.1111/j.1538-7836.2007.02786.x; Han JH, 2004, CIRCULATION, V110, P3472, DOI 10.1161/01.CIR.0000148368.79202.F1; Han JH, 2004, CIRCULATION, V109, P790, DOI 10.1161/01.CIR.0000112576.40815.13; Horie T, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003376; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109722; Markle RA, 2003, J CELL BIOCHEM, V90, P23, DOI 10.1002/jcb.10602; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Niesor EJ, 2015, CARDIOVASC DRUG THER, V29, P7, DOI 10.1007/s10557-015-6570-0; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Romaine SPR, 2015, HEART, V101, P921, DOI 10.1136/heartjnl-2013-305402; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Sun L, 2003, J LIPID RES, V44, P1877, DOI 10.1194/jlr.M300084-JLR200; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Wong J, 2008, ATHEROSCLEROSIS, V196, P180, DOI 10.1016/j.atherosclerosis.2007.03.030; Xu QL, 2014, CARDIOVASC THER, V32, P193, DOI 10.1111/1755-5922.12081	21	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159130	10.1371/journal.pone.0159130	http://dx.doi.org/10.1371/journal.pone.0159130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415822	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500084
J	BahadarKhan, K; Khaliq, AA; Shahid, M				BahadarKhan, Khan; Khaliq, Amir A.; Shahid, Muhammad			A Morphological Hessian Based Approach for Retinal Blood Vessels Segmentation and Denoising Using Region Based Otsu Thresholding	PLOS ONE			English	Article							MATCHED-FILTER; IMAGES	Diabetic Retinopathy (DR) harm retinal blood vessels in the eye causing visual deficiency. The appearance and structure of blood vessels in retinal images play an essential part in the diagnoses of an eye sicknesses. We proposed a less computational unsupervised automated technique with promising results for detection of retinal vasculature by using morphological hessian based approach and region based Otsu thresholding. Contrast Limited Adaptive Histogram Equalization (CLAHE) and morphological filters have been used for enhancement and to remove low frequency noise or geometrical objects, respectively. The hessian matrix and eigenvalues approach used has been in a modified form at two different scales to extract wide and thin vessel enhanced images separately. Otsu thresholding has been further applied in a novel way to classify vessel and non-vessel pixels from both enhanced images. Finally, postprocessing steps has been used to eliminate the unwanted region/ segment, non-vessel pixels, disease abnormalities and noise, to obtain a final segmented image. The proposed technique has been analyzed on the openly accessible DRIVE (Digital Retinal Images for Vessel Extraction) and STARE (STructured Analysis of the REtina) databases along with the ground truth data that has been precisely marked by the experts.	[BahadarKhan, Khan; Khaliq, Amir A.] Int Islamic Univ, Dept Elect Engn, Islamabad, Pakistan; [Shahid, Muhammad] CUST, Dept Comp Engn, Islamabad, Pakistan	International Islamic University, Pakistan	BahadarKhan, K (corresponding author), Int Islamic Univ, Dept Elect Engn, Islamabad, Pakistan.; BahadarKhan, K (corresponding author), Int Islamic Univ, Fac Engn & Technol, Dept Elect Engn, Sect H-10, Islamabad, Pakistan.	kb.khattak@gmail.com	Shahid, Muhammad/AAC-9720-2019; Khan, Khan Bahadar/E-2289-2019	Khan, Khan Bahadar/0000-0003-1409-7571				Al-Diri B, 2009, IEEE T MED IMAGING, V28, P1488, DOI 10.1109/TMI.2009.2017941; Asad AH, 2016, INTEL SYST REF LIBR, V96, P181, DOI 10.1007/978-3-319-21212-8_8; Azzopardi G, 2015, MED IMAGE ANAL, V19, P46, DOI 10.1016/j.media.2014.08.002; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; BEZDEK JC, 1980, IEEE T PATTERN ANAL, V2, P1, DOI 10.1109/TPAMI.1980.4766964; Cavallerano J, 2005, J TELEMED TELECARE, V11, P163, DOI 10.1258/1357633054068874; CHAUDHURI S, 1989, IEEE T MED IMAGING, V8, P263, DOI 10.1109/42.34715; Dai PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127748; Deng H, 2016, COMPUTATIONAL GEOSCI, P1; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P600, DOI 10.1016/j.cmpb.2011.08.009; Fritzsche KH, 2003, BIOMED EN S, P225; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Jain AK., 1988, TECHNOMETRICS; Jiang XY, 2003, IEEE T PATTERN ANAL, V25, P131, DOI 10.1109/TPAMI.2003.1159954; Klein R., 1995, DIABETES AM, V2nd ed., P293, DOI DOI 10.1063/1.1522643; Kose C, 2012, COMPUT METH PROG BIO, V107, P274, DOI 10.1016/j.cmpb.2011.06.007; Lai N, 2004, OPTOMETRY VISION SCI, V81, P295; Lam BSY, 2008, IEEE T MED IMAGING, V27, P237, DOI 10.1109/TMI.2007.909827; Lathen G, 2010, PATTERN RECOGN LETT, V31, P762, DOI 10.1016/j.patrec.2009.09.020; Lupascu CA, 2010, IEEE T INF TECHNOL B, V14, P1267, DOI 10.1109/TITB.2010.2052282; Mapayi T, 2015, COMPUTATIONAL MATH M; Marin D, 2011, IEEE T MED IMAGING, V30, P146, DOI 10.1109/TMI.2010.2064333; Martinez-Perez ME, 2007, MED IMAGE ANAL, V11, P47, DOI 10.1016/j.media.2006.11.004; Martinez-Perez ME, 1999, LECT NOTES COMPUT SC, V1679, P90; Mendonca AM, 2006, IEEE T MED IMAGING, V25, P1200, DOI 10.1109/TMI.2006.879955; Nguyen UTV, 2013, PATTERN RECOGN, V46, P703, DOI 10.1016/j.patcog.2012.08.009; Niblack W., 1985, INTRO DIGITAL IMAGE, P115; Niemeijer M, 2004, PROC SPIE, V5370, P648, DOI 10.1117/12.535349; Orlando JI, MED IMAGE COMPUTING, P634; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palomera-Perez MA, 2010, IEEE T INF TECHNOL B, V14, P500, DOI 10.1109/TITB.2009.2036604; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Ricci E, 2007, IEEE T MED IMAGING, V26, P1357, DOI 10.1109/TMI.2007.898551; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Truc PTH, 2009, COMPUT VIS IMAGE UND, V113, P101, DOI 10.1016/j.cviu.2008.07.009; TSAI WH, 1985, COMPUT VISION GRAPH, V29, P377, DOI 10.1016/0734-189X(85)90133-1; Vlachos M, 2010, COMPUT MED IMAG GRAP, V34, P213, DOI 10.1016/j.compmedimag.2009.09.006; Wang YF, 2013, PATTERN RECOGN, V46, P2117, DOI 10.1016/j.patcog.2012.12.014; Xu LL, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-14; Yavuz Z, 2010, INT C BIOINF BIOINFO; You XG, 2011, PATTERN RECOGN, V44, P2314, DOI 10.1016/j.patcog.2011.01.007; Zana F, 2001, IEEE T IMAGE PROCESS, V10, P1010, DOI 10.1109/83.931095; Zhang B, 2010, COMPUT BIOL MED, V40, P438, DOI 10.1016/j.compbiomed.2010.02.008; Zhang L, 2009, IEEE T INF TECHNOL B, V13, P528, DOI 10.1109/TITB.2008.2007201; Zhao YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122332; ZHOU LA, 1994, IEEE T MED IMAGING, V13, P619, DOI 10.1109/42.363106	49	54	59	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158996	10.1371/journal.pone.0158996	http://dx.doi.org/10.1371/journal.pone.0158996			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441646	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500035
J	Wong, FSY; Wong, CCH; Chan, BP; Lo, ACY				Wong, Francisca S. Y.; Wong, Calvin C. H.; Chan, Barbara P.; Lo, Amy C. Y.			Sustained Delivery of Bioactive GDNF from Collagen and Alginate-Based Cell-Encapsulating Gel Promoted Photoreceptor Survival in an Inherited Retinal Degeneration Model	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; RAT MODEL; GENE-THERAPY; PIGMENT-EPITHELIUM; GANGLION-CELLS; STEM-CELLS; SECRETION; DYSTROPHY; NEUROPROTECTION; MICROSPHERES	Encapsulated-cell therapy (ECT) is an attractive approach for continuously delivering freshly synthesized therapeutics to treat sight-threatening posterior eye diseases, circumventing repeated invasive intravitreal injections and improving local drug availability clinically. Composite collagen-alginate (CAC) scaffold contains an interpenetrating network that integrates the physical and biological merits of its constituents, including biocompatibility, mild gelling properties and availability. However, CAC ECT properties and performance in the eye are not well-understood. Previously, we reported a cultured 3D CAC system that supported the growth of GDNF-secreting HEK293 cells with sustainable GDNF delivery. Here, the system was further developed into an intravitreally injectable gel with 1x10(4) or 2x10(5) cells encapsulated in 2mg/ml type I collagen and 1% alginate. Gels with lower alginate concentration yielded higher initial cell viability but faster spheroid formation while increasing initial cell density encouraged cell growth. Continuous GDNF delivery was detected in culture and in healthy rat eyes for at least 14 days. The gels were well-tolerated with no host tissue attachment and contained living cell colonies. Most importantly, gel-implanted in dystrophic Royal College of Surgeons rat eyes for 28 days retained photoreceptors while those containing higher initial cell number yielded better photoreceptor survival. CAC ECT gels offers flexible system design and is a potential treatment option for posterior eye diseases.	[Wong, Francisca S. Y.; Wong, Calvin C. H.; Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China; [Chan, Barbara P.] Univ Hong Kong, Fac Engn, Dept Mech Engn, Tissue Engn Lab, Hong Kong, Hong Kong, Peoples R China; [Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Lo, ACY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China.; Lo, ACY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China.	amylo@hku.hk	Lo, Amy C. Y./C-1195-2009; Chan, Barbara Pui/AAM-7767-2020	Lo, Amy C. Y./0000-0003-4239-6851; Chan, BP/0000-0001-5419-2472	Hong Kong Research Grant Council, GRF [HKU773613M]; University of Hong Kong Seed Funding Programme for Basic Research [201011159005]	Hong Kong Research Grant Council, GRF(Hong Kong Research Grants Council); University of Hong Kong Seed Funding Programme for Basic Research(University of Hong Kong)	Funded by Hong Kong Research Grant Council, http://www.ugc.edu.hk/eng/rgc/, Grant number: GRF #HKU773613M and The University of Hong Kong Seed Funding Programme for Basic Research, http://www.rss.hku.hk/fund/seed-basic, Grant number: 201011159005. Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberch J, 2002, BRAIN RES BULL, V57, P817, DOI 10.1016/S0361-9230(01)00775-4; Andrieu-Soler C, 2005, MOL VIS, V11; Baniasadi M, 2015, MATERIALS, V8, P799, DOI 10.3390/ma8020799; Baruch L, 2006, BIOPOLYMERS, V82, P570, DOI 10.1002/bip.20509; Bohari SPM, 2011, BIO-MED MATER ENG, V21, P159, DOI 10.3233/BME-2011-0665; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Brun-Graeppi AKAS, 2011, J CONTROL RELEASE, V149, P209, DOI 10.1016/j.jconrel.2010.09.023; Brundin P, 2002, BRAIN, V125, P2149, DOI 10.1093/brain/awf217; Buch PK, 2006, MOL THER, V14, P700, DOI 10.1016/j.ymthe.2006.05.019; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Capone SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062032; CHANG TMS, 1968, NATURE, V218, P243, DOI 10.1038/218243a0; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; da Cunha CB, 2014, BIOMATERIALS, V35, P8927, DOI 10.1016/j.biomaterials.2014.06.047; de Guzman RC, 2008, J MICROENCAPSUL, V25, P487, DOI 10.1080/02652040802054745; Durrschmid M, 2003, BIOTECHNOL BIOENG, V83, P681, DOI 10.1002/bit.10700; Ejstrup R, 2010, EXP EYE RES, V91, P890, DOI 10.1016/j.exer.2010.09.016; Gamm DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000338; Gregory-Evans K, 2009, MOL VIS, V15, P962; Ikeda T, 2002, INT J DEV NEUROSCI, V20, P555, DOI 10.1016/S0736-5748(02)00082-5; Ishikawa H, 2005, GENE THER, V12, P289, DOI 10.1038/sj.gt.3302277; Janoria KG, 2007, EXPERT OPIN DRUG DEL, V4, P371, DOI 10.1517/17425247.4.4.371; Jiang C, 2007, MOL VIS, V13, P1783; Kauper K, 2012, INVEST OPHTH VIS SCI, V53, P7484, DOI 10.1167/iovs.12-9970; Kolomeyer AM, 2014, SURV OPHTHALMOL, V59, P134, DOI 10.1016/j.survophthal.2013.09.004; Kyhn MV, 2009, EXP EYE RES, V89, P1012, DOI 10.1016/j.exer.2009.08.014; Lawrence JM, 2004, INVEST OPHTH VIS SCI, V45, P267, DOI 10.1167/iovs.03-0093; Lee M, 2009, BIOMATERIALS, V30, P1214, DOI 10.1016/j.biomaterials.2008.11.017; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Marsich E, 2008, J BIOMED MATER RES A, V84A, P364, DOI 10.1002/jbm.a.31307; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Patel NK, 2007, ACTA NEUROCHIR SUPPL, V97, P135; Read SP, 2010, MOL THER, V18, P1917, DOI 10.1038/mt.2010.167; Rokstad AMA, 2014, ADV DRUG DELIVER REV, V67-68, P111, DOI 10.1016/j.addr.2013.07.010; Sanftner LHM, 2001, MOL THER, V4, P622, DOI 10.1006/mthe.2001.0498; Sang L, 2010, J MATER SCI-MATER M, V21, P2561, DOI 10.1007/s10856-010-4117-2; Santos E, 2012, J CONTROL RELEASE, V158, P443, DOI 10.1016/j.jconrel.2011.09.079; Schwartz SG, 2014, EXPERT OPIN DRUG DEL, V11, P61, DOI 10.1517/17425247.2013.859135; Thanos CG, 2007, J BIOMED MATER RES A, V83A, P216, DOI 10.1002/jbm.a.31472; Thanos CG, 2004, TISSUE ENG, V10, P1617, DOI 10.1089/ten.2004.10.1617; Touchard E, 2012, GENE THER, V19, P886, DOI 10.1038/gt.2011.154; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Ward MS, 2007, J PHARM SCI-US, V96, P558, DOI 10.1002/jps.20629; Wong FSY, 2014, INT J MOL SCI, V15, P10669, DOI 10.3390/ijms150610669; Wong FSY, CURRENT TISSUE ENG, V4; Wong HL, 2007, BIOMATERIALS, V28, P5369, DOI 10.1016/j.biomaterials.2007.08.016; Wu WC, 2004, MOL VIS, V10, P93; Wu WC, 2002, INVEST OPHTH VIS SCI, V43, P3480; Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067	51	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159342	10.1371/journal.pone.0159342	http://dx.doi.org/10.1371/journal.pone.0159342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441692	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500057
J	Zhang, WY; Li, HF; Su, M; Lin, RF; Chen, XX; Zhang, P; Zou, CL				Zhang, Wen-Yi; Li, Hui-Fang; Su, Meng; Lin, Rui-Fang; Chen, Xing-Xing; Zhang, Ping; Zou, Chang-Lin			A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT	PLOS ONE			English	Article							SPINAL-CORD COMPRESSION; PROGNOSTIC SCORE; CANCER; CHEMOTHERAPY; RADIOTHERAPY; THERAPY	Objectives This study aimed to develop a scoring system to predict the survival time of patients with bone metastases after radiation therapy (RT). The scoring system can guide physicians to a better selection of appropriate treatment regimens. Materials and Methods The medical records of 125 patients with bone metastases treated with RT between January 2007 and September 2010 were reviewed retrospectively. Fifteen potential prognostic factors were investigated: sex, age, Karnofsky performance score (KPS), type of primary tumor, resection of tumor before bone metastases, interval between primary tumor diagnosis and diagnosis of bone metastases, Carcinoembryonic Antigen(CEA), lung metastases before bone metastases, liver metastases before bone metastases, brain metastases before bone metastases, stage, T, N, M, and degree of cellular differentiation. Results In an univariate analysis, 10 factors were significantly associated with survival time after bone metastasis: sex, KPS, breast cancer, esophageal cancer, colorectal cancer, interval between tumor diagnosis and diagnosis of bone metastases, CEA, lung metastases before bone metastases, T-staging, and differentiation. In a multivariate analysis, 7 factors were found to be significant: sex, KPS, esophageal cancer, colorectal cancer, interval between tumor diagnosis and diagnosis of bone metastases, T-staging, and differentiation. The median survival of all patients with bone metastases after RT was 14.1 months. There were significant differences in the median survival of patients with bone metastases after RT of 4.9 months, 10.5 months, and 29.7 months in groups 1, 2, and 3, respectively (P<0.001). Conclusion According to this scoring system, the survival time of patients after bone metastasis can be estimated.	[Zhang, Wen-Yi; Li, Hui-Fang; Su, Meng; Lin, Rui-Fang; Chen, Xing-Xing; Zhang, Ping; Zou, Chang-Lin] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiotherapy & Chemotherapy, Wenzhou, Peoples R China	Wenzhou Medical University	Zou, CL (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiotherapy & Chemotherapy, Wenzhou, Peoples R China.	zcl19670115@163.com						Byun WM, 2002, AM J NEURORADIOL, V23, P906; Chao ST, 2012, INT J RADIAT ONCOL, V82, P1738, DOI 10.1016/j.ijrobp.2011.02.019; Choi J, 2012, CANCER CONTROL, V19, P102, DOI 10.1177/107327481201900204; Fox P, 2013, BRIT J CANCER, V109, P147, DOI 10.1038/bjc.2013.300; HOSKIN PJ, 1995, PAIN, V63, P137, DOI 10.1016/0304-3959(95)00044-S; Lee YJ, 2014, SUPPORT CARE CANCER, V22, P1941, DOI 10.1007/s00520-014-2173-8; Li QQ, 2014, ASIAN PAC J CANCER P, V15, P945, DOI 10.7314/APJCP.2014.15.2.945; Lutz S, 2011, INT J RADIAT ONCOL, V79, P965, DOI 10.1016/j.ijrobp.2010.11.026; Nakayama M, 2015, HEAD NECK-J SCI SPEC, V37, P1745, DOI 10.1002/hed.23823; Nowicki A, 2015, WSPOLCZESNA ONKOL, V19, P333, DOI 10.5114/wo.2015.53249; Padhani A R, 2011, Cancer Imaging, V11 Spec No A, pS129, DOI 10.1102/1470-7330.2011.9034; Rades D, 2008, CANCER, V112, P157, DOI 10.1002/cncr.23150; Rades D, 2006, J CLIN ONCOL, V24, P3388, DOI 10.1200/JCO.2005.05.0542; Sharma K, 2008, INDIAN J PALLIAT CAR, V14, P7, DOI 10.4103/0973-1075.41924; Tassinari D, 2008, SUPPORT CARE CANCER, V16, P359, DOI 10.1007/s00520-007-0302-3; van den Hout WB, 2003, JNCI-J NATL CANCER I, V95, P222, DOI 10.1093/jnci/95.3.222; Wright AA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1219	17	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159506	10.1371/journal.pone.0159506	http://dx.doi.org/10.1371/journal.pone.0159506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438606	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100051
J	Villegas-Rodriguez, ME; Uribarri, J; Solorio-Meza, SE; Fajardo-Araujo, ME; Cai, WJ; Torres-Graciano, S; Rangel-Salazar, R; Wrobel, K; Garay-Sevilla, ME				Etzabel Villegas-Rodriguez, Ma.; Uribarri, Jaime; Solorio-Meza, Sergio E.; Fajardo-Araujo, Martha E.; Cai, Weijing; Torres-Graciano, Sofia; Rangel-Salazar, Ruben; Wrobel, Kazimierz; Eugenia Garay-Sevilla, Ma.			The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INTIMA-MEDIA THICKNESS; ENDOTHELIAL FUNCTION; ARTERIAL STIFFNESS; HEART-DISEASE; SOLUBLE FORM; SERUM-LEVELS; RECEPTOR; ATHEROSCLEROSIS; BIOMARKERS	Aim The purpose of the study was the simultaneous measurement of all the different components of the AGE-RAGE axis as well as several non-invasive markers of cardiovascular disease (CVD) in a cohort of newly diagnosed diabetic patients. Materials and Methods In 80 newly diagnosed diabetic patients we measured serum carboxymethyllysine (CML), soluble RAGE (sRAGE) and peripheral mononuclear (PMNC) RAGE and AGER1 mRNA together with ICAM-1, VCAM-1, and malondialdehyde (MDA). We also assessed cardiovascular function by measurement of flow-mediated vasodilation (FMD), intima-media thickness (IMT) and arterial stiffness. Univariant correlation analysis was used to determine correlation between the variables in the study and multiple regression analysis was used to examine the association between the AGE-RAGE axis components and FMD, IMT and arterial stiffness. Results Serum CML correlated positively with sRAGE, PMNC RAGE, HOMA-IR, ICAM-1, VCAM-1 and MDA, but inversely with PMNC AGER1. sRAGE and RAGE was positively correlated with AGER; IMT was positively correlated with HOMA-IR, ICAM-1, VCAM-1, MDA, and sRAGE and arterial stiffness had correlation with HOMA-IR, ICAM-1, VCAM-1, MDA, CML, sRAGE, AGER1 and RAGE. In multivariate analysis we found a significant relationship between CML with PMNC RAGE, HOMA-IR; sRAGE with VCAM-1 and MDA; PMNC RAGE with PMNC AGER1 and CML; PMNC AGER1 with PMNC RAGE; FMD with sRAGE, CML and HbA1c; IMT with sRAGE, and arterial stiffness with sRAGE, sCML and AGER1 Conclusions We found significant and strong associations between the different components of the AGE-RAGE axis and also found significant association between AGE-RAGE axis markers, especially sRAGE with several noninvasive markers of cardiovascular disease risk. sRAGE, an easily measured parameter in blood, may potentially be used as a surrogate marker of AGEs-RAGE in patients with diabetes.	[Etzabel Villegas-Rodriguez, Ma.; Fajardo-Araujo, Martha E.; Torres-Graciano, Sofia; Rangel-Salazar, Ruben; Eugenia Garay-Sevilla, Ma.] Dept Med Sci, Div Hlth Sci, Univ Guanajuato Campus, Guanajuato, Mexico; [Uribarri, Jaime; Cai, Weijing] Icahn Sch Med Mt Sinai, Dept Medicine, New York, NY 10029 USA; [Solorio-Meza, Sergio E.] Mexican Inst Social Secur, Guanajuato, Mexico; [Wrobel, Kazimierz] Univ Guanajuato, Dept Chem, Guanajuato, Guanajuato, Mexico	Universidad de Guanajuato; Icahn School of Medicine at Mount Sinai; Instituto Mexicano del Seguro Social; Universidad de Guanajuato	Garay-Sevilla, ME (corresponding author), Dept Med Sci, Div Hlth Sci, Univ Guanajuato Campus, Guanajuato, Mexico.	marugaray_2000@yahoo.com		Wrobel, Kazimierz/0000-0003-4357-3178; Solorio, Sergio/0000-0002-7501-6088	CONACYT Mexico [FOMIXGTO-2012-C03-195211]; University of Guanajuato (DAIP)	CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Guanajuato (DAIP)	This study has been supported by funds from CONACYT Mexico (FOMIXGTO-2012-C03-195211) and University of Guanajuato (DAIP 2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato M, 2007, EUR HEART J, V28, P2094, DOI 10.1093/eurheartj/ehm244; Arrebola-Moreno AL, 2012, REV ESP CARDIOL, V65, P80, DOI [10.1016/j.recesp.2011.09.012, 10.1016/j.rec.2011.10.004]; Basta G, 2008, ATHEROSCLEROSIS, V196, P9, DOI 10.1016/j.atherosclerosis.2007.07.025; Biswas SK, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/150325; Cai WJ, 2002, MOL MED, V8, P337, DOI 10.1007/BF03402014; Charakida M, 2010, EUR HEART J, V31, P2854, DOI 10.1093/eurheartj/ehq340; Chiang KH, 2009, CORONARY ARTERY DIS, V20, P267, DOI 10.1097/MCA.0b013e32832c459c; Colhoun HM, 2011, DIABETES, V60, P2379, DOI 10.2337/db11-0291; Di Pino A, 2014, DIABETES CARE, V37, P1447, DOI 10.2337/dc13-2357; Flore R, 2015, EUR REV MED PHARMACO, V19, P1430; Fujisawa K, 2013, ATHEROSCLEROSIS, V227, P425, DOI 10.1016/j.atherosclerosis.2013.01.016; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Kajikawa M, 2015, DIABETES CARE, V38, P119, DOI 10.2337/dc14-1435; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Lu B, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001990; Lu CY, 2004, P NATL ACAD SCI USA, V101, P11767, DOI 10.1073/pnas.0401588101; Mackenzie IS, 2002, QJM-INT J MED, V95, P67, DOI 10.1093/qjmed/95.2.67; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Montalcini T, 2014, AM J THER, V21, P535, DOI 10.1097/MJT.0b013e318255bc26; Nakamura K, 2007, CLIN EXP MED, V7, P188, DOI 10.1007/s10238-007-0146-7; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Pierzchalska M, 2007, J PHYSIOL PHARMACOL, V58, P207; Prasad K, 2014, INT J ANGIOL, V23, P11, DOI 10.1055/s-0033-1363423; Ramasamy R, 2012, VASC PHARMACOL, V57, P160, DOI 10.1016/j.vph.2012.06.004; Ruszkowska-Ciastek B, 2015, J ZHEJIANG UNIV-SC B, V16, P355, DOI 10.1631/jzus.B1400218; Sessa L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086903; Smriti Komal, 2016, J Oral Biol Craniofac Res, V6, P41, DOI 10.1016/j.jobcr.2015.12.004; Stirban A, 2014, MOL METAB, V3, P94, DOI 10.1016/j.molmet.2013.11.006; Tahara N, 2012, CARDIOVASC THER, V30, P42, DOI 10.1111/j.1755-5922.2010.00177.x; Tam XHL, 2011, CLIN SCI, V120, P81, DOI 10.1042/CS20100256; Timmis AD, 2001, HEART, V85, P463, DOI 10.1136/heart.85.4.463; Uribarri J, 2005, ANN NY ACAD SCI, V1043, P461, DOI 10.1196/annals.1333.052; Uribarri J, 2007, DIABETES CARE, V30, P2579, DOI 10.2337/dc07-0320; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Vlassara H, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0453-1; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Vlassara H, 2009, J CLIN ENDOCR METAB, V94, P4483, DOI 10.1210/jc.2009-0089; Wilk G, 2013, POL ARCH MED WEWN, V123, P443, DOI 10.20452/pamw.1879	38	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159175	10.1371/journal.pone.0159175	http://dx.doi.org/10.1371/journal.pone.0159175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434539	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600037
J	Harrington, BK; Gardner, HL; Izumi, R; Hamdy, A; Rothbaum, W; Coombes, KR; Covey, T; Kaptein, A; Gulrajani, M; Van Lith, B; Krejsa, C; Coss, CC; Russell, DS; Zhang, XL; Urie, BK; London, CA; Byrd, JC; Johnson, AJ; Kisseberth, WC				Harrington, Bonnie K.; Gardner, Heather L.; Izumi, Raquel; Hamdy, Ahmed; Rothbaum, Wayne; Coombes, Kevin R.; Covey, Todd; Kaptein, Allard; Gulrajani, Michael; Van Lith, Bart; Krejsa, Cecile; Coss, Christopher C.; Russell, Duncan S.; Zhang, Xiaoli; Urie, Bridget K.; London, Cheryl A.; Byrd, John C.; Johnson, Amy J.; Kisseberth, William C.			Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BRUTON TYROSINE KINASE; GERMINAL CENTER; IBRUTINIB; SURVIVAL; PCI-32765; ANTIGEN; CLL; ACTIVATION; ONCOLOGY	Acalabrutinib (ACP-196) is a second-generation inhibitor of Bruton agammaglobulinemia tyrosine kinase (BTK) with increased target selectivity and potency compared to ibrutinib. In this study, we evaluated acalabrutinib in spontaneously occurring canine lymphoma, a model of B-cell malignancy similar to human diffuse large B-cell lymphoma (DLBCL). First, we demonstrated that acalabrutinib potently inhibited BTK activity and downstream effectors in CLBL1, a canine B-cell lymphoma cell line, and primary canine lymphoma cells. Acalabrutinib also inhibited proliferation in CLBL1 cells. Twenty dogs were enrolled in the clinical trial and treated with acalabrutinib at dosages of 2.5 to 20mg/kg every 12 or 24 hours. Acalabrutinib was generally well tolerated, with adverse events consisting primarily of grade 1 or 2 anorexia, weight loss, vomiting, diarrhea and lethargy. Overall response rate (ORR) was 25% (5/20) with a median progression free survival (PFS) of 22.5 days. Clinical benefit was observed in 30% (6/20) of dogs. These findings suggest that acalabrutinib is safe and exhibits activity in canine B-cell lymphoma patients and support the use of canine lymphoma as a relevant model for human non-Hodgkin lymphoma (NHL).	[Harrington, Bonnie K.; London, Cheryl A.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Gardner, Heather L.; London, Cheryl A.; Kisseberth, William C.] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Izumi, Raquel; Hamdy, Ahmed; Rothbaum, Wayne; Covey, Todd; Kaptein, Allard; Gulrajani, Michael; Van Lith, Bart; Krejsa, Cecile] Acerta Pharma BV, Oss, Netherlands; [Coombes, Kevin R.] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA; [Coss, Christopher C.] Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA; [Russell, Duncan S.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Zhang, Xiaoli] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Urie, Bridget K.] Pittsburgh Vet Specialty & Emergency Ctr, Pittsburgh, PA USA; [Byrd, John C.; Johnson, Amy J.] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Oregon State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kisseberth, WC (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA.; Johnson, AJ (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA.	amy.johnson@osumc.edu; kisseberth.2@osu.edu	Kisseberth, William/A-2587-2013	Harrington, Bonnie/0000-0003-2658-6188; Coss, Christopher/0000-0002-8184-9190	NIH [R35 CA197734, R01 CA177292, T32CA009338]; D. Warren Brown Foundation; CLL Research Consortium (CRC) [P01 CA081534]; OSU Comprehensive Cancer Center Support Grant from the National Center for Advancing Translational Sciences [P30 CA016058, UL1TR001070]; Acerta Pharma; NATIONAL CANCER INSTITUTE [R35CA197734, T32CA009338, P30CA016058, R01CA177292, P01CA081534] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); D. Warren Brown Foundation; CLL Research Consortium (CRC); OSU Comprehensive Cancer Center Support Grant from the National Center for Advancing Translational Sciences; Acerta Pharma; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work is supported by NIH R35 CA197734, R01 CA177292, Oncology T32 Training Grant T32CA009338, the D. Warren Brown Foundation, CLL Research Consortium (CRC) P01 CA081534, OSU Comprehensive Cancer Center Support Grant P30 CA016058, UL1TR001070 from the National Center for Advancing Translational Sciences, and a grant from Acerta Pharma. Acerta Pharma provided financial and technical support for the canine clinical trial. Acerta Pharma provided support in the form of salaries for authors Raquel Izumi, Ahmed Hamdy, Allard Kaptein, Michael Gulrajani, Bart Van Lith, Todd Covey, Wayne Rothbaum, and Cecile Krejsa, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work is supported by NIH R35 CA197734, R01 CA177292, NIH T32CA009338, the D. Warren Brown Foundation, CLL Research Consortium (CRC) P01 CA081534, OSU Comprehensive Cancer Center Support Grant P30 CA016058, and UL1TR001070 from the National Center for Advancing Translational Sciences. We would also like to acknowledge the staff of the Veterinary Clinical Research Support Shared Resource and the Comparative Pathology and Mouse Phenotyping Shared Resource at The Ohio State University College of Veterinary Medicine for their efforts in this publication. Funding for the clinical trial associated with this manuscript was provided by Acerta Pharma.	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Agero ALC, 2006, J AM ACAD DERMATOL, V55, P657, DOI 10.1016/j.jaad.2005.10.010; [Anonymous], WHO CLASS TUM HAEM L; Benito JM, 2012, BLOOD, V120; Burger JA, 2013, TRENDS IMMUNOL, V34, P592, DOI 10.1016/j.it.2013.07.002; Burnett RC, 2003, VET PATHOL, V40, P32, DOI 10.1354/vp.40-1-32; Byrd JC, 1998, BLOOD, V92, P3804, DOI 10.1182/blood.V92.10.3804; Byrd JC, 2016, NEW ENGL J MED, V374, P323, DOI 10.1056/NEJMoa1509981; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; Chen SS, 2016, LEUKEMIA, V30, P833, DOI 10.1038/leu.2015.316; Cheng S, 2014, LEUKEMIA, V28, P649, DOI 10.1038/leu.2013.358; Chu CC, 2008, BLOOD, V112, P5122, DOI 10.1182/blood-2008-06-162024; Cinar M, 2013, LEUKEMIA RES, V37, P1271, DOI 10.1016/j.leukres.2013.07.028; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Covey T, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2596; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; EBELING SB, 1993, BLOOD, V82, P1626; Ettinger SN, 2003, CLIN TECH SMALL AN P, V18, P92, DOI 10.1053/svms.2003.36622; Frantz AM, 2013, VET PATHOL, V50, P693, DOI 10.1177/0300985812465325; Gao W, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju204; Gordon IK, 2010, ILAR J, V51, P214, DOI 10.1093/ilar.51.3.214; Hadzidimitriou A, 2011, BLOOD, V118, P3088, DOI 10.1182/blood-2011-03-343434; Harandi A, 2009, J ONCOL, V2009, DOI 10.1155/2009/567486; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Herman SEM, 2010, BLOOD, V116, P2078, DOI 10.1182/blood-2010-02-271171; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Hoogeboom R, 2013, J EXP MED, V210, P59, DOI 10.1084/jem.20121801; Khurana D, 2007, J IMMUNOL, V178, P3575, DOI 10.4049/jimmunol.178.6.3575; Kohrt HE, 2014, BLOOD, V123, P1957, DOI 10.1182/blood-2014-01-547869; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; London CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087585; London CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027018; Messmer BT, 2004, J EXP MED, V200, P519, DOI 10.1084/jem.20040544; Morges MA, 2014, J VET INTERN MED, V28, P1569, DOI 10.1111/jvim.12429; Mudaliar MAV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072591; Mueller A, 2005, AM J PATHOL, V167, P797, DOI 10.1016/S0002-9440(10)62052-4; Myklebust JH, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.1768.1768; Nguyen SM, 2015, VET COMP ONCOL, V13, P176, DOI 10.1111/vco.12032; O'Brien S, 2014, LANCET ONCOL, V15, P48, DOI 10.1016/S1470-2045(13)70513-8; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Richards KL, 2013, CANCER RES, V73, P5029, DOI 10.1158/0008-5472.CAN-12-3546; Rutgen BC, 2010, LEUKEMIA RES, V34, P932, DOI 10.1016/j.leukres.2010.01.021; Sachen KL, 2012, BLOOD, V120, P4182, DOI 10.1182/blood-2012-05-427534; Sivina M., 2012, BLOOD, V120, P1802, DOI [10.1182/blood.V120.21.1802.1802, DOI 10.1182/BLOOD.V120.21.1802.1802]; Vail DM, 2004, CANC DRUG DISC DEV, P259; Veterinary Co-operative Oncology Group (VCOG), 2004, Vet Comp Oncol, V2, P195, DOI 10.1111/j.1476-5810.2004.0053b.x; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Wilson WH, 2015, NAT MED, V21, P922, DOI 10.1038/nm.3884; Zheng XH, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-32	51	43	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159607	10.1371/journal.pone.0159607	http://dx.doi.org/10.1371/journal.pone.0159607			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434128	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600076
J	Brunisholz, KD; Joy, EA; Hashibe, M; Gren, LH; Savitz, LA; Hamilton, S; Cannon, W; Kim, J				Brunisholz, Kimberly D.; Joy, Elizabeth A.; Hashibe, Mia; Gren, Lisa H.; Savitz, Lucy A.; Hamilton, Sharon; Cannon, Wayne; Kim, Jaewhan			Incidental Risk of Type 2 Diabetes Mellitus among Patients with Confirmed and Unconfirmed Prediabetes	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; PREVENTION PROGRAM; DIAGNOSIS; PEOPLE	Objective To determine the risk of type 2 diabetes (T2DM) diagnosis among patients with confirmed and unconfirmed prediabetes (preDM) relative to an at-risk group receiving care from primary care physicians over a 5-year period. Study Design Utilizing data from the Intermountain Healthcare (IH) Enterprise Data Warehouse (EDW) from 2006-2013, we performed a prospective analysis using discrete survival analysis to estimate the time to diagnosis of T2DM among groups. Population Studied Adult patients who had at least one outpatient visit with a primary care physician during 2006-2008 at an IH clinic and subsequent visits through 2013. Patients were included for the study if they were (a) at-risk for diabetes (BMI >= 25 kg/m2 and one additional risk factor: high risk ethnicity, first degree relative with diabetes, elevated triglycerides or blood pressure, low HDL, diagnosis of gestational diabetes or polycystic ovarian syndrome, or birth of a baby weighing >9 lbs); or (b) confirmed preDM (HbA1c >= 5.7-6.49% or fasting blood glucose 100-125 mg/dL); or (c) unconfirmed preDM (documented fasting lipid panel and glucose 100-125 mg/dL on the same day). Principal Findings Of the 33,838 patients who were eligible for study, 57.0% were considered at-risk, 38.4% had unconfirmed preDM, and 4.6% had confirmed preDM. Those with unconfirmed and confirmed preDM tended to be Caucasian and a greater proportion were obese compared to those at-risk for disease. Patients with unconfirmed and confirmed preDM tended to have more prevalent high blood pressure and depression as compared to the at-risk group. Based on the discrete survival analyses, patients with unconfirmed preDM and confirmed preDM were more likely to develop T2DM when compared to at-risk patients. Conclusions Unconfirmed and confirmed preDM are strongly associated with the development of T2DM as compared to patients with only risk factors for disease.	[Brunisholz, Kimberly D.; Savitz, Lucy A.] Intermt Healthcare, Inst Healthcare Delivery Res, Salt Lake City, UT USA; [Brunisholz, Kimberly D.; Hashibe, Mia; Gren, Lisa H.; Kim, Jaewhan] Univ Utah, Sch Med, Div Publ Hlth, Salt Lake City, UT USA; [Brunisholz, Kimberly D.; Hamilton, Sharon; Cannon, Wayne] Intermt Healthcare, Primary Care Clin Program, Salt Lake City, UT USA; [Brunisholz, Kimberly D.; Joy, Elizabeth A.] Intermt Healthcare, Res Off, Salt Lake City, UT USA	Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Intermountain Healthcare; Intermountain Medical Center	Brunisholz, KD (corresponding author), Intermt Healthcare, Inst Healthcare Delivery Res, Salt Lake City, UT USA.; Brunisholz, KD (corresponding author), Univ Utah, Sch Med, Div Publ Hlth, Salt Lake City, UT USA.; Brunisholz, KD (corresponding author), Intermt Healthcare, Primary Care Clin Program, Salt Lake City, UT USA.; Brunisholz, KD (corresponding author), Intermt Healthcare, Res Off, Salt Lake City, UT USA.	kim.brunisholz@imail.org						Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; American Diabetes Association, 2014, DIABETES CARE S1, V37, pS16; Bansal N, 2015, WORLD J DIABETES, V6, P296, DOI 10.4239/wjd.v6.i2.296; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bray GA, 2012, DIABETES CARE, V35, P731, DOI 10.2337/dc11-1299; Garber AJ, 2012, DIABETES OBES METAB, V14, P399, DOI 10.1111/j.1463-1326.2011.01536.x; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Healthcare Intermountain, 2001, OUTP MAN AD DIAB MEL, P1; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Herman WH, 2012, DIABETES CARE, V35, P723, DOI 10.2337/dc11-1468; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; National Audit Office, 2009, POW PREV CHRON DIS P, P1; National Center for Chronic Disease Prevention and Health Promotion, 2012, DIAB REP CARD 2012; National Committee for Quality Assurance (NCQA), 2013, HEDIS 2014 HEALTHC E, P1; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Sheehy AM, 2010, MAYO CLIN PROC, V85, P27, DOI 10.4065/mcp.2009.0289; Tuomilehto H, 2009, DIABETES CARE, V32, P1965, DOI 10.2337/dc08-1980; Utah Department of Health, 2012, UT HLTH STAT UPD UNC; Warram JH, 1996, DIABETIC MED, V13, pS40; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	22	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0157729	10.1371/journal.pone.0157729	http://dx.doi.org/10.1371/journal.pone.0157729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427913	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169300005
J	Ma, WSP; Pun, TC				Ma, Wai Sze Paulin; Pun, Ting Chung			Prevalence of Domestic Violence in Hong Kong Chinese Women Presenting with Urinary Symptoms	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; SEXUAL-ABUSE; DETRUSOR INSTABILITY; OVERACTIVE BLADDER; GYNECOLOGY PATIENTS; TRACT SYMPTOMS; MENTAL-HEALTH; INCONTINENCE; ASSOCIATION; DYSFUNCTION	Objectives To determine the prevalence of domestic violence and its risk factors in women presenting with urinary symptoms. Methods The study was carried out in the urogynecology clinic and general gynecology clinic, Department of Obstetrics and Gynecology, Queen Mary Hospital, Hong Kong from 1st May 2013 till 31st October 2014. Two hundred and twenty-five women presenting to the urogynecology clinic with urinary symptoms were categorized according to their symptoms and were asked to complete the Modified Abuse Assessment Screen. Demographic data of the subjects and their partners were collected. Mann-Whitney U test were used for analysis of continuous variables, while Chi-square test and Fisher Exact test were used for analysis of categorical variables between the abused and non-abused group. Prevalence of domestic violence were calculated and compared. Results The prevalence of domestic violence among this group of patients (7.6%) was found to be lower when compared with other studies. Verbal abuse was the commonest form of violence in our locality. The median age of the abused group and the non-abused group were both 56 years old, with the age ranging from 40 to 64 and 29 to 70 years old respectively. The prevalence of domestic violence among patients with overactive bladder syndrome, stress urinary incontinence and mixed urinary incontinence were 19.5%, 4.2% and 5.5% respectively (Fisher Exact test for whole group, P<0.05). Conclusion The prevalence and nature of abuse in our locality was different from the quoted figures worldwide. Patients with overactive bladder syndrome were more likely to be victims of abuse than patients with other urinary symptoms. The difference in the prevalence of domestic violence among patients with different urinary symptoms could be related to their underlying pathophysiology. When encountering patients with overactive bladder syndrome, clinicians should consider this high incidence of domestic violence and provide prompt referral whenever necessary.	[Ma, Wai Sze Paulin; Pun, Ting Chung] Queen Mary Hosp, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Ma, WSP (corresponding author), Queen Mary Hosp, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China.	mawsp@hotmail.com						Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; [Anonymous], LONG TERM CONS CHILD; Ates E, 2014, NEUROUROL URODYN; Ben-Dror I, 2012, INT UROGYNECOL J, V23, P1081, DOI 10.1007/s00192-012-1738-7; Bonomi AE, 2009, ARCH INTERN MED, V169, P1692, DOI 10.1001/archinternmed.2009.292; Coker A L, 2001, J Am Med Womens Assoc (1972), V56, P19; Coker AL, 2000, AM J PUBLIC HEALTH, V90, P553, DOI 10.2105/AJPH.90.4.553; DeLago C, 2008, PEDIATRICS, V122, pE281, DOI 10.1542/peds.2008-0450; Elliott B A, 1995, Arch Fam Med, V4, P113; FREEMAN RM, 1985, UROL INT, V40, P257, DOI 10.1159/000281094; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Hathaway JE, 2000, AM J PREV MED, V19, P302, DOI 10.1016/S0749-3797(00)00236-1; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Heise L., 2002, WORLD REPORT VIOLENC, V1, P87, DOI DOI 10.1503/CMAJ.1150071; Hensel G, 2014, GEBURTSH FRAUENHEILK, V74, P63, DOI 10.1055/s-0033-1351073; Hsiao SM, 2014, MATURITAS, V79, P65, DOI 10.1016/j.maturitas.2014.06.001; Jewkes R, 2000, INT CLIN PSYCHOPHARM, V15, pS37; Johnson JK, 2007, EUR J OBSTET GYN R B, V133, P95, DOI 10.1016/j.ejogrb.2006.04.035; Jundt K, 2007, INT UROGYNECOL J, V18, P449, DOI 10.1007/s00192-006-0173-z; Jung SY, 1999, J UROLOGY, V162, P204, DOI 10.1097/00005392-199907000-00069; KARLSON S, 1953, Acta Obstet Gynecol Scand, V32, P285; Lai HH, 2016, NEUROUROL URODYNAM, V35, P1017, DOI 10.1002/nau.22872; Lee YS, 2014, J ELDER ABUSE NEGL, V26, P244, DOI 10.1080/08946566.2013.820656; Leithner K, 2009, EUR J OBSTET GYN R B, V144, P168, DOI 10.1016/j.ejogrb.2009.03.003; Leung TW, 2002, INT J GYNECOL OBSTET, V77, P47, DOI 10.1016/S0020-7292(01)00596-3; Leung WC, 1999, INT J GYNECOL OBSTET, V66, P23, DOI 10.1016/S0020-7292(99)00053-3; Link CL, 2007, EUR UROL, V52, P397, DOI 10.1016/j.eururo.2007.03.024; Ma PWS, 2011, HONG KONG J GYNAECOL, V11, P13; MCCAULEY J, 1995, ANN INTERN MED, V123, P737, DOI 10.7326/0003-4819-123-10-199511150-00001; Moreno CG, UNDERSTANDING ADDRES; Naved RT, 2012, J HEALTH POPUL NUTR, V30, P181, DOI 10.3329/jhpn.v30i2.11312; NORTON KRW, 1990, BRIT MED J, V301, P271, DOI 10.1136/bmj.301.6746.271; Peterman A, 2009, SOC SCI MED, V68, P971, DOI 10.1016/j.socscimed.2008.12.006; Pico-Alfonso MA, 2004, BIOL PSYCHIAT, V56, P233, DOI 10.1016/j.biopsych.2004.06.001; Pikarinen U, 2007, OBSTET GYNECOL, V109, P1116, DOI 10.1097/01.AOG.0000259906.16474.86; Romito P, 2005, SOC SCI MED, V60, P1717, DOI 10.1016/j.socscimed.2004.08.026; VEREECKEN RL, 1989, PSYCHOTHER PSYCHOSOM, V51, P128, DOI 10.1159/000288146; WALTERS MD, 1990, OBSTET GYNECOL, V75, P22; Yildirim A, 2011, UROL J, V8, P38; Yip SK, 2003, INT UROGYNECOL J, V14, P27, DOI 10.1007/s00192-002-1003-6; Yoshioka M. R., 2000, ASIAN FAMILY VIOLENC; Zhao PT, 2015, J UROLOGY, V193, P1743, DOI 10.1016/j.juro.2014.08.123	43	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159367	10.1371/journal.pone.0159367	http://dx.doi.org/10.1371/journal.pone.0159367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428060	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169300058
J	Qiu, JJ; Guan, JQ; Yang, XC; Wu, J; Liu, GY; Di, GH; Chen, CM; Hou, YF; Han, QX; Shen, ZZ; Shao, ZM; Hu, Z				Qiu, Jiajia; Guan, Jiaqin; Yang, Xiaochen; Wu, Jiong; Liu, Guangyu; Di, Genhong; Chen, Canming; Hou, Yifeng; Han, Qixia; Shen, Zhenzhou; Shao, Zhimin; Hu, Zhen			Quality of Life and Psychological State in Chinese Breast Cancer Patients Who Received BRCA1/2 Genetic Testing	PLOS ONE			English	Article							IMPACT; WOMEN; DISTRESS	Background This study aims to understand the quality of life (QOL) and psychological state (PS) of Chinese breast cancer patients who received BRCA1/2 genetic testing; to examine the psychological changes between BRCA1/2 mutation carriers and non-carriers; and to further explore the psychological experience of BRCA1/2 mutation carriers. Methods This study was combined with quantitative and qualitative designs. First, we performed a quantitative investigation using FACT-B (Chinese version) and Irritability, Depression and Anxiety scale (IDA) to assess the QOL and PS in breast cancer patients who received BRCA1/2 genetic testing. Then semi-structured in-depth qualitative interviews among 13 mutation carriers were conducted in hospital. Results Results from the quantitative study showed QOL scores were relatively high and the IDA scores were relatively low among the patients, and there was no significant difference in the QOL or IDA scores between non-carriers and carriers. Based on the qualitative analysis, four main themes emerged: (1) Finding the reason for having breast cancer; (2) Negative emotions; (3) Behavioral changes; (4) Lack of information. Conclusions The present study showed that QOL and PS are good among the breast cancer patients who received genetic testing. Genetic testing itself does not cause long psychosocial effects. BRCA1/2 mutation carriers may have certain negative emotions at the first stage they knew the testing results and may initiate behavioral and lifestyle changes. The patients with a BRCA1/2 mutation desire knowledge with regard to genetic aspects in mainland China. Professional information and advice can be provided to relieve the patients' negative emotions when they were informed of gene defect.	[Qiu, Jiajia; Guan, Jiaqin] Fudan Univ, Shanghai Canc Ctr, Dept Nursing Adm, Shanghai, Peoples R China; [Yang, Xiaochen; Wu, Jiong; Liu, Guangyu; Di, Genhong; Chen, Canming; Hou, Yifeng; Han, Qixia; Shen, Zhenzhou; Shao, Zhimin; Hu, Zhen] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai, Peoples R China; [Qiu, Jiajia; Guan, Jiaqin; Yang, Xiaochen; Wu, Jiong; Liu, Guangyu; Di, Genhong; Chen, Canming; Hou, Yifeng; Han, Qixia; Shen, Zhenzhou; Shao, Zhimin; Hu, Zhen] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Hu, Z (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai, Peoples R China.; Hu, Z (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.	zhenhu@fudan.edu.cn		Di, Genhong/0000-0003-1171-7907	Shanghai Committee of Science and Technology Funds [14441901402]	Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee)	This work is supported by the Shanghai Committee of Science and Technology Funds (http://www.stcsm.gov.cn/) grant 14441901402. ZH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardern-Jones A, 2010, HERED CANCER CLIN PR, V8, DOI 10.1186/1897-4287-8-1; Bredart A, 2013, BRIT J CANCER, V108, P1012, DOI 10.1038/bjc.2012.599; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Colaizzi Paul, 1978, EXISTENTIAL PHENOMEN, P48; Graves KD, 2012, CANCER EPIDEM BIOMAR, V21, P445, DOI 10.1158/1055-9965.EPI-11-0991; Hamilton R, 2013, ADV NURS SCI, V36, pE41, DOI 10.1097/ANS.0b013e3182901ff1; Hooker GW, 2014, HERED CANCER CLIN PR, V12, DOI 10.1186/1897-4287-12-9; Hoskins LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087696; Kwong A, 2012, ASIAN PAC J CANCER P, V13, P2241, DOI 10.7314/APJCP.2012.13.5.2241; Meiser B, 2005, PSYCHO-ONCOL, V14, P1060, DOI 10.1002/pon.933; Roussi P, 2010, PSYCHOL HEALTH, V25, P401, DOI 10.1080/08870440802660884; Schlich-Bakker KJ, 2008, BREAST CANCER RES TR, V109, P507, DOI 10.1007/s10549-007-9680-y; Smith AW, 2008, PSYCHO-ONCOL, V17, P767, DOI 10.1002/pon.1291; SNAITH RP, 1985, BRIT J PSYCHIAT, V147, P127, DOI 10.1192/bjp.147.2.127; Song Chuan-gui, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P27; Uyei A, 2006, CANCER-AM CANCER SOC, V107, P2745, DOI 10.1002/cncr.22352; Wan C., 2002, CHINA CANC, V11, P318; [万崇华 Wan Chonghua], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P298; Xue CY, 2008, SHANGHAI ARCH PSYCHI, V20, P352; Yang XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125571; Yuan Y., 2002, SICHUAN MENT HLTH, V15, P11	21	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158531	10.1371/journal.pone.0158531	http://dx.doi.org/10.1371/journal.pone.0158531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27428375	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300012
J	Chen, LH; Huang, YN; Xu, M; Cheng, ZX; Zhang, DS; Zheng, JG				Chen, Linghua; Huang, Yining; Xu, Ming; Cheng, Zuxin; Zhang, Dasheng; Zheng, Jingui			iTRAQ-Based Quantitative Proteomics Analysis of Black Rice Grain Development Reveals Metabolic Pathways Associated with Anthocyanin Biosynthesis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SATIVA L. INDICA; ARABIDOPSIS-THALIANA; GRAPE BERRY; EXPRESSION ANALYSIS; GENE-EXPRESSION; WHEAT-GRAIN; PLANTS; SUGAR; TEMPERATURE	Background Black rice (Oryza sativa L.), whose pericarp is rich in anthocyanins (ACNs), is considered as a healthier alternative to white rice. Molecular species of ACNs in black rice have been well documented in previous studies; however, information about the metabolic mechanisms underlying ACN biosynthesis during black rice grain development is unclear. Results The aim of the present study was to determine changes in the metabolic pathways that are involved in the dynamic grain proteome during the development of black rice indica cultivar, (Oryza sativa L. indica var. SSP). Isobaric tags for relative and absolute quantification (iTRAQ) MS/MS were employed to identify statistically significant alterations in the grain proteome. Approximately 928 proteins were detected, of which 230 were differentially expressed throughout 5 successive developmental stages, starting from 3 to 20 days after flowering (DAF). The greatest number of differentially expressed proteins was observed on 7 and 10 DAF, including 76 proteins that were upregulated and 39 that were downregulated. The biological process analysis of gene ontology revealed that the 230 differentially expressed proteins could be sorted into 14 functional groups. Proteins in the largest group were related to metabolic process, which could be integrated intomultiple biochemical pathways. Specifically, proteins with a role in ACN biosynthesis, sugar synthesis, and the regulation of gene expression were upregulated, particularly from the onset of black rice grain development and during development. In contrast, the expression of proteins related to signal transduction, redox homeostasis, photosynthesis and N-metabolism decreased during grainmaturation. Finally, 8 representative genes encoding different metabolic proteins were verified via quantitative real-time polymerase chain reaction (qRT-PCR) analysis, these genes had differed in transcriptional and translational expression during grain development. Conclusions Expression analyses of metabolism-related protein groups belonging to different functional categories and subcategories indicated that significantly upregulated proteins were related to flavonoid and starch synthesis. On the other hand, the downregulated proteins were determined to be related to nitrogen metabolism, as well as other functional categories and subcategories, including photosynthesis, redox homeostasis, tocopherol biosynthetic, and signal transduction. The results provide valuable new insights into the characterization and understanding of ACN pigment production in black rice.	[Chen, Linghua; Huang, Yining; Xu, Ming; Cheng, Zuxin; Zheng, Jingui] FujianAgr & Forestry Univ, Fuzhou, Fujian, Peoples R China; [Chen, Linghua] Fujian Agr & Forestry Univ, Jinshan Coll, Fuzhou, Fujian, Peoples R China; [Huang, Yining] Zhangzhou Inst Technol, Dept Food & Biol Engn, Zhangzhou, Fujian, Peoples R China; [Xu, Ming; Cheng, Zuxin; Zheng, Jingui] Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Fujian, Peoples R China; [Zhang, Dasheng] Chinese Acad Sci, Shanghai Chenshan Bot Garden, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China; [Zhang, Dasheng] Shanghai Key Lab Plant Funct Genom & Resources, Shanghai, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zheng, JG (corresponding author), FujianAgr & Forestry Univ, Fuzhou, Fujian, Peoples R China.; Zheng, JG (corresponding author), Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Fujian, Peoples R China.	jinguizheng@126.com		Zheng, Jingui/0000-0003-4976-9024	National Key Technology RD Program [2013BAD01B05]; Science and Technology Innovation Platform Development Program of Fujian Agriculture and Forestry University [PTJH13001, PTJH12015]	National Key Technology RD Program(National Key Technology R&D Program); Science and Technology Innovation Platform Development Program of Fujian Agriculture and Forestry University	This work was supported by the National Key Technology R&D Program (2013BAD01B05) and the Science and Technology Innovation Platform Development Program of Fujian Agriculture and Forestry University (PTJH13001, PTJH12015).; This work was supported by the National Key Technology R&D Program (2013BAD01B05) and the Science and Technology Innovation Platform Development Program of Fujian Agriculture and Forestry University (PTJH13001, PTJH12015). We gratefully acknowledge Shanghai Omicsspace Biotechnology Co. Ltd. for technical assistance with the peptide/protein identification.	Abdel-Aal ESM, 2006, J AGR FOOD CHEM, V54, P4696, DOI 10.1021/jf0606609; Abdel-Aal ESM, 1999, CEREAL CHEM, V76, P350, DOI 10.1094/CCHEM.1999.76.3.350; Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Baier M, 2004, PLANT PHYSIOL, V134, P81, DOI 10.1104/pp.103.031674; BUDDE RJA, 1990, P NATL ACAD SCI USA, V87, P673, DOI 10.1073/pnas.87.2.673; Cahoon EB, 2003, NAT BIOTECHNOL, V21, P1082, DOI 10.1038/nbt853; Calvino M, 2008, RICE, V1, P166, DOI 10.1007/s12284-008-9012-9; Chen JZ, 2008, PROTEOM CLIN APPL, V2, P585, DOI 10.1002/prca.200780006; Chong PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082622; CHRISTIE PJ, 1994, PLANTA, V194, P541, DOI 10.1007/BF00714468; Chu P, 2015, J PROTEOMICS, V113, P244, DOI 10.1016/j.jprot.2014.10.005; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; D'Ambrosio C, 2013, J PROTEOMICS, V78, P39, DOI 10.1016/j.jprot.2012.11.008; Dai SJ, 2007, MOL CELL PROTEOMICS, V6, P207, DOI 10.1074/mcp.M600146-MCP200; Di Carli M, 2011, J PROTEOME RES, V10, P429, DOI 10.1021/pr1005313; Ding M, 2006, J BIOL CHEM, V281, P17359, DOI 10.1074/jbc.M600861200; Dong MH, 2014, J PROTEOMICS, V109, P382, DOI 10.1016/j.jprot.2014.07.001; Du C, 2014, J PROTEOME RES, V13, P720, DOI 10.1021/pr400803w; Faurobert M, 2007, PLANT PHYSIOL, V143, P1327, DOI 10.1104/pp.106.092817; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Guo HH, 2007, PLANT FOOD HUM NUTR, V62, P1, DOI 10.1007/s11130-006-0031-7; He DL, 2011, PROTEOMICS, V11, P2693, DOI 10.1002/pmic.201000598; He F, 2008, MOLECULES, V13, P2674, DOI 10.3390/molecules13102674; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hiemori M, 2009, J AGR FOOD CHEM, V57, P1908, DOI 10.1021/jf803153z; Hii S.L., 2012, ENZYME RES, V2012; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hou DX, 2004, J BIOMED BIOTECHNOL, P321, DOI 10.1155/S1110724304403040; Hu C, 2003, J AGR FOOD CHEM, V51, P5271, DOI 10.1021/jf034466n; Ichikawa Haruyo, 2001, J Med Food, V4, P211, DOI 10.1089/10966200152744481; Ishimaru T, 2003, FUNCT PLANT BIOL, V30, P1139, DOI 10.1071/FP03122; Jia LG, 2013, ANN BOT-LONDON, V111, P839, DOI 10.1093/aob/mct045; Martinez-Esteso MJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-167; Martinez-Esteso MJ, 2011, J EXP BOT, V62, P2521, DOI 10.1093/jxb/erq434; Kambiranda D, 2014, J PROTEOME RES, V13, P555, DOI 10.1021/pr400731p; KEELING PL, 1988, PLANT PHYSIOL, V87, P311, DOI 10.1104/pp.87.2.311; Kim BG, 2007, J PLANT BIOL, V50, P156, DOI 10.1007/BF03030624; Kim CK, 2011, J APPL GENET, V52, P161, DOI 10.1007/s13353-011-0027-3; Kwon SH, 2007, J MED FOOD, V10, P552, DOI 10.1089/jmf.2006.147; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li Y, 2008, J INTEGR PLANT BIOL, V50, P1057, DOI 10.1111/j.1744-7909.2008.00689.x; Lin SK, 2005, PROTEOMICS, V5, P2140, DOI 10.1002/pmic.200401105; Lin YK, 1996, PLANT CELL, V8, P293, DOI 10.1105/tpc.8.2.293; Lo Piero AR, 2005, J AGR FOOD CHEM, V53, P9083, DOI 10.1021/jf051609s; Lucker J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-50; Ma CY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1029; Marondedze C, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.39; Matsumoto H, 2003, J AGR FOOD CHEM, V51, P3560, DOI 10.1021/jf034132y; McClung CR, 2000, PLANT PHYSIOL, V123, P381, DOI 10.1104/pp.123.1.381; Millar AA, 1998, PLANT CELL, V10, P1889, DOI 10.1105/tpc.10.11.1889; Miron D, 2000, PLANT PHYSIOL, V123, P655, DOI 10.1104/pp.123.2.655; Mita S, 1997, PLANT PHYSIOL, V114, P575, DOI 10.1104/pp.114.2.575; Moon H, 2003, P NATL ACAD SCI USA, V100, P358, DOI 10.1073/pnas.252641899; Mori K, 2005, SCI HORTIC-AMSTERDAM, V105, P319, DOI 10.1016/j.scienta.2005.01.032; Munne-Bosch S, 2005, NEW PHYTOL, V166, P363, DOI 10.1111/j.1469-8137.2005.01411.x; Nam SH, 2006, FOOD CHEM, V94, P613, DOI 10.1016/j.foodchem.2004.12.010; Nemeth K, 1998, GENE DEV, V12, P3059, DOI 10.1101/gad.12.19.3059; Nunn BL, 2009, AQUAT MICROB ECOL, V55, P241, DOI 10.3354/ame01284; Ohto M, 2001, PLANT PHYSIOL, V127, P252, DOI 10.1104/pp.127.1.252; Oike Y, 2009, CIRC J, V73, P2192, DOI 10.1253/circj.CJ-09-0710; Page M, 2012, PLANT CELL ENVIRON, V35, P388, DOI 10.1111/j.1365-3040.2011.02369.x; Paris S, 2002, PROTEIN EXPRES PURIF, V24, P99, DOI 10.1006/prep.2001.1538; Peng MS, 2008, J EXP BOT, V59, P2933, DOI 10.1093/jxb/ern148; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philpott M, 2004, J AGR FOOD CHEM, V52, P1511, DOI 10.1021/jf034593j; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Ryu SN, 1998, J FOOD DRUG ANAL, V6, P729; Ryu SY, 2008, CANCER INFORM, V6, P243; Rie S, 2007, BIOCHEM PHARMACOL, V74, P1619, DOI 10.1016/j.bcp.2007.08.008; Sato T, 2011, PLANT SIGNAL BEHAV, V6, P1465, DOI 10.4161/psb.6.10.17343; Seeram NP, 2004, J AGR FOOD CHEM, V52, P2512, DOI 10.1021/jf0352778; Shan XY, 2009, J EXP BOT, V60, P3849, DOI 10.1093/jxb/erp223; Shao YF, 2014, FOOD CHEM, V143, P90, DOI 10.1016/j.foodchem.2013.07.042; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Sompong R, 2011, FOOD CHEM, V124, P132, DOI 10.1016/j.foodchem.2010.05.115; Suzuki M, 2006, PLANT J, V48, P85, DOI 10.1111/j.1365-313X.2006.02853.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terrier N, 2001, J PLANT PHYSIOL, V158, P1575, DOI 10.1078/0176-1617-00566; Tian QG, 2005, J CHROMATOGR A, V1091, P72, DOI 10.1016/j.chroma.2005.07.036; Tschiersch H, 2011, BIOSYSTEMS, V103, P302, DOI 10.1016/j.biosystems.2010.08.007; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; TSUKAYA H, 1991, PLANT PHYSIOL, V97, P1414, DOI 10.1104/pp.97.4.1414; Ubi BE, 2006, PLANT SCI, V170, P571, DOI 10.1016/j.plantsci.2005.10.009; Vertommen A, 2011, J PROTEOMICS, V74, P1165, DOI 10.1016/j.jprot.2011.02.016; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang Q, 2007, ASIA PAC J CLIN NUTR, V16, P295; Weiss D, 2000, PHYSIOL PLANTARUM, V110, P152, DOI 10.1034/j.1399-3054.2000.110202.x; Wilmouth RC, 2002, STRUCTURE, V10, P93, DOI 10.1016/S0969-2126(01)00695-5; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu XL, 2006, J AGR FOOD CHEM, V54, P4069, DOI 10.1021/jf060300l; Xia CA, 2010, PLANT J, V63, P189, DOI 10.1111/j.1365-313X.2010.04237.x; Xia XD, 2006, J NUTR, V136, P2220, DOI 10.1093/jn/136.8.2220; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Xu SB, 2010, J PROTEOME RES, V9, P4906, DOI 10.1021/pr900954p; Zhang Y, 2014, CURR OPIN PLANT BIOL, V19, P81, DOI 10.1016/j.pbi.2014.05.011; Zhang ZX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100416, 10.1371/journal.pone.0089140, 10.1371/journal.pone.0099511]; Zhao XQ, 2006, PLANT SCI, V170, P748, DOI 10.1016/j.plantsci.2005.11.006	100	14	15	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159238	10.1371/journal.pone.0159238	http://dx.doi.org/10.1371/journal.pone.0159238			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415428	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500104
J	Peron, IH; Reichert-Lima, F; Busso-Lopes, AF; Nagasako, CK; Lyra, L; Moretti, ML; Schreiber, AZ				Peron, Isabela Haddad; Reichert-Lima, Franqueline; Busso-Lopes, Ariane Fidelis; Nagasako, Cristiane Kibune; Lyra, Luzia; Moretti, Maria Luiza; Schreiber, Angelica Zaninelli			Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; SPECIES DISTRIBUTION; RISK-FACTORS; SENTINEL SURVEILLANCE; INVASIVE CANDIDIASIS; AZOLE RESISTANCE; DRUG-RESISTANCE; 2009 UPDATE; EPIDEMIOLOGY	Candida albicans caused 44% of the overall candidemia episodes from 2006 to 2010 in our university tertiary care hospital. As different antifungal agents are used in therapy and also immunocompromised patients receive fluconazole prophylaxis in our institution, this study aimed to perform an antifungal susceptibility surveillance with the C. albicans bloodstream isolates and to characterize the fluconazole resistance in 2 non-blood C. albicans isolates by sequencing ERG11 gene. The study included 147 C. albicans bloodstream samples and 2 fluconazole resistant isolates: one from oral cavity (LIF 12560 fluconazole MIC: 8 mu g/mL) and one from esophageal cavity (LIF-E10 fluconazole MIC: 64 mu g/mL) of two different patients previously treated with oral fluconazole. The in vitro antifungal susceptibility to amphotericin B (AMB), 5-flucytosine (5FC), fluconazole (FLC), itraconazole (ITC), voriconazole (VRC), caspofungin (CASP) was performed by broth microdilution methodology recommended by the Clinical and Laboratory Standards Institute documents (M27-A3 and M27-S4, CLSI). All blood isolates were classified as susceptible according to CLSI guidelines for all evaluated antifungal agents (MIC range: 0,125-1.00 mu g/mL for AMB, <= 0.125-1.00 mu g/mL for 5FC, <= 0.125-0.5 mu g/mL for FLC, <= 0.015-0.125 mu g/mL for ITC, <= 0.015-0.06 mu g/mL for VRC and <= 0.015-0.125 mu g/mL for CASP). In this study, we also amplified and sequenced the ERG11 gene of LIF 12560 and LIF-E10 C. albicans isolates. Six mutations encoding distinct amino acid substitutions were found (E116D, T128K, E266D, A298V, G448V and G464S) and these mutations were previously described as associated with fluconazole resistance. Despite the large consumption of antifungals in our institution, resistant blood isolates were not found over the trial period. Further studies should be conducted, but it may be that the very prolonged direct contact with the oral antifungal agent administered to the patient from which was isolated LIF E-10, may have contributed to the development of resistance.	[Peron, Isabela Haddad; Reichert-Lima, Franqueline; Lyra, Luzia; Schreiber, Angelica Zaninelli] Univ Estadual Campinas, Fac Med Sci, Dept Clin Pathol, Campinas, SP, Brazil; [Busso-Lopes, Ariane Fidelis; Nagasako, Cristiane Kibune; Moretti, Maria Luiza] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Peron, IH (corresponding author), Univ Estadual Campinas, Fac Med Sci, Dept Clin Pathol, Campinas, SP, Brazil.	zaninele@fcm.unicamp.br	Schreiber, Angelica/ABB-8568-2021; Schreiber, Angelica Zaninelli/C-8759-2012; Busso-Lopes, Ariane Fidelis/K-1383-2015	Schreiber, Angelica/0000-0002-5095-5054; Schreiber, Angelica Zaninelli/0000-0002-5095-5054; Busso-Lopes, Ariane Fidelis/0000-0003-2280-1848; Kibune Nagasako, Cristiane/0000-0002-8403-1677; HADDAD PERON, ISABELA/0000-0003-4760-0540	Science and Technology Research Partnership for Sustainable Development, Japan (SATREPS); University of Campinas, Brazil [02P -29548 -09]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/08693-8]; Japan International Cooperation Agency [029-29548/2009]	Science and Technology Research Partnership for Sustainable Development, Japan (SATREPS); University of Campinas, Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Japan International Cooperation Agency	This project was supported by grants from the collaborative research project: Science and Technology Research Partnership for Sustainable Development, Japan (SATREPS) and University of Campinas, Brazil, No. 02P -29548 -09 and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant number 2014/08693-8, and 029-29548/2009 Japan International Cooperation Agency - Antifungal susceptibility supplies. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alangaden GJ, 2011, INFECT DIS CLIN N AM, V25, P201, DOI 10.1016/j.idc.2010.11.003; Cortes JA, 2014, BRAZ J INFECT DIS, V18, P631, DOI 10.1016/j.bjid.2014.06.009; Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021239; Arendrup MC, 2013, DAN MED J, V60; Bassetti M, 2013, J CLIN MICROBIOL, V51, P4167, DOI 10.1128/JCM.01998-13; Bustamante B, 2014, J MED MICROBIOL, V63, P855, DOI 10.1099/jmm.0.071167-0; Chau AS, 2004, ANTIMICROB AGENTS CH, V48, P2124, DOI 10.1128/AAC.48.6.2124-2131.2004; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI; CLSI, 2008, REF METH BROTH DIL A, P40; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Colombo AL, 2014, INTENS CARE MED, V40, P1489, DOI 10.1007/s00134-014-3400-y; Colombo AL, 2013, BRAZ J INFECT DIS, V17, P283, DOI 10.1016/j.bjid.2013.02.001; da Costa VG, 2014, MYCOPATHOLOGIA, V178, P243, DOI 10.1007/s11046-014-9791-z; de Repentigny L, 2004, CLIN MICROBIOL REV, V17, P729, DOI 10.1128/CMR.17.4.729-759.2004; Delaloye J, 2014, VIRULENCE, V5, P161, DOI 10.4161/viru.26187; Doi AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146909; Egusa H, 2008, CURR HIV RES, V6, P485, DOI 10.2174/157016208786501445; Gupta PPS, 2015, INT J CURRENT MICROB, V4, P10; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Kakati B, 2015, J CLIN DIAGN RES, V9, pDC16, DOI 10.7860/JCDR/2015/15171.6975; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Kelly SL, 1999, BIOCHEM BIOPH RES CO, V262, P174, DOI 10.1006/bbrc.1999.1136; Khan PA, 2012, IRAN J MICROBIOL, V4, P204; Klepser ME, 2006, PHARMACOTHERAPY, V26, p68S, DOI 10.1592/phco.26.6part2.68S; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; MacCallum DM, 2010, ANTIMICROB AGENTS CH, V54, P1476, DOI 10.1128/AAC.01645-09; Manastir L, 2011, MYCOSES, V54, P99, DOI 10.1111/j.1439-0507.2009.01766.x; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Mokaddas EM, 2007, J MED MICROBIOL, V56, P255, DOI 10.1099/jmm.0.46817-0; Moretti ML, 2013, MED MYCOL, V51, P225, DOI 10.3109/13693786.2012.708107; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Motta AL, 2010, BRAZ J INFECT DIS, V14, P441, DOI 10.1590/S1413-86702010000500004; Nieto MC, 2015, DIAGN MICR INFEC DIS, V81, P34, DOI 10.1016/j.diagmicrobio.2014.05.021; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Peman J, 2012, J ANTIMICROB CHEMOTH, V67, P1181, DOI 10.1093/jac/dks019; Peres-Bota D, 2004, CLIN MICROBIOL INFEC, V10, P550, DOI 10.1111/j.1469-0691.2004.00873.x; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; RODRIGUES EG, 1992, REV INST MED TROP SP, V34, P159, DOI 10.1590/S0036-46651992000200012; Salari S, 2015, J MYCOL MED; SAMARANAYAKE LP, 1992, ORAL SURG ORAL MED O, V73, P171, DOI 10.1016/0030-4220(92)90191-R; Sanglard D, 2003, ANTIMICROB AGENTS CH, V47, P2404, DOI 10.1128/AAC.47.8.2404-2412.2003; Sanglard D, 2002, ENFERM INFEC MICR CL, V20, P462, DOI 10.1016/S0213-005X(02)72842-5; Viudes A, 2002, EUR J CLIN MICROBIOL, V21, P767, DOI 10.1007/s10096-002-0822-1; Xu YH, 2008, J ANTIMICROB CHEMOTH, V61, P798, DOI 10.1093/jac/dkn015; Yapar N, 2014, THER CLIN RISK MANAG, V10, P95, DOI 10.2147/TCRM.S40160	46	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158126	10.1371/journal.pone.0158126	http://dx.doi.org/10.1371/journal.pone.0158126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414653	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500017
J	Shen, YF; Chen, YY; Li, SQ				Shen, Yufang; Chen, Yingying; Li, Shiqing			Microbial Functional Diversity, Biomass and Activity as Affected by Soil Surface Mulching in a Semiarid Farmland	PLOS ONE			English	Article							WATER-USE EFFICIENCY; LONG-TERM APPLICATION; GRAVEL-SAND MULCH; ORGANIC-CARBON; COMMUNITY COMPOSITION; ENZYME-ACTIVITIES; PLASTIC FILM; MANAGEMENT-PRACTICES; EXTRACTION METHOD; TILLAGE PRACTICES	Mulching is widely used to increase crop yield in semiarid regions in northwestern China, but little is known about the effect of different mulching systems on the microbial properties of the soil, which play an important role in agroecosystemic functioning and nutrient cycling. Based on a 4-year spring maize (Zea mays L.) field experiment at Changwu Agricultural and Ecological Experimental Station, Shaanxi, we evaluated the responses of soil microbial activity and crop to various management systems. The treatments were NMC (no mulching with inorganic N fertilizer), GMC (gravel mulching with inorganic N fertilizer), FMC (plasticfilm mulching with inorganic N fertilizer) and FMO (plastic-film mulching with inorganic N fertilizer and organic manure addition). The results showed that the FMO soil had the highest contents of microbial biomass carbon and nitrogen, dehydrogenase activity, microbial activity and Shannon diversity index. The relative use of carbohydrates and amino acids by microbes was highest in the FMO soil, whereas the relative use of polymers, phenolic compounds and amines was highest in the soil in the NMC soil. Compared with the NMC, an increased but no significant trend of biomass production and nitrogen accumulation was observed under the GMC treatment. The FMC and FMO led a greater increase in biomass production than GMC and NMC. Compare with the NMC treatment, FMC increased grain yield, maize biomass and nitrogen accumulation by 62.2, 62.9 and 86.2%, but no significant difference was found between the FMO and FMC treatments. Some soil biological properties, i.e. microbial biomass carbon, microbial biomass nitrogen, being sensitive to the mulching and organic fertilizer, were significant correlated with yield and nitrogen availability. Film mulching over gravel mulching can serve as an effective measure for crop production and nutrient cycling, and plus organic fertilization additions may thus have improvements in the biological quality of the soil and its sustainability in the rainfall-limited semiarid region.	[Shen, Yufang; Chen, Yingying; Li, Shiqing] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; [Shen, Yufang; Li, Shiqing] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Shen, Yufang; Li, Shiqing] Minist Water Resources, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources	Li, SQ (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China.; Li, SQ (corresponding author), Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China.; Li, SQ (corresponding author), Minist Water Resources, Yangling 712100, Shaanxi, Peoples R China.	sqli@ms.iswc.ac.cn	Li, Shiqing/AAG-8907-2019; chen, ying/HHS-8254-2022	Li, Shiqing/0000-0001-6886-7637; 	National Natural Science Foundation of China [51279197, 50809068]; Fundamental Research Funds for the Central Universities [YQ2013009, 2452015493]; Ministry of Science and Technology of China [2015CB150402]; Science and Technology Planning Project of Yangling Demonstration Zone, China [2014NY-30]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Planning Project of Yangling Demonstration Zone, China	This research was financially supported by the National Natural Science Foundation of China (51279197, 50809068) to YFS (http://www.nsfc.gov.cn/), the Fundamental Research Funds for the Central Universities (YQ2013009, 2452015493) to YFS (http://www.moe.gov.cn/), the Ministry of Science and Technology of China (2015CB150402) to SQL (http://www.most.gov.cn/) and Science and Technology Planning Project of Yangling Demonstration Zone, China (2014NY-30) to YFS (http://kjj.yangling.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, APPL SOIL ECOL, V38, P249, DOI 10.1016/j.apsoil.2007.10.012; Allison VJ, 2007, SOIL BIOL BIOCHEM, V39, P1770, DOI 10.1016/j.soilbio.2007.02.006; An TT, 2015, SOIL BIOL BIOCHEM, V80, P53, DOI 10.1016/j.soilbio.2014.09.024; Banger K, 2009, PLANT SOIL, V318, P27, DOI 10.1007/s11104-008-9813-z; Bell TH, 2010, SOIL SCI SOC AM J, V74, P820, DOI 10.2136/sssaj2009.0036; Benitez E, 2006, APPL SOIL ECOL, V32, P221, DOI 10.1016/j.apsoil.2005.06.002; Biau A, 2012, EUR J SOIL BIOL, V53, P56, DOI 10.1016/j.ejsobi.2012.08.008; Boateng SA, 2007, J SCI TECHNOL, V27, P71, DOI DOI 10.1371/J0URNAL.P0NE.0159144; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Bu LD, 2013, AGR WATER MANAGE, V123, P71, DOI 10.1016/j.agwat.2013.03.015; Butler JL, 2003, APPL ENVIRON MICROB, V69, P6793, DOI 10.1128/AEM.69.11.6793-6800.2003; Chivenge P, 2011, PLANT SOIL, V342, P1, DOI 10.1007/s11104-010-0626-5; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; Fisk MC, 2003, SOIL BIOL BIOCHEM, V35, P591, DOI 10.1016/S0038-0717(03)00053-1; Gao YH, 2014, FIELD CROP RES, V156, P40, DOI 10.1016/j.fcr.2013.10.016; Garland JL, 1996, SOIL BIOL BIOCHEM, V28, P213, DOI 10.1016/0038-0717(95)00112-3; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Giacometti C, 2013, APPL SOIL ECOL, V64, P32, DOI 10.1016/j.apsoil.2012.10.002; Gil-Sotres F, 2005, SOIL BIOL BIOCHEM, V37, P877, DOI 10.1016/j.soilbio.2004.10.003; Gomez E, 2006, BIORESOURCE TECHNOL, V97, P1484, DOI 10.1016/j.biortech.2005.06.021; Gong W, 2009, GEODERMA, V149, P318, DOI 10.1016/j.geoderma.2008.12.010; HAM JM, 1993, J AM SOC HORTIC SCI, V118, P188, DOI 10.21273/JASHS.118.2.188; Jenkinson D. S., 1988, Advances in nitrogen cycling in agricultural ecosystems, P368; Jin K, 2009, SOIL TILL RES, V104, P115, DOI 10.1016/j.still.2009.02.004; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Kiikkila O, 2014, PLANT SOIL, V377, P169, DOI 10.1007/s11104-013-1988-2; Klose S, 2006, SOIL BIOL BIOCHEM, V38, P1243, DOI 10.1016/j.soilbio.2005.09.025; Korschens M, 2013, ARCH AGRON SOIL SCI, V59, P1017, DOI 10.1080/03650340.2012.704548; Kong AYY, 2011, SOIL BIOL BIOCHEM, V43, P20, DOI 10.1016/j.soilbio.2010.09.005; Li FM, 2004, SOIL BIOL BIOCHEM, V36, P1893, DOI 10.1016/j.soilbio.2004.04.040; Li SX, 2013, AGR WATER MANAGE, V116, P39, DOI 10.1016/j.agwat.2012.10.004; Li XY, 2003, CATENA, V52, P105, DOI 10.1016/S0341-8162(02)00181-9; Li YS, 2006, BIOL FERT SOILS, V43, P107, DOI 10.1007/s00374-005-0069-y; Liu JL, 2014, AGR ECOSYST ENVIRON, V188, P20, DOI 10.1016/j.agee.2014.02.010; Liu JL, 2014, AGRON J, V106, P390, DOI 10.2134/agronj2013.0404; Lopes AR, 2011, SOIL BIOL BIOCHEM, V43, P115, DOI 10.1016/j.soilbio.2010.09.021; Luo SS, 2015, EUR J SOIL BIOL, V67, P35, DOI 10.1016/j.ejsobi.2015.01.004; Mancinelli R, 2013, ECOL INDIC, V34, P31, DOI 10.1016/j.ecolind.2013.04.011; Nieder R, 2008, J PLANT NUTR SOIL SC, V171, P878, DOI 10.1002/jpln.200700024; O'Donnell AG, 2001, PLANT SOIL, V232, P135, DOI 10.1023/A:1010394221729; Philippot L, 2011, GLOBAL CHANGE BIOL, V17, P1497, DOI 10.1111/j.1365-2486.2010.02334.x; Rasool R, 2008, SOIL TILL RES, V101, P31, DOI 10.1016/j.still.2008.05.015; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Roldan A, 2005, APPL SOIL ECOL, V30, P11, DOI 10.1016/j.apsoil.2005.01.004; Rudrappa L, 2006, SOIL TILL RES, V88, P180, DOI 10.1016/j.still.2005.05.008; Ruidisch M, 2013, AGR ECOSYST ENVIRON, V169, P21, DOI 10.1016/j.agee.2013.02.006; Saha S, 2008, EUR J SOIL BIOL, V44, P309, DOI 10.1016/j.ejsobi.2008.02.004; Tian W, 2015, AGR ECOSYST ENVIRON, V213, P219, DOI 10.1016/j.agee.2015.08.009; van Groenigen KJ, 2010, SOIL BIOL BIOCHEM, V42, P48, DOI 10.1016/j.soilbio.2009.09.023; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang XB, 2011, FIELD CROP RES, V120, P47, DOI 10.1016/j.fcr.2010.08.010; Wang YJ, 2011, AGR WATER MANAGE, V101, P88, DOI 10.1016/j.agwat.2011.09.006; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; [张成娥 Zhang Chenge], 2002, [生态学报, Acta Ecologica Sinica], V22, P508; Zhang QC, 2012, APPL SOIL ECOL, V57, P1, DOI 10.1016/j.apsoil.2012.02.012; Zhang SL, 2011, SOIL TILL RES, V112, P92, DOI 10.1016/j.still.2010.11.006; Zhong WH, 2010, PLANT SOIL, V326, P511, DOI 10.1007/s11104-009-9988-y; Zhong YQ, 2015, SOIL BIOL BIOCHEM, V91, P151, DOI 10.1016/j.soilbio.2015.08.030; Zhou LM, 2009, FIELD CROP RES, V113, P41, DOI 10.1016/j.fcr.2009.04.005; Zhou ZC, 2013, EUR J AGRON, V45, P20, DOI 10.1016/j.eja.2012.11.002	60	22	24	11	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159144	10.1371/journal.pone.0159144	http://dx.doi.org/10.1371/journal.pone.0159144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414400	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500088
J	Zhao, H; Zhang, BP; Chen, Y; Zhou, X; Zuo, PX				Zhao, Hua; Zhang, Baoping; Chen, Yun; Zhou, Xiang; Zuo, Pengxiang			Environmental Risk Factors in Han and Uyghur Children with Dyslexia: A Comparative Study	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; CHINESE CHILDREN; ENGLISH; GENE; SKILLS	Background Several studies have been conducted to explore risk factors for dyslexia. However, most studies examining dyslexia have been skewed toward Western countries, and few have considered two nationalities simultaneously. This study focused on differences in dyslexia prevalence and potential environmental risk factors between Han and Uyghur children. Methods A cross-sectional study was conducted in Kashgar and Aksu, cities in Xinjiang province, China. A two-stage sampling strategy was used to recruit 2,854 students in grades 3-6 from 5 primary schools in 5 districts; 2,348 valid student questionnaires were included in the analysis. Dyslexia checklists for Chinese and Uyghur children and pupil rating scales were used to identify children with dyslexia. Questions related to the home literacy environment and reading ability were used to evaluate potential environmental risk factors. Single factor analysis and multivariate logistic regression were used to examine prevalence and risk factors for dyslexia. Results Dyslexia prevalence differed significantly between Han (3.9%) and Uyghur (7.0%) children (P < 0.05), and the boy-to-girl diagnosis ratio was almost 2:1. Multiple logistic regression analysis showed that ethnic differences in dyslexia prevalence between Han and Uyghur children could have occurred because of factors such as mother's occupation (P = 0.02, OR = 0.04, 95% CI = 0.01-0.68) and the frequency with which parents told stories (P = 0.00, OR = 4.50, 95% CI = 1.67-12.11). Conclusions The prevalence of dyslexia was high in all children, particularly those in the Uyghur group. Environmental factors could have been responsible for some of the differences observed. The results contribute to the early identification and management of dyslexia in children from these two groups and research examining developmental dyslexia and differences in racial genetics.	[Zhao, Hua; Zhang, Baoping; Chen, Yun; Zhou, Xiang; Zuo, Pengxiang] Univ Shihezi, Sch Med, Xinjiang, Peoples R China; [Zhao, Hua] Quzhou Coll Technol, Sch Med, Quzhou, Zhejiang, Peoples R China		Zuo, PX (corresponding author), Univ Shihezi, Sch Med, Xinjiang, Peoples R China.	zuo_pengxiang@sina.com		Pengxiang, Zuo/0000-0001-7881-8644	National Natural Science Foundation of China [81360434]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China Project No. 81360434.; This research was supported by the National Natural Science Foundation of China, Project No. 81360434	Chung KKH, 2010, J LEARN DISABIL-US, V43, P195, DOI 10.1177/0022219409345018; Cope N, 2005, AM J HUM GENET, V76, P581, DOI 10.1086/429131; Donfrancesco R, 2010, ANN DYSLEXIA, V60, P175, DOI 10.1007/s11881-010-0037-6; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; GONG Y. X., 1994, CHINESE J CLIN PSYCH, V1, P1; He Z, 2014, RES DEV DISABIL, V35, P3645, DOI 10.1016/j.ridd.2014.08.037; Jing J, 1998, CHINESE J CHILD CARE, V9, P197; Karahmadi M, 2014, IRAN J PSYCHIATRY BE, V8, P51; Le Normand MT, 2008, CLIN LINGUIST PHONET, V22, P47, DOI 10.1080/02699200701669945; Li X, 2012, SURVEY INTERMARRIAGE, P59; Liederman J, 2005, J LEARN DISABIL-US, V38, P109, DOI 10.1177/00222194050380020201; Liu LL, 2010, MATERN CHILD HLTH J, V25, P54; Mascheretti S, 2013, GENES BRAIN BEHAV, V12, P47, DOI 10.1111/gbb.12000; Moll K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103537; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Paracchini S, 2007, ANNU REV GENOM HUM G, V8, P57, DOI 10.1146/annurev.genom.8.080706.092312; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Raman I, 2005, ANN DYSLEXIA, V55, P79, DOI 10.1007/s11881-005-0005-8; Rashid FL, 2005, J LEARN DISABIL-US, V38, P2, DOI 10.1177/00222194050380010101; Shastry BS, 2007, J HUM GENET, V52, P104, DOI 10.1007/s10038-006-0088-z; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Siok WT, 2008, P NATL ACAD SCI USA, V105, P5561, DOI 10.1073/pnas.0801750105; Snowling MJ, 2013, J RES SPEC EDUC NEED, V13, P7, DOI 10.1111/j.1471-3802.2012.01262.x; Su MM, 2015, J NEUROLINGUIST, V33, P172, DOI 10.1016/j.jneuroling.2014.09.007; Sun ZZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055124, 10.1371/journal.pone.0055249, 10.1371/journal.pone.0074672]; Wong SWL, 2014, DEV PSYCHOL, V50, P2539, DOI 10.1037/a0037836; Wu HR, 2006, J HUM GENET, V27, P189; Xi YL, 2015, INT J CLIN EXP MED, V8, P13724; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Zuo P.X., 2013, CHIN J CHILD HLTH CA, V21, P1254; Zuo PX, 2013, CHINESE J CHILD CARE, V21, P1265	31	16	17	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159042	10.1371/journal.pone.0159042	http://dx.doi.org/10.1371/journal.pone.0159042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27416106	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500062
J	Watermeyer, KE; Hutchings, L; Jarre, A; Shannon, LJ				Watermeyer, Katherine E.; Hutchings, Laurence; Jarre, Astrid; Shannon, Lynne J.			Patterns of Distribution and Spatial Indicators of Ecosystem Change Based on Key Species in the Southern Benguela	PLOS ONE			English	Article							ANCHOVY ENGRAULIS-ENCRASICOLUS; AFRICAN CONTINENTAL-SHELF; ACOUSTIC SURVEYS; REGIME-SHIFTS; CLIMATE-CHANGE; MARINE FISHES; LIFE-HISTORY; SARDINE; COAST; ABUNDANCE	Several commercially and ecologically important species in the southern Benguela have undergone southward and eastward shifts in their distributions over previous decades, most notably the small pelagic fish sardine Sardinops sagax and anchovy Engraulis encrasicolus. Understanding these changes and their implications is essential in implementing an ecosystem approach to fisheries in the southern Benguela and attempting to appreciate the potential impacts of future environmental change. To investigate possible impacts of these shifts at an ecosystem level, distribution maps for before (1985-1991), during (1997-2000) and after (2003-2008) the shift in small pelagic fish were constructed for 14 key species from catch and survey data, and used to calculate spatial indicators including proportion east and west of Cape Agulhas, relative overlap in biomass and area, index of diversity, connectivity. Potential interactions on the south and west coasts were also compared. For several species (redeye; chub mackerel; kingklip; chokka squid; yellowtail), previously unidentified increases in the proportion of biomass east of Cape Agulhas were shown to have occurred over the same period as that of small pelagic fish, although none to the same degree. On average, overlap with small pelagic fish increased over time and overall system connectivity was lowest in the intermediate period, possibly indicating a system under transition. Connectivity declined over time on the west coast while increasing on the east coast. Distributions of other species have changed over time, with the region east of Cape Agulhas becoming increasingly important in terms of potential trophic interaction. Variations in distribution of biomass and structural complexity affect the trophic structure and hence functioning of the system, and implications should be considered when attempting to identify the possible ecosystem impacts of current and future system-level change.	[Watermeyer, Katherine E.] Univ Cape Town, Marine Res Inst Ma Re, Cape Town, South Africa; Univ Cape Town, Dept Biol Sci, Cape Town, South Africa	University of Cape Town; University of Cape Town	Watermeyer, KE (corresponding author), Univ Cape Town, Marine Res Inst Ma Re, Cape Town, South Africa.	kwatermeyer@gmail.com	Shannon, Lynne/A-1612-2015	Shannon, Lynne/0000-0001-7842-0636	South African Research Chairs Initiative; DST	South African Research Chairs Initiative; DST(Department of Science & Technology (India))	This work was funded by the South African Research Chairs Initiative, funded by DST and administered by the NRF, through the SA Research Chair in Marine Ecology and Fisheries, and the CEC FP7 project 'Defragmenting African Resource Management' (DARMA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson LJ, 2011, AFR J MAR SCI, V33, P157, DOI 10.2989/1814232X.2011.572378; Atkinson LJ, 2012, ALASKA SEA GRANT, P20; Babcock EA, 2005, ICES J MAR SCI, V62, P469, DOI 10.1016/j.icesjms.2005.01.010; BADENHORST A, 1991, S AFR J MARINE SCI, V11, P377, DOI 10.2989/025776191784287565; Barange M, 1998, S AFR J MARINE SCI, V19, P433; Barange M, 1999, S AFR J MARINE SCI, V21, P367; Beare DJ, 2004, MAR ECOL PROG SER, V284, P269, DOI 10.3354/meps284269; Blamey LK, 2015, J MARINE SYST, V144, P9, DOI 10.1016/j.jmarsys.2014.11.006; Blamey LK, 2012, PROG OCEANOGR, V106, P80, DOI 10.1016/j.pocean.2012.07.001; Cadenasso ML, 2006, ECOL COMPLEX, V3, P1, DOI 10.1016/j.ecocom.2005.07.002; Coetzee JC, 2008, AFR J MAR SCI, V30, P205, DOI 10.2989/AJMS.2008.30.2.1.551; Coetzee JC, 2008, ICES J MAR SCI, V65, P1676, DOI 10.1093/icesjms/fsn184; Crawford RJM, 2008, AFR J MAR SCI, V30, P177, DOI 10.2989/AJMS.2008.30.1.18.468; Crawford RJM, 2008, AFR J MAR SCI, V30, P167, DOI 10.2989/AJMS.2008.30.1.17.467; Crawford RJM, 2011, AFR J MAR SCI, V33, P139, DOI 10.2989/1814232X.2011.572377; Crawford RJM, 2007, EMU, V107, P253, DOI 10.1071/MU07015; Crawford RJM, 2009, PROG OCEANOGR, V83, P398, DOI 10.1016/j.pocean.2009.07.021; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Cury P, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P103, DOI 10.1079/9780851996332.0103; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Cury PA, 2005, ICES J MAR SCI, V62, P307, DOI 10.1016/j.icesjms.2005.02.003; DAFF, 2012, STATUS OF THE SOUTH; DAVID JHM, 1987, S AFR J MARINE SCI, V5, P693, DOI 10.2989/025776187784522568; de Moor CL, 2008, AFR J MAR SCI, V30, P219, DOI 10.2989/AJMS.2008.30.2.2.552; deYoung B, 2004, PROG OCEANOGR, V60, P143, DOI 10.1016/j.pocean.2004.02.017; Drapeau L, 2004, AFR J MAR SCI, V26, P141, DOI 10.2989/18142320409504054; Fairweather TP, 2006, AFR J MAR SCI, V28, P661, DOI 10.2989/18142320609504215; Field JG, 2013, J FISH BIOL, V83, P1019, DOI 10.1111/jfb.12118; Freon P, 2005, ICES J MAR SCI, V62, P459, DOI 10.1016/j.icesjms.2004.12.010; Garcia SM, 2000, MAR FRESHWATER RES, V51, P385, DOI 10.1071/MF99092; Griffiths MH, 2000, S AFR J MARINE SCI, V22, P81, DOI 10.2989/025776100784125663; Griffiths MH, 1995, J FISH BIOL, V47, P962, DOI 10.1111/j.1095-8649.1995.tb06022.x; Griffiths MH, 1997, FISH RES, V30, P103, DOI 10.1016/S0165-7836(96)00552-8; HAMPTON I, 1992, S AFR J MARINE SCI, V12, P1031; Hiddink JG, 2008, GLOBAL CHANGE BIOL, V14, P453, DOI 10.1111/j.1365-2486.2007.01518.x; Howard JAE, 2007, AFR J MAR SCI, V29, P437, DOI 10.2989/AJMS.2007.29.3.11.341; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; Jarre A, 2006, LAR MAR ECOSYST, V14, P239; Kirkman SP, 2006, FINAL REPORT OF BCLM; Kirkman SP, 2013, MAR MAMMAL SCI, V29, P497, DOI 10.1111/j.1748-7692.2012.00584.x; Lees R., 1969, THE STORY OF THE FIS; Lehodey P, 2006, J CLIMATE, V19, P5009, DOI 10.1175/JCLI3898.1; Link J, 2002, MAR ECOL PROG SER, V230, P1, DOI 10.3354/meps230001; MURAWSKI SA, 1993, T AM FISH SOC, V122, P647, DOI 10.1577/1548-8659(1993)122<0647:CCAMFD>2.3.CO;2; Nepgen CS., 1982, MOL, V16, P75; Osman W., 2010, TROPHIC MODEL GENERA; Pecquerie L, 2004, AFR J MAR SCI, V26, P115, DOI 10.2989/18142320409504053; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Rijnsdorp AD, 2009, RESOLVING THE EFFECT; Roy C, 2007, AFR J MAR SCI, V29, P309, DOI 10.2989/AJMS.2007.29.3.1.331; Shannon LJ, 2003, J MARINE SYST, V39, P83, DOI 10.1016/S0924-7963(02)00250-6; Shannon LJ, 2007, THE ROLE OF SMALL PE; SHANNON LV, 1985, OCEANOGR MAR BIOL, V23, P105; Shin YJ, 2012, REV FISH BIOL FISHER, V22, P835, DOI 10.1007/s11160-012-9252-z; Simpson SD, 2013, IMPACTS OF CLIMATE C, P113, DOI 10.14465/2013.arc13.113-124; SMALE MJ, 1986, S AFR J ZOOL, V21, P111; van der Lingen C.D., 2005, GLOBEC International Newsletter, V11, P17; van der Lingen CD, 2002, GLOBEC SPACC IDYLE E, P46; Watermeyer KE, 2008, AFR J MAR SCI, V30, P351, DOI 10.2989/AJMS.2008.30.2.11.561; Winker H, MARAM IWS NOV12 LF P; Winker H, 2013, FISH RES, V139, P118, DOI 10.1016/j.fishres.2012.10.014; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811; Yemane D, 2008, FISH RES, V93, P163, DOI 10.1016/j.fishres.2008.03.005	63	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158734	10.1371/journal.pone.0158734	http://dx.doi.org/10.1371/journal.pone.0158734			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441550	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500022
J	Gomez-Gonzalez, S; Ojeda, F; Torres-Morales, P; Palma, JE				Gomez-Gonzalez, Susana; Ojeda, Fernando; Torres-Morales, Patricio; Palma, Jazmin E.			Seed Pubescence and Shape Modulate Adaptive Responses to Fire Cues	PLOS ONE			English	Article							ANTHROPOGENIC FIRE; SAVANNA VEGETATION; PLANT; EVOLUTION; GERMINATION; TRAITS; RAINFALL; ECOLOGY; HISTORY; SMOKE	Post-fire recruitment by seeds is regarded as an adaptive response in fire-prone ecosystems. Nevertheless, little is known about which heritable seed traits are functional to the main signals of fire (heat and smoke), thus having the potential to evolve. Here, we explored whether three seed traits (pubescence, dormancy and shape) and fire regime modulate seed response to fire cues(heat and smoke). As a model study system, we used Helenium aromaticum (Asteraceae), a native annual forb from the Chilean matorral, where fires are anthropogenic. We related seed trait values with fitness responses (germination and survival) after exposure to heat-shock and smoke experimental treatments on seeds from 10 H. aromaticum wild populations. We performed a phenotypic selection experiment to examine the relationship of seed traits with post-treatment fitness within a population (adaptive hypothesis). We then explored whether fire frequency in natural habitats was associated with trait expression across populations, and with germination and survival responses to experimental fire-cues. We found that populations subjected to higher fire frequency had, in average, more rounded and pubescent seeds than populations from rarely burned areas. Populations with more rounded and pubescent seeds were more resistant to 80 degrees C heat-shock and smoke treatments. There was correlated selection on seed traits: pubescent-rounded or glabrouscent-elongated seeds had the highest probability of germinating after heat-shock treatments. Seed pubescence and shape in H. aromaticum are heritable traits that modulate adaptive responses to fire. Our results provide new insights into the process of plant adaptation to fire and highlight the relevance of human-made fires as a strong evolutionary agent in the Anthropocene.	[Gomez-Gonzalez, Susana; Palma, Jazmin E.] Univ Chile, Ctr Sci & Resilience Res CR2, Santiago, Chile; [Gomez-Gonzalez, Susana; Ojeda, Fernando] Univ Cadiz, Dept Biol, IVAGRO, Campus Rio San Pedro, Puerto Real, Spain; [Torres-Morales, Patricio] Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile	Universidad de Chile; Universidad de Cadiz; Universidad Austral de Chile	Gomez-Gonzalez, S (corresponding author), Univ Chile, Ctr Sci & Resilience Res CR2, Santiago, Chile.; Gomez-Gonzalez, S (corresponding author), Univ Cadiz, Dept Biol, IVAGRO, Campus Rio San Pedro, Puerto Real, Spain.	sgomezgo@gmail.com	Gómez-González, Susana/AAL-2631-2021; Ojeda, Fernando/L-1626-2014	Gómez-González, Susana/0000-0002-3779-8701; Ojeda, Fernando/0000-0001-5480-0925	CONICYT-FONDECYT INICIACION [11121264]; CONICYT-FONDAP [15110009]	CONICYT-FONDECYT INICIACION(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	CONICYT-FONDECYT INICIACION #11121264 financed the equipment, reagents, materials, fieldwork travels and publication expenses. CONICYT-FONDAP #15110009 financed the travels for meetings. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarzua AM, 2016, PALAEOGEOGR PALAEOCL, V459, P76, DOI 10.1016/j.palaeo.2016.06.036; Aravena JC, 2003, ECOL STU AN, V160, P343; Austin DF., 1998, DIVERSITY TAXONOMY T, P201; Barthlott W., 1981, Nordic Journal of Botany, V1, P345, DOI 10.1111/j.1756-1051.1981.tb00704.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BIERNER MW, 1978, SYST BOT, V3, P277, DOI 10.2307/2418298; Bond WJ, 2010, NEW PHYTOL, V188, P1137, DOI 10.1111/j.1469-8137.2010.03418.x; BOND WJ, 1995, OIKOS, V73, P79, DOI 10.2307/3545728; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bradshaw SD, 2011, TRENDS PLANT SCI, V16, P69, DOI 10.1016/j.tplants.2010.10.007; BROWN NAC, 1993, NEW PHYTOL, V123, P575, DOI 10.1111/j.1469-8137.1993.tb03770.x; Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001; Climent J, 2004, PLANT ECOL, V171, P185, DOI 10.1023/B:VEGE.0000029374.64778.68; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cowling RM, 2005, GLOBAL ECOL BIOGEOGR, V14, P509, DOI 10.1111/j.1466-822x.2005.00166.x; Crisp MD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1191; Di Castri F, 1976, BIOCLIMATOLOGIA CHIL; DIXON KW, 1995, OECOLOGIA, V101, P185, DOI 10.1007/BF00317282; Endler J. A., 1986, NATURAL SELECTION WI; Ghermandi L, 2013, J ARID ENVIRON, V97, P9, DOI 10.1016/j.jaridenv.2013.05.005; Gomez-Gonzalez S, 2008, FOREST ECOL MANAG, V255, P1510, DOI 10.1016/j.foreco.2007.11.006; Gomez-Gonzalez S, 2011, P NATL ACAD SCI USA, V108, P18743, DOI 10.1073/pnas.1108863108; Gomez-Gonzalez S, 2011, DIVERS DISTRIB, V17, P58, DOI 10.1111/j.1472-4642.2010.00728.x; Gomez-Gonzalez S, 2009, INT J WILDLAND FIRE, V18, P213, DOI 10.1071/WF07074; Govender N, 2006, J APPL ECOL, V43, P748, DOI 10.1111/j.1365-2664.2006.01184.x; He TH, 2012, NEW PHYTOL, V194, P751, DOI 10.1111/j.1469-8137.2012.04079.x; He TH, 2011, NEW PHYTOL, V191, P184, DOI 10.1111/j.1469-8137.2011.03663.x; Hernandez-Serrano A, 2013, AM J BOT, V100, P2349, DOI 10.3732/ajb.1300182; HEUSSER CJ, 1994, REV CHIL HIST NAT, V67, P435; JANZEN DH, 1977, ECOLOGY, V58, P921, DOI 10.2307/1936229; JOHNSON HB, 1975, BOT REV, V41, P233, DOI 10.1007/BF02860838; Keeley J. E., 2000, Seeds: the ecology of regeneration in plant communities, P311, DOI 10.1079/9780851994321.0311; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Keeley JE, 2005, ECOL LETT, V8, P683, DOI 10.1111/j.1461-0248.2005.00767.x; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; LAMONT BB, 1991, BOT REV, V57, P277, DOI 10.1007/BF02858770; Lamont BB, 2011, PLANT ECOL, V212, P1945, DOI 10.1007/s11258-011-9982-3; Le Stradic S, 2015, AUSTRAL ECOL, V40, P537, DOI 10.1111/aec.12221; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; Moreira B, 2014, MOL ECOL, V23, P1213, DOI 10.1111/mec.12665; Moreira B, 2010, ANN BOT-LONDON, V105, P627, DOI 10.1093/aob/mcq017; Moreira B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051523; MUNOZ MR, 1989, OIKOS, V56, P177, DOI 10.2307/3565333; Ojeda F, 2005, NEW PHYTOL, V168, P155, DOI 10.1111/j.1469-8137.2005.01486.x; Ojeda F, 2010, OECOLOGIA, V163, P729, DOI 10.1007/s00442-009-1550-3; Pausas JG, 2006, J ECOL, V94, P31, DOI 10.1111/j.1365-2745.2005.01092.x; Pausas JG, 2015, TRENDS PLANT SCI, V20, P318, DOI 10.1016/j.tplants.2015.03.001; Pausas JG, 2012, NEW PHYTOL, V193, P301, DOI 10.1111/j.1469-8137.2011.04010.x; Pausas JG, 2012, NEW PHYTOL, V193, P18, DOI 10.1111/j.1469-8137.2011.03945.x; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pigliucci M, 2003, ECOL LETT, V6, P265, DOI 10.1046/j.1461-0248.2003.00428.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ruprecht E, 2015, PERSPECT PLANT ECOL, V17, P397, DOI 10.1016/j.ppees.2015.07.001; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sheuyange A, 2005, J ENVIRON MANAGE, V75, P189, DOI 10.1016/j.jenvman.2004.11.004; Shryock DF, 2014, ECOL EVOL, V4, P3046, DOI 10.1002/ece3.1159; Stephens SL, 2006, J BIOGEOGR, V33, P648, DOI 10.1111/j.1365-2699.2005.01387.x; Verdu M, 2007, J ECOL, V95, P1316, DOI 10.1111/j.1365-2745.2007.01300.x; Villa-Martinez R, 2003, QUATERNARY RES, V60, P284, DOI 10.1016/j.yqres.2003.07.007; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Willis CG, 2014, NEW PHYTOL, V203, P300, DOI 10.1111/nph.12782	64	7	8	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159655	10.1371/journal.pone.0159655	http://dx.doi.org/10.1371/journal.pone.0159655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438267	gold, Green Submitted, Green Published			2022-12-27	WOS:000380170100061
J	Kulakowski, D; Veblen, TT; Bebi, P				Kulakowski, Dominik; Veblen, Thomas T.; Bebi, Peter			Fire Severity Controlled Susceptibility to a 1940s Spruce Beetle Outbreak in Colorado, USA	PLOS ONE			English	Article							SUB-ALPINE FORESTS; MOUNTAIN PINE-BEETLE; WESTERN COLORADO; DISTURBANCE REGIME; TREE REGENERATION; UNITED-STATES; BARK BEETLES; WILDFIRE; HISTORY; FUELS	The frequency, magnitude, and size of forest disturbances are increasing globally. Much recent research has focused on how the occurrence of one disturbance may affect susceptibility to subsequent disturbances. While much has been learned about such linked disturbances, the strength of the interactions is likely to be contingent on the severity of disturbances as well as climatic conditions, both of which can affect disturbance intensity and tree resistance to disturbances. Subalpine forests in western Colorado were affected by extensive and severe wildfires in the late 19th century and an extensive and severe outbreak of spruce beetle (Dendroctonus rufipennis) in the 1940s. Previous research found that most, but not all, of the stands that burned and established following the late 19th century fires were not susceptible to the 1940s outbreak as beetles preferentially attack larger trees and stands in advanced stages of development. However, previous research also left open the possibility that some stands that burned and established following the 19th century fires may have been attacked during the 1940s outbreak. Understanding how strongly stand structure, as shaped by disturbances of varying severity, affected susceptibility to past outbreaks is important to provide a baseline for assessing the degree to which recent climate change may be relaxing the preferences of beetles for larger trees and for stands in latter stages of structural development and thereby changing the nature of linked disturbances. Here, dendroecological methods were used to study disturbance history and tree age of stands in the White River National Forest in Western Colorado that were identified in historical documents or remotely-sensed images as having burned in the 19th century and having been attacked by spruce beetle in the 1940s. Dendroecological reconstructions indicate that in young post-fire stands only old remnant trees that survived the otherwise stand-replacing fires were killed in the 1940s outbreak. No young post-fire trees (< ca. 128 years) were susceptible to the 1940s outbreak, implying that under the relatively cool and wet conditions of the mid-20th century, susceptibility to and spatial patterns of spruce beetle outbreak were most likely controlled by variations in severity of prior disturbance by fire. This study provides a baseline for comparing linked disturbances under the relatively warmer and drier conditions of recent (e.g. post-1990) outbreaks in order to assess how climate mitigates the degree to which pre-disturbance history and structure affect susceptibility to disturbances.	[Kulakowski, Dominik] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA; [Kulakowski, Dominik; Bebi, Peter] WSL Inst Snow & Avalanche Res SLF, Davos, Switzerland; [Veblen, Thomas T.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA	Clark University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Colorado System; University of Colorado Boulder	Kulakowski, D (corresponding author), Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA.; Kulakowski, D (corresponding author), WSL Inst Snow & Avalanche Res SLF, Davos, Switzerland.	dkulakowski@clarku.edu	Veblen, Thomas T./U-6461-2018		National Science Foundation [1262691, 1262687]	National Science Foundation(National Science Foundation (NSF))	This material was supported by Awards 1262691 and 1262687 from the National Science Foundation.	Andrus RA, 2016, ECOL APPL, V26, P700, DOI 10.1890/15-1121; Bebi P, 2003, ECOLOGY, V84, P362, DOI 10.1890/0012-9658(2003)084[0362:IBFASB]2.0.CO;2; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Black SH, 2013, NAT AREA J, V33, P59, DOI 10.3375/043.033.0107; Cybis Elektronik, 2014, CDENDRO COORECORDER; Dennison PE, 2014, GEOPHYS RES LETT, V41, P2928, DOI 10.1002/2014GL059576; DeRose RJ, 2013, FOREST ECOL MANAG, V308, P198, DOI 10.1016/j.foreco.2013.07.061; DeRose RJ, 2012, CAN J FOREST RES, V42, P1649, DOI [10.1139/X2012-102, 10.1139/x2012-102]; DUNCAN R P, 1989, New Zealand Natural Sciences, V16, P31; Eisenhart KS, 2000, CAN J FOREST RES, V30, P1788, DOI 10.1139/cjfr-30-11-1788; Hansen EM, 2003, CAN ENTOMOL, V135, P697; Hart SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127975; Hart SJ, 2014, FOREST ECOL MANAG, V318, P44, DOI 10.1016/j.foreco.2013.12.035; Hart SJ, 2014, ECOLOGY, V95, P930, DOI 10.1890/13-0230.1; Harvey BJ, 2014, P NATL ACAD SCI USA, V111, P15120, DOI 10.1073/pnas.1411346111; Harvey BJ, 2014, ECOL APPL, V24, P1608, DOI 10.1890/13-1851.1; Hebertson EG, 2008, ENVIRON ENTOMOL, V37, P281; Herring SC, 2015, B AM METEOROLOGICAL, V96, P1; Hicke JA, 2012, FOREST ECOL MANAG, V271, P81, DOI 10.1016/j.foreco.2012.02.005; HINDS THOMAS E., 1965, J FOREST, V63, P536; Jarvis DS, 2015, J BIOGEOGR, V42, P1029, DOI 10.1111/jbi.12489; Jenkins MJ, 2008, FOREST ECOL MANAG, V254, P16, DOI 10.1016/j.foreco.2007.09.045; Jenkins MJ, 2014, FOREST SCI, V60, P489, DOI 10.5849/forsci.13-017; Jenkins MJ, 2012, FOREST ECOL MANAG, V275, P23, DOI 10.1016/j.foreco.2012.02.036; Kipfmueller KF, 1998, FOREST ECOL MANAG, V104, P171, DOI 10.1016/S0378-1127(97)00245-4; Kulakowski D, 2003, J BIOGEOGR, V30, P1445, DOI 10.1046/j.1365-2699.2003.00912.x; Kulakowski D, 2002, J ECOL, V90, P806, DOI 10.1046/j.1365-2745.2002.00722.x; Kulakowski D., 2015, MIXED HIGH SEVERITY, P149, DOI DOI 10.1016/B978-0-12-802749-3.00006-2; Kulakowski D, 2007, ECOLOGY, V88, P759, DOI 10.1890/06-0124; Kulakowski D, 2006, CAN J FOREST RES, V36, P2974, DOI 10.1139/X06-182; Kulakowski D, 2013, J VEG SCI, V24, P168, DOI 10.1111/j.1654-1103.2012.01437.x; Kulakowski D, 2012, J BIOGEOGR, V39, P2052, DOI 10.1111/j.1365-2699.2012.02748.x; Lukas J., 2014, CLIMATE CHANGE COLOR; MAST JN, 1994, PHYS GEOGR, V15, P529, DOI 10.1080/02723646.1994.10642533; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Meigs GW, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00037.1; Peterson TC, 2013, B AM METEOROL SOC, V94, P821, DOI 10.1175/BAMS-D-12-00066.1; ROMME WH, 1989, BIOSCIENCE, V39, P695, DOI 10.2307/1311000; Schmid J., 1974, RM131 USDA FOR SERV; Schmid J. M., 1977, USDA Forest Service General Technical Report, Rocky Mountain Forest and Range Experiment Station; Schoennagel T, 2007, ECOLOGY, V88, P2891, DOI 10.1890/06-1860.1; Sibold JS, 2006, J BIOGEOGR, V33, P631, DOI 10.1111/j.1365-2699.2005.01404.x; Simard M, 2011, ECOL MONOGR, V81, P3, DOI 10.1890/10-1176.1; Stokes M.A., 1968, INTRO TREE RING DATI; SUDWORTH GB, 2000, 20 ANN REPORT US G 5, P117; Temperli C, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00394.1; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; VEBLEN TT, 1991, ECOLOGY, V72, P213, DOI 10.2307/1938916; VEBLEN TT, 1994, J ECOL, V82, P125, DOI 10.2307/2261392	49	11	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158138	10.1371/journal.pone.0158138	http://dx.doi.org/10.1371/journal.pone.0158138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438289	Green Published, gold			2022-12-27	WOS:000380170100007
J	Mari-Sanchis, A; Gea, A; Basterra-Gortari, FJ; Martinez-Gonzalez, MA; Beunza, JJ; Bes-Rastrollo, M				Mari-Sanchis, A.; Gea, A.; Basterra-Gortari, F. J.; Martinez-Gonzalez, M. A.; Beunza, J. J.; Bes-Rastrollo, M.			Meat Consumption and Risk of Developing Type 2 Diabetes in the SUN Project: A Highly Educated Middle-Class Population	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; FOOD-FREQUENCY QUESTIONNAIRE; MEDITERRANEAN DIET; PHYSICAL-ACTIVITY; SEGUIMIENTO-UNIVERSIDAD; UNPROCESSED RED; PROCESSED MEATS; PUBLIC-HEALTH; HEART-DISEASE; WEIGHT-GAIN	Background Meat consumption has been consistently associated with the risk of diabetes in different populations. The aim of our study was to investigate the incidence of type 2 diabetes according to baseline total meat consumption in a longitudinal assessment of a middle-aged Mediterranean population. Methods We followed 18,527 participants (mean age: 38 years, 61% women) in the SUN Project, an open-enrolment cohort of a highly educated population of middle-class Spanish graduate students. All participants were initially free of diabetes. Diet was assessed at baseline using a semi-quantitative food frequency questionnaire of 136-items previously validated. Incident diabetes was defined according to the American Diabetes Association's criteria. Results We identified 146 incident cases of diabetes after a maximum of 14 years of follow-up period (mean: 8.7 years). In the fully adjusted model, the consumption of >= 3 servings/day of all types of meat was significantly associated with a higher risk of diabetes (HR: 1.85; 95% CI: 1.03-3.31; p for trend = 0.031) in comparison with the reference category (<2 servings/day). When we separated processed from non-processed meat, we observed a non-significant higher risk associated with greater consumption of processed meat and a non-significant lower risk associated with non-processed meat consumption (p for trend = 0.123 and 0.487, respectively). No significant difference was found between the two types of meat (p = 0.594). Conclusions Our results suggest that meat consumption, especially processed meat, was associated with a higher risk of developing diabetes in our young Mediterranean cohort.	[Mari-Sanchis, A.; Gea, A.; Basterra-Gortari, F. J.; Martinez-Gonzalez, M. A.; Bes-Rastrollo, M.] Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain; [Mari-Sanchis, A.] Hosp Navarra, Dept Endocrinol & Nutr, Nutr Unit, Pamplona, Spain; [Gea, A.; Martinez-Gonzalez, M. A.; Bes-Rastrollo, M.] Inst Salud Carlos III, CIBERobn, Madrid, Spain; [Gea, A.; Basterra-Gortari, F. J.; Martinez-Gonzalez, M. A.; Bes-Rastrollo, M.] Navarras Res Hlth Inst, IDISNA, Pamplona, Spain; [Basterra-Gortari, F. J.] Hosp Reina Sofia, Dept Internal Med, Endocrinol Unit, Tudela, Spain; [Beunza, J. J.] Univ Europea Madrid, Laureate Int Univ, Sch Biomed & Hlth Sci, Dept Clin Sci, Madrid, Spain	University of Navarra; Servicio Navarro de Salud - Osasunbidea; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Servicio Navarro de Salud - Osasunbidea; European University of Madrid	Bes-Rastrollo, M (corresponding author), Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain.; Bes-Rastrollo, M (corresponding author), Inst Salud Carlos III, CIBERobn, Madrid, Spain.; Bes-Rastrollo, M (corresponding author), Navarras Res Hlth Inst, IDISNA, Pamplona, Spain.	mbes@unav.es	Beunza, Juan-Jose/ABF-4650-2020; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Bes-Rastrollo, Maira/A-1329-2009	Bes-Rastrollo, Maira/0000-0002-9139-4206; Beunza, Juan-Jose/0000-0001-8192-2952; Gea, Alfredo/0000-0002-2229-4690; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Spanish Government-Instituto de Salud Carlos III; European Regional Development Fund (FEDER) [RD 06/0045]; Navarra Regional Government [45/2011, 122/2014]; University of Navarra; European Regional Development Fund (FEDER) (CIBER-OBN) [PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, G03/140]	Spanish Government-Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Regional Development Fund (FEDER)(European Commission); Navarra Regional Government; University of Navarra; European Regional Development Fund (FEDER) (CIBER-OBN)	The SUN Project has received funding from the Spanish Government-Instituto de Salud Carlos III, and the European Regional Development Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, and G03/140), the Navarra Regional Government (45/2011, 122/2014), and the University of Navarra.	Alemany M, 2012, NUTR RES REV, V25, P18, DOI 10.1017/S0954422411000163; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; [Anonymous], 2013, DIABETOLOGIA, V56, P47, DOI [10.1007/s00125-012-2718-7, DOI 10.1007/S00125-012-2718-7]; Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x; Bes-Rastrollo M, 2005, REV ESP OBESIDAD, V3, P352; Fernandez-Cao JC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1042; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065; Dominguez LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106627; Ericson U, 2013, BRIT J NUTR, V109, P1143, DOI 10.1017/S0007114512003017; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Feskens EJM, 2013, CURR DIABETES REP, V13, P298, DOI 10.1007/s11892-013-0365-0; FESKENS EJM, 1990, INT J EPIDEMIOL, V19, P953, DOI 10.1093/ije/19.4.953; FESKENS EJM, 1994, AM J EPIDEMIOL, V140, P350, DOI 10.1093/oxfordjournals.aje.a117257; FESKENS EJM, 1995, DIABETES CARE, V18, P1104, DOI 10.2337/diacare.18.8.1104; Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s; Fretts AM, 2015, AM J CLIN NUTR, V102, P1266, DOI 10.3945/ajcn.114.101238; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; Hodge AM, 2007, AM J EPIDEMIOL, V165, P603, DOI 10.1093/aje/kwk061; Hofmann SM, 2002, DIABETES, V51, P2082, DOI 10.2337/diabetes.51.7.2082; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892; International Diabetes Federation, 2013, IDF DIABETES ATLAS; KEYS A, 1995, AM J CLIN NUTR, V61, p1321S, DOI 10.1093/ajcn/61.6.1321S; Kim Y, 2015, METABOLISM, V64, P768, DOI 10.1016/j.metabol.2015.03.008; Kurotani K, 2013, BRIT J NUTR, V110, P1910, DOI 10.1017/S0007114513001128; Lajous M, 2012, DIABETES CARE, V35, P128, DOI 10.2337/dc11-1518; Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9; Mann JI, 2004, NUTR METAB CARDIOVAS, V14, P373, DOI 10.1016/S0939-4753(04)80028-0; Mannisto S, 2010, BRIT J NUTR, V103, P1817, DOI 10.1017/S0007114510000073; MARSHALL JA, 1994, DIABETES CARE, V17, P50, DOI 10.2337/diacare.17.1.50; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528; Micha R, 2012, CURR ATHEROSCLER REP, V14, P515, DOI 10.1007/s11883-012-0282-8; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094; Moreiras O., 2007, TABLA COMPOSICION AL, P37; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Peppa M, 2002, DIABETES CARE, V25, P1898, DOI 10.2337/diacare.25.10.1898; Salas-Salvado J, 2011, NUTR METAB CARDIOVAS, V21, pB32, DOI 10.1016/j.numecd.2011.03.009; Salas-Salvado J, 2014, ANN INTERN MED, V160, P1, DOI 10.7326/M13-1725; Salas-Salvado J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288; Sanchez-Villegas A, 2003, EUR J CLIN NUTR, V57, P285, DOI 10.1038/sj.ejcn.1601528; Sanchez-Villegas A, 2002, EUR J NUTR, V41, P249, DOI 10.1007/s00394-002-0382-2; Schulze MB, 2003, DIABETOLOGIA, V46, P1465, DOI 10.1007/s00125-003-1220-7; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; SNOWDON DA, 1985, AM J PUBLIC HEALTH, V75, P507, DOI 10.2105/AJPH.75.5.507; Song Y, 2004, DIABETES CARE, V27, P2108, DOI 10.2337/diacare.27.9.2108; Steinbrecher A, 2011, PUBLIC HEALTH NUTR, V14, P568, DOI 10.1017/S1368980010002004; Swaminathan S, 2007, DIABETES CARE, V30, P1926, DOI 10.2337/dc06-2625; Takata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056963; Tong M, 2009, J ALZHEIMERS DIS, V17, P827, DOI 10.3233/JAD-2009-1115; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Vang A, 2008, ANN NUTR METAB, V52, P96, DOI 10.1159/000121365; Villegas Raquel, 2006, Int J Med Sci, V3, P152; Zhao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041641	63	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0157990	10.1371/journal.pone.0157990	http://dx.doi.org/10.1371/journal.pone.0157990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437689	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100005
J	Meneses, ME; Martinez-Carrera, D; Torres, N; Sanchez-Tapia, M; Aguilar-Lopez, M; Morales, P; Sobal, M; Bernabe, T; Escudero, H; Granados-Portillo, O; Tovar, AR				Meneses, Maria E.; Martinez-Carrera, Daniel; Torres, Nimbe; Sanchez-Tapia, Monica; Aguilar-Lopez, Miriam; Morales, Porfirio; Sobal, Mercedes; Bernabe, Teodoro; Escudero, Helios; Granados-Portillo, Omar; Tovar, Armando R.			Hypocholesterolemic Properties and Prebiotic Effects of Mexican Ganoderma lucidum in C57BL/6 Mice	PLOS ONE			English	Article							BETA-GLUCANS; CHOLESTEROL; GUT; SUPPLEMENTATION; MODULATION; MICROBIOTA; MUSHROOMS; STEROLS; OBESITY; FIBER	Edible and medicinal mushrooms contain bioactive compounds with promising effects on several cardiovascular risk biomarkers. However, strains of Ganoderma lucidum of Mexican origin have not yet been studied. Standardized extracts of G. lucidum (Gl) were given to C57BL/6 mice fed a high-cholesterol diet compared with the drug simvastatin. The effects of the extracts on serum biochemical parameters, liver lipid content, cholesterol metabolism, and the composition of gut microbiota were assessed. Acetylsalicylic acid (10 mM) added to the cultivation substrate modulated properties of Gl extracts obtained from mature basidiomata. Compared to the high-cholesterol diet group, the consumption of Gl extracts significantly reduced total serum cholesterol (by 19.2% to 27.1%), LDL-C (by 4.5% to 35.1%), triglyceride concentration (by 16.3% to 46.6%), hepatic cholesterol (by 28.7% to 52%) and hepatic triglycerides (by 43.8% to 56.6%). These effects were associated with a significant reduction in the expression of lipogenic genes (Hmgcr, Srebp1c, Fasn, and Acaca) and genes involved in reverse cholesterol transport (Abcg5 and Abcg8), as well as an increase in Ldlr gene expression in the liver. No significant changes were observed in the gene expression of Srebp2, Abca1 or Cyp7a1. In several cases, Gl-1 or Gl-2 extracts showed better effects on lipid metabolism than the drug simvastatin. A proposed mechanism of action for the reduction in cholesterol levels is mediated by alpha-glucans and beta-glucans from Gl, which promoted decreased absorption of cholesterol in the gut, as well as greater excretion of fecal bile acids and cholesterol. The prebiotic effects of Gl-1 and Gl-2 extracts modulated the composition of gut microbiota and produced an increase in the Lactobacillaceae family and Lactobacillus genus level compared to the control group, high-cholesterol diet group and group supplemented with simvastatin. Mexican genetic resources of Gl represent a new source of bioactive compounds showing hypocholesterolemic properties and prebiotic effects.	[Meneses, Maria E.] CONACYT Colegio Postgrad, Campus Puebla, Puebla, Puebla, Mexico; [Martinez-Carrera, Daniel; Morales, Porfirio; Sobal, Mercedes; Bernabe, Teodoro; Escudero, Helios] CP, Biotecnol Hongos Comestibles Func & Med, Campus Puebla, Puebla, Puebla, Mexico; [Torres, Nimbe; Sanchez-Tapia, Monica; Aguilar-Lopez, Miriam; Granados-Portillo, Omar; Tovar, Armando R.] INCMNSZ, Dept Fisiol Nutr, Ciudad De Mexico, Mexico		Martinez-Carrera, D (corresponding author), CP, Biotecnol Hongos Comestibles Func & Med, Campus Puebla, Puebla, Puebla, Mexico.; Tovar, AR (corresponding author), INCMNSZ, Dept Fisiol Nutr, Ciudad De Mexico, Mexico.	dcarrera@colpos.mx; tovar.ar@gmail.com	Aguilar-Lopez, Miriam/CJH-4026-2022; González, Teodoro Bernabé/AAQ-4183-2020; Torres, Nimbe/AAY-8821-2020; Meneses, María E./HHN-1339-2022; Torres, Nimbe/AAI-4340-2020	Aguilar-Lopez, Miriam/0000-0003-2010-1653; González, Teodoro Bernabé/0000-0003-1428-7332; Torres, Nimbe/0000-0002-1741-0984; Meneses, María E./0000-0002-7689-7024; Sanchez-Tapia, Monica/0000-0001-9748-5734	National Council of Science and Technology (CONACYT) in Mexico, through Research Project "105 Genomica de las Propiedades Funcionales y Medicinales de los Hongos Comestibles de Mexico"; CONACYT [290754]; Dannon Institute of Mexico	National Council of Science and Technology (CONACYT) in Mexico, through Research Project "105 Genomica de las Propiedades Funcionales y Medicinales de los Hongos Comestibles de Mexico"; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Dannon Institute of Mexico	The research work was supported by the National Council of Science and Technology (CONACYT; www.conacyt.mx) in Mexico, through the Research Project "105 Genomica de las Propiedades Funcionales y Medicinales de los Hongos Comestibles de Mexico," directed by DMC; CONACYT also supported the Postdoctoral Position for MEM (agreement no. 290754). A grant from Dannon Institute of Mexico was received by NT. The funders had no role in study design, data collection	Batta AK, 1999, J LIPID RES, V40, P1148; Berger A, 2004, Lipids Health Dis, V3, P2, DOI 10.1186/1476-511X-3-2; Brownawell AM, 2010, NUTR REV, V68, P355, DOI 10.1111/j.1753-4887.2010.00294.x; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Caz V, 2015, J AGR FOOD CHEM, V63, P7371, DOI 10.1021/acs.jafc.5b02942; Chang CJ, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8489, 10.1038/ncomms8216]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freckmann G, 2014, DIABETES TECHNOL THE, V16, P113, DOI 10.1089/dia.2013.0208; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guillamon E, 2010, FITOTERAPIA, V81, P715, DOI 10.1016/j.fitote.2010.06.005; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Hajjaj H, 2005, APPL ENVIRON MICROB, V71, P3653, DOI 10.1128/AEM.71.7.3653-3658.2005; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jones ML, 2012, BRIT J NUTR, V107, P1505, DOI 10.1017/S0007114511004703; Keller S, 2004, J CHROMATOGR B, V813, P199, DOI 10.1016/j.jchromb.2004.09.046; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Nicolosi R, 1999, AM J CLIN NUTR, V70, P208; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Pan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068332; Ramuirez JuuYrez J., 2016, CIENCIA TECNOLOGIA I; Reeves PG, 1997, J NUTR, V127, pS838; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rop O, 2009, NUTR REV, V67, P624, DOI 10.1111/j.1753-4887.2009.00230.x; Snart J, 2006, APPL ENVIRON MICROB, V72, P1925, DOI 10.1128/AEM.72.3.1925-1931.2006; Theuwissen E, 2008, PHYSIOL BEHAV, V94, P285, DOI 10.1016/j.physbeh.2008.01.001; Torres N, 2015, ARCH MED RES, V46, P408, DOI 10.1016/j.arcmed.2015.05.010; Vetvicka V, 2009, J IMMUNOTOXICOL, V6, P30, DOI 10.1080/15476910802604317; Wachtel-Galor S, 2004, INT J FOOD SCI NUTR, V55, P75, DOI 10.1080/09637480310001642510; Wang CD, 2012, BRIT J NUTR, V108, P2014, DOI 10.1017/S0007114512000153; Wang LX, 2013, WORLD J GASTROENTERO, V19, P3150, DOI 10.3748/wjg.v19.i20.3150; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65	37	36	39	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159631	10.1371/journal.pone.0159631	http://dx.doi.org/10.1371/journal.pone.0159631			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438015	gold, Green Submitted, Green Published			2022-12-27	WOS:000380170100058
J	Sandstrom, GM; Tseng, VWS; Costa, J; Okeke, F; Choudhury, T; Dunn, EW				Sandstrom, Gillian M.; Tseng, Vincent Wen-Sheng; Costa, Jean; Okeke, Fabian; Choudhury, Tanzeem; Dunn, Elizabeth W.			Talking Less during Social Interactions Predicts Enjoyment: A Mobile Sensing Pilot Study	PLOS ONE			English	Article							PERSONALITY; PERFORMANCE; EXPRESSION; DOMINANCE; TIME; MOOD	Can we predict which conversations are enjoyable without hearing the words that are spoken? A total of 36 participants used a mobile app, My Social Ties, which collected data about 473 conversations that the participants engaged in as they went about their daily lives. We tested whether conversational properties (conversation length, rate of turn taking, proportion of speaking time) and acoustical properties (volume, pitch) could predict enjoyment of a conversation. Surprisingly, people enjoyed their conversations more when they spoke a smaller proportion of the time. This pilot study demonstrates how conversational properties of social interactions can predict psychologically meaningful outcomes, such as how much a person enjoys the conversation. It also illustrates how mobile phones can provide a window into everyday social experiences and well-being.	[Sandstrom, Gillian M.; Dunn, Elizabeth W.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Tseng, Vincent Wen-Sheng; Costa, Jean; Okeke, Fabian; Choudhury, Tanzeem] Cornell Univ, Dept Informat Sci, Ithaca, NY USA; [Sandstrom, Gillian M.] Univ Essex, Dept Psychol, Colchester, Essex, England	University of British Columbia; Cornell University; University of Essex	Sandstrom, GM (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	gsands@essex.ac.uk		Sandstrom, Gillian/0000-0002-0549-9600	Social Sciences and Humanities Research Council of Canada [752-2011-2192, 410-2011-0582]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was funded by the Social Sciences and Humanities Research Council of Canada, both through a Doctoral Fellowship to GMS [752-2011-2192] and a Standard Research Grant to EWD [410-2011-0582]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aron A, 1997, PERS SOC PSYCHOL B, V23, P363, DOI 10.1177/0146167297234003; Berry DS, 1996, J PERS SOC PSYCHOL, V71, P796, DOI 10.1037/0022-3514.71.4.796; Carney DR, 2005, J NONVERBAL BEHAV, V29, P105, DOI 10.1007/s10919-005-2743-z; Cheng JT, 2016, J EXP PSYCHOL GEN, V145, P536, DOI 10.1037/xge0000166; Choudhury T, 2004, P NAACOS; Choudhury T, 2004, ADV NEURAL INF PROCE; CLARK LA, 1988, J PERS SOC PSYCHOL, V54, P296, DOI 10.1037/0022-3514.54.2.296; Fiori KL, 2013, GERONTOLOGY, V59, P40, DOI 10.1159/000339747; FRICK RW, 1985, PSYCHOL BULL, V97, P412, DOI 10.1037/0033-2909.97.3.412; Human LJ, 2011, J PERS SOC PSYCHOL, V100, P349, DOI 10.1037/a0021850; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Krueger A.B., 2009, MEASURING SUBJECTIVE, P9; Little MA, 2009, IEEE T BIO-MED ENG, V56, P1015, DOI 10.1109/TBME.2008.2005954; LITTLEPAGE GE, 1995, J PERS SOC PSYCHOL, V69, P877, DOI 10.1037/0022-3514.69.5.877; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Madan A, 2005, P INT C AUGM COGN LA; Mast MS, 2002, HUM COMMUN RES, V28, P420, DOI 10.1111/j.1468-2958.2002.tb00814.x; Mehl MR, 2006, J PERS SOC PSYCHOL, V90, P862, DOI 10.1037/0022-3514.90.5.862; Pantic M., 2011, VISUAL ANAL HUMANS, P511, DOI DOI 10.1007/978-0-85729-997-0_26; PAVOT W, 1990, PERS INDIV DIFFER, V11, P1299, DOI 10.1016/0191-8869(90)90157-M; Pentland Alex, 2004, INT C DEV LEARN, V5; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROOK KS, 1990, S AP PSYC S, P173; Sandstrom GM, 2014, PERS SOC PSYCHOL B, V40, P910, DOI 10.1177/0146167214529799; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Shum  S., 2011, THESIS; Shum S, 2011, 12TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2011 (INTERSPEECH 2011), VOLS 1-5, P952; Thompson WF, 2004, EMOTION, V4, P46, DOI 10.1037/1528-3542.4.1.46; Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; vanBezooijen R, 1995, LANG SPEECH, V38, P253, DOI 10.1177/002383099503800303; Vittengl JR, 1998, MOTIV EMOTION, V22, P255, DOI 10.1023/A:1022388123550; WATSON D, 1992, J PERS SOC PSYCHOL, V63, P1011, DOI 10.1037/0022-3514.63.6.1011; Wyatt D., 2007, INTERSPEECH, P586; Wyatt D, 2007, INT CONF ACOUST SPEE, P213; Yuan J., 2006, INTERSPEECH	37	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158834	10.1371/journal.pone.0158834	http://dx.doi.org/10.1371/journal.pone.0158834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27438475	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000380170100023
J	Hill, LJB; Coats, RO; Mushtaq, F; Williams, JHG; Aucott, LS; Mon-Williams, M				Hill, Liam J. B.; Coats, Rachel O.; Mushtaq, Faisal; Williams, Justin H. G.; Aucott, Lorna S.; Mon-Williams, Mark			Moving to Capture Children's Attention: Developing a Methodology for Measuring Visuomotor Attention	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; REACTION-TIME VARIABILITY; FEATURE-INTEGRATION-THEORY; PARENT RATING-SCALE; DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; POSTURAL STABILITY; EXECUTIVE FUNCTION; ACADEMIC-ACHIEVEMENT; SUSTAINED ATTENTION	Attention underpins many activities integral to a child's development. However, methodological limitations currently make large-scale assessment of children's attentional skill impractical, costly and lacking in ecological validity. Consequently we developed a measure of 'Visual Motor Attention' (VMA)-a construct defined as the ability to sustain and adapt visuomotor behaviour in response to task-relevant visual information. In a series of experiments, we evaluated the capability of our method to measure attentional processes and their contributions in guiding visuomotor behaviour. Experiment 1 established the method's core features (ability to track stimuli moving on a tablet-computer screen with a hand-held stylus) and demonstrated its sensitivity to principled manipulations in adults' attentional load. Experiment 2 standardised a format suitable for use with children and showed construct validity by capturing developmental changes in executive attention processes. Experiment 3 tested the hypothesis that children with and without coordination difficulties would show qualitatively different response patterns, finding an interaction between the cognitive and motor factors underpinning responses. Experiment 4 identified associations between VMA performance and existing standardised attention assessments and thereby confirmed convergent validity. These results establish a novel approach to measuring childhood attention that can produce meaningful functional assessments that capture how attention operates in an ecologically valid context (i.e. attention's specific contribution to visuomanual action).	[Hill, Liam J. B.; Coats, Rachel O.; Mushtaq, Faisal; Mon-Williams, Mark] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England; [Williams, Justin H. G.; Aucott, Lorna S.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	University of Leeds; University of Aberdeen	Hill, LJB (corresponding author), Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England.	paclab@leeds.ac.uk	Mushtaq, Faisal/H-4800-2019; Williams, Justin/AAE-5903-2020; Coats, Rachel/AAH-6980-2019	Mushtaq, Faisal/0000-0001-7881-1127; Coats, Rachel/0000-0003-4415-408X; Aucott, Lorna/0000-0001-6277-7972; Mon-Williams, Mark/0000-0001-7595-8545; Hill, Liam/0000-0002-4069-5121	Medical Research Council (MRC) scholarship; MRC Centenary Early Career Award; Waterloo Foundation (TWF) [1285/1986]	Medical Research Council (MRC) scholarship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centenary Early Career Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Waterloo Foundation (TWF)	Authors LH and MMW are part of the Healthy Children, Healthy Families Theme of the National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Yorkshire and Humber (www.clahrc-yh.nihr.ac.uk/). Please note, the views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR and the Department of Health. At different points in time this programme of research has been supported by a Medical Research Council (MRC; www.mrc.ac.uk) scholarship, an MRC Centenary Early Career Award and a grant from The Waterloo Foundation (TWF reference: 1285/1986; www. waterloofoundation.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo N, 2014, J ATTEN DISORD, V18, P434, DOI 10.1177/1087054712439419; Altman D.G., 1991, PRACTICAL STATISTIC; AMMONS RB, 1955, J EXP PSYCHOL, V49, P127, DOI 10.1037/h0044345; Antonini TN, 2013, NEUROPSYCHOLOGY, V27, P201, DOI 10.1037/a0032071; Aylward GP, 1997, ASSESSMENT, V4, P325, DOI 10.1177/107319119700400403; Bard DE, 2013, J DEV BEHAV PEDIATR, V34, P72, DOI 10.1097/DBP.0b013e31827a3a22; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bernardi M, 2016, CHILD NEUROPSYCHOL, V22, P627, DOI 10.1080/09297049.2015.1014898; Best JR, 2011, LEARN INDIVID DIFFER, V21, P327, DOI 10.1016/j.lindif.2011.01.007; Boiteau TW, 2014, J EXP PSYCHOL GEN, V143, P295, DOI 10.1037/a0031858; Boonyong S, 2012, GAIT POSTURE, V35, P428, DOI 10.1016/j.gaitpost.2011.11.002; Breckenridge K, 2013, BRIT J DEV PSYCHOL, V31, P271, DOI 10.1111/bjdp.12004; Brockmole JR, 2013, CURR DIR PSYCHOL SCI, V22, P38, DOI 10.1177/0963721412465065; Brogan E, 2014, ARCH DIS CHILD, V99, P834, DOI 10.1136/archdischild-2013-305532; Brossard-Racine M, 2011, RES DEV DISABIL, V32, P2927, DOI 10.1016/j.ridd.2011.05.010; Brown JD, 2006, AMBUL PEDIATR, V6, P347, DOI 10.1016/j.ambp.2006.09.004; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cairney J, 2010, CURR OPIN PSYCHIATR, V23, P324, DOI 10.1097/YCO.0b013e32833aa0aa; Carter L, 2013, BRAIN COGNITION, V82, P35, DOI 10.1016/j.bandc.2013.02.002; Clark A, 1999, TRENDS COGN SCI, V3, P345, DOI 10.1016/S1364-6613(99)01361-3; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Culmer PR, 2009, J NEUROSCI METH, V184, P184, DOI 10.1016/j.jneumeth.2009.07.025; Danna J, 2012, J EXP CHILD PSYCHOL, V111, P37, DOI 10.1016/j.jecp.2011.07.005; Davies SC, 2013, LANCET, V382, P1383, DOI 10.1016/S0140-6736(13)62004-8; Desjardins JL, 2013, EAR HEARING, V34, P261, DOI 10.1097/AUD.0b013e31826d0ba4; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Dickerson MS, 2001, CHILD NEUROPSYCHOL, V7, P32, DOI DOI 10.1076/CHIN.7.1.32.3151; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Finley JR, 2014, J EXP PSYCHOL-APPL, V20, P158, DOI 10.1037/xap0000010; Flatters I, 2014, EXP BRAIN RES, V232, P2907, DOI 10.1007/s00221-014-3947-4; Flatters I, 2014, EXP BRAIN RES, V232, P1953, DOI 10.1007/s00221-014-3886-0; Flatters I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088692; Forbes GB, 1998, J CLIN PSYCHOL, V54, P461, DOI 10.1002/(SICI)1097-4679(199806)54:4<461::AID-JCLP8>3.3.CO;2-S; Forns J, 2014, NEUROPSYCHOLOGY, V28, P519, DOI 10.1037/neu0000085; Freund AM, 1998, PSYCHOL AGING, V13, P531, DOI 10.1037/0882-7974.13.4.531; Fuentes CT, 2009, NEUROLOGY, V73, P1532, DOI 10.1212/WNL.0b013e3181c0d48c; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gilden DL, 2007, PSYCHOL SCI, V18, P796, DOI 10.1111/j.1467-9280.2007.01982.x; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; GORDON M, 1988, Journal of Clinical Psychology, V44, P682, DOI 10.1002/1097-4679(198809)44:5<682::AID-JCLP2270440504>3.0.CO;2-E; GORDON M, 1996, GORDON DIAGNOSTIC SY; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Helps SK, 2011, NEUROPSYCHOLOGY, V25, P711, DOI 10.1037/a0024479; Helton WS, 2009, J CLIN EXP NEUROPSYC, V31, P39, DOI 10.1080/13803390801978856; Herwig A, 2015, NEUROSCI BIOBEHAV R, V52, P105, DOI 10.1016/j.neubiorev.2015.02.013; Hill LJB, 2016, EUR CHILD ADOLES PSY, V25, P283, DOI 10.1007/s00787-015-0732-2; HOLLERBACH JM, 1981, BIOL CYBERN, V39, P139, DOI 10.1007/BF00336740; Irwin-Chase H, 2000, J EXP CHILD PSYCHOL, V77, P61, DOI 10.1006/jecp.1999.2557; Jacobi-Polishook T, 2009, J NEUROL SCI, V280, P15, DOI 10.1016/j.jns.2009.01.007; Jaekel J, 2013, PSYCHOL MED, V43, P183, DOI 10.1017/S0033291712001031; Jans B, 2010, PSYCHOL REV, V117, P637, DOI 10.1037/a0019082; Johnson S, 2014, DEV MED CHILD NEUROL, V56, P453, DOI 10.1111/dmcn.12360; Kahneman D, 1973, ATTENTION EFFORT; Kane MJ, 2006, J EXP PSYCHOL LEARN, V32, P749, DOI 10.1037/0278-7393.32.4.749; Kelly TP, 2000, CHILD NEUROPSYCHOL, V6, P24, DOI 10.1076/0929-7049(200003)6:1;1-B;FT024; Kemper S, 2010, PSYCHOL AGING, V25, P949, DOI 10.1037/a0020000; Kofler MJ, 2013, CLIN PSYCHOL REV, V33, P795, DOI 10.1016/j.cpr.2013.06.001; Korkman M, 2001, DEV NEUROPSYCHOL, V20, P331, DOI 10.1207/S15326942DN2001_2; Krampe RT, 2011, GAIT POSTURE, V33, P401, DOI 10.1016/j.gaitpost.2010.12.012; Leitner Y, 2007, J NEUROL, V254, P1330, DOI 10.1007/s00415-006-0522-3; Leslie LK, 2004, PEDIATRICS, V114, P129, DOI 10.1542/peds.114.1.129; Marmot M, 2010, FAIR SOC HLTH LIVES; Martin NC, 2010, HUM MOVEMENT SCI, V29, P799, DOI 10.1016/j.humov.2009.09.005; Mayes SD, 2007, CHILD NEUROPSYCHOL, V13, P469, DOI 10.1080/09297040601112773; Mayes SD, 2009, J ATTEN DISORD, V12, P540, DOI 10.1177/1087054708320402; McClelland MM, 2013, EARLY CHILD RES Q, V28, P314, DOI 10.1016/j.ecresq.2012.07.008; McDermott PA, 2014, PSYCHOL ASSESSMENT, V26, P207, DOI 10.1037/a0034832; Medwell J, 2014, LANG EDUC-UK, V28, P34, DOI 10.1080/09500782.2013.763819; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Ogundele MO, 2011, PROG NEUROL PSYCHIAT, V15, P8, DOI 10.1002/pnp.198; Papaioannou S, 2016, EDUC PSYCHOL-UK, V36, P138, DOI 10.1080/01443410.2014.915931; Perou R, 2013, MMWR-MORBID MORTAL W, V62, P1; Pieters S, 2012, CHILD CARE HLTH DEV, V38, P139, DOI 10.1111/j.1365-2214.2011.01225.x; Piper BJ, 2011, J NEUROSCI METH, V195, P88, DOI 10.1016/j.jneumeth.2010.11.018; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Quinlan PT, 2003, PSYCHOL BULL, V129, P643, DOI 10.1037/0033-2909.129.5.643; Racine MB, 2008, J CHILD NEUROL, V23, P399, DOI 10.1177/0883073807309244; Rapp MA, 2006, AM J GERIAT PSYCHIAT, V14, P52, DOI 10.1097/01.JGP.0000192490.43179.e7; Reilly DS, 2008, J MOTOR BEHAV, V40, P90, DOI 10.3200/JMBR.40.2.90-102; Ren XZ, 2013, ACTA PSYCHOL, V142, P195, DOI 10.1016/j.actpsy.2012.12.007; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Russell G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080247; Schaefer S, 2008, DEV PSYCHOL, V44, P747, DOI 10.1037/0012-1649.44.3.747; Shalev L, 2011, NEUROPSYCHOLOGIA, V49, P2584, DOI 10.1016/j.neuropsychologia.2011.05.006; Shaw M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-99; Sjowall D, 2014, DEV NEUROPSYCHOL, V39, P187, DOI 10.1080/87565641.2014.886691; Skogsberg K, 2015, J EXP PSYCHOL HUMAN, V41, P761, DOI 10.1037/a0039000; Stirling LA, 2013, J GERONTOL A-BIOL, V68, P938, DOI 10.1093/gerona/glt003; Tamm L, 2012, NEUROTHERAPEUTICS, V9, P500, DOI 10.1007/s13311-012-0138-5; Tarantino V, 2013, J INT NEUROPSYCH SOC, V19, P820, DOI 10.1017/S1355617713000623; Teicher MH, 2004, J CHILD ADOL PSYCHOP, V14, P219, DOI 10.1089/1044546041648995; Thelen E., 1994, DYNAMIC SYSTEMS APPR; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tseng MH, 2004, DEV MED CHILD NEUROL, V46, P381, DOI 10.1017/S0012162204000623; Ullebo AK, 2011, EUR CHILD ADOLES PSY, V20, P451, DOI 10.1007/s00787-011-0198-9; Westendorp M, 2011, RES DEV DISABIL, V32, P2773, DOI 10.1016/j.ridd.2011.05.032; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Wolraich ML, 2003, J PEDIATR PSYCHOL, V28, P559, DOI 10.1093/jpepsy/jsg046; Wu SY, 2013, RES DEV DISABIL, V34, P505, DOI 10.1016/j.ridd.2012.09.004; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	106	0	0	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159543	10.1371/journal.pone.0159543	http://dx.doi.org/10.1371/journal.pone.0159543			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434198	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600066
J	Nakano, Y; Shimazaki, T; Kobayashi, N; Miyoshi, Y; Ono, A; Kobayashi, M; Shiragami, C; Hirooka, K; Tsujikawa, A				Nakano, Yuki; Shimazaki, Takeru; Kobayashi, Nobuko; Miyoshi, Yukiko; Ono, Aoi; Kobayashi, Mamoru; Shiragami, Chieko; Hirooka, Kazuyuki; Tsujikawa, Akitaka			Retinal Oximetry in a Healthy Japanese Population	PLOS ONE			English	Article							VESSEL OXYGEN-SATURATION; RETINITIS-PIGMENTOSA; GLAUCOMA PATIENTS; VEIN OCCLUSION; DIAMETER; EYES; RELIABILITY; REPRODUCIBILITY; VALUES	Purpose To establish the normative database of retinal oximetry using Oxymap T1 in a healthy Japanese population, and study the reproducibility of the measurements in Japanese. Methods We measured oxygen saturation in the major retinal vessels with Oxymap T1 in 252 eyes of 252 healthy Japanese subjects. Fundus images acquired using Oxymap T1 were processed using built-in Oxymap Analyzer software. Reproducibility of retinal oximetry was investigated using 20 eyes of 20 healthy subjects. Results The mean retinal oxygen saturation of 4 quadrants in healthy Japanese was 97.0 +/- 6.9% in arteries and 52.8 +/- 8.3% in veins. The mean arteriovenous difference in oxygen saturation was 44.2 +/- 9.2%. Both arterial and venous oxygen saturation were significantly lower in the temporal side of the retina, especially in the temporal-inferior vessels. However, the arteriovenous difference in oxygen saturation was limited in the 4 quadrants. Interphotograph, intervisit, and interevaluator intraclass correlation coefficients were 0.936-0.979, 0.809-0.837, and 0.732-0.947, respectively. In the major retinal arteries, oxygen saturation increased with age (r = 0.18, p<0.01), at a rate of 0.67% per 10 years. However, venous oxygen saturation showed no correlation with age. Conclusions This study provides the normative database for the Japanese population. The arterial saturation value appears to be higher than other previous studies. Mean retinal oximetry in 4 quadrants with Oxymap T1 has high reproducibility.	[Nakano, Yuki; Shimazaki, Takeru; Kobayashi, Nobuko; Miyoshi, Yukiko; Ono, Aoi; Kobayashi, Mamoru; Shiragami, Chieko; Hirooka, Kazuyuki; Tsujikawa, Akitaka] Kagawa Univ, Fac Med, Dept Ophthalmol, Miki, Kagawa, Japan	Kagawa University	Nakano, Y (corresponding author), Kagawa Univ, Fac Med, Dept Ophthalmol, Miki, Kagawa, Japan.	nakano.tee@gmail.com		Tsujikawa, Akitaka/0000-0003-0779-7799				Battu R, 2015, INVEST OPHTH VIS SCI, V56, P2798, DOI 10.1167/iovs.14-15993; Beach JM, 1999, J APPL PHYSIOL, V86, P748, DOI 10.1152/jappl.1999.86.2.748; Blondal R, 2011, GRAEF ARCH CLIN EXP, V249, P1311, DOI 10.1007/s00417-011-1680-2; Boeckaert J, 2012, Bull Soc Belge Ophtalmol, P75; Eliasdottir TS, 2015, GRAEF ARCH CLIN EXP, V253, P1653, DOI 10.1007/s00417-014-2849-2; Eysteinsson T, 2014, ACTA OPHTHALMOL, V92, P449, DOI 10.1111/aos.12359; Geirsdottir A, 2012, INVEST OPHTH VIS SCI, V53, P5433, DOI 10.1167/iovs.12-9912; Goharian I, 2015, BRIT J OPHTHALMOL, V99, P318, DOI 10.1136/bjophthalmol-2014-305718; Hammer M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976032; Hardarson SH, 2013, ACTA OPHTHALMOL, V91, P1, DOI 10.1111/aos.12086; Heitmar R, 2016, ACTA OPHTHALMOL, V94, P48, DOI 10.1111/aos.12826; Heitmar R, 2013, INVEST OPHTH VIS SCI, V54, P2807, DOI 10.1167/iovs.12-10493; Jani PD, 2014, RETINA-J RET VIT DIS, V34, P394, DOI 10.1097/IAE.0b013e3182979e7b; Jorgensen CM, 2014, ACTA OPHTHALMOL, V92, P34, DOI 10.1111/aos.12283; Kaur C, 2008, CLIN OPHTHALMOL, V2, P879, DOI 10.2147/opth.s3361; Leung H, 2003, INVEST OPHTH VIS SCI, V44, P2900, DOI 10.1167/iovs.02-1114; Mohan A, 2016, CURR EYE RES, V41, P1223, DOI 10.3109/02713683.2015.1104361; Mohan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126179; O'Connell RA, 2014, OPTOMETRY VISION SCI, V91, P608, DOI 10.1097/OPX.0000000000000257; Olafsdottir OB, 2014, BRIT J OPHTHALMOL, V98, P329, DOI 10.1136/bjophthalmol-2013-303162; Palsson O, 2012, INVEST OPHTH VIS SCI, V53, P1729, DOI 10.1167/iovs.11-8621; Paul JP, 2013, OPTOMETRY VISION SCI, V90, P1104, DOI 10.1097/OPX.0000000000000028; Schweitzer D, 1999, IEEE T BIO-MED ENG, V46, P1454, DOI 10.1109/10.804573; Shahidi AM, 2013, EXP EYE RES, V113, P143, DOI 10.1016/j.exer.2013.06.001; Traustason S, 2014, BRIT J OPHTHALMOL, V98, P1208, DOI 10.1136/bjophthalmol-2013-304580; Traustason S, 2013, INVEST OPHTH VIS SCI, V54, P2746, DOI 10.1167/iovs.12-11284; Turksever C, 2015, ACTA OPHTHALMOL, V93, pE439, DOI 10.1111/aos.12598; Ueda-Consolvo T, 2015, ACTA OPHTHALMOL, V93, pE446, DOI 10.1111/aos.12597; Vandewalle E, 2014, ACTA OPHTHALMOL, V92, P105, DOI 10.1111/aos.12011; Vandewalle E, 2013, ACTA OPHTHALMOL, V91, P733, DOI 10.1111/j.1755-3768.2012.02545.x; Yip W, 2014, INVEST OPHTH VIS SCI, V55, P7104, DOI 10.1167/iovs.13-13854; Zheng QS, 2015, OPHTHAL PHYSL OPT, V35, P562, DOI 10.1111/opo.12223; Zong Y, 2016, GRAEF ARCH CLIN EXP, V254, P243, DOI 10.1007/s00417-015-3039-6	33	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159650	10.1371/journal.pone.0159650	http://dx.doi.org/10.1371/journal.pone.0159650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434373	Green Submitted, gold, Green Published			2022-12-27	WOS:000380169600079
J	Soriano, LC; Soriano-Gabarro, M; Rodriguez, LAG				Cea Soriano, Lucia; Soriano-Gabarro, Montse; Garcia Rodriguez, Luis A.			The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice	PLOS ONE			English	Article							HEALTH IMPROVEMENT NETWORK; TRIALS; PREVENTION; VALIDATION; DATABASE; RISK	Background We conducted three differently designed nested case-control studies to evaluate whether the protective effect of low-dose aspirin against colorectal cancer (CRC) is explained by selection bias. Methods Using a large validated UK primary care database, we followed different cohorts of patients, who varied in their demographic and clinical characteristics, to identify first ever cases of CRC. In Studies 1 and 2, two cohorts were followed, i) new users of low-dose aspirin at start of follow-up (N = 170,336 in Study 1, N = 171,527 in Study 2) and either ii) non-users of low-dose aspirin (Study 1, N = 170,336) or new users of paracetamol (Study 2, N = 149,597) at start of follow-up. In Study 3 a single cohort of individuals naive to low-dose aspirin at the start of observation was followed. Controls were selected using incidence sampling and logistic regression used to obtain an unbiased estimate of the incidence rate ratio (RR) with 95% confidence intervals (CIs). Low-dose aspirin exposure was analyzed 'as-treated' before the index date (CRC date for cases, random date for controls). Results In the three studies, median (maximum) follow-up was 5.1 (12), 5.8 (12) and 7.5 (13) years, respectively. 3033 incident CRC cases were identified in Study 1, 3174 in Study 2, and 12,333 in Study 3. Current use of low-dose aspirin was associated with a significantly reduced risk of 34%, 29% and 31% in the three studies, respectively; corresponding RRs (95% CIs) were 0.66 (0.60-0.73), 0.71 (0.63-0.80) and 0.69 (0.64-0.74). In each study, significantly reduced risks of CRC were seen when low-dose aspirin was used for primary or secondary cardiovascular disease prevention, in both sexes, and across all age groups evaluated. Conclusion Low-dose aspirin is associated with a significantly reduced risk of CRC. The consistency of our findings across different studies makes selection bias an unlikely explanation.	[Cea Soriano, Lucia; Garcia Rodriguez, Luis A.] Spanish Ctr Pharmacoepidemiol Res, Madrid, Spain; [Soriano-Gabarro, Montse] Bayer Pharma AG, Epidemiol, Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals	Rodriguez, LAG (corresponding author), Spanish Ctr Pharmacoepidemiol Res, Madrid, Spain.	lagarcia@ceife.es	Soriano, Lucia Cea/D-4380-2018; rodriguez, luis a garcia/B-1980-2010	Soriano, Lucia Cea/0000-0002-7051-0730; 	Bayer Pharma AG	Bayer Pharma AG	This study was funded by Bayer Pharma AG. The funder provided support in the form of salaries for MS-G, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Susan Bromley of EpiMed Communications Ltd for medical writing assistance funded by Bayer Pharma AG.	Blak Betina T, 2011, Inform Prim Care, V19, P251; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Soriano LC, 2016, PHARMACOEPIDEM DR S, V25, P385, DOI 10.1002/pds.3877; Soriano LC, 2016, PHARMACOEPIDEM DR S, V25, P392, DOI 10.1002/pds.3926; Soriano LC, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00126; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garcia Rodriguez LA, 2015, DIG DIS WEEK WASH DC; Rodriguez LAG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4094; Health IMS, THIN DAT STAT; Information Services Division Scotland, CANC STAT COL CANC; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Office for National Statistics, 2009, COLORECTAL CANC; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138	19	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159179	10.1371/journal.pone.0159179	http://dx.doi.org/10.1371/journal.pone.0159179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428004	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300039
J	Ritchey, M; Tsipas, S; Loustalot, F; Wozniak, G				Ritchey, Matthew; Tsipas, Stavros; Loustalot, Fleetwood; Wozniak, Gregory			Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; IMPROVING ADHERENCE; UNITED-STATES; HEALTH; TRENDS; THERAPIES; OUTCOMES; AGENTS; ADULTS	Background Effective hypertension management often necessitates patients' adherence to the blood pressure (BP)-lowering medication regimen they are prescribed. Patients' adherence to that regimen can be affected by prescription- and payment-related factors that are typically controlled by prescribers, filling pharmacies, pharmacy benefit managers, and/or patients' health insurance plans. This study describes patterns and changes from 2009 to 2014 in factors that the literature reports are associated with increased adherence to BP-lowering medication. Methods and Findings We use a robust source of United States prescription sales data-IMS Health's National Prescription Audit-to describe BP-lowering medication fill counts and spending in 2009 compared with 2014. Moreover, we describe patterns and changes in adherence-promoting factors across age groups, payment sources, and medication classes. From 2009 to 2014, the BP-lowering medication prescription fill count increased from 613.7 million to 653.0 million. Encouraging changes in adherence-promoting factors included: the share of generic fills increased from 82.5% to 95.0%; average days' supply per fill increased from 45.9 to 51.8 days; and average total (patient contribution) spending per years' supply decreased from $359 ($54) to $311 ($37). Possibly undesirable changes included: the percentage of fills for fixed-dose combinations decreased from 17.1% to 14.2% and acquired via mail order decreased from 10.7% to 8.2%. In 2014: 653.0 million fills occurred accounting for $28.81B in spending; adults aged 45-64 years had the highest percentage of fixed-dose combinations fills (16.9%); and fills with Medicaid as the payment source had the lowest average patient spending per fill ($1.19). Conclusions We identified both encouraging and possibly undesirable patterns and changes from 2009 to 2014 in factors that promote adherence to BP-lowering medications during this period. Continued tracking of these metrics using pharmacy sales data can help identify areas that can be addressed by clinical and policy interventions to improve adherence for medications commonly used to treat hypertension.	[Ritchey, Matthew; Loustalot, Fleetwood] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Tsipas, Stavros; Wozniak, Gregory] Amer Med Assoc, Hlth Outcomes Grp, 515 N State St, Chicago, IL 60610 USA	Centers for Disease Control & Prevention - USA; American Medical Association	Ritchey, M (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.	hha7@cdc.gov			Centers for Disease Control and Prevention; American Medical Association	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Medical Association	This study was entirely supported by the Centers for Disease Control and Prevention and American Medical Association.	American Medical Association, IMPR HLTH OUTC; Bangalore S, 2007, AM J MED, V120, P713, DOI 10.1016/j.amjmed.2006.08.033; Bitton A, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.09.004; Burnier M, 2006, AM J HYPERTENS, V19, P1190, DOI 10.1016/j.amjhyper.2006.04.006; Campbell NRC, 2009, HYPERTENSION, V53, P128, DOI 10.1161/HYPERTENSIONAHA.108.119784; Chernew M, 2008, J GEN INTERN MED, V23, P1131, DOI 10.1007/s11606-008-0614-0; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choudhry NK, 2011, ARCH INTERN MED, V171, P814, DOI 10.1001/archinternmed.2010.495; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Domino FJ, 2005, AM FAM PHYSICIAN, V71, P2089; Dragomir A, 2010, MED CARE, V48, P418, DOI 10.1097/MLR.0b013e3181d567bd; Duru OK, 2010, AM J MANAG CARE, V16, P33; El Azizi GB, 2012, PHARMACOEPIDEM DR S, V21, P1067, DOI 10.1002/pds.3288; Frieden TR, 2014, JAMA-J AM MED ASSOC, V311, P21, DOI 10.1001/jama.2013.282615; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Gellad WF, 2009, REV BARRIERS MED ADH; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Gu Qiuping, 2010, NCHS Data Brief, P1; Guide to Community Preventive Services, 2019, CARD DIS PREV CONTR; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hicks LA, 2013, NEW ENGL J MED, V368, P1461, DOI 10.1056/NEJMc1212055; Hill SC, 2014, HEALTH AFFAIR, V33, P691, DOI 10.1377/hlthaff.2013.0743; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; IMS Institute for Healthcare Informatics, HSRN DAT BRIEF NAT P; Iskedjian M, 2002, CLIN THER, V24, P302, DOI 10.1016/S0149-2918(02)85026-3; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; Kettani FZ, 2009, STROKE, V40, P213, DOI 10.1161/STROKEAHA.108.522193; Mazzaglia G, 2009, CIRCULATION, V120, P1598, DOI 10.1161/CIRCULATIONAHA.108.830299; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; National Conference of State Legislatures, 2009, 4 FREE DRUG PROM LAR; Neal B, 2000, LANCET, V356, P1955; Nieuwlaat R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub4; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; Ogden LG, 2000, HYPERTENSION, V35, P539, DOI 10.1161/01.HYP.35.2.539; Olfson M, 2015, JAMA PSYCHIAT, V72, P136, DOI 10.1001/jamapsychiatry.2014.1763; Paulozzi LJ, 2014, J SAFETY RES, V51, P125, DOI 10.1016/j.jsr.2014.09.001; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; PWC, 2013, MED COST TREND NUMBE; SabatU E., 2003, ADHERENCE LONG TERM; Schmittdiel JA, 2011, J GEN INTERN MED, V26, P1396, DOI 10.1007/s11606-011-1805-7; Schroeder K, 2004, Cochrane Database Syst Rev, pCD004804; Sherrill B, 2011, J CLIN HYPERTENS, V13, P898, DOI 10.1111/j.1751-7176.2011.00550.x; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Walker RL, 2011, CAN J CARDIOL, V27, P461, DOI 10.1016/j.cjca.2010.12.071; Wozniak G, 2016, J CLIN HYPERTENS, V18, P232, DOI 10.1111/jch.12654; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	46	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159366	10.1371/journal.pone.0159366	http://dx.doi.org/10.1371/journal.pone.0159366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428008	Green Submitted, gold, Green Published			2022-12-27	WOS:000380169300057
J	Roncalli, V; Jungbluth, MJ; Lenz, PH				Roncalli, Vittoria; Jungbluth, Michelle J.; Lenz, Petra H.			Glutathione S-Transferase Regulation in Calanus finmarchicus Feeding on the Toxic Dinoflagellate Alexandrium fundyense	PLOS ONE			English	Article							DIATOM SKELETONEMA-MARINOI; GENE-EXPRESSION LEVELS; REAL-TIME PCR; INSECTICIDE RESISTANCE; GST GENES; HELGOLANDICUS; REPRODUCTION; PUBLICATION; RESPONSES; COPEPODS	The effect of the dinoflagellate, Alexandrium fundyense, on relative expression of glutathione S-transferase (GST) transcripts was examined in the copepod Calanus finmarchicus. Adult females were fed for 5-days on one of three experimental diets: control (100% Rhodomonas spp.), low dose of A. fundyense (25% by volume, 75% Rhodomonas spp.), and high dose (100% A. fundyense). Relative expression of three GST genes was measured using RT-qPCR on days 0.5, 1, 2 and 5 in two independent experiments. Differential regulation was found for the Delta and the Sigma GSTs between 0.5 to 2 days, but not on day 5 in both experiments. The third GST, a microsomal, was not differentially expressed in either treatment or day. RT-qPCR results from the two experiments were similar, even though experimental females were collected from the Gulf of Maine on different dates and their reproductive output differed. In the second experiment, expression of 39 GSTs was determined on days 2 and 5 using RNA-Seq. Global gene expression analyses agreed with the RT-qPCR results. Furthermore, the RNA-Seq measurements indicated that only four GSTs were differentially expressed under the experimental conditions, and the response was small in amplitude. In summary, the A. fundyense diet led to a rapid and transient response in C. finmarchicus in three cytosolic GSTs, while a fourth GST (Omega I) was significantly up-regulated on day 5. Although there was some regulation of GSTs in response the toxic dinoflagellate, the tolerance to A. fundyense by C. finmarchicus is not dependent on the long-term up-regulation of specific GSTs.	[Roncalli, Vittoria; Lenz, Petra H.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Bekesy Lab Neurobiol, 1993 East West Rd, Honolulu, HI 96822 USA; [Jungbluth, Michelle J.] Univ Hawaii Manoa, Dept Oceanog, 1000 Pope Rd, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Roncalli, V (corresponding author), Univ Hawaii Manoa, Pacific Biosci Res Ctr, Bekesy Lab Neurobiol, 1993 East West Rd, Honolulu, HI 96822 USA.	roncalli@hawaii.edu	Lenz, Petra H/ABE-4940-2021	Roncalli, Vittoria/0000-0003-3024-7568; Jungbluth, Michelle/0000-0001-9339-7497	National Science Foundation [OCE-1040597, OCE-1235549]; Cades Foundation of Honolulu; Mount Desert Island Biological Laboratory's David W. Towle Fellowship	National Science Foundation(National Science Foundation (NSF)); Cades Foundation of Honolulu; Mount Desert Island Biological Laboratory's David W. Towle Fellowship	This work was supported by the National Science Foundation [grant numbers OCE-1040597, OCE-1235549] to PHL, the Cades Foundation of Honolulu to Daniel K. Hartline and Mount Desert Island Biological Laboratory's David W. Towle Fellowship 2012 to VR. The views expressed herein are those of the authors and do not reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson DM, 2014, DEEP-SEA RES PT II, V103, P264, DOI 10.1016/j.dsr2.2013.09.018; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; Asselman J, 2012, ENVIRON SCI TECHNOL, V46, P8448, DOI 10.1021/es301100j; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carotenuto Y, 2014, HARMFUL ALGAE, V31, P153, DOI 10.1016/j.hal.2013.11.002; Che-Mendoza A, 2009, AFR J BIOTECHNOL, V8, P1386; da Fonseca RR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-281; Darbyson E, 2003, J FISH BIOL, V63, P1235, DOI 10.1046/j.1095-8649.2003.00247.x; Davis C.S., 1987, P256; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gallardo-Escarate C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092239; Han J, 2015, AQUAT TOXICOL, V165, P136, DOI 10.1016/j.aquatox.2015.05.022; Hansen BH, 2011, SCI TOTAL ENVIRON, V409, P704, DOI 10.1016/j.scitotenv.2010.10.035; Hansen BH, 2010, AQUAT TOXICOL, V99, P212, DOI 10.1016/j.aquatox.2010.04.018; Hansen BH, 2009, J TOXICOL ENV HEAL A, V72, P131, DOI 10.1080/15287390802537313; Harris RP, 2000, ICES J MAR SCI, V57, P1708, DOI 10.1006/jmsc.2000.0959; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauritano C, 2016, HARMFUL ALGAE, V55, P221, DOI 10.1016/j.hal.2016.03.015; Lauritano C, 2015, MAR GENOM, V24, P89, DOI 10.1016/j.margen.2015.01.007; Lauritano C, 2013, HARMFUL ALGAE, V28, P23, DOI 10.1016/j.hal.2013.05.004; Lauritano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047262; Lauritano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026850; Lauritano C, 2011, J EXP MAR BIOL ECOL, V404, P79, DOI 10.1016/j.jembe.2011.05.009; Lee KW, 2008, AQUAT TOXICOL, V89, P158, DOI 10.1016/j.aquatox.2008.06.011; Lenz PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088589; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Melle W, 2014, PROG OCEANOGR, V129, P244, DOI 10.1016/j.pocean.2014.04.026; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roncalli V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25708; Roncalli V, 2016, HARMFUL ALGAE, V51, P56, DOI 10.1016/j.hal.2015.11.003; Roncalli V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123322; Schoville SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-170; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sherman K., 1987, P268; Shi HX, 2012, GENOMICS, V100, P327, DOI 10.1016/j.ygeno.2012.07.010; Starr M, 1999, SARSIA, V84, P379, DOI 10.1080/00364827.1999.10807345; Turner JT, 2014, HARMFUL ALGAE, V32, P81, DOI 10.1016/j.hal.2013.12.001; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004	47	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159563	10.1371/journal.pone.0159563	http://dx.doi.org/10.1371/journal.pone.0159563			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427938	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300076
J	Schneider, AD				Schneider, Adam D.			Model Vestibular Nuclei Neurons Can Exhibit a Boosting Nonlinearity Due to an Adaptation Current Regulated by Spike-Triggered Calcium and Calcium-Activated Potassium Channels	PLOS ONE			English	Article							DYNAMICS	In vitro studies have previously found a class of vestibular nuclei neurons to exhibit a bidirectional afterhyperpolarization (AHP) in their membrane potential, due to calcium and calcium-activated potassium conductances. More recently in vivo studies of such vestibular neurons were found to exhibit a boosting nonlinearity in their input-output tuning curves. In this paper, a Hodgkin-Huxley (HH) type neuron model, originally developed to reproduce the in vitro AHP, is shown to produce a boosting nonlinearity similar to that seen in vivo for increased the calcium conductance. Indicative of a bifurcation, the HH model is reduced to a generalized integrate-and-fire (IF) model that preserves the bifurcation structure and boosting nonlinearity. By then projecting the neuron model's phase space trajectories into 2D, the underlying geometric mechanism relating the AHP and boosting nonlinearity is revealed. Further simplifications and approximations are made to derive analytic expressions for the steady steady state firing rate as a function of bias current, mu, as well as the gain (i.e. its slope) and the position of its peak at mu = mu*. Finally, although the boosting nonlinearity has not yet been experimentally observed in vitro, testable predictions indicate how it might be found.	[Schneider, Adam D.] McGill Univ, Phys, Montreal, PQ, Canada	McGill University	Schneider, AD (corresponding author), McGill Univ, Phys, Montreal, PQ, Canada.	adam.schneider@mail.mcgill.ca						Av-Ron E, 1999, BIOL CYBERN, V80, P383, DOI 10.1007/s004220050533; Badel L, 2008, J NEUROPHYSIOL, V99, P656, DOI 10.1152/jn.01107.2007; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Cullen KE, 2004, CURR OPIN NEUROBIOL, V14, P698, DOI 10.1016/j.conb.2004.10.002; Fourcaud-Trocme N, 2003, J NEUROSCIENCE; Hertag L, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00116; Hertag L, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00062; Izhikevich E. M., 2010, DYNAMICAL SYSTEMS NE; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Massot C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001365; Naud R, 2008, BIOL CYBERN, V99, P335, DOI 10.1007/s00422-008-0264-7; Richardson MJE, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021928; Rieke F., 1997, SPIKES EXPLORING NEU; Sadeghi S, 2007, J NEUROPHYSIOLOGY; Sadeghi SG, 2007, J NEUROSCI, V27, P771, DOI 10.1523/JNEUROSCI.4690-06.2007; Schneider AD, 2015, J NEUROSCI, V35, P5522, DOI 10.1523/JNEUROSCI.3841-14.2015; Schneider AD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002120; Shlizerman E, 2012, NEURAL COMPUT, V24, P2078, DOI 10.1162/NECO_a_00308; Touboul J, 2008, BIOL CYBERN, V99, P319, DOI 10.1007/s00422-008-0267-4	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159300	10.1371/journal.pone.0159300	http://dx.doi.org/10.1371/journal.pone.0159300			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427914	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300045
J	Schoorl, J; van Rijn, S; de Wied, M; van Goozen, S; Swaab, H				Schoorl, Jantiene; van Rijn, Sophie; de Wied, Minet; van Goozen, Stephanie; Swaab, Hanna			Emotion Regulation Difficulties in Boys with Oppositional Defiant Disorder/Conduct Disorder and the Relation with Comorbid Autism Traits and Attention Deficit Traits	PLOS ONE			English	Article							ECONOMIC DECISION-MAKING; SPECTRUM DISORDERS; SELF-REGULATION; CHILDREN; BEHAVIOR; ULTIMATUM; ADOLESCENTS; AGGRESSION; SYMPTOMS; DIMENSIONS	Previous research has pointed towards a link between emotion dysregulation and aggressive behavior in children. Emotion regulation difficulties are not specific for children with persistent aggression problems, i.e. oppositional defiant disorder or conduct disorder (ODD/CD), children with other psychiatric conditions, such as autism spectrum disorders or attention-deficit/hyperactivity disorder, have emotion regulation difficulties too. On a behavioral level some overlap exists between these disorders and comorbidity is high. The aim of this study was therefore twofold: 1) to examine emotion regulation difficulties in 65 boys with ODD/CD in comparison to a non-clinical control group (NC) of 38 boys (8-12 years) using a performance measure (Ultimatum Game), parent report and self-report, and 2) to establish to what extent emotion regulation in the ODD/CD group was correlated with severity of autism and/or attention deficit traits. Results on the Ultimatum Game showed that the ODD/CD group rejected more ambiguous offers than the NC group, which is seen as an indication of poor emotion regulation. Parents also reported that the ODD/CD group experienced more emotion regulation problems in daily life than the NC group. In contrast to these cognitive and behavioral measures, self-reports did not reveal any difference, indicating that boys with ODD/CD do not perceive themselves as having impairments in regulating their emotions. Emotional decision making within the ODD/CD group was not related to variation in autism or attention deficit traits. These results support the idea that emotion dysregulation is an important problem within ODD/CD, yet boys with ODD/CD have reduced awareness of this.	[Schoorl, Jantiene; van Rijn, Sophie; van Goozen, Stephanie; Swaab, Hanna] Leiden Univ, Dept Clin Child & Adolescent Studies, Leiden, Netherlands; [Schoorl, Jantiene; van Rijn, Sophie; Swaab, Hanna] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [de Wied, Minet] Univ Utrecht, Dept Adolescent Dev, Utrecht, Netherlands; [van Goozen, Stephanie] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Cardiff University	Schoorl, J (corresponding author), Leiden Univ, Dept Clin Child & Adolescent Studies, Leiden, Netherlands.; Schoorl, J (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	j.schoorl@fsw.leidenuniv.nl; hswaab@fsw.leidenuniv.nl	Swaab, Hanna/AAD-2555-2019	van rijn, sophie/0000-0002-9179-7515; Swaab, Hanna/0000-0003-3697-060X	Netherlands Organization for Scientific Research (NWO) [056-21-010]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study is funded by the Netherlands Organization for Scientific Research (NWO), grant number: 056-21-010.	Achenbach T. M, 2001, MANUAL ASEBA SCH AGE; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anastopoulos AD, 2011, J ATTEN DISORD, V15, P583, DOI 10.1177/1087054710370567; Banaschewski T, 2012, J CHILD PSYCHOL PSYC, V53, P1139, DOI 10.1111/j.1469-7610.2012.02596.x; Barkley RA, 2006, ATTENTION DEFICIT HY; Barrett PM, 1996, J ABNORM CHILD PSYCH, V24, P187, DOI 10.1007/BF01441484; Blair KA, 2004, J SCHOOL PSYCHOL, V42, P419, DOI 10.1016/j.jsp.2004.10.002; Bradshaw CP, 2010, J YOUTH ADOLESCENCE, V39, P953, DOI 10.1007/s10964-009-9442-8; Burke JD, 2012, J CHILD PSYCHOL PSYC, V53, P1176, DOI 10.1111/j.1469-7610.2012.02598.x; Burke JD, 2010, J AM ACAD CHILD PSY, V49, P484, DOI 10.1016/j.jaac.2010.01.016; Cavanagh M, 2017, J ATTEN DISORD, V21, P381, DOI 10.1177/1087054713520221; Constantino J. N., 2005, SOCIAL RESPONSIVENES; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Crick NR, 1996, CHILD DEV, V67, P993, DOI 10.2307/1131875; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; de Castro BO, 2002, CHILD DEV, V73, P916, DOI 10.1111/1467-8624.00447; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; Denham SA, 2003, CHILD DEV, V74, P238, DOI 10.1111/1467-8624.00533; DODGE KA, 1980, CHILD DEV, V51, P162, DOI 10.1111/j.1467-8624.1980.tb02522.x; Factor PI, 2014, J PSYCHOPATHOL BEHAV, V36, P530, DOI 10.1007/s10862-014-9428-z; Factor PI, 2016, J ATTEN DISORD, V20, P168, DOI 10.1177/1087054713494005; Garcia-Sancho E, 2014, AGGRESS VIOLENT BEH, V19, P584, DOI 10.1016/j.avb.2014.07.007; Garnefski N, 2007, EUR CHILD ADOLES PSY, V16, P1, DOI 10.1007/s00787-006-0562-3; Gioia GA, 2000, BEHAV RATING INVENTO; Graziano PA, 2007, J SCHOOL PSYCHOL, V45, P3, DOI 10.1016/j.jsp.2006.09.002; Grecucci A, 2013, CEREB CORTEX, V23, P399, DOI 10.1093/cercor/bhs028; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Harle KM, 2007, EMOTION, V7, P876, DOI 10.1037/1528-3542.7.4.876; Kaat AJ, 2013, RES AUTISM SPECT DIS, V7, P1579, DOI 10.1016/j.rasd.2013.08.012; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Koenigs M, 2010, NEUROPSYCHOLOGIA, V48, P2198, DOI 10.1016/j.neuropsychologia.2010.04.012; Kring AM, 2004, REGULATION OF EMOTION, P359; Lambie JA, 2002, PSYCHOL REV, V109, P219, DOI 10.1037//0033-295X.109.2.219; Lopes PN, 2005, EMOTION, V5, P113, DOI 10.1037/1528-3542.5.1.113; Manninen M, 2011, J NERV MENT DIS, V199, P506, DOI 10.1097/NMD.0b013e3182214281; Matson JL, 2014, RES DEV DISABIL, V35, P3269, DOI 10.1016/j.ridd.2014.08.004; Mazefsky CA, 2013, J AM ACAD CHILD PSY, V52, P679, DOI 10.1016/j.jaac.2013.05.006; McLaughlin KA, 2011, BEHAV RES THER, V49, P544, DOI 10.1016/j.brat.2011.06.003; Mehta PH, 2010, J COGNITIVE NEUROSCI, V22, P2357, DOI 10.1162/jocn.2009.21389; Northover C, 2015, BRAIN SCI, V5, P369, DOI 10.3390/brainsci5030369; Rieffe C, 2008, PERS INDIV DIFFER, V45, P756, DOI 10.1016/j.paid.2008.08.001; Rieffe C, 2011, AUTISM, V15, P655, DOI 10.1177/1362361310366571; Roll J, 2012, CHILD PSYCHIAT HUM D, V43, P909, DOI 10.1007/s10578-012-0303-4; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sattler J., 1992, ASSESSMENT CHILDREN; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shawler PM, 2015, PARENTAL STRESS DISC; Stringaris A, 2009, J CHILD PSYCHOL PSYC, V50, P216, DOI 10.1111/j.1469-7610.2008.01989.x; Tyson P, 2005, J AM PSYCHOANAL ASS, V53, P159, DOI 10.1177/00030651050530012201; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; van't Wout M, 2010, EMOTION, V10, P815, DOI 10.1037/a0020069; Wechsler D., 2003, WISC 4 WECHSLER INTE, V4th ed.; Zeman J, 2002, J CLIN CHILD ADOLESC, V31, P393, DOI 10.1207/153744202760082658; Zimmermann G, 2006, J ADOLESCENCE, V29, P321, DOI 10.1016/j.adolescence.2005.08.001	56	9	9	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0159323	10.1371/journal.pone.0159323	http://dx.doi.org/10.1371/journal.pone.0159323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR1JR	27420110	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000379662300012
J	Breuer, A; Haj, CG; Fogaca, MV; Gomes, FV; Silva, NR; Pedrazzi, JF; Del Bel, EA; Hallak, JC; Crippa, JA; Zuardi, AW; Mechoulam, R; Guimaraes, FS				Breuer, Aviva; Haj, Christeene G.; Fogaca, Manoela V.; Gomes, Felipe V.; Silva, Nicole Rodrigues; Pedrazzi, Joao Francisco; Del Bel, Elaine A.; Hallak, Jaime C.; Crippa, Jose A.; Zuardi, Antonio W.; Mechoulam, Raphael; Guimaraes, Francisco S.			Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects	PLOS ONE			English	Article							MARBLE-BURYING BEHAVIOR; ELEVATED PLUS-MAZE; PREPULSE INHIBITION; ANIMAL-MODELS; ENDOCANNABINOID SYSTEM; ANXIETY DISORDERS; 5-HT1A RECEPTORS; HASHISH; INVOLVEMENT; DISRUPTION	Cannabidiol (CBD) is a major Cannabis sativa constituent, which does not cause the typical marijuana psychoactivity. However, it has been shown to be active in a numerous pharmacological assays, including mice tests for anxiety, obsessive-compulsive disorder, depression and schizophrenia. In human trials the doses of CBD needed to achieve effects in anxiety and schizophrenia are high. We report now the synthesis of 3 fluorinated CBD derivatives, one of which, 4'-F-CBD (HUF-101) (1), is considerably more potent than CBD in behavioral assays in mice predictive of anxiolytic, antidepressant, antipsychotic and anti-compulsive activity. Similar to CBD, the anti-compulsive effects of HUF-101 depend on cannabinoid receptors.	[Breuer, Aviva; Haj, Christeene G.; Mechoulam, Raphael] Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Jerusalem, Israel; [Fogaca, Manoela V.; Gomes, Felipe V.; Silva, Nicole Rodrigues; Guimaraes, Francisco S.] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil; [Pedrazzi, Joao Francisco; Hallak, Jaime C.; Crippa, Jose A.; Zuardi, Antonio W.] Univ Sao Paulo, Med Sch Ribeirao Preto, Neurosci & Behav, Sao Paulo, Brazil; [Del Bel, Elaine A.] Univ Sao Paulo, Sch Odontol Ribeirao Preto, Dept Morphol Physiol & Pathol, Sao Paulo, Brazil	Hebrew University of Jerusalem; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Mechoulam, R (corresponding author), Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Jerusalem, Israel.; Guimaraes, FS (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil.	mechou@cc.huji.ac.il; fsguimar@uol.com.br	de Souza Crippa, José Alexandre/A-1215-2008; Del Bel, Elaine A/E-2308-2012; Guimaraes, Francisco Silveira/C-1059-2012; Del Bel, Elaine/ABH-1331-2020; Gomes, Felipe/Q-3153-2019; Zuardi, Antonio W/B-6078-2016; Silva, Nicole NRS/E-8267-2018; Pedrazzi, João Francisco/A-4559-2019	Del Bel, Elaine A/0000-0002-4158-7376; Guimaraes, Francisco Silveira/0000-0003-4092-7778; Del Bel, Elaine/0000-0003-3483-8074; Gomes, Felipe/0000-0003-1033-1850; Rodrigues, Nicole/0000-0002-1149-0776	Kessler Foundation, Boston; CNPq; Capes; Fapesp	Kessler Foundation, Boston; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The research in Israel was supported by the Kessler Foundation, Boston.; The research in Brazil was supported by grants from CNPq, Capes, Fapesp. The research in Israel was supported by the Kessler Foundation, Boston.	Adams R, 1940, J AM CHEM SOC, V62, P196, DOI 10.1021/ja01858a058; Begue J.-P., 2008, BIOORGANIC AND MEDIC; Bergamaschi MM, 2011, NEUROPSYCHOPHARMACOL, V36, P1219, DOI 10.1038/npp.2011.6; Bisogno T, 2009, BBA-MOL CELL BIOL L, V1791, P53, DOI 10.1016/j.bbalip.2008.10.007; Blessing EM, 2015, NEUROTHERAPEUTICS, V12, P825, DOI 10.1007/s13311-015-0387-1; Boukerb A, 1998, J FLUORINE CHEM, V88, P23, DOI 10.1016/S0022-1139(98)00115-8; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Campos AC, 2013, INT J NEUROPSYCHOPH, V16, P1407, DOI 10.1017/S1461145712001502; Campos AC, 2012, PHILOS T R SOC B, V367, P3364, DOI 10.1098/rstb.2011.0389; Casarotto PC, 2010, BEHAV PHARMACOL, V21, P353, DOI 10.1097/FBP.0b013e32833b33c5; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; CUNHA JM, 1980, PHARMACOLOGY, V21, P175, DOI 10.1159/000137430; Detyniecki K, 2016, LANCET NEUROL, V15, P235, DOI 10.1016/S1474-4422(16)00002-8; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; Fernandez-Ruiz J, 2013, BRIT J CLIN PHARMACO, V75, P323, DOI 10.1111/j.1365-2125.2012.04341.x; FILE SE, 1992, BIOL COUN S, P25; GAONI Y, 1971, J AM CHEM SOC, V93, P217, DOI 10.1021/ja00730a036; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Gomes FV, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu041; Gomes FV, 2011, PROG NEURO-PSYCHOPH, V35, P434, DOI 10.1016/j.pnpbp.2010.11.027; GUIMARAES FS, 1990, PSYCHOPHARMACOLOGY, V100, P558, DOI 10.1007/BF02244012; GUIMARAES FS, 1994, GEN PHARMACOL, V25, P161, DOI 10.1016/0306-3623(94)90027-2; HANDLEY SL, 1984, N-S ARCH PHARMACOL, V327, P1, DOI 10.1007/BF00504983; Jacob A, 1940, J CHEM SOC, P649, DOI 10.1039/jr9400000649; JORAPUR VS, 1984, SYNTHETIC COMMUN, V14, P655, DOI 10.1080/00397918408063751; Kozela E, 2016, CHEM BIOL DRUG DES, V87, P143, DOI 10.1111/cbdd.12637; Leweke FM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.15; Linge R, 2016, NEUROPHARMACOLOGY, V103, P16, DOI 10.1016/j.neuropharm.2015.12.017; Long LE, 2006, NEUROPSYCHOPHARMACOL, V31, P795, DOI 10.1038/sj.npp.1300838; Mechoulam R, 2002, J CLIN PHARMACOL, V42, p11S, DOI 10.1002/j.1552-4604.2002.tb05998.x; MECHOULAM R, 1967, TETRAHEDRON LETT, P1109; MECHOULAM R, 1963, TETRAHEDRON, V19, P2073, DOI 10.1016/0040-4020(63)85022-X; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; Meuth SG, 2015, EXPERT REV NEUROTHER, V15, P909, DOI 10.1586/14737175.2015.1067607; Moreira FA, 2005, EUR J PHARMACOL, V512, P199, DOI 10.1016/j.ejphar.2005.02.040; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Pedrazzi JFC, 2015, PSYCHOPHARMACOLOGY, V232, P3057, DOI 10.1007/s00213-015-3945-7; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Renard J, 2016, J NEUROSCI, V36, P5160, DOI 10.1523/JNEUROSCI.3387-15.2016; Stern CAJ, 2012, NEUROPSYCHOPHARMACOL, V37, P2132, DOI 10.1038/npp.2012.63; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Tzadok M, 2016, SEIZURE-EUR J EPILEP, V35, P41, DOI 10.1016/j.seizure.2016.01.004; UMEMOTO T, 1990, J AM CHEM SOC, V112, P8563, DOI 10.1021/ja00179a047; Viveros MP, 2005, PHARMACOL BIOCHEM BE, V81, P331, DOI 10.1016/j.pbb.2005.01.029; Zanelati TV, 2010, BRIT J PHARMACOL, V159, P122, DOI 10.1111/j.1476-5381.2009.00521.x; Zhornitsky S, 2012, PHARMACEUTICALS, V5, P529, DOI 10.3390/ph5050529; Zuardi AW, 2006, J PSYCHOPHARMACOL, V20, P683, DOI 10.1177/0269881106060967; ZUARDI AW, 1991, PSYCHOPHARMACOLOGY, V104, P260, DOI 10.1007/BF02244189; ZUARDI AW, 1982, PSYCHOPHARMACOLOGY, V76, P245, DOI 10.1007/BF00432554; ZUARDI AW, 1995, J CLIN PSYCHIAT, V56, P485	52	27	29	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158779	10.1371/journal.pone.0158779	http://dx.doi.org/10.1371/journal.pone.0158779			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416026	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500038
J	Dutriaux, L; Gyselinck, V				Dutriaux, Leo; Gyselinck, Valerie			Learning Is Better with the Hands Free: The Role of Posture in the Memory of Manipulable Objects	PLOS ONE			English	Article							MOTOR SIMULATION; MENTAL ROTATION; WORKING-MEMORY; KNOWLEDGE; IMAGERY; WORDS; REPRESENTATIONS; CATEGORIZATION; RECOGNITION; AFFORDANCE	Grounded cognition proposes that memory shares processing resources with sensorimotor systems. The aim of the present study was to show that motor simulation participates in the conceptual representation of manipulable objects in long-term memory. In two experiments, lists of manipulable and nonmanipulable objects were presented. Participants were instructed to memorize the items while adopting different postures. In the control condition, they had to keep their hands at rest in front of them. In the interference condition, participants had to keep their hands crossed behind their back to make their hands less free for action. After each list, participants had to perform first a distractive task, and then an oral free recall. The results showed that the interfering posture produced a specific decrease in the recall of manipulable objects, but not of nonmanipulable ones. This decrease was similar when the items were presented as pictures (Experiment 1) or as words (Experiment 2), thus excluding a purely visual effect. These results provide strong evidence that the motor simulation plays a role in the memory trace of the object.	[Dutriaux, Leo; Gyselinck, Valerie] Univ Paris 05, Sorbonne Paris Cite, Lab Memoire & Cognit, Paris, France; [Dutriaux, Leo; Gyselinck, Valerie] Ctr Henri Pieron, Inst Psychol, Boulogne Billancourt, France; [Dutriaux, Leo; Gyselinck, Valerie] INSERM U894, Ctr Psychiatr & Neurosci, Paris, France; [Gyselinck, Valerie] IFSTTAR LPC, Versailles, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel	Dutriaux, L (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Lab Memoire & Cognit, Paris, France.; Dutriaux, L (corresponding author), Ctr Henri Pieron, Inst Psychol, Boulogne Billancourt, France.; Dutriaux, L (corresponding author), INSERM U894, Ctr Psychiatr & Neurosci, Paris, France.	leo.dutriaux@parisdescartes.fr		Gyselinck, Valerie/0000-0001-9715-6148; Dutriaux, Leo/0000-0001-6304-8691	French National Research Agency (ANR) [ANR-13-APPR-0009]	French National Research Agency (ANR)(French National Research Agency (ANR))	The work was supported by Grant ANR-13-APPR-0009 from the French National Research Agency (ANR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Alix Seigneuric and Jane Oakhill for fruitful comments on an earlier version of the manuscript. The work was supported by Grant ANR-13-APPR-0009 from the French National Research Agency (ANR).	[Anonymous], 1983, CANADIAN PSYCHOL; Apel JK, 2012, EXP BRAIN RES, V223, P199, DOI 10.1007/s00221-012-3251-0; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bonin P, 2011, ANN PSYCHOL, V111, P327; Bub DN, 2008, COGNITION, V106, P27, DOI 10.1016/j.cognition.2006.12.010; Bub DN, 2013, PSYCHOL SCI, V24, P1269, DOI 10.1177/0956797612472909; Buccino G, 2009, NEUROPSYCHOLOGIA, V47, P3074, DOI 10.1016/j.neuropsychologia.2009.07.003; Buxbaum LJ, 2010, ANN NY ACAD SCI, V1191, P201, DOI 10.1111/j.1749-6632.2010.05447.x; Buxbaum LJ, 2002, BRAIN LANG, V82, P179, DOI 10.1016/S0093-934X(02)00014-7; Campanella F, 2011, EXP BRAIN RES, V208, P369, DOI 10.1007/s00221-010-2489-7; Cardellicchio P, 2011, NEUROPSYCHOLOGIA, V49, P1369, DOI 10.1016/j.neuropsychologia.2011.01.021; Carota F, 2012, J COGNITIVE NEUROSCI, V24, P1492, DOI 10.1162/jocn_a_00219; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; de Vega M., 2012, MENTAL IMAGERY SPATI, P177; Desrochers A, 2000, CAN J EXP PSYCHOL, V54, P274, DOI 10.1037/h0087347; Desrochers A, 2009, BEHAV RES METHODS, V41, P546, DOI 10.3758/BRM.41.2.546; Downing-Doucet F, 2014, PSYCHON B REV, V21, P1033, DOI 10.3758/s13423-013-0570-5; Franzen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037359; Funk M, 2005, DEVELOPMENTAL SCI, V8, P402, DOI 10.1111/j.1467-7687.2005.00428.x; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Garcea Frank E, 2013, Front Hum Neurosci, V7, P120, DOI 10.3389/fnhum.2013.00120; Gerlach C, 2002, J COGNITIVE NEUROSCI, V14, P1230, DOI 10.1162/089892902760807221; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Iachini T, 2008, BRAIN COGNITION, V67, P31, DOI 10.1016/j.bandc.2007.11.002; Iachini T, 2014, ACTA PSYCHOL, V153, P20, DOI 10.1016/j.actpsy.2014.09.001; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Lagace S, 2015, ACTA PSYCHOL, V157, P65, DOI 10.1016/j.actpsy.2015.02.009; Lorey B, 2009, EXP BRAIN RES, V194, P233, DOI 10.1007/s00221-008-1693-1; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Masson MEJ, 2008, J MEM LANG, V59, P256, DOI 10.1016/j.jml.2008.05.003; Matheson HE, 2014, ACTA PSYCHOL, V145, P33, DOI 10.1016/j.actpsy.2013.10.012; Morlino G, 2015, COGNITIVE SCI, V39, P39, DOI 10.1111/cogs.12130; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Myung JY, 2010, BRAIN LANG, V112, P101, DOI 10.1016/j.bandl.2009.12.003; Negri GAL, 2007, COGN NEUROPSYCHOL, V24, P795, DOI 10.1080/02643290701707412; New B, 2001, ANN PSYCHOL, V101, P447; PAIVIO A, 1969, J EXP PSYCHOL, V80, P279, DOI 10.1037/h0027273; Pecher D, 2013, J COGN PSYCHOL, V25, P107, DOI 10.1080/20445911.2012.750324; Pecher D, 2013, J EXP PSYCHOL LEARN, V39, P2, DOI 10.1037/a0028642; Pezzulo G, 2010, BRAIN COGNITION, V73, P68, DOI 10.1016/j.bandc.2010.03.002; Phillips JC, 2002, VIS COGN, V9, P540, DOI 10.1080/13506280143000575; Pobric G, 2010, CURR BIOL, V20, P964, DOI 10.1016/j.cub.2010.03.070; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Quak M, 2014, ATTEN PERCEPT PSYCHO, V76, P2063, DOI 10.3758/s13414-014-0654-y; Rueschemeyer SA, 2010, J COGNITIVE NEUROSCI, V22, P1844, DOI 10.1162/jocn.2009.21310; Rueschemeyer SA, 2010, NEUROPSYCHOLOGIA, V48, P774, DOI 10.1016/j.neuropsychologia.2009.09.019; Shebani Z, 2013, CORTEX, V49, P222, DOI 10.1016/j.cortex.2011.10.005; Sirigu A, 2001, J COGNITIVE NEUROSCI, V13, P910, DOI 10.1162/089892901753165827; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; van Elk M, 2009, J EXP PSYCHOL HUMAN, V35, P1118, DOI 10.1037/a0015024; Vargas CD, 2004, CEREB CORTEX, V14, P1200, DOI 10.1093/cercor/bhh080; Versace R, 2014, J COGN PSYCHOL, V26, P280, DOI 10.1080/20445911.2014.892113; Witt JK, 2010, PSYCHOL SCI, V21, P1215, DOI 10.1177/0956797610378307; Yee E, 2013, PSYCHOL SCI, V24, P909, DOI 10.1177/0956797612464658; Zeelenberg R, 2016, PSYCHOL LEARN MOTIV, V64, P161, DOI 10.1016/bs.plm.2015.09.005; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1	63	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159108	10.1371/journal.pone.0159108	http://dx.doi.org/10.1371/journal.pone.0159108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414407	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500076
J	Gebremedhin, B; Flagstad, O; Bekele, A; Chala, D; Bakkestuen, V; Boessenkool, S; Popp, M; Gussarova, G; Schroder-Nielsen, A; Nemomissa, S; Brochmann, C; Stenseth, NC; Epp, LS				Gebremedhin, Berihun; Flagstad, Oystein; Bekele, Afework; Chala, Desalegn; Bakkestuen, Vegar; Boessenkool, Sanne; Popp, Magnus; Gussarova, Galina; Schroder-Nielsen, Audun; Nemomissa, Sileshi; Brochmann, Christian; Stenseth, Nils Chr.; Epp, Laura S.			DNA Metabarcoding Reveals Diet Overlap between the Endangered Walia Ibex and Domestic Goats - Implications for Conservation	PLOS ONE			English	Article							MOUNTAINS NATIONAL-PARK; LARGE HERBIVORES; CAPRA-HIRCUS; WILD; LIVESTOCK; CLIMATE; SHEEP; COMPETITION; VEGETATION; FUTURE	Human population expansion and associated degradation of the habitat of many wildlife species cause loss of biodiversity and species extinctions. The small Simen Mountains National Park in Ethiopia is one of the last strongholds for the preservation of a number of afro-alpine mammals, plants and birds, and it is home to the rare endemic Walia ibex, Capra walie. The narrow distribution range of this species as well as potential competition for resources with livestock, especially with domestic goat, Capra hircus, may compromise its future survival. Based on a curated afro-alpine taxonomic reference library constructed for plant taxon identification, we investigated the diet of the Walia ibex and addressed the dietary overlap with domestic goat using DNA metabarcoding of faecal samples. Faeces of both species were collected from different localities in the National Park. We show that both species are browsers, with forbs, shrubs and trees comprising the largest proportion of their diet, supplemented by grasses. There was a considerable overlap in dietary preferences. Several of the preferred diet items of the Walia ibex (Alchemilla sp., Hypericum revolutum, Erica arborea and Rumex sp.) were also among the most preferred diet items of the domestic goat. These results indicate that there is potential for competition between the two species, especially during the dry season, when resources are limited. Our findings, in combination with the expected increase in domestic herbivores, suggest that management plans should consider the potential threat posed by domestic goats to ensure future survival of the endangered Walia ibex.	[Gebremedhin, Berihun; Stenseth, Nils Chr.] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [Flagstad, Oystein; Bakkestuen, Vegar] Norwegian Inst Nat Res, Trondheim, Norway; [Bekele, Afework] Univ Addis Ababa, Dept Zool Sci, Addis Ababa, Ethiopia; [Chala, Desalegn; Bakkestuen, Vegar; Boessenkool, Sanne; Popp, Magnus; Gussarova, Galina; Schroder-Nielsen, Audun; Brochmann, Christian; Epp, Laura S.] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Nemomissa, Sileshi] Univ Addis Ababa, Dept Plant Biol & Biodivers Management, Addis Ababa, Ethiopia; [Epp, Laura S.] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Periglacial Res, Potsdam, Germany	University of Oslo; Norwegian Institute Nature Research; Addis Ababa University; University of Oslo; Addis Ababa University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Epp, LS (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.; Epp, LS (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Periglacial Res, Potsdam, Germany.	laura.saskia.epp@gmail.com	Brochmann, Christian/A-4105-2009; Boessenkool, Sanne/K-4274-2017; Gussarova, Galina/E-4758-2015; Chala, Desalegn/AAA-8024-2020; Nemomissa, Sileshi/AAB-7270-2022; Epp, Laura/AFS-1695-2022; Gussarova, Galina/ABC-8696-2021; Epp, Laura Saskia/J-5301-2016	Boessenkool, Sanne/0000-0001-8033-1165; Gussarova, Galina/0000-0001-5388-7491; Chala, Desalegn/0000-0002-8045-6950; Gussarova, Galina/0000-0001-5388-7491; Gebremedhin, Berihun/0000-0002-2585-7743; Bakkestuen, Vegar/0000-0003-2573-6615; Popp, Magnus/0000-0001-6745-3301; Epp, Laura Saskia/0000-0002-2230-9477	Research Council of Norway [191627/V40]; Center for Ecology and Evolutionary Synthesis (CEES) at the University of Oslo; Mohamed Bin Zyad Species Conservation Foundation Fund [11052467]; Norwegian Programme for Development, Research and Higher Education (NUFU) [2007/10058]; Conservation des Especes et des Populations Animals, CEPA; Conservation des Especes et des Populations Animals (CEPA)	Research Council of Norway(Research Council of Norway); Center for Ecology and Evolutionary Synthesis (CEES) at the University of Oslo; Mohamed Bin Zyad Species Conservation Foundation Fund; Norwegian Programme for Development, Research and Higher Education (NUFU); Conservation des Especes et des Populations Animals, CEPA; Conservation des Especes et des Populations Animals (CEPA)	The laboratory analyses were funded by the Research Council of Norway [http://www.forskningsradet.no], grant no. 191627/V40 to CB, the Center for Ecology and Evolutionary Synthesis (CEES, [http://www.mn.uio.no/cees/]) at the University of Oslo, the Mohamed Bin Zyad Species Conservation Foundation Fund [http://www.speciesconservation.org], Project ID. 11052467, and the Norwegian Programme for Development, Research and Higher Education (NUFU, [http://siu.no/eng/Programme-information/Developmentcooperation/NUFU]; project 2007/10058 to SN and CB). Field work and sample collection was funded by the Conservation des Especes et des Populations Animals [http://www.cepa-association.org], CEPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The laboratory analyses were funded by the Research Council of Norway (grant no. 191627/V40 to C.B.), the Center for Ecology and Evolutionary Synthesis (CEES) at the University of Oslo, the Mohamed Bin Zyad Species Conservation Foundation Fund (Project ID. 11052467), and the Norwegian Programme for Development, Research and Higher Education (NUFU; project 2007/10058 to S.N. and C.B.). Field work and sample collection was funded by the Conservation des Especes et des Populations Animals (CEPA). B.G. is grateful for the assistance from Pierre Taberlet and Mebrahtu Ateweberhan.	Acevedo P, 2007, BIODIVERS CONSERV, V16, P3361, DOI 10.1007/s10531-006-9032-y; Alemayehu K, 2011, AFR J AGR RES, V6, P856; Alemayehu K, 2011, AFR J ECOL, V49, P292, DOI 10.1111/j.1365-2028.2011.01264.x; Amhara National Regional State Parks Development and Protection Authority, 2007, GRAZ PRESS RED STRAT; [Anonymous], 2000, FLORA ETHIOPIA ERITR; Baamrane MAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035643; Bagchi S, 2004, ANIM CONSERV, V7, P121, DOI 10.1017/S1367943003001148; Bellemain E, 2013, ENVIRON MICROBIOL, V15, P1176, DOI 10.1111/1462-2920.12020; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Boessenkool S, 2014, CONSERV BIOL, V28, P446, DOI 10.1111/cobi.12195; Boessenkool S, 2012, MOL ECOL, V21, P1806, DOI 10.1111/j.1365-294X.2011.05306.x; Bogale B., 2014, ACTA PARASITOL GLOB, V5, P19, DOI 10.5829/idosi.apg.2014.5.1.8346; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Braak Ter C., 1998, CANOCO REFERENCE MAN; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; Burnand J., 1998, SURVEY FLORA FAUNA S, P24; Chynoweth MW, 2013, PAC SCI, V67, P141, DOI 10.2984/67.2.1; COBLENTZ BE, 1977, J RANGE MANAGE, V30, P415, DOI 10.2307/3897801; DEBOER WF, 1990, OECOLOGIA, V82, P264, DOI 10.1007/BF00323544; DUNBAR RIM, 1978, E AFR WILDL J, V16, P183; Ejigu D., 2012, THESIS; [Ethiopian Wildlife Conservation Authority Simien Mountains National Park], 2013, CHALL CONS PROT AR M; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Gebremedhin B, 2009, ANIM CONSERV, V12, P89, DOI 10.1111/j.1469-1795.2009.00238.x; Gebremedhin B, 2008, IUCN RED LIST THREAT; Gordon IJ, 2009, WILDLIFE BIOL, V15, P1, DOI 10.2981/06-087; Gottelli D, 2013, ANIM CONSERV, V16, P234, DOI 10.1111/j.1469-1795.2012.00591.x; Grunenfelder J., 2005, THESIS; Hagedorn F, 2010, BIOGEOCHEMISTRY, V97, P1, DOI 10.1007/s10533-009-9386-9; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hedberg I, 2006, FLORA ETHIOPIA ERITR, V5; Hedberg I., 2003, FLORA ETHIOPIA ERITR, V4, P1; Hedberg I, 1997, FLORA ETHIOPIA ERITR, V7; Hibert F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060799; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Hurni H, 1986, MANAGEMENT PLAN SIME; Hurni H., 2010, GLOBAL CHANGE SUSTAI, P187, DOI DOI 10.13140/2.1.3976.5449; Hurni H, 2000, RECONCILING CONSERVA; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jongman RHG, 1995, DATA ANAL COMMUNITY; Kartzinel TR, 2015, P NATL ACAD SCI USA, V112, P8019, DOI 10.1073/pnas.1503283112; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; LANGTON RW, 1982, FISH B-NOAA, V80, P745; Li ZQ, 2008, J WILDLIFE MANAGE, V72, P944, DOI 10.2193/2007-233; Liu BM, 2008, HYDROL PROCESS, V22, P1059, DOI 10.1002/hyp.7022; Mason THE, 2014, GLOBAL CHANGE BIOL, V20, P3872, DOI 10.1111/gcb.12641; Mendelsohn R, 2007, CLIMATE CHANGE IMPAC; Mysterud A, 2000, OECOLOGIA, V124, P130, DOI 10.1007/s004420050032; Nievergelt B., 1981, IBEXES AFRICAN ENV E; Nyssen J, 2014, SCI TOTAL ENVIRON, V485, P164, DOI 10.1016/j.scitotenv.2014.03.052; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Phillips S., 1995, FLORA ETHIOPIA ERITR, V7; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Puff C., 2005, PLANTS SIMEN FLORA S; Putman R. J., 1996, COMPETITION RESOURCE; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; SCHOENER TW, 1974, THEOR POPUL BIOL, V6, P265, DOI 10.1016/0040-5809(74)90013-6; Shrestha R, 2005, J ZOOL, V266, P111, DOI 10.1017/S0952836905006527; Shrestha R, 2008, ENVIRON CONSERV, V35, P125, DOI 10.1017/S0376892908004724; Soininen EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115335; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; TER BRAAK CJF, 1987, VEGETATIO, V69, P69, DOI 10.1007/BF00038688; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Verdcourt B., 1989, FLORA ETHIOPIA ERITR, P511; Voeten MM, 1999, OECOLOGIA, V120, P287, DOI 10.1007/s004420050860; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921	72	25	27	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159133	10.1371/journal.pone.0159133	http://dx.doi.org/10.1371/journal.pone.0159133			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416020	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500085
J	Korona-Glowniak, I; Maj, M; Siwiec, R; Niedzielski, A; Malm, A				Korona-Glowniak, Izabela; Maj, Maciej; Siwiec, Radoslaw; Niedzielski, Artur; Malm, Anna			Molecular Epidemiology of Streptococcus pneumoniae Isolates from Children with Recurrent Upper Respiratory Tract Infections	PLOS ONE			English	Article							SEROTYPE 19A; CLONAL COMPLEX; RESISTANCE; ELEMENTS; PNEUMOCOCCI; MECHANISMS; DIVERSITY; TRANSPOSONS; ASSOCIATION; EVOLUTION	A total of 125 isolates were recovered from adenoids and/or nasopharynx of 170 children aged 2 to 5 from south-east Poland; they had undergone adenoidectomy for recurrent and/or persistent symptoms of upper respiratory tract infections. Pneumococcal isolates were analyzed by phenotyping (serotyping and antimicrobial resistance tests) and genotyping together with the clonality of the pneumococcal isolates based on resistance determinants, transposon distribution and multilocus sequence typing (MLST). Serotypes 19F, 6B and 23F constituted 44.8% of the isolates. Among all of the strains, 44.8% showed decreased susceptibility to penicillin and resistance to co-trimoxazole (52.8%), tetracycline (38.4%), erythromycin (53.6%), clindamycin (52.8%) and chloramphenicol (27.2%) was observed. Tn6002 was found in 34.8% of erythromycin-resistant isolates while composite Tn2010-in 16.7% of erm(B)-carrying isolates that harboured also mef(E) gene. Tn3872-related elements were detected in 27.3% of erythromycin-resistant strains. In the majority of chloramphenicol-resistant cat(pC194)-carrying isolates (79.4%), ICESp23FST81-family elements were detected. The genotyping showed that pneumococcal population was very heterogeneous; 82 sequence types (STs) were identified, and the most frequent contributed to not more than 8% of the isolates. Nearly 44% STs were novel, each of them was recovered only from one child. Four STs belonged to one of the 43 worldwide spread resistant pneumococcal clones currently accepted by Pneumococcal Molecular Epidemiology Network (PMEN), i.e. Spain 9V-3, Spain 23F-1, Norway NT-42 and Poland 6B-20, accounting for 12 (16.7%) of the 75 nonususceptible isolates, and five STs were single-locus variants of PMEN resistant clones (England 14-9, Spain 9V-3, Spain 23F-1, Greece 21-30, Denmark 14-32), accounting 9 (12%) of nonsusceptible isolates. A few MDR clones belonging to 6B and 19F serotypes found among preschool children emphasizes rather the role of clonal dissemination of local strains in the community than international clones spreading in the increase of resistance among pneumococcal strains.	[Korona-Glowniak, Izabela; Siwiec, Radoslaw; Malm, Anna] Med Univ Lublin, Dept Pharmaceut Microbiol, Lab Microbiol Diagnost, Lublin, Poland; [Maj, Maciej] Med Univ Lublin, Dept Clin Immunol, Lublin, Poland; [Niedzielski, Artur] Med Univ Lublin, Otoneurol Lab 3, Chair Paediat, Lublin, Poland; [Niedzielski, Artur] Med Univ Lublin, Dept Pediat Otolaryngol Phoniatr & Audiol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Korona-Glowniak, I (corresponding author), Med Univ Lublin, Dept Pharmaceut Microbiol, Lab Microbiol Diagnost, Lublin, Poland.	iza.glowniak@umlub.pl		Korona-Glowniak, Izabela/0000-0003-1634-0387; Malm, Anna/0000-0003-1503-7634; Maj, Maciej/0000-0002-3435-2544; Siwiec, Radoslaw/0000-0002-2959-5015; Niedzielski, Artur/0000-0001-9062-0403				Appelbaum PC, 2002, CLIN INFECT DIS, V34, P1613, DOI 10.1086/340400; Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Calatayud L, 2007, ANTIMICROB AGENTS CH, V51, P3240, DOI 10.1128/AAC.00157-07; Calatayud L, 2010, J CLIN MICROBIOL, V48, P1310, DOI 10.1128/JCM.01868-09; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; Cochetti I, 2008, ANTIMICROB AGENTS CH, V52, P1285, DOI 10.1128/AAC.01457-07; Cochetti I, 2007, J ANTIMICROB CHEMOTH, V60, P127, DOI 10.1093/jac/dkm120; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; de Lencastre H, 2002, J ANTIMICROB CHEMOTH, V50, P75, DOI 10.1093/jac/dkf511; Del Grosso M, 2007, ANTIMICROB AGENTS CH, V51, P4184, DOI 10.1128/AAC.00598-07; Del Grosso M, 2006, ANTIMICROB AGENTS CH, V50, P3361, DOI 10.1128/AAC.00277-06; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Geng Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093752; Henderson-Begg SK, 2009, INT J ANTIMICROB AG, V33, P364, DOI 10.1016/j.ijantimicag.2008.10.002; Isaacman D. J., 2010, INT J INFECT DIS, V14, pE197, DOI DOI 10.1016/j.ijid.2009.05.010; Izdebski R, 2007, ANTIMICROB AGENTS CH, V51, P1155, DOI 10.1128/AAC.01384-06; Jacobs MR, 2008, J CLIN MICROBIOL, V46, P982, DOI 10.1128/JCM.02321-07; Korona-Glowniak I, 2015, EPIDEMIOL INFECT, V143, P821, DOI 10.1017/S0950268814001460; Korona-Glowniak I, 2013, POL J MICROBIOL, V62, P385; Li Y, 2011, J APPL MICROBIOL, V110, P254, DOI 10.1111/j.1365-2672.2010.04875.x; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Mingoia M, 2011, ANTIMICROB AGENTS CH, V55, P1453, DOI 10.1128/AAC.01087-10; Montanari MP, 2003, J CLIN MICROBIOL, V41, P428, DOI 10.1128/JCM.41.1.428-431.2003; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pillai DR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-642; Quintero B, 2011, ANTIMICROB AGENTS CH, V55, P4930, DOI 10.1128/AAC.00242-11; Rice LB, 1998, ANTIMICROB AGENTS CH, V42, P1871, DOI 10.1128/AAC.42.8.1871; Sadowy E, 2007, ANTIMICROB AGENTS CH, V51, P40, DOI 10.1128/AAC.01072-06; Sadowy E, 2010, ANTIMICROB AGENTS CH, V54, P1720, DOI 10.1128/AAC.01340-09; Siira L, 2012, EUR J CLIN MICROBIOL, V31, P867, DOI 10.1007/s10096-011-1386-8; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Vestrheim DF, 2008, J CLIN MICROBIOL, V46, P2508, DOI 10.1128/JCM.02296-07; Widdowson CA, 2000, ANTIMICROB AGENTS CH, V44, P393, DOI 10.1128/AAC.44.2.393-395.2000; Xu XP, 2010, ANTIMICROB AGENTS CH, V54, P1152, DOI 10.1128/AAC.01268-09; Zhou L, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-228	37	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158909	10.1371/journal.pone.0158909	http://dx.doi.org/10.1371/journal.pone.0158909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415833	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500049
J	Li, J; Tang, Y; Huang, L; Yu, QQ; Hu, GY; Yuan, XL				Li, Jing; Tang, Yang; Huang, Liu; Yu, Qianqian; Hu, Guangyuan; Yuan, Xianglin			Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection	PLOS ONE			English	Article							P53; POLYMORPHISMS	The p14ARF/MDM2/TP53 pathway is known to play an important role in tumor progression by cell cycle control, although the association between this pathway and the prognosis of esophageal squamous cell carcinoma (ESCC) is unclear. In this study, we explored the association between genetic variants in the p14ARF/MDM2/TP53 pathway and prognosis in ESCC patients with radical resection. 124 ESCC patients with radical resection were included in this retrospective study and genotyped using the MassArray method. According to multivariate Cox hazard analysis and multiple testing, the TC/CC genotype of p14ARF rs3814960 was shown to be strongly related to a decreased overall survival (OS) (HR = 2.77, 95% CI: 1.33-5.75, P = 0.006, Pc = 0.030) and disease-free survival (DFS) (HR = 2.45, 95% CI: 1.30-4.61, P = 0.005, Pc = 0.025). Moreover, patients with the DEL/A + AA genotype of MDM2 rs34886328 had a notably increased OS (HR = 0.27, 95% CI: 0.13-0.56, P = 4.7x10(-4), Pc = 0.003) and DFS (HR = 0.22, 95% CI: 0.11-0.43, P = 1.1x10(-5), Pc = 6.6x10(-5)). We also found that these two SNPs had a cumulative effect on the prognosis of ESCC, with the OS (P < 0.001) and DFS (P < 0.001) being shortest for patients carrying both of these unfavorable genotypes. In conclusion, genetic variants of the p14ARF/MDM2/TP53 pathway are significantly related to OS and DFS, and may be predictors of the prognosis of ESCC after surgery. We speculate the individuals with the TC/CC genotype of p14ARF rs3814960 and/or the DEL/DEL genotype of MDMD2 rs34886328 should have more aggressive treatment and may greatly benefit from early prediction and prevention of an unfavorable prognosis by genotyping before the initiation of therapy. These findings should be further validated in a larger population.	[Li, Jing; Tang, Yang; Huang, Liu; Yu, Qianqian; Hu, Guangyuan; Yuan, Xianglin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan, Hubei Province, Peoples R China	Huazhong University of Science & Technology	Yuan, XL (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan, Hubei Province, Peoples R China.	YXL@medmail.com.cn			Merck Serono Oncology Rearch Fund of Chinese Society of Clinical Oncology [Y-MT2014-001]	Merck Serono Oncology Rearch Fund of Chinese Society of Clinical Oncology	This work was supported by the Merck Serono Oncology Rearch Fund of Chinese Society of Clinical Oncology (Y-MT2014-001) [http://www.csco.org.cn/cat/158/show/6961.html] to XLY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2000, CANCER, V89, P946; Ajani JA, 2005, J CLIN ONCOL, V23, P4256, DOI 10.1200/JCO.2005.12.911; Ando N, 2000, ANN SURG, V232, P225, DOI 10.1097/00000658-200008000-00013; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheng TH, 2009, J CANCER RES CLIN, V135, P1577, DOI 10.1007/s00432-009-0605-5; Gryshchenko I, 2008, J CLIN ONCOL, V26, P2252, DOI 10.1200/JCO.2007.11.5212; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kleinberg L, 2007, J CLIN ONCOL, V25, P4110, DOI 10.1200/JCO.2007.12.0881; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kwon JM, 2000, ALCOHOL RES HEALTH, V24, P164; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Post SM, 2010, CANCER CELL, V18, P220, DOI 10.1016/j.ccr.2010.07.010; Prives C, 1999, J PATHOL, V187, P112; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Yang J, 2013, CANCER EPIDEMIOL, V37, P629, DOI 10.1016/j.canep.2013.06.001; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099255; Zhang Y, 2011, CANCER-AM CANCER SOC, V117, P1227, DOI 10.1002/cncr.25605	25	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158613	10.1371/journal.pone.0158613	http://dx.doi.org/10.1371/journal.pone.0158613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414035	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500027
J	Sasakawa, K				Sasakawa, Koji			Notes on the Reproductive Ecology and Description of the Preimaginal Morphology of Elaphrus sugai Nakane, the Most Endangered Species of Elaphrus Fabricius (Coleoptera: Carabidae) Ground Beetle Worldwide	PLOS ONE			English	Article							LARVAL DEVELOPMENT; LIFE-CYCLE; DIET; FECUNDITY; CHAUDOIR; CARABUS; KEY	Elucidating the basic life-history of endangered species is the first important step in the conservation of such species. This study examined the reproductive ecology and the preimaginal morphology of the endangered ground beetle Elaphrus sugai Nakane (Coleoptera: Carabidae); currently, the Watarase wetland of the central Kanto Plain, Japan is the only confirmed locality of this beetle species. Laboratory rearing of reproductive adults collected in early April revealed that females can lay more than 131 eggs. Eggs were laid in mud, without an egg chamber. Larvae reached adulthood when fed a diet of mealworms, indicating that E. sugai larvae are insect larvae feeders. An earthworm diet, the optimal diet for larvae of a congeneric species (E. punctatus Motschulsky), was lethal to E. sugai larvae. The egg stage was 3-4 days in duration under a 16L8D cycle (22 degrees C). The duration from hatching to adult eclosion was 23-42 days at various temperatures simulating those of the reproductive period. Larval morphology was similar to that of consubgeneric species described previously. The pupa is unusual, in that the setae on the abdominal tergites are long (twice as long as those of the abdominal segment) and have somewhat "coiled" apices. Finally, the current endangered status of E. sugai was compared to that of E. viridis Horn, which has been regarded as the most endangered species of the genus worldwide.	[Sasakawa, Koji] Chiba Univ, Fac Educ, Dept Sci Educ, Zool Lab,Inage Ku, Yayoi Cho, Chiba, Japan; [Sasakawa, Koji] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Tokyo, Japan	Chiba University; University of Tokyo	Sasakawa, K (corresponding author), Chiba Univ, Fac Educ, Dept Sci Educ, Zool Lab,Inage Ku, Yayoi Cho, Chiba, Japan.; Sasakawa, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Tokyo, Japan.	ksasa@chiba-u.jp			Japan Society for the Promotion of Science [25830150]; Grants-in-Aid for Scientific Research [25830150] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science (no. 25830150), https://kaken.nii.ac.jp/d/p/25830150.en.html.; I thank Dr. D.H. Kavanaugh (California Academy of Sciences, CA, U.S.A.) and Dr. T. Kishimoto (Museum of Natural and Environmental History, Shizuoka, Japan) for recent information of E. viridis and E. sugai, respectively. The present study was partly supported by a grantin-aid from the Japan Society for the Promotion of Science (no. 25830150).	BALL GE, 1969, CAN J ZOOLOG, V47, P877, DOI 10.1139/z69-146; BOUSQUET Y, 1986, SYST ENTOMOL, V11, P25, DOI 10.1111/j.1365-3113.1986.tb00160.x; BOUSQUET Y, 1984, CAN J ZOOL, V62, P573, DOI 10.1139/z84-085; Bousquet Y., 1985, REV ECOLOGIE SYSTEMA, V112, P191; BURAKOWSKI B, 1989, Annales Zoologici (Warsaw), V42, P181; Busato E, 2012, ZOOTAXA, P1; Busato E, 2014, ZOOTAXA, V3866, P451, DOI 10.11646/zootaxa.3866.4.1; Cardenas Talaveron AM, 1993, ELYTRON, V7, P123; Costa C, 2011, ZOOTAXA, P30; Dajoz Roger, 2005, Nouvelle Revue d'Entomologie, V22, P283; Fish Sacramento & Office Wildlife, 2006, DELT GREEN GROUND BE; GOULET H, 1983, Quaestiones Entomologicae, V19, P219; Huk T, 1999, OECOLOGIA, V121, P348, DOI 10.1007/s004420050938; Ikeda H, 2010, ECOL ENTOMOL, V35, P307, DOI 10.1111/j.1365-2311.2010.01182.x; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jorgensen HB, 1997, PEDOBIOLOGIA, V41, P307; Jorgensen HB, 1997, ECOL ENTOMOL, V22, P7, DOI 10.1046/j.1365-2311.1997.00045.x; Kishimoto T, 2015, RED DATA BOOK 2014 T, V5, P91; Kleinwachter M, 2008, ECOL ENTOMOL, V33, P286, DOI 10.1111/j.1365-2311.2007.00963.x; Kurata K., 2012, JAPAN RURIBOSHI, V41, P87; MAKAROV KV, 1994, SERIES ENTOM, V51, P177; Monitoring Committee for Wetland Conservation and Restoration in the Watarase Flood Control Basin, 2012, C MAT 7 5 M RES INS; Monitoring Committee for Wetland Conservation and Restoration in the Watarase Flood Control Basin, 2014, C MAT 6 9 M ANN REP; Monitoring Committee for Wetland Conservation and Restoration in the Watarase Flood Control Basin, 2014, C MAT 6 7 M ANN REP; Okuzaki Y, 2010, ENTOMOL EXP APPL, V135, P263, DOI 10.1111/j.1570-7458.2010.00987.x; Pavel VR, 2002, COLEOPT B, V56, P310; Sasakawa K., 2016, ZOOKEYS IN PRESS; Sasakawa K., 2015, DRYAD DIGITAL REPOSI; Sasakawa K, 2009, ENTOMOL EXP APPL, V130, P106, DOI 10.1111/j.1570-7458.2008.00799.x; Sasakawa K, 2016, BIOL J LINN SOC, V118, P394, DOI 10.1111/bij.12727; Sasakawa K, 2011, APPL ENTOMOL ZOOL, V46, P511, DOI 10.1007/s13355-011-0070-x; Sasakawa K, 2011, ZOOL STUD, V50, P264; Sasakawa K, 2009, ECOL ENTOMOL, V34, P406, DOI 10.1111/j.1365-2311.2009.01092.x; Sota, 1998, NATURE INSECTS, V33, P38; Sota T., 2000, CARABUS 4 SEASONS LI; Thiele H. -U., 1977, CARABID BEETLES THEI, DOI 10.1007/978-3-642-81154-8; ZANGGER A, 1994, SERIES ENTOM, V51, P469	37	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159164	10.1371/journal.pone.0159164	http://dx.doi.org/10.1371/journal.pone.0159164			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415755	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500094
J	Yan, IK; Wang, X; Asmann, YW; Haga, H; Patel, T				Yan, Irene K.; Wang, Xue; Asmann, Yan W.; Haga, Hiroaki; Patel, Tushar			Circulating Extracellular RNA Markers of Liver Regeneration	PLOS ONE			English	Article							HEPATOCELLULAR CANCER; PARTIAL-HEPATECTOMY; MICRORNAS; MODULATION; TARGETS; GROWTH	Background and Aims Although a key determinant of hepatic recovery after injury is active liver regeneration, the ability to detect ongoing regeneration is lacking. The restoration of liver mass after hepatectomy involves systemic changes with coordinated changes in gene expression guiding regenerative responses, activation of progenitor cells, and proliferation of quiescent hepatocytes. We postulated that these responses involve intercellular communication involving extracellular RNA and that these could represent biomarkers of active regenerative responses. Methods RNA sequencing was performed to identify temporal changes in serum extracellular non-coding RNA after partial hepatectomy in C57BL/6 male mice. Tissue expression of selected RNA was performed by microarray analysis and validated using qRT-PCR. Digital PCR was used to detect and quantify serum expression of selected RNA. Results A peak increase in extracellular RNA content occurred six hours after hepatectomy. RNA sequencing identified alterations in several small non-coding RNA including known and novel microRNAs, snoRNAs, tRNA, antisense and repeat elements after partial hepatectomy. Combinatorial effects and network analyses identified signal regulation, protein complex assembly, and signal transduction as the most common biological processes targeted by miRNA that altered. miR-1A and miR-181 were most significantly altered microRNA in both serum and in hepatic tissues, and their presence in serum was quantitated using digital PCR. Conclusions Extracellular RNA selectively enriched during acute regeneration can be detected within serum and represent biomarkers of ongoing liver regeneration in mice. The ability to detect ongoing active regeneration would improve the assessment of hepatic recovery from liver injury.	[Yan, Irene K.; Haga, Hiroaki; Patel, Tushar] Mayo Clin, Dept Transplantat, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA; [Yan, Irene K.; Haga, Hiroaki; Patel, Tushar] Dept Canc Biol, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA; [Wang, Xue; Asmann, Yan W.] Dept Hlth Sci Res, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA	Mayo Clinic	Patel, T (corresponding author), Mayo Clin, Dept Transplantat, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA.; Patel, T (corresponding author), Dept Canc Biol, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA.	patel.tushar@mayo.edu			Office of the Director, National Institutes of Health and NCATS [R01DK069370, UH3TR000884]; Mayo Clinic Center for Regenerative Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069370] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health and NCATS; Mayo Clinic Center for Regenerative Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grants R01DK069370 and UH3TR000884 from the Office of the Director, National Institutes of Health and NCATS, and the Mayo Clinic Center for Regenerative Medicine.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Castro RE, 2010, AM J PHYSIOL-GASTR L, V299, pG887, DOI 10.1152/ajpgi.00216.2010; Chiba M, 2013, BIOMED REP, V1, P383, DOI [10.3892/br.2013.80, 10.3892/br.2012.15]; Elfimova N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00476; Friedman Y, 2010, BIOINFORMATICS, V26, P1920, DOI 10.1093/bioinformatics/btq298; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kogure Takayuki, 2013, Genes Cancer, V4, P261, DOI 10.1177/1947601913499020; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kren BT, 2009, AM J PHYSIOL-GASTR L, V297, pG1181, DOI 10.1152/ajpgi.90636.2008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Michalopoulos GK, 2013, COMPR PHYSIOL, V3, P485, DOI 10.1002/cphy.c120014; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sabin K, 2014, TRANSL RES, V163, P286, DOI 10.1016/j.trsl.2013.10.005; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schug J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-264; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Sun ZF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-423; Takahashi K, 2014, MOL CANCER RES, V12, P1377, DOI 10.1158/1541-7786.MCR-13-0636; Takahashi K, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00129; Takahashi K, 2014, FEBS OPEN BIO, V4, P458, DOI 10.1016/j.fob.2014.04.007; Wei W, 2015, EUR SURG RES, V54, P97, DOI 10.1159/000368573	27	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0155888	10.1371/journal.pone.0155888	http://dx.doi.org/10.1371/journal.pone.0155888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415797	Green Submitted, gold, Green Published			2022-12-27	WOS:000379579500011
J	Zeng, CY; Yu, FL; Yang, Y; Cheng, XH; Liu, Y; Zhang, H; Zhao, SQ; Yang, ZB; Li, MY; Li, ZP; Mei, XG				Zeng, Chunying; Yu, Fanglin; Yang, Yang; Cheng, Xiaohui; Liu, Yan; Zhang, Hui; Zhao, Shiqing; Yang, Zhenbo; Li, Mingyuan; Li, Zhiping; Mei, Xingguo			Preparation and Evaluation of Oxaliplatin Thermosensitive Liposomes with Rapid Release and High Stability	PLOS ONE			English	Article							TARGETED DRUG-DELIVERY; IN-VITRO; TUMOR; DOXORUBICIN; TEMPERATURE; EFFICACY; CANCER; PHARMACOKINETICS; CYTOTOXICITY; HYPERTHERMIA	Oxaliplatin (OXP) was reported to show low anti-tumor activity when used alone and to display side effects; this low activity was attributed to high partitioning to erythrocytes and low accumulation in tumors. Thermosensitive liposomes (TSL) were considered able to specifically deliver drugs to heated tumors and to resolve the OXP distribution problem. Regretfully, TSL encapsulating doxorubicin did not demonstrate significant improvement in progression-free survival. Drug release below 41 degrees C and significant leakage were considered major reasons for the failure. The purpose of this study was to acquire OXP TSL with rapid release at the triggered temperature and high stability at body temperature and at storage temperatures. A small quantity of poloxamer 188 was introduced into the TSL formulation to stabilize the encapsulated drug. It was shown that the addition of poloxamer 188 had no influence on the TSL characteristics. More than 90% of OXP was released within 10 min at 42 degrees C, and less than 15% was released within 60 min at temperatures below 39 degrees C. TSL were stable at 37 degrees C for 96 h and at 4 degrees C for 6 months. The anti-tumor activity of TSL at the dose of 2.5 mg/kg was certified to be equal to those of OXP injection and non-thermosensitive liposomes (NTSL) at the dose of 5 mg/kg, and significant improvement of tumor inhibition was observed in TSL compared with injection and NTSL at the same dose. It was also shown from the histological transmutation of tumors that TSL had stronger anti-tumor activity. Therefore, it could be concluded that TSL composed of a proper amount of poloxamer had rapid release and high stability, and OXP TSL would be anticipated to exert prominent anti-tumor activity in the clinic.	[Zeng, Chunying] Capital Med Univ, Fu Xing Hosp, Dept Pharm, Beijing, Peoples R China; [Yu, Fanglin; Yang, Yang; Cheng, Xiaohui; Liu, Yan; Zhang, Hui; Zhao, Shiqing; Li, Mingyuan; Li, Zhiping; Mei, Xingguo] Beijing Inst Pharmacol & Toxicol, Dept Pharmaceut, Beijing, Peoples R China; [Yang, Zhenbo] 261 Hosp PLA, Dept Pharm, Beijing, Peoples R China	Capital Medical University; Academy of Military Medical Sciences - China	Li, ZP; Mei, XG (corresponding author), Beijing Inst Pharmacol & Toxicol, Dept Pharmaceut, Beijing, Peoples R China.	dearwood2010@126.com; newdds@126.com			Natural Science Foundation of China [81502675]; National Key Technologies R&D Program for New Drugs [2012ZX09301003-001-009]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for New Drugs(National Key Technology R&D Program)	This work was supported by Natural Science Foundation of China (No. 81502675; Zhiping Li; http://www.nsfc.gov.cn/) and the National Key Technologies R&D Program for New Drugs (No. 2012ZX09301003-001-009; Xingguo Mei, Zhiping Li, Yang Yang, Fanglin Yu).	Abu Lila AS, 2012, INT J PHARMACEUT, V438, P176, DOI 10.1016/j.ijpharm.2012.08.030; Abu-Lila A, 2009, J CONTROL RELEASE, V134, P18, DOI 10.1016/j.jconrel.2008.10.018; Andresen TL, 2005, PROG LIPID RES, V44, P68, DOI 10.1016/j.plipres.2004.12.001; Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006; Chen D, 2013, INT J PHARMACEUT, V449, P1, DOI 10.1016/j.ijpharm.2013.04.002; Chen J, 2014, INT J PHARMACEUT, V475, P408, DOI 10.1016/j.ijpharm.2014.09.009; Church Jeffrey W., 2014, 2014 AM SOC IN PRESS, V5, P16; Dewhirst MW, 1997, SEMIN ONCOL, V24, P616; Di Francesco AM, 2002, CELL MOL LIFE SCI, V59, P1914, DOI 10.1007/PL00012514; Dicheva BM, 2015, PHARM RES-DORDR, V32, P3862, DOI 10.1007/s11095-015-1746-7; Dromi S, 2007, CLIN CANCER RES, V13, P2722, DOI 10.1158/1078-0432.CCR-06-2443; Franzena U, 2010, J PHARM BIOMED ANAL, V55, P16; Judson I, 2001, EUR J CANCER, V37, P870, DOI 10.1016/S0959-8049(01)00050-8; Kong G, 2000, CANCER RES, V60, P6950; Kwon HJ, 2015, J CONTROL RELEASE, V216, P132, DOI 10.1016/j.jconrel.2015.08.002; Li Y, 2015, BIOMATERIALS, V41, P1, DOI 10.1016/j.biomaterials.2014.11.010; Lu T, 2015, J CONTROL RELEASE, V220, P425, DOI 10.1016/j.jconrel.2015.10.056; Mady MM, 2012, PHYS MEDICA, V28, P48, DOI 10.1016/j.ejmp.2011.02.003; May JP, 2013, MOL PHARMACEUT, V10, P4499, DOI 10.1021/mp400321e; Monsky WL, 1999, CANCER RES, V59, P4129; Mosquera M, 2014, FOOD CHEM, V156, P144, DOI 10.1016/j.foodchem.2014.02.011; Nie SF, 2011, INT J NANOMED, V6, P151, DOI 10.2147/IJN.S15057; PENDYALA L, 1993, CANCER RES, V53, P5970; Ponce AM, 2007, J NATL CANCER I, V99, P53, DOI 10.1093/jnci/djk005; Poon RTP, 2009, EXPERT OPIN PHARMACO, V10, P333, DOI [10.1517/14656560802677874 , 10.1517/14656560802677874]; Quinteros D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110344; Romberg B, 2007, BBA-BIOMEMBRANES, V1768, P737, DOI 10.1016/j.bbamem.2006.12.005; Suzuki R, 2008, INT J PHARM, V346, P143, DOI 10.1016/j.ijpharm.2007.06.010; Tagami T, 2015, J PHARM SCI-US, V104, P3824, DOI 10.1002/jps.24593; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Wang M, 2014, INT J PHARMACEUT, V468, P243, DOI 10.1016/j.ijpharm.2014.04.014; Yang C, 2014, BIOMED REP, V2, P335, DOI 10.3892/br.2014.249; Yang CA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-21; Yang YF, 2014, BIOMATERIALS, V35, P4368, DOI 10.1016/j.biomaterials.2014.01.076; Yuba E, 2013, BIOMATERIALS, V34, P3042, DOI 10.1016/j.biomaterials.2012.12.031; Zalba S, 2012, EUR J PHARM BIOPHARM, V81, P273, DOI 10.1016/j.ejpb.2012.02.007; Zhang B, 2013, INT J PHARMACEUT, V455, P276, DOI 10.1016/j.ijpharm.2013.07.020; Zhang H, 2011, ANAL BIOCHEM, V417, P292, DOI 10.1016/j.ab.2011.06.025; Zhang WL, 2015, J CONTROL RELEASE, V203, P161, DOI 10.1016/j.jconrel.2015.02.026	39	21	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158517	10.1371/journal.pone.0158517	http://dx.doi.org/10.1371/journal.pone.0158517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415823	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500024
J	Dalko, E; Tchitchek, N; Pays, L; Herbert, F; Cazenave, PA; Ravindran, B; Sharma, S; Nataf, S; Das, B; Pied, S				Dalko, Esther; Tchitchek, Nicolas; Pays, Laurent; Herbert, Fabien; Cazenave, Pierre-Andre; Ravindran, Balachandran; Sharma, Shobhona; Nataf, Serge; Das, Bidyut; Pied, Sylviane			Erythropoietin Levels Increase during Cerebral Malaria and Correlate with Heme, Interleukin-10 and Tumor Necrosis Factor-Alpha in India	PLOS ONE			English	Article							FALCIPARUM-MALARIA; PLASMODIUM-FALCIPARUM; GENE; EXPRESSION; PROTECTION; RECEPTORS; CYTOSCAPE; APOPTOSIS; CYTOKINES; CHILDREN	Cerebral malaria (CM) caused by Plasmodium falciparum parasites often leads to the death of infected patients or to persisting neurological sequelae despite anti-parasitic treatments. Erythropoietin (EPO) was recently suggested as a potential adjunctive treatment for CM. However diverging results were obtained in patients from Sub-Saharan countries infected with P. falciparum. In this study, we measured EPO levels in the plasma of well-defined groups of P. falciparum-infected patients, from the state of Odisha in India, with mild malaria (MM), CM, or severe non-CM (NCM). EPO levels were then correlated with biological parameters, including parasite biomass, heme, tumor necrosis factor (TNF)-alpha, interleukin (IL)-10, interferon gamma-induced protein (IP)-10, and monocyte chemoattractant protein (MCP)-1 plasma concentrations by Spearman's rank and multiple correlation analyses. We found a significant increase in EPO levels with malaria severity degree, and more specifically during fatal CM. In addition, EPO levels were also found correlated positively with heme, TNF-alpha, IL-10, IP-10 and MCP-1 during CM. We also found a significant multivariate correlation between EPO, TNF-alpha, IL-10, IP-10 MCP-1 and heme, suggesting an association of EPO with a network of immune factors in CM patients. The contradictory levels of circulating EPO reported in CM patients in India when compared to Africa highlights the need for the optimization of adjunctive treatments according to the targeted population.	[Dalko, Esther; Herbert, Fabien; Cazenave, Pierre-Andre; Pied, Sylviane] Univ Lille Nord France, Inst Pasteur Lille, CNRS UMR 8204, Ctr Infect & Immun Lille,INSERM U1019, F-59019 Lille, France; [Tchitchek, Nicolas] CEA, IDMIT Infrastruct, DSV iMETI,UMR1184, Immunol Viral Infect & Autoimmune Dis Res Unit, Fontenay Aux Roses, France; [Pays, Laurent; Nataf, Serge] Univ Lyon 1, CarMeN Lab, INSERM U1060, INRA USC 1235, Oullins, France; [Pays, Laurent; Nataf, Serge] Hop Edouard Herriot, Banque Tissus & Cellules, Hosp Civils Lyon, Lyon, France; [Ravindran, Balachandran] Inst Life Sci, Bhubaneswar, Odisha, India; [Sharma, Shobhona] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Das, Bidyut] SCB Med Coll, Cuttack 753007, Odisha, India; [Dalko, Esther] Univ Quebec, Dept Sci Biol, Montreal, PQ H2X 1Y4, Canada; [Cazenave, Pierre-Andre] UPMC, CNRS UMR 7211, Immunol Immunopathol Immunotherapie, F-75651 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; CEA; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Tata Institute of Fundamental Research (TIFR); Srirama Chandra Bhanja Medical College & Hospital; University of Quebec; University of Quebec Montreal; UDICE-French Research Universities; Sorbonne Universite	Pied, S (corresponding author), Univ Lille Nord France, Inst Pasteur Lille, CNRS UMR 8204, Ctr Infect & Immun Lille,INSERM U1019, F-59019 Lille, France.	sylviane.pied@pasteur-lille.fr	HERBERT, Fabien/I-3069-2018	HERBERT, Fabien/0000-0001-7988-3819; Nataf, Serge/0000-0003-3462-579X; Tchitchek, Nicolas/0000-0003-3307-0446; Pays, Laurent/0000-0003-0720-2273; Pied, Sylviane/0000-0003-0642-1423; Cazenave, Pierre-Andre/0000-0002-1345-8526; Dalko, Esther/0000-0001-7166-7417	Indo-French Centre for the Promotion of Advanced Research (IFCPAR); Associated International Laboratory Systems Immunology and Genetics of Infectious Diseases (SIGID); Department of Biotechnology from the Ministry of Science and Technology of India (DBT); Tata Institute of Fundamental Research; IFCPAR; College Doctoral Lille Nord de France [AAP n10]	Indo-French Centre for the Promotion of Advanced Research (IFCPAR)(Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA)); Associated International Laboratory Systems Immunology and Genetics of Infectious Diseases (SIGID); Department of Biotechnology from the Ministry of Science and Technology of India (DBT); Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); IFCPAR; College Doctoral Lille Nord de France	This work was supported by the Indo-French Centre for the Promotion of Advanced Research (IFCPAR), the Associated International Laboratory Systems Immunology and Genetics of Infectious Diseases (SIGID), the Department of Biotechnology from the Ministry of Science and Technology of India (DBT), and intramural funds from Tata Institute of Fundamental Research. The project was supported by the Raman-Charpak award from the IFCPAR and by the AAP n10 award from the College Doctoral Lille Nord de France.	Bansal D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008245; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; Casals-Pascual C, 2009, TRENDS PARASITOL, V25, P30, DOI 10.1016/j.pt.2008.10.002; Casals-Pascual C, 2008, P NATL ACAD SCI USA, V105, P2634, DOI 10.1073/pnas.0709715105; Dalko E, 2015, INFECT IMMUN, V83, P3793, DOI 10.1128/IAI.00531-15; Dalko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054744; Diez-Padrisa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024090; Dolznig H, 2002, CURR BIOL, V12, P1076, DOI 10.1016/S0960-9822(02)00930-2; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; ECKARDT KU, 1992, J CLIN INVEST, V89, P753, DOI 10.1172/JCI115652; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; GRAU GE, 1989, IMMUNOL REV, V112, P49, DOI 10.1111/j.1600-065X.1989.tb00552.x; Herbert F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0731-6; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Idro Richard, 2010, BMC Res Notes, V3, P104, DOI 10.1186/1756-0500-3-104; Kaiser K, 2006, J INFECT DIS, V193, P987, DOI 10.1086/500844; Kossodo S, 1997, IMMUNOLOGY, V91, P536, DOI 10.1046/j.1365-2567.1997.00290.x; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Lifshitz L, 2009, MOL IMMUNOL, V46, P713, DOI 10.1016/j.molimm.2008.10.004; Medana IM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-261; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Noedl H, 2005, ANTIMICROB AGENTS CH, V49, P3575, DOI 10.1128/AAC.49.8.3575-3577.2005; Panda AK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-309; Pathak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035592; PICOT S, 2009, MALARIA J, V8, DOI DOI 10.1186/1475-; Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720; R Development Core Team, 2008, R A LANGUAGE AND ENV; Rudin W, 1997, AM J PATHOL, V150, P257; Shabani E, 2015, CLIN INFECT DIS, V60, P27, DOI 10.1093/cid/ciu735; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Su SB, 1997, BLOOD, V90, P605, DOI 10.1182/blood.V90.2.605.605_605_611; Subiros N, 2012, THER ADV NEUROL DISO, V5, P161, DOI 10.1177/1756285611434926; Wei X, 2014, INFECT IMMUN, V82, P165, DOI 10.1128/IAI.00929-13; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, GUIDELINES FOR THE T; Wiese L, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-3; World Health Organization, 2012, MANAGEMENT OF SEVERE	42	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158420	10.1371/journal.pone.0158420	http://dx.doi.org/10.1371/journal.pone.0158420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441662	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500013
J	Groenendyk, J; Lee, D; Jung, J; Dyck, JRB; Lopaschuk, GD; Agellon, LB; Michalak, M				Groenendyk, Jody; Lee, Dukgyu; Jung, Joanna; Dyck, Jason R. B.; Lopaschuk, Gary D.; Agellon, Luis B.; Michalak, Marek			Inhibition of the Unfolded Protein Response Mechanism Prevents Cardiac Fibrosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TGF-BETA; CALRETICULIN INCREASES; MYOCARDIAL FIBROSIS; HEART; ARRHYTHMOGENESIS; OVEREXPRESSION; NORMALIZATION; EXPRESSION; CHAPERONE	Background Cardiac fibrosis attributed to excessive deposition of extracellular matrix proteins is a major cause of heart failure and death. Cardiac fibrosis is extremely difficult and challenging to treat in a clinical setting due to lack of understanding of molecular mechanisms leading to cardiac fibrosis and effective anti-fibrotic therapies. The objective in this study was to examine whether unfolded protein response (UPR) pathway mediates cardiac fibrosis and whether a pharmacological intervention to modulate UPR can prevent cardiac fibrosis and preserve heart function. Methodology/Principal Findings We demonstrate here that the mechanism leading to development of fibrosis in a mouse with increased expression of calreticulin, a model of heart failure, stems from impairment of endoplasmic reticulum (ER) homeostasis, transient activation of the unfolded protein response (UPR) pathway and stimulation of the TGF beta 1/Smad2/3 signaling pathway. Remarkably, sustained pharmacologic inhibition of the UPR pathway by tauroursodeoxycholic acid (TUDCA) is sufficient to prevent cardiac fibrosis, and improved exercise tolerance. Conclusions We show that the mechanism leading to development of fibrosis in a mouse model of heart failure stems from transient activation of UPR pathway leading to persistent remodelling of cardiac tissue. Blocking the activation of the transiently activated UPR pathway by TUDCA prevented cardiac fibrosis, and improved prognosis. These findings offer a window for additional interventions that can preserve heart function.	[Groenendyk, Jody; Lee, Dukgyu; Jung, Joanna; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Lee, Dukgyu; Agellon, Luis B.] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Dyck, Jason R. B.; Lopaschuk, Gary D.; Michalak, Marek] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2H7, Canada; [Dyck, Jason R. B.; Lopaschuk, Gary D.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada	University of Alberta; McGill University; University of Alberta; University of Alberta	Michalak, M (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.; Agellon, LB (corresponding author), McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada.; Michalak, M (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB T6G 2H7, Canada.	luis.agellon@mcgill.ca; marek.michalak@ualberta.ca		Dyck, Jason/0000-0002-7045-2884	Canadian Institutes of Health Research [MOP-15291, MOP-15415, MOP-53050, MOP-86750, MOP-123472]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research grants MOP-15291, MOP-15415, and MOP-53050 to M.M; MOP-15291 and MOP-86750 to LBA; and MOP-123472 to GDL.	Arnaudeau S, 2002, J BIOL CHEM, V277, P46696, DOI 10.1074/jbc.M202395200; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; BHARATI S, 1995, AM HEART J, V129, P273, DOI 10.1016/0002-8703(95)90008-X; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Braunwald E, 2013, EUR HEART J, V34, P1391, DOI 10.1093/eurheartj/ehs363; Brooks A, 2003, HEART, V89, P1255, DOI 10.1136/heart.89.10.1255; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Chusri P, 2016, SCI REP-UK, V6, DOI 10.1038/srep22487; Doroudgar S, 2013, J MOL CELL CARDIOL, V55, P85, DOI 10.1016/j.yjmcc.2012.10.006; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; GOMORI G, 1950, AM J CLIN PATHOL, V20, P661, DOI 10.1093/ajcp/20.7_ts.661; Graham LV, 2010, J BIOL CHEM, V285, P7067, DOI 10.1074/jbc.M109.006841; Groenendyk J, 2013, ANNU REV PHYSIOL, V75, P49, DOI 10.1146/annurev-physiol-030212-183707; Guo WK, 2014, INT J MOL SCI, V15, P484, DOI 10.3390/ijms15010484; Habtewold TD, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3571368; Hasenfuss G, 1997, BASIC RES CARDIOL, V92, P87, DOI 10.1007/BF00794072; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kypreou KP, 2008, PROTEOMICS, V8, P2407, DOI 10.1002/pmic.200700831; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056387; Lee YM, 2005, SEMIN LIVER DIS, V25, P321, DOI 10.1055/s-2005-916323; Lenna S, 2012, CURR OPIN RHEUMATOL, V24, P663, DOI 10.1097/BOR.0b013e3283588dbb; Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032; Lorts A, 2012, P NATL ACAD SCI USA, V109, P10978, DOI 10.1073/pnas.1204708109; Majumder R, 2016, SCI REP-UK, V6, DOI 10.1038/srep24334; Mery A, 2005, MOL BIOL CELL, V16, P2414, DOI 10.1091/mbc.E04-10-0883; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; OHTANI K, 1995, J AM COLL CARDIOL, V25, P1162, DOI 10.1016/0735-1097(94)00529-Y; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; PATTON WF, 1995, J BIOL CHEM, V270, P21404, DOI 10.1074/jbc.270.36.21404; Poupon R, 1999, J HEPATOL, V30, P408, DOI 10.1016/S0168-8278(99)80098-1; Prakoura N, 2013, AM J PATHOL, V183, P1474, DOI 10.1016/j.ajpath.2013.07.014; Segura A, 2014, HEART FAIL REV, V19, P173, DOI 10.1007/s10741-012-9365-4; Sun Y, 2005, METH MOLEC MED, V117, P273; Tarone G, 2014, CARDIOVASC RES, V102, P346, DOI 10.1093/cvr/cvu049; Tse G, 2016, ACTA PHYSIOL, V218, P234, DOI 10.1111/apha.12694; Tse G, 2016, J ARRYTHM, V32, P75, DOI 10.1016/j.joa.2015.11.003; Tse G, 2015, IJC HEART VASC, V9, P75, DOI 10.1016/j.ijcha.2015.10.003; Tsutsui H, 1997, AM J PHYSIOL-HEART C, V272, pH168, DOI 10.1152/ajpheart.1997.272.1.H168; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zwicker BL, 2013, INT J BIOCHEM CELL B, V45, P1389, DOI 10.1016/j.biocel.2013.04.012	53	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159682	10.1371/journal.pone.0159682	http://dx.doi.org/10.1371/journal.pone.0159682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441395	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500120
J	Yu, ZW; Lv, HY; Han, G; Ma, K				Yu, Zhenwei; Lv, Hongyan; Han, Gang; Ma, Ke			Ethosomes Loaded with Cryptotanshinone for Acne Treatment through Topical Gel Formulation	PLOS ONE			English	Article							DERMAL DELIVERY; SKIN DELIVERY; LIPOSOMES; VESICLES; CARRIERS	The aim of this study was to develop ethosomes loaded with cryptotanshinone (CPT) and formulate them as a topical gel for the treatment of acne. Ethosomes were prepared and evaluated for vesicle size, CPT loading and encapsulation efficiency. Optimized ethosomes were formulated as Carbomer 974 gels and compared with conventional hydroethanolic gels for transdermal permeation and skin deposition in vitro. The anti- acne activity and skin irritation of the gel was investigated in rabbits. Optimized ethosomes had an average vesicle size of 69.1 +/- 1.9 nm with CPT loading and encapsulation efficiency of 0.445 +/- 0.007 mg/mL and 40.31 +/- 0.67%, respectively. The transdermal flux and skin deposition of the optimized ethosomal gel were 2.5- and 2.1-times those of conventional gels. The ethosomal gel revealed better anti- acne effect with only slight skin irritation. This study demonstrates that ethosomal formulation is an effective dermal delivery system for CPT, and that CPT ethosomal gels are promising future acne treatments.	[Yu, Zhenwei; Lv, Hongyan; Han, Gang; Ma, Ke] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Pharm, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Han, G (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Pharm, Hangzhou, Zhejiang, Peoples R China.	hanpharm_srrsh@sina.com		YU, Zhenwei/0000-0002-3776-2290	Zhejiang Provincial Chinese Traditional Medicine Research Program [2011ZB082]	Zhejiang Provincial Chinese Traditional Medicine Research Program	This work was supported by Zhejiang Provincial Chinese Traditional Medicine Research Program (2011ZB082). URLs of funder: http://zgj.zjtcm.net/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2014, CURR DRUG DELIV, V11, P87, DOI 10.2174/15672018113106660064; Arora MK, 2011, CLIN BIOCHEM, V44, P1035, DOI 10.1016/j.clinbiochem.2011.06.984; Babaie S, 2015, ADV PHARM BULL, V5, P549, DOI 10.15171/apb.2015.074; Baek JS, 2015, INT J PHARMACEUT, V495, P701, DOI 10.1016/j.ijpharm.2015.09.054; Bloom DF, 2004, MED HYPOTHESES, V62, P462, DOI 10.1016/j.mehy.2003.11.003; Cai YE, 2016, INT J NANOMED, V11, P121, DOI 10.2147/IJN.S84035; Choi EH, 1997, EXP DERMATOL, V6, P29, DOI 10.1111/j.1600-0625.1997.tb00142.x; Choi JH, 2015, J NANOSCI NANOTECHNO, V15, P5660, DOI 10.1166/jnn.2015.10462; Dubey V, 2007, EUR J PHARM BIOPHARM, V67, P398, DOI 10.1016/j.ejpb.2007.03.007; Elsayed MMA, 2006, INT J PHARMACEUT, V322, P60, DOI 10.1016/j.ijpharm.2006.05.027; Ema M, 2013, CUTAN OCUL TOXICOL, V32, P128, DOI 10.3109/15569527.2012.727937; Ghanbarzadeh S, 2015, COLLOID SURFACE B, V136, P1004, DOI 10.1016/j.colsurfb.2015.10.041; KLIGMAN AM, 1979, BRIT J DERMATOL, V100, P699, DOI 10.1111/j.1365-2133.1979.tb08075.x; Kwon HH, 2013, BRIT J DERMATOL, V168, P1088, DOI 10.1111/bjd.12186; Lee DS, 1999, BIOSCI BIOTECH BIOCH, V63, P2236, DOI 10.1271/bbb.63.2236; Li X, 2011, INT IMMUNOPHARMACOL, V11, P1871, DOI 10.1016/j.intimp.2011.07.018; Limpongsa E, 2014, PHARM DEV TECHNOL, V20, P1; Liu PF, 2015, CURR DRUG METAB, V16, P245, DOI 10.2174/1389200216666150812124801; Manca ML, 2013, COLLOID SURFACE B, V111, P609, DOI 10.1016/j.colsurfb.2013.07.014; Mothana RAA, 2009, PHARMAZIE, V64, P613, DOI 10.1691/ph.2009.9543; National Society for Histotechnology, 2001, GUID HAEM EOS STAIN; OECD, 2015, TEST 404 AC DERM IRR; Tang S, 2011, INFLAMMATION, V34, P111, DOI 10.1007/s10753-010-9214-3; Touitou E, 2000, J CONTROL RELEASE, V65, P403, DOI 10.1016/S0168-3659(99)00222-9; Touitou E, 2001, BIOMATERIALS, V22, P3053, DOI 10.1016/S0142-9612(01)00052-7; de Sousa ICVD, 2014, EXPERT OPIN INV DRUG, V23, P1389, DOI 10.1517/13543784.2014.923401; Verma DD, 2003, INT J PHARM, V258, P141, DOI 10.1016/S0378-5173(03)00183-2; Verma P, 2012, NANOMED-NANOTECHNOL, V8, P489, DOI 10.1016/j.nano.2011.07.004; Wu CY, 2012, INT J CANCER, V131, P1423, DOI 10.1002/ijc.27343; Wu J, 2004, CHIN J DERM VENEREOL, V18, P637; Xu DF, 2012, CANCER LETT, V316, P11, DOI 10.1016/j.canlet.2011.10.006; Yamakoshi T, 2012, CLIN COSMET INVESTI, V5, P79, DOI 10.2147/CCID.S33361; Zhang J, 2006, J PHARMACOL EXP THER, V317, P1285, DOI 10.1124/jpet.105.100701; Zhang YT, 2014, INT J PHARMACEUT, V471, P449, DOI 10.1016/j.ijpharm.2014.06.001	34	35	38	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159967	10.1371/journal.pone.0159967	http://dx.doi.org/10.1371/journal.pone.0159967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441661	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500156
J	Huls, A; Kramer, U; Gappa, M; Muller-Brandes, C; Schikowski, T; von Berg, A; Hoffmann, B; Schuster, A; Wisbauer, M; Flexeder, C; Heinrich, J; Schulz, H; Berdel, D				Huels, Anke; Kraemer, Ursula; Gappa, Monika; Mueller-Brandes, Christine; Schikowski, Tamara; von Berg, Andrea; Hoffmann, Barbara; Schuster, Antje; Wisbauer, Matthias; Flexeder, Claudia; Heinrich, Joachim; Schulz, Holger; Berdel, Dietrich			Age Dependency of GLI Reference Values Compared with Paediatric Lung Function Data in Two German Studies (GINIplus and LUNOKID)	PLOS ONE			English	Article							CONTEMPORARY AUSTRALASIAN SPIROMETRY; PUBERTAL GROWTH; EQUATIONS; CHILDREN; SAMPLE; ECZEMA	A hallmark of the newly published GLI (Global Lungs Initiative) spirometric reference values is their "all-age" (3-95yr) predictive power, accomplished by incorporating non-linear age dependencies into modelling parameters. This modelling strategy is especially promising for the age range of puberty; however, the performance of GLI-values for adolescents is currently unknown. We calculated GLI-based z-scores for children/adolescents without apparent respiratory diseases from two different German studies, LUNOKID (N = 1943, 4-19 years) and GINIplus (N = 1042, 15 years) and determined the goodness of fit for specific age groups. We defined fit sufficient if the absolute mean of z-scores was <0.5. For children (<10yr) the mean GLI-based z-scores for FEV1 and FVC reached a good fit with mean z-scores for FEV1 between -0.11 and 0.01 and mean z-scores for FVC between 0.01 and 0.16, but larger deviations were observed in adolescents, especially boys (mean z-score -0.58 for FEV1 and -0.57 for FVC in GINIplus). The fit for FEV1/FVC was sufficient. GLI reference values provided reasonable estimates for the individuals enrolled in our studies, which span the age range of lung growth and development. However, we found that GLI-predictions overestimated lung volumes, especially those for German adolescent boys, which may, left unrecognised, lead to erroneous diagnosis of lung disease. Caution should be taken when applying these reference values to epidemiologic studies.	[Huels, Anke; Kraemer, Ursula; Schikowski, Tamara; Hoffmann, Barbara] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Gappa, Monika; von Berg, Andrea; Berdel, Dietrich] Marien Hosp Wesel, Childrens Hosp & Res Inst, Wesel, Germany; [Mueller-Brandes, Christine] Med Sch Hanover, Dept Anaesthesiol & Intens Care Med, Hannover, Germany; [Hoffmann, Barbara] Univ Dusseldorf, Fac Med, Dusseldorf, Germany; [Schuster, Antje; Wisbauer, Matthias] Univ Dusseldorf, Univ Childrens Hosp, Dusseldorf, Germany; [Flexeder, Claudia; Heinrich, Joachim; Schulz, Holger] Helmholtz Zentrum Munchen Erman Res Ctr Environm, Inst Epidemiol 1, Munich, Germany; [Heinrich, Joachim; Schulz, Holger] CPC M, Munich, Germany	Leibniz Institut fur Umweltmedizinische Forschung (IUF); St. Marien Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Huls, A (corresponding author), IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.	Anke.Huels@IUF-Duesseldorf.de	Schulz, Holger/J-5643-2015; Heinrich, Joachim/N-1720-2013; Huels, Anke/J-8743-2019	Schulz, Holger/0000-0002-1157-200X; Heinrich, Joachim/0000-0002-9620-1629; Huels, Anke/0000-0002-6005-417X	GlaxoSmithKline GmbH & Co. KG, Munich, Germany; Aerocrine AB, Solna, Sweden; MSD Sharp & Dohme GmbH, Haar, Germany; AstraZeneca GmbH, Wedel, Germany; Novartis Pharma GmbH, Nuernberg, Germany; Astellas Pharma GmbH, Munich, Germany; Ndd Medizintechnik AG, Zurich, Switzerland, Lions Club Wesel; Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Federal Ministry for Environment (IUF) [FKZ 20462296]; Commission of the European Communities, the 7th Framework Program (MeDALL project); Mead Johnson company; Nestle company; Leibniz Association; Deutsche Atemwegsliga	GlaxoSmithKline GmbH & Co. KG, Munich, Germany(GlaxoSmithKline); Aerocrine AB, Solna, Sweden; MSD Sharp & Dohme GmbH, Haar, Germany; AstraZeneca GmbH, Wedel, Germany(AstraZeneca); Novartis Pharma GmbH, Nuernberg, Germany; Astellas Pharma GmbH, Munich, Germany(Astellas Pharmaceuticals); Ndd Medizintechnik AG, Zurich, Switzerland, Lions Club Wesel; Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Federal Ministry for Environment (IUF); Commission of the European Communities, the 7th Framework Program (MeDALL project); Mead Johnson company; Nestle company(Nestle SA); Leibniz Association; Deutsche Atemwegsliga	LUNOKID was supported by GlaxoSmithKline GmbH & Co. KG, Munich, Germany; Aerocrine AB, Solna, Sweden; MSD Sharp & Dohme GmbH, Haar, Germany; AstraZeneca GmbH, Wedel, Germany; Novartis Pharma GmbH, Nuernberg, Germany; Astellas Pharma GmbH, Munich, Germany, Deutsche Atemwegsliga; Ndd Medizintechnik AG, Zurich, Switzerland, Lions Club Wesel. The GINIplus study was mainly supported for the first 3 years by the Federal Ministry for Education, Science, Research and Technology (interventional arm) and Helmholtz Zentrum Munich (former GSF) (observational arm). The 4-year, 6-year and 10-year follow-up examinations of the GINIplus study were covered from the respective budgets of the 5 study centres (Helmholtz Zentrum Munich (former GSF), Marien-Hospital Wesel, LMU Munich, TU Munich and from 6 years onward also from IUF - Leibniz Research-Institute for Environmental Medicine) and a grant from the Federal Ministry for Environment (IUF, FKZ 20462296). The 15-year follow-up examination of the GINIplus study was supported by the Commission of the European Communities, the 7th Framework Program (MeDALL project) and the Mead Johnson and Nestle companies. The publication of this article was funded by the Open Access fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman H, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0022-2; Ben Saad H, 2013, RESP MED, V107, P2000, DOI 10.1016/j.rmed.2013.10.015; Berdel D, 2010, ATEMWEG LUNGENKRANK, P395; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bonner R, 2013, AM J RESP CRIT CARE, V188, P515, DOI 10.1164/rccm.201212-2208LE; Bonthuis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042506; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; de Muinich Keizer-Schrama SMPF, HUM REPROD UPDATE, V7, P287; DEGROODT EG, 1986, RESP PHYSIOL, V65, P139, DOI 10.1016/0034-5687(86)90046-0; DEGROODT EG, 1988, EUR RESPIR J, V1, P102; Filipiak B, 2007, J PEDIATR-US, V151, P352, DOI 10.1016/j.jpeds.2007.05.018; Fuertes E, 2015, INT J HYG ENVIR HEAL, V218, P656, DOI 10.1016/j.ijheh.2015.07.003; Hall GL, 2012, RESPIROLOGY, V17, P1150, DOI 10.1111/j.1440-1843.2012.02232.x; Huls A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157569; Huls A, 2016, EUR RESPIR J, V47, P1890, DOI 10.1183/13993003.01465-2015; Huls A, 2014, Pneumologie, V68, P393, DOI 10.1055/s-0034-1367575; Kainu A, 2016, CLIN PHYSIOL FUNCT I, V36, P346, DOI 10.1111/cpf.12237; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Muller-Brandes C, 2014, EUR RESPIR J, V43, P1347, DOI 10.1183/09031936.00058813; Quanjer PH, 2011, EUR RESPIR J, V37, P658, DOI 10.1183/09031936.00110010; Quanjer PH, 2015, CHEST, V147, P792, DOI 10.1378/chest.14-1365; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Quanjer PH, 2008, AM J RESP CRIT CARE, V178, P1262, DOI 10.1164/rccm.200805-700OC; R Development Core Team, 2014, R LANG ENV STAT COMP; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; SCHRADER PC, 1984, B EUR PHYSIOPATH RES, V20, P381; Stasinopoulos DM, 2007, J STAT SOFTW, V23; Thompson BR, 2011, RESPIROLOGY, V16, P912, DOI 10.1111/j.1440-1843.2011.01970.x; von Berg A, 2010, CLIN EXP ALLERGY, V40, P627, DOI 10.1111/j.1365-2222.2009.03444.x; Zapletal A, 1987, LUNG FUNCTION CHILDR	30	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159678	10.1371/journal.pone.0159678	http://dx.doi.org/10.1371/journal.pone.0159678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438002	Green Submitted, gold, Green Published			2022-12-27	WOS:000380170100067
J	Yi, CH; Lei, WY; Hung, JS; Liu, TT; Orr, WC; Fabio, P; Chen, CL				Yi, Chih-Hsun; Lei, Wei-Yi; Hung, Jui-Sheng; Liu, Tso-Tsai; Orr, William C.; Fabio, Pace; Chen, Chien-Lin			Differences in the Control of Secondary Peristalsis in the Human Esophagus: Influence of the 5-HT4 Receptor versus the TRPV1 Receptor	PLOS ONE			English	Article							RED-PEPPER SAUCE; GASTROESOPHAGEAL-REFLUX DISEASE; VAGAL AFFERENT-FIBERS; GASTROINTESTINAL MOTILITY; MOSAPRIDE CITRATE; BOLUS TRANSIT; ION CHANNELS; ACID REFLUX; IN-VITRO; STIMULATION	Objective Acute administration of 5-hydroxytryptamine4 (5-HT4) receptor agonist, mosapride or esophageal infusion of the transient receptor potential vanilloid receptor-1 (TRPV1) agonist capsaicin promotes secondary peristalsis. We aimed to investigate whether acute esophageal instillation of capsaicin-containing red pepper sauce or administration of mosapride has different effects on the physiological characteristics of secondary peristalsis. Methods Secondary peristalsis was induced with mid-esophageal air injections in 14 healthy subjects. We compared the effects on secondary peristalsis subsequent to capsaicin-containing red pepper sauce (pure capsaicin, 0.84 mg) or 40 mg oral mosapride. Results The threshold volume for generating secondary peristalsis during slow air distensions was significantly decreased with capsaicin infusion compared to mosapride (11.6 +/- 1.0 vs. 14.1 +/- 0.8 mL, P = 0.02). The threshold volume required to produce secondary peristalsis during rapid air distension was also significantly decreased with capsaicin infusion (4.6 +/- 0.5 vs. 5.2 +/- 0.6 mL, P = 0.02). Secondary peristalsis was noted more frequently in response to rapid air distension after capsaicin infusion than mosapride (80% [60-100%] vs. 65% [5-100%], P = 0.04). Infusion of capsaicin or mosapride administration didn't change any parameters of primary or secondary peristalsis. Conclusions Esophageal infusion with capsaicin-containing red pepper sauce suspension does create greater mechanosensitivity as measured by secondary peristalsis than 5-HT4 receptor agonist mosapride. Capsaicin-sensitive afferents appear to be more involved in the sensory modulation of distension-induced secondary peristalsis.	[Yi, Chih-Hsun; Lei, Wei-Yi; Hung, Jui-Sheng; Liu, Tso-Tsai; Chen, Chien-Lin] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med, Hualien, Taiwan; [Yi, Chih-Hsun; Lei, Wei-Yi; Hung, Jui-Sheng; Liu, Tso-Tsai; Chen, Chien-Lin] Tzu Chi Univ, Hualien, Taiwan; [Orr, William C.] Univ Oklahoma, Hlth Sci Ctr, Lynn Inst Healthcare Res, Oklahoma City, OK USA; [Fabio, Pace] L Sacco Univ Hosp, Div Gastroenterol, Dept Clin Sci, Milan, Italy	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Milan; Luigi Sacco Hospital	Chen, CL (corresponding author), Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med, Hualien, Taiwan.; Chen, CL (corresponding author), Tzu Chi Univ, Hualien, Taiwan.	harry.clchen@msa.hinet.net	Lei, Wei-Yi/AAW-8292-2020		National Science Council, Taiwan [NSC 101-2314-B-303-005-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant, NSC 101-2314-B-303-005-MY3, from National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, DRUGS FUTURE, V18, P513; Bardan E, 2000, AM J PHYSIOL-GASTR L, V279, pG255, DOI 10.1152/ajpgi.2000.279.2.G255; BASS BL, 1991, SURGERY, V110, P419; Berthoud HR, 1997, BRAIN RES, V746, P195, DOI 10.1016/S0006-8993(96)01222-X; Bourinet E, 2014, PHYSIOL REV, V94, P81, DOI 10.1152/physrev.00023.2013; Chen CL, 2011, NEUROGASTROENT MOTIL, V23, P606, DOI 10.1111/j.1365-2982.2011.01714.x; Chen CL, 2010, NEUROGASTROENT MOTIL, V22, P1177, DOI 10.1111/j.1365-2982.2010.01561.x; Chen CL, 2013, DIGEST DIS SCI, V58, P1948, DOI 10.1007/s10620-013-2584-2; Chen CL, 2008, EUR J GASTROEN HEPAT, V20, P1129, DOI 10.1097/MEG.0b013e328303bff1; Cho YK, 2006, J CLIN GASTROENTEROL, V40, P286, DOI 10.1097/01.mcg.0000210103.82241.97; CLERC N, 1983, J PHYSIOL-LONDON, V336, P487, DOI 10.1113/jphysiol.1983.sp014593; Gonzalez R, 1998, DIGEST DIS SCI, V43, P1165, DOI 10.1023/A:1018831018566; Grider JR, 2003, J PHARMACOL EXP THER, V307, P460, DOI 10.1124/jpet.103.053512; HELM JF, 1984, NEW ENGL J MED, V310, P284, DOI 10.1056/NEJM198402023100503; Holzer P, 2003, CURR OPIN PHARMACOL, V3, P618, DOI 10.1016/j.coph.2003.06.008; HWANG K, 1954, J APPL PHYSIOL, V6, P781, DOI 10.1152/jappl.1954.6.12.781; Itoh H, 2001, BIOL PHARM BULL, V24, P1072, DOI 10.1248/bpb.24.1072; Kessing Boudewijn F, 2012, Curr Gastroenterol Rep, V14, P197, DOI 10.1007/s11894-012-0253-9; Kiraly A, 2001, J PHYSIOLOGY-PARIS, V95, P197, DOI 10.1016/S0928-4257(01)00025-0; KRAVITZ JJ, 1978, AM J PHYSIOL, V234, pE359, DOI 10.1152/ajpendo.1978.234.4.E359; Lang IM, 2001, AM J PHYSIOL-GASTR L, V281, pG1246, DOI 10.1152/ajpgi.2001.281.5.G1246; Lee KJ, 2003, ALIMENT PHARM THERAP, V18, P199, DOI 10.1046/j.1365-2036.2003.01605.x; Liu TT, 2014, NEUROGASTROENT MOTIL, V26, P1487, DOI 10.1111/nmo.12414; Makimoto N, 2002, JPN J PHARMACOL, V90, P28, DOI 10.1254/jjp.90.28; Mantyh PW, 1998, NEURON, V21, P644, DOI 10.1016/S0896-6273(00)80575-9; Mine Y, 1997, J PHARMACOL EXP THER, V283, P1000; Page AJ, 1998, J PHYSIOL-LONDON, V512, P907, DOI 10.1111/j.1469-7793.1998.907bd.x; Pandolfino JE, 2005, AM J PHYSIOL-GASTR L, V288, pG671, DOI 10.1152/ajpgi.00388.2004; Ruth M, 1998, ALIMENT PHARM THERAP, V12, P35; Ruth M, 2003, EUR J GASTROEN HEPAT, V15, P1115, DOI 10.1097/00042737-200310000-00009; SATCHELL PM, 1984, J PHYSIOL-LONDON, V346, P287, DOI 10.1113/jphysiol.1984.sp015022; SCHOEMAN MN, 1995, GUT, V36, P499, DOI 10.1136/gut.36.4.499; SCHOEMAN MN, 1994, GUT, V35, P1523, DOI 10.1136/gut.35.11.1523; SCHOEMAN MN, 1994, GUT, V35, P152, DOI 10.1136/gut.35.2.152; Sekizawa SI, 1999, J APPL PHYSIOL, V86, P1231, DOI 10.1152/jappl.1999.86.4.1231; Sifrim D, 1996, DIGESTION, V57, P73, DOI 10.1159/000201316; Szallasi A, 1995, BRAIN RES, V703, P175, DOI 10.1016/0006-8993(95)01094-7	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159452	10.1371/journal.pone.0159452	http://dx.doi.org/10.1371/journal.pone.0159452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438088	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100048
J	Biersack, MG; Hajdukiewicz, M; Uebelhack, R; Franke, L; Piazena, H; Klaus, P; Hohne-Zimmer, V; Braun, T; Buttgereit, F; Burmester, GR; Detert, J				Biersack, Maria Gudrun; Hajdukiewicz, Malgorzata; Uebelhack, Ralf; Franke, Leonora; Piazena, Helmut; Klaus, Pascal; Hoehne-Zimmer, Vera; Braun, Tanja; Buttgereit, Frank; Burmester, Gerd-Ruediger; Detert, Jacqueline			Sustained Increase of 25-Hydroxyvitamin D Levels in Healthy Young Women during Wintertime after Three Suberythemal UV Irradiations-The MUVY Pilot Study	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; ORAL-CONTRACEPTIVE USE; ULTRAVIOLET-IRRADIATION; DEPRESSIVE SYMPTOMS; SERUM; SUNLIGHT; EXPOSURE; PREVENTION; RADIATION; ADULTS	Objectives Vitamin D (VitD) deficiency is a health problem prevalent not only in the elderly but also in young adults. The primary objective of our observational pilot study "MUVY" (Mood, UVR, Vitamin D in Young women) was to test both the short-term and long-term effects of a series of three suberythemal UV radiation (UVR) exposures on the VitD status and well-being of young healthy women during winter in a repeat measure design. Methods 20 healthy young women (Fitzpatrick skin types I-III, aged 21-25 years) received three full body broad band UVR exposures with an escalating erythemally weighted dose schedule during one week in winter, and completed self-report questionnaires monitoring symptoms of depression (Beck Depression Inventory, BDI) and affective state/well-being (Profile of Mood States, POMS) at baseline and three days after the last UVR exposure. 25-hydroxy-vitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)(2)D) were measured in serum at baseline, and at study days 8, 36 and 50. Results Mean baseline 25(OH) D level was 54.3 nmol/L (standard deviation (s.d.) = 24.1), with seven women having VitD deficient status. Relevant symptoms of depression, as indicated by low BDI total scores (0-8), were absent. After the three UVR exposures the increment of 25(OH)D was an average of 13.9 nmol/L (95% confidence interval (CI) = 9.4-18.4) and 26.2 pmol/L (95% CI = 7.2-45.1) for 1,25(OH)(2)D.Delta 25(OH)D, and corresponding baseline levels were significantly and inversely associated (rho = -0.493, p = 0.027). Only 25(OH)D remained significantly increased above baseline for at least six weeks after the last UVR exposure. A strong inverse correlation of the POMS subscale "Vigor/Activity" and the increment in 1,25(OH)(2)D was found (rho = -0.739, p<0.001) at day 8. Conclusions Three suberythemal whole body UVR exposures during one week are a simple and suitable method for improving 25(OH)D levels during winter, for at least six weeks, and especially in young women with VitD deficient status.	[Biersack, Maria Gudrun; Hajdukiewicz, Malgorzata; Klaus, Pascal; Hoehne-Zimmer, Vera; Braun, Tanja; Buttgereit, Frank; Burmester, Gerd-Ruediger; Detert, Jacqueline] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Uebelhack, Ralf; Franke, Leonora] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Berlin, Germany; [Piazena, Helmut] Charite Univ Med Berlin, Dept Internal Med, Med Photobiol Grp, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Biersack, MG (corresponding author), Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany.	maria.biersack@charite.de	Burmester, Gerd R./AAY-7514-2020; Franke, Lude/P-7036-2016	Braun, Tanja/0000-0002-6012-2742; Franke, Lude/0000-0002-5159-8802; Buttgereit, Frank/0000-0003-2534-550X				Albani C, 2006, PSYCHOTHER PSYCH MED, V56, P172, DOI 10.1055/s-2005-915467; Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Annweiler C, 2013, J CLIN PSYCHIAT, V74, P1121, DOI 10.4088/JCP.13ac08783; Armas LAG, 2007, J AM ACAD DERMATOL, V57, P588, DOI 10.1016/j.jaad.2007.03.004; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bertone-Johnson ER, 2012, AM J EPIDEMIOL, V176, P1, DOI 10.1093/aje/kwr482; Bischoff-Ferrari HA., 2011, VITAMIN D PRAVENTION; Bogh MKB, 2012, BRIT J DERMATOL, V167, P625, DOI 10.1111/j.1365-2133.2012.11069.x; Bogh MKB, 2012, BRIT J DERMATOL, V166, P430, DOI 10.1111/j.1365-2133.2011.10697.x; Bogh MKB, 2011, EXP DERMATOL, V20, P14, DOI 10.1111/j.1600-0625.2010.01201.x; Bogh MKB, 2010, J INVEST DERMATOL, V130, P546, DOI 10.1038/jid.2009.323; BOUILLON RA, 1987, AM J CLIN NUTR, V45, P755, DOI 10.1093/ajcn/45.4.755; Bundesministerium fur Umwelt, 2011, VER ZUM SCHUTZ SCHAD; Chandra P, 2007, PHOTODERMATOL PHOTO, V23, P179, DOI 10.1111/j.1600-0781.2007.00302.x; Chel VGM, 2011, AGE AGEING, V40, P211, DOI 10.1093/ageing/afq159; Chel VGM, 1998, J BONE MINER RES, V13, P1238, DOI 10.1359/jbmr.1998.13.8.1238; Chuck A, 2001, PHOTODERMATOL PHOTO, V17, P168, DOI 10.1034/j.1600-0781.2001.170405.x; CIE, S007E1998 CIE; CORLESS D, 1978, LANCET, V2, P649; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Edstrom DW, 2010, J EUR ACAD DERMATOL, V24, P403, DOI 10.1111/j.1468-3083.2009.03423.x; Farrar MD, 2013, AM J CLIN NUTR, V97, P1210, DOI 10.3945/ajcn.112.052639; Farrar MD, 2011, AM J CLIN NUTR, V94, P1219, DOI 10.3945/ajcn.111.019976; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Gloth F M 3rd, 1999, J Nutr Health Aging, V3, P5; Harari M, 2011, ISR MED ASSOC J, V13, P212; HARRIS S, 1993, PSYCHIAT RES, V49, P77, DOI 10.1016/0165-1781(93)90031-B; Harris SS, 1998, J AM COLL NUTR, V17, P282, DOI 10.1080/07315724.1998.10718760; Heaney RP, 2008, AM J CLIN NUTR, V87, P1738, DOI 10.1093/ajcn/87.6.1738; Hilger J, 2014, BRIT J NUTR, V111, P23, DOI 10.1017/S0007114513001840; Ho R., 2006, HDB UNIVARIATE MULTI, P117; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; HOLICK MF, 1990, J NUTR, V120, P1464, DOI 10.1093/jn/120.suppl_11.1464; Holick MF., 2002, CURR OPIN ENDOCRINOL, V9, P87, DOI DOI 10.1097/00060793-200202000-00011; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; Hronek M, 2004, Ceska Gynekol, V69, P397; Humble MB, 2010, J PHOTOCH PHOTOBIO B, V101, P142, DOI 10.1016/j.jphotobiol.2010.08.003; Johanson GA, 2010, EDUC PSYCHOL MEAS, V70, P394, DOI 10.1177/0013164409355692; Ju SY, 2013, J NUTR HEALTH AGING, V17, P447, DOI 10.1007/s12603-012-0418-0; Juzeniene A, 2015, SCAND J PUBLIC HEALT, V43, P324, DOI 10.1177/1403494815572206; KASPER S, 1989, ARCH GEN PSYCHIAT, V46, P837; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Libon F, 2013, DERMATOLOGY, V227, P250, DOI 10.1159/000354750; Lips P, 2007, J BONE MINER RES, V22, P1668, DOI 10.1359/JBMR.070716; MCNAIR D, 1971, POMS MANUAL; Milaneschi Y, 2014, MOL PSYCHIATR, V19, P444, DOI 10.1038/mp.2013.36; Milaneschi Y, 2010, J CLIN ENDOCR METAB, V95, P3225, DOI 10.1210/jc.2010-0347; Moller UK, 2013, NUTRIENTS, V5, P3470, DOI 10.3390/nu5093470; Mozaffari-Khosravi H, 2013, J CLIN PSYCHOPHARM, V33, P378, DOI 10.1097/JCP.0b013e31828f619a; National Institutes of Health National Cancer Institute, 2010, COMM TERM CRIT ADV E; Naveilhan P, 1996, NEUROREPORT, V7, P2171, DOI 10.1097/00001756-199609020-00023; Norman A W, 2001, Rev Endocr Metab Disord, V2, P229, DOI 10.1023/A:1010067030049; Norman AW, 2010, EXP BIOL MED, V235, P1034, DOI 10.1258/ebm.2010.010014; Osmancevic A, 2015, J PHOTOCH PHOTOBIO B, V149, P224, DOI 10.1016/j.jphotobiol.2015.06.008; Pinter B, 2003, CONTRACEPTION, V67, P33, DOI 10.1016/S0010-7824(02)00432-8; Puchacz E, 1996, MOL BRAIN RES, V36, P193, DOI 10.1016/0169-328X(95)00314-I; Richter K, 2014, J PHOTOCH PHOTOBIO B, V140, P120, DOI 10.1016/j.jphotobiol.2014.07.018; Sachdeva S, 2009, INDIAN J DERMATOL VE, V75, P93, DOI 10.4103/0378-6323.45238; Seggar LB, 2002, BEHAV THER, V33, P253, DOI 10.1016/S0005-7894(02)80028-4; Shipowick CD, 2009, APPL NURS RES, V22, P221, DOI 10.1016/j.apnr.2007.08.001; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; SNELL A P, 1978, Age and Ageing, V7, P225, DOI 10.1093/ageing/7.4.225; Taylor DK, 2002, BRIT J DERMATOL, V146, P755, DOI 10.1046/j.1365-2133.2002.04740.x; van Hoof HJC, 2001, EUR J ENDOCRINOL, V144, P391, DOI 10.1530/eje.0.1440391; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Xiang F, 2015, PHOTOCH PHOTOBIO SCI, V14, P2138, DOI 10.1039/c5pp00168d; Zhang XB, 2008, PROG NEURO-PSYCHOPH, V32, P886, DOI 10.1016/j.pnpbp.2008.01.004	71	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159040	10.1371/journal.pone.0159040	http://dx.doi.org/10.1371/journal.pone.0159040			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434043	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600030
J	Chen, G; Glasmeier, AK; Zhang, M; Shao, Y				Chen, Guo; Glasmeier, Amy K.; Zhang, Min; Shao, Yang			Urbanization and Income Inequality in Post-Reform China: A Causal Analysis Based on Time Series Data	PLOS ONE			English	Article							REGIONAL INEQUALITY; URBAN; REFORM; LAND; SUSTAINABILITY; PRIVATIZATION; POLICIES; POVERTY; MARKET	This paper investigates the potential causal relationship(s) between China's urbanization and income inequality since the start of the economic reform. Based on the economic theory of urbanization and income distribution, we analyze the annual time series of China's urbanization rate and Gini index from 1978 to 2014. The results show that urbanization has an immediate alleviating effect on income inequality, as indicated by the negative relationship between the two time series at the same year (lag = 0). However, urbanization also seems to have a lagged aggravating effect on income inequality, as indicated by positive relationship between urbanization and the Gini index series at lag 1. Although the link between urbanization and income inequality is not surprising, the lagged aggravating effect of urbanization on the Gini index challenges the popular belief that urbanization in post-reform China generally helps reduce income inequality. At deeper levels, our results suggest an urgent need to focus on the social dimension of urbanization as China transitions to the next stage of modernization. Comprehensive social reforms must be prioritized to avoid a long-term economic dichotomy and permanent social segregation.	[Chen, Guo] Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA; [Chen, Guo] Michigan State Univ, Global Urban Studies Program, E Lansing, MI 48824 USA; [Glasmeier, Amy K.] MIT, Dept Urban Studies & Planning, Cambridge, MA 02139 USA; [Zhang, Min] Nanjing Univ, Sch Architecture & Urban Planning, Nanjing, Jiangsu, Peoples R China; [Shao, Yang] Virginia Polytech Inst & State Univ, Dept Geog, Coll Nat Resources & Environm, Blacksburg, VA 24061 USA	Michigan State University; Michigan State University; Massachusetts Institute of Technology (MIT); Nanjing University; Virginia Polytechnic Institute & State University	Chen, G (corresponding author), Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA.; Chen, G (corresponding author), Michigan State Univ, Global Urban Studies Program, E Lansing, MI 48824 USA.	guochen@msu.edu	Shao, Yang/A-7213-2019	Shao, Yang/0000-0001-8808-7144				Ambrose B. W., 2015, UNDERSTANDING RISK C; Appleton S, 2005, J COMP ECON, V33, P644, DOI 10.1016/j.jce.2005.08.005; Bai XM, 2012, ENVIRON SCI TECHNOL, V46, P132, DOI 10.1021/es202329f; Baiocchi G, 2003, J APPL ECONOM, V18, P105, DOI 10.1002/jae.704; Bao S., 2002, CHINA ECON REV, V13, P89, DOI DOI 10.1016/S1043-951X; BROWN JAC, 1984, OXFORD B ECON STAT, V46, P273; Cai Y, 2014, J ECON SURV, V28, P636, DOI 10.1111/joes.12082; Candelaria C, 2013, CITESEER; Chan K.W., 1994, CITIES INVISIBLE WAL; Chen G, 2006, HABITAT INT, V30, P1, DOI 10.1016/j.habitatint.2004.06.001; Chen G, 2015, URBAN STUD; Chen G, 2011, ENVIRON PLANN A, V43, P1135, DOI 10.1068/a43444; Chen J, 2010, TREND GINI COEFFICIE; Chen S, 2014, RURAL TAX REFORM AGR; Cheng Y, 2007, SOCIAL SCI CHINA; Cheng Y, 2006, EC RES J, V1, P109; DORFMAN R, 1979, REV ECON STAT, V61, P146, DOI 10.2307/1924845; Du R, 1989, MANY PEOPLE LITTLE L; Fan CC, 2002, ANN ASSOC AM GEOGR, V92, P103, DOI 10.1111/1467-8306.00282; Fan CC, 1997, INT J URBAN REGIONAL, V21, P620, DOI 10.1111/1468-2427.00105; Gao Q, 2015, Q REV ECON FINANC, V56, P30, DOI 10.1016/j.qref.2014.06.005; Garnaut R, 2006, CHINA J, V55, P35, DOI 10.2307/20066119; Gini C., 1997, RIV POLIT ECON, V87, P769; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Ho P, 2001, CHINA QUART, P394; Ho P, 2004, RURAL DEV TRANSITION; Hu Y., 2003, CHINA REV, V3, P49, DOI DOI 10.2307/23461904; Huang Y, 2008, CAPITALISM WITH CHINESE CHARACTERISTICS: ENTREPRENEURSHIP AND THE STATE, P1; Jin SQ, 2009, J COMP ECON, V37, P629, DOI 10.1016/j.jce.2009.04.005; Kanbur SMR, 2014, INEQUALITY ASIA PACI, Vxxiii; Knight J., 1999, RURAL URBAN DIVIDE E; Knight J, 2008, INEQUALITY AND PUBLIC POLICY IN CHINA, P221, DOI 10.1017/CBO9780511510922.009; Kuznets S, 1955, AM ECON REV, V45, P1; Lemoine F, 2015, CHINA ECON REV, V34, P39, DOI 10.1016/j.chieco.2015.03.007; Lin JY, 2011, FRONT ECON CHINA, V6, P1, DOI 10.1007/s11459-011-0119-3; Lin Justin Yifu, 2001, STATE OWNED ENTERPRI, P125; Liu YT, 2008, URBAN GEOGR, V29, P811, DOI 10.2747/0272-3638.29.8.811; Mckenzie CR, 2007, J APPL ECONOMET, V22, P1145, DOI 10.1002/jae.947; National Bureau of Statistics of China, 2015, CHIN STAT YB; R Core Team, 2021, R LANGUAGE ENV STAT; Ravallion M, 2014, OXFORD COMPANION EC, P441; Ravallion M, 2007, J DEV ECON, V82, P1, DOI 10.1016/j.jdeveco.2005.07.003; Shi L, 2002, CHINESE HOUSEHOLD IN; SIMS CA, 1980, ECONOMETRICA, V48, P1, DOI 10.2307/1912017; tkepohl H, 2005, NEW INTRO MULTIPLE T, Vxxi; Wu FL, 2001, HABITAT INT, V25, P273, DOI 10.1016/S0197-3975(00)00034-5; Wu XM, 2005, REV ECON STAT, V87, P763, DOI 10.1162/003465305775098206; Xie HL, 2014, SUSTAINABILITY-BASEL, V6, P1260, DOI 10.3390/su6031260; Xie Y, 2014, CHINA MINSHENG DEV R; Xie Y, 2014, CHINESE SOCIOL REV, V47, P3, DOI 10.2753/CSA2162-0555470101; Xie Y, 2014, P NATL ACAD SCI USA, V111, P6928, DOI 10.1073/pnas.1403158111; Yang DT, 1999, AM ECON REV, V89, P306, DOI 10.1257/aer.89.2.306; Yao SJ, 2001, J COMP ECON, V29, P466, DOI 10.1006/jcec.2001.1726; Yao SJ, 2000, ECON DEV CULT CHANGE, V48, P447, DOI 10.1086/452606; Ye J, 2010, LEFT BEHIND POPULATI; Yep R, 2004, CHINA QUART, P42, DOI 10.1017/S0305741004000049; Yip W, 2015, HEALTH SYST REFORM, V1, P52, DOI 10.4161/23288604.2014.995005; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Yueh L. Y., 2004, ASIAN ECON J, V18, P149, DOI DOI 10.1111/J.1467-8381.2004.00187.X; Zhang QF, 2013, J CONTEMP CHINA, V22, P255, DOI 10.1080/10670564.2012.734081; Zhang QH, 2012, ANN ECON FINANC, V13, P113; Zhao Yuepeng, 2011, CHINAS RURAL FINANCI	62	21	23	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158826	10.1371/journal.pone.0158826	http://dx.doi.org/10.1371/journal.pone.0158826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27433966	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600017
J	Chen, YWR; Leung, JM; Sin, DD				Chen, Yu-Wei Roy; Leung, Janice M.; Sin, Don D.			A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation	PLOS ONE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; EXHALED BREATH CONDENSATE; SURFACTANT PROTEIN D; INFLAMMATORY BIOMARKERS; SERUM; PLASMA; PROCALCITONIN; RECOVERY; RECEPTOR; ADIPONECTIN	The aims of this systematic review were to determine which blood-based molecules have been evaluated as possible biomarkers to diagnose chronic obstructive pulmonary disease (COPD) exacerbations (AECOPD) and to ascertain the quality of these biomarker publications. Patients of interest were those that have been diagnosed with COPD. MEDLINE, EMBASE, and CINAHL databases were searched systematically through February 2015 for publications relating to AECOPD diagnostic biomarkers. We used a modified guideline for the REporting of tumor MARKer Studies (mREMARK) to assess study quality. Additional components of quality included the reporting of findings in a replication cohort and the use of receiver-operating characteristics area-under-the curve statistics in evaluating performance. 59 studies were included, in which the most studied biomarkers were C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). CRP showed consistent elevations in AECOPD compared to control subjects, while IL-6 and TNF-alpha had variable statistical significance and results. mREMARK scores ranged from 6 to 18 (median score of 13). 12 articles reported ROC analyses and only one study employed a replication cohort to confirm biomarker performance. Studies of AECOPD diagnostic biomarkers remain inconsistent in their reporting, with few studies employing ROC analyses and even fewer demonstrating replication in independent cohorts.	[Sin, Don D.] Univ British Columbia, St Pauls Hosp, Inst Heart Lung Hlth, Ctr Heart Lung Innovat, Vancouver, BC, Canada; Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia	Sin, DD (corresponding author), Univ British Columbia, St Pauls Hosp, Inst Heart Lung Hlth, Ctr Heart Lung Innovat, Vancouver, BC, Canada.	Don.Sin@hli.ubc.ca	Sin, Don/AAC-2219-2021		Genome Canada	Genome Canada(Genome Canada)	Funding was provided by Genome Canada (www.genomecanada.ca), grant title "Clinical Implementation and Outcomes Evaluation of Blood-Based Biomarkers for COPD Management", recipient DDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnan AM, 2013, INT J PHARM SCI REV, V21, P10; Agusti A, 2014, CLIN CHEST MED, V35, P131, DOI 10.1016/j.ccm.2013.09.006; Airola A, 2011, COMPUT STAT DATA AN, V55, P1828, DOI 10.1016/j.csda.2010.11.018; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Andelid K, 2015, INT J CHRONIC OBSTR, V10, P1253, DOI 10.2147/COPD.S77274; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Beller EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001419; Carter RI, 2013, EUR RESPIR J, V41, P31, DOI 10.1183/09031936.00197411; Cazzola M, 2010, PULM PHARMACOL THER, V23, P493, DOI 10.1016/j.pupt.2010.05.001; Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; Chang C, 2014, SCI REP-UK, V4, DOI 10.1038/srep05516; Chang C, 2014, MED SCI MONITOR, V20, P311, DOI 10.12659/MSM.889828; CHEN H, 2011, RESPIROLOGY S2, V16, P126; Chen H, 2012, J PROTEOMICS, V75, P2835, DOI 10.1016/j.jprot.2012.01.027; CIHI, 2008, HLTH IND 2008, P21; Falsey AR, 2012, INT J CHRONIC OBSTR, V7, P127, DOI 10.2147/COPD.S29149; Fattouh M, 2014, EGYPT J CHEST DIS TU, V63, P799, DOI 10.1016/j.ejcdt.2014.06.011; Fiorini G, 2000, BIOMED PHARMACOTHER, V54, P274, DOI 10.1016/S0753-3322(00)80071-2; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Gao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057678; Groenewegen KH, 2007, RESP MED, V101, P2409, DOI 10.1016/j.rmed.2007.05.026; Gumus A, 2015, INT J CHRONIC OBSTR, V10, P357, DOI 10.2147/COPD.S77654; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Huang JTJ, 2012, THORAX, V67, P502, DOI 10.1136/thoraxjnl-2011-200279; Hurst JR, 2006, AM J RESP CRIT CARE, V174, P867, DOI 10.1164/rccm.200604-506OC; Jin QH, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-31; Johansson SL, 2014, RESP MED, V108, P1336, DOI 10.1016/j.rmed.2014.06.003; Ju CR, 2012, DIS MARKERS, V32, P281, DOI [10.1155/2012/509063, 10.3233/DMA-2011-0887]; Karadag F, 2008, LUNG, V186, P403, DOI 10.1007/s00408-008-9106-6; Koczulla AR, 2012, RESP MED, V106, P120, DOI 10.1016/j.rmed.2011.06.015; Koutsokera A, 2009, RESP MED, V103, P919, DOI 10.1016/j.rmed.2008.12.006; Krommidas G, 2010, RESP MED, V104, P40, DOI 10.1016/j.rmed.2009.08.012; Kwiatkowska S, 2012, RESPIRATION, V84, P231, DOI 10.1159/000339417; Kythreotis Prokopis, 2009, BMC Pulm Med, V9, P11, DOI 10.1186/1471-2466-9-11; Labib S, 2014, EGYPT J CHEST DIS TU, V63, P569, DOI 10.1016/j.ejcdt.2014.03.005; Lacoma A, 2009, EUR RESPIR REV, V18, P96, DOI 10.1183/09059180.00000609; Lacoma A, 2011, INT J CHRONIC OBSTR, V6, P157, DOI 10.2147/COPD.S16070; Lacoma A, 2011, CLIN CHIM ACTA, V412, P470, DOI 10.1016/j.cca.2010.11.032; Lee SJ, 2014, CLIN RESPIR J, V8, P305, DOI 10.1111/crj.12072; Lim SC, 2011, YONSEI MED J, V52, P581, DOI 10.3349/ymj.2011.52.4.581; Liu HC, 2014, J FORMOS MED ASSOC, V113, P908, DOI 10.1016/j.jfma.2012.09.018; Liu YL, 2014, HEART LUNG CIRC, V23, P875, DOI 10.1016/j.hlc.2014.03.008; Marcun R, 2012, INT J CARDIOL, V161, P156, DOI 10.1016/j.ijcard.2012.05.044; Markoulaki D, 2011, EUR J INTERN MED, V22, P103, DOI 10.1016/j.ejim.2010.07.010; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Meng DQ, 2014, RESP CARE, V59, P1542, DOI 10.4187/respcare.03046; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mohamed KH, 2012, EGYPT J CHEST DIS TU, V61, P301, DOI 10.1016/j.ejcdt.2012.08.011; Mohamed NA, 2013, EGYPT J CHEST DIS TU, V62, P45, DOI 10.1016/j.ejcdt.2013.03.005; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Najafzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046746; Nikolakopoulou S, 2014, COPD, V11, P46, DOI 10.3109/15412555.2013.829436; Nishimura K, 2014, INT J CHRONIC OBSTR, V9, P155, DOI 10.2147/COPD.S55143; Omar MM, 2014, EGYPT J CHEST DIS TU, V63, P313, DOI 10.1016/j.ejcdt.2014.01.004; Oraby SS, 2014, EGYPT J CHEST DIS TU, V63, P583, DOI 10.1016/j.ejcdt.2014.02.006; Patel ARC, 2013, AM J RESP CRIT CARE, V188, P1091, DOI 10.1164/rccm.201306-1170OC; Pauwels R, 2004, RESP MED, V98, P99, DOI 10.1016/j.rmed.2003.09.001; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pazarli AC, 2012, J RES MED SCI, V17, P1047; Perera WR, 2007, EUR RESPIR J, V29, P527, DOI 10.1183/09031936.00092506; Phua J, 2006, EUR RESPIR J, V28, P695, DOI 10.1183/09031936.06.00005606; Pinto-Plata VM, 2007, CHEST, V131, P37, DOI 10.1378/chest.06-0668; Quint JK, 2010, CHEST, V137, P812, DOI 10.1378/chest.09-1541; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Rohde G, 2012, RESPIRATION, V83, P133, DOI 10.1159/000328413; Roland M, 2001, THORAX, V56, P30, DOI 10.1136/thorax.56.1.30; Scherr A, 2013, CHEST, V143, P379, DOI 10.1378/chest.12-0730; Shaker A, 2012, EGYPT J CHEST DIS TU, V61, P81, DOI 10.1016/j.ejcdt.2012.10.011; Shakoori TA, 2009, DIS MARKERS, V27, P287, DOI [10.3233/DMA-2009-0674, 10.1155/2009/759304]; Shoukry A, 2013, EGYPT J CHEST DIS TU, V62, P567, DOI 10.1016/j.ejcdt.2013.08.011; Sin DD, 2015, AM J RESP CRIT CARE, V192, P1162, DOI 10.1164/rccm.201505-0871PP; Snell N, 2008, CURR OPIN PHARMACOL, V8, P222, DOI 10.1016/j.coph.2008.04.001; Stanojkovic I, 2013, CLIN BIOCHEM, V46, P1678, DOI 10.1016/j.clinbiochem.2013.08.003; Stolz D, 2008, CHEST, V133, P1088, DOI 10.1378/chest.07-1959; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; Urban MH, 2014, RESP MED, V108, P891, DOI 10.1016/j.rmed.2014.03.013; Yerkovich ST, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-37; Yoon HI, 2011, DRUGS, V71, P1821, DOI 10.2165/11595180-000000000-00000; Zhang YH, 2014, J THORAC DIS, V6, P734, DOI 10.3978/j.issn.2072-1439.2014.04.31; Zhao YF, 2014, AM J MED SCI, V347, P393, DOI 10.1097/MAJ.0b013e31829a63b1	84	61	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158843	10.1371/journal.pone.0158843	http://dx.doi.org/10.1371/journal.pone.0158843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434033	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600018
J	Devlin, KL; Sanford, T; Harrison, LM; LeBourgeois, P; Lashinger, LM; Mambo, E; Hursting, SD				Devlin, Kaylyn L.; Sanford, Tiffany; Harrison, Lauren M.; LeBourgeois, Paul; Lashinger, Laura M.; Mambo, Elizabeth; Hursting, Stephen D.			Stage-Specific MicroRNAs and Their Role in the Anticancer Effects of Calorie Restriction in a Rat Model of ER-Positive Luminal Breast Cancer	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; INDUCED MAMMARY-TUMORS; ENERGY RESTRICTION; PROMOTION PHASE; EXPRESSION; PROGRESSION; TUMORIGENESIS; PREVENTION; BIOMARKERS; PROGNOSIS	MicroRNAs have emerged as ubiquitous post-transcriptional regulators that coordinate many fundamental processes within cells, including those commonly linked to cancer when dysregulated. Profiling microRNAs across stages of cancer progression provides focus as to which microRNAs are key players in cancer development and are therefore important to manipulate with interventions to delay cancer onset and progression. Calorie restriction is one of the most effective preventive interventions across many types of cancer, although its effects on microRNAs have not been well characterized. We used the dimethylbenz[a]-anthracene-induced model of luminal mammary cancer in Sprague Dawley rats to elucidate which microRNAs are linked to progression in this type of cancer and, subsequently, to study how calorie restriction affects such microRNAs. We identified eight microRNAs (miR-10a, miR-10b, miR-21, miR-124, miR-125b, miR-126, miR-145 and miR-200a) to be associated with DMBA-induced mammary tumor progression. Calorie restriction, which greatly increased tumor-free survival and decreased the overall size of tumors that did develop, significantly decreased the expression of one microRNA, miR-200a, which was positively associated with tumor progression. We further showed that inhibition of miR-200a function, mimicking the effect of calorie restriction on this microRNA, inhibited proliferation in both rat (LA7) and human (MCF7) luminal mammary cancer cell lines. These findings present, for the first time, a stage-specific profile of microRNAs in a rodent model of luminal mammary cancer. Furthermore, we have identified the regulation of miR-200a, a microRNA that is positively associated with progression in this model, as a possible mechanism contributing to the anticancer effects of calorie restriction.	[Devlin, Kaylyn L.] Univ Texas Austin, Dept Mol Biosci, Austin, TX USA; [Sanford, Tiffany; LeBourgeois, Paul; Mambo, Elizabeth] Asuragen Inc, Austin, TX USA; [Harrison, Lauren M.; Lashinger, Laura M.; Hursting, Stephen D.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Sanford, Tiffany; Harrison, Lauren M.] Luminex Corp, Austin, TX USA; [LeBourgeois, Paul] Live Edge LLC, Mandeville, LA USA; [Mambo, Elizabeth] Mol Hlth, The Woodlands, TX USA; [Hursting, Stephen D.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA	University of Texas System; University of Texas Austin; Asuragen; University of Texas System; University of Texas Austin; University of North Carolina; University of North Carolina Chapel Hill	Hursting, SD (corresponding author), Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA.; Hursting, SD (corresponding author), Univ N Carolina, Dept Nutr, Chapel Hill, NC USA.	hursting@email.unc.edu			National Institute of Environmental Health Sciences [T32 ES07247]; Winker Family Foundation; Breast Cancer Research Foundation; National Institute of Health [R35 CA197627]; Asuragen, Inc.; NATIONAL CANCER INSTITUTE [R35CA197627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Winker Family Foundation; Breast Cancer Research Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Asuragen, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This publication is made possible by a predoctoral fellowship to KLD by grant T32 ES07247 from the National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/), and grants to SDH from the Winker Family Foundation, the Breast Cancer Research Foundation (http://www.bcrfcure.org/), and R35 CA197627 from the National Institute of Health (http://www.nih.gov/). Asuragen, Inc. provided support in the form of salaries for authors TS, PL, EM. Funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors have been clarified in the 'Author Contributions' section.	Barron N, 2012, PROSTATE, V72, P1193, DOI 10.1002/pros.22469; Bertoli G, 2015, THERANOSTICS, V5, P1122, DOI 10.7150/thno.11543; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054213; Cheung SY, 2003, INT J ONCOL, V22, P1383; Costa I, 2002, ARCH PATHOL LAB MED, V126, P915; Dunlap SM, 2012, CANCER PREV RES, V5, P930, DOI 10.1158/1940-6207.CAPR-12-0034; Ford NA, 2013, ENDOCR-RELAT CANCER, V20, P39, DOI 10.1530/ERC-12-0329; Greene SB, 2010, CURR DRUG TARGETS, V11, P1059; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Harvie M, 2012, P NUTR SOC, V71, P263, DOI 10.1017/S0029665112000195; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Hursting SD, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-10; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kan CWS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-627; KLURFELD DM, 1989, J NUTR, V119, P286, DOI 10.1093/jn/119.2.286; Kohler BA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv048; KRITCHEVSKY D, 1989, NUTR CANCER, V12, P259, DOI 10.1080/01635588909514025; Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mizuno NK, 2013, CANCER PREV RES, V6, P540, DOI 10.1158/1940-6207.CAPR-13-0033; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Ovcharenko D, 2011, EXP HEMATOL, V39, P1030, DOI 10.1016/j.exphem.2011.07.008; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; RUGGERI BA, 1989, CANCER RES, V49, P4135; Russo J, 1996, BREAST CANCER RES TR, V39, P7, DOI 10.1007/BF01806074; Thompson HJ, 2000, J MAMMARY GLAND BIOL, V5, P409, DOI 10.1023/A:1009582012493; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Yu SJ, 2013, CLIN CANCER RES, V19, P1389, DOI 10.1158/1078-0432.CCR-12-1959	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159686	10.1371/journal.pone.0159686	http://dx.doi.org/10.1371/journal.pone.0159686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433802	Green Submitted, gold, Green Published			2022-12-27	WOS:000380169600082
J	Ozawa, S; Singh, S; Singh, K; Chhabra, V; Bennett, S				Ozawa, Sachiko; Singh, Suneeta; Singh, Kriti; Chhabra, Vibha; Bennett, Sara			The Avahan Transition: Effects of Transition Readiness on Program Institutionalization and Sustained Outcomes	PLOS ONE			English	Article							HIV-PREVENTION PROGRAM; PUBLIC-HEALTH PROGRAMS; SUSTAINABILITY ASSESSMENT; COUNTRY OWNERSHIP; GLOBAL HEALTH; SCALING-UP; INDIA; RECOMMENDATIONS; ORGANIZATIONS; INNOVATIONS	Background With declines in development assistance for health and growing interest in country ownership, donors are increasingly faced with the task of transitioning health programs to local actors towards a path to sustainability. Yet there is little available guidance on how to measure and evaluate the success of a transition and its subsequent effects. This study assesses the transition of the Avahan HIV/AIDS prevention program in India to investigate how preparations for transition affected continuation of program activities post-transition. Methods Two rounds of two surveys were conducted and supplemented by data from government and Avahan Computerized Management Information Systems (CMIS). Exploratory factor analysis was used to develop two measures: 1) transition readiness pre-transition, and 2) institutionalization (i.e. integration of initial program systems into organizational procedures and behaviors) post-transition. A fixed effects model was built to examine changes in key program delivery outcomes over time. An ordinary least square regression was used to assess the relationship between transition readiness and sustainability of service outcomes both directly, and indirectly through institutionalization. Results Transition readiness data revealed 3 factors (capacity, alignment and communication), on a 15-item scale with adequate internal consistency (alpha 0.73). Institutionalization was modeled as a unidimensional construct, and a 12-item scale demonstrated moderate internal consistency (alpha 0.60). Coverage of key populations and condom distribution were sustained compared to pre-transition levels (p<0.01). Transition readiness, but not institutionalization, predicted sustained outcomes post-transition. Transition readiness did not necessarily lead to institutionalization of key program elements one year after transition. Conclusion Greater preparedness prior to transition is important to achieve better service delivery outcomes post-transition. This paper illustrates a methodology to measure transition readiness pre-transition to identify less ready organizations or program components in advance, improving the likelihood of service sustainability. Further research is needed around the conceptualization and development of measures of institutionalization and its effects on long-term program sustainability.	[Ozawa, Sachiko; Bennett, Sara] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Singh, Suneeta; Singh, Kriti; Chhabra, Vibha] Amaltas Consulting Private Ltd, New Delhi, India	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ozawa, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	ozawa@jhu.edu	Ozawa, Sachiko/Z-4944-2019; Singh, Kriti/ABE-3814-2020	Ozawa, Sachiko/0000-0001-7608-9038; bennett, sara/0000-0001-8094-8798	Bill and Melinda Gates Foundation [OPPGH5190]; Amaltas Consulting Pvt. Ltd.	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Amaltas Consulting Pvt. Ltd.	This study was funded by the Bill and Melinda Gates Foundation (OPPGH5190, http://www.gatesfoundation.org). Foundation staff advised the study team, but did not substantively affect the study design, instruments, interpretation of data, or decision to publish. The authors confirm that Amaltas Consulting Pvt. Ltd. provided support in the form of salaries for authors SS, KS, and VC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2008, BUS HIV AIDS PREV SC; [Anonymous], 2014, 360 FHI CMIS; Atun R, 2009, JAIDS-J ACQ IMM DEF, V52, pS67, DOI 10.1097/QAI.0b013e3181bbcd58; Bennett S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136177; Bennett S, 2015, EVAL PROGRAM PLANN, V52, P148, DOI 10.1016/j.evalprogplan.2015.05.003; Bennett S, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0894-0; Bennett S, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7360; BREUSCH TS, 1980, REV ECON STUD, V47, P239, DOI 10.2307/2297111; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; COOK RD, 1983, BIOMETRIKA, V70, P1, DOI 10.1093/biomet/70.1.1; Dieleman JL, 2014, HEALTH AFFAIR, V33, P878, DOI 10.1377/hlthaff.2013.1432; Funders Concerned About AIDS, 2013, GLOB PHIL SUPP ADDR; GOODMAN RM, 1993, HEALTH EDUC QUART, V20, P161, DOI 10.1177/109019819302000208; Goosby E, 2012, JAIDS-J ACQ IMM DEF, V60, pS158, DOI 10.1097/QAI.0b013e31825d057c; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Gruen RL, 2008, LANCET, V372, P1579, DOI 10.1016/S0140-6736(08)61659-1; Hirschhorn LR, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-57; Institute of Medicine of the National Academies, 2010, PREP FUT HIV AIDS AF; Katz I, 2014, HEALTH POLICY PLANN, V29, P379, DOI 10.1093/heapol/czt024; Le Gargasson JB, 2013, VACCINE, V31, P1886, DOI 10.1016/j.vaccine.2013.02.024; Mabuchi S, 2013, INT J HEALTH PLAN M, V28, P333, DOI 10.1002/hpm.2153; National AIDS Control Organization, 2006, NAT AIDS CONTR PROGR; Paina L, 2012, HEALTH POLICY PLANN, V27, P365, DOI 10.1093/heapol/czr054; Palen J, 2012, JAIDS-J ACQ IMM DEF, V60, pS113, DOI 10.1097/QAI.0b013e31825d28d7; Pickles M, 2013, LANCET GLOB HEALTH, V1, pE289, DOI 10.1016/S2214-109X(13)70083-4; Pluye P, 2004, EVAL PROGRAM PLANN, V27, P121, DOI 10.1016/j.evalprogplan.2004.01.001; Ridde V, 2006, REV EPIDEMIOL SANTE, V54, P421, DOI 10.1016/S0398-7620(06)76740-2; Rodriguez DC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1068-8; Sarriot EG, 2004, INT J HEALTH PLAN M, V19, P23, DOI 10.1002/hpm.744; Sarriot E, 2009, INT J HEALTH PLAN M, V24, P326, DOI 10.1002/hpm.1012; Saxenian H, 2015, HEALTH POLICY PLANN, V30, P197, DOI 10.1093/heapol/czu003; Scheirer MA, 2005, AM J EVAL, V26, P320, DOI 10.1177/1098214005278752; Scheirer MA, 2011, AM J PUBLIC HEALTH, V101, P2059, DOI 10.2105/AJPH.2011.300193; Sgaier SK, 2013, HEALTH AFFAIR, V32, P1265, DOI 10.1377/hlthaff.2012.0646; Shen AK, 2015, HEALTH POLICY PLANN, V30, P687, DOI 10.1093/heapol/czu045; Slaghuis SS, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-314; Smith K, KAISER UNAIDS STUDY; Stirman SW, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-17; Swidler A, 2009, WORLD DEV, V37, P1182, DOI 10.1016/j.worlddev.2008.11.002; Torpey K, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-19; Valentine A, 2015, DONOR FUNDING HLTH L; Wheeler T, 2012, J EPIDEMIOL COMMUN H, V66, pII16, DOI 10.1136/jech-2012-201081	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158659	10.1371/journal.pone.0158659	http://dx.doi.org/10.1371/journal.pone.0158659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434542	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600013
J	Taylor, MM; Nurse-Findlay, S; Zhang, XL; Hedman, L; Kamb, ML; Broutet, N; Kiarie, J				Taylor, Melanie M.; Nurse-Findlay, Stephen; Zhang, Xiulei; Hedman, Lisa; Kamb, Mary L.; Broutet, Nathalie; Kiarie, James			Estimating Benzathine Penicillin Need for the Treatment of Pregnant Women Diagnosed with Syphilis during Antenatal Care in High-Morbidity Countries	PLOS ONE			English	Article							CONGENITAL-SYPHILIS	Background Congenital syphilis continues to be a preventable cause of global stillbirth and neonatal morbidity and mortality. Shortages of injectable penicillin, the only recommended treatment for pregnant women and infants with syphilis, have been reported by high-morbidity countries. We sought to estimate current and projected annual needs for benzathine penicillin in antenatal care settings for 30 high morbidity countries that account for approximately 33% of the global burden of congenital syphilis. Methods Proportions of antenatal care attendance, syphilis screening coverage in pregnancy, syphilis prevalence among pregnant women, and adverse pregnancy outcomes due to untreated maternal syphilis reported to WHO were applied to 2012 birth estimates for 30 high syphilis burden countries to estimate current and projected benzathine penicillin need for prevention of congenital syphilis. Results Using current antenatal care syphilis screening coverage and seroprevalence, we estimated the total number of women requiring treatment with at least one injection of 2.4 MU of benzathine penicillin in these 30 countries to be 351,016. Syphilis screening coverage at or above 95% for all 30 countries would increase the number of women requiring treatment with benzathine penicillin to 712,030. Based on WHO management guidelines, 351,016 doses of weight-based benzathine penicillin would also be needed for the live-born infants of mothers who test positive and are treated for syphilis in pregnancy. Assuming availability of penicillin and provision of treatment for all mothers diagnosed with syphilis, an estimated 95,938 adverse birth outcomes overall would be prevented including 37,822 stillbirths, 15,814 neonatal deaths, and 34,088 other congenital syphilis cases. Conclusion Penicillin need for maternal and infant syphilis treatment is high among this group of syphilis burdened countries. Initiatives to ensure a stable and adequate supply of benzathine penicillin for treatment of maternal syphilis are important for congenital syphilis prevention, and will be increasingly critical in the future as more countries move toward elimination targets.	[Taylor, Melanie M.; Kamb, Mary L.] Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA; [Taylor, Melanie M.; Nurse-Findlay, Stephen; Broutet, Nathalie; Kiarie, James] WHO, Dept Reprod Hlth, Geneva, Switzerland; [Zhang, Xiulei; Hedman, Lisa] WHO, Dept Essential Med & Hlth Prod, Geneva, Switzerland; [Zhang, Xiulei] Shandong Prov Chest Hosp, Ctr TB Control, Jinan, Peoples R China	Centers for Disease Control & Prevention - USA; World Health Organization; World Health Organization; Shandong University	Taylor, MM (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA.; Taylor, MM (corresponding author), WHO, Dept Reprod Hlth, Geneva, Switzerland.	mtaylor@who.int		kiarie, james/0000-0003-4180-7858	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2015, TECHN CONS PREV MAN; [Anonymous], 2003, GLOB STRAT INF YOUNG, P41; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Centers for Disease Control and Prevention (CDC), 2015, MMWR-MORBID MORTAL W, V64, P34; Galvao TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056463; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Ham D Cal, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS10, DOI 10.1016/j.ijgo.2015.04.012; Hawkes SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056713; Heikkinen T, 2000, BRIT J OBSTET GYNAEC, V107, P770, DOI 10.1111/j.1471-0528.2000.tb13339.x; LANG R, 1993, CHEMOTHERAPY, V39, P77, DOI 10.1159/000239106; Lawn JE, 2016, LANCET; Nations United, 2012, WORLD FERT DAT 2012; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Qin J, 2014, PLOS ONE, V9, P1; Sandoz Novartis Company, BENZ BENZ; Watson-Jones D, 2005, TROP MED INT HEALTH, V10, P934, DOI 10.1111/j.1365-3156.2005.01473.x; Wedderburn C., 2015, INT C AIDS SEX TRANS; Wendel GD, 2002, CLIN INFECT DIS, V35, pS200, DOI 10.1086/342108; Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8; World Health Organization, GLOB HLTH OBS; World Health Organization, 2015, REP GLOB SEX TRANSM, P52; World Health Organization, 2012, INV CAS EL MOTH CHIL, P9; World Health Organization, 2007, GLOB EL CONG SYPH RA, P33; World Health Organization, 2005, WHOFCHCAH0508; World Health Organization, 2014, GLOB GUID CRIT PROC; World Health Organization, 2015, GLOB AIDS RESP PROGR, P24; World Health Organization Prequalification of In Vitro Diagnostics Programme, WHO PREQ IN VITR DIA; Zhou PY, 2007, SEX TRANSM DIS, V34, P472, DOI 10.1097/01.olq.0000246314.35047.91	28	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159483	10.1371/journal.pone.0159483	http://dx.doi.org/10.1371/journal.pone.0159483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434236	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600055
J	Wang, D; Liu, JX; Gao, YL; Yu, JG; Zheng, CH; Xu, Y				Wang, Dong; Liu, Jin-Xing; Gao, Ying-Lian; Yu, Jiguo; Zheng, Chun-Hou; Xu, Yong			An NMF-L-2,L-1-Norm Constraint Method for Characteristic Gene Selection	PLOS ONE			English	Article							NONNEGATIVE MATRIX FACTORIZATION; EXPRESSION DATA; CORE GENES; NOISE	Recent research has demonstrated that characteristic gene selection based on gene expression data remains faced with considerable challenges. This is primarily because gene expression data are typically high dimensional, negative, non-sparse and noisy. However, existing methods for data analysis are able to cope with only some of these challenges. In this paper, we address all of these challenges with a unified method: nonnegative matrix factorization via the L-2,L-1-norm (NMF-L-2,L-1). While L-2,L-1-norm minimization is applied to both the error function and the regularization term, our method is robust to outliers and noise in the data and generates sparse results. The application of our method to plant and tumor gene expression data demonstrates that NMF-L-2,L-1 can extract more characteristic genes than other existing state-of-the-art methods.	[Wang, Dong; Liu, Jin-Xing; Yu, Jiguo; Zheng, Chun-Hou] Qufu Normal Univ, Sch Informat Sci & Engn, Rizhao 276826, Peoples R China; [Gao, Ying-Lian] Qufu Normal Univ, Lib Qufu Normal Univ, Rizhao 276826, Peoples R China; [Liu, Jin-Xing; Xu, Yong] Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen 518055, Peoples R China	Qufu Normal University; Qufu Normal University; Harbin Institute of Technology; University Town of Shenzhen	Liu, JX (corresponding author), Qufu Normal Univ, Sch Informat Sci & Engn, Rizhao 276826, Peoples R China.; Liu, JX (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen 518055, Peoples R China.	sdcavell@126.com	Yu, Jiguo Albert/I-5242-2014; Liu, Jin-Xing/AAU-7257-2020	Yu, Jiguo Albert/0000-0001-6451-1158; 	NSFC [61572284, 61502272, 61370163, 61272339]; Shandong Provincial Natural Science Foundation [ZR2013FL016, BS2014DX004]; Shenzhen Municipal Science and Technology Innovation Council [JCYJ20140904154645958, JCYJ20140417172417174, CXZZ20140904154910774]	NSFC(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Shenzhen Municipal Science and Technology Innovation Council	This work was supported in part by the NSFC under grant nos. 61572284, 61502272, 61370163 and 61272339; the Shandong Provincial Natural Science Foundation, under grant nos. ZR2013FL016 and BS2014DX004; and Shenzhen Municipal Science and Technology Innovation Council (Nos. JCYJ20140904154645958, JCYJ20140417172417174 and CXZZ20140904154910774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; BALADANDAYUTHAPANI V, 2014, IEEE ACM T COMPUTATI, V1; Chen D, 2013, PROC CVPR IEEE, P3025, DOI 10.1109/CVPR.2013.389; Di L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-233; Ding H, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-203; Dinkla K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-201; Fa R, 2014, IEEE ACM T COMPUT BI, V11, P741, DOI 10.1109/TCBB.2014.2312006; Fang XZ, 2014, NEUROCOMPUTING, V128, P304, DOI 10.1016/j.neucom.2013.08.040; Feigelman J, 2014, ARXIV14072112; Ferson W, 2013, J FINANC ECON, V107, P537, DOI 10.1016/j.jfineco.2012.09.006; Hou CP, 2014, IEEE T CYBERNETICS, V44, P793, DOI 10.1109/TCYB.2013.2272642; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Jauhari S, 2014, IEEE ACM T COMPUT BI, V11, P533, DOI 10.1109/TCBB.2014.2312002; Jenks M. A., 2008, PLANT ABIOTIC STRESS; Journee M, 2010, J MACH LEARN RES, V11, P517; Kong D, 2011, ROBUST NONNEGATIVE M, P673; Lee DD, 2001, ADV NEUR IN, V13, P556; Lin CF, 2004, PATTERN RECOGN LETT, V25, P1647, DOI 10.1016/j.patrec.2004.06.009; Liu J, 2009, MULTITASK FEATURE LE, P339; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133124; Liu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106097; Liu JX, 2012, COMPUT BIOL MED, V42, P582, DOI 10.1016/j.compbiomed.2012.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazza T, 2015, IEEE ACM T COMPUTATI, V1; Nie F, 2010, EFFICIENT ROBUST FEA, P1813; Nie F, 2014, OPTIMAL MEAN ROBUST, P1062; Nie F, 2008, TRACE RATIO CRITERIO, P671; Nie F., 2010, ADV NEURAL INFORM PR, V2, P1813; Nikolova M, 2004, J MATH IMAGING VIS, V20, P99, DOI 10.1023/B:JMIV.0000011920.58935.9c; Nyamundanda G, 2014, J ROYAL STAT SOC C; Ortega-Martorell S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-38; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Utreras F, 2013, SIAM J SCI STAT COMP, V2; Witten Daniela M, 2009, BIOSTATISTICS; Wu M., 2013, PLOS ONE, P8; Yalavarthy PK, 2007, MED PHYS, V34, P2085, DOI 10.1118/1.2733803; Yang SZ, 2013, NEURAL COMPUT APPL, V23, P541, DOI 10.1007/s00521-013-1371-5; Zhang Y., 2006, J COMPUTER APPL, V4; Zheng CH, 2011, IEEE T NANOBIOSCI, V10, P86, DOI 10.1109/TNB.2011.2144998; Zheng CH, 2009, IEEE T INF TECHNOL B, V13, P599, DOI 10.1109/TITB.2009.2018115	42	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158494	10.1371/journal.pone.0158494	http://dx.doi.org/10.1371/journal.pone.0158494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428058	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300009
J	Wongjaikam, S; Kumfu, S; Khamseekaew, J; Sripetchwandee, J; Srichairatanakool, S; Fucharoen, S; Chattipakorn, SC; Chattipakorn, N				Wongjaikam, Suwakon; Kumfu, Sirinart; Khamseekaew, Juthamas; Sripetchwandee, Jirapas; Srichairatanakool, Somdet; Fucharoen, Suthat; Chattipakorn, Siriporn C.; Chattipakorn, Nipon			Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats	PLOS ONE			English	Article							BETA-THALASSEMIA MAJOR; OXIDATIVE STRESS; N-ACETYLCYSTEINE; CARDIAC IRON; MITOCHONDRIAL DYSFUNCTION; CURRENT KNOWLEDGE; CALCIUM-CHANNEL; DEFERIPRONE; DEFERASIROX; CARDIOMYOPATHY	Background Iron chelators are used to treat iron overload cardiomyopathy patients. However, a direct comparison of the benefits of three common iron chelators (deferoxamine (DFO), deferiprone (DFP) and deferasirox (DFX)) or an antioxidant (N-acetyl cysteine (NAC)) with a combined DFP and NAC treatments on left ventricular (LV) function with iron overload has not been investigated. Methods and Findings Male Wistar rats were fed with either a normal diet or a high iron diet (HFe group) for 4 months. After 2 months, the HFe-fed rats were divided into 6 groups to receive either: a vehicle, DFO (25 mg/kg/day), DFP (75 mg/kg/day), DFX (20 mg/kg/day), NAC (100 mg/kg/day) or the combined DFP and NAC for 2 months. Our results demonstrated that HFe rats had increased plasma non-transferrin bound iron (NTBI), malondialdehyde (MDA), cardiac iron and MDA levels and cardiac mitochondrial dysfunction, leading to LV dysfunction. Although DFO, DFP, DFX or NAC improved these parameters, leading to improved LV function, the combined DFP and NAC therapy caused greater improvement, leading to more extensively improved LV function. Conclusions The combined DFP and NAC treatment had greater efficacy than monotherapy in cardioprotection through the reduction of cardiac iron deposition and improved cardiac mitochondrial function in iron-overloaded rats.	[Wongjaikam, Suwakon; Kumfu, Sirinart; Khamseekaew, Juthamas; Sripetchwandee, Jirapas; Chattipakorn, Siriporn C.; Chattipakorn, Nipon] Chiang Mai Univ, Cardiac Electrophysiol Res & Training Ctr, Fac Med, Chiang Mai, Thailand; [Wongjaikam, Suwakon; Kumfu, Sirinart; Khamseekaew, Juthamas; Sripetchwandee, Jirapas; Chattipakorn, Siriporn C.; Chattipakorn, Nipon] Chiang Mai Univ, Dept Physiol, Fac Med, Cardiac Electrophysiol Unit, Chiang Mai, Thailand; [Wongjaikam, Suwakon; Kumfu, Sirinart; Khamseekaew, Juthamas; Sripetchwandee, Jirapas; Chattipakorn, Nipon] Chiang Mai Univ, Ctr Excellence Cardiac Electrophysiol Res, Chiang Mai, Thailand; [Chattipakorn, Siriporn C.] Chiang Mai Univ, Dept Oral Biol & Diagnost Sci, Fac Dent, Chiang Mai, Thailand; [Srichairatanakool, Somdet] Chiang Mai Univ, Dept Biochem, Fac Med, Chiang Mai, Thailand; [Fucharoen, Suthat] Mahidol Univ, Inst Mol Biosci, Thalassemia Res Ctr, Nakhon Pathom, Thailand	Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Mahidol University	Chattipakorn, N (corresponding author), Chiang Mai Univ, Cardiac Electrophysiol Res & Training Ctr, Fac Med, Chiang Mai, Thailand.; Chattipakorn, N (corresponding author), Chiang Mai Univ, Dept Physiol, Fac Med, Cardiac Electrophysiol Unit, Chiang Mai, Thailand.; Chattipakorn, N (corresponding author), Chiang Mai Univ, Ctr Excellence Cardiac Electrophysiol Res, Chiang Mai, Thailand.	nchattip@gmail.com	Chattipakorn, Nipon/AAJ-4049-2021	Srichairatanakool, Somdet/0000-0002-5706-8781; Chattipakorn, Nipon/0000-0003-3026-718X; Sripetchwandee, Jirapas/0000-0002-4473-7018	NSTDA Research Chair Grant from National Science and Technology Development Agency Thailand; Thailand Research Fund [BRG5780016, MRG5980222, TRG5880045]; Royal Golden Jubilee PhD program; Chiang Mai University Center of Excellence Award; Faculty of Medicine Chiang Mai University Fund	NSTDA Research Chair Grant from National Science and Technology Development Agency Thailand; Thailand Research Fund(Thailand Research Fund (TRF)); Royal Golden Jubilee PhD program(Thailand Research Fund (TRF)); Chiang Mai University Center of Excellence Award; Faculty of Medicine Chiang Mai University Fund	This work was supported by the NSTDA Research Chair Grant from the National Science and Technology Development Agency Thailand (NC) and grants from the Thailand Research Fund BRG5780016 (SC), MRG5980222 (SK), TRG5880045 (JS), the Royal Golden Jubilee PhD program (SC and SW), Chiang Mai University Center of Excellence Award (NC), and the Faculty of Medicine Chiang Mai University Fund (SW and NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abetz L, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-73; Apaijai N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102374; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Asif M, 2015, J PAK MED ASSOC, V65, P838; Aziza Samy Ali Hussein, 2014, Pak J Biol Sci, V17, P964, DOI 10.3923/pjbs.2014.964.977; BANNER W, 1986, TOXICOL APPL PHARM, V83, P142, DOI 10.1016/0041-008X(86)90331-5; Bartfay WJ, 1999, CARDIOVASC RES, V43, P892, DOI 10.1016/S0008-6363(99)00040-1; Berdoukas V, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-20; Burke W, 2002, BEST PRACT RES CL HA, V15, P315, DOI 10.1053/beha.2002.0002; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chinda K, 2014, DIABETES VASC DIS RE, V11, P75, DOI 10.1177/1479164113516134; Darley-Usmar V, 2004, FREE RADICAL BIO MED, V37, P753, DOI 10.1016/j.freeradbiomed.2004.05.026; Lima AHRD, 2011, ARQ BRAS CARDIOL, V96, P498; Fibach E, 2010, ANN NY ACAD SCI, V1202, P10, DOI 10.1111/j.1749-6632.2010.05577.x; Gao XS, 2010, FREE RADICAL BIO MED, V49, P401, DOI 10.1016/j.freeradbiomed.2010.04.033; Gao XS, 2009, J BIOL CHEM, V284, P4767, DOI 10.1074/jbc.M806235200; Glickstein H, 2005, BLOOD, V106, P3242, DOI 10.1182/blood-2005-02-0460; Glos M, 2007, P ANN INT IEEE EMBS, P263, DOI 10.1109/IEMBS.2007.4352274; Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030; HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509; Hershko C, 2006, HAEMATOLOGICA, V91, P1307; Hershko C, 2010, ANN NY ACAD SCI, V1202, P1, DOI 10.1111/j.1749-6632.2010.05544.x; Hider RC, 2010, ANN NY ACAD SCI, V1202, P94, DOI 10.1111/j.1749-6632.2010.05573.x; HJORTSO E, 1990, EUR J CLIN PHARMACOL, V39, P29, DOI 10.1007/BF02657052; HOUGLUM K, 1990, J CLIN INVEST, V86, P1991, DOI 10.1172/JCI114934; Hui L, 2003, HEART, V89, P669, DOI 10.1136/heart.89.6.669; Knutson MD, 2000, J NUTR, V130, P621, DOI 10.1093/jn/130.3.621; Kramer JH, 2012, CAN J PHYSIOL PHARM, V90, P1257, DOI [10.1139/y2012-091, 10.1139/Y2012-091]; Kremastinos DT, 2011, CIRCULATION, V124, P2253, DOI 10.1161/CIRCULATIONAHA.111.050773; Kremastinos DT, 2010, CIRC-HEART FAIL, V3, P451, DOI 10.1161/CIRCHEARTFAILURE.109.913863; Kumfu S, 2012, BIOMETALS, V25, P1167, DOI 10.1007/s10534-012-9579-x; Kumfu S, 2012, EUR J HAEMATOL, V88, P535, DOI 10.1111/j.1600-0609.2012.01779.x; Kumfu S, 2011, EUR J HAEMATOL, V86, P156, DOI 10.1111/j.1600-0609.2010.01549.x; Latchman PL, 2011, CLIN AUTON RES, V21, P319, DOI 10.1007/s10286-011-0116-8; Lekawanvijit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041281; Ma YM, 2014, BIOCHEM J, V463, P351, DOI 10.1042/BJ20140795; Maggio A, 2002, BLOOD CELL MOL DIS, V28, P196, DOI 10.1006/bcmd.2002.0510; Montuschi P, 1999, AM J RESP CRIT CARE, V160, P216, DOI 10.1164/ajrccm.160.1.9809140; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Morrow JD, 1996, BIOCHEM PHARMACOL, V51, P1, DOI 10.1016/0006-2952(95)02072-1; Murphy CJ, 2010, J CARD FAIL, V16, P888, DOI 10.1016/j.cardfail.2010.05.009; Oudit GY, 2006, J MOL MED, V84, P349, DOI 10.1007/s00109-005-0029-x; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Ozdemir ZC, 2014, HEMOGLOBIN, V15, P1; Pennell DJ, 2006, BLOOD, V107, P3738, DOI 10.1182/blood-2005-07-2948; Pennell DJ, 2012, HAEMATOL-HEMATOL J, V97, P842, DOI 10.3324/haematol.2011.049957; Pepe A, 2006, EUR J HAEMATOL, V76, P183, DOI 10.1111/j.1600-0609.2005.00587.x; Pepe A, 2011, HAEMATOL-HEMATOL J, V96, P41, DOI 10.3324/haematol.2009.019042; Piga A, 2010, ANN NY ACAD SCI, V1202, P75, DOI 10.1111/j.1749-6632.2010.05586.x; Pongkan W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122503; Porter JB, 2010, ANN NY ACAD SCI, V1202, P87, DOI 10.1111/j.1749-6632.2010.05582.x; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Samniang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep19749; Shahripour RB, 2014, BRAIN BEHAV, V4, P108, DOI 10.1002/brb3.208; SINGH S, 1990, ANAL BIOCHEM, V186, P320, DOI 10.1016/0003-2697(90)90088-Q; Sripetchwandee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085115; Surinkaew S, 2013, J CARDIOVASC PHARM, V61, P133, DOI 10.1097/FJC.0b013e318279b7b1; Tabatabaie M, 2013, IRAN J KIDNEY DIS, V7, P299; Tanner MA, 2007, CIRCULATION, V115, P1876, DOI 10.1161/CIRCULATIONAHA.106.648790; Thummasorn S, 2011, MITOCHONDRION, V11, P457, DOI 10.1016/j.mito.2011.01.008; Walker J M, 1994, Methods Mol Biol, V32, P5; Wijarnpreecha K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130837; Wongjaikam S, 2015, EUR J PHARMACOL, V765, P86, DOI 10.1016/j.ejphar.2015.08.017; Wood JC, 2006, TRANSL RES, V148, P272, DOI 10.1016/j.trsl.2006.05.005; Wood JC, 2010, BLOOD, V116, P537, DOI 10.1182/blood-2009-11-250308; Zannos-Mariolea L, 2008, BRIT J HAEMATOL, V26, P193; Ziegler D, 2015, ACTA DIABETOL, V52, P65, DOI 10.1007/s00592-014-0601-3; ZURLO MG, 1989, LANCET, V2, P27, DOI 10.1016/S0140-6736(89)90264-X	68	34	35	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159414	10.1371/journal.pone.0159414	http://dx.doi.org/10.1371/journal.pone.0159414			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428732	Green Submitted, gold, Green Published			2022-12-27	WOS:000380169300063
J	Prado-Oviedo, NA; Bonaparte-Saller, MK; Malloy, EJ; Meehan, CL; Mench, JA; Carlstead, K; Brown, JL				Prado-Oviedo, Natalia A.; Bonaparte-Saller, Mary K.; Malloy, Elizabeth J.; Meehan, Cheryl L.; Mench, Joy A.; Carlstead, Kathy; Brown, Janine L.			Evaluation of Demographics and Social Life Events of Asian (Elephas maximus) and African Elephants (Loxodonta africana) in North American Zoos	PLOS ONE			English	Article							ARTIFICIAL-INSEMINATION; STRESS; ORGANIZATION; SENESCENCE; MANAGEMENT; DYNAMICS; BEHAVIOR; STATE; MUSTH	This study quantified social life events hypothesized to affect the welfare of zoo African and Asian elephants, focusing on animals that were part of a large multi-disciplinary, multi-institutional elephant welfare study in North America. Age was calculated based on recorded birth dates and an age-based account of life event data for each elephant was compiled. These event histories included facility transfers, births and deaths of offspring, and births and deaths of non-offspring herd mates. Each event was evaluated as a total number of events per elephant, lifetime rate of event exposure, and age at first event exposure. These were then compared across three categories: species (African vs. Asian); sex (male vs. female); and origin (imported vs. captive-born). Mean age distributions differed (p<0.05) between the categories: African elephants were 6 years younger than Asian elephants, males were 12 years younger than females, and captive-born elephants were 20 years younger than imported elephants. Overall, the number of transfers ranged from 0 to 10, with a 33% higher age-adjusted transfer rate for imported African than imported Asian elephants, and 37% lower rate for imported females than males (p<0.05). Other differences (p<0.05) included a 96% higher rate of offspring births for captive-born females than those imported from range countries, a 159% higher rate of birthing event exposures for captive-born males than for their imported counterparts, and Asian elephant females being 4 years younger than African females when they produced their first calf. In summarizing demographic and social life events of elephants in North American zoos, we found both qualitative and quantitative differences in the early lives of imported versus captive-born elephants that could have long-term welfare implications.	[Prado-Oviedo, Natalia A.; Brown, Janine L.] Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Prado-Oviedo, Natalia A.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Bonaparte-Saller, Mary K.; Mench, Joy A.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Bonaparte-Saller, Mary K.; Mench, Joy A.] Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA; [Malloy, Elizabeth J.] American Univ, Dept Math & Stat, 4400 Massachusetts Ave NW, Washington, DC 20016 USA; [Meehan, Cheryl L.] AWARE Inst, Portland, OR USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; George Mason University; University of California System; University of California Davis; University of California System; University of California Davis; American University	Prado-Oviedo, NA (corresponding author), Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA.; Prado-Oviedo, NA (corresponding author), George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA.	PradoN@si.edu	Malloy, Elizabeth/AAP-6243-2021; Malloy, Elizabeth/AAV-6244-2021	Malloy, Elizabeth/0000-0002-7209-5147	Institution of Museum and Library Services [LG-25-10-0033-10]; Smithsonian National Zoological Park; Honolulu Zoo; IMLS; AWARE Institute	Institution of Museum and Library Services; Smithsonian National Zoological Park(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Honolulu Zoo; IMLS; AWARE Institute	Funding for this project was received from The Institution of Museum and Library Services; grant number LG-25-10-0033-10. Employers provided financial support in the form of authors' salaries as follows: Smithsonian National Zoological Park (JLB, NP-O); Honolulu Zoo (KC). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLOU J, 1985, INT STUDBOOK GOLDEN; Baranyi J, 2005, PHYSIOL BEHAV, V84, P511, DOI 10.1016/j.physbeh.2005.01.005; Bartolomucci A, 2001, PHYSIOL BEHAV, V73, P401, DOI 10.1016/S0031-9384(01)00453-X; Boedeker NC, 2012, J ZOO WILDLIFE MED, V43, P603, DOI 10.1638/2011-0270.1; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; Brown JL, 2007, GEN COMP ENDOCR, V151, P153, DOI 10.1016/j.ygcen.2007.01.006; Brown JL, 2014, ADV EXP MED BIOL, V753, P135, DOI 10.1007/978-1-4939-0820-2_8; Brown JL, 2004, ZOO BIOL, V23, P45, DOI 10.1002/zoo.10116; Brown JL, 2016, PLOS ONE; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Christensen JW, 2011, APPL ANIM BEHAV SCI, V133, P199, DOI 10.1016/j.applanim.2011.05.013; Clubb R, 2009, ANIM WELFARE, V18, P237; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; COOPER KA, 1990, ZOO BIOL, V9, P297, DOI 10.1002/zoo.1430090405; Coutellier L, 2007, APPL ANIM BEHAV SCI, V105, P102, DOI 10.1016/j.applanim.2006.05.007; de Groot J, 2001, PHYSIOL BEHAV, V73, P145, DOI 10.1016/S0031-9384(01)00472-3; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; Douglas-Hamilton I.O., 1975, ELEPHANTS, V113, P72; Evans KE, 2008, ANIM BEHAV, V76, P779, DOI 10.1016/j.anbehav.2008.03.019; FAIRBANKS LA, 1990, ANIM BEHAV, V40, P553, DOI 10.1016/S0003-3472(05)80536-6; Faust L., 2011, TECHNICAL REPORT ZOO; Fernando P, 2000, BEHAV ECOL SOCIOBIOL, V48, P84, DOI 10.1007/s002650000218; FOOSE TJ, 1978, ACTA ZOOL PATHOL ANT, P119; Fowler M.E., 1993, ZOO WILD ANIMAL MED; FRASER D, 1978, ANIM BEHAV, V26, P22, DOI 10.1016/0003-3472(78)90004-0; Glaeser SS, 2012, THERIOGENOLOGY, V78, P285, DOI 10.1016/j.theriogenology.2012.01.014; Glatson AR, 1998, P 5 C BREED END SPEC, P53; Glatston AR, 1986, INT ZOO YB, V24, P162; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Goldenberg SZ, 2014, ANIM BEHAV, V95, P111, DOI 10.1016/j.anbehav.2014.07.002; Greco BJ, 2016, PLOS ONE; Haller J, 1999, BRAIN RES BULL, V50, P33, DOI 10.1016/S0361-9230(99)00087-8; Hayward AD, 2014, J EVOLUTION BIOL, V27, P772, DOI 10.1111/jeb.12350; Held SDE, 2011, ANIM BEHAV, V81, P891, DOI 10.1016/j.anbehav.2011.01.007; Hermes R, 2008, THERIOGENOLOGY, V70, P131, DOI 10.1016/j.theriogenology.2008.04.003; Hermes R, 2004, ANIM REPROD SCI, V82-3, P49, DOI 10.1016/j.anireprosci.2004.05.015; Hildebrandt T. B., 2006, International Zoo Yearbook, V40, P20, DOI 10.1111/j.1748-1090.2006.00020.x; Hildebrandt TB, 2012, THERIOGENOLOGY, V78, P1398, DOI 10.1016/j.theriogenology.2012.06.014; Hildebrandt TB, 2000, ZOO BIOL, V19, P333, DOI 10.1002/1098-2361(2000)19:5&lt;333::AID-ZOO5&gt;3.0.CO;2-A; Holdgate MR, 2016, PLOS ONE; IBM Corp, 2016, IBM SPSS STAT WIND V; Kleiman D. G., 1977, International Zoo Yearbook, V17, DOI 10.1111/j.1748-1090.1977.tb00923.x; KOROSI A, 2012, PLOS ONE 2016, V227, P400, DOI DOI 10.1016/J.BBR.2011.07.037; Lahdenpera M, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0054-0; Latham N.R, 2005, REFINING ROLE STEREO; LEE PC, 1987, ANIM BEHAV, V35, P278, DOI 10.1016/S0003-3472(87)80234-8; Lee Phyllis C., 1999, Symposia of the Zoological Society of London, V72, P102; Lee PC, 2016, BEHAV ECOL SOCIOBIOL, V70, P337, DOI 10.1007/s00265-015-2051-5; Lei R, 2008, J ZOOL, V275, P252, DOI 10.1111/j.1469-7998.2008.00437.x; Ljungberg T, 2000, PRIMATES, V41, P79, DOI 10.1007/BF02557463; Meehan CL, 2016, PLOS ONE; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Moss C, 1988, ELEPHANT MEMORIES; Moss C.J., 2011, AMBOSELI ELEPHANTS L, DOI DOI 10.7208/CHICAGO/9780226542263.001.0001; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Newberry RC, 2008, APPL ANIM BEHAV SCI, V110, P3, DOI 10.1016/j.applanim.2007.03.021; Olson D, 2000, ZOO BIOL, V19, P311, DOI 10.1002/1098-2361(2000)19:5<311::AID-ZOO3>3.3.CO;2-F; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; POOLE JH, 1989, SYM ZOOL S, V61, P111; POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6; Rietkerk F, 1998, EEP YB 1997 98; Ryan S, 2002, ZOO BIOL, V21, P389, DOI 10.1002/zoo.10045; Schulte BA, 2000, ZOO BIOL, V19, P447, DOI 10.1002/1098-2361(2000)19:5&lt;447::AID-ZOO12&gt;3.0.CO;2-#; Shannon G, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-62; Slotow R., 2001, Koedoe, V44, P85; Spinage C.A., 1994, ELEPHANTS; Stone AI, 2010, BEHAV PROCESS, V83, P8, DOI 10.1016/j.beproc.2009.08.008; Suderman M, 2012, P NATL ACAD SCI USA, V109, P17266, DOI 10.1073/pnas.1121260109; Sukumar R., 2003, LIVING EVOLUTIONARY; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Sukumar Raman, 1994, ELEPHANT DAYS NIGHTS; Vidya TNC, 2005, J ETHOL, V23, P205, DOI 10.1007/s10164-005-0144-8; VISALBERGHI E, 1993, ANIM WELFARE, V2, P3; Wiese R. J., 2006, International Zoo Yearbook, V40, P80, DOI 10.1111/j.1748-1090.2006.00080.x; Wiese RJ, 2000, ZOO BIOL, V19, P299, DOI 10.1002/1098-2361(2000)19:5<299::AID-ZOO2>3.0.CO;2-Z; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018	78	24	25	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0154750	10.1371/journal.pone.0154750	http://dx.doi.org/10.1371/journal.pone.0154750			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415437	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500008
J	Shimono, M; Higaki, T; Kaku, H; Shibuya, N; Hasezawa, S; Day, B				Shimono, Masaki; Higaki, Takumi; Kaku, Hanae; Shibuya, Naoto; Hasezawa, Seiichiro; Day, Brad			Quantitative Evaluation of Stomatal Cytoskeletal Patterns during the Activation of Immune Signaling in Arabidopsis thaliana	PLOS ONE			English	Article							PLANT INNATE IMMUNITY; ACTIN DYNAMICS; POWDERY MILDEW; PATHWAYS; RECEPTOR; PROTEIN; RESISTANCE; FILAMENTS; NETWORK	Historically viewed as primarily functioning in the regulation of gas and water vapor exchange, it is now evident that stomata serve an important role in plant immunity. Indeed, in addition to classically defined functions related to cell architecture and movement, the actin cytoskeleton has emerged as a central component of the plant immune system, underpinning not only processes related to cell shape and movement, but also receptor activation and signaling. Using high resolution quantitative imaging techniques, the temporal and spatial changes in the actin microfilament array during diurnal cycling of stomatal guard cells has revealed a highly orchestrated transition from random arrays to ordered bundled filaments. While recent studies have demonstrated that plant stomata close in response to pathogen infection, an evaluation of stimulus-induced changes in actin cytoskeletal dynamics during immune activation in the guard cell, as well as the relationship of these changes to the function of the actin cytoskeleton and stomatal aperture, remains undefined. In the current study, we employed quantitative cell imaging and hierarchical clustering analyses to define the response of the guard cell actin cytoskeleton to pathogen infection and the elicitation of immune signaling. Using this approach, we demonstrate that stomatal-localized actin filaments respond rapidly, and specifically, to both bacterial phytopathogens and purified pathogen elicitors. Notably, we demonstrate that higher order temporal and spatial changes in the filament array show distinct patterns of organization during immune activation, and that changes in the naive diurnal oscillations of guard cell actin filaments are perturbed by pathogens, and that these changes parallel pathogen-induced stomatal gating. The data presented herein demonstrate the application of a highly tractable and quantifiable method to assign transitions in actin filament organization to the activation of immune signaling in plants.	[Shimono, Masaki; Day, Brad] Michigan State Univ, Dept Plant Soil & Microbial Sci, 1066 Bogue St A286, E Lansing, MI 48824 USA; [Higaki, Takumi; Hasezawa, Seiichiro] Univ Tokyo, Dept Integrated Biosci, Kashiwanoha 5-1-5, Kashiwa, Chiba 2778562, Japan; [Kaku, Hanae; Shibuya, Naoto] Meiji Univ, Sch Agr, Dept Life Sci, Tama Ku, 1-1-1 Higashimita, Kawasaki, Kanagawa 2148571, Japan; [Day, Brad] Michigan State Univ, Grad Program Genet, 2240E Biomed Phys Sci, E Lansing, MI 48824 USA; [Day, Brad] Michigan State Univ, Grad Program Cell & Mol Biol, 2240A Biomed Phys Sci, E Lansing, MI 48824 USA	Michigan State University; University of Tokyo; Meiji University; Michigan State University; Michigan State University	Day, B (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, 1066 Bogue St A286, E Lansing, MI 48824 USA.; Day, B (corresponding author), Michigan State Univ, Grad Program Genet, 2240E Biomed Phys Sci, E Lansing, MI 48824 USA.; Day, B (corresponding author), Michigan State Univ, Grad Program Cell & Mol Biol, 2240A Biomed Phys Sci, E Lansing, MI 48824 USA.	bday@msu.edu		Day, Brad/0000-0002-9880-4319	Ministry of Education, Science and Culture of Japan [25711017, 22248041, 26650104]; MEXT [S1411023]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Institute of Science and Technology from Meiji University; U.S. National Science Foundation [IOS-1557437];  [15H01240]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute of Science and Technology from Meiji University; U.S. National Science Foundation(National Science Foundation (NSF)); 	This work was supported by Grants-in-Aid to TH (25711017) and NS (22248041 and 26650104) from the Ministry of Education, Science and Culture of Japan. Research in the lab of HK is supported by Grants-in-Aid for Scientific Research on Innovative Areas (15H01240), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1411023), the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a Research Project Grant from the Institute of Science and Technology from Meiji University. Research in the laboratory of BD is supported the U.S. National Science Foundation (IOS-1557437).; We thank Amy Baetsen-Young, Alex Corrion, and Yi-Ju Lu for critical reading of the manuscript. This work was supported by Grants-in-Aid to TH (25711017) and NS (22248041 and 26650104) from the Ministry of Education, Science and Culture of Japan. Research in the lab of HK is supported by Grants-in-Aid for Scientific Research on Innovative Areas (15H01240), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1411023), the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a Research Project Grant from the Institute of Science and Technology from Meiji University. Research in the laboratory of BD is supported the U.S. National Science Foundation (IOS-1557437).	Bamburg James R, 2010, F1000 Biol Rep, V2, P62, DOI 10.3410/B2-62; Beck M, 2012, PLANT CELL, V24, P4205, DOI 10.1105/tpc.112.100263; Bigeard J, 2015, MOL PLANT, V8, P521, DOI 10.1016/j.molp.2014.12.022; Cai G, 2011, PLANT PHYSIOL, V155, P1169, DOI 10.1104/pp.110.171371; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Day B, 2011, ANNU REV PHYTOPATHOL, V49, P483, DOI 10.1146/annurev-phyto-072910-095426; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Guo M, 2016, CELL HOST MICROBE, V19, P67, DOI 10.1016/j.chom.2015.12.007; Harries PA, 2009, P NATL ACAD SCI USA, V106, P17594, DOI 10.1073/pnas.0909239106; Hayafune M, 2014, P NATL ACAD SCI USA, V111, pE404, DOI 10.1073/pnas.1312099111; Henty-Ridilla JL, 2014, PLANT CELL, V26, P340, DOI 10.1105/tpc.113.122499; Henty-Ridilla JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003290; Higaki T, 2007, CURR OPIN PLANT BIOL, V10, P549, DOI 10.1016/j.pbi.2007.08.012; Higaki T, 2010, PLANT J, V61, P156, DOI 10.1111/j.1365-313X.2009.04032.x; Higaki T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-80; Inada N, 2016, PLANT PHYSIOL; Inada N, 2016, J PLANT RES, V129, P103, DOI 10.1007/s10265-015-0769-9; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kang YS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004232; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; KUNKEL BN, 1993, PLANT CELL, V5, P865, DOI 10.1105/tpc.5.8.865; Li JJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8206; Liu SG, 2012, PLANT CELL REP, V31, P1219, DOI 10.1007/s00299-012-1242-z; Lozano-Duran R, 2014, NEW PHYTOL, V202, P259, DOI 10.1111/nph.12651; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Miklis M, 2007, PLANT PHYSIOL, V144, P1132, DOI 10.1104/pp.107.098897; Moes D, 2013, MOL PLANT, V6, P483, DOI 10.1093/mp/sss075; Murata Y, 2015, ANNU REV PLANT BIOL, V66, P369, DOI 10.1146/annurev-arplant-043014-114707; Ou XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101587; Porter K, 2016, J INTEGR PLANT BIOL, V58, P299, DOI 10.1111/jipb.12445; Porter K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003006; Sawinski K, 2013, MOL PLANT MICROBE IN, V26, P626, DOI 10.1094/MPMI-12-12-0288-CR; Shimono M, 2016, PLANT PHYSIOL; Shinya T, 2015, CURR OPIN PLANT BIOL, V26, P64, DOI 10.1016/j.pbi.2015.05.032; Staiger CJ, 2009, J CELL BIOL, V184, P269, DOI 10.1083/jcb.200806185; Tian MY, 2009, PLANT PHYSIOL, V150, P815, DOI 10.1104/pp.109.137604; Wang WM, 2009, PLANT CELL, V21, P2898, DOI 10.1105/tpc.109.067587; Zeng WQ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002291	39	13	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159291	10.1371/journal.pone.0159291	http://dx.doi.org/10.1371/journal.pone.0159291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415815	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500121
J	Takaya, A; Hirohashi, Y; Murai, A; Morita, R; Saijo, H; Yamamoto, E; Kubo, T; Nakatsugawa, M; Kanaseki, T; Tsukahara, T; Tamura, Y; Takemasa, I; Kondo, T; Sato, N; Torigoe, T				Takaya, Akari; Hirohashi, Yoshihiko; Murai, Aiko; Morita, Rena; Saijo, Hiroshi; Yamamoto, Eri; Kubo, Terufumi; Nakatsugawa, Munehide; Kanaseki, Takayuki; Tsukahara, Tomohide; Tamura, Yasuaki; Takemasa, Ichiro; Kondo, Toru; Sato, Noriyuki; Torigoe, Toshihiko			Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480	PLOS ONE			English	Article							SIDE POPULATION; STATE	Human cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) can be isolated as side population (SP) cells, aldehyde dehydrogenase high (ALDH(high)) cells or cell surface marker-positive cells including CD44(+) cells and CD133(+) cells. CSCs/CICs and non-CSCs/CICs are unstable in in vitro culture, and CSCs/CICs can differentiate into non-CSCs/CICs and some non-CSCs/CICs can dedifferentiate into CSCs/CICs. Therefore, experiments using a large amount of CSCs/CICs are technically very difficult. In this study, we isolated single cell clones from SP cells and main population (MP) cells derived from the human colon cancer cell line SW480. SP analysis revealed that SP clone cells had relatively high percentages of SP cells, whereas MP clone cells showed very few SP cells, and the phenotypes were sustainable for more than 2 months of in vitro culture. Xenograft transplantation revealed that SP clone cells have higher tumor-initiating ability than that of MP clone cells and SP clone cell showed higher chemo-resistance compared with MP clone cells. These results indicate that SP clone cells derived from SW480 cells are enriched with CSCs/CICs, whereas MP clone cells are pure non-CSCs/CICs. SP clone cells and MP clone cells are a very stable in vitro CSC/CIC-enriched and non-CSC/CIC model for further analysis.	[Takaya, Akari; Hirohashi, Yoshihiko; Murai, Aiko; Morita, Rena; Saijo, Hiroshi; Yamamoto, Eri; Kubo, Terufumi; Nakatsugawa, Munehide; Kanaseki, Takayuki; Tsukahara, Tomohide; Sato, Noriyuki; Torigoe, Toshihiko] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido 0608556, Japan; [Saijo, Hiroshi] Sapporo Med Univ, Sch Med, Dept Resp Med & Allergol, Sapporo, Hokkaido 0608543, Japan; [Tamura, Yasuaki] Hokkaido Univ, Ctr Food & Med Innovat, Dept Mol Therapeut, Sapporo, Hokkaido 0608638, Japan; [Takemasa, Ichiro] Sapporo Med Univ, Sch Med, Dept Surg, Sapporo, Hokkaido 0608543, Japan; [Kondo, Toru] Hokkaido Univ, Inst Med Genet, Div Stem Cell Biol, Sapporo, Hokkaido 0608638, Japan	Sapporo Medical University; Sapporo Medical University; Hokkaido University; Sapporo Medical University; Hokkaido University	Hirohashi, Y; Torigoe, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido 0608556, Japan.	hirohash@sapmed.ac.jp; torigoe@sapmed.ac.jp	Hirohashi, Yoshihiko/AFQ-4227-2022	Kanaseki, Takayuki/0000-0001-7294-6880	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Sagawa Foundation for Promotion of Cancer Research; Suharakinenzaidan Co., Ltd.; Kobayashi foundation for cancer research; Northern Advancement Center for Science & Technology of Hokkaido Japan; Project for Cancer Research And Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and development, AMED	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sagawa Foundation for Promotion of Cancer Research; Suharakinenzaidan Co., Ltd.; Kobayashi foundation for cancer research(Kobayashi Foundation for Cancer Research); Northern Advancement Center for Science & Technology of Hokkaido Japan; Project for Cancer Research And Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N. S.), program for developing the supporting system for upgrading education and research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N. S.) and Takeda Science Foundation (to Y. H.), Sagawa Foundation for Promotion of Cancer Research (to Y. H.), Suharakinenzaidan Co., Ltd. (to Y.H.) and Kobayashi foundation for cancer research (to Y.H.). This study was supported in part by Grants-in-Aid for Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan (to Y.H. and T. Torigoe). This research is supported by the Project for Cancer Research And Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and development, AMED (to T. Torigoe).	Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Inoda S, 2011, AM J PATHOL, V178, P1805, DOI 10.1016/j.ajpath.2011.01.004; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Mitsutake N, 2007, ENDOCRINOLOGY, V148, P1797, DOI 10.1210/en.2006-1553; Moti N, 2015, ONCOGENE, V34, P1843, DOI 10.1038/onc.2014.112; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Nakatsugawa M, 2011, J IMMUNOASS IMMUNOCH, V32, P93, DOI 10.1080/15321819.2010.543219; Nishizawa S, 2012, CANCER RES, V72, P2844, DOI 10.1158/0008-5472.CAN-11-3062; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Yasuda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068187	20	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158903	10.1371/journal.pone.0158903	http://dx.doi.org/10.1371/journal.pone.0158903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415781	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500047
J	Xu, R; Lian, Y; Li, WX				Xu, Rui; Lian, Ying; Li, Wen Xian			Airway Complications during and after General Anesthesia: A Comparison, Systematic Review and Meta-Analysis of Using Flexible Laryngeal Mask Airways and Endotracheal Tubes	PLOS ONE			English	Review							QUALITY-EFFECTS MODEL; TRACHEAL INTUBATION; SORE THROAT; CUFF PRESSURES; RISK-FACTORS; LARYNGOSPASM; CHILDREN; SURGERY; ADENOTONSILLECTOMY; HOARSENESS	Objective Flexible laryngeal mask airways (FLMAs) have been widely used in thyroidectomy as well as cleft palate, nasal, upper chest, head and neck oncoplastic surgeries. This systematic review aims to compare the incidence of airway complications that occur during and after general anesthesia when using the FLMA and endotracheal intubation (ETT). We performed a quantitative meta-analysis of the results of randomized trials. Methods A comprehensive search of the PubMed, Embase and Cochrane Library databases was conducted using the key words "flexible laryngeal mask airway" and "endotracheal intubation". Only prospective randomized controlled trials (RCTs) that compared the FLMA and ETT were included. The relative risks (RRs) and the corresponding 95% confidence intervals (95% CIs) were calculated using a quality effects model in MetaXL 1.3 software to analyze the outcome data. Results Ten RCTs were included in this meta-analysis. There were no significant differences between the FLMA and ETT groups in the incidence of difficulty in positioning the airway [RR = 1.75, 95% CI = (0.70-4.40)]; the occurrence of sore throat at one hour and 24 hours postoperative [RR = 0.90, 95% CI = (0.13-6.18) and RR = 0.95, 95% CI = (0.81-1.13), respectively]; laryngospasms [RR = 0.58, 95% CI = (0.27-1.23)]; airway displacement [RR = 2.88, 95% CI = (0.58-14.33)]; aspiration [RR = 0.76, 95% CI = (0.06-8.88)]; or laryngotracheal soiling [RR = 0.34, 95% CI = (0.10-1.06)]. Patients treated with the FLMA had a lower incidence of hoarseness [RR = 0.31, 95% CI = (0.15-0.62)]; coughing [RR = 0.28, 95% CI = (0.15-0.51)] during recovery in the postanesthesia care unit (PACU); and oxygen desaturation [RR = 0.43, 95% CI = (0.26-0.72)] than did patients treated with ETT. However, the incidence of partial upper airway obstruction in FLMA patients was significantly greater than it was for ETT patients [RR = 4.01, 95% CI = (1.44-11.18)]. Conclusion This systematic review showed that the FLMA has some advantages over ETT because it results in a lower incidence of hoarseness, coughing and oxygen desaturation. There were no statistically significant differences in the difficulty of intubation or in the occurrence of laryngospasms, postoperative sore throat, airway displacement, aspiration or laryngotracheal soiling. However, there was a higher incidence of partial upper airway obstruction in the FLMA than in the ETT group. We conclude that the FLMA has some advantages over ETT, but surgeons and anesthesiologists should be cautious when applying the mouth gag, moving the head and neck, or performing oropharyngeal procedures to avoid partial upper airway obstruction and airway displacement. The FLMA should not be used on patients at high risk for aspiration.	[Xu, Rui; Li, Wen Xian] Fudan Univ, Eye Ear Nose & Throat Hosp, Shanghai Med Coll, Dept Anesthesiol, Shanghai, Peoples R China; [Lian, Ying] Shandong Univ, Shandong Prov Qian Foshan Hosp, Dept Case Adm, Jinan, Peoples R China	Fudan University; Shandong University	Li, WX (corresponding author), Fudan Univ, Eye Ear Nose & Throat Hosp, Shanghai Med Coll, Dept Anesthesiol, Shanghai, Peoples R China.	wenxianli66@gmail.com			Department of Biomedicine of Science and Technology Commission of Science and Technology Commission of Shanghai Municipality [14411969700]	Department of Biomedicine of Science and Technology Commission of Science and Technology Commission of Shanghai Municipality	This study was supported by Department of Biomedicine of Science and Technology Commission of Science and Technology Commission of Shanghai Municipality (No14411969700) to Wen Xian Li.	Ahmed MZ, 2002, CAN J ANAESTH, V49, P863, DOI 10.1007/BF03017421; Al-Metwalli RR, 2010, J ANESTH, V24, P854, DOI 10.1007/s00540-010-1036-9; ALEXANDER CA, 1990, ANAESTHESIA, V45, P892, DOI 10.1111/j.1365-2044.1990.tb14601.x; Brimacombe J, 2000, ANESTHESIOLOGY, V93, P26, DOI 10.1097/00000542-200007000-00009; Brimacombe J, 2000, BRIT J ANAESTH, V84, P290, DOI 10.1093/oxfordjournals.bja.a013421; BRIMACOMBE J, 1995, CAN J ANAESTH, V42, P1017, DOI 10.1007/BF03011075; Brimacombe J, 1999, CAN J ANAESTH, V46, P558, DOI 10.1007/BF03013546; Burgoyne LL, 2008, PEDIATR ANESTH, V18, P297, DOI 10.1111/j.1460-9592.2008.02445.x; Cravero JP, 2006, PEDIATRICS, V118, P1087, DOI 10.1542/peds.2006-0313; D'Aragon F, 2013, CAN J ANESTH, V60, P370, DOI 10.1007/s12630-013-9896-8; Doi SAR, 2008, EPIDEMIOLOGY, V19, P94, DOI 10.1097/EDE.0b013e31815c24e7; Doi SAR, 2009, EPIDEMIOLOGY, V20, P314, DOI 10.1097/EDE.0b013e318196a8d0; Doksrod S, 2010, EUR J ANAESTH, V27, P941, DOI 10.1097/EJA.0b013e32833d69c6; Fabregas N, 2007, BEST PRACT RES-CLIN, V21, P431, DOI 10.1016/j.bpa.2007.06.006; Flick RP, 2008, PEDIATR ANESTH, V18, P289, DOI 10.1111/j.1460-9592.2008.02447.x; Frerk C, 2015, BRIT J ANAESTH, V115, P827, DOI 10.1093/bja/aev371; Grady DM, 2001, ANESTHESIOLOGY, V94, P760, DOI 10.1097/00000542-200105000-00012; Hernandez MR, 2012, ANESTH ANALG, V114, P349, DOI 10.1213/ANE.0b013e31823b6748; Hettige R, 2014, ANN OTO RHINOL LARYN, V123, P338, DOI 10.1177/0003489414526365; Jaensson M, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-56; Jakobsson J, 2010, MINERVA ANESTESIOL, V76, P38; Kaplan A, 2004, LARYNGOSCOPE, V114, P652, DOI 10.1097/00005537-200404000-00010; Keller C, 2004, BRIT J ANAESTH, V93, P579, DOI 10.1093/bja/aeh228; Kundra P, 2009, CLEFT PALATE-CRAN J, V46, P368, DOI 10.1597/08-009.1; Lalwani K, 2013, INT J PEDIATR OTORHI, V77, P25, DOI 10.1016/j.ijporl.2012.09.021; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lu Y H, 1999, Acta Anaesthesiol Sin, V37, P221; Martin-Castro C, 2008, EUR J ANAESTH, V25, P261, DOI 10.1017/S0265021507002980; Mathew PJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007082.pub2; McHardy FE, 1999, ANAESTHESIA, V54, P444, DOI 10.1046/j.1365-2044.1999.00780.x; Moris D, 2014, HORM-INT J ENDOCRINO, V13, P5, DOI 10.1007/BF03401316; NUUTINEN J, 1981, LARYNGOSCOPE, V91, P83; OLSSON GL, 1984, ACTA ANAESTH SCAND, V28, P567, DOI 10.1111/j.1399-6576.1984.tb02121.x; Ong M, 2008, ANAESTHESIA, V63, P738, DOI 10.1111/j.1365-2044.2008.05486.x; Oofuvong M, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-13; Orestes MI, 2012, LARYNGOSCOPE, V122, P425, DOI 10.1002/lary.22423; Peng A, 2011, ARCH OTOLARYNGOL, V137, P42, DOI 10.1001/archoto.2010.230; Puyo CA, 2012, ARCH OTOLARYNGOL, V138, P854, DOI 10.1001/archoto.2012.1746; Quinn AC, 1996, BRIT J ANAESTH, V77, P185, DOI 10.1093/bja/77.2.185; Ranieri D, 2012, REV BRAS ANESTESIOL, V62, P788, DOI 10.1016/S0034-7094(12)70179-4; RUNCIMAN WB, 1993, ANAESTH INTENS CARE, V21, P579, DOI 10.1177/0310057X9302100515; Ryu JH, 2014, WORLD J SURG, V38, P378, DOI 10.1007/s00268-013-2269-1; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; van Zundert TCRV, 2012, ANAESTHESIA, V67, P1375, DOI 10.1111/anae.12003.x; WEBSTER AC, 1993, CAN J ANAESTH, V40, P1171, DOI 10.1007/BF03009607; Webster AC, 1999, ANESTH ANALG, V88, P421, DOI 10.1097/00000539-199902000-00037; WELSH BE, 1995, ANAESTHESIA, V50, P1002, DOI 10.1111/j.1365-2044.1995.tb05897.x; William A, 2010, PEDIATR ANESTH, V20, P839, DOI 10.1111/j.1460-9592.2010.03372.x; WILLIAMS PJ, 1993, BRIT J ANAESTH, V70, P30, DOI 10.1093/bja/70.1.30; WILLIAMS PJ, 1995, ANAESTHESIA, V50, P987, DOI 10.1111/j.1365-2044.1995.tb05936.x; Wong JGL, 2009, PEDIATR ANESTH, V19, P464, DOI 10.1111/j.1460-9592.2009.02968.x; Yodfat UA, 1999, ANESTH ANALG, V89, P1327, DOI 10.1097/00000539-199911000-00054; Yu SH, 2010, J ORAL MAXIL SURG, V68, P2359, DOI 10.1016/j.joms.2010.04.017	53	36	41	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158137	10.1371/journal.pone.0158137	http://dx.doi.org/10.1371/journal.pone.0158137			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414807	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500018
J	Bouch, S; Harding, R; O'Reilly, M; Wood, LG; Sozo, F				Bouch, Sheena; Harding, Richard; O'Reilly, Megan; Wood, Lisa G.; Sozo, Foula			Impact of Dietary Tomato Juice on Changes in Pulmonary Oxidative Stress, Inflammation and Structure Induced by Neonatal Hyperoxia in Mice (Mus musculus)	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; LUNG-FUNCTION; AIRWAY INFLAMMATION; PROLONGED HYPEROXIA; EXERCISE CAPACITY; CHILDREN BORN; PRETERM BIRTH; ADULT MICE; SUPPLEMENTATION; ANTIOXIDANTS	Many preterm infants require hyperoxic gas for survival, although it can contribute to lung injury. Experimentally, neonatal hyperoxia leads to persistent alterations in lung structure and increases leukocytes in bronchoalveolar lavage fluid (BALF). These effects of hyperoxia on the lungs are considered to be caused, at least in part, by increased oxidative stress. Our objective was to determine if dietary supplementation with a known source of antioxidants (tomato juice, TJ) could protect the developing lung from injury caused by breathing hyperoxic gas. Neonatal mice (C57BL6/J) breathed either 65% O-2 (hyperoxia) or room air from birth until postnatal day 7 (P7d); some underwent necropsy at P7d and others were raised in room air until adulthood (P56d). In subsets of both groups, drinking water was replaced with TJ (diluted 50: 50 in water) from late gestation to necropsy. At P7d and P56d, we analyzed total antioxidant capacity (TAC), markers of oxidative stress (nitrotyrosine and heme oxygenase-1 expression), inflammation (interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) expression), collagen (COL) and smooth muscle in the lungs; we also assessed lung structure. We quantified macrophages in lung tissue (at P7d) and leukocytes in BALF (at P56d). At P7d, TJ increased pulmonary TAC and COL1a1 expression and attenuated the hyperoxia-induced increase in nitrotyrosine and macrophage influx; however, changes in lung structure were not affected. At P56d, TJ increased TAC, decreased oxidative stress and reversed the hyperoxia-induced increase in bronchiolar smooth muscle. Additionally, TJ alone decreased IL-1 beta expression, but following hyperoxia TJ increased TNF-alpha expression and did not alter the hyperoxia-induced increase in leukocyte number. We conclude that TJ supplementation during and after neonatal exposure to hyperoxia protects the lung from some but not all aspects of hyperoxia-induced injury, but may also have adverse side-effects. The effects of TJ are likely due to elevation of circulating antioxidant concentrations.	[Bouch, Sheena; Harding, Richard; O'Reilly, Megan; Sozo, Foula] Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Melbourne, Vic, Australia; [Bouch, Sheena; Harding, Richard; O'Reilly, Megan; Sozo, Foula] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia; [Wood, Lisa G.] Univ Newcastle, Hunter Med Res Inst, Ctr Asthma & Resp Dis, Newcastle, NSW, Australia; [Bouch, Sheena] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Toronto, ON, Canada; [O'Reilly, Megan] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	Monash University; Monash University; Hunter Medical Research Institute; University of Newcastle; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta	Bouch, S (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Toronto, ON, Canada.	sheena.bouch@sickkids.ca		Wood, Lisa/0000-0002-0941-9225	National Health and Medical Research Council of Australia [606789]; Monash University, Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Monash University, Australia(Monash University)	This study was supported by the National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au) Program Grant #606789 and Monash University, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2000, CAN MED ASSOC J, V163, P739; Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Auten RL, 2009, AM J PHYSIOL-LUNG C, V297, pL134, DOI 10.1152/ajplung.00112.2009; BAI A, 1994, J APPL PHYSIOL, V77, P1011, DOI 10.1152/jappl.1994.77.2.1011; Bara I, 2010, EUR RESPIR J, V36, P1174, DOI 10.1183/09031936.00019810; BARUA AB, 1993, J CHROMATOGR-BIOMED, V617, P257, DOI 10.1016/0378-4347(93)80496-Q; Been JV, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001596; Belik J, 2003, J APPL PHYSIOL, V94, P2303, DOI 10.1152/japplphysiol.00820.2002; Berger J, 2014, AM J PHYSL LUNG CELL; Berger TM, 1998, PEDIATR RES, V43, P719, DOI 10.1203/00006450-199806000-00002; Berkelhamer SK, 2014, ANTIOXID REDOX SIGN, V21, P1837, DOI 10.1089/ars.2013.5515; Berkelhamer SK, 2013, FREE RADICAL BIO MED, V61, P51, DOI 10.1016/j.freeradbiomed.2013.03.003; Bouayed J, 2010, OXID MED CELL LONGEV, V3, P228, DOI 10.4161/oxim.3.4.12858; Bouch S, 2015, AM J PHYSIOL-LUNG C, V309, pL488, DOI 10.1152/ajplung.00359.2014; Brion LP., 2003, COCHRANE DB SYST REV, V(4), pCd003665, DOI [10.1002/14651858.CD003665, DOI 10.1002/14651858.CD003665]; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Chow SW, 2013, REPORT AUSTR NZ NEON; Clark RH, 2001, J PEDIATR-US, V139, P478, DOI 10.1067/mpd.2001.118201; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Davis JM, 2010, SEMIN FETAL NEONAT M, V15, P191, DOI 10.1016/j.siny.2010.04.001; Denis K, 2001, PEDIATR RES, V50, P515, DOI 10.1203/00006450-200110000-00015; Doyle LW, 2006, PEDIATRICS, V118, P108, DOI 10.1542/peds.2005-2522; Doyle LW, 2006, PEDIATR PULM, V41, P570, DOI 10.1002/ppul.20412; Erdman JW, 2009, ARCH BIOCHEM BIOPHYS, V483, P229, DOI 10.1016/j.abb.2008.10.022; Farstad T, 2011, ACTA PAEDIATR, V100, P53, DOI 10.1111/j.1651-2227.2010.01959.x; Gessner BD, 2007, THORAX, V62, P231, DOI 10.1136/thx.2005.053363; Gross SJ, 1998, J PEDIATR-US, V133, P188, DOI 10.1016/S0022-3476(98)70219-7; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Hazlewood LC, 2011, J NUTR BIOCHEM, V22, P95, DOI 10.1016/j.jnutbio.2009.12.003; HERSHENSON MB, 1992, AM REV RESPIR DIS, V146, P1294, DOI 10.1164/ajrccm/146.5_Pt_1.1294; Husari Ahmad, 2014, BMC Res Notes, V7, P664, DOI 10.1186/1756-0500-7-664; James ML, 2013, AM J PHYSIOL-LUNG C, V304, pL803, DOI 10.1152/ajplung.00257.2012; Kilbride HW, 2003, J PEDIATR-US, V143, P488, DOI 10.1067/S0022-3476(03)00413-X; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Korhonen P, 2004, ACTA PAEDIATR, V93, P316, DOI 10.1080/08035250410023593; Landete JM, 2013, CRIT REV FOOD SCI, V53, P706, DOI 10.1080/10408398.2011.555018; LANGLEY SC, 1992, COMP BIOCHEM PHYS A, V103, P793, DOI 10.1016/0300-9629(92)90183-Q; Lee JW, 2011, CURR OPIN PEDIATR, V23, P161, DOI 10.1097/MOP.0b013e3283423e51; Mantell LL, 1999, ANN NY ACAD SCI, V887, P171, DOI 10.1111/j.1749-6632.1999.tb07931.x; Maritz GS, 2011, PEDIATR PULM, V46, P976, DOI 10.1002/ppul.21462; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; McGrath-Morrow SA, 2004, AM J RESP CELL MOL, V30, P635, DOI 10.1165/rcmb.2003-0049OC; McGrath-Morrow SA, 2001, AM J RESP CELL MOL, V25, P150, DOI 10.1165/ajrcmb.25.2.4362; McGrath-Morrow SA, 2011, AM J RESP CELL MOL, V45, P610, DOI 10.1165/rcmb.2010-0259OC; Nagato AC, 2012, INT J EXP PATHOL, V93, P269, DOI 10.1111/j.1365-2613.2012.00823.x; O'Reilly M, 2014, ANAT REC, V297, P758, DOI 10.1002/ar.22867; O'Reilly M, 2014, NEONATOLOGY, V105, P39, DOI 10.1159/000355641; O'Reilly M, 2009, AM J PHYSIOL-LUNG C, V297, pL992, DOI 10.1152/ajplung.00099.2009; Ozdemir OM, 2014, PEDIAT NEONATOL; Poggi C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/721043; Rozycki HJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1222, DOI 10.1152/ajplung.00230.2001; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; SAETTA M, 1985, AM REV RESPIR DIS, V132, P894; Shi J, 2000, CRIT REV BIOTECHNOL, V20, P293, DOI 10.1080/07388550091144212; Smith LJ, 2008, PEDIATRICS, V122, pE287, DOI 10.1542/peds.2007-3657; Speer CP, 2006, J PERINATOL, V26, pS57, DOI 10.1038/sj.jp.7211476; Sumi Yuki, 2007, Allergol Int, V56, P341, DOI 10.2332/allergolint.R-07-153; ter Horst Simone A J, 2006, BMC Pulm Med, V6, P8, DOI 10.1186/1471-2466-6-8; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Trembath A, 2012, CLIN PERINATOL, V39, P585, DOI 10.1016/j.clp.2012.06.014; Tyson JE, 1999, NEW ENGL J MED, V340, P1962, DOI 10.1056/NEJM199906243402505; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Veness-Meehan KA, 2000, PEDIATR RES, V48, P434, DOI 10.1203/00006450-200010000-00004; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Weibel ER, 1963, MORPHOMETRY OF THE H; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wood LG, 2008, FREE RADICAL RES, V42, P94, DOI 10.1080/10715760701767307; Yee M, 2009, AM J PHYSIOL-LUNG C, V297, pL641, DOI 10.1152/ajplung.00023.2009; Zuberi RI, 2004, AM J PATHOL, V165, P2045, DOI 10.1016/S0002-9440(10)63255-5	70	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159633	10.1371/journal.pone.0159633	http://dx.doi.org/10.1371/journal.pone.0159633			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438045	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100059
J	Narayanan, V; Veeramuthu, V; Ahmad-Annuar, A; Ramli, N; Waran, V; Chinna, K; Bondi, MW; Delano-Wood, L; Ganesan, D				Narayanan, Vairavan; Veeramuthu, Vigneswaran; Ahmad-Annuar, Azlina; Ramli, Norlisah; Waran, Vicknes; Chinna, Karuthan; Bondi, Mark William; Delano-Wood, Lisa; Ganesan, Dharmendra			Missense Mutation of Brain Derived Neurotrophic Factor (BDNF) Alters Neurocognitive Performance in Patients with Mild Traumatic Brain Injury: A Longitudinal Study	PLOS ONE			English	Article							FACTOR VAL66MET POLYMORPHISM; APOLIPOPROTEIN-E POLYMORPHISM; FACTOR GENE; VAL(66)MET POLYMORPHISM; HIPPOCAMPAL ACTIVITY; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; MEMORY FORMATION; RAT HIPPOCAMPUS; ASSOCIATION	The predictability of neurocognitive outcomes in patients with traumatic brain injury is not straightforward. The extent and nature of recovery in patients with mild traumatic brain injury (mTBI) are usually heterogeneous and not substantially explained by the commonly known demographic and injury-related prognostic factors despite having sustained similar injuries or injury severity. Hence, this study evaluated the effects and association of the Brain Derived Neurotrophic Factor (BDNF) missense mutations in relation to neurocognitive performance among patients with mTBI. 48 patients with mTBI were prospectively recruited and MRI scans of the brain were performed within an average 10.1 (SD 4.2) hours post trauma with assessment of their neuropsychological performance post full Glasgow Coma Scale (GCS) recovery. Neurocognitive assessments were repeated again at 6 months follow-up. The paired t-test, Cohen's d effect size and repeated measure ANOVA were performed to delineate statistically significant differences between the groups [wildtype G allele (Val homozygotes) vs. minor A allele (Met carriers)] and their neuropsychological performance across the time point (T-1 = baseline/admission vs. T-2 = 6th month follow-up). Minor A allele carriers in this study generally performed more poorly on neuropsychological testing in comparison wildtype G allele group at both time points. Significant mean differences were observed among the wildtype group in the domains of memory (M = -11.44, SD = 10.0, p = .01, d = 1.22), executive function (M = -11.56, SD = 11.7, p = .02, d = 1.05) and overall performance (M = -6.89 SD = 5.3, p = .00, d = 1.39), while the minor A allele carriers showed significant mean differences in the domains of attention (M = -11.0, SD = 13.1, p = .00, d = .86) and overall cognitive performance ( M = -5.25, SD = 8.1, p = .01, d = .66). The minor A allele carriers in comparison to the wildtype G allele group, showed considerably lower scores at admission and remained impaired in most domains across the timepoints, although delayed signs of recovery were noted to be significant in the domains attention and overall cognition. In conclusion, the current study has demonstrated the role of the BDNF rs6265 Val66Met polymorphism in influencing specific neurocognitive outcomes in patients with mTBI. Findings were more detrimentally profound among Met allele carriers.	[Narayanan, Vairavan; Veeramuthu, Vigneswaran; Waran, Vicknes; Ganesan, Dharmendra] Univ Malaya, Fac Med, Dept Surg, Div Neurosurg, Kuala Lumpur, Wilayah Perseku, Malaysia; [Ahmad-Annuar, Azlina] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Wilayah Perseku, Malaysia; [Ramli, Norlisah] Univ Malaya, Res Imaging Ctr, Kuala Lumpur, Wilayah Perseku, Malaysia; [Chinna, Karuthan] Univ Malaya, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Wilayah Perseku, Malaysia; [Bondi, Mark William; Delano-Wood, Lisa] VA San Diego Healthcare Syst, San Diego, CA USA; [Bondi, Mark William; Delano-Wood, Lisa] Univ Calif San Diego, Dept Psychiat, San Diego, CA USA	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Narayanan, V; Veeramuthu, V (corresponding author), Univ Malaya, Fac Med, Dept Surg, Div Neurosurg, Kuala Lumpur, Wilayah Perseku, Malaysia.	nvairavan@um.edu.my; vicveera@gmail.com	GANESAN, DHARMENDRA/B-8437-2010; RAMLI, NORLISAH MOHD/G-5209-2010; Veeramuthu, Vigneswaran/F-2220-2015; AHMAD ANNUAR, AZLINA/B-8305-2010; NARAYANAN, VAIRAVAN/B-9191-2010; Mathaneswaran, Vickneswaran/E-5180-2010	GANESAN, DHARMENDRA/0000-0003-1595-3659; RAMLI, NORLISAH MOHD/0000-0001-7497-8093; Veeramuthu, Vigneswaran/0000-0003-2052-0858; AHMAD ANNUAR, AZLINA/0000-0001-6329-4366; NARAYANAN, VAIRAVAN/0000-0002-1118-5042; 	University Malaya Research Grant (UMRG) [RG447-12HTM]; High Impact Research Grant of University of Malaya [HIR-UM.C/625/1/HIRMOHE/12]	University Malaya Research Grant (UMRG); High Impact Research Grant of University of Malaya	This study was partially funded by University Malaya Research Grant (UMRG; RG447-12HTM) (to VN)-Link: http://umresearch.um.edu.my/; High Impact Research Grant of University of Malaya (HIR-UM.C/625/1/HIRMOHE/12) (VW)-Link: http://hir.um.edu.my/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Ashman TA, 2006, MT SINAI J MED, V73, P999; Bales James W, 2010, Open Drug Discov J, V2, P119; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850; Bennett ER, 2016, TRANSLATIONAL RES TR; Beste C, 2010, J NEUROSCI, V30, P10727, DOI 10.1523/JNEUROSCI.2493-10.2010; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Chao HM, 2008, AM J MED GENET B, V147B, P505, DOI 10.1002/ajmg.b.30619; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Comings DE, 1996, PHARMACOGENETICS, V6, P223, DOI 10.1097/00008571-199606000-00004; Coronado V. G., 2011, SURVEILLANCE TRAUMAT; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; DEKOSKY ST, 1998, SEMIN CLIN NEUROPSYC, V3, P176; Dennis NA, 2011, HIPPOCAMPUS, V21, P980, DOI 10.1002/hipo.20809; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dutcher SA, 2001, NEUROL RES, V23, P203, DOI 10.1179/016164101101198343; Ebstein RP, 2000, EUR J PHARMACOL, V410, P205, DOI 10.1016/S0014-2999(00)00852-9; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Failla M.D., 2015, NEUROREHABIL NEURAL; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Gajewski PD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.010; Getzmann S, 2013, NEUROIMAGE, V64, P290, DOI 10.1016/j.neuroimage.2012.08.079; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799; Hartman RE, 2002, J NEUROSCI, V22, P10083; Hashimoto R, 2008, NEUROSCI RES, V61, P360, DOI 10.1016/j.neures.2008.04.003; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Hong CJ, 2011, BRAIN RES BULL, V86, P287, DOI 10.1016/j.brainresbull.2011.08.019; Horch HW, 1999, NEURON, V23, P353; Huang CC, 2014, PSYCHONEUROENDOCRINO, V39, P94, DOI 10.1016/j.psyneuen.2013.09.027; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Jonsson EG, 2006, PROG NEURO-PSYCHOPH, V30, P924, DOI 10.1016/j.pnpbp.2006.02.008; Kang JI, 2010, NEUROPHARMACOLOGY, V58, P1109, DOI 10.1016/j.neuropharm.2010.02.001; Karpova NN, 2014, NEUROPHARMACOLOGY, V76, P709, DOI 10.1016/j.neuropharm.2013.04.002; Kauppi K, 2013, NEUROPSYCHOLOGIA, V51, P2462, DOI 10.1016/j.neuropsychologia.2012.11.028; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; Kurowski BG, 2015, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.0000000000000162, DOI 10.1097/HTR.00000000000001621545968315586465]; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Laurer HL, 2001, CURR PHARM DESIGN, V7, P1505, DOI 10.2174/1381612013397285; Lin WJ, 2013, FRONT ENDOCRINOL, P4; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Martinez-Lucas P, 2005, INTENS CARE MED, V31, P1168, DOI 10.1007/s00134-005-2715-0; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McAllister TW, 2014, HDB CLIN NEUROL, V128, P723; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Mohajeri MH, 2012, BRAIN RES BULL, V88, P429, DOI 10.1016/j.brainresbull.2011.12.003; Morley KI, 2001, BEHAV GENET, V31, P511, DOI 10.1023/A:1013337209957; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Ninan I, 2014, NEUROPHARMACOLOGY, V76, P684, DOI 10.1016/j.neuropharm.2013.04.011; Okada T, 2006, MOL PSYCHIATR, V11, P695, DOI 10.1038/sj.mp.4001822; Parasuraman R, 2002, NEUROPSYCHOLOGY, V16, P254, DOI 10.1037//0894-4105.16.2.254; Perkovic MN, 2014, PSYCHOPHARMACOLOGY, V231, P3757, DOI 10.1007/s00213-014-3515-4; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Pivac N, 2009, CROAT MED J, V50, P43, DOI 10.3325/cmj.2009.50.43; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Quan N, 2002, HISTOL HISTOPATHOL, V17, P273, DOI 10.14670/HH-17.273; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Rybakowski JK, 2003, BIPOLAR DISORD, V5, P468, DOI 10.1046/j.1399-5618.2003.00071.x; Rybakowski JK, 2006, MOL PSYCHIATR, V11, P122, DOI 10.1038/sj.mp.4001765; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Stam AH, 2009, J NEUROL NEUROSUR PS, V80, P1125, DOI 10.1136/jnnp.2009.177279; Stern R. A., 2003, NEUROPSYCHOLOGICAL A; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tost H, 2013, NEUROPSYCHOPHARMACOL, V38, P525, DOI 10.1038/npp.2012.214; UniProt Consortium, UNIPROTKB P23560 BDN; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; van Wingen G, 2010, NEUROIMAGE, V50, P1212, DOI 10.1016/j.neuroimage.2010.01.058; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194; Wang HY, 2013, NEURAL REGEN RES, V8, P843, DOI 10.3969/j.issn.1673-5374.2013.09.009; Wang JC, 2004, HUM MOL GENET, V13, P1903, DOI 10.1093/hmg/ddh194; Weese-Mayer DE, 2002, AM J MED GENET, V107, P306, DOI 10.1002/ajmg.10133; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; World Health Organization, 2013, WHO GLOB STAT REP RO; World Health Organization, 2009, GLOB STAT REP ROAD S; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; Yue JK, 2015, NEUROSURGERY, V62, P225	102	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158838	10.1371/journal.pone.0158838	http://dx.doi.org/10.1371/journal.pone.0158838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438599	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000380170100024
J	Yurist-Doutsch, S; Arrieta, MC; Tupin, A; Valdez, Y; Antunes, LCM; Yen, R; Finlay, BB				Yurist-Doutsch, Sophie; Arrieta, Marie-Claire; Tupin, Audrey; Valdez, Yanet; Antunes, L. Caetano M.; Yen, Ryan; Finlay, B. Brett			Nutrient Deprivation Affects Salmonella Invasion and Its Interaction with the Gastrointestinal Microbiota	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PATHOGENICITY ISLAND 2; INTESTINAL MICROBIOTA; GENE-EXPRESSION; CELLS; INFLAMMATION; COMMUNITIES; INFECTIONS; HOST; SURVIVAL	Salmonella enterica serovar Typhimurium (S. Typhimurium) is a foodborne enteric pathogen and a major cause of gastroenteritis in humans. It is known that molecules derived from the human fecal microbiota downregulate S. Typhimurium virulence gene expression and induce a starvation-like response. In this study, S. Typhimurium was cultured in minimal media to mimic starvation conditions such as that experienced by S. Typhimurium in the human intestinal tract, and the pathogen's virulence in vitro and in vivo was measured. S. Typhimurium cultured in minimal media displayed a reduced ability to invade human epithelial cells in a manner that was at least partially independent of the Salmonella Pathogenicity Island 1 (SPI-1) type III secretion system. Nutrient deprivation did not, however, alter the ability of S. Typhimurium to replicate and survive inside epithelial cells. In a murine model of S. Typhimurium-induced gastroenteritis, prior cultivation in minimal media did not alter the pathogen's ability to colonize mice, nor did it affect levels of gastrointestinal inflammation. Upon examining the post-infection fecal gastrointestinal microbiota, we found that specifically in the 129Sv/ImJ murine strain S. Typhimurium cultured in minimal media induced differential microbiota compositional shifts compared to that of S. Typhimurium cultured in rich media. Together these findings demonstrate that S. Typhimurium remains a potent pathogen even in the face of nutritional deprivation, but nevertheless that nutrient deprivation encountered in this environment elicits significant changes in the bacterium genetic programme, as well as its capacity to alter host microbiota composition.	[Yurist-Doutsch, Sophie; Arrieta, Marie-Claire; Tupin, Audrey; Valdez, Yanet; Yen, Ryan; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Yurist-Doutsch, Sophie; Arrieta, Marie-Claire; Tupin, Audrey; Valdez, Yanet; Yen, Ryan; Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Antunes, L. Caetano M.] Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Inst Nacl Ciencia & Tecnol Inovacao Doencas Negli, BR-21040900 Rio De Janeiro, RJ, Brazil; [Antunes, L. Caetano M.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, BR-22780194 Rio De Janeiro, RJ, Brazil; [Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of British Columbia	Finlay, BB (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada.; Finlay, BB (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.; Finlay, BB (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada.	bfinlay@interchange.ubc.ca	Antunes, Luis Caetano Martha/P-4988-2019; Arrieta, Marie-Claire/AAU-2427-2021		Canadian Institutes of Health Research [CIHR-27R18706]; Science without Borders program of the National Council of Technological and Scientific Development (CNPq-Brazil); Michael Smith Foundation for Health research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Science without Borders program of the National Council of Technological and Scientific Development (CNPq-Brazil); Michael Smith Foundation for Health research(Michael Smith Foundation for Health Research)	The work in BBF lab is funded by Canadian Institutes of Health Research (CIHR-27R18706). LCMA was supported by a fellowship from the Science without Borders program of the National Council of Technological and Scientific Development (CNPq-Brazil). YV was supported by a fellowship from the Michael Smith Foundation for Health research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, RES VET SCI, V25, P139; Antunes LCM, 2014, MBIO, V5, DOI 10.1128/mBio.01183-14; Antunes LCM, 2011, ANTIMICROB AGENTS CH, V55, P1494, DOI 10.1128/AAC.01664-10; Bajaj V, 1995, MOL MICROBIOL, V18, P715, DOI 10.1111/j.1365-2958.1995.mmi_18040715.x; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Blair JMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063912; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Ferreira RBR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020338; Forbester JL, 2015, INFECT IMMUN, V83, P2926, DOI 10.1128/IAI.00161-15; GALAN JE, 1991, INFECT IMMUN, V59, P2901; GALAN JE, 1992, J BACTERIOL, V174, P4338; Gill N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049646; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; Hartmann M, 2012, ISME J, V6, P2199, DOI 10.1038/ismej.2012.84; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McKenney PT, 2015, CELL, V163, P1326, DOI 10.1016/j.cell.2015.11.032; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NELSON K, 1991, P NATL ACAD SCI USA, V88, P6667, DOI 10.1073/pnas.88.15.6667; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; RICCA E, 1990, NUCLEIC ACIDS RES, V18, P1290, DOI 10.1093/nar/18.5.1290; Saito N, 2010, CURR OPIN MICROBIOL, V13, P358, DOI 10.1016/j.mib.2010.04.006; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Singh P, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0109-2; SONTI RV, 1989, GENETICS, V123, P19; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Valdez Y, 2009, CELL MICROBIOL, V11, P351, DOI 10.1111/j.1462-5822.2008.01258.x; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Yurist-Doutsch S, 2014, ANNU REV GENET, V48, P361, DOI 10.1146/annurev-genet-120213-092421	45	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159676	10.1371/journal.pone.0159676	http://dx.doi.org/10.1371/journal.pone.0159676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437699	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100065
J	Conteduca, V; Crabb, SJ; Jones, RJ; Caffo, O; Elliott, T; Scarpi, E; Fabbri, P; Derosa, L; Massari, F; Numico, G; Zarif, S; Hanna, C; Maines, F; Joyce, H; Lolli, C; De Giorgi, U				Conteduca, Vincenza; Crabb, Simon J.; Jones, Robert J.; Caffo, Orazio; Elliott, Tony; Scarpi, Emanuela; Fabbri, Paolo; Derosa, Lisa; Massari, Francesco; Numico, Gianmauro; Zarif, Sunnya; Hanna, Catherine; Maines, Francesca; Joyce, Helen; Lolli, Cristian; De Giorgi, Ugo			Persistent Neutrophil to Lymphocyte Ratio > 3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INCREASED SURVIVAL; CHEMOTHERAPY; INFLAMMATION; ABIRATERONE; DOCETAXEL; INTERLEUKIN-6; MECHANISMS; MEN	The baseline value of neutrophil to lymphocyte ratio (NLR) has been found to be prognostic in patients with metastatic castration resistant prostate cancer (CRPC). We evaluated the impact of baseline NLR and its change in patients receiving enzalutamide. We included consecutive metastatic CRPC patients treated with enzalutamide after docetaxel and studies the change of NLR (>3 vs <= 3) after week 4 and 12 weeks. Progression-free survival (PFS), overall survival (OS) and their 95% Confidence Intervals (95% CI) were estimated by the Kaplan-Meier method and compared with the log-rank test. The impact of NLR on PFS and OS was evaluated by Cox regression analyses and on prostate-specific antigen response rates (PSA RR; PSA decline >50%) were evaluated by binary logistic regression. Data collected on 193 patients from 9 centers were evaluated. Median age was 73.1 years (range, 42.8-90.7). The median baseline NLR was 3.2. The median PFS was 3.2 months (95% CI = 2.7-4.2) in patients with baseline NLR >3 and 7.4 months (95% CI = 5.5-9.7) in those with NLR <= 3, p < 0.0001. The median OS was 10.4 months (95% CI = 6.5-14.9) in patients with baseline NLR >3 and 16.9 months (95% CI = 11.2-20.9) in those with baseline NLR <= 3, p < 0.0001. In multivariate analysis, changes in NLR at 4 weeks were significant predictors of both PFS [hazard ratio (HR) 1.24, 95% confidence interval (95% CI) 1.07-1.42, p = 0.003, and OS (HR 1.29, 95% CI 1.10-1.51, p = 0.001. A persistent NLR >3 during treatment with enzalutamide seems to have both prognostic and predictive value in CRPC patients.	[Conteduca, Vincenza; Scarpi, Emanuela; Lolli, Cristian; De Giorgi, Ugo] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, Italy; [Crabb, Simon J.; Zarif, Sunnya] Univ Southampton, Canc Sci Unit, Southampton, Hants, England; [Jones, Robert J.; Hanna, Catherine] Univ Glasgow, Beatson West Scotland Canc Ctr, Inst Canc Sci, Glasgow, Lanark, Scotland; [Caffo, Orazio; Maines, Francesca] Santa Chiara Hosp, Dept Med Oncol, Trento, Italy; [Elliott, Tony; Joyce, Helen] Christie Hosp, Manchester, Lancs, England; [Fabbri, Paolo] Cervesi Hosp, Oncol Unit, Cattolica, Italy; [Derosa, Lisa] Santa Chiara Hosp, Dept Med Oncol, Pisa, Italy; [Massari, Francesco] Inst Gustave Roussy, Villejuif, France; [Numico, Gianmauro] Azienda USL Valle Aosta, Med Oncol & Hematol, Aosta, Italy	IRCCS Meldola (IRST); University of Southampton; Beatson Oncology Centre; University of Glasgow; Santa Chiara Hospital; Christie NHS Foundation Trust; Christie Hospital; Santa Chiara Hospital; UNICANCER; Gustave Roussy; Azienda USL della Valle d'Aosta	De Giorgi, U (corresponding author), IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, Italy.	ugo.degiorgi@irst.emr.it	Numico, Gianmauro/AAE-4489-2020; Scarpi, Emanuela/AAD-7036-2019; Lolli, Cristian/AAC-4116-2022; DEROSA, LISA/E-6814-2015; Caffo, Orazio/AAE-5485-2020; Massari, Francesco/K-7239-2016; conteduca, vincenza/E-8640-2019	Numico, Gianmauro/0000-0003-3253-2960; Scarpi, Emanuela/0000-0001-7230-9267; Caffo, Orazio/0000-0001-7968-2531; Massari, Francesco/0000-0001-6476-6871; conteduca, vincenza/0000-0002-6921-714X; Derosa, Lisa/0000-0003-0527-2964; Crabb, Simon/0000-0003-3521-9064	ESMO Translational Research Fellowships	ESMO Translational Research Fellowships	Vincenza Conteduca acknowledges support from an ESMO Translational Research Fellowships 2014-2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Vincenza Conteduca acknowledges support from an ESMO Translational Research Fellowships 2014-2016.	Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Beer TM, 2008, CANCER, V112, P2377, DOI 10.1002/cncr.23461; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Di Mitri D, 2014, NATURE, V515, P134, DOI 10.1038/nature13638; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; FAUCI AS, 1975, IMMUNOLOGY, V28, P669; Gannon PO, 2009, J IMMUNOL METHODS, V348, P9, DOI 10.1016/j.jim.2009.06.004; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Keizman D, 2012, ONCOLOGIST, V17, P1508, DOI 10.1634/theoncologist.2012-0125; Leibowitz-Amit R, 2014, ANN ONCOL, V25, P657, DOI 10.1093/annonc/mdt581; Lorente D, 2015, ANN ONCOL, V26, P750, DOI 10.1093/annonc/mdu587; Mahon KL, 2015, BRIT J CANCER, V112, P1340, DOI 10.1038/bjc.2015.74; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McDonald AC, 2014, PROSTATE, V74, P561, DOI 10.1002/pros.22782; Nuhn P, 2014, BJU INT, V114, pE11, DOI 10.1111/bju.12531; Ohno Y, 2012, J UROLOGY, V187, P411, DOI 10.1016/j.juro.2011.10.026; Olmos D, 2012, LANCET ONCOL, V13, P1114, DOI 10.1016/S1470-2045(12)70372-8; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ross RW, 2012, LANCET ONCOL, V13, P1105, DOI 10.1016/S1470-2045(12)70263-2; Rossi L, 2015, ANN SURG ONCOL, V22, P1377, DOI 10.1245/s10434-014-4097-4; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shafique K, 2012, PROSTATE CANCER P D, V15, P195, DOI 10.1038/pcan.2011.60; Sonpavde G, 2014, CLIN GENITOURIN CANC, V12, P317, DOI 10.1016/j.clgc.2014.03.005; Stark JR, 2009, INT J CANCER, V124, P2683, DOI 10.1002/ijc.24241; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, P1, DOI [10.1093/jnci/dju124, DOI 10.1093/JNCI/DJU124]; Wilson C, 2008, J PHARMACOL EXP THER, V327, P746, DOI 10.1124/jpet.108.143826; Zhao LL, 2009, CANCER RES, V69, P7696, DOI 10.1158/0008-5472.CAN-08-4901	36	42	43	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158952	10.1371/journal.pone.0158952	http://dx.doi.org/10.1371/journal.pone.0158952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434372	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000380169600024
J	Lin, BC; Chen, BK; Gao, YC; Tse, CK; Dong, CF; Miao, LX; Wang, BH				Lin, Benchuan; Chen, Bokui; Gao, Yachun; Tse, Chi K.; Dong, Chuanfei; Miao, Lixin; Wang, Binghong			Advanced Algorithms for Local Routing Strategy on Complex Networks	PLOS ONE			English	Article							INTELLIGENT TRAFFIC SYSTEMS; INFORMATION FEEDBACK; COMMUNICATION; BREAKDOWN	Despite the significant improvement on network performance provided by global routing strategies, their applications are still limited to small-scale networks, due to the need for acquiring global information of the network which grows and changes rapidly with time. Local routing strategies, however, need much less local information, though their transmission efficiency and network capacity are much lower than that of global routing strategies. In view of this, three algorithms are proposed and a thorough investigation is conducted in this paper. These algorithms include a node duplication avoidance algorithm, a next-nearest-neighbor algorithm and a restrictive queue length algorithm. After applying them to typical local routing strategies, the critical generation rate of information packets R-c increases by over ten-fold and the average transmission time < T > decreases by 70-90 percent, both of which are key physical quantities to assess the efficiency of routing strategies on complex networks. More importantly, in comparison with global routing strategies, the improved local routing strategies can yield better network performance under certain circumstances. This is a revolutionary leap for communication networks, because local routing strategy enjoys great superiority over global routing strategy not only in terms of the reduction of computational expense, but also in terms of the flexibility of implementation, especially for large-scale networks.	[Lin, Benchuan; Wang, Binghong] Univ Sci & Technol China, Dept Modern Phys, Hefei, Peoples R China; [Chen, Bokui] Natl Univ Singapore, Sch Comp, Singapore, Singapore; [Chen, Bokui] Macau Univ Sci & Technol, Fac Informat Technol, Macau, Peoples R China; [Gao, Yachun] Univ Elect Sci & Technol China, Sch Phys Elect, Chengdu, Peoples R China; [Tse, Chi K.] Hong Kong Polytech Univ, Elect & Informat Engn Dept, Kowloon, Hong Kong, Peoples R China; [Miao, Lixin] Tsinghua Univ, Grad Sch Shenzhen, Div Logist & Transportat, Shenzhen, Peoples R China; [Miao, Lixin] Tsinghua Berkeley Shenzhen Inst, Ctr Environm Sci & New Energy Technol, Shenzhen, Peoples R China; [Dong, Chuanfei] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; National University of Singapore; Macau University of Science & Technology; University of Electronic Science & Technology of China; Hong Kong Polytechnic University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; University of Michigan System; University of Michigan	Chen, BK (corresponding author), Natl Univ Singapore, Sch Comp, Singapore, Singapore.; Chen, BK (corresponding author), Macau Univ Sci & Technol, Fac Informat Technol, Macau, Peoples R China.	chenssx@mail.ustc.edu.cn	Lin, Benchuan/F-6081-2019; Dong, Chuanfei/E-6485-2010	Dong, Chuanfei/0000-0002-8990-094X; Tse, Chi/0000-0002-0462-3999; hu, xiao/0000-0001-9930-778X	Singapore Ministry of Education Research Grant [MOE2013-T2-2-033]; Hong Kong Polytechnic University Grant [G-YBAT]; National Natural Science Foundation of China [61370218]	Singapore Ministry of Education Research Grant(Ministry of Education, Singapore); Hong Kong Polytechnic University Grant(Hong Kong Polytechnic University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Singapore Ministry of Education Research Grant (Grant No. MOE2013-T2-2-033), Hong Kong Polytechnic University Grant (Grant No. G-YBAT), and the National Natural Science Foundation of China (Grant No. 61370218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Singapore Ministry of Education Research Grant (MOE2013-T2-2-033), Hong Kong Polytechnic University Grant (G-YBAT) and National Natural Science Foundation of China (61370218).	Adamic LA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046135; Arenas A, 2001, PHYS REV LETT, V86, P3196, DOI 10.1103/PhysRevLett.86.3196; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bonabeau E, 2000, NATURE, V406, P39, DOI 10.1038/35017500; Chen BK, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/14001; Chen BK, 2012, COMPUT PHYS COMMUN, V183, P2081, DOI 10.1016/j.cpc.2012.05.010; Chen BK, 2012, PHYSICA A, V391, P2730, DOI 10.1016/j.physa.2011.12.032; Chen BK, 2011, INT J MOD PHYS C, V22, P849, DOI 10.1142/S0129183111016658; Cholvi V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.035103; Guimera R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026704; Guimera R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248701; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066109; Li WT, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/64001; Ling X, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016113; Ling X, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066110; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016101; Wang WX, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066702; Wang WX, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026111; Yan G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046108; Zhao L, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.035101	20	10	11	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0156756	10.1371/journal.pone.0156756	http://dx.doi.org/10.1371/journal.pone.0156756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434502	Green Published, gold			2022-12-27	WOS:000380169600003
J	Ehrenpreis, ED; Zhou, Y; Alexoff, A; Melitas, C				Ehrenpreis, Eli D.; Zhou, Ying; Alexoff, Aimee; Melitas, Constantine			Effect of the Diagnosis of Inflammatory Bowel Disease on Risk-Adjusted Mortality in Hospitalized Patients with Acute Myocardial Infarction, Congestive Heart Failure and Pneumonia	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RATES	Introduction Measurement of mortality in patients with acute myocardial infarction (AMI), congestive heart failure (CHF) and pneumonia (PN) is a high priority since these are common reasons for hospitalization. However, mortality in patients with inflammatory bowel disease (IBD) that are hospitalized for these common medical conditions is unknown. Methods A retrospective review of the 2005-2011 National Inpatient Sample (NIS), (approximately a 20% sample of discharges from community hospitals) was performed. A dataset for all patients with ICD-9-CM codes for primary diagnosis of acute myocardial infarction, pneumonia or congestive heart failure with a co-diagnosis of IBD, Crohn's disease (CD) or ulcerative colitis (UC). 1: 3 propensity score matching between patients with co-diagnosed disease vs. controls was performed. Continuous variables were compared between IBD and controls. Categorical variables were reported as frequency (percentage) and analyzed by Chi-square tests or Fisher's exact test for co-diagnosed disease vs. control comparisons. Propensity scores were computed through multivariable logistic regression accounting for demographic and hospital factors. In-hospital mortality between the groups was compared. Results Patients with IBD, CD and UC had improved survival after AMI compared to controls. 94/2280 (4.1%) of patients with IBD and AMI died, compared to 251/5460 (5.5%) of controls, p = 0.01. This represents a 25% improved survival in IBD patients that were hospitalized with AMI. There was a 34% improved survival in patients with CD and AMI. There was a trend toward worsening survival in patients with IBD and CHF. Patients with CD and PN had improved survival compared to controls. 87/3362 (2.59%) patients with CD and PN died, compared to 428/10076 (4.25%) of controls, p < .0001. This represents a 39% improved survival in patients with CD that are hospitalized for PN. Conclusion IBD confers a survival benefit for patients hospitalized with AMI. A diagnosis of CD benefits survival in patients that are hospitalized with PN.	[Ehrenpreis, Eli D.; Zhou, Ying; Alexoff, Aimee; Melitas, Constantine] NorthShore Univ HealthSyst, Ctr Study Complex Dis, Evanston, IL 60201 USA	NorthShore University Health System	Ehrenpreis, ED (corresponding author), NorthShore Univ HealthSyst, Ctr Study Complex Dis, Evanston, IL 60201 USA.	ehrenpreis@gipharm.net	Ehrenpreis, Eli D/F-4586-2017	Ehrenpreis, Eli D/0000-0002-7209-729X; Melitas, Constantine/0000-0002-1166-0106	Keyser Family Fund	Keyser Family Fund	This study was funded in part by a grant by the Keyser Family Fund to the Center for the Study of Complex Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2013, J CROHNS COLITIS, V7, P107, DOI 10.1016/j.crohns.2012.02.015; [Anonymous], 2012, MED HOSP QUAL CHARB; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fang L, 2015, J GERIATR CARDIOL, V12, P305, DOI 10.11909/j.issn.1671-5411.2015.03.020; Fischer LM, 2004, AM J CARDIOL, V93, P198, DOI 10.1016/j.amjcard.2003.09.037; Fumery M, 2014, J CROHNS COLITIS, V8, P469, DOI 10.1016/j.crohns.2013.09.021; Hak AE, 2009, ARTHRIT CARE RES, V61, P1396, DOI 10.1002/art.24537; IEZZONI LI, 1992, JAMA-J AM MED ASSOC, V267, P2197, DOI 10.1001/jama.267.16.2197; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Long MD, 2013, AM J GASTROENTEROL, V108, P240, DOI 10.1038/ajg.2012.406; Mohammed AM, 2009, BMJ-BRIT MED J, V338, pb780, DOI [10.1136/bmj.b780, DOI 10.1136/BMJ.B780]; Murthy SK, 2011, AM J GASTROENTEROL, V106, P713, DOI 10.1038/ajg.2011.53; Normand SLT, 2007, STAT SCI, V22, P206, DOI 10.1214/088342307000000096; Okafor PN, 2015, DIGEST DIS SCI, V60, P3743, DOI 10.1007/s10620-015-3796-4; Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288; Osterman MT, 2011, CLIN GASTROENTEROL H, V9, P875, DOI 10.1016/j.cgh.2011.06.032; Owczarek D, 2014, WORLD J GASTROENTERO, V20, P53, DOI 10.3748/wjg.v20.i1.53; Sadowski M, 2011, EUROINTERVENTION, V6, P1068, DOI 10.4244/EIJV6I9A186; Shea KM, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu024; Vaughan- Sarrazin M, 2011, MED MED RES REV, V1; Vester-Andersen MK, 2014, AM J GASTROENTEROL, V109, P705, DOI 10.1038/ajg.2014.45; Zakroysky P, 2015, AM J MED, V128, P303, DOI 10.1016/j.amjmed.2014.10.033	26	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158926	10.1371/journal.pone.0158926	http://dx.doi.org/10.1371/journal.pone.0158926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427905	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300025
J	Shen, MM; Qu, L; Ma, M; Dou, TC; Lu, J; Guo, J; Hu, YP; Yi, GQ; Yuan, JW; Sun, CJ; Wang, KH; Yang, N				Shen, Manman; Qu, Liang; Ma, Meng; Dou, Taocun; Lu, Jian; Guo, Jun; Hu, Yuping; Yi, Guoqiang; Yuan, Jingwei; Sun, Congjiao; Wang, Kehua; Yang, Ning			Genome-Wide Association Studies for Comb Traits in Chickens	PLOS ONE			English	Article							ANDROGEN RECEPTOR; SEXUAL SELECTION; COMPLEX TRAITS; BROILER; TESTIS; WNT; ALLOCATION; ORNAMENTS; WEIGHTS; SIGNALS	The comb, as a secondary sexual character, is an important trait in chicken. Indicators of comb length (CL), comb height (CH), and comb weight (CW) are often selected in production. DNA-based marker-assisted selection could help chicken breeders to accelerate genetic improvement for comb or related economic characters by early selection. Although a number of quantitative trait loci (QTL) and candidate genes have been identified with advances in molecular genetics, candidate genes underlying comb traits are limited. The aim of the study was to use genome-wide association (GWA) studies by 600 K Affymetrix chicken SNP arrays to detect genes that are related to comb, using an F-2 resource population. For all comb characters, comb exhibited high SNP-based heritability estimates (0.61-0.69). Chromosome 1 explained 20.80% genetic variance, while chromosome 4 explained 6.89%. Independent univariate genome-wide screens for each character identified 127, 197, and 268 novel significant SNPs with CL, CH, and CW, respectively. Three candidate genes, VPS36, AR, and WNT11B, were determined to have a plausible function in all comb characters. These genes are important to the initiation of follicle development, gonadal growth, and dermal development, respectively. The current study provides the first GWA analysis for comb traits. Identification of the genetic basis as well as promising candidate genes will help us understand the underlying genetic architecture of comb development and has practical significance in breeding programs for the selection of comb as an index for sexual maturity or reproduction.	[Shen, Manman; Qu, Liang; Ma, Meng; Dou, Taocun; Lu, Jian; Guo, Jun; Hu, Yuping; Wang, Kehua] Chinese Acad Agr Sci, Layer Breeding & Prod, Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China; [Yi, Guoqiang; Yuan, Jingwei; Sun, Congjiao; Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing, Peoples R China; [Yi, Guoqiang; Yuan, Jingwei; Sun, Congjiao; Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, MOA Key Lab Anim Genet & Breeding, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; China Agricultural University; China Agricultural University	Wang, KH (corresponding author), Chinese Acad Agr Sci, Layer Breeding & Prod, Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China.	sqbreeding@126.com	沈, 曼曼/AAL-5661-2021; Shen, Manman/AAC-5554-2020	Shen, Manman/0000-0003-1923-861X; Yang, Ning/0000-0001-5772-3320	National Science & Technology Pillar Program during the 12th Five-year Plan Period [2012BAD39B0401]; China Agriculture Research Systems, PR China [CARS-41-K02]	National Science & Technology Pillar Program during the 12th Five-year Plan Period; China Agriculture Research Systems, PR China	This work was supported in part by the National Science & Technology Pillar Program during the 12th Five-year Plan Period (2012BAD39B0401), and China Agriculture Research Systems (CARS-41-K02, http://119.253.58.231/), PR China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the National Science & Technology Pillar Program during the 12th Five-year Plan Period (2012BAD39B0401), and China Agriculture Research Systems (CARS-41-K02, http://119.253.58.231/), PR China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors also gratefully acknowledge the staff of China Agricultural University for involvement in this program.	Abasht B, 2006, POULTRY SCI, V85, P2079, DOI 10.1093/ps/85.12.2079; Abdollahi-Arpanahi R, 2015, J ANIM BREED GENET, V132, P218, DOI 10.1111/jbg.12131; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boije H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050890; BORIS A, 1970, P SOC EXP BIOL MED, V134, P985; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Christian JL, 2000, CURR OPIN CELL BIOL, V12, P244, DOI 10.1016/S0955-0674(99)00082-4; Cornwallis CK, 2007, P ROY SOC B-BIOL SCI, V274, P583, DOI 10.1098/rspb.2006.3757; Cui XX, 2014, FRONT AGRIC SCI ENG, V1, P130, DOI 10.15302/J-FASE-2014013; Eitan Y, 1998, POULTRY SCI, V77, P1593, DOI 10.1093/ps/77.11.1593; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huang CK, 2016, J ENDOCRINOL, V229, pR1, DOI 10.1530/JOE-15-0518; Huang SX, 2015, ARCH DERMATOL RES, V307, P835, DOI 10.1007/s00403-015-1587-6; Imsland F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002775; JAAP RG, 1961, POULTRY SCI, V40, P354, DOI 10.3382/ps.0400354; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; JOHNSON K, 1993, BEHAV ECOL, V4, P254, DOI 10.1093/beheco/4.3.254; Johnsson M, 2014, MOL ECOL, V23, P2275, DOI 10.1111/mec.12723; Johnsson M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002914; Joseph NS, 2003, J APPL POULTRY RES, V12, P7, DOI 10.1093/japr/12.1.7; Kang L, 2012, MOL BIOL REP, V39, P3037, DOI 10.1007/s11033-011-1066-x; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Moro C, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0118706, DOI 10.1371/J0URNAL.P0NE.0118706]; Mukhtar N, 2012, WORLD POULTRY SCI J, V68, P425, DOI 10.1017/S0043933912000542; Ohlsson T, 2002, P ROY SOC B-BIOL SCI, V269, P21, DOI 10.1098/rspb.2001.1848; Parker TH, 2003, EVOLUTION, V57, P2157, DOI 10.1111/j.0014-3820.2003.tb00393.x; Pizzari T, 2003, NATURE, V426, P70, DOI 10.1038/nature02004; Pizzari T, 2003, EVOLUTION, V57, P1223, DOI 10.1111/j.0014-3820.2003.tb00331.x; Podisi BK, 2011, QUANTITATIVE TRAIT L; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Sakashita S, 2011, PATHOL INT, V61, P130, DOI 10.1111/j.1440-1827.2011.02644.x; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Shanbhag BA, 1996, GEN COMP ENDOCR, V101, P76, DOI 10.1006/gcen.1996.0009; SHARP PJ, 1979, J ENDOCRINOL, V80, P51, DOI 10.1677/joe.0.0800051; Shotelersuk V, 2006, CLEFT PALATE-CRAN J, V43, P152, DOI 10.1597/05-014.1; Sun CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137145; Sun CJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1795-7; TANDA N, 1995, BIOCHEM BIOPH RES CO, V211, P123, DOI 10.1006/bbrc.1995.1786; Tufvesson M, 1999, J ANIM BREED GENET, V116, P127, DOI 10.1046/j.1439-0388.1999.00179.x; Tyler NC, 2008, S AFR J ANIM SCI, V38, P153; Van Goor A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2601-x; van Kampen M, 1971, Int J Biometeorol, V15, P244, DOI 10.1007/BF01803906; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; VONSCHANTZ T, 1995, HEREDITY, V75, P518, DOI 10.1038/hdy.1995.168; Wang WH, 2019, ANIM GENET, V50, P175, DOI 10.1111/age.12346; Wolc A, 2014, J ANIM BREED GENET, V131, P173, DOI 10.1111/jbg.12086; Wright D, 2012, REPROD DOMEST ANIM, V47, P31, DOI 10.1111/j.1439-0531.2011.01963.x; Wright D, 2008, EVOLUTION, V62, P86, DOI 10.1111/j.1558-5646.2007.00281.x; Xie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030910; Xu G. F., 2003, GUANGXI SANHUANG, VFirst, P114; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yi G, 2015, ANIM GENET, V46, P148, DOI 10.1111/age.12267; Yi GQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1945-y; Yoshioka K, 2010, BRIT POULTRY SCI, V51, P185, DOI 10.1080/00071661003745810; Yu G, 2015, MOL CANCER RES, V13, P348, DOI 10.1158/1541-7786.MCR-14-0384-T; Yuan JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140615; Yuan JW, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0161-1; Yuan JW, 2015, POULTRY SCI, V94, P1470, DOI 10.3382/ps/pev122; ZELLER FJ, 1971, J REPROD FERTIL, V25, P125; Zhao JH, 2007, GAP GENETIC ANAL PAC; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; ZUK M, 1990, AM NAT, V136, P459, DOI 10.1086/285107	73	17	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159081	10.1371/journal.pone.0159081	http://dx.doi.org/10.1371/journal.pone.0159081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427764	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169300034
J	Fang, Y; Ding, Y; Feinstein, WP; Koppelman, DM; Moreno, J; Jarrell, M; Ramanujam, J; Brylinski, M				Fang, Ye; Ding, Yun; Feinstein, Wei P.; Koppelman, David M.; Moreno, Juana; Jarrell, Mark; Ramanujam, J.; Brylinski, Michal			GeauxDock: Accelerating Structure-Based Virtual Screening with Heterogeneous Computing	PLOS ONE			English	Article							FLEXIBLE LIGAND DOCKING; DRUG DISCOVERY; BINDING SITES; OPTIMIZATION; CHEMISTRY; SUBSTRATE; MODELS	Computational modeling of drug binding to proteins is an integral component of direct drug design. Particularly, structure-based virtual screening is often used to perform large-scale modeling of putative associations between small organic molecules and their pharmacologically relevant protein targets. Because of a large number of drug candidates to be evaluated, an accurate and fast docking engine is a critical element of virtual screening. Consequently, highly optimized docking codes are of paramount importance for the effectiveness of virtual screening methods. In this communication, we describe the implementation, tuning and performance characteristics of GeauxDock, a recently developed molecular docking program. GeauxDock is built upon the Monte Carlo algorithm and features a novel scoring function combining physics-based energy terms with statistical and knowledge-based potentials. Developed specifically for heterogeneous computing platforms, the current version of GeauxDock can be deployed on modern, multi-core Central Processing Units (CPUs) as well as massively parallel accelerators, Intel Xeon Phi and NVIDIA Graphics Processing Unit (GPU). First, we carried out a thorough performance tuning of the high-level framework and the docking kernel to produce a fast serial code, which was then ported to shared-memory multi-core CPUs yielding a near-ideal scaling. Further, using Xeon Phi gives 1.9x performance improvement over a dual 10-core Xeon CPU, whereas the best GPU accelerator, GeForce GTX 980, achieves a speedup as high as 3.5x. On that account, GeauxDock can take advantage of modern heterogeneous architectures to considerably accelerate structure-based virtual screening applications. GeauxDock is open-sourced and publicly available at www.brylinski.org/geauxdock and https://figshare.com/articles/geauxdock_tar_gz/3205249.	[Fang, Ye; Koppelman, David M.; Ramanujam, J.] Louisiana State Univ, Sch Elect Engn & Comp Sci, Baton Rouge, LA USA; [Ding, Yun; Jarrell, Mark] Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA USA; [Feinstein, Wei P.] Louisiana State Univ, High Performance Comp, Baton Rouge, LA USA; [Brylinski, Michal] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Fang, Ye; Moreno, Juana; Jarrell, Mark; Ramanujam, J.; Brylinski, Michal] Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Brylinski, M (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.; Brylinski, M (corresponding author), Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA.	michal@brylinski.org	Ramanujam, Jagannathan/R-3584-2019; Moreno, Juana/D-5882-2012	Moreno, Juana/0000-0002-7601-9934; Ramanujam, Jagannathan/0000-0002-4349-1327	National Science Foundation under the NSF EPSCoR [EPS-1003897]; Louisiana Board of Regents through the Board of Regents Support Fund [LEQSF(2012-15)-RD-A-05]; National Institutes of Health [GM-119524]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119524] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1205682] Funding Source: National Science Foundation; Office of Advanced Cyberinfrastructure (OAC) [1338051] Funding Source: National Science Foundation	National Science Foundation under the NSF EPSCoR; Louisiana Board of Regents through the Board of Regents Support Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This study was supported by the National Science Foundation under the NSF EPSCoR Cooperative Agreement No. EPS-1003897, the Louisiana Board of Regents through the Board of Regents Support Fund [contract LEQSF(2012-15)-RD-A-05] and the National Institutes of Health grant No. GM-119524. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beyls K., 2001, P IASTED C PAR DISTR, P350; Blem E., 2013, DETAILED ANAL CONT A; Board OAR, 2015, OPENMP APPLICATION P; Brylinski M, 2008, J COMPUT CHEM, V29, P1574, DOI 10.1002/jcc.20917; Brylinski M, 2013, J COMPUT AID MOL DES, V27, P551, DOI 10.1007/s10822-013-9663-5; Cavasotto CN, 2009, DRUG DISCOV TODAY, V14, P676, DOI 10.1016/j.drudis.2009.04.006; Charifson PS, 1997, BIOCHEMISTRY-US, V36, P6283, DOI 10.1021/bi970019n; Cheng TJ, 2012, AAPS J, V14, P133, DOI 10.1208/s12248-012-9322-0; Chirgadze NY, 1997, PROTEIN SCI, V6, P1412, DOI 10.1002/pro.5560060705; Clark DE, 2008, EXPERT OPIN DRUG DIS, V3, P841, DOI 10.1517/17460441.3.8.841; Ding Y, 2015, J COMPUT CHEM, V36, P2013, DOI 10.1002/jcc.24031; Earl DJ, 2005, PHYS CHEM CHEM PHYS, V7, P3910, DOI 10.1039/b509983h; Esmaeilzadeh H, 2011, ISCA 2011: PROCEEDINGS OF THE 38TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P365, DOI 10.1145/2024723.2000108; Feinstein WP, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0067-5; Feinstein WP, 2014, MOL INFORM, V33, P135, DOI 10.1002/minf.201300143; Ferrara P, 2007, J MOL MODEL, V13, P897, DOI 10.1007/s00894-007-0207-6; Gabel J, 2014, J CHEM INF MODEL, V54, P2807, DOI 10.1021/ci500406k; Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071; Guerrero G. D., 2012, Proceedings of the 2012 20th Euromicro International Conference on Parallel, Distributed and Network-Based Processing (PDP 2012), P588, DOI 10.1109/PDP.2012.26; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jeffers J., 2013, INTEL XEON PHI COPRO; Karp PD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004087; Katzgraber H. G., 2009, ARXIV09051629; Korb O, 2011, J CHEM INF MODEL, V51, P865, DOI 10.1021/ci100459b; Kruger DM, 2012, J CHEM INF MODEL, V52, P2807, DOI 10.1021/ci3003599; Li Y, 2014, J CHEM INF MODEL, V54, P1700, DOI 10.1021/ci500080q; Lill MA, 2011, BIOCHEMISTRY-US, V50, P6157, DOI 10.1021/bi2004558; Merlitz H, 2002, CHEM PHYS LETT, V362, P271, DOI 10.1016/S0009-2614(02)01035-7; Message Passing Interface Forum, 2015, MPI MESSAGE PASSING; Mucci P. J., 1999, PROC DEP DEFENSE HPC, V710, P1; Nvidia, 2016, CUDA C PROGRAMMING G; Prade L, 1997, STRUCTURE, V5, P1287, DOI 10.1016/S0969-2126(97)00281-5; RAAG R, 1989, BIOCHEMISTRY-US, V28, P917, DOI 10.1021/bi00428a077; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Reymond JL, 2012, ACS CHEM NEUROSCI, V3, P649, DOI 10.1021/cn3000422; Ripphausen P, 2010, J MED CHEM, V53, P8461, DOI 10.1021/jm101020z; Simon N AM-S, 2014, INT J HIGH PERFORM C, V29, P119, DOI [10.1177/1094342014528252, DOI 10.1177/1094342014528252]; Simonsen M, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1803; Stone JE, 2010, COMPUT SCI ENG, V12, P66, DOI 10.1109/MCSE.2010.69; Sutter H, 2005, DR DOBBS J, V30, P16; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wu-chun Feng, 2008, IT Professional, V10, P17, DOI 10.1109/MITP.2008.8	45	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0158898	10.1371/journal.pone.0158898	http://dx.doi.org/10.1371/journal.pone.0158898			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420300	Green Published, gold, Green Submitted			2022-12-27	WOS:000379662300005
J	Delfani, P; Mellby, LD; Nordstrom, M; Holmer, A; Ohlsson, M; Borrebaeck, CAK; Wingren, C				Delfani, Payam; Mellby, Linda Dexlin; Nordstrom, Malin; Holmer, Andreas; Ohlsson, Mattias; Borrebaeck, Carl A. K.; Wingren, Christer			Technical Advances of the Recombinant Antibody Microarray Technology Platform for Clinical Immunoproteomics	PLOS ONE			English	Article							DESIGN; PROTEIN; NORMALIZATION; GENERATION; PROTEOMICS	In the quest for deciphering disease-associated biomarkers, high-performing tools for multiplexed protein expression profiling of crude clinical samples will be crucial. Affinity proteomics, mainly represented by antibody-based microarrays, have during recent years been established as a proteomic tool providing unique opportunities for parallelized protein expression profiling. But despite the progress, several main technical features and assay procedures remains to be (fully) resolved. Among these issues, the handling of protein microarray data, i.e. the biostatistics parts, is one of the key features to solve. In this study, we have therefore further optimized, validated, and standardized our in-house designed recombinant antibody microarray technology platform. To this end, we addressed the main remaining technical issues (e.g. antibody quality, array production, sample labelling, and selected assay conditions) and most importantly key biostatistics subjects (e.g. array data pre-processing and biomarker panel condensation). This represents one of the first antibody array studies in which these key biostatistics subjects have been studied in detail. Here, we thus present the next generation of the recombinant antibody microarray technology platform designed for clinical immunoproteomics.	[Delfani, Payam; Mellby, Linda Dexlin; Borrebaeck, Carl A. K.; Wingren, Christer] Lund Univ, Dept Immunotechnol & CREATE Hlth, Lund, Sweden; [Mellby, Linda Dexlin; Nordstrom, Malin; Holmer, Andreas] Immunovia AB, Lund, Sweden; [Ohlsson, Mattias] Lund Univ, Dept Astron & Theoret Phys, Computat Biol & Biol Phys, Lund, Sweden	Lund University; Lund University	Wingren, C (corresponding author), Lund Univ, Dept Immunotechnol & CREATE Hlth, Lund, Sweden.	christer.wingren@immun.lth.se		Ohlsson, Mattias/0000-0003-1145-4297	Swedish Research Council (VR-NT); VINNOVA; Foundation of Strategic Research (Strategic Center for Translational Cancer Research-CREATE Health; Immunovia	Swedish Research Council (VR-NT)(Swedish Research Council); VINNOVA(Vinnova); Foundation of Strategic Research (Strategic Center for Translational Cancer Research-CREATE Health; Immunovia	This study was supported by research grants from the Swedish Research Council (VR-NT) (CW), VINNOVA (CAKB), and the Foundation of Strategic Research (Strategic Center for Translational Cancer Research-CREATE Health (www.createhealth.lth.se) (CAKB). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Immunovia) provided support in the form of reagents and salaries for authors (LDM, MN, AH), but did not have any additional role in the study design, data collection and analysis, and decision to publish, or preparation of the manuscript.; This study was supported by research grants from the Swedish Research Council (VR-NT) (CW), VINNOVA (CAKB), and the Foundation of Strategic Research (Strategic Center for Translational Cancer Research-CREATE Health (www.createhealth.lth.se) (CAKB). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Immunovia) provided support in the form of reagents and salaries for authors (LDM, MN, AH), but did not have any additional role in the study design, data collection and analysis, and decision to publish, or preparation of the manuscript. We would like to thank Dr. Aakash Chawade for valuable discussions about normalization approaches.	Angenendt P, 2003, J CHROMATOGR A, V1009, P97, DOI 10.1016/S0021-9673(03)00769-6; Bergeron S, 2015, ANAL BIOANAL CHEM; Bolstad B, 2010, PREPROCESSCORE COLLE; Borrebaeck CAK, 2014, METHODS MOL BIOL, V1131, P563, DOI 10.1007/978-1-62703-992-5_36; Borrebaeck CAK, 2014, METHODS MOL BIOL, V1134, P67, DOI 10.1007/978-1-4939-0326-9_6; Borrebaeck CAK, 2011, METHODS MOL BIOL, V785, P247, DOI 10.1007/978-1-61779-286-1_17; Borrebaeck CAK, 2009, J PROTEOMICS, V72, P928, DOI 10.1016/j.jprot.2009.01.027; Borrebaeck CAK, 2009, EXPERT REV PROTEOMIC, V6, P11, DOI 10.1586/14789450.6.1.11; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2015, RANDOMFOREST BREIMAN; Carlsson A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005033; Carlsson A, 2011, P NATL ACAD SCI USA, V108, P14252, DOI 10.1073/pnas.1103125108; Chiechi Antonella, 2012, Biotechniques, V0, P1, DOI 10.2144/000113926; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Dexlin-Mellby L, 2010, PROTEOM CLIN APPL, V4, P794, DOI 10.1002/prca.201000001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerdtsson Anna S, 2015, Int J Proteomics, V2015, P587250, DOI 10.1155/2015/587250; Gerdtsson AS, 2016, MICROARRAYS IN PRESS; Gustavsson E, 2011, NEW BIOTECHNOL, V28, P302, DOI 10.1016/j.nbt.2010.12.005; Hamelinck D, 2005, MOL CELL PROTEOMICS, V4, P773, DOI 10.1074/mcp.M400180-MCP200; Hoheisel JD, 2013, PROTEOM CLIN APPL, V7, P8, DOI 10.1002/prca.201200114; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Ingvarsson J, 2008, PROTEOMICS, V8, P2211, DOI 10.1002/pmic.200701167; Ingvarsson J, 2007, J PROTEOME RES, V6, P3527, DOI 10.1021/pr070204f; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kristensson M, 2012, PROTEOM CLIN APPL, V6, P291, DOI 10.1002/prca.201100055; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Olsson N, 2012, PROTEIN SCI, V21, P1897, DOI 10.1002/pro.2173; Pauly F, 2013, J PROTEOME RES, V12, P5943, DOI 10.1021/pr4003245; Pernemalm M, 2014, EXPERT REV PROTEOMIC, V11, P431, DOI 10.1586/14789450.2014.901157; Petersson L, 2014, BBA-PROTEINS PROTEOM, V1844, P2164, DOI 10.1016/j.bbapap.2014.08.010; Rimini R, 2009, J PROTEOMICS, V73, P252, DOI 10.1016/j.jprot.2009.09.009; Risso D, 2009, BIOINFORMATICS, V25, P2685, DOI 10.1093/bioinformatics/btp443; Rotter A, 2008, OMICS, V12, P171, DOI 10.1089/omi.2008.0032; Sanchez-Carbayo M, 2006, AM J PATHOL, V168, P93, DOI 10.2353/ajpath.2006.050601; Sanchez-Carbayo M, 2011, METHODS MOL BIOL, V785, P159, DOI 10.1007/978-1-61779-286-1_11; Schroder C, 2010, MOL CELL PROTEOMICS, V9, P1271, DOI 10.1074/mcp.M900419-MCP200; Seurynck-Servoss SL, 2007, FRONT BIOSCI-LANDMRK, V12, P3956, DOI 10.2741/2362; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soderlind E, 2000, NAT BIOTECHNOL, V18, P852, DOI 10.1038/78458; Willem T, 2009, GENE EXPRESSION STUD, p[76, 37]; Wingren C, 2007, PROTEOMICS, V7, P3055, DOI 10.1002/pmic.200700025; Wingren C, 2012, CANCER RES, V72, P2481, DOI 10.1158/0008-5472.CAN-11-2883; Wu YWB, 2005, NURS RES, V54, P212; Yauk CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-266; Zhang AH, 2013, APPL BIOCHEM BIOTECH, V170, P774, DOI 10.1007/s12010-013-0238-7	46	25	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159138	10.1371/journal.pone.0159138	http://dx.doi.org/10.1371/journal.pone.0159138			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414037	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500087
J	Drepper, VJ; Kihm, LP; Kalble, F; Diekmann, C; Seckinger, J; Sommerer, C; Zeier, M; Schwenger, V				Drepper, Valerie Jotterand; Kihm, Lars P.; Kaelble, Florian; Diekmann, Christian; Seckinger, Joerg; Sommerer, Claudia; Zeier, Martin; Schwenger, Vedat			Overhydration Is a Strong Predictor of Mortality in Peritoneal Dialysis Patients-Independently of Cardiac Failure	PLOS ONE			English	Article							WHOLE-BODY BIOIMPEDANCE; RESIDUAL RENAL-FUNCTION; HEMODIALYSIS-PATIENTS; INCIDENT PERITONEAL; NATRIURETIC PEPTIDE; TROPONIN-T; SPECTROSCOPY; SURVIVAL; RISK; INFLAMMATION	Background Overhydration is a common problem in peritoneal dialysis patients and has been shown to be associated with mortality. However, it still remains unclear whether overhydration per se is predictive of mortality or whether it is mainly a reflection of underlying comorbidities. The purpose of our study was to assess overhydration in peritoneal dialysis patients using bioimpedance spectroscopy and to investigate whether overhydration is an independent predictor of mortality. Methods We analyzed and followed 54 peritoneal dialysis patients between June 2008 and December 2014. All patients underwent bioimpedance spectroscopy measurement once and were allocated to normohydrated and overhydrated groups. Overhydration was defined as an absolute overhydration/extracellular volume ratio > 15%. Simultaneously, clinical, echocardiographic and laboratory data were assessed. Heart failure was defined either on echocardiography, as a reduced left ventricular ejection fraction, or clinically according to the New York Heart Association functional classification. Patient survival was documented up until December 31st 2014. Factors associated with mortality were identified and a multivariable Cox regression model was used to identify independent predictors of mortality. Results Apart from higher daily peritoneal ultrafiltration rate and cumulative diuretic dose in overhydrated patients, there were no significant differences between the 2 groups, in particular with respect to gender, body mass index, comorbidity and cardiac medication. Mortality was higher in overhydrated than in euvolemic patients. In the univariate analysis, increased age, overhydration, low diastolic blood pressure, raised troponin and NTproBNP, hypoalbuminemia, heart failure but not CRP were predictive of mortality. After adjustment, only overhydration, increased age and low diastolic blood pressure remained statistically significant in the multivariate analysis. Conclusions Overhydration remains an independent predictor of mortality even after adjustment for heart failure in peritoneal dialysis patients and should therefore be actively sought and managed in order to improve survival in this population.	[Drepper, Valerie Jotterand] Univ Hosp Geneva, Dept Nephrol, Geneva, Switzerland; [Drepper, Valerie Jotterand; Kihm, Lars P.; Kaelble, Florian; Diekmann, Christian; Seckinger, Joerg; Sommerer, Claudia; Zeier, Martin; Schwenger, Vedat] Univ Heidelberg Hosp, Dept Nephrol, Heidelberg, Germany; [Seckinger, Joerg] Zug Cantonal Hosp, Dept Nephrol, Zug, Switzerland; [Schwenger, Vedat] Klinikum Stuttgart, Dept Nephrol, Stuttgart, Germany	University of Geneva; Ruprecht Karls University Heidelberg; Klinikum Stuttgart	Drepper, VJ (corresponding author), Univ Hosp Geneva, Dept Nephrol, Geneva, Switzerland.; Drepper, VJ (corresponding author), Univ Heidelberg Hosp, Dept Nephrol, Heidelberg, Germany.	Valerie.JotterandDrepper@hcuge.ch						Afshinnia F, 2015, PERIT DIAL INT; Chamney PW, 2002, KIDNEY INT, V61, P2250, DOI 10.1046/j.1523-1755.2002.00377.x; Chung SH, 2003, NEPHROL DIAL TRANSPL, V18, P590, DOI 10.1093/ndt/18.3.590; Cox-Reijven PL, 2001, AM J KIDNEY DIS, V38, P832, DOI 10.1053/ajkd.2001.27703; Devolder I, 2010, PERITON DIALYSIS INT, V30, P208, DOI 10.3747/pdi.2008.00284; Duman D, 2005, NEPHROL DIAL TRANSPL, V20, P962, DOI 10.1093/ndt/gfh741; Ellis KJ, 1998, J APPL PHYSIOL, V85, P1056, DOI 10.1152/jappl.1998.85.3.1056; Fahim MA, 2015, CLIN J AM SOC NEPHRO, V10, P620, DOI 10.2215/CJN.09060914; Franklin SS, 1997, CIRCULATION; Heaf JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090119; Hickman PE, 2015, AM J CARDIOL, V115, P1601, DOI 10.1016/j.amjcard.2015.02.066; Jovanovic DB, 2015, RENAL FAILURE, V37, P230, DOI 10.3109/0886022X.2014.982478; Kang SH, 2012, RENAL FAILURE, V34, P149, DOI 10.3109/0886022X.2011.646808; Kraemer M, 2006, KIDNEY INT, V69, P1609, DOI 10.1038/sj.ki.5000286; Kumar VA, 2014, KIDNEY INT, V86, P1016, DOI 10.1038/ki.2014.224; Leinig CE, 2011, J RENAL NUTR, V21, P176, DOI 10.1053/j.jrn.2010.06.026; Mathew S, 2015, RENAL FAILURE, V37, P66, DOI 10.3109/0886022X.2014.964147; Mehrotra R, 2011, AM J KIDNEY DIS, V58, P418, DOI 10.1053/j.ajkd.2011.03.018; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Noh H, 1998, PERITON DIALYSIS INT, V18, P387; O'Lone EL, 2014, NEPHROL DIAL TRANSPL, V29, P1430, DOI 10.1093/ndt/gfu049; Paniagua R, 2008, CLIN J AM SOC NEPHRO, V3, P407, DOI 10.2215/CJN.03820907; Paniagua R, 2010, NEPHROL DIAL TRANSPL, V25, P551, DOI 10.1093/ndt/gfp395; Ronco C, 2015, NEPHROL DIAL TRANSPL, V30, P849, DOI 10.1093/ndt/gfv013; Van Biesen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017148; Wabel P, 2009, BLOOD PURIFICAT, V27, P75, DOI 10.1159/000167013; Wang AYM, 2007, CLIN CHEM, V53, P882, DOI 10.1373/clinchem.2006.078378; Wang AYM, 2007, J AM SOC NEPHROL, V18, P321, DOI 10.1681/ASN.2005121299; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; Xie Q, 2015, PERIT DIAL INT	30	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158741	10.1371/journal.pone.0158741	http://dx.doi.org/10.1371/journal.pone.0158741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415758	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500034
J	Hodgson, EE; Essington, TE; Kaplan, IC				Hodgson, Emma E.; Essington, Timothy E.; Kaplan, Isaac C.			Extending Vulnerability Assessment to Include Life Stages Considerations	PLOS ONE			English	Article							QUALITATIVE RISK-ASSESSMENT; LOGGERHEAD SEA-TURTLES; OCEAN ACIDIFICATION; POPULATION BIOLOGY; CLIMATE-CHANGE; FISHERIES; IMPACTS; SUSTAINABILITY; ADAPTATION; ELASTICITY	Species are experiencing a suite of novel stressors from anthropogenic activities that have impacts at multiple scales. Vulnerability assessment is one tool to evaluate the likely impacts that these stressors pose to species so that high-vulnerability cases can be identified and prioritized for monitoring, protection, or mitigation. Commonly used semi-quantitative methods lack a framework to explicitly account for differences in exposure to stressors and organism responses across life stages. Here we propose a modification to commonly used spatial vulnerability assessment methods that includes such an approach, using ocean acidification in the California Current as an illustrative case study. Life stage considerations were included by assessing vulnerability of each life stage to ocean acidification and were used to estimate population vulnerability in two ways. We set population vulnerability equal to: (1) the maximum stage vulnerability and (2) a weighted mean across all stages, with weights calculated using Lefkovitch matrix models. Vulnerability was found to vary across life stages for the six species explored in this case study: two krill-Euphausia pacifica and Thysanoessa spinifera, pteropod-Limacina helicina, pink shrimp-Pandalus jordani, Dungeness crab-Metacarcinus magister and Pacific hake-Merluccius productus. The maximum vulnerability estimates ranged from larval to subadult and adult stages with no consistent stage having maximum vulnerability across species. Similarly, integrated vulnerability metrics varied greatly across species. A comparison showed that some species had vulnerabilities that were similar between the two metrics, while other species' vulnerabilities varied substantially between the two metrics. These differences primarily resulted from cases where the most vulnerable stage had a low relative weight. We compare these methods and explore circumstances where each method may be appropriate.	[Hodgson, Emma E.; Essington, Timothy E.] Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA; [Kaplan, Isaac C.] Natl Marine Fisheries Serv NOAA, Northwest Fisheries Sci Ctr, Conservat Biol Div, 2725 Montlake Blvd, Seattle, WA 98112 USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Hodgson, EE (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	hodgsone@uw.edu			National Science Foundation Graduate Research Fellowship Program [DGE-1256082]; National Centers for Coastal Ocean Science; NOAA Ocean Acidification Program [NA12NOS4780147]; University of Washington Graduate School Top Scholar Award	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Centers for Coastal Ocean Science(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA Ocean Acidification Program; University of Washington Graduate School Top Scholar Award	This work was supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-1256082 to EEH and by the National Centers for Coastal Ocean Science, and NOAA Ocean Acidification Program, grant No. NA12NOS4780147 to EEH, TEE and ICK. Additional funding was provided to EEH through the University of Washington Graduate School Top Scholar Award (no grant number associated with this funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; [Anonymous], 2009, 310001 ISO; Arnberg M, 2013, MAR BIOL, V160, P2037, DOI 10.1007/s00227-012-2072-9; Astles KL, 2006, FISH RES, V82, P290, DOI 10.1016/j.fishres.2006.05.013; Barnthouse LW, 1992, ENV TOXICOLOGY CHEM, V11; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; Bednarsek N, 2012, NAT GEOSCI, V5, P881, DOI 10.1038/NGEO1635; Bi HS, 2011, J PLANKTON RES, V33, P751, DOI 10.1093/plankt/fbq138; Bolten AB, 1998, ECOL APPL, V8, P1; Breitburg DL, 2003, ESTUARIES, V26, P280, DOI 10.1007/BF02695967; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 1996, DEMOGRAPHY MEETS ECO, V2, P255; Chambers RC, 2014, BIOGEOSCIENCES, V11, P1613, DOI 10.5194/bg-11-1613-2014; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chaumot A, 2002, ECOL APPL, V12, P1771, DOI 10.1890/1051-0761(2002)012[1771:UAMTAT]2.0.CO;2; Cheung WWL, 2016, ICES J MAR SCI, V73, P1283, DOI 10.1093/icesjms/fsv250; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; De Lange HJ, 2010, SCI TOTAL ENVIRON, V408, P3871, DOI 10.1016/j.scitotenv.2009.11.009; DEKROON H, 1986, ECOLOGY, V67, P1427, DOI 10.2307/1938700; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Fletcher WJ, 2005, ICES J MAR SCI, V62, P1576, DOI 10.1016/j.icesjms.2005.06.005; Froehlich HE, 2014, ESTUAR COAST, V37, P449, DOI 10.1007/s12237-013-9676-2; Frommel AY, 2014, ECOL APPL, V24, P1131, DOI 10.1890/13-0297.1; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Grantham BA, 2003, ECOL APPL, V13, pS108; Gruber N, 2012, SCIENCE, V337, P220, DOI 10.1126/science.1216773; Haidvogel DB, 2008, J COMPUT PHYS, V227, P3595, DOI 10.1016/j.jcp.2007.06.016; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Harvey HR, 2010, DEEP-SEA RES PT II, V57, P663, DOI 10.1016/j.dsr2.2009.10.015; Hatton IA, 2006, ECOL APPL, V16, P1238, DOI 10.1890/1051-0761(2006)016[1238:ADATER]2.0.CO;2; Heppell S, 2000, ECOLOGY, V81, P605, DOI 10.1890/0012-9658(2000)081[0605:EAIPBM]2.0.CO;2; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Hofmann GE, 2014, BIOGEOSCIENCES, V11, P1053, DOI 10.5194/bg-11-1053-2014; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hurst TP, 2013, ICES J MAR SCI, V70, P812, DOI 10.1093/icesjms/fst053; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Mastrandrea M.D., 2010, GUIDANCE NOTE LEAD A; McCarthy J.J., 2001, CLIMATE CHANGE 2001; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Metzger MJ, 2005, INT J APPL EARTH OBS, V7, P253, DOI 10.1016/j.jag.2005.06.011; Miller JJ, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2883-1; Miller TW, 2010, MAR ECOL PROG SER, V420, P15, DOI 10.3354/meps08876; Morris W. F., 2002, QUANTITATIVE CONSERV; Moyle PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063883; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; PIHL L, 1991, MAR BIOL, V108, P349, DOI 10.1007/BF01313644; Pinsky ML, 2014, OCEANOGRAPHY, V27, P146, DOI 10.5670/oceanog.2014.93; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Reum JCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089619; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; Samhouri JF, 2012, BIOL CONSERV, V145, P118, DOI 10.1016/j.biocon.2011.10.021; Schindler DE, 2015, SCIENCE, V347, P953, DOI 10.1126/science.1261824; Small-Lorenz SL, 2013, NAT CLIM CHANGE, V3, P91, DOI 10.1038/nclimate1810; Smith PE, 1995, CAL COOP OCEAN FISH, V36, P144; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Stobutzki I, 2001, ENVIRON CONSERV, V28, P167, DOI 10.1017/S0376892901000170; Teck SJ, 2010, ECOL APPL, V20, P1402, DOI 10.1890/09-1173.1; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; U. S. EPA, 1998, GUID EC RISK ASS; Williams A, 2011, FISH RES, V112, P154, DOI 10.1016/j.fishres.2011.01.028; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	77	13	13	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158917	10.1371/journal.pone.0158917	http://dx.doi.org/10.1371/journal.pone.0158917			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416031	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500050
J	Shi, C; Song, KK; Zhang, XR; Sun, Y; Sui, Y; Chen, YF; Jia, ZY; Sun, HH; Sun, Z; Xia, XD				Shi, Chao; Song, Kaikuo; Zhang, Xiaorong; Sun, Yi; Sui, Yue; Chen, Yifei; Jia, Zhenyu; Sun, Huihui; Sun, Zheng; Xia, Xiaodong			Antimicrobial Activity and Possible Mechanism of Action of Citral against Cronobacter sakazakii	PLOS ONE			English	Article							RECONSTITUTED INFANT FORMULA; ENTEROBACTER-SAKAZAKII; ESSENTIAL OILS; ESCHERICHIA-COLI; ACID; FOOD; INACTIVATION; COMBINATION; COMPONENTS; LEMON	Citral is a flavor component that is commonly used in food, beverage and fragrance industries. Cronobacter sakazakii is a food-borne pathogen associated with severe illness and high mortality in neonates and infants. The objective of the present study was to evaluate antimicrobial effect of citral against C. sakazakii strains. The minimum inhibitory concentration (MIC) of citral against C. sakazakii was determined via agar dilution method, then Gompertz models were used to quantitate the effect of citral on microbial growth kinetics. Changes in intracellular pH (pH(in)), membrane potential, intracellular ATP concentration, and membrane integrity were measured to elucidate the possible antimicrobial mechanism. Cell morphology changes were also examined using a field emission scanning electron microscope. The MICs of citral against C. sakazakii strains ranged from 0.27 to 0.54 mg/mL, and citral resulted in a longer lag phase and lower growth rate of C. sakazakii compared to the control. Citral affected the cell membrane of C. sakazakii, as evidenced by decreased intracellular ATP concentration, reduced pHin, and cell membrane hyperpolarization. Scanning electron microscopy analysis further confirmed that C. sakazakii cell membranes were damaged by citral. These findings suggest that citral exhibits antimicrobial effect against C. sakazakii strains and could be potentially used to control C. sakazakii in foods. However, how it works in food systems where many other components may interfere with its efficacy should be tested in future research before its real application.	[Shi, Chao; Song, Kaikuo; Zhang, Xiaorong; Sun, Yi; Sui, Yue; Chen, Yifei; Jia, Zhenyu; Sun, Huihui; Sun, Zheng; Xia, Xiaodong] Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Shaanxi, Peoples R China; [Xia, Xiaodong] Sino US Joint Res Ctr Food Safety, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Xia, XD (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Shaanxi, Peoples R China.; Xia, XD (corresponding author), Sino US Joint Res Ctr Food Safety, Yangling, Shaanxi, Peoples R China.	foodscixiaodong@yahoo.com	Xia, Xiaodong/R-9279-2019; Chen, Yi/HIR-2608-2022		New Century Excellent Talent Support Plan [NCET-13-0488]; Twelve-five Science and Technology Support Program [2015BAD16B08]; National Natural Science Foundation of China [31301498]; International Collaboration Partner Plan in Northwest AF University [A213021203]; Special Fund for Sino-US Joint Research Center for Food Safety [A200021501]	New Century Excellent Talent Support Plan; Twelve-five Science and Technology Support Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Collaboration Partner Plan in Northwest AF University; Special Fund for Sino-US Joint Research Center for Food Safety	This work was supported in part by New Century Excellent Talent Support Plan (NCET-13-0488), the Twelve-five Science and Technology Support Program (No. 2015BAD16B08), National Natural Science Foundation of China (31301498), International Collaboration Partner Plan (A213021203) in Northwest A&F University and Special Fund for Sino-US Joint Research Center for Food Safety (A200021501).	Bajpai VK, 2013, FOOD CONTROL, V32, P582, DOI 10.1016/j.foodcont.2013.01.032; Benvenuti F, 2001, J SUPERCRIT FLUID, V20, P29, DOI 10.1016/S0896-8446(01)00058-4; Bot C, 2009, EUR BIOPHYS J BIOPHY, V38, P1049, DOI 10.1007/s00249-009-0507-0; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Choi SJ, 2010, FOOD CHEM, V122, P111, DOI 10.1016/j.foodchem.2010.02.025; da Silva CD, 2008, BRAZ J INFECT DIS, V12, P63, DOI 10.1590/S1413-86702008000100014; Di Pasqua R, 2007, J AGR FOOD CHEM, V55, P4863, DOI 10.1021/jf0636465; EUCAST, 2000, CLIN MICROBIOL INFEC, V6, P570; Fisher K, 2006, J APPL MICROBIOL, V101, P1232, DOI 10.1111/j.1365-2672.2006.03035.x; Fisher K, 2008, TRENDS FOOD SCI TECH, V19, P156, DOI 10.1016/j.tifs.2007.11.006; Gyawali R, 2014, FOOD CONTROL, V46, P412, DOI 10.1016/j.foodcont.2014.05.047; Hayes M, 2009, J FOOD PROTECT, V72, P340, DOI 10.4315/0362-028X-72.2.340; Healy B, 2010, FOODBORNE PATHOG DIS, V7, P339, DOI 10.1089/fpd.2009.0379; Holley RA, 2005, FOOD MICROBIOL, V22, P273, DOI 10.1016/j.fm.2004.08.006; Holyoak CD, 1996, APPL ENVIRON MICROB, V62, P3158, DOI 10.1128/AEM.62.9.3158-3164.1996; Hyldgaard M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00012; Iversen C, 2004, J CLIN MICROBIOL, V42, P5368, DOI 10.1128/JCM.42.11.5368-5370.2004; Iversen C, 2003, TRENDS FOOD SCI TECH, V14, P443, DOI 10.1016/S0924-2244(03)00155-9; Koluman A, 2013, CRIT REV MICROBIOL, V39, P57, DOI 10.3109/1040841X.2012.691458; Korenblum E, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-44; Lee SY, 2008, LETT APPL MICROBIOL, V47, P315, DOI 10.1111/j.1472-765X.2008.02432.x; Li GH, 2014, EUR FOOD RES TECHNOL, V238, P589, DOI 10.1007/s00217-013-2140-5; Li R, 2016, J DAIRY SCI, V99, P1019, DOI 10.3168/jds.2015-10039; MATES SM, 1982, P NATL ACAD SCI-BIOL, V79, P6693, DOI 10.1073/pnas.79.21.6693; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; MUYTJENS HL, 1990, PEDIATR INFECT DIS J, V9, P372, DOI 10.1097/00006454-199005000-00016; Nair MKM, 2004, J FOOD PROTECT, V67, P2815, DOI 10.4315/0362-028X-67.12.2815; Ortiz MI, 2010, PHYTOMEDICINE, V18, P74, DOI 10.1016/j.phymed.2010.05.009; Rhayour K, 2003, J ESSENT OIL RES, V15, P356, DOI 10.1080/10412905.2003.9698611; Sanchez E, 2010, APPL ENVIRON MICROB, V76, P6888, DOI 10.1128/AEM.03052-09; Shi C, 2015, J APPL MICROBIOL, V119, P1700, DOI 10.1111/jam.12964; Shi C, 2016, FOOD CONTROL, V59, P352, DOI 10.1016/j.foodcont.2015.05.041; Silva-Angulo AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114026; Somolinos M, 2008, INT J FOOD MICROBIOL, V124, P260, DOI 10.1016/j.ijfoodmicro.2008.03.021; Suzuki H, 2003, ANAL SCI, V19, P1239, DOI 10.2116/analsci.19.1239; Tajkarimi MM, 2010, FOOD CONTROL, V21, P1199, DOI 10.1016/j.foodcont.2010.02.003; Turgis M, 2009, FOOD CONTROL, V20, P1073, DOI 10.1016/j.foodcont.2009.02.001; Whiteaker KL, 2001, J BIOMOL SCREEN, V6, P305, DOI 10.1177/108705710100600504	38	106	119	15	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159006	10.1371/journal.pone.0159006	http://dx.doi.org/10.1371/journal.pone.0159006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415761	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500058
J	Ahlgren, E; Hagberg, L; Fuchs, D; Andersson, LM; Nilsson, S; Zetterberg, H; Gisslen, M				Ahlgren, Erika; Hagberg, Lars; Fuchs, Dietmar; Andersson, Lars-Magnus; Nilsson, Staffan; Zetterberg, Henrik; Gisslen, Magnus			Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; HYPERHOMOCYSTEINEMIA; METAANALYSIS; DEFICIENCY; METABOLISM; NEOPTERIN	Objective To investigate the role of homocysteine in neuronal injury in HIV infection. Methods Using a cross-sectional design and archived samples, we compared concentrations of plasma homocysteine and cerebrospinal fluid (CSF) neurofilament light protein (NFL), a sensitive marker of neuronal injury, in 83 HIV-1-infected subjects without antiretroviral treatment. We also analyzed plasma vitamin B12, serum folate, CSF, and plasma HIV RNA, the immune activation marker neopterin in CSF and serum, and albumin ratio as a marker of blood-brain barrier integrity. Twenty-two subjects provided a second sample median of 12.5 months after antiretroviral treatment initiation. Results A significant correlation was found between plasma homocysteine and CSF NFL concentrations in untreated individuals (r = 0.52, p < 0.0001). As expected, there was a significant inverse correlation between homocysteine and B12 (r = -0.41, p < 0.001) and folate (r = -0.40, p = < 0.001) levels. In a multiple linear regression analysis homocysteine stood out as an independent predictor of CSF NFL in HIV-1-infected individuals. The correlation of plasma homocysteine and CSF NFL was also present in the group receiving antiretroviral therapy (r = 0.51, p = 0.016). Conclusion A correlation between plasma homocysteine and axonal injury, as measured by CSF NFL, was found in both untreated and treated HIV. While this study is not able to prove a causal link, homocysteine and functional B12/folate deficiency appear to play a role in neural injury in HIV-infected individuals.	[Ahlgren, Erika; Hagberg, Lars; Andersson, Lars-Magnus; Gisslen, Magnus] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Fuchs, Dietmar] Med Univ Innsbruck, Bioctr, Div Biol Chem, Innsbruck, Austria; [Nilsson, Staffan] Chalmers, Math Sci, Gothenburg, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England	University of Gothenburg; Medical University of Innsbruck; Chalmers University of Technology; University of Gothenburg; University of London; University College London	Ahlgren, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden.	erika.ahlgren@vgregion.se	Fuchs, Dietmar/AAL-8011-2021; Gisslen, Magnus/D-7454-2015	Fuchs, Dietmar/0000-0003-1627-9563; Gisslen, Magnus/0000-0002-2357-1020; Nilsson, Staffan/0000-0003-4748-0446	Swedish Research Council [K2011-58P-20931-01-4, K2010-63P-21562-01-4, K2011-61X-20401-05-6, 2013-2546, K2013-61X-14002-13-5]; Sahlgrenska University Hospital [ALFGBG-430271, ALFGBG-441051, ALFGBG-139671]; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sahlgrenska University Hospital; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council (K2011-58P-20931-01-4, K2010-63P-21562-01-4, K2011-61X-20401-05-6, 2013-2546, K2013-61X-14002-13-5), the Sahlgrenska University Hospital (ALFGBG-430271, ALFGBG-441051, ALFGBG-139671) and the Knut and Alice Wallenberg Foundation.	Abdulle S, 2007, J NEUROL, V254, P1026, DOI 10.1007/s00415-006-0481-8; BEACH RS, 1992, ARCH NEUROL-CHICAGO, V49, P501, DOI 10.1001/archneur.1992.00530290089016; Bongiovanni M, 2007, JAIDS-J ACQ IMM DEF, V44, P117, DOI 10.1097/QAI.0b013e31802be3e8; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Frick B, 2006, J NEURAL TRANSM, V113, P1815, DOI 10.1007/s00702-006-0539-x; Fuchs D, 2001, CLIN CHEM LAB MED, V39, P691, DOI 10.1515/CCLM.2001.113; Gisslen M, 2007, J INFECT DIS, V195, P1774, DOI 10.1086/518043; Hagberg L, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-15; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Ho RCM, 2011, AM J GERIAT PSYCHIAT, V19, P607, DOI 10.1097/JGP.0b013e3181f17eed; KIEBURTZ KD, 1991, ARCH NEUROL-CHICAGO, V48, P312, DOI 10.1001/archneur.1991.00530150082023; Krut JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088591; Look MP, 2001, METABOLISM, V50, P1275, DOI 10.1053/meta.2001.27201; Magera MJ, 1999, CLIN CHEM, V45, P1517; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; PORTEGIES P, 1989, BRIT MED J, V299, P819, DOI 10.1136/bmj.299.6703.819; Remacha AF, 2003, AM J CLIN NUTR, V77, P420, DOI 10.1093/ajcn/77.2.420; ROBERTSON KR, 1993, ARCH NEUROL-CHICAGO, V50, P807, DOI 10.1001/archneur.1993.00540080018007; SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X; Schroecksnadel K, 2003, CLIN CHEM LAB MED, V41, P1438, DOI 10.1515/CCLM.2003.221; SMITH I, 1987, LANCET, V2, P215; Smulders Y M., 2001, Eur J Intern Med, V12, P363, DOI 10.1016/S0953-6205(01)00134-0; Smulders YM, 1998, LANCET, V352, P1827, DOI 10.1016/S0140-6736(05)79890-1; Tan SV, 1998, J NEUROL NEUROSUR PS, V65, P23, DOI 10.1136/jnnp.65.1.23; Wald DS, 2011, ALZHEIMERS DEMENT, V7, P412, DOI 10.1016/j.jalz.2010.08.234	25	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158973	10.1371/journal.pone.0158973	http://dx.doi.org/10.1371/journal.pone.0158973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441551	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500033
J	Chae, KJ; Shin, JY				Chae, Kum Ju; Shin, Jin Yong			Is Angiosome-Targeted Angioplasty Effective for Limb Salvage and Wound Healing in Diabetic Foot? : A Meta-Analysis	PLOS ONE			English	Article							ISCHEMIC FOOT; REVASCULARIZATION; DISEASE; RECONSTRUCTION; BYPASS; MODEL	Purpose Given that the efficacy of employing angiosome-targeted angioplasty in the treatment of diabetic foot remains controversial, this study was conducted to examine its efficacy. Methods We performed a systematic literature review and meta-analysis using core databases, extracting the treatment modality of angiosome-targeted angioplasty as the predictor variable, and limb salvage, wound healing, and revision rate as the outcome variables. We used the Newcastle-Ottawa Scale to assess the study quality, along with the Cochrane Risk of Bias Tool. We evaluated publication bias using a funnel plot. Results The search strategy identified 518 publications. After screening these, we selected four articles for review. The meta-analysis revealed that overall limb salvage and wound healing rates were significantly higher (Odds ratio = 2.209, 3.290, p = 0.001, p<0.001) in patients who received angiosome-targeted angioplasty than in those who received nonangiosome-targeted angioplasty. The revision rate between the angiosome and nonangiosome groups was not significantly different (Odds ratio = 0.747, p = 0.314). Conclusion Although a further randomized controlled trial is required for confirmation, angiosome-targeted angioplasty in diabetic foot was more effective than nonangiosome-targeted angioplasty with respect to wound healing and limb salvage.	[Chae, Kum Ju] Chonbuk Natl Univ Hosp, Dept Radiol, Jeonju, South Korea; [Shin, Jin Yong] Chonbuk Natl Univ Hosp, Dept Plast & Reconstruct Surg, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University Hospital	Shin, JY (corresponding author), Chonbuk Natl Univ Hosp, Dept Plast & Reconstruct Surg, Jeonju, South Korea.	psjyshin@gmail.com		Shin, Jinyong/0000-0003-2680-7411				Acin F, 2014, INT J VASC MED, V2014, DOI 10.1155/2014/270539; Alexandrescu V, 2012, J CARDIOVASC SURG, V53, P3; Alexandrescu V, 2011, DIABET METAB SYND OB, V4, P327, DOI 10.2147/DMSO.S23471; Alexandrescu V, 2011, J ENDOVASC THER, V18, P376, DOI 10.1583/10-3260.1; Alexandrescu VA, 2008, J ENDOVASC THER, V15, P580, DOI 10.1583/08-2460.1; Attinger CE, 2006, PLAST RECONSTR SURG, V117, p261S, DOI 10.1097/01.prs.0000222582.84385.54; Azuma N, 2012, EUR J VASC ENDOVASC, V43, P322, DOI 10.1016/j.ejvs.2011.12.001; Berceli SA, 1999, J VASC SURG, V30, P499, DOI 10.1016/S0741-5214(99)70077-7; Biancari F, 2014, EUR J VASC ENDOVASC, V47, P517, DOI 10.1016/j.ejvs.2013.12.010; Bosanquet DC, 2014, EUR J VASC ENDOVASC, V48, P88, DOI 10.1016/j.ejvs.2014.04.002; Deeks J J, 2003, Health Technol Assess, V7, piii; Edmonds M, 2008, BR J NURS, V17, pS2, DOI 10.12968/bjon.2008.17.Sup5.29648; Edmonds M, 2008, BR J NURS, V17, pS4, DOI 10.12968/bjon.2008.17.Sup5.29648; Edmonds Michael, 2008, Br J Nurs, V17, pS24; Forsythe RO, 2015, DIABETES OBES METAB, V17, P435, DOI 10.1111/dom.12422; Fossaceca R, 2013, CARDIOVASC INTER RAD, V36, P637, DOI 10.1007/s00270-012-0544-4; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang TY, 2015, MEDICINE, V94, P1, DOI 10.1097/MD.0000000000001427; Lee KM, 2013, ARCH PLAST SURG-APS, V40, P123, DOI 10.5999/aps.2013.40.2.123; Lejay A, 2014, ANN VASC SURG, V28, P983, DOI 10.1016/j.avsg.2013.08.026; Neville RF, 2009, ANN VASC SURG, V23, P367, DOI 10.1016/j.avsg.2008.08.022; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Peppa M, 2009, WOUND REPAIR REGEN, V17, P461, DOI 10.1111/j.1524-475X.2009.00518.x; Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Serra R, 2015, INT WOUND J, V12, P555, DOI 10.1111/iwj.12162; Soderstrom M, 2013, J VASC SURG, V57, P427, DOI 10.1016/j.jvs.2012.07.057; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; TAYLOR GI, 1987, BRIT J PLAST SURG, V40, P113, DOI 10.1016/0007-1226(87)90185-8; Turina M, 2005, CRIT CARE MED, V33, P1624, DOI 10.1097/01.CCM.0000170106.61978.D8; Varela C, 2010, VASC ENDOVASC SURG, V44, P654, DOI 10.1177/1538574410376601; Wolfle KD, 2003, EUR J VASC ENDOVASC, V25, P229, DOI 10.1053/ejvs.2002.1849	32	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159523	10.1371/journal.pone.0159523	http://dx.doi.org/10.1371/journal.pone.0159523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441570	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500088
J	Chiang, CY; Liu, SA; Sheu, ML; Chen, FC; Chen, CJ; Su, HL; Pan, HC				Chiang, Chien-Yi; Liu, Shih-An; Sheu, Meei-Ling; Chen, Fu-Chou; Chen, Chun-Jung; Su, Hong-Lin; Pan, Hung-Chuan			Feasibility of Human Amniotic Fluid Derived Stem Cells in Alleviation of Neuropathic Pain in Chronic Constrictive Injury Nerve Model	PLOS ONE			English	Article							RAT SCIATIC-NERVE; FORELIMB-STUMP REPRESENTATION; CATWALK GAIT ANALYSIS; SPINAL-CORD; NOCICEPTIVE HYPERSENSITIVITY; MECHANICAL ALLODYNIA; STROMAL CELLS; REGENERATION; TRANSPLANTATION; EXPRESSION	Purpose The neurobehavior of neuropathic pain by chronic constriction injury (CCI) of sciatic nerve is very similar to that in humans, and it is accompanied by a profound local inflammation response. In this study, we assess the potentiality of human amniotic fluid derived mesenchymal stem cells (hAFMSCs) for alleviating the neuropathic pain in a chronic constriction nerve injury model. Methods and Methods This neuropathic pain animal model was conducted by four 3-0 chromic gut ligatures loosely ligated around the left sciatic nerve in Sprague-Dawley rats. The intravenous administration of hAFMSCs with 5x10(5) cells was conducted for three consecutive days. Results The expression IL-1 beta, TNF-alpha and synaptophysin in dorsal root ganglion cell culture was remarkably attenuated when co-cultured with hAFMSCs. The significant decrease of PGP 9.5 in the skin after CCI was restored by administration of hAFMSCs. Remarkably increased expression of CD 68 and TNF-alpha and decreased S-100 and neurofilament expression in injured nerve were rescued by hAFMSCs administration. Increases in synaptophysin and TNF-alpha over the dorsal root ganglion were attenuated by hAFMSCs. Significant expression of TNF-alpha and OX-42 over the dorsal spinal cord was substantially attenuated by hAFMSCs. The increased amplitude of sensory evoked potential as well as expression of synaptophysin and TNF-alpha expression was alleviated by hAFMSCs. Human AFMSCs significantly improved the threshold of mechanical allodynia and thermal hyperalgesia as well as various parameters of CatWalk XT gait analysis. Conclusion Human AFMSCs administration could alleviate the neuropathic pain demonstrated in histomorphological alteration and neurobehavior possibly through the modulation of the inflammatory response.	[Chiang, Chien-Yi; Sheu, Meei-Ling] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Su, Hong-Lin] Natl Chung Hsing Univ, Inst Life Sci, Taichung, Taiwan; [Pan, Hung-Chuan] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Chen, Fu-Chou; Chen, Chun-Jung] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Liu, Shih-An; Pan, Hung-Chuan] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan	National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Pan, HC (corresponding author), Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan.; Pan, HC (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.	hcpan2003@yahoo.com.tw	Sheu, Meei-Ling/AAT-3401-2020	Sheu, Meei-Ling/0000-0002-0431-1282	Taichung Veterans General Hospital [TCVGH-1014905C, TCVGH-NCHU9976071]; Chung-Hsing University [TCVGH-NCHU9976071]	Taichung Veterans General Hospital; Chung-Hsing University	This work received support from Taichung Veterans General Hospital (TCVGH-1014905C) and conjoint support from Taichung Veterans General Hospital and Chung-Hsing University TCVGH-NCHU9976071.; The authors would like to thank all assistants and the support of Taichung Veterans General Hospital (TCVGH-1014905C) and conjoint support of Taichung Veterans General Hospital and Chung-Hsing University (TCVGH-NCHU9976071), and the Biostatistics Task Force of Taichung Veterans General Hospital for their kind assistances in the manuscript preparation and statistical analysis.	Abumaree M, 2012, STEM CELL REV REP, V8, P375, DOI 10.1007/s12015-011-9312-0; Aronin CEP, 2010, BIRTH DEFECTS RES C, V90, P67, DOI 10.1002/bdrc.20174; Baron Ralf, 2008, Curr Opin Support Palliat Care, V2, P1, DOI 10.1097/SPC.0b013e3282f57da5; Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bozkurt A, 2008, J NEUROSCI METH, V173, P91, DOI 10.1016/j.jneumeth.2008.05.020; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Carraro G, 2008, STEM CELLS, V26, P2902, DOI 10.1634/stemcells.2008-0090; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chiang CY, 2014, J NEUROSURG, V120, P250, DOI 10.3171/2013.9.JNS13353; Chou AK, 2002, NEUROSCI LETT, V333, P155, DOI 10.1016/S0304-3940(02)00575-X; Coulthard P, 2002, J NEUROSCI METH, V116, P197, DOI 10.1016/S0165-0270(02)00042-0; Coulthard P, 2003, J NEUROSCI METH, V128, P95, DOI 10.1016/S0165-0270(03)00154-7; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; de Luca AC, 2015, JOVE-J VIS EXP, DOI 10.3791/52543; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; Dowdall T, 2005, PHARMACOL BIOCHEM BE, V80, P93, DOI 10.1016/j.pbb.2004.10.016; Evans LJ, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-1; Ferreira-Gomes J, 2008, J PAIN, V9, P945, DOI 10.1016/j.jpain.2008.05.012; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Franchi S, 2012, PAIN, V153, P850, DOI 10.1016/j.pain.2012.01.008; Gabriel AF, 2007, J NEUROSCI METH, V163, P9, DOI 10.1016/j.jneumeth.2007.02.003; Galluzzi KE, 2005, J AM OSTEOPATH ASSOC, V105, pS12; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Iyer SS, 2008, EXPERT OPIN BIOL TH, V8, P569, DOI 10.1517/14712598.8.5.569 ; Jones BJ, 2008, EXP HEMATOL, V36, P733, DOI 10.1016/j.exphem.2008.03.006; Kang SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/342968; Kingham PJ, 2011, METHODS MOL BIOL, V695, P115, DOI 10.1007/978-1-60761-984-0_8; Klass M, 2007, ANESTH ANALG, V104, P944, DOI 10.1213/01.ane.0000258021.03211.d0; Klein S, 2005, NAT NEUROSCI, V8, P259, DOI 10.1038/nn0305-259; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Lindvall O, 2005, KIDNEY INT, V68, P1937, DOI 10.1111/j.1523-1755.2005.00623.x; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Mareschi K, 2006, EXP HEMATOL, V34, P1563, DOI 10.1016/j.exphem.2006.06.020; Marquez-Curtis LA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/561098; Melzer P, 1998, NEUROSCIENCE, V83, P43, DOI 10.1016/S0306-4522(97)00333-3; Musolino PL, 2007, NEUROSCI LETT, V418, P97, DOI 10.1016/j.neulet.2007.03.001; Okamoto K, 2001, EXP NEUROL, V169, P386, DOI 10.1006/exnr.2001.7677; Owen Davina E, 2012, Methods Mol Biol, V846, P179, DOI 10.1007/978-1-61779-536-7_16; Pan HC, 2007, J CLIN NEUROSCI, V14, P1089, DOI 10.1016/j.jocn.2006.08.008; Pan HC, 2006, J CLIN NEUROSCI, V13, P570, DOI 10.1016/j.jocn.2005.06.007; Pan HC, 2009, NEUROCHEM RES, V34, P1304, DOI 10.1007/s11064-008-9910-7; Pan HC, 2009, NEUROCHEM RES, V34, P518, DOI 10.1007/s11064-008-9815-5; Pitcher GM, 1999, J NEUROSCI METH, V87, P185, DOI 10.1016/S0165-0270(99)00004-7; Pluto CP, 2005, J NEUROPHYSIOL, V94, P1727, DOI 10.1152/jn.00228.2005; POLGAR K, 1989, AM J HUM GENET, V45, P786; Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289; PRIEST RE, 1978, LAB INVEST, V39, P106; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Ren WJ, 2011, NEUROPSYCHOPHARMACOL, V36, P979, DOI 10.1038/npp.2010.236; Roh DH, 2013, CELL TRANSPLANT, V22, P1577, DOI 10.3727/096368912X659907; Rustad KC, 2012, ADV WOUND CARE, V1, P147, DOI 10.1089/wound.2011.0314; Sacerdote P, 2013, STEM CELLS DEV, V22, P1252, DOI 10.1089/scd.2012.0398; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Schafer S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0157-8; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Scuteri A, 2006, BRAIN RES, V1116, P75, DOI 10.1016/j.brainres.2006.07.127; Siniscalco D, 2005, CURR DRUG TARGETS, V6, P75, DOI 10.2174/1389450053344966; Siniscalco D, 2007, CURR MED CHEM, V14, P1783; Siniscalco D, 2011, CURR NEUROPHARMACOL, V9, P523, DOI 10.2174/157015911798376208; Siniscalco D, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00079; Siniscalco D, 2010, CELL MOL LIFE SCI, V67, P655, DOI 10.1007/s00018-009-0202-4; Stojic AS, 2000, J NEUROPHYSIOL, V83, P3377, DOI 10.1152/jn.2000.83.6.3377; Svenningsen AF, 2003, J NEUROSCI RES, V72, P565, DOI 10.1002/jnr.10610; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Vallejo R, 2010, PAIN PRACT, V10, P167, DOI 10.1111/j.1533-2500.2010.00367.x; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Wislet-Gendebien S, 2005, BRAIN RES BULL, V68, P95, DOI 10.1016/j.brainresbull.2005.08.016; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0; Yang DY, 2012, J NEUROSURG, V116, P1357, DOI 10.3171/2012.2.JNS111360; Zelenka M, 2005, PAIN, V116, P257, DOI 10.1016/j.pain.2005.04.018; Zhou J, 2014, ARCH GYNECOL OBSTET, V290, P223, DOI 10.1007/s00404-014-3231-7; Zhou M, 2015, NEUROSCI LETT, V584, P184, DOI 10.1016/j.neulet.2014.10.032; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	80	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							0159482	10.1371/journal.pone.0159482	http://dx.doi.org/10.1371/journal.pone.0159482			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441756	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500080
J	Qi, DY; Roe, BE				Qi, Danyi; Roe, Brian E.			Household Food Waste: Multivariate Regression and Principal Components Analyses of Awareness and Attitudes among US Consumers	PLOS ONE			English	Article							BEHAVIOR; DETERMINANTS; LABELS; GUILT	We estimate models of consumer food waste awareness and attitudes using responses from a national survey of U.S. residents. Our models are interpreted through the lens of several theories that describe how pro-social behaviors relate to awareness, attitudes and opinions. Our analysis of patterns among respondents' food waste attitudes yields a model with three principal components: one that represents perceived practical benefits households may lose if food waste were reduced, one that represents the guilt associated with food waste, and one that represents whether households feel they could be doing more to reduce food waste. We find our respondents express significant agreement that some perceived practical benefits are ascribed to throwing away uneaten food, e.g., nearly 70% of respondents agree that throwing away food after the package date has passed reduces the odds of foodborne illness, while nearly 60% agree that some food waste is necessary to ensure meals taste fresh. We identify that these attitudinal responses significantly load onto a single principal component that may represent a key attitudinal construct useful for policy guidance. Further, multivariate regression analysis reveals a significant positive association between the strength of this component and household income, suggesting that higher income households most strongly agree with statements that link throwing away uneaten food to perceived private benefits.	[Qi, Danyi; Roe, Brian E.] Ohio State Univ, Dept Agr Environm & Dev Econ, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Roe, BE (corresponding author), Ohio State Univ, Dept Agr Environm & Dev Econ, Columbus, OH 43210 USA.	roe.30@osu.edu	Roe, Brian E/A-7386-2009	Roe, Brian E/0000-0003-4228-2889	McCormick Program in Agricultural Marketing and Policy, Department of Agricultural, Environmental and Development Economics, Ohio State University; Ohio Agricultural Research and Development Center, Ohio State University	McCormick Program in Agricultural Marketing and Policy, Department of Agricultural, Environmental and Development Economics, Ohio State University; Ohio Agricultural Research and Development Center, Ohio State University(Ohio State University)	Funding for the survey is from the McCormick Program in Agricultural Marketing and Policy, Department of Agricultural, Environmental and Development Economics, Ohio State University. Partial support for Roe's salary is recognized from the Ohio Agricultural Research and Development Center, Ohio State University. The funders had no role in the study design, data collection and analysis, decision to publish or the preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Alexandratos N, 2012, ESA WORK PAP, V3; Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; Amodio DM, 2007, PSYCHOL SCI, V18, P524, DOI 10.1111/j.1467-9280.2007.01933.x; [Anonymous], 2009, 7 WORKSH GHG INV AS; Aschemann-Witzel J, 2016, SCIENCE, V352, P408, DOI 10.1126/science.aaf2978; Aschemann-Witzel J, 2015, SUSTAINABILITY-BASEL, V7, P6457, DOI 10.3390/su7066457; Ayres I., 2012, J LAW ECON ORGAN; Bagherzadeh M., 2014, FOOD WASTE FOOD CHAI; Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P14, DOI 10.1016/j.jenvp.2006.12.002; Baulcombe D., 2009, REAP BEN SCI SUST IN; BAUMEISTER RF, 1994, PSYCHOL BULL, V115, P243, DOI 10.1037/0033-2909.115.2.243; Bedford T, 2011, RESOLVE WORKING PAPE, V07-11; Bureau USC, 2013, AM HOUS SURV TABL C; Buzby J.C., 2014, USDA ERS EC INFORM B, V121, pEIB; Commission E, 2014, FLASH EUR SURV EUR, DOI 1016/j.wasman.2014.09.019; EPA US, 2015, CART ADV SUST MAT MA; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Grizzetti B, 2013, ENVIRON SCI POLICY, V33, P186, DOI 10.1016/j.envsci.2013.05.013; Gustavsson J, 2011, FOOD LOSSES FOOD WAS; Hatton C., 2013, OPERATION EMPTY PLAT; Kallbekken S, 2013, ECON LETT, V119, P325, DOI 10.1016/j.econlet.2013.03.019; Koivupuro HK, 2012, INT J CONSUM STUD, V36, P183, DOI 10.1111/j.1470-6431.2011.01080.x; Leib EB, 2016, CONSUMER PERCEPTIONS, V23, P19; Mariani J.F., 2014, ENCY AM FOOD DRINK; Mazzoni M., 2013, S KOREA BEGINS CHARG; Milne R, 2012, SOCIOL REV, V60, P84, DOI 10.1111/1467-954X.12039; Neff RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127881; Parizeau K, 2015, WASTE MANAGE, V35, P207, DOI 10.1016/j.wasman.2014.09.019; Porpino G, 2015, INT J CONSUMER STUDI; Porpino G., 2016, J ASSOC CONSUM RES, V1, P41, DOI DOI 10.1086/684528; Quested T., 2013, HOUSEHOLD FOOD DRINK; Quested TE, 2013, RESOUR CONSERV RECY, V79, P43, DOI 10.1016/j.resconrec.2013.04.011; Schneider F, 2009, 12 INT WAST MAN LAND; SCHOELLER DA, 1990, CAN J PHYSIOL PHARM, V68, P941, DOI 10.1139/y90-143; SCHOELLER DA, 1990, NUTR REV, V48, P373, DOI 10.1111/j.1753-4887.1990.tb02882.x; Schwartz S. H., 1977, ADV EXP SOC PSYCHOL, V10, P221, DOI [10.1016/s0065-2601(08)60358-5, 10.1016/S0065-2601(08) 60358-5, DOI 10.1016/S0065-2601(08)60358-5]; Secondi L, 2015, FOOD POLICY, V56, P25, DOI 10.1016/j.foodpol.2015.07.007; Stancu V, 2016, APPETITE, V96, P7, DOI 10.1016/j.appet.2015.08.025; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Van Boxstael S, 2014, FOOD CONTROL, V37, P85, DOI 10.1016/j.foodcont.2013.08.043; WorldBank, 2008, WORLD ENV REP 2008 A; Yoon S, 2005, J KOREA ORG RES RECY, V13, P63	44	134	134	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159250	10.1371/journal.pone.0159250	http://dx.doi.org/10.1371/journal.pone.0159250			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS5CG	27441687	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500046
J	Coria, RA; Currie, PJ				Coria, Rodolfo A.; Currie, Philip J.			A New Megaraptoran Dinosaur (Dinosauria, Theropoda, Megaraptoridae) from the Late Cretaceous of Patagonia	PLOS ONE			English	Article							CARNIVOROUS DINOSAUR; CARNOSAUR DINOSAURIA; EVOLUTION; SPECIMEN; ABELISAURIDAE; NAMUNHUAIQUII; NEUQUEN; ANATOMY; ORIGIN; GEN.	A skeleton discovered in the Upper Cretaceous Sierra Barrosa Formation (Turonian-Coniacian) of Neuquen Province, Argentina represents a new species of theropod dinosaur related to the long snouted, highly pneumatized Megaraptoridae. The holotype specimen of Murusraptor barrosaensis n.gen et n.sp. (MCF-PVPH-411) includes much of the skull, axial skeleton, pelvis and tibia. Murusraptor is unique in having several diagnostic features that include anterodorsal process of lacrimal longer than height of preorbital process, and a thick, shelf-like thickening on the lateral surface of surangular ventral to the groove between the anterior surangular foramen and the insert for the uppermost intramandibular process of the dentary. Other characteristic features of Murusraptor barrosaensis n.gen. et n.sp. include a large mandibular fenestra, distal ends of caudal neural spines laterally thickened into lateral knob-like processes, short ischia distally flattened and slightly expanded dorsoventrally. Murusraptor belongs to a Patagonian radiation of megaraptorids together with Aerosteon, Megaraptor and Orkoraptor. In spite being immature, it is a larger but more gracile animal than existing specimens of Megaraptor, and is comparable in size with Aerosteon and Orkoraptor. The controversial phylogeny of the Megaraptoridae as members of the Allosauroidea or a clade of Coelurosauria is considered analyzing two alternative data sets.	[Coria, Rodolfo A.] Consejo Nacl Invest Cient & Tecn, Gral Roca, Argentina; [Coria, Rodolfo A.] Univ Nacl Rio Negro, Gral Roca, Argentina; [Coria, Rodolfo A.] Museo Carmen Funes, Secretaria Estado Cultura Neuquen, Plaza Huincul, Neuquen, Argentina; [Currie, Philip J.] Univ Alberta, Edmonton, AB, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Alberta	Coria, RA (corresponding author), Consejo Nacl Invest Cient & Tecn, Gral Roca, Argentina.; Coria, RA (corresponding author), Univ Nacl Rio Negro, Gral Roca, Argentina.; Coria, RA (corresponding author), Museo Carmen Funes, Secretaria Estado Cultura Neuquen, Plaza Huincul, Neuquen, Argentina.	rcoria@unrn.edu.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-0233]; National Sciences and Engineering Reserach Council [203091-06]; Troodon Resources; Municipalidad de Plaza Huincul; NSERC [203091-06]; Dinosaur Research Institute; Troodon Resources (Calgary, Canada); Dinosaur Research Institute (Calgary, Canada)	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Sciences and Engineering Reserach Council; Troodon Resources; Municipalidad de Plaza Huincul; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dinosaur Research Institute; Troodon Resources (Calgary, Canada); Dinosaur Research Institute (Calgary, Canada)	Funding was provided by Consejo Nacional de Investigaciones Cientificas y Tecnicas, PIP-0233, RAC National Sciences and Engineering Reserach Council grant #203091-06, PJC, Troodon Resources, Dinosaur Research Institute and Municipalidad de Plaza Huincul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The specimen was found by S. Saldivia (MCF). The authors also thanks to the many people involved in the fieldwork of 2001-2002 in Sierra Barrosa (L. Filippi, A. Garrido, M. Getty, D. Hernandez, A. Paulina Carabajal, M. Ryan, S. Saldivia and W. Sloboda) that participated in collecting MCF-PVPH-411. Thanks are extended for funding support to P.J. Currie, NSERC grant (Grant #203091-06), Troodon Resources (Calgary, Canada), the Dinosaur Research Institute (Calgary, Canada), and Municipalidad de Plaza Huincul for travel and fieldwork assistance. E. Snively (University of Calgary) for photography and A. Paulina Carabajal (MCF) for preparation of braincase of MCF-PVPH-411. E. Koppelhus (UofA) for photography, picture setup, field assistance and logistics. To A. Gerez (MCF) for pencil drawings for Figs 2, 4, 5, 14, 15 and 22. Other figures were done by first author. To K. Kamra for helping in the editing of reviewed version of the manuscript. We thank to the reviewers F. Novas and S. Brusatte, and the PLoSOne Editor L. Claessens whose comments and suggestions greately improved the manuscript. J. Calvo and J. Porfiri (Universidad Nacional del Comahue) gave us access to specimens under their care. F. Novas (Museo Argentino de Ciencias Naturales, Buenos Aires) for access to unpublished information about Megaraptor and Orkoraptor. We also thank the docents and students of School number 291 of Sierra Barrosa, for their hospitality during our stay.	Arcucci AB, 2003, AMEGHINIANA, V40, P217; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Bell PR, 2016, GONDWANA RES, V36, P473, DOI 10.1016/j.gr.2015.08.004; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Bever GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023393; Bonaparte J.F., 1985, Ameghiniana, V21, P259; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P247; Bonaparte J. F., 1990, NATURAL HIST MUSEUM, V416, P1; Bonaparte JF., 1980, MEMOIRES SOC GEOLOGI, V139, P19; Britt B.B., 1991, Brigham Young University Geology Studies, V37, P1; Calvo JO, 2004, AMEGHINIANA, V41, P565; Calvo JO, 2002, 1 C LAT PAL VERT RES, P20; Canale J, 2009, NATURWISSENSCHAFTEN, V96, P409, DOI 10.1007/s00114-008-0487-4; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Claessens LPAM, 2004, J VERTEBR PALEONTOL, V24, P89, DOI 10.1671/A1116-8; Colbert E. H., 1969, American Museum Novitates, VNo. 2380, P1; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; Coria RA, 2006, GEODIVERSITAS, V28, P71; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P802, DOI 10.1671/0272-4634(2002)022[0802:TBOGCD]2.0.CO;2; Coria RA, 2002, AMEGHINIANA, V39, P453; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P460, DOI 10.1671/0272-4634(2002)022[0460:ANCROC]2.0.CO;2; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Coria RA, 1998, GAIA, V15, P89; Coria RA, 2006, CAN J EARTH SCI, V43, P1283, DOI 10.1139/E06-025; Coria Rodolfo A., 2001, P3; Currie Philip J., 2000, Geodiversitas, V22, P207; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Eddy DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017932; Ezcurra M. D., 2016, CONTRIBUCIONES MUSEO, V6, P139; Ezcurra M.D., 2006, HIST BIOL, V19, P185; Forasiepi AM, 2012, AMEGHINIANA, V49, P497, DOI 10.5710/AMGH.8.8.2012.581; Garrido Alberto C., 2010, Rev. Mus. Argent. Cienc. Nat., V12, P121; Gilmore CW., 1920, B US NATL MUSEUM, V110, P1, DOI [10.5479/si.03629236.110.i, DOI 10.5479/SI.03629236.110.I]; Goloboff P.A., 2003, TREE ANAL USING NEW; Hasiotis ST, 1997, COMB ROCK MOUNT SOUT, V29, p13A; Heaton M.J., 1979, OKLAHOMA GEOL SURV B, V127, P1; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Lamanna M, 2004, J VERTEBR PALEONTOL, V64, p252A; Lambe LM, 1904, GEOLOGICAL SURVEY CA, V3, P1; Madsen JH., 2000, UTAH GEOLOGICAL SURV, V2, P1; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Martinelli AG, 2013, RIV ITAL PALEONTOL S, V119, P205, DOI 10.13130/2039-4942/6035; Martinez R, 2004, AMEGHINIANA, V41, P577; Martinez R., 1986, 4 C ARG PAL BIOESTR, V2, P23; Mendez AH, 2012, CR PALEVOL, V11, P251, DOI 10.1016/j.crpv.2011.12.007; Molnar R.E., 1990, P169; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; Novas FE, 1998, J VERTEBR PALEONTOL, V18, P4, DOI 10.1080/02724634.1998.10011030; Novas FE, 2005, NATURWISSENSCHAFTEN, V92, P226, DOI 10.1007/s00114-005-0623-3; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Novas FE, 2005, NATURE, V433, P858, DOI 10.1038/nature03285; Novas FE, 1997, ENCY DINOSAURS; Novas FE, 2008, CRETACEOUS RES, V29, P468, DOI 10.1016/j.cretres.2008.01.001; Novas Fernando E., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P61; Novas FE, 2013, CRETACEOUS RES, V45, P174, DOI 10.1016/j.cretres.2013.04.001; Oelrich T. M., 1956, Miscellaneous Publications Museum of Zoology University of Michigan, V94, P1; Ortega-Colonga F, 2012, AMEGHINIANA, V49, pR33; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Ostrom JH, 1969, OSTEOLOGY DEINONYCHU, V30, P1; Poblete F, 2003, AMEGHINIANA, V40, p66R; Porfiri JD, 2014, CRETACEOUS RES, V51, P35, DOI 10.1016/j.cretres.2014.04.007; RICH TH, 2000, GAIA, V15, P111; Rogers R.R., 1992, Journal of Vertebrate Paleontology, V12, P528; Salgado L, 2009, ZOOTAXA, P1; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; Smith JB, 2007, J VERTEBR PALEONTOL, V27, P103, DOI 10.1671/0272-4634(2007)27[103:DMAVIM]2.0.CO;2; Sues HD, 2002, J VERTEBR PALEONTOL, V22, P535, DOI 10.1671/0272-4634(2002)022[0535:ICASDT]2.0.CO;2; Veralli C., 2003, AMEGHINIANA, V40, p74R; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; White MA, 2015, PEERJ, V3, DOI 10.7717/peerj.1512; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827	78	48	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0157973	10.1371/journal.pone.0157973	http://dx.doi.org/10.1371/journal.pone.0157973			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27439002	gold, Green Published, Green Submitted			2022-12-27	WOS:000380170100004
J	Kanninen, O; Karhula, A				Kanninen, Ohto; Karhula, Aleksi			Changes in Income at Macro Level Predict Sex Ratio at Birth in OECD Countries	PLOS ONE			English	Article							TRIVERS-WILLARD; OFFSPRING SEX; POPULATION; HYPOTHESIS; SELECTION; DECLINE; HUMANS; WAR	The human sex ratio at birth (SRB) is approximately 107 boys for every 100 girls. SRB was rising until the World War II and has been declining slightly after the 1950s in several industrial countries. Recent studies have shown that SRB varies according to exposure to disasters and socioeconomic conditions. However, it remains unknown whether changes in SRB can be explained by observable macro-level socioeconomic variables across multiple years and countries. Here we show that changes in disposable income at the macro level positively predict SRB in OECD countries. A one standard deviation increase in the change of disposable income is associated with an increase of 1.03 male births per 1000 female births. The relationship is possibly nonlinear and driven by extreme changes. The association varies from country to country being particular strong in Estonia. This is the first evidence to show that economic and social conditions are connected to SRB across countries at the macro level. This calls for further research on the effects of societal conditions on general characteristics at birth.	[Kanninen, Ohto] Labour Inst Econ Res, Helsinki, Finland; [Karhula, Aleksi] Univ Turku, Dept Social Res, Turku, Finland	University of Turku	Karhula, A (corresponding author), Univ Turku, Dept Social Res, Turku, Finland.	aleksi.karhula@utu.fi		Karhula, Aleksi/0000-0002-2396-7084				Acemoglu D., 2012, FOREIGN POLICY, P85; Almond D, 2007, P ROY SOC B-BIOL SCI, V274, P2491, DOI 10.1098/rspb.2007.0524; [Anonymous], 2008, SOCIOECONOMIC STATUS; Catalano R, 2006, HUM REPROD, V21, P3127, DOI 10.1093/humrep/del283; Catalano RA, 2003, HUM REPROD, V18, P1972, DOI 10.1093/humrep/deg370; Catalano R, 2008, P NATL ACAD SCI USA, V105, P2244, DOI 10.1073/pnas.0710711104; Catalano R, 2010, AM J HUM BIOL, V22, P396, DOI 10.1002/ajhb.21011; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; Deaton A., 2013, GREAT ESCAPE HLTH WE; Frederick S, 1999, WELL BEING FDN HEDON, P302; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Graffelman J, 2000, HUM BIOL, V72, P433; Grech V., 2015, EUR J SPORTS MED, V2; Grech V, 2012, SCAND J PUBLIC HEALT, V40, P761, DOI 10.1177/1403494812464447; Irgens A, 1999, NOR EPIDEMIOL, V9; Johns SE, 2004, P ROY SOC B-BIOL SCI, V271, pS474, DOI 10.1098/rsbl.2004.0220; Kanazawa S, 2005, J THEOR BIOL, V235, P583, DOI 10.1016/j.jtbi.2005.02.010; Khashan AS, 2009, HUM REPROD, V24, P1754, DOI 10.1093/humrep/dep082; Kolk M, 2016, AM J HUM BIOL, V28, P67, DOI 10.1002/ajhb.22756; LYSTER WR, 1974, J OBSTET GYN BR COMM, V81, P626; Mathews F, 2008, P ROY SOC B-BIOL SCI, V275, P1661, DOI 10.1098/rspb.2008.0105; MEALEY L, 1990, ETHOL SOCIOBIOL, V11, P83, DOI 10.1016/0162-3095(90)90030-A; Navara KJ, 2009, BIOL LETTERS, V5, P524, DOI 10.1098/rsbl.2009.0069; Piketty T., 2014, CAPITAL 21 CENTURY; Polasek O, 2005, HUM REPROD, V20, P2489, DOI 10.1093/humrep/dei097; Ruckstuhl KE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-269; Rueness J, 2012, HUM REPROD, V27, P283, DOI 10.1093/humrep/der347; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WILLIAMS RJ, 1992, SOC BIOL, V39, P285; Zorn B, 2002, HUM REPROD, V17, P3173, DOI 10.1093/humrep/17.12.3173	30	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158943	10.1371/journal.pone.0158943	http://dx.doi.org/10.1371/journal.pone.0158943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437701	Green Submitted, Green Published, gold			2022-12-27	WOS:000380170100025
J	Chowdhury, A; Kalurupalle, S; Tharun, S				Chowdhury, Ashis; Kalurupalle, Swathi; Tharun, Sundaresan			Mutagenic Analysis of the C-Terminal Extension of Lsm1	PLOS ONE			English	Article							MESSENGER-RNA DEGRADATION; SM-LIKE PROTEINS; LSM1-7-PAT1 COMPLEX; SACCHAROMYCES-CEREVISIAE; LSM1P-7P-PAT1P COMPLEX; YEAST; MUTATIONS; DECAY; DEADENYLATION; ASSOCIATION	The Sm-like proteins (also known as Lsm proteins) are ubiquitous in nature and exist as hexa or heptameric RNA binding complexes. They are characterized by the presence of the Sm-domain. The Lsm1 through Lsm7 proteins are highly conserved in eukaryotes and they form a hetero-octameric complex together with the protein Pat1. The Lsm1-7-Pat1 complex plays a key role in mRNA decapping and 3'-end protection and therefore is required for normal mRNA decay rates in vivo. Lsm1 is a key subunit that is critical for the unique RNA binding properties of this complex. We showed earlier that unlike most Sm-like proteins, Lsm1 uniquely requires both its Sm domain and its C-terminal extension to contribute to the function of the Lsm1-7-Pat1 complex and that the C-terminal segment can associate with the rest of the complex and support the function even in trans. The studies presented here identify a set of residues at the very C-terminal end of Lsm1 to be functionally important and suggest that these residues support the function of the Lsm1-7-Pat1 complex by facilitating RNA binding either directly or indirectly.	[Chowdhury, Ashis; Kalurupalle, Swathi; Tharun, Sundaresan] Uniformed Serv Univ Hlth Sci, Dept Biochem, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Tharun, S (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	tharun.sundaresan@usuhs.edu			National Institutes of Health (NIH) [GM072718]; Uniformed Services University of the Health Sciences (USUHS) [RO71JX, BIO-71-3020]; NIH RO1 grant [GM072718]; USUHS [RO71JX, BIO-71-3020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072718] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uniformed Services University of the Health Sciences (USUHS); NIH RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USUHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant# GM072718 to ST; Uniformed Services University of the Health Sciences (USUHS) exploratory grant# RO71JX to ST; and Uniformed Services University of the Health Sciences (USUHS) standard grant# BIO-71-3020 to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funds from NIH RO1 grant (GM072718) and USUHS exploratory (RO71JX) and standard (BIO-71-3020) grants to S.T.	Beggs JD, 2005, BIOCHEM SOC T, V33, P433, DOI 10.1042/BST0330433; Boeck R, 1998, MOL CELL BIOL, V18, P5062, DOI 10.1128/MCB.18.9.5062; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Chowdhury A, 2008, RNA, V14, P2149, DOI 10.1261/rna.1094208; Chowdhury A, 2007, RNA, V13, P998, DOI 10.1261/rna.502507; Chowdhury A, 2012, RNA, V18, P936, DOI 10.1261/rna.029876.111; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; He WH, 2001, GENETICS, V158, P1445; Jungfleisch J, 2015, RNA, V21, P1469, DOI 10.1261/rna.052209.115; Ling SHM, 2011, WIRES RNA, V2, P193, DOI 10.1002/wrna.44; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Sharif H, 2013, CELL REP, V5, P283, DOI 10.1016/j.celrep.2013.10.004; Tharun S, 2005, GENETICS, V170, P33, DOI 10.1534/genetics.104.034322; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; Tharun S, 2009, RNA BIOL, V6, P228, DOI 10.4161/rna.6.3.8282; Tharun S, 2009, INT REV CEL MOL BIO, V272, P149, DOI 10.1016/S1937-6448(08)01604-3; Totaro A, 2011, NUCLEIC ACIDS RES, V39, P635, DOI 10.1093/nar/gkq797; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Zhou L, 2014, CELL RES	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158876	10.1371/journal.pone.0158876	http://dx.doi.org/10.1371/journal.pone.0158876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434131	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600021
J	Kokudo, T; Hasegawa, K; Amikura, K; Uldry, E; Shirata, C; Yamaguchi, T; Arita, J; Kaneko, J; Akamatsu, N; Sakamoto, Y; Takahashi, A; Sakamoto, H; Makuuchi, M; Matsuyama, Y; Demartines, N; Malago, M; Kokudo, N; Halkic, N				Kokudo, Takashi; Hasegawa, Kiyoshi; Amikura, Katsumi; Uldry, Emilie; Shirata, Chikara; Yamaguchi, Takamune; Arita, Junichi; Kaneko, Junichi; Akamatsu, Nobuhisa; Sakamoto, Yoshihiro; Takahashi, Amane; Sakamoto, Hirohiko; Makuuchi, Masatoshi; Matsuyama, Yutaka; Demartines, Nicolas; Malago, Massimo; Kokudo, Norihiro; Halkic, Nermin			Assessment of Preoperative Liver Function in Patients with Hepatocellular Carcinoma - The Albumin-Indocyanine Green Evaluation (ALICE) Grade	PLOS ONE			English	Article							PORTAL-HYPERTENSION; HEPATECTOMY; CIRRHOSIS; RESECTION; SURGERY	Background Most patients with hepatocellular carcinoma (HCC) have underlying liver disease, therefore, precise preoperative evaluation of the patient's liver function is essential for surgical decision making. Methods We developed a grading system incorporating only two variables, namely, the serum albumin level and the indocyanine green retention rate at 15 minutes (ICG R15), to assess the preoperative liver function, based on the overall survival of 1868 patients with HCC who underwent liver resection. We then tested the model in a European cohort (n = 70) and analyzed the predictive power for the postoperative short-term outcome. Results The Albumin-Indocyanine Green Evaluation (ALICE) grading system was developed in a randomly assigned training cohort: linear predictor = 0.663 x log(10)ICG R15 (%)-0.0718 x albumin (g/L) (cut-off value: -2.20 and -1.39). This new grading system showed a predictive power for the overall survival similar to the Child-Pugh grading system in the validation cohort. Determination of the ALICE grade in Child-Pugh A patients allowed further stratification of the postoperative prognosis. This result was reproducible in the European cohort. Determination of the ALICE grade allowed better prediction of the risk of postoperative liver failure and mortality (ascites: grade 1, 2.1%; grade 2, 6.5%; grade 3, 16.0%; mortality: grade 1, 0%; grade 2, 1.3%; grade 3, 5.3%) than the previously reported model based on the presence/absence of portal hypertension. Conclusions This new grading system is a simple method for prediction of the postoperative long-term and short-term outcomes.	[Kokudo, Takashi; Hasegawa, Kiyoshi; Shirata, Chikara; Yamaguchi, Takamune; Arita, Junichi; Kaneko, Junichi; Akamatsu, Nobuhisa; Sakamoto, Yoshihiro; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; [Kokudo, Takashi; Hasegawa, Kiyoshi; Shirata, Chikara; Yamaguchi, Takamune; Arita, Junichi; Kaneko, Junichi; Akamatsu, Nobuhisa; Sakamoto, Yoshihiro; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Artificial Organ & Transplantat Div, Tokyo, Japan; [Kokudo, Takashi; Amikura, Katsumi; Takahashi, Amane; Sakamoto, Hirohiko] Saitama Canc Ctr, Div Gastroenterol Surg, Saitama, Japan; [Uldry, Emilie; Demartines, Nicolas; Halkic, Nermin] CHU Vaudois, Univ Hosp, Dept Visceral Surg, Lausanne, Switzerland; [Makuuchi, Masatoshi] Japanese Red Cross Med Ctr, Div Hepatobilliary Pancreat Surg, Tokyo, Japan; [Matsuyama, Yutaka] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; [Malago, Massimo] UCL, UCL Div Surg & Intervent Sci, Dept Surg, London, England	University of Tokyo; University of Tokyo; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Japanese Red Cross Medical Center; University of Tokyo; University of Tokyo; University of London; University College London	Kokudo, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan.; Kokudo, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Surg, Artificial Organ & Transplantat Div, Tokyo, Japan.	KOKUDO-2SU@h.u-tokyo.ac.jp	Yamaguchi, Takamune/U-8076-2019; Halkic, Nermin/J-6670-2017	Halkic, Nermin/0000-0002-0117-0453; Demartines, Nicolas/0000-0002-1530-3114				Berzigotti A, 2015, HEPATOLOGY, V61, P526, DOI 10.1002/hep.27431; Bruix J, 1996, GASTROENTEROLOGY, V111, P1018, DOI 10.1016/S0016-5085(96)70070-7; Cucchetti A, 2016, J HEPATOL, V64, P79, DOI 10.1016/j.jhep.2015.08.025; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Donadon M, 2015, WORLD J SURG, V39, P237, DOI 10.1007/s00268-014-2786-6; Fan ST, 1999, ANN SURG, V229, P322, DOI 10.1097/00000658-199903000-00004; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Ichikawa T, 2009, J HEPATO-BILIARY-PAN, V16, P42, DOI 10.1007/s00534-008-0003-4; Imamura H, 2003, ARCH SURG-CHICAGO, V138, P1198, DOI 10.1001/archsurg.138.11.1198; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kokudo N, 2015, HEPATOL RES, V45, DOI 10.1111/hepr.12464; Kokudo T, 2014, J HEPATOL, V61, P583, DOI 10.1016/j.jhep.2014.04.032; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Makuuchi M, 1986, SHINDAN TO CHIRYO, V74, P1225; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Mise Y, 2015, ANN SURG, V262, P347, DOI 10.1097/SLA.0000000000000882; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Santambrogio R, 2013, HPB, V15, P78, DOI 10.1111/j.1477-2574.2012.00594.x; Seyama Y, 2009, HEPATOL RES, V39, P107, DOI 10.1111/j.1872-034X.2008.00441.x; Torzilli G, 2013, ANN SURG, V257, P929, DOI 10.1097/SLA.0b013e31828329b8	22	44	48	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159530	10.1371/journal.pone.0159530	http://dx.doi.org/10.1371/journal.pone.0159530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434062	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600064
J	Lee, JH; Chun, JL; Kim, KJ; Kim, EY; Kim, DH; Lee, BM; Han, KW; Park, KS; Lee, KB; Kim, MK				Lee, Ji Hye; Chun, Ju Lan; Kim, Keun Jung; Kim, Eun Young; Kim, Dong-hee; Lee, Bo Myeong; Han, Kil Woo; Park, Kang-Sun; Lee, Kyung-Bon; Kim, Min Kyu			Effect of Acteoside as a Cell Protector to Produce a Cloned Dog	PLOS ONE			English	Article							IN-VITRO DEVELOPMENT; INSULIN-TRANSFERRIN-SELENIUM; DONOR SOMATIC-CELLS; OXYGEN SPECIES ROS; NUCLEAR TRANSFER; CYCLE SYNCHRONIZATION; OXIDATIVE STRESS; CULTURE-MEDIUM; DEVELOPMENTAL ABILITY; FOLLICULAR-FLUID	Somatic cell nuclear transfer (SCNT) is a well-known laboratory technique. The principle of the SCNT involves the reprogramming a somatic nucleus by injecting a somatic cell into a recipient oocyte whose nucleus has been removed. Therefore, the nucleus donor cells are considered as a crucial factor in SCNT. Cell cycle synchronization of nucleus donor cells at G0/G1 stage can be induced by contact inhibition or serum starvation. In this study, acteoside, a phenylpropanoid glycoside compound, was investigated to determine whether it is applicable for inducing cell cycle synchronization, cytoprotection, and improving SCNT efficiency in canine fetal fibroblasts. Primary canine fetal fibroblasts were treated with acteoside (10, 30, 50 mu M) for various time periods (24, 48 and 72 hours). Cell cycle synchronization at G0/G1 stage did not differ significantly with the method of induction: acteoside treatment, contact inhibition or serum starvation. However, of these three treatments, serum starvation resulted in significantly increased level of reactive oxygen species (ROS) (99.5 +/- 0.3%) and apoptosis. The results also revealed that acteoside reduced ROS and apoptosis processes including necrosis in canine fetal fibroblasts, and improved the cell survival. Canine fetal fibroblasts treated with acteoside were successfully arrested at the G0/G1 stage. Moreover, the reconstructed embryos using nucleus donor cells treated with acteoside produced a healthy cloned dog, but not the embryos produced using nucleus donor cells subjected to contact inhibition. In conclusion, acteoside induced cell cycle synchronization of nucleus donor cells would be an alternative method to improve the efficiency of canine SCNT because of its cytoprotective effects.	[Lee, Ji Hye; Chun, Ju Lan; Kim, Keun Jung; Kim, Eun Young; Kim, Dong-hee; Lee, Bo Myeong; Han, Kil Woo; Park, Kang-Sun; Kim, Min Kyu] Chungnam Natl Univ, Coll Agr & Life Sci, Div Anim & Dairy Sci, Daejeon, South Korea; [Lee, Kyung-Bon] Chonnam Natl Univ, Dept Biol Educ, Coll Educ, Gwangju, South Korea	Chungnam National University; Chonnam National University	Kim, MK (corresponding author), Chungnam Natl Univ, Coll Agr & Life Sci, Div Anim & Dairy Sci, Daejeon, South Korea.	kminkyu@cnu.ac.kr		Kim, Keun Jung/0000-0003-2340-8319; KIM, MINKYU/0000-0001-7099-9735	Korea Research institute of Bioscience & Biotechnology (KRIBB) Research Initiative Program [KGM4611613]	Korea Research institute of Bioscience & Biotechnology (KRIBB) Research Initiative Program	This work was supported by a grant from Korea Research institute of Bioscience & Biotechnology (KRIBB) Research Initiative Program (KGM4611613), http://www.kribb.re.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOMED ONLINE, V11, P641, DOI 10.1016/S1472-6483(10)61174-1; Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Arruda ALA, 2011, J MED FOOD, V14, P1604, DOI 10.1089/jmf.2010.0251; Avila JG, 1999, J ETHNOPHARMACOL, V66, P75, DOI 10.1016/S0378-8741(98)00203-7; Boquest AC, 1999, BIOL REPROD, V60, P1013, DOI 10.1095/biolreprod60.4.1013; Campbell K H, 1999, Cloning, V1, P3, DOI 10.1089/15204559950020058; Cho JK, 2002, THERIOGENOLOGY, V57, P1819, DOI 10.1016/S0093-691X(01)00699-9; Cho SR, 2005, REPROD DOMEST ANIM, V40, P171, DOI 10.1111/j.1439-0531.2005.00577.x; Choi YH, 2002, THERIOGENOLOGY, V58, P1187, DOI 10.1016/S0093-691X(02)00946-9; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Das ZC, 2014, ZYGOTE, V22, P411, DOI 10.1017/S0967199412000731; Goissis MD, 2007, REPROD DOMEST ANIM, V42, P660, DOI 10.1111/j.1439-0531.2006.00839.x; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Hase M, 2000, J VET MED SCI, V62, P243, DOI 10.1292/jvms.62.243; Hashem MA, 2006, CELL BIOL INT, V30, P698, DOI 10.1016/j.cellbi.2006.04.008; Jang G, 2004, THERIOGENOLOGY, V62, P512, DOI 10.1016/j.theriogenology.2003.11.022; Jang G, 2010, THERIOGENOLOGY, V74, P1311, DOI 10.1016/j.theriogenology.2010.05.036; Jeong YW, 2008, ANIM REPROD SCI, V106, P13, DOI 10.1016/j.anireprosci.2007.03.021; Kang EJ, 2014, NATURE, V509, P101, DOI 10.1038/nature13134; Kang JT, 2009, J PINEAL RES, V46, P22, DOI 10.1111/j.1600-079X.2008.00602.x; Kasinathan P, 2001, NAT BIOTECHNOL, V19, P1176, DOI 10.1038/nbt1201-1176; Khammanit R, 2008, THERIOGENOLOGY, V70, P27, DOI 10.1016/j.theriogenology.2008.02.015; Kim EY, 2013, J REPROD DEVELOP, V59, P536, DOI 10.1262/jrd.2013-047; Kim KS, 2001, GENES GENET SYST, V76, P243, DOI 10.1266/ggs.76.243; Kitagawa Y, 2004, THERIOGENOLOGY, V62, P1186, DOI 10.1016/j.theriogenology.2004.01.011; Koo OJ, 2009, ZYGOTE, V17, P37, DOI 10.1017/S096719940800498X; Kues Wilfried A., 2002, Cloning and Stem Cells, V4, P231, DOI 10.1089/15362300260339511; Lai LX, 2002, MOL REPROD DEV, V62, P300, DOI 10.1002/mrd.10146; Lee BC, 2005, NATURE, V436, P641, DOI 10.1038/436641a; Lee KW, 2007, CARCINOGENESIS, V28, P1928, DOI 10.1093/carcin/bgm126; Mastromonaco GF, 2007, REPROD FERT DEVELOP, V19, P748, DOI 10.1071/RD07034; Miyamoto K, 2007, J REPROD DEVELOP, V53, P237, DOI 10.1262/jrd.18085; Oback Bjorn, 2002, Cloning and Stem Cells, V4, P147, DOI 10.1089/153623002320253328; Ozawa M, 2006, MOL REPROD DEV, V73, P998, DOI 10.1002/mrd.20533; Park ES, 2004, MOL REPROD DEV, V68, P65, DOI 10.1002/mrd.20046; Park SH, 2014, REPROD DOMEST ANIM, V49, P370, DOI 10.1111/rda.12281; Pendota SC, 2013, J ETHNOPHARMACOL, V148, P515, DOI 10.1016/j.jep.2013.04.047; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Shimatsu Y, 2013, XENOTRANSPLANTATION, V20, P157, DOI 10.1111/xen.12031; Shufaro Y, 2011, METHODS MOL BIOL, V761, P239, DOI 10.1007/978-1-61779-182-6_16; Uhm SJ, 2007, MOL REPROD DEV, V74, P1386, DOI 10.1002/mrd.20701; Umeyama K, 2013, J REPROD DEVELOP, V59, P599, DOI 10.1262/jrd.2013-069; Urakawa M, 2004, THERIOGENOLOGY, V62, P714, DOI 10.1016/j.theriogenology.2003.11.024; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu SC, 2007, AM J EMERG MED, V25, DOI [10.1016/j.ajem.2007.02.039, DOI 10.1016/J.AJEM.2007.02.039]; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yoneda A, 2004, J REPROD DEVELOP, V50, P287, DOI 10.1262/jrd.50.287; You J, 2012, THERIOGENOLOGY, V78, P235, DOI 10.1016/j.theriogenology.2012.02.027; You J, 2010, THERIOGENOLOGY, V74, P777, DOI 10.1016/j.theriogenology.2010.04.002; Zhang FX, 2002, PLANTA MED, V68, P115, DOI 10.1055/s-2002-20255	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159330	10.1371/journal.pone.0159330	http://dx.doi.org/10.1371/journal.pone.0159330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428333	Green Submitted, gold, Green Published			2022-12-27	WOS:000380169300050
J	McTaggart, LR; Brown, EM; Richardson, SE				McTaggart, Lisa R.; Brown, Elizabeth M.; Richardson, Susan E.			Phylogeographic Analysis of Blastomyces dermatitidis and Blastomyces gilchristii Reveals an Association with North American Freshwater Drainage Basins	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; HISTOPLASMA-CAPSULATUM; ASPERGILLUS-FUMIGATUS; COCCIDIOIDES-IMMITIS; PHYLOGENETIC TREES; NATURAL SITES; WISCONSIN; EPIDEMIOLOGY; FUNGUS	Blastomyces dermatitidis and Blastomyces gilchristii are dimorphic fungal pathogens that cause serious pulmonary and systemic infections in humans. Although their natural habitat is in the environment, little is known about their specific ecologic niche(s). Here, we analyzed 25 microsatellite loci from 169 strains collected from various regions throughout their known endemic range in North America, representing the largest and most geographically diverse collection of isolates studied to date. Genetic analysis of multilocus microsatellite data divided the strains into four populations of B. dermatitidis and four populations of B. gilchristii. B. dermatitidis isolates were recovered from areas throughout North America, while the B. gilchristii strains were restricted to Canada and some northern US states. Furthermore, the populations of both species were associated with major freshwater drainage basins. The four B. dermatitidis populations were partitioned among (1) the Nelson River drainage basin, (2) the St. Lawrence River and northeast Atlantic Ocean Seaboard drainage basins, (3) the Mississippi River System drainage basin, and (4) the Gulf of Mexico Seaboard and southeast Atlantic Ocean Seaboard drainage basins. A similar partitioning of the B. gilchristii populations was observed among the more northerly drainage basins only. These associations suggest that the ecologic niche where the sexual reproduction, growth, and dispersal of B. dermatitidis and B. gilchristii occur is intimately linked to freshwater systems. For most populations, sexual reproduction was rare enough to produce significant linkage disequilibrium among loci but frequent enough that mating-type idiomorphic ratios were not skewed from 1:1. Furthermore, the evolutionary divergence of B. dermatitidis and B. gilchristii was estimated at 1.9 MYA during the Pleistocene epoch. We suggest that repeated glaciations during the Pleistocene period and resulting biotic refugia may have provided the impetus for speciation as theorized for other species associated with temperate freshwater systems.	[McTaggart, Lisa R.; Brown, Elizabeth M.; Richardson, Susan E.] Publ Hlth Ontario, Publ Hlth Labs Toronto, Toronto, ON, Canada; [Brown, Elizabeth M.; Richardson, Susan E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Richardson, Susan E.] Hosp Sick Children, Div Microbiol, Dept Paediat Lab Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	McTaggart, LR (corresponding author), Publ Hlth Ontario, Publ Hlth Labs Toronto, Toronto, ON, Canada.	lisa.mctaggart@oahpp.ca	Brown, Elizabeth M./AAI-2537-2019	Brown, Elizabeth M./0000-0003-1411-5792				Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Ali S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003903; [Anonymous], 2014, TRACER V1 6; [Anonymous], 2014, R LANG ENV STAT COMP; April J, 2013, MOL ECOL, V22, P409, DOI 10.1111/mec.12116; Arceneaux KA, 1998, J AM VET MED ASSOC, V213, P658; BAILY GG, 1991, REV INFECT DIS, V13, P1005; BAKERSPIGEL A, 1986, J CLIN MICROBIOL, V24, P890, DOI 10.1128/JCM.24.5.890-891.1986; Barres B, 2012, HEREDITY, V109, P269, DOI 10.1038/hdy.2012.37; Baumgardner D J, 1998, WMJ, V97, P44; Baumgardner DJ, 2006, MYCOPATHOLOGIA, V161, P275, DOI 10.1007/s11046-006-0018-9; Baumgardner DJ, 2005, MED MYCOL, V43, P117, DOI 10.1080/13693780410001731529; Baumgardner DJ, 1999, MED MYCOL, V37, P163, DOI 10.1046/j.1365-280X.1999.00214.x; Benedict K, 2012, CURR FUNGAL INFECT R, V6, P327, DOI 10.1007/s12281-012-0110-1; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BRADSHER RW, 1987, AM REV RESPIR DIS, V136, P1324, DOI 10.1164/ajrccm/136.6.1324; Brisse S, 2009, EUKARYOT CELL, V8, P287, DOI 10.1128/EC.00215-08; Brown EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059237; Cano MV, 2003, EPIDEMIOL INFECT, V131, P907, DOI 10.1017/S0950268803008987; Chapman S W, 1997, Semin Respir Infect, V12, P219; DENTON JF, 1961, SCIENCE, V133, P1126, DOI 10.1126/science.133.3459.1126; DENTON JF, 1964, AM J TROP MED HYG, V13, P716, DOI 10.4269/ajtmh.1964.13.716; DENTON JF, 1979, AM J TROP MED HYG, V28, P697, DOI 10.4269/ajtmh.1979.28.697; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Disalvo Arthur F., 1992, P43; DIXON DM, 1977, MYCOLOGIA, V69, P1193, DOI 10.2307/3758943; Dodgson AR, 2003, J CLIN MICROBIOL, V41, P5709, DOI 10.1128/JCM.41.12.5709-5717.2003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dutech C, 2010, HEREDITY, V105, P220, DOI 10.1038/hdy.2009.164; DUTTERA J, 1969, SOUTHERN MED J, V62, P295; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Fisher MC, 2005, PLOS PATHOG, V1, P159, DOI 10.1371/journal.ppat.0010020; Fisher MC, 2002, P NATL ACAD SCI USA, V99, P9067, DOI 10.1073/pnas.132178099; Fisher MC, 2001, P NATL ACAD SCI USA, V98, P4558, DOI 10.1073/pnas.071406098; Fisher MC, 2000, J CLIN MICROBIOL, V38, P807, DOI 10.1128/JCM.38.2.807-813.2000; FREAN JA, 1989, S AFR MED J, V76, P13; Garcia-Cunchillos I, 2014, MYCORRHIZA, V24, pS89, DOI 10.1007/s00572-013-0540-9; Geml J, 2008, MOL PHYLOGENET EVOL, V48, P694, DOI 10.1016/j.ympev.2008.04.029; Gueho E, 1997, MYCOSES, V40, P69, DOI 10.1111/j.1439-0507.1997.tb00191.x; Hagen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071148; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; HARVEY RP, 1978, AM REV RESPIR DIS, V117, P695; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Henk DA, 2011, MOL ECOL, V20, P4288, DOI 10.1111/j.1365-294X.2011.05244.x; Henk DA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002851; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Institute Broad, 2010, B DERM GEN IND; KANE J, 1984, J CLIN MICROBIOL, V20, P594, DOI 10.1128/JCM.20.3.594-596.1984; Kasuga T, 2003, MOL ECOL, V12, P3383, DOI 10.1046/j.1365-294X.2003.01995.x; Kasuga T, 2002, MOL BIOL EVOL, V19, P2318, DOI 10.1093/oxfordjournals.molbev.a004056; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; KLEIN BS, 1987, AM REV RESPIR DIS, V136, P1333, DOI 10.1164/ajrccm/136.6.1333; KLEIN BS, 1986, NEW ENGL J MED, V314, P529, DOI 10.1056/NEJM198602273140901; LOWRY PW, 1989, AM J EPIDEMIOL, V130, P151, DOI 10.1093/oxfordjournals.aje.a115307; McCullough MJ, 2000, CLIN INFECT DIS, V30, P328, DOI 10.1086/313649; MCDONOUG.ES, 1967, SCIENCE, V156, P528, DOI 10.1126/science.156.3774.528; MCDONOUGH ES, 1970, MYCOPATH MYCOL APPL, V41, P195, DOI 10.1007/BF02051495; MCDONOUGH ES, 1976, SABOURAUDIA, V14, P199; Meece JK, 2013, J INFECT DIS, V207, P814, DOI 10.1093/infdis/jis756; Meece JK, 2011, APPL ENVIRON MICROB, V77, P5123, DOI 10.1128/AEM.00258-11; MENGES RW, 1965, AM J EPIDEMIOL, V81, P164, DOI 10.1093/oxfordjournals.aje.a120505; Munoz JF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005493; Neal COS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-203; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pan WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032868; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pfister JR, 2011, CLIN MED RES, V9, P57, DOI 10.3121/cmr.2010.958; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Pritchard JK, 2000, GENETICS, V155, P945; Randhawa HS, 2013, MED MYCOL, V51, P185, DOI 10.3109/13693786.2012.685960; Reed KD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002034; Rydholm C, 2006, EUKARYOT CELL, V5, P650, DOI 10.1128/EC.5.4.650-657.2006; Saccente M, 2010, CLIN MICROBIOL REV, V23, P367, DOI 10.1128/CMR.00056-09; SAROSI GA, 1976, AM REV RESPIR DIS, V114, P1179; Stefanini I, 2012, P NATL ACAD SCI USA, V109, P13398, DOI 10.1073/pnas.1208362109; Swofford DL, 2003, PAUP PHYLOGENETIC AN, V4; Takezaki N, 1996, GENETICS, V144, P389; Theodoro RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037694; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Weir B. S., 1996, GENETIC DATA ANAL; Zhao TM, 2011, CHINESE MED J-PEKING, V124, P4368, DOI 10.3760/cma.j.issn.0366-6999.2011.24.044	87	24	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159396	10.1371/journal.pone.0159396	http://dx.doi.org/10.1371/journal.pone.0159396			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428521	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300061
J	Petit, O; Merunka, D; Anton, JL; Nazarian, B; Spence, C; Cheok, AD; Raccah, D; Oullier, O				Petit, Olivia; Merunka, Dwight; Anton, Jean-Luc; Nazarian, Bruno; Spence, Charles; Cheok, Adrian David; Raccah, Denis; Oullier, Olivier			Health and Pleasure in Consumers' Dietary Food Choices: Individual Differences in the Brain's Value System	PLOS ONE			English	Article							DECISION-MAKING; SELF-CONTROL; ORBITOFRONTAL CORTEX; TASTY INTUITION; GOAL VALUES; VALUATION; UNHEALTHY; VMPFC; COMPUTATION; TEMPTATION	Taking into account how people value the healthiness and tastiness of food at both the behavioral and brain levels may help to better understand and address overweight and obesity-related issues. Here, we investigate whether brain activity in those areas involved in self-control may increase significantly when individuals with a high body-mass index (BMI) focus their attention on the taste rather than on the health benefits related to healthy food choices. Under such conditions, BMI is positively correlated with both the neural responses to healthy food choices in those brain areas associated with gustation (insula), reward value (orbitofrontal cortex), and self-control (inferior frontal gyrus), and with the percent of healthy food choices. By contrast, when attention is directed towards health benefits, BMI is negatively correlated with neural activity in gustatory and reward-related brain areas (insula, inferior frontal operculum). Taken together, these findings suggest that those individuals with a high BMI do not necessarily have reduced capacities for self-control but that they may be facilitated by external cues that direct their attention toward the tastiness of healthy food. Thus, promoting the taste of healthy food in communication campaigns and/or food packaging may lead to more successful self-control and healthy food behaviors for consumers with a higher BMI, an issue which needs to be further researched.	[Petit, Olivia; Cheok, Adrian David] Imagineering Inst, Iskandar Puteri, Malaysia; [Petit, Olivia; Cheok, Adrian David] City Univ London, London, England; [Petit, Olivia; Merunka, Dwight] Aix Marseille Univ, Aix Marseille Grad Sch Management IAE, CERGAM EA 4225, Aix En Provence, France; [Petit, Olivia; Oullier, Olivier] Aix Marseille Univ, FR-3512 Marseille, France; [Petit, Olivia; Oullier, Olivier] CNRS, Behav Brain & Cognit Inst, LPC, FED 3C,UMR 7290, FR-3512 Marseille, France; [Merunka, Dwight] Kedge Business Sch, Marseille, France; [Anton, Jean-Luc; Nazarian, Bruno] Aix Marseille Univ, CNRS, Ctr IRMf, INT UMR 7289, Marseille, France; [Spence, Charles] Univ Oxford, Crossmodal Res Lab, Oxford, England; [Raccah, Denis] Univ Hosp St Marguerite, Dept Diabetol, Marseille, France	City University London; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Kedge Business School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Oxford; UDICE-French Research Universities; Aix-Marseille Universite	Petit, O (corresponding author), Imagineering Inst, Iskandar Puteri, Malaysia.; Petit, O (corresponding author), City Univ London, London, England.; Petit, O (corresponding author), Aix Marseille Univ, Aix Marseille Grad Sch Management IAE, CERGAM EA 4225, Aix En Provence, France.; Petit, O (corresponding author), Aix Marseille Univ, FR-3512 Marseille, France.; Petit, O (corresponding author), CNRS, Behav Brain & Cognit Inst, LPC, FED 3C,UMR 7290, FR-3512 Marseille, France.	oliviapetit@imagineeringinstitute.org	Cheok, Adrian David/AAT-6141-2021; Petit, Olivia/Y-2937-2018	Cheok, Adrian David/0000-0001-6316-2339; Petit, Olivia/0000-0001-9340-5370				Basso F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100368; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Block LG, 2011, J PUBLIC POLICY MARK, V30, P5, DOI 10.1509/jppm.30.1.5; Booth SL, 2001, NUTR REV, V59, pS21, DOI 10.1111/j.1753-4887.2001.tb06983.x; Brooks SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060393; Bublitz MG, 2010, J CONSUM PSYCHOL, V20, P239, DOI 10.1016/j.jcps.2010.06.008; Fishbach A, 2009, J CONSUM PSYCHOL, V19, P129, DOI 10.1016/j.jcps.2009.02.005; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hofmann W, 2007, J EXP SOC PSYCHOL, V43, P497, DOI 10.1016/j.jesp.2006.05.004; Hollmann M, 2012, INT J OBESITY, V36, P648, DOI 10.1038/ijo.2011.125; Hutcherson CA, 2012, J NEUROSCI, V32, P13543, DOI 10.1523/JNEUROSCI.6387-11.2012; Lallukka T, 2007, EUR J CLIN NUTR, V61, P701, DOI 10.1038/sj.ejcn.1602583; Larson N, 2009, ANN BEHAV MED, V38, pS56, DOI 10.1007/s12160-009-9120-9; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Lurquin JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147770; Mai R, 2015, J PUBLIC POLICY MARK, V34, P63, DOI 10.1509/jppm.14.006; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Pavlicek B., 2013, THESIS, P6; Petit O, 2016, PSYCHOL MARKET, V33, P608, DOI 10.1002/mar.20903; Petit O, 2011, M S-MED SCI, V27, P1000, DOI 10.1051/medsci/201127111000; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Pursey Kirrilly M, 2014, Front Nutr, V1, P7, DOI 10.3389/fnut.2014.00007; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; Rangel A, 2013, NAT NEUROSCI, V16, P1717, DOI 10.1038/nn.3561; Rudorf S, 2014, J NEUROSCI, V34, P15988, DOI 10.1523/JNEUROSCI.3192-14.2014; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Sokol-Hessner P, 2012, EUR J NEUROSCI, V35, P1065, DOI 10.1111/j.1460-9568.2012.08076.x; Spence C, 2016, BRAIN COGNITION, V110, P53, DOI 10.1016/j.bandc.2015.08.006; Sullivan N, 2015, PSYCHOL SCI, V26, P122, DOI 10.1177/0956797614559543; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Turrell G, 2006, PUBLIC HEALTH NUTR, V9, P375, DOI 10.1079/PHN2006850; Tuulari JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116640; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; van der Laan LN, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00308; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Wagner DD, 2013, PSYCHOL SCI, V24, P2262, DOI 10.1177/0956797613492985; Werle COC, 2013, FOOD QUAL PREFER, V28, P116, DOI 10.1016/j.foodqual.2012.07.007	42	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0156333	10.1371/journal.pone.0156333	http://dx.doi.org/10.1371/journal.pone.0156333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27428267	Green Published, gold, Green Accepted			2022-12-27	WOS:000380169300001
J	Yao, ZX; Yuan, Y; Buchanan, TW; Zhang, K; Zhang, L; Wu, JH				Yao, Zhuxi; Yuan, Yi; Buchanan, Tony W.; Zhang, Kan; Zhang, Liang; Wu, Jianhui			Greater Heart Rate Responses to Acute Stress Are Associated with Better Post-Error Adjustment in Special Police Cadets	PLOS ONE			English	Article							COGNITIVE CONTROL; MENTAL FATIGUE; PERFORMANCE; BRAIN; CONTROLLABILITY; DISORDER; BEHAVIOR; FITNESS; SYSTEM; THREAT	High-stress jobs require both appropriate physiological regulation and behavioral adjustment to meet the demands of emergencies. Here, we investigated the relationship between the autonomic stress response and behavioral adjustment after errors in special police cadets. Sixty-eight healthy male special police cadets were randomly assigned to perform a first-time walk on an aerial rope bridge to induce stress responses or a walk on a cushion on the ground serving as a control condition. Subsequently, the participants completed a Go/No-go task to assess behavioral adjustment after false alarm responses. Heart rate measurements and subjective reports confirmed that stress responses were successfully elicited by the aerial rope bridge task in the stress group. In addition, greater heart rate increases during the rope bridge task were positively correlated with post-error slowing and had a trend of negative correlation with post-error miss rate increase in the subsequent Go/No-go task. These results suggested that stronger autonomic stress responses are related to better post-error adjustment under acute stress in this highly selected population and demonstrate that, under certain conditions, individuals with high-stress jobs might show cognitive benefits from a stronger physiological stress response.	[Yao, Zhuxi; Yuan, Yi; Zhang, Kan; Zhang, Liang; Wu, Jianhui] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing, Peoples R China; [Yao, Zhuxi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yuan, Yi] Special Police Acad, Beijing, Peoples R China; [Buchanan, Tony W.] St Louis Univ, Dept Psychol, 221 N Grand Blvd, St Louis, MO 63103 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Saint Louis University	Wu, JH (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing, Peoples R China.	wujh@psych.ac.cn			National Natural Science Foundation of China [81371203, 31100734, 91124003]; China Postdoctoral Science Foundation [2012M520425]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (81371203) received by JW, the National Natural Science Foundation of China (31100734) received by LZ, the National Natural Science Foundation of China (91124003) received by KZ, and a China Postdoctoral Science Foundation Grant (2012M520425) received by YY. The National Natural Science Foundation of China (81371203) supported study design, decision to publish, and preparation of the manuscript. The National Natural Science Foundation of China (31100734) supported data collection and analysis, decision to publish, and preparation of the manuscript. The National Natural Science Foundation of China (91124003) supported decision to publish, and preparation of the manuscript. The China Postdoctoral Science Foundation Grant (2012M520425) supported data collection and analysis.	Akinola M, 2012, BEHAV NEUROSCI, V126, P167, DOI 10.1037/a0026657; Alpers GW, 2008, J ANXIETY DISORD, V22, P591, DOI 10.1016/j.janxdis.2007.05.008; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bratzke D, 2008, INT J PSYCHOL, V43, P712; Cavanagh JF, 2008, PSYCHONEUROENDOCRINO, V33, P41, DOI 10.1016/j.psyneuen.2007.09.007; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; Dishman RK, 2003, PSYCHOPHYSIOLOGY, V40, P370, DOI 10.1111/1469-8986.00040; Donnellan MB, 2006, PSYCHOL ASSESSMENT, V18, P192, DOI 10.1037/1040-3590.18.2.192; Dudschig C, 2009, BRAIN RES, V1296, P56, DOI 10.1016/j.brainres.2009.08.009; Duncko R, 2009, NEUROBIOL LEARN MEM, V91, P377, DOI 10.1016/j.nlm.2009.01.006; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Henderson RK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00179; Hester R, 2004, CEREB CORTEX, V14, P986, DOI 10.1093/cercor/bhh059; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Jentzsch I, 2006, Q J EXP PSYCHOL, V59, P1329, DOI 10.1080/17470210600674394; Jentzsch I, 2009, Q J EXP PSYCHOL, V62, P209, DOI 10.1080/17470210802240655; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Laming DR, 1968, INFORM THEORY CHOICE; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Murphy TI, 2006, J SLEEP RES, V15, P15, DOI 10.1111/j.1365-2869.2006.00503.x; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; Peters ML, 1998, PSYCHONEUROENDOCRINO, V23, P1, DOI 10.1016/S0306-4530(97)00082-6; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Regev S, 2014, ACTA PSYCHOL, V152, P10, DOI 10.1016/j.actpsy.2014.07.006; Schommer NC, 2003, PSYCHOSOM MED, V65, P450, DOI 10.1097/01.PSY.0000035721.12441.17; Themanson JR, 2006, NEUROSCIENCE, V141, P757, DOI 10.1016/j.neuroscience.2006.04.004; Themanson JR, 2012, BRAIN COGNITION, V80, P257, DOI 10.1016/j.bandc.2012.07.003; Tops M, 2011, PSYCHOPHYSIOLOGY, V48, P723, DOI 10.1111/j.1469-8986.2010.01131.x; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Van De Voorde S, 2010, BIOL PSYCHOL, V84, P176, DOI 10.1016/j.biopsycho.2010.01.011; van Meel CS, 2007, PSYCHIAT RES, V151, P211, DOI 10.1016/j.psychres.2006.05.011; van Westerloo DJ, 2011, MOL MED, V17, P180, DOI 10.2119/molmed.2010.00204; Vandewalle G, 2007, J SLEEP RES, V16, P148, DOI 10.1111/j.1365-2869.2007.00581.x; Wessel JR, 2014, CORTEX, V50, P45, DOI 10.1016/j.cortex.2013.09.002; Wu JH, 2014, BIOL PSYCHOL, V99, P77, DOI 10.1016/j.biopsycho.2014.03.002; [张金凤 Zhang Jinfeng], 2012, [中国心理卫生杂志, Chinese Mental Health Journal], V26, P357; Zhang L, 2015, STRESS, V18, P561, DOI 10.3109/10253890.2015.1058356	40	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159322	10.1371/journal.pone.0159322	http://dx.doi.org/10.1371/journal.pone.0159322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27428280	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300049
J	Zhao, ZY; Zou, J; Zhao, LL; Cheng, Y; Cai, HQ; Li, M; Liu, EW; Yu, LP; Liu, Y				Zhao, Zhiyuan; Zou, Jing; Zhao, Lingling; Cheng, Yan; Cai, Hanqing; Li, Mo; Liu, Edwin; Yu, Liping; Liu, Yu			Celiac Disease Autoimmunity in Patients with Autoimmune Diabetes and Thyroid Disease among Chinese Population	PLOS ONE			English	Article							AT-RISK; TYPE-1; AUTOANTIBODIES; PREVALENCE; MECHANISMS	The prevalence of celiac disease autoimmunity or tissue transglutaminase autoantibodies (TGA) amongst patients with type 1 diabetes (T1D) and autoimmune thyroid disease (AITD) in the Chinese population remains unknown. This study examined the rate of celiac disease autoimmunity amongst patients with T1D and AITD in the Chinese population. The study included 178 patients with type 1 diabetes and 119 with AITD where 36 had both T1D and AITD, classified as autoimmune polyglandular syndrome type 3 variant (APS3v). The study also included 145 patients with type 2 diabetes (T2D), 97 patients with non-autoimmune thyroid disease (NAITD), and 102 healthy controls. Serum islet autoantibodies, thyroid autoantibodies and TGA were measured by radioimmunoassay. TGA positivity was found in 22% of patients with either type 1 diabetes or AITD, much higher than that in patients with T2D (3.4%; p < 0.0001) or NAITD (3.1%; P < 0.0001) or healthy controls (1%; p < 0.0001). The patients with APS3v having both T1D and AITD were 36% positive for TGA, significantly higher than patients with T1D alone (p = 0.040) or with AITD alone (p = 0.017). T1D and AITD were found to have a 20% and 30% frequency of overlap respectively at diagnosis. In conclusion, TGA positivity was high in the Chinese population having existing T1D and/or AITD, and even higher when both diseases were present. Routine TGA screening in patients with T1D or AITD will be important to early identify celiac disease autoimmunity for better clinical care of patients.	[Zhao, Zhiyuan; Zou, Jing; Zhao, Lingling; Cheng, Yan; Cai, Hanqing; Li, Mo; Liu, Yu] Jilin Univ, Hosp 2, Dept Endocrinol, Changchun, Jilin, Peoples R China; [Liu, Edwin; Yu, Liping] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA	Jilin University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Liu, Y (corresponding author), Jilin Univ, Hosp 2, Dept Endocrinol, Changchun, Jilin, Peoples R China.	drliuyu@jlu.edu.cn						Agardh D, 2001, Pediatr Diabetes, V2, P58, DOI 10.1034/j.1399-5448.2001.002002058.x; Bao F, 1999, J AUTOIMMUN, V13, P143, DOI 10.1006/jaut.1999.0303; Ch'ng CL, 2007, CLIN MED RES, V5, P184, DOI 10.3121/cmr.2007.738; Ciclitira Paul J., 2005, Molecular Aspects of Medicine, V26, P421, DOI 10.1016/j.mam.2005.05.001; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Eisenbarth GS, 2004, NEW ENGL J MED, V350, P2068, DOI 10.1056/NEJMra030158; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Guariso G, 2007, ALIMENT PHARM THER, V26, P1409, DOI 10.1111/j.1365-2036.2007.03526.x; Horie I, 2012, J CLIN ENDOCR METAB, V97, pE1043, DOI 10.1210/jc.2011-3109; Huber A, 2008, ENDOCR REV, V29, P697, DOI 10.1210/er.2008-0015; Norstrom F, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-125; Tomer Y, 2014, ANNU REV PATHOL-MECH, V9, P147, DOI 10.1146/annurev-pathol-012513-104713; Viljamaa M, 2005, SCAND J GASTROENTERO, V40, P437, DOI 10.1080/00365520510012181; Wenzlau JM, 2008, ANN NY ACAD SCI, V1150, P256, DOI 10.1196/annals.1447.029; Yu LP, 2001, DIABETES, V50, P1735, DOI 10.2337/diabetes.50.8.1735; Yuan JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081151	16	17	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0157510	10.1371/journal.pone.0157510	http://dx.doi.org/10.1371/journal.pone.0157510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427767	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300004
J	Yun, KE; Nam, GE; Lim, J; Park, HS; Chang, Y; Jung, HS; Kim, CW; Ko, BJ; Chung, EC; Shin, H; Ryu, S				Yun, Kyung Eun; Nam, Ga Eun; Lim, Jisun; Park, Hye Soon; Chang, Yoosoo; Jung, Hyun-Suk; Kim, Chan-Won; Ko, Byung-Joon; Chung, Eun Chul; Shin, Hocheol; Ryu, Seungho			Waist Gain Is Associated with a Higher Incidence of Nonalcoholic Fatty Liver Disease in Korean Adults: A Cohort Study	PLOS ONE			English	Article							CARDIOMETABOLIC RISK PROFILE; BODY-MASS INDEX; CARDIOVASCULAR RISK; VISCERAL ADIPOSITY; ABDOMINAL OBESITY; STEATOHEPATITIS; DIAGNOSIS; ATHEROSCLEROSIS; COMPLICATIONS; CIRCUMFERENCE	Background We examined the relationship between changes in waist circumference (WC) and the incidence of nonalcoholic fatty liver disease (NAFLD). Methods A cohort study of 37,130 men and women were followed-up annually or biennially. Differences in WC between baseline and subsequent measurements were categorized in quartiles: first (WC loss), second (no change in WC as the reference), third and highest quartiles (WC gain). The presence of fatty liver was determined using ultrasound. Parametric Cox modeling was used to estimate the adjusted hazard ratios (aHR) and 95% confidence intervals (CIs) of the incidence of NAFLD. Results During 127,324.4 person-years of follow-up, 6249 participants developed NAFLD. Despite adjusting for possible confounders, the risk of development of NAFLD increased with increasing quartiles of WC change in a dose-response manner (p for trend < 0.001). Compared with the reference, WC loss was associated with a lower risk of NAFLD (men: aHR 0.79 [95% CI: 0.73-0.87]; women: 0.72 [0.63-0.81]), and the highest quartile (WC gain) was associated with a higher risk of NAFLD (men: 1.30 [1.19-1.42]; women: 1.48 [1.31-1.67]). Conclusion Waist gain appears to increase the risk of developing NAFLD, independently of the baseline body mass index and WC.	[Yun, Kyung Eun; Chang, Yoosoo; Jung, Hyun-Suk; Kim, Chan-Won; Ko, Byung-Joon; Chung, Eun Chul; Shin, Hocheol; Ryu, Seungho] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Total Healthcare Ctr, Ctr Cohort Studies,Sch Med, Seoul, South Korea; [Nam, Ga Eun] Korea Univ, Ansan Hosp, Coll Med, Dept Family Med, Ansan, South Korea; [Lim, Jisun; Park, Hye Soon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Family Med, Seoul, South Korea; [Chung, Eun Chul] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea; [Shin, Hocheol] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Family Med, Seoul, South Korea; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Occupat & Environm Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Ryu, S (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Total Healthcare Ctr, Ctr Cohort Studies,Sch Med, Seoul, South Korea.; Park, HS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Family Med, Seoul, South Korea.; Ryu, S (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Occupat & Environm Med, Seoul, South Korea.	hyesoon@amc.seoul.kr; sh703.yoo@gmail.com	Nam, Ga Eun/AAU-6055-2020; Nam, Ga Eun/AAA-1577-2021	Nam, Ga Eun/0000-0002-6739-9904; Ryu, Seungho/0000-0002-3927-8646; Chang, Yoosoo/0000-0002-6945-9050; Kim, Chan-Won/0000-0001-5836-1974	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2012 R1A1A2 004869]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2012 R1A1A2 004869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2012 R1A1A2 004869).	Ahmed MH, 2012, J OBES, V2012, DOI 10.1155/2012/483135; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Ballestri S, 2014, WORLD J GASTROENTERO, V20, P1724, DOI 10.3748/wjg.v20.i7.1724; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chang Y, 2006, INT J OBESITY, V30, P800, DOI 10.1038/sj.ijo.0803210; Chang Y, 2014, J AM COLL CARDIOL, V63, P2679, DOI 10.1016/j.jacc.2014.03.042; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Foster T, 2013, DIGEST DIS SCI, V58, P2392, DOI 10.1007/s10620-013-2652-7; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Heilbronn L, 2014, INT J OBESITY, pS12; Joy D, 2003, EUR J GASTROEN HEPAT, V15, P539, DOI 10.1097/01.meg.0000059112.41030.2e; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Kim D, 2016, CLIN GASTROENTEROL H, V14, P132, DOI 10.1016/j.cgh.2015.07.024; Lonardo A, 2000, J GASTROEN HEPATOL, V15, P775, DOI 10.1046/j.1440-1746.2000.02226.x; Lonardo A, 2006, J HEPATOL, V44, P1196, DOI 10.1016/j.jhep.2006.03.005; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; Nazare JA, 2015, AM J CARDIOL, V115, P307, DOI 10.1016/j.amjcard.2014.10.039; Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758; Otgonsuren M, 2013, DIGEST DIS SCI, V58, P1132, DOI 10.1007/s10620-012-2446-3; Pan JJ, 2014, WORLD J HEPATOL, V6, P274, DOI 10.4254/wjh.v6.i5.274; Pang Q, 2015, WORLD J GASTROENTERO, V21, P1650, DOI 10.3748/wjg.v21.i5.1650; Reue K, 2011, J LIPID RES, V52, P1865, DOI 10.1194/jlr.E020602; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Sung KC, 2007, DIABETES CARE, V30, P2113, DOI 10.2337/dc07-0512; Suomela E, 2015, ANN MED, V47, P40, DOI 10.3109/07853890.2014.966752; Suzuki A, 2005, J HEPATOL, V43, P1060, DOI 10.1016/j.jhep.2005.06.008; Targher G, 2016, J HEPATOL; Tison Geoffrey H, 2015, Am J Cardiol, V116, P541, DOI 10.1016/j.amjcard.2015.05.012; van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350; Yang JD, 2014, HEPATOLOGY, V59, P1406, DOI 10.1002/hep.26761; Zhou YJ, 2012, J DIGEST DIS, V13, P153, DOI 10.1111/j.1751-2980.2011.00571.x	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0158710	10.1371/journal.pone.0158710	http://dx.doi.org/10.1371/journal.pone.0158710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420035	Green Published, Green Submitted, gold			2022-12-27	WOS:000379662300004
J	Irrgang, M; Egermann, H				Irrgang, Melanie; Egermann, Hauke			From Motion to Emotion: Accelerometer Data Predict Subjective Experience of Music	PLOS ONE			English	Article								Music is often discussed to be emotional because it reflects expressive movements in audible form. Thus, a valid approach to measure musical emotion could be to assess movement stimulated by music. In two experiments we evaluated the discriminative power of mobile-device generated acceleration data produced by free movement during music listening for the prediction of ratings on the Geneva Emotion Music Scales (GEMS-9). The quality of prediction for different dimensions of GEMS varied between experiments for tenderness (R-1(2)(first experiment) = 0.50, R-2(2)(second experiment) = 0.39), nostalgia (R-1(2) = 0.42, R-2(2) = 0.30), wonder (R-1(2) = 0.25, R-2(2) = 0.34), sadness (R-1(2) = 0.24, R-2(2) = 0.35), peacefulness (R-1(2) = 0.20, R-2(2) = 0.35) and joy (R-1(2) = 0.19, R-2(2) = 0.33) and transcendence (R-1(2) = 0.14, R-2(2) = 0.00). For others like power (R-1(2) = 0.42, R-2(2) = 0.49) and tension (R-1(2) = 0.28, R-2(2) = 0.27) results could be almost reproduced. Furthermore, we extracted two principle components from GEMS ratings, one representing arousal and the other one valence of the experienced feeling. Both qualities, arousal and valence, could be predicted by acceleration data, indicating, that they provide information on the quantity and quality of experience. On the one hand, these findings show how music-evoked movement patterns relate to music-evoked feelings. On the other hand, they contribute to integrate findings from the field of embodied music cognition into music recommender systems.	[Irrgang, Melanie; Egermann, Hauke] Tech Univ Berlin, Audio Commun Grp, Berlin, Germany; [Egermann, Hauke] Univ York, Dept Mus, York, N Yorkshire, England	Technical University of Berlin; University of York - UK	Egermann, H (corresponding author), Tech Univ Berlin, Audio Commun Grp, Berlin, Germany.; Egermann, H (corresponding author), Univ York, Dept Mus, York, N Yorkshire, England.	hauke@egermann.net		Egermann, Hauke/0000-0001-7014-7989				Amelynck D, 2012, IEEE T AFFECT COMPUT, V3, P250, DOI 10.1109/T-AFFC.2011.39; Bergold J, 2012, HIST SOC RES, V37, P191; De Bruyn L, 2011, MUSIC MED, V4; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Egermann H, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01341; Egermann H, 2013, COGN AFFECT BEHAV NE, V13, P533, DOI 10.3758/s13415-013-0161-y; Garrido S, 2011, EMPIR MUSICOL REV, V6, P214, DOI 10.18061/1811/52950; Giordano LB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115587, DOI 10.1371/J0URNAL.P0NE.0115587]; Gomez P, 2007, EMOTION, V7, P377, DOI 10.1037/1528-3542.7.2.377; Hedder KM, 2010, NEW NONVERBAL MEASUR; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2004, J NEW MUSIC RES, V33, P217, DOI 10.1080/0929821042000317813; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; LEMAN M, 2008, EMBODIED MUSIC COGNI; Lepa S, 2013, MEDIA PERSPEKTIVEN, P545; Liljestrom S, 2013, PSYCHOL MUSIC, V41, P579, DOI 10.1177/0305735612440615; Longhi E, 2008, BEHAV BRAIN SCI, V31, P586, DOI 10.1017/S0140525X08005402; Lykartsis A, 2013, MUSIC EMOTION ICME3; PARNCUTT R., 1987, ACTION PERCEPTION RH, P127; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Saarikallio S., 2007, PSYCHOL MUSIC, V35, P88, DOI DOI 10.1177/0305735607068889; Sievers B, 2013, P NATL ACAD SCI USA, V110, P70, DOI 10.1073/pnas.1209023110; Soleymani M, 2013, P MEDEIEVAL 2013 MUL; Torres-Eliard K., 2012, INTELLIGENT TECHNOLO, P252, DOI DOI 10.1007/978-3-642-30214; Trost W, 2014, NEUROIMAGE, V103, P55, DOI 10.1016/j.neuroimage.2014.09.009; Van Someren WM, 1994, THINK ALOUD METHOD P; Zentner M., 2010, HDB MUSIC EMOTION TH, P187, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0008; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494	28	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0154360	10.1371/journal.pone.0154360	http://dx.doi.org/10.1371/journal.pone.0154360			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27415015	Green Published, gold, Green Accepted			2022-12-27	WOS:000379579500007
J	Kanata, S; Koike, S; Ando, S; Nishida, A; Usami, S; Yamasaki, S; Morimoto, Y; Toriyama, R; Fujikawa, S; Sugimoto, N; Sasaki, T; Furukawa, TA; Hiraiwa-Hasegawa, M; Kasai, K				Kanata, Sho; Koike, Shinsuke; Ando, Shuntaro; Nishida, Atsushi; Usami, Satoshi; Yamasaki, Syudo; Morimoto, Yuko; Toriyama, Rie; Fujikawa, Shinya; Sugimoto, Noriko; Sasaki, Tsukasa; Furukawa, Toshiaki A.; Hiraiwa-Hasegawa, Mariko; Kasai, Kiyoto			Enuresis and Hyperactivity-Inattention in Early Adolescence: Findings from a Population-Based Survey in Tokyo (Tokyo Early Adolescence Survey)	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PRIMARY NOCTURNAL ENURESIS; PREPULSE INHIBITION; DIFFICULTIES QUESTIONNAIRE; PROBLEM BEHAVIOR; US CHILDREN; STARTLE; INCONTINENCE; ASSOCIATION; PREVALENCE	Background Enuresis (9% at age 9.5) negatively affects children's psychosocial status. Clinically-diagnosed enuresis (2% at the age) is associated with hyperactivity-inattention, and common neural bases have been postulated to underlie this association. It is, however, unclear whether this association is applicable to enuresis overall among the general population of early adolescents when considered comorbid behavioral problems. We aimed to examine whether enuresis correlates with hyperactivity-inattention after controlling for the effects of other behavioral problems. Methods Participants were 4,478 children (mean age 10.2 +/- 0.3 years old) and their parents from the Tokyo Early Adolescence Survey (T-EAS), a population-representative cross-sectional study conducted in Tokyo, Japan conducted from 2012 to 2015. Children's enuresis and behavioral problems, including hyperactivity-inattention (as measured by the Strength and Difficulties Questionnaire), were examined using parent-reporting questionnaires. Multivariate linear regression was used to explore whether enuresis predicts hyperactivity-inattention. Results The hyperactivity-inattention score was significantly higher in the enuretic group than the non-enuretic group (enuretic: M (SD) = 3.8 (2.3), non-enuretic: M (SD) = 3.0 (2.1), Hedge's g = 0.39, p < .001). This association remained significant even after controlling for other behavioral problems and including sex, age, intelligence quotient (IQ), low birth weight and parents' education (beta = .054 [95% CI:.028-.080], p < .001). Conclusions Enuresis was independently associated with hyperactivity-inattention in early adolescents among general population even when other behavioral problems were considered. These results suggest that, as with clinically-diagnosed cases, enuresis may predict need for screening and psychosocial support for hyperactivity-inattention.	[Kanata, Sho; Koike, Shinsuke; Ando, Shuntaro; Toriyama, Rie; Fujikawa, Shinya; Sugimoto, Noriko; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Kanata, Sho] Teikyo Univ, Sch Med, Dept Psychiat, Tokyo, Japan; [Koike, Shinsuke] Univ Tokyo, UTIDAHM, Tokyo, Japan; [Koike, Shinsuke] Univ Tokyo, Grad Sch Art & Sci, Ctr Evolutionary Cognit Sci, Tokyo, Japan; [Ando, Shuntaro; Nishida, Atsushi; Yamasaki, Syudo; Morimoto, Yuko] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo, Japan; [Usami, Satoshi] Univ Tsukuba, Div Psychol, Fac Human Sci, Tsukuba, Ibaraki, Japan; [Morimoto, Yuko; Hiraiwa-Hasegawa, Mariko] Grad Univ Adv Studies, SOKENDAI, Sch Adv Sci, Dept Evolutionary Studies Biosyst, Hayama, Japan; [Sasaki, Tsukasa] Univ Tokyo, Grad Sch Educ, Lab Hlth Educ, Tokyo, Japan; [Furukawa, Toshiaki A.] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Hlth Promot & Human Behav, Kyoto, Japan	University of Tokyo; Teikyo University; University of Tokyo; University of Tokyo; Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Graduate University for Advanced Studies - Japan; University of Tokyo; Kyoto University	Ando, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan.; Ando, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo, Japan.	ando-st@igakuken.or.jp	Furukawa, Toshi A./B-9259-2011; Andoh, Akira/AAB-9303-2022; Kanata, Sho/AAY-7770-2021; Koike, Shinsuke/AIC-4690-2022	Furukawa, Toshi A./0000-0003-2159-3776; Kasai, Kiyoto/0000-0002-4443-4535; Koike, Shinsuke/0000-0002-3375-236X	Ministry of Education, Culture, Sports, Science and Technology of Japan [23118002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (23118002; Adolescent Mind & Self-Regulation to Kiyoto Kasai) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in the study.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2014, DIAGN STAT MAN MENT, Vfifth; Austin PF, 2016, NEUROUROL URODYNAM, V35, P471, DOI 10.1002/nau.22751; Baeyens D, 2004, J UROLOGY, V171, P2576, DOI 10.1097/01.ju.0000108665.22072.b2; Baeyens D, 2006, J UROLOGY, V176, P744, DOI 10.1016/S0022-5347(06)00295-3; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Bush G, 2011, BIOL PSYCHIAT, V69, P1160, DOI 10.1016/j.biopsych.2011.01.022; Butler R, 2008, CHILD CARE HLTH DEV, V34, P65, DOI 10.1111/j.1365-2214.2007.00781.x; Butler RJ, 2008, SCAND J UROL NEPHROL, V42, P257, DOI 10.1080/00365590701748054; BUTLER RJ, 1990, J CHILD PSYCHOL PSYC, V31, P447, DOI 10.1111/j.1469-7610.1990.tb01581.x; Butler RJ, 2004, CLIN PSYCHOL REV, V24, P909, DOI 10.1016/j.cpr.2004.07.001; Butler RJ, 1998, J CHILD PSYCHOL PSYC, V39, P453, DOI 10.1111/1469-7610.00342; Byrd RS, 1996, PEDIATRICS, V98, P414; Casey BJ, 2010, NEURON, V67, P749, DOI 10.1016/j.neuron.2010.08.033; Coppola G, 2011, PEDIATR NEPHROL, V26, P1829, DOI 10.1007/s00467-011-1880-3; De Bruyne E, 2009, J UROLOGY, V182, P2015, DOI 10.1016/j.juro.2009.05.102; Freitag CM, 2006, DEV MED CHILD NEUROL, V48, P278, DOI 10.1017/S0012162206000600; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hollingshead AB., 2011, YJS, V8, P21, DOI DOI 10.1016/J.MATERRESBULL.2011.04.018; Inada N., 2010, JPN J CHILD ADOLESC, V51, P11; Joinson C, 2007, PEDIATRICS, V120, pE308, DOI 10.1542/peds.2006-2891; Joinson C, 2007, J PEDIATR PSYCHOL, V32, P605, DOI 10.1093/jpepsy/jsl039; Kasai K, 2013, NEUROSCI RES, V75, P89, DOI 10.1016/j.neures.2012.12.001; Lei D, 2012, HUM BRAIN MAPP, V33, P2913, DOI 10.1002/hbm.21411; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; Najman JM, 2001, SOC PSYCH PSYCH EPID, V36, P186, DOI 10.1007/s001270170062; Nappo S, 2002, BJU INT, V90, P912, DOI 10.1046/j.1464-410X.2002.03030.x; Neveus T, 2000, SCAND J UROL NEPHROL, V34, P1; OPPEL WC, 1968, PEDIATRICS, V42, P627; Ornitz EM, 1999, BIOL PSYCHIAT, V45, P1455, DOI 10.1016/S0006-3223(98)00205-4; Park S, 2013, PSYCHIAT INVEST, V10, P253, DOI 10.4306/pi.2013.10.3.253; Redsell SA, 2001, CHILD CARE HLTH DEV, V27, P149, DOI 10.1046/j.1365-2214.2001.00195.x; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Shreeram S, 2009, J AM ACAD CHILD PSY, V48, P35, DOI 10.1097/CHI.0b013e318190045c; Sullivan S, 2015, J DEV BEHAV PEDIATR, V36, P724, DOI 10.1097/DBP.0000000000000229; Van Hoecke E, 2003, J DEV BEHAV PEDIATR, V24, P109, DOI 10.1097/00004703-200304000-00006; Van Hoecke E, 2006, J PEDIATR PSYCHOL, V31, P460, DOI 10.1093/jpepsy/jsj037; von Gontard A, 2006, DEV MED CHILD NEUROL, V48, P744, DOI 10.1017/S0012162206001599; von Gontard A, 2015, EUR CHILD ADOLES PSY, V24, P127, DOI 10.1007/s00787-014-0577-0; von Gontard A, 2011, J UROLOGY, V185, P1432, DOI 10.1016/j.juro.2010.11.051; von Gontard A, 2011, EUR CHILD ADOLES PSY, V20, P83, DOI 10.1007/s00787-010-0152-2; Whalen CK, 2002, CHILD DEV, V73, P209, DOI 10.1111/1467-8624.00401; World Health Organization, 1992, 20 REV INT CLASS DIS; Zink S, 2008, J UROLOGY, V179, P295, DOI 10.1016/j.juro.2007.09.007	44	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158786	10.1371/journal.pone.0158786	http://dx.doi.org/10.1371/journal.pone.0158786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414399	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500040
J	Okami, S; Kohtake, N				Okami, Suguru; Kohtake, Naohiko			Fine-Scale Mapping by Spatial Risk Distribution Modeling for Regional Malaria Endemicity and Its Implications under the Low-to-Moderate Transmission Setting in Western Cambodia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; DIHYDROARTEMISININ-PIPERAQUINE; WETNESS INDEXES; ARTEMISININ; ELIMINATION; POPULATION; EPIDEMIOLOGY; PREVALENCE; RESISTANCE; PROVINCE	The disease burden of malaria has decreased as malaria elimination efforts progress. The mapping approach that uses spatial risk distribution modeling needs some adjustment and reinvestigation in accordance with situational changes. Here we applied a mathematical modeling approach for standardized morbidity ratio (SMR) calculated by annual parasite incidence using routinely aggregated surveillance reports, environmental data such as remote sensing data, and non-environmental anthropogenic data to create fine-scale spatial risk distribution maps of western Cambodia. Furthermore, we incorporated a combination of containment status indicators into the model to demonstrate spatial heterogeneities of the relationship between containment status and risks. The explanatory model was fitted to estimate the SMR of each area (adjusted Pearson correlation coefficient R-2 = 0.774; Akaike information criterion AIC = 149.423). A Bayesian modeling framework was applied to estimate the uncertainty of the model and cross-scale predictions. Fine-scale maps were created by the spatial interpolation of estimated SMRs at each village. Compared with geocoded case data, corresponding predicted values showed conformity [Spearman's rank correlation r = 0.662 in the inverse distance weighed interpolation and 0.645 in ordinal kriging (95% confidence intervals of 0.414-0.827 and 0.368-0.813, respectively), Welch's t-test; Not significant]. The proposed approach successfully explained regional malaria risks and fine-scale risk maps were created under low-to-moderate malaria transmission settings where reinvestigations of existing risk modeling approaches were needed. Moreover, different representations of simulated outcomes of containment status indicators for respective areas provided useful insights for tailored interventional planning, considering regional malaria endemicity.	[Okami, Suguru; Kohtake, Naohiko] Keio Univ, Grad Sch Syst Design & Management, Tokyo, Kanagawa 108, Japan	Keio University	Okami, S (corresponding author), Keio Univ, Grad Sch Syst Design & Management, Tokyo, Kanagawa 108, Japan.	yiu68252@nifty.com		Okami, Suguru/0000-0003-4402-0209	Japanese Ministry of Education, Culture, Sports, Science and Technology; Space Application Promotion Program - NEC Corporation	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Space Application Promotion Program - NEC Corporation	This research has been conducted as a part of the G-SPASE Program supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology, and the Space Application Promotion Program funded by NEC Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], 2013, EM RESP ART RES GREA; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Cheng T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100465; Cianci D, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0001-0; Clements ACA, 2013, LANCET INFECT DIS, V13, P709, DOI 10.1016/S1473-3099(13)70140-3; Cohen JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-61; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-328; Cohen JM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-40; Cox J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-282; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Ghebreyesus TA, 1999, BRIT MED J, V319, P663, DOI 10.1136/bmj.319.7211.663; Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hoyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045797; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Jelinski DE, 1996, LANDSCAPE ECOL, V11, P129, DOI 10.1007/BF02447512; Kurshcke JK, 2014, DOING BAYESIAN DATA; Leang R, 2015, ANTIMICROB AGENTS CH, V59, P4719, DOI 10.1128/AAC.00835-15; Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12; Lowe R, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-416; Lwin KM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0838-5; Martin C, 2002, HEALTH PLACE, V8, P227, DOI 10.1016/S1353-8292(02)00008-4; Martuzzi M, 1996, STAT MED, V15, P1867; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; McCann RS, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-17; Medecins Sans Frontieres, 2005, UNPUB; Mellor S, 2013, MOVING MALARIA ELIMI; Meyer DJ, 2012, INT ARCH PHOTOGRAMM, V39-B4, P291; Moyes CL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-161; National Center for Parasitology Entomology and Malaria Control, 2005, REP CAMB NAT MAL BAS; National Center for Parasitology Entomology and Malaria Control, 2007, CAMB MAL SURV 2007 R; National Center for Parasitology Entomology and Malaria Control, 2014, BEN NAT MAL PROGR RE; National Center for Parasitology Entomology and Malaria Control, 2011, CAMB MAL B; National Center for Parasitology Entomology and Malaria Control, 2013, CAMB MAL B; National Center for Parasitology Entomology and Malaria Control, 2011, STRAT PLAN EL MAL CA; National Centre for Parasitology Entomology and Malaria Control (CNM), 2010, CAMB MAL SURV 2010; Nihei N, 2002, JPN J INFECT DIS, V55, P160; Nmor JC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-14; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Oloukoi G, 2014, HEALTH PLACE, V25, P47, DOI 10.1016/j.healthplace.2013.09.009; Smith DL, 2009, SHRINKING MALARIA MA, P108; St Laurent B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9614; Sturrock HJW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-421; Tango T., 2007, INTRO SPATIAL EPIDEM; Targett GA, 2009, PROSPECTUS MALARIA E; Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133; Tatem AJ, 2010, LANCET, V376, P1579, DOI 10.1016/S0140-6736(10)61301-3; Tatem AJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-218; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2015, Q A ART RES; World Health Organization, 2007, MAL EL FIELD MAN LOW; World Health Organization, 2015, UPD ART ACT RES SEP; World Health Organization, 2015, GUID TREATM MAL, Vthird	65	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158737	10.1371/journal.pone.0158737	http://dx.doi.org/10.1371/journal.pone.0158737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415623	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500033
J	Martin, JE; Raffel, J; Nicholas, R				Martin, Jessica E.; Raffel, Joel; Nicholas, Richard			Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care	PLOS ONE			English	Article							PALLIATIVE CARE; UNMET NEEDS; PEOPLE; MORTALITY; SERVICE; TRIAL; DEATH; HOME	Introduction In the general ageing population, 40% of deaths occur following a prolonged trajectory of "progressive dwindling," characterised by chronic accumulation of disability and frailty, and associated with increased dependency and reduced reserves. Those who progressively dwindle are poorly catered for by current healthcare systems and would benefit from a coordinated approach to their medical and social care, known as formative care. People with multiple sclerosis (pwMS) may be more likely to progressively dwindle, and may be appropriate targets for formative care pathways. Objectives To determine the proportion of pwMS who follow a progressive dwindling trajectory prior to death. To relate trajectory to place of death, and examine what factors predict the progressively dwindling trajectory. Methods A retrospective observational study of 582 deceased pwMS enrolled in the UK MS Tissue Bank, including death certificates and extensive clinical summaries. Results 73.7% of pwMS had a "progressively dwindling" trajectory of dying. This was predicted by those who reach MS disease milestones earlier. 72.5% of pwMS died an MS-related death, which was predicted by an aggressive disease course from onset. Those who progressively dwindled were equally likely to die in hospital as those with other trajectories to death. Conclusions The progressively dwindling trajectory of dying is very common in pwMS, and can be predicted by earlier disease milestones. Pathways could target pwMS in these years prior to death, to improve care.	[Martin, Jessica E.; Raffel, Joel; Nicholas, Richard] Imperial Coll London, Dept Med, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, London, England	Imperial College London	Nicholas, R (corresponding author), Imperial Coll London, Dept Med, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, London, England.	r.nicholas@imperial.ac.uk			National Institute for Health Research; Parkinson&quot;s UK [J-1402] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	Dr. Richard Nicholas is supported by the National Institute for Health Research.	[Anonymous], 2008, 9840 DEP HLTH REP; Borreani C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109679; Bowman C, 2014, J ROY SOC MED, V107, P95, DOI 10.1177/0141076813512298; Comptroller and Auditor General, 2019, CHALL US DAT GOV; Degenhardt A, 2009, NAT REV NEUROL, V5, P672, DOI 10.1038/nrneurol.2009.178; Edmonds P, 2010, MULT SCLER J, V16, P627, DOI 10.1177/1352458510364632; Galushko M, 2014, J PALLIAT MED, V17, P274, DOI 10.1089/jpm.2013.0497; Goldacre MJ, 2010, J NEUROL, V257, P706, DOI 10.1007/s00415-009-5392-z; Golla H, 2015, PALLIAT SUPPORT CARE, V13, P1685, DOI 10.1017/S1478951515000607; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Higginson IJ, 2011, POSTGRAD MED J, V87, P769, DOI 10.1136/postgradmedj-2011-130290; Higginson IJ, 2009, J PAIN SYMPTOM MANAG, V38, P816, DOI 10.1016/j.jpainsymman.2009.07.002; Hirst C, 2008, J NEUROL NEUROSUR PS, V79, P1016, DOI 10.1136/jnnp.2007.127332; Jick SS, 2014, J NEUROL, V261, P1508, DOI 10.1007/s00415-014-7370-3; Koffman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075431; Lynn J, 2003, LIVING WELL END LIFE; Moens K, 2014, J PAIN SYMPTOM MANAG, V48, P660, DOI 10.1016/j.jpainsymman.2013.11.009; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murtagh FEM, 2014, PALLIATIVE MED, V28, P49, DOI 10.1177/0269216313489367; Office for National Statistics, 2013, DEATHS ENGL WAL 2013; Office for National Statistics, SUIC UK 2013; Parliamentary and Health Service Ombudsman, DYING DIGN 2015; Pring A., 2013, CLASSIFICATION PLACE; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Reynolds R, 2011, ACTA NEUROPATHOL, V122, P155, DOI 10.1007/s00401-011-0840-0; Scalfari A, 2013, NEUROLOGY, V81, P184, DOI 10.1212/WNL.0b013e31829a3388; Shipman C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1720; Sleeman KE, 2013, PALLIATIVE MED, V27, P840, DOI 10.1177/0269216313490436; Solari A, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0695-0; Strupp J, 2014, J PALLIAT MED, V17, P1128, DOI 10.1089/jpm.2013.0667	30	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159210	10.1371/journal.pone.0159210	http://dx.doi.org/10.1371/journal.pone.0159210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441557	Green Submitted, gold, Green Published			2022-12-27	WOS:000380797500044
J	Moshayoff, V; Faktor, O; Laghi, L; Celesti, G; Peretz, T; Keret, D; Cohen, D; Israeli, E				Moshayoff, Vardit; Faktor, Ouriel; Laghi, Luigi; Celesti, Giuseppe; Peretz, Tamar; Keret, Dan; Cohen, Dana; Israeli, Eran			Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle	PLOS ONE			English	Article							MESSENGER-RNA; AMERICAN-COLLEGE; CANCER; SURVEILLANCE; BIOMARKERS; GUIDELINE; PLASMA; TRANSCRIPTOME; MICRORNAS; DIAGNOSIS	Despite recent advances in molecular profiling of colorectal cancer (CRC), as of yet this has not translated into an unbiased molecular liquid biopsy profile which can accurately screen for early CRC. In this study we depict the profile of early stage CRC as well as for advanced adenomas (AA) by combination of current molecular knowledge with microarray technology, using efficient circulating free plasma RNA purification from blood and RNA amplification technologies. We joined literature search with Affymetrix gene chip experimental procedure to draw the circulating free plasma RNA profile of colorectal cancer disease reflected in blood. The RNA panel was tested by two datasets comparing patients with CRC with healthy subjects and patients with AA to healthy subjects. For the CRC patient cohort (28 CRC cases vs. 41 healthy controls), the ROC analysis of the selected biomarker panel generated a sensitivity of 75% and a specificity of 93% for the detection of CRC using 8-gene classification model. For the AA patient cohort (28 subjects vs. 46 healthy controls), a sensitivity of 60% and a specificity of 87% were calculated using a 2-gene classification model. We have identified a panel of 8 plasma RNA markers as a preliminary panel for CRC detection and subset markers suitable for AA detection. Subjected to extensive clinical validation we suggest that this panel represents a feasible approach and a potential strategy for noninvasive early diagnosis, as a first-line screening test for asymptomatic, average-risk population before colonoscopy.	[Moshayoff, Vardit; Faktor, Ouriel; Cohen, Dana] Biomarcare Technol, BioPk, Jerusalem, Israel; [Laghi, Luigi; Celesti, Giuseppe] Humanitas Clin & Res Ctr, Milan, Italy; [Peretz, Tamar] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel; [Keret, Dan] Clalit Hlth Serv, Dept Gastroenterol & Hepatol, Jerusalem, Israel; [Israeli, Eran] Hadassah Hebrew Univ, Med Ctr, Inst Gastroenterol & Liver Dis, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Clalit Health Services; Hebrew University of Jerusalem; Hadassah University Medical Center	Israeli, E (corresponding author), Hadassah Hebrew Univ, Med Ctr, Inst Gastroenterol & Liver Dis, Jerusalem, Israel.	erani@hadassah.org.il	Laghi, Luigi/GZM-5831-2022	Laghi, Luigi/0000-0003-4187-1059; Israeli, Eran/0000-0001-8679-4363	BioMarCare Technologies Ltd.; BioMarCare	BioMarCare Technologies Ltd.; BioMarCare	The research was funded by BioMarCare Technologies Ltd. BioMarCare Technologies is a commercial for-profit company. BioMarCare provided support in the form of salaries for authors [OF, DC, VM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne ST, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1327-5; Ahlquist DA, 2010, GASTROENTEROLOGY, V138, P2127, DOI 10.1053/j.gastro.2010.01.055; [Anonymous], 2014, JAMA, V312, P2566, DOI 10.1001/jama.2014.15746; Brenner H, 2014, GASTROENTEROLOGY, V146, P709, DOI 10.1053/j.gastro.2013.09.001; Vega AB, 2013, ONCOL REP, V30, P320, DOI 10.3892/or.2013.2475; Carter HB, 2013, BJU INT, V112, P543, DOI 10.1111/bju.12318; Collado M, 2007, CLIN CHEM, V53, P1860, DOI 10.1373/clinchem.2007.089201; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Davis KC, 1998, PUBLIC HEALTH REP, V113, P346; De Maio G, 2014, WORLD J GASTROENTERO, V20, P957, DOI 10.3748/wjg.v20.i4.957; Fernandez-Mercado M, 2015, J CELL MOL MED, V19, P2307, DOI 10.1111/jcmm.12625; Ganepola GAP, 2014, WORLD J GASTRO ONCOL, V6, P83, DOI 10.4251/wjgo.v6.i4.83; Gonzalo DH, 2013, J PATHOL, V230, P420, DOI 10.1002/path.4200; Hamm A, 2016, GUT, V65, P990, DOI 10.1136/gutjnl-2014-308988; Kasap E, 2016, TUMOR BIOL, V37, P3071, DOI 10.1007/s13277-015-4131-6; Koga Y, 2014, EXPERT REV MOL DIAGN, V14, P107, DOI 10.1586/14737159.2014.863152; Kopreski MS, 1999, CLIN CANCER RES, V5, P1961; Lauriola M, 2010, INT J ONCOL, V37, P519, DOI 10.3892/ijo_0000070; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lo KW, 1999, CLIN CHEM, V45, P1292; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Marshall KW, 2010, INT J CANCER, V126, P1177, DOI 10.1002/ijc.24910; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mohammed N, 2011, ONCOL LETT, V2, P719, DOI 10.3892/ol.2011.294; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Oliveros J., VENNY 2 0 INTERACTIV; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Shi XY, 2013, BIOCHEM BIOPH RES CO, V435, P282, DOI 10.1016/j.bbrc.2013.04.063; Svec J, 2010, INT J EXP PATHOL, V91, P44, DOI 10.1111/j.1365-2613.2009.00698.x; Syngal S, 2015, AM J GASTROENTEROL, V110, P223, DOI 10.1038/ajg.2014.435; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Van Roosbroeck K, 2013, EXPERT REV MOL DIAGN, V13, P183, DOI [10.1586/ERM.12.134, 10.1586/erm.12.134]; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087451, 10.1371/journal.pone.0107012]; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wu YA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041001; Xu Y, 2013, RADIAT ONCOL, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0062397	40	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159522	10.1371/journal.pone.0159522	http://dx.doi.org/10.1371/journal.pone.0159522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441409	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500087
J	Peng, W; Tariq, K; Xie, JF; Zhang, HY				Peng, Wei; Tariq, Kaleem; Xie, Junfei; Zhang, Hongyu			Identification and Characterization of Sex-Biased MicroRNAs in Bactrocera dorsalis (Hendel)	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; DROSOPHILA-MELANOGASTER; FRUIT-FLY; EXPRESSION; GENE; LET-7; CHROMOSOME; MATURATION; REGULATOR; EVOLUTION	MicroRNAs (miRNAs) are a class of endogenous small non-coding RNAs that regulate various biological processes including sexual dimorphism. The oriental fruit fly Bactrocera dorsalis is one of the most destructive agricultural insect pests in many Asian countries. However, no miRNAs have been identified from the separate sex and gonads to elucidate sex gonad differentiation in B. dorsalis. In this study, we constructed four small RNA libraries from whole body of females, males (except ovaries and testes) and ovaries, testes of B. dorsalis for deep sequencing. The data analysis revealed 183 known and 120 novel miRNAs from these libraries. 18 female-biased and 16 male-biased miRNAs that may be involved in sexual differentiation were found by comparing the miRNA expression profiles in the four libraries. Using a bioinformatic approach, we predicted doublesex (dsx) as a target gene of the female-biased miR-989-3p which is considered as the key switch gene in the sex determination of tephritid insects. This study reveals the first miRNA profile related to the sex differentiation and gives a first insight into sex differences in miRNA expression of B. dorsalis which could facilitate studies of the reproductive organ specific roles of miRNAs.	[Zhang, Hongyu] Huazhong Agr Univ, State Key Lab Agr Microbiol, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Hubei, Peoples R China; Huazhong Agr Univ, Inst Urban & Hort Entomol, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Zhang, HY (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Hubei, Peoples R China.	hongyu.zhang@mail.hzau.edu.cn	TARIQ, KALEEM/J-7875-2015	TARIQ, KALEEM/0000-0002-0951-509X; xie, junfei/0000-0001-7418-7355	earmarked fund for the China Agricultural Research System [CARS-27]; Fundamental Research Funds for the Central Universities [2014PY005]	earmarked fund for the China Agricultural Research System; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the earmarked fund for the China Agricultural Research System (No. CARS-27) and Fundamental Research Funds for the Central Universities (No. 2014PY005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the earmarked fund for the China Agricultural Research System (No. CARS-27) and Fundamental Research Funds for the Central Universities (No. 2014PY005).	Ashburner M, 2005, GENOME RES, V15, P1661, DOI 10.1101/gr.3726705; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Cutting AD, 2012, CHROMOSOME RES, V20, P201, DOI 10.1007/s10577-011-9263-y; Dezulian T., 2005, GENOME BIOL, V6, pP13, DOI DOI 10.1186/GB-2005-6-11-P13; Du Y, 2014, MOL REPROD DEV, V81, P1042, DOI 10.1002/mrd.22426; Enright AJ, 2004, GENOME BIOL, V5; Fagegaltier D, 2014, GENETICS, V198, P647, DOI 10.1534/genetics.114.169268; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fisher B., 2012, BDGP INSITU HOMEPAGE; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; Huang Y, 2014, INSECT MOL BIOL, V23, P656, DOI 10.1111/imb.12111; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li SC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S13; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano J, 2015, P NATL ACAD SCI USA, V112, P3740, DOI 10.1073/pnas.1418522112; Marco A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140024; Marco A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002402; Marco A, 2010, GENOME BIOL EVOL, V2, P686, DOI 10.1093/gbe/evq053; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; Ninova M, 2015, BIORXIV; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peng W, 2015, GENETICA, V143, P717, DOI 10.1007/s10709-015-9869-7; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shepotitiovskaya IV, 2008, BIOCHEMISTRY-US, V47, P7034, DOI 10.1021/bi7025358; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Tariq K, 2016, INSECT MOL BIOL, V25, P32, DOI 10.1111/imb.12196; Tehler D, 2011, RNA BIOL, V8, P728, DOI 10.4161/rna.8.5.16324; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WILKINS AS, 1995, BIOESSAYS, V17, P71, DOI 10.1002/bies.950170113; Willhoeft U, 1996, GENETICS, V144, P737; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zhang H., 2012, PHOTOGRAPHIC GUIDE K; Zhang XF, 2012, INSECT BIOCHEM MOLEC, V42, P381, DOI 10.1016/j.ibmb.2012.01.006	58	16	17	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159591	10.1371/journal.pone.0159591	http://dx.doi.org/10.1371/journal.pone.0159591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441641	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500100
J	Panzarin, V; Toffan, A; Abbadi, M; Buratin, A; Mancin, M; Braaen, S; Olsen, CM; Bargelloni, L; Rimstad, E; Cattoli, G				Panzarin, Valentina; Toffan, Anna; Abbadi, Miriam; Buratin, Alessandra; Mancin, Marzia; Braaen, Stine; Olsen, Christel Moraeus; Bargelloni, Luca; Rimstad, Espen; Cattoli, Giovanni			Molecular Basis for Antigenic Diversity of Genus Betanodavirus	PLOS ONE			English	Article							VIRAL NERVOUS NECROSIS; HALIBUT HIPPOGLOSSUS-HIPPOGLOSSUS; JACK PSEUDOCARANX-DENTEX; JUVENILE SEA BASS; DICENTRARCHUS-LABRAX; MASS MORTALITIES; LATES-CALCARIFER; SUBGENOMIC RNA3; CELL-LINE; NODAVIRUS	Betanodaviruses are the causative agents of viral nervous necrosis (VNN), a devastating disease for the Mediterranean mariculture. Four different betanodavirus species are recognized, Striped jack-, Redspotted grouper-, Tiger puffer-, and Barfin flounder nervous necrosis virus (SJNNV, RGNNV, TPNNV and BFNNV), but there is little knowledge on their antigenic properties. In order to describe the serological relationships among different betanodavirus genotypes, serum neutralization assays were performed using rabbit polyclonal antisera against eight fish nodaviruses that cover a wide species-, temporal-, spatial- and genetic range. The results indicate that the SJNNV and RGNNV are antigenically distinct, constituting serotypes A and C, respectively. The TPNNV and BFNNV, the latter representing cold-water betanodaviruses, are antigenically related and cluster within serotype B. The reassortant viruses RGNNV/SJNNV and SJNNV/RGNNV group within serotypes A and C, respectively, indicating that the coat protein encoded by RNA2 acts as major immunoreactivity determinant. Immunostaining of in vitro expressed wild type and chimeric capsid proteins between the RGNNV and the SJNNV species indicated that the C-terminal part of the capsid protein retains the immunoreactive portion. The amino acid (aa) residues determining RGNNV and SJNNV antigenic diversity were mapped to aa residues 217-256 and aa 257-341, respectively. Neutralization of reverse genetics derived chimeric viruses indicated that these areas determine the neutralizing epitopes. The data obtained are crucial for the development of targeted serological tests for the diagnosis of VNN, and informative for development of cross-protective vaccines against various betanodavirus genotypes.	[Panzarin, Valentina; Toffan, Anna; Abbadi, Miriam; Buratin, Alessandra; Mancin, Marzia; Cattoli, Giovanni] Ist Zooprofilatt Sperimentale Venezie, Dept Comparat Biomed Sci, OIE Reference Lab Viral Encephalopathy & Retinopa, Legnaro, PD, Italy; [Panzarin, Valentina; Bargelloni, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy; [Braaen, Stine; Olsen, Christel Moraeus; Rimstad, Espen] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway	IZS delle Venezie; University of Padua; Norwegian University of Life Sciences	Panzarin, V (corresponding author), Ist Zooprofilatt Sperimentale Venezie, Dept Comparat Biomed Sci, OIE Reference Lab Viral Encephalopathy & Retinopa, Legnaro, PD, Italy.; Panzarin, V (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.	vpanzarin@izsvenezie.it	TOFFAN, ANNA/AAW-8725-2020	TOFFAN, ANNA/0000-0003-4389-3489; Panzarin, Valentina/0000-0002-9376-1612; mancin, marzia/0000-0002-7260-6031	Italian Ministry of Health [IZSVE 5/11 RC, IZSVE 2/14 RC]	Italian Ministry of Health(Ministry of Health, Italy)	This study was funded by the Italian Ministry of Health (http://www.salute.gov.it/), grant numbers IZSVE 5/11 RC and IZSVE 2/14 RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441; Athanassopoulou F, 2003, J FISH DIS, V26, P361, DOI 10.1046/j.1365-2761.2003.00458.x; Azad IS, 2005, DIS AQUAT ORGAN, V63, P113, DOI 10.3354/dao063113; Beato MS, 2013, VIROLOGY, V435, P350, DOI 10.1016/j.virol.2012.09.016; Bovo G, 1999, VIRUS RES, V63, P143, DOI 10.1016/S0168-1702(99)00068-4; Chen NC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005203; Cherif N, 2009, VET RES COMMUN, V33, P345, DOI 10.1007/s11259-008-9182-3; Chi SC, 2003, DIS AQUAT ORGAN, V55, P221, DOI 10.3354/dao055221; Chi SC, 1997, J FISH DIS, V20, P185, DOI 10.1046/j.1365-2761.1997.00291.x; Costa JZ, 2007, J FISH DIS, V30, P419, DOI 10.1111/j.1365-2761.2007.00824.x; FAO, 2014, FISHSTATJ SOFTW FISH; Fenner BJ, 2006, J VIROL, V80, P85, DOI 10.1128/JVI.80.1.85-94.2006; Frerichs GN, 1996, J GEN VIROL, V77, P2067, DOI 10.1099/0022-1317-77-9-2067; Gagne N, 2004, DIS AQUAT ORGAN, V62, P181, DOI 10.3354/dao062181; Grotmol S, 2000, DIS AQUAT ORGAN, V39, P79, DOI 10.3354/dao039079; Hellberg H, 2010, J FISH DIS, V33, P75, DOI 10.1111/j.1365-2761.2009.01092.x; Hill B. J., 1995, Annual Review of Fish Diseases, V5, P55, DOI 10.1016/0959-8030(95)00011-9; Ito Y, 2008, DIS AQUAT ORGAN, V79, P199, DOI 10.3354/dao01906; Iwamoto T, 2005, J GEN VIROL, V86, P2807, DOI 10.1099/vir.0.80902-0; Iwamoto T, 2004, J VIROL, V78, P1256, DOI 10.1128/JVI.78.3.1256-1262.2004; Iwamoto T, 2000, DIS AQUAT ORGAN, V43, P81, DOI 10.3354/dao043081; Iwamoto T, 2001, J GEN VIROL, V82, P2653, DOI 10.1099/0022-1317-82-11-2653; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; LeBreton A, 1997, J FISH DIS, V20, P145, DOI 10.1046/j.1365-2761.1997.00284.x; Maeno Y, 2004, JARQ-JPN AGR RES Q, V38, P69, DOI 10.6090/jarq.38.69; Mori K, 2003, DIS AQUAT ORGAN, V57, P19, DOI 10.3354/dao057019; MORI KI, 1992, VIROLOGY, V187, P368, DOI 10.1016/0042-6822(92)90329-N; MUNDAY BL, 1992, AQUACULTURE, V103, P197, DOI 10.1016/0044-8486(92)90166-I; Nishizawa T, 1999, J GEN VIROL, V80, P3023, DOI 10.1099/0022-1317-80-11-3023; Nishizawa T, 1997, APPL ENV MICROBIOL, V63; Okinaka Y, 2008, DIS AQUAT ORGAN, V80, P113, DOI 10.3354/dao01914; Olveira JG, 2009, J GEN VIROL, V90, P2940, DOI 10.1099/vir.0.013912-0; Panzarin V, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-56; Panzarin V, 2012, INFECT GENET EVOL, V12, P63, DOI 10.1016/j.meegid.2011.10.007; Parameswaran V, 2008, AQUACULTURE, V275, P366, DOI 10.1016/j.aquaculture.2008.01.023; Rigos G, 2010, REV FISH BIOL FISHER, V20, P47, DOI 10.1007/s11160-009-9120-7; Shetty M, 2012, INDIAN J VIROL, V23, P114, DOI 10.1007/s13337-012-0088-x; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Skliris GP, 2001, VIRUS RES, V75, P59, DOI 10.1016/S0168-1702(01)00225-8; Sommerset I, 2004, DIS AQUAT ORGAN, V58, P117, DOI 10.3354/dao058117; Spearman-Karber P., 1978, STAT METHODIN BIOL A, P1; Stamatakis A., 2006, P 20 IEEE INT PAR DI, P1, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang L, 2002, J VIROL, V76, P6370, DOI 10.1128/JVI.76.12.6370-6375.2002; Thiery R, 1999, VIRUS RES, V63, P11, DOI 10.1016/S0168-1702(99)00053-2; Toffolo V, 2007, MOL PHYLOGENET EVOL, V43, P298, DOI 10.1016/j.ympev.2006.08.003; Totland GK, 1999, DIS AQUAT ORGAN, V38, P169, DOI 10.3354/dao038169; Ucko M, 2004, J FISH DIS, V27, P459, DOI 10.1111/j.1365-2761.2004.00565.x; Vendramin N, 2014, J FISH DIS, V37, P371, DOI 10.1111/jfd.12117; Vendramin N, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-20; Winton J, 2010, J FISH DIS, V33, P701, DOI 10.1111/j.1365-2761.2010.01165.x; [No title captured]; [No title captured]	54	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158814	10.1371/journal.pone.0158814	http://dx.doi.org/10.1371/journal.pone.0158814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438093	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000380170100021
J	Soriano, S; Calap-Quintana, P; Llorens, JV; Al-Ramahi, I; Gutierrez, L; Martinez-Sebastian, MJ; Botas, J; Molto, MD				Soriano, Sirena; Calap-Quintana, Pablo; Vicente Llorens, Jose; Al-Ramahi, Ismael; Gutierrez, Lucia; Jose Martinez-Sebastian, Maria; Botas, Juan; Dolores Molto, Maria			Metal Homeostasis Regulators Suppress FRDA Phenotypes in a Drosophila Model of the Disease	PLOS ONE			English	Article							FRIEDREICHS-ATAXIA; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; FRATAXIN DEFICIENCY; COPPER HOMEOSTASIS; HYDROGEN-PEROXIDE; HYDROXYL RADICALS; DENTATE NUCLEUS; IRON CHELATION; METALLOTHIONEIN	Friedreich's ataxia (FRDA), the most commonly inherited ataxia in populations of European origin, is a neurodegenerative disorder caused by a decrease in frataxin levels. One of the hallmarks of the disease is the accumulation of iron in several tissues including the brain, and frataxin has been proposed to play a key role in iron homeostasis. We found that the levels of zinc, copper, manganese and aluminum were also increased in a Drosophila model of FRDA, and that copper and zinc chelation improve their impaired motor performance. By means of a candidate genetic screen, we identified that genes implicated in iron, zinc and copper transport and metal detoxification can restore frataxin deficiency-induced phenotypes. Taken together, these results demonstrate that the metal dysregulation in FRDA includes other metals besides iron, therefore providing a new set of potential therapeutic targets.	[Soriano, Sirena; Calap-Quintana, Pablo; Vicente Llorens, Jose; Jose Martinez-Sebastian, Maria; Dolores Molto, Maria] Univ Valencia, Dept Genet, Valencia, Spain; [Soriano, Sirena; Al-Ramahi, Ismael; Botas, Juan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gutierrez, Lucia] CSIC, Inst Ciencia Mat Madrid, Dept Biomat & Bioinspired Mat, Madrid, Spain; [Dolores Molto, Maria] INCLIVA, CIBERSAM, CIBERSAM INCLIVA, Valencia, Spain; [Vicente Llorens, Jose] Uppsala Univ, Evolutionary Biol Ctr, Uppsala, Sweden	University of Valencia; Baylor College of Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Uppsala University	Molto, MD (corresponding author), Univ Valencia, Dept Genet, Valencia, Spain.	dmolto@uv.es	Gutierrez, Lucia/A-4305-2008; VICENTE, LIERN/B-6112-2008; Al-Ramahi, Ismael/B-4000-2017	Gutierrez, Lucia/0000-0003-2366-3598; VICENTE, LIERN/0000-0001-5883-9640; Al-Ramahi, Ismael/0000-0002-1275-1114; Molto, Maria Dolores/0000-0001-5219-2022; Martinez-Sebastian, Maria-Jose/0000-0001-5549-7921; Soriano, Sirena/0000-0001-9967-7262; Llorens, Jose V./0000-0001-9823-6246	European Community's Seventh Framework Program FP7 [242193 EFACTS]; Fundacio la Marato TV3 of Spain [101932]; Prometeo Program from Generalitat Valenciana [PROMETEOII/2014/067]; NIH [R01-NS42179]; Ministerio de Ciencia e Innovacion of Spain; Generalitat Valenciana of Spain; AXA Research Fund	European Community's Seventh Framework Program FP7; Fundacio la Marato TV3 of Spain; Prometeo Program from Generalitat Valenciana; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana of Spain(Center for Forestry Research & Experimentation (CIEF)); AXA Research Fund(AXA Research Fund)	This work was supported by grants from the European Community's Seventh Framework Program FP7/2007-2013 [grant agreement no. 242193 EFACTS], the Fundacio la Marato TV3 of Spain [exp 101932] and the Prometeo Program from Generalitat Valenciana [PROMETEOII/2014/067]. Work in the Botas laboratory was supported by the R01-NS42179 NIH grant. S.S. was a recipient of a fellowship from Ministerio de Ciencia e Innovacion of Spain; P.C.-Q. is a recipient of a fellowship from Generalitat Valenciana of Spain, J.V.L. was supported by a research contract from the European Community's Seventh Framework Program FP7/2007-2013 [grant agreement no. 242193 EFACTS] and L.G. is the beneficiary of a postdoctoral grant from the AXA Research Fund.	Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Babcock M, 1997, SCIENCE, V276; Bahadorani S, 2010, NEUROBIOL AGING, V31, P1215, DOI 10.1016/j.neurobiolaging.2008.08.001; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Calap-Quintana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132376; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Delatycki MB, 2012, J CHILD NEUROL, V27, P1133, DOI 10.1177/0883073812448230; Dunkov B, 2006, INSECT BIOCHEM MOLEC, V36, P300, DOI 10.1016/j.ibmb.2006.01.007; Fabisiak JP, 1999, ANTIOXID REDOX SIGN, V1, P349, DOI 10.1089/ars.1999.1.3-349; Gomes CM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/487534; Gonzalez-Cabo P, 2011, J BIOL CHEM, V286, P21304, DOI 10.1074/jbc.M110.211201; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Hua HQ, 2011, BIOL CHEM, V392, P919, DOI 10.1515/BC.2011.084; Jellinger KA, 2013, INT REV NEUROBIOL, V110, P1, DOI 10.1016/B978-0-12-410502-7.00002-8; Kakhlon O, 2008, BLOOD, V112, P5219, DOI 10.1182/blood-2008-06-161919; Koeppen AH, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-26; Koeppen AH, 2012, CEREBELLUM, V11, P845, DOI 10.1007/s12311-012-0383-5; Kumar V, 2014, NEUROTOXICOLOGY, V41, P154, DOI 10.1016/j.neuro.2014.02.004; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; Lang ML, 2012, PLOS GENET, V8, P623, DOI 10.1371/journal.pgen.1002683; Levy F, 2004, BIOCHIMIE, V86, P607, DOI 10.1016/j.biochi.2004.07.007; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Li YJ, 2010, J STRUCT BIOL, V169, P399, DOI 10.1016/j.jsb.2009.10.012; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; Lye JC, 2012, J EXP BIOL, V215, P3254, DOI 10.1242/jeb.069260; Mandilaras K, 2013, NUTRIENTS, V5, P1622, DOI 10.3390/nu5051622; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; Muckenthaler M, 1998, EUR J BIOCHEM, V254, P230, DOI 10.1046/j.1432-1327.1998.2540230.x; Navarro JA, 2015, FREE RADICAL BIO MED, V85, P71, DOI 10.1016/j.freeradbiomed.2015.03.014; Navarro JA, 2010, HUM MOL GENET, V19, P2828, DOI 10.1093/hmg/ddq183; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Pandolfo M, 2014, ANN NEUROL, V76, P509, DOI 10.1002/ana.24248; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; RODRIGUES V, 1995, EMBO J, V14, P3007, DOI 10.1002/j.1460-2075.1995.tb07303.x; Saini N, 2011, MOL CELL BIOL, V31, P2151, DOI 10.1128/MCB.05207-11; SANCHEZ-CASIS G, 1976, Canadian Journal of Neurological Sciences, V3, P349; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Soragni E, 2008, NUCLEIC ACIDS RES, V36, P6056, DOI 10.1093/nar/gkn604; Soriano S, 2013, GENE, V521, P274, DOI 10.1016/j.gene.2013.02.049; Suntres ZE, 2006, TOXICOLOGY, V217, P155, DOI 10.1016/j.tox.2005.09.004; Suzuki KT, 1996, TOXICOL APPL PHARM, V141, P231; THORNALLEY PJ, 1985, BIOCHIM BIOPHYS ACTA, V827, P36, DOI 10.1016/0167-4838(85)90098-6; Viarengo A, 2000, CELL MOL BIOL, V46, P407; Waldvogel D, 1999, ANN NEUROL, V46, P123, DOI 10.1002/1531-8249(199907)46:1<123::AID-ANA19>3.0.CO;2-H; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Whitnall M, 2008, P NATL ACAD SCI USA, V105, P9757, DOI 10.1073/pnas.0804261105; Wu Z, 2012, NEUROBIOL AGING, V33, P1, DOI DOI 10.1016/J.NEUR0BI0LAGING.2010.06.018; Xiao GR, 2014, ELIFE, V3, DOI 10.7554/eLife.03191; Yoshiga T, 1999, EUR J BIOCHEM, V260, P414, DOI 10.1046/j.1432-1327.1999.00173.x	58	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159209	10.1371/journal.pone.0159209	http://dx.doi.org/10.1371/journal.pone.0159209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433942	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169600039
J	Habets, THPM; Oth, T; Houben, AW; Huijskens, MJAJ; Senden-Gijsbers, BLMG; Schnijderberg, MCA; Brans, B; Dubois, LJ; Lambin, P; De Saint-Hubert, M; Germeraad, WTV; Tilanus, MGJ; Mottaghy, FM; Bos, GMJ; Vanderlocht, J				Habets, Thomas H. P. M.; Oth, Tammy; Houben, Ans W.; Huijskens, Mirelle J. A. J.; Senden-Gijsbers, Birgit L. M. G.; Schnijderberg, Melanie C. A.; Brans, Boudewijn; Dubois, Ludwig J.; Lambin, Philippe; De Saint-Hubert, Marijke; Germeraad, Wilfred T. V.; Tilanus, Marcel G. J.; Mottaghy, Felix M.; Bos, Gerard M. J.; Vanderlocht, Joris			Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; CELL DEATH; RADIATION; REGRESSION; IMMUNOTHERAPY; COMBINATIONS; MECHANISMS; ANTIBODIES; PATIENT; GROWTH	Accumulating evidence indicates that fractionated radiotherapy (RT) can result in distant non-irradiated (abscopal) tumour regression. Although preclinical studies indicate the importance of T cells in this infrequent phenomenon, these studies do not preclude that other immune mechanisms exhibit an addition role in the abscopal effect. We therefore addressed the question whether in addition to T cell mediated responses also humoral antitumour responses are modulated after fractionated RT and whether systemic dendritic cell (DC) stimulation can enhance tumour-specific antibody production. We selected the 67NR mammary carcinoma model since this tumour showed spontaneous antibody production in all tumour-bearing mice. Fractionated RT to the primary tumour was associated with a survival benefit and a delayed growth of a non-irradiated (contralateral) secondary tumour. Notably, fractionated RT did not affect anti-tumour antibody titers and the composition of the immunoglobulin (Ig) isotypes. Likewise, we demonstrated that treatment of tumour-bearing Balb/C mice with DC stimulating growth factor Flt3-L did neither modulate the magnitude nor the composition of the humoral immune response. Finally, we evaluated the immune infiltrate and Ig isotype content of the tumour tissue using flow cytometry and found no differences between treatment groups that were indicative for local antibody production. In conclusion, we demonstrate that the 67NR mammary carcinoma in Balb/C mice is associated with a pre-existing antibody response. And, we show that in tumour-bearing Balb/C mice with abscopal tumour regression such pre-existing antibody responses are not altered upon fractionated RT and/or DC stimulation with Flt3-L. Our research indicates that evaluating the humoral immune response in the setting of abscopal tumour regression is not invariably associated with therapeutic effects.	[Habets, Thomas H. P. M.; Oth, Tammy; Houben, Ans W.; Huijskens, Mirelle J. A. J.; Senden-Gijsbers, Birgit L. M. G.; Schnijderberg, Melanie C. A.; Germeraad, Wilfred T. V.; Bos, Gerard M. J.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Div Hematol,Dept Internal Med, Maastricht, Netherlands; [Habets, Thomas H. P. M.; Tilanus, Marcel G. J.; Vanderlocht, Joris] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Tissue Typing Lab,Dept Transplantat Immunol, Maastricht, Netherlands; [Houben, Ans W.; Brans, Boudewijn; De Saint-Hubert, Marijke; Mottaghy, Felix M.] Maastricht Univ, Med Ctr, Sch NUTRIM, Div Nucl Med,Dept Internal Med, Maastricht, Netherlands; [Dubois, Ludwig J.; Lambin, Philippe] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, MaastRO Lab,Dept Radiat Oncol, Maastricht, Netherlands; [Germeraad, Wilfred T. V.; Bos, Gerard M. J.] CiMaas BV, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University	Vanderlocht, J (corresponding author), Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Tissue Typing Lab,Dept Transplantat Immunol, Maastricht, Netherlands.	joris.vanderlocht@mumc.nl	Mottaghy, Felix/AAU-2673-2020	Mottaghy, Felix/0000-0002-7212-6521; Lambin, Philippe/0000-0001-7961-0191; De Saint-Hubert, Marijke/0000-0003-2374-3280				Abuodeh Y, 2015, CURRENT PROBLEMS CAN; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Blank CU, 2015, INT IMMUNOL, V27, P3, DOI 10.1093/intimm/dxu076; Blank CU, 2014, CURR OPIN ONCOL, V26, P204, DOI 10.1097/CCO.0000000000000054; Bramhall RJ, 2014, EJSO-EUR J SURG ONC, V40, P34, DOI 10.1016/j.ejso.2013.09.026; Chakravarty PK, 1999, CANCER RES, V59, P6028; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Demaria S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00153; Derer A, 2015, CANC IMMUNOLOGY IMMU; Derer A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00505; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Formenti SC, 2013, JNCI-J NATL CANCER I, V105, P256, DOI 10.1093/jnci/djs629; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Girit IC, 2008, COMPARATIVE MED, V58, P264; Golden EB, 2015, LANCET ONCOL, V16, P795, DOI 10.1016/S1470-2045(15)00054-6; Golden EB, 2015, SEMIN RADIAT ONCOL, V25, P11, DOI 10.1016/j.semradonc.2014.07.005; Golden EB, 2013, CANCER IMMUNOL RES, V1, P365, DOI 10.1158/2326-6066.CIR-13-0115; GREENBERG AH, 1975, IMMUNOLOGY, V29, P719; Grimaldi AM, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28780; HERLYN D, 1982, P NATL ACAD SCI-BIOL, V79, P4761, DOI 10.1073/pnas.79.15.4761; Honeychurch J, 2015, EXPERT OPIN BIOL TH, V15, P787, DOI 10.1517/14712598.2015.1036737; Ito A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/605478; Kaczanowska S, 2013, J LEUKOCYTE BIOL, V93, P847, DOI 10.1189/jlb.1012501; Kaminski JM, 2005, CANCER TREAT REV, V31, P159, DOI 10.1016/j.ctrv.2005.03.004; Kono K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.207; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Lakshmanagowda Preethi Bangalore, 2009, Cases J, V2, P204, DOI 10.1186/1757-1626-2-204; Liauw SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005148; Lynch DH, 1997, NAT MED, V3, P625, DOI 10.1038/nm0697-625; Melero I, 2015, NAT REV CANCER, V15, P457, DOI 10.1038/nrc3973; MOLE RH, 1953, BRIT J RADIOL, V26, P234, DOI 10.1259/0007-1285-26-305-234; Ohba K, 1998, GUT, V43, P575, DOI 10.1136/gut.43.4.575; Okuma Kae, 2011, J Med Case Rep, V5, P111, DOI 10.1186/1752-1947-5-111; Pio R, 2014, ADV EXP MED BIOL, V772, P229, DOI 10.1007/978-1-4614-5915-6_11; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Siva S, 2013, CANC LETT; Smith KM, 2000, J IMMUNOL, V165, P3136, DOI 10.4049/jimmunol.165.6.3136; Spiegelberg H L, 1974, Adv Immunol, V19, P259, DOI 10.1016/S0065-2776(08)60254-0; Stamell EF, 2013, INT J RADIAT ONCOL, V85, P293, DOI 10.1016/j.ijrobp.2012.03.017; Sullivan RJ, 2013, NEW ENGL J MED, V369, P173, DOI 10.1056/NEJMcpc1302332; Tesniere A, 2008, CURR OPIN IMMUNOL, V20, P504, DOI 10.1016/j.coi.2008.05.007; Vatner RE, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00325; Wersall PJ, 2006, ACTA ONCOL, V45, P493, DOI 10.1080/02841860600604611	44	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159515	10.1371/journal.pone.0159515	http://dx.doi.org/10.1371/journal.pone.0159515			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427766	gold, Green Submitted, Green Published			2022-12-27	WOS:000380169300074
J	Khera, P; Pandey, MK; Wang, H; Feng, SP; Qiao, LX; Culbreath, AK; Kale, S; Wang, JP; Holbrook, CC; Zhuang, WJ; Varshney, RK; Guo, BZ				Khera, Pawan; Pandey, Manish K.; Wang, Hui; Feng, Suping; Qiao, Lixian; Culbreath, Albert K.; Kale, Sandip; Wang, Jianping; Holbrook, C. Corley; Zhuang, Weijian; Varshney, Rajeev K.; Guo, Baozhu			Mapping Quantitative Trait Loci of Resistance to Tomato Spotted Wilt Virus and Leaf Spots in a Recombinant Inbred Line Population of Peanut (Arachis hypogaea L.) from SunOleic 97R and NC94022	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; RUST RESISTANCE; FIELD RESPONSE; OIL QUALITY; IDENTIFICATION; SOFTWARE; GENOMICS; QTL	Peanut is vulnerable to a range of diseases, such as Tomato spotted wilt virus (TSWV) and leaf spots which will cause significant yield loss. The most sustainable, economical and eco-friendly solution for managing peanut diseases is development of improved cultivars with high level of resistance. We developed a recombinant inbred line population from the cross between SunOleic 97R and NC94022, named as the S-population. An improved genetic linkage map was developed for the S-population with 248 marker loci and a marker density of 5.7 cM/loci. This genetic map was also compared with the physical map of diploid progenitors of tetraploid peanut, resulting in an overall co-linearity of about 60% with the average co-linearity of 68% for the A sub-genome and 47% for the B sub-genome. The analysis using the improved genetic map and multi-season (2010-2013) phenotypic data resulted in the identification of 48 quantitative trait loci (QTLs) with phenotypic variance explained (PVE) from 3.88 to 29.14%. Of the 48 QTLs, six QTLs were identified for resistance to TSWV, 22 QTLs for early leaf spot (ELS) and 20 QTLs for late leaf spot (LLS), which included four, six, and six major QTLs ( PVE larger than 10%) for each disease, respectively. A total of six major genomic regions (MGR) were found to have QTLs controlling more than one disease resistance. The identified QTLs and resistance gene-rich MGRs will facilitate further discovery of resistance genes and development of molecular markers for these important diseases.	[Khera, Pawan; Wang, Hui; Guo, Baozhu] USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA; [Khera, Pawan; Pandey, Manish K.; Kale, Sandip; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Khera, Pawan; Wang, Hui; Culbreath, Albert K.; Guo, Baozhu] Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA; [Feng, Suping] Hainan Trop Marine Univ, Coll Trop Biol & Agron, Sanya, Peoples R China; [Qiao, Lixian] Qingdao Agr Univ, Coll Life Sci, Qingdao, Shandong, Peoples R China; [Wang, Jianping] Univ Florida, Dept Agron, Gainesville, FL 32611 USA; [Holbrook, C. Corley] USDA ARS, Crop Genet & Breeding Res Unit, Tifton, GA 31793 USA; [Zhuang, Weijian] Fujian Agr & Forestry Univ, Coll Plant Protect, Fuzhou, Peoples R China	United States Department of Agriculture (USDA); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University System of Georgia; University of Georgia; Qingdao Agricultural University; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Fujian Agriculture & Forestry University	Guo, BZ (corresponding author), USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA.; Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India.; Guo, BZ (corresponding author), Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA.	r.k.varshney@cgiar.org; Baozhu.Guo@ars.usda.gov	Varshney, Rajeev K/C-5295-2014	Varshney, Rajeev K/0000-0002-4562-9131; Pandey, Manish/0000-0002-4101-6530	USDA Agricultural Research Service; Georgia Peanut Commission; Peanut Foundation; National Peanut Board of USA; World Bank assisted Watershed Development Project-II (KWDP-II) by Government of Karnataka, India; ARS [ARS-0425281] Funding Source: Federal RePORTER	USDA Agricultural Research Service(United States Department of Agriculture (USDA)); Georgia Peanut Commission; Peanut Foundation; National Peanut Board of USA; World Bank assisted Watershed Development Project-II (KWDP-II) by Government of Karnataka, India; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was partially supported by funds provided by the USDA Agricultural Research Service, the Georgia Peanut Commission, Peanut Foundation and National Peanut Board of USA and World Bank assisted Watershed Development Project-II (KWDP-II) by Government of Karnataka, India. This work has been also undertaken as part of the CGIAR Research Program on Grain Legumes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Billy Wilson, Jake Fountain, Stephanie Lee, Lucero Gutierrez, Sara Beth Pelham, Victoria Weaver, and Jake Weaver for technical assistance in the field and the laboratory. This research was partially supported by funds provided by the USDA Agricultural Research Service, the Georgia Peanut Commission, Peanut Foundation and National Peanut Board of USA and World Bank assisted Watershed Development Project-II (KWDP-II) by Government of Karnataka, India. This work has been also undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture.	Baldessari J. J., 2008, THESIS; Barrientos-Priego L., 2002, Peanut Science, V29, P72, DOI 10.3146/pnut.29.1.0013; Bayer M, 2011, BIOINFORMATICS, V27, P1307, DOI 10.1093/bioinformatics/btr111; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Bertioli DJ, 2014, GENETICS GENOMICS BR, P114; CHITEKA Z A, 1988, Peanut Science, V15, P25, DOI 10.3146/i0095-3679-15-1-8; Culbreath A. K., 2005, Peanut Science, V32, P20, DOI 10.3146/0095-3679(2005)32[20:HLOFRT]2.0.CO;2; Culbreath AK, 1997, PLANT DIS, V81, P1410, DOI 10.1094/PDIS.1997.81.12.1410; Food and Agriculture Organization (FAO), 2004, STAT FOOD AGR BIOT M; Gorbet DW, 2000, CROP SCI, V40, P1190, DOI 10.2135/cropsci2000.0032rcv; Gorbet DW, 1997, S400 FL AGR EXP STN; Guo Baozhu, 2013, Peanut Science, V40, P95, DOI 10.3146/PS13-03.1; Guo YF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-608; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Leal-Bertioli SCM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-112; Li Yan, 2012, Peanut Science, V39, P30, DOI 10.3146/PS11-6.1; MILLER I L, 1990, Peanut Science, V17, P52, DOI 10.3146/i0095-3679-17-2-2; NORDEN AJ, 1985, CROP SCI, V25, P1126, DOI 10.2135/cropsci1985.0011183X002500060061x; Ogwulumba SI, 2008, AFR J BIOTECHNOL, V7, P2878; Pandey MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113326; Pandey MK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00455; Pandey MK, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0133-4; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Pasupuleti J, 2016, PLANT BREEDING, V135, P355, DOI 10.1111/pbr.12358; Qin HD, 2012, THEOR APPL GENET, V124, P653, DOI 10.1007/s00122-011-1737-y; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; Smith AF, 1984, PLANT DIS, V64, P356; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Surbrahmayan P, 1980, P INT WORKSH GROUNDN, P193; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Varshney RK, 2009, THEOR APPL GENET, V118, P729, DOI 10.1007/s00122-008-0933-x; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Varshney RK, 2013, BIOTECHNOL ADV, V31, P1120, DOI 10.1016/j.biotechadv.2013.01.001; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang H, 2013, PLANT GENOME, V6, P3; Wang ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119454; Wang S., 2011, WINDOWS QTL CARTOGRA	42	20	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158452	10.1371/journal.pone.0158452	http://dx.doi.org/10.1371/journal.pone.0158452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427980	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000380169300007
J	Sureshchandra, S; Rais, M; Stull, C; Grant, K; Messaoudi, I				Sureshchandra, Suhas; Rais, Maham; Stull, Cara; Grant, Kathleen; Messaoudi, Ilhem			Transcriptome Profiling Reveals Disruption of Innate Immunity in Chronic Heavy Ethanol Consuming Female Rhesus Macaques	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; NATURAL-KILLER-CELLS; MESSENGER-RNA LEVELS; GENE-EXPRESSION DATA; P-SELECTIN LEVELS; ALCOHOL-CONSUMPTION; HUMAN MONOCYTES; HEART-FAILURE; CARDIOVASCULAR-DISEASE; CYTOKINE PRODUCTION	It is well established that heavy ethanol consumption interferes with the immune system and inflammatory processes, resulting in increased risk for infectious and chronic diseases. However, these processes have yet to be systematically studied in a dose and sex-dependent manner. In this study, we investigated the impact of chronic heavy ethanol consumption on gene expression using RNA-seq in peripheral blood mononuclear cells isolated from female rhesus macaques with daily consumption of 4% ethanol available 22hr/day for 12 months resulting in average ethanol consumption of 4.3 g/kg/day (considered heavy drinking). Differential gene expression analysis was performed using edgeR and gene enrichment analysis using MetaCore (TM). We identified 1106 differentially expressed genes, meeting the criterion of >= two-fold change and p-value <= 0.05 in expression (445 up-and 661 down-regulated). Pathway analysis of the 879 genes with characterized identifiers showed that the most enriched gene ontology processes were "response to wounding", "blood coagulation", "immune system process", and "regulation of signaling". Changes in gene expression were seen despite the lack of differences in the frequency of any major immune cell subtype between ethanol and controls, suggesting that heavy ethanol consumption modulates gene expression at the cellular level rather than altering the distribution of peripheral blood mononuclear cells. Collectively, these observations provide mechanisms to explain the higher incidence of infection, delay in wound healing, and increase in cardiovascular disease seen in subjects with Alcohol use disorder.	[Sureshchandra, Suhas; Messaoudi, Ilhem] Univ Calif Riverside, Grad Program Genet Genom & Bioinformat, Riverside, CA 92521 USA; [Sureshchandra, Suhas; Rais, Maham; Messaoudi, Ilhem] Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA; [Stull, Cara; Grant, Kathleen; Messaoudi, Ilhem] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; Oregon Health & Science University; Oregon National Primate Research Center	Messaoudi, I (corresponding author), Univ Calif Riverside, Grad Program Genet Genom & Bioinformat, Riverside, CA 92521 USA.; Messaoudi, I (corresponding author), Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA.; Messaoudi, I (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA.	ilhem.messaoudi@ucr.edu	Sureshchandra, Suhas/AAW-4606-2021	Rais, Maham/0000-0003-2555-2111	NIAAA grant [AA021947-02, U01 AA013510, R24 AA109431]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA019431] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	NIAAA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIAAA grant AA021947-02, U01 AA013510, and R24 AA109431.	Amelot AA, 2007, J BIOL CHEM, V282, P710, DOI 10.1074/jbc.M606650200; An XL, 2015, CURR OPIN HEMATOL, V22, P206, DOI 10.1097/MOH.0000000000000134; Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Ashenhurst JR, 2015, PSYCHOL ADDICT BEHAV, V29, P978, DOI 10.1037/adb0000116; Asquith M, 2014, ALCOHOL CLIN EXP RES, V38, P980, DOI 10.1111/acer.12325; Baker EJ, 2014, ALCOHOL CLIN EXP RES, V38, P2835, DOI 10.1111/acer.12547; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barr T, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.09.001; Barr T, 2016, J IMMUNOL, V196, P182, DOI 10.4049/jimmunol.1501527; Bartel Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00362; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; Bilal Erhan, 2010, Genes Cancer, V1, P1063, DOI 10.1177/1947601910395583; Blanco-Mezquita JT, 2013, INVEST OPHTH VIS SCI, V54, P6262, DOI 10.1167/iovs.13-11710; Bonsch D, 2005, ALCOHOL CLIN EXP RES, V29, P763, DOI 10.1097/01.ALC.0000164360.43907.24; Bonsch D, 2004, BIOL PSYCHIAT, V56, P984, DOI 10.1016/j.biopsych.2004.09.016; Borrego F, 1999, IMMUNOLOGY, V97, P159, DOI 10.1046/j.1365-2567.1999.00738.x; Bot I, 2011, THROMB HAEMOSTASIS, V106, P820, DOI 10.1160/TH11-05-0291; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brckalo T, 2010, EUR J IMMUNOL, V40, P722, DOI 10.1002/eji.200939468; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Brutkiewicz RR, 2006, J IMMUNOL, V177, P769, DOI 10.4049/jimmunol.177.2.769; Carter AM, 2003, J THROMB HAEMOST, V1, P1718, DOI 10.1046/j.1538-7836.2003.00312.x; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Cho S, 2016, J EXP MED, V213, P235, DOI 10.1084/jem.20150990; Choudhury M, 2010, ALCOHOL, V44, P531, DOI 10.1016/j.alcohol.2010.06.003; Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Corsetti JP, 2012, METABOLISM, V61, P996, DOI 10.1016/j.metabol.2011.11.010; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; DAWSON DA, 1994, ADDICTION, V89, P345, DOI 10.1111/j.1360-0443.1994.tb00901.x; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Delaguillaumie A, 2004, J CELL SCI, V117, P5269, DOI 10.1242/jcs.01380; Dimmitt SB, 1998, BLOOD COAGUL FIBRIN, V9, P39, DOI 10.1097/00001721-199801000-00005; Djousse L, 2008, CURR ATHEROSCLER REP, V10, P117, DOI 10.1007/s11883-008-0017-z; Djousse L, 2008, AM J CARDIOL, V102, P593, DOI 10.1016/j.amjcard.2008.04.031; Ezell SA, 2012, TRANSCR-AUSTIN, V3, P305, DOI 10.4161/trns.21904; Falati S, 1999, BLOOD, V94, P1648, DOI 10.1182/blood.V94.5.1648.417k31_1648_1656; Faucher K, 2003, BIOCHIMIE, V85, P611, DOI 10.1016/S0300-9084(03)00089-0; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Freeman WM, 2010, BIOL PSYCHIAT, V68, P219, DOI 10.1016/j.biopsych.2010.01.028; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Gavala ML, 2010, J BIOL CHEM, V285, P34288, DOI 10.1074/jbc.M110.142091; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Graeme IM, 2001, ANN REV PHARM TOXICO, V41, P297, DOI [10.1146/annurev.pharmtox.41.1.297, DOI 10.1146/ANNUREV.PHARMTOX.41.1.297]; Grant KA, 2008, ALCOHOL CLIN EXP RES, V32, P1824, DOI 10.1111/j.1530-0277.2008.00765.x; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Guo Y, 2013, INFECT IMMUN, V81, P3923, DOI 10.1128/IAI.00887-13; Hagiwara N, 2011, DEV DYNAM, V240, P1311, DOI 10.1002/dvdy.22639; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Harris DR, 2001, ANN INTERN MED, V134, P120, DOI 10.7326/0003-4819-134-2-200101160-00012; He Lei, 2009, Human Genomics, V3, P195; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hermann-Kleiter N, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-38; Hinks A, 2010, GENES IMMUN, V11, P194, DOI 10.1038/gene.2009.105; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jimenez VA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00260; Kayama Y, 2009, J EXP MED, V206, P1565, DOI 10.1084/jem.20082596; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee KN, 2005, IMMUNITY, V22, P195, DOI 10.1016/j.immuni.2004.12.012; Li-Saw-Hee FL, 2001, EUR HEART J, V22, P1741, DOI 10.1053/euhj.2000.2531; Liang TB, 2003, P NATL ACAD SCI USA, V100, P4690, DOI 10.1073/pnas.0737182100; Lucero CMJ, 2013, J CELL PHYSIOL, V228, P714, DOI 10.1002/jcp.24218; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mandrekar P, 2002, ALCOHOL CLIN EXP RES, V26, P1609, DOI 10.1097/01.ALC.0000036926.46632.57; Mandrekar P, 1997, ALCOHOL CLIN EXP RES, V21, P988, DOI 10.1111/j.1530-0277.1997.tb04242.x; Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494; Minagawa K, 2009, MOL CANCER RES, V7, P880, DOI 10.1158/1541-7786.MCR-08-0511; Mirabet M, 1999, J CELL SCI, V112, P491; Momen-Heravi F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09991; Mukamal KJ, 2001, ALCOHOL RES HEALTH, V25, P255; Mukamal KJ, 2001, CIRCULATION, V104, P1367, DOI 10.1161/hc3701.096067; Mun GI, 2013, BIOCHEM BIOPH RES CO, V430, P554, DOI 10.1016/j.bbrc.2012.11.114; Nachbur U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7442; Nair J, 2014, J ATHEROSCLER THROMB, V21, P329, DOI 10.5551/jat.20123; Nam CH, 2006, MOL THER, V13, P15, DOI 10.1016/j.ymthe.2005.09.010; Okada Y, 2003, BLOOD, V101, P4748, DOI 10.1182/blood-2002-02-0380; Okazaki H, 2008, J BIOL CHEM, V283, P33357, DOI 10.1074/jbc.M802686200; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; Pasala S, 2015, ALCOHOL RES-CURR REV, V37, P185; Peng SL, 2008, ONCOGENE, V27, P2337, DOI 10.1038/onc.2008.26; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Pise-Masison CA, 2009, BLOOD, V113, P4016, DOI 10.1182/blood-2008-08-175901; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Reiner AP, 2002, BRIT J HAEMATOL, V116, P376, DOI 10.1046/j.1365-2141.2002.03265.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruggeri ZM, 2007, THROMB RES, V120, pS5, DOI 10.1016/j.thromres.2007.03.011; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sadlon TJ, 1999, INT J BIOCHEM CELL B, V31, P1153, DOI 10.1016/S1357-2725(99)00073-4; Saha B, 2015, J IMMUNOL, V194, P3079, DOI 10.4049/jimmunol.1402190; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Shay T, 2013, TRENDS IMMUNOL, V34, P602, DOI 10.1016/j.it.2013.03.004; Shukla SD, 2015, BIOMOLECULES, V5, P3280, DOI 10.3390/biom5043280; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Smith JL, 2008, STEROIDS, V73, P1160, DOI 10.1016/j.steroids.2008.05.003; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; Stote KS, 2016, EUR J CLIN NUTR, V70, P470, DOI 10.1038/ejcn.2015.182; Su XM, 2012, J CLIN INVEST, V122, P3579, DOI 10.1172/JCI38576; Suzuki M, 2011, INT J HEMATOL, V93, P150, DOI 10.1007/s12185-011-0770-6; Szabo G, 2010, ALCOHOL RES HEALTH, V33, P87; Szeles L, 2007, BBA-MOL CELL BIOL L, V1771, P1014, DOI 10.1016/j.bbalip.2007.02.005; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Tallack MR, 2010, IUBMB LIFE, V62, P886, DOI 10.1002/iub.404; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Tigges J, 2013, J INVEST DERMATOL, V133, P87, DOI 10.1038/jid.2012.259; Tonnesen H, 2009, BRIT J ANAESTH, V102, P297, DOI 10.1093/bja/aen401; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Verhaar MC, 1998, J HYPERTENS, V16, P45, DOI 10.1097/00004872-199816010-00008; Walker SJ, 2006, ALCOHOL, V38, P1, DOI 10.1016/j.alcohol.2006.03.008; Wang XL, 2015, J CONTROL RELEASE, V197, P138, DOI 10.1016/j.jconrel.2014.11.001; Washington AV, 2009, J CLIN INVEST, V119, P1489, DOI 10.1172/JCI36175; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Xia YY, 1997, AM J PATHOL, V151, P375; Xie N, 2014, J IMMUNOL, V193, P327, DOI 10.4049/jimmunol.1400203; Yeang HXA, 2012, J BIOL CHEM, V287, P10556, DOI 10.1074/jbc.M111.322420; Yonezawa T, 2004, BIOCHEM BIOPH RES CO, V314, P805, DOI 10.1016/j.bbrc.2003.12.175; Yoon HS, 2012, J IMMUNOL, V189, P2393, DOI 10.4049/jimmunol.1103371; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zisman DA, 1998, ALCOHOL CLIN EXP RES, V22, P621, DOI 10.1111/j.1530-0277.1998.tb04303.x	133	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159295	10.1371/journal.pone.0159295	http://dx.doi.org/10.1371/journal.pone.0159295			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427759	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169300044
J	Van Dyke, MW; Beyer, MD; Clay, E; Hiam, KJ; McMurry, JL; Xie, Y				Van Dyke, Michael W.; Beyer, Matthew D.; Clay, Emily; Hiam, Kamir J.; McMurry, Jonathan L.; Xie, Ying			Identification of Preferred DNA-Binding Sites for the Thermus thermophilus Transcriptional Regulator SbtR by the Combinatorial Approach REPSA	PLOS ONE			English	Article							SEQUENCE SPECIFICITY; PROTEIN COMPLEXES; HB8; GENE; GENOME; EVOLUTION; SELECTION; RESOURCE; DATABASE; INTEGRATION	One of the first steps towards elucidating the biological function of a putative transcriptional regulator is to ascertain its preferred DNA-binding sequences. This may be rapidly and effectively achieved through the application of a combinatorial approach, one involving very large numbers of randomized oligonucleotides and reiterative selection and amplification steps to enrich for high-affinity nucleic acid-binding sequences. Previously, we had developed the novel combinatorial approach Restriction Endonuclease Protection, Selection and Amplification (REPSA), which relies not on the physical separation of ligand-nucleic acid complexes but instead selects on the basis of ligand-dependent inhibition of enzymatic template inactivation, specifically cleavage by type IIS restriction endonucleases. Thus, no prior knowledge of the ligand is required for REPSA, making it more amenable for discovery purposes. Here we describe using REPSA, massively parallel sequencing, and bioinformatics to identify the preferred DNA-binding sites for the transcriptional regulator SbtR, encoded by the TTHA0167 gene from the model extreme thermophile Thermus thermophilus HB8. From the resulting position weight matrix, we can identify multiple operons potentially regulated by SbtR and postulate a biological role for this protein in regulating extracellular transport processes. Our study provides a proof-of-concept for the application of REPSA for the identification of preferred DNA-binding sites for orphan transcriptional regulators and a first step towards determining their possible biological roles.	[Van Dyke, Michael W.; Beyer, Matthew D.; Clay, Emily; Hiam, Kamir J.] Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA; [McMurry, Jonathan L.] Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA USA; [Xie, Ying] Kennesaw State Univ, Dept Comp Sci, Kennesaw, GA USA	University System of Georgia; Kennesaw State University; University System of Georgia; Kennesaw State University; University System of Georgia; Kennesaw State University	Van Dyke, MW (corresponding author), Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA.	mvandyk2@kennesaw.edu	Van Dyke, Michael W./AAY-6751-2020	Van Dyke, Michael W./0000-0003-0306-4002; Hiam, Kamir/0000-0002-1956-0257	US National Institutes of Health [1R15GM104833-01]; Kennesaw State University Foundation (Foundation Fellow in Biochemistry); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104833] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kennesaw State University Foundation (Foundation Fellow in Biochemistry); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (http:www.nih.gov, Grant 1R15GM104833-01, MVD) and by the Kennesaw State University Foundation (http://www.kennesaw.edu/foundation/, Foundation Fellow in Biochemistry, MVD). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; Agari Y, 2013, PROTEINS, V81, P1166, DOI 10.1002/prot.24266; Agari Y, 2012, J BACTERIOL, V194, P4630, DOI 10.1128/JB.00668-12; Agari Y, 2011, MICROBIOL-SGM, V157, P1589, DOI 10.1099/mic.0.048017-0; Al-Zyoud WA, 2016, NUCLEIC ACIDS RES, V44, P1411, DOI 10.1093/nar/gkv1466; Amar D, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0329-9; Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Cava F, 2009, EXTREMOPHILES, V13, P213, DOI 10.1007/s00792-009-0226-6; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Gopal YNV, 2003, BIOCHEMISTRY-US, V42, P6891, DOI 10.1021/bi027373s; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Hardenbol P, 1996, P NATL ACAD SCI USA, V93, P2811, DOI 10.1073/pnas.93.7.2811; Hardenbol P, 1997, NUCLEIC ACIDS RES, V25, P3339, DOI 10.1093/nar/25.16.3339; Hardenbol P, 1997, BIOCONJUGATE CHEM, V8, P617, DOI 10.1021/bc970066s; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Hu JC, 2014, NUCLEIC ACIDS RES, V42, pD677, DOI 10.1093/nar/gkt1203; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Iino H, 2008, ACTA CRYSTALLOGR F, V64, P487, DOI 10.1107/S1744309108013572; Iwanaga N, 2014, EXTREMOPHILES, V18, P995, DOI 10.1007/s00792-014-0669-2; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Mao XZ, 2014, NUCLEIC ACIDS RES, V42, pD654, DOI 10.1093/nar/gkt1048; Meier M, 2013, P NATL ACAD SCI USA, V110, P477, DOI 10.1073/pnas.1210634110; OSHIMA T, 1974, INT J SYST BACTERIOL, V24, P102, DOI 10.1099/00207713-24-1-102; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Sakamoto K, 2011, J BACTERIOL, V193, P4388, DOI 10.1128/JB.05203-11; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Shen J, 2001, BIOORGAN MED CHEM, V9, P2285, DOI 10.1016/S0968-0896(01)00146-8; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Solovjev V, 2011, METAGENOMICITAPP, P61; Sunavala-Dossabhoy G, 2005, BIOCHEMISTRY-US, V44, P2510, DOI 10.1021/bi047877l; Swarup A, 2014, METAB ENG, V24, P173, DOI 10.1016/j.ymben.2014.05.013; SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C; Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020; Takano H, 2014, MICROBIOL-SGM, V160, P2650, DOI 10.1099/mic.0.082263-0; Takano H, 2011, J BACTERIOL, V193, P2451, DOI 10.1128/JB.01125-10; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	54	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159408	10.1371/journal.pone.0159408	http://dx.doi.org/10.1371/journal.pone.0159408			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428627	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169300062
J	Zhou, T; Perez, SN; Cheng, ZM; Kinney, MC; Lemieux, ME; Scott, LM; Rebel, VI				Zhou, Ting; Perez, Stephanie N.; Cheng, Ziming; Kinney, Marsha C.; Lemieux, Madeleine E.; Scott, Linda M.; Rebel, Vivienne I.			Context Matters: Distinct Disease Outcomes as a Result of Crebbp Hemizygosity in Different Mouse Bone Marrow Compartments	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELL; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDERS; MYELOMONOCYTIC LEUKEMIA; TUMOR MICROENVIRONMENT; PROGNOSTIC-FACTORS; BINDING-PROTEIN; B-CELL	Perturbations in CREB binding protein (CREBBP) are associated with hematopoietic malignancies, including myelodysplastic syndrome (MDS). Mice hemizygous for Crebbp develop myelodysplasia with proliferative features, reminiscent of human MDS/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U), and a proportion goes on to develop acute myeloid leukemia (AML). We have also shown that the Crebbp(+/-) non-hematopoietic bone marrow microenvironment induces excessive myeloproliferation of wild-type cells. We now report that transplantation of unfractionated Crebbp(+/-) bone marrow into wild-type recipients resulted in either early-onset AML or late-onset MDS and MDS/MPN-U. In contrast, purified Lin(-)Sca-1(+)c-Kit(++) cells primarily gave rise to MDS with occasional transformation to AML. Furthermore, Crebbp(+/-) common myeloid progenitors and granulocyte/macrophage progenitors could trigger skewed myelopoiesis, myelodysplasia and late-onset AML. Surprisingly, the phenotypically abnormal cells were all of wild-type origin. MDS, MPN and AML can thus all be transferred from Crebbp(+/-) BM to wild-type hosts but fractionated bone marrow does not recapitulate the full disease spectrum of whole bone marrow, indicating that not only mutational status but also cellular context contribute to disease outcome. This has important consequences for structuring and interpreting future investigations into the underlying mechanisms of myeloid malignancies as well as for their treatment.	[Zhou, Ting; Cheng, Ziming; Rebel, Vivienne I.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Zhou, Ting; Rebel, Vivienne I.] UTHSCSA, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Perez, Stephanie N.] Texas Lutheran Univ, Dept Biol, Seguin, TX USA; [Kinney, Marsha C.] UTHSCSA, Dept Pathol, San Antonio, TX USA; [Lemieux, Madeleine E.] Bioinfo, Plantagenet, ON, Canada; [Scott, Linda M.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Scott, Linda M.] Univ Queensland, Translat Res Inst, Brisbane, Qld, Australia; [Rebel, Vivienne I.] UTHSCSA, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Queensland; University of Queensland; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Rebel, VI (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.; Rebel, VI (corresponding author), UTHSCSA, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.; Rebel, VI (corresponding author), UTHSCSA, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA.	vr@bioaffinitytech.com	Scott, Linda/D-9777-2012	Scott, Linda/0000-0003-0334-1479; Rebel, Vivienne/0000-0002-3862-3903	GCCRI; University of Texas System's Graduate Programs Initiative; Hyundai Hope Grant Award; National Cancer Institute Cancer Center Support Grant [2P30 CA054174- 17]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	GCCRI; University of Texas System's Graduate Programs Initiative; Hyundai Hope Grant Award; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research for this publication was supported by funding from the GCCRI (V.I.R.) and the University of Texas System's Graduate Programs Initiative that funded the Translational Science Training Across Disciplines program (T.Z.) at the University of Texas Health Science Center at San Antonio. T.Z. was also supported by a Hyundai Hope Grant Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Karla Moncada and Ben Daniel of the UTHSCSA Flow Cytometry Core (supported by National Cancer Institute Cancer Center Support Grant 2P30 CA054174- 17) and Jennifer Rebeles of the GCCRI Shared Instrumentation Facility for assistance with flow cytometry, Lisa White and her staff (Genomic and RNA Profiling Core, Baylor College of Medicine, Houston TX) for conducting the NanoString experiments and David Rodriguez for help with preparing the images for publication.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Beer PA, 2010, BLOOD, V115, P2891, DOI 10.1182/blood-2009-08-236596; BEHRENS WEV, 1973, AUSTRALAS RADIOL, V17, P440, DOI 10.1111/j.1440-1673.1973.tb01482.x; Brumbaugh CD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-479; Brunning RD, 2008, WHO CLASSIFICATION T; Campbell PJ, 2006, BLOOD, V108, P3548, DOI 10.1182/blood-2005-12-013748; Chen XH, 2013, J CLIN INVEST, V123, P4595, DOI 10.1172/JCI67580; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dupriez B, 1996, BLOOD, V88, P1013; Elpek KG, 2014, CANCER IMMUNOL RES, V2, P655, DOI 10.1158/2326-6066.CIR-13-0209; Finazzi G, 2005, BLOOD, V105, P2664, DOI 10.1182/blood-2004-09-3426; Greeneltch KM, 2007, CANCER RES, V67, P10406, DOI 10.1158/0008-5472.CAN-07-1228; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Imamura T, 2003, GENE CHROMOSOME CANC, V36, P413, DOI 10.1002/gcc.10172; Inthal A, 2012, LEUKEMIA, V26, P1797, DOI 10.1038/leu.2012.60; Itzykson R, 2011, ED BOOK, V31, P251; Kennedy JA, 2006, P NATL ACAD SCI USA, V103, P16930, DOI 10.1073/pnas.0604902103; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kojima K, 2003, BRIT J HAEMATOL, V120, P271, DOI 10.1046/j.1365-2141.2003.04059.x; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kung AL, 2000, GENE DEV, V14, P272; Lemieux ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024153; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANOHARAN A, 1988, PATHOLOGY, V20, P7, DOI 10.3109/00313028809085188; Mattei F, 2012, NEOPLASIA, V14, P1223, DOI 10.1593/neo.121444; Minami Y, 2008, P NATL ACAD SCI USA, V105, P17967, DOI 10.1073/pnas.0808303105; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Muntion S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146722; OHSAKA A, 1989, BRIT J HAEMATOL, V73, P568, DOI 10.1111/j.1365-2141.1989.tb00301.x; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rebel V I, 1995, Biol Blood Marrow Transplant, V1, P32; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Rizzuti AE, 2008, ARCH OPHTHALMOL-CHIC, V126, P862, DOI 10.1001/archopht.126.6.862; Rowley JD, 1997, BLOOD, V90, P535; Satake N, 1997, GENE CHROMOSOME CANC, V20, P60, DOI 10.1002/(SICI)1098-2264(199709)20:1<60::AID-GCC9>3.3.CO;2-O; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Stewart TJ, 2009, J IMMUNOL, V183, P117, DOI 10.4049/jimmunol.0804132; Suggs JL, 2007, EXP MOL PATHOL, V83, P471, DOI 10.1016/j.yexmp.2007.08.012; Taki T, 1997, BLOOD, V89, P3945, DOI 10.1182/blood.V89.11.3945; Theocharides A, 2007, BLOOD, V110, P375, DOI 10.1182/blood-2006-12-062125; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; VERFAILLIE CM, 1992, J CLIN INVEST, V90, P1232, DOI 10.1172/JCI115985; Vinante F, 1999, BLOOD, V93, P1715, DOI 10.1182/blood.V93.5.1715.405k26_1715_1723; Wolanskyj AP, 2006, MAYO CLIN PROC, V81, P159, DOI 10.4065/81.2.159; Xiao WB, 2010, BLOOD, V116, P6003, DOI 10.1182/blood-2010-05-283937; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Ye M, 2015, CELL STEM CELL, V17, P611, DOI 10.1016/j.stem.2015.08.011; Zimmer SN, 2012, EXP HEMATOL, V40, P295, DOI 10.1016/j.exphem.2011.12.004; Zimmer SN, 2011, BLOOD, V118, P69, DOI 10.1182/blood-2010-09-307942	57	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158649	10.1371/journal.pone.0158649	http://dx.doi.org/10.1371/journal.pone.0158649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427906	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169300015
J	Grover, S; Furnham, A				Grover, Simmy; Furnham, Adrian			Coaching as a Developmental Intervention in Organisations: A Systematic Review of Its Effectiveness and the Mechanisms Underlying It	PLOS ONE			English	Review							STATISTICAL POWER; WORKPLACE STRESS; GOAL ATTAINMENT; IMPACT; PERFORMANCE; ATTITUDES; FEEDBACK; METAANALYSIS; PERSONALITY; ENGAGEMENT	Purpose The primary aim of this paper is to conduct a thorough and systematic review of the empirical and practitioner research on executive, leadership and business coaching to assess the current empirical evidence for the effectiveness of coaching and the mechanisms underlying it. Background Organisations are increasingly using business coaching as an intervention to improve the productivity and performance of their senior personnel. A consequence of this increased application is the demand for empirical data to understand the process by which it operates and its demonstrable efficacy in achieving pre-set goals. Method This paper is a systematic review of the academic and practitioner literature pertaining to the effectiveness of business and executive coaching as a developmental intervention for organisations. It focuses on published articles, conference papers and theses that cover business, leadership or executive coaching within organisations over the last 10 years. Conclusions The main findings show that coaching is an effective tool that benefits organisations and a number of underlying facets contribute to this effectiveness. However, there is deficiency and scope for further investigation in key aspects of the academic research and we identify several areas that need further research and practitioner attention.	[Grover, Simmy; Furnham, Adrian] UCL, Res Dept Clin Educ & Hlth Psychol, 26 Bedford Way, London WC1H 0AP, England; [Furnham, Adrian] Norwegian Business Sch BI, Nydalveien, Olso, Norway	University of London; University College London; BI Norwegian Business School	Furnham, A (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, 26 Bedford Way, London WC1H 0AP, England.; Furnham, A (corresponding author), Norwegian Business Sch BI, Nydalveien, Olso, Norway.	a.furnham@ucl.ac.uk	Furnham, Adrian/ABB-2072-2020					Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Allen TD, 2008, J VOCAT BEHAV, V73, P343, DOI 10.1016/j.jvb.2007.08.004; Aluko FS, 2006, IFE PSYCHOL, V14, P198; Antonakis J, 2010, LEADERSHIP QUART, V21, P1086, DOI 10.1016/j.leaqua.2010.10.010; Avey JB, 2011, HUM RESOUR DEV Q, V22, P127, DOI 10.1002/hrdq.20070; Barak A, 2008, J TECHNOL HUMAN SERV, V26, P109, DOI 10.1080/15228830802094429; Bargh JA, 2004, ANNU REV PSYCHOL, V55, P573, DOI 10.1146/annurev.psych.55.090902.141922; Baron L, 2011, J MANAG DEV, V30, P847, DOI 10.1108/02621711111164330; Baron L, 2009, HUM RESOUR DEV Q, V20, P85, DOI 10.1002/hrdq.20009; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Biggs A, 2014, INT J STRESS MANAGE, V21, P43, DOI 10.1037/a0034508; Blackman A, EXPLORING COACHING E, P5; Bono JE, 2011, ACAD MANAGE J, V54, P657, DOI 10.5465/AMJ.2011.64869103; Bowles S.V., 2007, LEADERSHIP ORG DEV J, V28, P388, DOI DOI 10.1108/01437730710761715; Bozer G., 2015, CONSULTING PSYCHOL J, V67, P218, DOI DOI 10.1037/CPB0000044; Bozer G, 2014, PERS REV, V43, P881, DOI 10.1108/PR-10-2013-0171; Bozer G, 2012, INT J EVID BASED COA, V10, P14; Bozer G, 2013, J MANAG DEV, V32, P277, DOI 10.1108/02621711311318319; Bright D., 2012, COACHING INT J THEOR, V5, P4, DOI [DOI 10.1080/17521882.2011.648332, 10.1080/17521882.2011.648332]; Cerni T., 2010, INT COACHING PSYCHOL, V5, P81; Cook TD., 1979, QUASIEXPERIMENTATION; Coutu D, 2009, HARVARD BUS REV, V87, P91; Crompton B, 2012, EFFECT BUSINESS COAC; De Haan E., 2013, CONSULT PSYCH J, V65, P40, DOI [DOI 10.1037/A0031635, 10.1037/a0031635]; de Haan E, 2011, PERS REV, V40, P24, DOI 10.1108/00483481111095500; De Meuse KP., 2009, COACHING-INT J THEOR, V2, DOI [10.1080/17521880902882413, DOI 10.1080/17521880902882413]; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Vidal-Salazar MD, 2012, COMPET REV, V22, P423, DOI 10.1108/10595421211266302; Douge B., 1993, SPORT SCI REV, V2, P14; Ely K, 2010, LEADERSHIP QUART, V21, P585, DOI 10.1016/j.leaqua.2010.06.003; Evers W. J., 2006, CONSULTING PSYCHOL J, V58, P174, DOI [DOI 10.1037/1065-9293.58.3.174, 10.1037/1065-9293.58.3.174, DOI 10.1037/10659293.58.3.174]; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Federici RA, 2012, ORGAN DEV J, V30, P63; FESTINGER L, 1959, J ABNORM SOC PSYCH, V58, P203, DOI 10.1037/h0041593; Finn FA, 2007, THESIS; Gan GC, 2015, J MANAG DEV, V34, P476, DOI 10.1108/JMD-08-2013-0104; Gorby C. B., 1937, FACTORY MANAGEMENT M, V95, P82; Grant A, 2004, INT J COACH ORGAN, V2, P6; Grant A.M., 2010, CONSULTING PSYCHOL J, V62, P151, DOI [DOI 10.1037/A0019212, 10.1037/a0019212]; Grant A.M., 2014, COACHING-INT J THEOR, V7, P18, DOI [10.1080/17521882.2013.850106, DOI 10.1080/17521882.2013.850106]; Grant A.M., 2012, COACHING-INT J THEOR, V5, P74, DOI DOI 10.1080/17521882.2012.672438; Grant AM, 2003, SOC BEHAV PERSONAL, V31, P253, DOI 10.2224/sbp.2003.31.3.253; Grant AM, 2014, J CHANG MANAG, V14, P258, DOI 10.1080/14697017.2013.805159; Grant AM, 2010, INT REV IND ORGAN PS, V25, P125; Grant AM, 2009, J POSIT PSYCHOL, V4, P396, DOI 10.1080/17439760902992456; Gyllensten K, 2005, INT J EVID BASED COA, V3, P75; Gyllensten K, 2005, INT J HEALTH PROMOT, V43, P97, DOI 10.1080/14635240.2005.10708048; Harrah WF, INT J EVID BASED COA, V12; Hoven H, 2014, RES SOCIAL WORK PRAC; Hunter J. E., 2004, METHODS METAANALYSIS; Ianiro P.M., 2013, COACHING INT J THEOR, V6, P25, DOI [10.1080/17521882.2012.740489, DOI 10.1080/17521882.2012.740489]; ICF, 2012, 2012 ICF GLOB COACH; Jones R. A., 2006, LEADERSHIP ORG DEV J, V27, P584, DOI DOI 10.1108/01437730610692434; Jones RJ, 2014, INT J EVID BASED COA, V12, P109; Jones RJ, 2015, J OCCUP ORGAN PSYCH; Joo B., 2005, HUMAN RESOURCE DEV R, V4, P462, DOI DOI 10.1177/1534484305280866; Kampa-Kokesch S., 2001, CONSULT PSYCH J, V53, P205, DOI [10.1037/1061-4087.53.4.205, DOI 10.1037/1061-4087.53.4.205]; Kochanowski S., 2010, J LEADERSH ORG STUD, V17, P363, DOI DOI 10.1177/1548051809352663; Ladegard G, INT H EVID BASED COA, V9; Ladegard G, 2014, LEADERSHIP QUART, V25, P631, DOI 10.1016/j.leaqua.2014.02.002; Lawrence P., 2014, COACHING-INT J THEOR, V7, P4, DOI DOI 10.1080/17521882.2013.811694; Leonard-Cross Elouise., 2010, INT COACHING PSYCHOL, V5, P36; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; Luthans F, 2003, HUM RESOUR MANAGE-US, V42, P243, DOI 10.1002/hrm.10083; MacKie D., 2014, CONSULTING PSYCHOL J, V66, P118, DOI [10.1037/cpb0000005, DOI 10.1037/CPB0000005]; Maltbia TE, 2014, ADV DEV HUM RESOUR, V16, P161, DOI 10.1177/1523422313520474; McKenna DD, 2009, IND ORGAN PSYCHOL-US, V2, P244, DOI 10.1111/j.1754-9434.2009.01143.x; Messick S, 1980, ETS RES REP SER, V1980, pii; Moen F., 2012, COACHING, V5, P113, DOI DOI 10.1080/17521882.2012.708355; Moen F, 2009, INT J EVID BASED COA, V7, P31; Nicholson N, 2005, ACAD MANAG P, V2005, pF1, DOI DOI 10.5465/AMBPP.2005.18779257; Nieminen LRG, 2013, HUM RESOUR DEV Q, V24, P145, DOI 10.1002/hrdq.21152; O'Connor S, 2013, PSYCHOL WELL-BEING, V3, DOI 10.1186/2211-1522-3-2; Offley N, 2005, RES REALITY INNOVATI; Olsen Jeanette M, 2010, Am J Health Promot, V25, pe1, DOI 10.4278/ajhp.090313-LIT-101; Orenstein RL, 2006, CONSULT PSYCHOL J PR, V58, P106, DOI DOI 10.3109/02699206.2014.927002; ORTH CD, 1990, J NURS ADMIN, V20, P11; Passmore J., 2011, COACHING INT J THEOR, V4, P70, DOI [10.1080/17521882.2011.596484, DOI 10.1080/17521882.2011.596484]; Perkins R.D., 2009, CONSULT PSYCH J, V61, P298, DOI [10.1037/a0017842, DOI 10.1037/A0017842]; Poepsel MA, 2011, IMPACT ONLINE EVIDEN; Porto PR, 2009, J NEUROPSYCHIATRY CL; Richardson TM, 2010, SOLUTION FOCUSED BRI; Robertson IT, 2012, LEADERSHIP ORG DEV J, V33, P224, DOI 10.1108/01437731211216443; Roth A., 2005, WHAT WORKS WHOM CRIT, V2nd; Scoular A., 2006, COACHING PSYCHOL, V2, P9; Scriffignano RS, 2011, COACH INT J THEORY R, V4, P20, DOI DOI 10.1080/17521882.2010.550898; Seehausen M, 2014, NEUROIMAGE, V84, P951, DOI 10.1016/j.neuroimage.2013.09.056; Servaas MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069606; Smith I.M., 2013, COACHING-INT J THEOR, V6, P57, DOI [10.1080/17521882.2012.758649, DOI 10.1080/17521882.2012.758649]; Smither JW, 2003, PERS PSYCHOL, V56, P23, DOI 10.1111/j.1744-6570.2003.tb00142.x; Sonesh SC., 2015, CONSULT PSYCH J, V67, P189, DOI DOI 10.1037/CPB0000042; SPECTOR PE, 1994, J ORGAN BEHAV, V15, P385, DOI 10.1002/job.4030150503; Stajkovic AD, 1998, PSYCHOL BULL, V124, P240, DOI 10.1037/0033-2909.124.2.240; Stewart LJ, 2008, INT J EVID BASED COA, V6, P32; Sue-Chan C, 2004, APPL PSYCHOL-INT REV, V53, P260, DOI 10.1111/j.1464-0597.2004.00171.x; Theeboom T, 2014, J POSIT PSYCHOL, V9, P1, DOI 10.1080/17439760.2013.837499; Valentine JC, 2010, J EDUC BEHAV STAT, V35, P215, DOI 10.3102/1076998609346961; Wright T A, 2000, J Occup Health Psychol, V5, P84, DOI 10.1037/1076-8998.5.1.84; Yu N., 2008, INT COACHING PSYCHOL, V3, P110	99	48	48	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159137	10.1371/journal.pone.0159137	http://dx.doi.org/10.1371/journal.pone.0159137			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27416061	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500086
J	Kussman, BD; Aasted, CM; Yucel, MA; Steele, SC; Alexander, ME; Boas, DA; Borsook, D; Becerra, L				Kussman, Barry D.; Aasted, Christopher M.; Yucel, Meryem A.; Steele, Sarah C.; Alexander, Mark E.; Boas, David A.; Borsook, David; Becerra, Lino			Capturing Pain in the Cortex during General Anesthesia: Near Infrared Spectroscopy Measures in Patients Undergoing Catheter Ablation of Arrhythmias	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; CEREBRAL-BLOOD-FLOW; POSTTRAUMATIC-STRESS-DISORDER; POSITRON-EMISSION-TOMOGRAPHY; DIFFUSE OPTICAL TOMOGRAPHY; PULMONARY VEIN ISOLATION; FRONTAL-CORTEX; RADIOFREQUENCY ABLATION; BRAIN ACTIVATION; CENTRAL SENSITIZATION	The predictability of pain makes surgery an ideal model for the study of pain and the development of strategies for analgesia and reduction of perioperative pain. As functional near-infrared spectroscopy reproduces the known functional magnetic resonance imaging activations in response to a painful stimulus, we evaluated the feasibility of functional near-infrared spectroscopy to measure cortical responses to noxious stimulation during general anesthesia. A multichannel continuous wave near-infrared imager was used to measure somatosensory and frontal cortical activation in patients undergoing catheter ablation of arrhythmias under general anesthesia. Anesthetic technique was standardized and intra-operative NIRS signals recorded continuously with markers placed in the data set for the timing and duration of each cardiac ablation event. Frontal cortical signals only were suitable for analysis in five of eight patients studied (mean age 14 +/- 1 years, weight 66.7 +/- 17.6 kg, 2 males). Thirty ablative lesions were recorded for the five patients. Radiofrequency or cryoablation was temporally associated with a hemodynamic response function in the frontal cortex characterized by a significant decrease in oxyhemoglobin concentration (paired t-test, p<0.05) with the nadir occurring in the period 4 to 6 seconds after application of the ablative lesion. Cortical signals produced by catheter ablation of arrhythmias in patients under general anesthesia mirrored those seen with noxious stimulation in awake, healthy volunteers, during sedation for colonoscopy, and functional Magnetic Resonance Imaging activations in response to pain. This study demonstrates the feasibility and potential utility of functional near-infrared spectroscopy as an objective measure of cortical activation under general anesthesia.	[Kussman, Barry D.; Aasted, Christopher M.; Steele, Sarah C.; Borsook, David; Becerra, Lino] Harvard Med Sch, Ctr Pain & Brain, Boston, MA 02115 USA; [Kussman, Barry D.; Aasted, Christopher M.; Steele, Sarah C.; Borsook, David; Becerra, Lino] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Kussman, Barry D.; Aasted, Christopher M.; Yucel, Meryem A.; Steele, Sarah C.; Alexander, Mark E.; Boas, David A.; Borsook, David; Becerra, Lino] Harvard Med Sch, Boston, MA 02115 USA; [Aasted, Christopher M.; Yucel, Meryem A.; Steele, Sarah C.; Boas, David A.; Borsook, David; Becerra, Lino] Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, 32 Fruit St, Boston, MA 02114 USA; [Alexander, Mark E.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital	Becerra, L (corresponding author), Harvard Med Sch, Ctr Pain & Brain, Boston, MA 02115 USA.; Becerra, L (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.; Becerra, L (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Becerra, L (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, 32 Fruit St, Boston, MA 02114 USA.	Lino.Becerra@childrens.harvard.edu		YUCEL, MERYEM/0000-0002-4291-2847	Mayday Foundation; Anesthesia Research Distinguished Trailblazer Award; National Institute of General Medical Science of the National Institutes of Health [R01GM104986]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104986] Funding Source: NIH RePORTER	Mayday Foundation; Anesthesia Research Distinguished Trailblazer Award; National Institute of General Medical Science of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this article was supported by the Mayday Foundation, the Anesthesia Research Distinguished Trailblazer Award, and the National Institute of General Medical Science of the National Institutes of Health under award number R01GM104986. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Azawy M, 2015, APPL NURS RES, V28, P268, DOI 10.1016/j.apnr.2015.01.011; Alaeddini J, 2007, PACE, V30, P1210, DOI 10.1111/j.1540-8159.2007.00842.x; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; An X, 1998, J COMP NEUROL, V401, P455; [Anonymous], 2015, EUR HEART J, V36, P140; Aryana A, 2008, J CARDIOVASC ELECTR, V19, P32, DOI 10.1111/j.1540-8167.2007.00975.x; Austin VC, 2005, NEUROIMAGE, V24, P92, DOI 10.1016/j.neuroimage.2004.08.011; Avidan MS, 2008, NEW ENGL J MED, V358, P1097, DOI 10.1056/NEJMoa0707361; Bayle DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008207; Becerra L, 2008, NEUROIMAGE, V41, P252, DOI 10.1016/j.neuroimage.2008.01.047; Becerra L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008016; Becerra LR, 1999, MAGN RESON MED, V41, P1044, DOI 10.1002/(SICI)1522-2594(199905)41:5<1044::AID-MRM25>3.0.CO;2-M; Boas DA, 2014, NEUROIMAGE, V85, P1, DOI 10.1016/j.neuroimage.2013.11.033; Borsook D, 2013, ANN SURG, V257, P403, DOI 10.1097/SLA.0b013e3182701a7b; Borsook D, 2011, NEUROSCI BIOBEHAV R, V35, P1125, DOI 10.1016/j.neubiorev.2010.11.005; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Bryant RA, 2008, HUM BRAIN MAPP, V29, P517, DOI 10.1002/hbm.20415; Carnlof C, 2014, SCAND CARDIOVASC J, V48, P35, DOI 10.3109/14017431.2013.859296; Castro A, 2015, J CLIN MONIT COMPUT, V29, P561, DOI 10.1007/s10877-014-9632-0; Chen JI, 2002, J NEUROPHYSIOL, V88, P464, DOI 10.1152/jn.2002.88.1.464; Chen WG, 2002, CHINESE MED J-PEKING, V115, P84; Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114; Cooper RJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00147; Dahl JB, 2011, CURR OPIN ANESTHESIO, V24, P331, DOI 10.1097/ACO.0b013e328345afd9; Fiset P, 1999, J NEUROSCI, V19, P5506; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Foreman RD, 2015, COMPR PHYSIOL, V5, P929, DOI 10.1002/cphy.c140032; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Gagnon L, 2012, NEUROIMAGE, V59, P2518, DOI 10.1016/j.neuroimage.2011.08.095; Ghoneim MM, 2009, ANESTH ANALG, V108, P527, DOI 10.1213/ane.0b013e318193c634; Gruenewald M, 2013, BEST PRACT RES-CLIN, V27, P235, DOI 10.1016/j.bpa.2013.06.007; Hobson AR, 2003, NEWS PHYSIOL SCI, V18, P109, DOI 10.1152/nips.01428.2002; Holper L, 2014, BRAIN RES, V1557, P141, DOI 10.1016/j.brainres.2014.02.013; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Ji GC, 2011, J NEUROPHYSIOL, V106, P2642, DOI 10.1152/jn.00461.2011; Kaisti KK, 2002, ANESTHESIOLOGY, V96, P1358, DOI 10.1097/00000542-200206000-00015; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kehlet H, 2006, ANESTH ANALG, V103, P494, DOI 10.1213/01.ANE.0000227067.35946.A2; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lenz FA, 1998, J NEUROPHYSIOL, V79, P2231, DOI 10.1152/jn.1998.79.4.2231; Leslie K, 2010, ANESTH ANALG, V110, P823, DOI 10.1213/ANE.0b013e3181b8b6ca; Lorenz J, 2002, NEURON, V35, P383, DOI 10.1016/S0896-6273(02)00767-5; Maroun M, 2013, NEUROSCIENTIST, V19, P370, DOI 10.1177/1073858412464527; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1218, DOI 10.1097/ALN.0b013e31820fc9b6; Matos SC, 2015, J NEUROSCI, V35, P13244, DOI 10.1523/JNEUROSCI.0799-15.2015; Norgaard MW, 2013, PACE, V36, P203, DOI 10.1111/pace.12032; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Peeters RR, 2001, MAGN RESON IMAGING, V19, P821, DOI 10.1016/S0730-725X(01)00391-5; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ridderinkhof KR, 2007, COGN AFFECT BEHAV NE, V7, P261, DOI 10.3758/CABN.7.4.261; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rosen SD, 2000, ANN MED, V32, P350, DOI 10.3109/07853890008995938; Sakuma S, 2014, NEUROSCI LETT, V575, P74, DOI 10.1016/j.neulet.2014.05.040; Sanders RD, 2012, ANESTHESIOLOGY, V116, P946, DOI 10.1097/ALN.0b013e318249d0a7; Schlunzen L, 2012, ACTA ANAESTH SCAND, V56, P248, DOI 10.1111/j.1399-6576.2011.02561.x; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Seifert F, 2009, J NEUROSCI, V29, P6167, DOI 10.1523/JNEUROSCI.4654-08.2009; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Symonds LL, 2006, J NEUROPHYSIOL, V95, P3823, DOI 10.1152/jn.01162.2005; Tracey I, 2000, NEUROSCI LETT, V288, P159, DOI 10.1016/S0304-3940(00)01224-6; Untergehrer G, 2013, ANESTHESIOLOGY, V118, P308, DOI 10.1097/ALN.0b013e318279fb21; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yucel MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09469	66	24	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158975	10.1371/journal.pone.0158975	http://dx.doi.org/10.1371/journal.pone.0158975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415436	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500056
J	Naegele, RP; Mitchell, J; Hausbeck, MK				Naegele, Rachel P.; Mitchell, Jenna; Hausbeck, Mary K.			Genetic Diversity, Population Structure, and Heritability of Fruit Traits in Capsicum annuum	PLOS ONE			English	Article							TOMATO; SHAPE; PEPPER; RESISTANCE; LOCI; QTL; INHERITANCE; COLLECTION; GERMPLASM; THICKNESS	Cultivated pepper (Capsicum annuum) is a phenotypically diverse species grown throughout the world. Wild and landrace peppers are typically small-fruited and pungent, but contain many important traits such as insect and disease resistance. Cultivated peppers vary dramatically in size, shape, pungency, and color, and often lack resistance traits. Fruit characteristics (e.g. shape and pericarp thickness) are major determinants for cultivar selection, and their association with disease susceptibility can reduce breeding efficacy. This study evaluated a diverse collection of peppers for mature fruit phenotypic traits, correlation among fruit traits and Phytophthora fruit rot resistance, genetic diversity, population structure, and trait broad sense heritability. Significant differences within all fruit phenotype categories were detected among pepper lines. Fruit from Europe had the thickest pericarp, and fruit from Ecuador had the thinnest. For fruit shape index, fruit from Africa had the highest index, while fruit from Europe had the lowest. Five genetic clusters were detected in the pepper population and were significantly associated with fruit thickness, end shape, and fruit shape index. The genetic differentiation between clusters ranged from little to very great differentiation when grouped by the predefined categories. Broad sense heritability for fruit traits ranged from 0.56 (shoulder height) to 0.98 (pericarp thickness). When correlations among fruit phenotypes and fruit disease were evaluated, fruit shape index was negatively correlated with pericarp thickness, and positively correlated with fruit perimeter. Pepper fruit pericarp, perimeter, and width had a slight positive correlation with Phytophthora fruit rot, whereas fruit shape index had a slight negative correlation.	[Naegele, Rachel P.] ARS, USDA, San Joaquin Valley Agr Sci Ctr, 9611 South Riverbend Ave, Parlier, CA USA; [Mitchell, Jenna; Hausbeck, Mary K.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA	United States Department of Agriculture (USDA); Michigan State University	Hausbeck, MK (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.	hausbec1@msu.edu			ARS [ARS-0425023] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		Ashrafi H, 2009, GENOME, V52, P935, DOI [10.1139/G09-065, 10.1139/g09-065]; Ben Chaim A, 2003, GENOME, V46, P1, DOI [10.1139/g02-096, 10.1139/G02-096]; Ben Chaim A, 2001, THEOR APPL GENET, V102, P1016, DOI 10.1007/s001220000461; Bharath SM, 2013, HORTSCIENCE, V48, P531, DOI 10.21273/HORTSCI.48.5.531; BILES CL, 1993, PHYTOPATHOLOGY, V83, P607, DOI 10.1094/Phyto-83-607; Brewer MT, 2007, J EXP BOT, V58, P1339, DOI 10.1093/jxb/erl301; Brewer MT, 2006, PLANT PHYSIOL, V141, P15, DOI 10.1104/pp.106.077867; Cheng CH, 2014, EUPHYTICA, V198, P305, DOI 10.1007/s10681-014-1107-3; Dwivedi N, 2015, J PLANT BIOCHEM BIOT, V24, P154, DOI 10.1007/s13562-013-0247-1; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fehr W.R., 1987, PRINCIPLES CULTIVAR, V2; Haggard JE, 2013, G3-GENES GENOM GENET, V3, P2131, DOI 10.1534/g3.113.007195; Hurtado M, 2013, SCI HORTIC-AMSTERDAM, V164, P625, DOI 10.1016/j.scienta.2013.10.028; Gonzalo MJ, 2009, J AM SOC HORTIC SCI, V134, P77, DOI 10.21273/JASHS.134.1.77; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Knapp SJ., 1985, CROP SCI, V25, P192, DOI [10.2135/cropsci1985.0011183X002500010046x, DOI 10.2135/cropsci1985.0011183X002500010046x]; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Ku HM, 1999, THEOR APPL GENET, V99, P844, DOI 10.1007/s001220051304; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Moreau P, 1998, MOL PLANT MICROBE IN, V11, P259, DOI 10.1094/MPMI.1998.11.4.259; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Naegele R, 2013, PHYTOPATHOLOGY; Naegele RP, 2015, PHYTOPATHOLOGY, V105, P110, DOI 10.1094/PHYTO-02-14-0031-R; Naegele RP, 2014, PLANT DIS, V98, P885, DOI 10.1094/PDIS-03-13-0295-RE; Naegele RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095930; Nicolai M, 2013, GENET RESOUR CROP EV, V60, P2375, DOI 10.1007/s10722-013-0006-0; Nunome T, 2001, BREEDING SCI, V51, P19, DOI 10.1270/jsbbs.51.19; Vilarinho LBO, 2015, J AM SOC HORTIC SCI, V140, P597, DOI 10.21273/JASHS.140.6.597; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Pritchard JK, 2000, GENETICS, V155, P945; Qiao Jun, 2012, Acta Horticulturae Sinica, V39, P1115; Rao GU, 2003, THEOR APPL GENET, V106, P1457, DOI 10.1007/s00122-003-1204-5; Rodriguez GR, 2011, PLANT PHYSIOL, V156, P275, DOI 10.1104/pp.110.167577; Rodriguez JM, 1999, THEOR APPL GENET, V99, P147, DOI 10.1007/s001220051219; Sage-Palloix AM, 2007, ANAL DIVERSITY PEPER; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Tsaballa A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-46; *USDA, NAT GEN RES PROGR; Wahyuni Y, 2013, METABOLOMICS, V9, P130, DOI 10.1007/s11306-012-0432-6; Xiao H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-49; Xue-jun C, 2012, XIBEI ZHIWU XUEBAO, V32, P246; Zhang ShuGen, 2008, Acta Horticulturae Sinica, V35, P515; Zygier S, 2005, THEOR APPL GENET, V111, P437, DOI 10.1007/s00122-005-2015-7	45	34	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0156969	10.1371/journal.pone.0156969	http://dx.doi.org/10.1371/journal.pone.0156969			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415818	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500012
J	Vidal-Castineira, JR; Lopez-Vazquez, A; Diaz-Pena, R; Diaz-Bulnes, P; Martinez-Camblor, P; Coto, E; Coto-Segura, P; Bruges-Armas, J; Pinto, JA; Blanco, FJ; Sanchez, A; Mulero, J; Queiro, R; Lopez-Larrea, C				Ramon Vidal-Castineira, Jose; Lopez-Vazquez, Antonio; Diaz-Pena, Roberto; Diaz-Bulnes, Paula; Martinez-Camblor, Pablo; Coto, Eliecer; Coto-Segura, Pablo; Bruges-Armas, Jacome; Antonio Pinto, Jose; Jose Blanco, Francisco; Sanchez, Alejandra; Mulero, Juan; Queiro, Ruben; Lopez-Larrea, Carlos			A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; POPULATION; FAMILY; RISK; PSORIASIS; RS4819554; VARIANTS; ANTIGEN; COHORT	The aim of this study was to identify new genetic variants associated with the severity of ankylosing spondylitis (AS). We sequenced the exome of eight patients diagnosed with AS, selected on the basis of the severity of their clinical parameters. We identified 27 variants in exons and regulatory regions. The contribution of candidate variants found to AS severity was validated by genotyping two Spanish cohorts consisting of 180 cases/300 controls and 419 cases/656 controls. Relationships of SNPs and clinical variables with the Bath Ankylosing Spondylitis Disease Activity and Functional Indices BASDAI and BASFI were analyzed. BASFI was standardized by adjusting for the duration of the disease since the appearance of the first symptoms. Refining the analysis of SNPs in the two cohorts, we found that the rs4819554 minor allele G in the promoter of the IL17RA gene was associated with AS (p<0.005). This variant was also associated with the BASFI score. Classifying AS patients by the severity of their functional status with respect to BASFI/disease duration of the 60th, 65th, 70th and 75th percentiles, we found the association increased from p60 to p75 (cohort 1: p<0.05 to p<0.01; cohort 2: p<0.01 to p<0.005). Our findings indicate a genetic role for the IL17/ILRA axis in the development of severe forms of AS.	[Ramon Vidal-Castineira, Jose; Lopez-Vazquez, Antonio; Diaz-Pena, Roberto; Diaz-Bulnes, Paula; Lopez-Larrea, Carlos] Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain; [Diaz-Pena, Roberto] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile; [Martinez-Camblor, Pablo] Hosp Univ Cent Asturias, Dept Stat, Oviedo, Spain; [Martinez-Camblor, Pablo] Univ Autonoma Chile, Fac Ciencias Educ, Santiago, Chile; [Coto, Eliecer] Hosp Univ Cent Asturias, Dept Mol Genet, Oviedo, Spain; [Coto-Segura, Pablo] Hosp Univ Cent Asturias, Dept Dermatol 2, Oviedo, Spain; [Bruges-Armas, Jacome] Univ Porto, Inst Mol & Cell Biol IBMC, Oporto, Portugal; [Antonio Pinto, Jose; Jose Blanco, Francisco] UDC, CHUAC, Inst Invest Biomed Coruna INIBIC, Rheumatol Serv, A Courna, Spain; [Sanchez, Alejandra; Mulero, Juan] Puerta Hierro Univ Hosp, Rheumatol Serv, Madrid, Spain; [Queiro, Ruben] Hosp Univ Cent Asturias, Rheumatol Serv, Oviedo, Spain; [Lopez-Larrea, Carlos] Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain	Central University Hospital Asturias; Universidad Autonoma de Chile; Central University Hospital Asturias; Universidad Autonoma de Chile; Central University Hospital Asturias; Central University Hospital Asturias; Universidade do Porto; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Hospital Puerta de Hierro-Majadahonda; Central University Hospital Asturias	Lopez-Larrea, C (corresponding author), Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain.; Lopez-Larrea, C (corresponding author), Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain.	inmuno@hca.es	Díaz-Peña, Roberto/ABF-4396-2020; Blanco, Francisco J./C-3192-2014; Sánchez, Alejandra/G-7826-2012; Camblor, Pablo Martinez/Z-4834-2019; Queiro, Rubén/D-5358-2016; Díaz-Peña, Roberto/AAB-1205-2020; Silva, Rúben/GYE-3599-2022; Coto-Segura, Pablo/AAR-4593-2021; RG, SMABSS/N-3322-2018	Díaz-Peña, Roberto/0000-0002-0114-2292; Blanco, Francisco J./0000-0001-9821-7635; Sánchez, Alejandra/0000-0003-4620-6744; Camblor, Pablo Martinez/0000-0001-7845-3905; Queiro, Rubén/0000-0002-8418-7145; Lopez-Larrea, Carlos/0000-0001-9988-1730; Armas, Jacome/0000-0001-7671-6521; RG, SMABSS/0000-0001-9944-3861; Vidal-Castineira, Jose Ramon/0000-0003-4877-3566; Research Group, SMIRE+CoDiRE/0000-0002-8871-4942	Spanish Fondo de Investigaciones Sanitarias-Fondos FEDER European Union del Plan Nacional de I+D+I, Spain [FIS PI12/0287]; Red de Investigacion Renal, Spain [REDinREN RD12/0021/0018, RD12/0021/0021]; PCTI from Principado de Asturias, Spain [GRUPIN 14-030]	Spanish Fondo de Investigaciones Sanitarias-Fondos FEDER European Union del Plan Nacional de I+D+I, Spain; Red de Investigacion Renal, Spain; PCTI from Principado de Asturias, Spain	This work was supported by grants from the Spanish Fondo de Investigaciones Sanitarias-Fondos FEDER European Union (FIS PI12/0287) del Plan Nacional de I+D+I 2008-2011, Red de Investigacion Renal (REDinREN RD12/0021/0018 and RD12/0021/0021), and the PCTI 2013-2017 (GRUPIN 14-030) from the Principado de Asturias, Spain.	Bartolome N, 2012, RHEUMATOLOGY, V51, P1471, DOI 10.1093/rheumatology/kes056; Batalla A, 2015, J DERMATOL SCI, V80, P111, DOI 10.1016/j.jdermsci.2015.06.011; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Burton PR, 2007, NAT GENET, P39; CAFFREY MFP, 1973, NATURE, V242, P121, DOI 10.1038/242121a0; Catanoso MG, 2013, RHEUMATOL INT, V33, P1165, DOI 10.1007/s00296-012-2501-6; Ciccia F, 2015, ANN RHEUM DIS; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Coto E, 2015, HUM IMMUNOL, V76, P75, DOI 10.1016/j.humimm.2015.01.027; Diaz-Pena R, 2011, ARTHRITIS RHEUM-US, V63, P3305, DOI 10.1002/art.30555; Diaz-Pena R, 2010, ARTHRITIS RHEUM-US, V62, P1000, DOI 10.1002/art.27332; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Khan Muhammad Asim, 2010, Curr Rheumatol Rep, V12, P337, DOI 10.1007/s11926-010-0126-x; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Lew BL, 2012, ANN DERMATOL, V24, P61, DOI 10.5021/ad.2012.24.1.61; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; Lubberts Erik, 2003, Curr Opin Investig Drugs, V4, P572; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P883, DOI 10.1002/ibd.20855; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Omrane I, 2014, IMMUNOL LETT, V158, P189, DOI 10.1016/j.imlet.2014.01.002; Pedersen SJ, 2011, ANN RHEUM DIS, V70, P1375, DOI 10.1136/ard.2010.138883; Rahman P, 2008, ARTHRITIS RHEUM-US, V58, P1020, DOI 10.1002/art.23389; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Schiotis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043428; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Sveaas SH, 2015, SCAND J RHEUMATOL, V44, P118, DOI 10.3109/03009742.2014.956142; Szczypiorska M, 2011, RHEUMATOLOGY, V50, P1969, DOI 10.1093/rheumatology/ker229; Thomas GP, 2010, IMMUNOL REV, V233, P162, DOI 10.1111/j.0105-2896.2009.00852.x; VANDERLINDEN S, 1983, BRIT J RHEUMATOL, V22, P18; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wong LY, 2013, J BIOL CHEM, V288, P35170, DOI 10.1074/jbc.M113.481440; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	40	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158905	10.1371/journal.pone.0158905	http://dx.doi.org/10.1371/journal.pone.0158905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415816	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500048
J	Martinez, JE; Mack, ML; Gelman, BD; Preston, AR				Martinez, Joel E.; Mack, Michael L.; Gelman, Bernard D.; Preston, Alison R.			Knowledge of Social Affiliations Biases Economic Decisions	PLOS ONE			English	Article							SOURCE MEMORY; IMPLICIT; FACES; ASSOCIATIONS; MECHANISMS; EVOLUTION; HIPPOCAMPUS; COOPERATION; RECIPROCITY; GENEROSITY	An individual's reputation and group membership can produce automatic judgments and behaviors toward that individual. Whether an individual's social reputation impacts interactions with affiliates has yet to be demonstrated. We tested the hypothesis that during initial encounters with others, existing knowledge of their social network guides behavior toward them. Participants learned reputations (cooperate, defect, or equal mix) for virtual players through an iterated economic game (EG). Then, participants learned one novel friend for each player. The critical question was how participants treated the friends in a single-shot EG after the friend-learning phase. Participants tended to cooperate with friends of cooperators and defect on friends of defectors, indicative of a decision making bias based on memory for social affiliations. Interestingly, participants' explicit predictions of the friends' future behavior showed no such bias. Moreover, the bias to defect on friends of defectors was enhanced when affiliations were learned in a social context; participants who learned to associate novel faces with player faces during reinforcement learning did not show reputation-based bias for associates of defectors during single-shot EG. These data indicate that when faced with risky social decisions, memories of social connections influence behavior implicitly.	[Martinez, Joel E.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Mack, Michael L.; Preston, Alison R.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Mack, Michael L.; Gelman, Bernard D.; Preston, Alison R.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA; [Preston, Alison R.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA	Princeton University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Martinez, JE (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.; Preston, AR (corresponding author), Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA.; Preston, AR (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA.; Preston, AR (corresponding author), Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA.	joeledmartinez@gmail.com; apreston@utexas.edu		Martinez, Joel/0000-0003-4949-303X	National Institute of Mental Health [R01-MH100121, F32-MH100904]; National Science Foundation [1056019]; NIMH [R01-MH100121, F32-MH100904]; NSF [1056019]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100121, F32MH100904] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health grant R01-MH100121 ARP https://www.nimh.nih.gov/index.shtml; National Institute of Mental Health Grant F32-MH100904 MLM https://www.nimh.nih.gov/index.shtml; National Science Foundation Career Award (1056019) ARP http://www.nsf.gov/.; The authors thank Parth Kalaria for data collection and Margaret Schlichting and Evan Stein for helpful comments. This project was supported by NIMH grant R01-MH100121 (A.R.P.), NIMH Grant F32-MH100904 (M.L.M), and an NSF Career Award (1056019) (A.R.P).	Amodio DM, 2011, CURR DIR PSYCHOL SCI, V20, P143, DOI 10.1177/0963721411408562; Aviezer H, 2012, SCIENCE, V338, P1225, DOI 10.1126/science.1224313; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Barclay P, 2013, EVOL HUM BEHAV, V34, P164, DOI 10.1016/j.evolhumbehav.2013.02.002; Barclay P, 2012, EVOL PSYCHOL-US, V10, P868, DOI 10.1177/147470491201000509; Barclay P, 2010, BRIT J PSYCHOL, V101, P123, DOI 10.1348/000712609X435733; Bargh JA, 2008, PERSPECT PSYCHOL SCI, V3, P73, DOI 10.1111/j.1745-6916.2008.00064.x; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Bell R, 2012, CURR DIR PSYCHOL SCI, V21, P403, DOI 10.1177/0963721412458525; Bell R, 2012, J EXP PSYCHOL LEARN, V38, P457, DOI 10.1037/a0026017; Bell R, 2011, EMOTION, V11, P249, DOI 10.1037/a0022597; Brent LJN, 2014, ANN NY ACAD SCI, V1316, P1, DOI 10.1111/nyas.12315; Brown RD, 2002, J EXP SOC PSYCHOL, V38, P87, DOI 10.1006/jesp.2001.1486; Buchner A, 2009, EVOL HUM BEHAV, V30, P212, DOI 10.1016/j.evolhumbehav.2009.01.004; Cikara M, 2014, PERSPECT PSYCHOL SCI, V9, P245, DOI 10.1177/1745691614527464; Davachi L, 2014, COGNITIVE NEUROSCIEN, P539; De Houwer J, 2001, PSYCHOL BULL, V127, P853, DOI 10.1037//0033-2909.127.6.853; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; Feinberg M, 2014, PSYCHOL SCI, V25, P656, DOI 10.1177/0956797613510184; Gawronski B, 2003, EUR J SOC PSYCHOL, V33, P573, DOI 10.1002/ejsp.166; Gawronski B, 2013, PERS SOC PSYCHOL REV, V17, P187, DOI 10.1177/1088868313480096; Gawronski B, 2013, J EXP SOC PSYCHOL, V49, P120, DOI 10.1016/j.jesp.2012.07.016; Gawronski B, 2011, ADV EXP SOC PSYCHOL, V44, P59, DOI 10.1016/B978-0-12-385522-0.00002-0; Ghuman AS, 2006, EMOTION, V6, P215, DOI 10.1037/1528-3542.6.2.215; Glaser T, 2015, PERS SOC PSYCHOL REV, V19, P257, DOI 10.1177/1088868314546489; Hawkins CB, 2015, BASIC APPL SOC PSYCH, V37, P31, DOI 10.1080/01973533.2014.995378; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Hu XQ, 2015, SCIENCE, V348, P1013, DOI 10.1126/science.aaa3841; Krasnow MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045662; Kumaran D, 2012, NEURON, V76, P653, DOI 10.1016/j.neuron.2012.09.035; Kurzban R, 2015, ANNU REV PSYCHOL, V66, P575, DOI 10.1146/annurev-psych-010814-015355; Lenth RV, 2015, LSMEANS LEAST SQUARE; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Phan KL, 2010, P NATL ACAD SCI USA, V107, P13099, DOI 10.1073/pnas.1008137107; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Ranganath KA, 2008, PSYCHOL SCI, V19, P249, DOI 10.1111/j.1467-9280.2008.02076.x; Ratliff KA, 2011, PERS SOC PSYCHOL B, V37, P1692, DOI 10.1177/0146167211420168; Ruz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015762; Rydell RJ, 2006, J PERS SOC PSYCHOL, V91, P995, DOI 10.1037/0022-3514.91.6.995; Schlichting ML, 2015, CURR OPIN BEHAV SCI, V1, P1, DOI 10.1016/j.cobeha.2014.07.005; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Solina F., 2003, C COMP VIS COMP GRAP, P38; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tavares RM, 2015, NEURON, V87, P231, DOI 10.1016/j.neuron.2015.06.011; Todorov A, 2015, ANNU REV PSYCHOL, P1; ULEMAN JS, 2005, NEW UNCONSCIOUS, P362; Van Bavel JJ, 2009, PERS SOC PSYCHOL B, V35, P321, DOI 10.1177/0146167208327743; Verosky SC, 2013, J EXP SOC PSYCHOL, V49, P661, DOI 10.1016/j.jesp.2013.02.004; Verosky SC, 2010, PSYCHOL SCI, V21, P779, DOI 10.1177/0956797610371965; Volstorf J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018945; Walther E, 2002, J PERS SOC PSYCHOL, V82, P919, DOI 10.1037//0022-3514.82.6.919; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252; Zeithamova D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00070	56	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159918	10.1371/journal.pone.0159918	http://dx.doi.org/10.1371/journal.pone.0159918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS5CG	27441563	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500154
J	Blumenthal, KG; Shenoy, ES; Huang, MS; Kuhlen, JL; Ware, WA; Parker, RA; Walensky, RP				Blumenthal, Kimberly G.; Shenoy, Erica S.; Huang, Mingshu; Kuhlen, James L.; Ware, Winston A.; Parker, Robert A.; Walensky, Rochelle P.			The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia	PLOS ONE			English	Article							INFECTIOUS-DISEASE CONSULTATION; QUALITY-OF-CARE; ANTIMICROBIAL THERAPY; CLINICAL MANAGEMENT; DRUG ALLERGY; BETA-LACTAMS; CEPHALOSPORINS; OUTCOMES; GUIDELINE; HISTORY	Background Methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia is a morbid infection with mortality benefit from receipt of parenteral beta-lactam therapy. A substantial portion of MSSA bacteremia patients report penicillin allergy, but infrequently have true allergy. Objective To determine the frequency and predictors of optimal and adequate therapy in patients with MSSA bacteremia. Design Retrospective cohort. Participants Adult inpatients with MSSA bacteremia, January 2009 through October 2013. Main Measures The primary measure was a trial of optimal therapy (OT), defined as >= 3 inpatient days or discharge on any first-line agents (nafcillin, oxacillin, cefazolin, or penicillin G, if susceptible). The secondary measure was completion of adequate therapy (AT), defined as >= 10 inpatient days or discharge on an agent appropriate for MSSA bacteremia. Data were electronically gathered with key variables manually validated through chart review. Logbinomial regression models were used to determine the frequency and predictors of outcomes. Key Results Of 456 patients, 346 (76%) received a trial of OT. Patients reporting penicillin allergy (13%) were less likely to receive OT trial than those without penicillin allergy (47% vs. 80%, p<0.001). Adjusting for other factors, penicillin allergy was the largest negative predictor of OT trial (RR 0.64 [0.49, 0.83]). Infectious Disease (ID) consultation was the largest positive predictor of OT trial across all patients (RR 1.34 [1.14, 1.57]). Allergy/Immunology consultation was the single most important predictor of OT trial among patients reporting penicillin allergy (RR 2.33 [1.44, 3.77]). Of 440 patients, 391 (89%) completed AT, with ID consultation the largest positive predictor of the outcome (RR 1.28 [1.15, 1.43]). Conclusions Nearly 25% of patients with MSSA bacteremia did not receive OT trial and about 10% did not receive AT completion. Reported penicillin allergy reduced, and ID consult increased, the likelihood of OT. Allergy evaluation, coupled with ID consultation, may improve outcomes in MSSA bacteremic patients.	[Blumenthal, Kimberly G.] Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Blumenthal, Kimberly G.; Shenoy, Erica S.; Huang, Mingshu; Parker, Robert A.; Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Blumenthal, Kimberly G.; Shenoy, Erica S.; Parker, Robert A.; Walensky, Rochelle P.] Harvard Med Sch, Boston, MA 02115 USA; [Blumenthal, Kimberly G.; Ware, Winston A.] Massachusetts Gen Hosp, Edward P Lawrence Ctr Qual & Safety, Boston, MA 02114 USA; [Shenoy, Erica S.; Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Shenoy, Erica S.] Massachusetts Gen Hosp, Infect Control Unit, Boston, MA 02114 USA; [Huang, Mingshu; Parker, Robert A.] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Kuhlen, James L.] Univ South Carolina, Sch Med, Dept Med, Acadia Allergy & Immunol, Greenville, SC USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Blumenthal, KG (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA.; Blumenthal, KG (corresponding author), Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA.; Blumenthal, KG (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Blumenthal, KG (corresponding author), Massachusetts Gen Hosp, Edward P Lawrence Ctr Qual & Safety, Boston, MA 02114 USA.	kblumenthal1@partners.org	Shenoy, Erica/AAD-7521-2021; Blumenthal, Kimberly/AAG-8290-2019	Blumenthal, Kimberly/0000-0003-4773-9817	National Institutes of Health [T32 HL116275]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL116275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health T32 HL116275 and the Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	American Academy Of Allergy Asthma and Immunology, 2015, FIND ALL IMM; [Anonymous], 2012, RED BOOK REPORT COMM; Arroliga ME, 2000, CHEST, V118, P1106, DOI 10.1378/chest.118.4.1106; Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Bai AD, 2015, CLIN INFECT DIS, V60, P1451, DOI 10.1093/cid/civ120; Banks TA, 2015, ANN ALLERG ASTHMA IM, V115, P451, DOI 10.1016/j.anai.2015.08.008; Barr DA, 2012, INT J ANTIMICROB AG, V39, P407, DOI 10.1016/j.ijantimicag.2012.01.016; Blumenthal KG, 2015, ANN ALLERG ASTHMA IM, V115, P294, DOI 10.1016/j.anai.2015.05.011; Blumenthal KG, 2015, CLIN INFECT DIS, V61, P741, DOI 10.1093/cid/civ394; Blumenthal KG, 2014, J ALLER CL IMM-PRACT, V2, P407, DOI 10.1016/j.jaip.2014.02.003; Bourke J, 2015, J ALLER CL IMM-PRACT, V3, P365, DOI 10.1016/j.jaip.2014.11.002; Chan KE, 2012, J AM SOC NEPHROL, V23, P1551, DOI 10.1681/ASN.2012010050; Chang FY, 2003, MEDICINE, V82, P333, DOI 10.1097/01.md.0000091184.93122.09; Chapman ALN, 2009, J ANTIMICROB CHEMOTH, V64, P1316, DOI 10.1093/jac/dkp343; Cox AM, 2007, J AM GERIATR SOC, V55, P645, DOI 10.1111/j.1532-5415.2007.01133.x; Daulat S, 2004, J ALLERGY CLIN IMMUN, V113, P1220, DOI 10.1016/j.jaci.2004.03.023; David MZ, 2014, CLIN INFECT DIS, V59, P798, DOI 10.1093/cid/ciu410; Davis L., 2013, E COMMUNICATION; del Real GA, 2007, ANN ALLERG ASTHMA IM, V98, P355, DOI 10.1016/S1081-1206(10)60882-4; Dodek P, 1999, CLIN INFECT DIS, V29, P1251, DOI 10.1086/313435; Forrest DM, 2001, CLIN INFECT DIS, V32, P1685, DOI 10.1086/320752; Fowler VG, 2013, UPTODATE; Gonzalez C, 1999, CLIN INFECT DIS, V29, P1171, DOI 10.1086/313440; Goodman EJ, 2001, J CLIN ANESTH, V13, P561, DOI 10.1016/S0952-8180(01)00329-4; Holland TL, 2014, JAMA-J AM MED ASSOC, V312, P1330, DOI 10.1001/jama.2014.9743; Honda H, 2010, AM J MED, V123, P631, DOI 10.1016/j.amjmed.2010.01.015; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Kim SH, 2008, ANTIMICROB AGENTS CH, V52, P192, DOI 10.1128/AAC.00700-07; Lee CE, 2000, ARCH INTERN MED, V160, P2819, DOI 10.1001/archinte.160.18.2819; Lee S, 2011, ANTIMICROB AGENTS CH, V55, P5122, DOI 10.1128/AAC.00485-11; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lopez-Cortes LE, 2013, CLIN INFECT DIS, V57, P1225, DOI 10.1093/cid/cit499; Macy E, 2015, J ALLERGY CLIN IMMUN, V135, P745, DOI 10.1016/j.jaci.2014.07.062; Macy E, 2013, J ALLER CL IMM-PRACT, V1, P258, DOI 10.1016/j.jaip.2013.02.002; McDanel JS, 2015, CLIN INFECT DIS, V61, P361, DOI 10.1093/cid/civ308; Naidoo R, 1922, PLOS ONE, V22; Paladino JA, 2010, CLIN INFECT DIS, V51, pS198, DOI 10.1086/653520; Pichichero ME, 2005, PEDIATRICS, V115, P1048, DOI 10.1542/peds.2004-1276; Pichichero ME, 2007, DIAGN MICR INFEC DIS, V57, p13S, DOI 10.1016/j.diagmicrobio.2006.12.004; Pichichero ME, 2006, J FAM PRACTICE, V55, P106; Prematta T, 2012, ALLERGY ASTHMA PROC, V33, P145, DOI 10.2500/aap.2012.33.3526; Raja AS, 2009, ANN EMERG MED, V54, P72, DOI 10.1016/j.annemergmed.2008.12.034; Reed SD, 2005, INFECT CONT HOSP EP, V26, P175, DOI 10.1086/502523; Ressner RA, 2016, CLIN INFECT DIS, V62, P400, DOI 10.1093/cid/civ886; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; Rimawi RH, 2013, J HOSP MED, V8, P341, DOI 10.1002/jhm.2036; Saunderson RB, 2015, CLIN MICROBIOL INFEC, V21, P779, DOI 10.1016/j.cmi.2015.05.026; Schweizer ML, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-279; Solensky R, 2010, ANN ALLERG ASTHMA IM, V105, P259, DOI 10.1016/j.anai.2010.08.002; Stryjewski ME, 2007, CLIN INFECT DIS, V44, P190, DOI 10.1086/510386; Tom S, 2014, CLIN MICROBIOL INFEC, V20, pO630, DOI 10.1111/1469-0691.12564; WICKERN GM, 1994, J ALLERGY CLIN IMMUN, V94, P725, DOI 10.1016/0091-6749(94)90180-5	52	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159406	10.1371/journal.pone.0159406	http://dx.doi.org/10.1371/journal.pone.0159406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438379	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100042
J	Fengler, S; Kessler, J; Timmermann, L; Zapf, A; Elben, S; Wojtecki, L; Tucha, O; Kalbe, E				Fengler, Sophie; Kessler, Josef; Timmermann, Lars; Zapf, Alexandra; Elben, Saskia; Wojtecki, Lars; Tucha, Oliver; Kalbe, Elke			Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting	PLOS ONE			English	Article							MINI-MENTAL-STATE; QUALITY-OF-LIFE; EXECUTIVE DYSFUNCTION; VISUAL DYSFUNCTION; DEMENTIA; INSTRUMENTS; DEPRESSION; POPULATION; DISABILITY; DEFICITS	Background Given the high prevalence of cognitive impairment in Parkinson's disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson's disease dementia (PD-D). However, the proportion in which the subtests are represented in the MoCA total score does not seem reasonable. We present the development and preliminary evaluation of an empirically based alternative scoring system of the MoCA which aims at increasing the overall diagnostic accuracy. Methods In study 1, the MoCA was administered to 40 patients with PD without cognitive impairment (PD-N), PD-MCI, or PD-D, as defined by a comprehensive neuropsychological test battery. The new MoCA scoring algorithm was developed by defining Areas under the Curve (AUC) for MoCA subtests in a Receiver Operating Characteristic (ROC) and by weighting the sub-tests according to their sensitivities and specificities. In study 2, an independent sample of 24 PD patients (PD-N, PD-MCI, or PD-D) was tested with the MoCA. In both studies, diagnostic accuracy of the original and the new scoring procedure was calculated. Results Diagnostic accuracy increased with the new MoCA scoring algorithm. In study 1, the sensitivity to detect cognitive impairment increased from 62.5% to 92%, while specificity decreased only slightly from 77.7% to 73%; in study 2, sensitivity increased from 68.8% to 81.3%, while specificity stayed stable at 75%. Conclusion This pilot study demonstrates that the sensitivity of the MoCA can be enhanced substantially by an empirically based weighting procedure and that the proposed scoring algorithm may serve the MoCA's actual purpose as a screening tool in the detection of cognitive dysfunction in PD patients better than the original scoring of the MoCA. Further research with larger sample sizes is necessary to establish efficacy of the alternate scoring system.	[Fengler, Sophie; Zapf, Alexandra; Kalbe, Elke] Univ Hosp Cologne, Dept Med Psychol Neuropsychol & Gender Studies, Cologne, Germany; [Fengler, Sophie; Kalbe, Elke] Univ Vechta, Inst Gerontol, Vechta, Germany; [Fengler, Sophie; Kalbe, Elke] Univ Vechta, Ctr Neuropsychol Diagnost & Intervent CeNDI, Vechta, Germany; [Kessler, Josef; Timmermann, Lars] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Elben, Saskia; Wojtecki, Lars] Univ Hosp Dusseldorf, Ctr Movement Disorders & Neuromodulat, Dept Neurol, Dusseldorf, Germany; [Tucha, Oliver] Univ Groningen, Fac Behav & Social Sci, Dept Clin & Dev Neuropsychol, Groningen, Netherlands	University of Cologne; University of Cologne; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Groningen	Kalbe, E (corresponding author), Univ Hosp Cologne, Dept Med Psychol Neuropsychol & Gender Studies, Cologne, Germany.; Kalbe, E (corresponding author), Univ Vechta, Inst Gerontol, Vechta, Germany.; Kalbe, E (corresponding author), Univ Vechta, Ctr Neuropsychol Diagnost & Intervent CeNDI, Vechta, Germany.	Elke.Kalbe@uk-koeln.de	Wojtecki, Lars/AAT-6604-2021; Tucha, Oliver/AAD-1403-2019	Wojtecki, Lars/0000-0002-6205-4405; Timmermann, Lars/0000-0002-5301-3580	German Ministry for Education and Research (BMBF; Bundesministerium fur Bildung und Forschung; LANDSCAPE study project) [01GI1008c]	German Ministry for Education and Research (BMBF; Bundesministerium fur Bildung und Forschung; LANDSCAPE study project)(Federal Ministry of Education & Research (BMBF))	This study was in part supported by the German Ministry for Education and Research (BMBF; Bundesministerium fur Bildung und Forschung; LANDSCAPE study project-nr: 01GI1008c).	Aarsland D, 2004, ARCH NEUROL-CHICAGO, V61, P1906, DOI 10.1001/archneur.61.12.1906; Aarsland D, 2009, NEUROLOGY, V72, P1121, DOI 10.1212/01.wnl.0000338632.00552.cb; Aarsland D, 2010, J NEUROL SCI, V289, P18, DOI 10.1016/j.jns.2009.08.034; Botha H, 2012, PARKINSONISM RELAT D, V18, P742, DOI 10.1016/j.parkreldis.2012.03.004; Buter TC, 2008, NEUROLOGY, V70, P1017, DOI 10.1212/01.wnl.0000306632.43729.24; Caviness JN, 2007, MOVEMENT DISORD, V22, P1272, DOI 10.1002/mds.21453; Cecato JF, 2015, INT PSYCHOGERIATR, V1, P1; Chou KL, 2010, MOVEMENT DISORD, V25, P2501, DOI 10.1002/mds.23362; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Damian AM, 2011, DEMENT GERIATR COGN, V31, P126, DOI 10.1159/000323867; De Lau LM, 2009, PARKINSONISM RELAT D, V20, P613; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fahn S., 1987, RECENT DEV PARKINSON, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galtier I, 2009, PSICOTHEMA, V21, P21; Harting C, 2000, WECHSLER MEMORY SCAL; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Hindle JV, 2013, MOVEMENT DISORD, V28, P1034, DOI 10.1002/mds.25377; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Kalbe E, 2005, J CLIN EXP NEUROPSYC, V27, P779, DOI 10.1080/13803390490918273; Kalbe E, 2013, J ALZHEIMERS DIS, V34, P813, DOI 10.3233/JAD-122128; Kessler J., 2000, MINI MENTAL STATUS T; Koski L, 2011, INT PSYCHOGERIATR, V23, P1107, DOI 10.1017/S1041610210002450; Koski L, 2009, J GERIATR PSYCH NEUR, V22, P151, DOI 10.1177/0891988709332944; Larner AJ, 2012, INT PSYCHOGERIATR, V24, P391, DOI 10.1017/S1041610211001839; Leroi I, 2012, J GERIATR PSYCH NEUR, V25, P208, DOI 10.1177/0891988712464823; Lessig S, 2012, MOVEMENT DISORD, V27, P1125, DOI 10.1002/mds.25070; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Luis CA, 2009, INT J GERIATR PSYCH, V24, P197, DOI 10.1002/gps.2101; Markwick A, 2012, J CLIN EXP NEUROPSYC, V34, P750, DOI 10.1080/13803395.2012.672966; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nazem S, 2009, J AM GERIATR SOC, V57, P304, DOI 10.1111/j.1532-5415.2008.02096.x; Ohta K, 2014, DEMENT GER COGN D EX, V4, P147, DOI 10.1159/000362124; Pagonabarraga J, 2012, NEUROBIOL DIS, V46, P590, DOI 10.1016/j.nbd.2012.03.029; Pedersen KF, 2013, JAMA NEUROL, V70, P580, DOI 10.1001/jamaneurol.2013.2110; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Riedel O, 2010, J GERIATR PSYCH NEUR, V23, P27, DOI 10.1177/0891988709351833; Shah A, 1997, AGE AGEING, V26, P217, DOI 10.1093/ageing/26.3.217; Sollberger M, 2007, DIAGNOSTIC MANUAL FO; Sturm W., 1993, LEISTUNGSPRUFSYSTEM; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Uc EY, 2005, NEUROLOGY, V65, P1907, DOI 10.1212/01.wnl.0000191565.11065.11; Velseboer DC, 2013, NEUROLOGY, V80, P627, DOI 10.1212/WNL.0b013e318281cc99; Waldron-Perrine B, 2012, INT J GERIATR PSYCH, V27, P1189, DOI 10.1002/gps.3768; Weintraub D, 2006, AM J GERIAT PSYCHIAT, V14, P169, DOI 10.1097/01.JGP.0000192488.66049.4b; Weintraub Daniel, 2004, Cogn Behav Neurol, V17, P195; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Whittington CJ, 2006, J CLIN EXP NEUROPSYC, V28, P738, DOI 10.1080/13803390590954236; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zgaljardic DJ, 2006, J CLIN EXP NEUROPSYC, V28, P1127, DOI 10.1080/13803390500246910	57	23	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159318	10.1371/journal.pone.0159318	http://dx.doi.org/10.1371/journal.pone.0159318			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27437705	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100035
J	Xia, F; Li, XY; Li, XZ; Zheng, DS; Sun, QX; Liu, J; Li, YX; Hua, JP; Qi, BX				Xia, Fei; Li, Xueying; Li, Xinzheng; Zheng, Desong; Sun, Quanxi; Liu, Jiang; Li, Yaxiao; Hua, Jinping; Qi, Baoxiu			Elevation of the Yields of Very Long Chain Polyunsaturated Fatty Acids via Minimal Codon Optimization of Two Key Biosynthetic Enzymes	PLOS ONE			English	Article							HETEROLOGOUS PROTEIN EXPRESSION; ESCHERICHIA-COLI; PICHIA-PASTORIS; ARABIDOPSIS-THALIANA; TRANSGENIC OILSEEDS; ISOCHRYSIS-GALBANA; GENE; USAGE; PLANTS; TRANSFORMATION	Eicosapentaenoic acid (EPA, 20:5 Delta(5,8,11,14,17)) and Docosahexaenoic acid (DHA, 22:6 Delta(4,7,10,13,16,19)) are nutritionally beneficial to human health. Transgenic production of EPA and DHA in oilseed crops by transferring genes originating from lower eukaryotes, such as microalgae and fungi, has been attempted in recent years. However, the low yield of EPA and DHA produced in these transgenic crops is a major hurdle for the commercialization of these transgenics. Many factors can negatively affect transgene expression, leading to a low level of converted fatty acid products. Among these the codon bias between the transgene donor and the host crop is one of the major contributing factors. Therefore, we carried out codon optimization of a fatty acid delta-6 desaturase gene PinD6 from the fungus Phytophthora infestans, and a delta-9 elongase gene, IgASE1 from the microalga Isochrysis galbana for expression in Saccharomyces cerevisiae and Arabidopsis respectively. These are the two key genes encoding enzymes for driving the first catalytic steps in the Delta 6 desaturation/Delta 6 elongation and the Delta 9 elongation/Delta 8 desaturation pathways for EPA/DHA biosynthesis. Hence expression levels of these two genes are important in determining the final yield of EPA/DHA. Via PCR-based mutagenesis we optimized the least preferred codons within the first 16 codons at their N-termini, as well as the most biased CGC codons (coding for arginine) within the entire sequences of both genes. An expression study showed that transgenic Arabidopsis plants harbouring the codon-optimized IgASE1 contained 64% more elongated fatty acid products than plants expressing the native IgASE1 sequence, whilst Saccharomyces cerevisiae expressing the codon optimized PinD6 yielded 20 times more desaturated products than yeast expressing wild-type (WT) PinD6. Thus the codon optimization strategy we developed here offers a simple, effective and low-cost alternative to whole gene synthesis for high expression of foreign genes in yeast and Arabidopsis.	[Xia, Fei; Li, Xueying; Li, Xinzheng; Zheng, Desong; Sun, Quanxi; Liu, Jiang; Li, Yaxiao; Qi, Baoxiu] Shandong Agr Univ, State Key Lab Crop Biol, Tai An 271000, Shandong, Peoples R China; [Hua, Jinping] China Agr Univ, Dept Plant Genet & Breeding, Coll Agron & Biotechnol, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China	Shandong Agricultural University; China Agricultural University	Qi, BX (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An 271000, Shandong, Peoples R China.	bssbq@bath.ac.uk	Hua, Jinping/L-3221-2019	Qi, Baoxiu/0000-0002-9425-935X	National Natural Science Foundation of China [30970222]; genetically modified organisms breeding major projects of China [009ZX08005-024B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); genetically modified organisms breeding major projects of China	This work was supported to BQ by the National Natural Science Foundation of China (Grant No. 30970222) and genetically modified organisms breeding major projects of China (Grant No. 009ZX08005-024B).; This work was supported by the National Natural Science Foundation of China (Grant No. 30970222 to BQ) and Genetically Modified Organisms Breeding Major Projects of China Grant No. 009ZX08005-024B to BQ). We thank Dr. James Doughty, University of Bath, for assisting with editing the manuscript.	Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; CHEN GFT, 1994, GENE DEV, V8, P2641, DOI 10.1101/gad.8.21.2641; Cheng BF, 2010, TRANSGENIC RES, V19, P221, DOI 10.1007/s11248-009-9302-z; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng TL, 1997, FEBS LETT, V409, P269, DOI 10.1016/S0014-5793(97)00522-X; Domergue F, 2005, TRENDS PLANT SCI, V10, P112, DOI 10.1016/j.tplants.2005.01.003; Eiamsa-ard P, 2013, APPL MICROBIOL BIOT, V97, P3485, DOI 10.1007/s00253-012-4556-4; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fraser TCM, 2004, PLANT PHYSIOL, V135, P859, DOI 10.1104/pp.104.038984; Frelin L, 2004, GENE THER, V11, P522, DOI 10.1038/sj.gt.3302184; GOLDMAN E, 1995, J MOL BIOL, V245, P467, DOI 10.1006/jmbi.1994.0038; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Griswold KE, 2003, PROTEIN EXPRES PURIF, V27, P134, DOI 10.1016/S1046-5928(02)00578-8; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu SY, 2006, PROTEIN EXPRES PURIF, V47, P249, DOI 10.1016/j.pep.2005.11.014; ITAKURA K, 1977, SCIENCE, V198, P1056, DOI 10.1126/science.412251; Johansson AS, 1999, PROTEIN EXPRES PURIF, V17, P105, DOI 10.1006/prep.1999.1117; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kim MS, 2013, J SCI FOOD AGR, V93, P2683, DOI 10.1002/jsfa.6084; Kim S, 2006, PROTEIN EXPRES PURIF, V50, P49, DOI 10.1016/j.pep.2006.07.014; KINK JA, 1991, J PROTOZOOL, V38, P441, DOI 10.1111/j.1550-7408.1991.tb04814.x; Laguia-Becher M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-52; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Mirzahoseini H, 2011, YAKHTEH, V12, P453; Olivares-Trejo JJ, 2003, MOL MICROBIOL, V49, P1043, DOI 10.1046/j.1365-2958.2003.03611.x; Outchkourov NS, 2002, PROTEIN EXPRES PURIF, V24, P18, DOI 10.1006/prep.2001.1523; Petrie JR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035214, 10.1371/journal.pone.0049165]; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Qi BX, 2004, NAT BIOTECHNOL, V22, P739, DOI 10.1038/nbt972; Qi BX, 2003, FEBS LETT, V547, P137, DOI 10.1016/S0014-5793(03)00676-8; Qi BX, 2002, FEBS LETT, V510, P159, DOI 10.1016/S0014-5793(01)03247-1; Ruiz-Lopez N, 2014, PLANT J, V77, P198, DOI 10.1111/tpj.12378; Ruiz-Lopez N, 2012, TRANSGENIC RES, V21, P1233, DOI 10.1007/s11248-012-9596-0; Sayanova OV, 2004, PHYTOCHEMISTRY, V65, P147, DOI 10.1016/j.phytochem.2003.10.017; Simopoulos AP, 2004, WORLD REV NUTR DIET, V93, P1; Sinclair G, 2002, PROTEIN EXPRES PURIF, V26, P96, DOI 10.1016/S1046-5928(02)00526-0; Stenoien HK, 2005, HEREDITY, V94, P87, DOI 10.1038/sj.hdy.6800547; Sun QX, 2013, PLANT MOL BIOL, V83, P391, DOI 10.1007/s11103-013-0096-2; Sun QX, 2013, APPL MICROBIOL BIOT, V97, P7689, DOI 10.1007/s00253-012-4613-z; Teng D, 2007, APPL MICROBIOL BIOT, V74, P1074, DOI 10.1007/s00253-006-0765-z; Thangadurai C, 2008, BIOCHEM BIOPH RES CO, V376, P647, DOI 10.1016/j.bbrc.2008.09.024; Trautwein EA, 2001, EUR J LIPID SCI TECH, V103, P45, DOI 10.1002/1438-9312(200101)103:1<45::AID-EJLT45>3.0.CO;2-9; Truksa M, 2006, TRANSGENIC RES, V15, P131, DOI 10.1007/s11248-005-6069-8; Uttaro AD, 2006, IUBMB LIFE, V58, P563, DOI 10.1080/15216540600920899; WANG BQ, 1994, PROTEIN EXPRES PURIF, V5, P476, DOI 10.1006/prep.1994.1067; Wood CC, 2009, PLANT BIOTECHNOL J, V7, P914, DOI 10.1111/j.1467-7652.2009.00453.x; Wu GH, 2005, NAT BIOTECHNOL, V23, P1013, DOI 10.1038/nbt1107; Yadava A, 2003, INFECT IMMUN, V71, P4961, DOI 10.1128/IAI.71.9.4961-4969.2003	53	4	5	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158103	10.1371/journal.pone.0158103	http://dx.doi.org/10.1371/journal.pone.0158103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433934	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000380169600006
J	Zhang, Z; Zhao, YJ; Meng, XG; Zhao, D; Zhang, D; Wang, L; Liu, CL				Zhang, Zhe; Zhao, Yanjie; Meng, Xianggao; Zhao, Dan; Zhang, Dan; Wang, Li; Liu, Changlin			A Simple Zn2+ Complex-Based Composite System for Efficient Gene Delivery	PLOS ONE			English	Article							DNA CONDENSATION; SIRNA DELIVERY; ACID; NANOPARTICLES; LIPOPLEXES; NUCLEATION; CURVATURE; EFFICACY; SEQUENCE; BINDING	Metal complexes might become a new type of promising gene delivery systems because of their low cytotoxicity, structural diversity, controllable aqua-and lipo-solubility, and appropriate density and distribution of positive charges. In this study, Zn2+ complexes (1-10) formed with a series of ligands contained benzimidazole(bzim) were prepared and characterized. They were observed to have different affinities for DNA, dependent on their numbers of positive charges, bzim groups, and coordination structures around Zn2+. The binding induced DNA to condensate into spherical nanoparticles with similar to 50 nm in diameter. The cell transfection efficiency of the DNA nanoparticles was poor, although they were low toxic. The sequential addition of the cell-penetrating peptide (CPP) TAT(48-60) and polyethylene glycol (PEG) resulted in the large DNA condensates (similar to 100 nm in diameter) and the increased cellular uptake. The clathrin-mediated endocytosis was found to be a key cellular uptake pathway of the nanoparticles formed with or without TAT(48-60) or/and PEG. The DNA nanoparticles with TAT(48-60) and PEG was found to have the cell transfection efficiency up to 20% of the commercial carrier Lipofect. These results indicated that a simple Zn2+-bzim complex-based composite system can be developed for efficient and low toxic gene delivery through the combination with PEG and CPPs such as TAT.	[Wang, Li; Liu, Changlin] Cent China Normal Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan 430079, Peoples R China; Cent China Normal Univ, Sch Chem, Wuhan 430079, Peoples R China	Central China Normal University; Central China Normal University	Wang, L; Liu, CL (corresponding author), Cent China Normal Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan 430079, Peoples R China.	wl_928@mail.ccnu.edu.cn; liuchl@mail.ccnu.edu.cn		meng, xiangguang/0000-0003-4131-296X	NSFC [21271079, 21001047, 21072074]; CCNU from the colleges' basic research and operation of MOE [CCNU14A05004, CCNU14A05012, CCNU14KFY003]	NSFC(National Natural Science Foundation of China (NSFC)); CCNU from the colleges' basic research and operation of MOE(Ministry of Education, Singapore)	This study is supported by NSFC (No. 21271079, 21001047, and 21072074) and by self-determined research funds of CCNU from the colleges' basic research and operation of MOE (No. CCNU14A05004, CCNU14A05012 and CCNU14KFY003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NL, 2005, J AM CHEM SOC, V127, P11576, DOI 10.1021/ja054038t; ALLISON SA, 1981, BIOPOLYMERS, V20, P469, DOI 10.1002/bip.1981.360200305; Aytar BS, 2013, J AM CHEM SOC, V135, P9111, DOI 10.1021/ja403546b; Aytar BS, 2012, J CONTROL RELEASE, V157, P249, DOI 10.1016/j.jconrel.2011.09.074; Bhat SS, 2012, CHEM-EUR J, V18, P16383, DOI 10.1002/chem.201200407; Bhat SS, 2011, CHEM COMMUN, V47, P11068, DOI 10.1039/c1cc13863d; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Conwell CC, 2004, BIOCHEMISTRY-US, V43, P5380, DOI 10.1021/bi049872u; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; Copolovici DM, 2014, ACS NANO, V8, P1972, DOI 10.1021/nn4057269; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Dong XD, 2010, CHEM-EUR J, V16, P14181, DOI 10.1002/chem.201001457; Draghici B, 2015, J MED CHEM, V58, P4091, DOI 10.1021/jm500330k; Golan S, 2011, LANGMUIR, V27, P6615, DOI 10.1021/la200450x; He CB, 2014, J AM CHEM SOC, V136, P5181, DOI 10.1021/ja4098862; He SQ, 2000, BIOPOLYMERS, V53, P329; Hsu CYM, 2012, BIOMATERIALS, V33, P7834, DOI 10.1016/j.biomaterials.2012.06.093; Huang XY, 2012, CHEM J CHINESE U, V33, P1151, DOI 10.3969/j.issn.0251-0790.2012.06.006; Huang XY, 2013, J INORG BIOCHEM, V129, P102, DOI 10.1016/j.jinorgbio.2013.09.009; HUD NV, 1995, P NATL ACAD SCI USA, V92, P3581, DOI 10.1073/pnas.92.8.3581; Hud NV, 2001, P NATL ACAD SCI USA, V98, P14925, DOI 10.1073/pnas.261560398; Jewell CM, 2008, BIOCONJUGATE CHEM, V19, P2120, DOI 10.1021/bc8002138; Jewell CM, 2006, J CONTROL RELEASE, V112, P129, DOI 10.1016/j.jconrel.2006.01.014; Jiang RW, 2013, CURR DRUG DELIV, V10, P122, DOI 10.2174/1567201811310010018; Kankia BI, 2001, NUCLEIC ACIDS RES, V29, P2795, DOI 10.1093/nar/29.13.2795; Kikuchi T, 2014, CHEM SCI, V5, P3257, DOI 10.1039/c4sc00656a; Kim HJ, 2014, ACS NANO, V8, P8979, DOI 10.1021/nn502125h; Kolate A, 2014, J CONTROL RELEASE, V192, P67, DOI 10.1016/j.jconrel.2014.06.046; Lachelt U, 2015, CHEM REV, V115, P11043, DOI 10.1021/cr5006793; Li GY, 2014, COORDIN CHEM REV, V281, P100, DOI 10.1016/j.ccr.2014.09.005; Li J, 2012, BIOMACROMOLECULES, V13, P3220, DOI 10.1021/bm3009999; Liu G, 2012, ANGEW CHEM INT EDIT, V51, P445, DOI 10.1002/anie.201105565; Liu L, 2010, BIOMATERIALS, V31, P1380, DOI 10.1016/j.biomaterials.2009.10.056; Malina J, 2014, INORG CHEM, V53, P1662, DOI 10.1021/ic402796k; Matulis D, 2000, J MOL BIOL, V296, P1053, DOI 10.1006/jmbi.1999.3470; Meng XG, 2008, INORG CHEM, V47, P6572, DOI 10.1021/ic800532q; Meng XG, 2011, DALTON T, V40, P12846, DOI 10.1039/c1dt10695c; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; Pelta J, 1996, J BIOL CHEM, V271, P5656, DOI 10.1074/jbc.271.10.5656; Peng LH, 2014, BIOMATERIALS, V35, P5605, DOI 10.1016/j.biomaterials.2014.03.062; Ruvinov E, 2015, J CONTROL RELEASE, V203, P150, DOI 10.1016/j.jconrel.2015.02.029; Shen MR, 2000, J AM CHEM SOC, V122, P4833, DOI 10.1021/ja000200a; Sun B, 2009, INORG CHEM, V48, P4637, DOI 10.1021/ic900102r; Vilfan ID, 2006, BIOCHEMISTRY-US, V45, P8174, DOI 10.1021/bi060396c; WIDOM J, 1983, BIOPOLYMERS, V22, P1595, DOI 10.1002/bip.360220612; WIDOM J, 1980, J MOL BIOL, V144, P431, DOI 10.1016/0022-2836(80)90330-7; Yang CL, 2013, PROG CHEM, V25, P555; Yin J, 2012, BIOMATERIALS, V33, P7884, DOI 10.1016/j.biomaterials.2012.07.017; Yu BL, 2013, CHEM COMMUN, V49, P810, DOI 10.1039/c2cc37896e; Zhao Y. J., 2014, SCI SINICA CHIMICA, V44, P102	50	10	10	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158766	10.1371/journal.pone.0158766	http://dx.doi.org/10.1371/journal.pone.0158766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433798	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600016
J	Begum, YA; Talukder, KA; Azmi, IJ; Shahnaij, M; Sheikh, A; Sharmin, S; Svennerholm, AM; Qadri, F				Begum, Yasmin A.; Talukder, K. A.; Azmi, Ishrat J.; Shahnaij, Mohammad; Sheikh, A.; Sharmin, Salma; Svennerholm, A. -M.; Qadri, Firdausi			Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh	PLOS ONE			English	Article							SHIGELLA-DYSENTERIAE TYPE-1; COLONIZATION FACTORS; MONOCLONAL-ANTIBODIES; TRAVELERS DIARRHEA; FLUOROQUINOLONE RESISTANCE; GYRA GENE; CHOLERA; DISEASE; TOXIN; CIPROFLOXACIN	Background Enterotoxigenic Escherichia coli (ETEC) is a common cause of bacterial infection leading to acute watery diarrhea in infants and young children as well as in travellers to ETEC endemic countries. Ciprofloxacin is a broad-spectrum antimicrobial agent nowadays used for the treatment of diarrhea. This study aimed to characterize ciprofloxacin resistant ETEC strains isolated from diarrheal patients in Bangladesh. Methods A total of 8580 stool specimens from diarrheal patients attending the icddr, b Dhaka hospital was screened for ETEC between 2005 and 2009. PCR and Ganglioside GM1-Enzyme Linked Immuno sorbent Assay (ELISA) was used for detection of Heat labile (LT) and Heat stable (ST) toxins of ETEC. Antimicrobial susceptibilities for commonly used antibiotics and the minimum inhibitory concentration (MIC) of nalidixic acid, ciprofloxacin and azithromycin were examined. DNA sequencing of representative ciprofloxacin resistant strains was performed to analyze mutations of the quinolone resistance-determining region of gyrA, gyrB, parC and parE. PCR was used for the detection of qnr, a plasmid mediated ciprofloxacin resistance gene. Clonal variations among ciprofloxacin resistant (Cip(R)) and ciprofloxacin susceptible (Cip(S)) strains were determined by Pulsed-field gel electrophoresis (PFGE). Results Among 1067 (12%) ETEC isolates identified, 42% produced LT/ST, 28% ST and 30% LT alone. Forty nine percent (n = 523) of the ETEC strains expressed one or more of the 13 tested colonization factors (CFs) as determined by dot blot immunoassay. Antibiotic resistance of the ETEC strains was observed as follows: ampicillin 66%, azithromycin 27%, ciprofloxacin 27%, ceftriazone 13%, cotrimaxazole 46%, doxycycline 44%, erythromycin 96%, nalidixic acid 83%, norfloxacin 27%, streptomycin 48% and tetracycline 42%. Resistance to ciprofloxacin increased from 13% in 2005 to 34% in 2009. None of the strains was resistant to mecillinam. The MIC of the nalidixic acid and ciprofloxacin of representative Cip(R) strains were 256 mu g/ml and 32 mu g/ml respectively. A single mutation (Ser(83)-Leu) in gyrA was observed in the nalidixic acid resistant ETEC strains. In contrast, double mutation in gyrA (Ser(83)-Leu, Asp(87)-Asn) and a single mutation in parC (Glu(84)-Ly) were found in ciprofloxacin resistant strains. Mutation of gyrB was not found in either the nalidixic acid or ciprofloxacin resistant strains. None of the ciprofloxacin resistant strains was found to be positive for the qnr gene. Diverse clones were identified from all ciprofloxacin resistant strains by PFGE analysis in both CF positive and CF negative ETEC strains. Conclusion Emergence of ciprofloxacin resistant ETEC strains results in a major challenge in current treatment strategies of ETEC diarrhea.	[Begum, Yasmin A.; Talukder, K. A.; Azmi, Ishrat J.; Shahnaij, Mohammad; Sharmin, Salma; Qadri, Firdausi] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Sheikh, A.] Washington Univ, Div Biol & Biomed Sci, Mol Microbiol & Microbial Pathogenesis Program, St Louis, MO USA; [Svennerholm, A. -M.] Univ Gothenborg, Sahlgrenska Acad, Dept Microbiol & Immunol, Gothenburg, Sweden	International Centre for Diarrhoeal Disease Research (ICDDR); Washington University (WUSTL); University of Gothenburg	Qadri, F (corresponding author), Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	fqadri@icddrb.org	Al, Mamun M./AAF-5850-2019; Sheikh, Alaullah/H-3125-2019; Qadri, Firdausi/AAF-4583-2019; Shahnaij, Mohammad/GMX-3978-2022	Sheikh, Alaullah/0000-0002-2972-6978; Mohammad, Shahnaij/0000-0002-3693-7239	Swedish Sida (SIDA) (grant INT-ICDDR) [B-HN-01-AV]; Swedish collaborative grant [SIDA-SWE2009-023]; Commission of the European Communities [HEALTH-F3-2010-261472]; Government of the Australia; Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	Swedish Sida (SIDA) (grant INT-ICDDR); Swedish collaborative grant; Commission of the European Communities(European Commission); Government of the Australia; Government of Bangladesh; Government of Canada(CGIAR); Government of Sweden; Government of UK	This research was supported by the core grants to the icddr,b, by the Governments of the Australia, Bangladesh, Canada, Sweden, and the UK for providing core/unrestricted support. This work was also supported by a Swedish Sida (SIDA) (grant INT-ICDDR, B-HN-01-AV) and Swedish collaborative grant SIDA-SWE2009-023, as well as by the Commission of the European Communities grant to STOPENTERICS (grant HEALTH-F3-2010-261472).	AGUIAR JM, 1992, J ANTIMICROB CHEMOTH, V29, P349, DOI 10.1093/jac/29.3.349; Ahmed D, 2006, ANTIMICROB AGENTS CH, V50, P3516, DOI 10.1128/AAC.00667-06; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Azmi IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102533; Begum YA, 2007, CAN J MICROBIOL, V53, P19, DOI 10.1139/W06-098; Chakraborty S, 2001, J CLIN MICROBIOL, V39, P3241, DOI 10.1128/JCM.39.9.3241-3246.2001; Das SK, 2013, J INFECT DEV COUNTR, V7, P900, DOI 10.3855/jidc.3003; Diemert DJ, 2006, CLIN MICROBIOL REV, V19, P583, DOI 10.1128/CMR.00052-05; DUPONT HL, 1981, PHARMACOL THERAPEUT, V13, P249, DOI 10.1016/0163-7258(81)90002-4; Ericsson CD, 2003, INT J ANTIMICROB AG, V21, P116, DOI 10.1016/S0924-8579(02)00282-0; Everett MJ, 1996, ANTIMICROB AGENTS CH, V40, P2380, DOI 10.1128/AAC.40.10.2380; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; GILL DM, 1980, J INFECT DIS, V141, P64, DOI 10.1093/infdis/141.1.64; Harris AM, 2008, AM J TROP MED HYG, V79, P708, DOI 10.4269/ajtmh.2008.79.708; Hooper D C, 1993, Drugs, V45 Suppl 3, P8; Khan WA, 2002, LANCET, V360, P1722, DOI 10.1016/S0140-6736(02)11680-1; Matsushita S, 2001, Kansenshogaku Zasshi, V75, P785; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; MCCONNELL MM, 1989, J GEN MICROBIOL, V135, P1135; MERSON MH, 1980, J INFECT DIS, V141, P702, DOI 10.1093/infdis/141.6.702; National Committee for Clinical Laboratory Standards, 2000, PERFORMANCE STANDARD; Oethinger M, 1996, ANTIMICROB AGENTS CH, V40, P387, DOI 10.1128/AAC.40.2.387; Pichel M, 2012, FOODBORNE PATHOG DIS, V9, P418, DOI 10.1089/fpd.2011.1067; QADRI F, 1994, CLIN DIAGN LAB IMMUN, V1, P51, DOI 10.1128/CDLI.1.1.51-54.1994; Qadri F, 2000, J INFECT DIS, V181, P2071, DOI 10.1086/315507; Qadri F, 2005, EMERG INFECT DIS, V11, P1104, DOI 10.3201/eid1107.041266; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; RAHMAN M, 1987, J CLIN MICROBIOL, V25, P2204, DOI 10.1128/JCM.25.11.2204-2206.1987; RAHMAN M, 1994, ANTIMICROB AGENTS CH, V38, P2488, DOI 10.1128/AAC.38.10.2488; RAO MC, 1985, CIBA F SYMP, V112, P74; Rodas C, 2011, BRAZ J INFECT DIS, V15, P132, DOI [10.1016/S1413-8670(11)70158-1, 10.1590/S1413-86702011000200007]; SACK RB, 1975, NEW ENGL J MED, V292, P1041, DOI 10.1056/NEJM197505152922001; SACK RB, 1990, REV INFECT DIS, V12, pS59; Shaheen Hind I., 2003, International Journal of Infectious Diseases, V7, P35, DOI 10.1016/S1201-9712(03)90040-3; Sjoling A, 2007, J CLIN MICROBIOL, V45, P3295, DOI 10.1128/JCM.00471-07; SO M, 1978, INFECT IMMUN, V21, P405, DOI 10.1128/IAI.21.2.405-411.1978; STOLL BJ, 1982, BRIT MED J, V285, P1185, DOI 10.1136/bmj.285.6349.1185; SVENNERHOLM AM, 1986, J CLIN MICROBIOL, V24, P585, DOI 10.1128/JCM.24.4.585-590.1986; Talukdar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061090; Talukder KA, 2006, CURR MICROBIOL, V52, P108, DOI 10.1007/s00284-005-0140-9; Talukder KA, 2002, J CLIN MICROBIOL, V40, P2490, DOI 10.1128/JCM.40.7.2490-2497.2002; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson CJ, 1999, J ANTIMICROB CHEMOTH, V43, P31, DOI 10.1093/jac/43.suppl_1.31; Vila J, 1996, ANTIMICROB AGENTS CH, V40, P491, DOI 10.1128/AAC.40.2.491; VILA J, 1994, ANTIMICROB AGENTS CH, V38, P2477, DOI 10.1128/AAC.38.10.2477; Wang H, 2001, ANTIMICROB AGENTS CH, V45, P1515, DOI 10.1128/AAC.45.5.1515-1521.2001; WHO, 1987, PROGR CONTR DIARR DI, P9	48	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0157415	10.1371/journal.pone.0157415	http://dx.doi.org/10.1371/journal.pone.0157415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428376	gold, Green Submitted, Green Published			2022-12-27	WOS:000380169300003
J	Dean, AJ; Fielding, KS; Newton, FJ				Dean, Angela J.; Fielding, Kelly S.; Newton, Fiona J.			Community Knowledge about Water: Who Has Better Knowledge and Is This Associated with Water-Related Behaviors and Support for Water-Related Policies?	PLOS ONE			English	Article							PRO-ENVIRONMENTAL BEHAVIOR; HEALTH LITERACY; PUBLIC KNOWLEDGE; DOMAIN KNOWLEDGE; INFORMATION; CONSERVATION; MANAGEMENT; ATTITUDES; PARTICIPATION; CITIZENSHIP	Sustainable approaches to water management require broad community acceptance of changes in policy, practice and technology, which in turn, requires an engaged community. A critical first step in building an engaged community is to identify community knowledge about water management, an issue rarely examined in research. To address this, we surveyed a representative sample of Australian adults (n = 5172). Knowledge was assessed using 15 questions about impact of household activities on waterways, the urban water cycle, and water management. This survey also examined demographics, psychosocial characteristics, exposure to water-related information, and water-related behaviors and policy support. Participants correctly answered a mean of 8.0 questions (Range 0-15). Most respondents knew that household actions can reduce water use and influence waterway health, whereas less than one third correctly identified that domestic wastewater is treated prior to entering waterways, urban stormwater is not treated, and that these are carried via different pipes. Higher water knowledge was associated with older age, higher education and living in non-urban areas. Poorer water knowledge was associated with speaking a language other than English in the home. Garden size, experience of water restrictions, satisfaction, waterway use for swimming, and certain information sources were also associated with knowledge. Greater water knowledge was associated with adoption of water-saving and pollution-reduction behaviors, and support for both alternative water sources and rain-gardens. These findings confirm the importance of community knowledge, and identify potential subgroups who may require additional targeting to build knowledge and support for water management initiatives.	[Dean, Angela J.; Fielding, Kelly S.] Univ Queensland, Sch Commun & Arts, St Lucia, Qld, Australia; [Dean, Angela J.; Fielding, Kelly S.; Newton, Fiona J.] Monash Univ, Cooperat Res Ctr Water Sensit Cities, Clayton, Vic, Australia; [Dean, Angela J.] Monash Univ, Monash Sustainabil Inst, BehaviourWorks, Clayton, Vic, Australia; [Newton, Fiona J.] Monash Univ, Fac Business & Econ, Caulfield, Vic, Australia	University of Queensland; Monash University; Monash University; Monash University	Dean, AJ (corresponding author), Univ Queensland, Sch Commun & Arts, St Lucia, Qld, Australia.; Dean, AJ (corresponding author), Monash Univ, Cooperat Res Ctr Water Sensit Cities, Clayton, Vic, Australia.; Dean, AJ (corresponding author), Monash Univ, Monash Sustainabil Inst, BehaviourWorks, Clayton, Vic, Australia.	a.dean@uq.edu.au	Dean, Angela/D-5618-2011	Dean, Angela/0000-0003-4017-4809; FIELDING, Kelly/0000-0001-5301-0331	Cooperative Research Centre for Water Sensitive Cities; Commonwealth of Australia; Australian Research Council [FT100100704]	Cooperative Research Centre for Water Sensitive Cities(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Commonwealth of Australia(Australian Government); Australian Research Council(Australian Research Council)	This research was supported by the Cooperative Research Centre for Water Sensitive Cities, Commonwealth of Australia and an the Australian Research Council grant FT100100704 to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Cooperative Research Centre for Water Sensitive Cities, Commonwealth of Australia and an Australian Research Council grant FT100100704 to the second author.	ABS, 2014, 31010 ABS; Ackerman PL, 1996, INTELLIGENCE, V22, P227, DOI 10.1016/S0160-2896(96)90016-1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALEXANDER PA, 1994, LEARN INDIVID DIFFER, V6, P379, DOI 10.1016/1041-6080(94)90001-9; [Anonymous], AUSTR STAT GEOGR STA; [Anonymous], 2015, ENV LIT US AG LEAD 2; [Anonymous], [No title captured]; Aslin H.J., 2013, ENGAGED ENV CITIZENS, P1; Australian Water Association, 2010, ATT WAT AUSTR COMM S; Vicente-Molina MA, 2013, J CLEAN PROD, V61, P130, DOI 10.1016/j.jclepro.2013.05.015; Baggett S, 2008, DESALINATION, V218, P132, DOI 10.1016/j.desal.2006.08.025; Beier ME, 2005, PSYCHOL AGING, V20, P341, DOI 10.1037/0882-7974.20.2.341; Beier ME, 2001, PSYCHOL AGING, V16, P615, DOI 10.1037//0882-7974.16.4.615; Bo A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1095; Brown RR, 2009, WATER SCI TECHNOL, V59, P847, DOI 10.2166/wst.2009.029; BRUVOLD WH, 1972, WATER RESOUR RES, V8, P1145, DOI 10.1029/WR008i005p01145; Buhr K, 2014, ENERGY RES SOC SCI, V3, P5, DOI 10.1016/j.erss.2014.05.004; Bureau of Meterology, CLIM DAT ONL; Carmi N, 2015, J ENVIRON EDUC, V46, P183, DOI 10.1080/00958964.2015.1028517; CH2MHILL, 2004, SO CAL WAT REC PROJ; Cockerill K, 2010, J ENVIRON EDUC, V41, P151, DOI 10.1080/00958960903295266; Daugs DR, 1984, WATER INT, V9, P84; Davies A., 2012, VALUE ROLE CITIZEN E; De Vriendt T, 2009, APPETITE, V52, P788, DOI 10.1016/j.appet.2009.02.014; de Vries G, 2014, J ENVIRON PSYCHOL, V38, P116, DOI 10.1016/j.jenvp.2014.01.003; Dean AJ, SUSTAINABLE IN PRESS; Dean AJ, 2016, ENVIRON SCI POLICY, V55, P238, DOI 10.1016/j.envsci.2015.10.016; Department of Sustainability E Water Population and Communities, 2012, NAT WAT KNOWL RES PL; Dobson A, 2007, SUSTAIN DEV, V15, P276, DOI 10.1002/sd.344; Dolnicar S, 2010, AUSTRALAS J WAT RESO, V14, P43, DOI 10.1080/13241583.2010.11465373; Dolnicar S, 2012, J ENVIRON MANAGE, V105, P44, DOI 10.1016/j.jenvman.2012.03.042; Dolnicar S, 2011, WATER RES, V45, P933, DOI 10.1016/j.watres.2010.09.030; Dolnicar S, 2010, J ENVIRON MANAGE, V91, P1288, DOI 10.1016/j.jenvman.2010.02.003; Duerden MD, 2010, J ENVIRON PSYCHOL, V30, P379, DOI 10.1016/j.jenvp.2010.03.007; Dupont DP, 2013, WATER RESOUR ECON, V4, P22, DOI 10.1016/j.wre.2013.12.003; European Social Survey, 2014, ESS 1 2002 DOC REP E; Fielding K, 2010, 152 AHURI; Fielding KS, 2014, WATER RES, V61, P86, DOI 10.1016/j.watres.2014.05.002; Frederiks ER, 2015, ENERGIES, V8, P573, DOI 10.3390/en8010573; Frisk E., 2011, J SUSTAINABILITY ED, V2, P20; Giacalone K, 2010, J CONTEMP WAT RES ED, V146, P92, DOI 10.1111/j.1936-704X.2010.00395.x; Gill R, 2011, DROUGHTS FLOODING RA; Guest H, 2015, MAR POLICY, V58, P98, DOI 10.1016/j.marpol.2015.04.007; Head BW, 2007, AUST J POLIT SCI, V42, P441, DOI 10.1080/10361140701513570; Hurlimann A, 2010, WATER RES, V44, P287, DOI 10.1016/j.watres.2009.09.020; James A, 2010, BEHAV ATTITUDES WATE; Kahlor L, 2009, SCI COMMUN, V30, P380, DOI 10.1177/1075547008328798; Kaiser FG, 2003, APPL PSYCHOL-INT REV, V52, P598, DOI 10.1111/1464-0597.00153; Larson KL, 2008, J ENVIRON MANAGE, V88, P817, DOI 10.1016/j.jenvman.2007.04.008; Leonard R, 2014, ADELAIDE SA GOYDER I; LOVRICH NP, 1984, COMMUN RES, V11, P415, DOI 10.1177/009365084011003005; Mankad A., 2010, QUALITATIVE EXPLORAT; Marlow DR, 2013, WATER RES, V47, P7150, DOI 10.1016/j.watres.2013.07.046; McDuff MM, 2008, LAKE RESERV MANAGE, V24, P47, DOI 10.1080/07438140809354050; McKenzie-Mohr D, 2014, SOCIAL MARKETING Q, V20, P35; Miller E, 2008, SOC NATUR RESOUR, V21, P244, DOI 10.1080/08941920701818258; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Otto S, 2014, J ENVIRON PSYCHOL, V40, P331, DOI 10.1016/j.jenvp.2014.08.004; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Padowski JC, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104004; Pritchett J., 2009, 17 COL STAT U COL WA; Randolph B, 2008, ENVIRON SCI POLICY, V11, P441, DOI 10.1016/j.envsci.2008.03.003; Rathnayaka K, 2014, RESOUR CONSERV RECY, V92, P85, DOI 10.1016/j.resconrec.2014.08.012; Ren LJ, 2014, ENVIRON SCI POLLUT R, V21, P13646, DOI 10.1007/s11356-014-3242-8; Safford TG, 2014, ENVIRON MANAGE, V53, P757, DOI 10.1007/s00267-014-0236-8; Salvaggio M, 2014, J ENVIRON PLANN MAN, V57, P588, DOI 10.1080/09640568.2012.756806; Schewe J, 2014, P NATL ACAD SCI USA, V111, P3245, DOI 10.1073/pnas.1222460110; SPSS&REG;, 2002, LIN MIX EFF MOD SPSS; STANOVICH KE, 1993, J EDUC PSYCHOL, V85, P211, DOI 10.1037/0022-0663.85.2.211; Steel B, 2005, COAST MANAGE, V33, P37, DOI 10.1080/08920750590883105; Steg L, 2014, J ENVIRON PSYCHOL, V38, P104, DOI 10.1016/j.jenvp.2014.01.002; Suka M, 2015, PATIENT EDUC COUNS, V98, P660, DOI 10.1016/j.pec.2015.02.013; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; von Wagner C, 2011, EPIDEMIOL REV, V33, P135, DOI 10.1093/epirev/mxq018; von Wagner C, 2009, HEALTH EDUC BEHAV, V36, P860, DOI 10.1177/1090198108322819; West B. T., 2007, LINEAR MIXED MODELS; Wooden M, 2007, ECON REC, V83, P208, DOI 10.1111/j.1475-4932.2007.00395.x; Zhang HX., 2012, ENCY SUSTAINABILITY, P2061, DOI [10.1007/978-1-4419-0851-3_388, DOI 10.1007/978-1-4419-0851-3_388]; Zuur Alain F., 2009, P1	79	59	60	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159063	10.1371/journal.pone.0159063	http://dx.doi.org/10.1371/journal.pone.0159063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27428372	gold, Green Published			2022-12-27	WOS:000380169300032
J	Margolis, EB; Fields, HL				Margolis, Elyssa B.; Fields, Howard L.			Mu Opioid Receptor Actions in the Lateral Habenula	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; SUBSTANTIA-GELATINOSA NEURONS; PERIAQUEDUCTAL GRAY; NUCLEUS-ACCUMBENS; GABA NEURONS; RAT; PROJECTIONS; EPITHALAMUS; CORTEX; INPUTS	Increased activity of lateral habenula (LHb) neurons is correlated with aversive states including pain, opioid abstinence, rodent models of depression, and failure to receive a predicted reward. Agonists at the mu opioid receptor (MOR) are among the most powerful rewarding and pain relieving drugs. Injection of the MOR agonist morphine directly into the habenula produces analgesia, raising the possibility that MOR acts locally within the LHb. Consequently, we examined the synaptic actions of MOR agonists in the LHb using whole cell patch clamp recording. We found that the MOR selective agonist DAMGO inhibits a subset of LHb neurons both directly and by inhibiting glutamate release onto these cells. Paradoxically, DAMGO also presynaptically inhibited GABA release onto most LHb neurons. The behavioral effect of MOR activation will thus depend upon both the level of intrinsic neuronal activity in the LHb and the balance of activity in glutamate and GABA inputs to different LHb neuronal populations.	[Margolis, Elyssa B.; Fields, Howard L.] Univ Calif San Francisco, Dept Neurol, Wheeler Ctr Neurobiol Addict, Alcoholism & Addict Res Grp, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Margolis, EB (corresponding author), Univ Calif San Francisco, Dept Neurol, Wheeler Ctr Neurobiol Addict, Alcoholism & Addict Res Grp, San Francisco, CA 94143 USA.	elyssa.margolis@ucsf.edu	Fields, Howard/ABG-9073-2020		NIDA [R01DA030529]; Wheeler Center for the Neurobiology of Addiction	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Wheeler Center for the Neurobiology of Addiction	This work was supported by NIDA grant R01DA030529 to EBM and The Wheeler Center for the Neurobiology of Addiction.	Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8; BENABID AL, 1989, NEUROSCI LETT, V96, P289, DOI 10.1016/0304-3940(89)90393-5; Bernard R, 2012, J COMP NEUROL, V520, P2545, DOI 10.1002/cne.23080; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; FUCHS P, 1993, NEUROREPORT, V4, P121, DOI 10.1097/00001756-199302000-00001; Goncalves L, 2012, J COMP NEUROL, V520, P1278, DOI 10.1002/cne.22787; GREATREX RM, 1982, BRAIN RES, V238, P192, DOI 10.1016/0006-8993(82)90782-X; GRUDT TJ, 1994, J NEUROSCI, V14, P1646, DOI 10.1523/JNEUROSCI.14-03-01646.1994; HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; Kim U, 2005, J COMP NEUROL, V483, P236, DOI 10.1002/cne.20410; Kim U, 2012, EUR J NEUROSCI, V35, P1253, DOI 10.1111/j.1460-9568.2012.08030.x; Lavezzi HN, 2012, BRAIN STRUCT FUNCT, V217, P719, DOI 10.1007/s00429-011-0368-z; LI YQ, 1993, NEUROSCI LETT, V158, P55, DOI 10.1016/0304-3940(93)90611-N; Lur G, 2015, CELL REP, V12, P326, DOI 10.1016/j.celrep.2015.06.029; MA QP, 1992, BRAIN RES, V583, P292, DOI 10.1016/S0006-8993(10)80036-8; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Navratilova E, 2015, J NEUROSCI, V35, P7264, DOI 10.1523/JNEUROSCI.3862-14.2015; Neugebauer NM, 2013, PHARMACOL BIOCHEM BE, V109, P77, DOI 10.1016/j.pbb.2013.04.015; Omelchenko N, 2009, EUR J NEUROSCI, V30, P1239, DOI 10.1111/j.1460-9568.2009.06924.x; Poller WC, 2013, BRAIN RES, V1507, P45, DOI 10.1016/j.brainres.2013.01.029; Root DH, 2014, NAT NEUROSCI, V17, P1543, DOI 10.1038/nn.3823; Root DH, 2014, J NEUROSCI, V34, P13906, DOI 10.1523/JNEUROSCI.2029-14.2014; Shabel SJ, 2014, SCIENCE, V345, P1494, DOI 10.1126/science.1250469; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Wang LY, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00455; Weiss T, 2011, NEUROSCIENCE, V172, P74, DOI 10.1016/j.neuroscience.2010.10.047; Xie Qiang, 1998, Okajimas Folia Anatomica Japonica, V75, P167; YOSHIMURA M, 1983, NATURE, V305, P529, DOI 10.1038/305529a0; Zhang CX, 2013, NEUROSCI LETT, V555, P12, DOI 10.1016/j.neulet.2013.09.019	31	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159097	10.1371/journal.pone.0159097	http://dx.doi.org/10.1371/journal.pone.0159097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427945	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300036
J	Weissenbacher-Lang, C; Kureljusic, B; Nedorost, N; Matula, B; Schiessl, W; Stixenberger, D; Weissenbock, H				Weissenbacher-Lang, Christiane; Kureljusic, Branislav; Nedorost, Nora; Matula, Bettina; Schiessl, Wolfgang; Stixenberger, Daniela; Weissenboeck, Herbert			Retrospective Analysis of Bacterial and Viral Co-Infections in Pneumocystis spp. Positive Lung Samples of Austrian Pigs with Pneumonia	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; RESPIRATORY-SYNDROME VIRUS; PORCINE CIRCOVIRUS TYPE-2; TORQUE-TENO-VIRUS; CONCURRENT INFECTIONS; DUAL INFECTION; RAT MODEL; CARINII; INOCULATION; PATHOGENS	Aim of this study was the retrospective investigation of viral (porcine circovirus type 2 (PCV2), porcine reproductive and respiratory syndrome virus (PRRSV), torque teno sus virus type 1 and 2 (TTSuV1, TTSuV2)) and bacterial (Bordetella bronchiseptica (B.b.), Mycoplasma hyopneumoniae (M. h.), and Pasteurella multocida (P. m.)) co-infections in 110 Pneumocystis spp. positive lung samples of Austrian pigs with pneumonia. Fifty-one % were positive for PCV2, 7% for PRRSV, 22% for TTSuV1, 48% for TTSuV2, 6% for B. b., 29% for M. h., and 21% for P. m. In 38.2% only viral, in 3.6% only bacterial and in 40.0% both, viral and bacterial pathogens were detected. In 29.1% of the cases a co-infection with 1 pathogen, in 28.2% with 2, in 17.3% with 3, and in 7.3% with 4 different infectious agents were observed. The exposure to Pneumocystis significantly decreased the risk of a co-infection with PRRSV in weaning piglets; all other odds ratios were not significant. Four categories of results were compared: I = P. spp. + only viral co-infectants, II = P. spp. + both viral and bacterial co-infectants, III = P. spp. + only bacterial co-infectants, and IV = P. spp. single infection. The evaluation of all samples and the age class of the weaning piglets resulted in a predomination of the categories I and II. In contrast, the suckling piglets showed more samples of category I and IV. In the group of fattening pigs, category II predominated. Suckling piglets can be infected with P. spp. early in life. With increasing age this single infections can be complicated by co-infections with other respiratory diseases.	[Weissenbacher-Lang, Christiane; Kureljusic, Branislav; Nedorost, Nora; Matula, Bettina; Schiessl, Wolfgang; Stixenberger, Daniela; Weissenboeck, Herbert] Univ Vet Med Vienna, Dept Pathobiol, Inst Pathol & Forens Vet Med, Vienna, Austria; [Kureljusic, Branislav] Inst Vet Med Serbia, Dept Pathol, Belgrade, Serbia	University of Veterinary Medicine Vienna	Weissenbacher-Lang, C (corresponding author), Univ Vet Med Vienna, Dept Pathobiol, Inst Pathol & Forens Vet Med, Vienna, Austria.	christiane.weissenbacher-lang@vetmeduni.ac.at		Kureljusic, Branislav/0000-0003-4281-1672; Weissenbacher-Lang, Christiane/0000-0002-1527-7593; Weissenbock, Herbert/0000-0001-8197-6379	Profile lines, University of Veterinary Medicine Vienna, Austria; Verein der Freunde und Forderer der Schweinemedizin, University of Veterinary Medicine Vienna, Austria	Profile lines, University of Veterinary Medicine Vienna, Austria; Verein der Freunde und Forderer der Schweinemedizin, University of Veterinary Medicine Vienna, Austria	Funding provided by Profile lines, University of Veterinary Medicine Vienna, Austria; no grant number available; recipient: CWL; https://veteasy.vetmeduni.ac.at/Bereiche/Start/FFI/Public/SitePages/Profillinien.aspx and Verein der Freunde und Forderer der Schweinemedizin, University of Veterinary Medicine Vienna, Austria; no grant number available; recipient: CWL; http://www.schweinemedizin.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; Aliouat-Denis CM, 2014, REV IBEROAM MICOL, V31, P54, DOI 10.1016/j.riam.2013.10.006; Altman DG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d2304; BARTLETT MS, 1988, J CLIN MICROBIOL, V26, P1100, DOI 10.1128/JCM.26.6.1100-1102.1988; Binanti D, 2014, MED MYCOL, V52, P196, DOI 10.3109/13693786.2013.809631; Blomstrom AL, 2010, VIRUS RES, V152, P59, DOI 10.1016/j.virusres.2010.06.004; Borba MR, 2011, MED MYCOL, V49, P172, DOI 10.3109/13693786.2010.510540; BOYLAN CJ, 1992, INFECT IMMUN, V60, P1589, DOI 10.1128/IAI.60.4.1589-1597.1992; Brockmeier SL, 2001, AM J VET RES, V62, P521, DOI 10.2460/ajvr.2001.62.521; Bukovsky C, 2007, VET REC, V161, P552, DOI 10.1136/vr.161.16.552; Cho JG, 2006, CAN J VET RES, V70, P297; Choi YK, 2003, CAN VET J, V44, P735; Dei-Cas E, 2000, MED MYCOL, V38, P23, DOI 10.1080/mmy.38.s1.23.32; Fablet C, 2012, RES VET SCI, V93, P627, DOI 10.1016/j.rvsc.2011.11.002; Fablet C, 2012, VET MICROBIOL, V157, P152, DOI 10.1016/j.vetmic.2011.12.015; Fablet C, 2011, VET MICROBIOL, V147, P329, DOI 10.1016/j.vetmic.2010.07.005; Farsani SMJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-323; Galeziok Michal, 2009, J Med Case Rep, V3, P76, DOI 10.1186/1752-1947-3-76; Govender S., 2008, Southern African Journal of Epidemiology & Infection, V23, P21; Harms PA, 2002, J SWINE HEALTH PROD, V10, P27; Kekarainen T, 2006, J GEN VIROL, V87, P833, DOI 10.1099/vir.0.81586-0; Kim KS, 2011, J VET SCI, V12, P15, DOI 10.4142/jvs.2011.12.1.15; Krakowka S, 2008, AM J VET RES, V69, P1623, DOI 10.2460/ajvr.69.12.1623; Kureljusic B, 2016, VET J, V207, P177, DOI 10.1016/j.tvjl.2015.11.003; Lang C, 2011, TIERAERZTL PRAX G N, V39, P201; Lang C, 2011, BERL MUNCH TIERARZTL, V124, P142, DOI 10.2376/0005-9366-124-142; Macy JD, 2000, COMPARATIVE MED, V50, P49; Opriessnig T, 2004, VET PATHOL, V41, P624, DOI 10.1354/vp.41-6-624; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Opriessnig T, 2012, VIRUS RES, V164, P20, DOI 10.1016/j.virusres.2011.09.014; Quintana J, 2001, VET REC, V149, P357, DOI 10.1136/vr.149.12.357; Rovira A, 2002, J VIROL, V76, P3232, DOI 10.1128/JVI.76.7.3232-3239.2002; Sanches EMC, 2006, J EUKARYOT MICROBIOL, V53, pS92, DOI 10.1111/j.1550-7408.2006.00185.x; Sorden SD, 2000, SWINE HEALTH PROD, V8, P133; Thacker EL, 1999, J CLIN MICROBIOL, V37, P620, DOI 10.1128/JCM.37.3.620-627.1999; Weisbroth SH, 1999, J CLIN MICROBIOL, V37, P1441, DOI 10.1128/JCM.37.5.1441-1446.1999; Weissenbacher-Lang C, 2014, J EUKARYOT MICROBIOL, V61, P537, DOI 10.1111/jeu.12132	37	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158479	10.1371/journal.pone.0158479	http://dx.doi.org/10.1371/journal.pone.0158479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428002	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169300008
J	Akimoto-Gunther, L; Bonfim-Mendonca, PD; Takahachi, G; Irie, MMT; Miyamoto, S; Consolaro, MEL; Svidzinsk, TIE				Akimoto-Gunther, Luciene; Bonfim-Mendonca, Patricia de Souza; Takahachi, Gisele; Irie, Mary Mayumi T.; Miyamoto, Sonia; Lopes Consolaro, Marcia Edilaine; Estivalet Svidzinsk, Terezinha I.			Highlights Regarding Host Predisposing Factors to Recurrent Vulvovaginal Candidiasis: Chronic Stress and Reduced Antioxidant Capacity	PLOS ONE			English	Article							ALBICANS; WOMEN; COLONIZATION; INFECTIONS; SYMPTOMS; IMMUNITY; GLUCOSE; DEFENSE	We studied host factors that could predispose women to develop recurrent vulvovaginal candidiasis (RVVC), including glycemia, insulin resistance, chronic stress, antioxidant capacity, overall immune status, local inflammation and vaginal microbiota. The presence of yeasts in vaginal culture was screened in 277 women, with or without signs and symptoms of VVC and RVVC. The presence of an inflammatory process and microbiota were analyzed through vaginal bacterioscopy and cervical-vaginal cytology, respectively. Fasting-blood samples were collected by standard venipuncture for biochemical analyses. Flow cytometry was employed to obtain the T helper/T cytotoxic lymphocyte ratio, and insulin resistance was assessed by the HOMA index (HI). Yeasts were isolated from 71 (26%) women: 23 (32.4%) with a positive culture but without symptoms (COL), 22 (31%) in an acute episode (VVC), and 26 (36.6%) with RVVC. C. albicans was the main yeast isolated in all clinical profiles. The control group (negative culture) comprised 206 women. Diabetes mellitus and insulin resistance were more associated with the positive-culture groups (COL, VVC and RVVC) than with negative ones. The RVVC group showed lower mean levels of cortisol than the control group and lower antioxidant capacity than all other groups. The T Helper/T cytotoxic lymphocyte ratio was similar in all groups. The RVVC group showed a similar level of vaginal inflammation to the control group, and lower than in the COL and VVC groups. Only the CVV group showed a reduction in vaginal lactobacillus microbiota. Our data suggest that both chronic stress (decreased early-morning cortisol levels) and reduced antioxidant capacity can be host predisposing factors to RVVC.	[Akimoto-Gunther, Luciene; Bonfim-Mendonca, Patricia de Souza; Lopes Consolaro, Marcia Edilaine; Estivalet Svidzinsk, Terezinha I.] Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, Parana, Brazil; [Akimoto-Gunther, Luciene; Bonfim-Mendonca, Patricia de Souza; Takahachi, Gisele; Irie, Mary Mayumi T.; Miyamoto, Sonia; Lopes Consolaro, Marcia Edilaine; Estivalet Svidzinsk, Terezinha I.] Univ Estadual Maringa, Dept Clin Anal & Biomed, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Svidzinsk, TIE (corresponding author), Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, Parana, Brazil.; Svidzinsk, TIE (corresponding author), Univ Estadual Maringa, Dept Clin Anal & Biomed, Maringa, Parana, Brazil.	terezinha.svidzinski@gmail.com	Consolaro, Marcia EL/I-4932-2014	Consolaro, Marcia EL/0000-0001-9102-4865	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Government; Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), Brazilian Government; Fundacao Araucaria de Apoio ao Desenvolvimento Tecnologico e Cientifico do Parana, Brazilian Government	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Government(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), Brazilian Government(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria de Apoio ao Desenvolvimento Tecnologico e Cientifico do Parana, Brazilian Government	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES) and Fundacao Araucaria de Apoio ao Desenvolvimento Tecnologico e Cientifico do Parana, Brazilian Government.	Gunther LSA, 2014, SAO PAULO MED J, V132, P116, DOI 10.1590/1516-3180.2014.1322640; Amouri I, 2013, ANN BIOL CLIN-PARIS, V71, P151, DOI 10.1684/abc.2013.0797; [Anonymous], 2015, DIABETES CARE, V38, pS4, DOI 10.2337/dc15-S003; Bassyouni RH, 2015, J MICROBIOL BIOTECHN, V25, P1734, DOI 10.4014/jmb.1504.04009; Bonfim-Mendonca PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107805; Buchta V, 2013, Ceska Gynekol, V78, P537; Carrara MA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.011; Cassone A, 2015, BJOG-INT J OBSTET GY, V122, P785, DOI 10.1111/1471-0528.12994; Donders GGG, 2002, AM J OBSTET GYNECOL, V187, P989, DOI 10.1067/mob.2002.126285; Ehrstrom SM, 2005, AM J OBSTET GYNECOL, V193, P1376, DOI 10.1016/j.ajog.2005.03.068; Fidel PL, 2007, AM J REPROD IMMUNOL, V57, P2, DOI 10.1111/j.1600-0897.2006.00450.x; FIDEL PL, 1995, INFECT IMMUN, V63, P2403, DOI 10.1128/IAI.63.7.2403-2408.1995; Jonsson P, 2015, PHYSIOL BEHAV, V15, P30034; Kurtzman CP, 1998, YEAST TAXONOMIC STUD; Liu MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079812; Meyer H, 2006, MYCOSES, V49, P202, DOI 10.1111/j.1439-0507.2006.01235.x; Muzny CA, 2015, CLIN INFECT DIS, V61, P601, DOI 10.1093/cid/civ353; Nayar R., 2015, BETHESDA SYSTEM REPO, V3rd; Nyirjesy P, 2013, POSTGRAD MED, V125, DOI 10.3810/pgm.2013.05.2650; Nyirjesy P, 2012, CURR MED RES OPIN, V28, P1173, DOI 10.1185/03007995.2012.697053; ODDS FC, 1988, J MED VET MYCOL, V26, P277; Ratti BA, 2015, CELL IMMUNOL, V293, P22, DOI 10.1016/j.cellimm.2014.11.004; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Richardson M, 2009, FRONT BIOSCI-LANDMRK, V14, P4363, DOI 10.2741/3533; Sandini S, 2011, FEMS IMMUNOL MED MIC, V62, P215, DOI 10.1111/j.1574-695X.2011.00802.x; Smith RAJ, 2008, ANN NY ACAD SCI, V1147, P105, DOI 10.1196/annals.1427.003; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sobel JD, 2015, AM J OBSTET GYNECOL, V15, P716; Straub RH, 2011, Z RHEUMATOL, V70, P767, DOI 10.1007/s00393-011-0784-8; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Zhou X, 2009, INFECT IMMUN, V77, P4130, DOI 10.1128/IAI.00436-09	31	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158870	10.1371/journal.pone.0158870	http://dx.doi.org/10.1371/journal.pone.0158870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415762	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500046
J	Cheong, AT; Khoo, EM; Tong, SF; Liew, SM				Cheong, Ai Theng; Khoo, Ee Ming; Tong, Seng Fah; Liew, Su May			To Check or Not to Check? A Qualitative Study on How the Public Decides on Health Checks for Cardiovascular Disease Prevention	PLOS ONE			English	Article							PRIMARY-CARE; RISK-FACTORS; MORTALITY; BEHAVIOR; EPIDEMIOLOGY; WILLINGNESS; POPULATIONS; MODEL; ASIA	Background More than half of the general population does not attend screening for cardiovascular diseases (CVD) hence they are unaware of their risks. The objective of this study was to explore the views and experiences of the public in deciding to undergo health checks for CVD prevention. Methods This was a qualitative study utilising the constructivist grounded theory approach. A total of 31 individuals aged 30 years and above from the community were sampled purposively. Eight interviews and six focus groups were involved, using a semi-structured topic guide. Results A conceptual framework was developed to explain the public's decision-making process on health check participation for CVD prevention. The intention to participate in health checks was influenced by the interplay between perceived relevance and the individual's readiness to face the outcome of health checks. Health checks were deemed relevant if people perceived themselves to be at risk of CVD and there was an advantage in knowing their cardiovascular status. People were ready to face the outcome of health checks if they wanted to know the results and were prepared to deal with the subsequent management. The decision to participate in health checks was also influenced by external factors such as the views of significant others, and the accessibility and availability of resources including time and finances. Conclusions The intention to screen for CVD is motivated by two internal factors: the perceived relevance of the disease and readiness to face screening outcomes. Strategies targeting the internal decision-making process may prove to be key in improving the uptake of screening.	[Cheong, Ai Theng; Khoo, Ee Ming] Univ Malaya, Fac Med, Primary Care Res Grp, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Cheong, Ai Theng] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang, Malaysia; [Tong, Seng Fah; Liew, Su May] Univ Kebangsaan Malaysia, Fac Med, Dept Family Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia	Khoo, EM (corresponding author), Univ Malaya, Fac Med, Primary Care Res Grp, Dept Primary Care Med, Kuala Lumpur, Malaysia.	khooem@um.edu.my	LIEW, Su May/B-8852-2010; KHOO, EE MING/B-8785-2010; Cheong, Ai Theng/H-9884-2014	LIEW, Su May/0000-0003-2865-7955; KHOO, EE MING/0000-0003-3191-1264; Cheong, Ai Theng/0000-0002-3895-530X	University of Malaya Postgraduate Research Fund [PG049-2014A]	University of Malaya Postgraduate Research Fund(Universiti Malaya)	Financial support for this study was provided by University of Malaya Postgraduate Research Fund (PG049-2014A) via EMK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas SZ, 2015, OCCUP ENVIRON MED, V72, P664, DOI 10.1136/oemed-2014-102743; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Amoroso C, 2009, AUST FAM PHYSICIAN, V38, P358; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Burgess C, 2015, HEALTH EXPECT, V18, P2437, DOI 10.1111/hex.12212; Capewell S, 2000, CIRCULATION, V102; Celermajer DS, 2012, J AM COLL CARDIOL, V60, P1207, DOI 10.1016/j.jacc.2012.03.074; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Community Development Department (KEMAS), 2015, KOSPEN B; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Department of Health, 2009, NHS HLTH CHECK VASC; Ellis N, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0064-1; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fishbein M, 2008, MED DECIS MAKING, V28, P834, DOI 10.1177/0272989X08326092; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Harkins C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-391; Hata J, 2013, CIRC J, V77, P1923, DOI 10.1253/circj.CJ-13-0786; Institute for Public Health (IPH), 2011, NAT HLTH MORB SURV 2, V2; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jenkinson CE, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0244-7; Leavy Patricia Lina, 2011, PRACTICE QUALITATIVE; Members of the Expert Panel, 2011, PRACT GUID MAN DYSL; National Vascular Disease Prevention Alliance (NVDPA), 2012, GUIDELINES MANAGEMEN; Nielsen KDB, 2004, FAM PRACT, V21, P28, DOI 10.1093/fampra/cmh107; Ohira T, 2013, CIRC J, V77, P1646, DOI 10.1253/circj.CJ-13-0702; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Tong SF, 2011, FAM PRACT, V28, P307, DOI 10.1093/fampra/cmq101; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Vallis M, 2013, CAN FAM PHYSICIAN, V59, P27; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Wall M, 2004, SCAND J PRIM HEALTH, V22, P248, DOI 10.1080/02813430410006611; WHO, PROJ MORT CAUS DEATH; World Health Organization, 2007, PREV CARD DIS GUID A; World Health Organization, 2004, GLOB BURD DIS 2004 U	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159438	10.1371/journal.pone.0159438	http://dx.doi.org/10.1371/journal.pone.0159438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415432	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500128
J	Pailthorpe, BA				Pailthorpe, Bernard A.			Network Analysis and Visualization of Mouse Retina Connectivity Data	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ORGANIZATION; CIRCUIT; GRAPHS	The largest available cellular level connectivity map, of a 0.1 mm sample of the mouse retina Inner Plexiform Layer, was analysed using network models and visualized using spectral graph layouts and observed cell coordinates. This allows key nodes in the network to be identified with retinal neurons. Their strongest synaptic links can trace pathways in the network, elucidating possible circuits. Modular decomposition of the network, by sampling signal flows over nodes and links using the InfoMap method, shows discrete modules of cone bipolar cells that form a tiled mosaic in the retinal plane. The highest flow nodes, calculated by InfoMap, proved to be the most useful landmarks for elucidating possible circuits. Their dominant links to high flow amacrine cells reveal possible circuits linking bipolar through to ganglion cells and show an Off-On discrimination between the Left-Right sections of the sample. Circuits suggested by this analysis confirm known roles for some cells and point to roles for others.	[Pailthorpe, Bernard A.] Univ Sydney, Sch Phys, Brain Dynam Grp, Sydney, NSW 2006, Australia	University of Sydney	Pailthorpe, BA (corresponding author), Univ Sydney, Sch Phys, Brain Dynam Grp, Sydney, NSW 2006, Australia.	bernard.pailthorpe@sydney.edu.au						Battista GD, 1998, GRAPH DRAWING ALGORI; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chung, 1997, SPECTRAL GRAPH THEOR, DOI DOI 10.1090/CBMS/092; Civril A, 2006, LECT NOTES COMPUT SC, V3843, P512; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; Cvetkovic D., 2009, INTRO THEORY GRAPH S; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Herman I, 2000, IEEE T VIS COMPUT GR, V6, P24, DOI 10.1109/2945.841119; Hubel David H, 1995, EYE BRAIN VISION, P6; Koren Y, 2005, COMPUT MATH APPL, V49, P1867, DOI 10.1016/j.camwa.2004.08.015; Lambiotte R, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056107; Lauritzen JS, 2013, J COMP NEUROL, V521, P977, DOI 10.1002/cne.23244; Le Martelot E., 2012, INT J WEB BASED COMM, V9, P323; Marc RE, 2013, PROG RETIN EYE RES, V37, P141, DOI 10.1016/j.preteyeres.2013.08.002; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Masland RH, 2011, INVEST OPHTH VIS SCI, V52, P4581, DOI 10.1167/iovs.10-7083; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042822; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Purchase HC, 2002, J VISUAL LANG COMPUT, V13, P501, DOI 10.1006/S1045-926X(02)00016-2; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sohn Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001139; Sporns O., 2011, NETWORKS BRAIN; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yonehara K, 2013, NEURON, V79, P1078, DOI 10.1016/j.neuron.2013.08.005	40	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158626	10.1371/journal.pone.0158626	http://dx.doi.org/10.1371/journal.pone.0158626			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414405	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500028
J	Pereyra-Elias, R; Mayta-Tristan, P; Montenegro-Idrogo, JJ; Mejia, CR; Abudinen, AG; Azucas-Peralta, R; Barrezueta-Fernandez, J; Cerna-Urrutia, L; DaSilva-DeAbreu, A; Mondragon-Cardona, A; Moya, G; Valverde-Solano, CD; Theodorus-Villar, R; Vizarraga-Leon, M				Pereyra-Elias, Renee; Mayta-Tristan, Percy; Jose Montenegro-Idrogo, Juan; Mejia, Christian R.; Gabriel Abudinen, A.; Azucas-Peralta, Rita; Barrezueta-Fernandez, Jorge; Cerna-Urrutia, Luis; DaSilva-DeAbreu, Adrian; Mondragon-Cardona, Alvaro; Moya, Geovanna; Valverde-Solano, Christian D.; Theodorus-Villar, Rhanniel; Vizarraga-Leon, Maribel		Red-LIRHUS	Differences on Primary Care Labor Perceptions in Medical Students from 11 Latin American Countries	PLOS ONE			English	Article							SESPAS REPORT 2012; FAMILY MEDICINE; HEALTH WORKFORCE; WORK; PHYSICIANS; SERVICES; SWITZERLAND; ECUADOR; CHILE; PERU	Background The shortage in Latin-American Primary Care (PC) workforce may be due to negative perceptions about it. These perceptions might be probably influenced by particular features of health systems and academic environments, thus varying between countries. Methods Observational, analytic and cross-sectional multicountry study that evaluated 9,561 first and fifth-year medical students from 63 medical schools of 11 Latin American countries through a survey. Perceptions on PC work was evaluated through a previously validated scale. Tertiles of the scores were created in order to compare the different countries. Crude and adjusted prevalence ratios were calculated using simple and multiple Poisson regression with robust variance. Results Approximately 53% of subjects were female; mean age was 20.4 +/- 2.9 years; 35.5% were fifth-year students. Statistically significant differences were found between the study subjects' country, using Peru as reference. Students from Chile, Colombia, Mexico and Paraguay perceived PC work more positively, while those from Ecuador showed a less favorable position. No differences were found among perceptions of Bolivian, Salvadoran, Honduran and Venezuelan students when compared to their Peruvian peers. Conclusions Perceptions of PC among medical students from Latin America vary according to country. Considering such differences can be of major importance for potential local specific interventions.	[Pereyra-Elias, Renee; Mayta-Tristan, Percy; Mejia, Christian R.] Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru; [Jose Montenegro-Idrogo, Juan] Univ Nacl Mayor San Marcos, Fac Med, Lima, Peru; [Gabriel Abudinen, A.] Hosp Illapel, Illapel, Chile; [Azucas-Peralta, Rita] Univ Nacl Asuncion, Fac Med, Asuncion, Paraguay; [Barrezueta-Fernandez, Jorge] Univ Guayaquil, Fac Med, Guayaquil, Ecuador; [Cerna-Urrutia, Luis] Univ Dr Jose Matias Delgado, Fac Med, San Salvador, El Salvador; [DaSilva-DeAbreu, Adrian] Cent Univ Venezuela, Fac Med, Caracas, Venezuela; [Mondragon-Cardona, Alvaro] Univ Tecnol Pereira, Fac Med, Pereira, Colombia; [Moya, Geovanna] Univ Nacl Autonoma Honduras, Fac Med, Tegucigalpa, Honduras; [Valverde-Solano, Christian D.] Univ Hispanoamer, Fac Med, San Jose, Costa Rica; [Theodorus-Villar, Rhanniel] Univ Catolica Boliviana San Pablo, Fac Med, Santa Cruz, Bolivia; [Vizarraga-Leon, Maribel] Univ Juarez, Fac Med, Durango, Mexico; [Mayta-Tristan, Percy] Univ Privada Antenor Orrego, Escuela Postgrad, Trujillo, Peru	Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Nacional Mayor de San Marcos; Universidad Nacional de Asuncion; University of Central Venezuela; Universidad Tecnologica de Pereira; Universidad Nacional Autonoma de Honduras; Universidad Privada Antenor Orrego	Mayta-Tristan, P (corresponding author), Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru.; Mayta-Tristan, P (corresponding author), Univ Privada Antenor Orrego, Escuela Postgrad, Trujillo, Peru.	p.mayta@gmail.com	Moya, Geovanna/H-5601-2017; moreno-loaiza, oscar oml/L-3959-2016; Mayta-Tristan, Percy/D-8587-2011; DS, Adrian/AFR-6774-2022; Pereyra-Elías, Reneé/AAP-5975-2021; Montenegro-Idrogo, Juan José/AAT-9476-2021	Moya, Geovanna/0000-0003-1555-7904; moreno-loaiza, oscar oml/0000-0001-6675-6562; Mayta-Tristan, Percy/0000-0002-0861-6606; DS, Adrian/0000-0002-6739-5946; Montenegro-Idrogo, Juan José/0000-0002-3874-1432; Mejia, Christian R./0000-0002-5940-7281				Arroyo J, 2013, REV PANAM SALUD PUBL, V33, P391; Barnighausen T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-86; Borroto Cruz Eugenio Radamés, 2010, Educ Med Super, V24, P111; Buddeberg-Fischer B, 2007, FAM MED, V39, P651; Buddeberg-Fischer B, 2006, SWISS MED WKLY, V136, P416, DOI 10.57187/smw.2006.11542; Carrera LI, 2004, ED MED, V7, P132; Vicente VC, 2012, GAC SANIT, V26, P69, DOI 10.1016/j.gaceta.2011.07.018; Curioso Walter H, 2013, Rev. perú. med. exp. salud publica, V30, P175; Echeverri O, 2008, REV PANAM SALUD PUBL, V24, P210; Garcia LAP, 2005, REV CUB MED GEN INTE, V21, P1; Garcia-Huidobro D, 2013, FAM MED, V45, P272; Gaus D, 2008, REV PANAM SALUD PUBL, V23, P212, DOI 10.1590/S1020-49892008000300013; Gaus DP, 2009, HEALTH AFFAIR, V28, P1003, DOI 10.1377/hlthaff.28.4.1003; Girasek E, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-13; Lopez-Valcarcel BG, 2012, GAC SANIT, V26, P46, DOI 10.1016/j.gaceta.2011.07.029; Guillou M, 2011, REV MED CHILE, V139, P559, DOI [10.4067/S0034-98872011000500001, /S0034-98872011000500001]; Hernandez T, 2011, REV PANAM SALUD PUBL, V30, P177; Homedes N, 2005, REV PANAM SALUD PUBL, V17, P210, DOI 10.1590/S1020-49892005000300012; Huicho L, 2012, CAD SAUDE PUBLICA, V28, P729, DOI 10.1590/S0102-311X2012000400012; Kuikka L, 2012, SCAND J PRIM HEALTH, V30, P121, DOI 10.3109/02813432.2012.654194; Malo-Serrano Miguel, 2014, Rev Peru Med Exp Salud Publica, V31, P754; Zurro AM, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-47; Mayta-Tristan P, 2016, BMC RES NOT IN PRESS; Mayta-Tristan P, 2010, CIMEL, V15, P3; Mayta-Tristán Percy, 2013, Rev. perú. med. exp. salud publica, V30, P190; Ministerio de Salud de Chile, 2013, OR IMPL MOD AT INT S; Montoya MCG, 2000, REV SALUD PUBLICA, V2, P97; Muench John, 2013, Rev. perú. med. exp. salud publica, V30, P297; Muldoon LK, 2006, CAN J PUBLIC HEALTH, V97, P409, DOI 10.1007/BF03405354; Muntaner C, 2006, CAN J PUBLIC HEALTH, V97, pI19, DOI 10.1007/BF03405240; Organizacion Panamericana de la Salud, 2012, SAL AM CHIL; Organizacion Panamericana de la Salud, 2012, SAL AM VEN; Organizacion Panamericana de la Salud, 2012, SAL AM COST RIC; Organizacion Panamericana de la Salud, 2007, ACT EP AUM MAL AM; Organizacion Panamericana de la Salud, 2012, SAL AM PAR; Pan American Health Organization, 2012, HLTH AM; Pereyra-Elias R, 2012, EPIDEMIOLOGY, V23, P500, DOI 10.1097/EDE.0b013e31824d9cd7; Periago MR, 2007, REV PANAM SALUD PUBL, V21, P69, DOI 10.1590/S1020-49892007000200002; Phillips J, 2012, FAM MED, V44, P7; Ramirez M, 2008, AN FM LIMA, V69, P176; Rodriguez C, 2012, EDUC PRIM CARE, V23, P158, DOI 10.1080/14739879.2012.11494099; Roman O, 2007, REV MED CHILE, V135, P251; Sanchez-Moreno Francisco, 2013, Rev Peru Med Exp Salud Publica, V30, P676; Scott I, 2011, CAN MED ASSOC J, V183, pE1, DOI 10.1503/cmaj.091805; Serneels P, 2010, B WORLD HEALTH ORGAN, V88, P342, DOI 10.2471/BLT.09.072728; WHO, 2008, WORLD HLTH REP PRIM; World Health Organization, 2014, HUM RES HLTH FDN UN; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Wright S, 1997, J GEN INTERN MED, V12, P53, DOI 10.1007/s11606-006-0007-1	49	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159147	10.1371/journal.pone.0159147	http://dx.doi.org/10.1371/journal.pone.0159147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414643	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500089
J	Shapiro, ALB; Boyle, KE; Dabelea, D; Patinkin, ZW; De la Houssaye, B; Ringham, BM; Glueck, DH; Barbour, LA; Norris, JM; Friedman, JE				Shapiro, Allison L. B.; Boyle, Kristen E.; Dabelea, Dana; Patinkin, Zachary W.; De la Houssaye, Becky; Ringham, Brandy M.; Glueck, Deborah H.; Barbour, Linda A.; Norris, Jill M.; Friedman, Jacob E.			Nicotinamide Promotes Adipogenesis in Umbilical Cord-Derived Mesenchymal Stem Cells and Is Associated with Neonatal Adiposity: The Healthy Start BabyBUMP Project	PLOS ONE			English	Article							PPAR-GAMMA; SIRT1; DIFFERENTIATION; ADIPOCYTES; METABOLISM; SENESCENCE; OBESITY; NAMPT; GENE	The cellular mechanisms whereby excess maternal nutrition during pregnancy increases adiposity of the offspring are not well understood. However, nicotinamide (NAM), a fundamental micronutrient that is important in energy metabolism, has been shown to regulate adipogenesis through inhibition of SIRT1. Here we tested three novel hypotheses: 1) NAM increases the adipogenic response of human umbilical cord tissue-derived mesenchymal stem cells (MSCs) through a SIRT1 and PPAR gamma pathway; 2) lipid potentiates the NAM-enhanced adipogenic response; and 3) the adipogenic response to NAM is associated with increased percent fat mass (%FM) among neonates. MSCs were derived from the umbilical cord of 46 neonates born to non-obese mothers enrolled in the Healthy Start study. Neonatal %FM was measured using air displacement plethysmography (Pea Pod) shortly after birth. Adipogenic differentiation was induced for 21 days in the 46 MSC sets under four conditions, +NAM (3mM)/-lipid (200 mu M oleate/palmitate mix), +NAM/+lipid, -NAM/+lipid, and vehicle-control (-NAM/-lipid). Cells incubated in the presence of NAM had significantly higher PPAR. protein (+24%, p < 0.01), FABP4 protein (+57%, p < 0.01), and intracellular lipid content (+51%, p < 0.01). Lipid did not significantly increase either PPAR. protein (p = 0.98) or FABP4 protein content (p = 0.82). There was no evidence of an interaction between NAM and lipid on adipogenic response of PPAR gamma or FABP4 protein (p = 0.99 and p = 0.09). In a subset of 9 MSC, SIRT1 activity was measured in the +NAM/-lipid and vehicle control conditions. SIRT1 enzymatic activity was significantly lower (-70%, p < 0.05) in the +NAM/-lipid condition than in vehicle-control. In a linear model with neonatal %FM as the outcome, the percent increase in PPAR. protein in the +NAM/-lipid condition compared to vehicle-control was a significant predictor (beta = 0.04, 95% CI 0.01-0.06, p <0.001). These are the first data to support that chronic NAM exposure potentiates adipogenesis in human MSCs in-vitro, and that this process involves PPAR gamma and SIRT1.	[Shapiro, Allison L. B.; Dabelea, Dana; Norris, Jill M.] CSPH, Dept Epidemiol, Aurora, CO 80045 USA; [Boyle, Kristen E.; Patinkin, Zachary W.; De la Houssaye, Becky; Friedman, Jacob E.] UC SOM, Dept Pediat, Aurora, CO USA; [Ringham, Brandy M.; Glueck, Deborah H.] CSPH, Dept Biostat & Informat, Aurora, CO USA; [De la Houssaye, Becky; Friedman, Jacob E.] UC SOM, Dept Biochem & Mol Genet, Aurora, CO USA; [Barbour, Linda A.] UC SOM, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO USA; [Barbour, Linda A.] UC SOM, Div Maternal Fetal Med, Dept Obstet & Gynecol, Aurora, CO USA		Shapiro, ALB (corresponding author), CSPH, Dept Epidemiol, Aurora, CO 80045 USA.	allison.shapiro@ucdenver.edu	Boyle, Kristen/N-7442-2018	Boyle, Kristen/0000-0001-9689-3322; Patinkin, Zachary/0000-0001-5946-6217	American Heart Association [14PRE18230008]; Colorado Nutrition and Obesity Research Center [DK048520]; parent Healthy Start study; National Institute of Diabetes and Digestive and Kidney Disease [DK076648]; NIH/NCATS Colorado CTSA Grant [UL1 TR001082]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK106347, P30DK048520, R01DK076648] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Colorado Nutrition and Obesity Research Center; parent Healthy Start study; National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NCATS Colorado CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Healthy Start BabyBUMP Project is supported by grants from the American Heart Association (Pre-doctoral Fellowship 14PRE18230008, PI: A.L.B.S.) and the Colorado Nutrition and Obesity Research Center (DK048520, PI: J.E.F.), and by the parent Healthy Start study (PI: D.D.). The Healthy Start study is supported by the National Institute of Diabetes and Digestive and Kidney Disease (DK076648, PI: D.D.) and NIH/NCATS Colorado CTSA Grant Number UL1 TR001082.	Ahmed T, 2012, ANN NUTR METAB, V61, P8, DOI 10.1159/000345165; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Boyle KE, 2016, DIABETES, V65, P647, DOI 10.2337/db15-0849; Burgos ES, 2011, CURR MED CHEM, V18, P1947; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Fischer-Posovszky P, 2010, AM J CLIN NUTR, V92, P5, DOI 10.3945/ajcn.2009.28435; Goldie C, 2016, HEART, V102, P198, DOI 10.1136/heartjnl-2015-308055; Grant WF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017261; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kralisch S, 2005, J ENDOCRINOL, V185, pR1, DOI 10.1677/joe.1.06211; Krasnow SM, 2011, AM J PHYSIOL-ENDOC M, V301, pE1243, DOI 10.1152/ajpendo.00261.2011; Maples JM, 2015, AM J PHYSIOL-ENDOC M, V309, pE345, DOI 10.1152/ajpendo.00505.2014; Mayoral R, 2015, MOL METAB, V4, P378, DOI 10.1016/j.molmet.2015.02.007; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Polidori GP, 2012, MOL CELL ENDOCRINOL, V361, P40, DOI 10.1016/j.mce.2012.03.010; Rebholz SL, 2011, AM J PHYSIOL-ENDOC M, V301, pE416, DOI 10.1152/ajpendo.00619.2010; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Song TY, 2015, BIOGERONTOLOGY, V16, P789, DOI 10.1007/s10522-015-9605-9; Starling AP, 2015, AM J CLIN NUTR, V101, P302, DOI 10.3945/ajcn.114.094946; Suter MA, 2012, FASEB J, V26, P5106, DOI 10.1096/fj.12-212878; U. S. National Library of Medicine, 2015, DIET SUPPL LAB DAT; Zeljkovic A, 2013, MATERN CHILD HLTH J, V17, P556, DOI 10.1007/s10995-012-1031-x; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469	26	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159575	10.1371/journal.pone.0159575	http://dx.doi.org/10.1371/journal.pone.0159575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414406	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500136
J	ElHefnawi, M; Kim, T; Kamar, MA; Min, S; Hassan, NM; El-Ahwany, E; Kim, H; Zada, S; Amer, M; Windisch, MP				ElHefnawi, Mahmoud; Kim, TaeKyu; Kamar, Mona A.; Min, Saehong; Hassan, Nafisa M.; El-Ahwany, Eman; Kim, Heeyoung; Zada, Suher; Amer, Marwa; Windisch, Marc P.			In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes	PLOS ONE			English	Article							RIBOSOME-ENTRY SITE; GREEN FLUORESCENT PROTEIN; FUNCTIONAL SIRNA; RNA REPLICATION; INTRACELLULAR DELIVERY; CELL-CULTURE; INHIBITION; SELECTION; SEQUENCES; GENOME	RNA interference (RNAi) is a post-transcriptional gene silencing mechanism that mediates the sequence-specific degradation of targeted RNA and thus provides a tremendous opportunity for development of oligonucleotide-based drugs. Here, we report on the design and validation of small interfering RNAs (siRNAs) targeting highly conserved regions of the hepatitis C virus (HCV) genome. To aim for therapeutic applications by optimizing the RNAi efficacy and reducing potential side effects, we considered different factors such as target RNA variations, thermodynamics and accessibility of the siRNA and target RNA, and off-target effects. This aim was achieved using an in silico design and selection protocol complemented by an automated MysiRNA-Designer pipeline. The protocol included the design and filtration of siRNAs targeting highly conserved and accessible regions within the HCV internal ribosome entry site, and adjacent core sequences of the viral genome with high-ranking efficacy scores. Off-target analysis excluded siRNAs with potential binding to human mRNAs. Under this strict selection process, two siRNAs (HCV353 and HCV258) were selected based on their predicted high specificity and potency. These siRNAs were tested for antiviral efficacy in HCV genotype 1 and 2 replicon cell lines. Both in silico-designed siRNAs efficiently inhibited HCV RNA replication, even at low concentrations and for short exposure times (24h); they also exceeded the antiviral potencies of reference siRNAs targeting HCV. Furthermore, HCV353 and HCV258 siRNAs also inhibited replication of patient-derived HCV genotype 4 isolates in infected Huh-7 cells. Prolonged treatment of HCV replicon cells with HCV353 did not result in the appearance of escape mutant viruses. Taken together, these results reveal the accuracy and strength of our integrated siRNA design and selection protocols. These protocols could be used to design highly potent and specific RNAi-based therapeutic oligonucleotide interventions.	[ElHefnawi, Mahmoud] Natl Res Ctr, Div Engn Res, CEAS, Informat & Syst Dept,Biomed Informat & Chemoinfom, Cairo, Egypt; [ElHefnawi, Mahmoud] Nile Univ, Ctr Informat, Shiekh Zayed City, Egypt; [ElHefnawi, Mahmoud; Kamar, Mona A.; Hassan, Nafisa M.; Zada, Suher] Amer Univ Cairo, Yousef Jameel Sci & Technol Res Ctr, New Cairo, Egypt; [El-Ahwany, Eman; Zada, Suher; Amer, Marwa] Amer Univ Cairo, Dept Biol, New Cairo, Egypt; [El-Ahwany, Eman] Theodor Bilharz Res Inst, Dept Immunol, Giza, Egypt; [Amer, Marwa] Misr Univ Sci & Technol, Fac Biotechnol, 6th Of October City, Egypt; [Kim, TaeKyu; Min, Saehong; Kim, Heeyoung; Windisch, Marc P.] Inst Pasteur Korea, Hepatitis Res Lab, 696 Sampyung Dong, Songnam, Gyeonggi Do, South Korea	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Nile University; Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); Theodor Bilharz Research Institute (TBRI); Egyptian Knowledge Bank (EKB); Misr University for Science & Technology; Institut Pasteur Korea	ElHefnawi, M (corresponding author), Natl Res Ctr, Div Engn Res, CEAS, Informat & Syst Dept,Biomed Informat & Chemoinfom, Cairo, Egypt.; ElHefnawi, M (corresponding author), Nile Univ, Ctr Informat, Shiekh Zayed City, Egypt.; ElHefnawi, M (corresponding author), Amer Univ Cairo, Yousef Jameel Sci & Technol Res Ctr, New Cairo, Egypt.; Windisch, MP (corresponding author), Inst Pasteur Korea, Hepatitis Res Lab, 696 Sampyung Dong, Songnam, Gyeonggi Do, South Korea.	mahef@aucegypt.edu; marc.windisch@ip-korea.org	; ElHefnawi, Mahmoud/S-7426-2016	El-Ahwany, Eman/0000-0003-4871-5892; ElHefnawi, Mahmoud/0000-0003-3896-6911; Ramadan, Nafisa/0000-0002-0378-7828	Science and Technology for Development Fund grant (Ministry of Scientific Research and Technology, Egypt) [1679]; Yousef-Jameel Science and Technology Research Center grant (American University in Cairo, Egypt) [4.14]; National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2014K1A4A7A01074644]; Gyeonggi-do; KISTI	Science and Technology for Development Fund grant (Ministry of Scientific Research and Technology, Egypt)(Science and Technology Development Fund (STDF)); Yousef-Jameel Science and Technology Research Center grant (American University in Cairo, Egypt)(American University Cairo); National Research Foundation of Korea (NRF) grant - Korean government (MSIP); Gyeonggi-do; KISTI(Korea Institute of Science & Technology Information (KISTI))	This work was supported by a Science and Technology for Development Fund grant (#1679, Ministry of Scientific Research and Technology, Egypt), and a Yousef-Jameel Science and Technology Research Center grant (#4.14, American University in Cairo, Egypt). The research was also supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (2014K1A4A7A01074644), Gyeonggi-do, and KISTI. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Aghemo A, 2012, DIG LIVER DIS; Ali S, 2004, J VIROL, V78, P491, DOI 10.1128/JVI.78.1.491-501.2004; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; BUKH J, 1992, P NATL ACAD SCI USA, V89, P4942, DOI 10.1073/pnas.89.11.4942; Bung C, 2010, FEBS LETT, V584, P837, DOI 10.1016/j.febslet.2010.01.015; Chalk AM, 2008, BIOINFORMATICS, V24, P1316, DOI 10.1093/bioinformatics/btn121; Chandra PK, 2012, MOL THER, V20, P1724, DOI 10.1038/mt.2012.107; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; DOI I, 1976, GANN, V67, P1; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Eid FE, 2014, MID EAST CONF BIO, P184, DOI 10.1109/MECBME.2014.6783236; El Awady MK, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-18; ElHefnawi MM, 2010, RES PREDICTION PROGN; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Gallego J, 2002, BIOCHEM SOC T, V30, P140, DOI 10.1042/BST0300140; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ichihara M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm699; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Kronke J, 2004, J VIROL, V78, P3436, DOI 10.1128/JVI.78.7.3436-3446.2004; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Ladunga I, 2007, NUCLEIC ACIDS RES, V35, P433, DOI 10.1093/nar/gkl1065; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lee HS, 2009, BIOCHEM BIOPH RES CO, V384, P431, DOI 10.1016/j.bbrc.2009.04.143; Li Y, 2013, RNA BIOL, V10, P919, DOI 10.4161/rna.25137; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Long G, 2011, GASTROENTEROLOGY, V141, P1057, DOI 10.1053/j.gastro.2011.06.010; Lukavsky PJ, 2000, NAT STRUCT BIOL, V7, P1105; Ma H, 2005, VIROLOGY, V332, P8, DOI 10.1016/j.virol.2004.11.024; Miyagishi M, 2005, NAT BIOTECHNOL, V23, P946, DOI 10.1038/nbt0805-946; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Muhonen P, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-8; Mysara M, 2012, J BIOMEDICAL INFORM; Mysara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025642; Naito Y, 2006, NUCLEIC ACIDS RES, V34, pW448, DOI 10.1093/nar/gkl214; Naito Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-392; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Patzel V, 2007, DRUG DISCOV TODAY, V12, P139, DOI 10.1016/j.drudis.2006.11.015; Paulsen RB, 2010, P NATL ACAD SCI USA, V107, P7263, DOI 10.1073/pnas.0911896107; Prabhu R, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-100; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Randall G, 2003, P NATL ACAD SCI USA, V100, P235, DOI 10.1073/pnas.0235524100; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saebo PE, 2005, NUCLEIC ACIDS RES, V33, pW535, DOI 10.1093/nar/gki423; Santoyo J, 2005, BIOINFORMATICS, V21, P1376, DOI 10.1093/bioinformatics/bti196; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Seo MY, 2003, J VIROL, V77, P810, DOI 10.1128/JVI.77.1.810-812.2003; Shaat H, 2016, INT J PHARMACEUT, V504, P125, DOI 10.1016/j.ijpharm.2016.03.051; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Shimoike T, 2006, VIROLOGY, V345, P434, DOI 10.1016/j.virol.2005.10.013; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Takasaki S, 2004, CELL CYCLE, V3, P790; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Tong X, 2014, J INFECT DIS, V209, P668, DOI 10.1093/infdis/jit562; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P7100, DOI 10.1093/nar/gkn902; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Van Regenmortel MHV, 2007, INFECT GENET EVOL, V7, P133, DOI 10.1016/j.meegid.2006.04.002; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WAKITA T, 1994, J BIOL CHEM, V269, P14205; Watanabe T, 2006, GENE THER, V13, P883, DOI 10.1038/sj.gt.3302734; Watanabe T, 2007, ADV DRUG DELIVER REV, V59, P1263, DOI 10.1016/j.addr.2007.03.022; Webster DP, 2009, LANCET INFECT DIS, V9, P108, DOI 10.1016/S1473-3099(09)70020-9; Windisch MP, 2005, J VIROL, V79, P13778, DOI 10.1128/JVI.79.21.13778-13793.2005; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Xie Zhao-Hui, 2009, Yichuan, V31, P1205, DOI 10.3724/SP.J.1005.2009.01205; Yi ZG, 2011, J VIROL, V85, P6996, DOI 10.1128/JVI.00013-11; Youssef SS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/196712; Zekri ARN, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-13	89	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159211	10.1371/journal.pone.0159211	http://dx.doi.org/10.1371/journal.pone.0159211			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441640	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500045
J	Raza, H; John, A; Shafarin, J				Raza, Haider; John, Annie; Shafarin, Jasmin			Potentiation of LPS-Induced Apoptotic Cell Death in Human Hepatoma HepG2 Cells by Aspirin via ROS and Mitochondrial Dysfunction: Protection by N-Acetyl Cysteine	PLOS ONE			English	Article							ACETYLSALICYLIC-ACID; OXIDATIVE STRESS; LIVER-INJURY; GLUTATHIONE; ACTIVATION; ACETAMINOPHEN; PERMEABILITY; MECHANISMS; SALICYLATE; CYTOKINES	Cytotoxicity and inflammation-associated toxic responses have been observed to be induced by bacterial lipopolysaccharides (LPS) in vitro and in vivo respectively. Use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, has been reported to be beneficial in inflammation-associated diseases like cancer, diabetes and cardiovascular disorders. Their precise molecular mechanisms, however, are not clearly understood. Our previous studies on aspirin treated HepG2 cells strongly suggest cell cycle arrest and induction of apoptosis associated with mitochondrial dysfunction. In the present study, we have further demonstrated that HepG2 cells treated with LPS alone or in combination with aspirin induces subcellular toxic responses which are accompanied by increase in reactive oxygen species (ROS) production, oxidative stress, mitochondrial respiratory dysfunction and apoptosis. The LPS/Aspirin induced toxicity was attenuated by pre-treatment of cells with N-acetyl cysteine (NAC). Alterations in oxidative stress and glutathione-dependent redox-homeostasis were more pronounced in mitochondria compared to extra-mitochondrial cellular compartments. Pre-treatment of HepG2 cells with NAC exhibited a selective protection in redox homeostasis and mitochondrial dysfunction. Our results suggest that the altered redox metabolism, oxidative stress and mitochondrial function in HepG2 cells play a critical role in LPS/aspirin-induced cytotoxicity. These results may help in better understanding the pharmacological, toxicological and therapeutic properties of NSAIDs in cancer cells exposed to bacterial endotoxins.	[Raza, Haider; John, Annie; Shafarin, Jasmin] UAE Univ, CMHS, Dept Biochem, Al Ain, U Arab Emirates	United Arab Emirates University	Raza, H (corresponding author), UAE Univ, CMHS, Dept Biochem, Al Ain, U Arab Emirates.	h.raza@uaeu.ac.ae			Sheikh Hamdan bin Rashid Al Maktoum Medical Research Award; Research Committee of the College of Medicine and Health Sciences; Terry Fox Cancer Research Foundation; Research Committee, College of Medicine and Health Sciences	Sheikh Hamdan bin Rashid Al Maktoum Medical Research Award; Research Committee of the College of Medicine and Health Sciences; Terry Fox Cancer Research Foundation; Research Committee, College of Medicine and Health Sciences	This work was supported by the Sheikh Hamdan bin Rashid Al Maktoum Medical Research Award, and by the Research Committee of the College of Medicine and Health Sciences, and from the Terry Fox Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences. Thanks are also due to the supports from Research Committee, College of Medicine and Health Sciences and from Terry Fox Cancer Research Foundation.	Al-Belooshi T, 2010, FOOD CHEM TOXICOL, V48, P2624, DOI 10.1016/j.fct.2010.06.031; Battaglia V, 2005, J BIOL CHEM, V280, P33864, DOI 10.1074/jbc.M502391200; Bian K, 2001, FREE RADICAL BIO MED, V31, P421, DOI 10.1016/S0891-5849(01)00600-1; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bykov I, 2003, SCAND J GASTROENTERO, V38, P1256, DOI 10.1080/00365520310007116; Cederbaum AI, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/582790; Chung YM, 2003, FREE RADICAL BIO MED, V34, P434, DOI 10.1016/S0891-5849(02)01301-1; Cosgrove BD, 2009, TOXICOL APPL PHARM, V237, P317, DOI 10.1016/j.taap.2009.04.002; Crowley SD, 2014, ANTIOXID REDOX SIGN, V20, P102, DOI 10.1089/ars.2013.5258; CZYGAN P, 1973, CANCER RES, V33, P2983; Endres S, 1996, IMMUNOLOGY, V87, P264, DOI 10.1046/j.1365-2567.1996.472535.x; Farrugia G, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/504230; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hartel C, 2004, SCAND J IMMUNOL, V60, P412, DOI 10.1111/j.0300-9475.2004.01481.x; Ho LJ, 2001, SCAND J RHEUMATOL, V30, P346; Kang PT, 2014, BIOCHEM PHARMACOL, V89, P490, DOI 10.1016/j.bcp.2014.03.012; Kim KM, 2005, J BIOL CHEM, V280, P41047, DOI 10.1074/jbc.M503713200; Lacour S, 2009, J IMMUNOTOXICOL, V6, P84, DOI 10.1080/15476910902938250; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu YK, 2005, AM J PHYSIOL-GASTR L, V289, pG308, DOI 10.1152/ajpgi.00054.2005; Lu YK, 2010, GENES NUTR, V5, P149, DOI 10.1007/s12263-009-0150-5; Nandakishore Ravindran, 2014, Curr Drug Discov Technol, V11, P127; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; Raza H, 2014, HAMDAN MED J, V2014, P1; Raza H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145965; Raza H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103379; Raza H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036325; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; Roberts RA, 2009, TOXICOL SCI, V112, P4, DOI 10.1093/toxsci/kfp179; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Stark LA, 2007, CARCINOGENESIS, V28, P968, DOI 10.1093/carcin/bgl220; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Varga ZV, 2015, BBA-MOL BASIS DIS, V1852, P232, DOI 10.1016/j.bbadis.2014.06.030; Verdile G, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/105828; Wang RW, 1997, DRUG METAB DISPOS, V25, P502; Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292; Zhao GQ, 2013, MOL PHARMACOL, V83, P167, DOI 10.1124/mol.112.080762	40	30	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159750	10.1371/journal.pone.0159750	http://dx.doi.org/10.1371/journal.pone.0159750			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441638	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500133
J	Tachibana, H; Sho, R; Takeda, Y; Zhang, XH; Yoshida, Y; Narimatsu, H; Otani, K; Ishikawa, S; Fukao, A; Asao, H; Iino, M				Tachibana, Hirohiko; Sho, Ri; Takeda, Yuji; Zhang, Xuhong; Yoshida, Yukie; Narimatsu, Hiroto; Otani, Katsumi; Ishikawa, Shigeo; Fukao, Akira; Asao, Hironobu; Iino, Mitsuyoshi			Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic Biomarker and Therapeutic Target	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MICRORNA; PLASMA; MIRNAS; EXPRESSION; INFECTION; ORIGIN; MARKER; SERUM; HEAD	Circulating microRNAs (miRNAs) have been detected in various types of cancer and have been proposed as novel biomarkers for diagnosis and treatment. Until recently, however, no studies had comprehensively examined circulating miRNAs in oral cancer. The current study used an ultra-sensitive genome-wide miRNA array to investigate changes in circulating miRNAs in plasma from five patients with oral cancer and ten healthy individuals. Results indicated that there were only a few circulating miRNAs, including miR-223, miR26a, miR-126, and miR-21, that were up-regulated in patients with oral cancer. A subsequent validation test indicated that circulating miR-223 levels were significantly higher (similar to 2-fold, P < 0.05) in patients with oral cancer (n = 31) than in those without cancer (n = 31). Moreover, miR-223 was found to be up-regulated in tumor-adjacent normal tissue compared to tumor tissue from patients with oral cancer. A gain-of-function assay was performed to explore the potential roles of circulating miR-223 in the development of oral cancer. Results revealed that miR-223 functions as a tumor suppressor by inhibiting cell proliferation and inducing apoptosis. In conclusion, this study suggested that circulating miR-223 may serve as a potential biomarker for diagnosis and that it may represent a novel therapeutic target for treatment of oral cancer.	[Tachibana, Hirohiko; Yoshida, Yukie; Ishikawa, Shigeo; Iino, Mitsuyoshi] Yamagata Univ, Fac Med, Dept Dent & Oral & Maxillofacial Surg, Yamagata, Japan; [Sho, Ri; Narimatsu, Hiroto; Otani, Katsumi; Fukao, Akira] Yamagata Univ, Fac Med, Dept Publ Hlth, Yamagata, Japan; [Takeda, Yuji; Asao, Hironobu] Yamagata Univ, Fac Med, Dept Immunol, Yamagata, Japan; [Zhang, Xuhong] Yamagata Univ, Fac Med, Dept Biochem & Mol Biol, Yamagata, Japan; [Narimatsu, Hiroto] Kanagawa Canc Ctr, Canc Prevent & Canc Control Div, Yokohama, Kanagawa, Japan	Yamagata University; Yamagata University; Yamagata University; Yamagata University; Kanagawa Prefectural Cancer Center	Sho, R (corresponding author), Yamagata Univ, Fac Med, Dept Publ Hlth, Yamagata, Japan.	shori@med.id.med.yamagata-u.ac.jp	Narimatsu, Hiroto/ABC-9150-2021	Narimatsu, Hiroto/0000-0002-5302-5872	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590953]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Sho R. is supported by a Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (24590953; http://www.jsps.go.jp/index1.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bose P, 2013, INT J CANCER, V133, P2013, DOI 10.1002/ijc.28112; Bouchie A, 2013, NAT BIOTECHNOL, V31, P577, DOI 10.1038/nbt0713-577; Chen Dan, 2013, J Oral Maxillofac Res, V4, pe2, DOI 10.5037/jomr.2013.4102; Chi KN, 2012, CLIN CANCER RES, V18, P3407, DOI 10.1158/1078-0432.CCR-12-0482; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; de Planell-Saguer M, 2013, CLIN BIOCHEM, V46, P869, DOI 10.1016/j.clinbiochem.2013.02.017; Denaro N, 2014, ONCOLOGY-BASEL, V86, P212, DOI 10.1159/000357712; Gleber-Netto FO, 2016, CLIN CANCER RES, V22, P3340, DOI 10.1158/1078-0432.CCR-15-1761; Hammond SM, 2015, ADV DRUG DELIVER REV, V87, P3, DOI 10.1016/j.addr.2015.05.001; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Kang H, 2015, NAT REV CLIN ONCOL, V12, P11, DOI 10.1038/nrclinonc.2014.192; Katanoda K, 2015, JPN J CLIN ONCOL, V45, P390, DOI 10.1093/jjco/hyv002; Komatsu S, 2014, BRIT J CANCER, V111, P1614, DOI 10.1038/bjc.2014.451; Konishi H, 2012, BRIT J CANCER, V106, P740, DOI 10.1038/bjc.2011.588; Kosaka Nobuyoshi, 2013, Frontiers in Genetics, V4, P173, DOI 10.3389/fgene.2013.00173; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lin SC, 2010, ORAL ONCOL, V46, P204, DOI 10.1016/j.oraloncology.2009.12.005; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Liu CJ, 2010, ORAL DIS, V16, P360, DOI 10.1111/j.1601-0825.2009.01646.x; Lu YC, 2015, CLIN BIOCHEM, V48, P115, DOI 10.1016/j.clinbiochem.2014.11.020; Lu YC, 2012, CANCER PREV RES, V5, P665, DOI 10.1158/1940-6207.CAPR-11-0358; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; MacLellan SA, 2012, CANCER MED-US, V1, P268, DOI 10.1002/cam4.17; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Ries J, 2014, ONCOL REP, V31, P1429, DOI 10.3892/or.2014.2983; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Tanaka Takuji, 2011, Patholog Res Int, V2011, P431246, DOI 10.4061/2011/431246; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Wittekind C, 2002, CANCER-AM CANCER SOC, V94, P2511, DOI 10.1002/cncr.10492; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yang CC, 2011, J ORAL PATHOL MED, V40, P397, DOI 10.1111/j.1600-0714.2010.01003.x; Yen TC, 1998, CLIN OTOLARYNGOL, V23, P82	43	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159693	10.1371/journal.pone.0159693	http://dx.doi.org/10.1371/journal.pone.0159693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441818	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500124
J	Bromley, M; Johns, A; Davies, E; Fraczek, M; Gilsenan, JM; Kurbatova, N; Keays, M; Kapushesky, M; Gut, M; Gut, I; Denning, DW; Bowyer, P				Bromley, Mike; Johns, Anna; Davies, Emma; Fraczek, Marcin; Gilsenan, Jane Mabey; Kurbatova, Natalya; Keays, Maria; Kapushesky, Misha; Gut, Marta; Gut, Ivo; Denning, David W.; Bowyer, Paul			Mitochondrial Complex I Is a Global Regulator of Secondary Metabolism, Virulence and Azole Sensitivity in Fungi	PLOS ONE			English	Article							CANDIDA-ALBICANS; ASPERGILLUS-FUMIGATUS; NEUROSPORA-CRASSA; ANTIFUNGAL AGENTS; CONFERRING RESISTANCE; EFFLUX TRANSPORTER; MAJOR FACILITATOR; DRUG-RESISTANCE; FLUCONAZOLE; SUSCEPTIBILITY	Recent estimates of the global burden of fungal disease suggest that that their incidence has been drastically underestimated and that mortality may rival that of malaria or tuberculosis. Azoles are the principal class of antifungal drug and the only available oral treatment for fungal disease. Recent occurrence and increase in azole resistance is a major concern worldwide. Known azole resistance mechanisms include over-expression of efflux pumps and mutation of the gene encoding the target protein cyp51a, however, for one of the most important fungal pathogens of humans, Aspergillus fumigatus, much of the observed azole resistance does not appear to involve such mechanisms. Here we present evidence that azole resistance in A. fumigatus can arise through mutation of components of mitochondrial complex I. Gene deletions of the 29.9KD subunit of this complex are azole resistant, less virulent and exhibit dysregulation of secondary metabolite gene clusters in a manner analogous to deletion mutants of the secondary metabolism regulator, LaeA. Additionally we observe that a mutation leading to an E180D amino acid change in the 29.9 KD subunit is strongly associated with clinical azole resistant A. fumigatus isolates. Evidence presented in this paper suggests that complex I may play a role in the hypoxic response and that one possible mechanism for cell death during azole treatment is a dysfunctional hypoxic response that may be restored by dysregulation of complex I. Both deletion of the 29.9 KD subunit of complex I and azole treatment alone profoundly change expression of gene clusters involved in secondary metabolism and immunotoxin production raising potential concerns about long term azole therapy.	[Bromley, Mike; Johns, Anna; Fraczek, Marcin; Gilsenan, Jane Mabey; Bowyer, Paul] Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Manchester Fungal Infect Grp, 2-24 Core Technol Bldg,Grafton St, Manchester M13 9NT, Lancs, England; [Davies, Emma; Denning, David W.; Bowyer, Paul] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Translat Med, Natl Aspergillosis Ctr,Univ Hosp South Manchester, 2nd Floor Educ & Res Ctr, Manchester M23 9LT, Lancs, England; [Gut, Marta; Gut, Ivo] Ctr Nacl Anal Genom, Parc Cient Barcelona,Baldiri Reixac,4,PCB Tower 1, Barcelona 08028, Spain; [Kurbatova, Natalya; Keays, Maria; Kapushesky, Misha] EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England; [Kapushesky, Misha] Genestack Ltd, Salisbury House,Stn Rd, Cambridge CB1 2LA, England	University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Bowyer, P (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Manchester Fungal Infect Grp, 2-24 Core Technol Bldg,Grafton St, Manchester M13 9NT, Lancs, England.; Bowyer, P (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Translat Med, Natl Aspergillosis Ctr,Univ Hosp South Manchester, 2nd Floor Educ & Res Ctr, Manchester M23 9LT, Lancs, England.	paul.bowyer@manchester.ac.uk	Denning, David/AAC-6931-2019; Fraczek, Marcin/AAZ-5748-2021; Gut, Ivo/ABF-3188-2020	Denning, David/0000-0001-5626-2251; Gut, Ivo/0000-0001-7219-632X; Davies, Emma/0000-0003-4704-736X; Bromley, Michael/0000-0002-7611-0201; Fraczek, Marcin/0000-0001-5134-4709; bowyer, paul/0000-0002-1083-9286; Keays, Maria/0000-0003-2034-601X	EU [242220]	EU(European Commission)	The work of the Mycology Reference Centre Manchester (ED, DWD) has been underwritten by the Fungal Research Trust since 1991. MB, MF, MKa, IG, MG and PB were funded by an EU Framework Programme 7 Collaborative Project, SYBARIS, Grant Agreement Number 242220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; [Anonymous], 1997, AGRIOS PLANT PATHOLO, pP25; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Barker BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-62; Barnes PD, 2007, BRIT J HAEMATOL, V139, P519, DOI 10.1111/j.1365-2141.2007.06812.x; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bennett J.W., 1999, ENCY BIOPROCESS TECH, P213; Bowyer P, 2012, FEMS MICROBIOL LETT, V332, P10, DOI 10.1111/j.1574-6968.2012.02575.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAMBL R, 1986, P NATL ACAD SCI USA, V83, P3644, DOI 10.1073/pnas.83.11.3644; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Bueid A, 2010, J ANTIMICROB CHEMOTH, V65, P2116, DOI 10.1093/jac/dkq279; Calabrese D, 2000, MICROBIOL-UK, V146, P2743, DOI 10.1099/00221287-146-11-2743; Cheng SJ, 2007, ANTIMICROB AGENTS CH, V51, P1855, DOI 10.1128/AAC.00182-07; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Ene IV, 2013, INFECT IMMUN, V81, P238, DOI 10.1128/IAI.01092-12; Ene IV, 2012, PROTEOMICS, V12, P3164, DOI 10.1002/pmic.201200228; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Fraczek MG, 2013, J ANTIMICROB CHEMOTH, V68, P1486, DOI 10.1093/jac/dkt075; Franz R, 1998, ANTIMICROB AGENTS CH, V42, P3065, DOI 10.1128/AAC.42.12.3065; Garmier M, 2008, PLANT PHYSIOL, V148, P1324, DOI 10.1104/pp.108.125880; Gupta V, 1998, CURR GENET, V34, P192, DOI 10.1007/s002940050385; Jantunen E, 2008, TRANSPL INFECT DIS, V10, P156, DOI 10.1111/j.1399-3062.2008.00301.x; KELLY SL, 1995, BIOCHEM BIOPH RES CO, V207, P910, DOI 10.1006/bbrc.1995.1272; Kelly SL, 1997, FEBS LETT, V400, P80, DOI 10.1016/S0014-5793(96)01360-9; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Khamooshi K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-56; Latge JP, 2002, CURR OPIN MICROBIOL, V5, P355, DOI 10.1016/S1369-5274(02)00343-0; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Law D, 1997, ANTIMICROB AGENTS CH, V41, P2310, DOI 10.1128/AAC.41.10.2310; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Manavathu EK, 1998, ANTIMICROB AGENTS CH, V42, P3018, DOI 10.1128/AAC.42.11.3018; Marichal P, 1999, ANTIMICROB AGENTS CH, V43, P2663, DOI 10.1128/AAC.43.11.2663; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Marques I, 2005, BBA-BIOENERGETICS, V1707, P211, DOI 10.1016/j.bbabio.2004.12.003; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nolte FS, 1997, ANTIMICROB AGENTS CH, V41, P196, DOI 10.1128/AAC.41.1.196; Nout MJR, 2002, MYCOTA, V10, P23; Oerke EC, 2004, CROP PROT, V23, P275, DOI 10.1016/j.cropro.2003.10.001; Oerke EC., 1994, CROP PRODUCTION CROP; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; Pfaller MA, 2006, CLIN MICROBIOL REV, V19, P435, DOI 10.1128/CMR.19.2.435-447.2006; Ronning Catherine M., 2005, Revista Iberoamericana de Micologia, V22, P223; Ruijter GJG, 2002, MYCOTA, V10, P213; SACKMANN U, 1991, EUR J BIOCHEM, V200, P463, DOI 10.1111/j.1432-1033.1991.tb16205.x; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Sanglard D, 1997, MICROBIOL-UK, V143, P405, DOI 10.1099/00221287-143-2-405; Schaller M, 1998, MOL MICROBIOL, V29, P605, DOI 10.1046/j.1365-2958.1998.00957.x; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Silveira FP, 2007, MED MYCOL, V45, P305, DOI 10.1080/13693780701200372; Sun N, 2013, ANTIMICROB AGENTS CH, V57, P532, DOI 10.1128/AAC.01520-12; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Thomas E, 2013, ANTIMICROB AGENTS CH, V57, P5580, DOI 10.1128/AAC.00889-13; Thompson GR, 2008, SEMIN RESP CRIT CARE, V29, P103, DOI 10.1055/s-2008-1063849; Torres HA, 2005, LANCET INFECT DIS, V5, P775, DOI 10.1016/S1473-3099(05)70297-8; Ushakova AV, 2005, J MOL BIOL, V351, P327, DOI 10.1016/j.jmb.2005.06.005; Vanden Bossche H, 1985, Curr Top Med Mycol, V1, P313; VANDENBOSSCHE H, 1993, ANTIMICROB AGENTS CH, V37, P2101, DOI 10.1128/AAC.37.10.2101; Videira A, 2002, BBA-BIOENERGETICS, V1555, P187, DOI 10.1016/S0005-2728(02)00276-1; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; WRIGHT GD, 1990, BIOCHIM BIOPHYS ACTA, V1040, P95, DOI 10.1016/0167-4838(90)90151-5; Yang Yun-Liang, 2001, Journal of Microbiology Immunology and Infection, V34, P79; YOSHIDA Y, 1984, J BIOL CHEM, V259, P1655; YOSHIDA Y, 1987, BIOCHEM PHARMACOL, V36, P229, DOI 10.1016/0006-2952(87)90694-0	66	27	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158724	10.1371/journal.pone.0158724	http://dx.doi.org/10.1371/journal.pone.0158724			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438017	Green Submitted, Green Published, gold			2022-12-27	WOS:000380170100019
J	Davies, JL; Thompson, S; Kaur-Sandhu, H; Sawcer, S; Coles, A; Ban, M; Jones, J				Davies, Jessica L.; Thompson, Sara; Kaur-Sandhu, Harpreet; Sawcer, Stephen; Coles, Alasdair; Ban, Maria; Jones, Joanne			Increased THEMIS First Exon Usage in CD4+T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis	PLOS ONE			English	Article							REGULATORY T-CELLS; THYMOCYTE DEVELOPMENT; POSITIVE SELECTION; CELIAC-DISEASE; TRANSCRIPTION; HOMEOSTASIS; VARIANTS; PROTEIN; COMMON; RNA	Multiple sclerosis is an autoimmune disease of the central nervous system. Genome wide association studies have identified over 100 common variants associated with multiple sclerosis, the majority of which implicate immunologically relevant genes, particularly those involved in T-cell development. SNP rs13204742 at the THEMIS/PTPRK locus is one such variant. Here, we have demonstrated mutually exclusive use of exon 1 and 2 amongst 16 novel THEMIS isoforms. We also show inverse correlation between THEMIS expression in human CD4+ T-cells and dosage of the multiple sclerosis risk allele at rs13204742, driven by reduced expression of exon 1-containing isoforms. In silico analysis suggests that this may be due to cell-specific, allele-dependent binding of the transcription factors FoxP3 and/or E47. Research exploring the functional implications of GWAS variants is important for gaining an understanding of disease pathogenesis, with the ultimate aim of identifying new therapeutic targets.	[Davies, Jessica L.; Thompson, Sara; Kaur-Sandhu, Harpreet; Sawcer, Stephen; Coles, Alasdair; Ban, Maria; Jones, Joanne] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	University of Cambridge	Davies, JL (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	jessicaldavies6@gmail.com		Sawcer, Stephen/0000-0001-7685-0974; /0000-0002-8888-1441; Jones, Joanne/0000-0003-4974-1371; Coles, Alasdair/0000-0003-4738-0760	Cambridge NIHR Biomedical Research Centre; Department of Clinical Neurosciences at University of Cambridge; Wellcome Trust Clinical Research Facility; Pattinson family; National Institute for Health Research [CL-2008-14-004] Funding Source: researchfish; Wellcome Trust [105924/Z/14/Z] Funding Source: researchfish	Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Department of Clinical Neurosciences at University of Cambridge; Wellcome Trust Clinical Research Facility(Wellcome Trust); Pattinson family; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Cambridge NIHR Biomedical Research Centre, the Department of Clinical Neurosciences at University of Cambridge and the Wellcome Trust Clinical Research Facility. JLD was supported by the Pattinson family through personal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Cambridge BioResource for sample provision; Simon McCallum from the Cambridge NIHR BRC Cell Phenotyping Hub for advice and support in flow cytometry; and Dr Lorenzi and Julie Diboll at Newcastle University for their advice with TREC assays and providing the sjTREC plasmid. This work was supported by the Cambridge NIHR Biomedical Research Centre and the Wellcome Trust Clinical Research Facility.	Andersen M, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-8; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bondar C, 2014, EUR J HUM GENET, V22, P358, DOI 10.1038/ejhg.2013.136; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Bros M, 2006, GENOMICS, V87, P463, DOI 10.1016/j.ygeno.2005.11.013; Broux B, 2010, GENES IMMUN, V11, P326, DOI 10.1038/gene.2009.106; Chabod M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002461; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Duszczyszyn DA, 2010, J NEUROIMMUNOL, V221, P73, DOI 10.1016/j.jneuroim.2010.02.005; Erdenebayar N, 2009, BIOCHEM BIOPH RES CO, V390, P489, DOI 10.1016/j.bbrc.2009.09.117; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Hug A, 2003, J IMMUNOL, V171, P432, DOI 10.4049/jimmunol.171.1.432; Iwata R, 2010, BIOMED RES-TOKYO, V31, P83, DOI 10.2220/biomedres.31.83; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lorenzi AR, 2008, J IMMUNOL METHODS, V339, P185, DOI 10.1016/j.jim.2008.09.013; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Morrissy AS, 2011, GENOME RES, V21, P1203, DOI 10.1101/gr.113431.110; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shabalina SA, 2010, GENOME BIOL EVOL, V2, P791, DOI 10.1093/gbe/evq058; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Stevenson WS, 2014, LEUKEMIA, V28, P787, DOI 10.1038/leu.2013.270; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	35	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158327	10.1371/journal.pone.0158327	http://dx.doi.org/10.1371/journal.pone.0158327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438997	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100011
J	Kohlbrenner, V; Deuba, K; Karki, DK; Marrone, G				Kohlbrenner, Verena; Deuba, Keshab; Karki, Deepak Kumar; Marrone, Gaetano			Perceived Discrimination Is an Independent Risk Factor for Suicidal Ideation among Sexual and Gender Minorities in Nepal	PLOS ONE			English	Article							MENTAL-HEALTH; BLOOD-PRESSURE; GAY; ORIENTATION; POPULATIONS; EXPERIENCES; PREVALENCE; STIGMA; RACISM; ADULTS	Sexual and gender minorities experience an elevated burden of suicidality compared with the general population. Still, little is known about that burden and the factors generating it in the context of low-and middle-income countries. The present study assessed the prevalence of suicidal ideation, planned suicide, and attempted suicide among men who have sex with men (MSM) and transgender people (TG) in Nepal, and examined the association of perceived discrimination on the basis of sexual orientation with suicidal ideation and with attempted suicide. Data were obtained from a surveillance survey among MSM and TG in Nepal in 2012. A sample of 400 MSM and TG, recruited using respondent-driven sampling, completed a structured face-to-face interview. Throughout their lifetime, 26.8% of the participants had experienced suicidal ideation, 12.0% had made a suicide plan, and 9.0% had attempted suicide. In particular, more TG than MSM had experienced suicidal ideation (39.8% vs. 21.3%), had made a suicide plan (19.5% vs. 8.9%), and had attempted suicide (15.3% vs. 6.4%). Overall, the odds of having experienced suicidal ideation was significantly higher among the 38.3% of participants who had perceived discrimination based on their sexual orientation (AOR: 3.17; 95% CI: 1.83-5.48). Moreover, the odds of suicidal ideation was significantly higher as the extent of perceived discrimination increased (AOR: 1.35; 95% CI: 1.15-1.60). However, the odds of attempted suicide was not significantly associated with perceived discrimination (AOR: 1.40; 95% CI: 0.62-3.15). The findings highlight perceived discrimination as an independent risk factor for suicidal ideation. Future suicide prevention programs should target sexual and gender minorities and include elements focusing on discrimination.	[Kohlbrenner, Verena] Karolinska Inst, Stockholm, Sweden; [Deuba, Keshab] Publ Hlth & Environm Res Ctr, Kathmandu, Nepal; [Deuba, Keshab; Marrone, Gaetano] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Karki, Deepak Kumar] Pokhara Univ, Dept Hlth Sci, Nobel Coll, Kathmandu, Nepal; [Marrone, Gaetano] Karolinska Hosp, Dept Infect Dis, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Deuba, K (corresponding author), Publ Hlth & Environm Res Ctr, Kathmandu, Nepal.; Deuba, K (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	deuba4k@gmail.com		Marrone, Gaetano/0000-0002-2991-1663; Deuba, Keshab/0000-0002-9933-2210; Karki, Deepak Kumar/0000-0002-0392-6592	Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM)	Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM)	All the IBBS survey related activities were funded by The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida J, 2009, J YOUTH ADOLESCENCE, V38, P1001, DOI 10.1007/s10964-009-9397-9; Amiya RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090959; Amon J, 2000, GUIDELINES REPEATED; Balsam KF, 2005, J ABNORM PSYCHOL, V114, P471, DOI 10.1037/0021-843X.114.3.471; Botega Neury José, 2005, Rev. Bras. Psiquiatr., V27, P45, DOI 10.1590/S1516-44462005000100011; Byne W., 2007, HLTH SEXUAL MINORITI, P65, DOI [10.1007/978-0-387-31334-4_4, DOI 10.1007/978-0-387-31334-4_4]; Caceres CF, 2008, SEX TRANSM INFECT, V84, pI49, DOI 10.1136/sti.2008.030569; de Graaf R, 2006, ARCH SEX BEHAV, V35, P253, DOI 10.1007/s10508-006-9020-z; Deuba K, 2014, ASIAN PACIFIC J T S2, V4, pS605, DOI [10.1016/S2222-1808(14)60688-5, DOI 10.1016/S2222-1808(14)60688-5]; Deuba K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058099; Diaz RM, 2001, AM J PUBLIC HEALTH, V91, P927, DOI 10.2105/AJPH.91.6.927; Haas AP, 2010, J HOMOSEXUAL, V58, P10, DOI 10.1080/00918369.2011.534038; Hatzenbuehler ML, 2011, PEDIATRICS, V127, P896, DOI 10.1542/peds.2010-3020; Hatzenbuehler ML, 2009, PSYCHOL BULL, V135, P707, DOI 10.1037/a0016441; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Herek GM, 2007, ANNU REV CLIN PSYCHO, V3, P353, DOI 10.1146/annurev.clinpsy.3.022806.091510; Hottes TS, 2015, CRIT PUBLIC HEALTH, V25, P513, DOI 10.1080/09581596.2014.946887; Huebner DM, 2004, AM J PUBLIC HEALTH, V94, P1200, DOI 10.2105/AJPH.94.7.1200; Institute of Medicine, 2011, HLTH LESB GAY BISEX; Johnston L., 2014, APPLYING RESPONDENT; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Krieger N, 1996, AM J PUBLIC HEALTH, V86, P1370, DOI 10.2105/AJPH.86.10.1370; KRIEGER N, 1990, SOC SCI MED, V30, P1273, DOI 10.1016/0277-9536(90)90307-E; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Krieger N., 2000, SOCIAL EPIDEMIOLOGY; Mays VM, 2001, AM J PUBLIC HEALTH, V91, P1869, DOI 10.2105/AJPH.91.11.1869; McDaniel JS, 2001, SUICIDE LIFE-THREAT, V31, P84, DOI 10.1521/suli.31.1.5.84.24224; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; MULROW CD, 1995, ANN INTERN MED, V122, P913, DOI 10.7326/0003-4819-122-12-199506150-00004; National Institute of Health (US) Consideration of the Institute of Medicine (IOM), 2013, NAT I HLTH US CONS I; NCASC, INT BIOL BEH SURV IB; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Schauer M., 2003, EUROPEAN SOC TRAUMAT, V10, P5; Shneidman E., 1995, SUICIDE PSYCHACHE CL; Van Orden KA, 2006, COGNITIVE THER RES, V30, P457, DOI 10.1007/s10608-006-9057-2; Volz E, 2008, J OFF STAT, V24, P79; Walls NE, 2008, SOC WORK, V53, P21, DOI 10.1093/sw/53.1.21; Wilson E, 2011, CULT HEALTH SEX, V13, P253, DOI 10.1080/13691058.2010.524247; World Health Organization, 2014, PREV SUIC PREV SUIC	44	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159359	10.1371/journal.pone.0159359	http://dx.doi.org/10.1371/journal.pone.0159359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27437996	gold, Green Submitted, Green Published			2022-12-27	WOS:000380170100037
J	Nohr, MK; Kroager, TP; Sanggaard, KW; Knudsen, AD; Stensballe, A; Enghild, JJ; Olholm, J; Richelsen, B; Pedersen, SB				Nohr, Mark K.; Kroager, Toke P.; Sanggaard, Kristian W.; Knudsen, Anders D.; Stensballe, Allan; Enghild, Jan J.; Olholm, Jens; Richelsen, Bjorn; Pedersen, Steen B.			SILAC-MS Based Characterization of LPS and Resveratrol Induced Changes in Adipocyte Proteomics - Resveratrol as Ameliorating Factor on LPS Induced Changes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN ADIPOSE-TISSUE; NF-KAPPA-B; TRIGLYCERIDE CLEARANCE; INDUCED ACTIVATION; GENE-EXPRESSION; INSULIN; ENDOTOXEMIA; GLYCOSYLATION; TRANSCRIPTION	Adipose tissue inflammation is believed to play a pivotal role in the development obesity-related morbidities such as insulin resistance. However, it is not known how this (low-grade) inflammatory state develops. It has been proposed that the leakage of lipopolysaccharides (LPS), originating from the gut microbiota, through the gut epithelium could drive initiation of inflammation. To get a better understanding of which proteins and intracellular pathways are affected by LPS in adipocytes, we performed SILAC proteomic analysis and identified proteins that were altered in expression. Furthermore, we tested the anti-inflammatory compound resveratrol. A total of 927 proteins were quantified by the SILAC method and of these 57- and 64 were significantly up- and downregulated by LPS, respectively. Bioinformatic analysis (GO analysis) revealed that the upregulated proteins were especially involved in the pathways of respiratory electron transport chain and inflammation. The downregulated proteins were especially involved in protein glycosylation. One of the latter proteins, GALNT2, has previously been described to regulate the expression of liver lipases such as ANGPTL3 and apoC-III affecting lipid metabolism. Furthermore, LPS treatment reduced the protein levels of the insulin sensitizing adipokine, adiponectin, and proteins participating in the final steps of triglyceride- and cholesterol synthesis. Generally, resveratrol opposed the effect induced by LPS and, as such, functioning as an ameliorating factor in disease state. Using an unbiased proteomic approach, we present novel insight of how the proteome is altered in adipocytes in response to LPS as seen in obesity. We suggest that LPS partly exerts its detrimental effects by altering glycosylation processes of the cell, which is starting to emerge as important posttranscriptional regulators of protein expression. Furthermore, resveratrol could be a prime candidate in ameliorating dysfunctioning adipose tissue induced by inflammatory stimulation.	[Nohr, Mark K.; Olholm, Jens; Richelsen, Bjorn; Pedersen, Steen B.] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Nohr, Mark K.; Olholm, Jens; Richelsen, Bjorn; Pedersen, Steen B.] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Kroager, Toke P.; Sanggaard, Kristian W.; Knudsen, Anders D.; Enghild, Jan J.] Aarhus Univ, Lab Proteome Anal & Prot Characterizat, Dept Mol Biol & Genet, Aarhus, Denmark; [Kroager, Toke P.; Sanggaard, Kristian W.; Knudsen, Anders D.; Enghild, Jan J.] Aarhus Univ, iNANO, Aarhus, Denmark; [Stensballe, Allan] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aalborg University	Nohr, MK (corresponding author), Aarhus Univ, Inst Clin Med, Aarhus, Denmark.; Nohr, MK (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark.	mkln@clin.au.dk	Pedersen, Steen B./AAB-3331-2019; Stensballe, Allan/K-6756-2019	Pedersen, Steen B./0000-0002-7838-8063; Stensballe, Allan/0000-0002-9888-1955; Richelsen, Bjoern/0000-0001-8886-9736; Enghild, Jan Johannes/0000-0001-9292-9172; Nohr, Mark Klitgaard/0000-0002-5536-654X	Graduate School of Health, Aarhus University; Rasmus Riisfort Foundation; Ejnar Danielsens Foundation; AP Moller Maersk Foundation; Danish Council for Strategic Research [10-093499]	Graduate School of Health, Aarhus University; Rasmus Riisfort Foundation; Ejnar Danielsens Foundation; AP Moller Maersk Foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	MKN was supported by a full PhD scholarship provided by the Graduate School of Health, Aarhus University. The study was supported by the Rasmus Riisfort Foundation, Ejnar Danielsens Foundation and the AP Moller Maersk Foundation. The study is part of the research program LIRMOI Research Center (www.LIRMOI.com), which is supported by the Danish Council for Strategic Research (Grant 10-093499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carobbio S, 2013, DIABETES, V62, P3697, DOI 10.2337/db12-1748; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cullberg KB, 2013, EUR J PHARM SCI, V49, P251, DOI 10.1016/j.ejps.2013.02.014; Dao TMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020700; Ezzati P, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00030; Gao XH, 2001, BIOCHEM PHARMACOL, V62, P1299, DOI 10.1016/S0006-2952(01)00775-4; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Heynekamp JJ, 2006, J MED CHEM, V49, P7182, DOI 10.1021/jm060630x; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Laugerette F, 2011, J NUTR BIOCHEM, V22, P53, DOI 10.1016/j.jnutbio.2009.11.011; Le Lay S, 2002, J BIOL CHEM, V277, P35625, DOI 10.1074/jbc.M203913200; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Misawa K, 2003, J BIOL CHEM, V278, P36176, DOI 10.1074/jbc.M302387200; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Molina H, 2009, J PROTEOME RES, V8, P48, DOI 10.1021/pr800650r; Nohr MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146840; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Olholm J, 2010, INT J OBESITY, V34, P1546, DOI 10.1038/ijo.2010.98; Ornstrup MJ, 2014, J CLIN ENDOCR METAB, V99, P4720, DOI 10.1210/jc.2014-2799; Pedersen SB, 2008, INT J OBESITY, V32, P1250, DOI 10.1038/ijo.2008.78; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Stensballe A, 2001, PROTEOMICS, V1, P207, DOI 10.1002/1615-9861(200102)1:2<207::AID-PROT207>3.3.CO;2-V; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vicennati V, 2002, INT J OBESITY, V26, P905, DOI 10.1038/sj.ijo.0802035; Wellhoener P, 2011, HORM METAB RES, V43, P754, DOI 10.1055/s-0031-1287854; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	56	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159747	10.1371/journal.pone.0159747	http://dx.doi.org/10.1371/journal.pone.0159747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438462	Green Submitted, Green Published, gold			2022-12-27	WOS:000380170100072
J	Verstraeten, T; Jiang, BG; Weil, JG; Lin, JH				Verstraeten, Thomas; Jiang, Baoguo; Weil, John G.; Lin, Jennifer H.			Modelling Estimates of Norovirus Disease in Patients with Chronic Medical Conditions	PLOS ONE			English	Article							GASTROENTERITIS; BURDEN; INFLUENZA; OUTBREAK; ENGLAND	Background The burden of disease due to norovirus infection has been well described in the general United States population, but studies of norovirus occurrence among persons with chronic medical conditions have been limited mostly to the immunocompromised. We assessed the impact of norovirus gastroenteritis on health care utilization in US subjects with a range of chronic medical conditions. Methods We performed a retrospective cohort study using MarketScan data from July 2002 to December 2013, comparing the rates of emergency department visits, outpatient visits and hospitalizations among patients with chronic conditions (renal, cardiovascular, respiratory, immunocompromising, gastrointestinal, hepatic/pancreatic and neurological conditions and diabetes) with those in a healthy population. We estimated the rates of these outcomes due to norovirus gastroenteritis using an indirect modelling approach whereby cases of gastroenteritis of unknown cause and not attributed to a range of other causes were assumed to be due to norovirus. Results Hospitalization rates for norovirus gastroenteritis were higher in all of the risk groups analyzed compared with data in otherwise healthy subjects, ranging from 3.2 per 10,000 person-years in persons with chronic respiratory conditions, to 23.1 per 10,000 person-years in persons with chronic renal conditions, compared to 2.1 per 10,000 among persons without chronic conditions. Over 51% of all norovirus hospitalizations occurred in the 37% of the population with some form of chronic medical condition. Outpatient visits for norovirus gastroenteritis were also increased in persons with chronic gastrointestinal or immunocompromising conditions. Conclusion Norovirus gastroenteritis leads to significantly higher rates of healthcare utilization in patients with a chronic medical condition compared to patients without any such condition.	[Verstraeten, Thomas] P95 Pharmacovigilance & Epidemiol Serv, Leuven, Belgium; [Jiang, Baoguo; Lin, Jennifer H.] Amer Inc, Takeda Dev Ctr, Deerfield, IL USA; [Weil, John G.] Takeda Pharmaceut Int, Zurich, Switzerland	Takeda Pharmaceutical Company Ltd; Takeda Development Center Americas, Inc.	Verstraeten, T (corresponding author), P95 Pharmacovigilance & Epidemiol Serv, Leuven, Belgium.	Thomas.Verstraeten@P-95.com			Takeda Development Center Americas, Inc.; Takeda Pharmaceuticals International; Takeda Vaccines Inc. Deerfield IL; Takeda	Takeda Development Center Americas, Inc.(Takeda Pharmaceutical Company Ltd); Takeda Pharmaceuticals International(Takeda Pharmaceutical Company Ltd); Takeda Vaccines Inc. Deerfield IL; Takeda(Takeda Pharmaceutical Company Ltd)	JW and BJ are employees of Takeda, a company developing a vaccine for the prevention of norovirus disease. BJ is supported by Takeda Development Center Americas, Inc. JW is supported by Takeda Pharmaceuticals International. JL, at the time of the study, was supported by Takeda Development Center Americas, Inc. TV has received consulting fees from Takeda. Takeda Vaccines Inc. Deerfield IL provided support in the form of salaries for authors [JW, BJ and JL], and played a role in the decision to publish and review of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P842; Bernard H, 2014, EPIDEMIOL INFECT, V142, P63, DOI 10.1017/S0950268813000435; Bernstein DI, 2015, J INFECT DIS, V211, P870, DOI 10.1093/infdis/jiu497; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P41; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Haustein T, 2009, CLIN INFECT DIS, V49, P1890, DOI 10.1086/648440; Karve S, 2014, HUM VACC IMMUNOTHER, V10, P1544, DOI 10.4161/hv.28704; Koo HL, 2010, DISCOV MED, V10, P61; Koo HL, 2009, CLIN INFECT DIS, V49, P1069, DOI 10.1086/605558; Lopman BA, 2004, CLIN INFECT DIS, V39, P318, DOI 10.1086/421948; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Lopman BA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001999; Markov PV, 2007, EPIDEMIOL INFECT, V135, P17, DOI 10.1017/S0950268806006625; Mattner F, 2006, CLIN MICROBIOL INFEC, V12, P69, DOI 10.1111/j.1469-0691.2005.01299.x; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021; Roddie C, 2009, CLIN INFECT DIS, V49, P1061, DOI 10.1086/605557; Siebenga JJ, 2008, J INFECT DIS, V198, P994, DOI 10.1086/591627; Simon A, 2006, SCAND J GASTROENTERO, V41, P693, DOI 10.1080/00365520500421694; Treanor JJ, 2014, J INFECT DIS, V210, P1763, DOI 10.1093/infdis/jiu337; [No title captured], DOI DOI 10.5888/PCD11.130389	25	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158822	10.1371/journal.pone.0158822	http://dx.doi.org/10.1371/journal.pone.0158822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438335	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100022
J	de Vries, EM; Lammers, LA; Achterbergh, R; Klumpen, HJ; Mathot, RAA; Boelen, A; Romijn, JA				de Vries, E. M.; Lammers, L. A.; Achterbergh, R.; Klumpen, H-J; Mathot, R. A. A.; Boelen, A.; Romijn, J. A.			Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR	PLOS ONE			English	Article							MOUSE; EXPRESSION; MIDAZOLAM; GENES; ALPHA; LIVER; MICE; RAT	Introduction Hepatic drug metabolism by cytochrome P450 enzymes is altered by the nutritional status of patients. The expression of P450 enzymes is partly regulated by the constitutive androstane receptor (CAR). Fasting regulates the expression of both P450 enzymes and CAR and affects hepatic drug clearance. We hypothesized that the fasting-induced alterations in P450 mediated drug clearance are mediated by CAR. Methods To investigate this we used a drug cocktail validated in humans consisting of five widely prescribed drugs as probes for specific P450 enzymes: caffeine (CYP1A2), metoprolol (CYP2D6), omeprazole (CYP2C19), midazolam (CYP3A4) and s-warfarin (CYP2C9). This cocktail was administered to wild type (WT, C57Bl/6) mice or mice deficient for CAR (CAR(-/-)) that were either fed ad libitum or fasted for 24 hours. Blood was sampled at predefined intervals and drug concentrations were measured as well as hepatic mRNA expression of homologous/orthologous P450 enzymes (Cyp1a2, Cyp2d22, Cyp3a11, Cyp2c37, Cyp2c38 and Cyp2c65). Results Fasting decreased Cyp1a2 and Cyp2d22 expression and increased Cyp3a11 and Cyp2c38 expression in both WT and CAR(-/-) mice. The decrease in Cyp1a2 was diminished in CAR(-/-) comparison with WT mice. Basal Cyp2c37 expression was lower in CAR(-/-) compared to WT mice. Fasting decreased the clearance of all drugs tested in both WT and CAR(-/-) mice. The absence of CAR was associated with an decrease in the clearance of omeprazole, metoprolol and midazolam in fed mice. The fasting-induced reduction in clearance of s-warfarin was greater in WT than in CAR(-/-). The changes in drug clearance correlated with the expression pattern of the specific P450 enzymes in case of Cyp1a2-caffeine and Cyp2c37-omeprazole. Conclusion We conclude that CAR is important for hepatic clearance of several widely prescribed drugs metabolized by P450 enzymes. However the fasting-induced alterations in P450 mediated drug clearance are largely independent of CAR.	[de Vries, E. M.; Romijn, J. A.] Acad Med Ctr, Dept Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Lammers, L. A.; Mathot, R. A. A.] Acad Med Ctr, Dept Hosp Pharm, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Achterbergh, R.; Klumpen, H-J] Acad Med Ctr, Dept Med Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Boelen, A.] Acad Med Ctr, Dept Endocrinol & Metab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Vries, EM (corresponding author), Acad Med Ctr, Dept Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.m.devries@amc.uva.nl		mathot, ron/0000-0001-8401-0879				Blume N, 2000, ARCH BIOCHEM BIOPHYS, V381, P191, DOI 10.1006/abbi.2000.1978; Buters JTM, 1996, PHARMACOGENETICS, V6, P291, DOI 10.1097/00008571-199608000-00002; Cui JY, 2016, BBA-GENE REGUL MECH, V1859, P1198, DOI 10.1016/j.bbagrm.2016.04.010; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321; Honkakoski P, 1998, J BIOCHEM MOL TOXIC, V12, P3; Kumar GN, 2001, MED RES REV, V21, P397, DOI 10.1002/med.1016; Lammers LA, 2015, DRUG METAB DISPOS, V43, P819, DOI 10.1124/dmd.114.062299; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Monostory K, 2009, DRUG METAB REV, V41, P547, DOI 10.1080/03602530903112284; Murray M, 2006, CURR DRUG METAB, V7, P67, DOI 10.2174/138920006774832569; Perloff MD, 2000, J PHARMACOL EXP THER, V292, P618; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Turpault S, 2009, BRIT J CLIN PHARMACO, V68, P928, DOI 10.1111/j.1365-2125.2009.03548.x; van Waterschoot RAB, 2008, MOL PHARMACOL, V73, P1029, DOI 10.1124/mol.107.043869; Wang H, 2004, MOL PHARMACOL, V65, P1148, DOI 10.1124/mol.65.5.1148; Wieneke N, 2007, FEBS LETT, V581, P5617, DOI 10.1016/j.febslet.2007.11.011; Yanagimoto T, 1997, ARCH BIOCHEM BIOPHYS, V340, P215, DOI 10.1006/abbi.1997.9900; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	21	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159552	10.1371/journal.pone.0159552	http://dx.doi.org/10.1371/journal.pone.0159552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434302	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169600068
J	Li, YX; Ren, YL; Fu, HJ; Zou, L; Yang, Y; Chen, Z				Li, Yang-Xia; Ren, Yan-Li; Fu, Hai-Jing; Zou, Ling; Yang, Ying; Chen, Zhi			Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-kappa B Pathways in an ER Stress-Dependent Manner	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SURFACE-ANTIGEN; LIVER-CANCER; X PROTEIN; SERUM INTERLEUKIN-6; OXIDATIVE STRESS; GENE-EXPRESSION; C/EBP-BETA; ACTIVATION; PROGRESSION	During hepatitis B virus (HBV) infection, three viral envelope proteins of HBV are over-expressed in the endoplasmic reticulum (ER). The large S protein (LHBs) and truncated middle S protein (MHBst) have been documented to play roles in regulating host gene expression and contribute to hepatic disease development. As a predominant protein at the ultrastructural level in biopsy samples taken from viremic patients, the role of the middle S protein (MHBs) remains to be understood despite its high immunogenicity. When we transfected hepatocytes with an enhanced green fluorescent protein (EGFP)-tagged MHBs expressing plasmid, the results showed that expression of MHBs cause an upregulation of IL-6 at the message RNA and protein levels through activating the p38 mitogen-activated protein kinase (p38 MAPK) and nuclear factor-kappa B (NF-kappa B) pathways. The use of specific inhibitors of the signaling pathways can diminish this upregulation. The use of BAPTA-AM attenuated the stimulation caused by MHBs. We further found that MHBs accumulated in the endoplasmic reticulum and increased the amount of glucose regulated protein 78 (GRP78/BiP). Our results provide a possibility that MHBs could be involved in liver disease progression.	[Li, Yang-Xia; Ren, Yan-Li; Fu, Hai-Jing; Zou, Ling; Yang, Ying; Chen, Zhi] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Inst Infect Dis, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China; [Li, Yang-Xia; Ren, Yan-Li; Fu, Hai-Jing; Zou, Ling; Yang, Ying; Chen, Zhi] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Li, Yang-Xia; Ren, Yan-Li; Fu, Hai-Jing; Zou, Ling; Chen, Zhi] Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Chen, Z (corresponding author), Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Inst Infect Dis, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China.; Chen, Z (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.; Chen, Z (corresponding author), Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China.	zjuchenzhi@zju.edu.cn			State Science and Technology Projects of 12th Five Year [2012ZX10002007]	State Science and Technology Projects of 12th Five Year	This work was supported by the State Science and Technology Projects of 12th Five Year, No. 2012ZX10002007.	Caselmann WH, 1997, J GEN VIROL, V78, P1487, DOI 10.1099/0022-1317-78-6-1487; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Chung JH, 2000, J INVEST DERMATOL, V115, P177, DOI 10.1046/j.1523-1747.2000.00009.x; DIENES HP, 1990, GASTROENTEROLOGY, V98, P1017, DOI 10.1016/0016-5085(90)90028-Y; EBLE BE, 1986, MOL CELL BIOL, V6, P1454, DOI 10.1128/MCB.6.5.1454; Ebrahim M, 2014, FUTURE VIROL, V9, P431, DOI 10.2217/fvl.14.21; Fan ZY, 2004, CYTOKINE, V28, P17, DOI 10.1016/j.cyto.2004.06.003; Florian PE, 2014, ROM BIOTECH LETT, V19, P9974; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Glebe D, 2007, WORLD J GASTROENTERO, V13, P8, DOI 10.3748/wjg.v13.i1.8; Gur A, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-30; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hildt E, 2002, EMBO J, V21, P525, DOI 10.1093/emboj/21.4.525; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; HUANG ZM, 1993, J VIROL, V67, P7032, DOI 10.1128/JVI.67.12.7032-7040.1993; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Jang JW, 2012, CYTOKINE, V60, P686, DOI 10.1016/j.cyto.2012.07.017; KAKUMU S, 1992, J CLIN PATHOL, V45, P408, DOI 10.1136/jcp.45.5.408; Kim JS, 2006, BIOCHEM BIOPH RES CO, V351, P253, DOI 10.1016/j.bbrc.2006.10.028; Lee IK, 2015, WORLD J GASTROENTERO, V21, P6872, DOI 10.3748/wjg.v21.i22.6872; Lee Y, 1998, CLIN CANCER RES, V4, P1711; Lentz TB, 2011, J VIROL, V85, P11916, DOI 10.1128/JVI.05373-11; Liu XF, 2015, EXP CELL RES, V331, P223, DOI 10.1016/j.yexcr.2014.08.040; MOLNARKIMBER KL, 1988, J VIROL, V62, P407, DOI 10.1128/JVI.62.2.407-416.1988; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ohishi W, 2014, INT J CANCER, V134, P154, DOI 10.1002/ijc.28337; Pollicino T, 2014, J HEPATOLOGY; Schluter V, 2001, DIGEST DIS, V19, P352, DOI 10.1159/000050703; Sengupta S, 2007, J MED VIROL, V79, P220, DOI 10.1002/jmv.20790; Shen ML, 2010, VACCINE, V28, P7288, DOI 10.1016/j.vaccine.2010.08.081; Suhail M, 2014, WORLD J GASTROENTERO, V20, P12462, DOI 10.3748/wjg.v20.i35.12462; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; Tilg H, 2010, DIGEST DIS, V28, P179, DOI 10.1159/000282083; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Waris G, 2002, J VIROL, V76, P2721, DOI 10.1128/JVI.76.6.2721-2729.2002; Xiang WQ, 2011, J HEPATOL, V54, P26, DOI 10.1016/j.jhep.2010.08.006; Xiao WH, 2004, PROSTATE, V61, P354, DOI 10.1002/pros.20113; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	39	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159089	10.1371/journal.pone.0159089	http://dx.doi.org/10.1371/journal.pone.0159089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434097	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600032
J	Minard, LV; Corkum, A; Sketris, I; Fisher, J; Zhang, Y; Saleh, A				Minard, Laura V.; Corkum, Amber; Sketris, Ingrid; Fisher, Judith; Zhang, Ying; Saleh, Ahmed			Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PRIMARY PREVENTION; JUPITER TRIAL; CARDIOVASCULAR-DISEASE; RISK-ASSESSMENT; ROSUVASTATIN; CHOLESTEROL; THERAPY; PEOPLE; HEALTH	Purpose To examine HMG-CoA reductase inhibitor (statin) drug dispensing patterns to Nova Scotia Seniors' Pharmacare program (NSSPP) beneficiaries over a 14-year period in response to: 1) rosuvastatin market entry in 2003, 2) JUPITER trial publication in 2008, and 3) generic atorvastatin availability in 2010. Methods All NSSPP beneficiaries who redeemed at least one prescription for a statin from April 1, 1999 to March 31, 2013 were included. Aggregated, anonymous monthly prescription counts were extracted by the Nova Scotia Department of Health and Wellness (Nova Scotia, Canada) and changes in dispensing patterns of statins were measured. Data were analyzed using descriptive analyses and interrupted time series methods. Results The percentage of NSSPP beneficiaries dispensed any statin increased from 5.3% in April 1999 to 20.7% in March 2013. In 1999, most NSSPP beneficiaries were dispensed either simvastatin (29.5%) or atorvastatin (28.7%). When rosuvastatin was added to the NSSPP Formulary in August 2003, prescriptions dispensed for simvastatin, lovastatin, pravastatin, and fluvastatin declined significantly (slope change, -0.0027; 95% confidence interval (CI), (-0.0046, -0.0009)). This significant decline continued following the publication of JUPITER (level change, -0.1974; 95% CI, (-0.2991, -0.0957)) and the availability of generic atorvastatin (level change, -0.2436; 95% CI, (-0.3314, -0.1558)). Atorvastatin was not significantly affected by any of the three interventions, although it maintained an overall decreasing trend. Only upon the availability of generic atorvastatin did the upward trend in rosuvastatin use decrease significantly (slope change, -0.0010, 95% CI, (-0.0015, -0.0005)). Conclusions The type and rate of statins dispensed to NSSPP beneficiaries changed from 1999 to 2013 in response to the availability of new agents and publication of the JUPITER trial. The overall proportion of NSSPP beneficiaries dispensed a statin increased approximately 4-fold during the study period. In 2013, rosuvastatin was the most commonly dispensed statin (44.1%) followed by atorvastatin (39.1%).	[Minard, Laura V.; Sketris, Ingrid] Dalhousie Univ, Coll Pharm, Halifax, NS, Canada; [Corkum, Amber; Zhang, Ying] Acadia Univ, Stat Consulting Unit, Wolfville, NS, Canada; [Fisher, Judith] Nova Scotia Dept Hlth & Wellness, Halifax, NS, Canada; [Saleh, Ahmed] Dalhousie Univ, Fac Med, Halifax, NS, Canada	Dalhousie University; Acadia University; Dalhousie University	Minard, LV (corresponding author), Dalhousie Univ, Coll Pharm, Halifax, NS, Canada.	lminard@dal.ca		Sketris, Ingrid/0000-0003-1820-5883; Minard, Laura/0000-0002-1545-3470	Canadian Institutes of Health Research; Drug Evaluation Alliance of Nova Scotia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Drug Evaluation Alliance of Nova Scotia	Funding for this research was provided by a grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to IS and though an unconditional grant from the Drug Evaluation Alliance of Nova Scotia (http://novascotia.ca/dhw/pharmacare/drug-evaluation-alliance-of-novascotia.asp) to LVM. The decision to publish and the content to be published was the decision of the research team. The data used in this report were made available by the Nova Scotia Department of Health and Wellness. Although this research is based on data obtained from the Nova Scotia Department of Health and Wellness, the observations and opinions expressed do not represent those of the Department of Health and Wellness.	Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; [Anonymous], NIH PUBLICATION; [Anonymous], 2013, LIP LOW PRIM PREV CA; [Anonymous], 2005, STAT CARD DIS; Barrett B, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0436-9; Brown JD, 2016, RES SOCIAL ADM PHARM; Canadian Institute of Health Information, 2014, DRUG US SEN PUBL DRU; Canadian Institute of Health Information, DRIV PRESCR DRUG SPE; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Carrera M., 2016, AM EC J IN PRESS; Charlesworth CJ, 2015, J GERONTOL A-BIOL, V70, P989, DOI 10.1093/gerona/glv013; de Lorgeril M, 2010, ARCH INTERN MED, V170, P1032, DOI 10.1001/archinternmed.2010.184; Dunne SS, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0415-3; Fraeyman J, 2013, EXPERT REV PHARM OUT, V13, P141, DOI [10.1586/ERP.12.88, 10.1586/erp.12.88]; Galper BZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138092; Gupta M, 2012, CAN J CARDIOL, V28, P14, DOI 10.1016/j.cjca.2011.09.014; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Jackevicius CA, 2001, ARCH INTERN MED, V161, P183, DOI 10.1001/archinte.161.2.183; Jackson G, 2009, INT J CLIN PRACT, V63, P347, DOI 10.1111/j.1742-1241.2009.02013.x; Kappagoda CT, 2009, AM J CARDIOL, V104, P1603, DOI 10.1016/j.amjcard.2009.07.033; Kildemoes HW, 2012, HEALTH POLICY, V108, P216, DOI 10.1016/j.healthpol.2012.08.008; Kones R, 2010, DRUG DES DEV THER, V4, P383, DOI 10.2147/DDDT.S10812; Kwon HY, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1356-z; Launer J, 2015, POSTGRAD MED J, V91, P663, DOI 10.1136/postgradmedj-2015-133766; Lindgren P, 2012, EUR J HEALTH ECON, V13, P445, DOI 10.1007/s10198-011-0315-1; Mamdani MM, 2001, CAN MED ASSOC J, V164, P1695; Manzoli L, 2015, EUR J EPIDEMIOL; Meissner B, 2006, J MANAG CARE PHARM, V12, P331, DOI 10.18553/jmcp.2006.12.4.331; Mintzes B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005699; Murphy AL, 2006, BMC NURS, V5, DOI 10.1186/1472-6955-5-5; Nanchen D, 2011, PREV MED, V52, P159, DOI 10.1016/j.ypmed.2010.11.018; Niederdeppe J, 2013, J GEN INTERN MED, V28, P886, DOI 10.1007/s11606-013-2379-3; Nissen Steven E, 2009, Curr Cardiol Rep, V11, P81; Patel MS, 2014, ANN INTERN MED, V161, pS44, DOI 10.7326/M13-3001; Pichetti S, 2013, APPL HEALTH ECON HEA, V11, P205, DOI 10.1007/s40258-013-0014-4; Polinski JM, 2008, J POPUL THER CLIN PH, V15, pE286; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, AM J CARDIOL, V100, P1659, DOI 10.1016/j.amjcard.2007.09.072; Ridker PM, 2010, AM J CARDIOL, V106, P1351, DOI 10.1016/j.amjcard.2010.08.025; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Rikala M, 2013, BASIC CLIN PHARMACOL, V113, P173, DOI 10.1111/bcpt.12075; Schneemann M, 2009, INT J CLIN PRACT, V63, P1118, DOI 10.1111/j.1742-1241.2009.02069.x; Shishehbor MH, 2009, CLEV CLIN J MED, V76, P37, DOI 10.3949/ccjm.75a.08105; Shrank WH, 2010, HEALTH AFFAIR, V29, P1383, DOI 10.1377/hlthaff.2009.0424; Sketris IS, 2009, J POPUL THER CLIN PH, V16, pE103; Slejko JF, 2010, CURR MED RES OPIN, V26, P2485, DOI 10.1185/03007995.2010.516994; Spatz ES, 2009, CIRC-CARDIOVASC QUAL, V2, P41, DOI 10.1161/CIRCOUTCOMES.108.832592; Statistics Canada, FOC GEOGR SER 2011 C; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Sullivan HW, 2015, J HEALTH COMMUN, V20, P1391, DOI 10.1080/10810730.2015.1018635; Teng JFT, 2014, PHARMACOTHERAPY, V34, P9, DOI 10.1002/phar.1340; Tziomalos K, 2009, CURR MED RES OPIN, V25, P133, DOI [10.1185/03007990802643557, 10.1185/03007990802643557 ]; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Walley T, 2005, BRIT J CLIN PHARMACO, V60, P543, DOI 10.1111/j.1365-2125.2005.02478.x; Wieringa S, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0229-x; Winkelmayer WC, 2010, WIEN KLIN WOCHENSCHR, V122, P89, DOI 10.1007/s00508-009-1292-6; Yang EY, 2009, J AM COLL CARDIOL, V54, P2388, DOI 10.1016/j.jacc.2009.10.006; Yusuf S, 2009, LANCET, V373, P1152, DOI 10.1016/S0140-6736(09)60357-3; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	59	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158608	10.1371/journal.pone.0158608	http://dx.doi.org/10.1371/journal.pone.0158608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434392	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600012
J	Mukhin, A; Palinauskas, V; Platonova, E; Kobylkov, D; Vakoliuk, I; Valkiunas, G				Mukhin, Andrey; Palinauskas, Vaidas; Platonova, Elena; Kobylkov, Dmitry; Vakoliuk, Irina; Valkiunas, Gediminas			The Strategy to Survive Primary Malaria Infection: An Experimental Study on Behavioural Changes in Parasitized Birds	PLOS ONE			English	Article							AVIAN BLOOD PARASITES; PLASMODIUM; WILD; HAEMOPROTEUS; HOSTS; LEUCOCYTOZOON	Avian malaria parasites (Haemosporida, Plasmodium) are of cosmopolitan distribution, and they have a significant impact on vertebrate host fitness. Experimental studies show that high parasitemia often develops during primary malaria infections. However, field studies only occasionally reveal high parasitemia in free-living birds sampled using the traditional methods of mist-netting or trapping, and light chronic infections predominate. The reason for this discrepancy between field observation and experimental data remains insufficiently understood. Since mist-netting is a passive capture method, two main parameters determine its success in sampling infected birds in wildlife, i. e. the presence of parasitized birds at a study site and their mobility. In other words, the trapping probability depends on the survival rate of birds and their locomotor activity during infection. Here we test (1) the mortality rate of wild birds infected with Plasmodium relictum (the lineage pSGS1), (2) the changes in their behaviour during presence of an aerial predator, and (3) the changes in their locomotor activity at the stage of high primary parasitemia. We show that some behavioural features which might affect a bird's survival during a predator attack (time of reaction, speed of flush flight and take off angle) did not change significantly during primary infection. However, the locomotor activity of infected birds was almost halved compared to control (non-infected) birds during the peak of parasitemia. We report (1) the markedly reduced mobility and (2) the 20% mortality rate caused by P. relictum and conclude that these factors are responsible for the underrepresentation of birds in mist nets and traps during the stage of high primary parasitemia in wildlife. This study indicates that the widespread parasite, P. relictum (pSGS1) influences the behaviour of birds during primary parasitemia. Experimental studies combined with field observations are needed to better understand the mechanisms of pathogenicity of avian malaria parasites and their influence on bird populations.	[Mukhin, Andrey; Platonova, Elena] RAS, Inst Zool, Biol Stn Rybachy, Rybachy 238535, Russia; [Palinauskas, Vaidas; Valkiunas, Gediminas] Nat Res Ctr, Akad 2, LT-08412 Vilnius, Lithuania; [Platonova, Elena] St Petersburg State Univ, St Petersburg 199034, Russia; [Kobylkov, Dmitry] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany; [Vakoliuk, Irina] Immanuel Kant Baltic Fed Univ, Kaliningrad 236041, Russia	Russian Academy of Sciences; Nature Research Center - Lithuania; Saint Petersburg State University; Carl von Ossietzky Universitat Oldenburg; Immanuel Kant Baltic Federal University	Mukhin, A (corresponding author), RAS, Inst Zool, Biol Stn Rybachy, Rybachy 238535, Russia.	a.l.mukhin@gmail.com	Mukhin, Andrey/P-6391-2015; Platonova, Elena/R-6750-2017; Palinauskas, Vaidas/J-1576-2016; Vakolyuk, Irina/E-1942-2014; Kobylkov, Dmitry/G-3162-2014	Platonova, Elena/0000-0002-9425-8998; Palinauskas, Vaidas/0000-0002-4714-0305; Vakoliuk, Irina/0000-0001-5480-1645; Mukhin, Andrey/0000-0003-1238-4163; Kobylkov, Dmitry/0000-0003-0380-5907	Russian Foundation for Basic Research [15-04-00417]; Zoological Institute RAS [01201351182]; European Social Fund under the Global Grant measure [VPI-3.1.- SMM-07-K-01-047]; Lithuanian Academy of Sciences [2014/06/17-30]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Zoological Institute RAS; European Social Fund under the Global Grant measure; Lithuanian Academy of Sciences(Research Council of Lithuania (LMTLT))	Financial support for this study was made available by the Russian Foundation for Basic Research (grant# 15-04-00417 to A.M. and E.P.) and by the Zoological Institute RAS (registered research project No 01201351182 to A.M.), by the European Social Fund under the Global Grant measure (grant # VPI-3.1.- SMM-07-K-01-047 to G.V.) and by the Lithuanian Academy of Sciences (grant # 2014/06/17-30 to V.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLANDER K, 1994, J AVIAN BIOL, V25, P69, DOI 10.2307/3677296; [Anonymous], 1998, MALARIA PARASITE BIO; Asghar M, 2011, J AVIAN BIOL, V42, P530, DOI 10.1111/j.1600-048X.2011.05281.x; Atkinson CT, 2008, PARASITIC DIS WILD B, P557, DOI [10.1002/9780813804620.fmatter, DOI 10.1002/9780813804620.FMATTER]; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; BENNETT GF, 1993, J NAT HIST, V27, P993, DOI 10.1080/00222939300770621; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Cellier-Holzem E, 2010, INT J PARASITOL, V40, P1447, DOI 10.1016/j.ijpara.2010.04.014; Cornet S, 2013, ECOL LETT, V16, P323, DOI 10.1111/ele.12041; Dinhopl N, 2015, PARASITOL RES, V114, P1455, DOI 10.1007/s00436-015-4328-z; Evans M, 1998, VET REC, V143, P72, DOI 10.1136/vr.143.3.72; Ferrell ST, 2007, J ZOO WILDLIFE MED, V38, P309, DOI 10.1638/1042-7260(2007)038[0309:FHIIMA]2.0.CO;2; Frevert U, 2008, INT J PARASITOL, V38, P655, DOI 10.1016/j.ijpara.2007.09.012; Garcia-Longoria L, 2015, PARASITOL RES, V114, P4493, DOI 10.1007/s00436-015-4693-7; Garnham PCC., 1966, MALARIA PARASITES OT; GODFREY RD, 1987, J WILDLIFE DIS, V23, P558, DOI 10.7589/0090-3558-23.4.558; Grim KC, 2003, J ZOO WILDLIFE MED, V34, P250, DOI 10.1638/02-070; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Holmstad PR, 2006, INT J PARASITOL, V36, P735, DOI 10.1016/j.ijpara.2006.02.015; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; Larcombe S, 2013, EXP PARASITOL, V135, P708, DOI 10.1016/j.exppara.2013.10.012; Lind J, 1999, BEHAV ECOL SOCIOBIOL, V46, P65, DOI 10.1007/s002650050593; Loiseau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044729; Lupianez JA, 1996, COMP BIOCHEM PHYS B, V113, P439, DOI 10.1016/0305-0491(95)02030-6; Marinov MP, 2017, ETHOL ECOL EVOL, V29, P126, DOI 10.1080/03949370.2015.1102776; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; McConkey GA, 1996, J EUKARYOT MICROBIOL, V43, P393, DOI 10.1111/j.1550-7408.1996.tb05049.x; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; Moore J., 2002, PARASITES BEHAV ANIM; Mouritsen KN, 2005, OIKOS, V108, P344, DOI 10.1111/j.0030-1299.2005.13507.x; Olias P, 2011, EMERG INFECT DIS, V17, P950, DOI 10.3201/eid1705.101618; Palinauskas V, 2008, EXP PARASITOL, V120, P372, DOI 10.1016/j.exppara.2008.09.001; Palinauskas Vaidas, 2005, Ekologija, V4, P8; Palinauskas V, 2015, INT J PARASITOL, V45, P51, DOI 10.1016/j.ijpara.2014.08.012; Palinauskas V, 2011, EXP PARASITOL, V127, P527, DOI 10.1016/j.exppara.2010.10.007; Payevsky V., 2000, BIRD STATION MANUAL, P20; Poulin R, 2007, PARASITOLOGY, V134, P763, DOI 10.1017/S0031182006002150; Poulin R, 1999, PARASITOL TODAY, V15, P28, DOI 10.1016/S0169-4758(98)01357-X; R Core Team, 2021, R LANGUAGE ENV STAT; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHALL JJ, 1982, SCIENCE, V217, P1057, DOI 10.1126/science.7112113; Shurulinkov P, 2009, PARASITOL RES, V104, P1453, DOI 10.1007/s00436-009-1349-5; Vanstreels RET, 2016, J WILDLIFE DIS, V52, P734, DOI 10.7589/2015-08-219; THOMPSON JN, 1987, BIOL J LINN SOC, V32, P385, DOI 10.1111/j.1095-8312.1987.tb00439.x; Valki<umacron>nas G, 2005, AVIAN MALARIA PARASI; Valkiunas Gediminas, 1998, Bulletin of the Scandinavian Society for Parasitology, V8, P39; Vanstreels RET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103670; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Yorinks N, 2000, AUK, V117, P731, DOI 10.1642/0004-8038(2000)117[0731:EOMOAB]2.0.CO;2; Zehtindjiev P, 2008, EXP PARASITOL, V119, P99, DOI 10.1016/j.exppara.2007.12.018	53	37	38	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159216	10.1371/journal.pone.0159216	http://dx.doi.org/10.1371/journal.pone.0159216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434058	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600041
J	Schenke, KC; Wyer, NA; Bach, P				Schenke, Kimberley C.; Wyer, Natalie A.; Bach, Patric			The Things You Do: Internal Models of Others' Expected Behaviour Guide Action Observation	PLOS ONE			English	Article							REACTION-TIME-TASK; PERSON MEMORY; SOCIAL COGNITION; IMPRESSION-FORMATION; FUNCTIONAL RELATIONS; RETRIEVAL-PROCESSES; SPONTANEOUS TRAIT; MOTOR ACTIVATION; PRIOR KNOWLEDGE; PERCEPTION	Predictions allow humans to manage uncertainties within social interactions. Here, we investigate how explicit and implicit person models-how different people behave in different situations-shape these predictions. In a novel action identification task, participants judged whether actors interacted with or withdrew from objects. In two experiments, we manipulated, unbeknownst to participants, the two actors action likelihoods across situations, such that one actor typically interacted with one object and withdrew from the other, while the other actor showed the opposite behaviour. In Experiment 2, participants additionally received explicit information about the two individuals that either matched or mismatched their actual behaviours. The data revealed direct but dissociable effects of both kinds of person information on action identification. Implicit action likelihoods affected response times, speeding up the identification of typical relative to atypical actions, irrespective of the explicit knowledge about the individual's behaviour. Explicit person knowledge, in contrast, affected error rates, causing participants to respond according to expectations instead of observed behaviour, even when they were aware that the explicit information might not be valid. Together, the data show that internal models of others' behaviour are routinely re-activated during action observation. They provide first evidence of a person-specific social anticipation system, which predicts forthcoming actions from both explicit information and an individuals' prior behaviour in a situation. These data link action observation to recent models of predictive coding in the non-social domain where similar dissociations between implicit effects on stimulus identification and explicit behavioural wagers have been reported.	[Schenke, Kimberley C.; Wyer, Natalie A.; Bach, Patric] Univ Plymouth, Sch Psychol, Plymouth, Devon, England	University of Plymouth	Schenke, KC (corresponding author), Univ Plymouth, Sch Psychol, Plymouth, Devon, England.	kimberley.schenke@plymouth.ac.uk	Bach, Patric/AAP-6513-2020	Schenke, Kimberley/0000-0002-1184-4802; Bach, Patric/0000-0003-4493-2080	Economic and Social Research Council grant [ES/J019178/1]; ESRC [ES/J019178/1] Funding Source: UKRI; Economic and Social Research Council [ES/J019178/1] Funding Source: researchfish	Economic and Social Research Council grant(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by an Economic and Social Research Council grant (http://www.esrc.ac.uk/; ES/J019178/1) to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2006, MOTIV EMOTION, V30, P179, DOI 10.1007/s11031-006-9020-2; Agnew ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032517; Bach P, 2005, J EXP PSYCHOL HUMAN, V31, P465, DOI 10.1037/0096-1523.31.3.465; Bach P, 2006, Q J EXP PSYCHOL, V59, P2033, DOI 10.1080/17470210600917801; Bach P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00254; Bach P, 2011, PSYCHON B REV, V18, P171, DOI 10.3758/s13423-010-0029-x; Bach P, 2010, CEREB CORTEX, V20, P2798, DOI 10.1093/cercor/bhq026; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Barresi J, 1996, BEHAV BRAIN SCI, V19, P107, DOI 10.1017/S0140525X00041790; Barsalou LW, 2009, PHILOS T R SOC B, V364, P1281, DOI 10.1098/rstb.2008.0319; Batterink LJ, 2015, J MEM LANG, V83, P62, DOI 10.1016/j.jml.2015.04.004; Bayliss AP, 2009, EUR J COGN PSYCHOL, V21, P1072, DOI 10.1080/09541440802553490; Beersma B, 2012, J APPL SOC PSYCHOL, V42, P2640, DOI 10.1111/j.1559-1816.2012.00956.x; BELMORE SM, 1987, J EXP PSYCHOL LEARN, V13, P480, DOI 10.1037/0278-7393.13.3.480; Brockmole JR, 2006, Q J EXP PSYCHOL, V59, P1177, DOI 10.1080/17470210600665996; Buchsbaum D, 2012, ADV CHILD DEV BEHAV, V43, P125, DOI 10.1016/B978-0-12-397919-3.00005-8; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; COHEN CE, 1981, J PERS SOC PSYCHOL, V40, P441; Coventry KR, 2013, PSYCHOL SCI, V24, P1379, DOI 10.1177/0956797612469209; Csibra G., 2007, ATTENTION AND PERFOR, VXXII; Dale R., 2009, P 31 ANN M COGN SCI, P893; Dale R, 2012, ADV COGN PSYCHOL, V8, P196, DOI [10.2478/v10053-008-0115-z, 10.5709/acp-0115-z]; Destrebecqz A., 2003, ADV CONSCIOUSNESS RE, V48, P181, DOI [10.1075/aicr.48.11des, DOI 10.1075/AICR.48.11DES]; Dickter C, 2012, SOC NEUROSCI-UK, V7, P240, DOI 10.1080/17470919.2011.609906; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FREYD JJ, 1983, MEM COGNITION, V11, P342, DOI 10.3758/BF03202447; Friedman O, 2005, DEVELOPMENTAL SCI, V8, P218, DOI 10.1111/j.1467-7687.2005.00410.x; Frischen A, 2006, VIS COGN, V14, P351, DOI 10.1080/13506280544000192; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; Goodman ND, 2009, P 31 ANN C COGN SCI, P2759; Halberstadt J, 2009, PSYCHOL SCI, V20, P1254, DOI 10.1111/j.1467-9280.2009.02432.x; Ham J, 2003, J EXP SOC PSYCHOL, V39, P434, DOI 10.1016/S0022-1031(03)00033-7; Hamilton DL, 1996, PSYCHOL REV, V103, P336, DOI 10.1037/0033-295X.103.2.336; Hassabis D, 2014, CEREB CORTEX, V24, P1979, DOI 10.1093/cercor/bht042; HASTIE R, 1986, PSYCHOL REV, V93, P258, DOI 10.1037/0033-295X.93.3.258; HASTIE R, 1984, J PERS SOC PSYCHOL, V46, P44, DOI 10.1037/0022-3514.46.1.44; Heider JD, 2007, J EXP SOC PSYCHOL, V43, P265, DOI 10.1016/j.jesp.2006.01.004; HUBBARD TL, 1995, PSYCHON B REV, V2, P322, DOI 10.3758/BF03210971; Hudson M, 2016, J EXP PSYCHOL GEN, V145, P1, DOI 10.1037/xge0000126; Hudson M, 2016, COGNITION, V146, P245, DOI 10.1016/j.cognition.2015.09.021; Hunnius S, 2010, DEV PSYCHOL, V46, P446, DOI 10.1037/a0016543; Iacoboni M, 2009, CURR OPIN NEUROBIOL, V19, P661, DOI 10.1016/j.conb.2009.09.008; Jamieson RK, 2009, Q J EXP PSYCHOL, V62, P1757, DOI 10.1080/17470210802557637; Johnston L, 2010, BRIT J SOC PSYCHOL, V49, P107, DOI 10.1348/014466609X412476; Joyce K, 2016, COGN NEUROSCI-UK, V7, P74, DOI 10.1080/17588928.2015.1053443; Kaiser D, 2014, P NATL ACAD SCI USA, V111, P11217, DOI 10.1073/pnas.1400559111; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Koster-Hale J, 2013, NEURON, V79, P836, DOI 10.1016/j.neuron.2013.08.020; Leslie AM, 2005, COGNITIVE PSYCHOL, V50, P45, DOI 10.1016/j.cogpsych.2004.06.002; Lindsay D.S., 2013, SAGE HDB APPL MEMORY, P292; LUPFER MB, 1990, J PERS SOC PSYCHOL, V58, P239, DOI 10.1037/0022-3514.58.2.239; Marcus DJ, 2006, MEM COGNITION, V34, P420, DOI 10.3758/BF03193419; Meltzoff A. N., 2013, UNDERSTANDING OTHER, P19; MISCHEL W, 1995, PSYCHOL REV, V102, P246, DOI 10.1037/0033-295X.102.2.246; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; PARK B, 1986, J PERS SOC PSYCHOL, V51, P907, DOI 10.1037/0022-3514.51.5.907; PARK B, 1994, J PERS SOC PSYCHOL, V66, P437, DOI 10.1037/0022-3514.66.3.437; Pellicano E, 2012, TRENDS COGN SCI, V16, P574, DOI 10.1016/j.tics.2012.10.004; Pierno AC, 2006, J COGNITIVE NEUROSCI, V18, P2130, DOI 10.1162/jocn.2006.18.12.2130; Press C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051934; Queller S, 2002, J PERS SOC PSYCHOL, V82, P300, DOI 10.1037//0022-3514.82.3.300; Quinn KA, 2011, BRIT J PSYCHOL, V102, P849, DOI 10.1111/j.2044-8295.2011.02030.x; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Remillard G, 2003, J EXP PSYCHOL LEARN, V29, P581, DOI 10.1037/0278-7393.29.4.581; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Ruffman T, 2012, BRIT J DEV PSYCHOL, V30, P87, DOI 10.1111/j.2044-835X.2011.02045.x; Schuck NW, 2012, ADV COGN PSYCHOL, V8, P83, DOI [10.2478/v10053-008-0106-0, 10.5709/acp-0106-0]; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Shanks DR, 2002, PSYCHON B REV, V9, P362, DOI 10.3758/BF03196294; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; SHERMAN JW, 1994, J EXP SOC PSYCHOL, V30, P203, DOI 10.1006/jesp.1994.1010; Silvera DH, 2001, SCAND J PSYCHOL, V42, P313, DOI 10.1111/1467-9450.00242; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; SRULL TK, 1985, J EXP PSYCHOL LEARN, V11, P316, DOI 10.1037/0278-7393.11.2.316; SRULL TK, 1989, PSYCHOL REV, V96, P58, DOI 10.1037/0033-295X.96.1.58; SRULL TK, 1983, J PERS SOC PSYCHOL, V44, P1157, DOI 10.1037/0022-3514.44.6.1157; STANGOR C, 1992, PSYCHOL BULL, V111, P42, DOI 10.1037/0033-2909.111.1.42; Stapel JC, 2012, PSYCHOL RES-PSYCH FO, V76, P434, DOI 10.1007/s00426-012-0423-2; Stapel JC, 2010, SOC NEUROSCI-UK, V5, P451, DOI 10.1080/17470919.2010.490667; Stefanics G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00666; STERN LD, 1984, J PERS SOC PSYCHOL, V47, P253, DOI 10.1037/0022-3514.47.2.253; STINSON L, 1992, J PERS SOC PSYCHOL, V62, P787, DOI 10.1037/0022-3514.62.5.787; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Tipper SP, 2011, J COGN PSYCHOL, V23, P45, DOI 10.1080/20445911.2011.451888; Todd AR, 2011, J EXP SOC PSYCHOL, V47, P37, DOI 10.1016/j.jesp.2010.08.006; Todorov A, 2007, NEUROPSYCHOLOGIA, V45, P163, DOI 10.1016/j.neuropsychologia.2006.04.018; Tormala ZL, 2001, PERS SOC PSYCHOL B, V27, P1599, DOI 10.1177/01461672012712004; van Elk M, 2009, J EXP PSYCHOL HUMAN, V35, P1118, DOI 10.1037/a0015024; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; Wright MJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00851; Yomogida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096534; Zaki J, 2013, PERSPECT PSYCHOL SCI, V8, P296, DOI 10.1177/1745691613475454	96	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158910	10.1371/journal.pone.0158910	http://dx.doi.org/10.1371/journal.pone.0158910			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434265	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000380169600023
J	Svennerholm, K; Rodsand, P; Hellman, U; Waldenstrom, A; Lundholm, M; Ahren, D; Biber, B; Ronquist, G; Haney, M				Svennerholm, Kristina; Rodsand, Pouria; Hellman, Urban; Waldenstrom, Anders; Lundholm, Marie; Ahren, Dag; Biber, Bjorn; Ronquist, Gunnar; Haney, Michael			DNA Content in Extracellular Vesicles Isolated from Porcine Coronary Venous Blood Directly after Myocardial Ischemic Preconditioning	PLOS ONE			English	Article							MEDIATED TRANSFER; GENOMIC DNA; EXOSOMES; PROSTASOMES; MECHANISM; CELLS; HEART; LEADS	Background Extracellular vesicles (EV) are nano-sized membranous structures released from most cells. They have the capacity to carry bioactive molecules and gene expression signals between cells, thus mediating intercellular communication. It is believed that EV confer protection after ischemic preconditioning (IPC). We hypothesize that myocardial ischemic preconditioning will lead to rapid alteration of EV DNA content in EV collected from coronary venous effluent. Materials and Methods In a porcine myocardial ischemic preconditioning model, EV were isolated from coronary venous blood before and after IPC by differential centrifugation steps culminating in preparative ultracentrifugation combined with density gradient ultracentrifugation. The EV preparation was validated, the DNA was extracted and further characterized by DNA sequencing followed by bioinformatics analysis. Results Porcine genomic DNA fragments representing each chromosome, including mitochondrial DNA sequences, were detected in EV isolated before and after IPC. There was no difference detected in the number of sequenced gene fragments (reads) or in the genomic coverage of the sequenced DNA fragments in EV isolated before and after IPC. Gene ontology analysis showed an enrichment of genes coding for ion channels, enzymes and proteins for basal metabolism and vesicle biogenesis and specific cardiac proteins. Conclusions This study demonstrates that porcine EV isolated from coronary venous blood plasma contain fragments of DNA from the entire genome, including the mitochondria. In this model we did not find specific qualitative or quantitative changes of the DNA content in EV collected immediately after an in vivo myocardial IPC provocation. This does not rule out the possibility that EV DNA content changes in response to myocardial IPC which could occur in a later time frame.	[Svennerholm, Kristina; Biber, Bjorn] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Anesthesiol & Intens Care Med, Gothenburg, Sweden; [Rodsand, Pouria; Haney, Michael] Umea Univ, Inst Surg & Perioperat Sci, Anesthesiol & Intens Care Med, Umea, Sweden; [Hellman, Urban; Waldenstrom, Anders] Umea Univ, Cardiol, Inst Heart Ctr, Umea, Sweden; [Hellman, Urban; Waldenstrom, Anders] Umea Univ, Dept Publ Hlth & Clin Med, Med, Umea, Sweden; [Lundholm, Marie] Umea Univ, Inst Med Biosci, Pathol, Umea, Sweden; [Ahren, Dag] Lund Univ, Inst Biol, Natl Bioinformat Infrastruct Sweden, Lund, Sweden; [Ronquist, Gunnar] Uppsala Univ, Inst Med Sci, Clin Chem, Uppsala, Sweden	University of Gothenburg; Umea University; Umea University; Umea University; Umea University; Lund University; Uppsala University	Svennerholm, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Anesthesiol & Intens Care Med, Gothenburg, Sweden.	Kristina.svennerholm@vgregion.se	Hellman, Urban/L-7820-2019	Hellman, Urban/0000-0002-3822-0725; Waldenstrom, Anders/0000-0002-5304-0802	Goteborgs Lakarsallskap [GLS-326401]; Kungliga Hvitfeldska Stiftelsen; Elsa och Gustav Lindhs fond; University of Gothenburg, Sahlgrenska academy, ALF-LUA; Umea University; Swedish Heart-Lung Foundation [2013-0690]	Goteborgs Lakarsallskap; Kungliga Hvitfeldska Stiftelsen; Elsa och Gustav Lindhs fond; University of Gothenburg, Sahlgrenska academy, ALF-LUA; Umea University; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This work was funded by Goteborgs Lakarsallskap GLS-326401 (www.gls.se) (KS); Kungliga Hvitfeldska Stiftelsen (www.hvitfeldtskastiftelsen.se), no grant number (KS); Elsa och Gustav Lindhs fond, no grant number or URL (KS); University of Gothenburg, Sahlgrenska academy, ALF-LUA no grant number (www.fou.nu/is/alfgbg) (BB); Umea University, no grant number (www.vll.se) (MH); and Swedish Heart-Lung Foundation 2013-0690 (MH).	Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Barile L, 2014, CARDIOVASC RES, V103, P530, DOI 10.1093/cvr/cvu167; Cai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105200; Cai J, 2013, J MOL CELL BIOL, V5, P227, DOI 10.1093/jmcb/mjt011; Cheng JL, 2012, P NATL ACAD SCI USA, V109, P10827, DOI 10.1073/pnas.1208716109; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Feng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088685; Genneback N, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20167; Giricz Z, 2014, J MOL CELL CARDIOL, V68, P75, DOI 10.1016/j.yjmcc.2014.01.004; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Kavianipour M, 2003, ACTA PHYSIOL SCAND, V178, P129, DOI 10.1046/j.1365-201X.2003.01108.x; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lampa S, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-9; Lee TH, 2014, BIOCHEM BIOPH RES CO, V451, P295, DOI 10.1016/j.bbrc.2014.07.109; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; OLSSON I, 1990, ARCH ANDROLOGY, V24, P1; Ronquist GK, 2012, PROSTATE, V72, P1736, DOI 10.1002/pros.22526; Ronquist GK, 2011, MOL REPROD DEV, V78, P467, DOI 10.1002/mrd.21327; Ronquist KG, 2009, PROSTATE, V69, P737, DOI 10.1002/pros.20921; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Svennerholm K, 2015, IJC HEART VASC, V8, P62, DOI 10.1016/j.ijcha.2015.05.006; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Yamaguchi T, 2015, INT J CARDIOL, V178, P239, DOI 10.1016/j.ijcard.2014.10.144	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159105	10.1371/journal.pone.0159105	http://dx.doi.org/10.1371/journal.pone.0159105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434143	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169600033
J	Yoshida, T; Sakamoto, A; Terui, Y; Takao, K; Sugita, Y; Yamamoto, K; Ishihama, A; Igarashi, K; Kashiwagi, K				Yoshida, Taketo; Sakamoto, Akihiko; Terui, Yusuke; Takao, Koichi; Sugita, Yoshiaki; Yamamoto, Kaneyoshi; Ishihama, Akira; Igarashi, Kazuei; Kashiwagi, Keiko			Effect of Spermidine Analogues on Cell Growth of Escherichia coli Polyamine Requiring Mutant MA261	PLOS ONE			English	Article							PREFERENTIAL UPTAKE SYSTEM; PROTEIN-SYNTHESIS; TRANSPORT-SYSTEM; RAT-LIVER; BINDING; POTD; RNA; HOMOSPERMIDINE; IDENTIFICATION; STIMULATION	The effects of spermidine analogues [norspermidine (NSPD, 33), spermidine (SPD, 34), homospermidine (HSPD, 44) and aminopropylcadaverine (APCAD, 35)] on cell growth were studied using Escherichia coli polyamine-requiring mutant MA261. Cell growth was compared at 32 degrees C, 37 degrees C, and 42 degrees C. All four analogues were taken up mainly by the PotABCD spermidine-preferential uptake system. The degree of stimulation of cell growth at 32 degrees C and 37 degrees C was NSPD >= SPD >= HSPD > APCAD, and SPD >= HSPD >= NSPD > APCAD, respectively. However, at 42 degrees C, it was HSPD >> SPD > NSPD > APCAD. One reason for this is HSPD was taken up effectively compared with other triamines. In addition, since natural polyamines (triamines and teteraamines) interact mainly with RNA, and the structure of RNA is more flexible at higher temperatures, HSPD probably stabilized RNA more tightly at 42 degrees C. We have thus far found that 20 kinds of protein syntheses are stimulated by polyamines at the translational level. Among them, synthesis of OppA, RpoE and StpA was more strongly stimulated by HSPD at 42 degrees C than at 37 degrees C. Stabilization of the initiation region of oppA and rpoE mRNA was tighter by HSPD at 42 degrees C than 37 degrees C determined by circular dichroism (CD). The degree of polyamine stimulation of OppA, RpoE and StpA synthesis by NSPD, SPD and APCAD was smaller than that by HSPD at 42 degrees C. Thus, the degree of stimulation of cell growth by spermidine analogues at the different temperatures is dependent on the stimulation of protein synthesis by some components of the polyamine modulon.	[Yoshida, Taketo; Sakamoto, Akihiko; Terui, Yusuke; Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, 15-8 Shiomi Cho, Choshi, Chiba 2880025, Japan; [Takao, Koichi; Sugita, Yoshiaki] Josai Univ, Dept Pharmaceut Technol, Bioorgan Chem Lab, 1-1 Keyaki Dai, Sakado, Saitama 3500295, Japan; [Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 1848584, Japan; [Igarashi, Kazuei] Innovat Plaza Chiba Univ, Amine Pharma Res Inst, Chuo Ku, 1-8-15 Inohana, Chiba, Chiba 2600856, Japan; [Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608675, Japan	Josai University; Hosei University; Chiba University	Kashiwagi, K (corresponding author), Chiba Inst Sci, Fac Pharm, 15-8 Shiomi Cho, Choshi, Chiba 2880025, Japan.	kkashiwagi@cis.ac.jp		Igarashi, Kazuei/0000-0003-3751-3187	Ministry of Education, Culture, Sports, Science and Technology, Japan (KAKENHI) [26860044]; Futaba Electronics Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Futaba Electronics Memorial Foundation	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (KAKENHI No. 26860044). T. Yoshida was supported by the Futaba Electronics Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. A. Michael for his help in preparing this manuscript. T. Yoshida was supported by the Futaba Electronics Memorial Foundation.	Antognoni F, 1999, J BIOL CHEM, V274, P1942, DOI 10.1074/jbc.274.4.1942; BEHE M, 1981, P NATL ACAD SCI-BIOL, V78, P1619, DOI 10.1073/pnas.78.3.1619; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791, DOI 10.1128/JB.124.2.791-799.1975; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; HAMANA K, 1992, CRIT REV MICROBIOL, V18, P261, DOI 10.3109/10408419209113518; Higashi K, 2008, J BIOL CHEM, V283, P32989, DOI 10.1074/jbc.M806027200; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; IGARASHI K, 1981, EUR J BIOCHEM, V114, P127; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; IGARASHI K, 1974, EUR J BIOCHEM, V48, P495, DOI 10.1111/j.1432-1033.1974.tb03790.x; Igarashi K, 2015, IUBMB LIFE, V67, P160, DOI 10.1002/iub.1363; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; Jishage M, 1997, J BACTERIOL, V179, P959, DOI 10.1128/jb.179.3.959-963.1997; KASHIWAGI K, 1993, J BIOL CHEM, V268, P19358; Kashiwagi K, 1996, J BIOL CHEM, V271, P12205, DOI 10.1074/jbc.271.21.12205; Lightfoot HL, 2014, NUCLEIC ACIDS RES, V42, P11275, DOI 10.1093/nar/gku837; LINDEROTH N, 1983, BIOCHEM BIOPH RES CO, V117, P616, DOI 10.1016/0006-291X(83)91245-7; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; Nakano S, 2004, J AM CHEM SOC, V126, P1088, DOI 10.1021/ja037314h; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; NIITSU M, 1993, J CHROMATOGR, V641, P115, DOI 10.1016/0021-9673(93)83465-5; NIITSU M, 1986, CHEM PHARM BULL, V34, P1032; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; Oshima T, 2011, METHODS MOL BIOL, V720, P81, DOI 10.1007/978-1-61779-034-8_5; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Sakamoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124883; Sugiyama S, 1996, J BIOL CHEM, V271, P9519, DOI 10.1074/jbc.271.16.9519; Terui Y, 2014, AMINO ACIDS, V46, P661, DOI 10.1007/s00726-013-1517-x; Terui Y, 2009, J BACTERIOL, V191, P5348, DOI 10.1128/JB.00387-09; THOMAS T, 1995, J STEROID BIOCHEM, V54, P89, DOI 10.1016/0960-0760(95)00126-K; WATANABE S, 1991, J BIOL CHEM, V266, P20803; YAMAMOTO S, 1986, CAN J MICROBIOL, V32, P99, DOI 10.1139/m86-021; YAMAMOTO S, 1993, J BIOCHEM-TOKYO, V114, P45, DOI 10.1093/oxfordjournals.jbchem.a124137	37	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159494	10.1371/journal.pone.0159494	http://dx.doi.org/10.1371/journal.pone.0159494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434546	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600058
J	Dahl, LCM; Nasa, Z; Chung, JY; Niego, B; Tarlac, V; Ho, HD; Galle, A; Petratos, S; Lee, JY; Alderuccio, F; Medcalf, RL				Dahl, Lisa C. M.; Nasa, Zeyad; Chung, JieYu; Niego, Be'eri; Tarlac, Volga; Ho, Heidi; Galle, Adam; Petratos, Steven; Lee, Jae Young; Alderuccio, Frank; Medcalf, Robert L.			The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXTRACELLULAR PROTEOLYSIS; MATRIX METALLOPROTEINASES; DEFICIENT MICE; DEMYELINATION; INFLAMMATION; FIBRINOLYSIS; INHIBITORS	Tissue type plasminogen activator (t-PA) has been implicated in the development of multiple sclerosis (MS) and in rodent models of experimental autoimmune encephalomyelitis (EAE). We show that levels of t-PA mRNA and activity are increased similar to 4 fold in the spinal cords of wild-type mice that are mice subjected to EAE. This was also accompanied with a significant increase in the levels of pro-matrix metalloproteinase 9 (pro-MMP-9) and an influx of fibrinogen. We next compared EAE severity in wild-type mice, t-PA(-/-) mice and T4+ transgenic mice that selectively over-express (similar to 14-fold) mouse t-PA in neurons of the central nervous system. Our results confirm that t-PA deficient mice have an earlier onset and more severe form of EAE. T4+ mice, despite expressing higher levels of endogenous t-PA, manifested a similar rate of onset and neurological severity of EAE. Levels of proMMP-9, and extravasated fibrinogen in spinal cord extracts were increased in mice following EAE onset regardless of the absence or over-expression of t-PA wild-type. Interestingly, MMP-2 levels also increased in spinal cord extracts of T4+ mice following EAE, but not in the other genotypes. Hence, while the absence of t-PA confers a more deleterious form of EAE, neuronal over-expression of t-PA does not overtly protect against this condition with regards to symptom onset or severity of EAE.	[Dahl, Lisa C. M.; Niego, Be'eri; Ho, Heidi; Galle, Adam; Medcalf, Robert L.] Monash Univ, Cent Clin Sch, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic 3004, Australia; [Nasa, Zeyad; Chung, JieYu; Alderuccio, Frank] Monash Univ, Dept Immunol, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Tarlac, Volga] Monash Univ, Cent Clin Sch, Van Cleef Roet Ctr Nervous Dis, Melbourne, Vic 3004, Australia; [Petratos, Steven; Lee, Jae Young] Monash Univ, Cent Clin Sch, Dept Med, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University; Monash University	Medcalf, RL (corresponding author), Monash Univ, Cent Clin Sch, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic 3004, Australia.	robert.medcalf@monash.edu	Medcalf, Robert L/E-9632-2011; Niego, Beeri/AAG-5534-2019	Niego, Beeri/0000-0001-6714-9131; Alderuccio, Frank/0000-0003-4853-3394; Tarlac, Volga/0000-0001-5566-075X	National Health and Medical Research Council of Australia [1045756]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by a grant awarded to RLM from the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/); Grant #1045756.	Adams RA, 2004, MOL INTERV, V4, P163; Akassoglou K, 2000, J CELL BIOL, V149, P1157, DOI 10.1083/jcb.149.5.1157; Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101; Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; Akenami FOT, 1999, J NEUROL SCI, V165, P71, DOI 10.1016/S0022-510X(99)00080-5; Akenami FOT, 1996, J CLIN PATHOL, V49, P577, DOI 10.1136/jcp.49.7.577; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; Chan J, 2008, J IMMUNOL, V181, P7571, DOI 10.4049/jimmunol.181.11.7571; Chevilley A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00415; CLAUDIO L, 1995, ACTA NEUROPATHOL, V90, P228; Cops EJ, 2013, EXP NEUROL, V249, P8, DOI 10.1016/j.expneurol.2013.08.001; Cuzner ML, 1996, J NEUROPATH EXP NEUR, V55, P1194, DOI 10.1097/00005072-199612000-00002; Defawe OD, 2005, CARDIOVASC RES, V66, P402, DOI 10.1016/j.cardiores.2004.11.025; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; East E, 2008, NEUROPATH APPL NEURO, V34, P216, DOI 10.1111/j.1365-2990.2007.00889.x; East E, 2005, AM J PATHOL, V167, P545, DOI 10.1016/S0002-9440(10)62996-3; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; GRANELLIPIPERNO A, 1978, J EXP MED, V148, P223, DOI 10.1084/jem.148.1.223; Grierson C, 2010, ANAL BIOCHEM, V404, P232, DOI 10.1016/j.ab.2010.05.020; Gveric D, 2003, BRAIN, V126, P1590, DOI 10.1093/brain/awg167; Gveric D, 2001, BRAIN, V124, P1978, DOI 10.1093/brain/124.10.1978; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Inoue A, 1997, J NEUROIMMUNOL, V77, P185, DOI 10.1016/S0165-5728(97)00072-6; ITOH Y, 1995, BIOCHEM J, V308, P645, DOI 10.1042/bj3080645; Ko HJ, 2011, AUTOIMMUNITY, V44, P177, DOI 10.3109/08916934.2010.515274; Konnecke H, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/914104; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Lu WQ, 2002, J NEUROSCI, V22, P10781; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Moon LDF, 2006, J NEUROSCI RES, V84, P1245, DOI 10.1002/jnr.21019; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Niego B, 2014, J CEREBR BLOOD F MET, V34, P1283, DOI 10.1038/jcbfm.2014.99; Niimi N, 2013, NEUROPATHOLOGY, V33, P612, DOI 10.1111/neup.12039; PATERSON PY, 1987, FED PROC, V46, P91; ROMANIC AM, 1994, BRAIN PATHOL, V4, P145, DOI 10.1111/j.1750-3639.1994.tb00825.x; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Seeds NW, 2003, J NEUROSCI, V23, P7368; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Suzuki Y, 2007, J THROMB HAEMOST, V5, P1732, DOI 10.1111/j.1538-7836.2007.02628.x; Suzuki Y, 2009, BLOOD, V114, P3352, DOI 10.1182/blood-2009-02-203919; Teesalu T, 2002, BIOCHEM SOC T, V30, P183, DOI 10.1042/BST0300183; Teesalu T, 2001, AM J PATHOL, V159, P2227, DOI 10.1016/S0002-9440(10)63073-8; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Wu F, 2012, J NEUROSCI, V32, P9848, DOI 10.1523/JNEUROSCI.1241-12.2012; Yang Y, 2011, CELL MOL NEUROBIOL, V31, P437, DOI 10.1007/s10571-010-9637-2; Yepes M, 2004, EXP BIOL MED, V229, P1097, DOI 10.1177/153537020422901103; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	57	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158653	10.1371/journal.pone.0158653	http://dx.doi.org/10.1371/journal.pone.0158653			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427941	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300016
J	Mitchell, S; Gao, J; Hallett, M; Voon, V				Mitchell, Simon; Gao, Jennifer; Hallett, Mark; Voon, Valerie			The Role of Social Novelty in Risk Seeking and Exploratory Behavior: Implications for Addictions	PLOS ONE			English	Article							SENSATION-SEEKING; DRUG-USE; DOPAMINE; ADOLESCENTS; IMPULSIVITY; STIMULI; ALCOHOL; MEMORY; MODEL	Novelty preference or sensation seeking is associated with disorders of addiction and predicts rodent compulsive drug use and adolescent binge drinking in humans. Novelty has also been shown to influence choice in the context of uncertainty and reward processing. Here we introduce a novel or familiar neutral face stimuli and investigate its influence on risk-taking choices in healthy volunteers. We focus on behavioural outcomes and imaging correlates to the prime that might predict risk seeking. We hypothesized that subjects would be more risk seeking following a novel relative to familiar stimulus. We adapted a risk-taking task involving acceptance or rejection of a 50: 50 choice of gain or loss that was preceded by a familiar (pre-test familiarization) or novel face prime. Neutral expression faces of males and females were used as primes. Twenty-four subjects were first tested behaviourally and then 18 scanned using a different variant of the same task under functional MRI. We show enhanced risk taking to both gain and loss anticipation following novel relative to familiar images and particularly for the low gain condition. Greater risk taking behaviour and selfreported exploratory behaviours was predicted by greater right ventral putaminal activity to novel versus familiar contexts. Social novelty appears to have a contextually enhancing effect on augmenting risky choices possibly mediated via ventral putaminal dopaminergic activity. Our findings link the observation that novelty preference and sensation seeking are important traits predicting the initiation and maintenance of risky behaviours, including substance and behavioural addictions.	[Mitchell, Simon; Voon, Valerie] Univ Cambridge, Dept Psychiat, Cambridge, England; [Mitchell, Simon; Voon, Valerie] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Gao, Jennifer; Hallett, Mark] NINDS, NIH, Human Motor Control Sect, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Gao, Jennifer] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Voon, Valerie] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England	University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Brown University; University of Cambridge	Voon, V (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge, England.; Voon, V (corresponding author), Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England.; Voon, V (corresponding author), Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England.	vv247@cam.ac.uk	Voon, Valerie/O-7038-2017	Voon, Valerie/0000-0001-6790-1776	NIH [Z01 NS002669]; Wellcome Trust [093705/Z/10/Z]; National Institute of Neurological Disorders and Stroke, National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002667, ZIANS002669] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by an internal NIH grant (Z01 NS002669). Valerie Voon was funded by a Wellcome Trust Intermediate Fellowship (093705/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; VV is a Wellcome Trust Intermediate Fellow in Clinical Neurosciences (093705/Z/10/Z). The study was conducted at, and supported by, the National Institute of Neurological Disorders and Stroke, National Institutes of Health.	Bellis MA, 2004, SEX TRANSM INFECT, V80, P43, DOI 10.1136/sti.2003.005199; Bevins RA, 1999, BEHAV BRAIN RES, V99, P53, DOI 10.1016/S0166-4328(98)00069-2; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Churchwell JC, 2012, DEV NEUROSCI-BASEL, V34, P310, DOI 10.1159/000337724; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Crotty J, 2009, CAMB J ECON, V33, P563, DOI 10.1093/cje/bep023; Donohew RL, 1999, J STUD ALCOHOL, V60, P622, DOI 10.15288/jsa.1999.60.622; Flykt A., 1998, KAROLINSKA DIRECTED, P91, DOI [10.1017/S0048577299971664, DOI 10.1017/S0048577299971664, 10.1037/t27732-000]; Grace AA, 2010, NEUROTOX RES, V18, P367, DOI 10.1007/s12640-010-9154-6; Griffiths Mark, 1999, J Gambl Stud, V15, P265, DOI 10.1023/A:1023053630588; Guitart-Masip M, 2010, J NEUROSCI, V30, P1721, DOI 10.1523/JNEUROSCI.5331-09.2010; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Klebaur JE, 2001, EXP CLIN PSYCHOPHARM, V9, P372, DOI 10.1037/1064-1297.9.4.372; Leeman RF, 2014, J ADOLESCENT HEALTH, V54, P460, DOI 10.1016/j.jadohealth.2013.09.014; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lodge DJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1356, DOI 10.1038/sj.npp.1300963; Reed P, 1996, ANIM LEARN BEHAV, V24, P38, DOI 10.3758/BF03198952; Schultz W, 1998, Adv Pharmacol, V42, P686; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Verbruggen F, 2012, PSYCHOL SCI, V23, P805, DOI 10.1177/0956797611434538; Vivancos R, 2010, INT J STD AIDS, V21, P46, DOI 10.1258/ijsa.2009.008501; Wittmann BC, 2008, NEURON, V58, P967, DOI 10.1016/j.neuron.2008.04.027	26	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158947	10.1371/journal.pone.0158947	http://dx.doi.org/10.1371/journal.pone.0158947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27427940	gold, Green Published			2022-12-27	WOS:000380169300026
J	Villegas, G; Calenda, G; Ugaonkar, S; Zhang, SM; Kizima, L; Mizenina, O; Gettie, A; Blanchard, J; Cooney, ML; Robbiani, M; Fernandez-Romero, JA; Zydowsky, TM; Teleshova, N				Villegas, Guillermo; Calenda, Giulia; Ugaonkar, Shweta; Zhang, Shimin; Kizima, Larisa; Mizenina, Olga; Gettie, Agegnehu; Blanchard, James; Cooney, Michael L.; Robbiani, Melissa; Fernandez-Romero, Jose A.; Zydowsky, Thomas M.; Teleshova, Natalia			A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex Vivo	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INFECTION; HIV ACQUISITION; IN-VITRO; PREVENTION; WOMEN; GEL; HPV; PHARMACOKINETICS; PHARMACODYNAMICS; CONTRACEPTIVES	Women need multipurpose prevention products (MPTs) that protect against sexually transmitted infections (STIs) and provide contraception. The Population Council has developed a prototype intravaginal ring (IVR) releasing the non-nucleoside reverse transcriptase inhibitor (NNRTI) MIV-150 (M), zinc acetate (ZA), carrageenan (CG) and levonorgestrel (LNG) (MZCL IVR) to protect against HIV, HSV-2, HPV and unintended pregnancy. Our objective was to evaluate the anti-SHIV-RT activity of MZCL IVR in genital mucosa. First, macaque vaginal tissues were challenged with SHIV-RT in the presence of (i) MIV-150 similar to LNG or (ii) vaginal fluids (VF); available from studies completed earlier) collected at various time points post insertion of MZCL and MZC IVRs. Then, (iii) MZCL IVRs (vs. LNG IVRs) were inserted in non-Depo Provera-treated macaques for 24h and VF, genital biopsies, and blood were collected and tissues were challenged with SHIV-RT. Infection was monitored with one step SIV gag qRT-PCR or p27 ELISA. MIV-150 (LCMS/ MS, RIA), LNG (RIA) and CG (ELISA) were measured in different compartments. Log-normal generalized mixed linear models were used for analysis. LNG did not affect the anti-SHIV-RT activity of MIV-150 in vitro. MIV-150 in VF from MZC/ MZCL IVR-treated macaques inhibited SHIV-RT in vaginal mucosa in a dose-dependent manner (p< 0.05). MIV-150 in vaginal tissue from MZCL IVRtreated animals inhibited ex vivo infection relative to baseline (96%; p< 0.0001) and post LNG IVR group (90%, p< 0.001). No MIV-150 dose-dependent protection was observed, likely because of high MIV-150 concentrations in all vaginal tissue samples. In cervical tissue, MIV-150 inhibited infection vs. baseline (99%; p< 0.05). No cervical tissue was available for MIV-150 measurement. Exposure to LNG IVR did not change tissue infection level. These observations support further development of MZCL IVR as a multipurpose prevention technology to improve women's sexual and reproductive health.	[Villegas, Guillermo; Calenda, Giulia; Ugaonkar, Shweta; Zhang, Shimin; Kizima, Larisa; Mizenina, Olga; Cooney, Michael L.; Robbiani, Melissa; Fernandez-Romero, Jose A.; Zydowsky, Thomas M.; Teleshova, Natalia] Populat Council, 1230 York Ave, New York, NY 10021 USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA; [Blanchard, James] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA	Population Council; Rockefeller University; Tulane University	Teleshova, N (corresponding author), Populat Council, 1230 York Ave, New York, NY 10021 USA.	nteleshova@popcouncil.org		Cooney, Michael/0000-0001-7943-1951	United States President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) [GPO-A-00-04-00019-00]; National Institute of Allergy and Infectious Diseases (NIH) [R21 AI098645]; Tulane National Primate Research Center [Primate Center base grant] [P51 OD011104]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098645] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	United States President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Tulane National Primate Research Center [Primate Center base grant]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by the United States President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) Cooperative Agreement [GPO-A-00-04-00019-00, www.usaid.gov]; The National Institute of Allergy and Infectious Diseases (NIH) [R21 AI098645, www.niaid.nih.gov]; The Tulane National Primate Research Center [Primate Center base grant P51 OD011104, http://tulane.edu/tnprc]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilles SL, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.016; [Anonymous], 1985, COMM CAR US LAB AN I; Aravantinou M, 2012, AIDS RES HUM RETROV, V28, P1467, DOI [10.1089/aid.2012.0080, 10.1089/AID.2012.0080]; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; BARBOSA I, 1990, CONTRACEPTION, V42, P51, DOI 10.1016/0010-7824(90)90092-A; Barnabas RV, 2012, CURR HIV RES, V10, P228, DOI 10.2174/157016212800618156; Barnable P, 2015, ANTIMICROB AGENTS CH, V59, P3829, DOI 10.1128/AAC.00073-15; Barnable P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108109; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Chen BA, 2015, JAIDS-J ACQ IMM DEF, V70, P242, DOI 10.1097/QAI.0000000000000702; Crostarosa F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008060; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Friedland B, 2016, 1 IN HUMAN TRIAL PC; Friend DR, 2013, ANTIVIR RES, V100, pS39, DOI 10.1016/j.antiviral.2013.09.030; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Goldfien GA, 2015, REPROD SCI, V22, P814, DOI 10.1177/1933719114565035; Goode D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004567; Harrison PF, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/790154; Hild-Petito S, 1998, AIDS RES HUM RETROV, V14, pS125; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; Hsu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089300; Jean-Pierre N, 2016, ANTIMICROB AGENTS CH, V60, P1141, DOI 10.1128/AAC.02468-15; Karim QA, 2010, CLIN INFECT DIS, V50, pS122, DOI 10.1086/651483; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Kenney J, 2012, AIDS RES HUM RETROV, V28, P1476, DOI [10.1089/aid.2012.0087, 10.1089/AID.2012.0087]; Kenney J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015835; Kizima L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094547; Levin ER, 2008, AM J PHYSIOL-REG I, V295, pR1425, DOI 10.1152/ajpregu.90605.2008; Lowy DR, 2012, CANCER PREV RES, V5, P18, DOI 10.1158/1940-6207.CAPR-11-0542; LUUKKAINEN T, 1995, CONTRACEPTION, V52, P269, DOI 10.1016/0010-7824(95)00210-2; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; NILSSON CG, 1980, CONTRACEPTION, V21, P225, DOI 10.1016/0010-7824(80)90003-7; Ostergaard SD, 2015, J MED PRIMATOL, V44, P97, DOI 10.1111/jmp.12157; Ouattara LA, 2014, ANTIMICROB AGENTS CH, V58, P2841, DOI 10.1128/AAC.01529-13; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Polis CB, 2014, CONTRACEPTION, V90, P360, DOI 10.1016/j.contraception.2014.07.009; Richardson-Harman N, 2012, AIDS RES HUM RETROV, V28, P1422, DOI [10.1089/aid.2012.0073, 10.1089/AID.2012.0073]; Richardson-Harman N, 2009, J CLIN MICROBIOL, V47, P3530, DOI 10.1128/JCM.00673-09; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Rodriguez A, 2014, ANTIVIR RES, V108, P88, DOI 10.1016/j.antiviral.2014.05.018; Romano J, 2013, AIDS RES HUM RETROV, V29, P1418, DOI [10.1089/aid.2013.0122, 10.1089/AID.2013.0122]; Sciaranghella G, 2015, J INFECT DIS, V212, P1397, DOI 10.1093/infdis/jiv233; Singer R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003936; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; Thurman AR, 2013, INT J WOMENS HEALTH, V5, P695, DOI 10.2147/IJWH.S34030; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; Ugaonkar SR, 2015, J CONTROL RELEASE, V213, P57, DOI 10.1016/j.jconrel.2015.06.018	48	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159332	10.1371/journal.pone.0159332	http://dx.doi.org/10.1371/journal.pone.0159332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428377	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300051
J	Bi, C; Zhang, L; Qi, M; Zheng, CX; Yi, YG; Wang, JZ; Zhang, BX				Bi, Chao; Zhang, Lei; Qi, Miao; Zheng, Caixia; Yi, Yugen; Wang, Jianzhong; Zhang, Baoxue			Supervised Filter Learning for Representation Based Face Recognition	PLOS ONE			English	Article							DIMENSIONALITY REDUCTION; DISCRIMINANT-ANALYSIS; CLASSIFICATION; EIGENFACES; PATTERNS; SCALE	Representation based classification methods, such as Sparse Representation Classification (SRC) and Linear Regression Classification (LRC) have been developed for face recognition problem successfully. However, most of these methods use the original face images without any preprocessing for recognition. Thus, their performances may be affected by some problematic factors (such as illumination and expression variances) in the face images. In order to overcome this limitation, a novel supervised filter learning algorithm is proposed for representation based face recognition in this paper. The underlying idea of our algorithm is to learn a filter so that the within-class representation residuals of the faces' Local Binary Pattern (LBP) features are minimized and the between-class representation residuals of the faces' LBP features are maximized. Therefore, the LBP features of filtered face images are more discriminative for representation based classifiers. Furthermore, we also extend our algorithm for heterogeneous face recognition problem. Extensive experiments are carried out on five databases and the experimental results verify the efficacy of the proposed algorithm.	[Bi, Chao; Qi, Miao; Zheng, Caixia; Wang, Jianzhong] Northeast Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China; [Zhang, Lei] Chinese Acad Sci, Changchun Inst Opt Fine Mech & Phys, Changchun, Peoples R China; [Yi, Yugen] Jiangxi Normal Univ, Sch Software, Nanchang, Peoples R China; [Zhang, Baoxue] Capital Univ Econ & Business, Sch Stat, Beijing, Peoples R China	Northeast Normal University - China; Chinese Academy of Sciences; Changchun Institute of Optics, Fine Mechanics & Physics, CAS; Jiangxi Normal University; Capital University of Economics & Business	Wang, JZ (corresponding author), Northeast Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China.; Zhang, BX (corresponding author), Capital Univ Econ & Business, Sch Stat, Beijing, Peoples R China.	wangjz019@nenu.edu.cn; zhangbaoxue@cueb.edu.cn	Zhang, Bao/B-3926-2012	Zhang, Lei/0000-0002-2830-2233; Yi, Yugen/0000-0002-1049-5022	Fund of Jilin Provincial Science AMP; Technology Department [20130206042GX]; Young scientific research fund of Jilin province science and technology development project [20130522115JH]; National Natural Science Foundation of China [11271064, 61403078, 61471111]	Fund of Jilin Provincial Science AMP; Technology Department; Young scientific research fund of Jilin province science and technology development project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Fund of Jilin Provincial Science & Technology Department (20130206042GX), Young scientific research fund of Jilin province science and technology development project (No. 20130522115JH) and National Natural Science Foundation of China (No. 11271064, 61403078, 61471111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; [Anonymous], 1997, YALE FACE DATABASE; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Chen Y, 2013, NEURAL PROCESS LETT, V37, P355, DOI 10.1007/s11063-012-9252-y; Chen ZM, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1186/S12929-015-0197-0; Deng WH, 2012, IEEE T PATTERN ANAL, V34, P1864, DOI 10.1109/TPAMI.2012.30; Gao SH, 2010, LECT NOTES COMPUT SC, V6314, P1; Howland P, 2004, IEEE T PATTERN ANAL, V26, P995, DOI 10.1109/TPAMI.2004.46; Huang G. B., 2007, 0749 U MASS; Huang M-W, 2010, IM SIGN PROC CISP 20; Jain A. K., 2005, HDB FACE RECOGNITION; Kang C, 2011, IM PROC ICIP 2011 18; Lee H, 2011, LECT NOTES COMPUT SC, V6513, P273, DOI 10.1007/978-3-642-17955-6_20; Lei Z., 2012, COMP VIS PATT REC CV; Lei Z, 2014, IEEE T PATTERN ANAL, V36, P289, DOI 10.1109/TPAMI.2013.112; Lei Z, 2011, IEEE T IMAGE PROCESS, V20, P247, DOI 10.1109/TIP.2010.2060207; Lu GF, 2012, KNOWL-BASED SYST, V31, P119, DOI 10.1016/j.knosys.2012.02.014; Martinez A., 1998, AR FACE DATABASE; Mi JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059430; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Min R, 2011, MULT EXP ICME 2011 I; Naseem I, 2010, IEEE T PATTERN ANAL, V32, P2106, DOI 10.1109/TPAMI.2010.128; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Penev PS, 1996, NETWORK-COMP NEURAL, V7, P477, DOI 10.1088/0954-898X/7/3/002; Pentland A, 1994, COMP VIS PATT REC 19; RAUDYS SJ, 1991, IEEE T PATTERN ANAL, V13, P252, DOI 10.1109/34.75512; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Scholkopft B., 1999, NEURAL NETW SIGNAL P, V1, P1; Shan S, 2004, PATT REC 2004 ICPR 2; Sim Terence, 2002, AUT FAC GEST REC 200; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Wang Jinjun, 2010, COMP VIS PATT REC CV; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Xu Y, 2011, OPTICAL ENG, V50; Yan SC, 2007, IEEE T PATTERN ANAL, V29, P40, DOI 10.1109/TPAMI.2007.250598; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Yang M, 2011, COMP VIS PATT REC CV; Ye JP, 2005, IEEE T PATTERN ANAL, V27, P929, DOI 10.1109/TPAMI.2005.110; Zhang BH, 2007, IEEE T IMAGE PROCESS, V16, P57, DOI 10.1109/TIP.2006.884956; Zhang W, 2005, COMP VIS 2005 ICCV 2; Zhao S, 2008, IM PROC 2008 ICIP 20; Zhu ML, 2006, IEEE T PATTERN ANAL, V28, P1274, DOI 10.1109/TPAMI.2006.172	45	2	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159084	10.1371/journal.pone.0159084	http://dx.doi.org/10.1371/journal.pone.0159084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416030	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500072
J	Das, K; Srivastava, M; Raghavan, SC				Das, Kohal; Srivastava, Mrinal; Raghavan, Sathees C.			GNG Motifs Can Replace a GGG Stretch during G-Quadruplex Formation in a Context Dependent Manner	PLOS ONE			English	Article							MAJOR BREAKPOINT REGION; B-DNA-STRUCTURE; CHROMOSOMAL TRANSLOCATIONS; T(14/18) TRANSLOCATION; MOLECULAR-STRUCTURE; NUCLEIC-ACIDS; HUMAN GENOME; STABILITY; PROMOTER; FRAGILITY	G-quadruplexes are one of the most commonly studied non-B DNA structures. Generally, these structures are formed using a minimum of 4, three guanine tracts, with connecting loops ranging from one to seven. Recent studies have reported deviation from this general convention. One such deviation is the involvement of bulges in the guanine tracts. In this study, guanines along with bulges, also referred to as GNG motifs have been extensively studied using recently reported HOX11 breakpoint fragile region I as a model template. By strategic mutagenesis approach we show that the contribution from continuous G-tracts may be dispensible during G-quadruplex formation when such motifs are flanked by GNGs. Importantly, the positioning and number of GNG/GNGNG can also influence the formation of G-quadruplexes. Further, we assessed three genomic regions from HIF1 alpha, VEGF and SHOX gene for G-quadruplex formation using GNG motifs. We show that HIF1 alpha sequence harbouring GNG motifs can fold into intramolecular G-quadruplex. In contrast, GNG motifs in mutant VEGF sequence could not participate in structure formation, suggesting that the usage of GNG is context dependent. Importantly, we show that when two continuous stretches of guanines are flanked by two independent GNG motifs in a naturally occurring sequence (SHOX), it can fold into an intramolecular G-quadruplex. Finally, we show the specific binding of G-quadruplex binding protein, Nucleolin and G-quadruplex antibody, BG4 to SHOX G-quadruplex. Overall, our study provides novel insights into the role of GNG motifs in G-quadruplex structure formation which may have both physiological and pathological implications.	[Das, Kohal; Srivastava, Mrinal; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in	Srivastava, Mrinal/AAM-5013-2020		IISc-DBT partnership programme [DBT/BF/PR/INS/2011-12/IISc]	IISc-DBT partnership programme [DBT/BF/PR/INS/2011-12/IISc]	This work was supported by grants IISc-DBT partnership programme [DBT/BF/PR/INS/2011-12/IISc] to SCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala P, 2015, ORG BIOMOL CHEM, V13, P5570, DOI 10.1039/c4ob02681k; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cer RZ, 2013, NUCLEIC ACIDS RES, V41, pD94, DOI 10.1093/nar/gks955; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Hurley LH, 2011, GENES CANC, V1, P641; Jiang HX, 2015, SCI REP-UK, V5, DOI 10.1038/srep09255; Katapadi VK, 2012, GENOMICS, V100, P72, DOI 10.1016/j.ygeno.2012.05.008; Kumari R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119722; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lim KW, 2015, NUCL ACIDS RES; Marusic M, 2012, NUCLEIC ACIDS RES, V40, P6946, DOI 10.1093/nar/gks329; Mathad RI, 2011, NUCLEIC ACIDS RES, V39, P9023, DOI 10.1093/nar/gkr612; Mirkin SM, 2013, NATURE, V497, P449, DOI 10.1038/nature12244; Mukundan VT, 2013, J AM CHEM SOC, V135, P5017, DOI 10.1021/ja310251r; Naik AK, 2008, DNA REPAIR, V7, P1384, DOI 10.1016/j.dnarep.2008.04.010; Nambiar M, 2013, MOL CELL BIOL, V33, P4266, DOI 10.1128/MCB.00540-13; Nambiar M, 2012, J BIOL CHEM, V287, P8688, DOI 10.1074/jbc.M111.307363; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P5813, DOI 10.1093/nar/gkr223; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Oganesian L, 2007, BIOCHEMISTRY-US, V46, P11279, DOI 10.1021/bi700993q; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Phan AT, 2003, J AM CHEM SOC, V125, P15021, DOI 10.1021/ja037616j; Tran PLT, 2011, NUCLEIC ACIDS RES, V39, P3282, DOI 10.1093/nar/gkq1292; Rachwal PA, 2007, BIOCHEMISTRY-US, V46, P3036, DOI 10.1021/bi062118j; Raghavan SC, 2005, J BIOL CHEM, V280, P22749, DOI 10.1074/jbc.M502952200; Raghavan SC, 2004, J BIOL CHEM, V279, P46213, DOI 10.1074/jbc.M406280200; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Raghavan SC, 2015, FEBS J; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Sharma S, 2011, CELL MOL LIFE SCI, V68, P661, DOI 10.1007/s00018-010-0472-x; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WILKINS MHF, 1953, NATURE, V171, P738, DOI 10.1038/171738a0; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	48	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158794	10.1371/journal.pone.0158794	http://dx.doi.org/10.1371/journal.pone.0158794			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414642	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500041
J	Dobrijevic, D; Abraham, AL; Jamet, A; Maguin, E; van de Guchte, M				Dobrijevic, Dragana; Abraham, Anne-Laure; Jamet, Alexandre; Maguin, Emmanuelle; van de Guchte, Maarten			Functional Comparison of Bacteria from the Human Gut and Closely Related Non-Gut Bacteria Reveals the Importance of Conjugation and a Paucity of Motility and Chemotaxis Functions in the Gut Environment	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; BACILLUS-SUBTILIS; MICROBIOME; GENES; BACTEROIDES; DIVERSITY; PROTEINS; CATALOG; FUCOSE; TREE	The human GI tract is a complex and still poorly understood environment, inhabited by one of the densest microbial communities on earth. The gut microbiota is shaped by millennia of evolution to co-exist with the host in commensal or symbiotic relationships. Members of the gut microbiota perform specific molecular functions important in the human gut environment. This can be illustrated by the presence of a highly expanded repertoire of proteins involved in carbohydrate metabolism, in phase with the large diversity of polysaccharides originating from the diet or from the host itself that can be encountered in this environment. In order to identify other bacterial functions that are important in the human gut environment, we investigated the distribution of functional groups of proteins in a group of human gut bacteria and their close non-gut relatives. Complementary to earlier global comparisons between different ecosystems, this approach should allow a closer focus on a group of functions directly related to the gut environment while avoiding functions related to taxonomically divergent microbiota composition, which may or may not be relevant for gut homeostasis. We identified several functions that are overrepresented in the human gut bacteria which had not been recognized in a global approach. The observed under-representation of certain other functions may be equally important for gut homeostasis. Together, these analyses provide us with new information about this environment so critical to our health and well-being.	[Dobrijevic, Dragana; Abraham, Anne-Laure; Jamet, Alexandre; Maguin, Emmanuelle; van de Guchte, Maarten] Univ Paris Saclay, Micalis Inst, INRA, AgroParisTech, F-78350 Jouy En Josas, France; [Dobrijevic, Dragana] UCL, Dept Biochem Engn, London WC1H 0AH, England	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London	van de Guchte, M (corresponding author), Univ Paris Saclay, Micalis Inst, INRA, AgroParisTech, F-78350 Jouy En Josas, France.	maarten.vandeguchte@jouy.inra.fr	Abraham, Anne-Laure/AAZ-3137-2021	Abraham, Anne-Laure/0000-0002-2074-3106; Dobrijevic, Dragana/0000-0001-7591-8105	Marie Curie EC FP7 Cross-talk project [PITN-GA-2008-215553]	Marie Curie EC FP7 Cross-talk project	Dragana Dobrijevic is the recipient of a grant in the Marie Curie EC FP7 Cross-talk project (PITN-GA-2008-215553).	Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benjdia A, 2011, J BIOL CHEM, V286, P25973, DOI 10.1074/jbc.M111.228841; Berteau O, 2006, J BIOL CHEM, V281, P22464, DOI 10.1074/jbc.M602504200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellrott K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000798; Francino MP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01543; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Juhas M, 2014, MICROBIOL-SGM, V160, P2341, DOI 10.1099/mic.0.079376-0; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Macfarlane S, 2006, APPL ENVIRON MICROB, V72, P6204, DOI 10.1128/AEM.00754-06; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nicolas P, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-141; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pons N, 2008, J MOL MICROB BIOTECH, V14, P67, DOI 10.1159/000106084; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vogel-Scheel J, 2010, APPL ENVIRON MICROB, V76, P5181, DOI 10.1128/AEM.00242-10; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	46	6	6	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159030	10.1371/journal.pone.0159030	http://dx.doi.org/10.1371/journal.pone.0159030			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416027	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500060
J	Holdgate, MR; Meehan, CL; Hogan, JN; Miller, LJ; Soltis, J; Andrews, J; Shepherdson, DJ				Holdgate, Matthew R.; Meehan, Cheryl L.; Hogan, Jennifer N.; Miller, Lance J.; Soltis, Joseph; Andrews, Jeff; Shepherdson, David J.			Walking Behavior of Zoo Elephants: Associations between GPS-Measured Daily Walking Distances and Environmental Factors, Social Factors, and Welfare Indicators	PLOS ONE			English	Article							NATIONAL-PARK; PHYSICAL-EXERCISE; ASIAN ELEPHANTS; ANIMAL-WELFARE; AFRICAN; MORTALITY; HEALTH; IMPACT; RATES; TOOL	Research with humans and other animals suggests that walking benefits physical health. Perhaps because these links have been demonstrated in other species, it has been suggested that walking is important to elephant welfare, and that zoo elephant exhibits should be designed to allow for more walking. Our study is the first to address this suggestion empirically by measuring the mean daily walking distance of elephants in North American zoos, determining the factors that are associated with variations in walking distance, and testing for associations between walking and welfare indicators. We used anklets equipped with GPS data loggers tomeasure outdoor daily walking distance in 56 adult female African (n = 33) and Asian (n = 23) elephants housed in 30 North American zoos. We collected 259 days of data and determined associations between distance walked and social, housing, management, and demographic factors. Elephants walked an average of 5.3 km/day with no significant difference between species. In our multivariable model, more diverse feeding regimens were correlated with increased walking, and elephants who were fed on a temporally unpredictable feeding schedule walked 1.29 km/daymore than elephants fed on a predictable schedule. Distance walked was also positively correlated with an increase in the number of social groupings and negatively correlated with age. We found a small but significant negative correlation between distance walked and nighttime Space Experience, but no other associations between walking distances and exhibit size were found. Finally, distance walked was not related to health or behavioral outcomes including foot health, joint health, body condition, and the performance of stereotypic behavior, suggesting that more research is necessary to determine explicitly how differences in walking may impact elephant welfare.	[Holdgate, Matthew R.; Shepherdson, David J.] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Holdgate, Matthew R.; Shepherdson, David J.] Oregon Zoo, Conservat Res Div, Portland, OR USA; [Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA; [Miller, Lance J.] Chicago Zool Soc, Brookfield Zoo, Brookfield, IL USA; [Soltis, Joseph] Disneys Anim Kingdom, Dept Educ & Sci, Lake Buena Vista, FL USA; [Andrews, Jeff] Busch Gardens, Zool Operat, Tampa, FL USA	Portland State University; Walt Disney Company	Holdgate, MR (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97207 USA.; Holdgate, MR (corresponding author), Oregon Zoo, Conservat Res Div, Portland, OR USA.	mholdgate@gmail.com			Institute of Museum and Library Services [LG-25-10-0033-10]; Forbes-Lea Research Grant; Marie Brown Award; Student Education Travel Grant; Oregon Zoo; Disney's Animal Kingdom; Chicago Zoological Society-Brookfield Zoo; Busch Gardens; IMLS; AWARE Institute	Institute of Museum and Library Services; Forbes-Lea Research Grant; Marie Brown Award; Student Education Travel Grant; Oregon Zoo; Disney's Animal Kingdom; Chicago Zoological Society-Brookfield Zoo; Busch Gardens; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. This paper was completed while MRH was undertaking a Ph.D. in Biology at Portland State University and in receipt of funding from the Forbes-Lea Research Grant, Marie Brown Award, and Student Education Travel Grant. Employers provided financial support in the form of authors' salaries as follows: Oregon Zoo (DS and MH); Disney's Animal Kingdom (JS); Chicago Zoological Society-Brookfield Zoo (LM); Busch Gardens (JA). After the IMLS-funded period of performance (November 2010 December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Brown JL, 2000, ZOO BIOL, V19, P347, DOI 10.1002/1098-2361(2000)19:5&lt;347::AID-ZOO6&gt;3.0.CO;2-V; Brown JL, 2004, GEN COMP ENDOCR, V136, P360, DOI 10.1016/j.ygcen.2004.01.013; Brown JL, 2016, PLOS ONE; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Clubb R, 2009, ANIM WELFARE, V18, P237; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; Ekelund U, 2015, AM J CLIN NUTR, V101, P613, DOI 10.3945/ajcn.114.100065; Fowler ME, 2001, ELEPHANT'S FOOT, P3; Franks B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083578; Gadd ME, 2002, AFR J ECOL, V40, P328, DOI 10.1046/j.1365-2028.2002.00385.x; Greco BJ, 2016, PLOS ONE; Hacker CE, 2015, APPL ANIM BEHAV SCI, V163, P175, DOI 10.1016/j.applanim.2014.12.005; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Hassmen P, 2000, PREV MED, V30, P17, DOI 10.1006/pmed.1999.0597; Holdgate MR, 2016, PLOS ONE; Hutchins M, 2006, ZOO BIOL, V25, P161, DOI 10.1002/zoo.20087; Jones B, 2007, J VET BEHAV, V2, P185, DOI 10.1016/j.jveb.2007.06.001; Kopp M, 2012, DIABETES RES CLIN PR, V95, P25, DOI 10.1016/j.diabres.2011.09.017; Langley R. B., 1999, GPS WORLD, P52; Lee J, 2011, APPL ANIM BEHAV SCI, V130, P91, DOI 10.1016/j.applanim.2011.01.001; Leighty KA, 2010, ZOO BIOL, V29, P210, DOI 10.1002/zoo.20250; Leighty KA, 2009, ZOO BIOL, V28, P16, DOI 10.1002/zoo.20199; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Loarie SR, 2009, BIOL CONSERV, V142, P3099, DOI 10.1016/j.biocon.2009.08.021; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0000; Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Meehan CL, 2016, PLOS ONE; Mench Joy A., 1998, P30; Menor-Campos DJ, 2011, VET REC, V169, P388, DOI 10.1136/vr.d4757; Mikota S.K., 1994, W BLOOMFIELD; Miller LJ, 2012, ANIM WELFARE, V21, P577, DOI 10.7120/09627286.21.4.577; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Morfeld KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093802; Moss Cynthia J., 2011, P205; Ozminkowski RJ, 2002, J OCCUP ENVIRON MED, V44, P21, DOI 10.1097/00043764-200201000-00005; Popescu S, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-43; Prado-Oviedo NA, 2016, PLOS ONE; Rothwell ES, 2011, ZOO BIOL, V30, P579, DOI 10.1002/zoo.20364; Rowell Z, 2014, J ZOO AQUAR RES, V2, P130; Rushen J, 2003, APPL ANIM BEHAV SCI, V81, P199, DOI 10.1016/S0168-1591(02)00281-2; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Shepherdson D, 2013, APPL ANIM BEHAV SCI, V147, P268, DOI 10.1016/j.applanim.2013.01.001; SHEPHERDSON DJ, 1993, ZOO BIOL, V12, P203, DOI 10.1002/zoo.1430120206; Slotow R., 2004, Koedoe, V47, P91; Soulsby KS, 2013, THESIS; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889; Stokke S, 2002, AFR J ECOL, V40, P360, DOI 10.1046/j.1365-2028.2002.00395.x; Sukumar R., 2003, LIVING ELEPHANTS EVO; Taylor VJ, 1998, ZOO BIOL, V17, P311, DOI 10.1002/(SICI)1098-2361(1998)17:4&lt;311::AID-ZOO5&gt;3.0.CO;2-C; Warren BS, 2011, BRIT J NUTR, V106, pS85, DOI 10.1017/S0007114511001814; WEIR JS, 1969, J ZOOL, V158, P293; WEIR JS, 1972, OIKOS, V23, P1, DOI 10.2307/3543921; Whisher L, 2011, APPL ANIM BEHAV SCI, V135, P63, DOI 10.1016/j.applanim.2011.09.001; Whitehouse AM, 2003, AFR ZOOL, V38, P95; Witte TH, 2005, J BIOMECH, V38, P1717, DOI 10.1016/j.jbiomech.2004.07.028; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018	63	30	31	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0150331	10.1371/journal.pone.0150331	http://dx.doi.org/10.1371/journal.pone.0150331			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414411	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500004
J	Meehan, CL; Hogan, JN; Bonaparte-Saller, MK; Mench, JA				Meehan, Cheryl L.; Hogan, Jennifer N.; Bonaparte-Saller, Mary K.; Mench, Joy A.			Housing and Social Environments of African (Loxodonta africana) and Asian (Elephas maximus) Elephants in North American Zoos	PLOS ONE			English	Article							ENCLOSURE SIZE; STEREOTYPIC BEHAVIOR; CAGE SIZE; AGGRESSION; WELFARE; ACCESS; WILD; HUSBANDRY; CORTISOL; CHOICE	We evaluated 255 African (Loxodonta africana) and Asian (Elephas maximus) elephants living in 68 North American zoos over one year to quantify housing and social variables. All parameters were quantified for the both the day and the night and comparisons were made across these time periods as well as by species and sex. To assess housing, we evaluated not only total exhibit size, but also individual animals' experiences based on the time they spent in the unique environments into which the exhibits were subdivided. Variables developed to assess housing included measurements of area as a function of time (Total Space Experience), environment type (Indoor, Outdoor, In/Out Choice) and time spent on hard and soft flooring. Over the year, Total Space Experience values ranged from 1,273 square feet to 169,692 square feet, with Day values significantly greater than Night values (p<0.001). Elephants spent an average of 55.1% of their time outdoors, 28.9% indoors, and 16% in areas with a choice between being in or out. Time spent on hard flooring substrate ranged from 0% to 66.7%, with Night values significantly greater than Day (p<0.001). Social factors included number of animals functionally housed together (Social Experience) and social group characteristics such as time spent with juveniles and in mixed-sex groups. Overall Social Experience scores ranged from 1 to 11.2 and were significantly greater during the Day than at Night (p<0.001). There were few significant social or housing differences between African (N = 138) and Asian (N = 117) species or between males (N = 54) and females (N = 201). The most notable exception was Total Space Experience, with African and male elephants having larger Total Space Experience than Asian and female elephants, respectively (P-value<0.05). The housing and social variables evaluated herein have been used in a series of subsequent epidemiological analyses relating to various elephant welfare outcomes.	[Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA; [Bonaparte-Saller, Mary K.; Mench, Joy A.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Bonaparte-Saller, Mary K.; Mench, Joy A.] Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Meehan, CL (corresponding author), AWARE Inst, Portland, OR USA.	Cheryl.meehan@aware.institute			Institute of Museum and Library Services [LG-25-10-0033-10]; IMLS; AWARE Institute	Institute of Museum and Library Services; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2006, ANIM BEHAV, V71, P117, DOI 10.1016/j.anbehav.2005.03.023; Barker ZE, 2009, J DAIRY SCI, V92, P1971, DOI 10.3168/jds.2008-1590; Brown JL, 2016, PLOS ONE; Brummer SP, 2010, APPL ANIM BEHAV SCI, V125, P171, DOI 10.1016/j.applanim.2010.04.012; Butterworth A., 2011, Animal welfare, P200, DOI 10.1079/9781845936594.0200; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; DeVries TJ, 2004, J DAIRY SCI, V87, P1432, DOI 10.3168/jds.S0022-0302(04)73293-2; Fagen RM, 1981, ANIMAL PLAY BEHAV; Fernando P, 2000, BEHAV ECOL SOCIOBIOL, V48, P84, DOI 10.1007/s002650000218; Fontenot MB, 2006, J AM ASSOC LAB ANIM, V45, P35; Fowler ME, 2001, ELEPHANT'S FOOT, P3; Fowler Murray E., 2006, P271, DOI 10.1002/9780470344484.ch20; Frankena K, 2009, PREV VET MED, V88, P150, DOI 10.1016/j.prevetmed.2008.08.004; Fuller G, 2013, ZOO BIOL, V32, P88, DOI 10.1002/zoo.21049; GADGIL M, 1984, P INDIAN AS-ANIM SCI, V93, P225, DOI 10.1007/BF03186282; Galindo F., 2011, Animal welfare, P228, DOI 10.1079/9781845936594.0228; Garner JP, 2012, POULTRY SCI, V91, P1522, DOI 10.3382/ps.2011-01969; Greco BJ, 2016, PLOS ONE; Haley DB, 2001, APPL ANIM BEHAV SCI, V71, P105, DOI 10.1016/S0168-1591(00)00175-1; Hansen SW, 2007, ANIM WELFARE, V16, P63; Harris M, 2008, WC05007 DEFRA U BRIS; Haufe HC, 2012, PREV VET MED, V105, P85, DOI 10.1016/j.prevetmed.2012.01.016; Hockenhull J, 2014, APPL ANIM BEHAV SCI, V155, P49, DOI 10.1016/j.applanim.2014.02.014; HOGAN ES, 1988, APPL ANIM BEHAV SCI, V21, P147, DOI 10.1016/0168-1591(88)90105-0; Holdgate MR, 2016, PLOS ONE; Johnsen PF, 2001, ACTA AGR SCAND A-AN, V51, P26, DOI 10.1080/090647001316923027; Kaufman BM, 2004, APPL ANIM BEHAV SCI, V88, P319, DOI 10.1016/j.applanim.2004.03.012; Kurtycz LM, 2014, J APPL ANIM WELF SCI, V17, P185, DOI 10.1080/10888705.2014.896213; LEE PC, 1987, ANIM BEHAV, V35, P278, DOI 10.1016/S0003-3472(87)80234-8; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Li CW, 2007, GEN COMP ENDOCR, V151, P202, DOI 10.1016/j.ygcen.2007.01.014; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Nakamura K, 2011, ANIM SCI J, V82, P161, DOI 10.1111/j.1740-0929.2010.00806.x; Nielsen B. L., 2011, Animal welfare, P215, DOI 10.1079/9781845936594.0215; Olsson IAS, 2007, APPL ANIM BEHAV SCI, V103, P229, DOI 10.1016/j.applanim.2006.05.022; Owen MA, 2005, ZOO BIOL, V24, P475, DOI 10.1002/zoo.20064; Price EE, 2007, APPL ANIM BEHAV SCI, V103, P255, DOI 10.1016/j.applanim.2006.05.021; Rault JL, 2012, APPL ANIM BEHAV SCI, V136, P1, DOI 10.1016/j.applanim.2011.10.002; Ross SR, 2006, BEHAV PROCESS, V73, P117, DOI 10.1016/j.beproc.2006.04.003; Schumann K, 2014, J APPL ANIM WELF SCI, V17, P111, DOI 10.1080/10888705.2014.884407; Shepherdson D, 2013, APPL ANIM BEHAV SCI, V147, P268, DOI 10.1016/j.applanim.2013.01.001; Thomas B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003902; Valuska AJ, 2013, APPL ANIM BEHAV SCI, V149, P72, DOI 10.1016/j.applanim.2013.10.002; West Gary, 2006, P263, DOI 10.1002/9780470344484.ch19; Wiedenmayer C, 1996, APPL ANIM BEHAV SCI, V47, P225, DOI 10.1016/0168-1591(95)00652-4	48	21	23	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0146703	10.1371/journal.pone.0146703	http://dx.doi.org/10.1371/journal.pone.0146703			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414034	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500003
J	Wang, TY; Santos, JH; Feng, J; Fargo, DC; Shen, L; Riadi, G; Keeley, E; Rosh, ZS; Nestler, EJ; Woychik, RP				Wang, Tianyuan; Santos, Janine H.; Feng, Jian; Fargo, David C.; Shen, Li; Riadi, Gonzalo; Keeley, Elizabeth; Rosh, Zachary S.; Nestler, Eric J.; Woychik, Richard P.			A Novel Analytical Strategy to Identify Fusion Transcripts between Repetitive Elements and Protein Coding-Exons Using RNA-Seq	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; CELLS; METHYLATION; ISOFORM; TOPHAT; BRAIN	Repetitive elements (REs) comprise 40-60% of the mammalian genome and have been shown to epigenetically influence the expression of genes through the formation of fusion transcript (FTs). We previously showed that an intracisternal A particle forms an FT with the agouti gene in mice, causing obesity/type 2 diabetes. To determine the frequency of FTs genome-wide, we developed a TopHat-Fusion-based analytical pipeline to identify FTs with high specificity. We applied it to an RNA-seq dataset from the nucleus accumbens (NAc) of mice repeatedly exposed to cocaine. Cocaine was previously shown to increase the expression of certain REs in this brain region. Using this pipeline that can be applied to single- or paired-end reads, we identified 438 genes expressing 813 different FTs in the NAc. Although all types of studied repeats were present in FTs, simple sequence repeats were underrepresented. Most importantly, reverse-transcription and quantitative PCR validated the expression of selected FTs in an independent cohort of animals, which also revealed that some FTs are the prominent isoforms expressed in the NAc by some genes. In other RNA-seq datasets, developmental expression as well as tissue specificity of some FTs differed from their corresponding non-fusion counterparts. Finally, in silico analysis predicted changes in the structure of proteins encoded by some FTs, potentially resulting in gain or loss of function. Collectively, these results indicate the robustness of our pipeline in detecting these new isoforms of genes, which we believe provides a valuable tool to aid in better understanding the broad role of REs in mammalian cellular biology.	[Wang, Tianyuan; Santos, Janine H.; Fargo, David C.; Woychik, Richard P.] NIEHS, 111 TW Alexander Dr,Bldg 101, Res Triangle Pk, NC 27709 USA; [Feng, Jian; Shen, Li; Keeley, Elizabeth; Rosh, Zachary S.; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, One Gustave L Levy Pl,Box 1065, New York, NY 10029 USA; [Feng, Jian; Shen, Li; Keeley, Elizabeth; Rosh, Zachary S.; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, One Gustave L Levy Pl,Box 1065, New York, NY 10029 USA; [Riadi, Gonzalo] Univ Talca, Fac Ingn, Dept Bioinformat, CBSM, Av 2 Norte 685, Talca 3465548, Chile	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Universidad de Talca	Woychik, RP (corresponding author), NIEHS, 111 TW Alexander Dr,Bldg 101, Res Triangle Pk, NC 27709 USA.; Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, One Gustave L Levy Pl,Box 1065, New York, NY 10029 USA.; Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, One Gustave L Levy Pl,Box 1065, New York, NY 10029 USA.	eric.nestler@mssm.edu; rick.woychik@nih.gov	Woychik, Richard P/C-8345-2019; Riadi, Gonzalo/ABG-2144-2020	Woychik, Richard P/0000-0001-8196-1732; Riadi, Gonzalo/0000-0002-7633-2365	Intramural Research Program of the NIH;  [P01DA008227];  [Fondecyt 11140869]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, R37DA007359] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the NIH (RPW) and by grants P01DA008227 (EJN) and Fondecyt 11140869 (GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Babaian A, 2016, ONCOGENE, V35, P2542, DOI 10.1038/onc.2015.308; Batut P, 2013, GENOME RES, V23, P169, DOI 10.1101/gr.139618.112; Bernal AJ, 2013, FASEB J, V27, P665, DOI 10.1096/fj.12-220350; Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047; Chaya T, 2011, J BIOL CHEM, V286, P29511, DOI 10.1074/jbc.M111.236810; Criscione SW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-583; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Ewing AD, 2015, GENOME RES, V25, P1536, DOI 10.1101/gr.196238.115; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feng J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r65; Fertuzinhos S, 2014, CELL REP, V6, P938, DOI 10.1016/j.celrep.2014.01.036; Herquel B, 2013, NAT STRUCT MOL BIOL, V20, P339, DOI 10.1038/nsmb.2496; Jin Y, 2015, BIOINFORMATICS, P1; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kumar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21597; Lock FE, 2014, P NATL ACAD SCI USA, V111, pE3534, DOI 10.1073/pnas.1405507111; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Rigal M, 2011, BBA-GENE REGUL MECH, V1809, P452, DOI 10.1016/j.bbagrm.2011.04.001; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Soyal SM, 2012, HUM MOL GENET, V21, P3461, DOI 10.1093/hmg/dds177; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114	36	25	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159028	10.1371/journal.pone.0159028	http://dx.doi.org/10.1371/journal.pone.0159028			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415830	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500059
J	Blake, RA; Park, S; Baltazar, P; Ayaso, EB; Monterde, DBS; Acosta, LP; Olveda, RM; Tallo, V; Friedman, JF				Blake, Rachel A.; Park, Sangshin; Baltazar, Palmera; Ayaso, Edna B.; Monterde, Donna Bella S.; Acosta, Luz P.; Olveda, Remigio M.; Tallo, Veronica; Friedman, Jennifer F.			LBW and SGA Impact Longitudinal Growth and Nutritional Status of Filipino Infants	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; FOR-GESTATIONAL-AGE; MIDDLE-INCOME COUNTRIES; METRO-CEBU; CATCH-UP; CHILDREN; RETARDATION; UNDERNUTRITION; INTRAUTERINE; CHILDHOOD	We performed this study to longitudinally compare rates of stunting, wasting and underweight among low birthweight (LBW), non-LBW, and/or small-for-gestational age (SGA) and non-SGA infants in Leyte, The Philippines and factors that predicted catch up. Birthweights of 357 infants born in Leyte, The Philippines were obtained within 48 hours of delivery and infants were evaluated at one, six and 12 months. Newborns were classified as LBW, SGA, or both. We derived length-for-age, weight-for-length and weight-for-age Z-scores using WHOAnthro. Generalized estimating equations models were used to compare the differences in prevalence and mean Z-scores for these growth and nutritional outcomes, with separate models made with LBW and SGA as distinct primary predictors. We compared the longitudinal risk of stunting, wasting and underweight during infancy among LBW versus non-LBWand SGA versus non-SGA infants, while also evaluating key potential confounding, explanatory and modifying covariates. Overall, 9.0% of infants were born prematurely, 14.0% of infants were LBW and 22.9% were SGA. LBW infants had significantly increased odds of stunting, wasting and underweight persisting to 12 months of age, and SGA infants had significantly increased odds of stunting and underweight. LBW and SGA infants had higher rates of weight-for-length gain in the first month of life. Maternal educational attainment and exclusive breastfeeding decreased the risk of stunting and undernutrition. In this setting, LBW and SGA infants have higher rates of growth stunting and undernutrition during the first year of life and do not exhibit catch-up growth by 12 months of age.	[Blake, Rachel A.; Park, Sangshin; Friedman, Jennifer F.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Park, Sangshin; Friedman, Jennifer F.] Brown Univ, Rhode Isl Hosp, Ctr Int Hlth Res, Warren Alpert Med Sch, Providence, RI 02903 USA; [Baltazar, Palmera; Acosta, Luz P.; Olveda, Remigio M.; Tallo, Veronica] Res Inst Trop Med, Manila, Philippines; [Baltazar, Palmera; Ayaso, Edna B.; Monterde, Donna Bella S.] Remedios Trinidad Romualdez Hosp, Tacloban City, Leyte, Philippines	Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Research Institute for Tropical Medicine - Philippines	Park, S (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.; Park, S (corresponding author), Brown Univ, Rhode Isl Hosp, Ctr Int Hlth Res, Warren Alpert Med Sch, Providence, RI 02903 USA.	dvm.spark@gmail.com	Park, Sangshin/K-6889-2014	Park, Sangshin/0000-0003-2407-0962	NIH/NIAID S. japonicum and pregnancy outcomes: An RCT [U01AI066050]; Thrasher Research Fund Infant hemoglobin, nutritional status and neuro-cognitive development following maternal treatment for S. japonicum during pregnancy [02826-5]; Alpert Medical School Summer Assistantship; American Society of Tropical Medicine & Hygiene's Benjamin Kean Travel Fellowship; Asian Pacific American Medical Student Association's Global Health Fellowship; Rhode Island Medical Women's Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI077708, K24AI112964] Funding Source: NIH RePORTER	NIH/NIAID S. japonicum and pregnancy outcomes: An RCT; Thrasher Research Fund Infant hemoglobin, nutritional status and neuro-cognitive development following maternal treatment for S. japonicum during pregnancy; Alpert Medical School Summer Assistantship; American Society of Tropical Medicine & Hygiene's Benjamin Kean Travel Fellowship; Asian Pacific American Medical Student Association's Global Health Fellowship; Rhode Island Medical Women's Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All phases of this study were supported by NIH/NIAID S. japonicum and pregnancy outcomes: An RCT (Grant #U01AI066050: https://www.niaid.nih.gov/researchfunding/grant/Pages/default.aspx), Thrasher Research Fund Infant hemoglobin, nutritional status and neuro-cognitive development following maternal treatment for S. japonicum during pregnancy (Grant #02826-5: https://www.thrasherresearch.org/default.aspx), Alpert Medical School Summer Assistantship, American Society of Tropical Medicine & Hygiene's Benjamin Kean Travel Fellowship, Asian Pacific American Medical Student Association's Global Health Fellowship and Rhode Island Medical Women's Association.	Adair LS, 1997, J NUTR, V127, P314, DOI 10.1093/jn/127.2.314; Adair LS, 1996, J NUTR, V126, P103, DOI 10.1093/jn/126.1.103; Ashworth A, 1997, J NUTR, V127, P1950, DOI 10.1093/jn/127.10.1950; BINKIN NJ, 1988, PEDIATRICS, V82, P828; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bollen KA, 2013, STAT MED, V32, P2950, DOI 10.1002/sim.5771; BROWN KH, 1986, PEDIATRICS, V78, P920; Christian P, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-58; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; CRUISE MO, 1973, PEDIATRICS, V51, P620; Daniels MC, 2005, J NUTR, V135, P2589, DOI 10.1093/jn/135.11.2589; Britto RPD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080159; Emmett PM, 1997, EARLY HUM DEV, V49, pS7, DOI 10.1016/S0378-3782(97)00051-0; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Fenske N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078692; Gibson RS, 1990, Q REV BIOL; Guellec I, 2011, PEDIATRICS, V127, pE883, DOI 10.1542/peds.2010-2442; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Harding JE, 2003, EARLY HUM DEV, V74, P13, DOI 10.1016/S0378-3782(03)00080-X; Hengstermann S, 2010, J HUM LACT, V26, P19, DOI 10.1177/0890334409344078; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Karlberg JPE, 1997, HORM RES, V48, P17, DOI 10.1159/000191279; KEBEDE A, 1994, TROP DOCT, V24, P64, DOI 10.1177/004947559402400207; Kozuki N, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.1438; LOW JA, 1982, AM J OBSTET GYNECOL, V142, P670, DOI 10.1016/S0002-9378(16)32439-5; Manning F., 1995, INTRAUTERINE GROWTH, P317; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Norgan NG, 2000, P NUTR SOC, V59, P245, DOI 10.1017/S0029665100000276; Olveda RM, 2016, LANCET INFECT DIS, V16, P199, DOI 10.1016/S1473-3099(15)00345-X; Onayade A A, 2004, East Afr Med J, V81, P146; Onsa Z. O., 2014, Pakistan Journal of Nutrition, V13, P99; OUNSTED M, 1982, EARLY HUM DEV, V7, P29, DOI 10.1016/0378-3782(82)90005-6; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Ricci JA, 1996, AM J CLIN NUTR, V63, P966, DOI 10.1093/ajcn/63.6.966; Rizzo G, 2009, Minerva Ginecol, V61, P411; Sania A, 2014, MATERN CHILD NUTR; United States Agency for International Development, 2005, HLTH PROF PHIL; Varela-Silva MI, 2009, AM J HUM BIOL, V21, P657, DOI 10.1002/ajhb.20883; VILLAR J, 1982, AM J OBSTET GYNECOL, V143, P793, DOI 10.1016/0002-9378(82)90012-6; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; WHO Anthro, 2005, WHO ANTR 2005 BET VE; Yoon PW, 1996, AM J EPIDEMIOL, V143, P1142, DOI 10.1093/oxfordjournals.aje.a008692; Zottarelli L. K., 2007, Eastern Mediterranean Health Journal, V13, P1330	44	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159461	10.1371/journal.pone.0159461	http://dx.doi.org/10.1371/journal.pone.0159461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441564	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500077
J	Shi, S; Zheng, S; Li, XF; Yang, LL; Liu, ZD; Yuan, W				Shi, Sheng; Zheng, Shuang; Li, Xin-Feng; Yang, Li-Li; Liu, Zu-De; Yuan, Wen			Comparison of 2 Zero-Profile Implants in the Treatment of Single-Level Cervical Spondylotic Myelopathy: A Preliminary Clinical Study of Cervical Disc Arthroplasty versus Fusion	PLOS ONE			English	Article							ALONE ANCHORED SPACER; PLATE-CAGE CONSTRUCT; HETEROTOPIC OSSIFICATION; SURGICAL-TREATMENT; FOLLOW-UP; REPLACEMENT; SEGMENT; MOTION; DISKECTOMY; ARTHRODESIS	Objectives Cervical disc arthroplasty (CDA) with Discover prosthesis or anterior cervical discectomy and fusion (ACDF) with Zero-P cage has been widely used in the treatment of cervical spon-dylotic myelopathy (CSM). However, little is known about the comparison of the 2 zero-profile implants in the treatment of single-level CSM. The aim was to compare the clinical outcomes and radiographic parameters of CDA with Discover prosthesis and ACDF with Zero-P cage for the treatment of single-level CSM. Methods A total of 128 consecutive patients who underwent 1-level CDA with Discover prosthesis or ACDF with Zero-P cage for single-level CSM between September 2009 and December 2012 were included in this study. Clinical outcomes were evaluated using the Japanese Orthopaedic Association (JOA) score and Neck Disability Index (NDI). For radiographic assessment, the overall sagittal alignment (OSA), functional spinal unit (FSU) angle, and range of motion (ROM) at the index and adjacent levels were measured before and after surgery. Additionally, the complications were also recorded. Results Both treatments significantly improved all clinical parameters (P < 0.05), without statistically relevant differences between the 2 groups. The OSA and FSU angle increased significantly in both groups (P < 0.05). Compared with Zero-P group, ROMs at the index levels were well maintained in the Discover group (P < 0.05). However, there were no statistical differences in the ROMs of adjacent levels between the 2 groups (P > 0.05). Besides, no significant differences existed in dysphagia, subsidence, or adjacent disc degeneration between the 2 groups (P > 0.05). However, significant differences occurred in prosthesis migration in CDA group. Conclusions The results of this study showed that clinical outcomes and radiographic parameters were satisfactory and comparable with the 2 techniques. However, more attention to prosthesis migration of artificial cervical disc should be paid in the postoperative early-term follow-up.	[Shi, Sheng; Li, Xin-Feng; Liu, Zu-De] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Orthopaed Surg, Shanghai 200127, Peoples R China; [Zheng, Shuang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Endocrinol, Shanghai 200127, Peoples R China; [Yang, Li-Li; Yuan, Wen] Second Mil Med Univ, Changzheng Hosp, Dept Spine Surg, Shanghai 200003, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Naval Medical University	Liu, ZD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Orthopaed Surg, Shanghai 200127, Peoples R China.; Yuan, W (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Spine Surg, Shanghai 200003, Peoples R China.	rjliuzd@163.com; spinewenyuan@126.com	Shi, Sheng/AAF-8784-2020		National Natural Science Foundation of China [81270027, 81271941, 30901508]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81270027, 81271941, 30901508)(URL: https://isisn.nsfc.gov.cn/egrantweb/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the National Natural Science Foundation of China (No. 81270027, 81271941, 30901508).	Aghayev E, 2014, SPINE J, V14, P916, DOI 10.1016/j.spinee.2013.07.446; Alvin MD, 2014, SPINE J, V14, P2231, DOI 10.1016/j.spinee.2014.03.047; Anderson PA, 2012, SPINE, V37, pS85, DOI 10.1097/BRS.0b013e31826d6628; Anderst WJ, 2015, SPINE J, V15, P2538, DOI 10.1016/j.spinee.2015.08.042; Chen H, 2013, EUR SPINE J, V22, P1570, DOI 10.1007/s00586-013-2791-8; Chen Y, 2013, EUR SPINE J, V22, P1539, DOI 10.1007/s00586-013-2772-y; Cheng CC, 2007, SPINE, V32, P1852, DOI 10.1097/BRS.0b013e31811ece5a; Dong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130223; Du JJ, 2011, SPINE J, V11, P281, DOI 10.1016/j.spinee.2011.01.037; Fallah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043407; Fountas KN, 2007, SPINE, V32, P2310, DOI 10.1097/BRS.0b013e318154c57e; Guerin P, 2012, J SPINAL DISORD TECH, V25, P10, DOI 10.1097/BSD.0b013e31820f916c; Han YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087191; Harrod CC, 2012, SPINE, V37, pS96, DOI 10.1097/BRS.0b013e31826cb2d6; Hoh DJ, 2015, WORLD NEUROSURG, V84, P235, DOI 10.1016/j.wneu.2015.04.034; Hou Y, 2014, SPINE J, V14, P867, DOI 10.1016/j.spinee.2013.07.432; Jin YJ, 2013, SPINE J, V13, P408, DOI 10.1016/j.spinee.2012.11.048; Joaquim AF, 2014, SPINE J, V14, P2246, DOI 10.1016/j.spinee.2014.03.030; Krieg SM, 2015, WORLD NEUROSURG, V84, P218, DOI 10.1016/j.wneu.2015.03.038; Krieg SM, 2014, WORLD NEUROSURG, V81, P501, DOI 10.1016/j.wneu.2013.10.041; Lee JH, 2014, SPINE J, V14, P1199, DOI 10.1016/j.spinee.2013.08.010; Li J, 2015, J CLIN NEUROSCI, V22, P566, DOI 10.1016/j.jocn.2014.08.019; Li J, 2013, EUR SPINE J, V22, P2303, DOI 10.1007/s00586-013-2897-z; Li XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140031; Liu JM, 2015, WORLD NEUROSURG, V84, P2022, DOI 10.1016/j.wneu.2015.08.039; McAfee PC, 2003, J SPINAL DISORD TECH, V16, P384, DOI 10.1097/00024720-200308000-00010; Miao JH, 2014, SPINE J, V14, P878, DOI 10.1016/j.spinee.2013.07.439; Nakagawa H, 2015, WORLD NEUROSURG, V84, P220, DOI 10.1016/j.wneu.2015.04.005; Nanda A, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.09.022; Nunley PD, 2013, SPINE J, V13, P5, DOI 10.1016/j.spinee.2012.11.032; Powell JW, 2010, J SPINAL DISORD TECH, V23, P89, DOI 10.1097/BSD.0b013e3181991413; Ren D, 2016, SPINE, V41, pE410, DOI 10.1097/BRS.0000000000001266; Rong X, 2014, SPINE, V39, pB12, DOI 10.1097/BRS.0000000000000634; Sasso RC, 2011, SPINE, V36, P991, DOI 10.1097/BRS.0b013e3182076d70; Shi S, 2016, WORLD NEUROSURG, V89, P285, DOI 10.1016/j.wneu.2016.02.009; Shi S, 2016, J CLIN NEUROSCI, V25, P69, DOI 10.1016/j.jocn.2015.05.050; Shi S, 2015, SPINE J, V15, P1973, DOI 10.1016/j.spinee.2015.04.024; Skeppholm M, 2015, SPINE J, V15, P1284, DOI 10.1016/j.spinee.2015.02.039; Song KJ, 2014, SPINE J, V14, P2954, DOI 10.1016/j.spinee.2014.06.005; Techy F, 2014, WORLD NEUROSURG, V81, P503, DOI 10.1016/j.wneu.2013.10.053; Tetreault L, 2015, WORLD NEUROSURG, V83, P679, DOI 10.1016/j.wneu.2015.01.021; Thaler M, 2013, EUR SPINE J, V22, P759, DOI 10.1007/s00586-012-2594-3; Wang ZD, 2014, J CLIN NEUROSCI, V21, P462, DOI 10.1016/j.jocn.2013.05.019; White NA, 2014, SPINE J, V14, P2195, DOI 10.1016/j.spinee.2014.03.001; Yanbin Z, 2011, J SPINAL DISORD TECH, V24, P381, DOI [10.1097/BSD.0b013e318201855f, DOI 10.1097/BSD.0B013E318201855F]; Yang HS, 2015, ARCH ORTHOP TRAUM SU, V135, P781, DOI 10.1007/s00402-015-2212-z; Yi S, 2010, SPINE, V35, P1556, DOI 10.1097/BRS.0b013e3181c6526b; Yu SZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091329; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096265; Zhang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117826	50	24	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159761	10.1371/journal.pone.0159761	http://dx.doi.org/10.1371/journal.pone.0159761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441736	gold, Green Published, Green Submitted			2022-12-27	WOS:000380797500135
J	Zhang, Q; Zheng, TQ; Hoang, L; Wang, CC; Nafisah; Joseph, C; Zhang, WZ; Xu, JL; Li, ZK				Zhang, Qiang; Zheng, Tianqing; Long Hoang; Wang, Chunchao; Nafisah; Joseph, Charles; Zhang, Wenzhong; Xu, Jianlong; Li, Zhikang			Joint Mapping and Allele Mining of the Rolled Leaf Trait in Rice (Oryza sativa L.)	PLOS ONE			English	Article							GENETIC-ANALYSIS; TRANSCRIPTION FACTOR; INTROGRESSION LINES; DROUGHT TOLERANCE; LINKAGE MAP; MUTANT; NARROW; IDENTIFICATION; PROTEIN; OVEREXPRESSION	The rolled leaf trait, long considered to be a key component of plant architecture, represents an important target trait for improving plant architecture at the population level. We therefore performed linkage mapping using a set of 262 highly variable RILs from two rice cultivars (Minghui 63 and 02428) with minor differences in leaf rolling index (LRI) in conjunction with GWAS mapping of a random subset of the 1127 germplasms from the 3K Rice Genomes Project (3K Rice). A total of seven main-effect loci were found to underlie the transgressive segregation of progenies from parents with minor differences in LRI. Five of these loci were previously identified and two (qRl7b and qRl9b) are newly reported with additional evidence from GWAS mapping for qRl7b. A total of 18 QTLs were identified by GWAS, including four newly identified QTLs. Six QTLs were confirmed by linkage mapping with the above RIL population, and 83.3% were found to be consistent with previously reported loci based on comparative mapping. We also performed allele mining with representative SNPs and identified the elite germplasms for the improvement of rolled leaf trait. Most favorable alleles at the detected loci were contributed by various 3K Rice germplasms. By a re-scanning of the candidate region with more saturated SNP markers, we dissected the region harboring gRl4-2 into three subregions, in which the average effect on LRI was 3.5% with a range from 2.4 to 4.1% in the third subregion, suggesting the presence of a new locus or loci within this region. The representative SNPs for favorable alleles in the reliable QTLs which were consistently identified in both bi-parental mapping and GWAS, such as qRl4, qRl5, qRl6, qRl7a, and qRl7b will be useful for future molecular breeding programs for ideal plant type in rice.	[Zhang, Qiang; Zhang, Wenzhong] Shenyang Agr Univ, 120 Dongling Rd, Shenyang 110866, Peoples R China; [Zheng, Tianqing; Long Hoang; Wang, Chunchao; Nafisah; Joseph, Charles; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, 12 South Zhong Guan Cun St, Beijing 100081, Peoples R China; [Xu, Jianlong] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen 518120, Peoples R China; [Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Shenzhen Inst Breeding & Innovat, Shenzhen 518120, Peoples R China; [Long Hoang] Inst Agr Sci Southern Vietnam, 121 Nguyen Binh Khiem,Dist 1, Ho Chi Minh City, Vietnam; [Nafisah] Indonesian Ctr Rice Res, Jalan Raya 9, Subang 41256, West Java, Indonesia; [Joseph, Charles] Univ Dar Es Salaam, Dept Bot, Box 35091, Dar Es Salaam, Tanzania	Shenyang Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Chinese Academy of Agricultural Sciences; University of Dar es Salaam	Zhang, WZ (corresponding author), Shenyang Agr Univ, 120 Dongling Rd, Shenyang 110866, Peoples R China.; Xu, JL (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, 12 South Zhong Guan Cun St, Beijing 100081, Peoples R China.; Xu, JL (corresponding author), Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen 518120, Peoples R China.; Xu, JL (corresponding author), Chinese Acad Agr Sci, Shenzhen Inst Breeding & Innovat, Shenzhen 518120, Peoples R China.	zwzhong@126.com; xujlcaas@126.com	Xu, Jianlong/AAI-8310-2020; Joseph, Charles/ABB-4494-2020		Chinese Ministry of Science Technology [2016YFD0101800]; "863" Key Project from the Chinese Ministry of Science Technology [2014AA10A601]; "Green Super Rice" project from the Bill and Melinda Gates Foundation [OPPGD1393]	Chinese Ministry of Science Technology(Ministry of Science and Technology, China); "863" Key Project from the Chinese Ministry of Science Technology; "Green Super Rice" project from the Bill and Melinda Gates Foundation	A subprogram of the Key Special Project on Molecular Design Breeding for Rice to TQZ (2016YFD0101800) from the Chinese Ministry of Science & Technology, the "863" Key Project to JLX (2014AA10A601) from the Chinese Ministry of Science & Technology, and the "Green Super Rice" project to ZKL (OPPGD1393) from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Ali AJ, 2006, FIELD CROP RES, V97, P66, DOI 10.1016/j.fcr.2005.08.016; Bai L, 2008, RICE SCI, V15, P201, DOI 10.1016/S1672-6308(08)60043-8; Chen QL, 2015, J EXP BOT, V66, P6047, DOI 10.1093/jxb/erv319; Chen W, 2014, THEOR APPL GENET, V127, P297, DOI 10.1007/s00122-013-2218-2; Chen YingZhi, 2010, Guangxi Agricultural Sciences, V41, P403; Chen ZongXiang, 2004, Acta Agronomica Sinica, V30, P465; Dai MQ, 2007, PLANT PHYSIOL, V144, P121, DOI 10.1104/pp.107.096586; DINGKUHN M, 1989, AUST J AGR RES, V40, P1171, DOI 10.1071/AR9891171; Fang LK, 2012, PLANT BIOTECHNOL J, V10, P524, DOI 10.1111/j.1467-7652.2012.00679.x; Fang Yun-xia, 2015, Zhongguo Shuidao Kexue, V29, P587, DOI 10.3969/j.issn.1001-7216.2015.06.004; Gao J, 2008, CLONING FUNCTIONAL A; Gao YanHong, 2007, Jiangsu Journal of Agricultural Sciences, V23, P5; Guo Y, 2010, RICE SCI, V17, P28, DOI 10.1016/S1672-6308(08)60101-8; He YX, 2010, PLANT BREEDING, V129, P167, DOI 10.1111/j.1439-0523.2009.01683.x; Hoang L, 2013, QTL MAPPING LEAF ROL; Hu J, 2010, PLANT MOL BIOL, V73, P283, DOI 10.1007/s11103-010-9614-7; Hu Ning, 2008, Zhongguo Shuidao Kexue, V22, P617; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Lai KK, 2012, GENETIC FINE MAPPING; Lang YouZhong, 2004, Acta Agronomica Sinica, V30, P883; Lang YouZhong, 2004, Acta Agronomica Sinica, V30, P806; Leung H, 2015, RICE, V8, P1, DOI 10.1186/s12284-015-0069-y; Li HB, 1989, CHINA SEED IND, P42; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li Li, 2013, Journal of Nanomaterials, DOI 10.1155/2013/821071; Li L, 2010, MOL PLANT, V3, P807, DOI 10.1093/mp/ssq022; Li Z., 2013, GENETICS GENOMICS RI, P349, DOI [10.1007/978-1-4614-7903-1_23, DOI 10.1007/978-1-4614-7903-1_23]; Li ZhiKang, 2001, Rice genetics IV. Proceedings of the Fourth International Rice Genetics Symposium, Los Banos, Philippines, 22-27 October 2000, P153; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; [刘晨 Liu Chen], 2015, [中国农业科学, Scientia Agricultura Sinica], V48, P2487; Liu C, 2014, INTERNATIONAL CONFERENCE ON ELECTRONIC AND ELECTRICAL ENGINEERING (CEEE 2014), P1; Lu JF, 2002, EFFECTS ROLLING LEAF; Lu YL, 2010, P NATL ACAD SCI USA, V107, P19585, DOI 10.1073/pnas.1006105107; LuChuanGen, 2003, Scientia Agricultura Sinica, V36, P633; Luo YuanZhang, 2009, Acta Agronomica Sinica, V35, P1967, DOI 10.3724/SP.J.1006.2009.01967; Luo ZK, 2007, GENOME, V50, P811, DOI 10.1139/G07-064; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Pan Cun-hong, 2011, Zhongguo Shuidao Kexue, V25, P455, DOI 10.3969/j.issn.1001-7216.2011.05.001; [潘银林 Pan Yinlin], 2015, [生物学杂志, Journal of Biology], V32, P92; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; [桑贤春 Sang Xianchun], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1819; Segami S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-4; Shao Yuan-Jian, 2005, Acta Genetica Sinica, V32, P501; Shen NW, 2011, GENETIC ANAL GENE MA; Shi ZY, 2007, PLANTA, V226, P99, DOI 10.1007/s00425-006-0472-0; Wang DK, 2009, CHINESE SCI BULL, V54, P752, DOI 10.1007/s11434-009-0098-2; Wang DeZhong, 2011, Acta Agronomica Sinica, V37, P1159; Wang F, 2012, CHINESE SCI BULL, V57, P3798, DOI 10.1007/s11434-012-5154-7; Wang LiFeng, 2012, African Journal of Biotechnology, V11, P6839, DOI 10.5897/AJB12.181; Wang X, 2012, J SOOCHOW U NATURAL, V28, P89; Wu C, 2010, PLANTA, V232, P313, DOI 10.1007/s00425-010-1180-3; Wu F X, 2011, FUJIAN J AGR SCI, V26, P1101; Wu RH, 2011, PLANT CELL, V23, P3392, DOI 10.1105/tpc.111.088625; Xia Ling, 2007, Xiamen Daxue Xuebao (Ziran Kexue Ban), V46, P847; Xiang JJ, 2012, PLANT PHYSIOL, V159, P1488, DOI 10.1104/pp.112.199968; Xie ZhiWei, 2013, Acta Agronomica Sinica, V39, P1970, DOI 10.3724/SP.J.1006.2013.01970; Xu JL, 1999, RICE GENET NEWSL, V16, P51; Xu Y, 2014, PLANTA, V239, P803, DOI 10.1007/s00425-013-2009-7; Yan S, 2008, PLANT MOL BIOL, V68, P239, DOI 10.1007/s11103-008-9365-x; Yang CH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-158; Yoshimura A, 1997, PLANT MOL BIOL, V35, P49, DOI 10.1023/A:1005764026871; [余东 Yu Dong], 2008, [分子植物育种, Molecular Plant Breeding], V6, P220; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001; Zang JP, 2008, SCI CHINA SER C, V51, P583, DOI 10.1007/s11427-008-0081-1; Zhang Fan-Tao, 2012, Yichuan, V34, P79, DOI 10.3724/SP.J.1005.2012.00079; Zhang GH, 2009, PLANT CELL, V21, P719, DOI 10.1105/tpc.108.061457; Zhang HJ, 2013, MOL BREEDING, V31, P181, DOI 10.1007/s11032-012-9782-z; [张礼霞 Zhang Lixia], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P2881; Zhang Xiao-hui, 2015, Zhongguo Shuidao Kexue, V29, P595, DOI 10.3969/j.issn.1001-7216.2015.06.005; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; [赵芳明 Zhao Fangming], 2015, [科学通报, Chinese Science Bulletin], V60, P3133; Zheng TQ, 2012, MOL BREEDING, V29, P925, DOI 10.1007/s11032-011-9691-6; Zhou Y, 2010, CHINESE SCI BULL, V55, P1763, DOI 10.1007/s11434-010-3137-0; Zou LP, 2011, PLANT PHYSIOL, V156, P1589, DOI 10.1104/pp.111.176016	76	9	9	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158246	10.1371/journal.pone.0158246	http://dx.doi.org/10.1371/journal.pone.0158246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441398	gold, Green Submitted, Green Published			2022-12-27	WOS:000380797500010
J	Alvarez Rojas, CA; Scheerlinck, JP; Ansell, BRE; Hall, RS; Gasser, RB; Jex, AR				Alvarez Rojas, Cristian A.; Scheerlinck, Jean-Pierre; Ansell, Brendan R. E.; Hall, Ross S.; Gasser, Robin B.; Jex, Aaron R.			Time-Course Study of the Transcriptome of Peripheral Blood Mononuclear Cells (PBMCs) from Sheep Infected with Fasciola hepatica	PLOS ONE			English	Article							IMMUNE-RESPONSE; IFN-GAMMA; TGF-BETA; ALTERNATIVE ACTIVATION; SECRETORY PRODUCTS; IN-VITRO; T-CELLS; B-CELLS; EXPRESSION; PROTEIN	Fasciola hepatica is a parasitic trematode that infects a wide range of mammalian hosts, including livestock and humans, in temperate and tropical regions globally. This trematode causes the disease fascioliasis, which consists of an acute phase (<= 12 weeks) during which juvenile parasites migrate through the host liver tissues, and a chronic phase (> 12 weeks) following the establishment of adult parasites in the liver bile ducts. Few studies have explored the progression of the host response over the course of Fasciola infection in the same animals. In this study, we characterized transcriptomic changes in peripheral blood mononuclear cells (PBMCs) collected from sheep at three time points over the first eight weeks of infection relative to uninfected controls. In total, 183 and 76 genes were found to be differentially transcribed at two and eight weeks post-infection respectively. Functional and pathway analysis of differentially transcribed genes revealed changes related to T-cell activation that may underpin a Th2-biased immune response against this parasite. This first insight into the dynamics of host responses during the early stages of infection improves the understanding of the pathogenesis of acute fascioliasis, informs vaccine development and presents a set of PBMC markers with diagnostic potential.	[Alvarez Rojas, Cristian A.; Scheerlinck, Jean-Pierre] Univ Melbourne, Fac Vet & Agr Sci, Ctr Anim Biotechnol, Parkville, Vic 3010, Australia; [Ansell, Brendan R. E.; Hall, Ross S.; Gasser, Robin B.; Jex, Aaron R.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia; [Jex, Aaron R.] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute	Alvarez Rojas, CA (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Ctr Anim Biotechnol, Parkville, Vic 3010, Australia.	alvarezc@unimelb.edu.au	Rojas, Cristian A Alvarez/AAR-1231-2020; Ansell, Brendan/O-4150-2014; Jex, Aaron/AGZ-7897-2022; Gasser, Robin/ABH-6185-2020	Rojas, Cristian A Alvarez/0000-0002-8069-7607; Ansell, Brendan/0000-0003-0297-897X; Jex, Aaron/0000-0002-1285-7947; Gasser, Robin/0000-0002-4423-1690; Scheerlinck, Jean-Pierre/0000-0002-8385-353X	Australian Research Council; ARC [DP110103175]; National Health and Medical Research Council (NHMRC) of Australia; Victorian Life Sciences Computation Initiative (VLSCI) [VR0007]; Victorian Government	Australian Research Council(Australian Research Council); ARC(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative (VLSCI); Victorian Government	This work was supported by the Australian Research Council and (ARC) grant number DP110103175 and the National Health and Medical Research Council (NHMRC) of Australia as well as by a Victorian Life Sciences Computation Initiative (VLSCI) grant number VR0007 on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government (to RB Gasser).	Akirav EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034698; Aldridge A, 2016, EUR J IMMUNOL, V46, P1180, DOI 10.1002/eji.201545905; Alvarez Rojas CA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0715-7; Ansari AW, 2006, INT IMMUNOL, V18, P1443, DOI 10.1093/intimm/dxl078; Ardia DR, 2011, FUNCT ECOL, V25, P61, DOI 10.1111/j.1365-2435.2010.01759.x; BAEZA E, 1994, VET PARASITOL, V51, P219, DOI 10.1016/0304-4017(94)90159-7; Basika T, 2012, PARASITOLOGY, V139, P271, DOI 10.1017/S003118201100179X; Behm CA, 1999, FASCIOLOSIS, P185; Boray J. C., 1969, Adv. Parasitol., V7, P95, DOI 10.1016/S0065-308X(08)60435-2; Brodeur SR, 2003, IMMUNITY, V18, P837, DOI 10.1016/S1074-7613(03)00149-3; Brown CT, REFERENCE FREE ALGOR; Chauvin A, 1996, PARASITE, V3, P209, DOI 10.1051/parasite/1996033209; CHAUVIN A, 1995, INT J PARASITOL, V25, P1227, DOI 10.1016/0020-7519(95)00039-5; Chauvin A, 2001, VET RES, V32, P87, DOI 10.1051/vetres:2001113; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Chen YL, 2008, J IMMUNOL, V181, P4272, DOI 10.4049/jimmunol.181.6.4272; Chuah C, 2014, CELL MICROBIOL, V16, P1666, DOI 10.1111/cmi.12316; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; deSchoolmeester ML, 2003, J IMMUNOL, V170; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Donnelly S, 2005, INFECT IMMUN, V73, P166, DOI 10.1128/IAI.73.1.166-173.2005; Dowling DJ, 2010, INFECT IMMUN, V78, P793, DOI 10.1128/IAI.00573-09; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; Fahel JS, 2015, INFECT IMMUN, V83, P1210, DOI 10.1128/IAI.02592-14; Ferre I, 1997, VET PARASITOL, V68, P261, DOI 10.1016/S0304-4017(96)01070-9; Flynn RJ, 2008, INT J PARASITOL, V38, P1673, DOI 10.1016/j.ijpara.2008.05.008; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Golbar HM, 2013, J VET MED SCI, V75, P857, DOI 10.1292/jvms.12-0536; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Guasconi L, 2011, IMMUNOLOGY, V133, P386, DOI 10.1111/j.1365-2567.2011.03449.x; Guerfali FZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-238; Hamilton CM, 2009, INFECT IMMUN, V77, P2488, DOI 10.1128/IAI.00919-08; Hermosilla C, 2014, PARASITOLOGY, V141, P1489, DOI 10.1017/S0031182014000316; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Jefferies JR, 1997, INT J PARASITOL, V27, P1025, DOI 10.1016/S0020-7519(97)00067-2; Jefferies JR, 1996, INT J PARASITOL, V26, P409, DOI 10.1016/0020-7519(95)00136-0; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Lee HW, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0855-4; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lopez-Bernad F, 2000, VET PARASITOL, V88, P1, DOI 10.1016/S0304-4017(99)00199-5; Lv K, 2013, MOL MED REP, V7, P205, DOI 10.3892/mmr.2012.1125; Machado FS, 2008, INT IMMUNOPHARMACOL, V8, P1316, DOI 10.1016/j.intimp.2008.01.001; Malissen B, 2014, NAT IMMUNOL, V15, P790, DOI 10.1038/ni.2959; Martin I, 2015, J IMMUNOL, V194, P3924, DOI 10.4049/jimmunol.1401182; Mendes EA, 2013, VET PARASITOL, V195, P177, DOI 10.1016/j.vetpar.2013.03.035; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; MONTGOMERY TD, 1986, VET PARASITOL, V19, P55, DOI 10.1016/0304-4017(86)90032-4; Moreau E, 1998, PARASITE, V5, P307, DOI 10.1051/parasite/1998054307; Nagashima T, 2011, AM J PATHOL, V178, P222, DOI 10.1016/j.ajpath.2010.11.033; Nitschke L, 2005, CURR OPIN IMMUNOL, V17, P290, DOI 10.1016/j.coi.2005.03.005; O'Neill SM, 2000, PARASITE IMMUNOL, V22, P147, DOI 10.1046/j.1365-3024.2000.00290.x; Parkinson John F., 2006, Inflammation & Allergy Drug Targets, V5, P91, DOI 10.2174/187152806776383125; Phiri IK, 2006, VET PARASITOL, V141, P234, DOI 10.1016/j.vetpar.2006.05.019; Preston S, 2015, METHODS MOL BIOL, V1207, P371, DOI 10.1007/978-1-4939-1396-1_25; Prowse RK, 2002, PARASITE IMMUNOL, V24, P57, DOI 10.1046/j.0141-9838.2001.00438.x; Raadsma HW, 2007, VET PARASITOL, V143, P275, DOI 10.1016/j.vetpar.2006.09.008; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Richardson MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00288; Rojas-Caraballo J, 2015, GENOM DATA, V6, P89, DOI 10.1016/j.gdata.2015.08.020; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; SANTIAGO N, 1988, J PARASITOL, V74, P810, DOI 10.2307/3282259; Scheerlinck JPY, 2001, VACCINE, V19, P4053, DOI 10.1016/S0264-410X(01)00133-5; Schnoor M, 2015, J IMMUNOL, V194, P3535, DOI 10.4049/jimmunol.1403250; Schroeder H, 2009, DEV COMP IMMUNOL, V33, P5, DOI 10.1016/j.dci.2008.07.010; Schweizer G, 2005, VET REC, V157, P188, DOI 10.1136/vr.157.7.188; Shih CH, 2005, EXP HEMATOL, V33, P1101, DOI 10.1016/j.exphem.2005.06.028; Sundrud MS, 2005, BLOOD, V106, P3440, DOI 10.1182/blood-2005-03-0857; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Vukman KV, 2013, J IMMUNOL, V190, P2873, DOI 10.4049/jimmunol.1203011; Waldvogel AS, 2004, VET IMMUNOL IMMUNOP, V97, P53, DOI 10.1016/j.vetimm.2003.08.002; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Young AR, 2009, GLYCOCONJUGATE J, V26, P423, DOI 10.1007/s10719-008-9190-0; Zhang WY, 2005, EXP PARASITOL, V111, P154, DOI 10.1016/j.exppara.2005.06.005	84	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159194	10.1371/journal.pone.0159194	http://dx.doi.org/10.1371/journal.pone.0159194			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438474	gold, Green Published			2022-12-27	WOS:000380170100031
J	Hill, DA; Anderson, LE; Hill, CJ; Mostaghim, A; Rodgers, VGJ; Grover, WH				Hill, Douglas A.; Anderson, Lindsey E.; Hill, Casey J.; Mostaghim, Afshin; Rodgers, Victor G. J.; Grover, William H.			MECs: "Building Blocks" for Creating Biological and Chemical Instruments	PLOS ONE			English	Article								The development of new biological and chemical instruments for research and diagnostic applications is often slowed by the cost, specialization, and custom nature of these instruments. New instruments are built from components that are drawn from a host of different disciplines and not designed to integrate together, and once built, an instrument typically performs a limited number of tasks and cannot be easily adapted for new applications. Consequently, the process of inventing new instruments is very inefficient, especially for researchers or clinicians in resource-limited settings. To improve this situation, we propose that a family of standardized multidisciplinary components is needed, a set of "building blocks" that perform a wide array of different tasks and are designed to integrate together. Using these components, scientists, engineers, and clinicians would be able to build custom instruments for their own unique needs quickly and easily. In this work we present the foundation of this set of components, a system we call Multifluidic Evolutionary Components (MECs). "Multifluidic" conveys the wide range of fluid volumes MECs operate upon (from nanoliters to milliliters and beyond); "multi" also reflects the multiple disciplines supported by the system (not only fluidics but also electronics, optics, and mechanics). "Evolutionary" refers to the design principles that enable the library of MEC parts to easily grow and adapt to new applications. Each MEC "building block" performs a fundamental function that is commonly found in biological or chemical instruments, functions like valving, pumping, mixing, controlling, and sensing. Each MEC also has a unique symbol linked to a physical definition, which enables instruments to be designed rapidly and efficiently using schematics. As a proof-of-concept, we use MECs to build a variety of instruments, including a fluidic routing and mixing system capable of manipulating fluid volumes over five orders of magnitude, an acid-base titration instrument suitable for use in schools, and a bioreactorsuitable for maintaining and analyzing cell cultures in research and diagnostic applications. These are the first of many instruments that can be built by researchers, clinicians, and students using the MEC system.	[Hill, Douglas A.; Anderson, Lindsey E.; Hill, Casey J.; Mostaghim, Afshin; Rodgers, Victor G. J.; Grover, William H.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Riverside	Grover, WH (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	wgrover@engr.ucr.edu	Rodgers, Victor G/G-3652-2016; Rodgers, Victor G. J./AAF-3838-2021	Rodgers, Victor G/0000-0002-1857-8025; Rodgers, Victor G. J./0000-0002-1857-8025; Grover, William/0000-0001-6854-8951	Instrument Development for Biological Research (IDBR) program of the National Science Foundation [DBI-1353974]; Center for Bioengineering Research, University of California Riverside; Center for Bioengineering Research at the University of California, Riverside; Direct For Biological Sciences [1353974] Funding Source: National Science Foundation	Instrument Development for Biological Research (IDBR) program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Center for Bioengineering Research, University of California Riverside; Center for Bioengineering Research at the University of California, Riverside; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Instrument Development for Biological Research (IDBR) program of the National Science Foundation under award DBI-1353974 (http://www.nsf.gov). The authors gratefully acknowledge funding from Prof. Jerome Schultz and the Center for Bioengineering Research, University of California Riverside (http://www.bioeng.ucr.edu/research/cbr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Instrument Development for Biological Research (IDBR) program of the National Science Foundation under award DBI-1353974. The authors gratefully acknowledge funding from Prof. Jerome Schultz and the Center for Bioengineering Research at the University of California, Riverside.	[Anonymous], 2016, OPEN STANDARD MEC IN; Bhargava KC, 2014, P NATL ACAD SCI USA, V111, P15013, DOI 10.1073/pnas.1414764111; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Galdieri L, 2010, OMICS, V14, P629, DOI 10.1089/omi.2010.0069; Gonzalez C, 1998, SENSOR ACTUAT B-CHEM, V49, P40, DOI 10.1016/S0925-4005(98)00035-5; Li WT, 2012, LAB CHIP, V12, P1587, DOI 10.1039/c2lc40125h; Moore G. E., 1965, CRAMMING MORE COMPON, P114; National Research Council, 2012, FRAM K 12 SCI ED PRA; Rhee M, 2008, LAB CHIP, V8, P1365, DOI 10.1039/b805137b; Simpson PC, 1998, BIOMED MICRODEVICES, V1, P7, DOI 10.1023/A:1009922004301; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Yuen PK, 2009, LAB CHIP, V9, P3303, DOI 10.1039/b912295h	12	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158706	10.1371/journal.pone.0158706	http://dx.doi.org/10.1371/journal.pone.0158706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437989	gold, Green Published			2022-12-27	WOS:000380170100017
J	Huang, Y; Su, LQ; Wu, J				Huang, Yan; Su, Lingqia; Wu, Jing			Pyridoxine Supplementation Improves the Activity of Recombinant Glutamate Decarboxylase and the Enzymatic Production of Gama-Aminobutyric Acid	PLOS ONE			English	Article							HYDROXYBUTYRIC ACID; BINDING-SITE; GABA; EXPRESSION; RESISTANCE; CLONING; GENE	Glutamate decarboxylase (GAD) catalyzes the irreversible decarboxylation of L-glutamate to the valuable food supplement gamma-aminobutyric acid (GABA). In this study, GAD from Escherichia coli K12, a pyridoxal phosphate (PLP)-dependent enzyme, was overexpressed in E. coli. The GAD produced in media supplemented with 0.05 mM soluble vitamin B-6 analog pyridoxine hydrochloride (GAD-V) activity was 154.8 U mL(-1), 1.8-fold higher than that of GAD obtained without supplementation (GAD-C). Purified GAD-V exhibited increased activity (193.4 U mg(-1), 1.5-fold higher than that of GAD-C), superior thermostability (2.8-fold greater than that of GAD-C), and higher k(cat)/K-m (1.6-fold higher than that of GAD-C). Under optimal conditions in reactions mixtures lacking added PLP, crude GAD-V converted 500 g L-1 monosodium glutamate (MSG) to GABA with a yield of 100%, and 750 g L-1 MSG with a yield of 88.7%. These results establish the utility of pyridoxine supplementation and lay the foundation for large-scale enzymatic production of GABA.	[Huang, Yan; Su, Lingqia; Wu, Jing] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Huang, Yan; Su, Lingqia; Wu, Jing] Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China; [Huang, Yan; Su, Lingqia; Wu, Jing] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Wu, J (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China.	jingwu@jiangnan.edu.cn	Wu, Jing/GZK-5063-2022		National Science Fund for Distinguished Young Scholars [31425020]; 111 Project [111-2-06]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 111 Project(Ministry of Education, China - 111 Project)	This work received financial support from the National Science Fund for Distinguished Young Scholars (No. 31425020), received by Jing Wu and the 111 Project (No. 111-2-06), received by Jing Wu.; This work received financial support from the National Science Fund for Distinguished Young Scholars (31425020), and the 111 Project (No. 111-2-06).	Ahboucha S, 2003, NEUROCHEM INT, V43, P551, DOI 10.1016/S0197-0186(03)00065-2; Chen XY, 2014, PROCESS BIOCHEM, V49, P1429, DOI 10.1016/j.procbio.2014.05.019; DEMPSEY WB, 1971, J BACTERIOL, V108, P415, DOI 10.1128/JB.108.1.415-421.1971; Dhakal R, 2012, BRAZ J MICROBIOL, V43, P1230, DOI 10.1590/S1517-83822012000400001; Fan EY, 2012, ANN MICROBIOL, V62, P689, DOI 10.1007/s13213-011-0307-5; Gut H, 2006, EMBO J, V25, P2643, DOI 10.1038/sj.emboj.7601107; Hagiwara H, 2004, BIOSCI BIOTECH BIOCH, V68, P444, DOI 10.1271/bbb.68.444; Hu RQ, 2000, NEUROPHARMACOLOGY, V39, P427, DOI 10.1016/S0028-3908(99)00152-5; Ito Y, 2013, J NEUROSCI, V 33, P17166, DOI 10.1523/JNEUROSCI.0897-13.2013; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Jiang DH, 2013, ANN MICROBIOL, V63, P487, DOI 10.1007/s13213-012-0493-9; Komatsuzaki N, 2005, FOOD MICROBIOL, V22, P497, DOI 10.1016/j.fm.2005.01.002; Li HX, 2010, AMINO ACIDS, V38, P1439, DOI 10.1007/s00726-009-0355-3; MANYAM BV, 1981, ANN NEUROL, V10, P35, DOI 10.1002/ana.410100107; Ho NAT, 2013, J BIOSCI BIOENG, V115, P154, DOI 10.1016/j.jbiosc.2012.09.002; Oh CH, 2004, J MED FOOD, V7, P19, DOI 10.1089/109662004322984653; Plokhov AY, 2000, APPL BIOCHEM BIOTECH, V88, P257, DOI 10.1385/ABAB:88:1-3:257; Qu KB, 1998, PROTEIN SCI, V7, P1092, DOI 10.1002/pro.5560070503; SASKIAWAN I., 2008, MICROBIOL INDONES, V2, P5; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STRAUSBA.PH, 1970, BIOCHEMISTRY-US, V9, P233, DOI 10.1021/bi00804a007; Vo TDL, 2013, BIOTECHNOL BIOPROC E, V18, P1062, DOI 10.1007/s12257-013-0282-8; Tam DLV, 2012, BIOPROC BIOSYST ENG, V35, P645, DOI 10.1007/s00449-011-0634-8; Ueno H, 2000, J MOL CATAL B-ENZYM, V10, P67, DOI 10.1016/S1381-1177(00)00114-4; Vella JG, 1980, VITAMIN B6 BIOSYNTHE; Wang Q, 2011, WORLD J MICROB BIOT, V27, P693, DOI 10.1007/s11274-010-0508-2; Wong CGT, 2003, ANN NEUROL, V54, pS3, DOI 10.1002/ana.10696; Yokoyama S, 2002, J BIOSCI BIOENG, V93, P95, DOI 10.1263/jbb.93.95; Zeng Zhen, 2012, African Journal of Biotechnology, V11, P11333	29	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0157466	10.1371/journal.pone.0157466	http://dx.doi.org/10.1371/journal.pone.0157466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438707	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100002
J	Ouyang, KX; Li, JC; Zhao, XH; Que, QM; Li, P; Huang, H; Deng, XM; Singh, SK; Wu, AM; Chen, XY				Ouyang, Kunxi; Li, Juncheng; Zhao, Xianhai; Que, Qingmin; Li, Pei; Huang, Hao; Deng, Xiaomei; Singh, Sunil Kumar; Wu, Ai-Min; Chen, Xiaoyang			Transcriptomic Analysis of Multipurpose Timber Yielding Tree Neolamarckia cadamba during Xylogenesis Using RNA-Seq	PLOS ONE			English	Article							CELL-WALL BIOSYNTHESIS; VASCULAR-RELATED NAC-DOMAIN7; WOOD FORMATION; LIGNIN BIOSYNTHESIS; DIRECT TARGET; ARABIDOPSIS; GENES; PROTEIN; SND1; EXPRESSION	Neolamarckia cadamba is a fast-growing tropical hardwood tree that is used extensively for plywood and pulp production, light furniture fabrication, building materials, and as a raw material for the preparation of certain indigenous medicines. Lack of genomic resources hampers progress in the molecular breeding and genetic improvement of this multipurpose tree species. In this study, transcriptome profiling of differentiating stems was performed to understand N. cadamba xylogenesis. The N. cadamba transcriptome was sequenced using Illumina paired-end sequencing technology. This generated 42.49 G of raw data that was then de novo assembled into 55,432 UniGenes with a mean length of 803.2bp. Approximately 47.8% of the UniGenes (26,487) were annotated against publically available protein databases, among which 21,699 and 7,754 UniGenes were assigned to Gene Ontology categories (GO) and Clusters of Orthologous Groups (COG), respectively. 5,589 UniGenes could be mapped onto 116 pathways using the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database. Among 6,202 UniGenes exhibiting differential expression during xylogenesis, 1,634 showed significantly higher levels of expression in the basal and middle stem segments compared to the apical stem segment. These genes included NAC and MYB transcription factors related to secondary cell wall biosynthesis, genes related to most metabolic steps of lignin biosynthesis, and CesA genes involved in cellulose biosynthesis. This study lays the foundation for further screening of key genes associated with xylogenesis in N. cadamba as well as enhancing our understanding of the mechanism of xylogenesis in fast-growing trees.	[Ouyang, Kunxi; Li, Juncheng; Zhao, Xianhai; Que, Qingmin; Li, Pei; Wu, Ai-Min; Chen, Xiaoyang] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Ouyang, Kunxi; Li, Juncheng; Zhao, Xianhai; Que, Qingmin; Li, Pei; Deng, Xiaomei; Wu, Ai-Min; Chen, Xiaoyang] Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou, Guangdong, Peoples R China; [Ouyang, Kunxi; Li, Juncheng; Zhao, Xianhai; Que, Qingmin; Li, Pei; Wu, Ai-Min; Chen, Xiaoyang] Guangdong Prov Res Ctr Woody Forage Engn Technol, Guangzhou, Guangdong, Peoples R China; [Ouyang, Kunxi; Li, Juncheng; Zhao, Xianhai; Que, Qingmin; Li, Pei; Deng, Xiaomei; Wu, Ai-Min; Chen, Xiaoyang] South China Agr Univ, Coll Forestry & Landscape Architecture, Guangzhou, Guangdong, Peoples R China; [Huang, Hao] Guangxi Bot Garden Med Plants, Nanning, Peoples R China; [Singh, Sunil Kumar] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Bot, Vadodara, Gujarat, India	South China Agricultural University; South China Agricultural University; Maharaja Sayajirao University Baroda	Wu, AM; Chen, XY (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.; Wu, AM; Chen, XY (corresponding author), Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou, Guangdong, Peoples R China.; Wu, AM; Chen, XY (corresponding author), Guangdong Prov Res Ctr Woody Forage Engn Technol, Guangzhou, Guangdong, Peoples R China.; Wu, AM; Chen, XY (corresponding author), South China Agr Univ, Coll Forestry & Landscape Architecture, Guangzhou, Guangdong, Peoples R China.	wuaimin@scau.edu.cn; xychen@scau.edu.cn	Wu, Aimin/AAG-9747-2020; zhao, xianhai/AAT-6896-2020	Wu, Aimin/0000-0001-8322-8833; zhao, xianhai/0000-0002-2080-5629; Singh, Sunil Kumar/0000-0001-6682-1512	National Science Foundation of China [31470681]; special funds project of Forestry Public Welfare Industry Research of China [201004020]; State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources in China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); special funds project of Forestry Public Welfare Industry Research of China; State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources in China	This work was supported by the National Science Foundation of China (Grant Number 31470681), the special funds project of Forestry Public Welfare Industry Research of China (Grant Number 201004020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Science Foundation of China (Grant Number 31470681), the special funds project of Forestry Public Welfare Industry Research of China (Grant Number 201004020) and State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources in China.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ATANASSOVA R, 1995, PLANT J, V8, P465, DOI 10.1046/j.1365-313X.1995.8040465.x; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bromley JR, 2013, PLANT J, V74, P423, DOI 10.1111/tpj.12135; BROWN RT, 1976, TETRAHEDRON LETT, P1629, DOI 10.1016/S0040-4039(01)91635-1; Carvalho Ana, 2013, Mol Biol Int, V2013, P974324, DOI 10.1155/2013/974324; Chan RL, 1998, BBA-GENE STRUCT EXPR, V1442, P1, DOI 10.1016/S0167-4781(98)00119-5; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Do CT, 2007, PLANTA, V226, P1117, DOI 10.1007/s00425-007-0558-3; Dubey A, 2011, PHARMACOGNOSY J, V2, P71, DOI [10.1016/S0975-3575(11)80029-5, DOI 10.1016/S0975-3575(11)80029-5]; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HANDA SS, 1983, J NAT PROD, V46, P325, DOI 10.1021/np50027a005; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang H, 2014, PLANT BIOTECHNOL-NAR, V31, P115, DOI 10.5511/plantbiotechnology.14.0125a; Jan A, 2013, PLANT PHYSIOL, V161, P1202, DOI 10.1104/pp.112.205385; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Ko JH, 2009, PLANT J, V60, P649, DOI 10.1111/j.1365-313X.2009.03989.x; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Lal M, 2010, TAPPI J, V9, P30; Lee CH, 2009, PLANT CELL PHYSIOL, V50, P812, DOI 10.1093/pcp/pcp025; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lin YC, 2013, PLANT CELL, V25, P4324, DOI 10.1105/tpc.113.117697; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Ohman D, 2013, PLANT J, V73, P63, DOI 10.1111/tpj.12018; Ouyang KX, 2013, GENET MOL RES, V12, P1061, DOI 10.4238/2013.April.10.2; Ouyang KX, 2014, BIOTECHNOL BIOTEC EQ, V28, P1008, DOI 10.1080/13102818.2014.981086; Pan QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043038; Paux E, 2004, PLANT MOL BIOL, V55, P263, DOI 10.1007/s11103-004-0621-4; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Schuetz M, 2013, J EXP BOT, V64, P11, DOI 10.1093/jxb/ers287; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Suzuki S, 2006, PLANT PHYSIOL, V142, P1233, DOI 10.1104/pp.106.086678; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Xu B, 2014, SCIENCE, V343, P1505, DOI 10.1126/science.1248417; Xu XY, 2011, J ASIAN NAT PROD RES, V13, P1008, DOI 10.1080/10286020.2011.606812; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Yamaguchi M, 2011, PLANT J, V66, P579, DOI [10.1111/j.1365-313X.2011.04514.x, 10.1111/j.1365-313x.2011.04514.x]; Yamaguchi M, 2010, PLANT PHYSIOL, V153, P906, DOI 10.1104/pp.110.154013; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang FS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105765; Zhang J, 2011, CURR OPIN BIOTECH, V22, P293, DOI 10.1016/j.copbio.2010.11.008; Zhao XH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00602; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	73	18	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159407	10.1371/journal.pone.0159407	http://dx.doi.org/10.1371/journal.pone.0159407			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438485	Green Submitted, Green Published, gold			2022-12-27	WOS:000380170100043
J	Balzarotti, S; Colombo, B				Balzarotti, Stefania; Colombo, Barbara			Effects of Unilateral Transcranial Direct Current Stimulation of Left Prefrontal Cortex on Processing and Memory of Emotional Visual Stimuli	PLOS ONE			English	Article							MAJOR DEPRESSION; FACIAL EXPRESSIONS; HEMISPHERIC-DIFFERENCES; NEURAL MECHANISMS; DOUBLE-BLIND; BRAIN; TDCS; PERCEPTION; VALENCE; MODULATION	The dorsolateral prefrontal cortex (DLPFC) is generally thought to be involved in affect and emotional processing; however, the specific contribution of each hemisphere continues to be debated. In the present study, we employed unilateral tDCS to test the unique contribution of left DLPFC in the encoding and retrieval of emotional stimuli in healthy subjects. Forty-two right handed undergraduate students received either anodal, cathodal or sham stimulation of left DLPFC while viewing neutral, pleasant, and unpleasant pictures. After completing a filler task, participants were asked to remember as many pictures as possible. Results showed that participants were able to remember a larger amount of emotional (both pleasant and unpleasant) pictures than of neutral ones, regardless of the type of tDCS condition. Participants who received anodal stimulation recalled a significantly higher number of pleasant images than participants in the sham and cathodal conditions, while no differences emerged in the recall of neutral and unpleasant pictures. We conclude that our results provide some support to the role of left prefrontal cortex in the encoding and retrieval of pleasant stimuli.	[Balzarotti, Stefania; Colombo, Barbara] Univ Cattolica Sacro Cuore, Dept Psychol, Largo Gemelli 1, I-20123 Milan, Italy; [Colombo, Barbara] Champlain Coll, Div Educ & Human Studies, 251 South Willard St, Burlington, VT 05402 USA	Catholic University of the Sacred Heart	Colombo, B (corresponding author), Univ Cattolica Sacro Cuore, Dept Psychol, Largo Gemelli 1, I-20123 Milan, Italy.; Colombo, B (corresponding author), Champlain Coll, Div Educ & Human Studies, 251 South Willard St, Burlington, VT 05402 USA.	bcolombo@champlain.edu	Colombo, Barbara/E-9443-2019	Colombo, Barbara/0000-0002-4095-9633; BALZAROTTI, Stefania/0000-0002-9273-8496				Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P516, DOI 10.1037//0894-4105.15.4.516; AHERN GL, 1985, NEUROPSYCHOLOGIA, V23, P745, DOI 10.1016/0028-3932(85)90081-8; Asthana Manish, 2013, Front Psychiatry, V4, P107, DOI 10.3389/fpsyt.2013.00107; Austin A, 2015, ARXIV151002261; Berlim MT, 2013, J PSYCHIATR RES, V47, P1, DOI 10.1016/j.jpsychires.2012.09.025; Bloise SM, 2007, MEMORY, V15, P192, DOI 10.1080/09658210701204456; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; Boggio PS, 2009, J AFFECT DISORDERS, V101, P91; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; Fregni F, 2006, BIPOLAR DISORD, V8, P203, DOI 10.1111/j.1399-5618.2006.00291.x; Grimm S, 2006, NEUROIMAGE, V30, P325, DOI 10.1016/j.neuroimage.2005.09.006; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Griskevicius V, 2010, EMOTION, V10, P190, DOI 10.1037/a0018421; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Hecht D, 2010, NEUROSCI RES, V68, P77, DOI 10.1016/j.neures.2010.06.013; Heller W, 1997, COGNITION EMOTION, V11, P637, DOI 10.1080/026999397379845a; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jansari A, 2000, COGNITION EMOTION, V14, P341, DOI 10.1080/026999300378860; Kalu UG, 2012, PSYCHOL MED, V42, P1791, DOI 10.1017/S0033291711003059; Kensinger EA, 2004, REV NEUROSCIENCE, V15, P241, DOI 10.1515/REVNEURO.2004.15.4.241; Koenigs M, 2009, CLIN NEUROPHYSIOL, V120, P80, DOI 10.1016/j.clinph.2008.10.010; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lang PJ, A6 U FLOR; LEY RG, 1979, BRAIN LANG, V7, P127, DOI 10.1016/0093-934X(79)90010-5; Maeoka H, 2012, NEUROSCI LETT, V512, P12, DOI 10.1016/j.neulet.2012.01.037; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Morgan HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092162; Nitsche M A, 2012, Front Psychiatry, V3, P58, DOI 10.3389/fpsyt.2012.00058; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2003, J PHYSIOL-LONDON, V527, P633; Nitsche MA, 2009, EXP NEUROL, V219, P14, DOI 10.1016/j.expneurol.2009.03.038; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Nitschke JB, 2004, BIOL PSYCHOL, V67, P125, DOI 10.1016/j.biopsycho.2004.03.004; Palm U, 2012, BRAIN STIMUL, V5, P242, DOI 10.1016/j.brs.2011.08.005; Pena-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022812; Penolazzi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010623; Priori A, 2003, CLIN NEUROPHYSIOL, V114, P589, DOI 10.1016/S1388-2457(02)00437-6; Quene H, 2008, J MEM LANG, V59, P413, DOI 10.1016/j.jml.2008.02.002; Rodway P, 2003, BRAIN COGNITION, V53, P452, DOI 10.1016/S0278-2626(03)00217-3; Sergerie K, 2005, NEUROIMAGE, V24, P580, DOI 10.1016/j.neuroimage.2004.08.051; Tamietto M, 2006, EXP BRAIN RES, V171, P389, DOI 10.1007/s00221-005-0279-4; Tremblay S, 2014, BRAIN STIMUL, V7, P773, DOI 10.1016/j.brs.2014.10.003; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Wager TD, 2003, NEUROIMAGE, V19, P513; WEDDING D, 1985, INT J NEUROSCI, V27, P277, DOI 10.3109/00207458509149773; Weigand A, 2013, EXP BRAIN RES, V227, P43, DOI 10.1007/s00221-013-3483-7; Yekta M., 2015, PRACTICE CLIN PSYCHO, V3, P185	56	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159555	10.1371/journal.pone.0159555	http://dx.doi.org/10.1371/journal.pone.0159555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433807	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169600071
J	Dennison, L; Smith, EM; Bradbury, K; Galea, I				Dennison, Laura; Smith, Ellen McCloy; Bradbury, Katherine; Galea, Ian			How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study	PLOS ONE			English	Article							NATURAL-HISTORY; ADJUSTMENT	Background Disease progression in multiple sclerosis (MS) is highly variable and predicting prognosis is notoriously challenging. Patients' prognosis beliefs, responses to prognostic uncertainty and experiences of prognosis-related communication with healthcare professionals (HCPs) have received little study. These issues have implications for patients' psychological adjustment and are important in the context of the recent development of personalised prognosis forecasting tools. This study explored patient perspectives on the experience of prognostic uncertainty, the formation of expectations about personal prognosis and the nature of received and desired prognosis communication. Methods 15 MS patients participated in in-depth semi-structured interviews which were analysed using inductive thematic analysis. Results Six themes captured key aspects of the data: Experiencing unsatisfactory communication with HCPs, Appreciating and accepting prognostic uncertainty, Trying to stay present-focused, Forming and editing personal prognosis beliefs, Ambivalence towards forecasting the future, and Prognosis information delivery. MS patients report having minimal communication with HCPs about prognosis. Over time MS patients appear to develop expectations about their disease trajectories, but do so with minimal HCP input. Provision of prognosis information by HCPs seems to run counter to patients' attempts to remain present-focused. Patients are often ambivalent about prognosis forecasting and consider it emotionally dangerous and of circumscribed usefulness. Conclusions HCPs must carefully consider whether, when and how to share prognosis information with patients; specific training may be beneficial. Future research should confirm findings about limited HCP-patient communication, distinguish predictors of patients' attitudes towards prognostication and identify circumstances under which prognostic forecasting benefits patients.	[Dennison, Laura; Bradbury, Katherine] Univ Southampton, Acad Unit Psychol, Southampton, Hants, England; [Smith, Ellen McCloy] Univ Southampton, Fac Med, Southampton, Hants, England; [Galea, Ian] Univ Southampton, Fac Med, Clin & Expt Sci, Clin Neurosci, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton	Dennison, L (corresponding author), Univ Southampton, Acad Unit Psychol, Southampton, Hants, England.	l.k.dennison@soton.ac.uk	Galea, Ian/B-7997-2011	Galea, Ian/0000-0002-1268-5102; Bradbury, Katherine/0000-0001-5513-7571; Dennison, Laura/0000-0003-0122-6610	UK MS Register; MS Society	UK MS Register; MS Society	The authors would like to thank the 15 people with MS who participated and the UK MS Register and MS Society for supporting recruitment.	Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Buecken R, 2012, PATIENT EDUC COUNS, V88, P318, DOI 10.1016/j.pec.2012.03.010; Daumer M, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-11; Degenhardt A, 2009, NAT REV NEUROL, V5, P672, DOI 10.1038/nrneurol.2009.178; Dennison L, 2013, PSYCHOL HEALTH, V28, P973, DOI 10.1080/08870446.2013.767904; Dennison L, 2011, J HEALTH PSYCHOL, V16, P478, DOI 10.1177/1359105310384299; Dennison L, 2010, J PSYCHOSOM RES, V69, P353, DOI 10.1016/j.jpsychores.2010.04.009; Dennison L, 2009, CLIN PSYCHOL REV, V29, P141, DOI 10.1016/j.cpr.2008.12.001; Edwards RG, 2008, J EVAL CLIN PRACT, V14, P460, DOI 10.1111/j.1365-2753.2007.00902.x; Finlayson M., 2005, BRIT J OCCUPATIONAL, V68, P117, DOI DOI 10.1177/030802260506800304; Galea I, 2013, EUR J NEUROL, V20, P1107, DOI 10.1111/ene.12016; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Heesen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059042; Jopson NM, 2003, J PSYCHOSOM RES, V54, P503, DOI 10.1016/S0022-3999(02)00455-5; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mackenzie IS, 2014, J NEUROL NEUROSUR PS, V85, P76, DOI 10.1136/jnnp-2013-305450; Malcomson KS, 2008, DISABIL REHABIL, V30, P662, DOI 10.1080/09638280701400730; Mishel M H, 1990, Image J Nurs Sch, V22, P256; Moss-Morris R, 2013, BRIT J HEALTH PSYCH, V18, P681, DOI 10.1111/bjhp.12072; Nerenz, 1980, CONTRIBUTIONS MED PS, V2, P7, DOI DOI 10.1093/GERONJ/46.4.P181; NICE, 2014, MULT SCLER AD MAN CG; Solari A, 2014, MULT SCLER J, V20, P397, DOI 10.1177/1352458514523061; Somerset Maggie, 2002, J Health Serv Res Policy, V7, P151, DOI 10.1258/135581902760082454; Synnot AJ, 2016, HEALTH EXPECT, V19, P727, DOI 10.1111/hex.12253; Tams R, 2016, NEUROREHABILITATION, V38, P257, DOI 10.3233/NRE-161317	27	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158982	10.1371/journal.pone.0158982	http://dx.doi.org/10.1371/journal.pone.0158982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434641	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000380169600026
J	Mokhtar, MM; Adawy, SS; El-Assal, SEDS; Hussein, EHA				Mokhtar, Morad M.; Adawy, Sami S.; El-Assal, Salah El-Din S.; Hussein, Ebtissam H. A.			Genic and Intergenic SSR Database Generation, SNPs Determination and Pathway Annotations, in Date Palm (Phoenix dactylifera L.)	PLOS ONE			English	Article							IN-SILICO ANALYSIS; MICROSATELLITE MARKERS; EST-SSR; SEQUENCE; GENOME; FREQUENCY; GENES	The present investigation was carried out aiming to use the bioinformatics tools in order to identify and characterize, simple sequence repeats within the third Version of the date palm genome and develop a new SSR primers database. In addition single nucleotide polymorphisms (SNPs) that are located within the SSR flanking regions were recognized. Moreover, the pathways for the sequences assigned by SSR primers, the biological functions and gene interaction were determined. A total of 172,075 SSR motifs was identified on date palm genome sequence with a frequency of 450.97 SSRs per Mb. Out of these, 130,014 SSRs (75.6%) were located within the intergenic regions with a frequency of 499 SSRs per Mb. While, only 42,061 SSRs (24.4%) were located within the genic regions with a frequency of 347.5 SSRs per Mb. A total of 111,403 of SSR primer pairs were designed, that represents 291.9 SSR primers per Mb. Out of the 111,403, only 31,380 SSR primers were in the genic regions, while 80,023 primers were in the intergenic regions. A number of 250,507 SNPs were recognized in 84,172 SSR flanking regions, which represents 75.55% of the total SSR flanking regions. Out of 12,274 genes only 463 genes comprising 896 SSR primers were mapped onto 111 pathways using KEGG data base. The most abundant enzymes were identified in the pathway related to the biosynthesis of antibiotics. We tested 1031 SSR primers using both publicly available date palm genome sequences as templates in the in silico PCR reactions. Concerning in vitro validation, 31 SSR primers among those used in the in silico PCR were synthesized and tested for their ability to detect polymorphism among six Egyptian date palm cultivars. All tested primers have successfully amplified products, but only 18 primers detected polymorphic amplicons among the studied date palm cultivars.	[Mokhtar, Morad M.; Adawy, Sami S.; Hussein, Ebtissam H. A.] ARC, Mol Genet & Genome Mapping Lab, Agr Genet Engn Res Inst, Giza, Egypt; [El-Assal, Salah El-Din S.; Hussein, Ebtissam H. A.] Cairo Univ, Dept Genet, Fac Agr, Giza, Egypt	Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); Cairo University	Mokhtar, MM (corresponding author), ARC, Mol Genet & Genome Mapping Lab, Agr Genet Engn Res Inst, Giza, Egypt.	morad.mokhtar@ageri.sci.eg	Mokhtar, Morad M./H-4715-2019; Mokhtar, Morad/GWV-2705-2022	Mokhtar, Morad M./0000-0002-9540-0458; 				Adawy S.S., 2005, ARAB J BIOTECHNOL, V8, P99; Adawy S.S., 2015, INT J SCI RES, V14, P1063; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Al-Farsi MA, 2008, CRIT REV FOOD SCI, V48, P877, DOI 10.1080/10408390701724264; Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; Barrow Sasha C., 1998, Kew Bulletin, V53, P513, DOI 10.2307/4110478; Beal JM, 1937, BOT GAZ, V99, P400, DOI 10.1086/334708; Billotte N, 2004, MOL ECOL NOTES, V4, P256, DOI 10.1111/j.1471-8286.2004.00634.x; Cardle L, 2000, GENETICS, V156, P847; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; Elhoumaizi MA, 2002, GENET RESOUR CROP EV, V49, P483, DOI 10.1023/A:1020968513494; Elmeer K, 2011, 3 BIOTECH, V1, P91, DOI 10.1007/s13205-011-0010-z; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; Hamwieh A, 2010, ACTA HORTIC, V882, P269; Hussein EHA, 2005, ARAB J BIOTECH JAN, V8, P83; Jia XP, 2007, GENET RESOUR CROP EV, V54, P233, DOI 10.1007/s10722-006-9139-8; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaur R, 2015, TURKISH J AGR FOR, V39, P1; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mun JH, 2006, GENETICS, V172, P2541, DOI 10.1534/genetics.105.054791; Pinto LR, 2004, GENOME, V47, P795, DOI [10.1139/g04-055, 10.1139/G04-055]; Rajendrakumar Passoupathy, 2008, In Silico Biology, V8, P87; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zhang GY, 2012, PLANT MOL BIOL, V79, P521, DOI 10.1007/s11103-012-9924-z; Zhao YL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-237; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319	36	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159268	10.1371/journal.pone.0159268	http://dx.doi.org/10.1371/journal.pone.0159268			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434138	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600043
J	Deng, HY; Liu, Q; Cao, W; Gui, R; Ma, CZ; Yi, M; Yao, YG				Deng, Haiyou; Liu, Quan; Cao, Wei; Gui, Rong; Ma, Chengzhang; Yi, Ming; Yao, Yuangen			qiRNApredictor: A Novel Computational Program for the Prediction of qiRNAs in Neurospora crassa	PLOS ONE			English	Article							MICRORNA-LIKE RNAS; NONCODING RNAS; RANDOM FOREST; IDENTIFICATION; CLASSIFICATION	Recently, a new type of small interfering RNAs (qiRNAs) of typically 20 similar to 21 nucleotides was found in Neurospora crassa and rice and has been shown to regulate gene silencing in the DNA damage response. Identification of qiRNAs is fundamental for dissecting regulatory functions and molecular mechanisms. In contrast to other expensive and time-consuming experimental methods, the computational prediction of qiRNAs is a conveniently rapid method for gaining valuable information for a subsequent experimental verification. However, no tool existed to date for the prediction of qiRNAs. To this purpose, we developed the novel qiRNA prediction software package qiRNApredictor. This software demonstrates a promising sensitivity of 93.55% and a specificity of 71.61% from the leave-one-out validation. These studies might be beneficial for further experimental investigation. Furthermore, the local package of qiRNApredictor was implemented and made freely available to the academic community at Supplementary material.	[Deng, Haiyou; Liu, Quan; Cao, Wei; Gui, Rong; Ma, Chengzhang; Yi, Ming; Yao, Yuangen] Huazhong Agr Univ, Coll Sci, Dept Phys, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Yao, YG (corresponding author), Huazhong Agr Univ, Coll Sci, Dept Phys, Wuhan, Hubei, Peoples R China.	yyg@mail.hzau.edu.cn	Yao, Yuangen/D-9327-2018; Yi, Ming/B-5383-2011; Yi, Ming/AAB-7928-2022	Yao, Yuangen/0000-0001-6967-2487; Yi, Ming/0000-0001-7198-5511; Yi, Ming/0000-0001-7534-3049	Innovation Fund of Huazhong Agricultural University [2662014BQ069, 2662015BQ045]	Innovation Fund of Huazhong Agricultural University	This work was supported by grants from Innovation Fund of Huazhong Agricultural University (2662014BQ069 YY; 2662015BQ045 HD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Bai YH, 2015, FUNGAL GENET BIOL, V81, P113, DOI 10.1016/j.fgb.2015.03.004; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055252; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104956; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chen Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12500; Dahlmann TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125989; Hertzberg L, 2005, J COMPUT BIOL, V12, P314, DOI 10.1089/cmb.2005.12.314; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076288; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Lau SKP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002398; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lin YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123245; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Yang F, 2015, FUNGAL BIOL-UK, V119, P631, DOI 10.1016/j.funbio.2015.03.008; Yao YG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-117; Zhang Y, 2011, BIOINFORMATICS, V27, P771, DOI 10.1093/bioinformatics/btr016; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8; Zhou Q, 2012, FUNGAL BIOL-UK, V116, P1156, DOI 10.1016/j.funbio.2012.09.001	28	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159487	10.1371/journal.pone.0159487	http://dx.doi.org/10.1371/journal.pone.0159487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428111	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300071
J	Hall, ANB; Joseph, B; Brelsfoard, JM; Saatman, KE				Hall, Amanda N. Bolton; Joseph, Binoy; Brelsfoard, Jennifer M.; Saatman, Kathryn E.			Repeated Closed Head Injury in Mice Results in Sustained Motor and Memory Deficits and Chronic Cellular Changes	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MOUSE MODEL; AXONAL INJURY; COGNITIVE IMPAIRMENT; ASTROCYTE ACTIVATION; OPTIC-NERVE; MILD; NEURODEGENERATION; ENCEPHALOPATHY; EPIDEMIOLOGY	Millions of mild traumatic brain injuries (TBIs) occur every year in the United States, with many people subject to multiple head injuries that can lead to chronic behavioral dysfunction. We previously reported that mild TBI induced using closed head injuries (CHI) repeated at 24h intervals produced more acute neuron death and glial reactivity than a single CHI, and increasing the length of time between injuries to 48h reduced the cumulative acute effects of repeated CHI. To determine whether repeated CHI is associated with behavioral dysfunction or persistent cellular damage, mice receiving either five CHI at 24h intervals, five CHI at 48h intervals, or five sham injuries at 24h intervals were evaluated across a 10 week period after injury. Animals with repeated CHI exhibited motor coordination and memory deficits, but not gait abnormalities when compared to sham animals. At 10wks post-injury, no notable neuron loss or glial reactivity was observed in the cortex, hippocampus, or corpus callosum. Argyrophilic axons were found in the pyramidal tract of some injured animals, but neither silver stain accumulation nor inflammatory responses in the injury groups were statistically different from the sham group in this region. However, argyrophilic axons, microgliosis and astrogliosis were significantly increased within the optic tract of injured animals. Repeated mild CHI also resulted in microgliosis and a loss of neurofilament protein 200 in the optic nerve. Lengthening the inter-injury interval from 24h to 48h did not effectively reduce these behavioral or cellular responses. These results suggest that repeated mild CHI results in persistent behavioral dysfunction and chronic pathological changes within the visual system, neither of which was significantly attenuated by lengthening the inter-injury interval from 24h to 48h.	[Hall, Amanda N. Bolton; Joseph, Binoy; Brelsfoard, Jennifer M.; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA; [Hall, Amanda N. Bolton; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA; [Saatman, Kathryn E.] Univ Kentucky, Coll Med, Dept Neurosurg, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Kentucky	Saatman, KE (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA.; Saatman, KE (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA.; Saatman, KE (corresponding author), Univ Kentucky, Coll Med, Dept Neurosurg, Lexington, KY 40506 USA.	k.saatman@uky.edu			National Institute of Neurological Disorders and Stroke [T32 NS077889, F31 NS087878-02, P30 NS051220]; Kentucky Spinal Cord and Head Injury Trust [14-13A, 9-13]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Kentucky Spinal Cord and Head Injury Trust	This study was supported by the National Institute of Neurological Disorders and Stroke T32 NS077889 and National Institute of Neurological Disorders and Stroke F31 NS087878-02 (ANBH); National Institute of Neurological Disorders and Stroke P30 NS051220, Kentucky Spinal Cord and Head Injury Trust 14-13A, Kentucky Spinal Cord and Head Injury Trust 9-13 (KES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Balaratnasingam C, 2010, INVEST OPHTH VIS SCI, V51, P3019, DOI 10.1167/iovs.09-4692; Bennett RE, 2014, J NEUROTRAUM, V31, P1647, DOI 10.1089/neu.2013.3320; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GRONWALL D, 1975, LANCET, V2, P995; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Huynh T, 2006, AM SURGEON, V72, P1162; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Luo Jian, 2014, Front Neurol, V5, P12, DOI 10.3389/fneur.2014.00012; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2005, BRIT J SPORT MED, V39, pI58, DOI 10.1136/bjsm.2005.020776; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Piccin D, 2011, STEM CELLS, V29, P528, DOI 10.1002/stem.589; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Selwyn RG, 2015, J NEUROTRAUMA; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Springer JE, 2010, J NEUROTRAUM, V27, P139, DOI 10.1089/neu.2009.0952; Syed A T, 2007, Int J Health Sci (Qassim), V1, P131; Tellier A, 1999, BRAIN INJURY, V13, P463; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Xu L, 2014, EXP NEUROL; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216	79	38	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159442	10.1371/journal.pone.0159442	http://dx.doi.org/10.1371/journal.pone.0159442			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427961	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300067
J	Semenchenko, K; Wasylyk, C; Cheung, H; Tourrette, Y; Maas, P; Schalken, JA; van der Pluijm, G; Wasylyk, B				Semenchenko, Kostyantyn; Wasylyk, Christine; Cheung, Henry; Tourrette, Yves; Maas, Peter; Schalken, Jack A.; van der Pluijm, Gabri; Wasylyk, Bohdan			XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice	PLOS ONE			English	Article							MOUSE PROSTATE MODEL; BREAST-CANCER CELLS; COMPLEX FACTOR NET; TRANSGENIC MOUSE; GENE-EXPRESSION; CARCINOMA-CELLS; TRAMP MOUSE; ADENOCARCINOMA; PROGRESSION; KERATINOCYTES	Transcription factors have an important role in cancer but are difficult targets for the development of tumour therapies. These factors include the Ets family, and in this study Elk3 that is activated by Ras oncogene /Erk signalling, and is involved in angiogenesis, malignant progression and epithelial-mesenchymal type processes. We previously described the identification and in-vitro characterisation of an inhibitor of Ras / Erk activation of Elk3 that also affects microtubules, XRP44X. We now report an initial characterisation of the effects of XRP44X in-vivo on tumour growth and metastasis in three preclinical models mouse models, subcutaneous xenografts, intra-cardiac injection-bone metastasis and the TRAMP transgenic mouse model of prostate cancer progression. XRP44X inhibits tumour growth and metastasis, with limited toxicity. Tumours from XRP44X-treated animals have decreased expression of genes containing Elk3-like binding motifs in their promoters, Elk3 protein and phosphorylated Elk3, suggesting that perhaps XRP44X acts in part by inhibiting the activity of Elk3. Further studies are now warranted to develop XRP44X for tumour therapy.	[Semenchenko, Kostyantyn; Wasylyk, Christine; Tourrette, Yves; Wasylyk, Bohdan] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Semenchenko, Kostyantyn; Wasylyk, Christine; Tourrette, Yves; Wasylyk, Bohdan] CNRS, UMR7104, Illkirch Graffenstaden, France; [Semenchenko, Kostyantyn; Wasylyk, Christine; Tourrette, Yves; Wasylyk, Bohdan] INSERM, U964, Illkirch Graffenstaden, France; [Semenchenko, Kostyantyn; Wasylyk, Christine; Tourrette, Yves; Wasylyk, Bohdan] Univ Strasbourg, Illkirch Graffenstaden, France; [Cheung, Henry; van der Pluijm, Gabri] Leiden Univ, Med Ctr, Leiden, Netherlands; [Maas, Peter] SPECS, Kluyverweg 6, NL-2629 HT Delft, Netherlands; [Schalken, Jack A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 GA Nijmegen, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Wasylyk, B (corresponding author), Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France.; Wasylyk, B (corresponding author), CNRS, UMR7104, Illkirch Graffenstaden, France.; Wasylyk, B (corresponding author), INSERM, U964, Illkirch Graffenstaden, France.; Wasylyk, B (corresponding author), Univ Strasbourg, Illkirch Graffenstaden, France.	boh@igbmc.fr	Schalken, Jack A/B-1277-2014; Wasylyk, Bohdan/ABG-6778-2020	Schalken, Jack A/0000-0001-8274-7797; Wasylyk, Bohdan/0000-0002-1718-1237	sixth framework program; seventh framework program; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Strasbourg (UdS); Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer; Association pour la Recherche contre le Cancer (ARC); Association for International Cancer Research (GB) [05-390]	sixth framework program(European Commission); seventh framework program(European Commission); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg (UdS); Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Association for International Cancer Research (GB)	The authors thank for financial support the sixth framework program (https://ec.europa.eu/research/fp6/index_en.cfm, PRIMA FP6, BW), the seventh framework program (https://ec.europa.eu/research/fp7/index_en.cfm, PRO-NEST, BW, ESR for KS), the Centre National de la Recherche Scientifique (CNRS, http://www.cnrs.fr/, institutional funding, BW), the Institut National de la Sante et de la Recherche Medicale (INSERM, http://www.inserm.fr/, institutional funding, BW), the Universite de Strasbourg (UdS, http://www.en.unistra.fr/index.php?id=21304, institutional funding, BW), the Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer (http://www.liguecancer-cd68.fr/CCIR_GE.html, project grants, BW), the Association pour la Recherche contre le Cancer (ARC, http://www.fondation-arc.org/, fellowship KS), and Association for International Cancer Research (GB), 05-390, Dr. Bohdan Wasylyk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assefa Z, 1997, J INVEST DERMATOL, V108, P886, DOI 10.1111/1523-1747.ep12292595; Ayadi A, 2001, MECH DEVELOP, V102, P205, DOI 10.1016/S0925-4773(01)00289-1; Ayadi A, 2001, EMBO J, V20, P5139, DOI 10.1093/emboj/20.18.5139; Beggs AE, 2012, AM J HEALTH-SYST PH, V69, P2147, DOI 10.2146/ajhp120330; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; Bhagwat AS, 2015, TRENDS CANCER, V1, P53, DOI 10.1016/j.trecan.2015.07.001; Bohn AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110091; Boro A, 2012, INT J CANCER, V131, P2153, DOI 10.1002/ijc.27472; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Buchwalter G, 2005, MOL CELL BIOL, V25, P10853, DOI 10.1128/MCB.25.24.10853-10862.2005; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Chen J, 2012, ANTI-CANCER DRUG, V23, P98, DOI 10.1097/CAD.0b013e32834bc978; Crawford J, 2004, CANCER-AM CANCER SOC, V100, P228, DOI 10.1002/cncr.11882; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Ducret C, 1999, MOL CELL BIOL, V19, P7076; Enk CD, 2006, ONCOGENE, V25, P2601, DOI 10.1038/sj.onc.1209292; Fanale D, 2015, ANAL CELL PATHOL, V2015, P1, DOI 10.1155/2015/690916; Feng FY, 2014, CLIN CANCER RES, V20, P4442, DOI 10.1158/1078-0432.CCR-13-0275; Field JJ, 2014, BIOORGAN MED CHEM, V22, P5050, DOI 10.1016/j.bmc.2014.02.035; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Gingrich JR, 1996, CANCER RES, V56, P4096; Grabowska MM, 2014, CANCER METAST REV, V33, P377, DOI 10.1007/s10555-013-9487-8; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; GREENBERG NM, 1994, MOL ENDOCRINOL, V8, P230, DOI 10.1210/me.8.2.230; Grohar PJ, 2011, NEOPLASIA, V13, P145, DOI 10.1593/neo.101202; Gross C, 2007, MOL CELL BIOL, V27, P4133, DOI 10.1128/MCB.01867-06; Heo SH, 2015, GENE EXPRESSION, V16, P197, DOI 10.3727/105221615X14399878166276; Heo SH, 2014, INT J BIOL SCI, V10, P438, DOI 10.7150/ijbs.8095; Herter-Sprie GS, 2013, J CLIN INVEST, V123, P3639, DOI 10.1172/JCI68340; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kar A, 2013, CRIT REV BIOCHEM MOL, V48, P522, DOI 10.3109/10409238.2013.838202; Kokkinakis DM, 2006, MOL CANCER RES, V4, P575, DOI 10.1158/1541-7786.MCR-05-0240; Kumar H, 2013, EUR J MED CHEM, V70, P248, DOI 10.1016/j.ejmech.2013.10.004; Lin X, 2002, UROLOGY, V60, P919, DOI 10.1016/S0090-4295(02)01863-0; Maira SM, 1996, EMBO J, V15, P5849, DOI 10.1002/j.1460-2075.1996.tb00972.x; Mentor-Marcel R, 2001, CANCER RES, V61, P6777; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Narayanan BA, 2004, CLIN CANCER RES, V10, P7727, DOI 10.1158/1078-0432.CCR-04-0732; Raina K, 2007, CANCER RES, V67, P11083, DOI 10.1158/0008-5472.CAN-07-2222; Robertson ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113050; Rogers CD, 2013, DEV BIOL, V374, P255, DOI 10.1016/j.ydbio.2012.12.009; Rosfjord E, 2014, BIOCHEM PHARMACOL, V91, P135, DOI 10.1016/j.bcp.2014.06.008; Ruggeri BA, 2014, BIOCHEM PHARMACOL, V87, P150, DOI 10.1016/j.bcp.2013.06.020; Serchov T, 2010, J BIOL CHEM, V285, P21223, DOI 10.1074/jbc.M110.121723; Stasevich I, 2015, BR J HAEMATOL; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suttie AW, 2005, TOXICOL PATHOL, V33, P386, DOI 10.1080/01926230590930272; Tang Y, 2009, PROSTATE, V69, P1763, DOI 10.1002/pros.21026; Tsui KH, 2012, INT J CANCER, V130, P2812, DOI 10.1002/ijc.26284; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; van der Horst G, 2011, EUR UROL, V60, P337, DOI 10.1016/j.eururo.2011.05.005; Wartha K, 2014, PHARMACOL THERAPEUT, V142, P351, DOI 10.1016/j.pharmthera.2014.01.001; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Wechter WJ, 2000, CANCER RES, V60, P2203; Weinl C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107048; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wozniak MA, 2012, CURR BIOL, V22, P2017, DOI 10.1016/j.cub.2012.08.050; Yang H, 2015, ELIFE, V4, DOI 10.7554/eLife.10870; Zheng H, 2003, GENE DEV, V17, P2283, DOI 10.1101/gad.272503	61	13	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159531	10.1371/journal.pone.0159531	http://dx.doi.org/10.1371/journal.pone.0159531			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427904	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300075
J	Ramakrishnan, M; Ceasar, SA; Duraipandiyan, V; Vinod, KK; Kalpana, K; Al-Dhabi, NA; Ignacimuthu, S				Ramakrishnan, M.; Ceasar, S. Antony; Duraipandiyan, V.; Vinod, K. K.; Kalpana, Krishnan; Al-Dhabi, N. A.; Ignacimuthu, S.			Tracing QTLs for Leaf Blast Resistance and Agronomic Performance of Finger Millet (Eleusine coracana (L.) Gaertn.) Genotypes through Association Mapping and in silico Comparative Genomics Analyses	PLOS ONE			English	Article							GENETIC DIVERSITY; MOLECULAR MARKERS; WIDE ASSOCIATION; POPULATION-STRUCTURE; LINKAGE DISEQUILIBRIUM; RICE; ARABIDOPSIS; PROTEIN; TRAITS; SEQUENCE	Finger millet is one of the small millets with high nutritive value. This crop is vulnerable to blast disease caused by Pyricularia grisea, which occurs annually during rainy and winter seasons. Leaf blast occurs at early crop stage and is highly damaging. Mapping of resistance genes and other quantitative trait loci (QTLs) for agronomic performance can be of great use for improving finger millet genotypes. Evaluation of one hundred and twenty-eight finger millet genotypes in natural field conditions revealed that leaf blast caused severe setback on agronomic performance for susceptible genotypes, most significant traits being plant height and root length. Plant height was reduced under disease severity while root length was increased. Among the genotypes, IE4795 showed superior response in terms of both disease resistance and better agronomic performance. A total of seven unambiguous QTLs were found to be associated with various agronomic traits including leaf blast resistance by association mapping analysis. The markers, UGEP101 and UGEP95, were strongly associated with blast resistance. UGEP98 was associated with tiller number and UGEP9 was associated with root length and seed yield. Cross species validation of markers revealed that 12 candidate genes were associated with 8 QTLs in the genomes of grass species such as rice, foxtail millet, maize, Brachypodium stacei, B. distachyon, Panicum hallii and switchgrass. Several candidate genes were found proximal to orthologous sequences of the identified QTLs such as 1,4-beta-glucanase for leaf blast resistance, cytokinin dehydrogenase (CKX) for tiller production, calmodulin (CaM) binding protein for seed yield and pectin methylesterase inhibitor (PMEI) for root growth and development. Most of these QTLs and their putatively associated candidate genes are reported for first time in finger millet. On validation, these novel QTLs may be utilized in future for marker assisted breeding for the development of fungal resistant and high yielding varieties of finger millet.	[Ramakrishnan, M.; Ceasar, S. Antony; Duraipandiyan, V.; Ignacimuthu, S.] Loyola Coll, Entomol Res Inst, Div Plant Biotechnol, Madras, Tamil Nadu, India; [Ceasar, S. Antony] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds, W Yorkshire, England; [Ceasar, S. Antony] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Duraipandiyan, V.; Al-Dhabi, N. A.] King Saud Univ, Coll Sci, Addiriyah Chair Environm Studies, Dept Bot & Microbiol, Riyadh, Saudi Arabia; [Vinod, K. K.] ICAR Indian Agr Res Inst, Div Genet, Rice Breeding & Genet Res Ctr, Aduthurai, India; [Kalpana, Krishnan] Tamil Nadu Agr Univ, Reg Res Stn, Paiyur, India; [Ignacimuthu, S.] King Saud Univ, ISPP, Vice Rectorate Grad Studies & Res, Riyadh, Saudi Arabia	Loyola College - Chennai; University of Leeds; University of Leeds; King Saud University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Tamil Nadu Agricultural University; King Saud University	Duraipandiyan, V; Ignacimuthu, S (corresponding author), Loyola Coll, Entomol Res Inst, Div Plant Biotechnol, Madras, Tamil Nadu, India.; Duraipandiyan, V (corresponding author), King Saud Univ, Coll Sci, Addiriyah Chair Environm Studies, Dept Bot & Microbiol, Riyadh, Saudi Arabia.; Ignacimuthu, S (corresponding author), King Saud Univ, ISPP, Vice Rectorate Grad Studies & Res, Riyadh, Saudi Arabia.	avdpandiyan@gmail.com; eriloyola@hotmail.com	CEASAR, STANISLAUS ANTONY/P-2479-2017; Ignacimuthu, S/ABH-3983-2020; Ramakrishnan, Muthusamy/AAM-6865-2021; Veeramuthu, Duraipandiyan/D-9924-2012; K K, Vinod/H-2938-2019; krishnan, kalpana/AAP-1297-2020; Al-Dhabi, Naif/E-7305-2014	CEASAR, STANISLAUS ANTONY/0000-0003-4106-1531; Ignacimuthu, S/0000-0002-8467-789X; Ramakrishnan, Muthusamy/0000-0001-7819-339X; Veeramuthu, Duraipandiyan/0000-0002-2107-3503; K K, Vinod/0000-0001-8927-4590; Al-Dhabi, Naif/0000-0002-2663-6328	Department of Biotechnology [BT/PR15011/AGR/02/772/2010]; Deanship of Scientific Research at King Saud University, Kingdom of Saudi Arabia [RGP-VPP-213]; Department of Biotechnology, New Delhi [BT/PR15011/AGR/02/772/2010]; King Saud University, through Vice Deanship of Research Chairs	Department of Biotechnology; Deanship of Scientific Research at King Saud University, Kingdom of Saudi Arabia; Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); King Saud University, through Vice Deanship of Research Chairs	This work was supported by 1) Grant number: BT/PR15011/AGR/02/772/2010. http://www.dbtindia.nic.in/ (Department of Biotechnology) MR, SI, SAC, and 2) Grant number: RGP-VPP-213. http://ksu.edu.sa/en/ (Deanship of Scientific Research at King Saud University, Kingdom of Saudi Arabia). VD, NAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Department of Biotechnology, New Delhi, for providing financial support (BT/PR15011/AGR/02/772/2010). We thank ICRISAT, UAS (GKVK) and TNAU for supplying the finger millet seeds. We thank Dr. M. Maheswaran, Director of Research, Prof and Head and all staff members, RRS, Paiyur-TNAU for providing facilities for phenotype screening and for their encouragement. We thank Dr Ketrien Devos, University of Georgia, College of Agricultural Science, USA for sharing the target EST sequences of the SSR markers. Also we thank the mentors of this project, Dr. P. Kadirvel, Senior Scientist, Directorate of oil seed research, Indian Council of Agricultural Research, Hyderabad, India, Prof. P. Balasubramanian, Centre for Plant Molecular Biology, TNAU, Coimbatore, India for their encouragement. This project was also partially financially supported by King Saud University, through Vice Deanship of Research Chairs is also acknowledged.	Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Anilkumar TB, 2003, DIS FINGER MILLET, P1; Aru J., 2013, 11th African Crop Science Proceedings, Sowing innovations for sustainable food and nutrition security in Africa. Entebbe, Uganda, 14-17 October, 2013, P483; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashkani S, 2013, BIOTECHNOL LETT, V35, P799, DOI 10.1007/s10529-012-1130-1; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Babu B. K., 2014, SABRAO Journal of Breeding and Genetics, V46, P202; Babu BK, 2014, MOL BREEDING, V34, P1261, DOI 10.1007/s11032-014-0115-2; Babu BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099182; Babu BK, 2014, MOL BIOL REP, V41, P3081, DOI 10.1007/s11033-014-3168-8; Babu TK, 2013, EUR J PLANT PATHOL, V135, P299, DOI 10.1007/s10658-012-0086-2; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bennetzen JL, 1997, GENOME RES, V7, P301, DOI 10.1101/gr.7.4.301; Bharathi A., 2011, THESIS; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cadic E, 2013, THEOR APPL GENET, V126, P1337, DOI 10.1007/s00122-013-2056-2; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; De Villiers SM, 2015, ELECTRON J BIOTECHN, V18, P77, DOI 10.1016/j.ejbt.2014.12.001; Dida MM, 2007, THEOR APPL GENET, V114, P321, DOI 10.1007/s00122-006-0435-7; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Endelman JB, 2012, G3-GENES GENOM GENET, V2, P1405, DOI 10.1534/g3.112.004259; Esele JP, 2008, DIS FINGER MILLET GL, P19; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 1995, FAO FOOD NUTR SER, V27, P186; Federer W, 1967, EXPT DESIGN THEORY A, P1; Fu Y, 2015, THEOR APPL GENET, V128, P1029, DOI 10.1007/s00122-015-2487-z; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Greco R, 1997, MOL GEN GENET, V253, P615, DOI 10.1007/s004380050364; Guo BH, 2011, MOL BREEDING, V27, P107, DOI 10.1007/s11032-010-9503-4; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Gupta S, 2014, PLANT CELL REP, V33, P881, DOI 10.1007/s00299-014-1564-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hao ZN, 2012, PLANT PHYSIOL BIOCH, V60, P150, DOI 10.1016/j.plaphy.2012.08.006; Ignacimuthu S, 2012, J BIOSCIENCES, V37, P135, DOI 10.1007/s12038-011-9178-y; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Joel A, 2005, MADRAS AGR J, V92, P375; Joukhadar R, 2013, MOL BREEDING, V32, P943, DOI 10.1007/s11032-013-9924-y; Karandikar RL, 2006, SADHANA-ACAD P ENG S, V31, P81, DOI 10.1007/BF02719775; Kole C, 2006, CEREALS AND MILLETS; Koutroubas SD, 2009, TURK J AGRIC FOR, V33, P487, DOI 10.3906/tar-0812-15; Kumar A, 2014, APPL BIOCHEM BIOTECH, V172, P2955, DOI 10.1007/s12010-013-0714-0; Kurotani Ken-Ich, 2015, Plant Signal Behav, V10, pe1046667, DOI 10.1080/15592324.2015.1046667; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; MACKILL DJ, 1992, PHYTOPATHOLOGY, V82, P746, DOI 10.1094/Phyto-82-746; Markakis MN, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-208; Mazzucato A, 2008, THEOR APPL GENET, V116, P657, DOI 10.1007/s00122-007-0699-6; McRAE W., 1922, Agric. Res. Inst. Pusa, Scientific Reports 1921-22, P44; Mirza N, 2014, P NATL ACAD SCI IN B, P1; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Nagaraja A., 2007, Journal of Mycopathological Research, V45, P237; Nagaraja A., 2010, Crop Research (Hisar), V39, P120; Nagaraja A., 2007, COMPENDIUM SMALL MIL, P1; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Nirgude M, 2014, MOL BIOL REP, V41, P1189, DOI 10.1007/s11033-013-2825-7; Opiyo Stephen O, 2010, Int J Bioinform Res Appl, V6, P209, DOI 10.1504/IJBRA.2010.032122; Pall BS, 1977, FOOD FARMING AGR, V9, P55; Pritchard JK, 2000, GENETICS, V155, P945; Ramakrishnan M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-015-1626-y; Ramakrishnan M, 2016, GENET RESOUR CROP EV, V63, P361, DOI 10.1007/s10722-015-0255-1; RAO A N S, 1990, Mysore Journal of Agricultural Sciences, V24, P57; Singh A.K., 2015, MARKER ASSISTED PLAN, P217, DOI 10.1007/978-81-322-2316-0_8; Singh UM, 2014, ACTA PHYSIOL PLANT, V36, P2521, DOI 10.1007/s11738-014-1625-6; SOCK J, 1990, PLANT PHYSIOL, V94, P1376, DOI 10.1104/pp.94.3.1376; Tabien RE, 2002, THEOR APPL GENET, V105, P313, DOI 10.1007/s00122-002-0940-2; Takan JP, 2012, MOL BIOTECHNOL, V50, P145, DOI 10.1007/s12033-011-9429-z; Tanaka W, 2013, PLANT CELL PHYSIOL, V54, P313, DOI 10.1093/pcp/pct016; Upadhyaya HD, 2013, THEOR APPL GENET, V126, P2003, DOI 10.1007/s00122-013-2113-x; Upadhyaya HD, 2006, GENET RESOUR CROP EV, V53, P679, DOI 10.1007/s10722-004-3228-3; Vanniarajan C, 2012, J GENET, V91, P9, DOI 10.1007/s12041-012-0146-6; Venkatarayan S., 1947, MYSORE AGR J, V24, P50; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Wheeler BEJ., 1969, INTRO PLANT DIS, V2, P301; Wu JL, 2004, THEOR APPL GENET, V108, P1024, DOI 10.1007/s00122-003-1528-1; Xu M, 2005, PLANT CELL PHYSIOL, V46, P1674, DOI 10.1093/pcp/pci183; Xu P, 2014, J EXP BOT, V65, P4285, DOI 10.1093/jxb/eru202; Yeh SY, 2015, RICE, V8, DOI 10.1186/s12284-015-0070-5; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou ZJ, 2013, NEW PHYTOL, V198, P699, DOI 10.1111/nph.12211; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	85	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159264	10.1371/journal.pone.0159264	http://dx.doi.org/10.1371/journal.pone.0159264			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415007	Green Submitted, gold, Green Published			2022-12-27	WOS:000379579500115
J	Robalino, J; Wilkins, B; Bracken-Grissom, HD; Chan, TY; O'Leary, MA				Robalino, Javier; Wilkins, Blake; Bracken-Grissom, Heather D.; Chan, Tin-Yam; O'Leary, Maureen A.			The Origin of Large-Bodied Shrimp that Dominate Modern Global Aquaculture	PLOS ONE			English	Article							ARTEMESIA-LONGINARIS DECAPODA; TEMPERATURE-SIZE RULE; BODY-SIZE; SPERMATOZOAL ULTRASTRUCTURE; POPULATION-STRUCTURE; MANGROVE FOREST; DENDROBRANCHIATA; CRUSTACEA; OXYGEN; PENAEIDAE	Several shrimp species from the clade Penaeidae are farmed industrially for human consumption, and this farming has turned shrimp into the largest seafood commodity in the world. The species that are in demand for farming are an anomaly within their clade because they grow to much larger sizes than other members of Penaeidae. Here we trace the evolutionary history of the anomalous farmed shrimp using combined data phylogenetic analysis of living and fossil species. We show that exquisitely preserved fossils of dagger Antrimpos speciosus from the Late Jurassic Solnhofen limestone belong to the same clade as the species that dominate modern farming, dating the origin of this clade to at least 145 mya. This finding contradicts a much younger Late Cretaceous age (ca. 95 mya) previously estimated for this clade using molecular clocks. The species in the farmed shrimp clade defy a widespread tendency, by reaching relatively large body sizes despite their warm water life-styles. Small body sizes have been shown to be physiologically favored in warm aquatic environments because satisfying oxygen demands is difficult for large organisms breathing in warm water. Our analysis shows that large-bodied, farmed shrimp have more gills than their smaller-bodied shallow-water relatives, suggesting that extra gills may have been key to the clade's ability to meet oxygen demands at a large size. Our combined data phylogenetic tree also suggests that, during penaeid evolution, the adoption of mangrove forests as habitats for young shrimp occurred multiple times independently.	[Robalino, Javier; O'Leary, Maureen A.] SUNY Stony Brook, Dept Anat Sci, HSC T-8,040, Stony Brook, NY 11794 USA; [Wilkins, Blake; Bracken-Grissom, Heather D.] Florida Int Univ, Dept Biol, Biscayne Bay Campus, North Miami, FL USA; [Chan, Tin-Yam] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Chan, Tin-Yam] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Robalino, Javier] Howard Hughes Med Inst, Sci Educ Dept, Chevy Chase, MD 20815 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; Florida International University; National Taiwan Ocean University; National Taiwan Ocean University; Howard Hughes Medical Institute	Robalino, J (corresponding author), SUNY Stony Brook, Dept Anat Sci, HSC T-8,040, Stony Brook, NY 11794 USA.; Robalino, J (corresponding author), Howard Hughes Med Inst, Sci Educ Dept, Chevy Chase, MD 20815 USA.	robalino.javier@gmail.com		O'Leary, Maureen A./0000-0001-7837-5708	National Science Foundation [DEB 1208270]; BP/Gulf of Mexico Research Initiative; Florida International University; Ministry of Science and Technology, Taiwan, R.O.C.; Division Of Environmental Biology [1208270] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); BP/Gulf of Mexico Research Initiative; Florida International University; Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by award DEB 1208270 from the National Science Foundation to MAO, and by grants from the BP/Gulf of Mexico Research Initiative and Florida International University to HBG. The work of TYC is funded by the Ministry of Science and Technology, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2011, CARIDEORUM CATALOGUS; Aragon-Noriega E, 2005, MAR BIOL, V146, P373, DOI 10.1007/s00227-004-1442-3; Asche F, 2012, MAR RESOUR ECON, V27, P181, DOI 10.5950/0738-1360-27.2.181; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D, 2006, EVOL DEV, V8, P202, DOI 10.1111/j.1525-142X.2006.00090.x; Atkinson D, 1997, TRENDS ECOL EVOL, V12, P235, DOI 10.1016/S0169-5347(97)01058-6; BALSS H, 1922, PALAEONTOL Z, V5, P123; Baudron AR, 2014, GLOBAL CHANGE BIOL, V20, P1023, DOI 10.1111/gcb.12514; Bauer RT, 1999, J MORPHOL, V242, P125, DOI 10.1002/(SICI)1097-4687(199911)242:2<125::AID-JMOR5>3.0.CO;2-O; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brown A, 2014, BIOL REV, V89, P406, DOI 10.1111/brv.12061; Burkenroad M., 1983, CRUSTACEAN ISSUES, V1; Burkenroad M. D., 1963, Tulane Studies in Geology, V2, P1; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; CARTES JE, 1993, J EXP MAR BIOL ECOL, V171, P63, DOI 10.1016/0022-0981(93)90140-J; Castilho AL, 2007, J CRUSTACEAN BIOL, V27, P548, DOI 10.1651/S-2788.1; Chamberlain GW, 2010, SHRIMP BOOK, P1; Charbonnier S, 2011, ACTA PALAEONTOLOGICA, V58, P335; Cochrane K., 2009, FAO FISHERIES AQUACU; Coulter Charles R, 2013, ENCY ANCIENT DEITIES; CRIALES MM, 1993, B MAR SCI, V53, P973; Crosnier A., 1978, FAUNE MADAGASCAR, V46; Dahl TW, 2010, P NATL ACAD SCI USA, V107, P17911, DOI 10.1073/pnas.1011287107; Dall W, 1990, ADV MAR BIOL, V27; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; de Carvalho M, 1995, AM MUS NOVIT, V21, P20; De Grave S, 2009, RAFFLES B ZOOL, P1; De Queiroz K, 2007, SYST BIOL, V56, P956, DOI 10.1080/10635150701656378; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellison AM, 1999, GLOBAL ECOL BIOGEOGR, V8, P95, DOI 10.1046/j.1365-2699.1999.00126.x; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; FAO, 2011, STAT WORLD FISH AQ O; Feldmann RM, 2010, J CRUSTACEAN BIOL, V30, P629, DOI 10.1651/09-3268.1; Forster J, 2012, P NATL ACAD SCI USA, V109, P19310, DOI 10.1073/pnas.1210460109; FOXTON P, 1970, J MAR BIOL ASSOC UK, V50, P961, DOI 10.1017/S0025315400005919; Franco AR, 2006, AQUACULTURE, V259, P268, DOI 10.1016/j.aquaculture.2006.05.051; Garassino A, ACANTHOCHIRANA TRIAS; Garassino A., 1994, MACRURAN DECAPOD CRU; Garassino A., 1995, ATTI SOC ITALIANA SC, V134, P85; Garassino A, 2014, NEUES JAHRB GEOL P-A, V274, P43, DOI 10.1127/njgpa/2014/0442; Garassino Alessandro, 2002, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V143, P95; Glaessner M., 1969, FOSSILIUM CATALOG 41, V464, P1969; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gonzalez RA, 2010, J THERM BIOL, V35, P218, DOI 10.1016/j.jtherbio.2010.05.004; GORE RH, 1985, CRUSTACEANA, V49, P119, DOI 10.1163/156854085X00369; Hamilton S, 2013, B MAR SCI, V89, P585, DOI 10.5343/bms.2012.1069; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Harrison JF, 2010, P ROY SOC B-BIOL SCI, V277, P1937, DOI 10.1098/rspb.2010.0001; HENDRICKX ME, 1989, CAL COOP OCEAN FISH, V30, P104; Henriksson PJG, 2014, AQUACULTURE; Holthuis L. B., 1980, FAO SPECIES CATALOGU, V1, p[xvii, 271]; HOPKINS TL, 1994, MAR ECOL PROG SER, V109, P143, DOI 10.3354/meps109143; Horne CR, 2015, ECOL LETT, V18, P327, DOI 10.1111/ele.12413; Huang JY, 2013, J PALEONTOL, V87, P603, DOI 10.1666/13-024; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt G, 2010, PALAEONTOLOGY, V53, P1255, DOI 10.1111/j.1475-4983.2010.01007.x; Jablonski D., 1996, BODY SIZE MACROEVOLU, P256; Kir M, 2008, J WORLD AQUACULT SOC, V39, P535, DOI 10.1111/j.1749-7345.2008.00185.x; Klok CJ, 2013, INTEGR COMP BIOL, V53, P557, DOI 10.1093/icb/ict075; Kumlu M, 2010, J THERM BIOL, V35, P305, DOI 10.1016/j.jtherbio.2010.06.009; Lefort S, 2015, GLOBAL CHANGE BIOL, V21, P154, DOI 10.1111/gcb.12679; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; M?nster G.G.zu., 1839, BEITRAGE PETREFAKTEN, V2, P1; Ma KY, 2009, MOL PHYLOGENET EVOL, V53, P45, DOI 10.1016/j.ympev.2009.05.019; Ma KY, 2011, ZOOL SCR, V40, P498, DOI 10.1111/j.1463-6409.2011.00483.x; Macia A., 2007, W INDIAN OCEAN J MAR, V3, P163; Maddison WP., 2021, MESQUITE MODULAR SYS; Maggio T, 2009, MAR ECOL-EVOL PERSP, V30, P354, DOI 10.1111/j.1439-0485.2008.00277.x; Matear RJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001997; Medina A, 2006, ZOOMORPHOLOGY, V125, P39, DOI 10.1007/s00435-005-0013-6; Medina A, 2006, J MORPHOL, V267, P300, DOI 10.1002/jmor.10404; MEDINA A, 1994, ZOOMORPHOLOGY, V114, P161, DOI 10.1007/BF00403263; MEDINA A, 1994, MAR BIOL, V119, P449, DOI 10.1007/BF00347542; MEDINA A, 1994, J SUBMICR CYTOL PATH, V26, P395; Miller M.A., 2011, P 2011 TERAGRID C EX; Niem V., 1998, LIVING MARINE RESOUR; Niem V.H., 1998, FAO SPECIES IDENTIFI, VII, P851; Norell MA, 1992, TAXIC ORIGIN TEMPORA, P89; O'Leary MA, 2011, CLADISTICS, V27, P529, DOI 10.1111/j.1096-0031.2011.00355.x; Payne JL, 2009, P NATL ACAD SCI USA, V106, P24, DOI 10.1073/pnas.0806314106; Pena C, 2006, MOL PHYLOGENET EVOL, V40, P29, DOI 10.1016/j.ympev.2006.02.007; Perez Farfante I., 1997, PENAEOID SERGESTOID; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Primavera JH, 1998, ESTUAR COAST SHELF S, V46, P457, DOI 10.1006/ecss.1997.0275; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; REYNOLDS WW, 1979, HYDROBIOLOGIA, V67, P179, DOI 10.1007/BF00126717; Riou B, 1991, ANN PALEONTOLOGIE; Ronnback P, 1999, ESTUAR COAST SHELF S, V48, P223, DOI 10.1006/ecss.1998.0415; Scelzo MA, 2004, ACTA ZOOL-STOCKHOLM, V85, P81, DOI 10.1111/j.0001-7272.2004.00160.x; Scelzo MA, 2003, J CRUSTACEAN BIOL, V23, P814, DOI 10.1651/C-2377; SCHMID Dieter U., 2005, Zitteliana Reihe B, V26, P31; Schweigert G., 2001, LATE JURASSIC DECAPO; Schweitzer CE, 2014, J PALEONTOL, V88, P457, DOI 10.1666/13-039; Seidman E.R., 1985, Journal of the World Mariculture Society, V16, P333; Simmons MP, 2004, MOL BIOL EVOL, V21, P188, DOI 10.1093/molbev/msh014; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Sperling EA, 2013, P NATL ACAD SCI USA, V110, P13446, DOI 10.1073/pnas.1312778110; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Strong EE, 1999, CLADISTICS, V15, P363, DOI 10.1111/j.1096-0031.1999.tb00272.x; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tavares C, 2009, CRUSTACEAN ISS, V18; Ha TTP, 2014, LAND USE POLICY, V36, P89, DOI 10.1016/j.landusepol.2013.07.002; van STRAELEN V., 1933, BULL MUS ROY HIST NAT BELGIQUE, V9, P1; Van Straelen VE, 1925, CONTRIBUTION ETUDE C; Vance DJ, 1996, MAR ECOL PROG SER, V131, P115, DOI 10.3354/meps131115; Verberk WCEP, 2013, FUNCT ECOL, V27, P1275, DOI 10.1111/1365-2435.12152; Verberk WCEP, 2011, ECOLOGY, V92, P1565, DOI 10.1890/10-2369.1; Wei C-L, 2010, BATHYMETRIC ZONATION; Wu RSS, 2002, ENVIRON POLLUT, V118, P351, DOI 10.1016/S0269-7491(01)00298-6; ZEUTHEN E, 1953, Q REV BIOL, V28, P1, DOI 10.1086/399308	116	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158840	10.1371/journal.pone.0158840	http://dx.doi.org/10.1371/journal.pone.0158840			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415002	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500043
J	Romao-Dumaresq, AS; Dourado, MN; Favaro, LCD; Mendes, R; Ferreira, A; Araujo, WL				Romao-Dumaresq, Aline Silva; Dourado, Manuella Nobrega; de Lima Favaro, Leia Cecilia; Mendes, Rodrigo; Ferreira, Anderson; Araujo, Welington Luiz			Diversity of Cultivated Fungi Associated with Conventional and Transgenic Sugarcane and the Interaction between Endophytic Trichoderma virens and the Host Plant	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; BIOLOGICAL-CONTROL; MEDIATED TRANSFORMATION; BACTERIAL COMMUNITIES; GLIOCLADIUM-VIRENS; FUSARIUM-OXYSPORUM; PYTHIUM-ULTIMUM; ROOT ENDOPHYTES; MUSA-ACUMINATA; POTATO ROOTS	Plant-associated fungi are considered a vast source for biotechnological processes whose potential has been poorly explored. The interactions and diversity of sugarcane, one of the most important crops in Brazil, have been rarely studied, mainly concerning fungal communities and their interactions with transgenic plants. Taking this into consideration, the purpose of this study was, based on culture dependent strategy, to determine the structure and diversity of the fungal community (root endophytes and rhizosphere) associated with two varieties of sugarcane, a non-genetically modified (SP80-1842) variety and its genetically modified counterpart (IMI-1, expressing imazapyr herbicide resistance). For this, the sugarcane varieties were evaluated in three sampling times (3, 10 and 17 months after planting) under two crop management (weeding and herbicide treatments). In addition, a strain of Trichoderma virens, an endophyte isolated from sugarcane with great potential as a biological control, growth promotion and enzyme production agent, was selected for the fungal-plant interaction assays. The results of the isolation, characterization and evaluation of fungal community changes showed that the sugarcane fungal community is composed of at least 35 different genera, mostly in the phylum Ascomycota. Many genera are observed at very low frequencies among a few most abundant genera, some of which were isolated from specific plant sites (e.g., the roots or the rhizosphere). An assessment of the possible effects upon the fungal community showed that the plant growth stage was the only factor that significantly affected the community's structure. Moreover, if transgenic effects are present, they may be minor compared to other natural sources of variation. The results of interaction studies using the Green fluorescent protein (GFP)-expressing T. virens strain T. v.223 revealed that this fungus did not promote any phenotypic changes in the host plant and was found mostly in the roots where it formed a dense mycelial cover and was able to penetrate the intercellular spaces of the root epidermis upper layers. The ability of T. virens to colonize plant roots suggests a potential for protecting plant health, inhibiting pathogens or inducing systemic resistance.	[Romao-Dumaresq, Aline Silva; Dourado, Manuella Nobrega; de Lima Favaro, Leia Cecilia; Mendes, Rodrigo; Ferreira, Anderson; Araujo, Welington Luiz] Univ Sao Paulo, Dept Genet, ESALQ, Sao Paulo, Brazil; [Dourado, Manuella Nobrega; Araujo, Welington Luiz] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Mol Biol & Microbial Ecol, Sao Paulo, Brazil; [de Lima Favaro, Leia Cecilia] Brazilian Agr Res Corp, Embrapa Agroenergy, Brasilia, DF, Brazil; [Mendes, Rodrigo] Brazilian Agr Res Corp, Embrapa Environm, Sao Paulo, Brazil; [Ferreira, Anderson] Brazilian Agr Res Corp, Embrapa Agrosilvopastoral, Sinop, Mato Grosso, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Araujo, WL (corresponding author), Univ Sao Paulo, Dept Genet, ESALQ, Sao Paulo, Brazil.; Araujo, WL (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Mol Biol & Microbial Ecol, Sao Paulo, Brazil.	wlaraujo@usp.br	Araújo, Welington/G-4905-2012; Mendes, Rodrigo/F-1534-2010; DE LIMA FAVARO, LEIA CECILIA/F-7350-2012; Dourado, Manuella N/P-2337-2018; Mendes, Rodrigo/AAV-6490-2020	Araújo, Welington/0000-0002-2120-8172; Mendes, Rodrigo/0000-0002-9817-4118; DE LIMA FAVARO, LEIA CECILIA/0000-0003-3260-0310; Dourado, Manuella N/0000-0002-2152-0246; Mendes, Rodrigo/0000-0002-9817-4118	FAPESP [2002/14143-3, 2003/13834-5]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (http://www.fapesp.br/), grant number: 2002/14143-3 and 2003/13834-5.	ALUKO MO, 1970, T BRIT MYCOL SOC, V55, P173, DOI 10.1016/S0007-1536(70)80001-8; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Atkinson D, 2000, APPL SOIL ECOL, V15, P99, DOI 10.1016/S0929-1393(00)00084-6; ATLAS RM, 1991, MICROBIAL ECOL, V22, P249, DOI 10.1007/BF02540227; Azevedo JL, 2007, FUNGI MULTIFACETED M, P191; Baek JM, 1999, CURR GENET, V35, P41, DOI 10.1007/s002940050431; Bailey BA, 2008, BIOL CONTROL, V46, P24, DOI 10.1016/j.biocontrol.2008.01.003; de Azevedo LCB, 2014, BRAZ J MICROBIOL, V45, P995, DOI 10.1590/S1517-83822014000300032; Benhamou N, 2002, APPL ENVIRON MICROB, V68, P4044, DOI 10.1128/AEM.68.8.4044-4060.2002; Bills Gerald F., 1996, P31; Britz H, 2002, MYCOLOGIA, V94, P722, DOI 10.2307/3761722; Camatti-Sartori V, 2005, J BASIC MICROB, V45, P397, DOI 10.1002/jobm.200410547; Cao LX, 2002, WORLD J MICROB BIOT, V18, P169, DOI 10.1023/A:1014491528811; Colla G, 2015, J SCI FOOD AGR, V95, P1706, DOI 10.1002/jsfa.6875; Crozier J, 2006, PLANT PATHOL, V55, P783, DOI 10.1111/j.1365-3059.2006.01446.x; Cui JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118204; Araujo FDD, 2012, EUR J ORG CHEM, V2012, P5225, DOI 10.1002/ejoc.201200757; Dal Bello GM, 2003, INT J PEST MANAGE, V49, P313, DOI 10.1080/09670870310001603883; Dal-Bianco M, 2012, CURR OPIN BIOTECH, V23, P265, DOI 10.1016/j.copbio.2011.09.002; Danielsen L, 2012, ECOL EVOL, V2, P1935, DOI 10.1002/ece3.305; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Favaro LCD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036826; Favaro LCD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014828; De Souza JT, 2008, BIOL CONTROL, V46, P36, DOI 10.1016/j.biocontrol.2008.01.010; Martinez FD, 2016, J SCI FOOD AGR, V96, P1934, DOI 10.1002/jsfa.7301; Doni F, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-532; dos Santos RMG, 2003, WORLD J MICROB BIOT, V19, P767, DOI 10.1023/A:1026000731189; Dunfield KE, 2001, FEMS MICROBIOL ECOL, V38, P1, DOI 10.1111/j.1574-6941.2001.tb00876.x; Dunham SM, 2007, MYCORRHIZA, V17, P633, DOI 10.1007/s00572-007-0141-6; El-Amin Al-Nur, 2007, International Journal of Botany, V3, P97; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferreira A, 2008, FEMS MICROBIOL LETT, V287, P8, DOI 10.1111/j.1574-6968.2008.01258.x; Fitzgerald AM, 2003, MYCOL RES, V107, P803, DOI 10.1017/S0953756203008086; Fravel D, 2003, NEW PHYTOL, V157, P493, DOI 10.1046/j.1469-8137.2003.00700.x; Frohlich J, 2000, MYCOL RES, V104, P1202, DOI 10.1017/S095375620000263X; Gamboa MA, 2001, BIOTROPICA, V33, P352, DOI 10.1111/j.1744-7429.2001.tb00187.x; Girlanda M, 2008, FEMS MICROBIOL LETT, V288, P9, DOI 10.1111/j.1574-6968.2008.01306.x; Gotz M, 2006, FEMS MICROBIOL ECOL, V58, P404, DOI 10.1111/j.1574-6941.2006.00169.x; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Hannula SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033819; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; Harman GE, 2000, PLANT DIS, V84, P377, DOI 10.1094/PDIS.2000.84.4.377; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hart MM, 2009, PEDOBIOLOGIA, V52, P253, DOI 10.1016/j.pedobi.2008.10.005; Harvey PJ, 2002, ENVIRON SCI POLLUT R, V9, P29, DOI 10.1007/BF02987315; Hawksworth DL, 2004, STUD MYCOL, P9; Heuer H, 2002, APPL ENVIRON MICROB, V68, P1325, DOI 10.1128/AEM.68.3.1325-1335.2002; Howell CR, 2006, PHYTOPATHOLOGY, V96, P178, DOI 10.1094/PHYTO-96-0178; HOWELL CR, 1982, PHYTOPATHOLOGY, V72, P496, DOI 10.1094/Phyto-72-496; Huang J, 2014, SCI WORLD J, DOI 10.1155/2014/798683; Hur M, 2011, APPL ENVIRON MICROB, V77, P7611, DOI 10.1128/AEM.06102-11; Iqtedar M, 2015, NAT PROD RES, V29, P1012, DOI 10.1080/14786419.2014.971320; Klein Dorothy, 1998, P57; Kubicek CP, 2003, FUNGAL GENET BIOL, V38, P310, DOI 10.1016/S1087-1845(02)00583-2; Kumar DSS, 2004, FUNGAL DIVERS, V17, P69; Lamarche J, 2007, APPL ENVIRON MICROB, V73, P6577, DOI 10.1128/AEM.00812-07; Larran S, 2007, WORLD J MICROB BIOT, V23, P565, DOI 10.1007/s11274-006-9266-6; Lee SH, 2011, MICROB ECOL, V61, P646, DOI 10.1007/s00248-010-9776-5; Liu W, 2008, SOIL BIOL BIOCHEM, V40, P475, DOI 10.1016/j.soilbio.2007.09.017; Lo CT, 1998, PHYTOPATHOLOGY, V88, P129, DOI 10.1094/PHYTO.1998.88.2.129; Lodge DJ, 1996, MYCOLOGIA, V88, P733, DOI 10.2307/3760967; Macia-Vicente JG, 2008, FEMS MICROBIOL ECOL, V64, P90, DOI 10.1111/j.1574-6941.2007.00443.x; Martino E, 2007, CURR GENET, V52, P65, DOI 10.1007/s00294-007-0139-9; Mendes R, 2007, APPL ENVIRON MICROB, V73, P7259, DOI 10.1128/AEM.01222-07; Metcalf DA, 2001, PLANT PATHOL, V50, P249, DOI 10.1046/j.1365-3059.2001.00549.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Orazova M. Kh., 1999, Mikrobiologiya, V68, P127; Pang SS, 1999, BIOCHEMISTRY-US, V38, P5222, DOI 10.1021/bi983013m; Pasonen HL, 2009, PLANTA, V230, P973, DOI 10.1007/s00425-009-1005-4; Paungfoo-Lonhienne C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08678; Pereira JO, 1999, WORLD J MICROB BIOT, V15, P43, DOI 10.1023/A:1008859823806; Petrini Orlando, 1992, Natural Toxins, V1, P185, DOI 10.1002/nt.2620010306; Photita W, 2001, MYCOL RES, V105, P1508, DOI 10.1017/S0953756201004968; Powell JR, 2007, APPL ENVIRON MICROB, V73, P4365, DOI 10.1128/AEM.00594-07; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; Rasche F, 2006, FEMS MICROBIOL ECOL, V56, P219, DOI 10.1111/j.1574-6941.2005.00027.x; Rasche F, 2006, J APPL ECOL, V43, P555, DOI 10.1111/j.1365-2664.2006.01169.x; Ricaud C., 2012, DIS SUGARCANE MAJOR; Romao-Dumaresq AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047888; Rossetto PB, 2011, BRAZ J MICROBIOL, V42, P878, DOI 10.1590/S1517-83822011000300006; Rudresh DL, 2005, APPL SOIL ECOL, V28, P139, DOI 10.1016/j.apsoil.2004.07.005; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Seifert KA, 2004, EUR J PLANT PATHOL, V110, P449, DOI 10.1023/B:EJPP.0000032385.41877.7a; Sessitsch A, 2004, PLANT SOIL, V266, P105; Singh AK, 2014, J APPL MICROBIOL, V117, P750, DOI 10.1111/jam.12549; Singh AK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-122; Sorensen J., 1997, Modern soil microbiology., P21; SRIDHAR KR, 1995, CURR SCI INDIA, V69, P570; Stevens R.R., 1974, MYCOLOGY GUIDEBOOK; Stuart RM, 2010, ARCH MICROBIOL, V192, P307, DOI 10.1007/s00203-010-0557-9; Suryanarayanan TS, 2001, FUNGAL DIVERS, V8, P155; Sylvia DM, 2001, ADV AGRON, V73, P1, DOI 10.1016/S0065-2113(01)73003-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan FX, 2010, PLANT SOIL, V329, P349, DOI 10.1007/s11104-009-0163-2; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Taylor JE, 1999, NEW PHYTOL, V142, P335, DOI 10.1046/j.1469-8137.1999.00391.x; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Thrane C, 1997, EUR J PLANT PATHOL, V103, P331, DOI 10.1023/A:1008679319544; Tsavkelova EA, 2005, MIKOL FITOPATOL, V39, P46; TU JC, 1980, PHYTOPATHOLOGY, V70, P670, DOI 10.1094/Phyto-70-670; Turco R. F., 1994, V35, P73; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; VIRET O, 1993, CAN J BOT, V71, P1520, DOI 10.1139/b93-184; Vujanovic V, 2007, MICROB ECOL, V54, P672, DOI 10.1007/s00248-007-9226-1; Wagner BL, 2000, APPL ENVIRON MICROB, V66, P3468, DOI 10.1128/AEM.66.8.3468-3473.2000; Wang Y, 2005, FUNGAL DIVERS, V20, P235; WARDLE DA, 1993, OECOLOGIA, V94, P165, DOI 10.1007/BF00341313; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Whipps J. M., 2001, Fungi as biocontrol agents: progress, problems and potential, P9, DOI 10.1079/9780851993560.0009; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Widmer F, 2007, ADV BIOCHEM ENG BIOT, V107, P207, DOI 10.1007/10_2007_047; Wu H, 2015, METHODS MOL BIOL, V1224, P307, DOI 10.1007/978-1-4939-1658-0_24; Wu JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098394; Wyss GS, 2004, WEED RES, V44, P469, DOI 10.1111/j.1365-3180.2004.00425.x; Yedidia I, 2001, PLANT SOIL, V235, P235, DOI 10.1023/A:1011990013955; Yedidia I, 2000, PLANT PHYSIOL BIOCH, V38, P863, DOI 10.1016/S0981-9428(00)01198-0; Zijlstra JD, 2005, STUD MYCOL, P147; Zuccaro A, 2003, MYCOL RES, V107, P1451, DOI 10.1017/S0953756203008657	125	24	27	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158974	10.1371/journal.pone.0158974	http://dx.doi.org/10.1371/journal.pone.0158974			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415014	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500055
J	Tan, XH; Zhu, Y; Chen, CA; Chen, XY; Qin, YY; Qu, B; Luo, LX; Lin, HT; Wu, MX; Chen, WR; Liu, YZ				Tan, Xuhua; Zhu, Yi; Chen, Chuan; Chen, Xiaoyun; Qin, Yingyan; Qu, Bo; Luo, Lixia; Lin, Haotian; Wu, Mingxing; Chen, Weirong; Liu, Yizhi			Sprouty2 Suppresses Epithelial-Mesenchymal Transition of Human Lens Epithelial Cells through Blockade of Smad2 and ERK1/2 Pathways	PLOS ONE			English	Article							POSTERIOR CAPSULE OPACIFICATION; GROWTH-FACTOR-BETA; ANTERIOR SUBCAPSULAR CATARACT; TGF-BETA; SIGNALING PATHWAYS; INTRAOCULAR-LENS; DOWN-REGULATION; AQUEOUS-HUMOR; PROLIFERATION; EXPRESSION	Transforming growth factor beta (TGF beta)-induced epithelial-mesenchymal transition (EMT) of lens epithelial cells (LECs) plays a key role in the pathogenesis of anterior subcapsular cataract (ASC) and capsule opacification. In mouse lens, Sprouty2 (Spry2) has a negative regulatory role on TGF beta signaling. However, the regulation of Spry2 during ASC development and how Spry2 modulates TGF beta signaling pathway in human LECs have not been characterized. Here, we demonstrate that Spry2 expression level is decreased in anterior capsule LECs of ASC patients. Spry2 negatively regulates TGF beta 2-induced EMT and migration of LECs through inhibition of Smad2 and ERK1/2 phosphorylation. Also, blockade of Smad2 or ERK1/2 activation suppresses EMT caused by Spry2 downregulation. Collectively, our results for the first time show in human LECs that Spry2 has an inhibitory role in TGF beta signaling pathway. Our findings in human lens tissue and epithelial cells suggest that Spry2 may become a novel therapeutic target for the prevention and treatment of ASC and capsule opacification.	[Tan, Xuhua; Zhu, Yi; Chen, Chuan; Chen, Xiaoyun; Qin, Yingyan; Qu, Bo; Luo, Lixia; Lin, Haotian; Wu, Mingxing; Chen, Weirong; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Liu, YZ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	yizhi_liu@aliyun.com	liu, yi/GXE-9662-2022; Chen, Chuan/I-1348-2019; Zhu, Yi/R-2283-2017; Chen, Wei/GZK-7348-2022	Chen, Chuan/0000-0001-5701-0857; Zhu, Yi/0000-0002-1778-8880; Lin, Haotian/0000-0003-4672-9721	National Natural Science Foundation of China [81270981, 81320108008]; Science and Technology Program of Guangdong Province [2013B051000029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong Province	This study was supported by the International Cooperation and Communication Project of the National Natural Science Foundation of China (No. 81320108008), the National Natural Science Foundation of China (No. 81270981) and the Science and Technology Program of Guangdong Province (No. 2013B051000029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnaof K, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-55; Akhurst RJ, 2012, NAT GENET, V44, P838, DOI 10.1038/ng.2366; Allen JB, 1998, GRAEF ARCH CLIN EXP, V236, P305, DOI 10.1007/s004170050083; APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3; Banh A, 2006, INVEST OPHTH VIS SCI, V47, P3450, DOI 10.1167/iovs.05-1208; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bill R, 2015, FEBS LETT, V589, P1577, DOI 10.1016/j.febslet.2015.05.002; Boros J, 2006, SEMIN CELL DEV BIOL, V17, P741, DOI 10.1016/j.semcdb.2006.10.007; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Chang KC, 2015, INVEST OPHTH VIS SCI, V56, P4198, DOI 10.1167/iovs.15-16557; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Chen XY, 2014, INT J MOL MED, V33, P1664, DOI 10.3892/ijmm.2014.1723; Dawes LJ, 2009, INVEST OPHTH VIS SCI, V50, P5318, DOI 10.1167/iovs.08-3223; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ding W, 2007, J CELL PHYSIOL, V212, P796, DOI 10.1002/jcp.21078; Dong N, 2015, INVEST OPHTH VIS SCI, V56, P993, DOI 10.1167/iovs.14-15860; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gadir N, 2007, CELL CYCLE, V6, P2840, DOI 10.4161/cc.6.22.4921; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Hodge WG, 1998, OPHTHALMOLOGY, V105, P943, DOI 10.1016/S0161-6420(98)96040-7; Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; Ishida I, 2005, J CATARACT REFR SURG, V31, P1219, DOI 10.1016/j.jcrs.2004.11.039; IWATA JL, 1995, CURR EYE RES, V14, P937, DOI 10.3109/02713689508995133; JAMPEL HD, 1990, CURR EYE RES, V9, P963, DOI 10.3109/02713689009069932; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kramer S, 1999, DEVELOPMENT, V126, P2515; Kunath T, 2014, PLACENTA, V35, P1079, DOI 10.1016/j.placenta.2014.09.008; Kuracha MR, 2011, INVEST OPHTH VIS SCI, V52, P6887, DOI 10.1167/iovs.11-7531; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lovicu FJ, 2002, BRIT J OPHTHALMOL, V86, P220, DOI 10.1136/bjo.86.2.220; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Macky TA, 2001, INT OPHTHALMOL CLIN, V41, P17, DOI 10.1097/00004397-200107000-00004; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1; Min Seong Hee, 2006, Korean J Ophthalmol, V20, P162; Minowada G, 2009, AM J RESP CELL MOL, V40, P31, DOI 10.1165/rcmb.2008-0147OC; Nahomi RB, 2016, BIOCHEM J, V473, P1455, DOI 10.1042/BCJ20160128; Nalluri SM, 2015, CYTOSKELETON, DOI [10.1002/cm21263, DOI 10.1002/CM21263]; Oida T, 2010, J IMMUNOL METHODS, V362, P195, DOI 10.1016/j.jim.2010.09.008; Petric I, 2004, CROAT MED J, V45, P287; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Saika S, 2004, PROG RETIN EYE RES, V23, P283, DOI 10.1016/j.preteyeres.2004.02.004; Shin EH, 2015, DEV BIOL, V406, P129, DOI 10.1016/j.ydbio.2015.09.005; Shin EHH, 2012, MOL MED, V18, P861, DOI 10.2119/molmed.2012.00111; Shirai K, 2006, MOL VIS, V12, P681; Sigurdsson V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060798; Sinha R, 2013, INDIAN J OPHTHALMOL, V61, P371, DOI 10.4103/0301-4738.115787; Sun CB, 2014, COLLOID SURFACE B, V113, P33, DOI 10.1016/j.colsurfb.2013.08.024; Werner L, 2001, OPHTHALMOLOGY, V108, P1675, DOI 10.1016/S0161-6420(01)00674-1; Wertheimer C, 2015, GRAEF ARCH CLIN EXP, V253, P409, DOI 10.1007/s00417-014-2875-0; Xiao W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08362; Yang YL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054736, 10.1371/journal.pone.0055384, 10.1371/journal.pone.0067755]; Yao J, 2012, MOL MED REP, V5, P1509, DOI 10.3892/mmr.2012.827; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang Q, 2016, ONCOGENE, V35, P3151, DOI 10.1038/onc.2015.365; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao GN, 2015, EXP EYE RES, V132, P9, DOI 10.1016/j.exer.2015.01.001; Zheng DY, 2012, MOL VIS, V18, P1238	62	20	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159275	10.1371/journal.pone.0159275	http://dx.doi.org/10.1371/journal.pone.0159275			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415760	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500118
J	Gao, LL; Bradeen, JM				Gao, Liangliang; Bradeen, James M.			Contrasting Potato Foliage and Tuber Defense Mechanisms against the Late Blight Pathogen Phytophthora infestans	PLOS ONE			English	Article							BROAD-SPECTRUM RESISTANCE; GENE RB; RT-PCR; TRANSCRIPT; TRANSGENE; DISPLAY	The late blight pathogen Phytophthora infestans can attack both potato foliage and tubers. When inoculated with P. infestans, foliage of nontransformed 'Russet Burbank' (WT) develops late blight disease while that of transgenic ` Russet Burbank' line SP2211 (+ RB) does not. We compared the foliar transcriptome responses of these two lines to P. infestans inoculation using an RNA-seq approach. A total of 515 million paired end RNA-seq reads were generated, representing the transcription of 29,970 genes. We also compared the differences and similarities of defense mechanisms against P. infestans in potato foliage and tubers. Differentially expressed genes, gene groups and ontology bins were identified to show similarities and differences in foliage and tuber defense mechanisms. Our results suggest that R gene dosage and shared biochemical pathways (such as ethylene and stress bins) contribute to RB-mediated incompatible potato-P. infestans interactions in both the foliage and tubers. Certain ontology bins such as cell wall and lipid metabolisms are potentially organ-specific.	[Gao, Liangliang; Bradeen, James M.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Gao, Liangliang] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Bradeen, James M.] Univ Minnesota, Stakman Borlaug Ctr Sustainable Plant Hlth, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bradeen, JM (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA.; Bradeen, JM (corresponding author), Univ Minnesota, Stakman Borlaug Ctr Sustainable Plant Hlth, St Paul, MN 55108 USA.	jbradeen@umn.edu		Gao, Liangliang/0000-0002-3864-0631; Bradeen, James/0000-0003-1930-4728	USDA NIFA [1007-35300-18255]; EPA P3 [SU-83434601-0]; Minnesota Area II Potato Research and Promotion Council	USDA NIFA(United States Department of Agriculture (USDA)); EPA P3; Minnesota Area II Potato Research and Promotion Council	This work was funded by USDA NIFA (grant 1007-35300-18255), EPA P3 (grant SU-83434601-0), and the Minnesota Area II Potato Research and Promotion Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradeen JM, 2009, MOL PLANT MICROBE IN, V22, P437, DOI 10.1094/MPMI-22-4-0437; Bradshaw JE, 2006, THEOR APPL GENET, V113, P943, DOI 10.1007/s00122-006-0353-8; Burra DD, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0254-y; Depuydt S, 2009, PLANT PHYSIOL, V149, P1366, DOI 10.1104/pp.108.131805; Draffehn AM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00423; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gao L, 2010, PLANT AN GEN 18 C SA; Gao LL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-340; Goyer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1666-2; Gyetvai G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031526; Halterman DA, 2008, PLANT DIS, V92, P339, DOI 10.1094/PDIS-92-3-0339; Haverkort AJ, 2009, POTATO RES, V52, P249, DOI 10.1007/s11540-009-9136-3; Kirk WW, 2001, AM J POTATO RES, V78, P319, DOI 10.1007/BF02875697; Kramer LC, 2009, MOL PLANT MICROBE IN, V22, P447, DOI 10.1094/MPMI-22-4-0447; Massa AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026801; Millett BP, 2007, THEOR APPL GENET, V114, P501, DOI 10.1007/s00122-006-0449-1; Millett BP, 2015, PHYTOPATHOLOGY, V105, P1131, DOI 10.1094/PHYTO-10-14-0291-R; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Park TH, 2005, EUPHYTICA, V143, P75, DOI 10.1007/s10681-005-2658-0; Pel M.A., 2010, MAPPING ISOLATION CH; Restrepo S, 2005, MOL PLANT MICROBE IN, V18, P913, DOI 10.1094/MPMI-18-0913; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; STEWART HE, 1994, POTATO RES, V37, P429, DOI 10.1007/BF02358357; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tumwine J., 2000, Mycologist, V14, P137, DOI 10.1016/S0269-915X(00)80096-8; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158	31	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159969	10.1371/journal.pone.0159969	http://dx.doi.org/10.1371/journal.pone.0159969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441721	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500157
J	Hope, CK; Billingsley, K; de Jong, ED; Higham, SM				Hope, Christopher K.; Billingsley, Karen; de Jong, Elbert de Josselin; Higham, Susan M.			A Preliminary Study of the Effects of pH upon Fluorescence in Suspensions of Prevotella intermedia	PLOS ONE			English	Article							PROTOPORPHYRIN-IX; COPROPORPHYRIN III; RED FLUORESCENCE; ENAMEL CARIES; DENTAL PLAQUE; PORPHYRINS; AGGREGATION; BACTERIA	The quantification of fluorescence in dental plaque is currently being developed as a diagnostic tool to help inform and improve oral health. The oral anaerobe Prevotella intermedia exhibits red fluorescence due to the accumulation of porphyrins. pH affects the fluorescence of abiotic preparations of porphyrins caused by changes in speciation between monomers, higher aggregates and dimers, but this phenomenon has not been demonstrated in bacteria. Fluorescence spectra were obtained from suspensions of P. intermedia that were adjusted to pHs commensurate with the range found within dental plaque. Two fluorescent motifs were identified; 410 nm excitation / 634 nm emission (peak A) and 398 nm excitation / 622 nm emission (peak B). A transition in the fluorescence spectra was observed from peak A to peak B with increasing pH which was also evident as culture age increased from 24 hours to 96 hours. In addition to these 'blue-shifts', the intensity of peak A increased with pH whilst decreasing with culture age from 24 to 96 hours. A bacterium's relationship with the local physiochemical environment at the time of image capture may therefore affect the quantification of dental plaque fluorescence.	[Hope, Christopher K.; Billingsley, Karen; de Jong, Elbert de Josselin; Higham, Susan M.] Univ Liverpool, Dept Hlth Serv Res, Liverpool, Merseyside, England; [Hope, Christopher K.; Higham, Susan M.] Univ Liverpool, Sch Dent, Liverpool, Merseyside, England; [Billingsley, Karen] Royal Liverpool & Broadgreen Univ Hosp, Dept Med Microbiol, Liverpool, Merseyside, England; [de Jong, Elbert de Josselin] Inspektor Res Syst BV, Amsterdam, Netherlands	University of Liverpool; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital	Hope, CK (corresponding author), Univ Liverpool, Dept Hlth Serv Res, Liverpool, Merseyside, England.; Hope, CK (corresponding author), Univ Liverpool, Sch Dent, Liverpool, Merseyside, England.	chope@liv.ac.uk	Hope, Christopher/A-1656-2009	Hope, Christopher/0000-0003-2986-0824	University of Liverpool, Institute of Psychology, Health and Society, Department of Health Services Research	University of Liverpool, Institute of Psychology, Health and Society, Department of Health Services Research	This project was internally funded by The University of Liverpool, Institute of Psychology, Health and Society, Department of Health Services Research. Inspektor Research Systems BV provided the salary for author EdJdJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai Akihiro, 1993, Aichi-Gakuin Journal of Dental Science, V31, P1; Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Bittar DG, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.6.065004; BRAZIER JS, 1986, J APPL BACTERIOL, V60, P121, DOI 10.1111/j.1365-2672.1986.tb03368.x; BROWN SB, 1976, BIOCHEM J, V153, P279, DOI 10.1042/bj1530279; Buchalla W, 2004, J PERIODONTAL RES, V39, P327, DOI 10.1111/j.1600-0765.2004.00747.x; Cox GSaW D. G, 1983, J AM CHEM SOC, V104, P6; Dawson RMC, 1989, PORPHYRINS RELATED C, P213; de Bruijn HS, 2013, PHOTOCH PHOTOBIO SCI, V12, P241, DOI 10.1039/c2pp25287b; DEJONG EDJ, 1995, CARIES RES, V29, P2, DOI 10.1159/000262032; Dietel W, 1996, J PHOTOCH PHOTOBIO B, V33, P225, DOI 10.1016/1011-1344(95)07249-7; Dietel W, 2007, J PHOTOCH PHOTOBIO B, V86, P77, DOI 10.1016/j.jphotobiol.2006.07.006; Ding HY, 2011, J CONTROL RELEASE, V151, P271, DOI 10.1016/j.jconrel.2011.01.004; Hope CK, 2011, J PERIODONTAL RES, V46, P228, DOI 10.1111/j.1600-0765.2010.01334.x; Hope CK, 2016, PHOTODIAGN PHOTODYN, V13, P344, DOI 10.1016/j.pdpdt.2015.07.173; Huang W, 2010, TALANTA, V82, P1516, DOI 10.1016/j.talanta.2010.07.034; Kathiravan A, 2013, DYES PIGMENTS, V96, P196, DOI 10.1016/j.dyepig.2012.07.004; Kruk MMaS A. S, 2009, MARCROHETEROCYCLES, V2, P4; Layer G, 2010, PROTEIN SCI, V19, P1137, DOI 10.1002/pro.405; Lingstrom P, 2000, J DENT RES, V79, P770, DOI 10.1177/00220345000790021101; Liu Q, 2012, TALANTA, V88, P663, DOI 10.1016/j.talanta.2011.11.057; Maiti NC, 1998, J PHYS CHEM B, V102, P1528, DOI 10.1021/jp9723372; Marcelli A, 2013, PHOTOCH PHOTOBIO SCI, V12, P348, DOI 10.1039/c2pp25247c; Matosevic D, 2010, ACTA STOMATOLOGICA C, V44, P9; MELO TB, 1986, BIOPHYS CHEM, V25, P99, DOI 10.1016/0301-4622(86)85070-0; Montcel B, 2013, BIOMED OPT EXPRESS, V4, P548, DOI 10.1364/BOE.4.000548; Nadkarni MA, 2012, EUR J CLIN MICROBIOL, V31, P2989, DOI 10.1007/s10096-012-1651-5; Nitzan Y, 2004, PHOTOCH PHOTOBIO SCI, V3, P430, DOI 10.1039/b315633h; Nunez SC, 2014, PHOTOCH PHOTOBIO SCI, V13, P595, DOI 10.1039/c3pp50325a; Postnikova GB, 1999, BIOCHEMISTRY-MOSCOW+, V64, P267; Schleier P, 2006, PROC SPIE, V6139, P46, DOI 10.1117/12.646533; Scolaro LM, 2002, J PHYS CHEM B, V106, P2453, DOI 10.1021/jp013155h; Seo I, 2009, P SOC PHOTO-OPT INS, V7161, DOI 10.1117/12.811913; SHAH HN, 1993, FEMS IMMUNOL MED MIC, V6, P89; SLOTS J, 1982, J CLIN MICROBIOL, V16, P1148, DOI 10.1128/JCM.16.6.1148-1151.1982; Smalley JW, 2003, MICROBIOL-SGM, V149, P1711, DOI 10.1099/mic.0.26258-0; Soukos NS, 2005, ANTIMICROB AGENTS CH, V49, P1391, DOI 10.1128/AAC.49.4.1391-1396.2005; Svensater G, 1997, ORAL MICROBIOL IMMUN, V12, P266, DOI 10.1111/j.1399-302X.1997.tb00390.x; TAKAHASHI N, 1990, J DENT RES, V69, P1266, DOI 10.1177/00220345900690060801; Tewari AK, 1998, J PLANT BIOCHEM BIOT, V7, P43, DOI 10.1007/BF03263032; Van der Veen MH, 2006, CARIES RES, V40, P542, DOI 10.1159/000095655; Villari V, 2012, RSC ADV, V2, P12989, DOI 10.1039/c2ra22260d; WILSON B C, 1986, Lasers in Medical Science, V1, P235, DOI 10.1007/BF02032418; Yuvaraj M, 2014, J PHOTOCH PHOTOBIO B, V130, P153, DOI 10.1016/j.jphotobiol.2013.11.006; Zezell DM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2821192	45	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158835	10.1371/journal.pone.0158835	http://dx.doi.org/10.1371/journal.pone.0158835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441707	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500025
J	Oh, YS; Seo, EH; Lee, YS; Cho, SC; Jung, HS; Park, SC; Jun, HS				Oh, Yoon Sin; Seo, Eun-Hui; Lee, Young-Sun; Cho, Sung Chun; Jung, Hye Seung; Park, Sang Chul; Jun, Hee-Sook			Increase of Calcium Sensing Receptor Expression Is Related to Compensatory Insulin Secretion during Aging in Mice	PLOS ONE			English	Article							BETA-CELL FUNCTION; TYPE-2 DIABETES-MELLITUS; GLUCOSE-TOLERANCE; SERUM-CALCIUM; BODY-FAT; SENSITIVITY; AGE; HOMEOSTASIS; POPULATION; RESISTANCE	Type 2 diabetes is caused by both insulin resistance and relative insulin deficiency. To investigate age-related changes in glucose metabolism and development of type 2 diabetes, we compared glucose homeostasis in different groups of C57BL/6J mice ranging in age from 4 months to 20 months (4, 8, 12, 16 and 20 months). Interestingly, we observed that non-fasting glucose levels were not significantly changed, but glucose tolerance gradually increased by 20 months of age, whereas insulin sensitivity declined with age. We found that the size of islets and glucose-stimulated insulin secretion increased with aging. However, mRNA expression of pancreatic and duodenal homeobox 1 and granuphilin was decreased in islets of older mice compared with that of 4-month-old mice. Serum calcium (Ca2+) levels were significantly decreased at 12, 20 and 28 months of age compared with 4 months and calcium sensing receptor (CaSR) mRNA expression in the islets significantly increased with age. An extracellular calcium depletion agent upregulated CaSR mRNA expression and consequently enhanced insulin secretion in INS-1 cells and mouse islets. In conclusion, we suggest that decreased Ca2+ levels and increased CaSR expression might be involved in increased insulin secretion to compensate for insulin resistance in aged mice.	[Oh, Yoon Sin; Seo, Eun-Hui; Lee, Young-Sun; Cho, Sung Chun; Park, Sang Chul; Jun, Hee-Sook] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Incheon, South Korea; [Oh, Yoon Sin; Jun, Hee-Sook] Gil Hosp, Gachon Med Res Inst, Incheon, South Korea; [Jung, Hye Seung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Jun, Hee-Sook] Gachon Univ, Coll Pharm, Incheon, South Korea; [Jun, Hee-Sook] Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea	Gachon University; Seoul National University (SNU); Gachon University; Gachon University	Jun, HS (corresponding author), Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Incheon, South Korea.; Jun, HS (corresponding author), Gil Hosp, Gachon Med Res Inst, Incheon, South Korea.; Jun, HS (corresponding author), Gachon Univ, Coll Pharm, Incheon, South Korea.; Jun, HS (corresponding author), Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea.	hsjun@gachon.ac.kr	오, 윤신/AAS-2225-2020	Jun, Hee-Sook/0000-0002-1166-4932; Oh, Yoon Sin/0000-0003-3995-4429	Innovative Research Institute for Cell Therapy [A062260]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C1135]	Innovative Research Institute for Cell Therapy; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grants from the Innovative Research Institute for Cell Therapy (A062260) and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1135).	BAILEY CJ, 1982, METABOLISM, V31, P238, DOI 10.1016/0026-0495(82)90059-2; Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; BODEN G, 1993, DIABETES CARE, V16, P728, DOI 10.2337/diacare.16.5.728; BOUREY RE, 1993, J GERONTOL, V48, pM122, DOI 10.1093/geronj/48.4.M122; BROUGHTON DL, 1991, EUR J CLIN INVEST, V21, P13, DOI 10.1111/j.1365-2362.1991.tb01352.x; Brown E. M., 2007, V45, P139; Chakraborty G, 2009, LAB ANIMAL, V38, P364, DOI 10.1038/laban1109-364; Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002; CHEN L, 1990, P NATL ACAD SCI USA, V87, P4088, DOI 10.1073/pnas.87.11.4088; CHEN M, 1985, J CLIN ENDOCR METAB, V60, P13, DOI 10.1210/jcem-60-1-13; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Gray E, 2006, J ENDOCRINOL, V190, P703, DOI 10.1677/joe.1.06891; Gu ZY, 2012, AGE, V34, P1393, DOI 10.1007/s11357-011-9312-7; Hagstrom E, 2007, DIABETOLOGIA, V50, P317, DOI 10.1007/s00125-006-0532-9; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; JACKSON RA, 1988, DIABETES, V37, P119, DOI 10.2337/diabetes.37.1.119; Jones Peter M., 2007, Archives of Physiology and Biochemistry, V113, P98, DOI 10.1080/13813450701531185; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kaneto H, 2007, CURR MED CHEM, V14, P1745; Kato T, 2006, CELL METAB, V4, P143, DOI 10.1016/j.cmet.2006.06.009; LAVINE RL, 1971, DIABETES, V20, P134, DOI 10.2337/diab.20.3.134; LEITER EH, 1988, FASEB J, V2, P2807, DOI 10.1096/fasebj.2.12.3044905; LEVY J, 1986, CALCIFIED TISSUE INT, V39, P316, DOI 10.1007/BF02555197; LI LW, 1995, J CELL PHYSIOL, V163, P105, DOI 10.1002/jcp.1041630112; Linetsky E, 1997, DIABETES, V46, P1120, DOI 10.2337/diabetes.46.7.1120; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; MORLEY JE, 1993, J AM COLL NUTR, V12, P337, DOI 10.1080/07315724.1993.10718319; Novelli M, 2000, EXP GERONTOL, V35, P641, DOI 10.1016/S0531-5565(00)00100-5; Oh YS, 2011, DIABETES-METAB RES, V27, P813, DOI 10.1002/dmrr.1233; PACINI G, 1988, J AM GERIATR SOC, V36, P317, DOI 10.1111/j.1532-5415.1988.tb02358.x; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; SILVER AJ, 1993, J AM GERIATR SOC, V41, P211, DOI 10.1111/j.1532-5415.1993.tb06693.x; Sing CW, 2015, SERUM CALCIUM AND IN, DOI DOI 10.1007/S00198-015-3444-Z; SORVA A, 1990, GERONTOLOGY, V36, P212, DOI 10.1159/000213202; Squires PE, 2000, J ENDOCRINOL, V165, P173, DOI 10.1677/joe.0.1650173; Sun G, 2005, DIABETES, V54, P3336, DOI 10.2337/diabetes.54.11.3336; Tfayli H, 2009, ARQ BRAS ENDOCRINOL, V53, P165, DOI 10.1590/S0004-27302009000200008; Torii S, 2002, MOL CELL BIOL, V22, P5518, DOI 10.1128/MCB.22.15.5518-5526.2002; van Haeften TW, 2000, METABOLISM, V49, P1318, DOI 10.1053/meta.2000.9526; Vitale G, 2013, NAT REV ENDOCRINOL, V9, P228, DOI 10.1038/nrendo.2013.29; Wareham NJ, 1997, METABOLISM, V46, P1171, DOI 10.1016/S0026-0495(97)90212-2; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Williamson DF, 1997, INT J OBESITY, V21, pS14; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; Yamaguchi T, 2011, METABOLISM, V60, P1334, DOI 10.1016/j.metabol.2011.02.003	49	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159689	10.1371/journal.pone.0159689	http://dx.doi.org/10.1371/journal.pone.0159689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441644	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500122
J	Okuyama, Y; Umeda, K; Negishi, M; Katoh, H				Okuyama, Yusuke; Umeda, Kentaro; Negishi, Manabu; Katoh, Hironori			Tyrosine Phosphorylation of SGEF Regulates RhoG Activity and Cell Migration	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SERINE 897 PHOSPHORYLATION; SMALL GTPASE RHOG; APOPTOTIC CELLS; RAC1 ACTIVATION; EPHA2; ANOIKIS; COMPLEX; CANCER; MORPHOGENESIS	SGEF and Ephexin4 are members of the Ephexin subfamily of RhoGEFs that specifically activate the small GTPase RhoG. It is reported that Ephexin1 and Ephexin5, two well-characterized Ephexin subfamily RhoGEFs, are tyrosine-phosphorylated by Src, and that their phosphorylation affect their activities and functions. In this study, we show that SGEF, but not Ephexin4, is tyrosine-phosphorylated by Src. Tyrosine phosphorylation of SGEF suppresses its interaction with RhoG, the elevation of RhoG activity, and SGEF-mediated promotion of cell migration. We identified tyrosine 530 (Y530), which is located within the Dbl homology domain, as a major phosphorylation site of SGEF by Src, and Y530F mutation blocked the inhibitory effect of Src on SGEF. Taken together, these results suggest that the activity of SGEF is negatively regulated by tyrosine phosphorylation of the DH domain.	[Okuyama, Yusuke; Umeda, Kentaro; Negishi, Manabu; Katoh, Hironori] Kyoto Univ, Grad Sch Pharmaceut Sci, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan; [Negishi, Manabu; Katoh, Hironori] Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Katoh, H (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.; Katoh, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	hirokato@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117	Ministry of Education, Science, Sports, and Culture of Japan [15K07928, 15K07043]; Takeda Science Foundation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (15K07928 and 15K07043) and by a grant from Takeda Science Foundation.	Abraham S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8286; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Akada M, 2014, CELL SIGNAL, V26, P2879, DOI 10.1016/j.cellsig.2014.08.031; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Ensign SPF, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.468686; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Fujimoto S, 2009, MOL BIOL CELL, V20, P4941, DOI 10.1091/mbc.E09-03-0200; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Gupta M, 2014, J BIOL CHEM, V289, P17195, DOI 10.1074/jbc.M114.573782; Harada K, 2015, J CELL SCI, V128, P1912, DOI 10.1242/jcs.163790; Harada K, 2011, EXP CELL RES, V317, P1701, DOI 10.1016/j.yexcr.2011.05.014; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kawai H, 2013, FEBS OPEN BIO, V3, P78, DOI 10.1016/j.fob.2013.01.002; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Kuroiwa M, 2011, J CELL SCI, V124, P1726, DOI 10.1242/jcs.080291; Kwiatkowska A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-65; Lee J, 2014, BBA-MOL CELL RES, V1843, P2438, DOI 10.1016/j.bbamcr.2014.07.006; Lu G, 2013, SCI WORLD J, DOI 10.1155/2013/424617; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Samson T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055202; Sato K, 2014, J BIOL CHEM, V289, P10045, DOI 10.1074/jbc.M113.521880; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wang HT, 2013, CARCINOGENESIS, V34, P1976, DOI 10.1093/carcin/bgt157; Wang HT, 2012, ONCOL REP, V28, P1468, DOI 10.3892/or.2012.1917; Wang YH, 2004, BIOCHEM BIOPH RES CO, V324, P1053, DOI 10.1016/j.bbrc.2004.09.153; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yamaki N, 2007, EXP CELL RES, V313, P2821, DOI 10.1016/j.yexcr.2007.05.010; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P5198, DOI 10.1073/pnas.0501160102; Yohe ME, 2007, J BIOL CHEM, V282, P13813, DOI 10.1074/jbc.M700185200	47	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159617	10.1371/journal.pone.0159617	http://dx.doi.org/10.1371/journal.pone.0159617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437949	gold, Green Published, Green Submitted			2022-12-27	WOS:000380170100056
J	De Santi, C; Willassen, NP; Williamson, A				De Santi, Concetta; Willassen, Nils Peder; Williamson, Adele			Biochemical Characterization of a Family 15 Carbohydrate Esterase from a Bacterial Marine Arctic Metagenome	PLOS ONE			English	Article							SALT-TOLERANT ESTERASE; GLUCURONOYL ESTERASE; COLD; MODEL; VERRUCOMICROBIA; ENVIRONMENT; DIVERSITY	Background The glucuronoyl esterase enzymes of wood-degrading fungi (Carbohydrate Esterase family 15; CE15) form part of the hemicellulolytic and cellulolytic enzyme systems that break down plant biomass, and have possible applications in biotechnology. Homologous enzymes are predicted in the genomes of several bacteria, however these have been much less studied than their fungal counterparts. Here we describe the recombinant production and biochemical characterization of a bacterial CE15 enzyme denoted MZ0003, which was identified by in silico screening of a prokaryotic metagenome library derived from marine Arctic sediment. MZ0003 has high similarity to several uncharacterized gene products of polysaccharide-degrading bacterial species, and phylogenetic analysis indicates a deep evolutionary split between these CE15s and fungal homologs. Results MZ0003 appears to differ from previously-studied CE15s in some aspects. Some glucuronoyl esterase activity could be measured by qualitative thin-layer chromatography which confirms its assignment as a CE15, however MZ0003 can also hydrolyze a range of other esters, including p-nitrophenyl acetate, which is not acted upon by some fungal homologs. The structure of MZ0003 also appears to differ as it is predicted to have several large loop regions that are absent in previously studied CE15s, and a combination of homology-based modelling and site-directed mutagenesis indicate its catalytic residues deviate from the conserved Ser-His-Glu triad of many fungal CE15s. Taken together, these results indicate that potentially unexplored diversity exists among bacterial CE15s, and this may be accessed by investigation of the microbial metagenome. The combination of low activity on typical glucuronoyl esterase substrates, and the lack of glucuronic acid esters in the marine environment suggest that the physiological substrate of MZ0003 and its homologs is likely to be different from that of related fungal enzymes.	[De Santi, Concetta; Willassen, Nils Peder; Williamson, Adele] UiT Arctic Univ Norway, Norwegian Struct Biol Ctr, Dept Chem, Tromso, Norway	UiT The Arctic University of Tromso	Williamson, A (corresponding author), UiT Arctic Univ Norway, Norwegian Struct Biol Ctr, Dept Chem, Tromso, Norway.	adele.k.williamson@uit.no	Willassen, Nils Peder/AAE-1843-2019	Willassen, Nils Peder/0000-0002-4397-8020; Williamson, Adele/0000-0001-8139-1071	Research Council of Norway [192123]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway, Grant no 192123 (http://www.forskningsradet.no/en/Home_page/1177315753906). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BERESS A, 1993, J NAT PROD, V56, P478, DOI 10.1021/np50094a005; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Biely P, 2015, FEBS LETT, V589, P2334, DOI 10.1016/j.febslet.2015.07.019; Bjerga GEK, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0185-1; Cardman Z, 2014, APPL ENVIRON MICROB, V80, P3749, DOI 10.1128/AEM.00899-14; Charavgi MD, 2013, ACTA CRYSTALLOGR D, V69, P63, DOI 10.1107/S0907444912042400; Chouari R, 2003, APPL ENVIRON MICROB, V69, P7354, DOI 10.1128/AEM.69.12.7354-7363.2003; d'Errico C, 2015, BIOTECHNOL BIOENG, V112, P914, DOI 10.1002/bit.25508; De Santi C, 2016, EXTREMOPHILES, V20, P323, DOI 10.1007/s00792-016-0824-z; De Santi C, 2016, BMC BIOCHEM, V17, DOI 10.1186/s12858-016-0057-x; Duranova M, 2009, ARCH MICROBIOL, V191, P133, DOI 10.1007/s00203-008-0434-y; Duranova M, 2009, BIOSCI BIOTECH BIOCH, V73, P2483, DOI 10.1271/bbb.90486; Esteban-Torres M, 2014, J AGR FOOD CHEM, V62, P5126, DOI 10.1021/jf501493z; Freitas S, 2012, ISME J, V6, P1499, DOI 10.1038/ismej.2012.3; Goldstone DC, 2010, PROTEINS, V78, P1457, DOI 10.1002/prot.22662; Guo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086752; Holdt SL, 2011, J APPL PHYCOL, V23, P543, DOI 10.1007/s10811-010-9632-5; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katsimpouras C, 2014, APPL MICROBIOL BIOT, V98, P5507, DOI 10.1007/s00253-014-5542-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XL, 2007, FEBS LETT, V581, P4029, DOI 10.1016/j.febslet.2007.07.041; Martinez-Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035314; Ohta Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15105; Peng Q, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-95; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pokkuluri PR, 2011, PROTEINS, V79, P2588, DOI 10.1002/prot.23088; Redouan E, 2009, CARBOHYD RES, V344, P1670, DOI 10.1016/j.carres.2009.05.031; Sangwan P, 2005, APPL ENVIRON MICROB, V71, P8402, DOI 10.1128/AEM.71.12.8402-8410.2005; Spanikova S, 2007, ARCH MICROBIOL, V188, P185, DOI 10.1007/s00203-007-0241-x; Spanikova S, 2006, FEBS LETT, V580, P4597, DOI 10.1016/j.febslet.2006.07.033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas F, 2012, ENVIRON MICROBIOL, V14, P2379, DOI 10.1111/j.1462-2920.2012.02751.x; Till M, 2013, PROTEINS; Topakas E, 2010, APPL MICROBIOL BIOT, V87, P1765, DOI 10.1007/s00253-010-2655-7; Vafiadi C, 2009, FEMS MICROBIOL LETT, V296, P178, DOI 10.1111/j.1574-6968.2009.01631.x; Vester JK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-72; Wijesekara I, 2011, CARBOHYD POLYM, V84, P14, DOI 10.1016/j.carbpol.2010.10.062; Woebken D, 2007, ISME J, V1, P419, DOI 10.1038/ismej.2007.63; Wong Dominic W S, 2012, Biotechnol Res Int, V2012, P951267, DOI 10.1155/2012/951267; Yang JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006085	44	21	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159345	10.1371/journal.pone.0159345	http://dx.doi.org/10.1371/journal.pone.0159345			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433797	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600049
J	Latvala, S; Hedberg, J; Di Bucchianico, S; Moller, L; Wallinder, IO; Elihn, K; Karlsson, HL				Latvala, Siiri; Hedberg, Jonas; Di Bucchianico, Sebastiano; Moller, Lennart; Wallinder, Inger Odnevall; Elihn, Karine; Karlsson, Hanna L.			Nickel Release, ROS Generation and Toxicity of Ni and NiO Micro- and Nanoparticles	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; LUNG EPITHELIAL-CELLS; OXIDATIVE DAMAGE; IN-VITRO; SURFACE CHARACTERISTICS; TRANSITION-METALS; REACTIVE OXYGEN; DNA-REPAIR; CANCER; ACTIVATION	Occupational exposure to airborne nickel is associated with an elevated risk for respiratory tract diseases including lung cancer. Therefore, the increased production of Ni-containing nanoparticles necessitates a thorough assessment of their physical, chemical, as well as toxicological properties. The aim of this study was to investigate and compare the characteristics of nickel metal (Ni) and nickel oxide (NiO) particles with a focus on Ni release, reactive oxygen species (ROS) generation, cellular uptake, cytotoxicity and genotoxicity. Four Ni-containing particles of both nano-size (Ni-n and NiO-n) and micron-size (Ni-m1 and Ni-m2) were tested. The released amount of Ni in solution was notably higher in artificial lysosomal fluid (e.g. 80-100 wt% for metallic Ni) than in cell medium after 24h (ca. 1-3 wt% for all particles). Each of the particles was taken up by the cells within 4 h and they remained in the cells to a high extent after 24 h post-incubation. Thus, the high dissolution in ALF appeared not to reflect the particle dissolution in the cells. Ni-m1 showed the most pronounced effect on cell viability after 48 h (alamar blue assay) whereas all particles showed increased cytotoxicity in the highest doses (20-40 mu g cm(2)) when assessed by colony forming efficiency (CFE). Interestingly an increased CFE, suggesting higher proliferation, was observed for all particles in low doses (0.1 or 1 mu g cm(-2)). Ni-m1 and NiO-n were the most potent in causing acellular ROS and DNA damage. However, no intracellular ROS was detected for any of the particles. Taken together, micron-sized Ni (Ni-m1) was more reactive and toxic compared to the nano-sized Ni. Furthermore, this study underlines that the low dose effect in terms of increased proliferation observed for all particles should be further investigated in future studies.	[Latvala, Siiri; Elihn, Karine] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Hedberg, Jonas; Wallinder, Inger Odnevall] KTH Royal Inst Technol, Div Surface & Corros Sci, Sch Chem Sci & Engn, Stockholm, Sweden; [Di Bucchianico, Sebastiano; Karlsson, Hanna L.] Karolinska Inst, Inst Environm Med, Biochem Toxicol Unit, Stockholm, Sweden; [Moller, Lennart] Karolinska Inst, Dept Biosci & Nutr, Analyt Toxicol, Huddinge, Sweden	Stockholm University; Royal Institute of Technology; Karolinska Institutet; Karolinska Institutet	Latvala, S (corresponding author), Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden.	siiri.latvala@aces.su.se	Di Bucchianico, Sebastiano/AAX-7000-2020; Di+Bucchianico, Sebastiano/AHI-8150-2022; Hedberg, Jonas/H-4226-2019; Wallinder, Inger Odnevall/Q-6875-2017	Di+Bucchianico, Sebastiano/0000-0002-6396-892X; Odnevall, Inger/0000-0003-2206-0082	Swedish Research Council FORMAS [2010-968]; Swedish Research Council for Health, Working Life and Welfare FORTE [2011-0832]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council for Health, Working Life and Welfare FORTE	This study was funded by the Swedish Research Council FORMAS (project: 2010-968, http://www.formas.se/en/) and the Swedish Research Council for Health, Working Life and Welfare FORTE (project: 2011-0832, http://forte.se/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2011, TOXICOL IN VITRO, V25, P930, DOI 10.1016/j.tiv.2011.02.015; Andersen A, 1996, OCCUP ENVIRON MED, V53, P708, DOI 10.1136/oem.53.10.708; Aranda A, 2013, TOXICOL IN VITRO, V27, P954, DOI 10.1016/j.tiv.2013.01.016; Barchowsky A, 2003, FREE RADICAL BIO MED, V34, P1130, DOI 10.1016/S0891-5849(03)00059-5; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Burello E, 2011, NANOTOXICOLOGY, V5, P228, DOI 10.3109/17435390.2010.502980; Capasso L, 2014, TOXICOL LETT, V226, P28, DOI 10.1016/j.toxlet.2014.01.040; Cavallo D, 2003, TOXICOL IN VITRO, V17, P603, DOI 10.1016/S0887-2333(03)00138-3; Chen HB, 2010, J BIOL CHEM, V285, P7374, DOI 10.1074/jbc.M109.058503; Chiou YH, 2014, ENVIRON MOL MUTAGEN, V55, P624, DOI 10.1002/em.21867; Cho WS, 2012, NANOTOXICOLOGY, V6, P22, DOI 10.3109/17435390.2011.552810; Cronholm P, 2013, SMALL, V9, P970, DOI 10.1002/smll.201201069; Di Pietro A, 2009, INT J HYG ENVIR HEAL, V212, P196, DOI 10.1016/j.ijheh.2008.05.005; Doak SH, 2009, MUTAGENESIS, V24, P285, DOI 10.1093/mutage/gep010; Goodman JE, 2011, CRIT REV TOXICOL, V41, P142, DOI 10.3109/10408444.2010.531460; Grimsrud TK, 2002, AM J EPIDEMIOL, V156, P1123, DOI 10.1093/aje/kwf165; Hedberg Y, 2013, ENVIRON SCI-PROC IMP, V15, P381, DOI 10.1039/c2em30818e; Hedberg Y, 2011, BIOMETALS, V24, P1099, DOI 10.1007/s10534-011-9469-7; Hedberg YS, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4934628; Horie M, 2011, J OCCUP HEALTH, V53, P64, DOI 10.1539/joh.L10121; Horie M, 2009, CHEM RES TOXICOL, V22, P1415, DOI 10.1021/tx900171n; IARC, 1990, IARC MON EV CARC RIS; Kain J, 2012, MUTAGENESIS, V27, P491, DOI 10.1093/mutage/ges010; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Karlsson HL, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0041-9; Karlsson HL, 2009, TOXICOL LETT, V188, P112, DOI 10.1016/j.toxlet.2009.03.014; KASPRZAK KS, 1991, CHEM RES TOXICOL, V4, P604, DOI 10.1021/tx00024a002; Liden C, 2008, CONTACT DERMATITIS, V59, P31, DOI 10.1111/j.1600-0536.2008.01363.x; Mazinanian N, 2013, REGUL TOXICOL PHARM, V65, P135, DOI 10.1016/j.yrtph.2012.10.014; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Mohammadi-Bardbori A, 2014, CHEM-BIOL INTERACT, V224, P183, DOI 10.1016/j.cbi.2014.10.034; Munoz A, 2012, TOXICOL APPL PHARM, V260, P1, DOI 10.1016/j.taap.2011.12.014; National Toxicology Program, 1996, Natl Toxicol Program Tech Rep Ser, V451, P1; Pietruska JR, 2011, TOXICOL SCI, V124, P138, DOI 10.1093/toxsci/kfr206; Rushton EK, 2010, J TOXICOL ENV HEAL A, V73, P445, DOI 10.1080/15287390903489422; Salnikow K, 2000, CANCER RES, V60, P3375; Sun H, 2013, GENES-BASEL, V4, P583, DOI 10.3390/genes4040583; Tsao TM, 2011, J ENVIRON MONITOR, V13, P1156, DOI 10.1039/c1em10013k; Valavanidis A, 2005, FREE RADICAL RES, V39, P1071, DOI 10.1080/10715760500188671; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vogelgesang J, 1998, ACCREDIT QUAL ASSUR, V3, P242, DOI 10.1007/s007690050234; XI H, 1993, TOXICOL APPL PHARM, V120, P29, DOI 10.1006/taap.1993.1083; Zhao JY, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2424-0	45	97	99	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159684	10.1371/journal.pone.0159684	http://dx.doi.org/10.1371/journal.pone.0159684			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434640	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169600081
J	Lam, Y; Westergaard, R; Kirk, G; Ahmadi, A; Genz, A; Keruly, J; Hutton, H; Surkan, PJ				Lam, Yukyan; Westergaard, Ryan; Kirk, Gregory; Ahmadi, Azal; Genz, Andrew; Keruly, Jeanne; Hutton, Heidi; Surkan, Pamela J.			Provider-Level and Other Health Systems Factors Influencing Engagement in HIV Care: A Qualitative Study of a Vulnerable Population	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ADHERENCE; RETENTION; PREDICTORS	Despite the existence of highly active antiretroviral therapy, HIV/AIDS morbidity and mortality continue to be public health burdens in the United States due to difficulties in engaging people living with HIV/AIDS (PLWHA) in continuous, effective care. In comparison to studies investigating patient-level characteristics associated with starting and remaining in care, there is relatively little research on how structural factors, such as those pertaining to healthcare providers and the infrastructure for delivery of health services, influence patients' engagement in HIV care. Our study, based in the city of Baltimore, Maryland, uses qualitative research methods with a population of predominantly African American PLWHA who have a history of drug abuse, to examine facilitators and barriers regarding adherence to antiretroviral therapy (ART) and HIV care appointment attendance. Data collection involved conducting one-on-one, in-depth interviews with 31 study participants, and data analysis entailed thematic coding of interview transcripts and writing analytic memos to develop ideas and concepts. Among other findings, factors described as influential by our study participants related to appointment reminders and scheduling, the attitudes and communication styles of HIV clinicians, and the disposition and availability of other healthcare workers on the care "team." Thus, improving quality of HIV care and means of delivering it may help mitigate the numerous points in the continuum of HIV care when a patient may disengage.	[Lam, Yukyan; Kirk, Gregory; Ahmadi, Azal; Genz, Andrew; Surkan, Pamela J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Westergaard, Ryan] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Kirk, Gregory; Keruly, Jeanne; Hutton, Heidi] Johns Hopkins Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; Johns Hopkins Medicine	Lam, Y (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	yukyan@jhu.edu			National Institutes of Health/National Institute on Drug Abuse [R34DA033181, U01DA036297, K23DA032306]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI118591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA032306, R34DA033181, R01DA012568, U01DA036297] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institutes of Health/National Institute on Drug Abuse grants R34DA033181, U01DA036297 and K23DA032306. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; [Anonymous], 2013, DET TABL NAT VIT STA; Beach MC, 2006, J GEN INTERN MED, V21, P661, DOI 10.1111/j.1525-1497.2006.00399.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brennan A, 2014, AIDS CARE, V26, P804, DOI 10.1080/09540121.2013.869536; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Eberhart MG, 2015, JAIDS-J ACQ IMM DEF, V69, pS37, DOI 10.1097/QAI.0000000000000587; Eldred L, 2007, AIDS PATIENT CARE ST, V21, pS1, DOI 10.1089/apc.2007.9993; Flickinger TE, 2013, JAIDS-J ACQ IMM DEF, V63, P362, DOI 10.1097/QAI.0b013e318295b86a; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Giordano TR, 2009, HIV CLIN TRIALS, V10, P299, DOI 10.1310/hct1005-299; Giordano TP, 2005, AIDS CARE, V17, P773, DOI 10.1080/09540120412331336652; Hill C Jeanne, 2005, Health Mark Q, V23, P69; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2011, CLIN INFECT DIS, V52, pS238, DOI 10.1093/cid/ciq048; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Park WB, 2008, INT J STD AIDS, V19, P125, DOI 10.1258/ijsa.2007.007101; Perron NJ, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-79; Philbin MM, 2014, AIDS CARE, V26; Rumptz MH, 2007, AIDS PATIENT CARE ST, V21, pS30, DOI 10.1089/apc.2007.9989; Smith LR, 2012, AIDS PATIENT CARE ST, V26, P344, DOI 10.1089/apc.2011.0388; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Yehia BR, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0990-0	27	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158759	10.1371/journal.pone.0158759	http://dx.doi.org/10.1371/journal.pone.0158759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27428012	Green Submitted, gold, Green Published			2022-12-27	WOS:000380169300020
J	Zhao, Y; Xia, QY; Yin, YP; Wang, ZK				Zhao, Yun; Xia, Qingyan; Yin, Youping; Wang, Zhongkang			Comparison of Droplet Digital PCR and Quantitative PCR Assays for Quantitative Detection of Xanthomonas citri Subsp citri	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; DNA COPY NUMBER; HIGH-THROUGHPUT; PV CITRI; QUANTIFICATION; CANKER; DIAGNOSIS; CYTOMEGALOVIRUS; PLATFORMS	Droplet digital polymerase chain reaction (ddPCR) is a novel molecular biology technique providing absolute quantification of target nucleic acids without the need for an external calibrator. Despite its emerging applications in medical diagnosis, there are few reports of its use for the detection of plant pathogens. This work was designed to assess the diagnosis potential of the ddPCR for absolute quantitative detection of Xanthomonas citri subsp. citri, a quarantine plant pathogenic bacterium that causes citrus bacterial canker in susceptible Citrus species. We transferred an established quantitative PCR (qPCR) assay for citrus bacterial canker diagnosis directly to the ddPCR format and compared the performance of the two methods. The qPCR assay has a broader dynamic range compared to the ddPCR assay and the ddPCR assay has a significantly higher degree of sensitivity compared to the qPCR assay. The influence of PCR inhibitors can be reduced considerably in the ddPCR assay because the collection of end-point fluorescent signals and the counting of binomial events (positive or negative droplets) are associated with a Poisson algorithm. The ddPCR assay also shows lower coefficient of variation compared to the qPCR assay especially in low target concentration. The linear association of the measurements by ddPCR and qPCR assays is strong (Pearson correlation = 0.8633; P<0.001). Receiver operating characteristic analysis indicates the ddPCR methodology is a more robust approach for diagnosis of citrus bacterial canker. In summary, the results demonstrated that the ddPCR assay has the potential for the quantitative detection of X. citri subsp. citri with high precision and accuracy as compared with the results from qPCR assay. Further studies are required to evaluate and validate the value of ddPCR technology in the diagnosis of plant disease and quarantine applications.	[Zhao, Yun; Xia, Qingyan; Yin, Youping; Wang, Zhongkang] Chongqing Univ, Sch Life Sci, Chongqing 400030, Peoples R China	Chongqing University	Wang, ZK (corresponding author), Chongqing Univ, Sch Life Sci, Chongqing 400030, Peoples R China.	w-zk@163.com						[Anonymous], GBT280682011; Bharuthram A, 2014, INFECT GENET EVOL, V25, P28, DOI 10.1016/j.meegid.2014.03.028; Bucher TB, 2016, EUR FOOD RES TECHNOL, V242, P927, DOI 10.1007/s00217-015-2599-3; Cao YP, 2015, WATER RES, V70, P337, DOI 10.1016/j.watres.2014.12.008; Cubero J, 2005, PHYTOPATHOLOGY, V95, P1333, DOI 10.1094/PHYTO-95-1333; Cubero J, 2001, APPL ENVIRON MICROB, V67, P2849, DOI 10.1128/AEM.67.6.2849-2852.2001; Dalmira F. U., 2016, Analytical Chemistry, V88, P812, DOI 10.1021/acs.analchem.5b03238; Das A. K., 2003, Journal of Applied Horticulture (Lucknow), V5, P52; Dingle TC, 2013, CLIN CHEM, V59, P1670, DOI 10.1373/clinchem.2013.211045; Dobnik D, 2015, ANAL CHEM, V87, P8218, DOI 10.1021/acs.analchem.5b01208; Dong LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13174; Dong LH, 2014, ANAL BIOANAL CHEM, V406, P1701, DOI 10.1007/s00216-013-7546-1; Dreo T, 2014, ANAL BIOANAL CHEM, V406, P6513, DOI 10.1007/s00216-014-8084-1; Floren C, 2015, FOOD CHEM, V173, P1054, DOI 10.1016/j.foodchem.2014.10.138; Golmohammadi M, 2007, J APPL MICROBIOL, V103, P2309, DOI 10.1111/j.1365-2672.2007.03484.x; HARTUNG JS, 1993, APPL ENVIRON MICROB, V59, P1143, DOI 10.1128/AEM.59.4.1143-1148.1993; Hartung JS, 1996, PHYTOPATHOLOGY, V86, P95, DOI 10.1094/Phyto-86-95; Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12; Haynes RJ, 2013, J MOL DIAGN, V15, P177, DOI 10.1016/j.jmoldx.2012.09.007; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Jin KyoungSik, 2001, Plant Pathology Journal, V17, P62; Kim TG, 2013, J ENVIRON SCI HEAL A, V48, P417, DOI 10.1080/10934529.2013.728915; Kim TG, 2014, BIOTECHNOLOGY REPORT, V48, P1; Laura M, 2014, ANAL CHEM, V86, P2618, DOI [10.1021/ac403843j, DOI 10.1021/AC403843J]; Ma J, 2013, BIOMARK INSIGHTS, V8, P127, DOI [10.4137/BMI.S13154, 10.4137/BMIMI.S13154]; Mavrodieva V, 2004, PHYTOPATHOLOGY, V94, P61, DOI 10.1094/PHYTO.2004.94.1.61; McCollum G, 2011, ACTA HORTIC, V892, P173; Morisset D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062583; Mukaide M, 2014, J VIROL METHODS, V207, P169, DOI 10.1016/j.jviromet.2014.07.006; Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Rothrock M. J., 2013, ADV MICROBIOL-IRVINE, V3, P403, DOI [10.4236/aim.2013.35055, DOI 10.4236/AIM.2013.35055]; Sedlak RH, 2014, DIAGN MICR INFEC DIS, V80, P285, DOI 10.1016/j.diagmicrobio.2014.09.004; STALL RE, 1991, ANNU REV PHYTOPATHOL, V29, P399, DOI 10.1146/annurev.py.29.090191.002151; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236	42	68	73	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159004	10.1371/journal.pone.0159004	http://dx.doi.org/10.1371/journal.pone.0159004			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427975	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169300028
J	Alvarez, GG; Van Dyk, DD; Colquhoun, H; Moreau, KA; Mulpuru, S; Graham, ID				Alvarez, Gonzalo G.; Van Dyk, Deborah D.; Colquhoun, Heather; Moreau, Katherine A.; Mulpuru, Sunita; Graham, Ian D.			Developing and Field Testing a Community Based Youth Initiative to Increase Tuberculosis Awareness in Remote Arctic Inuit Communities	PLOS ONE			English	Article							DISSEMINATION STRATEGIES; KNOWLEDGE TRANSLATION	Background Inuit in Canada have the highest reported tuberculosis (TB) incidence rate in Canada, even higher than other Canadian Indigenous groups. The aim of this study was to increase TB awareness among Inuit youth and their communities by equipping those who can best reach this population with a community based, youth focused, education initiative built on interventions adapted from a previous TB awareness study. Methods The Taima TB Youth Education Initiative was a field test case study of a knowledge translation (KT) strategy aimed at community members who provide health education in these communities. In the first stage of this study, interventions from a larger TB awareness campaign were adapted to focus on youth living in remote Inuit communities. During the second stage of the study, investigators field tested the initiative in two isolated Inuit communities. It was then applied by local implementation teams in two other communities. Evaluation criteria included feasibility, acceptability, knowledge uptake and health behavior change. Results Implementation of the adapted KT interventions resulted in participation of a total of 41 youth (19 females, 22 males) with an average age of 16 years (range 12-21 years) in four different communities in Nunavut. Community celebration events were attended by 271 community members where TB messaging were presented and discussed. All of the health care workers and community members surveyed reported that the adapted interventions were acceptable and a useful way of learning to some extent. Knowledge uptake measures indicated an average TB knowledge score of 64 out of 100. Local partners in all four communities indicated that they would use the Taima TB Youth Education Initiative again to raise awareness about TB among youth in their communities. Conclusions The TB awareness interventions adapted for the Taima TB Youth Education Initiative were acceptable to the Inuit communities involved in the study. They resulted in uptake of knowledge among participants. Implementation by local implementation teams was feasible as evidenced by the participation and attendance of youth and community members in all communities. The ability to implement the interventions by local implementation teams indicates there is potential to scale up in other remote communities in the arctic setting.	[Alvarez, Gonzalo G.; Van Dyk, Deborah D.; Mulpuru, Sunita; Graham, Ian D.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Colquhoun, Heather] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Moreau, Katherine A.] Univ Ottawa, Fac Educ, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Ottawa	Alvarez, GG (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	galvarez@ohri.ca	Graham, Ian D./ABD-5259-2021	Graham, Ian D./0000-0002-3669-1216; Alvarez, Gonzalo G/0000-0003-1562-5305	Canadian Institutes of Health Research [147574]; Canadian Institutes of Health Research Foundation Grant Scheme, RFN [143237]; Canadian Institutes of Health Research Foundation Grant [RFN] [143237]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Foundation Grant Scheme, RFN; Canadian Institutes of Health Research Foundation Grant [RFN]	The study was funded by the Canadian Institutes of Health Research. GGA received a Knowledge Translation Supplement grant (RN#147574) for this project from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). IDG is a recipient of a Canadian Institutes of Health Research Foundation Grant Scheme, RFN #143237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like thank those who contributed to the implementation of this study, including: Steve Lapp, Jesse Mike, Catherine Carry, the Taima TB Steering committee, Beth Cowie, Joan Killulark, Malvin Wright, Igah Sangoya, Anastazia Jurkova, Sandra Finn, Johnny Kuluguqtuq, Markus Wilke, Eileen Grady, Tina Chen, and Jeannie Aulaqiaq. The study was funded by the Canadian Institutes of Health Research. Gonzalo G. Alvarez received a Knowledge Translation Supplement grant (RN#147574) for this project from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). Ian D. Graham is a recipient of an inaugural Canadian Institutes of Health Research Foundation Grant [RFN #143237].	Alvarez G, 2013, CANADIAN TUBERCULOSI; Alvarez GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100975; [Anonymous], 2014, TUB CAN 2012 PRER; Assent Guidelines, 2012, ASS GUID; ENARSON DA, 1986, CAN MED ASSOC J, V134, P1149; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Grybowski S., 1976, B INTERNATION UNION, V51, P181; McShane KE, 2006, CAN J PUBLIC HEALTH, V97, P296, DOI 10.1007/BF03405607; Pufall EL, 2011, INT J CIRCUMPOL HEAL, V70, P532, DOI 10.3402/ijch.v70i5.17860; Santesso N, 2006, J CONTIN EDUC HEALTH, V26, P87, DOI 10.1002/chp.55; Stanchfield J., 2007, ART EXPT GROUP FACIL; Stewart S, 2008, J HEALTH PSYCHOL, V13, P180, DOI 10.1177/1359105307086709	12	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159241	10.1371/journal.pone.0159241	http://dx.doi.org/10.1371/journal.pone.0159241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415757	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500106
J	Jain, M; Batth, R; Kumari, S; Mustafiz, A				Jain, Muskan; Batth, Rituraj; Kumari, Sumita; Mustafiz, Ananda			Arabidopsis thaliana Contains Both Ni2+ and Zn2+ Dependent Glyoxalase I Enzymes and Ectopic Expression of the Latter Contributes More towards Abiotic Stress Tolerance in E-coli	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; METHYLGLYOXAL; PATHWAY; GLUTATHIONE; ACTIVATION; GENE	The glyoxalase pathway is ubiquitously found in all the organisms ranging from prokaryotes to eukaryotes. It acts as a major pathway for detoxification of methylglyoxal (MG), which deleteriously affects the biological system in stress conditions. The first important enzyme of this system is Glyoxalase I (GLYI). It is a metalloenzyme which requires divalent metal ions for its activity. This divalent metal ion can be either Zn2+ as found in most of eukaryotes or Ni2+ as seen in prokaryotes. In the present study, we have found three active GLYI enzymes (AtGLYI2, AtGLYI3 and AtGLYI6) belonging to different metal activation classes coexisting in Arabidopsis thaliana. These enzymes have been found to efficiently complement the GLYI yeast mutants. These three enzymes have been characterized in terms of their activity, metal dependency, kinetic parameters and their role in conferring tolerance to multiple abiotic stresses in E. coli and yeast. AtGLYI2 was found to be Zn2+ dependent whereas AtGLYI3 and AtGLYI6 were Ni2+ dependent. Enzyme activity of Zn2+ dependent enzyme, AtGLYI2, was observed to be exceptionally high (similar to 250-670 fold) as compared to Ni2+ dependent enzymes, AtGLYI3 and AtGLYI6. The activity of these GLYI enzymes correlated well to their role in stress tolerance. Heterologous expression of these enzymes in E. coli led to better tolerance against various stress conditions. This is the first report of a higher eukaryotic species having multiple active GLYI enzymes belonging to different metal activation classes.	[Jain, Muskan; Mustafiz, Ananda] South Asian Univ, Fac Life Sci & Biotechnol, Plant Mol Biol Lab, Akbar Bhawan, New Delhi 110021, India; [Batth, Rituraj; Kumari, Sumita] Sher E Kashmir Univ Agr Sci & Technol, Jammu 180009, India	South Asian University (SAU); Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu (SKUAST Jammu)	Mustafiz, A (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, Plant Mol Biol Lab, Akbar Bhawan, New Delhi 110021, India.	amustafiz@sau.ac.in		Batth, Rituraj/0000-0002-0205-645X	South Asian University	South Asian University	This work was supported by the South Asian University, Grant was received by AM. The funder have no role in study design and data collection.; Funding and support from South Asian University are duly acknowledged.	Bhomkar P, 2008, MOL BREEDING, V22, P169, DOI 10.1007/s11032-008-9164-8; CARRINGTON SJ, 1986, IRCS MED SCI-BIOCHEM, V14, P763; Clugston SL, 1998, BIOCHEMISTRY-US, V37, P8754, DOI 10.1021/bi972791w; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Frickel EM, 2001, J BIOL CHEM, V276, P1845, DOI 10.1074/jbc.M005760200; Hossain D, 2005, J CROP SCI BIOTECH, V10, P21; Iozef R, 2003, FEBS LETT, V554, P284, DOI 10.1016/S0014-5793(03)01146-3; Irsch T, 2004, J BIOL CHEM, V279, P22209, DOI 10.1074/jbc.M401240200; JAGT DLV, 1973, BIOCHEMISTRY-US, V12, P5161, DOI 10.1021/bi00749a022; KALAPOS MP, 1992, BIOCHIM BIOPHYS ACTA, V1135, P159, DOI 10.1016/0167-4889(92)90132-U; Lin FY, 2010, MOL BIOL REP, V37, P729, DOI 10.1007/s11033-009-9578-3; Mustafiz A, 2014, PLANT J, V78, P951, DOI 10.1111/tpj.12521; Mustafiz A, 2011, FUNCT INTEGR GENOMIC, V11, P293, DOI 10.1007/s10142-010-0203-2; Neuberg C, 1913, BIOCHEM Z, V49, P502; RACKER E, 1951, J BIOL CHEM, V190, P685; RAY S, 1994, BIOCHEM J, V303, P69, DOI 10.1042/bj3030069; Ridderstrom M, 1996, BIOCHEM J, V314, P463; Singla-Pareek SL, 2006, PLANT PHYSIOL, V140, P613, DOI 10.1104/pp.105.073734; Singla-Pareek SL, 2003, P NATL ACAD SCI USA, V100, P14672, DOI 10.1073/pnas.2034667100; Speer O, 2003, J BIOL CHEM, V278, P34757, DOI 10.1074/jbc.M301990200; Sukdeo N, 2004, BIOCHEM J, V384, P111, DOI 10.1042/BJ20041006; Sukdeo N, 2007, BBA-PROTEINS PROTEOM, V1774, P756, DOI 10.1016/j.bbapap.2007.04.005; Suttisansanee U, 2011, J BIOL CHEM, V286, P38367, DOI 10.1074/jbc.M111.251603; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Veena, 1999, PLANT J, V17, P385, DOI 10.1046/j.1365-313X.1999.00390.x; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu C, 2013, J PLANT RES, V126, P415, DOI 10.1007/s10265-012-0532-4; Yadav SK, 2005, BIOCHEM BIOPH RES CO, V337, P61, DOI 10.1016/j.bbrc.2005.08.263	30	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159348	10.1371/journal.pone.0159348	http://dx.doi.org/10.1371/journal.pone.0159348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415831	gold, Green Submitted, Green Published			2022-12-27	WOS:000379579500122
J	Jin, H; Won, M; Park, SE; Lee, S; Park, M; Bae, J				Jin, Hanyong; Won, Miae; Park, Si Eun; Lee, Seunghwa; Park, Mira; Bae, Jeehyeon			FOXL2 Is an Essential Activator of SF-1-Induced Transcriptional Regulation of Anti-Mullerian Hormone in Human Granulosa Cells	PLOS ONE			English	Article							STEROIDOGENIC FACTOR-I; INHIBITING SUBSTANCE GENE; ORPHAN NUCLEAR RECEPTOR; OVARIAN RESERVE; FOLLICLE DEVELOPMENT; EXPRESSION; SF-1; DIFFERENTIATION; PROMOTER; FACTOR-1	Anti-Mullerian hormone (AMH) is required for proper sexual differentiation by regulating the regression of the Mullerian ducts in males. Recent studies indicate that AMH could be an important factor for maintaining the ovarian reserve. However, the mechanisms of AMH regulation in the ovary are largely unknown. Here, we provide evidence that AMH is an ovarian target gene of steroidogenic factor-1 (SF-1), an orphan nuclear receptor required for proper follicle development. FOXL2 is an evolutionally conserved transcription factor, and its mutations cause blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES), wherein affected females display eyelid defects and premature ovarian failure (POF). Notably, we found that functional FOXL2 is essential for SF-1-induced AMH regulation, via protein-protein interactions between FOXL2 and SF-1. A BPES-inducing mutant of FOXL2 (290-291delCA) was unable to interact with SF-1 and failed to mediate the association between SF-1 and the AMH promoter. Therefore, this study identified a novel regulatory circuit for ovarian AMH production; specifically, through the coordinated interplay between FOXL2 and SF-1 that could control ovarian follicle development.	[Jin, Hanyong; Park, Si Eun; Park, Mira; Bae, Jeehyeon] Chung Ang Univ, Sch Pharm, Seoul, South Korea; [Won, Miae] CHA Univ, Dept Pharm, Songnam, South Korea; [Lee, Seunghwa] Chung Ang Univ, Dept Life Sci, Seoul, South Korea	Chung Ang University; Pochon Cha University; Chung Ang University	Bae, J (corresponding author), Chung Ang Univ, Sch Pharm, Seoul, South Korea.	jeehyeon@cau.ac.kr	Won, Miae/AAL-9049-2020	bae, jeehyeon/0000-0003-1995-1378; Jin, Hanyong/0000-0002-5850-0791	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2014R1A2A2A01006839, NRF-2015R1A2A1A15054332]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This research was supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT, and Future Planning (2014R1A2A2A01006839; NRF-2015R1A2A1A15054332) (http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none).	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; BEZARD J, 1988, REPROD NUTR DEV, V28, P1105, DOI 10.1051/rnd:19880708; BLOCK E, 1952, ACTA ANAT, V14, P108; BLOCK E., 1953, ARCH GYNSKOL, V183, P294, DOI 10.1007/BF01004865; Broekmans FJ, 2008, TRENDS ENDOCRIN MET, V19, P340, DOI 10.1016/j.tem.2008.08.002; Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020; CATE RL, 1986, CELL, V45, P685, DOI 10.1016/0092-8674(86)90783-X; Conway GS, 2000, BRIT MED BULL, V56, P643, DOI 10.1258/0007142001903445; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Dolleman M, 2014, HUM REPROD, V29, P584, DOI 10.1093/humrep/det446; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Durlinger ALL, 2001, ENDOCRINOLOGY, V142, P4891, DOI 10.1210/en.142.11.4891; Falender AE, 2003, ENDOCRINOLOGY, V144, P3598, DOI 10.1210/en.2002-0137; Forabosco A, 2007, FERTIL STERIL, V88, P675, DOI 10.1016/j.fertnstert.2006.11.191; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; HATANO O, 1994, DEVELOPMENT, V120, P2787; Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107; Hong CY, 2003, MOL CELL BIOL, V23, P6000, DOI 10.1128/MCB.23.17.6000-6012.2003; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Jagannathan V, 2011, MOL CELL ENDOCRINOL, V334, P91, DOI 10.1016/j.mce.2010.06.012; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; LYNCH JP, 1993, MOL ENDOCRINOL, V7, P776, DOI 10.1210/me.7.6.776; Meduri G, 2007, HUM REPROD, V22, P117, DOI 10.1093/humrep/del346; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Park M, 2014, FERTIL STERIL, V102, P847, DOI 10.1016/j.fertnstert.2014.05.031; Park M, 2010, MOL ENDOCRINOL, V24, P1024, DOI 10.1210/me.2009-0375; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Pelusi C, 2008, BIOL REPROD, V79, P1074, DOI 10.1095/biolreprod.108.069435; Peluso C, 2014, CLIN CHIM ACTA, V437, P175, DOI 10.1016/j.cca.2014.07.029; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; Schepers G, 2003, J BIOL CHEM, V278, P28101, DOI 10.1074/jbc.M304067200; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Seifer DB, 2002, FERTIL STERIL, V77, P468, DOI 10.1016/S0015-0282(01)03201-0; SHEN WH, 1994, CELL, V77, P651, DOI 10.1016/0092-8674(94)90050-7; Sugawara T, 1996, BIOCHEMISTRY-US, V35, P9052, DOI 10.1021/bi960057r; Thackray VG, 2014, MOL CELL ENDOCRINOL, V385, P62, DOI 10.1016/j.mce.2013.09.034; Tremblay JJ, 1999, MOL ENDOCRINOL, V13, P1388, DOI 10.1210/me.13.8.1388; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Uhlenhaut NH, 2006, MOL GENET METAB, V88, P225, DOI 10.1016/j.ymgme.2006.03.005; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015; Yu RN, 1998, MOL ENDOCRINOL, V12, P1010, DOI 10.1210/me.12.7.1010	48	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159112	10.1371/journal.pone.0159112	http://dx.doi.org/10.1371/journal.pone.0159112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414805	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500078
J	Krebs, BB; De Mesquita, JF				Krebs, Bruna Baumgarten; De Mesquita, Joelma Freire			Amyotrophic Lateral Sclerosis Type 20-In Silico Analysis and Molecular Dynamics Simulation of hnRNPA1	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; SECONDARY STRUCTURE; SERVER; WEB; MUTATIONS; CONSURF; DOMAINS; REGIONS	Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease that affects the upper and lower motor neurons. 5-10% of cases are genetically inherited, including ALS type 20, which is caused by mutations in the hnRNPA1 gene. The goals of this work are to analyze the effects of non-synonymous single nucleotide polymorphisms (nsSNPs) on hnRNPA1 protein function, to model the complete tridimensional structure of the protein using computational methods and to assess structural and functional differences between the wild type and its variants through Molecular Dynamics simulations. nsSNP, PhD-SNP, Polyphen2, SIFT, SNAP, SNPs&GO, SNPeffect and PROVEAN were used to predict the functional effects of nsSNPs. Ab initio modeling of hnRNPA1 was made using Rosetta and refined using KoBaMIN. The structure was validated by PROCHECK, Rampage, ERRAT, Verify3D, ProSA and Qmean. TM-align was used for the structural alignment. FoldIndex, DICHOT, ELM, D2P2, Disopred and DisEMBL were used to predict disordered regions within the protein. Amino acid conservation analysis was assessed by Consurf, and the molecular dynamics simulations were performed using GROMACS. Mutations D314V and D314N were predicted to increase amyloid propensity, and predicted as deleterious by at least three algorithms, while mutation N73S was predicted as neutral by all the algorithms. D314N and D314V occur in a highly conserved amino acid. The Molecular Dynamics results indicate that all mutations increase protein stability when compared to the wild type. Mutants D314N and N319S showed higher overall dimensions and accessible surface when compared to the wild type. The flexibility level of the C-terminal residues of hnRNPA1 is affected by all mutations, which may affect protein function, especially regarding the protein ability to interact with other proteins.	[Krebs, Bruna Baumgarten; De Mesquita, Joelma Freire] Fed Univ Rio de Janeiro State UNIRIO, Dept Genet & Mol Biol, Lab Bioinformat & Computat Biol, Rio De Janeiro, Brazil	Universidade Federal do Estado do Rio de Janeiro	De Mesquita, JF (corresponding author), Fed Univ Rio de Janeiro State UNIRIO, Dept Genet & Mol Biol, Lab Bioinformat & Computat Biol, Rio De Janeiro, Brazil.	joelma.mesquita@unirio.br	De Mesquita, Joelma/W-5553-2019; De Mesquita, Joelma/J-4837-2012	De Mesquita, Joelma/0000-0003-1684-3830	FAPERJ; CNPq	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPERJ and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Moreira LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081979; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Bekenstein U, 2013, MOL CELL NEUROSCI, V56, P436, DOI 10.1016/j.mcn.2012.12.002; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Calini D, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.05.025; Capriles PVSZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-610; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; de Carvalho MDC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065558; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dorn M, 2014, COMPUT BIOL CHEM, V53, P251, DOI 10.1016/j.compbiolchem.2014.10.001; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, P1; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Essman U, 1995, J CHEM PHYS, V102, P31; Eswar N, 2003, TOOLS COMP PROTEIN S, P31; Fernandez-Fuentes N, 2007, NUCL ACIDS RES S2, V35; Fukuchi S, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-26; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Honda H, 2015, NEUROPATHOLOGY, V35, P37, DOI 10.1111/neup.12153; Huang TT, 2015, NUCLEIC ACIDS RES, V43, pW338, DOI 10.1093/nar/gkv454; Huang Y, 2013, STEM CELLS, V31, P906, DOI 10.1002/stem.1324; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kamaraj B, 2015, J BIOMOL STRUCT DYN, V33, P834, DOI 10.1080/07391102.2014.915762; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kirubakaran P, 2013, J MOL MODEL, V19, P407, DOI 10.1007/s00894-012-1566-1; Kumar Chundi Vinay, 2014, Advances in Bioinformatics, V2014, P502618, DOI 10.1155/2014/502618; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leman JK, 2013, PROTEINS, V81, P1127, DOI 10.1002/prot.24258; Lima MA, 2014, BIOINFORMATICA BIOL, P1; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mancuso R, 2015, PROG NEUROBIOL, V133, P1, DOI 10.1016/j.pneurobio.2015.07.004; McGuffin LJ, 2015, NUCLEIC ACIDS RES, V43, pW169, DOI 10.1093/nar/gkv236; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rodrigues JPGLM, 2012, NUCLEIC ACIDS RES, V40, pW323, DOI 10.1093/nar/gks376; Roy R, 2014, NUCLEIC ACIDS RES, V42, P12483, DOI 10.1093/nar/gku953; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Taylor P, 2013, RARE DIS, P1; Turner, 2005, XMGRACE VERSION 51 1; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yang JY, 2016, J MOL BIOL, V428, P693, DOI 10.1016/j.jmb.2015.09.024; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004	65	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158939	10.1371/journal.pone.0158939	http://dx.doi.org/10.1371/journal.pone.0158939			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414033	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500051
J	Wang, SH; Zhang, YY; Yang, MY; Ye, LP; Gong, L; Qian, QJ; Shuai, YJ; You, ZY; Chen, YY; Zhong, BX				Wang, Shaohua; Zhang, Yuyu; Yang, Mingying; Ye, Lupeng; Gong, Lu; Qian, Qiujie; Shuai, Yajun; You, Zhengying; Chen, Yuyin; Zhong, Boxiong			Characterization of Transgenic Silkworm Yielded Biomaterials with Calcium-Binding Activity	PLOS ONE			English	Article							BOMBYX-MORI SILK; PIGGYBAC TRANSPOSON; FIBROIN; PROTEIN; TRANSFORMATION; FIBRONECTIN; SCAFFOLDS; SEQUENCE; GLAND	Silk fibers have many inherent properties that are suitable for their use in biomaterials. In this study, the silk fibroin was genetically modified by including a Ca-binding sequence, [(AGSGAG)(6)ASEYDYDDDSDDDDEWD](2) from shell nacreous matrix protein. It can be produced as fibers by transgenic silkworm. The Ca-binding activity and mineralization of the transgenic silk fibroin were examined in vitro. The results showed that this transgenic silk fibroin had relatively higher Ca-binding activity than unmodified silk fibroin. The increased Ca-binding activity could promote the usage of silk fibroin as a biomaterial in the pharmaceutical industry. This study shows the possibility of using silk fibroin as a mineralization accelerating medical material by generating genetically modified transgenic silkworm.	[Wang, Shaohua; Zhang, Yuyu; Yang, Mingying; Ye, Lupeng; Qian, Qiujie; Shuai, Yajun; You, Zhengying; Chen, Yuyin; Zhong, Boxiong] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Gong, Lu] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhong, BX (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China.	bxzhong@zju.edu.cn	Chen, Yu/Y-3292-2019; Gong, Lu/AAM-3697-2021; Shuai, Yajun/AAR-5168-2021; Gong, Lu/X-2715-2019; Chen, Yi/HIR-2608-2022	Gong, Lu/0000-0001-9151-0767; Shuai, Yajun/0000-0003-3313-1800; Yang, Mingying/0000-0003-1256-6514; Ye, Lupeng/0000-0003-3901-6598	Zhejiang Provincial Science and Technology Plans [2012C12910]; National Basic Research Program of China [2012CB114601]	Zhejiang Provincial Science and Technology Plans; National Basic Research Program of China(National Basic Research Program of China)	This work is supported by the Projects of Zhejiang Provincial Science and Technology Plans (No. 2012C12910), grants from the National Basic Research Program of China (No. 2012CB114601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura T, 2006, BIOMACROMOLECULES, V7, P1996, DOI 10.1021/bm060155k; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Kawakami M, 2011, BIO-MED MATER ENG, V21, P53, DOI 10.3233/BME-2011-0656; Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013; Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Li Z, 2015, MOL BIOL REP, V42, P19, DOI 10.1007/s11033-014-3735-z; Nagano A, 2011, ACTA BIOMATER, V7, P1192, DOI 10.1016/j.actbio.2010.10.032; Shi P, 2014, INT J NANOMED, V9, P1617, DOI 10.2147/IJN.S53886; Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Tanaka T, 2001, J THERM ANAL CALORIM, V64, P645, DOI 10.1023/A:1011575824042; Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109; Tomita M, 2007, TRANSGENIC RES, V16, P449, DOI 10.1007/s11248-007-9087-x; Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2; Xu HF, 2014, TRANSGENIC RES, V23, P697, DOI 10.1007/s11248-014-9826-8; Yanagisawa S, 2007, BIOMACROMOLECULES, V8, P3487, DOI 10.1021/bm700646f; Yang M, 2008, BIOMACROMOLECULES, V9, P416, DOI 10.1021/bm700665m; Yang M, 2008, J BIOMED MATER RES A, V84A, P353, DOI 10.1002/jbm.a.31348; Yang MY, 2012, INT J MOL SCI, V13, P7762, DOI 10.3390/ijms13067762; Ye L, 2015, SCI REP, V5; Zhong BX, 2007, ACTA BIOCH BIOPH SIN, V39, P117, DOI 10.1111/j.1745-7270.2007.00252.x; Zhou ZH, 2008, J PROTEOME RES, V7, P5103, DOI 10.1021/pr800383r	24	4	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159111	10.1371/journal.pone.0159111	http://dx.doi.org/10.1371/journal.pone.0159111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414647	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500077
J	Wei, XR; Smith, AJ; Forrest, DW; Cardenas, GA; Beck, DW; LaLota, M; Metsch, LR; Sionean, C; Owen, SM; Johnson, JA				Wei, Xierong; Smith, Amanda J.; Forrest, David W.; Cardenas, Gabriel A.; Beck, Dano W.; LaLota, Marlene; Metsch, Lisa R.; Sionean, Catlainn; Owen, S. Michele; Johnson, Jeffrey A.			Incident Infection and Resistance Mutation Analysis of Dried Blood Spots Collected in a Field Study of HIV Risk Groups, 2007-2010	PLOS ONE			English	Article							BEHAVIORAL SURVEILLANCE SYSTEM; SPECIMENS	Objective To assess the utility of cost-effective dried blood spot (DBS) field sampling for incidence and drug resistance surveillance of persons at high risk for HIV infection. Methods We evaluated DBS collected in 2007-2010 in non-clinical settings by finger-stick from HIV-positive heterosexuals at increased risk of HIV infection (n = 124), men who have sex with men (MSM, n = 110), and persons who inject drugs (PWID, n = 58). Relative proportions of recent-infection findings among risk groups were assessed at avidity index (AI) cutoffs of <= 25%, <= 30%, and <= 35%, corresponding to an infection mean duration of recency (MDR) of 220.6, 250.4, and 278.3 days, respectively. Drug resistance mutation prevalence was compared among the risk groups and avidity indices. Results HIV antibody avidity testing of all self-reported ARV-naive persons (n = 186) resulted in 9.7%, 11.3% and 14.0% with findings within the 221, 250, and 278-day MDRs, respectively. The proportion of ARV-naive MSM, heterosexuals, and PWID reporting only one risk category who had findings below the suggested 30% AI was 23.1%, 6.9% and 3.6% (p < 0.001), respectively. MSM had the highest prevalence of drug resistance and the only cases of transmitted multi-class resistance. Among the ARV-experienced, MSM had disproportionately more recent-infection results than did heterosexuals and PWID. Conclusions The disproportionately higher recent-infection findings for MSM as compared to PWID and heterosexuals increased as the MDR window increased. Unreported ARV use might explain greater recent-infection findings and drug resistance in this MSM population. DBS demonstrated utility in expanded HIV testing; however, optimal field handling is key to accurate recent-infection estimates.	[Wei, Xierong; Smith, Amanda J.; Sionean, Catlainn; Owen, S. Michele; Johnson, Jeffrey A.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329 USA; [Forrest, David W.; Cardenas, Gabriel A.; Metsch, Lisa R.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Beck, Dano W.; LaLota, Marlene] Florida Dept Hlth, HIV AIDS Sect, Tallahassee, FL 32399 USA; [Beck, Dano W.] Oregon Hlth Author, Portland, OR USA; [Metsch, Lisa R.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Centers for Disease Control & Prevention - USA; University of Miami; Florida Department of Health; Columbia University	Johnson, JA (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329 USA.	jjohnson1@cdc.gov			intramural CDC funds; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	intramural CDC funds; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by intramural CDC funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dinenno Elizabeth A, 2012, Open AIDS J, V6, P169, DOI 10.2174/1874613601206010169; Gallagher KM, 2007, PUBLIC HEALTH REP, V122, P32, DOI 10.1177/00333549071220S106; HANNON WH, 1989, INFECT CONT HOSP EP, V10, P8, DOI 10.1086/645908; JINKS DC, 1989, HUM GENET, V81, P363, DOI 10.1007/BF00283692; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; Laeyendecker O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013259; Lansky A, 2007, PUBLIC HEALTH REP, V122, P48, DOI 10.1177/00333549071220S108; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Wei XR, 2011, J CLIN VIROL, V50, P148, DOI 10.1016/j.jcv.2010.11.006; WILCKEN B, 1983, J PEDIATR-US, V102, P383, DOI 10.1016/S0022-3476(83)80653-2; Winand R, 2015, AIDS, V29, P2045, DOI 10.1097/QAD.0000000000000811; Youngpairoj AS, 2008, J ANTIMICROB CHEMOTH, V61, P1217, DOI 10.1093/jac/dkn100	14	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159266	10.1371/journal.pone.0159266	http://dx.doi.org/10.1371/journal.pone.0159266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415433	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500116
J	Ammar, ED; Ramos, JE; Hall, DG; Dawson, WO; Shatters, RG				Ammar, El-Desouky; Ramos, John E.; Hall, David G.; Dawson, William O.; Shatters, Robert G., Jr.			Acquisition, Replication and Inoculation of Candidatus Liberibacter asiaticus following Various Acquisition Periods on Huanglongbing-Infected Citrus by Nymphs and Adults of the Asian Citrus Psyllid	PLOS ONE			English	Article							COCKERELLI HEMIPTERA TRIOZIDAE; DIAPHORINA-CITRI; GREENING DISEASE; SALIVARY-GLANDS; VECTOR; TRANSMISSION; EFFICIENCY; PATHOGEN; TOMATO; IDENTIFICATION	The Asian citrus psyllid, Diaphorina citri (Hemiptera: Liviidae), is the primary vector of Candidatus Liberibacter asiaticus (Las) implicated as causative agent of citrus huanglongbing (citrus greening), currently the most serious citrus disease worldwide. Las is transmitted by D. citri in a persistent-circulative manner, but the question of replication of this bacterium in its psyllid vector has not been resolved. Thus, we studied the effects of the acquisition access period (AAP) by nymphs and adults of D. citri on Las acquisition, multiplication and inoculation/ transmission. D. citri nymphs or adults (previously non-exposed to Las) were caged on Las-infected citrus plants for an AAP of 1, 7 or 14 days. These ` Las-exposed' psyllids were then transferred weekly to healthy citrus or orange jasmine plants, and sampled via quantitative polymerase chain reaction (qPCR) analysis 1-42 days post-first access to diseased plants (padp); all tested nymphs became adults 7-14 days padp. Our results indicate that following 1 or 7 day AAP as nymphs 49-59% of Las-exposed psyllids became Las-infected (qPCR-positive), whereas only 8-29% of the psyllids were infected following 1-14 day AAP as adults. Q-PCR analysis also indicated that Las titer in the Las-exposed psyllids (relative to that of the psyllid S20 ribosomal protein gene) was: 1) significantly higher, and increasing at a faster rate, following Las acquisition as nymphs compared to that following Las acquisition as adults; 2) higher as post-acquisition time of psyllids on healthy plants increased reaching a peak at 14-28 days padp for nymphs and 21-35 days padp for adults, with Las titer decreasing or fluctuating after that; 3) higher with longer AAP on infected plants, especially with acquisition as adults. Our results strongly suggest that Las multiplies in both nymphs and adults of D. citri but attains much higher levels in a shorter period of time post-acquisition when acquired by nymphs than when acquired by adults, and that adults may require longer access to infected plants compared to nymphs for Las to reach higher levels in the vector. However, under the conditions of our experiments, only D. citri that had access to infected plants as nymphs were able to inoculate Las into healthy citrus seedlings or excised leaves. The higher probability of Las inoculation into citrus by psyllids when they have acquired this bacterium from infected plants during the nymphal rather than the adult stage, as reported by us and others, has significant implications in the epidemiology and control of this economically important citrus disease.	[Ammar, El-Desouky; Ramos, John E.; Hall, David G.; Shatters, Robert G., Jr.] USDA ARS, Hort Res Lab, Ft Pierce, FL 34945 USA; [Ammar, El-Desouky; Dawson, William O.] Univ Florida, IFAS CREC, Lake Alfred, FL 33850 USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Ammar, ED (corresponding author), USDA ARS, Hort Res Lab, Ft Pierce, FL 34945 USA.; Ammar, ED (corresponding author), Univ Florida, IFAS CREC, Lake Alfred, FL 33850 USA.	desoukyammar@gmail.com		Dawson, Warrick/0000-0003-0050-6717; Shatters, Robert/0000-0002-3903-772X	Florida Citrus Research and Development Foundation [Hall-93]; United States Department of Agriculture-Agricultural Research Service, Horticultural Research Laboratory, Fort Pierce, Florida, USA	Florida Citrus Research and Development Foundation; United States Department of Agriculture-Agricultural Research Service, Horticultural Research Laboratory, Fort Pierce, Florida, USA	This work was supported by Florida Citrus Research and Development Foundation (Grant no: Hall-93 to DG Hall); United States Department of Agriculture-Agricultural Research Service, Horticultural Research Laboratory, Fort Pierce, Florida, USA.	Ammar El Desouky, 1994, Advances in Disease Vector Research, V10, P289; Ammar E, 2013, J ECON ENTOMOL, V106, P25, DOI 10.1603/EC12245; Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Ammar E, 2011, ANN ENTOMOL SOC AM, V104, P526, DOI 10.1603/AN10134; Ammar El-Desouky, 2006, P97; AUBERT B, 1987, FRUITS, V42, P149; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brlansky RH., 2007, CITRUS HUANGLONGBING; Buchman JL, 2011, J ECON ENTOMOL, V104, P1486, DOI 10.1603/EC11123; Capoor S. P., 1974, Proceedings of the Sixth Conference of the International Organization of Citrus Virologists., P43; Coletta HD, 2014, PHYTOPATHOLOGY, V104, P416, DOI 10.1094/PHYTO-06-13-0157-R; Cooper WR, 2014, ANN ENTOMOL SOC AM, V107, P204, DOI 10.1603/AN13087; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; Garnier M, 2000, INT J SYST EVOL MICR, V50, P2119, DOI 10.1099/00207713-50-6-2119; Gomez K.A., 1984, STAT PROCEDURES AGR; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2007, J ECON ENTOMOL, V100, P847, DOI 10.1603/0022-0493(2007)100[847:EOAPFO]2.0.CO;2; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Huang C. H., 1984, J AGR RES CHINA, V33, P65; Hung TH, 2004, PLANT PATHOL, V53, P96, DOI 10.1111/j.1365-3059.2004.00948.x; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Liu SJ, 2010, VIROLOGY, V401, P107, DOI 10.1016/j.virol.2010.02.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; McKenzie CL, 2009, PLANT DIS, V93, P1074, DOI 10.1094/PDIS-93-10-1074A; MIYAKAWA T, 1980, Annals of the Phytopathological Society of Japan, V46, P224, DOI 10.3186/jjphytopath.46.224; Pakkianathan BC, 2015, J VIROL, V89, P9791, DOI 10.1128/JVI.00779-15; Pelz-Stelinski KS, 2016, ANN ENTOMOL SOC AM, V109, P371, DOI 10.1093/aesa/saw007; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; SAS Institute, 2010, SAS PROC GUID VERS 9; Sengoda VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093475; Sengoda VG, 2013, J ECON ENTOMOL, V106, P1964, DOI 10.1603/EC13129; Suzuki S, 2006, P NATL ACAD SCI USA, V103, P4252, DOI 10.1073/pnas.0508668103; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; Ueti MW, 2007, INFECT IMMUN, V75, P2959, DOI 10.1128/IAI.00284-07; Ukuda-Hosokawa R, 2015, APPL ENVIRON MICROB, V81, P3728, DOI 10.1128/AEM.00707-15; Walter AJ, 2012, HORTSCIENCE, V47, P1449, DOI 10.21273/HORTSCI.47.10.1449; Xu C.F., 1988, P 10 C INT ORG CITRU, P243	44	89	91	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159594	10.1371/journal.pone.0159594	http://dx.doi.org/10.1371/journal.pone.0159594			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441694	Green Submitted, gold, Green Published			2022-12-27	WOS:000380797500101
J	Cao, Y; Bansal, GP; Merino, K; Kumar, N				Cao, Yi; Bansal, Geetha P.; Merino, Kristen; Kumar, Nirbhay			Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses	PLOS ONE			English	Article							TRANSMISSION-BLOCKING ANTIBODIES; SPECIES IMMUNITY; SURFACE-ANTIGEN; SEXUAL STAGE; PROTEIN; PFS48/45; PARASITE; FERTILITY; CANDIDATE	In general, malaria immunity has been suggested to be species specific with very little, if any, known cross-reactivity between Plasmodium vivax and P. falciparum, both of which are responsible for >90% of human malaria, and co-endemic in many countries. It is therefore believed that species-specific immunity may be needed to target different species of Plasmodium. Pfs48/45 and Pvs48/45 are well established targets in the sexual stages of the malaria parasites, and are being pursued for the development of transmission blocking vaccines. Comparison of their sequences reveals 61% and 55% identity at the DNA and protein level, respectively raising the possibility that these two target antigens might share cross-reacting epitopes. Having succeeded in expressing recombinant Pfs48/45 and Pvs48/45 proteins, we hypothesized that these proteins will not only exhibit immunological cross-reactivity but also cross-boost immune responses. Mice were immunized with purified recombinant proteins using CFA, Montanide ISA-51 and alum as adjuvants, and the sera were analyzed by ELISA, Western blotting and indirect fixed and live IFA to address the hypothesis. Our studies revealed that Pvs48/45-immune sera showed strong cross-reactivity to full length Pfs48/45 protein, and the majority of this cross reactivity was in the amino-terminal and carboxyl-terminal sub-fragments of Pfs48/45. In cross-boosting experiments Pfs48/45 and Pvs48/45 antigens were able to cross-boost each other in mouse immunization studies. Additionally we also noticed an effect of adjuvants in the overall magnitude of observed cross-reactivity. These studies may have significant implications for immunity targeting transmission of both the species of malaria parasites.	[Kumar, Nirbhay] Tulane Univ, Dept Trop Med, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA; Tulane Univ, Vector Borne Infect Dis Res Ctr, New Orleans, LA 70112 USA	Tulane University; Tulane University	Kumar, N (corresponding author), Tulane Univ, Dept Trop Med, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA.	nkumar@tulane.edu			National Institute of Allergy and Infectious Diseases [RO1 AI47089, RO3 AI111138]; American Society of Microbiology	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Society of Microbiology	These studies were financially supported by research grants from National Institute of Allergy and Infectious Diseases, RO1 AI47089 (NK) and RO3 AI111138 (GB). KM was supported by The Robert D Watkins Graduate Research Fellowship provided by the American Society of Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KM was supported by The Robert D Watkins Graduate Research Fellowship provided by the American Society of Microbiology.	Arevalo-Herrera M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119335; Arredondo SA, 2012, P NATL ACAD SCI USA, V109, P6692, DOI 10.1073/pnas.1204363109; Bergmann-Leitner ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012294; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Douradinha B, 2008, INFECT IMMUN, V76, P873, DOI 10.1128/IAI.00431-07; Good MF, 2013, J CLIN INVEST, V123, P3353, DOI 10.1172/JCI66634; Hisaeda H, 2000, INFECT IMMUN, V68, P6618, DOI 10.1128/IAI.68.12.6618-6623.2000; Igonet S, 2007, J MOL BIOL, V366, P1523, DOI 10.1016/j.jmb.2006.12.028; KASLOW DC, 1988, NATURE, V333, P74, DOI 10.1038/333074a0; Merino MM, 2016, IMMUNOLOGY; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Costa JDN, 2013, MEM I OSWALDO CRUZ, V108, P98, DOI 10.1590/S0074-02762013000100016; Nikolaeva D, 2015, EXPERT REV VACCINES, V14, P653, DOI 10.1586/14760584.2015.993383; Ouedraogo AL, 2011, INFECT IMMUN, V79, P4957, DOI 10.1128/IAI.05288-11; Outchkourov N, 2007, J BIOL CHEM, V282, P17148, DOI 10.1074/jbc.M700948200; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; QUAKYI IA, 1987, J IMMUNOL, V139, P4213; RENER J, 1983, J EXP MED, V158, P976, DOI 10.1084/jem.158.3.976; RILEY EM, 1990, J IMMUNOL, V144, P4810; Singh SK, 2015, VACCINE, V33, P1981, DOI 10.1016/j.vaccine.2015.02.040; Tachibana M, VACCINE; Theisen M, 2014, VACCINE; Theisen M, 2014, VACCINE, V32, P2623, DOI 10.1016/j.vaccine.2014.03.020; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; Woodberry T, 2008, J INFECT DIS, V198, P134, DOI 10.1086/588711; Yadava A, 2012, J INFECT DIS, V205, P1456, DOI 10.1093/infdis/jis220	29	14	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158212	10.1371/journal.pone.0158212	http://dx.doi.org/10.1371/journal.pone.0158212			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438603	gold, Green Published, Green Submitted			2022-12-27	WOS:000380170100009
J	Hald, S; Schioldan, AG; Moore, ME; Dige, A; Laerke, HN; Agnholt, J; Knudsen, KEB; Hermansen, K; Marco, ML; Gregersen, S; Dahlerup, JF				Hald, Stine; Schioldan, Anne Grethe; Moore, Mary E.; Dige, Anders; Laerke, Helle Nygaard; Agnholt, Jorgen; Knudsen, Knud Erik Bach; Hermansen, Kjeld; Marco, Maria L.; Gregersen, Soren; Dahlerup, Jens F.			Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; WHOLE-GRAIN RYE; DIETARY FIBER; RUMINOCOCCUS-BROMII; GUT MICROBIOME; REFINED WHEAT; BUTYRATE; GLUCOSE; FERMENTATION; INSULIN	Recently, the intestinal microbiota has been emphasised as an important contributor to the development of metabolic syndrome. Dietary fibre may exert beneficial effects through modulation of the intestinal microbiota and metabolic end products. We investigated the effects of a diet enriched with two different dietary fibres, arabinoxylan and resistant starch type 2, on the gut microbiome and faecal short-chain fatty acids. Nineteen adults with metabolic syndrome completed this randomised crossover study with two 4-week interventions of a diet enriched with arabinoxylan and resistant starch and a low-fibre Western-style diet. Faecal samples were collected before and at the end of the interventions for fermentative end-product analysis and 16S ribosomal RNA bacterial gene amplification for identification of bacterial taxa. Faecal carbohydrate residues were used to verify compliance. The diet enriched with arabinoxylan and resistant starch resulted in significant reductions in the total species diversity of the faecal-associated intestinal microbiota but also increased the heterogeneity of bacterial communities both between and within subjects. The proportion of Bifidobacterium was increased by arabinoxylan and resistant starch consumption (P<0.001), whereas the proportions of certain bacterial genera associated with dysbiotic intestinal communities were reduced. Furthermore, the total short-chain fatty acids (P<0.01), acetate (P<0.01) and butyrate concentrations (P<0.01) were higher by the end of the diet enriched with arabinoxylan and resistant starch compared with those resulting from the Western-style diet. The concentrations of isobutyrate (P = 0.05) and isovalerate (P = 0.03) decreased in response to the arabinoxylan and resistant starch enriched diet, indicating reduced protein fermentation. In conclusion, arabinoxylan and resistant starch intake changes the microbiome and short-chain fatty acid compositions, with potential beneficial effects on colonic health and metabolic syndrome.	[Hald, Stine; Dige, Anders; Agnholt, Jorgen; Dahlerup, Jens F.] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark; [Schioldan, Anne Grethe; Hermansen, Kjeld; Gregersen, Soren] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Moore, Mary E.; Marco, Maria L.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Laerke, Helle Nygaard; Knudsen, Knud Erik Bach] Aarhus Univ, Dept Anim Sci, Tjele, Denmark	Aarhus University; Aarhus University; University of California System; University of California Davis; Aarhus University	Hald, S (corresponding author), Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark.; Schioldan, AG (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark.	Stine.Hald@aarhus.rm.dk; anneschioldan@gmail.com	hermansen, kjeld/AAY-4241-2021; Lærke, Helle Nygaard/D-9882-2011	Lærke, Helle Nygaard/0000-0002-0303-0745; Kable, Mary/0000-0002-5485-6539; Agnholt, Jorgen/0000-0003-2822-6442; Dahlerup, Jens Frederik/0000-0002-1587-7636	Danish Strategic Research Council [10-093526]	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	The Danish Strategic Research Council project, entitled "Concepts for enhanced butyrate production to improve colonic health and insulin sensitivity - ButCoIns" (project no. 10-093526), financially supported the study but had no role in the design, analysis or writing of this article.	Abell GCJ, 2008, FEMS MICROBIOL ECOL, V66, P505, DOI 10.1111/j.1574-6941.2008.00527.x; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Belobrajdic DP, 2012, BRIT J NUTR, V107, P1274, DOI 10.1017/S0007114511004338; Bland M, 2015, CROSS OVER TRIALS; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036357; Bourriaud C, 2005, J APPL MICROBIOL, V99, P201, DOI 10.1111/j.1365-2672.2005.02605.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cummings JH, 1996, BRIT J NUTR, V75, P733, DOI 10.1079/BJN19960177; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33; ENGLYST HN, 1984, ANALYST, V109, P937, DOI 10.1039/an9840900937; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Fukuda S, 2012, GUT MICROBES, V3, P449, DOI [10.4161.gmic.21214, 10.4161/gmic.21214]; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Garcia AL, 2007, EUR J CLIN NUTR, V61, P334, DOI 10.1038/sj.ejcn.1602525; Garcia AL, 2006, HORM METAB RES, V38, P761, DOI 10.1055/s-2006-955089; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hartvigsen ML, 2014, EUR J CLIN NUTR, V68, P84, DOI 10.1038/ejcn.2013.236; Ingerslev AK, 2014, BRIT J NUTR, V111, P1564, DOI 10.1017/S0007114513004066; JENSEN MT, 1995, ANIM SCI, V61, P293, DOI 10.1017/S1357729800013837; Jonsdottir SE, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.21391; Julious S A, 1999, J Biopharm Stat, V9, P241, DOI 10.1081/BIP-100101174; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Knudsen KEB, 2005, J NUTR, V135, P1696, DOI 10.1093/jn/135.7.1696; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; Kovatcheva-Datchary P, 2013, BEST PRACT RES CL GA, V27, P59, DOI 10.1016/j.bpg.2013.03.017; Lappi J, 2013, J NUTR, V143, P648, DOI 10.3945/jn.112.172668; Lattimer JM, 2010, NUTRIENTS, V2, P1266, DOI 10.3390/nu2121266; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Lin HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031286, 10.1371/journal.pone.0035240]; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu ZX, 2004, EUR J CLIN NUTR, V58, P621, DOI 10.1038/sj.ejcn.1601857; MACFARLANE GT, 1986, J APPL BACTERIOL, V60, P195, DOI 10.1111/j.1365-2672.1986.tb01073.x; Margolles A, 2012, APPL ENVIRON MICROB, V78, P3338, DOI 10.1128/AEM.00129-12; McCleary BV, 2002, J AOAC INT, V85, P665; McInnis EA, 2015, FOOD MICROBIOL, V46, P121, DOI 10.1016/j.fm.2014.07.021; McIntosh GH, 2003, AM J CLIN NUTR, V77, P967, DOI 10.1093/ajcn/77.4.967; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Nielsen TS, 2014, BRIT J NUTR, V112, P1837, DOI 10.1017/S000711451400302X; Nordgaard I, 1996, SCAND J GASTROENTERO, V31, P1011, DOI 10.3109/00365529609003122; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Poslusna K, 2009, BRIT J NUTR, V101, pS73, DOI 10.1017/S0007114509990602; R Core Team, 2021, R LANGUAGE ENV STAT; Rigottier-Gois L, 2003, FEMS MICROBIOL ECOL, V43, P237, DOI 10.1111/j.1574-6941.2003.tb01063.x; Rios-Covian D, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv176; Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63; Saulnier L, 2007, J CEREAL SCI, V46, P261, DOI 10.1016/j.jcs.2007.06.014; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Schoenfeld DA, 2015, STATISTICAL CONSIDER; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Starch Resistant, 1992, EUROPEAN J CLIN N S2, V46, pS1; Stjernman H, 2008, INFLAMM BOWEL DIS, V14, P47, DOI 10.1002/ibd.20255; Suresh Kp, 2011, J Hum Reprod Sci, V4, P8, DOI 10.4103/0974-1208.82352; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Tachon S, 2013, FEMS MICROBIOL ECOL, V83, P299, DOI 10.1111/j.1574-6941.2012.01475.x; Tanner SA, 2014, GUT PATHOG, V6, DOI 10.1186/s13099-014-0044-y; Tojo R, 2014, WORLD J GASTROENTERO, V20, P15163, DOI 10.3748/wjg.v20.i41.15163; VANMUNSTER IP, 1994, DIGEST DIS SCI, V39, P834, DOI 10.1007/BF02087431; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; WEAVER GA, 1992, AM J CLIN NUTR, V55, P70, DOI 10.1093/ajcn/55.1.70; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yamashita H, 2007, BIOSCI BIOTECH BIOCH, V71, P1236, DOI 10.1271/bbb.60668; Yang JY, 2013, J MED FOOD, V16, P862, DOI [10.1089/jmf.2012.0292, 10.1100/jmf.2012.0292]; Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4	71	95	98	7	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159223	10.1371/journal.pone.0159223	http://dx.doi.org/10.1371/journal.pone.0159223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434092	Green Published, gold			2022-12-27	WOS:000380169600042
J	Tempelaere, C; Pierrart, J; Lefevre-Colau, MM; Vuillemin, V; Cuenod, CA; Hansen, U; Mir, O; Skalli, W; Gregory, T				Tempelaere, Christine; Pierrart, Jerome; Lefevre-Colau, Marie-Martine; Vuillemin, Valerie; Cuenod, Charles-Andre; Hansen, Ulrich; Mir, Olivier; Skalli, Wafa; Gregory, Thomas			Dynamic Three-Dimensional Shoulder Mri during Active Motion for Investigation of Rotator Cuff Diseases	PLOS ONE			English	Article							GLENOHUMERAL JOINT; SUBACROMIAL SPACE; KINEMATICS; ABDUCTION; ELEVATION; WIDTH; TRANSLATION	Background MRI is the standard methodology in diagnosis of rotator cuff diseases. However, many patients continue to have pain despite treatment, and MRI of a static unloaded shoulder seems insufficient for best diagnosis and treatment. This study evaluated if Dynamic MRI provides novel kinematic data that can be used to improve the understanding, diagnosis and best treatment of rotator cuff diseases. Methods Dynamic MRI provided real-time 3D image series and was used to measure changes in the width of subacromial space, superior-inferior translation and anterior-posterior translation of the humeral head relative to the glenoid during active abduction. These measures were investigated for consistency with the rotator cuff diseases classifications from standard MRI. Results The study included: 4 shoulders with massive rotator cuff tears, 5 shoulders with an isolated full-thickness supraspinatus tear, 5 shoulders with tendinopathy and 6 normal shoulders. A change in the width of subacromial space greater than 4mm differentiated between rotator cuff diseases with tendon tears (massive cuff tears and supraspinatus tear) and without tears (tendinopathy) (p = 0.012). The range of the superior-inferior translation was higher in the massive cuff tears group (6.4mm) than in normals (3.4mm) (p = 0.02). The range of the anterior-posterior translation was higher in the massive cuff tears (9.2 mm) and supraspinatus tear (9.3 mm) shoulders compared to normals (3.5mm) and tendinopathy (4.8mm) shoulders (p = 0.05). Conclusion The Dynamic MRI enabled a novel measure; 'Looseness', i.e. the translation of the humeral head on the glenoid during an abduction cycle. Looseness was better able at differentiating different forms of rotator cuff disease than a simple static measure of relative glenohumeral position.	[Tempelaere, Christine; Pierrart, Jerome; Skalli, Wafa] ParisTech, Lab Biomech Arts & Matiers, Paris, France; [Tempelaere, Christine; Pierrart, Jerome; Gregory, Thomas] Univ Paris 05, European Hosp Georges Pompidou, AP HP, Sorbonne Paris Cite,Fac Med,Upper Limb Surg, Paris, France; [Lefevre-Colau, Marie-Martine] Univ Paris 05, Cochin Hosp, AP HP, Sorbonne Paris Cite,Phys Med & Rehabil Unit,Fac M, Sorbonne Paris Cite, Paris, France; [Vuillemin, Valerie; Cuenod, Charles-Andre] Univ Paris 05, European Hosp Georges Pompidou, AP HP, Sorbonne Paris Cite,Radiol Unit,Fac Med, Paris, France; [Hansen, Ulrich; Gregory, Thomas] Imperial Coll London, Dept Mech Engn, London, England; [Mir, Olivier; Gregory, Thomas] Univ Paris 05, Sorbonne Paris Cite, Inst MOVEO, Fac Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; UDICE-French Research Universities; Universite Paris Cite	Gregory, T (corresponding author), Univ Paris 05, European Hosp Georges Pompidou, AP HP, Sorbonne Paris Cite,Fac Med,Upper Limb Surg, Paris, France.; Gregory, T (corresponding author), Imperial Coll London, Dept Mech Engn, London, England.; Gregory, T (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Inst MOVEO, Fac Med, Paris, France.	tms.gregory@gmail.com	Mir, Olivier/GNP-7828-2022	Mir, Olivier/0000-0002-6761-4002; lefevre-colau, marie-martine/0000-0002-7493-1225; Cuenod, Charles Andre/0000-0002-6769-679X				Benoit DL, 2006, GAIT POSTURE, V24, P152, DOI 10.1016/j.gaitpost.2005.04.012; Bey MJ, 2011, AM J SPORT MED, V39, P2117, DOI 10.1177/0363546511412164; Billuart F, 2007, SURG RADIOL ANAT, V29, P291, DOI 10.1007/s00276-007-0208-2; Bodin J, 2012, AM J IND MED, V55, P605, DOI 10.1002/ajim.22002; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Deutsch A, 1996, J Shoulder Elbow Surg, V5, P186, DOI 10.1016/S1058-2746(05)80004-7; Giphart JE, 2012, J SHOULDER ELB SURG, V21, P1593, DOI 10.1016/j.jse.2011.11.023; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Graichen H, 1998, MAGN RESON MED, V40, P640, DOI 10.1002/mrm.1910400418; Graichen H, 2000, CLIN ORTHOP RELAT R, P154; Graichen H, 1999, AM J ROENTGENOL, V172, P1081, DOI 10.2214/ajr.172.4.10587151; Graichen H, 2005, J BIOMECH, V38, P755, DOI 10.1016/j.jbiomech.2004.05.020; Graichen H, 2001, J ORTHOP RES, V19, P1192, DOI 10.1016/S0736-0266(01)00035-3; Graichen H, 1999, SURG RADIOL ANAT, V21, P59, DOI 10.1007/BF01635055; Graichen H, 2000, J BIOMECH, V33, P609, DOI 10.1016/S0021-9290(99)00209-2; Hill AM, 2007, KNEE SURG SPORT TR A, V15, P1137, DOI 10.1007/s00167-007-0318-8; Illyes A, 2007, J ELECTROMYOGR KINES, V17, P355, DOI 10.1016/j.jelekin.2006.02.004; Lagace PY, 2012, COMPUT METHOD BIOMEC, V15, P221, DOI 10.1080/10255842.2010.522185; McPherson EJ, 1997, J SHOULDER ELB SURG, V6, P105, DOI 10.1016/S1058-2746(97)90030-6; Nove-Josserand L, 1999, REV CHIR ORTHOP, V85, P677; Paletta GA, 1997, J SHOULDER ELB SURG, V6, P516, DOI 10.1016/S1058-2746(97)90084-7; PATTE D, 1990, CLIN ORTHOP RELAT R, P81; Pierrart J, 2014, J MAGN RESON IMAGING, V39, P729, DOI 10.1002/jmri.24204; Sahara W, 2007, CLIN BIOMECH, V22, P304, DOI 10.1016/j.clinbiomech.2006.04.012; Sans N, 1996, J RADIOL, V77, P117; Thomazeau H, 1996, ACTA ORTHOP SCAND, V67, P264, DOI 10.3109/17453679608994685; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Yamaguchi K, 2000, J SHOULDER ELB SURG, V9, P6, DOI 10.1016/S1058-2746(00)90002-8; Zanetti M, 1998, INVEST RADIOL, V33, P163, DOI 10.1097/00004424-199803000-00006; Zhu ZL, 2012, MED ENG PHYS, V34, P1303, DOI 10.1016/j.medengphy.2011.12.021; Zumstein V, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-34	31	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158563	10.1371/journal.pone.0158563	http://dx.doi.org/10.1371/journal.pone.0158563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434235	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600011
J	Gharzai, L; Verma, V; Denniston, KA; Bhirud, AR; Bennion, NR; Lin, C				Gharzai, Laila; Verma, Vivek; Denniston, Kyle A.; Bhirud, Abhijeet R.; Bennion, Nathan R.; Lin, Chi			Radiation Therapy and Cardiac Death in Long-Term Survivors of Esophageal Cancer: An Analysis of the Surveillance, Epidemiology, and End Result Database	PLOS ONE			English	Article							3-DIMENSIONAL CONFORMAL RADIOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; HEART-DISEASE; CHEMORADIATION THERAPY; CHEMORADIOTHERAPY; PROTON; RISK; VOLUME; TOXICITY; OUTCOMES	Objective Radiation therapy (RT) for esophageal cancer often results in unintended radiation doses delivered to the heart owing to anatomic proximity. Using the Surveillance, Epidemiology, and End Results (SEER) database, we examined late cardiac death in survivors of esophageal cancer that had or had not received RT. Methods 5,630 patients were identified that were diagnosed with esophageal squamous cell carcinoma (SCC) or adenocarcinoma (AC) from 1973-2012, who were followed for at least 5 years after therapy. Examined risk factors for cardiac death included age (<= 55/56-65/66-75/>75), gender, race (white/non-white), stage (local/regional/distant), histology (SCC/AC), esophageal location (<18cm/18-24cm/25-32cm/33-40cm from incisors), diagnosis year (1973-1992/1993-2002/2003-2012), and receipt of surgery and/or RT. Time to cardiac death was evaluated using the Kaplan-Meier method. A Cox model was used to evaluate risk factors for cardiac death in propensity score matched data. Results Patients who received RT were younger, diagnosed more recently, had more advanced disease, SCC histology, and no surgery. The RT group had higher risk of cardiac death than the no-RT group (log-rank p<0.0001). The median time to cardiac death in the RT group was 289 months (95% CI, 255-367) and was not reached in the no-RT group. The probability of cardiac death increased with age and decreased with diagnosis year, and this trend was more pronounced in the RT group. Multivariate analysis found RT to be associated with higher probability of cardiac death (OR 1.23, 95% CI 1.03-1.47, HR 1.961, 95% CI 1.466-2.624). Lower esophageal subsite (33-40 cm) was also associated with a higher risk of cardiac death. Other variables were not associated with cardiac death. Conclusions Recognizing the limitations of a SEER analysis including lack of comorbidity accountability, these data should prompt more definitive study as to whether a possible associative effect of RT on cardiac death could potentially be a causative effect.	[Gharzai, Laila] Univ Nebraska Med Ctr, Coll Med, Omaha, NE 68198 USA; [Verma, Vivek; Denniston, Kyle A.; Bhirud, Abhijeet R.; Bennion, Nathan R.; Lin, Chi] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA; [Denniston, Kyle A.] St Peters Hlth Partners Radiat Oncol, Albany, NY USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Gharzai, L (corresponding author), Univ Nebraska Med Ctr, Coll Med, Omaha, NE 68198 USA.	Laila@gharzai.net	Lin, Chi/AAE-2495-2019					Akutsu Y, 2012, J SURG ONCOL, V105, P750, DOI 10.1002/jso.22127; Aleman BMP, 2003, J CLIN ONCOL, V21, P3431, DOI 10.1200/JCO.2003.07.131; Beukema JC, 2015, RADIOTHER ONCOL, V114, P85, DOI 10.1016/j.radonc.2014.11.037; Bosset JF, 1997, NEW ENGL J MED, V337, P161, DOI 10.1056/NEJM199707173370304; Chuong MD, 2016, INT J RADIAT ONCOL, V95, P488, DOI 10.1016/j.ijrobp.2015.11.043; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Eley JG, 2016, INT J RADIAT ONCOL, V95, P279, DOI 10.1016/j.ijrobp.2016.02.032; Frandsen J, 2015, J GASTROINTEST ONCOL, V6, P516, DOI 10.3978/j.issn.2078-6891.2015.040; Fukada J, 2013, INT J RADIAT ONCOL, V87, P487, DOI 10.1016/j.ijrobp.2013.07.008; Gayed I, 2009, INT J CARDIOVAS IMAG, V25, P487, DOI 10.1007/s10554-009-9440-7; Gayed IW, 2006, J NUCL MED, V47, P1756; HANCOCK SL, 1993, J CLIN ONCOL, V11, P1208, DOI 10.1200/JCO.1993.11.7.1208; Hatakenaka M, 2012, INT J RADIAT ONCOL, V83, pE67, DOI 10.1016/j.ijrobp.2011.12.018; Hayashi K, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140168; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; *INT AG RES CANC, 2012, GLOBOCAN 2012; Jingu K, 2006, INT J RADIAT ONCOL, V66, P845, DOI 10.1016/j.ijrobp.2006.06.007; Kataria T, 2014, J CANCER RES THER, V10, P871, DOI 10.4103/0973-1482.138217; Kole TP, 2012, INT J RADIAT ONCOL, V83, P1580, DOI 10.1016/j.ijrobp.2011.10.053; Konski A, 2012, RADIOTHER ONCOL, V104, P72, DOI 10.1016/j.radonc.2012.04.016; Lin SH, 2012, INT J RADIAT ONCOL, V84, P1078, DOI 10.1016/j.ijrobp.2012.02.015; Makishima H, 2015, J RADIAT RES, V56, P568, DOI 10.1093/jrr/rrv001; Mohammad NH, 2015, RADIOTHER ONCOL, V114, P91, DOI 10.1016/j.radonc.2014.12.005; Morota M, 2009, INT J RADIAT ONCOL, V75, P122, DOI 10.1016/j.ijrobp.2008.10.075; Mukherjee S, 2003, CLIN ONCOL-UK, V15, P115, DOI 10.1053/clon.2003.0218; National Cancer Institute, SURV EP END REPROG; Onwudiwe NC, 2014, CANCER MED-US, V3, P1342, DOI 10.1002/cam4.283; RODEMANN HP, 1995, RADIOTHER ONCOL, V35, P83, DOI 10.1016/0167-8140(95)01540-W; Rugbjerg K., 2014, JNCI-J NATL CANCER I, V106, P1; SPORN LA, 1984, BLOOD, V64, P567; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Tait LM, 2013, PRACT RADIAT ONCOL, V3, pE149, DOI 10.1016/j.prro.2013.02.001; Taylor CW, 2015, INT J RADIAT ONCOL, V93, P845, DOI 10.1016/j.ijrobp.2015.07.2292; Tripp P, 2005, DIS ESOPHAGUS, V18, P400, DOI 10.1111/j.1442-2050.2005.00523.x; Umezawa R, 2014, CLIN RADIOL, V69, P1273, DOI 10.1016/j.crad.2014.08.010; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; van Nimwegen FA, 2016, J CLIN ONCOL, V34, P235, DOI 10.1200/JCO.2015.63.4444; Verma V, 2016, CANCER-AM CANCER SOC, V122, P1483, DOI 10.1002/cncr.29882; VINKE B, 1962, ACTA MED SCAND, V172, P711; Walsh TN, 1996, NEW ENGL J MED, V335, P462, DOI 10.1056/NEJM199608153350702; Wang JY, 2013, INT J RADIAT ONCOL, V86, P885, DOI 10.1016/j.ijrobp.2013.04.006; Zhang P, 2015, RADIOTHER ONCOL, V115, P171, DOI 10.1016/j.radonc.2015.04.009	43	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158916	10.1371/journal.pone.0158916	http://dx.doi.org/10.1371/journal.pone.0158916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428362	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300023
J	Sutcliffe, AG; Dunbar, RIM; Wang, D				Sutcliffe, A. G.; Dunbar, R. I. M.; Wang, D.			Modelling the Evolution of Social Structure	PLOS ONE			English	Article							WILD FEMALE BABOONS; PREDATION RISK; NETWORK SIZE; PRIMATES; COOPERATION; FRIENDSHIP; COMMUNICATION; DETERMINANTS; ORGANIZATION; MECHANISMS	Although simple social structures are more common in animal societies, some taxa (mainly mammals) have complex, multi-level social systems, in which the levels reflect differential association. We develop a simulation model to explore the conditions under which multi-level social systems of this kind evolve. Our model focuses on the evolutionary trade-offs between foraging and social interaction, and explores the impact of alternative strategies for distributing social interaction, with fitness criteria for wellbeing, alliance formation, risk, stress and access to food resources that reward social strategies differentially. The results suggest that multi-level social structures characterised by a few strong relationships, more medium ties and large numbers of weak ties emerge only in a small part of the overall fitness landscape, namely where there are significant fitness benefits from wellbeing and alliance formation and there are high levels of social interaction. In contrast, 'favour-the-few' strategies are more competitive under a wide range of fitness conditions, including those producing homogeneous, single-level societies of the kind found in many birds and mammals. The simulations suggest that the development of complex, multi-level social structures of the kind found in many primates (including humans) depends on a capacity for high investment in social time, preferential social interaction strategies, high mortality risk and/or differential reproduction. These conditions are characteristic of only a few mammalian taxa.	[Sutcliffe, A. G.] Univ Manchester, Manchester Business Sch, Manchester, Lancs, England; [Dunbar, R. I. M.] Univ Oxford, Dept Expt Psychol, Oxford, England; [Wang, D.] Khalifa Univ, EBTIC, Abu Dhabi, U Arab Emirates	University of Manchester; University of Oxford; Khalifa University of Science & Technology	Sutcliffe, AG (corresponding author), Univ Manchester, Manchester Business Sch, Manchester, Lancs, England.	ags@manchester.ac.uk			Engineering and Physical Sciences Research Council, UK [EP/D05088X/1]; ERC Advanced Investigator award; ESRC/EPSRC Cognitive Foresight Programme project TESS (Developing Theory for Evolving Socio-technical Systems); EPSRC [EP/D05088X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D05088X/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council, UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ERC Advanced Investigator award; ESRC/EPSRC Cognitive Foresight Programme project TESS (Developing Theory for Evolving Socio-technical Systems)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council, UK EP/D05088X/1. RD's research is supported by an ERC Advanced Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The preparation of this paper was supported by ESRC/EPSRC Cognitive Foresight Programme project TESS (Developing Theory for Evolving Socio-technical Systems). RD's research is supported by an ERC Advanced Investigator award.	Abbott D.H., 1986, P329; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Brown SL, 2006, PSYCHOL INQ, V17, P1, DOI 10.1207/s15327965pli1701_01; BUYS CJ, 1979, PSYCHOL REP, V45, P547, DOI 10.2466/pr0.1979.45.2.547; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Crockford C, 2008, HORM BEHAV, V53, P254, DOI 10.1016/j.yhbeh.2007.10.007; David-Barrett T, 2012, J THEOR BIOL, V308, P88, DOI 10.1016/j.jtbi.2012.05.007; Dunbar R., 1984, REPROD DECISIONS EC; Dunbar RIM, 2015, SOC NETWORKS, V43, P39, DOI 10.1016/j.socnet.2015.04.005; Dunbar RIM, 2009, BIOL REV, V84, P413, DOI 10.1111/j.1469-185X.2009.00080.x; Dunbar R.I.M., 1988, PRIMATE SOCIAL SYSTE; DUNBAR RIM, 1980, BEHAV ECOL SOCIOBIOL, V7, P253, DOI 10.1007/BF00300665; DUNBAR RIM, 1987, INT J PRIMATOL, V8, P299, DOI 10.1007/BF02737386; DUNBAR RIM, 1995, HUM NATURE-INT BIOS, V6, P273, DOI 10.1007/BF02734142; Dunbar RIM, 2009, SOCIAL BRAIN DISTRIB, P159; Dunbar RIM, 2016, OPEN SCI IN PRESS; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; Gill SA, 2012, BEHAV ECOL SOCIOBIOL, V66, P757, DOI 10.1007/s00265-012-1323-6; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Greening BF, 2010, SCI REPORTS, V4, P3608; Grueter CC, 2010, BEHAV ECOL, V21, P63, DOI 10.1093/beheco/arp149; Hamilton MJ, 2007, P ROY SOC B-BIOL SCI, V274, P2195, DOI 10.1098/rspb.2007.0564; Hardy CL, 2006, PERS SOC PSYCHOL B, V32, P1402, DOI 10.1177/0146167206291006; HAYS RB, 1989, J SOC PERS RELAT, V6, P21, DOI 10.1177/026540758900600102; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Hewitt B R., 2003, NEXUS, V16, P27; Hill RA, 2000, BEHAV ECOL, V11, P560, DOI 10.1093/beheco/11.5.560; Hill RA, 2003, HUM NATURE-INT BIOS, V14, P53, DOI 10.1007/s12110-003-1016-y; Hill RA, 1998, BEHAVIOUR, V135, P411; Hill RA, 1998, J ZOOL, V245, P447, DOI 10.1111/j.1469-7998.1998.tb00119.x; Hill RA, 2008, BIOL LETTERS, V4, P748, DOI 10.1098/rsbl.2008.0393; Hruschka DJ, 2006, J THEOR BIOL, V239, P1, DOI 10.1016/j.jtbi.2005.07.006; KERR NL, 1983, J PERS SOC PSYCHOL, V45, P819, DOI 10.1037/0022-3514.45.4.819; Krause J, 2002, LIVING GROUPS; Kudo H, 2001, ANIM BEHAV, V62, P711, DOI 10.1006/anbe.2001.1808; Lehmann J., 2014, LUCY LANGUAGE BENCHM, P245, DOI DOI 10.1093/ACPROF:OSOBL/9780199652594.003.0011; Massen JJM, 2010, BEHAVIOUR, V147, P1379, DOI 10.1163/000579510X528224; McPherson M, 2006, AM SOCIOL REV, V71, P353, DOI 10.1177/000312240607100301; Miritello G, 2013, SCI REPORTS, V13, P1950; Miritello G, 2013, SOC NETWORKS, V35, P89, DOI 10.1016/j.socnet.2013.01.003; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Opie C, 2014, P NATL ACAD SCI USA, V111, pE1675, DOI 10.1073/pnas.1403165111; Oswald DL, 2004, J SOC CLIN PSYCHOL, V23, P413, DOI 10.1521/jscp.23.3.413.35460; Pasquaretta C, 2014, SCI REP-UK, V4, DOI 10.1038/srep07600; Pollet TV, 2011, J INDIVID DIFFER, V32, P161, DOI 10.1027/1614-0001/a000048; Roberts G, 2003, P ROY SOC B-BIOL SCI, V270, P2279, DOI 10.1098/rspb.2003.2491; Roberts SBG, 2015, HUM NATURE-INT BIOS, V26, P426, DOI 10.1007/s12110-015-9242-7; Rosas A, 2010, J THEOR BIOL, V264, P450, DOI 10.1016/j.jtbi.2010.02.015; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Rubenstein Daniel I., 2004, P266, DOI 10.1017/CBO9780511542459.017; Saramaki J, 2014, P NATL ACAD SCI USA, V111, P942, DOI 10.1073/pnas.1308540110; Shultz S, 2004, P ROY SOC B-BIOL SCI, V271, P725, DOI 10.1098/rspb.2003.2626; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Shultz S, 2010, P NATL ACAD SCI USA, V107, P21582, DOI 10.1073/pnas.1005246107; Shultz S, 2010, BEHAV ECOL, V21, P1073, DOI 10.1093/beheco/arq108; Silk JB, 2002, BEHAVIOUR, V139, P421, DOI 10.1163/156853902760102735; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Stiller J, 2007, SOC NETWORKS, V29, P93, DOI 10.1016/j.socnet.2006.04.001; Sutcliffe A, 2012, JASSS-J ARTIF SOC S, V15; Sutcliffe A, 2012, BRIT J PSYCHOL, V103, P149, DOI 10.1111/j.2044-8295.2011.02061.x; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147; VanSchaik CP, 1997, P ROY SOC B-BIOL SCI, V264, P1687, DOI 10.1098/rspb.1997.0234; WELLMAN B, 1990, AM J SOCIOL, V96, P558, DOI 10.1086/229572; Wellman B., 2006, NETWORKED NEIGHBORHO; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wittig RM, 2008, HORM BEHAV, V54, P170, DOI 10.1016/j.yhbeh.2008.02.009; Yamagishi T, 1998, AM J SOCIOL, V104, P165, DOI 10.1086/210005; Zhou WX, 2005, P ROY SOC B-BIOL SCI, V272, P439, DOI 10.1098/rspb.2004.2970	77	14	14	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158605	10.1371/journal.pone.0158605	http://dx.doi.org/10.1371/journal.pone.0158605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427758	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300014
J	Tsekoa, TL; Lotter-Stark, T; Buthelezi, S; Chakauya, E; Stoychev, SH; Sabeta, C; Shumba, W; Phahladira, B; Hume, S; Morton, J; Rupprecht, CE; Steinkellner, H; Pauly, M; Zeitlin, L; Whaley, K; Chikwamba, R				Tsekoa, Tsepo Lebiletsa; Lotter-Stark, Therese; Buthelezi, Sindisiwe; Chakauya, Ereck; Stoychev, Stoyan H.; Sabeta, Claude; Shumba, Wonderful; Phahladira, Baby; Hume, Steve; Morton, Josh; Rupprecht, Charles E.; Steinkellner, Herta; Pauly, Michael; Zeitlin, Larry; Whaley, Kevin; Chikwamba, Rachel			Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3	PLOS ONE			English	Article							PROPHYLAXIS; GLYCOSYLATION; PREVENTION; EXPRESSION	Rabies is a neglected zoonotic disease that has no effective treatment after onset of illness. However the disease can be prevented effectively by prompt administration of post exposure prophylaxis which includes administration of passive immunizing antibodies (Rabies Immune Globulin, RIG). Currently, human RIG suffers from many restrictions including limited availability, batch-to batch inconsistencies and potential for contamination with blood-borne pathogens. Anti-rabies monoclonal antibodies (mAbs) have been identified as a promising alternative to RIG. Here, we applied a plant-based transient expression system to achieve rapid, high level production and efficacy of the two highly potent anti-rabies mAbs E559 and 62-71-3. Expression levels of up to 490 mg/kg of recombinant mAbs were obtained in Nicotiana benthamiana glycosylation mutants by using a viral based transient expression system. The plant-made E559 and 62-71-3, carrying human-type fucose-free N-glycans, assembled properly and were structurally sound as determined by mass spectrometry and calorimetric density measurements. Both mAbs efficiently neutralised diverse rabies virus variants in vitro. Importantly, E559 and 62-71-3 exhibited enhanced protection against rabies virus compared to human RIG in a hamster model post-exposure challenge trial. Collectively, our results provide the basis for the development of a multi-mAb based alternative to RIG.	[Tsekoa, Tsepo Lebiletsa; Lotter-Stark, Therese; Buthelezi, Sindisiwe; Chakauya, Ereck; Stoychev, Stoyan H.; Chikwamba, Rachel] CSIR, Biosci Unit, Pretoria, South Africa; [Sabeta, Claude; Shumba, Wonderful; Phahladira, Baby] ARC Onderstepoort Vet Inst, Onderstepoort, South Africa; [Pauly, Michael; Zeitlin, Larry; Whaley, Kevin] Mapp Biopharmaceut, San Diego, CA USA; [Hume, Steve; Morton, Josh] Kentucky Bioproc, Owensboro, KY USA; [Rupprecht, Charles E.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Steinkellner, Herta] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria	Council for Scientific & Industrial Research (CSIR) - South Africa; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; The Wistar Institute; University of Natural Resources & Life Sciences, Vienna	Chikwamba, R (corresponding author), CSIR, Biosci Unit, Pretoria, South Africa.	rchikwamba@csir.co.za	Steinkellner, Herta/N-4267-2016; Rupprecht, Charles/AAI-1544-2020	Steinkellner, Herta/0000-0003-4823-1505; Tsekoa, Tsepo/0000-0002-5561-5462; Stark, Therese/0000-0002-0877-3695; Chakauya, Ereck/0000-0002-4282-1742; Stoychev, Stoyan/0000-0001-7504-4313	National Research Foundation; Technology Innovation Agency; Agricultural Research Council Rabies Diagnostic Cost Centre [15/04/P001]; Council for Scientific and Industrial Research; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	National Research Foundation; Technology Innovation Agency; Agricultural Research Council Rabies Diagnostic Cost Centre; Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	LZ and KW are owners of Mapp Biopharmaceutical, a commercial company. MP is employed by Mapp Biopharmaceutical, while JM and SH are employed by Kentucky Bioprocessing, a commercial company. The authors thank the National Research Foundation (SB) (www.nrf.ac.za), Technology Innovation Agency (RC) (www.tia.org.za), the Agricultural Research Council Rabies Diagnostic Cost Centre (15/04/P001) (CS) and Council for Scientific and Industrial Research (SA) (TT, RC) (www.csir.co.za) for funding support. The funders provided support in the form of salaries for authors SB, TT and RC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Both L, 2013, FASEB J, V27, P2055, DOI 10.1096/fj.12-219964; Both L, 2012, LANCET INFECT DIS, V12, P397, DOI 10.1016/S1473-3099(11)70340-1; Daugherty AL, 2006, ADV DRUG DELIVER REV, V58, P686, DOI 10.1016/j.addr.2006.03.011; DOI E, 1970, BIOCHEMISTRY-US, V9, P1066, DOI 10.1021/bi00807a003; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Gerdes CA, 2013, CLIN CANCER RES, V19, P1126, DOI 10.1158/1078-0432.CCR-12-0989; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hiatt A, 2014, P NATL ACAD SCI USA, V111, P5992, DOI 10.1073/pnas.1402458111; Junttila TT, 2010, CANCER RES, V70, P4481, DOI 10.1158/0008-5472.CAN-09-3704; Knobel D, 2005, B WORLD HEALTH ORGAN, V83, P931; Kuzmina N, 2013, J ANTIVIR ANTIRETROV, V5; Liu Y, 2007, BIOSENS BIOELECTRON, V23, P35, DOI 10.1016/j.bios.2007.03.009; Manning Susan E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Muller T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000542; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Rybicki EP, 2012, BIOTECHNOL ADV, V30, P449, DOI 10.1016/j.biotechadv.2011.07.014; Satpathy D M, 2005, J Indian Med Assoc, V103, P241; Satpathy DM, 2005, J INDIAN MED ASSOC, V103, P41; Shantavasinkul P, 2011, ADV VIRUS RES, V79, P291, DOI 10.1016/B978-0-12-387040-7.00013-5; Smith TG, 2011, ADV VIRUS RES, V79, P345, DOI 10.1016/B978-0-12-387040-7.00016-0; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; van Dolleweerd CJ, 2014, J INFECT DIS, V210, P200, DOI 10.1093/infdis/jiu085; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727	25	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159313	10.1371/journal.pone.0159313	http://dx.doi.org/10.1371/journal.pone.0159313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427976	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300047
J	Muchova, K; Chromikova, Z; Bradshaw, N; Wilkinson, AJ; Barak, I				Muchova, Katarina; Chromikova, Zuzana; Bradshaw, Niels; Wilkinson, Anthony J.; Barak, Imrich			Morphogenic Protein RodZ Interacts with Sporulation Specific SpoIIE in Bacillus subtilis	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; WALL SYNTHETIC COMPLEXES; ESCHERICHIA-COLI; GENE-EXPRESSION; MREB HELIX; SHAPE; LOCALIZATION; FTSZ; ENGULFMENT; TRANSCRIPTION	The first landmark in sporulation of Bacillus subtilis is the formation of an asymmetric septum followed by selective activation of the transcription factor sigma(F) in the resulting smaller cell. How the morphological transformations that occur during sporulation are coupled to cell-specific activation of transcription is largely unknown. The membrane protein SpoIIE is a constituent of the asymmetric sporulation septum and is a crucial determinant of sF activation. Here we report that the morphogenic protein, RodZ, which is essential for cell shape determination, is additionally required for asymmetric septum formation and sporulation. In cells depleted of RodZ, formation of asymmetric septa is disturbed and sF activation is perturbed. During sporulation, we found that SpoIIE recruits RodZ to the asymmetric septum. Moreover, we detected a direct interaction between SpoIIE and RodZ in vitro and in vivo, indicating that SpoIIE-RodZ may form a complex to coordinate asymmetric septum formation and sF activation. We propose that RodZ could provide a link between the cell shape machinery and the coordinated morphological and developmental transitions required to form a resistant spore.	[Muchova, Katarina; Chromikova, Zuzana; Barak, Imrich] Slovak Acad Sci, Inst Mol Biol, Bratislava, Slovakia; [Bradshaw, Niels] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Wilkinson, Anthony J.] Univ York, Dept Chem, Struct Biol Lab, York, N Yorkshire, England	Slovak Academy of Sciences; Harvard University; University of York - UK	Barak, I (corresponding author), Slovak Acad Sci, Inst Mol Biol, Bratislava, Slovakia.	imrich.barak@savba.sk	Barak, Imrich/H-7285-2019	Barak, Imrich/0000-0002-3690-404X; Bradshaw, Niels/0000-0002-6845-4717; Chromikova, Zuzana/0000-0001-6478-5984	Slovak Academy of Sciences [VEGA 2/0009/13]; Research & Development Operational Programme - ERDF (ITMS) [26240220044]; Wellcome Trust [082829/Z/07/Z];  [APVV-14-0181]	Slovak Academy of Sciences(Slovak Academy of Sciences); Research & Development Operational Programme - ERDF (ITMS); Wellcome Trust(Wellcome TrustEuropean Commission); 	This work was supported by Grant VEGA 2/0009/13 from the Slovak Academy of Sciences, by grant APVV-14-0181, by the Research & Development Operational Programme funded by the ERDF (ITMS code: 26240220044) to IB and from The Wellcome Trust Project Grant 082829/Z/07/Z to AJW and IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; Alyahya SA, 2009, P NATL ACAD SCI USA, V106, P1239, DOI 10.1073/pnas.0810794106; Arigoni F, 1999, MOL MICROBIOL, V31, P1407, DOI 10.1046/j.1365-2958.1999.01282.x; ARIGONI F, 1995, SCIENCE, V270, P637, DOI 10.1126/science.270.5236.637; Arigoni F, 1996, P NATL ACAD SCI USA, V93, P3238, DOI 10.1073/pnas.93.8.3238; Aung S, 2007, MOL MICROBIOL, V65, P1534, DOI 10.1111/j.1365-2958.2007.05887.x; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Barak I, 2005, MOL MICROBIOL, V57, P611, DOI 10.1111/j.1365-2958.2005.04687.x; Barak I, 1996, J BACTERIOL, V178, P4984, DOI 10.1128/jb.178.16.4984-4989.1996; Barak I, 1996, MOL MICROBIOL, V19, P1047, DOI 10.1046/j.1365-2958.1996.433963.x; Barak I, 2008, MOL MICROBIOL, V68, P1315, DOI 10.1111/j.1365-2958.2008.06236.x; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; Bradshaw N, 2015, ELIFE, V4, DOI 10.7554/eLife.08145; Broder DH, 2006, CELL, V126, P917, DOI 10.1016/j.cell.2006.06.053; Campo N, 2008, J BIOL CHEM, V283, P4975, DOI 10.1074/jbc.M708024200; Carballido-Lopez R, 2007, CURR OPIN MICROBIOL, V10, P611, DOI 10.1016/j.mib.2007.09.008; Carniol K, 2005, J BACTERIOL, V187, P3511, DOI 10.1128/JB.187.10.3511-3520.2005; Chastanet A, 2007, MOL MICROBIOL, V64, P139, DOI 10.1111/j.1365-2958.2007.05652.x; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Errington J, 2015, NAT REV MICROBIOL, V13, P241, DOI 10.1038/nrmicro3398; Eswaramoorthy P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004526; Favini-Stabile S, 2013, ENVIRON MICROBIOL, V15, P3218, DOI 10.1111/1462-2920.12171; Feucht A, 2001, GENE, V264, P289, DOI 10.1016/S0378-1119(01)00338-9; Feucht A, 1996, GENE DEV, V10, P794, DOI 10.1101/gad.10.7.794; Gaballah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025129; Gerdes K, 2009, EMBO J, V28, P171, DOI 10.1038/emboj.2008.287; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Hartl B, 2001, J BACTERIOL, V183, P2696, DOI 10.1128/JB.183.8.2696-2699.2001; Harwood C.R., 1990, MOL BIOL METHODS BAC; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; ILLING N, 1991, J BACTERIOL, V173, P3159, DOI 10.1128/JB.173.10.3159-3169.1991; Jacquier N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4578; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2009, MOL MICROBIOL, V71, P1131, DOI 10.1111/j.1365-2958.2009.06601.x; Levdikov VM, 2012, P NATL ACAD SCI USA, V109, P5441, DOI 10.1073/pnas.1120087109; Levdikov VM, 2012, J MOL BIOL, V415, P343, DOI 10.1016/j.jmb.2011.11.017; Levin PA, 1997, MOL MICROBIOL, V25, P839; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Lucet I, 2000, EMBO J, V19, P1467, DOI 10.1093/emboj/19.7.1467; Miller J.H., 1972, EXPT MOL GENETICS; Morgenstein RM, 2015, P NATL ACAD SCI USA, V112, P12510, DOI 10.1073/pnas.1509610112; Muchova K, 2013, ENVIRON MICROBIOL, V15, P3259, DOI 10.1111/1462-2920.12200; Rawlings AE, 2010, PROTEIN ENG DES SEL, V23, P817, DOI 10.1093/protein/gzq057; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Shiomi D, 2008, EMBO J, V27, P3081, DOI 10.1038/emboj.2008.234; Szwedziak P, 2013, CURR OPIN MICROBIOL, V16, P745, DOI 10.1016/j.mib.2013.09.003; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; van den Ent F, 2014, ELIFE, V3, DOI 10.7554/eLife.02634; van den Ent F, 2010, EMBO J, V29, P1081, DOI 10.1038/emboj.2010.9; Varma A, 2009, J BACTERIOL, V191, P3526, DOI 10.1128/JB.01812-08; Vavrova L, 2010, RES MICROBIOL, V161, P791, DOI 10.1016/j.resmic.2010.09.004; Wagner JK, 2005, J BACTERIOL, V187, P544, DOI 10.1128/JB.187.2.544-553.2005; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Williams AH, 2014, RES MICROBIOL, V165, P60, DOI 10.1016/j.resmic.2013.11.002; Young KD, 2010, ANNU REV MICROBIOL, V64, P223, DOI 10.1146/annurev.micro.112408.134102	61	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159076	10.1371/journal.pone.0159076	http://dx.doi.org/10.1371/journal.pone.0159076			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415800	Green Published, Green Accepted, gold			2022-12-27	WOS:000379579500071
J	Khan, F; Ahmed, F; Pushparaj, PN; Abuzenadah, A; Kumosani, T; Barbour, E; AlQahtani, M; Gauthaman, K				Khan, Fazal; Ahmed, Farid; Pushparaj, Peter Natesan; Abuzenadah, Adel; Kumosani, Taha; Barbour, Elie; AlQahtani, Mohammed; Gauthaman, Kalamegam			Ajwa Date (Phoenix dactylifera L.) Extract Inhibits Human Breast Adenocarcinoma (MCF7) Cells In Vitro by Inducing Apoptosis and Cell Cycle Arrest	PLOS ONE			English	Article							CYTOCHROME-C; CANCER; QUERCETIN; PROLIFERATION; MYRICETIN; MITOCHONDRIA; ANTIOXIDANT; ACTIVATION; FLAVONOIDS; INDUCTION	Introduction Phoenix dactylifera L (Date palm) is a native plant of the Kingdom of Saudi Arabia (KSA) and other Middle Eastern countries. Ajwa date has been described in the traditional and alternative medicine to provide several health benefits including anticholesteremic, antioxidant, hepatoprotective and anticancer effects, but most remains to be scientifically validated. Herein, we evaluated the anticancer effects of the Methanolic Extract of Ajwa Date (MEAD) on human breast adenocarcinoma (MCF7) cells in vitro. Methods MCF7 cells were treated with various concentrations (5, 10, 15, 20 and 25 mg/ml) of MEAD for 24, 48 and 72 h and changes in cell morphology, cell cycle, apoptosis related protein and gene expression were studied. Results Phase contrast microscopy showed various morphological changes such as cell shrinkage, vacuolation, blebbing and fragmentation. MTT (2-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay demonstrated statistically significant dose-dependent inhibitions of MCF7 cell proliferation from 35% to 95%. Annexin V-FITC and TUNEL assays showed positive staining for apoptosis of MCF7 cells treated with MEAD (15 mg and 25 mg for 48 h). Flow cytometric analyses of MCF7 cells with MEAD (15 mg/ml and 20 mg/ml) for 24 h demonstrated cell cycle arrest at 'S' phase; increased p53, Bax protein expression; caspase 3activation and decreased the mitochondrial membrane potential (MMP). Quantitative real time PCR (qRT-PCR) analysis showed up-regulation of p53, Bax, Fas, and FasL and downregulation of Bcl-2. Conclusions MEAD inhibited MCF7 cells in vitro by the inducing cell cycle arrest and apoptosis. Our results indicate the anticancer effects of Ajwa dates, which therefore may be used as an adjunct therapy with conventional chemotherapeutics to achieve a synergistic effect against breast cancer.	[Khan, Fazal; Kumosani, Taha; Barbour, Elie] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia; [Khan, Fazal; Ahmed, Farid; Pushparaj, Peter Natesan; AlQahtani, Mohammed; Gauthaman, Kalamegam] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah, Saudi Arabia; [Khan, Fazal; Abuzenadah, Adel] King Abdulaziz Univ, King Fahd Med Res Ctr, Ctr Innovat Personalized Med, Jeddah, Saudi Arabia; [Kumosani, Taha] King Abdulaziz Univ, King Fahd Med Res Ctr, Biochem Unit, Jeddah, Saudi Arabia; [Barbour, Elie] Amer Univ Beirut, Fac Agr & Food Sci, Dept Agr, Beirut, Lebanon	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; American University of Beirut	Gauthaman, K (corresponding author), King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah, Saudi Arabia.	kgauthaman@kau.edu.sa	Kalamegam, Gauthaman/O-6336-2019; Kalamegam, Gauthaman/H-9857-2012; Ahmed, Farid/GWV-5959-2022; Pushparaj, Peter Natesan/H-9871-2012; Ahmed, Farid/AAO-6286-2020; Kumosani, Taha A/E-4362-2013; Al-Qahtani, Mohammed Hussain/AAZ-1729-2020; Ahmed, Farid/I-1192-2012; KHAN, FAZAL/N-9792-2013	Kalamegam, Gauthaman/0000-0002-5208-4598; Pushparaj, Peter Natesan/0000-0001-7574-1880; Ahmed, Farid/0000-0002-7464-7726; Ahmed, Farid/0000-0002-7464-7726; KHAN, FAZAL/0000-0003-1794-8167	King Abdulaziz City for Science and Technology (KACST) [AT-34-237]	King Abdulaziz City for Science and Technology (KACST)	King Abdulaziz City for Science and Technology (KACST) provided the postgraduate grant funding [AT-34-237] to Fazal Khan, with which this study was performed. http://www.kacst.edu.sa/en/Pages/default.aspx.; would like to acknowledge the financial support by King Abdulaziz City for Science and Technology (KACST) through postgraduate grant funding [AT-34-237] as well as the technical and logistics support provided by the Center of Excellence in Genomic Medicine Research and the Center of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.	Ali A, 2011, FUNCT FOODS HEALTH D, V1, P118; American Cancer Society, 2016, CANC FACTS FIGURES 2; Baliga MS, 2011, FOOD RES INT, V44, P1812, DOI 10.1016/j.foodres.2010.07.004; Bhanot A., 2011, INT J PHYTOMED, V3, P9; Cao P, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/958243; Chien SY, 2009, HUM EXP TOXICOL, V28, P493, DOI 10.1177/0960327109107002; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chou CC, 2010, ARCH PHARM RES, V33, P1181, DOI 10.1007/s12272-010-0808-y; Duo J, 2012, MOL MED REP, V5, P1453, DOI 10.3892/mmr.2012.845; Eid N, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.16; El-Azim M. H. M. A., 2015, Journal of Microbial and Biochemical Technology, V7, P47; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Ishurd O, 2004, J MED FOOD, V7, P252, DOI 10.1089/1096620041224085; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kim Jin-Hyung, 2007, Ann N Y Acad Sci, V1095, P598, DOI 10.1196/annals.1397.102_2; Ko CH, 2005, BIOCHEM PHARMACOL, V69, P913, DOI 10.1016/j.bcp.2004.12.005; Lansky EP, 2005, INVEST NEW DRUG, V23, P11, DOI 10.1023/B:DRUG.0000047101.02178.07; Li LY, 2009, J AGR FOOD CHEM, V57, P826, DOI 10.1021/jf803407q; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mann J, 2002, NAT REV CANCER, V2, P143, DOI 10.1038/nrc723; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nihal M, 2014, ARCH BIOCHEM BIOPHYS, V563, P101, DOI 10.1016/j.abb.2014.04.019; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Phillips PA, 2011, CANCER LETT, V308, P181, DOI 10.1016/j.canlet.2011.05.002; Ragab AR, 2013, J ENV ANAL TOXICOL, V3, P2161; Rodgers EH, 1998, CHEM-BIOL INTERACT, V116, P213, DOI 10.1016/S0009-2797(98)00092-1; Saggu S, 2015, SAUDI MED J, V36, P1176, DOI 10.15537/smj.2015.10.12268; Saleh E. A., 2011, Food and Nutrition Sciences, V2, P1134, DOI 10.4236/fns.2011.210152; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Seeram NP, 2004, J AGR FOOD CHEM, V52, P2512, DOI 10.1021/jf0352778; Seo HS, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150165; Shahraki Samira, 2016, J Tradit Complement Med, V6, P89, DOI 10.1016/j.jtcme.2014.11.018; Sheikh BY, 2014, EUR SCI J, V10; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Syed DN, 2008, CANCER LETT, V265, P167, DOI 10.1016/j.canlet.2008.02.050; Thomasset SC, 2007, INT J CANCER, V120, P451, DOI 10.1002/ijc.22419; Unnati S, 2013, CHIN J NAT MEDICINES, V11, P16, DOI 10.3724/SP.J.1009.2013.00016; Wang IK, 1999, EUR J CANCER, V35, P1517, DOI 10.1016/S0959-8049(99)00168-9; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Zhang CR, 2013, J AGR FOOD CHEM, V61, P5834, DOI 10.1021/jf401371v	43	40	42	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158963	10.1371/journal.pone.0158963	http://dx.doi.org/10.1371/journal.pone.0158963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441372	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500032
J	Thevakumar, K; Chandren, JR; Perez-Perez, GI; Chua, EG; Teh, LK; Salleh, MZ; Tan, JAMA; Leow, AHR; Goh, KL; Tay, ACY; Marshall, BJ; Vadivelu, J; Loke, MF; Wong, LP				Thevakumar, Kavitha; Chandren, Josephine Rebecca; Perez-Perez, Guillermo Ignacio; Chua, Eng Guan; Teh, Lay Kek; Salleh, Mohd Zaki; Tan, Jin Ai Mary Anne; Leow, Alex Hwong Ruey; Goh, Khean Lee; Tay, Alfred Chin Yen; Marshall, Barry J.; Vadivelu, Jamuna; Loke, Mun Fai; Wong, Li Ping			Assessment of Risk and Sero-Prevalence of Helicobacter pylori Colonization among Remote Orang Asli Tribes in Peninsula Malaysia	PLOS ONE			English	Article							INFECTION; CAGA; SEROPREVALENCE; EPIDEMIOLOGY	The epidemiology of Helicobacter pylori (H. pylori) infection is related to human poverty with marked differences between developing and developed countries. Socioeconomic factors and living standards are the main determinants of the age-dependent acquisition rate of H. pylori, and consequently its prevalence. The aim of this study was to assess the risk and sero-prevalence of H. pylori colonization among Orang Asli in Peninsula Malaysia. This cross-sectional study was conducted on Orang Asli subjects in seven isolated settlements spanning across all three major tribes (Negrito, Proto Malay and Senoi) in Malaysia. Socio-demographic characteristics of the subjects were obtained through interview. Subjects were tested for H. pylori colonization based on CagA and whole cell (WC) antigen serological assays. A total of 275 subjects participated in this study. Among these subjects, 115 (44.7%) were H. pylori sero-positive with highest sero-prevalence among Negrito (65.7%). Among subjects who were H. pylori sero-positive, CagA sero positivity was also significantly higher among Negrito. The highest proportion of respondents reported to be H. pylori sero-positive was from age group 30 years old and below (57.9%), males (56.2%), Negrito (48.6%) and live in bamboo house (92.3%). The highest proportion of respondents reported to be CagA sero-positive was from age group 30 years old and below (41.4%), males (35.6%) and Negrito (48.6%). The results of this study demonstrate that H. pylori colonization can be related to age, gender, tribes and house materials and CagA sero-positive stain closely associated with age, gender and tribes.	[Thevakumar, Kavitha; Vadivelu, Jamuna; Loke, Mun Fai] Univ Malaya, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Chandren, Josephine Rebecca; Wong, Li Ping] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Perez-Perez, Guillermo Ignacio] NYU, Sch Med, Dept Med, New York, NY USA; [Perez-Perez, Guillermo Ignacio] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Perez-Perez, Guillermo Ignacio] VA Med Ctr, New York, NY USA; [Chua, Eng Guan; Tay, Alfred Chin Yen; Marshall, Barry J.] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Sch Pathol & Lab Med M502, Perth, WA, Australia; [Teh, Lay Kek; Salleh, Mohd Zaki] Univ Teknol MARA, Integrat Pharmacogen Inst, Selangor, Malaysia; [Tan, Jin Ai Mary Anne] Univ Malaya, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Leow, Alex Hwong Ruey; Goh, Khean Lee] Univ Malaya, Dept Med, Kuala Lumpur, Malaysia; [Marshall, Barry J.] Univ Malaya, UM Marshall Ctr, High Impact Res Bldg, Kuala Lumpur, Malaysia; [Wong, Li Ping] Univ Malaya, JCUM, Kuala Lumpur, Malaysia; [Loke, Mun Fai] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore	Universiti Malaya; Universiti Malaya; New York University; New York University; University of Western Australia; Universiti Teknologi MARA; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; National University of Singapore	Loke, MF (corresponding author), Univ Malaya, Dept Med Microbiol, Kuala Lumpur, Malaysia.; Wong, LP (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.; Wong, LP (corresponding author), Univ Malaya, JCUM, Kuala Lumpur, Malaysia.; Loke, MF (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.	lmunfai@gmail.com; wonglp@ummc.edu.my	Tay, Alfred Chin Yen/H-5938-2014; TAN, JIN AI MARY ANNE/B-8950-2010; Teh, Lay Kek/AAV-2790-2020; Tay, Chin Yen/AAZ-8785-2021; Perez, Guillermo Perez/AAJ-3761-2020; Teh, Lay Kek/ABH-6209-2020; Loke, Mun Fai/B-1060-2011; WONG, LI PING/B-2782-2010; Goh, Khean-Lee/B-6404-2009; VADIVELU, JAMUNARANI S/B-8696-2010; Leow, Alex HR/B-1626-2017; Chua, Eng Guan/W-3023-2019; Salleh, Mohd Zaki/ABD-4784-2020	Tay, Alfred Chin Yen/0000-0001-9705-4010; Tay, Chin Yen/0000-0001-9705-4010; Loke, Mun Fai/0000-0002-3554-5313; WONG, LI PING/0000-0002-0107-0532; Goh, Khean-Lee/0000-0002-9965-1561; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Leow, Alex HR/0000-0003-1752-0435; Chua, Eng Guan/0000-0002-1508-5284; Perez Perez, Guillermo/0000-0002-0131-5798; Marshall, Barry/0000-0003-4853-5015; Teh, Lay Kek/0000-0002-2830-4263	University of Malaya-Ministry of Education (UM-MoE) High Impact Research (HIR) Grant [UM.C/625/1/HIR/MoE/CHAN/13/3, H-50001-A000030]; Ministry of Higher Education Malaysia [LRGS 600-RMI/LRGS 5/3 (1/2011)-1]	University of Malaya-Ministry of Education (UM-MoE) High Impact Research (HIR) Grant; Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	This study was funded fully by the University of Malaya-Ministry of Education (UM-MoE) High Impact Research (HIR) Grant UM.C/625/1/HIR/MoE/CHAN/13/3 (Account No. H-50001-A000030) and the Ministry of Higher Education Malaysia (LRGS 600-RMI/LRGS 5/3 (1/2011)-1).	Baer A., 1999, HLTH DIS SURVIVAL BI; BLASER MJ, 1995, CANCER RES, V55, P2111; Carey I, 1976, ABORIGINAL TRIBES PE; Contreras M, 2008, AM J TROP MED HYG, V78, P574, DOI 10.4269/ajtmh.2008.78.574; ENDOH K, 1994, GASTROENTEROLOGY, V107, P864, DOI 10.1016/0016-5085(94)90138-4; FIX AG, 1995, AM ANTHROPOL, V97, P313, DOI 10.1525/aa.1995.97.2.02a00090; Goh KL, 2007, AM J GASTROENTEROL, V102, P40, DOI 10.1111/j.1572-0241.2006.00885.x; Goh KL, 1997, J GASTROEN HEPATOL, V12, pS29, DOI 10.1111/j.1440-1746.1997.tb00455.x; JHEOA, 2002, KEH BUD DAN PANT LAR; Kasimin Amran, 1991, RELIG SOCIAL CHANGE; Lim LS, 2010, J BIOL SCI, V10, P71, DOI DOI 10.3923/jbs.2010.71.83; Lu W, 2014, J BACTERIOL, V196, P1073, DOI 10.1128/JB.01021-13; Mahadeva S, 2010, ALIMENT PHARM THER, V31, P1141, DOI 10.1111/j.1365-2036.2010.04270.x; Malaty HM, 1996, AM J EPIDEMIOL, V143, P257, DOI 10.1093/oxfordjournals.aje.a008736; Malfertheiner P, 2011, DIGEST DIS, V29, P459, DOI 10.1159/000332213; Masron T., 2013, J RITSUMEIKAN SOC SC, V6, P75; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Mulchandani R, 2013, J PURE APPL MICROBIO, V7, P2429; Nicholas C., 2000, ORANG ASLI CONTEST R; Nicholas C., 1996, INDIGENOUS PEOPLES A; PEREZPEREZ GI, 1990, J INFECT DIS, V161, P1237, DOI 10.1093/infdis/161.6.1237; Porras C, 2013, CANCER CAUSE CONTROL, V24, P209, DOI 10.1007/s10552-012-0117-5; Rahim AA, 2010, AM J TROP MED HYG, V83, P1119, DOI 10.4269/ajtmh.2010.10-0226; Redeen S, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/940650; Romero-Gallo J, 2002, CLIN DIAGN LAB IMMUN, V9, P1313, DOI 10.1128/CDLI.9.6.1313-1317.2002; S Hood, 2006, PEOPLES TRADITIONS E, V12, P6; Sasidharan S, 2011, ASIAN PAC J TROP MED, V4, P72, DOI 10.1016/S1995-7645(11)60037-0; SATHAR MA, 1994, EUR J GASTROEN HEPAT, V6, P37; Schottker B, 2012, CLIN GASTROENTEROL H, V10, P487, DOI 10.1016/j.cgh.2011.12.036; Shiota S, 2014, J GASTROEN HEPATOL, V29, P67, DOI 10.1111/jgh.12359; Tan HJ, 2005, J GASTROEN HEPATOL, V20, P589, DOI 10.1111/j.1440-1746.2005.03783.x	31	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159830	10.1371/journal.pone.0159830	http://dx.doi.org/10.1371/journal.pone.0159830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441568	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500143
J	Chou, LM; Toh, TC; Ben Toh, K; Ng, CSL; Cabaitan, P; Tun, K; Goh, E; Afiq-Rosli, L; Taira, D; Du, RCP; Loke, HX; Khalis, A; Li, JH; Song, TC				Chou, Loke Ming; Toh, Tai Chong; Ben Toh, Kok; Ng, Chin Soon Lionel; Cabaitan, Patrick; Tun, Karenne; Goh, Eugene; Afiq-Rosli, Lutfi; Taira, Daisuke; Du, Rosa Celia Poquita; Loke, Hai Xin; Khalis, Aizat; Li, Jinghan; Song, Tiancheng			Differential Response of Coral Assemblages to Thermal Stress Underscores the Complexity in Predicting Bleaching Susceptibility	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CNIDARIA ANTHOZOA SCLERACTINIA; CLIMATE-CHANGE; TAXONOMIC CLASSIFICATION; WATER-QUALITY; SURVIVAL; TEMPERATURE; MORTALITY; SINGAPORE; ISLANDS	Coral bleaching events have been predicted to occur more frequently in the coming decades with global warming. The susceptibility of corals to bleaching during thermal stress episodes is dependent on many factors and an understanding of these underlying drivers is crucial for conservation management. In 2013, a mild bleaching episode ensued in response to elevated sea temperature on the sediment-burdened reefs in Singapore. Surveys of seven sites highlighted variable bleaching susceptibility among coral genera-Pachyseris and Podabacia were the most impacted (31% of colonies of both genera bleached). The most susceptible genera such as Acropora and Pocillopora, which were expected to bleach, did not. Susceptibility varied between less than 6% and more than 11% of the corals bleached, at four and three sites respectively. Analysis of four of the most bleached genera revealed that a statistical model that included a combination of the factors (genus, colony size and site) provided a better explanation of the observed bleaching patterns than any single factor alone. This underscored the complexity in predicting the coral susceptibility to future thermal stress events and the importance of monitoring coral bleaching episodes to facilitate more effective management of coral reefs under climate change.	[Chou, Loke Ming; Toh, Tai Chong; Ben Toh, Kok; Ng, Chin Soon Lionel; Cabaitan, Patrick; Afiq-Rosli, Lutfi; Taira, Daisuke; Du, Rosa Celia Poquita; Loke, Hai Xin] Natl Univ Singapore, Trop Marine Sci Inst, 18 Kent Ridge Rd, Singapore 119227, Singapore; [Tun, Karenne] Natl Pk Board, Natl Biodivers Ctr, 1 Cluny Rd, Singapore 259569, Singapore; [Goh, Eugene] DHI Water & Environm, 1 Cleantech Loop,03-04 CleanTech One, Singapore 637141, Singapore; [Khalis, Aizat; Li, Jinghan] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Song, Tiancheng] Maritime & Port Author Singapore, 460 Alexandra Rd,PSA Bldg, Singapore 119963, Singapore	National University of Singapore; National University of Singapore	Toh, TC (corresponding author), Natl Univ Singapore, Trop Marine Sci Inst, 18 Kent Ridge Rd, Singapore 119227, Singapore.	Taichong.toh@nus.edu.sg	Ng, Lionel/AAF-5117-2020; Chou, Loke/AAE-5266-2020; Afiq-Rosli, Lutfi/AAB-9151-2019	Ng, Lionel/0000-0003-2700-3474; Chou, Loke/0000-0001-6668-399X; Afiq-Rosli, Lutfi/0000-0002-3987-4712; Toh, Kok Ben/0000-0003-1371-817X; Toh, Tai Chong/0000-0003-2961-4199	Maritime and Port Authority of Singapore [R347-000-215-490]; DHI Water and Environment	Maritime and Port Authority of Singapore; DHI Water and Environment	This work was funded by the Maritime and Port Authority of Singapore (Grant number: R347-000-215-490, http://www.mpa.gov.sg/) granted to LMC. This study is part of the project "Enhancing Singapore's Coral Reef Ecosystem in a Green Port". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors, EG is employed by a commercial company: DHI Water and Environment. The funder provided support in the form of salaries for EG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.r We would like to express our gratitude to Dr. Danwei Huang (Department of Biological Sciences, NUS) for his advice on the coral taxonomy, and Dr. Kwek Yan Chong (Department of Biological Sciences, NUS) and Dr. Alex Thiery (Department of Statistics and Applied Probablity, NUS) for their advice on statistical analyses. This study is part of the project "Enhancing Singapore's Coral Reef Ecosystem in a Green Port" supported by the Maritime and Port Authority of Singapore.	Baird A, 2008, SCIENCE, V320, P315, DOI 10.1126/science.320.5874.315; Bena C, 2004, B MAR SCI, V75, P115; Benzoni F, 2010, ZOOL J LINN SOC-LOND, V160, P421, DOI 10.1111/j.1096-3642.2010.00622.x; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Browne NK, 2015, MAR ENVIRON RES, V105, P39, DOI 10.1016/j.marenvres.2015.02.002; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; CHOU L M, 1988, Galaxea, V7, P101; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; Dikou A, 2006, MAR POLLUT BULL, V52, P7, DOI 10.1016/j.marpolbul.2005.07.021; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Edwards AJ, 2001, MAR POLLUT BULL, V42, P7, DOI 10.1016/S0025-326X(00)00200-9; Gittenberger A, 2011, CONTRIB ZOOL, V80, P107, DOI 10.1163/18759866-08002002; GRIGG RW, 1992, SCIENCE, V255, P172, DOI 10.1126/science.255.5041.172; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2009, CORAL REEFS, V28, P569, DOI 10.1007/s00338-009-0508-6; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoeksema BW, 2009, RAFFLES B ZOOL, P81; Huang DW, 2014, ZOOL J LINN SOC-LOND, V171, P277, DOI 10.1111/zoj12140; Huang DW, 2009, RAFFLES B ZOOL, P69; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; Nadaoka K, 2001, CORAL REEFS, V20, P373, DOI 10.1007/s00338-001-0187-4; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; National Oceanic and Atmospheric Administration Coral Reef Watch, 2000, NOAA COR REEF WATCH; Ng CS, 2016, REGIONAL STUDIES MAR; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Toh TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098529; Tun K, 2011, 22 PAC SCI C; van Woesik R, 2012, ECOL EVOL, V2, P2474, DOI 10.1002/ece3.363; Veron J. E., 2000, CORALS WORLD, V1; Wagner DE, 2010, MAR ECOL PROG SER, V408, P65, DOI 10.3354/meps08584; Wallace CC, 2012, MEMOIRS QUEENSLAND M	39	30	30	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159755	10.1371/journal.pone.0159755	http://dx.doi.org/10.1371/journal.pone.0159755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438593	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100073
J	Gualda, GAR; Sutton, SR				Gualda, Guilherme A. R.; Sutton, Stephen R.			The Year Leading to a Supereruption	PLOS ONE			English	Article							SILICIC MAGMA SYSTEM; X-RAY TOMOGRAPHY; BISHOP-TUFF; LONG-VALLEY; MELT INCLUSIONS; EXSOLVED GAS; TI DIFFUSION; QUARTZ; TITANIQ; PRESSURE	Supereruptions catastrophically eject 100s-1000s of km(3) of magma to the surface in a matter of days to a few months. In this study, we use zoning in quartz crystals from the Bishop Tuff (California) to assess the timescales over which a giant magma body transitions from relatively quiescent, pre-eruptive crystallization to rapid decompression and eruption. Quartz crystals in the Bishop Tuff have distinctive rims (<200 mu m thick), which are Ti-rich and bright in cathodoluminescence (CL) images, and which can be used to calculate Ti diffusional relaxation times. We use synchrotron-based x-ray microfluorescence to obtain quantitative Ti maps and profiles along rim-interior contacts in quartz at resolutions of 1-5 mu m in each linear dimension. We perform CL imaging on a scanning electron microscope (SEM) using a low-energy (5 kV) incident beam to characterize these contacts in high resolution (< 1 mu m in linear dimensions). Quartz growth times were determined using a 1D model for Ti diffusion, assuming initial step functions. Minimum quartz growth rates were calculated using these calculated growth times and measured rim thicknesses. Maximum rim growth times span from similar to 1 min to 35 years, with a median of similar to 4 days. More than 70% of rim growth times are less than 1 year, showing that quartz rims have mostly grown in the days to months prior to eruption. Minimum growth rates show distinct modes between 10-8 and 10-10 m/s (depending on sample), revealing very fast crystal growth rates (100s of nm to 10s of mu m per day). Our data show that quartz rims grew well within a year of eruption, with most of the growth happening in the weeks or days preceding eruption. Growth took place under conditions of high supersaturation, suggesting that rim growth marks the onset of decompression and the transition from pre-eruptive to syn-eruptive conditions.	[Gualda, Guilherme A. R.] Vanderbilt Univ, Earth & Environm Sci, PMB 351805, Nashville, TN 37235 USA; [Sutton, Stephen R.] Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA; [Sutton, Stephen R.] Ctr Adv Radiat Sources, Chicago, IL 60637 USA	Vanderbilt University; University of Chicago	Gualda, GAR (corresponding author), Vanderbilt Univ, Earth & Environm Sci, PMB 351805, Nashville, TN 37235 USA.	g.gualda@vanderbilt.edu			NSF [EAR-1151337]; Vanderbilt Discovery Grant; National Science Foundation-Earth Sciences [EAR-1128799]; Department of Energy-GeoSciences [DE-FG02-94ER14466]; DOE Office of Science [DE-AC02-06CH11357]	NSF(National Science Foundation (NSF)); Vanderbilt Discovery Grant; National Science Foundation-Earth Sciences(National Science Foundation (NSF)); Department of Energy-GeoSciences(United States Department of Energy (DOE)); DOE Office of Science(United States Department of Energy (DOE))	The work was partly funded by NSF grant EAR-1151337 and a Vanderbilt Discovery Grant to Gualda. The synchrotron x-ray analysis portions of this work were performed at GeoSoilEnviroCARS (The University of Chicago, Sector 13), Advanced Photon Source (APS), Argonne National Laboratory. GeoSoilEnviroCARS is supported by the National Science Foundation-Earth Sciences (EAR-1128799) and Department of Energy-GeoSciences (DE-FG02-94ER14466). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Ayla Pamukcu, Mark Ghiorso, Darren Gravley, Lydia Harmon, and Samantha Tramontano for suggestions on earlier versions of the manuscript. Reviews by Naomi Matthews and an anonymous reviewer, and editorial handling by Axel Schmitt are greatly appreciated. The work was partly funded by NSF grant EAR-1151337 and a Vanderbilt Discovery Grant to Gualda. Portions of this work were performed at GeoSoilEnviroCARS (The University of Chicago, Sector 13), Advanced Photon Source (APS), Argonne National Laboratory. GeoSoilEnviroCARS is supported by the National Science Foundation-Earth Sciences (EAR-1128799) and Department of Energy-GeoSciences (DE-FG02-94ER14466). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.	ANDERSON AT, 1991, AM MINERAL, V76, P530; Anderson AT, 2000, J PETROL, V41, P449, DOI 10.1093/petrology/41.3.449; BAILEY RA, 1976, J GEOPHYS RES, V81, P725, DOI 10.1029/JB081i005p00725; Begue F, 2014, J PETROL, V55, P1653, DOI 10.1093/petrology/egu038; Bindeman IN, 2002, CONTRIB MINERAL PETR, V144, P185, DOI 10.1007/s00410-002-0371-8; Blundy J, 2001, CONTRIB MINERAL PETR, V140, P631, DOI 10.1007/s004100000219; Carslaw HS, 1984, CONDUCTION OF HEAT I, DOI [10.1093/pertology/egr080, DOI 10.1093/PETROLOGY/EGR080]; Chamberlain KJ, 2015, J PETROL, V56, P605, DOI 10.1093/petrology/egv012; Chamberlain KJ, 2014, J PETROL, V55, P395, DOI 10.1093/petrology/egt072; Chamberlain KJ, 2014, CONTRIB MINERAL PETR, V168, DOI 10.1007/s00410-014-1034-2; Cherniak DJ, 2007, CHEM GEOL, V236, P65, DOI 10.1016/j.chemgeo.2006.09.001; Cooper GF, 2012, EARTH PLANET SC LETT, V313, P23, DOI 10.1016/j.epsl.2011.11.006; Cooper KM, 2014, NATURE, V506, P480, DOI 10.1038/nature12991; Crowley JL, 2007, GEOLOGY, V35, P1123, DOI 10.1130/G24017A.1; Davies GR, 1998, GEOCHIM COSMOCHIM AC, V62, P3561, DOI 10.1016/S0016-7037(98)00247-6; Gualda GAR, 2004, T ROY SOC EDIN-EARTH, V95, P375; Gualda GAR, 2006, J VOLCANOL GEOTH RES, V154, P48, DOI 10.1016/j.jvolgeores.2005.09.019; Gualda GAR, 2013, J GEOL, V121, P537, DOI 10.1086/671395; Gualda GAR, 2013, CONTRIB MINERAL PETR, V166, P755, DOI 10.1007/s00410-013-0901-6; Gualda GAR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037492; Gualda GAR, 2012, J PETROL, V53, P875, DOI 10.1093/petrology/egr080; HALLIDAY AN, 1984, EARTH PLANET SC LETT, V68, P379, DOI 10.1016/0012-821X(84)90123-7; HERVIG RL, 1992, EARTH PLANET SC LETT, V111, P97, DOI 10.1016/0012-821X(92)90172-R; Hildreth W., 1979, GEOL SOC AM SPEC PAP, V180, P43, DOI DOI 10.1130/SPE180-P43; Hildreth W, 2007, J PETROL, V48, P951, DOI 10.1093/petrology/egm007; Holtz F, 2001, CONTRIB MINERAL PETR, V141, P347, DOI 10.1007/s004100100245; Huang RF, 2012, GEOCHIM COSMOCHIM AC, V84, P75, DOI 10.1016/j.gca.2012.01.009; Ickert RB, 2015, GEOCHIM COSMOCHIM AC, V168, P88, DOI 10.1016/j.gca.2015.07.018; Johannes W., 1996, PETROGENESIS EXPT PE, DOI 10.1007/978-3-642-61049-3_2; Leeman WP, 2012, MICROSC MICROANAL, V18, P1322, DOI 10.1017/S1431927612013426; Lowenstern JB, 2006, PHILOS T R SOC A, V364, P2055, DOI 10.1098/rsta.2006.1813; Matthews NE, 2012, J PETROL, V53, P1385, DOI 10.1093/petrology/egs020; Matthews NE, 2012, CONTRIB MINERAL PETR, V163, P87, DOI 10.1007/s00410-011-0660-1; MICHAEL PJ, 1983, GEOLOGY, V11, P31, DOI 10.1130/0091-7613(1983)11<31:CDOTBT>2.0.CO;2; Miller CF, 2008, ELEMENTS, V4, P11, DOI 10.2113/GSELEMENTS.4.1.11; Oppenheimer C, 2003, PROG PHYS GEOG, V27, P230, DOI 10.1191/0309133303pp379ra; Pamukcu AS, 2015, 2015 AGU FALL M; Pamukcu AS, 2015, GEOLOGY, V43, P947, DOI 10.1130/G37021.1; Pamukcu AS, 2015, CONTRIB MINERAL PETR, V169, DOI 10.1007/s00410-015-1122-y; Pamukcu AS, 2012, J PETROL, V53, P589, DOI 10.1093/petrology/egr072; Pamukcu AS, 2010, GEOSPHERE, V6, P775, DOI 10.1130/GES00565.1; Peppard BT, 2001, AM MINERAL, V86, P1034; Potts P.J., 1987, HDB SILICATE ROCK AN; Reid MR, 2011, CONTRIB MINERAL PETR, V161, P293, DOI 10.1007/s00410-010-0532-0; Roberge J, 2013, CONTRIB MINERAL PETR, V165, P237, DOI 10.1007/s00410-012-0807-8; Schopa A, 2013, J GEOPHYS RES-SOL EA, V118, P926, DOI 10.1002/jgrb.50127; Self S, 2006, PHILOS T R SOC A, V364, P2073, DOI 10.1098/rsta.2006.1814; Sheridan MF, 1965, MINERALOGY PETROLOGY; Simon JI, 2007, GEOCHIM COSMOCHIM AC, V71, P2014, DOI 10.1016/j.gca.2007.01.023; Simon JI, 2005, EARTH PLANET SC LETT, V235, P123, DOI 10.1016/j.epsl.2005.03.013; Sutton SR, 2002, REV MINERAL GEOCHEM, V49, P429, DOI 10.2138/rmg.2002.49.8; Thomas JB, 2015, CONTRIB MINERAL PETR, V169, DOI 10.1007/s00410-015-1120-0; Thomas JB, 2012, CONTRIB MINERAL PETR, V164, P369, DOI 10.1007/s00410-012-0761-5; Thomas JB, 2010, CONTRIB MINERAL PETR, V160, P743, DOI 10.1007/s00410-010-0505-3; Tuttle O.F., 1958, GEOL SOC AM BULL, V74, P1; Wallace PJ, 1999, J GEOPHYS RES-SOL EA, V104, P20097, DOI 10.1029/1999JB900207; WALLACE PJ, 1995, NATURE, V377, P612, DOI 10.1038/377612a0; Wark DA, 2007, GEOLOGY, V35, P235, DOI 10.1130/G23316A.1; Wark DA, 2006, CONTRIB MINERAL PETR, V152, P743, DOI 10.1007/s00410-006-0132-1; Wilson CJN, 2006, J PETROL, V47, P35, DOI 10.1093/petrology/egi066; Wilson CJN, 1997, J GEOL, V105, P407, DOI 10.1086/515937; Wilson CJN, 2012, CONTRIB MINERAL PETR, V164, P359, DOI 10.1007/s00410-012-0757-1; Wood GDA, 2014, TAMBORA ERUPTION CHA	63	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159200	10.1371/journal.pone.0159200	http://dx.doi.org/10.1371/journal.pone.0159200			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438605	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100032
J	Shang, SH; Li, P; Deng, MY; Jiang, Y; Chen, C; Qu, QM				Shang, Suhang; Li, Pei; Deng, Meiying; Jiang, Yu; Chen, Chen; Qu, Qiumin			The Age-Dependent Relationship between Blood Pressure and Cognitive Impairment: A Cross-Sectional Study in a Rural Area of Xi'an, China	PLOS ONE			English	Article							BETA-AMYLOID DEPOSITION; MINI-MENTAL STATE; CEREBRAL HYPOPERFUSION; INCIDENT DEMENTIA; DOUBLE-BLIND; MOUSE MODEL; LATE-LIFE; HYPERTENSION; MIDLIFE; DYSFUNCTION	Background Hypertension is a modifiable risk factor for cognitive impairment, although the relationship between hypertension and cognitive impairment is not fully understood. The objective of this study was to investigate the effect of age on the relationship between blood pressure and cognitive impairment. Methods Blood pressure and global cognitive function information was collected from 1799 participants (age 40-85) who lived in a village in the suburbs of Xi'an, China, during in-person interviews. Cognitive impairment was defined as a Mini-Mental State Examination (MMSE) score lower than the cutoff value. The effect of age on the relationship between blood pressure parameters [systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MABP), and high blood pressure (HBP, SBP >= 140 mm Hg and/or DBP >= 90 mm Hg)] and cognitive impairment was analyzed by logistic regression models using interaction and stratified analysis. Blood pressure and age were regarded as both continuous and categorical data. Results A total of 231 participants were diagnosed as having cognitive impairment based on our criteria. Interaction analysis for the total population showed that SBP (when regarded as continuous data) was positively correlated with cognitive impairment (OR = 1.130 [95% CI, 1.028-1.242] per 10mmHg, P = 0.011); however, the age by SBP interaction term was negatively correlated with cognitive impairment (OR = 0.989 [95% CI, 0.982-0.997] per 10mmHgxyear, P = 0.006), indicating that the relationship between SBP and cognitive impairment was age-dependent (OR = 1.130x0.989((age-55.5)) per 10mmHg, 40 <= age <= 85). When the blood pressure and age were considered as binary data, the results were similar to those obtained when they were considered as continuous variables. Stratified multivariate analysis revealed that the relationship between SBP (when regarded as continuous data) and cognitive impairment was positive for patients aged 40-49 years (OR = 1.349 [95% CI: 1.039-1.753] per 10mmHg, P = 0.025) and 50-59 years (OR = 1.185 [95% CI: 1.028-1.366] per 10mmHg, P = 0.019), whereas it tended to be negative for patients aged 60-69 years (OR = 0.878 [95% CI: 0.729-1.058] per 10mmHg, P = 0.171) and >= 70 years (OR = 0.927 [95% CI: 0.772-1.113] per 10mmHg, P = 0.416). Results similar to those for SBP were obtained for DBP, MABP and HBP as well. Subsequently, SBP, DBP and MABP were transformed into categorical data (SBP<140mmHg, 140mmHg <= SBP<160mmHg, and SBP >= 160mmHg; DBP<90mmHg, 90mmHg <= DBP< 100mmHg, and DBP >= 100mmHg; MABP<100mmHg, 100mmHg <= MABP<110mmHg, and MABP >= 110mmHg), and the stratified multivariate analysis was repeated. This analysis showed that the age-dependent association continued to exist and was especially prominent in the SBP >= 160 mmHg, DBP >= 90 mmHg and MABP >= 110 mmHg groups. Conclusions Elevated blood pressure is positively correlated with cognitive impairment in the middle-aged, but this positive association declines with increasing age. These results indicated that specific blood pressure management strategies for various age groups may be crucial for maintaining cognitive vitality.	[Shang, Suhang; Li, Pei; Deng, Meiying; Jiang, Yu; Chen, Chen; Qu, Qiumin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurol, 277 West Yanta Rd, Xian, Peoples R China	Xi'an Jiaotong University	Qu, QM (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurol, 277 West Yanta Rd, Xian, Peoples R China.	qiuminqu@outlook.com			National Science and Technology Major Project on Development of Major New Drugs [2012ZX09303-005-002]	National Science and Technology Major Project on Development of Major New Drugs	This work was supported by National Science and Technology Major Project on Development of Major New Drugs (NO. 2012ZX09303-005-002) URL: http://www.nmp.gov.cn/zxjs/zdxy/201012/t20101208_2128.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate and thank our study participants. This work was supported by the National Science and Technology Major Project on Development of Major New Drugs (NO. 2012ZX09303-005-002).	Bohm M, 2015, HYPERTENSION, V65, P651, DOI 10.1161/HYPERTENSIONAHA.114.04568; Budge MM, 2002, J AM GERIATR SOC, V50, P2014, DOI 10.1046/j.1532-5415.2002.50614.x; Carnevale D, 2012, HYPERTENSION, V60, P188, DOI 10.1161/HYPERTENSIONAHA.112.195511; Choi JY, 2015, NEUROSCIENCE, V303, P115, DOI 10.1016/j.neuroscience.2015.06.056; Cifuentes D, 2015, HYPERTENSION, V65, P218, DOI 10.1161/HYPERTENSIONAHA.114.04139; Elias MF, 2012, HYPERTENSION, V60, P260, DOI 10.1161/HYPERTENSIONAHA.111.186429; Faraco G, 2013, HYPERTENSION, V62, P810, DOI 10.1161/HYPERTENSIONAHA.113.01063; Firbank MJ, 2011, NEUROLOGY, V76, P1478, DOI 10.1212/WNL.0b013e318217e76a; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Gentile MT, 2009, NEUROBIOL AGING, V30, P222, DOI 10.1016/j.neurobiolaging.2007.06.005; Gorelick PB, 2014, JAMA NEUROL, V71, P1211, DOI 10.1001/jamaneurol.2014.2014; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Gottesman RF, 2014, JAMA NEUROL, V71, P1218, DOI 10.1001/jamaneurol.2014.1646; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joas E, 2012, HYPERTENSION, V59, P796, DOI 10.1161/HYPERTENSIONAHA.111.182204; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Kohler S, 2014, HYPERTENSION, V63, P245, DOI 10.1161/HYPERTENSIONAHA.113.02096; Kruyer A, 2015, HYPERTENSION, V66, P175, DOI 10.1161/HYPERTENSIONAHA.115.05524; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Mahoney JR, 2010, J INT NEUROPSYCH SOC, V16, P877, DOI 10.1017/S1355617710000767; Molander L, 2010, DEMENT GERIATR COGN, V29, P335, DOI 10.1159/000289821; Ninomiya T, 2011, HYPERTENSION, V58, P22, DOI 10.1161/HYPERTENSIONAHA.110.163055; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; Ogliari G, 2015, J AM GERIATR SOC, V63, P1741, DOI 10.1111/jgs.13616; Oveisgharan S, 2010, ARCH NEUROL-CHICAGO, V67, P187, DOI 10.1001/archneurol.2009.312; Peng D, 2005, CHINESE J NEUROIMMUN, V12, P187; Peng D, 2005, CHINESE J NEUROIMMUN, V12, P211; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Richmond R, 2011, AM J HYPERTENS, V24, P299, DOI 10.1038/ajh.2010.236; Rodrigue KM, 2013, JAMA NEUROL, V70, P600, DOI 10.1001/jamaneurol.2013.1342; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sabayan B, 2015, JAMA INTERN MED, V175, P586, DOI 10.1001/jamainternmed.2014.8202; Scuteri A, 2011, J HYPERTENS, V29, P1469, DOI 10.1097/HJH.0b013e328347cc17; Shah NS, 2012, HYPERTENSION, V59, P780, DOI 10.1161/HYPERTENSIONAHA.111.178962; Stewart R, 2009, HYPERTENSION, V54, P233, DOI 10.1161/HYPERTENSIONAHA.109.128744; Tzourio C, 2003, ARCH INTERN MED, V163, P1069; Yasar S., 2011, PLoS ONE, pe27976, DOI 10.1371/journal.pone.0027976; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	41	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159485	10.1371/journal.pone.0159485	http://dx.doi.org/10.1371/journal.pone.0159485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438476	Green Published, gold			2022-12-27	WOS:000380170100050
J	Wang, L; Chopp, M; Szalad, A; Lu, XR; Jia, LF; Lu, M; Zhang, RL; Zhang, ZG				Wang, Lei; Chopp, Michael; Szalad, Alexandra; Lu, XueRong; Jia, LongFei; Lu, Mei; Zhang, Rui Lan; Zhang, Zheng Gang			Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; SILDENAFIL; ANGIOGENESIS; ACTIVATION; BRAIN	We previously demonstrated that treatment of diabetic peripheral neuropathy with the short (4 hours) half-life phosphodiesterase 5 (PDE5) inhibitor, sildenafil, improved functional outcome in diabetic db/db mice. To further examine the effect of PDE5 inhibition on diabetic peripheral neuropathy, we investigated the effect of another potent PDE5 inhibitor, tadalafil, on diabetic peripheral neuropathy. Tadalafil is pharmacokinetically distinct from sildenafil and has a longer half-life (17+hours) than sildenafil. Diabetic mice (BKS.Cg-m+/+Lepr(db)/J, db/db) at age 20 weeks were treated with tadalafil every 48 hours for 8 consecutive weeks. Compared with diabetic mice treated with saline, tadalafil treatment significantly improved motor and sensory conduction velocities in the sciatic nerve and peripheral thermal sensitivity. Tadalafil treatment also markedly increased local blood flow and the density of FITC-dextran perfused vessels in the sciatic nerve concomitantly with increased intraepidermal nerve fiber density. Moreover, tadalafil reversed the diabetes-induced reductions of axon diameter and myelin thickness and reversed the diabetes-induced increased g-ratio in the sciatic nerve. Furthermore, tadalafil enhanced diabetes-reduced nerve growth factor (NGF) and platelet-derived growth factor-C (PDGF-C) protein levels in diabetic sciatic nerve tissue. The present study demonstrates that tadalafil increases regional blood flow in the sciatic nerve tissue, which may contribute to the improvement of peripheral nerve function and the amelioration of diabetic peripheral neuropathy.	[Wang, Lei; Chopp, Michael; Szalad, Alexandra; Lu, XueRong; Jia, LongFei; Lu, Mei; Zhang, Rui Lan; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Wang, L (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	leiwang@neuro.hfh.edu	zhang, zheng/HCH-9684-2022		U.S. National Institutes of Health: NINDS [RO1 NS075084, RO1 NS075156]; U.S. National Institutes of Health: NIDDK [RO1 DK097519]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075084] Funding Source: NIH RePORTER	U.S. National Institutes of Health: NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. National Institutes of Health: NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the U.S. National Institutes of Health: NINDS grants RO1 NS075084 (LW), RO1 NS075156 (ZGZ) and NIDDK grant RO1 DK097519 (LW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfel Stuart C., 1999, American Journal of Medicine, V107, p34S; Boolell M, 1996, Int J Impot Res, V8, P47; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Chen XM, 2014, CNS NEUROSCI THER, V20, P40, DOI 10.1111/cns.12162; Coward Robert M, 2008, Ther Clin Risk Manag, V4, P1315; Di Scipio F, 2008, MICROSC RES TECHNIQ, V71, P497, DOI 10.1002/jemt.20577; Dyck PJ, 1996, LANCET, V348, P1044, DOI 10.1016/S0140-6736(05)64409-1; Ebenezer GJ, 2011, BRAIN, V134, P1853, DOI 10.1093/brain/awr086; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Frajese GV, 2006, CLIN INTERV AGING, V1, P439, DOI 10.2147/ciia.2006.1.4.439; Hackett G, 2006, INT J CLIN PRACT, V60, P1123, DOI 10.1111/j.1742-1241.2006.01087.x; Hemnes Anna R, 2006, Expert Rev Cardiovasc Ther, V4, P293, DOI 10.1586/14779072.4.3.293; Ii M, 2005, CIRCULATION, V112, P93, DOI 10.1161/CIRCULATIONAHA.104.511964; Jacob A, 2002, AM J PHYSIOL-CELL PH, V283, pC704, DOI 10.1152/ajpcell.00110.2002; Kamenov ZA, 2011, J SEX MED, V8, P851, DOI 10.1111/j.1743-6109.2010.02148.x; Lazarovici P, 2006, CURR PHARM DESIGN, V12, P2609, DOI 10.2174/138161206777698738; Lee C, 2013, TRENDS MOL MED, V19, P474, DOI 10.1016/j.molmed.2013.04.006; Margolis DJ, 2005, WOUND REPAIR REGEN, V13, P531, DOI 10.1111/j.1524-475X.2005.00074.x; Nichols DJ, 2002, BRIT J CLIN PHARMACO, V53, p5S, DOI 10.1046/j.0306-5251.2001.00027.x; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Patil C. S., 2006, Inflammopharmacology, V14, P22, DOI 10.1007/s10787-006-1511-y; Pittenger Gary, 2003, Exp Diabesity Res, V4, P271, DOI 10.1155/EDR.2003.271; Rosen RC, 2002, ANN REV SEX RES, V13, P36; Rosengarten B, 2006, CEREBROVASC DIS, V21, P194, DOI 10.1159/000090555; Sameni H R, 2008, Pak J Biol Sci, V11, P1994, DOI 10.3923/pjbs.2008.1994.2000; Tantini B, 2005, BASIC RES CARDIOL, V100, P131, DOI 10.1007/s00395-004-0504-5; Thippeswamy T, 2007, J NEUROCHEM, V100, P790, DOI 10.1111/j.1471-4159.2006.04243.x; Van Dam PS, 2013, EUR J PHARMACOL, V719, P180, DOI 10.1016/j.ejphar.2013.07.017; Varma A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045243; Wang L, 2011, NEUROSCIENCE, V193, P399, DOI 10.1016/j.neuroscience.2011.07.039; Wang L, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/173656; Wang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118134; Wang L, 2012, NEUROBIOL DIS, V48, P546, DOI 10.1016/j.nbd.2012.08.002; Yorek Mark A, 2015, Rev Diabet Stud, V12, P13, DOI 10.1900/RDS.2015.12.13; Zhang AG, 1997, J CEREBR BLOOD F MET, V17, P123, DOI 10.1097/00004647-199702000-00001; Zhang L, 2006, BRAIN RES, V1118, P192, DOI 10.1016/j.brainres.2006.08.028; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; Zhang ZG, 1999, J CEREBR BLOOD F MET, V19, P68, DOI 10.1097/00004647-199901000-00008	38	15	15	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159665	10.1371/journal.pone.0159665	http://dx.doi.org/10.1371/journal.pone.0159665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438594	gold, Green Submitted, Green Published			2022-12-27	WOS:000380170100063
J	Tian, J; Pinto, JM; Cui, XL; Zhang, HH; Li, L; Liu, YL; Wu, C; Wei, YX				Tian, Jun; Pinto, Jayant M.; Cui, Xiaolan; Zhang, Henghui; Li, Li; Liu, Yulong; Wu, Chan; Wei, Yongxiang			Sendai Virus Induces Persistent Olfactory Dysfunction in a Murine Model of PVOD via Effects on Apoptosis, Cell Proliferation, and Response to Odorants	PLOS ONE			English	Article							SENSORY NEURONS; RECEPTOR NEURONS; NERVOUS-SYSTEM; INFECTION; BRAIN; MICE; SELECTIVITY; AGE; IDENTIFICATION; VULNERABILITY	Background Viral infection is a common cause of olfactory dysfunction. The complexities of studying post-viral olfactory loss in humans have impaired further progress in understanding the underlying mechanism. Recently, evidence from clinical studies has implicated Parainfluenza virus 3 as a causal agent. An animal model of post viral olfactory disorders (PVOD) would allow better understanding of disease pathogenesis and represent a major advance in the field. Objective To develop a mouse model of PVOD by evaluating the effects of Sendai virus (SeV), the murine counterpart of Parainfluenza virus, on olfactory function and regenerative ability of the olfactory epithelium. Methods C57BL/6 mice (6-8 months old) were inoculated intranasally with SeV or ultraviolet (UV)-inactivated virus (UV-SeV). On days 3, 10, 15, 30 and 60 post-infection, olfactory epithelium was harvested and analyzed by histopathology and immunohistochemical detection of S-phase nuclei. We also measured apoptosis by TUNEL assay and viral load by real-time PCR. The buried food test (BFT) was used to measure olfactory function of mice at day 60. In parallel, cultured murine olfactory sensory neurons (OSNs) infected with SeV or UV-SeV were tested for odorant-mixture response by measuring changes in intracellular calcium concentrations indicated by fura-4 AM assay. Results Mice infected with SeV suffered from olfactory dysfunction, peaking on day 15, with no loss observed with UV-SeV. At 60 days, four out of 12 mice infected with SeV still had not recovered, with continued normal function in controls. Viral copies of SeV persisted in both the olfactory epithelium (OE) and the olfactory bulb (OB) for at least 60 days. At day 10 and after, both unit length labeling index (ULLI) of apoptosis and ULLI of proliferation in the SeV group was markedly less than the UV-SeV group. In primary cultured OSNs infected by SeV, the percentage of cells responding to mixed odors was markedly lower in the SeV group compared to UV-SeV (P = 0.007). Conclusion We demonstrate that SeV impairs olfaction, persists in OE and OB tissue, reduces their regenerative ability, and impairs the normal physiological function of OSNs without gross cytopathology. This mouse model shares key features of human post-viral olfactory loss, supporting its future use in studies of PVOD. Further testing and development of this model should allow us to clarify the pathophysiology of PVOD.	[Tian, Jun] Shanxi Med Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Taiyuan, Shanxi Province, Peoples R China; [Pinto, Jayant M.] Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA; [Cui, Xiaolan] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Zhang, Henghui] Peking Univ, Inst Hepatol, Peoples Hosp, Beijing, Peoples R China; [Li, Li] Capital Med Univ, Beijing Chaoyang Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Liu, Yulong; Wu, Chan; Wei, Yongxiang] Capital Med Univ, Beijing Anzhen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Shanxi Medical University; University of Chicago; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Peking University; Capital Medical University; Capital Medical University	Wei, YX (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	weiyongxianglc@126.com			National Natural Science Foundation, government of China [81271062]; Beijing Natural Science Foundation, Government of China [KZ201310025029]	National Natural Science Foundation, government of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation, Government of China	This work was funded by National Natural Science Foundation, government of China (81271062) (URL: http://www.nsfc.gov.cn) (YXW), and Beijing Natural Science Foundation, Government of China (KZ201310025029) (URL: http://www.bjnsf.org) (YXW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armeanu S, 2005, J IMMUNOL, V175, P4971, DOI 10.4049/jimmunol.175.8.4971; Bauer S, 2005, J CELL BIOL, V171, P641, DOI 10.1083/jcb.200505072; Bauer S, 2003, J NEUROSCI, V23, P1792; Bitzer M, 1999, J VIROL, V73, P702, DOI 10.1128/JVI.73.1.702-708.1999; Chambers R, 2009, J GEN VIROL, V90, P1906, DOI 10.1099/vir.0.011700-0; Chen HY, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-22; Deng M, 2014, BRIT J ANAESTH, V113, P443, DOI 10.1093/bja/aet469; Duncan-Lewis CA, 2011, COMPARATIVE MED, V61, P361; Faisca P, 2007, RES VET SCI, V82, P115, DOI 10.1016/j.rvsc.2006.03.009; Gao Yong, 2009, V485, P27, DOI 10.1007/978-1-59745-170-3_3; Ge Y, 2002, CHEM SENSES, V27, P521, DOI 10.1093/chemse/27.6.521; Gomme EA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002971; Gong Q, 2012, CURR PROTOC NEUROSCI; GONG QZ, 1994, J COMP NEUROL, V344, P336, DOI 10.1002/cne.903440303; Hofacer RD, 2013, ANN NEUROL, V73, P695, DOI 10.1002/ana.23892; Holbrook Eric H, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P23, DOI 10.1097/01.moo.0000193174.77321.39; Hummel T, 2011, GMS CURR TOP OTORHIN, V10, DOI [10.3205/cto000077, DOI 10.3205/CTO000077]; Ishimura R, 2008, J NEUROSCI, V28, P4938, DOI 10.1523/JNEUROSCI.0229-08.2008; IWATA H, 1990, J INFECT DIS, V162, P402, DOI 10.1093/infdis/162.2.402; Kaneda Y, 2002, MOL THER, V6, P219, DOI 10.1006/mthe.2002.0647; KIMURA Y, 1979, ARCH VIROL, V61, P297, DOI 10.1007/BF01315016; Klemens JJ, 2006, LARYNGOSCOPE, V116, P1236, DOI 10.1097/01.mlg.0000224526.43698.52; Konstantinidis I, 2006, RHINOLOGY, V44, P135; KRISTENSSON K, 1984, ACTA NEUROPATHOL, V63, P89, DOI 10.1007/BF00697190; Leopold D, 2000, ARCH OTOLARYNGOL, V126, P803, DOI 10.1001/archotol.126.6.803; MERY S, 1994, TOXICOL PATHOL, V22, P353, DOI 10.1177/019262339402200402; MONTICELLO TM, 1990, TOXICOL PATHOL, V18, P24, DOI 10.1177/019262339001800104; MORI I, 1995, J GEN VIROL, V76, P1251, DOI 10.1099/0022-1317-76-5-1251; Mori I, 2004, REV MED VIROL, V14, P209, DOI 10.1002/rmv.426; Mori I, 2002, J GEN VIROL, V83, P2109, DOI 10.1099/0022-1317-83-9-2109; Nagai Y, 2004, CURR TOP MICROBIOL, V283, P197; Park CH, 2002, ARCH VIROL, V147, P1425, DOI 10.1007/s00705-001-0750-x; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Rawson NE, 2012, NEUROBIOL AGING, V33, P1913, DOI 10.1016/j.neurobiolaging.2011.09.036; Rawson NE, 1997, J NEUROPHYSIOL, V77, P1606, DOI 10.1152/jn.1997.77.3.1606; Sagheddu C, 2010, J PHYSIOL-LONDON, V588, P4189, DOI 10.1113/jphysiol.2010.194407; Schomacker H, 2012, CURR OPIN VIROL, V2, P294, DOI 10.1016/j.coviro.2012.02.001; Schrauwen EJA, 2012, J VIROL, V86, P3975, DOI 10.1128/JVI.06828-11; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Seiden AM, 2004, OTOLARYNG CLIN N AM, V37, P1159, DOI 10.1016/j.otc.2004.06.007; Shetty RS, 2005, MOL CELL NEUROSCI, V30, P583, DOI 10.1016/j.mcn.2005.06.003; Shi L, 2013, INACTIVATED SENDAI V, P205; Sugiura M, 1998, ACTA OTO-LARYNGOL, P191; Suzuki M, 2007, LARYNGOSCOPE, V117, P272, DOI 10.1097/01.mlg.0000249922.37381.1e; Thiemmara V, 2002, CELL DEATH DIFFER, V9, P1343, DOI 10.1038/sj.cdd.4401098; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Wang JH, 2007, LARYNGOSCOPE, V117, P1445, DOI 10.1097/MLG.0b013e318063e878; Wang L, 2013, CHEMOSPHERE, V93, P2639, DOI 10.1016/j.chemosphere.2013.08.044; Wiegand M, 2005, J GEN VIROL, V86, P2305, DOI 10.1099/vir.0.81022-0; Yamagishi Masuo, 1994, Rhinology (Utrecht), V32, P113; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092	51	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159033	10.1371/journal.pone.0159033	http://dx.doi.org/10.1371/journal.pone.0159033			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428110	gold, Green Submitted, Green Published			2022-12-27	WOS:000380169300030
J	Huang, CT; Chuang, YC; Tsai, YJ; Ko, WJ; Yu, CJ				Huang, Chun-Ta; Chuang, Yu-Chung; Tsai, Yi-Ju; Ko, Wen-Je; Yu, Chong-Jen			High Mortality in Severe Sepsis and Septic Shock Patients with Do-Not-Resuscitate Orders in East Asia	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; ICU ADMISSION; MULTICENTER; DECISIONS; OUTCOMES; THERAPY; DEATH; MORBIDITY; RISK; END	Background Severe sepsis is a potentially deadly illness and always requires intensive care. Do-not-resuscitate (DNR) orders remain a debated issue in critical care and limited data exist about its impact on care of septic patients, particularly in East Asia. We sought to assess outcome of severe sepsis patients with regard to DNR status in Taiwan. Methods A retrospective cohort study was conducted in intensive care units (ICUs) between 2008 and 2010. All severe sepsis patients were included for analysis. Primary outcome was association between DNR orders and ICU mortality. Volume of interventions was used as proxy indicator to indicate aggressiveness of care. Results Sixty-seven (9.4%) of 712 patients had DNR orders on ICU admission, and these patients were older and had higher disease severity compared with patients without DNR orders. Notably, DNR patients experienced high ICU mortality (90%). Multivariate analysis revealed that the presence of DNR orders was independently associated with ICU mortality (odds ratio: 6.13; 95% confidence interval: 2.66-14.10). In propensity score-matched cohort, ICU mortality rate (91%) in the DNR group was statistically higher than that (62%) in the non-DNR group (p < 0.001). Regarding ICU interventions, arterial and central venous catheterization were more commonly used in DNR patients than in non-DNR patients. Conclusions From the Asian perspective, septic patients placed on DNR orders on ICU admission had exceptionally high mortality. In contrast to Western reports, DNR patients received more ICU interventions, reflecting more aggressive approach to dealing with this patient population. The findings in some ways reflect differences between East and West cultures and suggest that DNR status is an important confounder in ICU studies involving severely septic patients.	[Huang, Chun-Ta; Chuang, Yu-Chung; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Tsai, Yi-Ju] Fu Jen Catholic Univ, Coll Med, Grad Inst Biomed & Pharmaceut Sci, New Taipei, Taiwan; [Ko, Wen-Je] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital	Huang, CT (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Huang, CT (corresponding author), Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan.; Huang, CT (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.	huangct@ntu.edu.tw	; CHUANG, YU-CHUNG/F-4627-2016	HUANG, CHUN-TA/0000-0002-5234-4986; CHUANG, YU-CHUNG/0000-0003-3094-8276; Yu, Chong-Jen/0000-0001-5664-9392	National Taiwan University Hospital [105-N3262]	National Taiwan University Hospital(National Taiwan University)	This study was supported by the National Taiwan University Hospital grant number 105-N3262 (CTH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, JAMA, V265, P1868; Arabi YM, 2013, CRIT CARE, V17, DOI 10.1186/cc12680; Azoulay E, 2009, INTENS CARE MED, V35, P623, DOI 10.1007/s00134-008-1310-6; Beach MC, 2002, J AM GERIATR SOC, V50, P2057, DOI 10.1046/j.1532-5415.2002.50620.x; BEDELL SE, 1986, JAMA-J AM MED ASSOC, V256, P233, DOI 10.1001/jama.256.2.233; Bradford MA, 2014, CRIT CARE MED, V42, P2042, DOI 10.1097/CCM.0000000000000403; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Chang DW, 2014, J GEN INTERN MED, V29, P1256, DOI 10.1007/s11606-014-2906-x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dzeng E, 2015, JAMA INTERN MED, V175, P812, DOI 10.1001/jamainternmed.2015.0295; Fuchs L, 2012, INTENS CARE MED, V38, P1654, DOI 10.1007/s00134-012-2629-6; Garnacho-Montero J, 2008, J ANTIMICROB CHEMOTH, V61, P436, DOI 10.1093/jac/dkm460; Garnacho-Montero J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1000-z; Hakim RB, 1996, ANN INTERN MED, V125, P284, DOI 10.7326/0003-4819-125-4-199608150-00005; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; HOLTZMAN J, 1994, J AM GERIATR SOC, V42, P275, DOI 10.1111/j.1532-5415.1994.tb01751.x; Hoste EAJ, 2003, J AM SOC NEPHROL, V14, P1022, DOI 10.1097/01.ASN.0000059863.48590.E9; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kazaure H, 2011, ARCH SURG-CHICAGO, V146, P922, DOI 10.1001/archsurg.2011.69; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Luo Zhehui, 2010, Med Care Res Rev, V67, P528, DOI 10.1177/1077558710361486; McLean RF, 2000, CRIT CARE MED, V28, P100, DOI 10.1097/00003246-200001000-00016; Mehter Hashim M, 2014, Ann Am Thorac Soc, V11, P1592, DOI 10.1513/AnnalsATS.201406-244BC; Meissner A, 2010, CRIT CARE MED, V38, P1060, DOI 10.1097/CCM.0b013e3181cd1110; Payne JK, 2008, J GERONTOL NURS, V34, P11, DOI 10.3928/00989134-20081001-06; Phua J, 2015, JAMA INTERN MED, V175, P363, DOI 10.1001/jamainternmed.2014.7386; Powell ES, 2013, J EMERG MED, V44, P742, DOI 10.1016/j.jemermed.2012.09.034; Quill CM, 2014, CHEST, V146, P573, DOI 10.1378/chest.13-2529; RABKIN MT, 1976, NEW ENGL J MED, V295, P364, DOI 10.1056/NEJM197608122950705; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Santonocito C, 2013, J CRIT CARE, V28, P14, DOI 10.1016/j.jcrc.2012.07.005; Shepardson LB, 1999, MED CARE, V37, P727, DOI 10.1097/00005650-199908000-00003; Stapleton RD, 2005, CHEST, V128, P525, DOI 10.1378/chest.128.2.525; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; WACHTER RM, 1989, ANN INTERN MED, V111, P525, DOI 10.7326/0003-4819-111-6-525; WENGER NS, 1995, ARCH INTERN MED, V155, P2063, DOI 10.1001/archinte.155.19.2063; Yang Y, 2010, J CRIT CARE, V25, P398, DOI 10.1016/j.jcrc.2009.09.001; Zingmond DS, 2005, ARCH INTERN MED, V165, P1705, DOI 10.1001/archinte.165.15.1705	41	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159501	10.1371/journal.pone.0159501	http://dx.doi.org/10.1371/journal.pone.0159501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27416064	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500133
J	Obradovic, D; Gaspersic, R; Caserman, S; Leonardi, A; Jamnik, M; Podlesek, Z; Seme, K; Anderluh, G; Krizaj, I; Macek, P; Butala, M				Obradovic, Davor; Gaspersic, Rok; Caserman, Simon; Leonardi, Adrijana; Jamnik, Maja; Podlesek, Zdravko; Seme, Katja; Anderluh, Gregor; Krizaj, Igor; Macek, Peter; Butala, Matej			A Cytolethal Distending Toxin Variant from Aggregatibacter actinomycetemcomitans with an Aberrant CdtB That Lacks the Conserved Catalytic Histidine 160	PLOS ONE			English	Article							CELL-CYCLE ARREST; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTERIAL GENOTOXIN; GENOMIC INSTABILITY; STRAND BREAKS; DNA-DAMAGE; 3 SUBUNITS; PERIODONTITIS; APOPTOSIS; GENES	The periodontopathogen Aggregatibacter actinomycetemcomitans synthesizes several virulence factors, including cytolethal distending toxin (CDT). The active CDT holoenzyme is an AB-type tripartite genotoxin that affects eukaryotic cells. Subunits CdtA and CdtC (B-components) allow binding and intracellular translocation of the active CdtB (A-component), which elicits nuclear DNA damage. Different strains of A. actinomycetemcomitans have diverse virulence genotypes, which results in varied pathogenic potential and disease progression. Here, we identified an A. actinomycetemcomitans strain isolated from two patients with advance chronic periodontitis that has a regular cdtABC operon, which, however, codes for a unique, shorter, variant of the CdtB subunit. We describe the characteristics of this CdtB Delta 116-188, which lacks the intact nuclear localisation signal and the catalytic histidine 160. We show that the A. actinomycetemcomitans DO15 isolate secretes CdtB Delta 116-188, and that this subunit cannot form a holotoxin and is also not genotoxic if expressed ectopically in HeLa cells. Furthermore, the A. actinomycetemcomitans DO15 isolate is not toxic, nor does it induce cellular distention upon infection of co-cultivated HeLa cells. Biological significance of this deletion in the cdtB remains to be explained.	[Obradovic, Davor; Podlesek, Zdravko; Macek, Peter; Butala, Matej] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Gaspersic, Rok] Univ Ljubljana, Dept Oral Med & Periodontol, Fac Med, Ljubljana, Slovenia; [Caserman, Simon; Jamnik, Maja; Anderluh, Gregor] Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Ljubljana, Slovenia; [Leonardi, Adrijana; Krizaj, Igor] Jozef Stefan Inst, Dept Mol & Biomed Sci, Ljubljana, Slovenia; [Seme, Katja] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Ljubljana, Slovenia; [Krizaj, Igor] Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem & Biochem, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; National Institute of Chemistry - Slovenia; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of Ljubljana	Macek, P; Butala, M (corresponding author), Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia.	peter.macek@bf.uni-lj.si; matej.butala@bf.uni-lj.si	Maček, Peter/U-4662-2017; Anderluh, Gregor/C-6905-2014; Maček, Peter/Y-9877-2019	Maček, Peter/0000-0001-6470-7759; Anderluh, Gregor/0000-0002-9916-8465; Maček, Peter/0000-0001-6470-7759	Slovenian Research Agency [P1-0207, P3-0293, P1-0391]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency; https://www.arrs.gov.si/en/ grants P1-0207 to DO, AL, IK, PM, MB, P3-0293 to RG and P1-0391 to SC and GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065781; Alsina M, 2001, J CLIN MICROBIOL, V39, P509, DOI 10.1128/JCM.39.2.509-513.2001; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Bandhaya P, 2012, J CLIN PERIODONTOL, V39, P519, DOI 10.1111/j.1600-051X.2012.01871.x; Belibasakis G, 2002, EUR J ORAL SCI, V110, P366, DOI 10.1034/j.1600-0722.2002.21350.x; Chen C, 2009, J BACTERIOL, V191, P7378, DOI 10.1128/JB.01203-09; Damek-Poprawa M, 2012, INFECT IMMUN, V80, P2761, DOI 10.1128/IAI.00385-12; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DiRienzo JM, 2014, CELLS-BASEL, V3, P476, DOI 10.3390/cells3020476; Dixon SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143977; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Fabris AS, 2002, ORAL MICROBIOL IMMUN, V17, P231, DOI 10.1034/j.1399-302X.2002.170405.x; Fahrer J, 2014, DNA REPAIR, V18, P31, DOI 10.1016/j.dnarep.2014.03.002; Fine DH, 2007, J CLIN MICROBIOL, V45, P3859, DOI 10.1128/JCM.00653-07; Frisan T, 2016, BBA-BIOMEMBRANES, V1858, P567, DOI 10.1016/j.bbamem.2015.08.016; Guidi R, 2013, CELL MICROBIOL, V15, P98, DOI 10.1111/cmi.12034; Haase EM, 1999, INFECT IMMUN, V67, P2901, DOI 10.1128/IAI.67.6.2901-2908.1999; Hassane DC, 2003, INFECT IMMUN, V71, P541, DOI 10.1128/IAI.71.1.541-545.2003; Henderson B, 2000, PERIODONTOL, V54, P78, DOI [10.1111/j.1600-0757.2009.00331.x, DOI 10.1111/J.1600-0757.2009.00331.X]; Herbert BA, 2016, MOL ORAL MICROBIOL, V31, P207, DOI 10.1111/omi.12119; Jentsch H, 2012, CLIN ORAL INVEST, V16, P1589, DOI 10.1007/s00784-012-0672-x; Jinadasa RN, 2011, MICROBIOL-SGM, V157, P1851, DOI 10.1099/mic.0.049536-0; Kaplan JB, 2001, INFECT IMMUN, V69, P5375, DOI 10.1128/IAI.69.9.5375-5384.2001; Kittichotirat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022420; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonardi A, 2012, J PROTEOME RES, V11, P5046, DOI 10.1021/pr3006155; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Mao XQ, 2002, CELL MICROBIOL, V4, P245, DOI 10.1046/j.1462-5822.2002.00186.x; Matangkasombut O, 2010, INFECT IMMUN, V78, P783, DOI 10.1128/IAI.00857-09; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nishikubo S, 2003, J BIOL CHEM, V278, P50671, DOI 10.1074/jbc.M305062200; Obradovic D, 2014, BOZDRAVSTVENI VEST, V69, P21; Ohara M, 2011, J PERIODONTAL RES, V46, P389, DOI 10.1111/j.1600-0765.2011.01348.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro ET, 2011, J PERIODONTAL RES, V46, P310, DOI 10.1111/j.1600-0765.2011.01344.x; Rabin SDP, 2009, INFECT IMMUN, V77, P3161, DOI 10.1128/IAI.01227-08; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rompikuntal PK, 2012, INFECT IMMUN, V80, P31, DOI 10.1128/IAI.06069-11; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanz M, 2000, EUR J ORAL SCI, V108, P383, DOI 10.1034/j.1600-0722.2000.108005383.x; Schreiner H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069382; Shenker BJ, 2005, J IMMUNOL, V174, P2228, DOI 10.4049/jimmunol.174.4.2228; Shenker BJ, 2004, J IMMUNOL, V172, P410, DOI 10.4049/jimmunol.172.1.410; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Toth I, 2009, INFECT IMMUN, V77, P492, DOI 10.1128/IAI.00962-08; Ueno Y, 2006, INFECT IMMUN, V74, P3480, DOI 10.1128/IAI.00739-05; Wahasugui TC, 2013, DIAGN MICR INFEC DIS, V75, P366, DOI 10.1016/j.diagmicrobio.2012.12.013; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082; Wang XQ, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-37; Wang Y, 2002, J BACTERIOL, V184, P3442, DOI 10.1128/JB.184.13.3442-3449.2002; Yamada T, 2006, PROTEIN SCI, V15, P362, DOI 10.1110/ps.051790506; Zijnge V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041662	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159231	10.1371/journal.pone.0159231	http://dx.doi.org/10.1371/journal.pone.0159231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414641	Green Submitted, gold, Green Published			2022-12-27	WOS:000379579500101
J	Reza, MH; Shah, H; Manjrekar, J; Chattoo, BB				Reza, Md. Hashim; Shah, Hiral; Manjrekar, Johannes; Chattoo, Bharat B.			Magnesium Uptake by CorA Transporters Is Essential for Growth, Development and Infection in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							HYDROPHOBIN GENE; PLANT INFECTION; RESISTANCE; PROTEIN; IONS; MPG1; CALCIUM; GENOME; TOOL; SUSCEPTIBILITY	Magnaporthe oryzae, the causative organism of rice blast, infects cereal crops and grasses at various stages of plant development. A comprehensive understanding of its metabolism and the implications on pathogenesis is necessary for countering this devastating crop disease. We present the role of the CorA magnesium transporters, MoAlr2 and MoMnr2, in development and pathogenicity of M. oryzae. The MoALR2 and MoMNR2 genes individually complement the Mg2+ uptake defects of a S. cerevisiae CorA transporter double mutant. MoALR2 and MoMNR2 respond to extracellular Mg2+ and Ca2+ levels and their expression is elevated under Mg2+ scarce conditions. RNA silencing mediated knockdown of MoALR2 (WT+siALR2, Delta mnr2+siALR2 and ALR2+MNR2 simultaneous silencing) drastically alters intracellular cation concentrations and sensitivity to metal ions. MoALR2 silencing is detrimental to vegetative growth and surface hydrophobicity of mycelia, and the transformants display loss of cell wall integrity. MoALR2 is required for conidiogenesis and appressorium development, and is essential for infection. Investigation of knockdown transformants reveal low cAMP levels and altered expression of genes encoding proteins involved in MoMps1 cell wall integrity and cAMP MoPmk1 driven MAP Kinase signaling pathways. In contrast to MoALR2 knockdowns, the MoMNR2 deletion (Delta mnr2) shows increased sensitivity to CorA inhibitors as well as altered cation sensitivity, but has limited effect on surface hydrophobicity and severity of plant infection. Interestingly, MoALR2 expression is elevated in Delta mnr2. Impairment of development and infectivity of knockdown transformants and altered intracellular cation composition suggest that CorA transporters are essential for Mg2+ homeostasis within the cell, and are crucial to maintaining normal gene expression associated with cell structure, signal transduction and surface hydrophobicity in M. oryzae. We suggest that CorA transporters, and especially MoALR2, constitute an attractive target for the development of antifungal agents against this pathogen.	[Chattoo, Bharat B.] Maharaja Sayajirao Univ Baroda, Dept Microbiol, Genome Res Ctr, Vadodara 390002, Gujarat, India; Maharaja Sayajirao Univ Baroda, Ctr Biotechnol, Fac Sci, Vadodara 390002, Gujarat, India	Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda	Chattoo, BB (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Microbiol, Genome Res Ctr, Vadodara 390002, Gujarat, India.	bharat.chattoo@bcmsu.ac.in		, Hiral Shah/0000-0002-8143-8244	Department of Biotechnology (DBT); Department of Science & Technology through J.C. Bose National Fellowship by the Government of India; University Grants Commission (UGC-NET); Council of Scientific & Industrial Research-Shyama Prasad Mukherjee Fellowship (CSIR-SPMF)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science & Technology through J.C. Bose National Fellowship by the Government of India; University Grants Commission (UGC-NET)(University Grants Commission, India); Council of Scientific & Industrial Research-Shyama Prasad Mukherjee Fellowship (CSIR-SPMF)	The work was funded by Department of Biotechnology (DBT) and Department of Science & Technology through J.C. Bose National Fellowship awarded to Bharat B. Chattoo by the Government of India. The authors thank University Grants Commission (UGC-NET) and Council of Scientific & Industrial Research-Shyama Prasad Mukherjee Fellowship (CSIR-SPMF) for providing the fellowship to Md. Hashim Reza and Hiral Shah respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; ASBELL MA, 1966, J BACTERIOL, V92, P380, DOI 10.1128/JB.92.2.380-387.1966; BELLPEDERSEN D, 1992, GENE DEV, V6, P2382, DOI 10.1101/gad.6.12a.2382; Calvo IA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006619; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; De Jong J. C., 1997, NATURE, V389, P471; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Filippi MC, 1998, J PLANT NUTR, V21, P1577, DOI 10.1080/01904169809365505; Graschopf A, 2001, J BIOL CHEM, V276, P16216, DOI 10.1074/jbc.M101504200; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Inoue K, 2016, J GEN PLANT PATHOL, V82, P18, DOI 10.1007/s10327-015-0632-9; KACHROO P, 1994, MOL GEN GENET, V245, P339, DOI 10.1007/BF00290114; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Knoop V, 2005, MOL GENET GENOMICS, V274, P205, DOI 10.1007/s00438-005-0011-x; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Lee JM, 2006, CURR GENET, V49, P7, DOI 10.1007/s00294-005-0037-y; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li LG, 2001, PLANT CELL, V13, P2761, DOI 10.1105/tpc.13.12.2761; Lim PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020896; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Mathioni SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-49; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Pasternak K, 2010, J ELEMENTOL, V15, P601; Patkar RN, 2006, MOL BREEDING, V17, P159, DOI 10.1007/s11032-005-4736-3; Pfeiffer J, 2002, INFECT IMMUN, V70, P3930, DOI 10.1128/IAI.70.7.3930-3934.2002; Pham CLL, 2016, SCI REP-UK, V6, DOI 10.1038/srep25288; Pisat NP, 2009, GENETICS, V183, P873, DOI 10.1534/genetics.109.106419; PRESCOTT AR, 1988, J CELL SCI, V89, P321; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Raman V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-326; Reidinger S, 2012, NEW PHYTOL, V195, P699, DOI 10.1111/j.1469-8137.2012.04179.x; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; SMIT G, 1992, APPL ENVIRON MICROB, V58, P3709, DOI 10.1128/AEM.58.11.3709-3714.1992; Soanes DM, 2002, MOL PLANT MICROBE IN, V15, P1253, DOI 10.1094/MPMI.2002.15.12.1253; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Trofimova Y, 2010, FEMS MICROBIOL LETT, V308, P55, DOI 10.1111/j.1574-6968.2010.01989.x; vanWetter MA, 1996, FEMS MICROBIOL LETT, V140, P265, DOI 10.1016/0378-1097(96)00192-9; WALKER GM, 1980, J CELL SCI, V42, P329; Walker GM, 2004, ADV APPL MICROBIOL, V54, P197, DOI 10.1016/S0065-2164(04)54008-X; WALKER GM, 1984, J GEN MICROBIOL, V130, P1941; Wiesenberger G, 2007, EUKARYOT CELL, V6, P592, DOI 10.1128/EC.00382-06; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; ZIMELIS VM, 1973, J INFECT DIS, V127, P663, DOI 10.1093/infdis/127.6.663; Zimmermann G, 1998, J BIOL CHEM, V273, P19650, DOI 10.1074/jbc.273.31.19650	58	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159244	10.1371/journal.pone.0159244	http://dx.doi.org/10.1371/journal.pone.0159244			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416318	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500109
J	Sanchez-de-la-Torre, A; Abad, J; Duran-Cantolla, J; Mediano, O; Cabriada, V; Masdeu, MJ; Teran, J; Masa, JF; de la Pena, M; Aldoma, A; Worner, F; Valls, J; Barbe, F; Sanchez-de-la-Torre, M				Sanchez-de-la-Torre, Alicia; Abad, Jorge; Duran-Cantolla, Joaquin; Mediano, Olga; Cabriada, Valentin; Jose Masdeu, Maria; Teran, Joaquin; Fernando Masa, Juan; de la Pena, Monica; Aldoma, Albina; Worner, Fernando; Valls, Joan; Barbe, Ferran; Sanchez-de-la-Torre, Manuel		Spanish Sleep Grp	Effect of Patient Sex on the Severity of Coronary Artery Disease in Patients with Newly Diagnosis of Obstructive Sleep Apnoea Admitted by an Acute Coronary Syndrome	PLOS ONE			English	Article							HEART HEALTH; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; ASSOCIATION; STROKE; PREVALENCE; PRESSURE; FAILURE; TRIAL	Background The cardiovascular consequences of obstructive sleep apnoea (OSA) differ by sex. We hypothesized that sex influences the severity of acute coronary syndrome (ACS) in patients with OSA. OSA was defined as an apnoea-hypopnoea index (AHI)>15 events.h(-1). We evaluated the severity of ACS according to the ejection fraction, Killip class, number of diseased vessels, number of stents implanted and plasma peak troponin level. Methods We included 663 men (mean +/- SD, AHI 37 +/- 18 events.h(-1)) and 133 women (AHI 35 +/- 18 events.h(-1)) with OSA. Results The men were younger than the women (59 +/- 11 versus 66 +/- 11 years, p<0.0001), exhibited a higher neck circumference (p<0.0001), and were more likely to be smokers and alcohol users than women (p<0.0001, p = 0.0005, respectively). Body mass index and percentage of hypertensive patients or diabetics were similar between sexes. We observed a slight tendency for a higher Killip classification in women, although it was not statistically significant (p = 0.055). For men, we observed that the number of diseased vessels and the number of stents implanted were higher (p = 0.02, p = 0.001, respectively), and a decrease in the ejection fraction (p = 0.002). Conclusions This study shows that sex in OSA influences the severity of ACS. Men show a lower ejection fraction and an increased number of diseased vessels and number of stents implanted.	[Sanchez-de-la-Torre, Alicia; Barbe, Ferran; Sanchez-de-la-Torre, Manuel] Hosp Univ Arnau de Vilanova & Santa Maria, IRBLleida, Grp Translat Res Resp Med, Resp Dept, Lleida, Catalonia, Spain; [Sanchez-de-la-Torre, Alicia; Abad, Jorge; Duran-Cantolla, Joaquin; Mediano, Olga; Teran, Joaquin; Fernando Masa, Juan; de la Pena, Monica; Barbe, Ferran; Sanchez-de-la-Torre, Manuel] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Abad, Jorge] Hosp Badalona Germans Trias & Pujol, Resp Dept, Barcelona, Catalonia, Spain; [Duran-Cantolla, Joaquin] Univ Basque Country, Dept Med, Araba Univ Hosp, Bioaraba Res Inst, Vitoria, Spain; [Mediano, Olga] Hosp Univ Guadalajara, Resp Dept, Guadalajara, Spain; [Cabriada, Valentin] Hosp Univ Cruces, Resp Dept, Bilbao, Spain; [Jose Masdeu, Maria] Hosp Parc Tauli, Resp Dept, Barcelona, Catalonia, Spain; [Teran, Joaquin] Hosp Gen Yague, Resp Dept, Burgos, Spain; [Fernando Masa, Juan] Hosp San Pedro Alcantara, Resp Dept, Caceres, Spain; [de la Pena, Monica] Hosp Univ Son Espases, Inst Invest Sanitaria Palma IdisPa, Clin Anal & Resp Serv, Palma De Mallorca, Spain; [Aldoma, Albina; Worner, Fernando] Hosp Arnau Vilanova, IRBLleida, Dept Cardiol, Lleida, Catalonia, Spain; [Valls, Joan; Barbe, Ferran] IRB Lleida, Dept Stat, Lleida, Catalonia, Spain	University Hospital Arnau de Vilanova; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Germans Trias i Pujol; Bioaraba Health Research Institute; University Hospital of Araba; University of Basque Country; Hospital Universitario Cruces; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital General Yague; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); University Hospital Arnau de Vilanova; Institut de Recerca Biomedica - IRB Lleida	Sanchez-de-la-Torre, M (corresponding author), Hosp Univ Arnau de Vilanova & Santa Maria, IRBLleida, Grp Translat Res Resp Med, Resp Dept, Lleida, Catalonia, Spain.; Sanchez-de-la-Torre, M (corresponding author), Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain.	sanchezdelatorre@gmail.com	de la Torre, Manuel Sanchez/B-5578-2009; Barbé, Ferran/A-5988-2010; Sánchez-de-la-Torre, Manuel/AAC-9514-2022; Valls, Joan/GXM-6532-2022; Sanchez-de-la-Torre, Manuel/AAP-2663-2020; Mediano, Olga/AAZ-2784-2021	de la Torre, Manuel Sanchez/0000-0002-5695-348X; Barbé, Ferran/0000-0002-2340-8928; Sanchez-de-la-Torre, Manuel/0000-0002-5695-348X; Mediano, Olga/0000-0001-7824-1523; Castro Quintas, Sonia/0000-0002-1623-3146; Valls, Joan/0000-0002-4806-7568; CABRIADA, VALENTIN/0000-0003-1124-7108; Sanchez-de-la-Torre, Alicia/0000-0003-3446-1481; Masdeu Margalef, Maria Jose/0000-0003-0437-2074; Pinar, Maria/0000-0003-1613-839X; Urrutia Gajate, Amaia/0000-0002-4088-4088	ResMed Ltd. (Australia); Fondo de Investigacion Sanitaria (Fondo Europeo de Desarrollo Regional (FEDER) Una manera de hacer Europa) [PI10/02763, PI10/02745]; Spanish Respiratory Society (SEPAR); Catalonian Cardiology Society; Esteve-Teijin (Spain); Oxigen Salud (Spain); ALLER; Union Europea: Fondo Europeo de Desarrollo Regional (FEDER): "Una manera de hacer Europa"	ResMed Ltd. (Australia); Fondo de Investigacion Sanitaria (Fondo Europeo de Desarrollo Regional (FEDER) Una manera de hacer Europa); Spanish Respiratory Society (SEPAR); Catalonian Cardiology Society; Esteve-Teijin (Spain); Oxigen Salud (Spain); ALLER; Union Europea: Fondo Europeo de Desarrollo Regional (FEDER): "Una manera de hacer Europa"	This research was supported by ResMed Ltd. (Australia), the Fondo de Investigacion Sanitaria (Fondo Europeo de Desarrollo Regional (FEDER) Una manera de hacer Europa (PI10/02763 and PI10/02745)), the Spanish Respiratory Society (SEPAR), the Catalonian Cardiology Society, Esteve-Teijin (Spain), Oxigen Salud (Spain), and ALLER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the clinicians of the Sleep and Cardiovascular Risk Units of participanting centers of ISAACC Study, as well as the support from Maricel Arbones, Cristina Giron, Montserrat Martinez, Ana Martinez, Olga Minguez, Lydia Pascual, and Silvia Ortega for technical contributions to this work and Union Europea: Fondo Europeo de Desarrollo Regional (FEDER): "Una manera de hacer Europa".	Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Barbe F, 2015, EUR RESPIR J, V45, P419, DOI 10.1183/09031936.00071714; Bassetti C, 1999, SLEEP, V22, P217, DOI 10.1093/sleep/22.2.217; Berger S, 2013, AM J RESP CRIT CARE, V187, P90, DOI 10.1164/rccm.201206-1144OC; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Esquinas C, 2013, CLIN CARDIOL, V36, P495, DOI 10.1002/clc.22166; Faux MD, 2004, SLEEP, V27, P1113, DOI 10.1093/sleep/27.6.1113; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Kaneko Y, 2003, SLEEP, V26, P293, DOI 10.1093/sleep/26.3.293; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Lloberes P, 2011, ARCH BRONCONEUMOL, V47, P143, DOI 10.1016/j.arbres.2011.01.001; Logan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022; Macey PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076631; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Mokhlesi B, 2016, EUROPEAN RESP J; Munoz R, 2006, STROKE, V37, P2317, DOI 10.1161/01.STR.0000236560.15735.0f; Peker Y, 1999, EUR RESPIR J, V14, P179, DOI 10.1034/j.1399-3003.1999.14a30.x; Peppard P., 2000, NEW ENGL J MED, V342; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Peppard PE, 2000, PROSPECTIVE STUDY AS, P1; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Roca GQ, 2015, CIRCULATION, V132, P1329, DOI 10.1161/CIRCULATIONAHA.115.016985; Sanchez-de-la-Torre M, 2013, LANCET RESP MED, V1, P61, DOI 10.1016/S2213-2600(12)70051-6; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Somers VK, 2008, CIRCULATION	29	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159207	10.1371/journal.pone.0159207	http://dx.doi.org/10.1371/journal.pone.0159207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416494	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500098
J	Sati, J; Mohanty, BP; Garg, ML; Koul, A				Sati, Jasmine; Mohanty, Biraja Prasad; Garg, Mohan Lal; Koul, Ashwani			Pro-Oxidant Role of Silibinin in DMBA/TPA Induced Skin Cancer: H-1 NMR Metabolomic and Biochemical Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; OXIDATIVE STRESS; AZADIRACHTA-INDICA; MOUSE SKIN; ULTRAVIOLET-RADIATION; FLAVONOID ANTIOXIDANT; LIPID-PEROXIDATION; TUMOR PROMOTION; RAT LUNG; CARCINOGENESIS	Silibinin, a major bioactive flavonolignan in Silybum marianum, has received considerable attention in view of its anticarcinogenic activity. The present study examines its anticancer potential against 7, 12-dimethylbenz(a) anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA) induced skin cancer. Male LACA mice were randomly segregated into 4 groups: Control, DMBA/TPA, Silibinin and Silibinin+DMBA/TPA. Tumors in DMBA/TPA and Silibinin+DMBA/TPA groups were histologically graded as squamous cell carcinoma. In the Silibinin+DMBA/TPA group, significant reduction in tumor incidence (23%), tumor volume (64.4%), and tumor burden (84.8%) was observed when compared to the DMBA/TPA group. The underlying protective mechanism of Silibinin action was studied at pre-initiation (2 weeks), post-initiation (10 weeks) and promotion (22 weeks) stages of the skin carcinogenesis. The antioxidant nature of Silibinin was evident at the end of 2 weeks of its treatment. However, towards the end of 10 and 22 weeks, elevated lipid peroxidation (LPO) levels indicate the pro-oxidative nature of Silibinin in the cancerous tissue. TUNEL assay revealed enhanced apoptosis in the Silibinin+DMBA/TPA group with respect to the DMBA/TPA group. Therefore, it may be suggested that raised LPO could be responsible for triggering apoptosis in the Silibinin+DMBA/TPA group. H-1 Nuclear Magnetic Resonance (NMR) spectroscopy was used to determine the metabolic profile of the skin /skin tumors. Dimethylamine (DMA), glycerophosphocholine (GPC), glucose, lactic acid, taurine and guanine were identified as the major contributors for separation between the groups from the Principal Component Analysis (PCA) of the metabolite data. Enhanced DMA levels with no alteration in GPC, glucose and lactate levels reflect altered choline metabolism with no marked Warburg effect in skin tumors. However, elevated guanine levels with potent suppression of taurine and glucose levels in the Silibinin+DMBA/TPA group are suggestive of the pro-oxidative nature of Silibinin in regressing tumors. Thus, supporting the theory of augmented LPO levels resulting in increased apoptosis in the skin tumors treated with Silibinin.	[Sati, Jasmine; Mohanty, Biraja Prasad; Garg, Mohan Lal; Koul, Ashwani] Panjab Univ, Dept Biophys, Basic Med Sci Block, Chandigarh 160014, India	Panjab University	Koul, A (corresponding author), Panjab Univ, Dept Biophys, Basic Med Sci Block, Chandigarh 160014, India.	ashwanik@pu.ac.in		Koul, Ashwani/0000-0001-7522-412X	University Grants Commission, New Delhi, India; Indian Council of Medical Research; Department of Science and Technology, Ministry of Science and Technology	University Grants Commission, New Delhi, India(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Science and Technology, Ministry of Science and Technology(Department of Science & Technology (DOST), Philippines)	This work was supported by the University Grants Commission, New Delhi, India (http://www.ugc.ac.in/), the Indian Council of Medical Research (http://www.icmr.nic.in/), and the Department of Science and Technology, Ministry of Science and Technology (http://www.dst.gov.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Ahmad MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119137; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Arora N, 2013, CELL BIOCHEM FUNCT, V31, P385, DOI 10.1002/cbf.2909; Arora N, 2011, PHYTOTHER RES, V25, P408, DOI 10.1002/ptr.3280; Bag S, 2015, BIOCHEM BIOPH RES CO, V459, P574, DOI 10.1016/j.bbrc.2015.02.149; Bilecova-Rabajdova M, 2013, CENT EUR J PUBL HEAL, V21, P213, DOI 10.21101/cejph.a3886; Boffetta P, 2014, SPRING CANC RES, P1, DOI 10.1007/978-3-319-05068-3; Boffetta P, 1997, CANCER CAUSE CONTROL, V8, P444, DOI 10.1023/A:1018465507029; Chang H, 2010, EUR J PHARMACOL, V648, P31, DOI 10.1016/j.ejphar.2010.08.020; Chao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096969; Chhabra N., 2013, INT J NUTR PHARM NEU, V3, P206, DOI DOI 10.4103/2231-0738.114836; Chu Yang LW, 2011, CHINESE HERBAL MED, V3, P309; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Dhanalakshmi S, 2004, CARCINOGENESIS, V25, P1459, DOI 10.1093/carcin/bgh152; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Dummer R, 2011, SKIN CANC WORLD WIDE, VXI; Eisemann N, 2014, J INVEST DERMATOL, V134, P43, DOI 10.1038/jid.2013.304; El-Sayed S, 2002, HEAD NECK-J SCI SPEC, V24, P766, DOI 10.1002/hed.10125; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gangar SC, 2008, PHYTOTHER RES, V22, P1229, DOI 10.1002/ptr.2453; Gu M, 2007, CANCER RES, V67, P3483, DOI 10.1158/0008-5472.CAN-06-3955; Guleria A, 2014, MAGN RESON CHEM, V52, P475, DOI 10.1002/mrc.4094; Hadi SM, 2000, IUBMB LIFE, V50, P167, DOI 10.1080/152165400300001471; Heidari R, 2014, RES PHARM SCI, V9, P97; Kaur M, 2009, MOL CANCER THER, V8, P2366, DOI 10.1158/1535-7163.MCT-09-0304; Khan AQ, 2014, NUTR CANCER, V66, P249, DOI 10.1080/01635581.2014.863365; Khullar G, 2014, INDIAN J DERMATOPATH, V1, P55; KIM YH, 1989, J INVEST DERMATOL, V92, P210, DOI 10.1111/1523-1747.ep12276738; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Koul A, 2006, MOL CELL BIOCHEM, V283, P47, DOI 10.1007/s11010-006-2269-7; Kroll DJ, 2007, INTEGR CANCER THER, V6, P110, DOI 10.1177/1534735407301825; Lahiri-Chatterjee M, 1999, CANCER RES, V59, P622; Larson SM, 2004, CLIN CANCER RES, V10, P2203, DOI 10.1158/1078-0432.CCR-0002-4; Liu JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005284; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luck H, 1963, METHODS ENZYMATIC AN, P885; [Lyon F Organization WH Cancer IAfRo Humans IWGotEoCRt], 2010, SOME NONHETEROCYCLIC; Mallikarjuna G, 2004, CANCER RES, V64, P6349, DOI 10.1158/0008-5472.CAN-04-1632; Marczynski B, 2009, ARCH TOXICOL, V83, P947, DOI 10.1007/s00204-009-0444-9; Moreno A, 1998, NMR BIOMED, V11, P93, DOI 10.1002/(SICI)1099-1492(199805)11:3<93::AID-NBM520>3.0.CO;2-H; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Narayanan DL, 2010, INT J DERMATOL, V49, P978, DOI 10.1111/j.1365-4632.2010.04474.x; Narayanapillai S, 2012, PHOTOCHEM PHOTOBIOL, V88, P1135, DOI 10.1111/j.1751-1097.2011.01050.x; Oka S, 2011, CANCER SCI, V102, P677, DOI 10.1111/j.1349-7006.2011.01869.x; Padmavathi B, 2005, EVID-BASED COMPL ALT, V2, P99, DOI 10.1093/ecam/neh064; Parola M, 1999, ANTIOXID REDOX SIGN, V1, P255, DOI 10.1089/ars.1999.1.3-255; Raina K, 2009, CANCER RES, V69, P3731, DOI 10.1158/0008-5472.CAN-09-0096; Roy S, 2012, CARCINOGENESIS, V33, P629, DOI 10.1093/carcin/bgr299; Samarasinghe Venura, 2012, J Cutan Aesthet Surg, V5, P3, DOI 10.4103/0974-2077.94323; Singh RP, 2005, EUR J CANCER, V41, P1969, DOI 10.1016/j.ejca.2005.03.033; Subapriya R, 2003, Asian Pac J Cancer Prev, V4, P215; Surdu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062359; Tewari-Singh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046149; Tiziani S, 2009, NEOPLASIA, V11, P269, DOI 10.1593/neo.81396; TRUSH MA, 1981, TOXICOL APPL PHARM, V60, P279, DOI 10.1016/0041-008X(91)90231-3; Umar A, 2012, NAT REV CANCER, V12, P835, DOI 10.1038/nrc3397; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Williams C.H., 1971, METHODS ENZYMOLOGY, V17, P503; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wu JW, 2007, J PHARMACEUT BIOMED, V45, P635, DOI 10.1016/j.jpba.2007.06.026; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yang JC, 2015, AMINO ACIDS, V47, P1549, DOI 10.1007/s00726-015-1995-0; You JS, 1998, ADV EXP MED BIOL, V442, P163; Zhao J, 2000, CARCINOGENESIS, V21, P811, DOI 10.1093/carcin/21.4.811	67	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158955	10.1371/journal.pone.0158955	http://dx.doi.org/10.1371/journal.pone.0158955			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414401	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500052
J	Stepien, CC; Pfister, CA; Wootton, JT				Stepien, Courtney C.; Pfister, Catherine A.; Wootton, J. Timothy			Functional Traits for Carbon Access in Macrophytes	PLOS ONE			English	Article							OCEAN ACIDIFICATION; INORGANIC CARBON; CONCENTRATING MECHANISMS; MARINE MACROALGAE; CORALLINE ALGAE; BOUNDARY-LAYERS; PHOTOSYNTHESIS; EVOLUTION; GROWTH; PATTERNS	Understanding functional trait distributions among organisms can inform impacts on and responses to environmental change. In marine systems, only 1% of dissolved inorganic carbon in seawater exists as CO2. Thus the majority of marine macrophytes not only passively access CO2 for photosynthesis, but also actively transport CO2 and the more common bicarbonate (HCO3-, 92% of seawater dissolved inorganic carbon) into their cells. Because species with these carbon concentrating mechanisms (CCMs) are non-randomly distributed in ecosystems, we ask whether there is a phylogenetic pattern to the distribution of CCMs among algal species. To determine macrophyte traits that influence carbon uptake, we assessed 40 common macrophyte species from the rocky intertidal community of the Northeast Pacific Ocean to a) query whether macrophytes have a CCM and b) determine the evolutionary history of CCMs, using ancestral state reconstructions and stochastic character mapping based on previously published data. Thirty-two species not only depleted CO2, but also concentrated and depleted HCO3-, indicative of a CCM. While analysis of CCMs as a continuous trait in 30 families within Phylum Rhodophyta showed a significant phylogenetic signal under a Brownian motion model, analysis of CCMs as a discrete trait (presence or absence) indicated that red algal families are more divergent than expected in their CCM presence or absence; CCMs are a labile trait within the Rhodophyta. In contrast, CCMs were present in each of 18 Ochrophyta families surveyed, indicating that CCMs are highly conserved in the brown algae. The trait of CCM presence or absence was largely conserved within Families. Fifteen of 23 species tested also changed the seawater buffering capacity, or Total Alkalinity (TA), shifting DIC composition towards increasing concentrations of HCO3- and CO2 for photosynthesis. Manipulating the external TA of the local environment may influence carbon availability in boundary layers and areas of low water mixing, offering an additional mechanism to increase CO2 availability.	[Stepien, Courtney C.; Pfister, Catherine A.; Wootton, J. Timothy] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Pfister, Catherine A.; Wootton, J. Timothy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL USA	University of Chicago; University of Chicago	Stepien, CC (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	courtney.stepien@gmail.com	Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344	National Science Foundation [DGE1144082, DEB1311286, OCE0928232, DEB0919240]; Department of Graduate Education [1144082]; National Science Foundation Department of Environmental Biology [1311286, 0919240, 1556874]; National Science Foundation Division of Ocean Sciences [0928232]; National Institutes of Health [T32 GM007197]; Genetics and Regulation Training Grant [T32 GM007197]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER; Direct For Biological Sciences [1556874] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Graduate Education; National Science Foundation Department of Environmental Biology; National Science Foundation Division of Ocean Sciences(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetics and Regulation Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Science Foundation (http://www.nsf.gov/) Department of Graduate Education (1144082 to CCS), the National Science Foundation Department of Environmental Biology (1311286 to CAP and CCS, 0919240 to JTW, and 1556874 to JTW) and the National Science Foundation Division of Ocean Sciences (0928232 to JTW). Funding was also provided by the National Institutes of Health (http://www.nih.gov/) Genetics and Regulation Training Grant (T32 GM007197 to CCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the National Park Service (Olympic NP) for access to Shi Shi Beach, and the Makah Tribal Nation for access to Tatoosh Island, D. and M. Hurd for providing research facilities, and T. Price and R. Ree for helpful comments. Research was supported in part by the National Science Foundation (DGE1144082 to CCS, DEB1311286 to CAP and CCS, OCE0928232 to CAP and DEB0919240 to JTW), and the National Institutes of Health (T32 GM007197).	ADEY W H, 1975, Phycologia, V14, P55, DOI 10.2216/i0031-8884-14-2-55.1; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Andersson AJ, 2014, NAT CLIM CHANGE, V4, P56, DOI 10.1038/NCLIMATE2050; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; AXELSSON L, 1988, MAR BIOL, V97, P295, DOI 10.1007/BF00391315; Bjork M, 2004, MAR ECOL PROG SER, V284, P109, DOI 10.3354/meps284109; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; BREWER PG, 1976, LIMNOL OCEANOGR, V21, P108, DOI 10.4319/lo.1976.21.1.0108; CHIN NKM, 1991, HYDROBIOLOGIA, V215, P1, DOI 10.1007/BF00005895; Christin PA, 2013, P NATL ACAD SCI USA, V110, P1381, DOI 10.1073/pnas.1216777110; Cornwall CE, 2015, PHOTOSYNTH RES, P1; Cornwall CE, 2015, MAR ECOL PROG SER, V525, P81, DOI 10.3354/meps11190; Cornwall CE, 2013, LIMNOL OCEANOGR, V58, P121, DOI 10.4319/lo.2013.58.1.0121; Cornwall CE, 2012, J PHYCOL, V48, P137, DOI 10.1111/j.1529-8817.2011.01085.x; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; FABREGAS J, 1987, BRIT PHYCOL J, V22, P269, DOI 10.1080/00071618700650331; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; GOLDMAN JC, 1980, LIMNOL OCEANOGR, V25, P352, DOI 10.4319/lo.1980.25.2.0352; Guidone M, 2012, J ECOL, V100, P1105, DOI 10.1111/j.1365-2745.2012.02002.x; Guiry MD, 2012, ALGAE BASE WORLD WID; Hellblom F, 2003, PHOTOSYNTH RES, V77, P173, DOI 10.1023/A:1025809415048; Hepburn CD, 2011, GLOBAL CHANGE BIOL, V17, P2488, DOI 10.1111/j.1365-2486.2011.02411.x; Hernandez-Ayon JM, 2007, LIMNOL OCEANOGR-METH, V5, P225; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Hurd CL, 2011, GLOBAL CHANGE BIOL, V17, P3254, DOI 10.1111/j.1365-2486.2011.02473.x; Hurd CL, 2000, J PHYCOL, V36; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; Lapiedra O, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2893; Larkum AWD, 2003, MAR BIOL, V142, P1073, DOI 10.1007/s00227-003-1022-y; Laubach T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-110; LEIGH EG, 1987, P NATL ACAD SCI USA, V84, P1314, DOI 10.1073/pnas.84.5.1314; Leonardos N, 2009, J PHYCOL, V45, P1046, DOI 10.1111/j.1529-8817.2009.00726.x; Lindstrom SC, 2011, PHYCOLOGIA, V50, P661, DOI 10.2216/10-38.1; Litsios G, 2012, P ROY SOC B-BIOL SCI, V279, P3662, DOI 10.1098/rspb.2012.1140; Lobban C.S., 1994, SEAWEED ECOLOGY PHYS; Low-Decarie E, 2014, TRENDS ECOL EVOL, V29, P223, DOI 10.1016/j.tree.2014.02.006; MABERLY SC, 1992, OECOLOGIA, V91, P481, DOI 10.1007/BF00650320; MABERLY SC, 1990, J PHYCOL, V26, P439, DOI 10.1111/j.0022-3646.1990.00439.x; Marconi M, 2011, J PHYCOL, V47, P1023, DOI 10.1111/j.1529-8817.2011.01045.x; McConnaughey TA, 1997, EARTH-SCI REV, V42, P95, DOI 10.1016/S0012-8252(96)00036-0; McCoy SJ, 2014, ECOL LETT, V17, P475, DOI 10.1111/ele.12247; Meyer M, 2013, J EXP BOT, V64, P769, DOI 10.1093/jxb/ers390; Middelboe AL, 2007, MAR ECOL PROG SER, V338, P107, DOI 10.3354/meps338107; Morel F. M. M., 1993, PRINCIPLES APPL AQUA; Murru M, 2004, J PHYCOL, V40, P837, DOI 10.1111/j.1529-8817.2004.03182.x; PADILLA DK, 1989, ECOLOGY, V70, P835, DOI 10.2307/1941352; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PAINE RT, 1966, LIMNOL OCEANOGR, V11, P126, DOI 10.4319/lo.1966.11.1.0126; Paradis E., 2014, APE ANAL PHYLOGENETI; Pierrot D., 2006, ORNLCDIAC105A US DEP; Prasad V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1482; Rautenberger R, 2015, ECOL EVOL, V5, P874, DOI 10.1002/ece3.1382; Raven JA, 1997, EUR J PHYCOL, V32, P319, DOI 10.1017/S0967026297001388; Raven JA, 2002, ANN BOT-LONDON, V90, P525, DOI 10.1093/aob/mcf171; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; SOUSA WP, 1984, ECOLOGY, V65, P1918, DOI 10.2307/1937789; Stepien CC, 2015, J ECOL, V103, P1372, DOI 10.1111/1365-2745.12451; Tilman D., 1981, MONOGR POPUL BIOL, V17, P1, DOI DOI 10.7861/CLINMEDICINE.14-3-000; Van Alstyne KL, 2015, INTEGR COMP BIOL; Verbruggen H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-16; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	66	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159062	10.1371/journal.pone.0159062	http://dx.doi.org/10.1371/journal.pone.0159062			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415005	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500067
J	Vinueza-Burgos, C; Cevallos, M; Ron-Garrido, L; Bertrand, S; De Zutter, L				Vinueza-Burgos, Christian; Cevallos, Maria; Ron-Garrido, Lenin; Bertrand, Sophie; De Zutter, Lieven			Prevalence and Diversity of Salmonella Serotypes in Ecuadorian Broilers at Slaughter Age	PLOS ONE			English	Article							RESISTANT ESCHERICHIA-COLI; ENTERICA SEROVAR INFANTIS; FIELD GEL-ELECTROPHORESIS; SPECTRUM BETA-LACTAMASES; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; CHICKEN MEAT; FOOD ANIMALS; POULTRY; SUSCEPTIBILITY	Salmonella is frequently found in poultry and represent an important source for human gastrointestinal infections worldwide. The aim of this study was to investigate the prevalence, genotypes and antimicrobial resistance of Salmonella serotypes in broilers from Ecuador. Caeca content from 388 at random selected broiler batches were collected in 6 slaughterhouses during 1 year and analyzed by the ISO 6579/Amd1 protocol for the isolation for Salmonella. Isolates were serotyped and genotypic variation was acceded by pulsed field gel electrophoresis. MIC values for sulfamethoxazole, gentamicin, ciprofloxacin, ampicillin, cefotaxime, ceftazidime, tetracycline, streptomycin, trimethropim, chloramphenicol, colistin, florfenicol, kanamycin and nalidixic acid were obtained. Presence of bla(CTX-M), bla(TEM), bla(SHV) and bla(CMY); and mcr-1 plasmid genes was investigated in resistant strains to cefotaxime and colistin respectively. Prevalence at batch level was 16.0%. The most common serotype was S. Infantis (83.9%) followed by S. Enteritidis (14.5%) and S. Corvallis (1.6%). The pulsed field gel electrophoresis analysis showed that S. Corvallis, S. Enteritidis and S. Infantis isolates belonged to 1, 2 and 12 genotypes respectively. S. Infantis isolates showed high resistance rates to 12 antibiotics ranging from 57.7%(kanamycin) up to 98.1% (nalidixic acid and sulfamethoxazole). All S. Enteritidis isolates showed resistance to colistin. High multiresistant patterns were found for all the serotypes. The bla(CTX-M) gene was present in 33 S. Infantis isolates while mcr-1 was negative in 10 colistin resistant isolates. This study provides the first set of scientific data on prevalence and multidrug-resistant Salmonella coming from commercial poultry in Ecuador.	[Vinueza-Burgos, Christian; Cevallos, Maria; Ron-Garrido, Lenin] Univ Cent Ecuador, Fac Med Vet & Zootecnia, Quito, Ecuador; [Bertrand, Sophie] Sci Inst Publ Hlth WIV ISP, Div Bacterial Dis, Natl Reference Ctr Salmonella & Shigella, Communicable & Infect Dis, Brussels, Belgium; [De Zutter, Lieven] Univ Ghent, Fac Vet, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium; [Ron-Garrido, Lenin] Ctr Int Zoonosis, Quito, Ecuador	Universidad Central del Ecuador; Ghent University	Vinueza-Burgos, C (corresponding author), Univ Cent Ecuador, Fac Med Vet & Zootecnia, Quito, Ecuador.	cvinueza@uce.edu.ec	Vinueza-Burgos, Christian/M-4430-2019	Ron, Lenin/0000-0001-9021-4376; Vinueza-Burgos, Christian/0000-0002-4893-502X	Secretaria de Educacion Superior Ciencia y Tecnologia del Ecuador; Programa de Becas Convocatoria Abierta Segunda Fase	Secretaria de Educacion Superior Ciencia y Tecnologia del Ecuador; Programa de Becas Convocatoria Abierta Segunda Fase	This work was supported by Secretaria de Educacion Superior Ciencia y Tecnologia del Ecuador; Programa de Becas Convocatoria Abierta 2012 Segunda Fase; http://www.educacionsuperior.gob.ec; to CVB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerso Y, 2012, FOODBORNE PATHOG DIS, V9, P367, DOI 10.1089/fpd.2011.1015; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Antunes P, 2016, CLIN MICROBIOL INFEC, V22, P110, DOI 10.1016/j.cmi.2015.12.004; Arlet G, 1997, FEMS MICROBIOL LETT, V152, P163, DOI 10.1111/j.1574-6968.1997.tb10423.x; Barrett TJ, 2006, FOODBORNE PATHOG DIS, V3, P20, DOI 10.1089/fpd.2006.3.20; Bates D, 2016, PACKAGE IME4 LINEAR; Benford D, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3802, 10.2903/j.efsa.2015.4260]; Boscan-Duque LA, 2007, J FOOD PROTECT, V70, P2030, DOI 10.4315/0362-028X-70.9.2030; Brasil. Ministerio da Saude, 2014, GUID BAL NUTR IND, P1; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; CDC, 2015, STAND OP PROC PLUSEN; CLSI, 2014, PERF STAND ANT SUSC; CLSI, 2015, PERF STAND ANT SUSC; CONAVE, 2014, EST PROD AV 2013, P1; de Jong A, 2014, VET MICROBIOL, V171, P298, DOI 10.1016/j.vetmic.2014.01.030; Diarra MS, 2014, J FOOD PROTECT, V77, P40, DOI 10.4315/0362-028.JFP-13-251; Donado-Godoy P, 2012, J FOOD PROTECT, V75, P874, DOI 10.4315/0362-028X.JFP-11-458; Donado-Godoy P, 2014, J FOOD PROTECT, V77, P227, DOI 10.4315/0362-028X.JFP-13-276; Donado-Godoy P, 2012, J FOOD PROTECT, V75, P1134, DOI 10.4315/0362-028X.JFP-11-513; Doumith M, 2016, J ANTIMICROB CHEMOTH, V71, P2300, DOI 10.1093/jac/dkw093; EUCAST, 2015, DAT EUCAST MIC DISTR; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4036; [FAO WHO FAO], 2002, RISH ASS SALM EGGS B; Fernandez J, 2003, J CLIN MICROBIOL, V41, P1617, DOI 10.1128/JCM.41.4.1617-1622.2003; Fitch FM, 2016, MICROB DRUG RESIST, V22, P164, DOI 10.1089/mdr.2015.0143; Franco A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144802; Giombelli A, 2014, J FOOD PROTECT, V77, P1851, DOI 10.4315/0362-028X.JFP-14-200; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Hasman H, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.49.30085; Hauser E, 2012, FOODBORNE PATHOG DIS, V9, P352, DOI 10.1089/fpd.2011.1038; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Herman KM, 2015, EPIDEMIOL INFECT, V143, P3011, DOI 10.1017/S0950268815000047; Hur J, 2012, FOOD RES INT, V45, P819, DOI 10.1016/j.foodres.2011.05.014; Hur J, 2011, VET J, V189, P306, DOI 10.1016/j.tvjl.2010.07.017; Kruger T, 2004, ANTIMICROB AGENTS CH, V48, P4263, DOI 10.1128/AAC.48.11.4263-4270.2004; Kuang XH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00602; Gelinski JMLN, 2014, INT J ENV RES PUB HE, V11, P11718, DOI 10.3390/ijerph111111718; Liu YF, 2015, J NANOMATER, V2015, DOI 10.1155/2015/792095; Lu Y, 2011, FOODBORNE PATHOG DIS, V8, P45, DOI 10.1089/fpd.2010.0605; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Malhotra-Kumar S, 2016, LANCET INFECT DIS, V16, P283, DOI 10.1016/S1473-3099(16)00012-8; Mattiello SP, 2015, ANTON LEEUW INT J G, V108, P1227, DOI 10.1007/s10482-015-0577-1; Mercado M, 2012, BIOMEDICA, V32, P375, DOI [10.7705/biomedica.v32i3.697, 10.1590/S0120-41572012000300008]; Miriagou V, 2004, INT J ANTIMICROB AG, V23, P547, DOI 10.1016/j.ijantimicag.2004.03.006; Morales AS, 2012, SCI WORLD J, DOI 10.1100/2012/109795; Medeiros MAN, 2011, REV PANAM SALUD PUBL, V30, P555, DOI 10.1590/S1020-49892011001200010; Olaitan AO, 2015, INT J ANTIMICROB AG, V45, P600, DOI 10.1016/j.ijantimicag.2015.01.010; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; PAZZAGLIA G, 1992, Boletin de la Oficina Sanitaria Panamericana, V112, P395; Pulido-Landinez M, 2013, LETT APPL MICROBIOL, V57, P288, DOI 10.1111/lam.12110; Quesada A, 2016, RES VET SCI, V105, P134, DOI 10.1016/j.rvsc.2016.02.003; R Core Team, R LANG ENV STAT COMP; Rahmani M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-66; Rapoport M, 2016, ANTIMICROB AGENTS CH, V60, P4412, DOI 10.1128/AAC.00573-16; Rasschaert G, 2005, J CLIN MICROBIOL, V43, P3615, DOI 10.1128/JCM.43.8.3615-3623.2005; Reardon S, 2014, NATURE, V509, P141, DOI 10.1038/509141a; Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001; Song W, 2007, DIAGN MICR INFEC DIS, V57, P315, DOI 10.1016/j.diagmicrobio.2006.08.023; Turki Y, 2014, J GEN APPL MICROBIOL, V60, P123, DOI 10.2323/jgam.60.123; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Velhner M, 2014, ZOONOSES PUBLIC HLTH, V61, P364, DOI 10.1111/zph.12081; Webb HE, 2016, LANCET INFECT DIS, V16, P144, DOI 10.1016/S1473-3099(15)00538-1; WHO, 2015, WORLDW CONTR SIT AN; WHO, 2015, ESS MED HLTH PROD; WHO (World Health Organization), 2015, WHO ESTIMATES GLOBAL; Winokur PL, 2001, CLIN INFECT DIS, V32, pS94, DOI 10.1086/320182; Wittum TE, 2012, APPL ENVIRON MICROB, V78, P7487, DOI 10.1128/AEM.01682-12	67	45	45	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159567	10.1371/journal.pone.0159567	http://dx.doi.org/10.1371/journal.pone.0159567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414038	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500135
J	Zonta, E; Garlan, F; Pecuchet, N; Perez-Toralla, K; Caen, O; Milbury, C; Didelot, A; Fabre, E; Blons, H; Laurent-Puig, P; Taly, V				Zonta, Eleonora; Garlan, Fanny; Pecuchet, Nicolas; Perez-Toralla, Karla; Caen, Ouriel; Milbury, Coren; Didelot, Audrey; Fabre, Elizabeth; Blons, Helene; Laurent-Puig, Pierre; Taly, Valerie			Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations	PLOS ONE			English	Article							CELL LUNG-CANCER; CIRCULATING TUMOR DNA; TYROSINE KINASE INHIBITORS; FACTOR RECEPTOR MUTATIONS; SINGLE-MOLECULE DETECTION; ANTI-EGFR THERAPY; COLORECTAL-CANCER; KRAS MUTATIONS; LIQUID BIOPSY; RESISTANCE	In cancer research, the accuracy of the technology used for biomarkers detection is remarkably important. In this context, digital PCR represents a highly sensitive and reproducible method that could serve as an appropriate tool for tumor mutational status analysis. In particular, droplet-based digital PCR approaches have been developed for detection of tumor-specific mutated alleles within plasmatic circulating DNA. Such an approach calls for the development and validation of a very significant quantity of assays, which can be extremely costly and time consuming. Herein, we evaluated assays for the detection and quantification of various mutations occurring in three genes often misregulated in cancers: the epidermal growth factor receptor (EGFR), the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) and the Tumoral Protein p53 (TP53) genes. In particular, commercial competitive allele-specific TaqMan (R) PCR (castPCR (TM)) technology, as well as TaqMan (R) and ZEN (TM) assays, have been evaluated for EGFR p.L858R, p.T790M, p.L861Q point mutations and in-frame deletions Del19. Specificity and sensitivity have been determined on cell lines DNA, plasmatic circulating DNA of lung cancer patients or Horizon Diagnostics Reference Standards. To show the multiplexing capabilities of this technology, several multiplex panels for EGFR (several three-and four-plexes) have been developed, offering new "ready-to-use" tests for lung cancer patients.	[Zonta, Eleonora; Garlan, Fanny; Pecuchet, Nicolas; Perez-Toralla, Karla; Caen, Ouriel; Didelot, Audrey; Fabre, Elizabeth; Blons, Helene; Laurent-Puig, Pierre; Taly, Valerie] USPC, INSERM UMR S1147, CNRS SNC 5014, Ctr Univ St Peres, Paris, France; [Pecuchet, Nicolas; Fabre, Elizabeth] HEGP, AP HP, Med Oncol, Paris, France; [Blons, Helene; Laurent-Puig, Pierre] HEGP, AP HP, Unit Pharmacogenet & Mol Oncol, Dept Biochem, Paris, France; [Milbury, Coren] RainDance Technol, Billerica, MA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Zonta, E; Taly, V (corresponding author), USPC, INSERM UMR S1147, CNRS SNC 5014, Ctr Univ St Peres, Paris, France.	eleonora.zonta@parisdescartes.fr; valerie.taly@parisdescartes.fr	Laurent-Puig, Pierre/K-3641-2019; TALY, VALERIE/N-9766-2014	Laurent-Puig, Pierre/0000-0001-8475-5459; Blons, Helene/0000-0002-0572-8426; Pecuchet, Nicolas/0000-0002-3321-5791; TALY, VALERIE/0000-0002-3116-8602; Didelot, Audrey/0000-0001-8693-1612; Fabre, Elizabeth/0000-0002-1244-873X	Ministere de l'Enseignement Superieur et de la Recherche; Universite Paris-Descartes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National du Cancer (INCA) [2009-1-RT-03-US-1, 2009-RT-03-UP5-1]; Agence Nationale de la Recherche (ANR Nanobiotechnologies) [ANR-10-NANO-0002-09]; SIRIC CARPEM and canceropole funding [2011-1-LABEL-UP5-2]; INSERM Physicancer program [PC201423]; Fondation Servier; RainDance Technologies	Ministere de l'Enseignement Superieur et de la Recherche; Universite Paris-Descartes; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche (ANR Nanobiotechnologies)(French National Research Agency (ANR)); SIRIC CARPEM and canceropole funding(Region Grand-Est); INSERM Physicancer program; Fondation Servier; RainDance Technologies	This work was supported by the Ministere de l'Enseignement Superieur et de la Recherche, the Universite Paris-Descartes, the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Institut National du Cancer (INCA, no. 2009-1-RT-03-US-1 and 2009-RT-03-UP5-1), the Agence Nationale de la Recherche (ANR Nanobiotechnologies; no. ANR-10-NANO-0002-09), the SIRIC CARPEM and canceropole funding (no. 2011-1-LABEL-UP5-2). Eleonora Zonta receives salary through the INSERM Physicancer program (no. PC201423). Fanny Garlan thanks the Fondation Servier for a fellowship within the Frontiers in Life Science PhD program (FdV). Karla Perez-Toralla receives salary through the Merieux Institution (Merieux Institute Advanced research Grant to VT/PLP). Ouriel Caen receives salary through the the Association pour la recherche contre le cancer (ARC, no. SL220100601375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Coren Milbury is employed by RainDance Technologies. RainDance Technologies provided support in the form of salary for author CM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Caen O, 2015, M S-MED SCI, V31, P180, DOI 10.1051/medsci/20153102015; Didelot A, 2012, EXP MOL PATHOL, V92, P275, DOI 10.1016/j.yexmp.2012.03.001; Douillard JY, 2014, J THORAC ONCOL, V9, P1345, DOI 10.1097/JTO.0000000000000263; Duffy MJ, 2014, CANCER TREAT REV, V40, P1153, DOI 10.1016/j.ctrv.2014.10.004; Francis G, 2015, INT J MOL SCI, V16, P14122, DOI 10.3390/ijms160614122; Gainor JF, 2013, J CLIN ONCOL, V31, P3987, DOI 10.1200/JCO.2012.45.2029; Guttery DS, 2015, CLIN CHEM, V61, P974, DOI 10.1373/clinchem.2015.238717; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Huang JQ, 2015, CLIN CHEM, V61, P1408, DOI 10.1373/clinchem.2015.238543; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Juchum M, 2015, DRUG RESIST UPDATE, V20, P12, DOI 10.1016/j.drup.2015.05.002; Laurent-Puig P, 2015, CLIN CANCER RES, V21, P1087, DOI 10.1158/1078-0432.CCR-14-0983; Li J, 2014, HUM MUTAT, V35, P575, DOI 10.1002/humu.22528; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Massarelli E, 2013, LUNG CANCER, V80, P235, DOI 10.1016/j.lungcan.2013.01.018; Milbury Coren A, 2014, Biomol Detect Quantif, V1, P8; Nishiyama A, 2015, LUNG CANCER, V89, P301, DOI 10.1016/j.lungcan.2015.06.017; Perez-Toralla K, 2015, M S-MED SCI, V31, P84, DOI 10.1051/medsci/20153101017; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Taly V, 2012, TRENDS MOL MED, V18, P405, DOI 10.1016/j.molmed.2012.05.001; Tougeron D, 2013, ANN ONCOL, V24, P1267, DOI 10.1093/annonc/mds620; Tsao SCH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11198; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang QS, 2015, J MOL DIAGN, V17, P515, DOI 10.1016/j.jmoldx.2015.04.002; Watanabe M, 2015, CLIN CANCER RES, V21, P3552, DOI 10.1158/1078-0432.CCR-14-2151; Yang X, 2016, ONCOTARGET, DOI [10.1039/c1ic20126c, DOI 10.1039/C1LC20126C]; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zhang Y, 2014, BIOCHIMIE, V99, P215, DOI 10.1016/j.biochi.2013.12.017; Zheng D, 2016, SCI REP-UK, V6, DOI 10.1038/srep20913; Zheng DF, 2016, ONCOTARGETS THER, V9, P833, DOI 10.2147/OTT.S96834; Zhong Q, 2011, LAB CHIP, V11, P2167, DOI 10.1039/c1lc20126c; Zonta E, 2015, ADV CLIN CHEM, V70, P197, DOI 10.1016/bs.acc.2015.03.002	36	65	67	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159094	10.1371/journal.pone.0159094	http://dx.doi.org/10.1371/journal.pone.0159094			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416070	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500073
J	Cai, YY; Chua, NG; Lim, TP; Teo, JQM; Lee, W; Kurup, A; Koh, TH; Tan, TT; Kwa, AL				Cai, Yiying; Chua, Nathalie Grace; Lim, Tze-Peng; Teo, Jocelyn Qi-Min; Lee, Winnie; Kurup, Asok; Koh, Tse-Hsien; Tan, Thuan-Tong; Kwa, Andrea L.			From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; KLEBSIELLA-PNEUMONIAE; INFECTIONS; PHARMACODYNAMICS; PHARMACOKINETICS; LEVOFLOXACIN; TIGECYCLINE; DEFINITION; INFUSION; THERAPY	Introduction Combination therapy is increasingly utilized against extensively-drug resistant (XDR) Gram negative bacteria (GNB). However, choosing a combination can be problematic as effective combinations are often strain-specific. An in vitro antibiotic combination testing (iACT) service, aimed to guide the selection of individualized and rationally optimized combination regimens within 48 hours, was developed. We described the role and feasibility of the iACT service in guiding individualized antibiotic combination selection in patients with XDR-GNB infections. Methods A retrospective case review was performed in two Singapore hospitals from April 2009-June 2014. All patients with XDR-GNB and antibiotic regimen guided by iACT for clinical management were included. The feasibility and role of the prospective iACT service was evaluated. The following patient outcomes were described: (i) 30-day in-hospital all-cause and infection-related mortality, (ii) clinical response, and (iii) microbiological eradication in patients with bloodstream infections. Results From 2009-2014, the iACT service was requested by Infectious Disease physicians for 39 cases (20 P. aeruginosa, 13 A. baumannii and 6 K. pneumoniae). Bloodstream infection was the predominant infection (36%), followed by pneumonia (31%). All iACT recommendations were provided within 48h from request for the service. Prior to iACT-guided therapy, most cases were prescribed combination antibiotics empirically (90%). Changes in the empiric antibiotic regimens were recommended in 21 (54%) cases; in 14 (36%) cases, changes were recommended as the empiric regimens were found to be non-bactericidal in vitro. In 7 (18%) cases, the number of antibiotics used in combination empirically was reduced by the iACT service. Overall, low 30-day infection-related mortality (15%) and high clinical response (82%) were observed. Microbiological eradication was observed in 79% of all bloodstream infections. Conclusions The iACT service can be feasibly employed to guide the timely selection of rationally optimized combination regimens, and played a role in reducing indiscreet antibiotic use.	[Cai, Yiying; Chua, Nathalie Grace; Lim, Tze-Peng; Teo, Jocelyn Qi-Min; Lee, Winnie; Kwa, Andrea L.] Singapore Gen Hosp, Dept Pharm, Singapore, Singapore; [Cai, Yiying; Chua, Nathalie Grace; Kwa, Andrea L.] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore, Singapore; [Lim, Tze-Peng] Duke NUS Med Sch, SingHlth Duke NUS Med Acad Clin Programme, Singapore, Singapore; [Kurup, Asok] Mt Elizabeth Hosp, Infect Dis Care, Singapore, Singapore; [Koh, Tse-Hsien] Singapore Gen Hosp, Dept Microbiol, Singapore, Singapore; [Tan, Thuan-Tong] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore; [Kwa, Andrea L.] Duke NUS Med Sch, Emerging Infect Dis, Singapore, Singapore	Singapore General Hospital; National University of Singapore; National University of Singapore; Singapore General Hospital; Singapore General Hospital; National University of Singapore	Kwa, AL (corresponding author), Singapore Gen Hosp, Dept Pharm, Singapore, Singapore.; Kwa, AL (corresponding author), Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore, Singapore.; Kwa, AL (corresponding author), Duke NUS Med Sch, Emerging Infect Dis, Singapore, Singapore.	andrea.kwa.l.h@sgh.com.sg	Teo, Jocelyn/ABA-1755-2021; Chua, Nathalie/GXG-3446-2022	Chua, Nathalie/0000-0003-2416-300X; Teo, Jocelyn Qi-Min/0000-0003-2508-3941	Singapore General Hospital Research Grant (SRG) [09/2011]; National Medical Research Council [EDG11may068]; National Medical Research Council Centre Grant [NMRC/CG/016/2013]	Singapore General Hospital Research Grant (SRG); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Medical Research Council Centre Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Singapore General Hospital Research Grant (SRG #09/2011), National Medical Research Council (EDG11may068) and National Medical Research Council Centre Grant (NMRC/CG/016/2013). The funding sources had no involvement in study design, data collection and analysis, and writing of the report.	Aaron SD, 2000, AM J RESP CRIT CARE, V161, P1206, DOI 10.1164/ajrccm.161.4.9907147; Ahmed A, 2014, INDIAN J CRIT CARE M, V18, P310, DOI 10.4103/0972-5229.132495; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Conte JE, 2007, INT J ANTIMICROB AG, V30, P422, DOI 10.1016/j.ijantimicag.2007.05.023; Crusio R, 2014, SCAND J INFECT DIS, V46, P1, DOI 10.3109/00365548.2013.844350; Durante-Mangoni E, 2013, CLIN INFECT DIS, V57, P349, DOI 10.1093/cid/cit253; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jaruratanasirikul S, 2005, ANTIMICROB AGENTS CH, V49, P1337, DOI 10.1128/AAC.49.4.1337-1339.2005; Jaruratanasirikul S, 2012, INT J ANTIMICROB AG, V40, P434, DOI 10.1016/j.ijantimicag.2012.07.014; Kellum JA, 2008, NEPHRON CLIN PRACT, V109, pC182, DOI 10.1159/000142926; Kitchel B, 2010, ANTIMICROB AGENTS CH, V54, P4201, DOI 10.1128/AAC.00008-10; Kollef MH, 2011, CLIN INFECT DIS, V53, pS33, DOI 10.1093/cid/cir475; Kwa ALH, 2008, DIAGN MICR INFEC DIS, V60, P163, DOI 10.1016/j.diagmicrobio.2007.08.008; LaPlante KL, 2009, ANTIMICROB AGENTS CH, V53, P4549, DOI 10.1128/AAC.00180-09; Lim TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028177; Lim TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018485; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Nakamura I, 2014, J INFECT CHEMOTHER, V20, P266, DOI 10.1016/j.jiac.2013.12.005; Ng E, 2012, ANN ACAD MED SINGAP, V41, P189; Patel SJ, 2014, AM J INFECT CONTROL, V42, P626, DOI 10.1016/j.ajic.2014.01.027; Rebuck JA, 2002, PHARMACOTHERAPY, V22, P1216, DOI 10.1592/phco.22.15.1216.33484; Rodvold KA, 2006, J ANTIMICROB CHEMOTH, V58, P1221, DOI 10.1093/jac/dkl403; Roy S, 2013, J ANTIMICROB CHEMOTH, V68, P1036, DOI 10.1093/jac/dks535; Sakka SG, 2007, ANTIMICROB AGENTS CH, V51, P3304, DOI 10.1128/AAC.01318-06; Shea KM, 2009, INT J ANTIMICROB AG, V34, P429, DOI 10.1016/j.ijantimicag.2009.07.004; Tam VH, 2003, ANTIMICROB AGENTS CH, V47, P1853, DOI 10.1128/AAC.47.6.1853-1861.2003; Teo J, 2012, WEST PAC SURVEILL RE, V3, P19, DOI [10.5365/wpsar.2011.2.4.010, 10.5365/WPSAR.2011.2.4.010]; Tod M, 1998, ANTIMICROB AGENTS CH, V42, P849, DOI 10.1128/AAC.42.4.849; Voets GM, 2011, INT J ANTIMICROB AG, V37, P356, DOI 10.1016/j.ijantimicag.2011.01.005; Yahav D, 2012, CLIN MICROBIOL INFEC, V18, P18, DOI 10.1111/j.1469-0691.2011.03734.x; Zavascki AP, 2013, EXPERT REV ANTI-INFE, V11, P1333, DOI 10.1586/14787210.2013.845523; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	33	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158740	10.1371/journal.pone.0158740	http://dx.doi.org/10.1371/journal.pone.0158740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441603	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500023
J	Kayigamba, FR; Franke, MF; Bakker, MI; Rodriguez, CA; Bagiruwigize, E; Wit, FWNM; Rich, ML; van der Loeff, MFS				Kayigamba, Felix R.; Franke, Molly F.; Bakker, Mirjam I.; Rodriguez, Carly A.; Bagiruwigize, Emmanuel; Wit, Ferdinand W. N. M.; Rich, Michael L.; van der Loeff, Maarten F. Schim			Discordant Treatment Responses to Combination Antiretroviral Therapy in Rwanda: A Prospective Cohort Study	PLOS ONE			English	Article							COMMUNITY-BASED ACCOMPANIMENT; VIRUS-INFECTED PATIENTS; VIROLOGICAL RESPONSES; RURAL RWANDA; SUPPRESSION; ADHERENCE; ADULTS; MORTALITY; OUTCOMES; VIREMIA	Introduction Some antiretroviral therapy naive patients starting combination antiretroviral therapy (cART) experience a limited CD4 count rise despite virological suppression, or vice versa. We assessed the prevalence and determinants of discordant treatment responses in a Rwandan cohort. Methods A discordant immunological cART response was defined as an increase of < 100 CD4 cells/mm3 at 12 months compared to baseline despite virological suppression (viral load [VL] < 40 copies/mL). A discordant virological cART response was defined as detectable VL at 12 months with an increase in CD4 count >= 100 cells/mm(3). The prevalence of, and independent predictors for these two types of discordant responses were analysed in two cohorts nested in a 12-month prospective study of cART-naive HIV patients treated at nine rural health facilities in two regions in Rwanda. Results Among 382 patients with an undetectable VL at 12 months, 112 (29%) had a CD4 rise of < 100 cells/mm(3). Age >= 35 years and longer travel to the clinic were independent determinants of an immunological discordant response, but sex, baseline CD4 count, body mass index and WHO HIV clinical stage were not. Among 326 patients with a CD4 rise of >= 100 cells/mm3, 56 (17%) had a detectable viral load at 12 months. Male sex was associated with a virological discordant treatment response (P = 0.05), but age, baseline CD4 count, BMI, WHO HIV clinical stage, and travel time to the clinic were not. Conclusions Discordant treatment responses were common in cART-naive HIV patients in Rwanda. Small CD4 increases could be misinterpreted as a (virological) treatment failure and lead to unnecessary treatment changes.	[Kayigamba, Felix R.; Bagiruwigize, Emmanuel] CPCD, INTERACT, POB 2181, Kigali, Rwanda; [Franke, Molly F.; Rodriguez, Carly A.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Franke, Molly F.; Rich, Michael L.] Inshuti Mu Buzima, Rwinkwavu, Rwanda; [Bakker, Mirjam I.] KIT Biomed Res, Royal Trop Inst, Amsterdam, Netherlands; [Wit, Ferdinand W. N. M.; van der Loeff, Maarten F. Schim] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Wit, Ferdinand W. N. M.; van der Loeff, Maarten F. Schim] Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands; [Rich, Michael L.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam GGD, Amsterdam, Netherlands	Harvard University; Harvard Medical School; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Brigham & Women's Hospital; Public Health Service Amsterdam	Kayigamba, FR (corresponding author), CPCD, INTERACT, POB 2181, Kigali, Rwanda.	fkaigamba@gmail.com	Wit, Ferdinand/AAC-3803-2019; Franke, Molly/AAK-7559-2020	Franke, Molly/0000-0002-4890-5728; Rodriguez, Carly A/0000-0003-0023-2111	Doris Duke Charitable Foundation; Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO); European Union [SANTE/2006/105-316]	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO); European Union(European Commission)	The Doris Duke Charitable Foundation provided financial support of this research. Technical support was provided by the Infectious Disease Network for Treatment and Research in Africa (INTERACT), funded by the Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO) and the European Union (SANTE/2006/105-316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge and thank the Doris Duke Charitable Foundation for financial support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Technical support was provided by the Infectious Disease Network for Treatment and Research in Africa (INTERACT), funded by the Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO) and the European Union (SANTE/2006/105-316). We are grateful to the study staff: Adrienne Socci, Massudi Hakizamungu, Wellars Ndayambaje, Eline Uwitonze, Albertine Mukeshimana, Ernest Nyirinkindi, Jean Damascene Uwamuhoro, Carine Dusenge, Claire Dusabe, and Jean Claude Nyiramana. We also thank Cheryl Amoroso, Benjamin Akimana, Christian Allen, Darius Jazayeri, Ellen Ball, the Rwanda-based PIH-EMR team, and Laboratory Management of the Rwanda National Reference Laboratory. We also thank Frank Cobelens for providing feedback on a draft of this manuscript.	Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff; Coffey S, 2012, SANDES HIV AIDS MED; Dronda F, 2002, CLIN INFECT DIS, V35, P1005, DOI 10.1086/342695; Falster K, 2009, JAIDS-J ACQ IMM DEF, V50, P307, DOI 10.1097/QAI.0b013e3181945ed4; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Franke MF, 2013, CLIN INFECT DIS, V56, P1319, DOI 10.1093/cid/cis1193; Gilson R, 2010, HIV MED, V11, P152, DOI 10.1111/j.1468-1293.2009.00755.x; Gupta N, 2016, AIDS BEHAV, V20, P1009, DOI 10.1007/s10461-015-1185-9; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, GLOB AIDS EP 2013; Julg B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031161; Mannheimer SB, 2006, AIDS CARE, V18, P853, DOI 10.1080/09540120500465160; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Nsanzimana S, 2012, JAIDS-J ACQ IMM DEF, V59, pE17, DOI 10.1097/QAI.0b013e31823e2278; Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861; Piketty C, 1998, AIDS, V12, P745, DOI 10.1097/00002030-199807000-00011; Podsadecki TJ, 2007, J INFECT DIS, V196, P1773, DOI 10.1086/523704; Prabhakar B, 2011, Indian J Sex Transm Dis AIDS, V32, P94, DOI 10.4103/0253-7184.85412; Saison J, 2014, J INT AIDS SOC, V17, P119, DOI 10.7448/IAS.17.4.19672; Casotti JAS, 2011, REV INST MED TROP SP, V53, P301, DOI 10.1590/S0036-46652011000600001; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; TRAC Plus Ministry of Health Rwanda, 2009, GUID PROV COMPR CAR; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; Tuboi SH, 2010, JAIDS-J ACQ IMM DEF, V53, P70, DOI 10.1097/QAI.0b013e3181c22d19; Wandeler G, 2013, AIDS LONDON ENGLAND, V27, DOI [10.1097/QAD.1090b1013e328362d328887, DOI 10.1097/QAD.1090B1013E328362D328887]; Wandeler G, 2013, AIDS, V27, P2225, DOI 10.1097/QAD.0b013e328362d887; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2009, RAP ADV ANT THER HIV; World Health Organization, 2006, ANT THER HIV INF AD; Zoufaly A, 2011, J INFECT DIS, V203, P364, DOI 10.1093/jinfdis/jiq055	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159446	10.1371/journal.pone.0159446	http://dx.doi.org/10.1371/journal.pone.0159446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438000	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100047
J	Dias, DT; Ushida, M; Sousa, MC; Dorairaj, S; Biteli, LG; Leite, MT; Paranhos, A; Prata, TS				Dias, Diego T.; Ushida, Michele; Sousa, Marina C.; Dorairaj, Syril; Biteli, Luis G.; Leite, Mauro T.; Paranhos, Augusto, Jr.; Prata, Tiago S.			Eyes with Suspicious Appearance of the Optic Disc and Normal Intraocular Pressure: Using Clinical and Epidemiological Characteristics to Differentiate Those with and without Glaucoma	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OPEN-ANGLE GLAUCOMA; VISUAL-FIELD PROGRESSION; OCULAR HYPERTENSION TREATMENT; PREDICTIVE FACTORS; RISK-FACTORS; DAMAGE; TRIAL; ONSET	Among all glaucoma suspects, eyes with optic nerve head features suspicious or suggestive of early glaucoma are probably those that offer the greatest challenge for clinicians. In contrast with the robust longitudinal data published on ocular hypertension, there is no specific management guideline for these patients. Therefore, evaluating eyes with suspicious optic disc appearance and normal intraocular pressure (IOP), we sought to investigate potential differences in clinical and epidemiological characteristics to differentiate those with normaltension glaucoma (NTG) from those with presumed large physiological optic disc cups (pLPC). In this observational case-control study, we consecutively enrolled individuals with pLPC and NTG. All eyes had vertical cup-to-disc ratio (VCDR)>= 0.6 and untreated IOP<21 mmHg. Glaucomatous eyes had reproducible visual field defects. Eyes with pLPC required normal visual fields and >= 30 months of follow-up with no evidence of glaucomatous neuropathy. Clinical and epidemiological parameters were compared between groups. Eighty-four individuals with pLPC and 40 NTG patients were included. Regarding our main results, NTG patients were significantly older and with a higher prevalence of Japanese descendants (p<0.01). Not only did pLPC eyes have smaller mean VCDR, but also larger optic discs (p <= 0.04). There were no significant differences for gender, central corneal thickness, and spherical equivalent (p >= 0.38). Significant odds ratios (OR) were found for race (OR = 2.42; for Japanese ancestry), age (OR = 1.05), VCDR (OR = 5.03), and disc size (OR = 0.04; p <= 0.04). In conclusion, in patients with suspicious optic disc and normal IOP, those with older age, Japanese ancestry, smaller optic discs, and larger VCDR are more likely to have NTG, and therefore, deserve deeper investigation and closer monitoring.	[Dias, Diego T.; Ushida, Michele; Sousa, Marina C.; Biteli, Luis G.; Leite, Mauro T.; Paranhos, Augusto, Jr.; Prata, Tiago S.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, SP, Brazil; [Dias, Diego T.; Ushida, Michele; Biteli, Luis G.; Prata, Tiago S.] Hosp Med Olhos, Glaucoma Unit, Osasco, SP, Brazil; [Dorairaj, Syril] Mayo Clin, Dept Ophthalmol, Jacksonville, FL 32224 USA	Universidade Federal de Sao Paulo (UNIFESP); Mayo Clinic	Dorairaj, S (corresponding author), Mayo Clin, Dept Ophthalmol, Jacksonville, FL 32224 USA.	dorairaj.syril@mayo.edu	Prata, Tiago/AAV-6676-2020; Paranhos, Augusto/A-6115-2010; Leite, Mauro Toledo/AAF-5666-2021; Paranhos Jr, Augusto/E-6297-2012	Prata, Tiago/0000-0003-1830-3766; Paranhos Jr, Augusto/0000-0001-6266-6922	Federal University of Sao Paulo	Federal University of Sao Paulo	The authors receive direct funding from the Federal University of Sao Paulo.	Alward WLM, 2001, OPHTHALMOLOGY, V108, P247; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; De Moraes CG, 2012, AM J OPHTHALMOL, V154, P702, DOI 10.1016/j.ajo.2012.04.015; De Moraes CGV, 2009, INVEST OPHTH VIS SCI, V50, P4727, DOI 10.1167/iovs.09-3446; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; KITAZAWA Y, 1977, ARCH OPHTHALMOL-CHIC, V95, P1180, DOI 10.1001/archopht.1977.04450070078004; KOLKER AE, 1977, ARCH OPHTHALMOL-CHIC, V95, P586; Lee J, 2012, EYE, V26, P1473, DOI 10.1038/eye.2012.204; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Martus P, 2005, AM J OPHTHALMOL, V139, P999, DOI 10.1016/j.ajo.2004.12.056; Miglior S, 2007, AM J OPHTHALMOL, V144, P266, DOI 10.1016/j.ajo.2007.04.040; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Nakagami T, 2006, JPN J OPHTHALMOL, V50, P38, DOI 10.1007/s10384-005-0273-1; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; PHELPS CD, 1977, ARCH OPHTHALMOL-CHIC, V95, P588; Prata Tiago S, 2014, Med Hypothesis Discov Innov Ophthalmol, V3, P91; Prata TS, 2010, OPHTHALMOLOGY, V117, P24, DOI 10.1016/j.ophtha.2009.06.028; Sakata R, 2013, J GLAUCOMA, V22, P250, DOI 10.1097/IJG.0b013e31823298fb; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; SHAFFER R, 1977, ARCH OPHTHALMOL-CHIC, V95, P588; SHIOSE Y, 1991, JPN J OPHTHALMOL, V35, P133; Sung KR, 2011, INVEST OPHTH VIS SCI, V52, P737, DOI 10.1167/iovs.10-5351; Swanson MW, 2011, OPTOMETRY VISION SCI, V88, P86, DOI 10.1097/OPX.0b013e3181fc3638; WILENSKY JT, 1974, ARCH OPHTHALMOL-CHIC, V91, P200	27	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158983	10.1371/journal.pone.0158983	http://dx.doi.org/10.1371/journal.pone.0158983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433805	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600027
J	Lown, L; Peters, BM; Walraven, CJ; Noverr, MC; Lee, SA				Lown, Livia; Peters, Brian M.; Walraven, Carla J.; Noverr, Mairi C.; Lee, Samuel A.			An Optimized Lock Solution Containing Micafungin, Ethanol and Doxycycline Inhibits Candida albicans and Mixed C-albicans - Staphyloccoccus aureus Biofilms	PLOS ONE			English	Article							IN-VITRO ACTIVITY; LIPOPEPTIDE ANTIFUNGAL AGENT; BLOOD-STREAM INFECTIONS; STAPHYLOCOCCUS-AUREUS; DRUG-RESISTANCE; POLYMICROBIAL BIOFILMS; FLUCONAZOLE RESISTANCE; MECHANICAL-PROPERTIES; EFFLUX PUMPS; SUSCEPTIBILITY	Candida albicans is a major cause of catheter-related bloodstream infections and is associated with high morbidity and mortality. Due to the propensity of C. albicans to form drug-resistant biofilms, the current standard of care includes catheter removal; however, reinsertion may be technically challenging or risky. Prolonged exposure of an antifungal lock solution within the catheter in conjunction with systemic therapy has been experimentally attempted for catheter salvage. Previously, we demonstrated excellent in vitro activity of micafungin, ethanol, and high-dose doxycycline as single agents for prevention and treatment of C. albicans biofilms. Thus, we sought to investigate optimal combinations of micafungin, ethanol, and/or doxycycline as a lock solution. We performed two-and three-drug checkerboard assays to determine the in vitro activity of pairwise or three agents in combination for prevention or treatment of C. albicans biofilms. Optimal lock solutions were tested for activity against C. albicans clinical isolates, reference strains and polymicrobial C. albicans-S. aureus biofilms. A solution containing 20% (v/v) ethanol, 0.01565 mu g/mL micafungin, and 800 mu g/mL doxycycline demonstrated a reduction of 98% metabolic activity and no fungal regrowth when used to prevent fungal biofilm formation; however there was no advantage over 20% ethanol alone. This solution was also successful in inhibiting the regrowth of C. albicans from mature polymicrobial biofilms, although it was not fully bactericidal. Solutions containing 5% ethanol with low concentrations of micafungin and doxycycline demonstrated synergistic activity when used to prevent monomicrobial C. albicans biofilm formation. A combined solution of micafungin, ethanol and doxycycline is highly effective for the prevention of C. albicans biofilm formation but did not demonstrate an advantage over 20% ethanol alone in these studies.	[Lown, Livia; Lee, Samuel A.] New Mexico Vet Healthcare Syst, Infect Dis Sect, Albuquerque, NM 87108 USA; [Lown, Livia; Lee, Samuel A.] Univ New Mexico, Div Infect Dis, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Peters, Brian M.; Noverr, Mairi C.] LSU Hlth Sci Ctr, Sch Dent, Dept Prosthodont, New Orleans, LA USA; [Peters, Brian M.; Noverr, Mairi C.] LSU Hlth Sci Ctr, Sch Med, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Peters, Brian M.] Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA; [Walraven, Carla J.] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Tennessee System; University of Tennessee Health Science Center; University of New Mexico	Lee, SA (corresponding author), New Mexico Vet Healthcare Syst, Infect Dis Sect, Albuquerque, NM 87108 USA.; Lee, SA (corresponding author), Univ New Mexico, Div Infect Dis, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	SamALee@salud.unm.edu		Noverr, Mairi/0000-0002-8812-1450	American Society of Microbiology Undergraduate Research Fellowship (ASM-URF); Astellas Pharma; Department of Veterans Affairs [5I01BX001130]; Biomedical Research Institute of New Mexico;  [R01-AI116025];  [R01-DE022069]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116025] Funding Source: NIH RePORTER	American Society of Microbiology Undergraduate Research Fellowship (ASM-URF); Astellas Pharma(Astellas Pharmaceuticals); Department of Veterans Affairs(US Department of Veterans Affairs); Biomedical Research Institute of New Mexico; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the American Society of Microbiology Undergraduate Research Fellowship (ASM-URF to L.L.; www.asm.org/), Astellas Pharma (Investigator-Initiated Grant to SAL; www.astellas.us/), Department of Veterans Affairs (Merit Award 5I01BX001130 to SAL; www.va.gov/), Biomedical Research Institute of New Mexico (award to SAL; www.brinm.org/), and R01-AI116025 (NIAID, to MCN; www.nih.gov/) and R01-DE022069 (NIDCR, to MCN; www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam B, 2002, J MED MICROBIOL, V51, P344, DOI 10.1099/0022-1317-51-4-344; Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; [Anonymous], 2015, P NATL ACAD SCI US; Bell AL, 2006, CLIN NEPHROL, V65, P342; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; CARLSON E, 1982, INFECT IMMUN, V38, P921, DOI 10.1128/IAI.38.3.921-924.1982; Cateau E, 2008, J ANTIMICROB CHEMOTH, V62, P153, DOI 10.1093/jac/dkn160; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chandra J, 2007, INFECT IMMUN, V75, P2612, DOI 10.1128/IAI.01841-06; Chandrasekar PH, 2006, CLIN INFECT DIS, V42, P1171, DOI 10.1086/501020; Chavez-Dozal AA, 2014, ANTIMICROB AGENTS CH, V58, P5855, DOI 10.1128/AAC.03137-14; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Crnich CJ, 2005, INFECT CONT HOSP EP, V26, P708, DOI 10.1086/502607; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; DiMondi VP, 2014, PHARMACOTHERAPY, V34, pE120, DOI 10.1002/phar.1433; El-Azizi M, 2007, J MED MICROBIOL, V56, P645, DOI 10.1099/jmm.0.46952-0; Ernst EJ, 2002, ANTIMICROB AGENTS CH, V46, P3846, DOI 10.1128/AAC.46.12.3846-3853.2002; Fiori A, 2012, ANTIMICROB AGENTS CH, V56, P3785, DOI 10.1128/AAC.06017-11; FONZI WA, 1993, GENETICS, V134, P717; Fothergill AW, 2012, INTERACTIONS OF YEASTS, MOULDS, AND ANTIFUNGAL AGENTS: HOW TO DETECT RESISTANCE, P65, DOI 10.1007/978-1-59745-134-5_2; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Guenu S, 2007, RAPID COMMUN MASS SP, V21, P229, DOI 10.1002/rcm.2837; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; Katragkou A, 2010, J INFECT DIS, V201, P1941, DOI 10.1086/652783; Klotz SA, 2007, DIAGN MICR INFEC DIS, V59, P401, DOI 10.1016/j.diagmicrobio.2007.07.001; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Lamfon H, 2004, J ANTIMICROB CHEMOTH, V53, P383, DOI 10.1093/jac/dkh071; LaPlante KL, 2008, ANTIMICROB AGENTS CH, V52, P2156, DOI 10.1128/AAC.01046-07; Liu SY, 2014, INT J ANTIMICROB AG, V43, P395, DOI 10.1016/j.ijantimicag.2013.12.009; Maiefski M, 2009, INFECT CONT HOSP EP, V30, P1096, DOI 10.1086/606162; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Mermel LA, 2014, J ANTIMICROB CHEMOTH, V69, P2611, DOI 10.1093/jac/dku182; Messer SA, 2006, J CLIN MICROBIOL, V44, P324, DOI 10.1128/JCM.44.2.324-326.2006; Metcalf SCL, 2004, J INFECTION, V49, P20, DOI 10.1016/j.jinf.2003.08.010; Miceli MH, 2009, INT J ANTIMICROB AG, V34, P326, DOI 10.1016/j.ijantimicag.2009.04.011; Mikamo H, 2000, J ANTIMICROB CHEMOTH, V46, P485, DOI 10.1093/jac/46.3.485; Mukherjee PK, 2003, INFECT IMMUN, V71, P4333, DOI 10.1128/IAI.71.8.4333-4340.2003; Mukherjee PK, 2004, DRUG RESIST UPDATE, V7, P301, DOI 10.1016/j.drup.2004.09.002; Nett JE, 2010, ANTIMICROB AGENTS CH, V54, P3505, DOI 10.1128/AAC.00227-10; Nett JE, 2010, J INFECT DIS, V202, P171, DOI 10.1086/651200; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Oliver BG, 2008, MICROBIOL-SGM, V154, P960, DOI 10.1099/mic.0.2007/013805-0; Ostrosky-Zeichner L, 2003, ANTIMICROB AGENTS CH, V47, P3149, DOI 10.1128/AAC.47.10.3149-3154.2003; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pemmaraju SC, 2013, INDIAN J EXP BIOL, V51, P1032; Peters BM, 2013, ANTIMICROB AGENTS CH, V57, P74, DOI 10.1128/AAC.01599-12; Pfaller MA, 2003, ANTIMICROB AGENTS CH, V47, P1068, DOI 10.1128/AAC.47.3.1068-1071.2003; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage G, 2002, J ANTIMICROB CHEMOTH, V49, P973, DOI 10.1093/jac/dkf049; Rane HS, 2012, ANTIMICROB AGENTS CH, V56, P4487, DOI 10.1128/AAC.00263-12; Rey-Jurado E, 2013, INT J ANTIMICROB AG, V41, P278, DOI 10.1016/j.ijantimicag.2012.11.011; Shanks RMQ, 2006, NEPHROL DIAL TRANSPL, V21, P2247, DOI 10.1093/ndt/gfl170; Taff HT, 2013, FUTURE MICROBIOL, V8, P1325, DOI 10.2217/fmb.13.101; Tawara S, 2000, ANTIMICROB AGENTS CH, V44, P57, DOI 10.1128/AAC.44.1.57-62.2000; Tobudic S, 2010, J ANTIMICROB CHEMOTH, V65, P271, DOI 10.1093/jac/dkp429; Uchida K, 2000, J ANTIBIOT, V53, P1175, DOI 10.7164/antibiotics.53.1175; Walraven CJ, 2013, ANTIMICROB AGENTS CH, V57, P1, DOI 10.1128/AAC.01351-12; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wiederhold NP, 2008, ANTIMICROB AGENTS CH, V52, P4145, DOI 10.1128/AAC.00959-08; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	62	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159225	10.1371/journal.pone.0159225	http://dx.doi.org/10.1371/journal.pone.0159225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428310	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169300041
J	Fukutani, A; Misaki, J; Isaka, T				Fukutani, Atsuki; Misaki, Jun; Isaka, Tadao			Effect of Preactivation on Torque Enhancement by the Stretch-Shortening Cycle in Knee Extensors	PLOS ONE			English	Article							RESIDUAL FORCE ENHANCEMENT; IN-VIVO; MUSCLE TENDON; MOVEMENT; BEHAVIOR; PRESTRETCH; EXERCISE	The stretch-shortening cycle is one of the most interesting topics in the field of sport sciences, because the performance of human movement is enhanced by the stretch-shortening cycle (eccentric contraction). The purpose of the present study was to examine whether the influence of preactivation on the torque enhancement by stretch-shortening cycle in knee extensors. Twelve men participated in this study. The following three conditions were conducted for knee extensors: (1) concentric contraction without preactivation (CON), (2) concentric contraction with eccentric preactivation (ECC), and (3) concentric contraction with isometric preactivation (ISO). Muscle contractions were evoked by electrical stimulation to discard the influence of neural activity. The range of motion of the knee joint was set from 80 to 140 degrees (full extension = 180 degrees). Angular velocities of the concentric and eccentric contractions were set at 180 and 90 degrees/s, respectively. In the concentric contraction phase, joint torques were recorded at 85, 95, and 105 degrees, and they were compared among the three conditions. In the early phase (85 degrees) of concentric contraction, the joint torque was larger in the ECC and ISO conditions than in the CON condition. However, these clear differences disappeared in the later phase (105 degrees) of concentric contraction. The results showed that joint torque was clearly different among the three conditions in the early phase whereas this difference disappeared in the later phase. Thus, preactivation, which is prominent in the early phase of contractions, plays an important role in torque enhancement by the stretch-shortening cycle in knee extensors.	[Fukutani, Atsuki] Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Shiga, Japan; [Fukutani, Atsuki] Japan Soc Promot Sci, Res Fellowship Young Scientists, Chiyoda Ku, Tokyo, Japan; [Misaki, Jun] Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Isaka, Tadao] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan	Ritsumeikan University; Japan Society for the Promotion of Science; Ritsumeikan University; Ritsumeikan University	Fukutani, A (corresponding author), Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Shiga, Japan.; Fukutani, A (corresponding author), Japan Soc Promot Sci, Res Fellowship Young Scientists, Chiyoda Ku, Tokyo, Japan.	atsukifukutani@gmail.com			Japanese society of biomechanics, research grant of Japanese Society of Biomechanics; Japan Society for the promotion of science [13J03159, 26750313]; Grants-in-Aid for Scientific Research [26560361] Funding Source: KAKEN	Japanese society of biomechanics, research grant of Japanese Society of Biomechanics; Japan Society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the following three funders in terms of data collection, analysis, and preparation of the manuscript: Japanese society of biomechanics, research grant of Japanese Society of Biomechanics (2014-2015) (AF) (http://biomechanics.jp/); Japan Society for the promotion of science, Grant-in-Aid for Japan Society for the Promotion of Science Fellows (13J03159) (AF) (https://www.jsps.go.jp/index.html); Japan Society for the promotion of science, Grant-in-Aid for Young Scientists B (26750313) (AF) (https://www.jsps.go.jp/index.html).	Andersen LL, 2010, SCAND J MED SCI SPOR, V20, pE162, DOI 10.1111/j.1600-0838.2009.00933.x; Bobbert MF, 2005, MED SCI SPORT EXER, V37, P440, DOI 10.1249/01.MSS.0000155389.34538.97; Bobbert MF, 1996, MED SCI SPORT EXER, V28, P1402, DOI 10.1097/00005768-199611000-00009; Burkholder TJ, 2001, J EXP BIOL, V204, P1529; DIETZ V, 1979, J NEUROPHYSIOL, V42, P1212, DOI 10.1152/jn.1979.42.5.1212; EDMAN KAP, 1982, J GEN PHYSIOL, V80, P769, DOI 10.1085/jgp.80.5.769; Ema R, 2013, EUR J APPL PHYSIOL, V113, P2691, DOI 10.1007/s00421-013-2700-1; ETTEMA GJC, 1990, J EXP BIOL, V152, P333; Finni T, 2001, ACTA PHYSIOL SCAND, V173, P369, DOI 10.1046/j.1365-201X.2001.00915.x; Fukunaga T, 2001, P ROY SOC B-BIOL SCI, V268, P229, DOI 10.1098/rspb.2000.1361; Fukutani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120579; HERZOG W, 1991, MED SCI SPORT EXER, V23, P108; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hisey B, 2009, J BIOMECH, V42, P1488, DOI 10.1016/j.jbiomech.2009.03.046; Ishikawa M, 2006, J ELECTROMYOGR KINES, V16, P423, DOI 10.1016/j.jelekin.2005.08.006; Joumaa V, 2008, P ROY SOC B-BIOL SCI, V275, P1411, DOI 10.1098/rspb.2008.0142; JOYCE GC, 1969, J PHYSIOL-LONDON, V204, P475, DOI 10.1113/jphysiol.1969.sp008925; Kawakami Y, 2002, J PHYSIOL-LONDON, V540, P635, DOI 10.1113/jphysiol.2001.013459; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398, DOI 10.1152/jappl.1998.85.2.398; Maganaris CN, 2001, ACTA PHYSIOL SCAND, V172, P279, DOI 10.1046/j.1365-201x.2001.00799.x; NICHOLS TR, 1973, SCIENCE, V181, P182, DOI 10.1126/science.181.4095.182; Power GA, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.4; Reeves ND, 2003, J APPL PHYSIOL, V95, P1090, DOI 10.1152/japplphysiol.01046.2002; Schachar R, 2004, J BIOMECH, V37, P917, DOI 10.1016/j.jbiomech.2003.10.006; Seiberl W, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12401; WESTING SH, 1988, EUR J APPL PHYSIOL O, V58, P100, DOI 10.1007/BF00636611	26	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159058	10.1371/journal.pone.0159058	http://dx.doi.org/10.1371/journal.pone.0159058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414804	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500066
J	Li, JH; Lin, XY; Teng, YY; Qi, SL; Xiao, DY; Zhang, JY; Kang, Y				Li, Jianhua; Lin, Xiaoyan; Teng, Yueyang; Qi, Shouliang; Xiao, Dayu; Zhang, Jianying; Kang, Yan			A Comprehensive Evaluation of Disease Phenotype Networks for Gene Prioritization	PLOS ONE			English	Article							WALKING; INTERACTOME; SIMILARITY	Identification of disease-causing genes is a fundamental challenge for human health studies. The phenotypic similarity among diseases may reflect the interactions at the molecular level, and phenotype comparison can be used to predict disease candidate genes. Online Mendelian Inheritance in Man (OMIM) is a database of human genetic diseases and related genes that has become an authoritative source of disease phenotypes. However, disease phenotypes have been described by free text; thus, standardization of phenotypic descriptions is needed before diseases can be compared. Several disease phenotype networks have been established in OMIM using different standardization methods. Two of these networks are important for phenotypic similarity analysis: the first and most commonly used network (mimMiner) is standardized by medical subject heading, and the other network (resnikHPO) is the first to be standardized by human phenotype ontology. This paper comprehensively evaluates for the first time the accuracy of these two networks in gene prioritization based on protein-protein interactions using large-scale, leave-one-out cross-validation experiments. The results show that both networks can effectively prioritize disease-causing genes, and the approach that relates two diseases using a logistic function improves prioritization performance. Tanimoto, one of four methods for normalizing resnikHPO, generates a symmetric network and it performs similarly to mimMiner. Furthermore, an integration of these two networks outperforms either network alone in gene prioritization, indicating that these two disease networks are complementary.	[Li, Jianhua; Lin, Xiaoyan; Zhang, Jianying] Northeastern Univ, Sino Dutch Biomed & Informat Engn Sch, Dept Biomed Informat, Shenyang, Liaoning, Peoples R China; [Li, Jianhua; Qi, Shouliang; Kang, Yan] Northeastern Univ, Minist Educ, Key Lab Med Image Comp, Shenyang, Liaoning, Peoples R China; [Teng, Yueyang; Qi, Shouliang; Xiao, Dayu; Kang, Yan] Northeastern Univ, Dept Biomed Imaging, Sino Dutch Biomed & Informat Engn Sch, Shenyang, Liaoning, Peoples R China; [Zhang, Jianying] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA	Northeastern University - China; Northeastern University - China; Northeastern University - China; University of Texas System; University of Texas El Paso	Kang, Y (corresponding author), Northeastern Univ, Minist Educ, Key Lab Med Image Comp, Shenyang, Liaoning, Peoples R China.; Kang, Y (corresponding author), Northeastern Univ, Dept Biomed Imaging, Sino Dutch Biomed & Informat Engn Sch, Shenyang, Liaoning, Peoples R China.	kangyan@bmie.neu.edu.cn	li, jian/GSE-0245-2022; LI, JIAN/GRY-2197-2022		National Natural Science Foundation of China [61302013, 61372014]; Science and Technology Plan of Liaoning Province of China [2014305001]; Fundamental Research Funds for the Central Universities of China [N141008001, N130219001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan of Liaoning Province of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was funded by the National Natural Science Foundation of China (61302013 and 61372014; http://www.nsfc.gov.cn) to YYT and YK, Science and Technology Plan of Liaoning Province of China (2014305001; http://www.lninfo.gov.cn/) to YYT and Fundamental Research Funds for the Central Universities of China (N141008001 and N130219001; http://www.moe.gov.cn) to YYT and SLQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000351; Bornigen D, 2012, BIOINFORMATICS, V28, P3081, DOI 10.1093/bioinformatics/bts581; Chen HL, 2013, SCI WORLD J, DOI 10.1155/2013/204658; Chen Y, 2015, J BIOMED INFORM, V53, P113, DOI 10.1016/j.jbi.2014.09.007; Cohen R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-65; Doncheva NT, 2012, WIRES SYST BIOL MED, V4, P429, DOI 10.1002/wsbm.1177; Erten S, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-19; Fang H, 2013, MOL BIOSYST, V9, P1686, DOI 10.1039/c3mb25495j; Gefen A, 2010, HUM MUTAT, V31, P229, DOI 10.1002/humu.21171; Hoehndorf R, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr538; Jiang QH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S2; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Martinez V, 2015, ARTIF INTELL MED, V63, P41, DOI 10.1016/j.artmed.2014.11.003; Martinez V, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S1-S5; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Nakazato T, 2009, NUCLEIC ACIDS RES, V37, pW166, DOI 10.1093/nar/gkp483; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Snider J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156351; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wang G, 2012, THESIS; Wang ZG, 2012, CHINESE J BIOINFORMA, V10, P154; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Zhang SZ, 2012, GENE, V497, P58, DOI 10.1016/j.gene.2012.01.014; Zhang SH, 2010, FEBS LETT, V584, P3635, DOI 10.1016/j.febslet.2010.07.038; Zhang WS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S11; Zhang WS, 2010, FRONT ELECT ELECT EN, V5, P107, DOI [10.1007/s11460-010-0018-x, DOI 10.1007/S11460-010-0018-X]; Zhang X, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00075; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212	36	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159457	10.1371/journal.pone.0159457	http://dx.doi.org/10.1371/journal.pone.0159457			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415759	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500130
J	Shim, W; Kwon, OJ; Moon, YH; Kim, KH				Shim, We; Kwon, Oh-jin; Moon, Yeong-ho; Kim, Keun-hwan			Understanding the Dynamic Convergence Phenomenon from the Perspective of Diversity and Persistence: A Cross-Sector Comparative Analysis between the United States and South Korea	PLOS ONE			English	Article							TECHNOLOGICAL CAPABILITIES; PATENT ANALYSIS; INFORMATION-TECHNOLOGY; BIOTECHNOLOGY INDUSTRY; INNOVATIVE ACTIVITIES; COUNTRY-LEVEL; NANOTECHNOLOGY; PATTERNS; SCIENCE; PRODUCTIVITY	This study was designed to improve the explanation for the behavior of the phenomenon of technology convergence. The concepts and measurements of diversity and persistence, as inherent attributes of the phenomenon, were elaborated by reviewing different theories. Diversity was examined by analyzing the degree of capability to absorb heterogeneous technologies, while persistence was investigated by analyzing the degree of continuity in the usage of cumulated technologies. With these two dimensions, an analytic framework was proposed to compare the differences and dynamic patterns of convergence competence by countries at the technology sector level. Three major technology sectors in the United States and South Korea, namely, information and communication technology, biotechnology, and nanotechnology, were explored to explicitly illustrate the differences in technology convergence competence. The results show that although Korea has narrowed the differences of capabilities for technology convergence compared to the US, Korea not only has to continuously pursue the improvement of specialization for all three sectors, but also has to encourage the exploitation of different technology fields. The suggested framework and indicators allow for monitoring of the dynamic patterns of a technology sector and identifying the sources of the gaps. Thus, the framework and indicators are able to ensure the purpose of government innovation policy and to provide strategic directions for redistributing the proper combination of sources to accomplish technology convergence.	[Shim, We; Kwon, Oh-jin; Moon, Yeong-ho] Korea Univ Sci & Technol UST, S&T Informat Sci, Seoul, South Korea; [Shim, We] KISTI, Dept Scientometr Res, Seoul, South Korea; [Kwon, Oh-jin] KISTI, Future Informat Res Ctr, Seoul, South Korea; [Moon, Yeong-ho] KISTI, Seoul, South Korea; [Kim, Keun-hwan] KISTI, Dept Enterprise Innovat Strategy, Seoul, South Korea	University of Science & Technology (UST); Korea Institute of Science & Technology Information (KISTI); Korea Institute of Science & Technology Information (KISTI); Korea Institute of Science & Technology Information (KISTI); Korea Institute of Science & Technology Information (KISTI)	Kim, KH (corresponding author), KISTI, Dept Enterprise Innovat Strategy, Seoul, South Korea.	khkim75@kisti.re.kr		Kwon, Oh Jin/0000-0002-0548-2630				ABERNATHY WJ, 1978, TECHNOL REV, V80, P40; Academies National, 2005, FAC INT RES; Acs ZJ, 2002, RES POLICY, V31, P1069, DOI 10.1016/S0048-7333(01)00184-6; Acuna-Narvaez R, 2005, J COMMERCIAL BIOTECH, V12, P105; Ahlgren P, 2003, J AM SOC INF SCI TEC, V54, P550, DOI 10.1002/asi.10242; ANDERSON P, 1990, ADMIN SCI QUART, V35, P604, DOI 10.2307/2393511; Archibugi, 1992, SCI PUBL POLICY, V19, P357, DOI DOI 10.1093/SPP/19.6.357; Archibugi D, 2005, RES POLICY, V34, P175, DOI 10.1016/j.respol.2004.12.002; Archibugi D, 2004, WORLD DEV, V32, P629, DOI 10.1016/j.worlddev.2003.10.008; Archibugi D, 1996, TECHNOVATION, V16, P451, DOI 10.1016/0166-4972(96)00031-4; Archibugi D, 2009, TECHNOL FORECAST SOC, V76, P917, DOI 10.1016/j.techfore.2009.01.002; Beckert B, 2007, INNOVATION-ABINGDON, V20, P375, DOI 10.1080/13511610701767932; Bhushan B., 2010, SPRINGER HDB NANOTEC; Bjorkdahl J, 2009, RES POLICY, V38, P1468, DOI 10.1016/j.respol.2009.07.006; Bradley G, 2010, TRIPLEC-COMMUN CAPIT, V8, P183; Brusoni S, 2003, RES POLICY, V32, P1897, DOI 10.1016/j.respol.2003.09.006; Cameron G, 2005, EUR ECON REV, V49, P775, DOI 10.1016/S0014-2921(03)00070-9; Campbell J.R., 2012, ISSUES TECHNOLOGY IN, V19, P1; Castellacci F, 2008, RES POLICY, V37, P1659, DOI 10.1016/j.respol.2008.08.006; Cefis E, 2001, RES POLICY, V30, P1139, DOI 10.1016/S0048-7333(00)00139-6; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Criscuolo P, 2006, SCIENTOMETRICS, V66, P23, DOI 10.1007/s11192-006-0003-6; Curran CS, 2011, TECHNOL FORECAST SOC, V78, P256, DOI 10.1016/j.techfore.2010.06.021; Debackere K, 1999, SCIENTOMETRICS, V44, P379, DOI 10.1007/BF02458486; Dewan S, 2000, MANAGE SCI, V46, P548, DOI 10.1287/mnsc.46.4.548.12057; Doms M., 2004, FRBSF EC REV, P19; DOSI G, 1982, RES POLICY, V11, P147, DOI 10.1016/0048-7333(82)90016-6; Duysters G, 2003, R&D MANAGE, V33, P49, DOI 10.1111/1467-9310.00281; Elster Jon, 1983, EXPLAINING TECHNICAL; Fagerberg J, 2007, WORLD DEV, V35, P1595, DOI 10.1016/j.worlddev.2007.01.004; Friedman Y, 2010, J COMMERCIAL BIOTECH, V16, P1; Garson G.D., 2006, PUBLIC INFORM TECHNO; Geroski PA, 1997, RES POLICY, V26, P33, DOI 10.1016/S0048-7333(96)00903-1; Grant RM, 1996, ORGAN SCI, V7, P375, DOI 10.1287/orsc.7.4.375; Grant T, 1998, INT DIRECTORY CO HIS, V20; Hacklin F, 2009, TECHNOL FORECAST SOC, V76, P723, DOI 10.1016/j.techfore.2009.03.003; Hagedoorn J, 2002, TECHNOL ANAL STRATEG, V14, P67, DOI 10.1080/09537320220125892; Helfat CE, 2003, STRATEGIC MANAGE J, V24, P997, DOI 10.1002/smj.332; Huang Z, 2003, J NANOPART RES, V5, P333, DOI 10.1023/A:1025556800994; Kang KN, 2008, BIOTECHNOL LETT, V30, P1699, DOI 10.1007/s10529-008-9745-y; Kang KN, 2012, TECHNOVATION, V32, P68, DOI 10.1016/j.technovation.2011.08.004; Karvonen M, 2011, FORESIGHT, V13, P34, DOI 10.1108/14636681111170202; Kim KH, 2014, FORESIGHT, V16, P270, DOI 10.1108/FS-11-2012-0082; Kim MS, 2012, PROCD SOC BEHV, V40, P657, DOI 10.1016/j.sbspro.2012.03.245; Kline S. J., 1986, POSITIVE SUM STRATEG, V14, P640, DOI DOI 10.1142/9789814273596_; Kodama M, 2015, ROUT STUD INNOV ORG, V39, P1; Kwon YI, 2013, INT J COMPUTER SCI E, V1, P30; Lei DT, 2000, INT J TECHNOL MANAGE, V19, P699, DOI 10.1504/IJTM.2000.002848; Lemola T, 2002, RES POLICY, V31, P1481, DOI 10.1016/S0048-7333(02)00077-X; Leydesdorff L, 2015, SCIENTOMETRICS, V105, P1441, DOI 10.1007/s11192-015-1639-x; Lim D, 2009, ASIAN BIOTECHN DEV R, V11, P1; Lind J., 2004, ITS BIANNUAL C, P4; Maine E, 2014, NAT NANOTECHNOL, V9, P2, DOI 10.1038/nnano.2013.288; Malerba F, 1997, INT J IND ORGAN, V15, P801, DOI 10.1016/S0167-7187(97)00012-X; Milojevic S, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-011-0685-4; Monedero I, 2010, LECT NOTES ARTIF INT, V6276, P410, DOI 10.1007/978-3-642-15387-7_45; Nelson R., 1982, EVOL THEOR; NELSON RR, 1992, J ECON LIT, V30, P1931; No HJ, 2010, TECHNOL FORECAST SOC, V77, P63, DOI 10.1016/j.techfore.2009.06.006; Organisation for Economic Co-operation and Development, 2012, OECD SCI TECHN IND O; Organisation for Economic Co-operation and Development, 2000, ID TECHN AR PAT; Pavitt K., 1989, STRATEGIES GLOBAL CO; Pennings JM, 2001, ECIS C 2001 JUN 27 2; Perez C., 1988, TECHNICAL CHANGE EC, P458; Porter AL, 2006, HIGH TECH INDICATORS; Porter AL, 2009, SCIENTOMETRICS, V81, P719, DOI 10.1007/s11192-008-2197-2; PRAHALAD CK, 1990, HARVARD BUS REV, V68, P79; Rafols I, 2012, RES POLICY, V41, P1262, DOI 10.1016/j.respol.2012.03.015; Rafols I, 2010, SCIENTOMETRICS, V82, P263, DOI 10.1007/s11192-009-0041-y; Roco MC, 2003, CURR OPIN BIOTECH, V14, P337, DOI 10.1016/S0958-1669(03)00068-5; Roco MC, 2002, J NANOPART RES, V4, P281, DOI 10.1023/A:1021152023349; Roco MC, 2011, CHEM ENG PROG, V107, P21; ROSENBERG N, 1963, J ECON HIST, V23, P414, DOI 10.1017/S0022050700109155; Rosenberg N., 1994, TECHNOLOGY EC HIST, P9; Rosenberg Nathan, 1976, PERSPECTIVES TECHNOL, DOI 10.1017/CBO9780511561313; Rosenberg Nathan, 1982, INSIDE BLACKBOX TECH; Schreyer P., 2002, OECD EC STUDIES, V2002, P153; Schumpeter Joseph, 1934, THEORY EC DEV INQUIR; Shmulewitz A, 2006, NAT BIOTECHNOL, V24, P277, DOI 10.1038/nbt0306-277a; Silberglitt R, 2006, GLOBAL TECHNOLOGY RE; Soos S, 2012, SCIENTOMETRICS, V93, P869, DOI 10.1007/s11192-012-0713-x; Stirling A, 2007, J R SOC INTERFACE, V4, P707, DOI 10.1098/rsif.2007.0213; Suzuki J, 2004, RES POLICY, V33, P531, DOI 10.1016/j.respol.2003.10.005; Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z; Thomson R, 2010, BUS HIST C JAN BHC A; Tiwari R., 2006, ASIA PACIFIC TECH MO, V23, P38; Tomczyk M., 2015, NANOINNOVATION WHAT; Verbeek A, 2002, INT J MANAG REV, V4, P179, DOI 10.1111/1468-2370.00083; Wang J, 2007, GOV INFORM Q, V24, P115, DOI 10.1016/j.giq.2006.04.001; West JL, 2000, CURR OPIN BIOTECH, V11, P215, DOI 10.1016/S0958-1669(00)00082-3; Wieczorek I, 2007, INNOVATION TECHNOLOG, P205; Wong J, 2004, NAT BIOTECHNOL, V22, pDC42, DOI 10.1038/nbt1204supp-DC42; Wong YC, 2009, BRIT J SOCIAL WORK	93	6	6	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159249	10.1371/journal.pone.0159249	http://dx.doi.org/10.1371/journal.pone.0159249			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27416495	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500110
J	Barral-Arca, R; Pischedda, S; Gomez-Carballa, A; Pastoriza, A; Mosquera-Miguel, A; Lopez-Soto, M; Martinon-Torres, F; Alvarez-Iglesias, V; Salas, A				Barral-Arca, Ruth; Pischedda, Sara; Gomez-Carballa, Alberto; Pastoriza, Ana; Mosquera-Miguel, Ana; Lopez-Soto, Manuel; Martinon-Torres, Federico; Alvarez-Iglesias, Vanesa; Salas, Antonio			Meta-Analysis of Mitochondrial DNA Variation in the Iberian Peninsula	PLOS ONE			English	Article							EUROPEAN VARIATION; FORENSIC GENETICS; HAPLOGROUP-H; NEAR-EASTERN; HUMAN MTDNA; POPULATION; SEQUENCES; ASSOCIATION; DIVERSITY; LINEAGES	The Iberian Peninsula has been the focus of attention of numerous studies dealing with mitochondrial DNA (mtDNA) variation, most of them targeting the control region segment. In the present study we sequenced the control region of 3,024 Spanish individuals from areas where available data were still limited. We also compiled mtDNA haplotypes from the literature involving 4,588 sequences and 28 population groups or small regions. We meta-analyzed all these data in order to shed further light on patterns of geographic variation, taking advantage of the large sample size and geographic coverage, in contrast with the atomized sampling strategy of previous work. The results indicate that the main mtDNA haplogroups show primarily clinal geographic patterns across the Iberian geography, roughly along a North-South axis. Haplogroup HV0 (where haplogroup U is nested) is more prevalent in the Franco Cantabrian region, in good agreement with previous findings that identified this area as a climate refuge during the Last Glacial Maximum (LGM), prior to a subsequent demographic re-expansion towards Central Europe and the Mediterranean. Typical sub-Saharan and North African lineages are slightly more prevalent in South Iberia, although at low frequencies; this pattern has been shaped mainly by the transatlantic slave trade and the Arab invasion of the Iberian Peninsula. The results also indicate that summary statistics that aim to measure molecular variation, or AMOVA, have limited sensitivity to detect population substructure, in contrast to patterns revealed by phylogeographic analysis. Overall, the results suggest that mtDNA variation in Iberia is substantially stratified. These patterns might be relevant in biomedical studies given that stratification is a common cause of false positives in case-control mtDNA association studies, and should be also considered when weighting the DNA evidence in forensic casework, which is strongly dependent on haplotype frequencies.	[Barral-Arca, Ruth; Pischedda, Sara; Gomez-Carballa, Alberto; Pastoriza, Ana; Mosquera-Miguel, Ana; Alvarez-Iglesias, Vanesa; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Inst Ciencias Forenses, Unidade Xenet,Dept Anat Patolox & Ciencias Forens, Galicia, Spain; [Barral-Arca, Ruth; Pischedda, Sara; Gomez-Carballa, Alberto; Salas, Antonio] Hosp Clin Univ Santiago, GenPop Res Grp, Inst Invest Sanitarias, Galicia, Spain; [Gomez-Carballa, Alberto; Martinon-Torres, Federico] Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain; [Gomez-Carballa, Alberto; Martinon-Torres, Federico] Univ Santiago de Compostela, Galicia, Spain; [Lopez-Soto, Manuel] Inst Nacl Toxicol & Ciencias Forenses, Dept Sevilla, Serv Biol, Seville, Spain; [Martinon-Torres, Federico] Hosp Clin Univ Santiago, Dept Pediat, Pediat Emergency & Crit Care Div, Santiago De Compostela, Galicia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Salas, A (corresponding author), Univ Santiago de Compostela, Fac Med, Inst Ciencias Forenses, Unidade Xenet,Dept Anat Patolox & Ciencias Forens, Galicia, Spain.; Salas, A (corresponding author), Hosp Clin Univ Santiago, GenPop Res Grp, Inst Invest Sanitarias, Galicia, Spain.	antonio.salas@usc.es	Salas, Antonio/E-3977-2012; Miguel, Ana Mosquera/ABG-9735-2020; Salas, Antonio/U-2029-2019; Martinon-Torres, Federico/E-4982-2016; Gómez-Carballa, Alberto/I-4610-2014	Salas, Antonio/0000-0002-2336-702X; Miguel, Ana Mosquera/0000-0003-3939-8338; Salas, Antonio/0000-0002-2336-702X; Martinon-Torres, Federico/0000-0002-9023-581X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Pischedda, Sara/0000-0001-6731-2349; Barral Arca, Ruth/0000-0003-2900-1288	Ministerio de Ciencia e Innovacion [SAF2011-26983]; Plan Galego IDT [EM 2012/045]; Sistema Universitario Gallego- Modalidad REDES from the Xunta de Galicia [2012-PG226]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Galego IDT; Sistema Universitario Gallego- Modalidad REDES from the Xunta de Galicia	The research leading to these results has received funding from the "Ministerio de Ciencia e Innovacion" (SAF2011-26983), the Plan Galego IDT (EM 2012/045) and a grant from the Sistema Universitario Gallego- Modalidad REDES (2012-PG226) from the Xunta de Galicia (AS).	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Alvarez L, 2010, AM J PHYS ANTHROPOL, V142, P531, DOI 10.1002/ajpa.21252; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2012, INT J LEGAL MED, V126, P901, DOI 10.1007/s00414-012-0762-y; Beleza S, 2006, ANN HUM GENET, V70, P181, DOI 10.1111/j.1529-8817.2005.00221.x; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Brehm A, 2003, HUM GENET, V114, P77, DOI 10.1007/s00439-003-1024-3; Cardoso S, 2011, AM J PHYS ANTHROPOL, V145, P480, DOI 10.1002/ajpa.21532; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Cerezo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007902; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Crespillo M, 2000, INT J LEGAL MED, V114, P130, DOI 10.1007/s004140000158; Egeland T, 2004, ANN HUM GENET, V68, P461, DOI 10.1046/j.1529-8817.2004.00109.x; Egeland T, 2008, TOFORENSICSJ, V1, P4; Egeland T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003988; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fachal L, 2015, AM J MED GENET B, V168, P54, DOI 10.1002/ajmg.b.32276; Falchi A, 2006, J HUM GENET, V51, P9, DOI 10.1007/s10038-005-0324-y; Gomez-Carballa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075397; Gomez-Carballa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032851; Gomez-Carballa A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018348; Gonzalez AM, 2003, AM J PHYS ANTHROPOL, V120, P391, DOI 10.1002/ajpa.10168; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Larruga JM, 2001, EUR J HUM GENET, V9, P708, DOI 10.1038/sj.ejhg.5200693; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maca-Meyer N, 2003, ANN HUM GENET, V67, P329, DOI 10.1046/j.1469-1809.2003.00045.x; Moorjani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058633; Parson W, 2014, FORENSIC SCI INT-GEN, V13, P134, DOI 10.1016/j.fsigen.2014.07.010; Pereira L, 2005, INT J ANDROL, V28, P241, DOI 10.1111/j.1365-2605.2005.00539.x; Pereira L, 2000, ANN HUM GENET, V64, P491, DOI 10.1046/j.1469-1809.2000.6460491.x; Picornell A, 2005, AM J PHYS ANTHROPOL, V128, P119, DOI 10.1002/ajpa.10423; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; Rando JC, 1999, ANN HUM GENET, V63, P413, DOI 10.1046/j.1469-1809.1999.6350413.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2000, EUR J HUM GENET, V8, P964, DOI 10.1038/sj.ejhg.5200563; Salas A, 2017, EUR J HUM GENET, V25, pS33, DOI 10.1038/sj.ejhg.5200202; Salas A, 2015, J GENET GENOMICS, V42, P169, DOI 10.1016/j.jgg.2015.03.002; Salas A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-659; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008347; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Toscanini U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049832; Toscanini U, 2010, INT J LEGAL MED, V124, P63, DOI 10.1007/s00414-009-0359-2; Tully G, 2001, FORENSIC SCI INT, V124, P83, DOI 10.1016/S0379-0738(01)00573-4; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	53	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159735	10.1371/journal.pone.0159735	http://dx.doi.org/10.1371/journal.pone.0159735			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441366	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500131
J	Kumari, R; Tripathi, R; Pandey, AP; Banerjee, T; Sinha, P; Anupurba, S				Kumari, Richa; Tripathi, Rajneesh; Pandey, Alok Prakash; Banerjee, Tuhina; Sinha, Pallavi; Anupurba, Shampa			Rapid Screening of MDR-TB in Cases of Extra Pulmonary Tuberculosis Using Geno Type MTBDRplus	PLOS ONE			English	Article							LINE PROBE ASSAY; RESISTANT MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; NORTHERN INDIA; RIFAMPIN; IDENTIFICATION; VALIDATION; DIAGNOSIS; STRAINS; RPOB	Background Drug resistance in tuberculosis is a major public health challenge in developing countries. The limited data available on drug resistance in extra pulmonary tuberculosis stimulated us to design our study on anti-tuberculosis drug resistance pattern in cases of extra pulmonary tuberculosis in a tertiary referral hospital of North India. We performed Geno Type MTBDRplus assay in comparison with conventional drug susceptibility testing by proportion method to study the mutation patterns in rpoB, katG and inhA genes. Methods A total of 510 extra pulmonary samples were included in this study. After the smear microscopy, all the specimens were subjected for culture on Lowenstein Jensen (LJ) media. Phenotypic drug susceptibility testing (DST) was performed on LJ media for all the MTB isolates and compared with the results of Geno Type MTBDRplus assay which was performed with the DNA isolated from the culture by conventional method. Results Of 510 specimens cultured, the total culture positivity obtained was 11.8% (60) encompassing 54 (10.6%) Mycobacterium tuberculosis and 6 (1.2%) non-tubercular mycobacteria (NTM). DST results by Geno Type MTBDRplus assay and solid culture methods were compared in 51 MTB isolates excluding the two Rif indeterminate and one invalid test. Geno Type MTBDRplus accurately identified 13 of 14 rifampicin-resistant strains, 14 of 15 isoniazid-resistant strains and 13 of 14 as multi drug resistant tuberculosis (MDR-TB) in comparison with conventional method. Sensitivity and specificity were 92.86% and 97.30% respectively for detection of RIF resistance, 93.33% and 94.44% respectively for detection of INH resistance, 92.86% and 97.30% respectively for detection of MDR-TB, while the overall concordance of Geno Type MTBDRplus assay with conventional DST was 94.11%. The turn-around time for performing Geno Type MTBDRplus assay test was 48 hours. Conclusion The problem of MDR in extra pulmonary tuberculosis (EPTB) cannot be overlooked and due attention on patients should be given. Routine use of Geno Type MTBDRplus assay for the diagnosis of MDR-EPTB can substantially reduce the time between diagnosis and drug therapy. Culture along with Geno Type MTBDRplus assay could be a solution for rapid and accurate diagnosis of MDR-TB in low bacillary non sputum specimens.	[Kumari, Richa; Tripathi, Rajneesh; Pandey, Alok Prakash; Banerjee, Tuhina; Sinha, Pallavi; Anupurba, Shampa] Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi, Uttar Pradesh, India	Banaras Hindu University (BHU)	Anupurba, S (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi, Uttar Pradesh, India.	shampa_anupurba@yahoo.co.in	Banerjee, Tuhina/AAP-7084-2021	Banerjee, Tuhina/0000-0003-0035-2842; Anupurba, Shampa/0000-0002-7644-1086	Department of Biotechnology (DBT), Government of India [DBT/2013/BHU/ 157]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This study was financially supported by Department of Biotechnology (DBT), Government of India (DBT/2013/BHU/ 157). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; Anek-vorapong R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-123; [Anonymous], 2009, TRAIN MAN MYC TUB CU; Cosme AE, 2009, BMC CLIN PATHOLOGY, V9, P1, DOI [10.1186/1472-6890-9-1, DOI 10.1186/1472-6890-9-1]; Gupta A, 2013, J CLIN LAB ANAL, V27, P31, DOI 10.1002/jcla.21558; Gupta R, 2015, J GLOB INFECT DIS, V7, P5, DOI 10.4103/0974-777X.150882; Gurung R, 2010, Kathmandu Univ Med J (KUMJ), V8, P57; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Huyen MNT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-149; Lacoma A, 2008, J CLIN MICROBIOL, V46, P3660, DOI 10.1128/JCM.00618-08; Lee JJ, 2003, INT J TUBERC LUNG D, V7, P569; Luetkemeyer AF, 2014, J CLIN MICROBIOL, V52, P1052, DOI 10.1128/JCM.02639-13; Maurya AK, 2012, J POSTGRAD MED, V58, P185, DOI 10.4103/0022-3859.101379; Miotto P, 2008, J CLIN MICROBIOL, V46, P393, DOI 10.1128/JCM.01066-07; Ocheretina O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090569; RAVIGLIONE MC, 1992, B WORLD HEALTH ORGAN, V70, P515; Rufai SB, 2014, J CLIN MICROBIOL, V52, P1846, DOI 10.1128/JCM.03005-13; Sachdeva R, 2002, INDIAN J MED RES, V115, P102; Siddiqi HS, 2006, MGIT TM PROCEDURE MA; Tan YJ, 2012, J CLIN MICROBIOL, V50, P81, DOI 10.1128/JCM.05092-11; TENOVER FC, 1993, J CLIN MICROBIOL, V31, P767, DOI 10.1128/JCM.31.4.767-770.1993; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; World Health Organization, GLOB TUB REP 2015; World Health Organization, 2007, US LIQ CULT DRUG SUC; Yadav RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072036; Yunting G, 2015, INT J INFECT DIS, DOI [10.1016/j.ijid.2015.05.014, DOI 10.1016/J.IJID.2015.05.014]	26	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159651	10.1371/journal.pone.0159651	http://dx.doi.org/10.1371/journal.pone.0159651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441660	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500112
J	Li, SZ; Zhu, YF; Zhi, LH; Han, XY; Shen, J; Liu, YL; Yao, JH; Yang, XJ				Li, Shizhao; Zhu, Yufei; Zhi, Lihui; Han, Xiaoying; Shen, Jing; Liu, Yanli; Yao, Junhu; Yang, Xiaojun			DNA Methylation Variation Trends during the Embryonic Development of Chicken	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MAMMALIAN DEVELOPMENT; MASS-SPECTROMETRY; GENE-EXPRESSION; X-CHROMOSOME; CANCER-CELLS; IGF-II; GENOME; PATTERNS; TISSUES	The embryogenesis period is critical for epigenetic reprogramming and is thus of great significance in the research field of poultry epigenetics for elucidation of the trends in DNA methylation variations during the embryonic development of birds, particularly due to differences in embryogenesis between birds and mammals. Here, we first examined the variations in genomic DNA methylation during chicken embryogenesis through high-performance liquid chromatography using broilers as the model organism. We then identified the degree of DNA methylation of the promoters and gene bodies involved in two specific genes (IGF2 and TNF-alpha) using the bisulfite sequencing polymerase chain reaction method. In addition, we measured the expression levels of IGF2, TNF-alpha and DNA methyl-transferase (DNMT) 1, 3a and 3b. Our results showed that the genomic DNA methylation levels in the liver, heart and muscle increased during embryonic development and that the methylation level of the liver was significantly higher in mid-anaphase. In both the muscle and liver, the promoter methylation levels of TNF-alpha first increased and then decreased, whereas the gene body methylation levels remained lower at embryonic ages E8, 11 and 14 before increasing notably at E17. The promoter methylation level of IGF2 decreased persistently, whereas the methylation levels in the gene body showed a continuous increase. No differences in the expression of TNF-alpha were found among E8, 11 and 14, whereas a significant increase was observed at E17. IGF2 showed increasing expression level during the examined embryonic stages. In addition, the mRNA and protein levels of DNMTs increased with increasing embryonic ages. These results suggest that chicken shows increasing genomic DNA methylation patterns during the embryonic period. Furthermore, the genomic DNA methylation levels in tissues are closely related to the genes expression levels, and gene expression may be simultaneously regulated by promoter hypomethylation and gene body hypermethylation.	[Li, Shizhao; Zhu, Yufei; Han, Xiaoying; Shen, Jing; Liu, Yanli; Yao, Junhu; Yang, Xiaojun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhi, Lihui] ShanXi Normal Univ, Sch Math & Comp Sci, Linfen, Shanxi, Peoples R China	Northwest A&F University - China; Shanxi Normal University	Yang, XJ (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	yangxj@nwsuaf.edu.cn	Liu, Yanli/GPK-8077-2022; Li, Shizhao/ABV-9057-2022	Liu, Yanli/0000-0002-8966-5011; Li, Shizhao/0000-0002-3464-1450	National Natural Science Foundation of China [31272464]; Program for New Century Excellent Talents in University [NCET-12-0476]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	The work was supported by the National Natural Science Foundation of China (No. 31272464, XJY, http://www.letpub.com.cn/?page=grant&name=&person=&no=31272464&company=&addcomment_s1=0&addcomment_s2=0&addcomment_s3=0&money1=&money2=&startTime=2011&endTime=2015&subcategory=&searchsubmit=true&submit.x=77&submit.y=10&submit=advSearch#fundlisttable), and the Program for New Century Excellent Talents in University (NCET-12-0476, XJY, http://www.cdpsn.org.cn/policy/dt104l36195.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban Q, 2009, J ANHUI AGR SCI, V29, P9902; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Burt D, 2003, SCIENCE, V300, P1669, DOI 10.1126/science.1086231; Cai DM, 2014, BRIT J NUTR, V112, P1459, DOI 10.1017/S0007114514002402; Choi SW, 2009, NUTRIENTS AND EPIGENETICS, P1, DOI 10.1201/9781420063561; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; DJEU JY, 1986, J IMMUNOL, V137, P2980; DOHERTY AS, 1994, MOL REPROD DEV, V37, P21, DOI 10.1002/mrd.1080370104; Erhardt S, 2003, DEV GENES EVOL, V213, P336, DOI 10.1007/s00427-003-0331-y; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; GEHRKE CW, 1984, J CHROMATOGR, V301, P199, DOI 10.1016/S0021-9673(01)89189-5; Gu DF, 2002, HUM GENET, V110, P173, DOI 10.1007/s00439-001-0663-5; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hemberger M, 2010, SCIENCE, V330, P598, DOI 10.1126/science.1199006; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Hyldig SMW, 2011, BIOL REPROD, V84, P1087, DOI 10.1095/biolreprod.110.086082; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee CI, 2001, PEDIATR RES, V49, P379, DOI 10.1203/00006450-200103000-00012; Li CW, 2015, POULTRY SCI, V94, P706, DOI 10.3382/ps/pev016; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019428; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MONK M, 1987, DEVELOPMENT, V99, P371; MUSTAFA MM, 1989, J CLIN INVEST, V84, P1253, DOI 10.1172/JCI114292; Nguyen CT, 2001, NUCLEIC ACIDS RES, V29, P4598, DOI 10.1093/nar/29.22.4598; O'Neill C., 2015, Animal Frontiers, V5, P42, DOI 10.2527/af.2015-0007; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Patten BM., 2008, EARLY EMBRYOLOGY CHI; Ratnam S, 2002, DEV BIOL, V245, P304, DOI 10.1006/dbio.2002.0628; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Rosenquist TH, 2001, P NUTR SOC, V60, P53; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Tawa R, 1998, J RADIAT RES, V39, P271, DOI 10.1269/jrr.39.271; Turker MS, 1997, MUTAT RES-REV MUTAT, V386, P119, DOI 10.1016/S1383-5742(96)00048-8; Vanyushin BF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P488, DOI 10.1007/s10541-005-0143-y; VINCE MA, 1975, COMP BIOCHEM PHYS A, V52, P331, DOI 10.1016/S0300-9629(75)80096-X; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; Xu HT, 2006, FEBS LETT, V580, P3610, DOI 10.1016/j.febslet.2006.05.044; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	59	40	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159230	10.1371/journal.pone.0159230	http://dx.doi.org/10.1371/journal.pone.0159230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438711	Green Submitted, Green Published, gold			2022-12-27	WOS:000380170100033
J	Bullard-Feibelman, KM; Fuller, BP; Geiss, BJ				Bullard-Feibelman, Kristen M.; Fuller, Benjamin P.; Geiss, Brian J.			A Sensitive and Robust High-Throughput Screening Assay for Inhibitors of the Chikungunya Virus nsP1 Capping Enzyme	PLOS ONE			English	Article							METHYLTRANSFERASE ACTIVITY; ESCHERICHIA-COLI; RNA-SYNTHESIS; IDENTIFICATION; BINDING; EXPRESSION; GUANOSINE	Chikungunya virus (CHIKV) is a mosquito-borne Alphavirus that causes severe and debilitating disease symptoms. Alarmingly, transmission rates of CHIKV have increased dramatically over the last decade resulting in 1.7 million suspected cases in the Western hemisphere alone. There are currently no antivirals for treatment of CHIKV infection and novel anti-alphaviral compounds are badly needed. nsP1 is the alphavirus protein responsible for the methyltransferase and guanylyltransferase activities necessary for formation of the 5' type 0 cap structure added to newly formed viral RNA. Formation of this cap depends on nsP1 binding GTP and transferring a methylated GMP to nascent viral RNA. We have developed a fluorescence polarization-based assay that monitors displacement of a fluorescently-labeled GTP analog in real time. Determining the relative affinities of 15 GTP analogs for nsP1 GTP revealed important structural aspects of GTP that will inform identification of inhibitors able to outcompete GTP for the nsP1 binding site. Validation of the assay for HTS was completed and a secondary orthogonal assay that measures guanylation activity was developed in order to evaluate hits from future drug screens. This platform provides an avenue for identification of potent nsP1 inhibitors, which would potentially provide compounds capable of treating disease caused by CHIKV infection.	[Bullard-Feibelman, Kristen M.; Fuller, Benjamin P.; Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Geiss, Brian J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Geiss, Brian J.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Geiss, BJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Geiss, BJ (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.; Geiss, BJ (corresponding author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.	Brian.Geiss@colostate.edu	Geiss, Brian/J-3021-2017	Geiss, Brian/0000-0001-8180-5772; Fuller, Benjamin/0000-0001-7572-4415	US National Institutes of Health National Institute of Allergy and Infectious Disease [5R01AI114675]; National Institutes of Health (NIAID) [R01AI114675]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114675] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of Allergy and Infectious Disease; National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this project was provided by the US National Institutes of Health National Institute of Allergy and Infectious Disease as a grant (5R01AI114675) to BJG.; The authors would like to acknowledge the Metabolomics and Proteomics facility at Colorado State University for conducting the mass spectromety and analysis of protein samples. This work was supported by a grant from the National Institutes of Health (NIAID R01AI114675) to B.J.G.	AHOLA T, 1995, P NATL ACAD SCI USA, V92, P507, DOI 10.1073/pnas.92.2.507; Bougie I, 2004, J BIOL CHEM, V279, P22124, DOI 10.1074/jbc.M400908200; Bullard KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130083; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Ferron F, 2012, ANTIVIR RES, V96, P21, DOI 10.1016/j.antiviral.2012.07.007; Geiss BJ, 2011, J BIOMOL SCREEN, V16, P852, DOI 10.1177/1087057111412183; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; Hyde JL, 2014, SCIENCE, V343, P783, DOI 10.1126/science.1248465; Johansson MA, 2015, TRENDS PARASITOL, V31, P43, DOI 10.1016/j.pt.2014.12.008; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; LAAKKONEN P, 1994, J VIROL, V68, P7418, DOI 10.1128/JVI.68.11.7418-7425.1994; Lampio A, 1999, ANTIVIR RES, V42, P35, DOI 10.1016/S0166-3542(99)00011-X; Li CQ, 2015, J VIROL, V89, P8292, DOI 10.1128/JVI.00599-15; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; MI S, 1991, VIROLOGY, V184, P423, DOI 10.1016/0042-6822(91)90862-6; MI S, 1989, VIROLOGY, V170, P385, DOI 10.1016/0042-6822(89)90429-7; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; PETTERSSON RF, 1980, EUR J BIOCHEM, V105, P435, DOI 10.1111/j.1432-1033.1980.tb04518.x; Pfeffer Martin, 2008, Wien Klin Wochenschr, V120, P95, DOI 10.1007/s00508-008-1035-0; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Rupp JC, 2015, J GEN VIROL, V96, P2483, DOI 10.1099/jgv.0.000249; SHIRAKO Y, 1994, J VIROL, V68, P1874, DOI 10.1128/JVI.68.3.1874-1885.1994; Sittampalam GS, 2004, HTS ASSAY VALIDATION; Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12; Vasiljeva L, 2000, J BIOL CHEM, V275, P17281, DOI 10.1074/jbc.M910340199; Wang HL, 1996, VIROLOGY, V217, P527, DOI 10.1006/viro.1996.0147; WENGLER G, 1979, NATURE, V282, P754, DOI 10.1038/282754a0	28	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158923	10.1371/journal.pone.0158923	http://dx.doi.org/10.1371/journal.pone.0158923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427769	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169300024
J	Costa, WJEM				Costa, Wilson J. E. M.			Inferring Evolution of Habitat Usage and Body Size in Endangered, Seasonal Cynopoeciline Killifishes from the South American Atlantic Forest through an Integrative Approach (Cyprinodontiformes: Rivulidae)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; HISTORICAL BIOGEOGRAPHY; FLORISTIC DIFFERENTIATION; BRAZIL CYPRINODONTIFORMES; COMPARATIVE MORPHOLOGY; LEPTOLEBIAS TELEOSTEI; CONTINUOUS CHARACTERS; EASTERN BRAZIL; GENUS; DIVERSIFICATION	Cynopoecilines comprise a diversified clade of small killifishes occurring in the Atlantic Forest, one of the most endangered biodiversity hotspots in the world. They are found in temporary pools of savannah-like and dense forest habitats, and most of them are highly threatened with extinction if not already extinct. The greatest gap in our knowledge of cynopoecilines stems from the absence of an integrative approach incorporating molecular phylogenetic data of species still found in their habitats with phylogenetic data taken from the rare and possibly extinct species without accessible molecular information. An integrative analysis combining 115 morphological characters with a multigene dataset of 2,108 bp comprising three nuclear loci (GLYT1, ENC1, Rho), provided a robust phylogeny of cynopoeciline killifishes, which was herein used to attain an accurate phylogenetic placement of nearly extinct species. The analysis indicates that the most recent common ancestor of the Cynopoecilini lived in open vegetation habitats of the Atlantic Forest of eastern Brazil and was a miniature species, reaching between 25 and 28mm of standard length. The rare cases of cynopoecilines specialized in inhabiting pools within dense forests are interpreted as derived from four independent evolutionary events. Shifts in habitat usage and biogeographic patterns are tentatively associated to Cenozoic paleogeographic events, but the evolutionary history of cynopoecilines may be partially lost by a combination of poor past sampling and recent habitat decline. A sharp evolutionary shift directed to increased body size in a clade encompassing the genera Campellole-bias and Cynopoecilus may be related to a parallel acquisition of an internally-fertilizing reproductive strategy, unique among aplocheiloid killifishes. This study reinforces the importance of adding morphological information to molecular databases as a tool to understand the biological complexity of organisms under intense pressure from loss of habitat.	[Costa, Wilson J. E. M.] Univ Fed Rio de Janeiro, Inst Biol, Lab Systemat & Evolut Teleost Fishes, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Costa, WJEM (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Lab Systemat & Evolut Teleost Fishes, Rio De Janeiro, RJ, Brazil.	wcosta@acd.ufrj.br	Costa, Wilson/A-9283-2013	Costa, Wilson/0000-0002-0428-638X	CNPq [303353/2010-4]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Grant 303353/2010-4, CNPq (BR) (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PEIXES ANUAIS BRASIL; [Anonymous], 2008, CATALOG APLOCHEILOID; Belote Drausio F., 2002, Boletim do Museu Nacional Rio de Janeiro Zoologia, P1; Belote Drausio F., 2003, Arquivos do Museu Nacional Rio de Janeiro, V61, P241; Belote Drausio F., 2004, Boletim do Museu Nacional Rio de Janeiro Zoologia, V514, P1; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Close B, 1996, LAB ANIM-UK, V30, P293, DOI 10.1258/002367796780739871; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Costa W.J.E.M., 1988, Revue Francaise d'Aquariologie Herpetologie, V15, P21; COSTA W J E M, 1990, Revista Brasileira de Biologia, V50, P83; COSTA W J E M, 1988, Revista Brasileira de Zoologia, V5, P557; COSTA W J E M, 1990, Revista Brasileira de Biologia, V50, P65; COSTA W. J. E. M., 2009, PEIXES APLOQUEILOIDE; Costa Wilson J.E.M., 2002, Ichthyological Exploration of Freshwaters, V13, P379; Costa WJEM, 2008, ZOOL J LINN SOC-LOND, V153, P147, DOI 10.1111/j.1096-3642.2008.00380.x; Costa Wilson J.E.M., 2004, Ichthyological Exploration of Freshwaters, V15, P105; Costa Wilson J. E. M., 1995, Cybium, V19, P349; Costa WJEM, 2006, NEOTROP ICHTHYOL, V4, P1, DOI 10.1590/S1679-62252006000100001; Costa WJEM, 2006, ZOOTAXA, P31; Costa Wilson J.E.M., 2002, Ichthyological Exploration of Freshwaters, V13, P41; Costa WJEM, 2016, MOL PHYLOGENET EVOL, V95, P94, DOI 10.1016/j.ympev.2015.11.011; Costa WJEM, 2015, ZOOL J LINN SOC-LOND, V175, P134, DOI 10.1111/zoj.12270; Costa WJEM, 2014, VERTEBR ZOOL, V64, P23; Costa WJEM, 2013, ICHTHYOL EXPLOR FRES, V24, P63; Costa WJEM, 2013, ICHTHYOL EXPLOR FRES, V23, P357; Costa WJEM, 2012, BIODIVERS CONSERV, V21, P2443, DOI 10.1007/s10531-012-0301-7; Costa WJEM, 2011, ZOOL J LINN SOC-LOND, V162, P131, DOI 10.1111/j.1096-3642.2010.00672.x; Costa Wilson J.E.M., 2001, Ichthyological Exploration of Freshwaters, V12, P333; Costa WJEM, 2010, J BIOGEOGR, V37, P1995, DOI 10.1111/j.1365-2699.2010.02339.x; Costa Wilson J.E.M., 2005, Zootaxa, V1067, P1; Costa Wilson J. E. M., 2009, Vertebrate Zoology, V59, P25; Costa Wilson J.E.M., 2002, Ichthyological Exploration of Freshwaters, V13, P11; Costa Wilson J.E.M., 1998, Journal of Comparative Biology, V3, P33; COSTA WJE, 1988, REV FRAN AQUARIOL HE, V14, P127; COSTA WJEM, 1995, COPEIA, P456; Costa WJEM, 1999, COPEIA, P1027; Costa WJEM, 1989, REV FRANCAISE AQUARI, V15, P65; Costa WJEM, 1995, PEARL KILLIFISHES CY; CRUZ C.A.G. DA, 1991, REV BRAS ZOOL, V7, P637, DOI DOI 10.1590/S0101-81751990000400017; da Silva JMC, 2004, GLOBAL ECOL BIOGEOGR, V13, P85, DOI 10.1111/j.1466-882X.2004.00077.x; Delsuc F, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-11; Fava D, 2007, J FISH BIOL, V71, P889, DOI 10.1111/j.1095-8649.2007.01572.x; Ferrer J, 2014, ZOOL J LINN SOC-LOND, V172, P846, DOI 10.1111/zoj.12190; Gamble T, 2008, MOL PHYLOGENET EVOL, V46, P269, DOI 10.1016/j.ympev.2007.08.013; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2006, CLADISTICS, V22, P589, DOI 10.1111/j.1096-0031.2006.00122.x; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; HOEDEMAN J. J., 1958, BULL AQUATIC BIOL, V1, P23; Hrbek T, 1999, EVOLUTION, V53, P1200, DOI 10.1111/j.1558-5646.1999.tb04533.x; Leary S, 2013, AVMA GUIDELINES EUTH; Ledru MP, 2009, PALAEOGEOGR PALAEOCL, V271, P140, DOI 10.1016/j.palaeo.2008.10.008; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Maddison, 2018, MESQUITE MODULAR SYS; Marques MCM, 2011, BIODIVERS CONSERV, V20, P153, DOI 10.1007/s10531-010-9952-4; Murphy WJ, 1999, MOL PHYLOGENET EVOL, V13, P289, DOI 10.1006/mpev.1999.0656; Myers G. S., 1952, Aquarium J, V23, P125; Myers George S., 1942, STANFORD ICHTHYOL BULL, V2, P89; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Near TJ, 2012, MOL PHYLOGENET EVOL, V63, P388, DOI 10.1016/j.ympev.2012.01.011; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Rambaut A, 2013, TRACER V1 5; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Roncal J, 2013, BOT J LINN SOC, V171, P120, DOI 10.1111/j.1095-8339.2012.01297.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Saia SEMG, 2008, QUATERN INT, V184, P195, DOI 10.1016/j.quaint.2007.06.029; Saint-Hilaire AFC, 1851, VIAGEM CURITIBA PROV, VII; Sanciangco MD, 2016, MOL PHYLOGENET EVOL, V94, P565, DOI 10.1016/j.ympev.2015.10.006; Sanmartin I, 2008, J BIOGEOGR, V35, P428, DOI 10.1111/j.1365-2699.2008.01885.x; Santos AMM, 2007, J BIOGEOGR, V34, P437, DOI 10.1111/j.1365-2699.2006.01604.x; Sereno PC, 2007, CLADISTICS, V23, P565, DOI 10.1111/j.1096-0031.2007.00161.x; Tabarelli M, 2005, CONSERV BIOL, V19, P695, DOI 10.1111/j.1523-1739.2005.00694.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tavares ES, 2006, SYST BIOL, V55, P454, DOI 10.1080/10635150600697390; TAYLOR W R, 1985, Cybium, V9, P107; VAZ-FERREIRA R, 1974, Comunicaciones Zoologicas del Museo de Historia Natural de Montevideo, V10, P1; von Spix JB, 1823, VIAGEM PELO BRASIL 1, V1; WEITZMAN SH, 1988, P BIOL SOC WASH, V101, P444; Wied-Neuwied APM, 1820, VIAGEM AO BRASIL POR; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; Yu Y., 2011, RASP RECONSTRUCT ANC	86	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159315	10.1371/journal.pone.0159315	http://dx.doi.org/10.1371/journal.pone.0159315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428070	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169300048
J	Goh, YS; Peng, KT; Chia, WN; Siau, A; Chotivanich, K; Gruner, AC; Preiser, P; Mayxay, M; Pukrittayakamee, S; Sriprawat, K; Nosten, F; White, NJ; Renia, L				Goh, Yun Shan; Peng, Kaitian; Chia, Wan Ni; Siau, Anthony; Chotivanich, Kesinee; Gruner, Anne-Charlotte; Preiser, Peter; Mayxay, Mayfong; Pukrittayakamee, Sasithon; Sriprawat, Kanlaya; Nosten, Francois; White, Nicholas J.; Renia, Laurent			Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy	PLOS ONE			English	Article							ACQUIRED-IMMUNITY; PROTEIN-PEPTIDES; HOST IMMUNITY; IN-VITRO; MALARIA; INVASION; BINDING	An effective antibody response can assist drug treatment to contribute to better parasite clearance in malaria patients. To examine this, sera were obtained from two groups of adult patients with acute falciparum malaria, prior to drug treatment: patients who (1) have subsequent recrudescent infection, or (2) were cured by Day 28 following treatment. Using a Plasmodium falciparum antigen library, we examined the antibody specificities in these sera. While the antibody repertoire of both sera groups was extremely broad and varied, there was a differential antibody profile between the two groups of sera. The proportion of cured patients with antibodies against EXP1, MSP3, GLURP, RAMA, SEA and EBA181 was higher than the proportion of patients with recrudescent infection. The presence of these antibodies was associated with higher odds of treatment cure. Sera containing all six antibodies impaired the invasion of P. falciparum clinical isolates into erythrocytes. These results suggest that antibodies specific against EXP1, MSP3, GLURP, RAMA, SEA and EBA181 in P. falciparum infections could assist anti-malarial drug treatment and contribute to the resolution of the malarial infection.	[Goh, Yun Shan; Peng, Kaitian; Chia, Wan Ni; Gruner, Anne-Charlotte; Renia, Laurent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Chia, Wan Ni] Natl Univ Singapore, Dept Microbiol & Immunol, Yong Loo Lin Sch Med, Singapore, Singapore; [Siau, Anthony; Preiser, Peter; Renia, Laurent] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Chotivanich, Kesinee; Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Mayxay, Mayfong] Mahosot Hosp, Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit, Viangchan, Laos; [Sriprawat, Kanlaya; Nosten, Francois] Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Mae Sot, Thailand; [Nosten, Francois; White, Nicholas J.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [White, Nicholas J.] Mahidol Univ, Mahidol Oxford Res Unit, Fac Trop Med, Bangkok, Thailand	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Renia, L (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore.; Renia, L (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	renia_laurent@immunol.a-star.edu.sg	Nosten, Francois/AAC-5509-2019; Goh, Yun Shan/GXM-6170-2022; Preiser, Peter R/A-2201-2011; Renia, Laurent/E-2117-2011; White, Nick/AAC-6527-2019	Nosten, Francois/0000-0002-7951-0745; Renia, Laurent/0000-0003-0349-1557; White, Nick/0000-0002-1897-1978; , Peter/0000-0003-4331-7000	Singapore Immunology Network grant [07-009]; Singapore's Agency for Science, Technology and Research (A*STAR); Wellcome Trust of Great Britain; Yong Loo Lin School of Medicine, National University of Singapore (Singapore)	Singapore Immunology Network grant(Agency for Science Technology & Research (A*STAR)); Singapore's Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Wellcome Trust of Great Britain(Wellcome Trust); Yong Loo Lin School of Medicine, National University of Singapore (Singapore)(National University of Singapore)	This work was supported by a Singapore Immunology Network grant No. 07-009 (PRR and LR) and an intramural grant from Singapore's Agency for Science, Technology and Research (A*STAR) (LR). Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit, supported by the Wellcome Trust of Great Britain. Wan Ni Chia was supported by a postgraduate scholarship from the Yong Loo Lin School of Medicine, National University of Singapore (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Boyle MJ, 2014, INFECT IMMUN, V82, P924, DOI 10.1128/IAI.00866-13; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Enevold A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-153; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Gupta S, 1999, P ROY SOC B-BIOL SCI, V266, P33, DOI 10.1098/rspb.1999.0600; Lisewski AM, 2014, CELL, V158, P916, DOI 10.1016/j.cell.2014.07.011; Mayxay M, 2001, AM J TROP MED HYG, V65, P918, DOI 10.4269/ajtmh.2001.65.918; Payne RO, 2016, J INFECT DIS; Peng K, 2016, CELL MICROBIOL; Persson KEM, 2013, J IMMUNOL, V191, P785, DOI 10.4049/jimmunol.1300444; Pinzon CG, 2008, VACCINE, V26, P853, DOI 10.1016/j.vaccine.2007.11.086; Raj DK, 2014, SCIENCE, V344, P871, DOI 10.1126/science.1254417; Rodriguez LE, 2005, PROTEIN SCI, V14, P1778, DOI 10.1110/ps.041304505; Rogerson SJ, 2010, LANCET INFECT DIS, V10, P51, DOI 10.1016/S1473-3099(09)70322-6; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; WHO, 2015, MAL FACTSH	20	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159347	10.1371/journal.pone.0159347	http://dx.doi.org/10.1371/journal.pone.0159347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427762	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169300054
J	Loeffen, R; van Oerle, R; Leers, MPG; Kragten, JA; Crijns, H; Spronk, HMH; ten Cate, H				Loeffen, Rinske a; van Oerle, Rene; Leers, Mathie P. G.; Kragten, Johannes A.; Crijns, Harry; Spronk, Henri M. H.; ten Cate, Hugo			Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ACTIVATED FACTOR-XI; TISSUE-FACTOR; ARTERY-DISEASE; COAGULATION-FACTORS; UNSTABLE ANGINA; HEART-DISEASE; IN-VIVO; MECHANISMS; ATHEROSCLEROSIS	Objective In acute coronary syndrome (ACS) cardiac cell damage is preceded by thrombosis. Therefore, plasma coagulation markers may have additional diagnostic relevance in ACS. By using novel coagulation assays this study aims to gain more insight into the relationship between the coagulation system and ACS. Methods We measured plasma thrombin generation, factor XIa and D-dimer levels in plasma from ACS (n = 104) and non-ACS patients (n = 42). Follow-up measurements (n = 73) were performed at 1 and 6 months. Associations between coagulation markers and recurrent cardiovascular events were calculated by logistic regression analysis. Results Thrombin generation was significantly enhanced in ACS compared to non-ACS patients: peak height 148 +/- 53 vs. 122 +/- 42 nM. There was a significantly diminished ETP reduction (32 vs. 41%) and increased intrinsic coagulation activation (25 vs. 7%) in ACS compared to non-ACS patients. Furthermore, compared to non-ACS patients factor XIa and D-dimer levels were significantly elevated in ACS patients: 1.9 +/- 1.1 vs. 1.4 +/- 0.7 pM and 495(310-885) vs. 380(235-540) mu g/L. Within the ACS spectrum, ST-elevated myocardial infarction patients had the highest prothrombotic profile. During the acute event, thrombin generation was significantly increased compared to 1 and 6 months afterwards: peak height 145 +/- 52 vs. 100 +/- 44 vs. 98 +/- 33 nM. Both peak height and factor XIa levels on admission predicted recurrent cardiovascular events (OR: 4.9 [95% CI 1.2-20.9] and 4.5 [1.1-18.9]). Conclusion ACS patients had an enhanced prothrombotic profile, demonstrated by an increased thrombin generation potential, factor XIa and D-dimer levels. This study is the first to demonstrate the positive association between factor XIa, thrombin generation and recurrent cardiovascular events.	[Loeffen, Rinske a; van Oerle, Rene; Spronk, Henri M. H.; ten Cate, Hugo] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Internal Med,Lab Clin Thrombosis & Haemostas, Maastricht, Netherlands; [Loeffen, Rinske a; van Oerle, Rene; Spronk, Henri M. H.; ten Cate, Hugo] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [Leers, Mathie P. G.] Atrium Med Ctr Parkstad, Dept Clin Chem, Heerlen, Netherlands; [Leers, Mathie P. G.] Atrium Med Ctr Parkstad, Dept Hematol, Heerlen, Netherlands; [Kragten, Johannes A.] Atrium Med Ctr Parkstad, Dept Cardiol, Heerlen, Netherlands; [Crijns, Harry] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands	Maastricht University; Maastricht University; Atrium Medical Center; Atrium Medical Center; Atrium Medical Center; Maastricht University	Loeffen, R (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Internal Med,Lab Clin Thrombosis & Haemostas, Maastricht, Netherlands.; Loeffen, R (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands.	rinske.loeffen@maastrichtuniversity.nl	Leers, Mathie/AFV-8239-2022; Cate, Hugo ten/AAM-4000-2021	Leers, Mathie/0000-0001-5186-5600; Spronk, Henri/0000-0002-3858-334X; ten Cate, Hugo/0000-0001-7796-4463	project INCOAG [01C-201]; Dutch Heart Foundation	project INCOAG; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project INCOAG (grant 01C-201), and supported by the Dutch Heart Foundation.	Biasucci LM, 1996, AM J CARDIOL, V77, P85, DOI 10.1016/S0002-9149(97)89141-2; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Butenas S, 2008, THROMB HAEMOSTASIS, V99, P142, DOI 10.1160/TH07-08-0499; Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918; Cooper JA, 2000, CIRCULATION, V102, P2816; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Doggen CJM, 2006, BLOOD, V108, P4045, DOI 10.1182/blood-2005-12-023697; FUSTER V, 1990, CIRCULATION, V82, P47; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315; Loeffen R, 2014, THROMB RES, V134, P1328, DOI 10.1016/j.thromres.2014.09.015; Loeffen R, 2012, J THROMB HAEMOST, V10, P2544, DOI 10.1111/jth.12012; Loeffen R, 2012, J THROMB HAEMOST, V10, P1207, DOI 10.1111/j.1538-7836.2012.04782.x; Loeffen R, 2014, J GERONTOLOGY A; Lowe GDO, 2004, ARTERIOSCL THROM VAS, V24, P1529, DOI 10.1161/01.ATV.0000135995.39488.6c; Luszczak J, 2011, BLOOD COAGUL FIBRIN, V22, P473, DOI 10.1097/MBC.0b013e328346c2bb; Manten A, 1998, CARDIOVASC RES, V40, P389, DOI 10.1016/S0008-6363(98)00130-8; MERLINI PA, 1994, CIRCULATION, V90, P61, DOI 10.1161/01.CIR.90.1.61; Minnema MC, 2000, ARTERIOSCL THROM VAS, V20, P2489, DOI 10.1161/01.ATV.20.11.2489; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Orbe J, 2008, THROMB HAEMOSTASIS, V99, P382, DOI 10.1160/TH07-07-0443; Ottani F, 2001, CLIN CHIM ACTA, V311, P33, DOI 10.1016/S0009-8981(01)00555-1; Rauch U, 2001, ANN INTERN MED, V134, P224, DOI 10.7326/0003-4819-134-3-200102060-00014; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Skeppholm M, 2011, THROMB RES, V128, P483, DOI 10.1016/j.thromres.2011.03.011; Smid M, 2011, J THROMB HAEMOST, V9, P450, DOI 10.1111/j.1538-7836.2010.04162.x; Smid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066977; Tucker EI, 2009, BLOOD, V113, P936, DOI 10.1182/blood-2008-06-163675; Undas A, 2012, EUR J CLIN INVEST, V42, P123, DOI 10.1111/j.1365-2362.2011.02565.x; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; van der Putten RFM, 2006, CLIN CHIM ACTA, V371, P37, DOI 10.1016/j.cca.2006.03.005; Zabczyk M, 2010, POL ARCH MED WEWN, V120, P334, DOI 10.20452/pamw.961	35	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0158355	10.1371/journal.pone.0158355	http://dx.doi.org/10.1371/journal.pone.0158355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27419389	Green Submitted, gold, Green Published			2022-12-27	WOS:000379662300002
J	Holdgate, MR; Meehan, CL; Hogan, JN; Miller, LJ; Rushen, J; de Passille, AM; Soltis, J; Andrews, J; Shepherdson, DJ				Holdgate, Matthew R.; Meehan, Cheryl L.; Hogan, Jennifer N.; Miller, Lance J.; Rushen, Jeff; de Passille, Anne Marie; Soltis, Joseph; Andrews, Jeff; Shepherdson, David J.			Recumbence Behavior in Zoo Elephants: Determination of Patterns and Frequency of Recumbent Rest and Associated Environmental and Social Factors	PLOS ONE			English	Article							CHOBE NATIONAL-PARK; SLEEP-DEPRIVATION; LYING BEHAVIOR; DAIRY-COWS; PHYLOGENETIC ANALYSIS; NOCTURNAL BEHAVIOR; LOXODONTA-AFRICANA; ASIAN ELEPHANT; TIME; LAMENESS	Resting behaviors are an essential component of animal welfare but have received little attention in zoological research. African savanna elephant (Loxodonta africana) and Asian elephant (Elephas maximus) rest includes recumbent postures, but no large-scale investigation of African and Asian zoo elephant recumbence has been previously conducted. We used anklets equipped with accelerometers to measure recumbence in 72 adult female African (n = 44) and Asian (n = 28) elephants housed in 40 North American zoos. We collected 344 days of data and determined associations between recumbence and social, housing, management, and demographic factors. African elephants were recumbent less (2.1 hours/day, S.D. = 1.1) than Asian elephants (3.2 hours/day, S.D. = 1.5; P < 0.001). Nearly one-third of elephants were non-recumbent on at least one night, suggesting this is a common behavior. Multi-variable regression models for each species showed that substrate, space, and social variables had the strongest associations with recumbence. In the African model, elephants who spent any amount of time housed on all-hard substrate were recumbent 0.6 hours less per day than those who were never on all-hard substrate, and elephants who experienced an additional acre of outdoor space at night increased their recumbence by 0.48 hours per day. In the Asian model, elephants who spent any amount of time housed on all-soft substrate were recumbent 1.1 hours more per day more than those who were never on all-soft substrate, and elephants who spent any amount of time housed alone were recumbent 0.77 hours more per day than elephants who were never housed alone. Our results draw attention to the significant interspecific difference in the amount of recumbent rest and in the factors affecting recumbence; however, in both species, the influence of flooring substrate is notably important to recumbent rest, and by extension, zoo elephant welfare.	[Holdgate, Matthew R.; Shepherdson, David J.] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Holdgate, Matthew R.; Shepherdson, David J.] Oregon Zoo, Conservat Res Div, Portland, OR USA; [Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA; [Miller, Lance J.] Chicago Zool Soc, Brookfield Zoo, Brookfield, IL USA; [Rushen, Jeff; de Passille, Anne Marie] Univ British Columbia, Dairy Educ & Res Ctr, Agassiz, BC, Canada; [Soltis, Joseph] Disneys Anim Kingdom, Dept Educ & Sci, Lake Buena Vista, FL USA; [Andrews, Jeff] Busch Gardens, Zool Operat, Tampa, FL USA	Portland State University; University of British Columbia; Walt Disney Company	Holdgate, MR (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97207 USA.; Holdgate, MR (corresponding author), Oregon Zoo, Conservat Res Div, Portland, OR USA.	mholdgate@gmail.com			Institute of Museum and Library Services [LG-25-10-0033-10]; Forbes-Lea Research Grant; Marie Brown Award; Student Education Travel Grant; Pittsburgh Zoo; Oregon Zoo; Disney's Animal Kingdom; Chicago Zoological Society-Brookfield Zoo; Busch Gardens; IMLS; AWARE Institute	Institute of Museum and Library Services; Forbes-Lea Research Grant; Marie Brown Award; Student Education Travel Grant; Pittsburgh Zoo; Oregon Zoo; Disney's Animal Kingdom; Chicago Zoological Society-Brookfield Zoo; Busch Gardens; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. This paper was completed while MRH was undertaking a Ph.D. in Biology at Portland State University and in receipt of funding from the Forbes-Lea Research Grant, Marie Brown Award, and Student Education Travel Grant. This study was also funded in part by a research grant from the Pittsburgh Zoo. Employers provided financial support in the form of authors' salaries as follows: Oregon Zoo (DS and MH); Disney's Animal Kingdom (JS); Chicago Zoological Society-Brookfield Zoo (LM); Busch Gardens (JA). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1980, APPL ANIM ETHOL, V6, P257, DOI 10.1016/0304-3762(80)90027-9; Bell NJ, 2009, VET J, V180, P178, DOI 10.1016/j.tvjl.2008.05.020; Bergsten C, 1996, ACTA VET SCAND, V37, P383; Botreau R, 2007, ANIM WELFARE, V16, P225; Brockett RC, 1999, ZOO BIOL, V18, P101, DOI 10.1002/(SICI)1098-2361(1999)18:2&lt;101::AID-ZOO2&gt;3.0.CO;2-4; Broom D.M., 2007, DOMESTIC ANIMAL BEHA, V4th; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; BURGER J, 1994, BEHAVIOUR, V131, P153, DOI 10.1163/156853994X00415; Capellini I, 2008, EVOLUTION, V62, P1764, DOI 10.1111/j.1558-5646.2008.00392.x; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Dimeo-Ediger N, 2000, THE ELEPHANTS FOOT, P153; Endres MI, 2007, J DAIRY SCI, V90, P4192, DOI 10.3168/jds.2006-751; EVERSON CA, 1995, BEHAV BRAIN RES, V69, P43, DOI 10.1016/0166-4328(95)00009-I; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; Fregonesi JA, 2007, J DAIRY SCI, V90, P3349, DOI 10.3168/jds.2006-794; Galindo F, 2000, RES VET SCI, V69, P75, DOI 10.1053/rvsc.2000.0391; Greco BJ, 2016, PLOS ONE; Guy P. R., 1976, AFR J ECOL, V14, P285; Haley DB, 2001, APPL ANIM BEHAV SCI, V71, P105, DOI 10.1016/S0168-1591(00)00175-1; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; HARTMANN E, 1968, PSYCHOPHYSIOLOGY, V4, P389; Hendrichs H., 1971, DIKDIK ELEFANTEN OKO; Holdgate MR, 2016, PLOS ONE; Ito K, 2009, J DAIRY SCI, V92, P4412, DOI 10.3168/jds.2009-2235; Jensen MB, 2005, APPL ANIM BEHAV SCI, V90, P207, DOI 10.1016/j.applanim.2004.08.006; Joubert D, 2006, AFR J ECOL, V44, P279, DOI 10.1111/j.1365-2028.2006.00626.x; Kandler C, 2010, THESIS; Kuhme W., 1963, P113; Ledgerwood DN, 2010, J DAIRY SCI, V93, P5129, DOI 10.3168/jds.2009-2945; Lesku JA, 2006, AM NAT, V168, P441, DOI 10.1086/506973; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MCKAY GM, 1973, SMITHSONIAN CONTRIBU; MCKNIGHT BL, 1995, AFR J ECOL, V33, P242, DOI 10.1111/j.1365-2028.1995.tb00802.x; Meehan CL, 2016, PLOS ONE; Meller CL, 2007, ZOO BIOL, V26, P51, DOI 10.1002/zoo.20119; METZ JHM, 1985, APPL ANIM BEHAV SCI, V13, P301, DOI 10.1016/0168-1591(85)90010-3; Miller LJ, 2012, ANIM WELFARE, V21, P577, DOI 10.7120/09627286.21.4.577; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Mills DS, 2000, ANIM SCI, V70, P95, DOI 10.1017/S1357729800051638; Moss C., 1975, PORTRAITS WILD BEHAV; MUNKSGAARD L, 1993, CAN J ANIM SCI, V73, P847, DOI 10.4141/cjas93-087; Munksgaard L, 1999, ACTA AGR SCAND A-AN, V49, P172, DOI 10.1080/090647099424088; Munksgaard L, 2005, APPL ANIM BEHAV SCI, V92, P3, DOI 10.1016/j.applanim.2004.11.005; NOAA, 2011, QUAL CONTR LOC CLIM; Opp MR, 2015, BRAIN BEHAV IMMUN, V47, P1, DOI 10.1016/j.bbi.2015.03.011; Ozminkowski RJ, 2002, J OCCUP ENVIRON MED, V44, P21, DOI 10.1097/00043764-200201000-00005; Pandi-Perumal SR, 2002, AGEING RES REV, V1, P559, DOI 10.1016/S1568-1637(02)00014-4; Pedersen GR, 2004, J EQUINE VET SCI, V24, P153, DOI 10.1016/j.jevs.2004.03.013; Posta B., 2013, INT J COMP PSYCHOL, V26, P37, DOI [DOI 10.46867/IJCP.2013.26.01.05, 10.46867/ijcp.2013.26.01.05]; Power RJ, 2009, AFR ZOOL, V44, P36, DOI 10.3377/004.044.0104; Prado-Oviedo NA, 2016, PLOS ONE; Preston BT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-7; Raabymagle P, 2006, J EQUINE VET SCI, V26, P11, DOI 10.1016/j.jevs.2005.11.015; Rechtschaffen A, 2002, SLEEP, V25, P18, DOI 10.1093/sleep/25.1.18; Rushen J, 2007, J DAIRY SCI, V90, P3647, DOI 10.3168/jds.2006-463; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Sikes S.K, 1971, NATURAL HIST AFRICAN; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889; TOBLER I, 1995, BEHAV BRAIN RES, V69, P35, DOI 10.1016/0166-4328(95)00025-O; TOBLER I, 1992, SLEEP, V15, P1; TOTH LA, 1995, ADV NEUROIMMUNOL, V5, P79, DOI 10.1016/0960-5428(94)00045-P; Tucker CB, 2004, J DAIRY SCI, V87, P1208, DOI 10.3168/jds.S0022-0302(04)73271-3; Weisz Isolde, 2000, IZN (International Zoo News), V47, P228; Wilson ML, 2006, ZOO BIOL, V25, P173, DOI 10.1002/zoo.20084; WYATT J R, 1974, East African Wildlife Journal, V12, P273	67	31	32	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0153301	10.1371/journal.pone.0153301	http://dx.doi.org/10.1371/journal.pone.0153301			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414809	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500006
J	Liljegren, MM; de Muinck, EJ; Trosvik, P				Liljegren, Mikkel Meyn; de Muinck, Eric Jacques; Trosvik, Pal			Microsatellite Length Scoring by Single Molecule Real Time Sequencing - Effects of Sequence Structure and PCR Regime	PLOS ONE			English	Article							ESCHERICHIA-COLI; MUTATION-RATES; INSTABILITY; POPULATION; NUMBER; DNA; EXPANSION; BACTERIA; ALLELES; CELLS	Microsatellites are DNA sequences consisting of repeated, short (1-6 bp) sequence motifs that are highly mutable by enzymatic slippage during replication. Due to their high intrinsic variability, microsatellites have important applications in population genetics, forensics, genome mapping, as well as cancer diagnostics and prognosis. The current analytical standard for microsatellites is based on length scoring by high precision electrophoresis, but due to increasing efficiency next-generation sequencing techniques may provide a viable alternative. Here, we evaluated single molecule real time (SMRT) sequencing, implemented in the PacBio series of sequencing apparatuses, as a means of microsatellite length scoring. To this end we carried out multiplexed SMRT sequencing of plasmid-carried artificial microsatellites of varying structure under different pre-sequencing PCR regimes. For each repeat structure, reads corresponding to the target length dominated. We found that pre-sequencing amplification had large effects on scoring accuracy and error distribution relative to controls, but that the effects of the number of amplification cycles were generally weak. In line with expectations enzymatic slippage decreased proportionally with microsatellite repeat unit length and increased with repetition number. Finally, we determined directional mutation trends, showing that PCR and SMRT sequencing introduced consistent but opposing error patterns in contraction and expansion of the microsatellites on the repeat motif and single nucleotide level.	[Liljegren, Mikkel Meyn; de Muinck, Eric Jacques; Trosvik, Pal] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway	University of Oslo	Trosvik, P (corresponding author), Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway.	pal.trosvik@ibv.uio.no		de Muinck, Eric/0000-0001-5606-3172	Research Council of Norway [214285/F20]	Research Council of Norway(Research Council of Norway)	This study was funded by Research Council of Norway grant 214285/F20. URL: http://www.forskningsradet.no/.	Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Bhargava A, 2010, MOL BIOTECHNOL, V44, P250, DOI 10.1007/s12033-009-9230-4; Boyer JC, 2002, HUM MOL GENET, V11, P707, DOI 10.1093/hmg/11.6.707; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; COVARRUBIAS L, 1982, GENE, V17, P79, DOI 10.1016/0378-1119(82)90103-2; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eckert KA, 2000, NUCLEIC ACIDS RES, V28, P2831, DOI 10.1093/nar/28.14.2831; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Gan C, 2015, GENES-BASEL, V6, P46, DOI 10.3390/genes6010046; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Grohme MA, 2013, BIOTECHNIQUES, V55, P255, DOI 10.2144/000114104; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Imhof M, 2001, P NATL ACAD SCI USA, V98, P1113, DOI 10.1073/pnas.98.3.1113; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Lai YL, 2003, MOL BIOL EVOL, V20, P2123, DOI 10.1093/molbev/msg228; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Loomis EW, 2013, GENOME RES, V23, P121, DOI 10.1101/gr.141705.112; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; Petit RJ, 2005, MOL ECOL, V14, P885, DOI 10.1111/j.1365-294X.2005.02446.x; R Core Team, 2013, R LANG ENV STAT COMP; Salipante SJ, 2014, CLIN CHEM, V60, P1192, DOI 10.1373/clinchem.2014.223677; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; SCHWARTZ LS, 1992, AM J HUM GENET, V51, P721; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; Twerdi CD, 1999, P NATL ACAD SCI USA, V96, P2875, DOI 10.1073/pnas.96.6.2875; Wang W, 2003, J HUM GENET, V48, P337, DOI 10.1007/s10038-003-0034-2; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	35	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159232	10.1371/journal.pone.0159232	http://dx.doi.org/10.1371/journal.pone.0159232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414800	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500102
J	McCarthy, KR; Johnson, WE; Kirmaier, A				McCarthy, Kevin R.; Johnson, Welkin E.; Kirmaier, Andrea			Phylogeny and History of the Lost SIV from Crab-Eating Macaques: SIVmfa	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MAURITIAN CYNOMOLGUS MACAQUES; CLASS-I ALLELES; MACACA-FASCICULARIS; RHESUS MACAQUES; HTLV-III; TRIM5-ALPHA GENOTYPE; FUNCTIONAL DIVERSITY; NONHUMAN-PRIMATES; HIV-1 INFECTION	In the 20th century, thirteen distinct human immunodeficiency viruses emerged following independent cross-species transmission events involving simian immunodeficiency viruses (SIV) from African primates. In the late 1900s, pathogenic SIV strains also emerged in the United Sates among captive Asian macaque species following their unintentional infection with SIV from African sooty mangabeys (SIVsmm). Since their discovery in the 1980s, SIVs from rhesus macaques (SIVmac) and pig-tailed macaques (SIVmne) have become invaluable models for studying HIV pathogenesis, vaccine design and the emergence of viruses. SIV isolates from captive crab-eating macaques (SIVmfa) were initially described but lost prior to any detailed molecular and genetic characterization. In order to infer the origins of the lost SIVmfa lineage, we located archived material and colony records, recovered its genomic sequence by PCR, and assessed its phylogenetic relationship to other SIV strains. We conclude that SIVmfa is the product of two cross-species transmission events. The first was the established transmission of SIVsmm to rhesus macaques, which occurred at the California National Primate Research Center in the late 1960s and the virus later emerged as SIVmac. In a second event, SIVmac was transmitted to crab-eating macaques, likely at the Laboratory for Experimental Medicine and Surgery in Primates in the early 1970s, and it was later spread to the New England Primate Research Center colony in 1973 and eventually isolated in 1986. Our analysis suggests that SIVmac had already emerged by the early 1970s and had begun to diverge into distinct lineages. Furthermore, our findings suggest that pathogenic SIV strains may have been more widely distributed than previously appreciated, raising the possibility that additional isolates may await discovery.	[McCarthy, Kevin R.] Harvard Med Sch, Program Virol, Boston, MA USA; [McCarthy, Kevin R.; Johnson, Welkin E.; Kirmaier, Andrea] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [McCarthy, Kevin R.] Boston Childrens Hosp, Boston, MA USA	Harvard University; Harvard Medical School; Boston College; Harvard University; Boston Children's Hospital	Kirmaier, A (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	kirmaier@bc.edu	Kirmaier, Andrea/H-4034-2019	Kirmaier, Andrea/0000-0001-7206-7640	National Institutes of Health/National Center for Research Resources grant [RR00168]	National Institutes of Health/National Center for Research Resources grant	This work was funded by National Institutes of Health/National Center for Research Resources grant RR00168 (to New England Primate Research Center).	Apetrei C, 2006, AIDS, V20, P317, DOI 10.1097/01.aids.0000206498.71041.0e; Apetrei C, 2005, J VIROL, V79, P8991, DOI 10.1128/JVI.79.14.8991-9005.2005; Apetrei C, 2004, FRONT BIOSCI-LANDMRK, V9, P225, DOI 10.2741/1154; Ayouba A, 2013, AIDS, V27, P2488, DOI 10.1097/01.aids.0000432443.22684.50; BASKIN GB, 1987, AM J PATHOL, V129, P345; BENVENISTE RE, 1986, J VIROL, V60, P483, DOI 10.1128/JVI.60.2.483-490.1986; Berry NJ, 2012, IMMUNOGENETICS, V64, P267, DOI 10.1007/s00251-011-0585-x; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; Burwitz BJ, 2009, J VIROL, V83, P6011, DOI 10.1128/JVI.00199-09; D'arc M, 2015, P NATL ACAD SCI USA, V112, pE1343, DOI 10.1073/pnas.1502022112; DANIEL MD, 1985, SCIENCE, V228, P1201, DOI 10.1126/science.3159089; DANIEL MD, 1988, INT J CANCER, V41, P601, DOI 10.1002/ijc.2910410421; de Groot NG, 2011, TISSUE ANTIGENS, V78, P256, DOI 10.1111/j.1399-0039.2011.01768.x; Dietrich EA, 2011, J VIROL, V85, P9956, DOI 10.1128/JVI.00097-11; Fischer W, 2012, J VIROL, V86, P13217, DOI 10.1128/JVI.01862-12; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Gao F, 2001, AIDS RES HUM RETROV, V17, P1217, DOI 10.1089/088922201316912826; Gardner MB, 1996, J MED PRIMATOL, V25, P148, DOI 10.1111/j.1600-0684.1996.tb00011.x; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Harris M, 2013, J VIROL, V87, P9353, DOI 10.1128/JVI.00909-13; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; KANKI PJ, 1985, SCIENCE, V228, P1199, DOI 10.1126/science.3873705; KESTLER HW, 1988, NATURE, V331, P619, DOI 10.1038/331619a0; KHAN AS, 1991, J VIROL, V65, P7061, DOI 10.1128/JVI.65.12.7061-7065.1991; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Krupp A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003641; Kuang YQ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-58; LETVIN NL, 1990, J ACQ IMMUN DEF SYND, V3, P1023; Liao CH, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000304692.09143.1b; LOWENSTINE LJ, 1992, J MED PRIMATOL, V21, P1; MANSFIELD KG, 1995, J MED PRIMATOL, V24, P116, DOI 10.1111/j.1600-0684.1995.tb00156.x; Mattiuzzo G, 2013, J GEN VIROL, V94, P606, DOI 10.1099/vir.0.047795-0; MOORJANKOWSKI J, 1964, NATURE, V202, P663, DOI 10.1038/202663a0; MOORJANKOWSKI J, 1963, EXP MED SURG, V21, P147; MOORJANKOWSKI J, 1977, J MED PRIMATOL, V6, P76; MOORJANKOWSKI J, 1969, ANN NY ACAD SCI, V162, P324, DOI 10.1111/j.1749-6632.1969.tb56379.x; MURPHEYCORB M, 1986, NATURE, V321, P435, DOI 10.1038/321435a0; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Newman RM, 2006, P NATL ACAD SCI USA, V103, P19134, DOI 10.1073/pnas.0605838103; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; Perkovic M, 2009, J BIOL CHEM, V284, P5819, DOI 10.1074/jbc.M808853200; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Reimann KA, 2005, J VIROL, V79, P8878, DOI 10.1128/JVI.79.14.8878-8885.2005; Reynolds MR, 2011, J VIROL, V85, P9637, DOI 10.1128/JVI.05074-11; Saito A, 2013, J GEN VIROL, V94, P1318, DOI 10.1099/vir.0.050252-0; Saito A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00314; Saito A, 2012, J GEN VIROL, V93, P594, DOI 10.1099/vir.0.038075-0; Sharp PM, 2000, BIOCHEM SOC T, V28, P275, DOI 10.1042/bst0280275; SIMON MA, 1992, AIDS RES HUM RETROV, V8, P327, DOI 10.1089/aid.1992.8.327; SOCHA WW, 1976, AM J PHYS ANTHROPOL, V45, P485, DOI 10.1002/ajpa.1330450309; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Swofford DL, 2002, PAUP PHYLOGENETIC AN; ten Haaft P, 2001, J MED PRIMATOL, V30, P207, DOI 10.1034/j.1600-0684.2001.d01-54.x; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; WIENER AS, 1967, J IMMUNOL, V98, P1011; WIENER AS, 1963, SCIENCE, V142, P67, DOI 10.1126/science.142.3588.67; Wilson SJ, 2008, J VIROL, V82, P7243, DOI 10.1128/JVI.00307-08; Wilson SJ, 2008, P NATL ACAD SCI USA, V105, P3557, DOI 10.1073/pnas.0709003105; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Wu F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003577; Yu CQ, 2013, IMMUNOGENETICS, V65, P185, DOI 10.1007/s00251-012-0670-9; Zhang GQ, 2013, AM J PRIMATOL, V75, P938, DOI 10.1002/ajp.22158; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	66	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159281	10.1371/journal.pone.0159281	http://dx.doi.org/10.1371/journal.pone.0159281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415779	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500119
J	Miller, MA; Hogan, JN; Meehan, CL				Miller, Michele A.; Hogan, Jennifer N.; Meehan, Cheryl L.			Housing and Demographic Risk Factors Impacting Foot and Musculoskeletal Health in African Elephants [Loxodonta africana] and Asian Elephants [Elephas maximus] in North American Zoos	PLOS ONE			English	Article							LOCOMOTION; DISEASE	For more than three decades, foot and musculoskeletal conditions have been documented among both Asian [Elephas maximus] and African [Loxodonta africana] elephants in zoos. Although environmental factors have been hypothesized to play a contributing role in the development of foot and musculoskeletal pathology, there is a paucity of evidence-based research assessing risk. We investigated the associations between foot and musculoskeletal health conditions with demographic characteristics, space, flooring, exercise, enrichment, and body condition for elephants housed in North American zoos during 2012. Clinical examinations and medical records were used to assess health indicators and provide scores to quantitate conditions. Using multivariable regression models, associations were found between foot health and age [P value = 0.076; Odds Ratio = 1.018], time spent on hard substrates [P value = 0.022; Odds Ratio = 1.014], space experienced during the night [P value = 0.041; Odds Ratio = 1.008], and percent of time spent in indoor/outdoor exhibits during the day [P value < 0.001; Odds Ratio = 1.003]. Similarly, the main risk factors for musculoskeletal disorders included time on hard substrate [P value = 0.002; Odds Ratio = 1.050] and space experienced in indoor/outdoor exhibits [P value = 0.039; Odds Ratio = 1.037]. These results suggest that facility and management changes that decrease time spent on hard substrates will improve elephant welfare through better foot and musculoskeletal health.	[Miller, Michele A.] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,Natl Res Fdn,Ctr Excel, MRC,Ctr Mol & Cellular Biol,Dept Sci & Technol, Cape Town, South Africa; [Hogan, Jennifer N.; Meehan, Cheryl L.] Anim Welf Assessment Res & Educ AWARE Inst, Portland, OR USA	National Research Foundation - South Africa; Stellenbosch University	Miller, MA (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,Natl Res Fdn,Ctr Excel, MRC,Ctr Mol & Cellular Biol,Dept Sci & Technol, Cape Town, South Africa.	michelemiller128@gmail.com	Miller, Michele/ABA-1332-2020	Miller, Michele/0000-0002-5883-6076	Institute of Museum and Library Services [LG-25-10-0033-10]; IMLS; AWARE Institute	Institute of Museum and Library Services; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. After the IMLS-funded period of performance (November 2010-December 2013) AWARE Institute provided support in the form of salaries for authors (CM, JH). The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1979, J ZOOL, V189, P135, DOI 10.1111/j.1469-7998.1979.tb03956.x; Barker ZE, 2009, J DAIRY SCI, V92, P1971, DOI 10.3168/jds.2008-1590; duPlessis I., 2007, SA ANIM SCI, V8, P11; Fowler ME, 2001, ELEPHANT'S FOOT, P3; Fowler Murray E., 2006, P271, DOI 10.1002/9780470344484.ch20; Frankena K, 2009, PREV VET MED, V88, P150, DOI 10.1016/j.prevetmed.2008.08.004; Gage LJ, 1997, J ZOO WILDLIFE MED, V28, P208; Greco BJ, 2016, PLOS ONE; Haufe HC, 2012, PREV VET MED, V105, P85, DOI 10.1016/j.prevetmed.2012.01.016; Holdgate MR, 2016, PLOS ONE; Houck Richard, 1993, P453; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Little JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097329; Luikart KA, 2005, J ZOO WILDLIFE MED, V36, P684, DOI 10.1638/04088.1; Meehan CL, 2016, PLOS ONE; Mikota S.K., 1994, W BLOOMFIELD; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Panagiotopoulou O, 2012, J EXP BIOL, V215, P1584, DOI 10.1242/jeb.065862; Prado-Oviedo NA, 2016, PLOS ONE; Schwammer HM, 2001, ELEPHANT'S FOOT, P69; Spelman L, 2000, ANN C AM ASS ZOO VET, P388; Veasey J., 2006, International Zoo Yearbook, V40, P63, DOI 10.1111/j.1748-1090.2006.00063.x; von Houwald F., 1998, EAZWV SCI M, V2, P323; Weissengruber GE, 2006, J ANAT, V209, P781, DOI 10.1111/j.1469-7580.2006.00648.x; West Gary, 2006, P263, DOI 10.1002/9780470344484.ch19	25	48	49	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0155223	10.1371/journal.pone.0155223	http://dx.doi.org/10.1371/journal.pone.0155223			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415763	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500010
J	Skoda, J; Hermanova, M; Loja, T; Nemec, P; Neradil, J; Karasek, P; Veselska, R				Skoda, Jan; Hermanova, Marketa; Loja, Tomas; Nemec, Pavel; Neradil, Jakub; Karasek, Petr; Veselska, Renata			Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma	PLOS ONE			English	Article							CYTOPLASMIC CD24 EXPRESSION; NESTIN EXPRESSION; TUMOR-GROWTH; CD133; TARGET; BREAST; LYN; FYN; DIFFERENTIATION; PROGRESSION	Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies. Its dismal prognosis is often attributed to the presence of cancer stem cells (CSCs) that have been identified in PDAC using various markers. However, the co-expression of all of these markers has not yet been evaluated. Furthermore, studies that compare the expression levels of CSC markers in PDAC tumor samples and in cell lines derived directly from those tumors are lacking. Here, we analyzed the expression of putative CSC markers-CD24, CD44, epithelial cell adhesion molecule (EpCAM), CD133, and nestin-by immunofluorescence, flow cytometry and quantitative PCR in 3 PDAC-derived cell lines and by immunohistochemistry in 3 corresponding tumor samples. We showed high expression of the examined CSC markers among all of the cell lines and tumor samples, with the exception of CD24 and CD44, which were enriched under in vitro conditions compared with tumor tissues. The proportions of cells positive for the remaining markers were comparable to those detected in the corresponding tumors. Co-expression analysis using flow cytometry revealed that CD24(+)/CD44(+)/EpCAM(+)/CD133(+) cells represented a significant population of the cells (range, 43 to 72%) among the cell lines. The highest proportion of CD24(+)/CD44(+)/EpCAM(+)/CD133(+) cells was detected in the cell line derived from the tumor of a patient with the shortest survival. Using gene expression profiling, we further identified the specific protumorigenic expression profile of this cell line compared with the profiles of the other two cell lines. Together, CD24(+)/CD44(+)/EpCAM(+)/CD133(+) cells are present in PDAC cell lines derived from primary tumors, and their increased proportion corresponds with a pro-tumorigenic gene expression profile.	[Skoda, Jan; Loja, Tomas; Nemec, Pavel; Neradil, Jakub; Veselska, Renata] Masaryk Univ, Fac Sci, Dept Expt Biol, Lab Tumor Biol, Brno, Czech Republic; [Skoda, Jan; Neradil, Jakub; Veselska, Renata] Univ Hosp Brno, Dept Pediat Oncol, Brno, Czech Republic; [Skoda, Jan; Hermanova, Marketa; Neradil, Jakub; Veselska, Renata] Masaryk Univ, Fac Med, Brno, Czech Republic; [Skoda, Jan; Neradil, Jakub; Veselska, Renata] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Hermanova, Marketa] St Annes Univ Hosp, Dept Pathol Anat 1, Brno, Czech Republic; [Karasek, Petr] Masaryk Mem Canc Inst, Dept Complex Oncol Care, Brno, Czech Republic	Masaryk University Brno; University Hospital Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk Memorial Cancer Institute	Veselska, R (corresponding author), Masaryk Univ, Fac Sci, Dept Expt Biol, Lab Tumor Biol, Brno, Czech Republic.; Veselska, R (corresponding author), Univ Hosp Brno, Dept Pediat Oncol, Brno, Czech Republic.; Veselska, R (corresponding author), Masaryk Univ, Fac Med, Brno, Czech Republic.; Veselska, R (corresponding author), St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.	veselska@sci.muni.cz	Neradil, Jakub/GQZ-7932-2022; Neradil, Jakub/F-1580-2019; Veselska, Renata/L-7661-2016; Loja, Tomas/I-2698-2014; Skoda, Jan/L-6566-2019	Neradil, Jakub/0000-0001-6781-7099; Loja, Tomas/0000-0002-9007-266X; Skoda, Jan/0000-0002-9292-8177; Hermanova, Marketa/0000-0002-3889-0905; Veselska, Renata/0000-0002-0048-9913	European Regional Development Fund [CZ.1.05/1.1.00/02.0123, CZ.1.07/2.3.00/20.0183]; National Program of Sustainability II - Project Translational Medicine [LQ1605]	European Regional Development Fund(European Commission); National Program of Sustainability II - Project Translational Medicine	This study was supported by grants from the European Regional Development Fund - Projects FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and CEB (No. CZ.1.07/2.3.00/20.0183), and by National Program of Sustainability II - Project Translational Medicine LQ1605. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balic A, 2012, EXP CELL RES, V318, P691, DOI 10.1016/j.yexcr.2011.11.007; Berwanger B, 2002, CANCER CELL, V2, P377, DOI 10.1016/S1535-6108(02)00179-4; Bircan S, 2006, PATHOL RES PRACT, V202, P569, DOI 10.1016/j.prp.2006.05.004; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Bunger S, 2012, EUR SURG RES, V49, P88, DOI 10.1159/000341669; Cantilena S, 2011, ONCOTARGET, V2, P976, DOI 10.18632/oncotarget.410; Chen HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056878; Chen ZY, 2010, J GASTROEN HEPATOL, V25, P293, DOI 10.1111/j.1440-1746.2009.06021.x; Choi YL, 2005, GYNECOL ONCOL, V97, P379, DOI 10.1016/j.ygyno.2005.01.018; Choi YL, 2010, CANCER RES, V70, P2296, DOI 10.1158/0008-5472.CAN-09-3141; Choi Yun La, 2006, Journal of Pathology and Translational Medicine, V40, P103; Chou YY, 2007, ANN SURG ONCOL, V14, P2748, DOI 10.1245/s10434-007-9501-x; Fernandez A, 2014, P NATL ACAD SCI USA, V111, P1409, DOI 10.1073/pnas.1323697111; Ford CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054362; Fu YG, 2006, INT J ONCOL, V29, P1453; Hashimoto K, 2014, GASTRIC CANCER, V17, P97, DOI 10.1007/s10120-013-0255-9; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang MM, 2015, J SENSORS, V2015, DOI 10.1155/2015/685154; Huang SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054579; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Jao SW, 2012, ANN SURG ONCOL, V19, P3432, DOI 10.1245/s10434-012-2394-3; Jiang H, 2014, INT J CLIN EXP PATHO, V7, P4531; Kim HS, 2012, INT J CLIN EXP PATHO, V5, P754; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Kristiansen G, 2010, LAB INVEST, V90, P1102, DOI 10.1038/labinvest.2010.70; Kure S, 2012, INT J ONCOL, V41, P1314, DOI 10.3892/ijo.2012.1565; Lee CJ, 2008, TRANSL ONCOL, V1, P14, DOI 10.1593/tlo.08013; Lenz J, 2011, J GASTROINTEST LIVER, V20, P389; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Liu WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070804; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda Y, 2012, MED MOL MORPHOL, V45, P59, DOI 10.1007/s00795-012-0571-x; Meyer MJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2449; Modarressi MH, 2000, BIOCHEM BIOPH RES CO, V272, P610, DOI 10.1006/bbrc.2000.2832; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Nunukova A, 2015, INT J MOL MED, V36, P65, DOI 10.3892/ijmm.2015.2210; Rostoker R, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0589-9; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Sasaki A, 2010, ONCOL REP, V24, P537, DOI 10.3892/or_00000890; Seufferlein T, 2012, ANN ONCOL, V23, P33, DOI 10.1093/annonc/mds224; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimozato O, 2015, ONCOGENE, V34, P1949, DOI 10.1038/onc.2014.141; Skoda J, 2016, TUMOR BIOL, V37, P9535, DOI 10.1007/s13277-016-4837-0; Skoda J, 2014, ONCOL REP, V31, P480, DOI 10.3892/or.2013.2864; Soave DF, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-29; Su N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-43; Taniuchi K, 2011, CANCER RES, V71, P895, DOI 10.1158/0008-5472.CAN-10-2743; Vaz AP, 2014, J CANC STEM CELL RES, V2, P1, DOI [10.14343/jcscr.2014.2e1004, DOI 10.14343/JCSCR.2014.2E1004]; Veselska R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-32; Wang LZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6909; Weichert W, 2005, CLIN CANCER RES, V11, P6574, DOI 10.1158/1078-0432.CCR-05-0606; Yajima I, 2014, AM J CANCER RES, V4, P182; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zhang X, 2014, STEM CELL RES, V13, P379, DOI 10.1016/j.scr.2014.09.007	57	27	28	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159255	10.1371/journal.pone.0159255	http://dx.doi.org/10.1371/journal.pone.0159255			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414409	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500112
J	Calderon-Dominguez, M; Sebastian, D; Fucho, R; Weber, M; Mir, JF; Garcia-Casarrubios, E; Obregon, MJ; Zorzano, A; Valverde, AM; Serra, D; Herrero, L				Calderon-Dominguez, Maria; Sebastian, David; Fucho, Raquel; Weber, Minela; Mir, Joan F.; Garcia-Casarrubios, Ester; Jesus Obregon, Maria; Zorzano, Antonio; Valverde, Angela M.; Serra, Dolors; Herrero, Laura			Carnitine Palmitoyltransferase 1 Increases Lipolysis, UCP1 Protein Expression and Mitochondrial Activity in Brown Adipocytes	PLOS ONE			English	Article							FATTY-ACID OXIDATION; ADIPOSE-TISSUE ACTIVITY; UNCOUPLING PROTEIN-1; INSULIN SENSITIVITY; GENE-EXPRESSION; BETA-OXIDATION; MUSCLE-CELLS; MALONYL-COA; CPT-I; METABOLISM	The discovery of active brown adipose tissue (BAT) in adult humans and the fact that it is reduced in obese and diabetic patients have put a spotlight on this tissue as a key player in obesity-induced metabolic disorders. BAT regulates energy expenditure through thermogenesis; therefore, harnessing its thermogenic fat-burning power is an attractive therapeutic approach. We aimed to enhance BAT thermogenesis by increasing its fatty acid oxidation (FAO) rate. Thus, we expressed carnitine palmitoyltransferase 1AM (CPT1AM), a permanently active mutant form of CPT1A (the rate-limiting enzyme in FAO), in a rat brown adipocyte (rBA) cell line through adenoviral infection. We found that CPT1AM-expressing rBA have increased FAO, lipolysis, UCP1 protein levels and mitochondrial activity. Additionally, enhanced FAO reduced the palmitate-induced increase in triglyceride content and the expression of obese and inflammatory markers. Thus, CPT1AM-expressing rBA had enhanced fat-burning capacity and improved lipid-induced derangements. This indicates that CPT1AM-mediated increase in brown adipocytes FAO may be a new approach to the treatment of obesity-induced disorders.	[Calderon-Dominguez, Maria; Fucho, Raquel; Weber, Minela; Mir, Joan F.; Serra, Dolors; Herrero, Laura] Univ Barcelona, IBUB, Dept Biochem & Physiol, E-08028 Barcelona, Spain; [Calderon-Dominguez, Maria; Fucho, Raquel; Weber, Minela; Mir, Joan F.; Serra, Dolors; Herrero, Laura] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, E-28029 Madrid, Spain; [Sebastian, David; Zorzano, Antonio] Univ Barcelona, Inst Res Biomed IRB Barcelona, Fac Biol, E-08028 Barcelona, Spain; [Sebastian, David; Zorzano, Antonio] Univ Barcelona, Dept Bioquim & Biol Mol, Fac Biol, E-08028 Barcelona, Spain; [Sebastian, David; Zorzano, Antonio; Valverde, Angela M.] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, E-28029 Madrid, Spain; [Garcia-Casarrubios, Ester; Jesus Obregon, Maria; Valverde, Angela M.] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Garcia-Casarrubios, Ester; Jesus Obregon, Maria; Valverde, Angela M.] Inst Invest Sanitaria La Paz, Madrid 28029, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Herrero, L (corresponding author), Univ Barcelona, IBUB, Dept Biochem & Physiol, E-08028 Barcelona, Spain.; Herrero, L (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, E-28029 Madrid, Spain.	lherrero@ub.edu	Calderon-Dominguez, Maria/AAU-3721-2020; Sebastián, David/ABH-1574-2020; Serra, Dolors/L-3657-2014; Blattes, Minéia Weber/N-4805-2018; Herrero, Laura/D-4011-2014; Zorzano, Antonio/R-5479-2018	Calderon-Dominguez, Maria/0000-0003-1797-3450; Serra, Dolors/0000-0002-4936-4206; Blattes, Minéia Weber/0000-0001-5496-3679; Herrero, Laura/0000-0003-4244-4673; Mir, Joan Francesc/0000-0001-8501-0969; Sebastian, David/0000-0002-7260-3869; Martinez Valverde, Angela/0000-0003-1192-9045	Ministry of Spain - MINECO (Fondos Europeos de Desarrollo Regional de la Union Europea [FEDER]) [SAF2012-32491, SAF2013-40987R]; Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN) [CB06/03/0001]; Centro de Investigacion Biomedica en red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); Generalitat de Catalunya [2014SGR465, 2014SGR48]; Comunidad de Madrid [S2010/BMD-2423]; INTERREG IV-B-SUDOE-FEDER (DIOMED) [SOE1/P1/E178]; European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star research fellowship; ICREA-Academia (Generalitat de Catalunya); Ciencia sem Fronteiras-CNPq fellowship [237976/2012-9]; European Foundation for the Study of Diabetes (EFSD)/L'Oreal-UNESCO "For Women in Science" research fellowship; Ministry of Spain - MINECO [SAF2013-45887-R, SAF2014-52223-C2-1-R, SAF-2015-65267-R]	Ministry of Spain - MINECO (Fondos Europeos de Desarrollo Regional de la Union Europea [FEDER]); Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN); Centro de Investigacion Biomedica en red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); Generalitat de Catalunya(Generalitat de Catalunya); Comunidad de Madrid(Comunidad de Madrid); INTERREG IV-B-SUDOE-FEDER (DIOMED); European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star research fellowship; ICREA-Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya); Ciencia sem Fronteiras-CNPq fellowship; European Foundation for the Study of Diabetes (EFSD)/L'Oreal-UNESCO "For Women in Science" research fellowship(L'Oreal Group); Ministry of Spain - MINECO	This work was supported by the Ministry of Spain - MINECO (SAF2013-45887-R to LH, SAF2014-52223-C2-1-R to DS and SAF-2015-65267-R to AMV that were cofunded by the Fondos Europeos de Desarrollo Regional de la Union Europea [FEDER], SAF2012-32491 to MJO, SAF2013-40987R to AZ, and a doctoral fellowship to JFM), the Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN) (Grant CB06/03/0001 to DS), the Centro de Investigacion Biomedica en red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), the Generalitat de Catalunya (2014SGR465 to DS, and 2014SGR48 to AZ), the Comunidad de Madrid (S2010/BMD-2423 to MJO and AMV), INTERREG IV-B-SUDOE-FEDER (DIOMED, SOE1/P1/E178) to AZ, and the European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star and L'Oreal-UNESCO "For Women in Science" research fellowships to LH. AZ is a recipient of ICREA-Academia (Generalitat de Catalunya) and MW is a recipient of the Ciencia sem Fronteiras-CNPq fellowship (237976/2012-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Brown NF, 1997, BIOCHEM J, V327, P225, DOI 10.1042/bj3270225; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Calderon-Dominguez M, 2016, ADIPOCYTE, V5, P98, DOI 10.1080/21623945.2015.1122857; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101; Chondronikola M, 2016, CELL METAB, V23, P1200, DOI 10.1016/j.cmet.2016.04.029; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Jong JMA, 2015, AM J PHYSIOL-ENDOC M, V308, pE1085, DOI 10.1152/ajpendo.00023.2015; Divakaruni AS, 2012, J BIOL CHEM, V287, P36845, DOI 10.1074/jbc.M112.381780; Doh KO, 2005, LIFE SCI, V77, P435, DOI 10.1016/j.lfs.2004.11.032; Festuccia William T, 2011, Front Endocrinol (Lausanne), V2, P84, DOI 10.3389/fendo.2011.00084; Festuccia WT, 2009, AM J PHYSIOL-REG I, V296, pR1327, DOI 10.1152/ajpregu.91012.2008; Gesta S, 2011, P NATL ACAD SCI USA, V108, P2771, DOI 10.1073/pnas.1019704108; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; Heppner KM, 2015, DIABETOLOGIA, V58, P2124, DOI 10.1007/s00125-015-3651-3; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Queipo-Ortuno MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048605; JAMAL Z, 1988, BIOCHEM J, V252, P293, DOI 10.1042/bj2520293; Ji S, 2008, MOL GENET METAB, V93, P314, DOI 10.1016/j.ymgme.2007.10.006; Lee J, 2015, CELL REP, V10, P266, DOI 10.1016/j.celrep.2014.12.023; Li YG, 2014, EMBO REP, V15, P1069, DOI 10.15252/embr.201438775; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598; LORENZO M, 1993, J CELL BIOL, V123, P1567, DOI 10.1083/jcb.123.6.1567; Malandrino MI, 2015, AM J PHYSIOL-ENDOC M, V308, pE756, DOI 10.1152/ajpendo.00362.2014; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; Mera P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097195; Monsenego J, 2012, J HEPATOL, V56, P632, DOI 10.1016/j.jhep.2011.10.008; Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; Orellana-Gavalda JM, 2011, HEPATOLOGY, V53, P821, DOI 10.1002/hep.24140; Perdomo G, 2004, J BIOL CHEM, V279, P27177, DOI 10.1074/jbc.M403566200; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Rubi B, 2002, BIOCHEM J, V364, P219, DOI 10.1042/bj3640219; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sebastian D, 2007, AM J PHYSIOL-ENDOC M, V292, pE677, DOI 10.1152/ajpendo.00360.2006; Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P773, DOI 10.1016/j.bbabio.2010.04.007; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Smith R., 1961, PHYSIOLOGIST, V4, P113; Stefanovic-Racic M, 2008, AM J PHYSIOL-ENDOC M, V294, pE969, DOI 10.1152/ajpendo.00497.2007; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Townsend KL, 2014, TRENDS ENDOCRIN MET, V25, P168, DOI 10.1016/j.tem.2013.12.004; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; World Health Organization, 2018, OB OV FACT SHEET 311; Xue RD, 2015, NAT MED, V21, P760, DOI 10.1038/nm.3881; Yu XX, 2002, FASEB J, V16, P155, DOI 10.1096/fj.01-0568com; Zhang Y, 2015, BIOMED ENVIRON SCI, V28, P97, DOI 10.3967/bes2015.012; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	57	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159399	10.1371/journal.pone.0159399	http://dx.doi.org/10.1371/journal.pone.0159399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438137	Green Published, gold			2022-12-27	WOS:000380170100041
J	Moncla, BJ; Chappell, CA; Debo, BM; Meyn, LA				Moncla, Bernard J.; Chappell, Catherine A.; Debo, Brian M.; Meyn, Leslie A.			The Effects of Hormones and Vaginal Microflora on the Glycome of the Female Genital Tract: Cervical-Vaginal Fluid	PLOS ONE			English	Article							RAPID PRESUMPTIVE IDENTIFICATION; BETA-N-ACETYLGLUCOSAMINIDASE; BINDING LECTIN MBL; LOW-BIRTH-WEIGHT; BACTERIAL VAGINOSIS; SIALIC-ACID; INFLAMMATORY CYTOKINES; GARDNERELLA-VAGINALIS; MUCIN EXPRESSION; CELL-SURFACE	In this study, we characterized the glycome of cervical-vaginal fluid, collected with a Catamenial cup. We quantified: glycosidase levels; sialic acid and high mannose specific lectin binding; mucins, MUC1, MUC4, MUC5AC, MUC7; and albumin in the samples collected. These data were analyzed in the context of hormonal status (day of menstrual cycle, hormonal contraception use) and role, if any, of the type of the vaginal microflora present. When the Nugent score was used to stratify the subjects by microflora as normal, intermediate, or bacterial vaginosis, several important differences were observed. The activities of four of six glycosidases in the samples from women with bacterial vaginosis were significantly increased when compared to normal or intermediate women: sialidase, P = < 0.001; alpha-galactosidase, P = 0.006; beta-galactosidase, P = 0.005; alpha-glucosidase, P = 0.056. Sialic acid binding sites as measured by two lectins, Maackia amurensis and Sambucus nigra binding, were significantly lower in women with BV compared to women with normal and intermediate scores (P = < 0.0001 and 0.008 respectively). High mannose binding sites, a measure of innate immunity were also significantly lower in women with BV (P = < 0.001). Additionally, we observed significant increases in MUC1, MUC4, MUC5AC, and MUC7 concentrations in women with BV (P = < 0.001, 0.001, < 0.001, 0.02 respectively). Among normal women we found that the membrane bound mucin MUC4 and the secreted MUC5AC were decreased in postmenopausal women (P = 0.02 and 0.07 respectively), while MUC7 (secreted) was decreased in women using levonorgestrel-containing IUDs (P = 0.02). The number of sialic acid binding sites was lower in the postmenopausal group (P = 0.04), but the number of high mannose binding sites, measured with Griffithsin, was not significantly different among the 6 hormonal groups. The glycosidase levels in the cervical-vaginal mucus were rather low in the groups, with exception of alpha-glucosidase activity that was much lower in the postmenopausal group (P<0.001). These studies present compelling evidence that the vaginal ecosystem responds to the presence of different vaginal microorganisms. These effects were so influential that it required us to remove subjects with BV for data interpretation of the impact of hormones. We also suggest that certain changes occurring in vaginal/cervical proteins are due to bacteria or their products. Therefore, the quantitation of vaginal mucins and lectin binding offers a new method to monitor bacteria-host interactions in the female reproductive tract. The data suggest that some of the changes in these components are the result of host processing, such as the increases in mucin content, while the microflora is responsible for the increases in glycosidases and the decreases in lectin binding. The methods should be considered a valid marker for insult to the female genital tract.	[Moncla, Bernard J.; Chappell, Catherine A.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Moncla, Bernard J.; Chappell, Catherine A.; Meyn, Leslie A.] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Debo, Brian M.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; University of Pennsylvania	Moncla, BJ (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.; Moncla, BJ (corresponding author), Magee Womens Res Inst, Pittsburgh, PA 15213 USA.	bjm4@pitt.edu			National Institutes of Health [U19AI082639]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant U19AI082639 @NIH.gov.	Albertsmeyer AC, 2010, EXP EYE RES, V90, P444, DOI 10.1016/j.exer.2009.12.009; Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Aplin JD, 1996, AM J REPROD IMMUNOL, V35, P261; Aplin JD, 1999, HUM REPROD, V14, P17, DOI 10.1093/humrep/14.suppl_2.17; Appelmelk BJ, 2000, TRENDS MICROBIOL, V8, P565, DOI 10.1016/S0966-842X(00)01875-8; Birse KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079505; Biswas N, 2014, ANTIMICROB AGENTS CH, V58, P6444, DOI 10.1128/AAC.03270-14; BRAHAM PH, 1992, J CLIN MICROBIOL, V30, P649, DOI 10.1128/JCM.30.3.649-654.1992; Brayman Melissa, 2004, Reprod Biol Endocrinol, V2, P4, DOI 10.1186/1477-7827-2-4; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; Carraway KL, 2001, BIOCHEM SOC T, V29, P162, DOI 10.1042/BST0290162; Carson DD, 1998, HUM REPROD UPDATE, V4, P459, DOI 10.1093/humupd/4.5.459; Cauci S, 1998, AM J OBSTET GYNECOL, V178, P511, DOI 10.1016/S0002-9378(98)70430-2; Cauci S, 2005, AM J OBSTET GYNECOL, V192, P489, DOI 10.1016/j.ajog.2004.07.023; Cauci S, 2002, J CLIN MICROBIOL, V40, P2147, DOI 10.1128/JCM.40.6.2147-2152.2002; Cauci S, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.035; Chappell CA, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.03.045; Chappell CA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.041; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Corfield AP, 2015, BBA-GEN SUBJECTS, V1850, P236, DOI 10.1016/j.bbagen.2014.05.003; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; Corti S, 2010, BRAIN, V133, P465, DOI 10.1093/brain/awp318; Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7; Dohrman A, 1998, BBA-MOL BASIS DIS, V1406, P251, DOI 10.1016/S0925-4439(98)00010-6; Escande F, 2001, BIOCHEM J, V358, P763, DOI 10.1042/0264-6021:3580763; Fields S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110980; FORSTNER G, 1995, ANNU REV PHYSIOL, V57, P585, DOI 10.1146/annurev.ph.57.030195.003101; Gallego MP, 2006, COLLOID SURFACE B, V52, P154, DOI 10.1016/j.colsurfb.2006.04.013; Gipson IK, 1997, BIOL REPROD, V56, P999, DOI 10.1095/biolreprod56.4.999; Gipson IK, 1999, BIOL REPROD, V60, P58, DOI 10.1095/biolreprod60.1.58; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; Gipson IK, 2001, J CLIN ENDOCR METAB, V86, P594, DOI 10.1210/jc.86.2.594; Gipson IK, 2008, BIOL REPROD, V78, P134, DOI 10.1095/biolreprod.106.058347; Hagen KT, 2014, GLYCOSCIENCE BIOL ME, P1; Hart ML, 2002, AIDS RES HUM RETROV, V18, P1311, DOI 10.1089/088922202320886352; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HOMER KA, 1994, J MED MICROBIOL, V41, P184, DOI 10.1099/00222615-41-3-184; Homer KA, 2001, J CLIN MICROBIOL, V39, P995, DOI 10.1128/JCM.39.3.995-1001.2001; Howe L, 1999, INT J STD AIDS, V10, P442, DOI 10.1258/0956462991914438; Imseis HM, 1997, J SOC GYNECOL INVEST, V4, P90, DOI 10.1016/S1071-5576(97)00003-8; Jacobson JC, 2014, CONTRACEPTION, V90, P130, DOI 10.1016/j.contraception.2014.04.006; Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015; JONES AH, 1986, J GEN MICROBIOL, V132, P3381; Keller MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P194, DOI 10.1097/QAI.0b013e31826867ae; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Klebanoff MA, 2005, AM J OBSTET GYNECOL, V192, P470, DOI 10.1016/j.ajog.2004.07.017; Lehman DA, 2014, JAIDS-J ACQ IMM DEF, V66, P135, DOI 10.1097/QAI.0000000000000104; Leite B, 1989, MICROBIAL ECOLOGY IN, V2, P255, DOI [10.3109/08910608909140228, DOI 10.3109/08910608909140228]; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Lewis WG, 2013, J BIOL CHEM, V288, P12067, DOI 10.1074/jbc.M113.453654; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; Li X, 2003, J DENT RES, V82, P883, DOI 10.1177/154405910308201107; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mitchell C, 2011, J CLIN MICROBIOL, V49, P735, DOI 10.1128/JCM.00991-10; MONCLA B J, 1986, Microbios Letters, V32, P81; Moncla BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127091; Moncla BJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-78; MONCLA BJ, 1991, J CLIN MICROBIOL, V29, P1955, DOI 10.1128/JCM.29.9.1955-1958.1991; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P422, DOI 10.1128/JCM.28.3.422-425.1990; Moncla LH, 2016, CELL HOST MICROBE, V19, P169, DOI 10.1016/j.chom.2016.01.011; Mueller Y, 2014, THE JOURNAL OF IMMUN, V192, P185; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Pang SS, 2014, J BIOL CHEM, V289, P6332, DOI 10.1074/jbc.M113.513135; Patton DL, 2007, ANTIMICROB AGENTS CH, V51, P1608, DOI 10.1128/AAC.00984-06; Petricevic L, 2013, CLIMACTERIC, V16, P356, DOI 10.3109/13697137.2012.725788; Radtke AL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103366; Roberton AM, 2005, J CLIN MICROBIOL, V43, P5504, DOI 10.1128/JCM.43.11.5504-5508.2005; Roberton AM, 1999, MEDICAL IMPORTANCE OF THE NORMAL MICROFLORA, P222; Roberts G, 2001, J MED MICROBIOL, V50, P620, DOI 10.1099/0022-1317-50-7-620; Roberts G, 2000, J BACTERIOL, V182, P882, DOI 10.1128/JB.182.4.882-890.2000; Rossi EA, 1996, J BIOL CHEM, V271, P33476, DOI 10.1074/jbc.271.52.33476; Rousseau K, 2006, ANN HUM GENET, V70, P417, DOI 10.1111/j.1469-1809.2006.00250.x; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Smirnova MG, 2003, CELL IMMUNOL, V221, P42, DOI 10.1016/S0008-8749(03)00059-5; Strober W, 1982, RECENT ADV MUCOSAL I; Stute P, 2014, MENOPAUSE, V21, P1; Tvaroska I, 2008, GLYCOSCIENCE, DOI [10.1007/978-3-540-30429-6, DOI 10.1007/978-3-540-30429-6]; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06; Valore EV, 2002, AM J OBSTET GYNECOL, V187, P561, DOI 10.1067/mob.2002.125280; Varki A., 2009, ESSENTIALS GLYCOBIOL; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Vogel I, 2003, INT J GYNECOL OBSTET, V83, P307, DOI 10.1016/S0020-7292(03)00268-6; Wang LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127021; Wiggins R, 2001, SEX TRANSM INFECT, V77, P402, DOI 10.1136/sti.77.6.402; Yanagihara K, 2001, AM J RESP CELL MOL, V24, P66, DOI 10.1165/ajrcmb.24.1.4122; Yudin MH, 2003, OBSTET GYNECOL, V102, P527, DOI 10.1016/S0029-7844(03)00566-0; YUREWICZ EC, 1982, J BIOL CHEM, V257, P2314; Zen Y, 2002, AM J PATHOL, V161, P1475, DOI 10.1016/S0002-9440(10)64423-9	97	39	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158687	10.1371/journal.pone.0158687	http://dx.doi.org/10.1371/journal.pone.0158687			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437931	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100016
J	Rogers, SL; Fay, N				Rogers, Shane L.; Fay, Nicolas			Stick or Switch: A Selection Heuristic Predicts when People Take the Perspective of Others or Communicate Egocentrically	PLOS ONE			English	Article							AUDIENCE; OVERESTIMATION; COMPREHENSION	This paper examines a cognitive mechanism that drives perspective-taking and egocentrism in interpersonal communication. Using a conceptual referential communication task, in which participants describe a range of abstract geometric shapes, Experiment 1 shows that perspective-taking and egocentric communication are frequent communication strategies. Experiment 2 tests a selection heuristic account of perspective-taking and egocentric communication. It uses participants' shape description ratings to predict their communication strategy. Participants' communication strategy was predicted by how informative they perceived the different shape descriptions to be. When participants' personal shape description was perceived to be more informative than their addressee's shape description, there was a strong bias to communicate egocentrically. By contrast, when their addressee's shape description was perceived to be more informative, there was a strong bias to take their addressee's perspective. When the shape descriptions were perceived to be equally informative, there was a moderate bias to communicate egocentrically. This simple, but powerful, selection heuristic may be critical to the cumulative cultural evolution of human communication systems, and cumulative cultural evolution more generally.	[Rogers, Shane L.] Edith Cowan Univ, Sch Psychol & Social Sci, Perth, WA, Australia; [Fay, Nicolas] Univ Western Australia, Sch Psychol, Perth, WA, Australia	Edith Cowan University; University of Western Australia	Fay, N (corresponding author), Univ Western Australia, Sch Psychol, Perth, WA, Australia.	nicolas.fay@gmail.com	Rogers, Shane L./I-8562-2019	Rogers, Shane L./0000-0002-6869-3400; Fay, Nicolas/0000-0001-9866-2800	Australian Research Council (ARC) Discovery Project [DP120104237]; ARC Discovery grant [DP120104237]	Australian Research Council (ARC) Discovery Project(Australian Research Council); ARC Discovery grant(Australian Research Council)	This work was supported by the Australian Research Council (ARC) Discovery Project awarded to NF (DP120104237); http://www.arc.gov.au/discovery-projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Simon Garrod and Monica Tamariz for comments on an earlier draft of the manuscript, and Dale Barr and Christophe Scheepers for statistical advice. We also thank Rachel Kendal, Christine Cuskley and an anonymous reviewer for their helpful feedback on an earlier version of this paper. N.F. acknowledges support by an ARC Discovery grant (no. DP120104237).	Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; BELL A, 1984, LANG SOC, V13, P145, DOI 10.1017/S004740450001037X; Branigan HP, 2011, COGNITION, V121, P41, DOI 10.1016/j.cognition.2011.05.011; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Brennan SE, 2009, TOP COGN SCI, V1, P274, DOI 10.1111/j.1756-8765.2009.01019.x; Clark H.H., 1996, USING LANGUAGE; Clark HH., 1982, LANGUAGE COMPREHENSI, V9, P287, DOI [DOI 10.1016/S0166-4115(09)60059-5, 10.1016/S0166-4115(09)60059-5]; Fay N, 2008, PHILOS T R SOC B, V363, P3553, DOI 10.1098/rstb.2008.0130; Fay N, 2014, PRAGMAT COGN, V22, P244, DOI 10.1075/pc.22.2.05fay; Fay N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071781; Fay N, 2010, J EXP SOC PSYCHOL, V46, P689, DOI 10.1016/j.jesp.2010.02.012; Fay N, 2010, COGNITIVE SCI, V34, P351, DOI 10.1111/j.1551-6709.2009.01090.x; Fay N, 2008, PSYCHON B REV, V15, P1160, DOI 10.3758/PBR.15.6.1160; FUSSELL SR, 1989, J EXP SOC PSYCHOL, V25, P203, DOI 10.1016/0022-1031(89)90019-X; Garrod S, 2007, COGNITIVE SCI, V31, P961, DOI 10.1080/03640210701703659; Garrod S, 2010, INTERACT STUD, V11, P33, DOI 10.1075/is.11.1.04gar; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Horton WS, 2005, COGNITION, V96, P127, DOI 10.1016/j.cognition.2004.07.001; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Keysar B, 2002, PSYCHOL SCI, V13, P207, DOI 10.1111/1467-9280.00439; Kronmuller E, 2015, J MEM LANG, V83, P1, DOI 10.1016/j.jml.2015.03.008; Levelt W., 1989, SPEAKING INTENTION A; Nuckles M, 2005, J EXP PSYCHOL-APPL, V11, P219, DOI 10.1037/1076-898X.11.4.219; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; R Core Team, 2021, R LANGUAGE ENV STAT; Rogers SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057211; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schlag KH, 1999, J MATH ECON, V31, P493, DOI 10.1016/S0304-4068(97)00068-2; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; SCHOBER MF, 1989, COGNITIVE PSYCHOL, V21, P211, DOI 10.1016/0010-0285(89)90008-X; SCHOBER MF, 1993, COGNITION, V47, P1, DOI 10.1016/0010-0277(93)90060-9; Shintel H, 2009, TOP COGN SCI, V1, P260, DOI 10.1111/j.1756-8765.2009.01018.x; Tamariz M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0488; Tomasello Michael, 1999, CULTURAL ORIGINS HUM	36	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159570	10.1371/journal.pone.0159570	http://dx.doi.org/10.1371/journal.pone.0159570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27437694	gold, Green Published, Green Submitted			2022-12-27	WOS:000380170100055
J	De Vries, RG; Tomlinson, T; Kim, HM; Krenz, C; Haggerty, D; Ryan, KA; Kim, SYH				De Vries, Raymond Gene; Tomlinson, Tom; Kim, Hyungjin Myra; Krenz, Chris; Haggerty, Diana; Ryan, Kerry A.; Kim, Scott Y. H.			Understanding the Public's Reservations about Broad Consent and Study-By-Study Consent for Donations to a Biobank: Results of a National Survey	PLOS ONE			English	Article							INFORMED-CONSENT; WILLINGNESS; CANCER; RISK	Researchers and policymakers do not agree about the most appropriate way to get consent for the use of donations to a biobank. The most commonly used method is blanket-or broad-consent where donors allow their donation to be used for any future research approved by the biobank. This approach does not account for the fact that some donors may have moral concerns about the uses of their biospecimens. This problem can be avoided using "real-time"-or study-by-study-consent, but this policy places a significant burden on biobanks. In order to better understand the public's preferences regarding biobank consent policy, we surveyed a sample that was representative of the population of the United States. Respondents were presented with 5 biobank consent policies and were asked to indicate which policies were acceptable/unacceptable and to identify the best/worst policies. They were also given 7 research scenarios that could create moral concern (e.g. research intending to make abortions safer and more effective) and asked how likely they would be to provide broad consent knowing that their donation might be used in that research. Substantial minorities found both broad and study-by-study consent to be unacceptable and identified those two options as the worst policies. Furthermore, while the type of moral concern (e.g., regarding abortion, the commercial use of donations, or stem cell research) had no effect on policy preferences, an increase in the number of research scenarios generating moral concerns was related to an increased likelihood of finding broad consent to be the worst policy. The rejection of these ethically problematic and costly extremes is good news for biobanks. The challenge now is to design a policy that combines consent with access to information in a way that assures potential donors that their interests and moral concerns are being respected.	[De Vries, Raymond Gene; Krenz, Chris; Ryan, Kerry A.] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Tomlinson, Tom] Michigan State Univ, Ctr Eth & Humanities Life Sci, E Lansing, MI 48824 USA; [Kim, Hyungjin Myra] Univ Michigan, Ctr Stat Consultat & Res, Ann Arbor, MI 48109 USA; [Haggerty, Diana] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Kim, Scott Y. H.] NIH, Ctr Clin, Dept Bioeth, Bldg 10, Bethesda, MD 20892 USA; [Kim, Scott Y. H.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Michigan State University; University of Michigan System; University of Michigan; Michigan State University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Michigan System; University of Michigan	De Vries, RG (corresponding author), Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA.	rdevries@med.umich.edu	Haggerty, Diana/AAA-5003-2022	De Vries, Raymond/0000-0003-3087-3040; Krenz, Chris/0000-0002-0514-4586	National Human Genome Research Institute (NHGRI) [5R01HG007172]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007172] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010540] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); CLINICAL CENTER	This research was funded by the National Human Genome Research Institute (NHGRI), grant number 5R01HG007172. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046454; De Vries RG, 2016, LIFE SCI SOC POLICY, V12, DOI 10.1186/s40504-016-0036-4; Federal Trade Commission Reynolds American Inc. and Lorillard Inc., 2015, FED REG; Garrison NA, 2015, GENET MED; Gefenas E, 2012, J MED ETHICS, V38, P351, DOI 10.1136/medethics-2011-100113; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; GfK Knowledge Networks, 2016, KNOWLEDGEPANEL DESIG; Gornick MC, 2014, J EMPIR RES HUM RES, V9, P22, DOI 10.1177/1556264614544277; Grady C, 2015, AM J BIOETHICS, V15, P34, DOI 10.1080/15265161.2015.1062162; Group TPMIW, 2015, PREC MED IN WORK GRO; Haddow G, 2007, SOC SCI MED, V64, P272, DOI 10.1016/j.socscimed.2006.08.028; Hallmans G, 2011, BEST PRACTICES ESTAB; Hewitt RE, 2011, CURR OPIN ONCOL, V23, P112, DOI 10.1097/CCO.0b013e32834161b8; Knoppers BM, 2013, HASTINGS CENT REP, V43, P4, DOI 10.1002/hast.201; Lehtinen M, 1996, BMJ-BRIT MED J, V312, P537, DOI 10.1136/bmj.312.7030.537; Lynch HF, 2016, HASTINGS CENT REP, V46, P4, DOI 10.1002/hast.528; Master Z, 2012, NAT METHODS, V9, P885, DOI 10.1038/nmeth.2142; Murphy J, 2009, AM J PUBLIC HEALTH, V99, P2128, DOI 10.2105/AJPH.2008.157099; National Research Council, 2005, GUID HUM EMBR STEM C; People Science & Policy Ltd, 2003, UK BIOB CONS ETH GOV; Petrini C, 2010, SOC SCI MED, V70, P217, DOI 10.1016/j.socscimed.2009.10.004; Pfeffer N, 2008, SOC SCI MED, V66, P2544, DOI 10.1016/j.socscimed.2008.01.050; Platt J, 2014, GENET MED, V16, P11, DOI 10.1038/gim.2013.59; Rubright JD, 2011, J EMPIR RES HUM RES, V6, P63, DOI 10.1525/jer.2011.6.1.63; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Selgelid MJ, 2009, B WORLD HEALTH ORGAN, V87, P720, DOI 10.2471/BLT.08.051383; Tomlinson T., 2009, NEW CHALLENGES BIOBA, P99; Tomlinson T, 2015, JAMA-J AM MED ASSOC, V313, P417, DOI 10.1001/jama.2014.16363; Tomlinson T, 2013, HASTINGS CENT REP, V43, P41, DOI 10.1002/hast.115; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201	30	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159113	10.1371/journal.pone.0159113	http://dx.doi.org/10.1371/journal.pone.0159113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27415017	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500079
J	Perez-Perez, A; Saanchez-Jimeenez, F; Vilarinno-Garciia, T; de la Cruz, L; Virizuela, JA; Saanchez-Margalet, V				Perez-Perez, Antonio; Sanchez-Jimenez, Flora; Vilarino-Garcia, Teresa; de la Cruz, Luis; Virizuela, Juan A.; Sanchez-Margalet, Victor			Sam68 Mediates the Activation of Insulin and Leptin Signalling in Breast Cancer Cells	PLOS ONE			English	Article							RNA-BINDING PROTEIN; BLOOD MONONUCLEAR-CELLS; MAMMARY TUMORIGENESIS; SH3 DOMAINS; RECEPTOR; EXPRESSION; MECHANISMS; PATHWAYS; OBESITY; GROWTH	Obesity is a well-known risk factor for breast cancer development in postmenopausal women. High insulin and leptin levels seem to have a role modulating the growth of these tumours. Sam68 is an RNA-binding protein with signalling functions that has been found to be overexpressed in breast cancer. Moreover, Sam68 may be recruited to insulin and leptin signalling pathways, mediating its effects on survival, growth and proliferation in different cellular types. We aimed to study the expression of Sam68 and its phosphorylation level upon insulin and leptin stimulation, and the role of Sam68 in the proliferative effect and signalling pathways that are activated by insulin or leptin in human breast adenocarcinoma cells. In the human breast adenocarcinoma cell lines MCF7, MDA-MB-231 and BT-474, Sam68 protein quantity and gene expression were increased upon leptin or insulin stimulation, as it was checked by qPCR and immunoblot. Moreover, both insulin and leptin stimulation promoted an increase in Sam68 tyrosine phosphorylation and negatively regulated its RNA binding capacity. siRNA was used to downregulate Sam68 expression, which resulted in lower proliferative effects of both insulin and leptin, as well as a lower activation of MAPK and PI3K pathways promoted by both hormones. These effects may be partly explained by the decrease in IRS-1 expression by down-regulation of Sam68. These results suggest the participation of Sam68 in both leptin and insulin receptor signaling in human breast cancer cells, mediating the trophic effects of these hormones in proliferation and cellular growth.	[Perez-Perez, Antonio; Sanchez-Jimenez, Flora; Vilarino-Garcia, Teresa; Sanchez-Margalet, Victor] Univ Seville, Virgen Macarena Univ Hosp, UGC Clin Biochem, Dept Med Biochem & Mol Biol & Immunol, Seville, Spain; [de la Cruz, Luis; Virizuela, Juan A.] Virgen Macarena Univ Hosp, UGC Clin Oncol, Seville, Spain	Hospital Universitario Virgen Macarena; University of Sevilla; Hospital Universitario Virgen Macarena	Saanchez-Margalet, V (corresponding author), Univ Seville, Virgen Macarena Univ Hosp, UGC Clin Biochem, Dept Med Biochem & Mol Biol & Immunol, Seville, Spain.	margalet@us.es	Pérez -Perez, Antonio/GRF-5099-2022; de la Cruz-Merino, Luis/K-8633-2017; Sánchez-Margalet, Victor/AAB-9986-2021; Vilariño, Teresa/AAT-3552-2021	Pérez -Perez, Antonio/0000-0002-5660-735X; de la Cruz-Merino, Luis/0000-0002-5333-0535; Sánchez-Margalet, Victor/0000-0001-8638-8680; 	Real Maestranza de Caballeria de Sevilla; Real Maestranza de Caballeria de Sevilla, Spain	Real Maestranza de Caballeria de Sevilla; Real Maestranza de Caballeria de Sevilla, Spain	The manuscript has been funded by the Real Maestranza de Caballeria de Sevilla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Real Maestranza de Caballeria de Sevilla, Spain.	Ando S, 2012, NAT REV ENDOCRINOL, V8, P263, DOI 10.1038/nrendo.2011.184; Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Babic I, 2004, ONCOGENE, V23, P3781, DOI 10.1038/sj.onc.1207484; Barlat I, 1997, J BIOL CHEM, V272, P3129, DOI 10.1074/jbc.272.6.3129; Bielli P, 2011, ENDOCR-RELAT CANCER, V18, pR91, DOI 10.1530/ERC-11-0041; Busa R, 2007, ONCOGENE, V26, P4372, DOI 10.1038/sj.onc.1210224; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Chawla G, 2009, MOL CELL BIOL, V29, P201, DOI 10.1128/MCB.01349-08; Chen H, 2012, J BUON, V17, P658; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Dieudonne MN, 2002, BIOCHEM BIOPH RES CO, V293, P622, DOI 10.1016/S0006-291X(02)00205-X; Elliott DJ, 2010, J PATHOL, V222, P223, DOI 10.1002/path.2753; Frasca Francesco, 2003, Breast Dis, V17, P73; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Fusaki N, 1997, J BIOL CHEM, V272, P6214, DOI 10.1074/jbc.272.10.6214; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; GROSS GE, 1984, CANCER RES, V44, P3570; Hu X, 2002, J NATL CANCER I, V94, P1704, DOI 10.1093/jnci/94.22.1704; Ishikawa M, 2004, CLIN CANCER RES, V10, P4325, DOI 10.1158/1078-0432.CCR-03-0749; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Kunkel GT, 2011, MOL CELL, V43, P157, DOI 10.1016/j.molcel.2011.07.004; Li QH, 2002, FEBS LETT, V525, P145, DOI 10.1016/S0014-5793(02)03103-4; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Locatelli A, 2012, HORM CANCER-US, V3, P14, DOI 10.1007/s12672-011-0097-z; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Lukong KE, 2005, J BIOL CHEM, V280, P38639, DOI 10.1074/jbc.M505802200; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Martin-Romero C, 2001, CELL IMMUNOL, V212, P83, DOI 10.1006/cimm.2001.1851; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Najib S, 2005, CELL MOL LIFE SCI, V62, P36, DOI 10.1007/s00018-004-4309-3; Najib S, 2002, CELL IMMUNOL, V220, P143, DOI 10.1016/S0008-8749(03)00027-3; Najib S, 2002, J CELL BIOCHEM, V86, P99, DOI 10.1002/jcb.10198; Newman G, 2014, MOL CELL ENDOCRINOL, V382, P570, DOI 10.1016/j.mce.2013.03.025; Nolan MK, 1997, INT J CANCER, V72, P828, DOI 10.1002/(SICI)1097-0215(19970904)72:5<828::AID-IJC20>3.0.CO;2-3; Palacios C, 2010, CANCER LETT, V287, P207, DOI 10.1016/j.canlet.2009.06.012; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Paronetto MP, 2009, J CELL BIOL, V185, P235, DOI 10.1083/jcb.200811138; Quintana-Portillo R, 2012, BIOCHEM PHARMACOL, V83, P78, DOI 10.1016/j.bcp.2011.09.030; Revillion F, 2006, CLIN CANCER RES, V12, P2088, DOI 10.1158/1078-0432.CCR-05-1904; Richard S, 2008, ONCOGENE, V27, P548, DOI 10.1038/sj.onc.1210652; Rose DP, 2012, ENDOCR-RELAT CANCER, V19, pR225, DOI 10.1530/ERC-12-0203; Rose DP, 2002, INT J ONCOL, V21, P1285; Sanchez-Jimenez F, 2011, HUM REPROD, V26, P2306, DOI 10.1093/humrep/der187; Sanchez-Jimenez F, 2013, INT J MOL SCI, V14, P23402, DOI 10.3390/ijms141223402; Sanchez-Jimenez F, 2011, MOL CELL ENDOCRINOL, V332, P221, DOI 10.1016/j.mce.2010.10.014; Sanchez-Margalet V, 1999, FEBS LETT, V455, P307, DOI 10.1016/S0014-5793(99)00887-X; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Sanchez-Margalet V, 2003, CELL MOL LIFE SCI, V60, P751, DOI 10.1007/s00018-003-2342-2; Sanchez-Margalet V, 2001, CELL IMMUNOL, V211, P30, DOI 10.1006/cimm.2001.1815; Sanchez-Margalet V, 2001, MOL CELL ENDOCRINOL, V183, P113, DOI 10.1016/S0303-7207(01)00587-1; Sette C, 2010, J ANDROL, V31, P66, DOI 10.2164/jandrol.109.008136; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song LB, 2010, J PATHOL, V222, P227, DOI 10.1002/path.2751; Stoss O, 2001, J BIOL CHEM, V276, P8665, DOI 10.1074/jbc.M006851200; Sulkowska M, 2006, PATHOL ONCOL RES, V12, P69, DOI 10.1007/BF02893446; Szanto I, 2000, P NATL ACAD SCI USA, V97, P2355, DOI 10.1073/pnas.050580497; Tanizawa Y, 1997, ENDOCRINOLOGY, V138, P4513, DOI 10.1210/en.138.10.4513; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Vigneri R, 1992, Cancer Treat Res, V63, P193; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WANG LL, 1995, J BIOL CHEM, V270, P2010, DOI 10.1074/jbc.270.5.2010	66	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158218	10.1371/journal.pone.0158218	http://dx.doi.org/10.1371/journal.pone.0158218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415018	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500019
J	Figuera, C; Irusta, U; Morgado, E; Aramendi, E; Ayala, U; Wik, L; Kramer-Johansen, J; Eftestol, T; Alonso-Atienza, F				Figuera, Carlos; Irusta, Unai; Morgado, Eduardo; Aramendi, Elisabete; Ayala, Unai; Wik, Lars; Kramer-Johansen, Jo; Eftestol, Trygve; Alonso-Atienza, Felipe			Machine Learning Techniques for the Detection of Shockable Rhythms in Automated External Defibrillators	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; ARRHYTHMIA ANALYSIS ALGORITHM; PUBLIC-ACCESS DEFIBRILLATION; CHEST COMPRESSION PAUSES; VENTRICULAR-FIBRILLATION; CARDIOPULMONARY-RESUSCITATION; SURFACE ECG; WAVE-FORM; TACHYCARDIA; PARAMETERS	Early recognition of ventricular fibrillation (VF) and electrical therapy are key for the survival of out-of-hospital cardiac arrest (OHCA) patients treated with automated external defibrillators (AED). AED algorithms for VF-detection are customarily assessed using Holter recordings from public electrocardiogram (ECG) databases, which may be different from the ECG seen during OHCA events. This study evaluates VF-detection using data from both OHCA patients and public Holter recordings. ECG-segments of 4-s and 8-s duration were analyzed. For each segment 30 features were computed and fed to state of the art machine learning (ML) algorithms. ML-algorithms with built-in feature selection capabilities were used to determine the optimal feature subsets for both databases. Patient-wise bootstrap techniques were used to evaluate algorithm performance in terms of sensitivity (Se), specificity (Sp) and balanced error rate (BER). Performance was significantly better for public data with a mean Se of 96.6%, Sp of 98.8% and BER 2.2% compared to a mean Se of 94.7%, Sp of 96.5% and BER 4.4% for OHCA data. OHCA data required two times more features than the data from public databases for an accurate detection (6 vs 3). No significant differences in performance were found for different segment lengths, the BER differences were below 0.5-points in all cases. Our results show that VF-detection is more challenging for OHCA data than for data from public databases, and that accurate VF-detection is possible with segments as short as 4-s.	[Figuera, Carlos; Morgado, Eduardo; Alonso-Atienza, Felipe] Univ Rey Juan Carlos, Dept Telecommun Engn, Madrid, Spain; [Irusta, Unai; Aramendi, Elisabete] Univ Basque Country, UPV EHU, Dept Commun Engn, Bilbao, Spain; [Ayala, Unai] Univ Mondragon, Elect & Comp Dept, Arrasate Mondragon, Spain; [Wik, Lars; Kramer-Johansen, Jo] Oslo Univ Hosp, Norwegian Natl Advisory Unit Prehosp Emergency Me, Oslo, Norway; [Wik, Lars; Kramer-Johansen, Jo] Univ Oslo, Oslo, Norway; [Eftestol, Trygve] Univ Stavanger, Dept Elect Engn & Comp Sci, Stavanger, Norway	Universidad Rey Juan Carlos; University of Basque Country; Mondragon Unibertsitatea; University of Oslo; University of Oslo; Universitetet i Stavanger	Figuera, C (corresponding author), Univ Rey Juan Carlos, Dept Telecommun Engn, Madrid, Spain.	carlos.figuera@urjc.es	Kramer-Johansen, Jo/P-5132-2018; Ayala, Unai/ABA-1382-2021; Irusta, Unai/J-3972-2014; Morgado, Eduardo/G-2185-2016; Irusta, Unai/T-6327-2019; Aramendi, Elisabete/H-8092-2015; Figuera, Carlos/F-4228-2016	Kramer-Johansen, Jo/0000-0002-7881-1757; Ayala, Unai/0000-0003-1079-752X; Irusta, Unai/0000-0001-9521-1852; Morgado, Eduardo/0000-0001-9243-409X; Irusta, Unai/0000-0001-9521-1852; Aramendi, Elisabete/0000-0002-6409-1429; Figuera, Carlos/0000-0002-2728-3552; Alonso-Atienza, Felipe/0000-0002-6442-1643	Ministerio de Economia y Competitividad, Gobierno de Espana [TEC201346067R, TEC201564678]	Ministerio de Economia y Competitividad, Gobierno de Espana	This work was supported by Ministerio de Economia y Competitividad, Gobierno de Espana (http://www.mineco.gob.es/), grant number TEC201346067R (grant recipients: CF and FAA) and grant number TEC201564678 (grant recipients: UI and EA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Anas EM, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-43; Alonso-Atienza F, 2014, IEEE T BIO-MED ENG, V61, P832, DOI 10.1109/TBME.2013.2290800; Amann A, 2005, COMPUT CARDIOL, V32, P559; Amann A, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-60; Amann A, 2007, IEEE T BIO-MED ENG, V54, P174, DOI 10.1109/TBME.2006.880909; Arafat MA, 2011, SIGNAL IMAGE VIDEO P, V5, P1, DOI 10.1007/s11760-009-0136-1; Aramendi E, 2010, PHYSIOL MEAS, V31, P749, DOI 10.1088/0967-3334/31/6/002; Ayala U, 2015, RESUSCITATION, V89, P25, DOI 10.1016/j.resuscitation.2014.11.022; Ayala U, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/872470; Ayala U, 2011, COMPUT CARDIOL CONF, V38, P545; BARRO S, 1989, J BIOMED ENG, V11, P320, DOI 10.1016/0141-5425(89)90067-8; BROWN CG, 1993, ANN EMERG MED, V22, P70, DOI 10.1016/S0196-0644(05)80253-7; CampsValls G, 2007, KERNEL METHODS IN BIOENGINEERING, SIGNAL AND IMAGE PROCESSING, P1; CHEN S, 1987, MED BIOL ENG COMPUT, V25, P241, DOI 10.1007/BF02447420; Cheskes S, 2011, CIRCULATION, V124, P58, DOI 10.1161/CIRCULATIONAHA.110.010736; CLAYTON RH, 1993, MED BIOL ENG COMPUT, V31, P111, DOI 10.1007/BF02446668; Clayton RH, 1998, IEE P-SCI MEAS TECH, V145, P301, DOI 10.1049/ip-smt:19982322; Daya MR, 2015, RESUSCITATION, V91, P108, DOI 10.1016/j.resuscitation.2015.02.003; Didon Jean-Philippe, 2011, Resuscitation, V82 Suppl 2, pS8, DOI 10.1016/S0300-9572(11)70145-9; Greenwald S. D, 1986, DEV ANAL VENTRICULAR; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Hastie T., 2001, THE ELEMENTS OF STAT; Hayashi M, 2015, CIRC RES, V116, P1887, DOI 10.1161/CIRCRESAHA.116.304521; Irusta U, 2012, RESUSCITATION, V83, P1090, DOI 10.1016/j.resuscitation.2012.01.032; Irusta U, 2009, RESUSCITATION, V80, P1229, DOI 10.1016/j.resuscitation.2009.07.013; Jekova I, 2000, PHYSIOL MEAS, V21, P429, DOI 10.1088/0967-3334/21/4/301; Jekova I, 2004, PHYSIOL MEAS, V25, P1167, DOI 10.1088/0967-3334/25/5/007; Jekova I, 2004, PHYSIOL MEAS, V25, P1179, DOI 10.1088/0967-3334/25/5/008; Jekova I, 2002, PHYSIOL MEAS, V23, P629, DOI 10.1088/0967-3334/23/4/303; Jekova I, 2007, BIOMED SIGNAL PROCES, V2, P25, DOI 10.1016/j.bspc.2007.01.002; Jekova I, 2009, PHYSIOL MEAS, V30, P695, DOI 10.1088/0967-3334/30/7/012; Kerber RE, 1997, CIRCULATION, V95, P1677; Kramer-Johansen J, 2006, RESUSCITATION, V71, P283, DOI 10.1016/j.resuscitation.2006.05.011; Krasteva V, 2005, PHYSIOL MEAS, V26, P707, DOI 10.1088/0967-3334/26/5/011; Krasteva V, 2010, ANN BIOMED ENG, V38, P1326, DOI 10.1007/s10439-009-9885-9; Kuo S., 1978, IEEE COMPUTERS CARDI, P2747; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Li Q, 2014, IEEE T BIO-MED ENG, V61, P1607, DOI 10.1109/TBME.2013.2275000; Li YQ, 2008, CRIT CARE MED, V36, P198, DOI 10.1097/01.CCM.0000295589.64729.6B; Li YQ, 2012, IEEE T BIO-MED ENG, V59, P78, DOI 10.1109/TBME.2011.2118755; Mehta C, 2012, AM J EMERG MED, V30, P236, DOI 10.1016/j.ajem.2010.08.017; Minami K, 1999, IEEE T BIO-MED ENG, V46, P179, DOI 10.1109/10.740880; Monsieurs KG, 2015, RESUSCITATION, V95, P1, DOI 10.1016/j.resuscitation.2015.07.038; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Nolle F.M., 1986, COMPUT CARDIOL, V13, P515; Ruiz J, 2013, RESUSCITATION, V84, P1223, DOI 10.1016/j.resuscitation.2013.01.034; Sherman LD, 2008, RESUSCITATION, V78, P346, DOI 10.1016/j.resuscitation.2008.04.009; Snyder David, 2004, Crit Care Med, V32, pS421, DOI 10.1097/01.CCM.0000134265.35871.2B; THAKOR NV, 1990, IEEE T BIO-MED ENG, V37, P837, DOI 10.1109/10.58594; WEAVER WD, 1985, ANN INTERN MED, V102, P53, DOI 10.7326/0003-4819-102-1-53; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Wik L, 2005, JAMA-J AM MED ASSOC, V293, P299, DOI 10.1001/jama.293.3.299; Zhang XS, 1999, IEEE T BIO-MED ENG, V46, P548, DOI 10.1109/10.759055	53	42	43	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159654	10.1371/journal.pone.0159654	http://dx.doi.org/10.1371/journal.pone.0159654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441719	Green Published, gold, Green Accepted			2022-12-27	WOS:000380797500113
J	Lutfi, MF; Elhakeem, RF				Lutfi, Mohamed Faisal; Elhakeem, Ramaze Farouke			Effect of Fasting Blood Glucose Level on Heart Rate Variability of Healthy Young Adults	PLOS ONE			English	Article							AUTONOMIC MODULATIONS; ORAL GLUCOSE; RISK-FACTOR; FOLLOW-UP; INSULIN; SYSTEM; YOUTH; POWER; TONE	Background Previous studies reported increased risk of cardiac events in subjects with fasting blood glucose (FBG) levels lower than the diagnostic threshold of diabetes mellitus. However, whether increased cardiac events in those with upper normal FBG is secondary to the shift of their cardiac sympathovagal balance towards sympathetic predominance is unknown. Aims To assess the association between FBG levels and cardiac autonomic modulation (CAM) in euglycaemic healthy subjects based on heart rate variability (HRV) derived indices. Subjects and Methods The study enrolled 42 healthy young adults. Following sociodemographic and clinical assessment, blood samples were collected to measure FBG levels. Five minutes ECG recordings were performed to all participants to obtain frequency domain HRV measurements, namely the natural logarithm (Ln) of total power (LnTP), very low frequency (LnVLF), low frequency (LnLF) and high frequency (LnHF), low frequency/high frequency ratio (LnLF/HF), normalized low frequency (LF Norm) and high frequency (HF Norm). Results FBG levels correlated positively with LnHF (r = 0.33, P = 0.031) and HF Norm (r = 0.35, P = 0.025) and negatively with LF Norm (r = -0.35, P = 0.025) and LnLF/HF (r = -0.33, P = 0.035). LnHF and HF Norm were significantly decreased in subjects with the lower (4.00 (1.34) ms(2)/Hz and 33.12 (11.94) n.u) compared to those with the upper FBG quartile (5.64 (1.63) ms(2)/Hz and 49.43 (17.73) n.u, P = 0.013 and 0.032 respectively). LF Norm and LnLF/HF were significantly increased in subjects with the lower (66.88 (11.94) n.u and 0.73 (0.53)) compared to those with the higher FBG quartile (50.58 (17.83) n.u and 0.03 (0.79), P = 0.032 and 0.038 respectively). Conclusion The present study is the first to demonstrate that rise of blood glucose concentration, within physiological range, is associated with higher parasympathetic, but lower sympathetic CAM. Further researches are needed to set out the glycemic threshold beyond which further increase in glucose level readjusts sympathovagal balance towards sympathetic predominance again.	[Lutfi, Mohamed Faisal; Elhakeem, Ramaze Farouke] Al Neelain Univ, Fac Med & Hlth Sci, Dept Physiol, Khartoum, Sudan		Lutfi, MF (corresponding author), Al Neelain Univ, Fac Med & Hlth Sci, Dept Physiol, Khartoum, Sudan.	mohamedfaisallutfi@gmail.com	MA, M LUTFI/GQH-0830-2022					[Anonymous], 1996, CIRCULATION, V93, P65; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Bellavere F, 1996, DIABETIC MED, V13, P709, DOI 10.1002/(SICI)1096-9136(199608)13:8<709::AID-DIA158>3.0.CO;2-8; Billman GE, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00055; Bjornholt JV, 1999, DIABETES CARE, V22, P45, DOI 10.2337/diacare.22.1.45; Chopra Sandeep, 2012, Indian J Endocrinol Metab, V16, P102, DOI 10.4103/2230-8210.91203; Freeman R, 2013, HAND CLINIC, V115, P115, DOI 10.1016/B978-0-444-52902-2.00007-2; Gasior JS, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00385; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Harris PRE, 2014, NEUROPSYCH DIS TREAT, V10, P1335, DOI 10.2147/NDT.S57523; Jaiswal M, 2013, DIABETES TECHNOL THE, V15, P977, DOI 10.1089/dia.2013.0147; Jaiswal M, 2013, DIABETES CARE, V36, P157, DOI 10.2337/dc12-0463; Koivikko ML, 2005, DIABETES, V54, P744, DOI 10.2337/diabetes.54.3.744; Kotecha D, 2012, HEART, V98, P395, DOI 10.1136/heartjnl-2011-300033; Lutfi M.F., 2011, KHARTOUM MED J, V4, P548; Lutfi MF, 2012, LUNG INDIA, V29, P254, DOI 10.4103/0970-2113.99111; Lutfi MF, 2011, SUDAN J MED SCI, V6, P43; Lutfi MF, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0118-8; Paolisso G, 2000, EUR J CLIN INVEST, V30, P277; Preethi B L, 2011, Fiziol Cheloveka, V37, P118; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Sacha J, 2008, INT J CARDIOL, V128, P444, DOI 10.1016/j.ijcard.2007.06.047; Sacha J, 2013, INT J CARDIOL, V168, P1660, DOI 10.1016/j.ijcard.2013.03.038; Straznicky NE, 2009, AM J CLIN NUTR, V89, P27, DOI 10.3945/ajcn.2008.26299; Tadic M, 2015, J HYPERTENS, V33, P1090, DOI 10.1097/HJH.0000000000000511; van de Borne P, 1999, AM J PHYSIOL-REG I, V276, pR178, DOI 10.1152/ajpregu.1999.276.1.R178; Watkins LL, 2000, DIABETES CARE, V23, P826, DOI 10.2337/diacare.23.6.826; Weissman A, 2006, DIABETES CARE, V29, P571, DOI 10.2337/diacare.29.03.06.dc05-2009	28	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159820	10.1371/journal.pone.0159820	http://dx.doi.org/10.1371/journal.pone.0159820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441373	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500142
J	Huynh, NCN; Everts, V; Leethanakul, C; Pavasant, P; Ampornaramveth, RS				Nam Cong-Nhat Huynh; Everts, Vincent; Leethanakul, Chidchanok; Pavasant, Prasit; Ampornaramveth, Ruchanee Salingcarnboriboon			Rinsing with Saline Promotes Human Gingival Fibroblast Wound Healing In Vitro	PLOS ONE			English	Article							CELL-MIGRATION; ADHESION	Rinsing the mouth with sodium chloride (NaCl) solution is believed to promote healthy gum and improve oral ulcer healing. Scientific evidence to support this assumption is, however, lacking. This study aims to investigate the effect and clarify underlying mechanisms of short-term rinsing with NaCl on human gingival fibroblast (hGFs) wound healing. Isolated primary hGFs and human normal oral keratinocytes (hNOKs) were rinsed with 0-7.2% NaCl for 2 min, 3 times a day. Scratch-tests, trans-well migration assays and MTT activity were performed. mRNA expression was assessed of type-I collagen, fibronectin and FAK. Changes in FAK and F-actin were detected by immunofluorescence. KCl, NaH2PO4, KH2PO4 were used to clarify the molecules involved. Rinsing with 0.9-1.8% NaCl significantly promoted hGFs cell migration but not proliferation. However, it had no effect on hNOKs. Rinsing with 1.8% NaCl significantly up-regulated the expression of type-I collagen and fibronectin. FAK and F-actin, molecules responsible for cytoskeleton re-organization and cell migration, were also up-regulated. Cl-seemed to be essential since rinsing with KCl resulted in a similar effect as noted with NaCl. In conclusion, short-term rinsing with NaCl promoted hGFs migration, and increased the expression of extracellular matrix as well as cytoskeletal proteins. These data strongly support the long held belief in the benefits of using NaCl mouth-rinse.	[Nam Cong-Nhat Huynh; Pavasant, Prasit] Chulalongkorn Univ, Fac Dent, Mineralized Tissue Res Unit, Bangkok, Thailand; [Everts, Vincent] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Gustav Mahlerlaan 3004, NL-1081 LA Amsterdam, Netherlands; [Everts, Vincent] Vrije Univ Amsterdam, Res Inst MOVE, Gustav Mahlerlaan 3004, NL-1081 LA Amsterdam, Netherlands; [Leethanakul, Chidchanok] Prince Songkla Univ, Fac Dent, Dept Prevent Dent, Hat Yai, Thailand; [Pavasant, Prasit] Chulalongkorn Univ, Fac Dent, Dept Anat, Bangkok, Thailand; [Ampornaramveth, Ruchanee Salingcarnboriboon] Chulalongkorn Univ, Fac Dent, Dept Microbiol, Res Unit Oral Microbiol & Immunol, Bangkok, Thailand	Chulalongkorn University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Prince of Songkla University; Chulalongkorn University; Chulalongkorn University	Ampornaramveth, RS (corresponding author), Chulalongkorn Univ, Fac Dent, Dept Microbiol, Res Unit Oral Microbiol & Immunol, Bangkok, Thailand.	ruchanee.a@chula.ac.th	Ampornaramveth, Ruchanee Salingcarnboriboon/U-1638-2019	Huynh, Nam/0000-0003-4718-7813	Ratchadapisek Sompoch Endowment Fund; Chulalongkorn University [CU-57-076-AS]; Integrated-Innovation Academic Center' Chulalongkorn University Centenary Academic Development Project; Research Chair Grant, Thailand National Science and Technology Development Agency (NSTDA)	Ratchadapisek Sompoch Endowment Fund; Chulalongkorn University(Chulalongkorn University); Integrated-Innovation Academic Center' Chulalongkorn University Centenary Academic Development Project; Research Chair Grant, Thailand National Science and Technology Development Agency (NSTDA)	This research was supported by the Ratchadapisek Sompoch Endowment Fund (2014), Chulalongkorn University (CU-57-076-AS), Integrated-Innovation Academic Center' Chulalongkorn University Centenary Academic Development Project, The 2012 Research Chair Grant, Thailand National Science and Technology Development Agency (NSTDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso FG, 2012, INT J DENT, V2012, DOI 10.1155/2012/719452; Bihani S N, 1997, J Indian Soc Pedod Prev Dent, V15, P34; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Caceres M, 2014, J DENT RES; Di Ciano C, 2002, AM J PHYSIOL-CELL PH, V283, pC850, DOI 10.1152/ajpcell.00018.2002; Dmitrieva NI, 2005, MUTAT RES-FUND MOL M, V569, P65, DOI 10.1016/j.mrfmmm.2004.06.053; Feber T, 1996, Clin Oncol (R Coll Radiol), V8, P106, DOI 10.1016/S0936-6555(96)80116-6; Gannon Robert, 2007, Nurs Times, V103, P44; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027097; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; HOU LT, 1993, J PERIODONTOL, V64, P1209, DOI 10.1902/jop.1993.64.12.1209; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim JK, 2000, BRIT J PLAST SURG, V53, P42, DOI 10.1054/bjps.1999.3246; Lunn JA, 2004, J BIOL CHEM, V279, P45266, DOI 10.1074/jbc.M314132200; Mah W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090715; Mao JW, 2009, BIOCHEM PHARMACOL, V77, P159, DOI 10.1016/j.bcp.2008.10.009; Mariotti AJ, 1999, J PERIODONTOL, V70, P1443, DOI 10.1902/jop.1999.70.12.1443; Poggi P, 2003, J PERIODONTOL, V74, P623, DOI 10.1902/jop.2003.74.5.623; Raja, 2007, Front Biosci, V12, P2849; Rupesh S, 2010, J Indian Soc Pedod Prev Dent, V28, P138, DOI 10.4103/0970-4388.73780; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Smith PC, 2006, J DENT RES, V85, P150, DOI 10.1177/154405910608500207; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Takagi M, 2000, CYTOTECHNOLOGY, V32, P171, DOI 10.1023/A:1008171921282; Tomar GB, 2010, BIOCHEM BIOPH RES CO, V393, P377, DOI 10.1016/j.bbrc.2010.01.126; Tsourounakis I, 2013, J PERIODONTOL, V84, P1211, DOI 10.1902/jop.2012.120312; Van Donkelaar C. C., 2003, Acta of Bioengineering and Biomechanics, V5, P3; Wanichpakorn S, PRIMARY CELL CULTURE; Zhang Z, 1998, AM J PHYSIOL-RENAL, V275, pF447, DOI 10.1152/ajprenal.1998.275.3.F447	31	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159843	10.1371/journal.pone.0159843	http://dx.doi.org/10.1371/journal.pone.0159843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441729	gold, Green Published, Green Submitted			2022-12-27	WOS:000380797500146
J	Kanda, T; Nishida, A; Ohno, M; Imaeda, H; Shimada, T; Inatomi, O; Bamba, S; Sugimoto, M; Andoh, A				Kanda, Toshihiro; Nishida, Atsushi; Ohno, Masashi; Imaeda, Hirotsugu; Shimada, Takashi; Inatomi, Osamu; Bamba, Shigeki; Sugimoto, Mitsushige; Andoh, Akira			Enterococcus durans TN-3 Induces Regulatory T Cells and Suppresses the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HUMAN COLONIC FLORA; ULCERATIVE-COLITIS; ANIMAL-MODELS; HUMAN FECES; MICROBIOTA; BACTERIA; INDUCTION; MICE; PATHOGENESIS	Background and Aims Probiotic properties of Enterococcus strains have been reported previously. In this study, we investigated the effects of Enterococcus (E.) durans TN-3 on the development of dextran sulfate sodium (DSS) colitis. Methods BALB/c mice were fed with 4.0% DSS in normal chow. Administration of TN-3 (10mg/day) was initiated 7days before the start of DSS feeding. Mucosal cytokine expression was analyzed by real time-PCR and immunohistochemistry. The lymphocyte subpopulation were analyzed by flow cytometry. The gut microbiota profile was analyzed by a terminal-restriction fragment length polymorphism method (T-RFLP). Results The disease activity index and histological colitis score were significantly lower in the DSS plus TN-3 group than in the DSS group. The mucosal mRNA expression of proinflammatory cytokines (IL-1 beta, IL-6, IL-17A and IFN-gamma) decreased significantly in the DSS plus TN-3 group as compared to the DSS group. The proportion of regulatory T cells (Treg cells) in the mucosa increased significantly in the DSS plus TN-3 group as compared to the DSS group. Both fecal butyrate levels and the diversity of fecal microbial community were significantly higher in the TN-3 plus DSS group than in the DSS group. Conclusions E. durans TN-3 exerted an inhibitory effect on the development of DSS colitis. This action might be mediated by the induction of Treg cells and the restoration of the diversity of the gut microbiota.	[Kanda, Toshihiro; Nishida, Atsushi; Ohno, Masashi; Imaeda, Hirotsugu; Inatomi, Osamu; Bamba, Shigeki; Sugimoto, Mitsushige; Andoh, Akira] Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan; [Shimada, Takashi] Nichinichi Pharmaceut Corp Ltd, Cent Res Labs, Iga, Mie, Japan	Shiga University of Medical Science	Nishida, A (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan.	atsuda@belle.shiga-med.ac.jp	Andoh, Akira/AAB-9303-2022	Bamba, Shigeki/0000-0002-4108-5894; Inatomi, Osamu/0000-0002-5837-6575	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K08967, 15K19322]; Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan [067]; Smoking Research Foundation [1828]; Nichinichi Pharmaceutical Corporation Ltd; Grants-in-Aid for Scientific Research [15K08948] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan; Smoking Research Foundation; Nichinichi Pharmaceutical Corporation Ltd; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, (15K08967, 15K19322), https://www.jsps.go.jp/english/e-grants/, the Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan, 067, http://www.mhlw.go.jp/english/, Smoking Research Foundation, 1828, http://www.srf.or.jp/english/, Nichinichi Pharmaceutical Corporation Ltd provided support in the form of salaries for T.S, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nichinichi Pharmaceutical Corporation Ltd and T.S. provided E. durans (TN-3) used in this study.; Authors appreciate technical supports of TechnoSuruga Laboratory Co., Ltd. (Sizuoka, Japan) and would like to express thanks. Authors thank Dr. Masahiro Kawahara for his useful advice and technical help. This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15K08967, 15K19322), a grant for the Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan (067), and a grant from Smoking Research Foundation (1828).	Andoh A, 2016, DIGESTION, V93, P176, DOI 10.1159/000444066; Andoh A, 2011, J GASTROENTEROL, V46, P479, DOI 10.1007/s00535-010-0368-4; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Avram-Hananel L, 2010, DIS COLON RECTUM, V53, P1676, DOI 10.1007/DCR.0b013e3181f4b148; Chassaing B, 2014, CURRENT PROTOCOLS IM; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; COOPER HS, 1993, LAB INVEST, V69, P238; DEANROSS D, 1989, APPL ENVIRON MICROB, V55, P2002, DOI 10.1128/AEM.55.8.2002-2009.1989; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Goldsmith JR, 2014, J GASTROENTEROL, V49, P785, DOI 10.1007/s00535-014-0953-z; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kawada M, 2007, WORLD J GASTROENTERO, V13, P5581, DOI 10.3748/wjg.v13.i42.5581; Kindlund B, 2016, GASTRIC CANC; Klein G, 1998, INT J FOOD MICROBIOL, V41, P103, DOI 10.1016/S0168-1605(98)00049-X; Kondoh M, 2009, BRIT J NUTR, V102, P3, DOI 10.1017/S0007114508158998; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mayer L, 2010, J GASTROENTEROL, V45, P9, DOI 10.1007/s00535-009-0138-3; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mizoguchi A, 2008, J GASTROENTEROL, V43, P1, DOI 10.1007/s00535-007-2111-3; Mizoguchi A, 2012, PROG MOL BIOL TRANSL, V105, P263, DOI 10.1016/B978-0-12-394596-9.00009-3; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Nami Y, 2014, J MED MICROBIOL, V63, P1044, DOI 10.1099/jmm.0.074161-0; Nishida A, 2012, J EXP MED, V209, P2383, DOI 10.1084/jem.20112631; Nishida A, 2012, GASTROENTEROLOGY, V142, P865, DOI 10.1053/j.gastro.2011.12.036; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Raz I, 2007, BRIT J NUTR, V97, P725, DOI 10.1017/S000711450747249X; Sands BE, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1995-7; Sheehan D, 2015, J GASTROENTEROL, V50, P495, DOI 10.1007/s00535-015-1064-1; Sood A, 2009, CLIN GASTROENTEROL H, V7, P1202, DOI 10.1016/j.cgh.2009.07.016; Torii T, 2010, ANN CLIN BIOCHEM, V47, P447, DOI 10.1258/acb.2010.010047; Tursi A, 2010, AM J GASTROENTEROL, V105, P2218, DOI 10.1038/ajg.2010.218; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; Zeng H, 2015, TRENDS IMMUNOL, V36, P3, DOI 10.1016/j.it.2014.08.003; Zheng SG, J IMMUNOL	43	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159705	10.1371/journal.pone.0159705	http://dx.doi.org/10.1371/journal.pone.0159705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438072	gold, Green Submitted, Green Published			2022-12-27	WOS:000380170100070
J	Xu, LJ; Li, BY; Huang, MW; Xie, K; Li, D; Li, Y; Gu, H; Fang, JM				Xu, Lijun; Li, Bingyu; Huang, Mengwen; Xie, Kun; Li, Dong; Li, You; Gu, Hua; Fang, Jianmin			Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy	PLOS ONE			English	Article							IMMUNOGLOBULIN-A IGA; FC-ALPHA RECEPTOR; GAMMA-CHAIN; IDENTIFICATION; PATHOGENESIS; GLYCOSYLATION; ACTIVATION; CLEARANCE; MONOCYTES; EFFICIENT	Although IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide, its etiology remains only partly understood. It is clear that the pathogenesis of IgAN involves the formation of macromolecular IgA1 complexes and increased levels of serum IgA1 and IgA1-immune complexes(IC), due to defective IgA1 clearance. Previous studies suggest that the blood and tissue myeloid cell-expressed IgA Fc receptor (FcaR/CD89) mediates IgA-IC clearance and its dysfunction, via decreased activity or excessive levels of soluble FcaR/sCD89 induces IgAN. Such a mechanism requires robust stimulation of IgAN levels via forced expression of CD89. In the absence of unequivocal evidence supporting such a mechanism to date, we attempted to test the extent of CD89-evoked IgAN by generating a transgenic mouse strain expressing human CD89 under the control of murine CD14 promotor. No deposition of IgA-CD89 complexes or glomerulonephritis was detected, however. Further studies showed that elimination of murine IgA was mediated by Kupffer cells. In patients, however, CD89/IgA complexes were detected, and injection of patient IgA induced IgAN-like features in CD89 Tg mice. In transgenic mice, IgAN pathogenesis involves impaired clearance of abnormal IgA via CD89, primarily by the Kupffer cells. Conditional IgAN progression in CD89 transgenic mice thus reveals important aspects of IgAN pathogenesis.	[Xu, Lijun; Li, Bingyu; Huang, Mengwen; Xie, Kun; Li, You; Gu, Hua; Fang, Jianmin] Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Li, Dong; Fang, Jianmin] Tongji Univ, Shanghai Tongji Hosp, Shanghai, Peoples R China; [Fang, Jianmin] Tongji Univ, Suzhou Inst, Suzhou, Jiangsu, Peoples R China; [Fang, Jianmin] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China	Tongji University; Tongji University; Tongji University; Sichuan University	Gu, H; Fang, JM (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; Fang, JM (corresponding author), Tongji Univ, Shanghai Tongji Hosp, Shanghai, Peoples R China.; Fang, JM (corresponding author), Tongji Univ, Suzhou Inst, Suzhou, Jiangsu, Peoples R China.; Fang, JM (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China.	gu_hua@tongji.edu.cn; jfang@tongji.edu.cn	xu, li/GNH-3667-2022		National Basic Research Program of China (973 Program) [2015CB553706]; National Natural Science Foundation of China [NSFC 31470896, NSFC 81402399]; Shanghai Science & Technology Pillar Program [12431901000]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science & Technology Pillar Program	This work was supported by the National Basic Research Program of China (973 Program 2015CB553706), the National Natural Science Foundation of China (NSFC 31470896 and NSFC 81402399), and Shanghai Science & Technology Pillar Program 12431901000).	Abe K, 2001, NEPHRON, V87, P231, DOI 10.1159/000045920; ALLEN AC, 1995, NEPHROL DIAL TRANSPL, V10, P1121, DOI 10.1093/ndt/10.7.1121; AntalSzalmas P, 1997, J LEUKOCYTE BIOL, V61, P721, DOI 10.1002/jlb.61.6.721; Bakema JE, 2006, J IMMUNOL, V176, P3603, DOI 10.4049/jimmunol.176.6.3603; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Barratt J, 2007, SEMIN IMMUNOPATHOL, V29, P427, DOI 10.1007/s00281-007-0089-9; BENE MC, 1983, J CLIN INVEST, V71, P1342, DOI 10.1172/JCI110886; Berthelot L, 2012, J EXP MED, V209, P793, DOI 10.1084/jem.20112005; BOGERS WMJM, 1991, CLIN EXP IMMUNOL, V85, P128; Boyd JK, 2010, KIDNEY INT, V78, P1211, DOI 10.1038/ki.2010.365; Breslin WL, 2013, J IMMUNOL METHODS, V390, P1, DOI 10.1016/j.jim.2011.03.005; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; DELACROIX DL, 1983, J CLIN INVEST, V71, P358, DOI 10.1172/JCI110777; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Floege J, 2014, SEMIN IMMUNOPATHOL, V36, P431, DOI 10.1007/s00281-013-0411-7; Geissmann F, 2001, J IMMUNOL, V166, P346, DOI 10.4049/jimmunol.166.1.346; Glassock RJ, 2011, CURR OPIN NEPHROL HY, V20, P153, DOI 10.1097/MNH.0b013e3283436f5c; Grossetete B, 1998, KIDNEY INT, V53, P1321, DOI 10.1046/j.1523-1755.1998.00885.x; Hiki Y, 1999, J AM SOC NEPHROL, V10, P760; JENNETTE JC, 1991, AM J KIDNEY DIS, V18, P466, DOI 10.1016/S0272-6386(12)80115-6; Kashem A, 1996, CLIN NEPHROL, V45, P1; Launay P, 2000, J EXP MED, V191, P1999, DOI 10.1084/jem.191.11.1999; Li PZ, 2014, IMMUNOL LETT, V158, P52, DOI 10.1016/j.imlet.2013.12.002; Martinet W, 2004, J PATHOL, V202, P382, DOI 10.1002/path.1525; Maruoka T, 2004, IMMUNOGENETICS, V55, P712, DOI 10.1007/s00251-003-0626-1; Men R, 2004, J VIROL, V78, P4665, DOI 10.1128/JVI.78.9.4665-4674.2004; Mills P, 2001, BIOCHEM J, V359, P249, DOI 10.1042/0264-6021:3590249; MOLE CM, 1995, NEPHRON, V71, P75, DOI 10.1159/000188677; MONTEIRO RC, 1993, J CLIN INVEST, V92, P1681, DOI 10.1172/JCI116754; MONTEIRO RC, 1990, J EXP MED, V171, P597, DOI 10.1084/jem.171.3.597; Monteiro RC, 2010, J CLIN IMMUNOL, V30, pS61, DOI 10.1007/s10875-010-9397-2; Morton HC, 2001, ARCH IMMUNOL THER EX, V49, P217; Rifai A, 2000, J EXP MED, V191, P2171, DOI 10.1084/jem.191.12.2171; ROSMARIN AG, 1989, BLOOD, V73, P131; STOCKERT RJ, 1982, P NATL ACAD SCI-BIOL, V79, P6229, DOI 10.1073/pnas.79.20.6229; van der Boog PJM, 2004, NEPHROL DIAL TRANSPL, V19, P2729, DOI 10.1093/ndt/gfh459; van der Boog PJM, 2004, NEPHROL DIAL TRANSPL, V19, P2487, DOI 10.1093/ndt/gfh394; van Egmond M, 2000, NAT MED, V6, P680, DOI 10.1038/76261; van Egmond M, 1999, BLOOD, V93, P4387, DOI 10.1182/blood.V93.12.4387.412k08_4387_4394; van Zandbergen G, 1998, NEPHROL DIAL TRANSPL, V13, P3058, DOI 10.1093/ndt/13.12.3058; Vuong MT, 2010, KIDNEY INT, V78, P1281, DOI 10.1038/ki.2010.314; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080	43	10	11	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159426	10.1371/journal.pone.0159426	http://dx.doi.org/10.1371/journal.pone.0159426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437939	gold, Green Published, Green Submitted			2022-12-27	WOS:000380170100046
J	Aryal, B; Rao, VA				Aryal, Baikuntha; Rao, V. Ashutosh			Deficiency in Cardiolipin Reduces Doxorubicin-Induced Oxidative Stress and Mitochondrial Damage in Human B-Lymphocytes	PLOS ONE			English	Article							SUPEROXIDE-PRODUCTION; SKELETAL-MUSCLE; CANCER-CELLS; ADRIAMYCIN; APOPTOSIS; COMPLEX; HEART; METABOLISM; COMPOUND; BLOCKADE	Cardiolipin (CL) is an inner mitochondrial membrane phospholipid which plays an important role in mitochondrial function. Perturbation in CL biosynthesis alters mitochondrial bioenergetics causing a severe genetic disorder commonly known as Barth syndrome. Barth syndrome patients are known to have a reduced concentration and altered composition of CL. Cardiolipin is also known to have a high affinity for the chemotherapeutic agent doxorubicin (Dox), resulting in an extensive mitochondrial accumulation of the drug. Our results indicate that B-lymphocytes from healthy individuals are more sensitive to Dox-induced oxidative stress and cellular toxicity compared to the B-lymphocytes from Barth syndrome as indicated by greater cell death and greater level of cleaved caspase-3 following Dox treatment. Barth lymphocytes, when compared to healthy lymphocytes, showed a greater basal level of mitochondrial reactive oxygen species (mito-ROS), yet exhibited a lower level of induced mito-ROS production in response to Dox. Significantly less ATP content and slightly greater OXPHOS protein levels were detected in healthy cells compared to Barth cells after Dox treatment. Consistent with greater mitochondrial ROS, treatment with Dox induced a higher level of lipid peroxidation and protein carbonylation in healthy lymphocytes compared to Barth lymphocytes. The final remodeling of CL during CL synthesis is catalyzed by the tafazzin protein. Knockdown of tafazzin gene in H9c2 cardiomyocytes using siRNA showed decreased oxidant-induced damage, as observed in Barth lymphocytes. Our findings demonstrate that a deficiency in CL might provide a therapeutic advantage in favor of oxidant-induced anticancer activities.	[Aryal, Baikuntha; Rao, V. Ashutosh] US FDA, Lab Appl Biochem, Div Biotechnol Review & Res 3, Off Biotechnol Prod,Off Pharmaceut Qual,Ctr Drug, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Rao, VA (corresponding author), US FDA, Lab Appl Biochem, Div Biotechnol Review & Res 3, Off Biotechnol Prod,Off Pharmaceut Qual,Ctr Drug, Silver Spring, MD 20993 USA.	ashutosh.rao@fda.hhs.gov	Rao, V Ashutosh/A-3569-2013	Rao, V Ashutosh/0000-0001-6817-8049	Center for Drug Evaluation and Research Critical Path Initiative	Center for Drug Evaluation and Research Critical Path Initiative	This research was supported by the Center for Drug Evaluation and Research Critical Path Initiative. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the United States Food and Drug Administration and the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government.; We would like to thank Dr. Shen Luo (FDA) for help with MS analysis. We would like to thank Elliot Rosen (FDA) for critical reading of the manuscript. This research was supported by the Center for Drug Evaluation and Research Critical Path Initiative. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the United States Food and Drug Administration and the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government.	Aryal B, 2014, P NATL ACAD SCI USA, V111, P2011, DOI 10.1073/pnas.1321783111; Ashour AE, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/434195; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216; Carvalho FS, 2014, MED RES REV, V34, P106, DOI 10.1002/med.21280; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Chen YM, 2006, FREE RADICAL BIO MED, V41, P1470, DOI 10.1016/j.freeradbiomed.2006.08.006; Childs AC, 2002, CANCER RES, V62, P4592; Choi SM, 2011, BLOOD, V118, P1801, DOI 10.1182/blood-2011-03-340620; Deavall DG, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/645460; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Dorn GW, 2013, BBA-MOL CELL RES, V1833, P233, DOI 10.1016/j.bbamcr.2012.03.008; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, pC195, DOI 10.1152/ajpcell.00217.2011; GOORMAGHTIGH E, 1980, BIOCHIM BIOPHYS ACTA, V597, P1, DOI 10.1016/0005-2736(80)90145-5; GOORMAGHTIGH E, 1980, BIOCHEM PHARMACOL, V29, P3003, DOI 10.1016/0006-2952(80)90050-7; GOORMAGHTIGH E, 1990, BIOPHYS CHEM, V35, P247, DOI 10.1016/0301-4622(90)80012-V; HASINOFF BB, 1988, BIOCHEM PHARMACOL, V37, P3663, DOI 10.1016/0006-2952(88)90399-1; Hasinoff Brian B, 2003, Cardiovasc Toxicol, V3, P89, DOI 10.1385/CT:3:2:89; He Q, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/654198; He Q, 2013, AM J PHYSIOL-HEART C, V305, pH1332, DOI 10.1152/ajpheart.00084.2013; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Jefferies JL, 2013, AM J MED GENET C, V163, P198, DOI 10.1002/ajmg.c.31372; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; KNIGHT JA, 1988, CLIN CHEM, V34, P2433; Kuznetsov AV, 2011, BBA-MOL CELL RES, V1813, P1144, DOI 10.1016/j.bbamcr.2011.03.002; Lampl T, 2015, JOVE-J VIS EXP, DOI 10.3791/52076; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Malugin A, 2006, MOL PHARMACEUT, V3, P351, DOI 10.1021/mp050065e; Marques-Aleixo I, 2015, MITOCHONDRION, V20, P22, DOI 10.1016/j.mito.2014.10.008; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; NOWAK D, 1995, FREE RADICAL BIO MED, V19, P659, DOI 10.1016/0891-5849(95)00028-V; PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2; Paradies G, 1997, FEBS LETT, V406, P136, DOI 10.1016/S0014-5793(97)00264-0; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Raja V, 2014, CHEM PHYS LIPIDS, V179, P49, DOI 10.1016/j.chemphyslip.2013.12.009; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 1999, J LIPID RES, V40, P1585; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Strigun A, 2012, TOXICOL SCI, V125, P595, DOI 10.1093/toxsci/kfr298; Szeto HH, 2014, CLIN PHARMACOL THER, V96, P672, DOI 10.1038/clpt.2014.174; Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Wong HL, 2006, J PHARMACOL EXP THER, V317, P1372, DOI 10.1124/jpet.106.101154; Yadav N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.405; Yamakawa-Karakida N, 2002, CELL DEATH DIFFER, V9, P513, DOI 10.1038/sj.cdd.4401000	50	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158376	10.1371/journal.pone.0158376	http://dx.doi.org/10.1371/journal.pone.0158376			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434059	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600008
J	Klatt, WK; Chesham, A; Lobmaier, JS				Klatt, Wilhelm K.; Chesham, Alvin; Lobmaier, Janek S.			Putting Up a Big Front: Car Design and Size Affect Road-Crossing Behaviour	PLOS ONE			English	Article							FACE-LIKE OBJECTS; VIRTUAL-REALITY	Previous research suggests that people tend to see faces in car fronts and that they attribute personality characteristics to car faces. In the present study we investigated whether car design influences pedestrian road-crossing behaviour. An immersive virtual reality environment with a zebra crossing scenario was used to determine a) whether the minimum accepted distance for crossing the street is larger for cars with a dominant appearance than for cars with a friendly appearance and b) whether the speed of dominant-looking cars is overestimated as compared to friendly-looking cars. Participants completed both tasks while either standing on the pavement or on the centre island. We found that people started to cross the road later in front of friendly-looking low-power cars compared to dominant-looking high-power cars, but only if the cars were relatively large in size. For small cars we found no effect of power. The speed of smaller cars was estimated to be higher compared to large cars (size-speed bias). Furthermore, there was an effect of starting position: From the centre island, participants entered the road significantly later (i.e. closer to the approaching car) and left the road later than when starting from the pavement. Similarly, the speed of the cars was estimated significantly lower when standing on the centre island compared to the pavement. To our knowledge, this is the first study to show that car fronts elicit responses on a behavioural level.	[Klatt, Wilhelm K.; Lobmaier, Janek S.] Univ Bern, Inst Psychol, Bern, Switzerland; [Klatt, Wilhelm K.; Chesham, Alvin; Lobmaier, Janek S.] Univ Bern, Ctr Cognit Learning & Memory, Bern, Switzerland; [Chesham, Alvin] Univ Bern, ARTORG Ctr Biomed Engn Res Gerontechnol & Rehabil, Bern, Switzerland	University of Bern; University of Bern; University of Bern	Klatt, WK (corresponding author), Univ Bern, Inst Psychol, Bern, Switzerland.; Klatt, WK (corresponding author), Univ Bern, Ctr Cognit Learning & Memory, Bern, Switzerland.	wilhelm.klatt@psy.unibe.ch		Chesham, Alvin/0000-0002-6367-8578	Swiss National Science Foundation [PP00P1 139072]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was funded by Swiss National Science Foundation, www.snf.ch, project no. PP00P1 139072, received by JSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz HMA, 2013, ACCIDENT ANAL PREV, V50, P1298, DOI 10.1016/j.aap.2012.09.034; Barton JE, 2007, 3D COMPUTER SIMULATI; Bulbulia J, 2004, BIOL PHILOS, V19, P655, DOI 10.1007/s10539-005-5568-6; Churches O, 2009, NEUROREPORT, V20, P1290, DOI 10.1097/WNR.0b013e3283305a65; Clancy TA, 2006, J CLIN CHILD ADOLESC, V35, P203, DOI 10.1207/s15374424jccp3502_4; Clark HE, 2013, ACCIDENT ANAL PREV, V55, P226, DOI 10.1016/j.aap.2013.02.037; DEMETRE JD, 1992, BRIT J PSYCHOL, V83, P189, DOI 10.1111/j.2044-8295.1992.tb02434.x; Dering B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00093; Erk S, 2002, NEUROREPORT, V13, P2499, DOI 10.1097/00001756-200212200-00024; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Guthrie Stewart, 1993, FACES CLOUDS NEW THE; Hadjikhani N, 2009, NEUROREPORT, V20, P403, DOI 10.1097/WNR.0b013e328325a8e1; Halpern AR, 1993, JEXPLMC, V19, P417; Hamed MM, 2001, SAFETY SCI, V38, P63, DOI 10.1016/S0925-7535(00)00058-8; Kloth N, 2013, BRAIN COGNITION, V81, P321, DOI 10.1016/j.bandc.2013.01.002; Landwehr JR, 2011, J MARKETING, V75, P132, DOI 10.1509/jmkg.75.3.132; LEIBOWITZ HW, 1985, AM SCI, V73, P558; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; Piff PK, 2012, P NATL ACAD SCI USA, V109, P4086, DOI 10.1073/pnas.1118373109; Pitcairn TK, 2000, BRIT J PSYCHOL, V91, P391, DOI 10.1348/000712600161899; Puchner H, 2012, 60849 EN; Purucker C, 2014, REV MANAG SCI, V8, P523, DOI 10.1007/s11846-013-0116-2; Schwebel DC, 2008, ACCIDENT ANAL PREV, V40, P1394, DOI 10.1016/j.aap.2008.03.005; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; Tooby J., 1992, ADAPTED MIND EVOLUTI, V163, P163; Windhager S, 2008, HUM NATURE-INT BIOS, V19, P331, DOI 10.1007/s12110-008-9047-z; Windhager S, 2012, EVOL HUM BEHAV, V33, P109, DOI 10.1016/j.evolhumbehav.2011.06.003; Windhager S, 2010, COLLEGIUM ANTROPOL, V34, P1075	28	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159455	10.1371/journal.pone.0159455	http://dx.doi.org/10.1371/journal.pone.0159455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434187	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600054
J	McCallie, BR; Parks, JC; Patton, AL; Griffin, DK; Schoolcraft, WB; Katz-Jaffe, MG				McCallie, Blair R.; Parks, Jason C.; Patton, Alyssa L.; Griffin, Darren K.; Schoolcraft, William B.; Katz-Jaffe, Mandy G.			Hypomethylation and Genetic Instability in Monosomy Blastocysts May Contribute to Decreased Implantation Potential	PLOS ONE			English	Article							DNA METHYLATION DYNAMICS; PREIMPLANTATION EMBRYOS; MAMMALIAN DEVELOPMENT; DOWN-SYNDROME; EXPRESSION; ANEUPLOIDY; PROTEINS; METHYLTRANSFERASES; MAINTENANCE; SEQUENCE	DNA methylation is a key epigenetic mechanism responsible for gene regulation, chromatin remodeling, and genome stability, playing a fundamental role during embryonic development. The aim of this study was to determine if these epigenetic marks are associated with chromosomal aneuploidy in human blastocysts. Surplus, cryopreserved blastocysts that were donated to research with IRB consent were chosen with varying chromosomal aneuploidies and respective implantation potential: monosomies and trisomies 7, 11, 15, 21, and 22. DNA methylation analysis was performed using the Illumina Infinium HumanMethylation450 BeadChip (similar to 485,000 CpG sites). The methylation profiles of these human blastocysts were found to be similar across all samples, independent of chromosome constitution; however, more detailed examination identified significant hypomethylation in the chromosome involved in the monosomy. Real-time PCR was also performed to determine if downstream messenger RNA (mRNA) was affected for genes on the monosomy chromosome. Gene dysregulation was observed for monosomy blastocysts within significant regions of hypo-methylation (AVEN, CYFIP1, FAM189A1, MYO9A, ADM2, PACSIN2, PARVB, and PIWIL3) (P < 0.05). Additional analysis was performed to examine the gene expression profiles of associated methylation regulators including: DNA methyltransferases (DNMT1, DNMT3A, DNMT3B, DNMT3L), chromatin modifying regulators (CSNK1E, KDM1, PRKCA), and a post-translational modifier (PRMT5). Decreased RNA transcription was confirmed for each DNMT, and the regulators that impact DNMT activity, for only monosomy blastocysts (P < 0.05). In summary, monosomy blastocysts displayed hypomethylation for the chromosome involved in the error, as well as transcription alterations of associated developmental genes. Together, these modifications may be contributing to genetic instability and therefore be responsible for the limited implantation potential observed for full monosomy blastocysts.	[McCallie, Blair R.; Parks, Jason C.; Patton, Alyssa L.; Katz-Jaffe, Mandy G.] Natl Fdn Fertil Res, Lone Tree, CO 80124 USA; [Schoolcraft, William B.; Katz-Jaffe, Mandy G.] Colorado Ctr Reprod Med, Lone Tree, CO 80124 USA; [McCallie, Blair R.; Parks, Jason C.; Griffin, Darren K.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England	University of Kent	McCallie, BR (corresponding author), Natl Fdn Fertil Res, Lone Tree, CO 80124 USA.; McCallie, BR (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.	bmccallie@fertilityresearch.org			BBSRC [BB/E024211/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [G19438/2, BB/E024211/1, BB/E010652/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abouhamed M, 2009, MOL BIOL CELL, V20, P5074, DOI 10.1091/mbc.E09-04-0291; Alfandari D, 2001, CURR BIOL, V11, P918, DOI 10.1016/S0960-9822(01)00263-9; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; CHAUHAN M, 2015, BIOL REPROD, V93, DOI DOI 10.1095/; Chen C, 2013, GENE CHROMOSOME CANC, V52, P564, DOI 10.1002/gcc.22054; Cousin H, 2008, DEV BIOL, V319, P86, DOI 10.1016/j.ydbio.2008.04.007; Fragouli E, 2011, MOL HUM REPROD, V17, P286, DOI 10.1093/molehr/gar024; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Gorman SW, 1999, GENOMICS, V59, P150, DOI 10.1006/geno.1999.5867; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hata K, 2002, DEVELOPMENT, V129, P1983; Jacob S, 2005, PEDIATR RES, V58, P437, DOI 10.1203/01.PDR.0000179401.17161.D3; Javerzat S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007856; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kim S, 2014, MOL CELL, V56, P564, DOI 10.1016/j.molcel.2014.10.003; Kimura M, 2010, J CELL SCI, V123, P747, DOI 10.1242/jcs.052498; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-38; Ludwig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096090; Luthardt FW, 2001, CHROMOSOMAL SYNDROME; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Modregger J, 2000, J CELL SCI, V113, P4511; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; O'Shea LC, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111880; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Parks JC, 2011, FERTIL STERIL, V95, P1367, DOI 10.1016/j.fertnstert.2010.08.009; Pathania M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.16; Robberech C, 2010, CURR GENOMICS, V11, P397, DOI 10.2174/138920210793175967; Rosenkranz D, 2015, GENOM DATA, V5, P309, DOI 10.1016/j.gdata.2015.06.026; Sanchez JM, 1999, PRENATAL DIAG, V19, P601, DOI 10.1002/(SICI)1097-0223(199907)19:7<601::AID-PD564>3.3.CO;2-S; Sharp AJ, 2011, GENOME RES, V21, P1592, DOI 10.1101/gr.112680.110; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Treff NR, 2013, FERTIL STERIL, V99, P1049, DOI 10.1016/j.fertnstert.2012.11.007; Veitia RA, 2015, TRENDS BIOCHEM SCI, V40, P309, DOI 10.1016/j.tibs.2015.03.011; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000; Yin LJ, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-26	40	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159507	10.1371/journal.pone.0159507	http://dx.doi.org/10.1371/journal.pone.0159507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434648	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600059
J	Moe, N; Pedersen, B; Nordbo, SA; Skanke, LH; Krokstad, S; Smyrnaios, A; Dollner, H				Moe, Nina; Pedersen, Bard; Nordbo, Svein Arne; Skanke, Lars Hosoien; Krokstad, Sidsel; Smyrnaios, Anastasios; Dollner, Henrik			Respiratory Virus Detection and Clinical Diagnosis in Children Attending Day Care	PLOS ONE			English	Article							TRACT INFECTIONS; HUMAN BOCAVIRUS; VIRAL ETIOLOGY; EPIDEMIOLOGY; RNA; TRANSMISSION; PERSISTENCE; RHINOVIRUS; INFANTS; ILLNESS	Background Respiratory viruses often have been studied in children with respiratory tract infection (RTI), but less knowledge exists about viruses in asymptomatic children. We have studied the occurrence of a broad panel of respiratory viruses in apparently healthy children attending day care, taking into account the influence of possible confounding factors, such as age, clinical signs of respiratory tract infection (RTI), location (day-care section) and season. Methods We have studied 161 children in two day-care centers, each with separate sections for younger and older children, during four autumn and winter visits over a two-year period. A total of 355 clinical examinations were performed, and 343 nasopharyngeal samples (NPS) were analyzed by semi-quantitative, real-time, polymerase chain reaction (PCR) tests for 19 respiratory pathogens. Result Forty-three percent of all NPS were PCR-positive for >= 1 of 13 virus species, with high species variation during visits. Rhinovirus 26% (88/343 NPS), enterovirus 12% (40/343) and parechovirus 9% (30/343) were detected in every visit, and the rates varied in relation to age, day-care section and season. Ten other viruses were detected in <= 3% of the NPS. Generally, viruses occurred together in the NPS. In 24% (79/331) of the clinical examinations with available NPS, the children had clear signs of RTI, while in 41% (135/331) they had mild signs, and in 35% (117/331) the children had no signs of RTI. Moreover, viruses were found in 70% (55/79) of children with clear signs of RTI, in 41% (55/135) with mild signs and in 30% (35/117) without any signs of RTI (p < 0.001). Conclusions Positive PCR tests for respiratory viruses, particularly picornaviruses, were frequently detected in apparently healthy children attending day care. Virus detection rates were related to age, presence of clinical signs of RTI, location in day care and season.	[Moe, Nina; Skanke, Lars Hosoien; Smyrnaios, Anastasios; Dollner, Henrik] Univ Trondheim Hosp, St Olavs Hosp, Dept Pediat, Trondheim, Norway; [Pedersen, Bard] Norwegian Inst Nat Res, Trondheim, Norway; [Nordbo, Svein Arne; Krokstad, Sidsel] Univ Trondheim Hosp, St Olavs Hosp, Dept Med Microbiol, Trondheim, Norway; [Moe, Nina; Nordbo, Svein Arne; Skanke, Lars Hosoien; Dollner, Henrik] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Fac Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moe, N (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Pediat, Trondheim, Norway.; Moe, N (corresponding author), Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Fac Med, Trondheim, Norway.	nina.moe@ntnu.no			St. Olavs University Hospital; University Hospital of Trondheim, Trondheim, Norway [11/8437]	St. Olavs University Hospital; University Hospital of Trondheim, Trondheim, Norway	The work was supported by a grant from St. Olavs University Hospital, The University Hospital of Trondheim, Trondheim, Norway (https://stolav.no/fag-og-forskning/forskning), grant no 11/8437. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1978, ANN I STAT MATH, V30, P9, DOI 10.1007/BF02480194; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Calvo C, 2010, ACTA PAEDIATR, V99, P883, DOI 10.1111/j.1651-2227.2010.01714.x; Christensen A, 2013, EMERG INFECT DIS, V19, P574, DOI 10.3201/eid1904.121775; Christensen A, 2010, J CLIN VIROL, V49, P158, DOI 10.1016/j.jcv.2010.07.016; Chu HY, 2013, J CLIN VIROL, V57, P343, DOI 10.1016/j.jcv.2013.04.011; Crawley MJ, 2007, R BOOK, pviii; da Silva ER, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-41; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Fairchok MP, 2010, J CLIN VIROL, V49, P16, DOI 10.1016/j.jcv.2010.06.013; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; Harvala H, 2008, J CLIN MICROBIOL, V46, P3446, DOI 10.1128/JCM.01207-08; Heinonen S, 2015, AM J RESP CRIT CARE; HOLM S, 1979, SCAND J STAT, V6, P65; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Jartti T, 2013, PAEDIATR RESPIR REV, V14, P38, DOI 10.1016/j.prrv.2012.04.002; Kristoffersen AW, 2011, PEDIATR INFECT DIS J, V30, P279, DOI 10.1097/INF.0b013e3181fcb159; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lambert SB, 2007, PEDIATRICS, V120, pe929, DOI 10.1542/peds.2006-3703; Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669; Martin ET, 2013, J INFECT DIS, V207, P982, DOI 10.1093/infdis/jis934; Martins RB, 2014, MEM I OSWALDO CRUZ, V109, P716, DOI 10.1590/0074-0276140046; Nokso-Koivisto J, 2002, J MED VIROL, V66, P417, DOI 10.1002/jmv.2161; Patefield W. M., 1981, APPL STAT, V30, P91, DOI DOI 10.2307/2346669; Peltola V, 2008, J INFECT DIS, V197, P382, DOI 10.1086/525542; Piralla A, 2012, J MED VIROL, V84, P686, DOI 10.1002/jmv.23197; R Core Team, 2021, R LANGUAGE ENV STAT; Rhedin S, 2014, PEDIATRICS, V133, pE538, DOI 10.1542/peds.2013-3042; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Skram MK, 2014, PEDIATR INFECT DIS J, V33, P1222, DOI 10.1097/INF.0000000000000456; Souza LSD, 2003, PEDIATR PULM, V35, P184, DOI 10.1002/ppul.10194; Taylor JA, 2010, PEDIATR RES, V68, P252, DOI 10.1203/00006450-201011001-00493; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; Wagner JC, 2016, PEDIATR INFECT DIS J, V35, P471, DOI 10.1097/INF.0000000000001058; Westerhuis B, 2013, J CLIN VIROL, V58, P211, DOI 10.1016/j.jcv.2013.06.036; Wong-Chew Rosa M, 2015, BMC Res Notes, V8, P261, DOI 10.1186/s13104-015-1239-0; Zuur Alain F., 2009, P1	42	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159196	10.1371/journal.pone.0159196	http://dx.doi.org/10.1371/journal.pone.0159196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433803	gold, Green Published, Green Accepted			2022-12-27	WOS:000380169600038
J	Byun, S; Han, JW; Kim, TH; Kim, KW				Byun, Seonjeong; Han, Ji Won; Kim, Tae Hui; Kim, Ki Woong			Test-Retest Reliability and Concurrent Validity of a Single Tri-Axial Accelerometer-Based Gait Analysis in Older Adults with Normal Cognition	PLOS ONE			English	Article							PARKINSONS-DISEASE; KOREAN VERSION; RATING-SCALE; PARAMETERS; WALKING; DEMENTIA; DECLINE	Objective We investigated the concurrent validity and test-retest reliability of spatio-temporal gait parameters measured with a single tri-axial accelerometer (TAA), determined the optimal number of steps required for obtaining acceptable levels of reliability, and compared the validity and reliability of the estimated gait parameters across the three reference axes of the TAA. Methods A total of 82 cognitively normal elderly participants walked around a 40-m long round walkway twice wearing a TAA at their center of body mass. Gait parameters such as cadence, gait velocity, step time, step length, step time variability, and step time asymmetry were estimated from the low pass-filtered signal of the TAA. The test-retest reliability and concurrent validity with the GAITRite (R) system were evaluated for the estimated gait parameters. Results Gait parameters using signals from the vertical axis showed excellent reliability for all gait parameters; the intraclass correlation coefficient (ICC) was 0.79-0.90. A minimum of 26 steps and 14 steps were needed to achieve excellent reliability in step time variability and step time asymmetry, respectively. A strong level of agreement was seen for the basic gait parameters between the TAA and GAITRite (R) (ICC = 0.91-0.96). Conclusions The measurement of gait parameters of elderly individuals with normal cognition using a TAA placed on the body's center of mass was reliable and showed superiority over the GAITRite (R) with regard to gait variability and asymmetry. The TAA system was a valid tool for measuring basic gait parameters. Considering its wearability and low price, the TAA system may be a promising alternative to the pressure sensor walkway system for measuring gait parameters.	[Byun, Seonjeong; Kim, Tae Hui; Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Byun, Seonjeong; Han, Ji Won; Kim, Ki Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea; [Kim, Tae Hui] Yonsei Univ, Wonju Severance Christian Hosp, Dept Psychiat, Wonju, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Seoul National University (SNU)	Kim, KW (corresponding author), Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea.; Kim, KW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea.; Kim, KW (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul, South Korea.	kwkimmd@snu.ac.kr	Kim, Tae Hui/AAR-9213-2020	Kim, Tae Hui/0000-0003-0133-5227	Research Settlement Fund for the faculty of SNU [800-2012-0092]; SNUBH Research Fund [11-2011-030]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI09C1379(A092077)]	Research Settlement Fund for the faculty of SNU; SNUBH Research Fund; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by Research Settlement Fund for the faculty of SNU (grant number; 800-2012-0092, URL; http://www.snu.ac.kr), a grant from the SNUBH Research Fund (grand number; 11-2011-030, URL; http://www.snubh.org), and a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (grant number; HI09C1379(A092077), URL; http://www.mw.go.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONSSON EK, 1985, J BIOMECH, V18, P39, DOI 10.1016/0021-9290(85)90043-0; Auvinet B, 2002, GAIT POSTURE, V16, P124, DOI 10.1016/S0966-6362(01)00203-X; Baltadjieva R, 2006, EUR J NEUROSCI, V24, P1815, DOI 10.1111/j.1460-9568.2006.05033.x; Bautmans I, 2011, GAIT POSTURE, V33, P366, DOI 10.1016/j.gaitpost.2010.12.003; Beauchet O, 2011, TEST RETEST RELIABIL; Brandes M, 2006, GAIT POSTURE, V24, P482, DOI 10.1016/j.gaitpost.2005.12.006; Del Din S, 2016, IEEE J BIOMED HEALTH, V20, P838, DOI 10.1109/JBHI.2015.2419317; Fleiss J. L., 2011, DESIGN ANAL CLIN EXP; Galna B, 2013, GAIT POSTURE, V37, P580, DOI 10.1016/j.gaitpost.2012.09.025; Godfrey A, 2015, MED ENG PHYS, V37, P400, DOI 10.1016/j.medengphy.2015.02.003; Hartmann A, 2009, GAIT POSTURE, V30, P351, DOI 10.1016/j.gaitpost.2009.06.008; Hartmann A, 2009, GAIT POSTURE, V29, P444, DOI 10.1016/j.gaitpost.2008.11.003; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Hollman JH, 2010, GAIT POSTURE, V32, P23, DOI 10.1016/j.gaitpost.2010.02.017; Kim JY, 2008, PSYCHIAT INVEST, V5, P232, DOI 10.4306/pi.2008.5.4.232; Kim TH, 2010, PSYCHIAT INVEST, V7, P102, DOI 10.4306/pi.2010.7.2.102; Kim TH, 2013, ALZHEIMERS DEMENT, V9, pP626; Kressig RW, 2006, AGING CLIN EXP RES, P3; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; Lewek MD, 2011, J NEUROL PHYS THER, V35, P116, DOI 10.1097/NPT.0b013e318227fe70; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Nishiguchi S, 2012, TELEMED E-HEALTH, V18, P292, DOI 10.1089/tmj.2011.0132; Scherder E, 2007, NEUROSCI BIOBEHAV R, V31, P485, DOI 10.1016/j.neubiorev.2006.11.007; Senden R, 2009, GAIT POSTURE, V30, P192, DOI 10.1016/j.gaitpost.2009.04.008; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Verghese J, 2007, J NEUROL NEUROSUR PS, V78, P929, DOI 10.1136/jnnp.2006.106914; Yoo S, 2006, ANXIETY MOOD, V2, P50; Zhu S, 2014, P ACM INT C MULT; Zijlstra A, 2013, GAIT POSTURE, V38, P940, DOI 10.1016/j.gaitpost.2013.04.021; Zijlstra W, 2004, EUR J APPL PHYSIOL, V92, P39, DOI 10.1007/s00421-004-1041-5; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	33	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158956	10.1371/journal.pone.0158956	http://dx.doi.org/10.1371/journal.pone.0158956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427965	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300027
J	Tang, HW; Li, BM; Zhang, AQ; Lu, WP; Xiang, CH; Dong, JH				Tang, Haowen; Li, Bingmin; Zhang, Aiqun; Lu, Wenping; Xiang, Canhong; Dong, Jiahong			Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ELEVATED PREOPERATIVE NEUTROPHIL; DISEASE-FREE SURVIVAL; HEPATIC RESECTION; HEPATOCELLULAR-CARCINOMA; POOR-PROGNOSIS; INFLAMMATION; RECURRENCE; CANCER; MANAGEMENT	Background and Objective Inflammation is deemed to play critical roles in tumor progression and metastasis, and an increased neutrophil-lymphocyte ratio (NLR) has been reported to correlate with poor survivals in various malignancies. However, association between NLR elevation and survival outcome in patients with colorectal liver metastasis (CRLM) remains controversial. The aim of this study was to investigate the prognostic significance of elevated NLR in CRLM. Methods The meta-analysis was conducted in adherence to the MOOSE guidelines. PubMed, Embase, Cochrane Library, Web of Science and the Chinese SinoMed were systematically searched to identify eligible studies from the initiation of the databases to May, 2016. Overall survival (OS) and recurrence free survival (RFS) were pooled by using hazard ratio (HR) with corresponding 95% confidence interval (CI). Correlation between NLR values and clinicopathological features was synthesized by using odds ratio (OR) with corresponding 95% CI. Results A total of 1685 patients from 8 studies (9 cohorts) were analyzed, consisting 347 (20.59%) in high pretreatment NLR value group and 1338 (79.41%) in low pretreatment NLR value one. The results demonstrated that elevated pretreatment NLR was significantly related to poor OS (HR 2.17, 95% CI 1.82-2.58) and RFS (HR 1.96, 95% CI 1.64-2.35) in patients with CRLM. Conclusion The result of this systematic review and meta-analysis indicated that an elevated pretreatment NLR was closely correlated with poor long-term survival (OS and RFS) in CRLM patients. NLR can be routinely monitored and serve as a useful and cost-effective marker with strong prognostic significance in patients with CRLM.	[Tang, Haowen; Zhang, Aiqun; Lu, Wenping; Dong, Jiahong] Chinese PLA Med Sch, Chinese PLA Gen Hosp, Hosp & Inst Hepatobiliary Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China; [Li, Bingmin] Chinese PLA Med Sch, 28 Fuxing Rd, Beijing 100853, Peoples R China; [Xiang, Canhong; Dong, Jiahong] Tsinghua Univ, Med Ctr, Ctr Hepatopancreatobiliary Dis, Beijing Tsinghua Changgung Hosp, 168 Litang Rd, Beijing 102218, Peoples R China	Chinese People's Liberation Army General Hospital; Tsinghua University	Dong, JH (corresponding author), Chinese PLA Med Sch, Chinese PLA Gen Hosp, Hosp & Inst Hepatobiliary Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China.; Dong, JH (corresponding author), Tsinghua Univ, Med Ctr, Ctr Hepatopancreatobiliary Dis, Beijing Tsinghua Changgung Hosp, 168 Litang Rd, Beijing 102218, Peoples R China.	dongjh301@163.com			National Key Technology R&D Program of China [2012BAI06B01]; National S&T Major Project for Infectious Diseases of China [2012ZX10002-017]	National Key Technology R&D Program of China(National Key Technology R&D Program); National S&T Major Project for Infectious Diseases of China	The work is supported by the National Key Technology R&D Program of China (no. 2012BAI06B01) and the National S&T Major Project for Infectious Diseases of China (no. 2012ZX10002-017).; The work is supported by the National Key Technology R&D Program of China (NO. 2012BAI06B01) and the National S&T Major Project for Infectious Diseases of China (NO. 2012ZX10002-017). In addition, we gratefully acknowledge the statistical assistance of Professor Dan Feng from Department of Medical Statistics, Chinese PLA Medical School. We also thank Professor Xuemei Zhang from Department of Medical English, Academy of Military Medical Sciences for assistance in language editing.	Bailey C, 2007, CLIN EXP METASTAS, V24, P121, DOI 10.1007/s10585-007-9060-3; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Chang ZH, 2014, J MODERN ONCOLOGY, V22, P1096; Chen Q, 2015, TUMOR BIOL, V36, P5283, DOI 10.1007/s13277-015-3188-6; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cummings LC, 2007, CANCER, V109, P718, DOI 10.1002/cncr.22448; de Jong MC, 2009, ANN SURG, V250, P440, DOI 10.1097/SLA.0b013e3181b4539b; Fong YM, 1999, SEMIN ONCOL, V26, P514; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Giakoustidis A, 2015, J SURG ONCOL, V111, P445, DOI 10.1002/jso.23845; Gomez D, 2010, HPB, V12, P84, DOI 10.1111/j.1477-2574.2009.00127.x; Gomez D, 2008, J SURG ONCOL, V98, P371, DOI 10.1002/jso.21103; Gomez D, 2008, J SURG ONCOL, V97, P513, DOI 10.1002/jso.21001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Hofman PM, 2010, WORLD J GASTROENTERO, V16, P5790, DOI 10.3748/wjg.v16.i46.5790; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karanjia ND, 2009, EJSO-EUR J SURG ONC, V35, P838, DOI 10.1016/j.ejso.2008.09.017; Kishi Y, 2009, ANN SURG ONCOL, V16, P614, DOI 10.1245/s10434-008-0267-6; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Leporrier J, 2006, BRIT J SURG, V93, P465, DOI 10.1002/bjs.5278; Lin G, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7680; Liu SZ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3148; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Minardi D, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1036-1; Mouta Carla, 2003, Lymphat Res Biol, V1, P201, DOI 10.1089/153968503768330247; Mueller L, 2010, BIOCHEM BIOPH RES CO, V397, P586, DOI 10.1016/j.bbrc.2010.05.163; Neal CP, 2009, EUR J CANCER, V45, P56, DOI 10.1016/j.ejca.2008.08.019; Neal CP, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0590-2; Neal CP, 2011, ARCH SURG-CHICAGO, V146, P471, DOI 10.1001/archsurg.2011.50; Neofytou K, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0239-6; Proctor MJ, 2010, BRIT J CANCER, V103, P870, DOI 10.1038/sj.bjc.6605855; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Ropponen KM, 1997, J PATHOL, V182, P318, DOI 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6; Sharaiha RZ, 2011, ANN SURG ONCOL, V18, P3362, DOI 10.1245/s10434-011-1754-8; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Szkandera J, 2013, BRIT J CANCER, V109, P2316, DOI 10.1038/bjc.2013.595; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Xiao WK, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-117; Yoshidome H, 2009, INT J ONCOL, V34, P923, DOI 10.3892/ijo_00000218; YOUNES RN, 1991, ANN SURG, V214, P107, DOI 10.1097/00000658-199108000-00003; Zeman Marcin, 2013, Pol Przegl Chir, V85, P333, DOI 10.2478/pjs-2013-0050; Zhang YJ, 2012, INT J HYPERTHER, V28, P132, DOI 10.3109/02656736.2011.654374; Zhu DX, 2012, ANN SURG ONCOL, V19, P2860, DOI 10.1245/s10434-012-2356-9	49	28	29	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159447	10.1371/journal.pone.0159447	http://dx.doi.org/10.1371/journal.pone.0159447			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427969	gold, Green Submitted, Green Published			2022-12-27	WOS:000380169300068
J	Yeung, KR; Chiu, CL; Pears, S; Heffernan, SJ; Makris, A; Hennessy, A; Lind, JM				Yeung, Kristen R.; Chiu, Christine L.; Pears, Suzanne; Heffernan, Scott J.; Makris, Angela; Hennessy, Annemarie; Lind, Joanne M.			A Cross-Sectional Study of Ageing and Cardiovascular Function over the Baboon Lifespan	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; BLOOD-PRESSURE; QUANTITATIVE PCR; NONHUMAN PRIMATE; TELOMERE LENGTH; PAPIO-HAMADRYAS; NATIONAL-HEALTH; AGE; HYPERTENSION; ATHEROSCLEROSIS	Background Ageing is associated with changes at the molecular and cellular level that can alter cardiovascular function and ultimately lead to disease. The baboon is an ideal model for studying ageing due to the similarities in genetic, anatomical, physiological and biochemical characteristics with humans. The aim of this cross-sectional study was to investigate the changes in cardiovascular profile of baboons over the course of their lifespan. Methods Data were collected from 109 healthy baboons (Papio hamadryas) at the Australian National Baboon Colony. A linear regression model, adjusting for sex, was used to analyse the association between age and markers of ageing with P < 0.01 considered significant. Results Male (n = 49, 1.5-28.5 years) and female (n = 60, 1.8-24.6 years) baboons were included in the study. Age was significantly correlated with systolic (R-2 = 0.23, P < 0.001) and diastolic blood pressure (R-2 = 0.44, P < 0.001), with blood pressure increasing with age. Age was also highly correlated with core augmentation index (R-2 = 0.17, P < 0.001) and core pulse pressure (R-2 = 0.30, P < 0.001). Creatinine and urea were significantly higher in older animals compared to young animals (P < 0.001 for both). Older animals (>12 years) had significantly shorter telomeres when compared to younger (< 3 years) baboons (P = 0.001). Conclusion This study is the first to demonstrate that cardiovascular function alters with age in the baboon. This research identifies similarities within cardiovascular parameters between humans and baboon even though the length of life differs between the two species.	[Yeung, Kristen R.; Chiu, Christine L.; Makris, Angela; Hennessy, Annemarie; Lind, Joanne M.] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [Pears, Suzanne; Heffernan, Scott J.] Royal Prince Alfred Hosp, Dept Renal Med, Sydney, NSW, Australia; [Makris, Angela; Hennessy, Annemarie] Heart Res Inst, Sydney, NSW, Australia; [Makris, Angela] Liverpool Hosp, Dept Nephrol, Sydney, NSW, Australia	Western Sydney University; University of Sydney; University of Sydney; Heart Research Institute; Liverpool Hospital	Lind, JM (corresponding author), Univ Western Sydney, Sch Med, Sydney, NSW, Australia.	j.lind@westernsydney.edu.au	Hennessy, Annemarie/HGB-5049-2022	Hennessy, Annemarie/0000-0002-5975-2843; Chiu, Christine L./0000-0002-6411-9719	National Health and Medical Research Council - Enabling Capabilities Grant [1054126]; National Health and Medical Research Australian Biomedical Fellowship [457139]	National Health and Medical Research Council - Enabling Capabilities Grant; National Health and Medical Research Australian Biomedical Fellowship	This work was supported by a National Health and Medical Research Council - Enabling Capabilities Grant (1054126) awarded to AM and AH (https://www.nhmrc.gov.au/). JML was supported by a National Health and Medical Research Australian Biomedical Fellowship (457139) (https://www.nhmrc.gov.au/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baerlocher GM, 2003, J LEUKOCYTE BIOL, V73, P289, DOI 10.1189/jlb.0702361; Bailey JF, 2014, OSTEOARTHR CARTILAGE, V22, P980, DOI 10.1016/j.joca.2014.04.027; Bansal N, 2012, AM J NEPHROL, V36, P405, DOI 10.1159/000343495; Beltran WA, 2007, VET OPHTHALMOL, V10, P43, DOI 10.1111/j.1463-5224.2007.00491.x; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BOHNEN N, 1992, Z GERONTOL, V25, P339; Bourdel-Marchasson I, 2010, MATURITAS, V66, P39, DOI 10.1016/j.maturitas.2010.02.004; Bronikowski AM, 2002, P NATL ACAD SCI USA, V99, P9591, DOI 10.1073/pnas.142675599; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; CARVALHO JJM, 1989, HYPERTENSION, V14, P238, DOI 10.1161/01.HYP.14.3.238; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cefalu WT, 1997, AGE, V20, P15, DOI 10.1007/s11357-997-0002-4; Chapman KM, 1996, J GERONTOL A-BIOL, V51, pB261, DOI 10.1093/gerona/51A.4.B261; DAHL LK, 1972, AM J CLIN NUTR, V25, P231; Darusman HS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00313; FRASER CG, 1993, DRUG AGING, V3, P246, DOI 10.2165/00002512-199303030-00006; Fyhrquist F, 2013, NAT REV CARDIOL, V10, P274, DOI 10.1038/nrcardio.2013.30; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HANSEN BC, 1993, DIABETES, V42, P1809, DOI 10.2337/diabetes.42.12.1809; Hubbard JM, 2014, J CLIN ONCOL, V32, P2611, DOI 10.1200/JCO.2014.55.4261; Huber HF, 2015, J MED PRIMATOL, V44, P373, DOI 10.1111/jmp.12199; Jolly CJ, 2001, YEARB PHYS ANTHROPOL, V44, P177, DOI 10.1002/ajpa.10021; Kurtz TW, 2005, ARTERIOSCL THROM VAS, V25, pE22, DOI 10.1161/01.ATV.0000158419.98675.d7; Lara J, 2013, MATURITAS, V76, P189, DOI 10.1016/j.maturitas.2013.07.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWENSTEIN F, 1961, LANCET, V1, P389; MCGILL HC, 1985, ARTERIOSCLEROSIS, V5, P481, DOI 10.1161/01.ATV.5.5.481; MURRAY CE, 1981, CLIN SCI, V61, P737, DOI 10.1042/cs0610737; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; Oliver JJ, 2003, ARTERIOSCL THROM VAS, V23, P554, DOI 10.1161/01.ATV.0000060460.52916.D6; OLIVER WJ, 1975, CIRCULATION, V52, P146, DOI 10.1161/01.CIR.52.1.146; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; PAGE LB, 1974, CIRCULATION, V49, P1132, DOI 10.1161/01.CIR.49.6.1132; RODRIGUEZ BL, 1994, HYPERTENSION, V24, P779, DOI 10.1161/01.HYP.24.6.779; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; SCHAEFER EJ, 1995, AM J CLIN NUTR, V61, p726S, DOI 10.1093/ajcn/61.3.726S; Smucny DA, 2001, J MED PRIMATOL, V30, P161, DOI 10.1111/j.1600-0684.2001.tb00005.x; Stamler J, 1997, AM J CLIN NUTR, V65, P626, DOI 10.1093/ajcn/65.2.626S; Steinert S, 2002, EXP CELL RES, V272, P146, DOI 10.1006/excr.2001.5409; Stoner L, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/903107; TIETZ NW, 1992, CLIN CHEM, V38, P1167; TRUSWELL AS, 1972, AM HEART J, V84, P5, DOI 10.1016/0002-8703(72)90299-2; Ungvari Z, 2010, J MOL MED, V88, P1021, DOI 10.1007/s00109-010-0667-5; Visser M, 2005, AM J CLIN NUTR, V82, P531; Vlachopoulos C, 2000, CURR PROB CARDIOLOGY, V25, P301; Wang XL, 2004, CELL BIOCHEM BIOPHYS, V40, P371, DOI 10.1385/CBB:40:3:371; Willis EL, 2014, GEN COMP ENDOCR, V195, P21, DOI 10.1016/j.ygcen.2013.10.004; Yeung KR, 2014, J MED PRIMATOL, V43, P217, DOI 10.1111/jmp.12113; Zheng HY, 2014, EXP GERONTOL, V55, P113, DOI 10.1016/j.exger.2014.04.004	53	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159576	10.1371/journal.pone.0159576	http://dx.doi.org/10.1371/journal.pone.0159576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427971	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300078
J	Memczak, H; Lauster, D; Kar, P; Di Lella, S; Volkmer, R; Knecht, V; Herrmann, A; Ehrentreich-Forster, E; Bier, FF; Stocklein, WFM				Memczak, Henry; Lauster, Daniel; Kar, Parimal; Di Lella, Santiago; Volkmer, Rudolf; Knecht, Volker; Herrmann, Andreas; Ehrentreich-Foerster, Eva; Bier, Frank F.; Stoecklein, Walter F. M.			Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding	PLOS ONE			English	Article							RECEPTOR-BINDING; NEUTRALIZING ANTIBODY; ORIGIN; INFECTION; ENTRY; SITES; IDENTIFICATION; NEURAMINIDASE; RECOGNITION; ENERGETICS	Antibodies against spike proteins of influenza are used as a tool for characterization of viruses and therapeutic approaches. However, development, production and quality control of antibodies is expensive and time consuming. To circumvent these difficulties, three peptides were derived from complementarity determining regions of an antibody heavy chain against influenza A spike glycoprotein. Their binding properties were studied experimentally, and by molecular dynamics simulations. Two peptide candidates showed binding to influenza A/Aichi/2/68 H3N2. One of them, termed PeB, with the highest affinity prevented binding to and infection of target cells in the micromolar region without any cytotoxic effect. PeB matches best the conserved receptor binding site of hemagglutinin. PeB bound also to other medical relevant influenza strains, such as human-pathogenic A/California/7/2009 H1N1, and avian-pathogenic A/MuteSwan/Rostock/R901/2006 H7N1. Strategies to improve the affinity and to adapt specificity are discussed and exemplified by a double amino acid substituted peptide, obtained by substitutional analysis. The peptides and their derivatives are of great potential for drug development as well as biosensing.	[Memczak, Henry; Ehrentreich-Foerster, Eva; Stoecklein, Walter F. M.] Fraunhofer Inst Cell Therapy & Immunol Branch Bio, Dept Bioanalyt & Biosensor, Potsdam, Germany; [Memczak, Henry; Bier, Frank F.] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Lauster, Daniel; Di Lella, Santiago; Herrmann, Andreas] Humboldt Univ, Dept Biol, Berlin, Germany; [Kar, Parimal; Knecht, Volker] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany; [Di Lella, Santiago] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Di Lella, Santiago] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IQUIBICEN CONICET, Buenos Aires, DF, Argentina; [Volkmer, Rudolf] Charite, Inst Immunol, Berlin, Germany; [Bier, Frank F.] Fraunhofer Inst Cell Therapy & Immunol Branch Bio, Dept Biosystem Integrat & Automat, Potsdam, Germany; [Kar, Parimal] Indian Inst Technol Indore, Ctr Biosci & Biomed Engn, Indore, MP, India; [Knecht, Volker] Univ Freiburg, Inst Phys, Dept Biomol Dynam, Freiburg, Germany	Fraunhofer Gesellschaft; University of Potsdam; Humboldt University of Berlin; Max Planck Society; University of Buenos Aires; University of Buenos Aires; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Fraunhofer Gesellschaft; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Indore; University of Freiburg	Stocklein, WFM (corresponding author), Fraunhofer Inst Cell Therapy & Immunol Branch Bio, Dept Bioanalyt & Biosensor, Potsdam, Germany.	walter.stoecklein@izi-bb.fraunhofer.de	Bier, Frank/AAN-2532-2020; Lauster, Daniel/AAD-5167-2022; Knecht, Volker/AAN-7337-2021	Bier, Frank/0000-0003-0375-9832; Volkmer, Rudolf/0000-0003-4710-1143; Lauster, Daniel/0000-0003-2009-633X; Kar, Parimal/0000-0001-8451-9739	German Federal Ministry of Education and Research [FKZ 03 IS2201 A]; Deutsche Forschungsgemeinschaft [SFB 765, C6]; Alexander von Humboldt foundation	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	This work was supported by grant FKZ 03 IS2201 A of the German Federal Ministry of Education and Research (www.bmbf.de). Additional funding was given by the Deutsche Forschungsgemeinschaft, project SFB 765, C6 (www.dfg.de). SDL is grateful for a postdoc stipend of the Alexander von Humboldt foundation (www.humboldt-foundation.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendolia MG, 2012, PATHOG GLOB HEALTH, V106, P12, DOI 10.1179/2047773212Y.0000000004; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; BIZEBARD T, 1994, ACTA CRYSTALLOGR D, V50, P768, DOI 10.1107/S0907444994001903; Case D.A., 2014, AMBER, V14, P29; Choi SK, 1996, CHEM BIOL, V3, P97, DOI 10.1016/S1074-5521(96)90285-9; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cross G, 2002, SEMIN AVIAN EXOT PET, V11, P15, DOI 10.1053/saep.2002.28236; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DESSELBERGER U, 1975, ARCH VIROL, V49, P365, DOI 10.1007/BF01318246; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Fasting C, 2012, ANGEW CHEM INT EDIT, V51, P10472, DOI 10.1002/anie.201201114; Favre M, 1999, J AM CHEM SOC, V121, P2679, DOI 10.1021/ja984016p; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Friesen RHE, 2014, P NATL ACAD SCI USA, V111, P445, DOI 10.1073/pnas.1319058110; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Grienke U, 2012, NAT PROD REP, V29, P11, DOI 10.1039/c1np00053e; Hatano K, 2014, J MED CHEM, V57, P8332, DOI 10.1021/jm5007676; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jones JC, 2011, ANTIMICROB AGENTS CH, V55, P1810, DOI 10.1128/AAC.01428-10; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Kar P, 2012, J PHYS CHEM B, V116, P6269, DOI 10.1021/jp300818c; Kar P, 2012, J PHYS CHEM B, V116, P6137, DOI 10.1021/jp3022612; Kar P, 2012, J COMPUT AID MOL DES, V26, P215, DOI 10.1007/s10822-012-9550-5; Kar P, 2012, J PHYS CHEM B, V116, P2605, DOI 10.1021/jp211768n; Kar P, 2011, J PHYS CHEM B, V115, P7661, DOI 10.1021/jp201538t; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Kubota-Koketsu R, 2009, BIOCHEM BIOPH RES CO, V387, P180, DOI 10.1016/j.bbrc.2009.06.151; Laune D, 1997, J BIOL CHEM, V272, P30937, DOI 10.1074/jbc.272.49.30937; Lauster D, 2015, BEILSTEIN J ORG CHEM, V11, P589, DOI 10.3762/bjoc.11.65; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Li QL, 2011, PEPTIDES, V32, P1518, DOI 10.1016/j.peptides.2011.05.015; Lopez-Martinez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076876; MAMMEN M, 1995, J MED CHEM, V38, P4179, DOI 10.1021/jm00021a007; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Matsubara T, 2010, J MED CHEM, V53, P4441, DOI 10.1021/jm1002183; Nicol MQ, 2012, J GEN VIROL, V93, P980, DOI 10.1099/vir.0.038679-0; Papp I, 2011, CHEMBIOCHEM, V12, P887, DOI 10.1002/cbic.201000776; Papp I, 2010, SMALL, V6, P2900, DOI 10.1002/smll.201001349; Pelay-Gimeno M, 2015, ANGEW CHEM INT EDIT, V54, P8896, DOI 10.1002/anie.201412070; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Rajik M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-74; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; van der Vries E, 2013, ADV PHARMACOL, V67, P217, DOI 10.1016/B978-0-12-405880-4.00006-8; Waldmann M, 2014, J AM CHEM SOC, V136, P783, DOI 10.1021/ja410918a; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; Weiser J, 1999, BIOPOLYMERS, V50, P373, DOI 10.1002/(SICI)1097-0282(19991005)50:4<373::AID-BIP3>3.0.CO;2-U; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023058; Yang J, 2013, VIRUSES-BASEL, V5, P352, DOI 10.3390/v5010352; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430; Yusuf M, 2013, J CHEM INF MODEL, V53, P2423, DOI 10.1021/ci400421e	61	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159074	10.1371/journal.pone.0159074	http://dx.doi.org/10.1371/journal.pone.0159074			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415624	gold, Green Submitted, Green Published			2022-12-27	WOS:000379579500069
J	Nymo, IH; Seppola, M; Al Dahouk, S; Bakkemo, KR; de Bagues, MPJ; Godfroid, J; Larsen, AK				Nymo, Ingebjorg Helena; Seppola, Marit; Al Dahouk, Sascha; Bakkemo, Kathrine Ryvold; Pilar Jimenez de Bagues, Maria; Godfroid, Jacques; Larsen, Anett Kristin			Experimental Challenge of Atlantic Cod (Gadus morhua) with a Brucella pinnipedialis Strain from Hooded Seal (Cystophora cristata)	PLOS ONE			English	Article							PHOCA-VITULINA-RICHARDSI; HEAD KIDNEY MACROPHAGES; CARASSIUS-AURATUS L.; MARINE-MAMMAL TYPE; MYCOBACTERIUM-MARINUM; EXPRESSION ANALYSIS; IMMUNE-RESPONSES; HARBOR SEALS; ANTIMICROBIAL RESPONSES; FRANCISELLA-NOATUNENSIS	Pathology has not been observed in true seals infected with Brucella pinnipedialis. A lack of intracellular survival and multiplication of B. pinnipedialis in hooded seal (Cystophora cristata) macrophages in vitro indicates a lack of chronic infection in hooded seals. Both epidemiology and bacteriological patterns in the hooded seal point to a transient infection of environmental origin, possibly through the food chain. To analyse the potential role of fish in the transmission of B. pinnipedialis, Atlantic cod (Gadus morhua) were injected intraperitoneally with 7.5 x 10(7) bacteria of a hooded seal field isolate. Samples of blood, liver, spleen, muscle, heart, head kidney, female gonads and feces were collected on days 1, 7, 14 and 28 post infection to assess the bacterial load, and to determine the expression of immune genes and the specific antibody response. Challenged fish showed an extended period of bacteremia through day 14 and viable bacteria were observed in all organs sampled, except muscle, until day 28. Neither gross lesions nor mortality were recorded. Anti-Brucella antibodies were detected from day 14 onwards and the expression of hepcidin, cathelicidin, interleukin (IL)-1 beta, IL-10, and interferon (IFN)-gamma genes were significantly increased in spleen at day 1 and 28. Primary mononuclear cells isolated from head kidneys of Atlantic cod were exposed to B. pinnipedialis reference (NCTC 12890) and hooded seal (17a-1) strain. Both bacterial strains invaded mononuclear cells and survived intracellularly without any major reduction in bacterial counts for at least 48 hours. Our study shows that the B. pinnipedialis strain isolated from hooded seal survives in Atlantic cod, and suggests that Atlantic cod could play a role in the transmission of B. pinnipedialis to hooded seals in the wild.	[Nymo, Ingebjorg Helena; Godfroid, Jacques; Larsen, Anett Kristin] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Arctic Infect Biol, Tromso, Norway; [Seppola, Marit] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Al Dahouk, Sascha] Fed Inst Risk Assessment, Berlin, Germany; [Al Dahouk, Sascha] Rhein Westfal TH Aachen, Dept Internal Med 3, Aachen, Germany; [Bakkemo, Kathrine Ryvold] PHARMAQ AS, Oslo, Norway; [Pilar Jimenez de Bagues, Maria] Univ Zaragoza, CITA, Inst Agroalimentario Aragon IA2, Unidad Tecnol Prod & Sanidad Anim, Zaragoza, Spain	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Federal Institute for Risk Assessment; RWTH Aachen University; University of Zaragoza	Larsen, AK (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Arctic Infect Biol, Tromso, Norway.	anett.k.larsen@uit.no	Godfroid, Jacques/HCI-7835-2022; Larsen, Anett Kristin/K-6020-2019; Godfroid, Jacques/U-3524-2017	Larsen, Anett Kristin/0000-0002-2121-2286; Godfroid, Jacques/0000-0002-0782-7858; Jimenez de Bagues, Maria Pilar/0000-0002-5490-5177; Al Dahouk, Sascha/0000-0003-3835-0818; Nymo, Ingebjorg Helena/0000-0002-4844-8344	German Federal Institute for Risk Assessment, Berlin, Germany [1329-520, 1322-578]; Fram Centre - High North Research Centre for Climate and the Environment, Tromso, Norway; National Institute for Agricultural and Food Research and Technology (INIA) in Spain [RTA 2013-00065-C02-01]; PHARMAQ AS	German Federal Institute for Risk Assessment, Berlin, Germany; Fram Centre - High North Research Centre for Climate and the Environment, Tromso, Norway; National Institute for Agricultural and Food Research and Technology (INIA) in Spain; PHARMAQ AS	This project was financed by the German Federal Institute for Risk Assessment, Berlin, Germany (grant no. 1329-520 and 1322-578), http://www.bfr.bund.de/en/home.html, and the Fram Centre - High North Research Centre for Climate and the Environment, Tromso, Norway, http://www.npolar.no/en/research/fram-centre.html. MPJdB was supported by the grant RTA 2013-00065-C02-01 from The National Institute for Agricultural and Food Research and Technology (INIA) in Spain, http://www.inia.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PHARMAQ AS provided support in the form of salaries for authors [KRB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Alton G G, 1975, Monogr Ser World Health Organ, P1; Bakkemo KR, 2011, FISH SHELLFISH IMMUN, V31, P993, DOI 10.1016/j.fsi.2011.08.020; Bakkemo KR, 2016, NOATUNENSIS INVADE S; BETTS M, 1993, INFECT IMMUN, V61, P1722, DOI 10.1128/IAI.61.5.1722-1729.1993; Bingham J, 2008, NEW ZEAL VET J, V56, P10, DOI 10.1080/00480169.2008.36798; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; de Figueiredo P, 2015, AM J PATHOL, V185, P1505, DOI 10.1016/j.ajpath.2015.03.003; Eisenberg T, 2012, APPL ENVIRON MICROB, V78, P3753, DOI 10.1128/AEM.07509-11; El-Tras WF, 2010, VET MICROBIOL, V141, P321, DOI 10.1016/j.vetmic.2009.09.017; Ellingsen T, 2011, FISH SHELLFISH IMMUN, V31, P326, DOI 10.1016/j.fsi.2011.05.021; ESPELID S, 1991, J FISH DIS, V14, P185, DOI 10.1111/j.1365-2761.1991.tb00588.x; Fischer D, 2012, J ZOO WILDLIFE MED, V43, P625, DOI 10.1638/2011-0005R2.1; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Furnes C, 2009, FISH SHELLFISH IMMUN, V26, P285, DOI 10.1016/j.fsi.2008.12.002; Garner MM, 1997, J VET DIAGN INVEST, V9, P298, DOI 10.1177/104063879700900311; Godfroid J, 2013, COMP IMMUNOL MICROB, V36, P241, DOI 10.1016/j.cimid.2012.09.001; Grayfer L, 2014, DEV COMP IMMUNOL, V43, P223, DOI 10.1016/j.dci.2013.08.003; Grayfer L, 2011, DEV COMP IMMUNOL, V35, P1146, DOI 10.1016/j.dci.2011.04.007; Grillo MJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-29; Hagenaars TJ, 2004, J THEOR BIOL, V229, P349, DOI 10.1016/j.jtbi.2004.04.002; Haug T, 2007, MAR BIOL RES, V3, P123, DOI 10.1080/17451000701358531; Hodgkinson JW, 2012, DEV COMP IMMUNOL, V38, P456, DOI 10.1016/j.dci.2012.07.006; Lambourn D, 2013, J WILDLIFE DIS, V49, P802, DOI 10.7589/2012-05-137; Larsen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084861; Larsen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070186; Larsen AK, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0188-5; Lehnert K, 2010, INT J PARASITOL, V40, P845, DOI 10.1016/j.ijpara.2009.12.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund V, 2006, DEV COMP IMMUNOL, V30, P1145, DOI 10.1016/j.dci.2006.02.004; Maier VH, 2008, MOL IMMUNOL, V45, P3723, DOI 10.1016/j.molimm.2008.06.002; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; McDonald WL, 2006, J CLIN MICROBIOL, V44, P4363, DOI 10.1128/JCM.00680-06; Mikalsen J, 2009, J FISH DIS, V32, P377, DOI 10.1111/j.1365-2761.2008.00987.x; Mikkelsen H, 2013, FISH SHELLFISH IMMUN, V34, P387, DOI 10.1016/j.fsi.2012.10.010; Mikkelsen H, 2011, FISH SHELLFISH IMMUN, V30, P330, DOI 10.1016/j.fsi.2010.11.007; Nielsen K, 2002, VET MICROBIOL, V90, P447, DOI 10.1016/S0378-1135(02)00229-8; NIELSEN K, 2008, OIE MANUAL DIAGNOSTI, P634; Nymo IH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150432; Nymo IH, 2014, COMP IMMUNOL MICROB, V37, P195, DOI 10.1016/j.cimid.2014.01.005; Nymo IH, 2013, DIS AQUAT ORGAN, V106, P187, DOI 10.3354/dao02659; Nymo IH, 2013, J VET DIAGN INVEST, V25, P369, DOI 10.1177/1040638713485073; Nymo IH, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-93; Olsen AB, 2006, J FISH DIS, V29, P307, DOI 10.1111/j.1365-2761.2006.00714.x; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Perrett LL, 2004, SMALL RUMINANT RES, V51, P221, DOI 10.1016/S0921-4488(03)00233-5; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Rhyan JC, 2001, J VET DIAGN INVEST, V13, P379, DOI 10.1177/104063870101300502; Ronneseth A, 2007, FISH SHELLFISH IMMUN, V23, P493, DOI 10.1016/j.fsi.2006.08.017; ROSS HM, 1994, VET REC, V134, P359, DOI 10.1136/vr.134.14.359-b; Salem SF, 1997, VET MED-CZECH, V42, P5; Scholz HC, 2008, EMERG INFECT DIS, V14, P1316, DOI 10.3201/eid1408.080286; Schroder M. B., 1992, Fish & Shellfish Immunology, V2, P211, DOI 10.1016/S1050-4648(05)80060-9; Schroder MB, 2009, FISH SHELLFISH IMMUN, V27, P112, DOI 10.1016/j.fsi.2008.11.016; Secombes CJ, 2011, DEV COMP IMMUNOL, V35, P1336, DOI 10.1016/j.dci.2011.05.001; Seppola M, 2008, MOL IMMUNOL, V45, P887, DOI 10.1016/j.molimm.2007.08.003; Seppola M, 2007, DEV COMP IMMUNOL, V31, P156, DOI 10.1016/j.dci.2006.05.009; Seppola M, 2009, DEV COMP IMMUNOL, V33, P1205, DOI 10.1016/j.dci.2009.06.013; Solstad T, 2008, FISH SHELLFISH IMMUN, V25, P298, DOI 10.1016/j.fsi.2008.05.013; Sorensen KK, 1997, J FISH DIS, V20, P93, DOI 10.1046/j.1365-2761.1997.d01-112.x; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Steiro K, 1998, J FISH DIS, V21, P335, DOI 10.1046/j.1365-2761.1998.00110.x; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Tryland M, 2005, VET MICROBIOL, V105, P103, DOI 10.1016/j.vetmic.2004.11.001; van der Sar AM, 2009, MOL IMMUNOL, V46, P2317, DOI 10.1016/j.molimm.2009.03.024; Vos Q, 2000, IMMUNOL REV, V176, P154; Wang TH, 2013, FISH SHELLFISH IMMUN, V35, P1703, DOI 10.1016/j.fsi.2013.08.030; Whatmore AM., 2015, JMM CASE REPORTS, V2, P1, DOI [10.1099/jmmcr.0.000017, DOI 10.1099/JMMCR.0.000017]; Young D, 2002, NAT IMMUNOL, V3, P1026, DOI 10.1038/ni1102-1026; Zarnke RL, 2006, J WILDLIFE DIS, V42, P290, DOI 10.7589/0090-3558-42.2.290; Zou Jun, 2016, Biology-Basel, V5, P23, DOI 10.3390/biology5020023	72	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159272	10.1371/journal.pone.0159272	http://dx.doi.org/10.1371/journal.pone.0159272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415626	Green Published, gold			2022-12-27	WOS:000379579500117
J	Forster, Y; Schmidt, JR; Wissenbach, DK; Pfeiffer, SEM; Baumann, S; Hofbauer, LC; von Bergen, M; Kalkhof, S; Rammelt, S				Foerster, Yvonne; Schmidt, Johannes R.; Wissenbach, Dirk K.; Pfeiffer, Susanne E. M.; Baumann, Sven; Hofbauer, Lorenz C.; von Bergen, Martin; Kalkhof, Stefan; Rammelt, Stefan			Microdialysis Sampling from Wound Fluids Enables Quantitative Assessment of Cytokines, Proteins, and Metabolites Reveals Bone Defect-Specific Molecular Profiles	PLOS ONE			English	Article							INDUCED NEUTROPHIL CHEMOATTRACTANTS; IN-VIVO MICRODIALYSIS; DERMAL MICRODIALYSIS; INDUCED INFLAMMATION; PROTEOMIC ANALYSIS; ANNEXIN A2; REPAIR; CELL; CHEMOKINES; RECOVERY	Bone healing involves a variety of different cell types and biological processes. Although certain key molecules have been identified, the molecular interactions of the healing progress are not completely understood. Moreover, a clinical routine for predicting the quality of bone healing after a fracture in an early phase is missing. This is mainly due to a lack of techniques to comprehensively screen for cytokines, growth factors and metabolites at their local site of action. Since all soluble molecules of interest are present in the fracture hematoma, its in- depth assessment could reveal potential markers for the monitoring of bone healing. Here, we describe an approach for sampling and quantification of cytokines and metabolites by using microdialysis, combined with solid phase extractions of proteins from wound fluids. By using a control group with an isolated soft tissue wound, we could reveal several bone defect- specific molecular features. In bone defect dialysates the neutrophil chemoattractants CXCL1, CXCL2 and CXCL3 were quantified with either a higher or earlier response compared to dialysate from soft tissue wound. Moreover, by analyzing downstream adaptions of the cells on protein level and focusing on early immune response, several proteins involved in the immune cell migration and activity could be identified to be specific for the bone defect group, e. g. immune modulators, proteases and their corresponding inhibitors. Additionally, the metabolite screening revealed different profiles between the bone defect group and the control group. In summary, we identified potential biomarkers to indicate imbalanced healing progress on all levels of analysis.	[Foerster, Yvonne; Rammelt, Stefan] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Univ Ctr Orthoped & Trauma Surg, Dresden, Germany; [Foerster, Yvonne; Rammelt, Stefan] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Ctr Translat Bone Joint & Soft Tissue Res, Dresden, Germany; [Schmidt, Johannes R.; Wissenbach, Dirk K.; Pfeiffer, Susanne E. M.; Baumann, Sven; von Bergen, Martin; Kalkhof, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Mol Syst Biol, Leipzig, Germany; [Baumann, Sven] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Pharm, Leipzig, Germany; [Hofbauer, Lorenz C.] Tech Univ Dresden, Div Endocrinol & Metab Bone Dis, Dept Med 3, Univ Hosp Carl Gustav Carus, Dresden, Germany; [von Bergen, Martin] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, Leipzig, Germany; [von Bergen, Martin] Aalborg Univ, Ctr Microbial Communities, Aalborg, Denmark; [Kalkhof, Stefan] Univ Appl Sci & Arts Coburg, Dept Bioanalyt, Coburg, Germany; [Rammelt, Stefan] Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Leipzig University; Aalborg University; Technische Universitat Dresden	Forster, Y (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Univ Ctr Orthoped & Trauma Surg, Dresden, Germany.; Forster, Y (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Ctr Translat Bone Joint & Soft Tissue Res, Dresden, Germany.	yvonne.foerster@uniklinikum-dresden.de	Kalkhof, Stefan/Z-2000-2019; von Bergen, Martin/D-7960-2011; Baumann, Sven/M-2177-2013; Rammelt, Stefan/AAE-5863-2019; Hofbauer, Lorenz C/G-2490-2010; Schmidt, Johannes/HIK-1379-2022	Kalkhof, Stefan/0000-0001-6121-7105; von Bergen, Martin/0000-0003-2732-2977; Baumann, Sven/0000-0002-3453-5308; Rammelt, Stefan/0000-0003-1141-6493; Hofbauer, Lorenz C/0000-0002-8691-8423; Schmidt, Johannes/0000-0002-2026-9715; Pfeiffer, Susanne/0000-0003-0665-1632	Deutsche Forschungsgemeinschaft (DFG) [Transregio 67]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	YF, JS, and SK are thankful to the Deutsche Forschungsgemeinschaft (DFG), Transregio 67 for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao XP, 2006, METHODS, V38, P331, DOI 10.1016/j.ymeth.2005.11.012; Averbeck M, 2006, EXP DERMATOL, V15, P447, DOI 10.1111/j.0906-6705.2006.00429.x; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; Baumann S, 2013, CURR METABOL, V1, P15, DOI 10.2174/2213235X11301010015; Bernay B, 2009, MOL CELL PROTEOMICS, V8, P946, DOI 10.1074/mcp.M800501-MCP200; Blume KE, 2009, J IMMUNOL, V183, P8138, DOI 10.4049/jimmunol.0902250; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; BRACIAK TA, 1988, J BIOL CHEM, V263, P3999; Brandt E, 2000, J LEUKOCYTE BIOL, V67, P471, DOI 10.1002/jlb.67.4.471; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075; Clausen Trine Schnedler, 2009, Journal of Pharmacological and Toxicological Methods, V60, P281, DOI 10.1016/j.vascn.2009.03.001; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Eming SA, 2010, J PROTEOME RES, V9, P4758, DOI 10.1021/pr100456d; Famularo G, 2004, ANN NY ACAD SCI, V1033, P132, DOI 10.1196/annals.1320.012; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Forster Y, 2013, ACTA ORTHOP, V84, P76, DOI 10.3109/17453674.2013.769080; Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078; Gauglitz GG, 2008, SHOCK, V30, P503, DOI 10.1097/SHK.0b013e31816e3373; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gill C, 2011, AAPS J, V13, P309, DOI 10.1208/s12248-011-9269-6; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Grinnell F, 1996, J INVEST DERMATOL, V106, P335, DOI 10.1111/1523-1747.ep12342990; Hagiwara H, 1998, CIRCULATION, V98, P2584, DOI 10.1161/01.CIR.98.23.2584; Haugaa H, 2012, LIVER TRANSPLANT, V18, P1421, DOI 10.1002/lt.23503; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hoeke H, 2015, DRUG TEST ANAL, V7, P695, DOI 10.1002/dta.1767; Kalkhof S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/934848; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Kirbs C, 2014, EUR J PHARM SCI, V57, P48, DOI 10.1016/j.ejps.2013.11.006; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Kohler A, 2011, BLOOD, V117, P4349, DOI 10.1182/blood-2010-09-308387; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Kuckleburg CJ, 2012, J IMMUNOL, V188, P2419, DOI 10.4049/jimmunol.1102540; LEBRETON JP, 1979, J CLIN INVEST, V64, P1118, DOI 10.1172/JCI109551; Liu WL, 2012, J IMMUNOL, V189, P2460, DOI 10.4049/jimmunol.1103179; LONBERGHOLM K, 1987, J BIOL CHEM, V262, P438; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Maurer Martin H, 2003, Proteome Sci, V1, P7, DOI 10.1186/1477-5956-1-7; NAKAGAWA H, 1994, BIOCHEM J, V301, P545, DOI 10.1042/bj3010545; Nakagawa H, 1998, INT ARCH ALLERGY IMM, V115, P137, DOI 10.1159/000023893; Nieminen J, 2005, J LEUKOCYTE BIOL, V78, P1127; Olausson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052560; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Perl M, 2003, SHOCK, V19, P299, DOI 10.1097/00024382-200304000-00001; Petersen LJ, 2013, SKIN RES TECHNOL, V19, P424, DOI 10.1111/srt.12063; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Schenk T, 2001, J PHARMACEUT BIOMED, V26, P975, DOI 10.1016/S0731-7085(01)00464-2; Schutte RJ, 2004, ANAL CHEM, V76, P6058, DOI 10.1021/ac0493626; SHIBATA F, 1995, EUR J BIOCHEM, V231, P306, DOI 10.1111/j.1432-1033.1995.tb20701.x; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283; SUGIMORI T, 1995, AM J RESP CELL MOL, V13, P314, DOI 10.1165/ajrcmb.13.3.7654387; Swisher JFA, 2007, J LEUKOCYTE BIOL, V82, P1174, DOI 10.1189/jlb.0307154; Swisher JFA, 2010, BLOOD, V115, P549, DOI 10.1182/blood-2009-06-226944; Takano K, 2001, INFLAMM RES, V50, P503, DOI 10.1007/PL00000226; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Team R. D. C, 2011, R LANG ENV STAT COMP; Vasicek TW, 2013, ACS CHEM NEUROSCI, V4, P737, DOI 10.1021/cn400025m; Vu V. Q., 2011, GGBIPLOT GGPLOT2 BAS; Wabnitz GH, 2007, EUR J IMMUNOL, V37, P649, DOI 10.1002/eji.200636320; Waelgaard L, 2006, SCAND J IMMUNOL, V64, P345, DOI 10.1111/j.1365-3083.2006.01826.x; Wang CY, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/308976; Welin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069575; Wilgus TA, 2013, ADV WOUND CARE, V2, P379, DOI 10.1089/wound.2012.0383; Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1; Xing ZQ, 2010, J ORTHOP RES, V28, P1000, DOI 10.1002/jor.21087; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Yager Dorne R, 2007, Int J Low Extrem Wounds, V6, P262, DOI 10.1177/1534734607307035; Yang LC, 1996, PAIN, V67, P345, DOI 10.1016/0304-3959(96)03106-5	88	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159580	10.1371/journal.pone.0159580	http://dx.doi.org/10.1371/journal.pone.0159580			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441377	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500098
J	Gal, A; Lin, PC; Cacioppo, JA; Hannon, PR; Mahoney, MM; Wolfe, A; Fernandez-Valdivia, R; Lydon, JP; Elias, CF; Ko, C				Gal, Arnon; Lin, Po-Ching; Cacioppo, Joseph A.; Hannon, Patrick R.; Mahoney, Megan M.; Wolfe, Andrew; Fernandez-Valdivia, Rodrigo; Lydon, John P.; Elias, Carol F.; Ko, CheMyong			Loss of Fertility in the Absence of Progesterone Receptor Expression in Kisspeptin Neurons of Female Mice	PLOS ONE			English	Article							LUTEINIZING-HORMONE SURGE; ARYL-HYDROCARBON RECEPTOR; REPRODUCTIVE-TRACT; GENE-EXPRESSION; GNRH NEURONS; LH SURGE; MOUSE; ESTROGEN; ESTRADIOL; BRAIN	Ovarian steroids, estradiol and progesterone, play central roles in regulating female reproduction by acting as both positive and negative regulators of gonadotropin-releasing hormone (GnRH) secretion in the hypothalamus. Recent studies have identified kisspeptin neurons of the hypothalamus as the target of estrogenic regulation of GnRH secretion. In this study, we aimed to determine the significance of progesterone receptor (PGR) expression in the kisspeptin neurons. To this end, the Pgr gene was selectively ablated in mouse kisspeptin neurons and the reproductive consequence assessed. The hypothalamus of the Pgr deficient female mouse expressed kisspeptin, the pituitary released LH in response to GnRH stimulation, and the ovary ovulated when stimulated with gonadotropins. However, the mutant mouse gradually lost cyclicity, was unable to generate a LH surge in response to rising estradiol, and eventually became infertile. Taken together, these results indicate that the loss of PGR impairs kisspeptin secretory machinery and therefore that PGR plays a critical role in regulating kisspeptin secretion.	[Gal, Arnon] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Gal, Arnon; Lin, Po-Ching; Cacioppo, Joseph A.; Hannon, Patrick R.; Mahoney, Megan M.; Ko, CheMyong] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL USA; [Wolfe, Andrew] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Fernandez-Valdivia, Rodrigo] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Fernandez-Valdivia, Rodrigo] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Fernandez-Valdivia, Rodrigo] Karmanos Canc Inst, Tumor Biol Microenvironm Program, Detroit, MI USA; [Lydon, John P.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Elias, Carol F.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Massey University; University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Baylor College of Medicine; Baylor College of Medicine; University of Michigan System; University of Michigan	Ko, C (corresponding author), Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL USA.	jayko@illinois.edu	Ko, CheMyong Jay/A-7475-2019; Gal, Arnon/U-4357-2019	Ko, CheMyong Jay/0000-0002-0963-3731; Gal, Arnon/0000-0002-6449-2812; Cacioppo, Joseph/0000-0002-9763-9139	National Institutes of Health [HD071875, U54 HD07495, HD61539, HD69702]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD071875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health Grants HD071875 (C.K.), U54 HD07495 (J.L.), HD61539 (C.E.), and HD69702 (C.E.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict JC, 2000, TOXICOL SCI, V56, P382, DOI 10.1093/toxsci/56.2.382; Benedict JC, 2003, BIOL REPROD, V68, P1511, DOI 10.1095/biolreprod.102.007492; Bulun SE, 2011, WILLIAMS TXB ENDOCRI; Chappell PE, 1999, ENDOCRINOLOGY, V140, P3653, DOI 10.1210/en.140.8.3653; Chappell PE, 2000, ENDOCRINOLOGY, V141, P1477, DOI 10.1210/en.141.4.1477; Christian CA, 2005, P NATL ACAD SCI USA, V102, P15682, DOI 10.1073/pnas.0504270102; Christian CA, 2010, ENDOCR REV, V31, P544, DOI 10.1210/er.2009-0023; Clarkson J, 2009, J NEUROENDOCRINOL, V21, P305, DOI 10.1111/j.1365-2826.2009.01835.x; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Clarkson J, 2010, MOL CELL ENDOCRINOL, V324, P45, DOI 10.1016/j.mce.2010.01.026; Cravo RM, 2011, NEUROSCIENCE, V173, P37, DOI 10.1016/j.neuroscience.2010.11.022; Dungan HM, 2006, ENDOCRINOLOGY, V147, P1154, DOI 10.1210/en.2005-1282; Fernandez-Valdivia R, 2010, GENESIS, V48, P106, DOI 10.1002/dvg.20586; FOWLER RE, 1957, J ENDOCRINOL, V15, P374, DOI 10.1677/joe.0.0150374; Gal A, 2014, TOXICOL PATHOL, V42, P1212, DOI 10.1177/0192623314526321; George P, 2007, MOUSE BRAIN STEREOTA; Glanowska KM, 2012, J NEUROSCI, V32, P14664, DOI 10.1523/JNEUROSCI.1303-12.2012; GOODMAN RL, 1980, ENDOCRINOLOGY, V107, P1286, DOI 10.1210/endo-107-5-1286; Gottsch ML, 2009, J NEUROSCI, V29, P9390, DOI 10.1523/JNEUROSCI.0763-09.2009; KREY LC, 1973, ENDOCRINOLOGY, V93, P385, DOI 10.1210/endo-93-2-385; Kurita T, 2000, BIOL REPROD, V62, P821, DOI 10.1095/biolreprod62.4.831; Lee S, 2009, ENDOCRINOLOGY, V150, P3855, DOI 10.1210/en.2008-1774; LEIPHEIMER RE, 1984, ENDOCRINOLOGY, V114, P1605, DOI 10.1210/endo-114-5-1605; LEVINE JE, 1980, ENDOCRINOLOGY, V107, P1782, DOI 10.1210/endo-107-6-1782; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luque RM, 2007, ENDOCRINOLOGY, V148, P4601, DOI 10.1210/en.2007-0500; McCartney CR, 2002, J CLIN ENDOCR METAB, V87, P2194, DOI 10.1210/jc.87.5.2194; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; McNeilly AS, 2003, REPRODUCTION, P463; NELSON JF, 1981, BIOL REPROD, V24, P784, DOI 10.1095/biolreprod24.4.784; Nett TM, 2002, DOMEST ANIM ENDOCRIN, V23, P33, DOI 10.1016/S0739-7240(02)00143-1; Novaira HJ, 2014, MOL ENDOCRINOL, V28, P225, DOI 10.1210/me.2013-1319; Olesen KM, 2005, ENDOCRINOLOGY, V146, P3705, DOI 10.1210/en.2005-0498; Pierce A, 2011, MOL CELL ENDOCRINOL, V339, P151, DOI 10.1016/j.mce.2011.04.007; Silveira LFG, 2010, FRONT HORM RES, V39, P13, DOI 10.1159/000312689; SMITH BJ, 1991, REPROD TOXICOL, V5, P379, DOI 10.1016/0890-6238(91)90097-Y; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Stephens SBZ, 2015, ENDOCRINOLOGY, V156, P3091, DOI 10.1210/en.2015-1300; Strauss Iii JF, 2009, YEN JAFFES REPROD EN, P155; Wagner CK, 2001, J NEUROBIOL, V47, P176, DOI 10.1002/neu.1025; WANG XN, 1993, J REPROD FERTIL, V99, P403, DOI 10.1530/jrf.0.0990403	42	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159534	10.1371/journal.pone.0159534	http://dx.doi.org/10.1371/journal.pone.0159534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441639	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500089
J	Halbert, CH; McDonald, J; Vadaparampil, S; Rice, L; Jefferson, M				Halbert, Chanita Hughes; McDonald, Jasmine; Vadaparampil, Susan; Rice, LaShanta; Jefferson, Melanie			Conducting Precision Medicine Research with African Americans	PLOS ONE			English	Article							RESEARCH PARTICIPATION; DIETARY INTERVENTIONS; PHYSICAL-ACTIVITY; GENETIC RESEARCH; PROSTATE-CANCER; INCREASED RISK; RECRUITMENT; RETENTION; INTENTIONS; TRIAL	Importance Precision medicine is an approach to detecting, treating, and managing disease that is based on individual variation in genetic, environmental, and lifestyle factors. Precision medicine is expected to reduce health disparities, but this will be possible only if studies have adequate representation of racial minorities. Objective It is critical to anticipate the rates at which individuals from diverse populations are likely to participate in precision medicine studies as research initiatives are being developed. We evaluated the likelihood of participating in a clinical study for precision medicine. Design, Setting, Participants Observational study conducted between October 2010 and February 2011 in a national sample of African Americans. Main Outcome Measure Intentions to participate in a government sponsored study that involves providing a biospecimen and generates data that could be shared with other researchers to conduct future studies. Results One third of respondents would participate in a clinical study for precision medicine. Only gender had a significant independent association with participation intentions. Men had a 1.86 (95% CI = 1.11, 3.12, p = 0.02) increased likelihood of participating in a precision medicine study compared to women in the model that included overall barriers and facilitators. In the model with specific participation barriers, distrust was associated with a reduced likelihood of participating in the research described in the vignette (OR = 0.57, 95% CI = 0.34, 0.96, p = 0.04). Conclusion and Relevance African Americans may have low enrollment in PMI research. As PMI research is implemented, extensive efforts will be needed to ensure adequate representation. Additional research is needed to identify optimal ways of ethically describing precision medicine studies to ensure sufficient recruitment of racial minorities.	[Halbert, Chanita Hughes; Rice, LaShanta] Med Univ South Carolina, Dept Psychiat & Behav Sci, 171 Ashley Ave, Charleston, SC 29425 USA; [Halbert, Chanita Hughes; Rice, LaShanta] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Halbert, Chanita Hughes; Rice, LaShanta] Ralph H Johnson Vet Adm Med Ctr, Charleston, SC 29401 USA; [McDonald, Jasmine; Jefferson, Melanie] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Vadaparampil, Susan] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Columbia University; H Lee Moffitt Cancer Center & Research Institute	Halbert, CH (corresponding author), Med Univ South Carolina, Dept Psychiat & Behav Sci, 171 Ashley Ave, Charleston, SC 29425 USA.; Halbert, CH (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.; Halbert, CH (corresponding author), Ralph H Johnson Vet Adm Med Ctr, Charleston, SC 29401 USA.	hughesha@musc.edu	McDonald, Jasmine/L-4249-2019	McDonald, Jasmine/0000-0002-8270-8074	National Human Genome Research Institute [R01HG004346]; American Cancer Society [RSG-11-268-01-CPPB]; National Cancer Institute [UG1CA189848]; National Center for Advancing Translational Science [UL1TR001450]	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Science	This research was supported by National Human Genome Research Institute grant #R01HG004346, grant #RSG-11-268-01-CPPB from the American Cancer Society, grant #UG1CA189848 from the National Cancer Institute, and grant #UL1TR001450 from the National Center for Advancing Translational Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahaghotu C, 2004, PROSTATE CANCER P D, V7, P165, DOI 10.1038/sj.pcan.4500719; Bussey-Jones J, 2010, GENET MED, V12, P116, DOI 10.1097/GIM.0b013e3181cd6689; Bussey-Jones J, 2009, J GEN INTERN MED, V24, P299, DOI 10.1007/s11606-008-0883-7; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; Corbie-Smith G, 2002, ARCH INTERN MED, V162, P2458, DOI 10.1001/archinte.162.21.2458; Ford JG, 2008, CANCER, V112, P228, DOI 10.1002/cncr.23157; Fuqua SR, 2005, ETHNIC DIS, V15, pS18; George S, 2014, AM J PUBLIC HEALTH, V104, pE16, DOI 10.2105/AJPH.2013.301706; Haga SB, 2010, GENET MED, V12, P81, DOI 10.1097/GIM.0b013e3181ca2bbf; Halbert CH, 2008, AM J MED GENET A, V146A, P166, DOI 10.1002/ajmg.a.32067; Halbert CH, 2006, GENET MED, V8, P576, DOI 10.1097/01.gim.0000237719.37908.54; Halbert CH, 2014, CANCER EPIDEM BIOMAR, V23, P1306, DOI 10.1158/1055-9965.EPI-13-1064; Henderson G, 2008, GENET MED, V10, P193, DOI 10.1097/GIM.0b013e318164e4f5; Kennedy BM, 2011, HEALTH EDUC RES, V26, P923, DOI 10.1093/her/cyr061; Kessler L, 2005, GENET MED, V7, P230, DOI 10.1097/01.GIM.0000159901.98315.FE; McDonald JA, 2014, PUBLIC HEALTH GENOM, V17, P173, DOI 10.1159/000360472; McDonald JA, 2012, J NATL MED ASSOC, V104, P324, DOI 10.1016/S0027-9684(15)30172-3; McDonald JA, 2012, GENET TEST MOL BIOMA, V16, P252, DOI 10.1089/gtmb.2011.0119; McQuillan Geraldine M, 2011, IRB, V33, P9; McQuillan GM, 2003, GENET MED, V5, P35, DOI 10.1097/00125817-200301000-00006; National Institutes of Health, THE PRECISION MEDICI; National Institutes of Health, PRECISION MEDICINE I; Newton RL, 2014, OBES REV, V15, P93, DOI 10.1111/obr.12209; Parra-Medina D, 2004, J AM DIET ASSOC, V104, P70, DOI 10.1016/j.jada.2003.10.014; Pew Research Institute, ASSESSING THE REPRES; Powell IJ, 2001, J NATL MED ASSOC, V93, P120; Smith TW, 2003, ALTRUISM IN CONTEMPO; Wyatt SB, 2003, ETHNIC DIS, V13, P438; Yancey AK, 2006, ANNU REV PUBL HEALTH, V27, P1, DOI 10.1146/annurev.publhealth.27.021405.102113	30	31	31	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0154850	10.1371/journal.pone.0154850	http://dx.doi.org/10.1371/journal.pone.0154850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS5CG	27441706	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500003
J	Haque, MZ; McIntosh, VJ; Abou Samra, AB; Mohammad, RM; Lasley, RD				Haque, Mohammed Z.; McIntosh, Victoria J.; Abou Samra, Abdul B.; Mohammad, Ramzi M.; Lasley, Robert D.			Cholesterol Depletion Alters Cardiomyocyte Subcellular Signaling and Increases Contractility	PLOS ONE			English	Article							CARDIAC MYOCYTES; VENTRICULAR MYOCYTES; MYOCARDIAL ISCHEMIA; PLASMA-MEMBRANE; NA+/K+-ATPASE; P38 MAPK; IN-VIVO; CAVEOLAE; ACTIVATION; PROTEIN	Membrane cholesterol levels play an important factor in regulating cell function. Sarcolemmal cholesterol is concentrated in lipid rafts and caveolae, which are flask-shaped invaginations of the plasma membrane. The scaffolding protein caveolin permits the enrichment of cholesterol in caveolae, and caveolin interactions with numerous proteins regulate their function. The purpose of this study was to determine whether acute reductions in cardio-myocyte cholesterol levels alter subcellular protein kinase activation, intracellular Ca2+ and contractility. Methods: Ventricular myocytes, isolated from adult Sprague Dawley rats, were treated with the cholesterol reducing agent methyl-beta-cyclodextrin (M beta CD, 5 mM, 1 hr, room temperature). Total cellular cholesterol levels, caveolin-3 localization, subcellular, ERK and p38 mitogen activated protein kinase (MAPK) signaling, contractility, and [Ca2+]i were assessed. Results: Treatment with M beta CD reduced cholesterol levels by similar to 45 and shifted caveolin-3 from cytoskeleton and triton-insoluble fractions to the triton-soluble fraction, and increased ERK isoform phosphorylation in cytoskeletal, cytosolic, triton-soluble and triton-insoluble membrane fractions without altering their subcellular distributions. In contrast the primary effect of M beta CD was on p38 subcellular distribution of p38 alpha with little effect on p38 phosphorylation. Cholesterol depletion increased cardiomyocyte twitch amplitude and the rates of shortening and relaxation in conjunction with increased diastolic and systolic [Ca2+]i. Conclusions: These results indicate that acute reductions in membrane cholesterol levels differentially modulate basal cardiomyocyte subcellular MAPK signaling, as well as increasing [Ca2+]i and contractility.	[Haque, Mohammed Z.; Abou Samra, Abdul B.; Mohammad, Ramzi M.] Hamad Med Corp, Acad Hlth Syst, Interim Translat Res Inst, Dept Internal Med, Doha, Qatar; [Haque, Mohammed Z.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res, 2799 West Grand Blvd, Detroit, MI 48202 USA; [McIntosh, Victoria J.; Lasley, Robert D.] Wayne State Univ, Sch Med, Dept Physiol, 1104 Elliman Bldg,421 East Canfield, Detroit, MI 48201 USA	Hamad Medical Corporation; Henry Ford Health System; Henry Ford Hospital; Wayne State University	Haque, MZ (corresponding author), Hamad Med Corp, Acad Hlth Syst, Interim Translat Res Inst, Dept Internal Med, Doha, Qatar.; Haque, MZ (corresponding author), Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res, 2799 West Grand Blvd, Detroit, MI 48202 USA.	mhaque4@hamad.qa	Abou-Samra, Abdul/ABE-8723-2020		National Heart, Lung, and Blood Institute [HL-66132]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute, Grants HL-66132 to RDL.	Agarwal SR, 2011, J MOL CELL CARDIOL, V50, P500, DOI 10.1016/j.yjmcc.2010.11.015; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Ando J, 2015, P NATL ACAD SCI USA, V112, P4558, DOI 10.1073/pnas.1418088112; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Ballard-Croft C, 2008, AM J PHYSIOL-HEART C, V294, pH263, DOI 10.1152/ajpheart.01067.2007; Ballard-Croft C, 2006, AM J PHYSIOL-HEART C, V291, pH658, DOI 10.1152/ajpheart.01354.2005; Bossuyt J, 2002, FEBS LETT, V511, P113, DOI 10.1016/S0014-5793(01)03323-3; Calaghan S, 2006, CARDIOVASC RES, V69, P816, DOI 10.1016/j.cardiores.2005.10.006; Camors E, 2006, J MOL CELL CARDIOL, V40, P47, DOI 10.1016/j.yjmcc.2005.08.009; Chen X, 2002, J BIOL CHEM, V277, P49631, DOI 10.1074/jbc.M208327200; Christian AE, 1997, J LIPID RES, V38, P2264; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; Chung CS, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.158; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Hammes A, 1998, CIRC RES, V83, P877; Hoe LES, 2014, AM J PHYSIOL-HEART C, V307, pH895, DOI 10.1152/ajpheart.00081.2014; Iino S, 1997, CIRC RES, V81, P879; Kanaya N, 2005, ANESTHESIOLOGY, V103, P1026, DOI 10.1097/00000542-200511000-00017; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kristo G, 2004, AM J PHYSIOL-HEART C, V286, pH517, DOI 10.1152/ajpheart.00777.2003; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; KUTRYK MJB, 1988, J BIOL CHEM, V263, P13167; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Liu LJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1550, DOI 10.1152/ajpcell.00555.2002; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Mohammadi K, 2003, J CARDIOVASC PHARM, V41, P609, DOI 10.1097/00005344-200304000-00014; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Pabbathi VK, 2004, DIABETOLOGIA, V47, P748, DOI 10.1007/s00125-004-1355-1; Patel HH, 2006, AM J PHYSIOL-HEART C, V291, pH344, DOI 10.1152/ajpheart.01100.2005; ROUSLIN W, 1982, AM J PHYSIOL, V242, pH254, DOI 10.1152/ajpheart.1982.242.2.H254; Saka SK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5509; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Scriven DRL, 2005, BIOPHYS J, V89, P1893, DOI 10.1529/biophysj.105.064212; Tsujikawa H, 2008, AM J PHYSIOL-HEART C, V294, pH285, DOI 10.1152/ajpheart.00824.2007; VEMURI R, 1989, J BIOL CHEM, V264, P8680; VENTER H, 1991, J MOL CELL CARDIOL, V23, P1271, DOI 10.1016/0022-2828(91)90084-Y; Wang JM, 2006, J BIOL CHEM, V281, P213, DOI 10.1074/jbc.M505061200; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Zeidan A, 2008, CARDIOVASC RES, V77, P64, DOI 10.1093/cvr/cvm020	43	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0154151	10.1371/journal.pone.0154151	http://dx.doi.org/10.1371/journal.pone.0154151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441649	Green Submitted, gold, Green Published			2022-12-27	WOS:000380797500002
J	Lodeyro, AF; Giro, M; Poli, HO; Bettucci, G; Cortadi, A; Ferri, AM; Carrillo, N				Lodeyro, Anabella F.; Giro, Mariana; Poli, Hugo O.; Bettucci, Gabriel; Cortadi, Adriana; Ferri, Alejandro M.; Carrillo, Nestor			Suppression of Reactive Oxygen Species Accumulation in Chloroplasts Prevents Leaf Damage but Not Growth Arrest in Salt-Stressed Tobacco Plants	PLOS ONE			English	Article							CYANOBACTERIAL FLAVODOXIN; OXIDATIVE STRESS; TOLERANCE; SALINITY; WATER; HOMEOSTASIS; LEAVES; PHOTOSYNTHESIS; FERREDOXIN; TRANSPORT	Crop yield reduction due to salinity is a growing agronomical concern in many regions. Increased production of reactive oxygen species (ROS) in plant cells accompanies many abiotic stresses including salinity, acting as toxic and signaling molecules during plant stress responses. While ROS are generated in various cellular compartments, chloroplasts represent a main source in the light, and plastid ROS synthesis and/or elimination have been manipulated to improve stress tolerance. Transgenic tobacco plants expressing a plastid- targeted cyanobacterial flavodoxin, a flavoprotein that prevents ROS accumulation specifically in chloroplasts, displayed increased tolerance to many environmental stresses, including drought, excess irradiation, extreme temperatures and iron starvation. Surprisingly, flavodoxin expression failed to protect transgenic plants against NaCl toxicity. However, when high salt was directly applied to leaf discs, flavodoxin did increase tolerance, as reflected by preservation of chlorophylls, carotenoids and photosynthetic activities. Flavodoxin decreased salt- dependent ROS accumulation in leaf tissue from discs and whole plants, but this decline did not improve tolerance at the whole plant level. NaCl accumulation in roots, as well as increased osmotic pressure and salt- induced root damage, were not prevented by flavodoxin expression. The results indicate that ROS formed in chloroplasts have a marginal effect on plant responses during salt stress, and that sensitive targets are present in roots which are not protected by flavodoxin.	[Lodeyro, Anabella F.; Giro, Mariana; Poli, Hugo O.; Carrillo, Nestor] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR UNR CONICET, RA-2000 Rosario, Santa Fe, Argentina; [Bettucci, Gabriel; Cortadi, Adriana] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Biol Sci, RA-2000 Rosario, Santa Fe, Argentina; [Ferri, Alejandro M.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Analyt Chem, RA-2000 Rosario, Santa Fe, Argentina; [Giro, Mariana] Labs NOVA SA, Canada De Gomez, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; National University of Rosario	Carrillo, N (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR UNR CONICET, RA-2000 Rosario, Santa Fe, Argentina.	carrillo@ibr-conicet.gov.ar		Lodeyro, Anabella Fernanda/0000-0001-9208-2194	National Agency for the Promotion of Science and Technology [PICT2012-2851]; National Research Council of Argentina [PIP 11220110101075]	National Agency for the Promotion of Science and Technology(ANPCyT); National Research Council of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was funded by Grant PICT2012-2851 to NC from the National Agency for the Promotion of Science and Technology (http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt), and Grant PIP 11220110101075 to AFL from National Research Council of Argentina (http://www.conicet.gov.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abogadallah GM, 2010, PLANT SIGNAL BEHAV, V5, P369, DOI 10.4161/psb.5.4.10873; Agarwal PK, 2013, MOL BIOTECHNOL, V54, P102, DOI 10.1007/s12033-012-9538-3; Apse MP, 2007, FEBS LETT, V581, P2247, DOI 10.1016/j.febslet.2007.04.014; Ashley MK, 2006, J EXP BOT, V57, P425, DOI 10.1093/jxb/erj034; Bagchi Suvendra Nath, 2012, Physiology and Molecular Biology of Plants, V18, P115, DOI 10.1007/s12298-012-0111-0; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Ball RA, 2005, ENVIRON EXP BOT, V53, P77, DOI 10.1016/j.envexpbot.2004.03.003; Bernstein N, 2010, FREE RADICAL BIO MED, V49, P1161, DOI 10.1016/j.freeradbiomed.2010.06.032; Blanco NE, 2011, PLANT J, V65, P922, DOI 10.1111/j.1365-313X.2010.04479.x; Bose J, 2014, J EXP BOT, V65, P1241, DOI 10.1093/jxb/ert430; Cabello JV, 2014, CURR OPIN BIOTECH, V26, P62, DOI 10.1016/j.copbio.2013.09.011; Cabot C, 2014, PLANT SCI, V226, P2, DOI 10.1016/j.plantsci.2014.04.013; Cavalcanti FR, 2007, J PLANT PHYSIOL, V164, P591, DOI 10.1016/j.jplph.2006.03.004; Ceccoli RD, 2012, PLANTA, V236, P1447, DOI 10.1007/s00425-012-1695-x; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; de la Pena TC, 2010, PLANT BIOTECHNOL J, V8, P954, DOI 10.1111/j.1467-7652.2010.00519.x; De Boer AH, 2003, PLANT CELL ENVIRON, V26, P87, DOI 10.1046/j.1365-3040.2003.00930.x; DeLong JM, 2002, J AGR FOOD CHEM, V50, P248, DOI 10.1021/jf0106695; Ding MQ, 2010, PLANT MOL BIOL, V73, P251, DOI 10.1007/s11103-010-9612-9; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; FULDA S, 1995, J PLANT PHYSIOL, V146, P520, DOI 10.1016/S0176-1617(11)82018-3; Gibon Y, 2000, PHYSIOL PLANTARUM, V110, P469, DOI 10.1111/j.1399-3054.2000.1100407.x; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Giro M, 2011, FEBS OPEN BIO, V1, P7, DOI 10.1016/j.fob.2011.10.004; Hagemann M, 1999, PHYSIOL PLANTARUM, V105, P670, DOI 10.1034/j.1399-3054.1999.105411.x; Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Hoagland DR, 1920, SCIENCE, V52, P562, DOI 10.1126/science.52.1354.562; Jing XS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00023; Katsuhara M, 2005, PLANT SCI, V169, P369, DOI 10.1016/j.plantsci.2005.03.030; Lazof DB, 1999, ADV BOT RES, V29, P113; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lodeyro A.F., 2015, STRESS RESPONSES PLA, P1; Lodeyro AF, 2012, FEBS LETT, V586, P2917, DOI 10.1016/j.febslet.2012.07.026; Luo XL, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/845459; Maia JM, 2010, BIOL PLANTARUM, V54, P159, DOI 10.1007/s10535-010-0026-y; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Noctor G, 2002, ANN BOT-LONDON, V89, P841, DOI 10.1093/aob/mcf096; Noreen Z, 2009, J PLANT PHYSIOL, V166, P1764, DOI 10.1016/j.jplph.2009.05.005; Peleg Z, 2011, ADV BOT RES, V57, P405, DOI 10.1016/B978-0-12-387692-8.00012-6; Karlusich JJP, 2014, J EXP BOT, V65, P5161, DOI 10.1093/jxb/eru273; Reguera M, 2012, BBA-GENE REGUL MECH, V1819, P186, DOI 10.1016/j.bbagrm.2011.08.005; Rodriguez Andres Alberto, 2012, Methods Mol Biol, V913, P225, DOI 10.1007/978-1-61779-986-0_15; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Rus A, 2004, PLANT PHYSIOL, V136, P2500, DOI 10.1104/pp.104.042234; Salisbury FB, 1992, PLANT PHYSIOL, P47; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; STEPONKUS PL, 1967, PLANT PHYSIOL, V42, P1423, DOI 10.1104/pp.42.10.1423; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Tognetti VB, 2007, P NATL ACAD SCI USA, V104, P11495, DOI 10.1073/pnas.0704553104; Tognetti VB, 2006, PLANT CELL, V18, P2035, DOI 10.1105/tpc.106.042424; Valderrama R, 2006, PLANT CELL ENVIRON, V29, P1449, DOI 10.1111/j.1365-3040.2006.01530.x; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Villar SR, 2004, BBA-MOL BASIS DIS, V1688, P204, DOI 10.1016/j.bbadis.2003.12.003; Wu HH, 2014, PLANT CELL PHYSIOL, V55, P1749, DOI 10.1093/pcp/pcu105; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Yeo A, 1998, J EXP BOT, V49, P915, DOI 10.1093/jexbot/49.323.915; Zurbriggen MD, 2008, TRENDS BIOTECHNOL, V26, P531, DOI 10.1016/j.tibtech.2008.07.001; Zurbriggen MD, 2009, PLANT J, V60, P962, DOI 10.1111/j.1365-313X.2009.04010.x	67	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159588	10.1371/journal.pone.0159588	http://dx.doi.org/10.1371/journal.pone.0159588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441560	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500099
J	Belchior, C; Sendoya, SF; Del-Claro, K				Belchior, Ceres; Sendoya, Sebastian F.; Del-Claro, Kleber			Temporal Variation in the Abundance and Richness of Foliage-Dwelling Ants Mediated by Extrafloral Nectar	PLOS ONE			English	Article							PLANT-HERBIVORE INTERACTIONS; ECOLOGICAL COMMUNITIES; NEOTROPICAL SAVANNA; SEASONAL-VARIATION; HOST-PLANT; PROTECTION; VEGETATION; FOREST; HONEYDEW; DEFENSE	Plants bearing extrafloral nectaries (EFNs) are common in the Brazilian cerrado savanna, where climatic conditions having marked seasonality influence arboreal ant fauna organization. These ant-plant interactions have rarely been studied at community level. Here, we tested whether: 1) EFN-bearing plants are more visited by ants than EFN-lacking plants; 2) ant visitation is higher in the rainy season than in dry season; 3) plants producing young leaves are more visited than those lacking young leaves in the rainy season; 4) during the dry season, plants with old leaves and flowers are more visited than plants with young leaves and bare of leaves or flowers; 5) the composition of visiting ant fauna differs between plants with and without EFNs. Field work was done in a cerrado reserve near Uberlandia, MG State, Brazil, along ten transects (total area 3,000 m(2)), in the rainy (October-January) and dry seasons (April-July) of 2010-2011. Plants (72 species; 762 individuals) were checked three times per season for ant presence. Results showed that 21 species (29%) and 266 individuals (35%) possessed EFNs. These plants attracted 38 ant species (36 in rainy, 26 in dry season). In the rainy season, plants with EFNs had higher ant abundance/richness than plants without EFNs, but in the dry season, EFN presence did not influence ant visitation. Plant phenology affected ant richness and abundance in different ways: plants with young leaves possessed higher ant richness in the rainy season, but in the dry season ant abundance was higher on plants possessing old leaves or flowers. The species composition of plant-associated ant communities, however, did not differ between plants with and without EFNs in either season. These findings suggest that the effect of EFN presence on a community of plant-visiting ants is context dependent, being conditioned to seasonal variation.	[Belchior, Ceres; Del-Claro, Kleber] Univ Fed Uberlandia, Inst Biol, Programa Posgrad Ecol & Conservacao Recursos, Uberlandia, MG, Brazil; [Sendoya, Sebastian F.] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, BR-6109 Campinas, SP, Brazil	Universidade Federal de Uberlandia; Universidade Estadual de Campinas	Del-Claro, K (corresponding author), Univ Fed Uberlandia, Inst Biol, Programa Posgrad Ecol & Conservacao Recursos, Uberlandia, MG, Brazil.	delclaro@ufu.br	Del-Claro, K/C-5570-2013; Sendoya, Sebastian/J-9716-2012; Del-Claro, Kleber/N-3700-2019	Del-Claro, K/0000-0001-8886-9568; Sendoya, Sebastian/0000-0003-3728-9090; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	CB received a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; KDC received research fellowship and grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; SFS received a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.	Aguirre A, 2013, FLORA, V208, P147, DOI 10.1016/j.flora.2013.02.008; Baker-Meio B, 2012, J ECOL, V100, P242, DOI 10.1111/j.1365-2745.2011.01892.x; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Belchior C, 2014, THESIS; Belchior C, 2012, ARTHROPOD-PLANT INTE, V6, P571, DOI 10.1007/s11829-012-9208-1; BENTLEY BL, 1977, ANNU REV ECOL SYST, V8, P407, DOI 10.1146/annurev.es.08.110177.002203; Bixenmann RJ, 2011, OECOLOGIA, V165, P417, DOI 10.1007/s00442-010-1787-x; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Bluthgen N, 2004, J ANIM ECOL, V73, P155, DOI 10.1111/j.1365-2656.2004.00789.x; Bluthgen N, 2000, OECOLOGIA, V125, P229, DOI 10.1007/s004420000449; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; BODINI A, 1989, BIOSYSTEMS, V22, P289, DOI 10.1016/0303-2647(89)90050-6; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borges MP, 2014, FLORA, V209, P73, DOI 10.1016/j.flora.2013.10.004; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Byk J, 2010, ACTA ETHOL, V13, P33, DOI 10.1007/s10211-010-0071-8; Camarota F, 2015, ECOLOGY, V96, P231, DOI 10.1890/14-0264.1; Campos RI, 2014, ARTHROPOD-PLANT INTE, V8, P507, DOI 10.1007/s11829-014-9338-8; Chamberlain SA, 2008, ECOLOGY, V89, P1364, DOI 10.1890/07-1139.1; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Damascos MA, 2005, ANN BOT-LONDON, V96, P1075, DOI 10.1093/aob/mci258; Dattilo W, 2013, OIKOS, V122, P1643, DOI 10.1111/j.1600-0706.2013.00562.x; Dejean A, 2000, SOCIOBIOLOGY, V36, P227; Del-Claro K, 1999, BIOTROPICA, V31, P135, DOI 10.2307/2663967; Del-Claro K, 2004, NEOTROP ENTOMOL, V33, P665, DOI 10.1590/S1519-566X2004000600002; Del-Claro K, 2016, INSECT SOC, V63, P207, DOI 10.1007/s00040-016-0466-2; Del-Claro K, 2015, BIOTROPICA, V47, P459, DOI 10.1111/btp.12227; Del-Claro K, 2009, NEOTROP ENTOMOL, V38, P159, DOI 10.1590/S1519-566X2009000200001; Diaz-Castelazo C, 2004, ECOSCIENCE, V11, P472, DOI 10.1080/11956860.2004.11682857; Diaz-Castelazo C, 2013, ANN BOT-LONDON, V111, P1285, DOI 10.1093/aob/mct071; Gonzalez-Teuber M, 2009, J CHEM ECOL, V35, P459, DOI 10.1007/s10886-009-9618-4; Gotelli NJ, 2011, PRINCIPIOS ESTATISTI, DOI DOI 10.1007/s10533-006-9007-9; Guimaraes PR, 2011, ECOL LETT, V14, P877, DOI 10.1111/j.1461-0248.2011.01649.x; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2015, ANNU REV ENTOMOL, V60, P213, DOI 10.1146/annurev-ento-010814-020753; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Ibarra-Isassi J, 2016, ARTHROPOD-PLANT INTE, V10, P221, DOI 10.1007/s11829-016-9429-9; JANZEN DANIEL H., 1967, UNIV KANS SCI SCI BULL, V47, P315; Junker RR, 2011, ECOL MONOGR, V81, P295, DOI 10.1890/10-1367.1; Kersch MF, 2005, ECOLOGY, V86, P2117, DOI 10.1890/04-1916; KISS A, 1981, OIKOS, V37, P382, DOI 10.2307/3544132; KOPPEN W, 1948, CLIMATOLOGIA CON UN; Koptur S, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P75, DOI 10.1017/CBO9780511542220.004; Korndorfer AP, 2006, BIOTROPICA, V38, P786, DOI 10.1111/j.1744-7429.2006.00200.x; Lach L, 2009, POPUL ECOL, V51, P237, DOI 10.1007/s10144-008-0132-2; Lange D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105574; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; Marazzi B, 2013, ANN BOT-LONDON, V111, P1243, DOI 10.1093/aob/mct109; Melo Y, 2010, ACTA BOT BRAS, V24, P1034, DOI 10.1590/S0102-33062010000400018; Mody K, 2004, ECOL ENTOMOL, V29, P217, DOI 10.1111/j.1365-2311.2004.0588.x; Moreira VSS, 2005, NEOTROP ENTOMOL, V34, P881, DOI 10.1590/S1519-566X2005000600002; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Muniz DG, 2012, STUD NEOTROP FAUNA E, V47, P111, DOI 10.1080/01650521.2012.698932; Nahas L, 2012, BIOTROPICA, V44, P498, DOI 10.1111/j.1744-7429.2011.00850.x; Nascimento EA, 2010, FLORA, V205, P754, DOI 10.1016/j.flora.2009.12.040; Ness JH, 2009, ECOLOGY, V90, P2823, DOI 10.1890/08-1580.1; Oliveira PS, 2004, NATURWISSENSCHAFTEN, V91, P557, DOI 10.1007/s00114-004-0585-x; OLIVEIRA PS, 1987, BIOTROPICA, V19, P140, DOI 10.2307/2388736; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; da Silva NAP, 2011, REV BRAS ENTOMOL, V55, P79, DOI 10.1590/S0085-56262011000100013; Powell S, 2011, J ANIM ECOL, V80, P352, DOI 10.1111/j.1365-2656.2010.01779.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ribas CR, 2003, AUSTRAL ECOL, V28, P305, DOI 10.1046/j.1442-9993.2003.01290.x; Rico-Gray V., 2008, V171, P221; Rico-Gray V, 1998, BIOTROPICA, V30, P190, DOI 10.1111/j.1744-7429.1998.tb00054.x; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; RICOGRAY V, 1993, BIOTROPICA, V25, P301, DOI 10.2307/2388788; RICOGRAY V, 1989, BIOL J LINN SOC, V38, P173, DOI 10.1111/j.1095-8312.1989.tb01572.x; Rosario-Martinez HD, 2015, PHIA POSTHOC INTERAC; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; RUFFNER GA, 1986, AM J BOT, V73, P185, DOI 10.2307/2444171; Santos MF, 2011, ACTA BOT BRAS, V25, P793, DOI 10.1590/S0102-33062011000400007; Schoereder Jose H., 2010, Terrestrial Arthropod Reviews, V3, P3, DOI 10.1163/187498310X487785; Sendoya SF, 2016, ARTHROPOD-PLANT INTE, V10, P183, DOI 10.1007/s11829-016-9423-2; Sendoya SF, 2015, J ANIM ECOL, V84, P442, DOI 10.1111/1365-2656.12286; Shenoy M, 2012, J CHEM ECOL, V38, P88, DOI 10.1007/s10886-011-0052-z; Silva DP, 2010, ENVIRON ENTOMOL, V39, P1903, DOI 10.1603/EN10129; Skaug H., 2013, GEN LINEAR MIXED MOD; Stefani V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131843; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson J., 2013, RELENTLESS EVOLUTION, DOI DOI 10.7208/CHICAGO/9780226018898.001.0001; Tizo-Pedroso E, 2007, INSECT SOC, V54, P124, DOI 10.1007/s00040-007-0931-z; Vasconcelos HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007762; Vilela AA, 2014, FLORA, V209, P359, DOI 10.1016/j.flora.2014.04.004; Wagner D, 2002, EVOL ECOL RES, V4, P293; Zuur Alain F., 2009, P1	87	23	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158283	10.1371/journal.pone.0158283	http://dx.doi.org/10.1371/journal.pone.0158283			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438722	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100010
J	Calamia, M; Bernstein, JPK; Keller, JN				Calamia, Matthew; Bernstein, John P. K.; Keller, Jeffrey N.			I'd Do Anything for Research, But I Won't Do That: Interest in Pharmacological Interventions in Older Adults Enrolled in a Longitudinal Aging Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL STATUS RBANS; ALZHEIMERS-DISEASE PATIENTS; CLINICAL-TRIALS; REPEATABLE BATTERY; DEMENTIA RESEARCH; DECISION-MAKING; PARTICIPATION; RECRUITMENT; ATTITUDES	Alzheimer's disease (AD) ranks as the 6th leading cause of death in the United States, yet unlike other diseases in this category, there are no disease-modifying medications for AD. Currently there is significant interest in exploring the benefits of pharmacological treatment before the onset of dementia (e.g., in those with mild cognitive impairment); however, recruitment for such studies is challenging. The current study examined interest in pharmacological intervention trials relative to other types of clinical interventions. A total of 67 non-demented older adults enrolled in a longitudinal cognitive aging study completed a questionnaire assessing interest in participating in a variety of hypothetical research study designs. Consistent with past research, results showed that the opportunities for participants to advance science, receive feedback about their current health, and help themselves or others, were associated with increased interest in clinical trial participation. Some factors were not associated with change in interest (e.g., a doctor not recommending participation) while others were associated with decreased interest (e.g., having to come in for multiple visits each week). Relative to other types of interventions, pharmacological intervention trials were associated with the least interest in participation, despite pharmacological interventions being rated as more likely to result in AD treatment. Decreased interest was not predicted by subjective memory concerns, number of current medications, cardiovascular risk, or beliefs about the likely success of pharmacological treatments. These results highlight the challenges faced by researchers investigating pharmacological treatments in non-demented older individuals, and suggest future research could contribute to more effective ways of recruiting participants in AD-related clinical trials.	[Calamia, Matthew; Bernstein, John P. K.] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; [Keller, Jeffrey N.] Pennington Biomed Res Ctr, Inst Dementia Res & Prevent, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Calamia, M (corresponding author), Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA.	mcalamia@lsu.edu	Keller, Jeffrey N/N-1975-2017	Calamia, Matthew/0000-0002-7252-7181; keller, jeffrey/0000-0002-9892-7423	NIH "Walking and Cognitive Remediation Effects on Cerebrovascular Function and Gait" [R21AG044258]	NIH "Walking and Cognitive Remediation Effects on Cerebrovascular Function and Gait"	This work was supported by NIH R21AG044258 "Walking and Cognitive Remediation Effects on Cerebrovascular Function and Gait" (JNK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Avent C, 2013, INT PSYCHOGERIATR, V25, P963, DOI 10.1017/S1041610213000252; Ayalon L, 2009, AM J GERIAT PSYCHIAT, V17, P65, DOI 10.1097/JGP.0b013e31818cd3d3; Barreira T, 2012, J SCI MED SPORT, V15, pS293; Beck CK, 1998, AM J GERIAT PSYCHIAT, V6, pS41, DOI 10.1097/00019442-199821001-00006; Black BS, 2013, AM J GERIAT PSYCHIAT, V21, P355, DOI 10.1016/j.jagp.2012.11.009; Brouillette RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065925; Brouillette RM, 2011, J ALZHEIMERS DIS, V23, P665, DOI 10.3233/JAD-2011-101455; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; Carr SA, 2010, ALZ DIS ASSOC DIS, V24, P165, DOI 10.1097/WAD.0b013e3181aba927; Cary MS, 2014, ALZ DIS ASSOC DIS, V29, P70; Cohen-Mansfield J, 2001, AM J GERIAT PSYCHIAT, V9, P361, DOI 10.1176/appi.ajgp.9.4.361; Comis RL, 2003, J CLIN ONCOL, V21, P830, DOI 10.1200/JCO.2003.02.105; Connell CM, 2001, ALZ DIS ASSOC DIS, V15, P137, DOI 10.1097/00002093-200107000-00005; Dunn Laura B, 2011, Narrat Inq Bioeth, V1, P107, DOI 10.1353/nib.2011.0034; Fagerlin A, 2011, JNCI-J NATL CANCER I, V103, P1436, DOI 10.1093/jnci/djr318; Fitzpatrick AL, 2006, CONTEMP CLIN TRIALS, V27, P541, DOI 10.1016/j.cct.2006.06.007; Garand L, 2009, RES GERONTOL NURS, V2, P112, DOI 10.3928/19404921-20090401-04; Grill JD, 2014, ALZ DIS ASSOC DIS, V28, P1, DOI 10.1097/WAD.0000000000000016; Grill JD, 2013, ALZHEIMERS DEMENT, V9, P356, DOI 10.1016/j.jalz.2012.03.001; Grill JD, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt58; Hansen RA, 2008, CLIN INTERV AGING, V3, P211; JAGER CA, 2012, INT J GERIATR PSYCH, V27, P592, DOI DOI 10.1002/GPS.2758; Jefferson AL, 2012, AM J GERIAT PSYCHIAT, V20, P878, DOI 10.1097/JGP.0b013e318252e5cb; Jefferson AL, 2011, J ALZHEIMERS DIS, V23, P443, DOI 10.3233/JAD-2010-101536; Karantzoulis S, 2013, ARCH CLIN NEUROPSYCH, V28, P837, DOI 10.1093/arclin/act057; Kim SYH, 2002, AM J PSYCHIAT, V159, P797, DOI 10.1176/appi.ajp.159.5.797; Lingler Jennifer Hagerty, 2010, Alzheimer Dis Assoc Disord, V24 Suppl, pS30, DOI 10.1097/WAD.0b013e3181f14ac0; MacAulay RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099436; Mastwyk M, 2002, INT PSYCHOGERIATR, V14, P39, DOI 10.1017/S1041610202008268; Montgomery SA, 2003, INT CLIN PSYCHOPHARM, V18, P61, DOI 10.1097/00004850-200303000-00001; Morrison K, 2014, J APPL GERONTOL; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Reiman EM, 2015, NATURE REV NEUROLOGY; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Rolison J. J., 2013, J GERONTOL B-PSYCHOL; Rollin-Sillaire A, 2013, BRIT J CLIN PHARMACO, V75, P1089, DOI 10.1111/j.1365-2125.2012.04423.x; Schuna JM, 2013, MED SCI SPORT EXER, V45, P914, DOI 10.1249/MSS.0b013e31827e47ac; Treves TA, 2000, ALZ DIS ASSOC DIS, V14, P209, DOI 10.1097/00002093-200010000-00004; Tudor-Locke C., 2012, J PHYS ACT HLTH; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Williams Monique M, 2010, Alzheimer Dis Assoc Disord, V24 Suppl, pS24, DOI 10.1097/WAD.0b013e3181f14a14	43	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159664	10.1371/journal.pone.0159664	http://dx.doi.org/10.1371/journal.pone.0159664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27438465	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100062
J	Cattadori, IM; Sebastian, A; Hao, H; Katani, R; Albert, I; Eilertson, KE; Kapur, V; Pathak, A; Mitchell, S				Cattadori, Isabella M.; Sebastian, Aswathy; Hao, Han; Katani, Robab; Albert, Istvan; Eilertson, Kirsten E.; Kapur, Vivek; Pathak, Ashutosh; Mitchell, Susan			Impact of Helminth Infections and Nutritional Constraints on the Small Intestine Microbiota	PLOS ONE			English	Article							GUT MICROBIOTA; DENDRITIC CELLS; TRICHOSTRONGYLUS-RETORTAEFORMIS; IMMUNITY; COMMUNITIES; ACTIVATION; EXPRESSION; DIVERSITY; OBESITY; SEARCH	Helminth infections and nutrition can independently alter the composition and abundance of the gastrointestinal microbiota, however, their combined effect is poorly understood. Here, we used the T. retortaeformis-rabbit system to examine how the helminth infection and host restriction from coprophagy/ready-to-absorb nutrients affected the duodenal microbiota, and how these changes related to the acquired immune response at the site of infection. A factorial experiment was performed where the bacterial community, its functionality and the immune response were examined in four treatments (Infect, Infect+Collar, Control+Collar and Control). Helminths reduced the diversity and abundance of the microbiota while the combination of parasites and coprophagic restriction led to a more diversified and abundant microbiota than infected cases, without significantly affecting the intensity of infection. Animals restricted from coprophagy and free from parasites exhibited the richest and most abundant bacterial community. By forcing the individuals to absorb nutrients from less digested food, the coprophagic restriction appears to have facilitated the diversity and proliferation of bacteria in the duodenum. Changes in the microbiota were more clearly associated with changes in the immune response for the infected than the nutrient restricted animals. The functional and metabolic characteristics of the duodenal microbiota were not significantly different between treatments. Overall, infection and diet affect the gut microbiota but their interactions and outcome can be complex. These findings can have important implications for the development of control measures to helminth infections where poor nutrition/malnutrition can also be a concern.	[Cattadori, Isabella M.; Pathak, Ashutosh; Mitchell, Susan] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16082 USA; [Cattadori, Isabella M.; Pathak, Ashutosh; Mitchell, Susan] Penn State Univ, Dept Biol, University Pk, PA 16082 USA; [Sebastian, Aswathy; Albert, Istvan] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16082 USA; [Hao, Han; Eilertson, Kirsten E.] Penn State Univ, Dept Stat, University Pk, PA 16082 USA; [Katani, Robab; Kapur, Vivek] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16082 USA; [Pathak, Ashutosh] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; University of Georgia	Cattadori, IM (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16082 USA.; Cattadori, IM (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16082 USA.	imc3@psu.edu	Katani, Robab/AAS-1292-2020; Hao, Han/E-4024-2019; Albert, Istvan/J-3734-2015	Hao, Han/0000-0001-6674-1352; Cattadori, Isabella/0000-0001-6618-316X; Albert, Istvan/0000-0001-8366-984X	Pennsylvania Department of Health Tobacco Cure Funds; Pennsylvania State University, Huck Institutes of the Life Sciences; SEED grant	Pennsylvania Department of Health Tobacco Cure Funds; Pennsylvania State University, Huck Institutes of the Life Sciences; SEED grant	This study was funded by the Pennsylvania Department of Health Tobacco Cure Funds and the Pennsylvania State University, Huck Institutes of the Life Sciences with a SEED grant. IMC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2015, SOIL TRANSM HELM INF; Audebert F, 2000, J HELMINTHOL, V74, P95; Audebert F, 2003, VET PARASITOL, V112, P131, DOI 10.1016/S0304-4017(02)00386-2; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Berg JM, 2011, BIOCHEMISTRY; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Berrilli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00141; Brandt LJ, 2013, AM J GASTROENTEROL, V108, P177, DOI 10.1038/ajg.2012.450; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cattadori IM, 2005, P ROY SOC B-BIOL SCI, V272, P1163, DOI 10.1098/rspb.2004.3050; Cattadori IM, 2014, ECOLOGY, V95, P1684, DOI 10.1890/13-1538.1; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Coop RL, 2001, TRENDS PARASITOL, V17, P325, DOI 10.1016/S1471-4922(01)01900-6; Cornell SJ, 2008, P ROY SOC B-BIOL SCI, V275, P511, DOI 10.1098/rspb.2007.1415; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Cranford JA, 1983, EFFECTS COPROPHAGY M; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; GRIFFITHS M, 1963, J NUTR, V80, P171, DOI 10.1093/jn/80.2.171; Harley ITW, 2012, MOL METAB, V1, P21, DOI 10.1016/j.molmet.2012.07.002; Hirakawa H, 2001, MAMMAL REV, V31, P61, DOI 10.1046/j.1365-2907.2001.00079.x; HOVINDHOUGEN K, 1979, INT J SYST BACTERIOL, V29, P245, DOI 10.1099/00207713-29-3-245; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kreisinger J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0295; Kuever J R F, 2005, BERGEYS MANUAL SYSTE; KULWICH R, 1953, J NUTR, V49, P639, DOI 10.1093/jn/49.4.639; Kutner M., 2004, APPL LINEAR STAT MOD; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002880; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Leung JM, 2013, INT J PARASITOL, V43, P253, DOI 10.1016/j.ijpara.2012.10.015; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mavrommatis B, 2013, CURR OPIN IMMUNOL, V25, P456, DOI 10.1016/j.coi.2013.05.009; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Mishra PK, 2014, MUCOSAL IMMUNOL, V7, P753, DOI 10.1038/mi.2014.23; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Murphy L, 2011, PARASITE IMMUNOL, V33, P287, DOI 10.1111/j.1365-3024.2011.01281.x; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Oksanen J, 2015, VEGAN COMMUNITY ECOL; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Rothman JM, 2013, NUTR ASPECTS DIET WI; Scalfone LK, 2013, INFECT IMMUN, V81, P1354, DOI 10.1128/IAI.01307-12; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Thakar J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002345; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Van Kuren AT, 2013, PARASITOLOGY, V140, P632, DOI 10.1017/S0031182012001898; VERNAY M, 1986, REPROD NUTR DEV, V26, P1137, DOI 10.1051/rnd:19860705; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Wei Y, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0973-1; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470; Yanagibashi T, 2009, BIOSCI BIOTECH BIOCH, V73, P372, DOI 10.1271/bbb.80612; YOSHIDA T, 1968, BRIT J NUTR, V22, P723, DOI 10.1079/BJN19680082; Zeng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09342	74	38	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159770	10.1371/journal.pone.0159770	http://dx.doi.org/10.1371/journal.pone.0159770			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438701	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100074
J	Mathieu, S; Henrissat, B; Labre, F; Skjak-Braek, G; Helbert, W				Mathieu, Sophie; Henrissat, Bernard; Labre, Flavien; Skjak-Braek, Gudmund; Helbert, William			Functional Exploration of the Polysaccharide Lyase Family PL6	PLOS ONE			English	Article							HYDROLASE FAMILY; ALGINATE LYASE; FLAVOBACTERIUM-HEPARINUM; SUBSTRATE-SPECIFICITY; ANGSTROM RESOLUTION; DEGRADING ENZYMES; CRYSTAL-STRUCTURE; CHONDROITINASE B; PROTEIN; ACID	Alginate, the main cell-wall polysaccharide of brown algae, is composed of two residues: mannuronic acid (M-residues) and, its C5-epimer, guluronic acid (G-residues). Alginate lyases define a class of enzymes that cleave the glycosidic bond of alginate by beta-elimination. They are classified according to their ability to recognize the distribution of M- and G-residues and are named M-, G-or MG-lyases. In the CAZy database, alginate lyases have been grouped by sequence similarity into seven distinct polysaccharide lyase families. The polysaccharide lyase family PL6 is subdivided into three subfamilies. Subfamily PL6_1 includes three biochemically characterized enzymes (two alginate lyases and one dermatan sulfatase lyase). No characterized enzymes have been described in the two other subfamilies (PL6_2 and PL6_3). To improve the prediction of polysaccharide-lyase activity in the PL6 family, we re-examined the classification of the PL6 family and biochemically characterized a set of enzymes reflecting the diversity of the protein sequences. Our results show that subfamily PL6_1 includes two dermatan sulfates lyases and several alginate lyases that have various substrate specificities and modes of action. In contrast, subfamilies PL6_2 and PL6_3 were found to contain only endo-poly-MG-lyases.	[Mathieu, Sophie; Labre, Flavien; Helbert, William] CNRS, CERMAV, BP53, F-38000 Grenoble 9, France; [Mathieu, Sophie; Labre, Flavien; Helbert, William] Grenoble Alpes Univ, BP53, F-38000 Grenoble 9, France; [Henrissat, Bernard] Univ Aix Marseille, CNRS, UMR7257, F-13288 Marseille, France; [Henrissat, Bernard] INRA, USC AFMB 1408, F-13288 Marseille, France; [Skjak-Braek, Gudmund] Norwegian Univ Sci & Technol, Dept Biotechnol, NTNU Sem Saelands Vei 6-8, N-7491 Trondheim, Norway	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Norwegian University of Science & Technology (NTNU)	Helbert, W (corresponding author), CNRS, CERMAV, BP53, F-38000 Grenoble 9, France.; Helbert, W (corresponding author), Grenoble Alpes Univ, BP53, F-38000 Grenoble 9, France.	william.helbert@cermav.cnrs.fr	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588	Brittany Regional Council; OSEO, "Poly-mer" project [FUI-AAP14]	Brittany Regional Council(Region Bretagne); OSEO, "Poly-mer" project	The research leading to these results received funding from Brittany Regional Council and OSEO as part of the FUI-AAP14 "Poly-mer" project.	Aarstad OA, 2012, BIOMACROMOLECULES, V13, P106, DOI 10.1021/bm2013026; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Draget KI, 2002, BIOPOLYMERS; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gimmestad M, 2003, J BACTERIOL, V185, P3515, DOI 10.1128/JB.185.12.3515-3523.2003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Heyraud A, 1996, CARBOHYD RES, V289, P11, DOI 10.1016/0008-6215(96)00060-2; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Kraiwattanapong J, 1997, BIOSCI BIOTECH BIOCH, V61, P1853, DOI 10.1271/bbb.61.1853; Lee SI, 2012, APPL MICROBIOL BIOT, V95, P1643, DOI 10.1007/s00253-012-4266-y; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; St John FJ, 2010, FEBS LETT, V584, P4435, DOI 10.1016/j.febslet.2010.09.051; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Tkalec AL, 2000, APPL ENVIRON MICROB, V66, P29, DOI 10.1128/AEM.66.1.29-35.2000; Wicker N, 2001, MOL BIOL EVOL, V18, P1435, DOI 10.1093/oxfordjournals.molbev.a003929; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200	26	22	24	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159415	10.1371/journal.pone.0159415	http://dx.doi.org/10.1371/journal.pone.0159415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438604	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100044
J	Moore, SN; Hawley, GD; Smith, EN; Mignemi, NA; Ihejirika, RC; Yuasa, M; Cates, JMM; Liu, XL; Schoenecker, JG				Moore, Stephanie N.; Hawley, Gregory D.; Smith, Emily N.; Mignemi, Nicholas A.; Ihejirika, Rivka C.; Yuasa, Masato; Cates, Justin M. M.; Liu, Xulei; Schoenecker, Jonathan G.			Validation of a Radiography-Based Quantification Designed to Longitudinally Monitor Soft Tissue Calcification in Skeletal Muscle	PLOS ONE			English	Article							HETEROTOPIC OSSIFICATION; CARDIOTOXIN INJURY; RADIATION-THERAPY; PREVENTION; BONE; REGENERATION; INFECTION; MICE	Introduction Soft tissue calcification, including both dystrophic calcification and heterotopic ossification, may occur following injury. These lesions have variable fates as they are either resorbed or persist. Persistent soft tissue calcification may result in chronic inflammation and/or loss of function of that soft tissue. The molecular mechanisms that result in the development and maturation of calcifications are uncertain. As a result, directed therapies that prevent or resorb soft tissue calcifications remain largely unsuccessful. Animal models of post-traumatic soft tissue calcification that allow for cost-effective, serial analysis of an individual animal over time are necessary to derive and test novel therapies. We have determined that a cardiotoxin-induced injury of the muscles in the posterior compartment of the lower extremity represents a useful model in which soft tissue calcification develops remote from adjacent bones, thereby allowing for serial analysis by plain radiography. The purpose of the study was to design and validate a method for quantifying soft tissue calcifications in mice longitudinally using plain radiographic techniques and an ordinal scoring system. Methods Muscle injury was induced by injecting cardiotoxin into the posterior compartment of the lower extremity in mice susceptible to developing soft tissue calcification. Seven days following injury, radiographs were obtained under anesthesia. Multiple researchers applied methods designed to standardize post-image processing of digital radiographs (N = 4) and quantify soft tissue calcification (N = 6) in these images using an ordinal scoring system. Inter-and intra-observer agreement for both post-image processing and the scoring system used was assessed using weighted kappa statistics. Soft tissue calcification quantifications by the ordinal scale were compared to mineral volume measurements (threshold 450.7mgHA/cm(3)) determined by mu CT. Finally, sample-size calculations necessary to discriminate between a 25%, 50%, 75%, and 100% difference in STiCSS score 7 days following burn/CTX induced muscle injury were determined. Results Precision analysis demonstrated substantial to good agreement for both post-image processing (kappa = 0.73 to 0.90) and scoring (kappa = 0.88 to 0.93), with low inter-and intra-observer variability. Additionally, there was a strong correlation in quantification of soft tissue calcification between the ordinal system and by mineral volume quantification by mu CT (Spearman r = 0.83 to 0.89). The ordinal scoring system reliably quantified soft tissue calcification in a burn/CTX-induced soft tissue calcification model compared to non-injured controls (Mann-Whitney rank test: P = 0.0002, ***). Sample size calculations revealed that 6 mice per group would be required to detect a 50% difference in STiCSS score with a power of 0.8. Finally, the STiCSS was demonstrated to reliably quantify soft tissue calcification [dystrophic calcification and heterotopic ossification] by radiographic analysis, independent of the histopathological state of the mineralization. Conclusions Radiographic analysis can discriminate muscle injury-induced soft tissue calcification from adjacent bone and follow its clinical course over time without requiring the sacrifice of the animal. While the STiCSS cannot identify the specific type of soft tissue calcification present, it is still a useful and valid method by which to quantify the degree of soft tissue calcification. This methodology allows for longitudinal measurements of soft tissue calcification in a single animal, which is relatively less expensive, less time-consuming, and exposes the animal to less radiation than in vivo mu CT. Therefore, this high-throughput, longitudinal analytic method for quantifying soft tissue calcification is a viable alternative for the study of soft tissue calcification.	[Moore, Stephanie N.; Hawley, Gregory D.; Smith, Emily N.; Mignemi, Nicholas A.; Yuasa, Masato; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, Med Ctr East, South Tower,Suite 4200,1215 21th Ave South, Nashville, TN 37232 USA; [Ihejirika, Rivka C.] Vanderbilt Univ, Sch Med, 2215 Garland Ave,Light Hall,Room 215, Nashville, TN 37232 USA; [Mignemi, Nicholas A.; Cates, Justin M. M.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 1161 21st Ave S, Nashville, TN 37232 USA; [Liu, Xulei] Vanderbilt Univ, Dept Biostat, 2525 West End,Ste 11000, Nashville, TN 37203 USA; [Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pediat, 4202 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA; [Moore, Stephanie N.; Schoenecker, Jonathan G.] Vanderbilt Univ, Dept Pharmacol, 2200 Pierce Ave,Robinson Res Bldg Nashville, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, Med Ctr East, South Tower,Suite 4200,1215 21th Ave South, Nashville, TN 37232 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 1161 21st Ave S, Nashville, TN 37232 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, 4202 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Dept Pharmacol, 2200 Pierce Ave,Robinson Res Bldg Nashville, Nashville, TN 37232 USA.	Jon.schoenecker@vanderbilt.edu	Cates, Justin M/D-5927-2014	Cates, Justin M/0000-0002-7336-5196; Ihejirika, Rivka/0000-0002-8858-6290	National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R03AR065762-01A1]; Caitlin Lovejoy Fund; Center for Small Animal Imaging at the Vanderbilt University Institute of Imaging Sciences; NIH [S10RR027631]; Predoctoral Training Program in Pharmacological Sciences [5T32GM007628-38]; Postdoctoral Vascular Biology Training Program [5T32HL007751]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Caitlin Lovejoy Fund; Center for Small Animal Imaging at the Vanderbilt University Institute of Imaging Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral Training Program in Pharmacological Sciences; Postdoctoral Vascular Biology Training Program	Funding was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (1R03AR065762-01A1, JGS) and the Caitlin Lovejoy Fund (JGS). mu CT imaging and analysis were supported in part by the Center for Small Animal Imaging at the Vanderbilt University Institute of Imaging Sciences and by grant S10RR027631 from the NIH. SNM was supported by the Predoctoral Training Program in Pharmacological Sciences (5T32GM007628-38). NAM was supported by the Postdoctoral Vascular Biology Training Program (5T32HL007751).	Anthonissen J, 2015, ACTA ORTHOP TRAUMATO, V49, P197, DOI 10.3944/AOTT.2015.14.0271; AYERS DC, 1986, J BONE JOINT SURG AM, V68A, P1423, DOI 10.2106/00004623-198668090-00016; Bohannon J, 2010, J IMMUNOL, V185, P2847, DOI 10.4049/jimmunol.0903619; Bohannon JK, 2016, J LEUKOCYTE BIOL, V99, P629, DOI 10.1189/jlb.4A0815-362R; Brownley RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141432; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COUTEAUX R, 1988, BIOL CELL, V62, P171, DOI 10.1016/0248-4900(88)90034-2; Czerwinska AM, 2012, FOLIA HISTOCHEM CYTO, V50, P144, DOI [10.5603/FHC.2012.0021, 10.2478/18710]; Ebrahim MK, 2003, BURNS, V29, P461, DOI 10.1016/S0305-4179(03)00057-3; Hunt JL, 2006, J BURN CARE RES, V27, P535, DOI 10.1097/01.BCR.0000226023.58438.14; Kan LX, 2009, STEM CELLS, V27, P150, DOI 10.1634/stemcells.2008-0576; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Mignemi MY, 2016, JBMR IN PRESS; O'Connor JP, 1998, CLIN ORTHOP RELAT R, P71; Parkinson J R, 1982, Hip, P211; Peterson JR, 2015, JOVE-J VIS EXP, DOI 10.3791/52880; Seegenschmiedt MH, 1997, INT J RADIAT ONCOL, V39, P161, DOI 10.1016/S0360-3016(97)00285-X; Seegenschmiedt MH, 2001, INT J RADIAT ONCOL, V51, P756, DOI 10.1016/S0360-3016(01)01640-6; Sergi C, 2001, AM J MED GENET, V103, P235, DOI 10.1002/ajmg.1541.abs; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Toliver-Kinsky TE, 2005, J IMMUNOL, V174, P404, DOI 10.4049/jimmunol.174.1.404; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Yuasa M, 2015, J CLIN INVEST, V125, P3117, DOI 10.1172/JCI80313	24	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159624	10.1371/journal.pone.0159624	http://dx.doi.org/10.1371/journal.pone.0159624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438007	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100057
J	Ershova, AI; Meshkov, AN; Rozhkova, TA; Kalinina, MV; Deev, AD; Rogoza, AN; Balakhonova, TV; Boytsov, SA				Ershova, Alexandra I.; Meshkov, Alexey N.; Rozhkova, Tatyana A.; Kalinina, Maria V.; Deev, Alexander D.; Rogoza, Anatoliy N.; Balakhonova, Tatyana V.; Boytsov, Sergey A.			Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; DENSITY-LIPOPROTEIN CHOLESTEROL; EXPERT CONSENSUS DOCUMENT; INTIMA-MEDIA THICKNESS; ARTERIAL STIFFNESS; RISK-FACTORS; AUGMENTATION INDEX; HEART-DISEASE; ATHEROSCLEROSIS; CALCIFICATION	Background The role of plasma cholesterol in impairing arterial function and elasticity remains unclear. We evaluated arterial stiffness, measured locally in the common carotid artery by high-resolution echo-tracking, and aortic stiffness, using carotid-femoral pulse wave velocity (PWV) (the "gold-standard" measurement of arterial stiffness), in treatment-naive patients with heterozygous familial hypercholesterolemia (FH). Methods The study included 66 patients with FH (10-66 years old) and 57 first-degree relatives without FH (11-61 years old). Carotid-femoral PWV was determined by SphygmoCor (AtCor, Australia). The parameters of carotid stiffness beta-index, Peterson elastic modulus and local PWV were assessed with regard to the common carotid artery at a distance of 1cm from the bifurcation (AlokaProsound Alpha7, Japan). Results FH patients showed significantly higher beta-index (6.3(4.8-8.2) vs. 5.2(4.2-6.4), p = 0.005), Ep (78(53-111) kPa vs. 62(48-79) kPa, p = 0.006), local PWV (5.4(4.5-6.4) m/c vs. 4.7 (4.2-5.4) m/c, p = 0.005), but comparable values of carotid-femoral PWV (6.76(7.0-7.92) m/c vs. 6.48(6.16-7.12) m/c, p = 0.138). Carotid arteries and the aorta stiffened with age in patients with FH, but after 30 years, carotid arteries stiffened more significantly than the aorta. Conclusions Our study demonstrated that treatment-naive patients with FH had stiffer carotid arteries than their relatives, but showed no difference in aortic stiffness. We also found out that the rate of reduction of elasticity of the aorta and carotid arteries in FH patients varies: it is observed earlier in carotid arteries than in the aorta.	[Ershova, Alexandra I.; Meshkov, Alexey N.; Boytsov, Sergey A.] Natl Res Ctr Prevent Med, Dept Clin Cardiol & Mol Genet, Moscow, Russia; [Rozhkova, Tatyana A.; Kalinina, Maria V.] Russian Cardiol Res Ctr, Dept Atherosclerosis, Moscow, Russia; [Deev, Alexander D.] Natl Res Ctr Prevent Med, Dept Epidemiol Chron Noninfect Dis, Moscow, Russia; [Rogoza, Anatoliy N.; Balakhonova, Tatyana V.] Russian Cardiol Res Ctr, Dept New Methods Diagnost, Moscow, Russia	National Medical Research Center for Therapy & Preventive Medicine; National Medical Research Center of Cardiology; National Medical Research Center for Therapy & Preventive Medicine; National Medical Research Center of Cardiology	Ershova, AI (corresponding author), Natl Res Ctr Prevent Med, Dept Clin Cardiol & Mol Genet, Moscow, Russia.	alersh@mail.ru	Ershova, Alexandra I/J-8772-2017; Meshkov, Alexey N/K-1056-2017; deev, alexander/M-7754-2014; Boytsov, Sergey/AAK-5354-2021; Stefanadis, Christodoulos/ABH-2232-2020; ROGOZA, ANATOLIY N/B-2724-2014; Tatyana, Balakhonova/AAB-4996-2020; Boytsov, Sergey A/M-4486-2014	Ershova, Alexandra I/0000-0001-7989-0760; Meshkov, Alexey N/0000-0001-5989-6233; Boytsov, Sergey/0000-0001-6998-8406; Stefanadis, Christodoulos/0000-0001-5974-6454; ROGOZA, ANATOLIY N/0000-0002-4829-0954; Boytsov, Sergey A/0000-0001-6998-8406	Ministry of Health of the Russian Federation [01201352208]	Ministry of Health of the Russian Federation	This work was supported by a Grant for Scientific Research (#01201352208) from The Ministry of Health of the Russian Federation.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Aggoun Y, 2000, ARTERIOSCL THROM VAS, V20, P2070; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Dilaveris P, 2007, CURR VASC PHARMACOL, V5, P227; Ershova AI, 2012, ULTRASOUND MED BIOL, V38, P417, DOI 10.1016/j.ultrasmedbio.2011.11.014; Ferreira I, 2005, ARCH INTERN MED, V165, P875, DOI 10.1001/archinte.165.8.875; Ferrieres J, 2009, AM J CARDIOVASC DRUG, V9, P109, DOI 10.2165/00129784-200909020-00005; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; HOPKINS KD, 1993, CLIN SCI, V84, P593, DOI 10.1042/cs0840593; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; LEHMANN ED, 1992, CLIN SCI, V83, P717, DOI 10.1042/cs0830717; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Martinez LRC, 2008, ATHEROSCLEROSIS, V200, P83, DOI 10.1016/j.atherosclerosis.2007.12.014; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Odink AE, 2010, J HUM HYPERTENS, V24, P86, DOI 10.1038/jhh.2009.42; Paik DC, 1997, CONNECT TISSUE RES, V36, P241, DOI 10.3109/03008209709160224; Paini A, 2006, HYPERTENSION, V47, P371, DOI 10.1161/01.HYP.0000202052.25238.68; Pirro M, 2004, EUR J CLIN INVEST, V34, P335, DOI 10.1111/j.1365-2362.2004.01345.x; Riggio S, 2010, EUR J CLIN INVEST, V40, P250, DOI 10.1111/j.1365-2362.2010.02260.x; Shaw E., 2008, CLIN GUIDELINES EVID; SOLBERG LA, 1983, ARTERIOSCLEROSIS, V3, P187, DOI 10.1161/01.ATV.3.3.187; Soljanlahti S, 2008, VASC HEALTH RISK MAN, V4, P1103, DOI 10.2147/VHRM.S3198; STRONG JP, 1976, ATHEROSCLEROSIS, V23, P451, DOI 10.1016/0021-9150(76)90007-1; TAQUET A, 1993, EUR J EPIDEMIOL, V9, P298, DOI 10.1007/BF00146267; Toikka JO, 1999, ARTERIOSCL THROM VAS, V19, P436, DOI 10.1161/01.ATV.19.2.436; Tomochika Y, 1999, AM J CARDIOL, V83, P703, DOI 10.1016/S0002-9149(98)00974-6; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; Wilkinson I, 2007, ADV CARDIOL, V44, P261, DOI 10.1159/000096747; Wilkinson IB, 1998, J HYPERTENS, V16, P2079, DOI 10.1097/00004872-199816121-00033; Wilkinson IB, 2002, J AM COLL CARDIOL, V39, P1005, DOI 10.1016/S0735-1097(02)01723-0; Yuan G, 2006, CAN MED ASSOC J, V174, P1124, DOI 10.1503/cmaj.051313; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	33	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158964	10.1371/journal.pone.0158964	http://dx.doi.org/10.1371/journal.pone.0158964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434535	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600025
J	Eyer, L; Vain, T; Parizkova, B; Oklestkova, J; Barbez, E; Kozubikova, H; Pospisil, T; Wierzbicka, R; Kleine-Vehn, J; Franek, M; Strnad, M; Robert, S; Novak, O				Eyer, Ludek; Vain, Thomas; Parizkova, Barbora; Oklestkova, Jana; Barbez, Elke; Kozubikova, Hana; Pospisil, Tomas; Wierzbicka, Roksana; Kleine-Vehn, Juergen; Franek, Milan; Strnad, Miroslav; Robert, Stephanie; Novak, Ondrej			2,4-D and IAA Amino Acid Conjugates Show Distinct Metabolism in Arabidopsis	PLOS ONE			English	Article							2,4-DICHLOROPHENOXYACETIC ACID; NAPHTHALENE-1-ACETIC ACID; BIOLOGICAL-PROPERTIES; QUECHERS EXTRACTION; AUXIN METABOLISM; PLANT HORMONES; CHROMATOGRAPHY; FAMILY; HERBICIDES; ENCODES	The herbicide 2,4-D exhibits an auxinic activity and therefore can be used as a synthetic and traceable analog to study auxin-related responses. Here we identified that not only exogenous 2,4-D but also its amide-linked metabolite 2,4-D-Glu displayed an inhibitory effect on plant growth via the TIR1/AFB auxin-mediated signaling pathway. To further investigate 2,4-D metabolite conversion, identity and activity, we have developed a novel purification procedure based on the combination of ion exchange and immuno-specific sorbents combined with a sensitive liquid chromatography-mass spectrometry method. In 2,4-D treated samples, 2,4-D-Glu and 2,4-D-Asp were detected at 100-fold lower concentrations compared to 2,4-D levels, showing that 2,4-D can be metabolized in the plant. Moreover, 2,4-D-Asp and 2,4-D-Glu were identified as reversible forms of 2,4-D homeostasis that can be converted to free 2,4-D. This work paves the way to new studies of auxin action in plant development.	[Eyer, Ludek; Wierzbicka, Roksana; Franek, Milan; Novak, Ondrej] Vet Res Inst, Dept Virol, Brno, Czech Republic; [Vain, Thomas; Robert, Stephanie] Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, Umea, Sweden; [Parizkova, Barbora; Oklestkova, Jana; Strnad, Miroslav; Novak, Ondrej] Palacky Univ, Lab Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot CAS, Olomouc, Czech Republic; [Parizkova, Barbora; Oklestkova, Jana; Strnad, Miroslav; Novak, Ondrej] Palacky Univ, Fac Sci, Olomouc, Czech Republic; [Barbez, Elke; Kleine-Vehn, Juergen] Univ Nat Resources & Life Sci BOKU, Dept Appl Genet & Cell Biol, Vienna, Austria; [Kozubikova, Hana; Pospisil, Tomas] Palacky Univ, Dept Chem Biol & Genet, Ctr Reg Hana Biotechnol & Agr Res, Fac Sci, Olomouc, Czech Republic; [Barbez, Elke] Austrian Acad Sci, Vienna Bioctr VBC, Gregor Mendel Inst Mol Plant Biol, Vienna, Austria; [Wierzbicka, Roksana] Swedish Univ Agr Sci, Dept Food Sci, Uppsala, Sweden	Czech Veterinary Research Institute; Swedish University of Agricultural Sciences; Umea University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Palacky University Olomouc; University of Natural Resources & Life Sciences, Vienna; Palacky University Olomouc; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Swedish University of Agricultural Sciences	Robert, S (corresponding author), Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, Umea, Sweden.; Novak, O (corresponding author), Palacky Univ, Lab Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot CAS, Olomouc, Czech Republic.; Novak, O (corresponding author), Palacky Univ, Fac Sci, Olomouc, Czech Republic.	stephanie.robert@slu.se; novako@ueb.cas.cz	Pospisil, Tomas/S-5023-2016; Eyer, Ludek/U-4883-2018; Robert, Stéphanie/K-7604-2012; Strnad, Miroslav/H-1858-2014; Oklestkova, Jana/ABD-7907-2021; Kleine-Vehn, Jürgen/C-8984-2014; NOVAK, Ondrej/F-7031-2014; POSPÍŠIL, Tomáš/AAY-1379-2020; Oklešťková, Jana/G-8010-2014; Pařízková, Barbora/D-4486-2018; Pařízková, Barbora/N-6947-2019; Barbez, Elke/AAP-2131-2021	Pospisil, Tomas/0000-0003-3634-828X; Eyer, Ludek/0000-0001-7761-0702; Robert, Stéphanie/0000-0002-0013-3239; Strnad, Miroslav/0000-0002-2806-794X; Oklestkova, Jana/0000-0002-7423-5537; Kleine-Vehn, Jürgen/0000-0002-4354-3756; NOVAK, Ondrej/0000-0003-3452-0154; POSPÍŠIL, Tomáš/0000-0003-3634-828X; Oklešťková, Jana/0000-0002-7423-5537; Pařízková, Barbora/0000-0002-8125-2271; Pařízková, Barbora/0000-0002-8125-2271; Vain, Thomas/0000-0002-8153-907X; Barbez, Elke/0000-0002-5531-7916	Czech Science Foundation [GA14-34792S]; Ministry of Education, Youth and Sports of the Czech Republic - NPU I program [LO1204, LO1218]; "Navrat" program [LK21306]; Internal Grant Agency of Palacky University [IGA_PrF_2016_011]; Vetenskapsradet; VINNOVA; IWT agency for innovation by science and technology; Vienna Science and Technology Fund (WWTF) Vienna Research Group program; Austrian Science Fund (FWF) [P26568-B16, P26591-B16]; European Research Council (ERC) [639478-AuxinER]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic - NPU I program; "Navrat" program; Internal Grant Agency of Palacky University; Vetenskapsradet(Swedish Research Council); VINNOVA(Vinnova); IWT agency for innovation by science and technology; Vienna Science and Technology Fund (WWTF) Vienna Research Group program; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was funded by the Czech Science Foundation (Nr. GA14-34792S; ON, JO, BP), by the Ministry of Education, Youth and Sports of the Czech Republic - NPU I program with projects LO1204 (ON, JO, HK, TP, MS) and LO1218 (LE, MF), the "Navrat" program LK21306 (ON, JO), by the Internal Grant Agency of Palacky University (Nr. IGA_PrF_2016_011; BP, HK), by Vetenskapsradet and VINNOVA (TV, SR), IWT agency for innovation by science and technology (EB), and by the Vienna Science and Technology Fund (WWTF) Vienna Research Group program (JK-V), Austrian Science Fund (FWF) (P26568-B16 and P26591-B16) (JK-V), and the European Research Council (ERC) Starting Grant 639478-AuxinER (JK-V).	Bandurski RS, 1995, PLANT HORMONES, P39, DOI [10.1007/978-94-011-0473-9_3, DOI 10.1007/978-94-011-0473-9_3]; BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; COHEN JD, 1982, ANNU REV PLANT PHYS, V33, P403, DOI 10.1146/annurev.pp.33.060182.002155; DAVIDONIS GH, 1982, PLANT PHYSIOL, V70, P357, DOI 10.1104/pp.70.2.357; DAVIDONIS GH, 1980, PLANT PHYSIOL, V66, P537, DOI 10.1104/pp.66.4.537; Davies RT, 1999, PLANT CELL, V11, P365, DOI 10.1105/tpc.11.3.365; De Rybel B, 2009, ACS CHEM BIOL, V4, P987, DOI 10.1021/cb9001624; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Dobrev PI, 2005, J CHROMATOGR A, V1075, P159, DOI 10.1016/j.chroma.2005.02.091; FEUNG CS, 1972, PLANT PHYSIOL, V50, P80, DOI 10.1104/pp.50.1.80; FEUNG CS, 1973, J AGR FOOD CHEM, V21, P637, DOI 10.1021/jf60188a058; FEUNG CS, 1978, J AGR FOOD CHEM, V26, P1064, DOI 10.1021/jf60219a009; FEUNG CS, 1974, J AGR FOOD CHEM, V22, P307, DOI 10.1021/jf60192a040; FRANEK M, 1994, J AGR FOOD CHEM, V42, P1369, DOI 10.1021/jf00042a024; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Grossmann K, 2010, PEST MANAG SCI, V66, P113, DOI 10.1002/ps.1860; HAGEN G, 1985, MOL CELL BIOL, V5, P1197, DOI 10.1128/MCB.5.6.1197; Hamburg A, 2001, J AGR FOOD CHEM, V49, P146, DOI 10.1021/jf000120q; HANGARTER RP, 1980, PLANT PHYSIOL, V65, P761, DOI 10.1104/pp.65.5.761; Hellmann H, 2003, EMBO J, V22, P3314, DOI 10.1093/emboj/cdg335; Hennion MC, 2003, J CHROMATOGR A, V1000, P29, DOI 10.1016/S0021-9673(03)00529-6; Hotton SK, 2011, PLANT MOL BIOL, V75, P515, DOI 10.1007/s11103-011-9750-8; Hradecka V, 2007, J CHROMATOGR B, V847, P162, DOI 10.1016/j.jchromb.2006.09.034; KAZEMIE M, 1969, PLANTA, V89, P76, DOI 10.1007/BF00386497; Kenny DJ, 2010, J AM SOC MASS SPECTR, V21, P1061, DOI 10.1016/j.jasms.2010.02.017; Koesukwiwat U, 2008, ANAL CHIM ACTA, V626, P10, DOI 10.1016/j.aca.2008.07.034; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Kowalczyk M, 2001, PLANT PHYSIOL, V127, P1845, DOI 10.1104/pp.010525; Laurent F, 2000, J AGR FOOD CHEM, V48, P5307, DOI 10.1021/jf990672c; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; Liang Y, 2012, METHODS, V56, P174, DOI 10.1016/j.ymeth.2011.08.006; Ljung K, 2013, DEVELOPMENT, V140, P943, DOI 10.1242/dev.086363; Loos MA, 1975, HERBICIDES CHEM DEGR, P1; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Mithila J, 2011, WEED SCI, V59, P445, DOI 10.1614/WS-D-11-00062.1; Moon J, 2007, PLANT PHYSIOL, V143, P684, DOI 10.1104/pp.106.091439; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Novak O, 2012, PLANT J, V72, P523, DOI 10.1111/j.1365-313X.2012.05085.x; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Peat TS, 2012, PLANT CELL, V24, P4525, DOI 10.1105/tpc.112.102921; Petersson SV, 2009, PLANT CELL, V21, P1659, DOI 10.1105/tpc.109.066480; Rampey RA, 2004, PLANT PHYSIOL, V135, P978, DOI 10.1104/pp.104.039677; Rampey RA, 2006, GENETICS, V174, P1841, DOI 10.1534/genetics.106.061044; Rodriguez I, 2005, ANAL CHIM ACTA, V537, P259, DOI 10.1016/j.aca.2004.12.083; Rolcik J, 2002, J CHROMATOGR B, V775, P9; Santner A, 2010, PLANT J, V61, P1029, DOI 10.1111/j.1365-313X.2010.04112.x; Santos-Delgado MJ, 2000, TALANTA, V53, P367, DOI 10.1016/S0039-9140(00)00498-7; Sauer M, 2013, J EXP BOT, V64, P2565, DOI 10.1093/jxb/ert139; Sauer M, 2011, PLANT CELL, V23, P2033, DOI 10.1105/tpc.111.087064; Shi XM, 2012, J AGR FOOD CHEM, V60, P60, DOI 10.1021/jf204183d; SMULDERS MJM, 1990, J PLANT GROWTH REGUL, V9, P27, DOI 10.1007/BF02041938; Staswick PE, 2009, PLANT PHYSIOL, V150, P1310, DOI 10.1104/pp.109.138529; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Sterling T, 1997, HERBICIDE ACTIVITY T, V1, P111; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Tam YY, 2000, PLANT PHYSIOL, V123, P589, DOI 10.1104/pp.123.2.589; Tarkowska D, 2014, PLANTA, V240, P55, DOI 10.1007/s00425-014-2063-9; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; VIJAYARAGHAVAN SJ, 1986, PLANT PHYSIOL, V80, P315, DOI 10.1104/pp.80.2.315; Westfall CS, 2010, PLANT SIGNAL BEHAV, V5, P1607, DOI 10.4161/psb.5.12.13941; Zanella R, 2012, OPEN ACCESS BOOK IMP, P355	63	24	25	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159269	10.1371/journal.pone.0159269	http://dx.doi.org/10.1371/journal.pone.0159269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434212	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600044
J	Wein, S; Beyer, B; Gohlke, A; Blank, R; Metges, CC; Wolffram, S				Wein, Silvia; Beyer, Birgit; Gohlke, Annika; Blank, Ralf; Metges, Cornelia C.; Wolffram, Siegfried			Systemic Absorption of Catechins after Intraruminal or Intraduodenal Application of a Green Tea Extract in Cows	PLOS ONE			English	Article							DAIRY-COWS; INTESTINAL BACTERIA; BIOLOGICAL-ACTIVITY; GLUCOSE-METABOLISM; CAMELLIA-SINENSIS; POLYPHENOLS; LIVER; QUERCETIN; RATS; PERFORMANCE	Green tea catechins have various potential health benefits in humans including anti-inflammatory, anti-oxidative and hepato-protective effects. If present in the circulation, they might have similar effects in ruminants, which are exposed to oxidative stress and fatty liver disease such as dairy cows during the periparturient phase. However, the bioavailability of a substance is a prerequisite for any post absorptive effect in vivo. This study aimed to investigate the appearance of catechins from a green tea extract (GTE) in cattle plasma after intraruminal and intraduodenal administration because absorption is of major importance regarding the bioavailability of catechins. The studies were performed in 5 rumen-fistulated non-lactating heifers and 6 duodenally fistulated lactating dairy cows, respectively, equipped with indwelling catheters placed in a jugular vein. The GTE was applied intraruminally (10 and 50 mg/kg BW, heifers) or duodenally (10, 20 and 30 mg/kg BW, dairy cows) in a cross-over design with a 2 d washout period between different dosages. Blood samples were drawn following the GTE administration at various pre-defined time intervals. The concentration of the major GTE catechins (gallocatechin, epigallocatechin, catechin, epicatechin, epigallocatechin-gallate, epicatechin-gallate) in plasma samples were analysed by HPLC with electrochemical detection. Irrespective of the dose, almost none of the catechins originally contained in the GTE were detected in plasma samples after intraruminal application. In contrast, intraduodenal administration of GTE resulted in increased plasma concentrations of epicatechin, epigallocatechin, epigallocatechin gallate in a dose-dependent manner. Thus, we can conclude that intraruminally or orally administered catechins are intensively metabolized by ruminal microorganisms.	[Wein, Silvia; Beyer, Birgit; Blank, Ralf; Wolffram, Siegfried] Univ Kiel, Inst Anim Nutr & Physiol, Kiel, Germany; [Gohlke, Annika; Metges, Cornelia C.] Leibniz Inst Farm Anim Biol, Inst Nutr Physiol, Dummerstorf, Germany	University of Kiel; Forschungsinstitut fur Nutztierbiologie (FBN)	Metges, CC (corresponding author), Leibniz Inst Farm Anim Biol, Inst Nutr Physiol, Dummerstorf, Germany.	metges@fbn-dummerstorf.de	Blank, Ralf/Q-1604-2019	Blank, Ralf/0000-0002-7439-7253	Federal Ministry of Education and Research, Germany (BMBF) [0315538A, 0315538B]; Open Access fund of Leibniz Association	Federal Ministry of Education and Research, Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); Open Access fund of Leibniz Association	This work is part of the joint research project Food Chain Plus (FoCus) and was financially supported by the Federal Ministry of Education and Research, Germany (BMBF grant no. 0315538A and 0315538B). The publication of this article was funded by the Open Access fund of Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2009, BIOMED RES-TOKYO, V30, P25, DOI 10.2220/biomedres.30.25; Abrahamse SL, 2005, NUTR RES, V25, P305, DOI 10.1016/j.nutres.2004.10.013; Aron PM, 2008, MOL NUTR FOOD RES, V52, P79, DOI 10.1002/mnfr.200700137; BRAVO L, 1994, BRIT J NUTR, V71, P933, DOI 10.1079/BJN19940197; Chen JH, 2004, AM J CLIN NUTR, V80, P742; Chen X, 2005, PHARM RES-DORDR, V22, P892, DOI 10.1007/s11095-005-4584-1; Cyboran S, 2015, LIFE SCI, V126, P1, DOI 10.1016/j.lfs.2014.12.025; DAS NP, 1969, BIOCHIM BIOPHYS ACTA, V177, P668, DOI 10.1016/0304-4165(69)90340-7; Mota MAD, 2015, ACTA CIR BRAS, V30, P242, DOI 10.1590/S0102-865020150040000002; Mata-Bilbao MD, 2008, BRIT J NUTR, V100, P496, DOI 10.1017/S0007114507898692; Dube A, 2011, FOOD CHEM, V128, P7, DOI 10.1016/j.foodchem.2011.02.038; Duske K, 2009, J DAIRY SCI, V92, P1670, DOI 10.3168/jds.2008-1543; Egert S, 2013, EUR J NUTR, V52, P281, DOI 10.1007/s00394-012-0330-8; Feng WY, 2006, CURR DRUG METAB, V7, P755, DOI 10.2174/138920006778520552; Forester SC, 2012, MOL NUTR FOOD RES, V56, P1647, DOI 10.1002/mnfr.201200206; Gesellschaft fur Ernahrungsphysiologie der Haustiere [German Society of Nutrition Physiology], 2001, AUSSCH BED GES ERN E; Gohlke A, 2013, J DAIRY SCI, V96, P6986, DOI 10.3168/jds.2013-6852; Gohlke A, 2013, J DAIRY SCI, V96, P2303, DOI 10.3168/jds.2012-6234; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Grum DE, 2002, J DAIRY SCI, V85, P3026, DOI 10.3168/jds.S0022-0302(02)74388-9; Hammon HM, 2009, J DAIRY SCI, V92, P1554, DOI 10.3168/jds.2008-1634; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011; Kutschera M, 2011, J APPL MICROBIOL, V111, P165, DOI 10.1111/j.1365-2672.2011.05025.x; Lambert JD, 2003, J NUTR, V133, P4172, DOI 10.1093/jn/133.12.4172; Lambert JD, 2003, MUTAT RES-FUND MOL M, V523, P201, DOI 10.1016/S0027-5107(02)00336-6; Lee MJ, 2000, ANAL BIOCHEM, V279, P164, DOI 10.1006/abio.2000.4487; Li C, 2000, CHEM RES TOXICOL, V13, P177, DOI 10.1021/tx9901837; Lohrke B, 2008, BRIT J NUTR, V99, P1255, DOI 10.1017/S000711450886240X; Lorz A, 2008, TIERSCHUTZGESETZ TIE, V6, P1; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Menke K.H, 1988, ANIM RES DEV, V28, P7, DOI DOI 10.1016/S0301-6226(01)00298-6.PALMQUIST; Nakagawa K, 1997, BIOSCI BIOTECH BIOCH, V61, P1981, DOI 10.1271/bbb.61.1981; Naumann C, 1997, METHODENBUCH; Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133; Okushio K, 1996, BIOL PHARM BULL, V19, P326, DOI 10.1248/bpb.19.326; Pastore RL, 2006, EXPLORE-NY, V2, P531, DOI 10.1016/j.explore.2006.08.008; Serisier S, 2008, BRIT J NUTR, V99, P1208, DOI 10.1017/S0007114507862386; Sordillo LM, 2007, J DAIRY SCI, V90, P1186, DOI 10.3168/jds.S0022-0302(07)71605-3; Starp C, 2006, ANN NUTR METAB, V50, P59, DOI 10.1159/000089640; Stoldt AK, 2015, J DAIRY SCI, V98, P4509, DOI 10.3168/jds.2014-9053; Swezey RR, 2003, INT J TOXICOL, V22, P187, DOI 10.1080/10915810305101; Tadera K, 2006, J NUTR SCI VITAMINOL, V52, P149, DOI 10.3177/jnsv.52.149; Takagaki A, 2014, ARCH MICROBIOL, V196, P681, DOI 10.1007/s00203-014-1006-y; Tomaszewska E, 2015, ENVIRON TOXICOL PHAR, V40, P708, DOI 10.1016/j.etap.2015.09.002; Wang X, 2001, BIOCHEM BIOPH RES CO, V288, P1200, DOI 10.1006/bbrc.2001.5923; Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c; Williamson G, 2013, MOL NUTR FOOD RES, V57, P48, DOI 10.1002/mnfr.201200511; Yuan GJ, 2006, INT J MOL SCI, V7, P204, DOI 10.3390/i7070204; Yun B, 2015, J FOOD SCI, V80, pM2925, DOI 10.1111/1750-3841.13145; Zhang X, 2015, J HUAZHONG U SCI-MED, V35, P378, DOI 10.1007/s11596-015-1441-2; Zhu QY, 1997, J AGR FOOD CHEM, V45, P4624, DOI 10.1021/jf9706080	54	16	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159428	10.1371/journal.pone.0159428	http://dx.doi.org/10.1371/journal.pone.0159428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427946	Green Submitted, gold, Green Published			2022-12-27	WOS:000380169300066
J	Voorn, EL; Koopman, FS; Brehm, MA; Beelen, A; de Haan, A; Gerrits, KHL; Nollet, F				Voorn, Eric L.; Koopman, Fieke S.; Brehm, Merel A.; Beelen, Anita; de Haan, Arnold; Gerrits, Karin H. L.; Nollet, Frans			Aerobic Exercise Training in Post-Polio Syndrome: Process Evaluation of a Randomized Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; CARDIORESPIRATORY RESPONSES; FATIGUE; FITNESS; POLIOMYELITIS; INDIVIDUALS; PERFORMANCE; THRESHOLD; THERAPY; LOAD	Objective To explore reasons for the lack of efficacy of a high intensity aerobic exercise program in post-polio syndrome (PPS) on cardiorespiratory fitness by evaluating adherence to the training program and effects on muscle function. Design A process evaluation using data from an RCT. Patients Forty-four severely fatigued individuals with PPS were randomized to exercise therapy (n = 22) or usual care (n = 22). Methods Participants in the exercise group were instructed to exercise 3 times weekly for 4 months on a bicycle ergometer (60-70% heart rate reserve). Results The attendance rate was high (median 89%). None of the participants trained within the target heart rate range during >75% of the designated time. Instead, participants exercised at lower intensities, though still around the anaerobic threshold (AT) most of the time. Muscle function did not improve in the exercise group. Conclusion Our results suggest that severely fatigued individuals with PPS cannot adhere to a high intensity aerobic exercise program on a cycle ergometer. Despite exercise intensities around the AT, lower extremity muscle function nor cardiorespiratory fitness improved. Improving the aerobic capacity in PPS is difficult through exercise primarily focusing on the lower extremities, and may require a more individualized approach, including the use of other large muscle groups instead.	[Voorn, Eric L.; Koopman, Fieke S.; Brehm, Merel A.; Beelen, Anita; Nollet, Frans] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, Amsterdam, Netherlands; [Voorn, Eric L.; de Haan, Arnold; Gerrits, Karin H. L.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Voorn, EL (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Rehabil, Amsterdam, Netherlands.; Voorn, EL (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands.	e.l.voorn@amc.uva.nl	Brehm, Merel-Anne/K-8638-2017; Brehm, Merel-Anne/AAK-7419-2020	Brehm, Merel-Anne/0000-0002-3425-4661; Brehm, Merel-Anne/0000-0002-3425-4661; Voorn, Eric/0000-0003-0807-2124; Koopman, Fieke Sophia/0000-0001-5260-0727	Prinses Beatrix SpierFonds (PBF; The Dutch Public Fund for Neuromuscular Disorders); ZonMw (the Netherlands Organisation for Health Research and Development) [ZonMw 89000003]	Prinses Beatrix SpierFonds (PBF; The Dutch Public Fund for Neuromuscular Disorders); ZonMw (the Netherlands Organisation for Health Research and Development)(Netherlands Organization for Health Research and Development)	This work was funded by Prinses Beatrix SpierFonds (PBF; The Dutch Public Fund for Neuromuscular Disorders), ZonMw (the Netherlands Organisation for Health Research and Development, ID: ZonMw 89000003) /het Revalidatiefonds/Revalidatie Nederland/de Nederlandse Vereniging van Revalidatieartsen (the Netherlands Society of Physical and Rehabilitation Medicine).	Akubat I, 2012, J SPORT SCI, V30, P1473, DOI 10.1080/02640414.2012.712711; Bickerstaffe A, 2014, CLIN NEUROPHYSIOL, V125, P1255, DOI 10.1016/j.clinph.2013.11.003; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BORG K, 1991, J NEUROL NEUROSUR PS, V54, P236, DOI 10.1136/jnnp.54.3.236; Borresen J, 2009, SPORTS MED, V39, P779, DOI 10.2165/11317780-000000000-00000; Cup EH, 2007, ARCH PHYS MED REHAB, V88, P1452, DOI 10.1016/j.apmr.2007.07.024; Durstine JL, 2009, ACSMS EXERCISE MANAG; Ernstoff B, 1996, ARCH PHYS MED REHAB, V77, P843, DOI 10.1016/S0003-9993(96)90268-3; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GRIMBY G, 1989, SCAND J REHABIL MED, V21, P19; JONES DR, 1989, JAMA-J AM MED ASSOC, V261, P3255, DOI 10.1001/jama.261.22.3255; Kenney WL, 2012, PHYSL SPORT EXERCISE; Klein MG, 2008, ARCH PHYS MED REHAB, V89, P297, DOI 10.1016/j.apmr.2007.08.156; Koopman FS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-8; Koopman FS, 2015, NEUROREHABILITATION; KRIZ JL, 1992, ARCH PHYS MED REHAB, V73, P49; Londeree BR, 1997, MED SCI SPORT EXER, V29, P837, DOI 10.1097/00005768-199706000-00016; Manzi V, 2009, MED SCI SPORT EXER, V41, P2090, DOI 10.1249/MSS.0b013e3181a6a959; March of Dimes, 2000, INT C POSTP SYNDR ID; Medical Research Council, 1976, 45 MED RES COUNC, V45; Mostert S, 2002, MULT SCLER J, V8, P161, DOI 10.1191/1352458502ms779oa; Nollet F, 1999, ARCH PHYS MED REHAB, V80, P136, DOI 10.1016/S0003-9993(99)90110-7; Oncu J, 2009, CLIN REHABIL, V23, P155, DOI 10.1177/0269215508098893; Rekand T, 2004, ACTA NEUROL SCAND, V109, P120, DOI 10.1034/j.1600-0404.2003.00186.x; SULLIVAN M, 1985, AM HEART J, V109, P458, DOI 10.1016/0002-8703(85)90548-4; Tan SJ, 2010, PEDIATR EXERC SCI, V22, P477, DOI 10.1123/pes.22.3.477; Tersteeg IM, 2011, ARCH PHYS MED REHAB, V92, P899, DOI 10.1016/j.apmr.2011.01.005; Vercoulen J., 1999, GEDRAGSTHERAPIE, V32, P131; Voorn EL, 2014, ARCH PHYS MED REHABI; Voorn EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101660; Voorn EL, 2013, NEUROMUSCULAR DISORD, V23, P892, DOI 10.1016/j.nmd.2013.06.372; Wasserman K, 2005, EUR RESP MON, P146, DOI DOI 10.1249/01.MSS.0000172593.20181.14; Willen C, 2001, ARCH PHYS MED REHAB, V82, P66, DOI 10.1053/apmr.2001.9626	33	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0159280	10.1371/journal.pone.0159280	http://dx.doi.org/10.1371/journal.pone.0159280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27419388	Green Submitted, Green Published, gold			2022-12-27	WOS:000379662300010
J	Liu, BH; Gomez, LD; Hua, CM; Sun, LL; Ali, I; Huang, LL; Yu, CY; Simister, R; Steele-King, C; Gan, YB; McQueen-Mason, SJ				Liu, Bohan; Gomez, Leonardo D.; Hua, Cangmei; Sun, Lili; Ali, Imran; Huang, Linli; Yu, Chunyan; Simister, Rachael; Steele-King, Clare; Gan, Yinbo; McQueen-Mason, Simon J.			Linkage Mapping of Stem Saccharification Digestibility in Rice	PLOS ONE			English	Article							CELL-WALL BIOSYNTHESIS; TRANSCRIPTION FACTOR; LIGNOCELLULOSIC BIOMASS; L-ARABINOFURANOSIDASE; DIRECT TARGET; FERULIC ACID; EXPRESSION; GENE; LIGNIN; LIGNIFICATION	Rice is the staple food of almost half of the world population, and in excess 90% of it is grown and consumed in Asia, but the disposal of rice straw poses a problem for farmers, who often burn it in the fields, causing health and environmental problems. However, with increased focus on the development of sustainable biofuel production, rice straw has been recognized as a potential feedstock for non-food derived biofuel production. Currently, the commercial realization of rice as a biofuel feedstock is constrained by the high cost of industrial saccharification processes needed to release sugar for fermentation. This study is focused on the alteration of lignin content, and cell wall chemotypes and structures, and their effects on the saccharification potential of rice lignocellulosic biomass. A recombinant inbred lines (RILs) population derived from a cross between the lowland rice variety IR1552 and the upland rice variety Azucena with 271 molecular markers for quantitative trait SNP (QTS) analyses was used. After association analysis of 271 markers for saccharification potential, 1 locus and 4 pairs of epistatic loci were found to contribute to the enzymatic digestibility phenotype, and an inverse relationship between reducing sugar and lignin content in these recombinant inbred lines was identified. As a result of QTS analyses, several cell-wall associated candidate genes are proposed that may be useful for marker-assisted breeding and may aid breeders to produce potential high saccharification rice varieties.	[Liu, Bohan; Hua, Cangmei; Sun, Lili; Ali, Imran; Huang, Linli; Yu, Chunyan; Gan, Yinbo] Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou, Zhejiang, Peoples R China; [Gomez, Leonardo D.; Simister, Rachael; Steele-King, Clare; McQueen-Mason, Simon J.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England	Zhejiang University; University of York - UK	Gan, YB (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou, Zhejiang, Peoples R China.; McQueen-Mason, SJ (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.	ygan@zju.edu.cn; simon.mcqueenmason@york.ac.uk	Liu, Bohan/D-4731-2015; Sun, lili/GQH-2057-2022; Gan, Yinbo/N-1480-2015; Liu, Bohan/G-4704-2017	Liu, Bohan/0000-0002-8318-9667; Liu, Bohan/0000-0002-8318-9667; Gomez, Leonardo Dario/0000-0001-6382-9447	Major State Basic Research Development Program (973 Program) [2015CB150200]; Zhejiang Provincial Natural Science Foundation of China [LZ15C020001]; National Natural Science Foundation of China [31570183, 31529001]; UK-China partnering award from BBSRC of UK [BB/H531419]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UK-China partnering award from BBSRC of UK	The research was funded by Major State Basic Research Development Program (973 Program, grant no. 2015CB150200); Zhejiang Provincial Natural Science Foundation of China (Grant No. LZ15C020001); National Natural Science Foundation of China (Grant No. 31570183; 31529001) and UK-China partnering award from BBSRC of UK (Grant No BB/H531419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was funded by Major State Basic Research Development Program (973 Program, grant no. 2015CB150200); Zhejiang Provincial Natural Science Foundation of China (Grant No. LZ15C020001); National Natural Science Foundation of China (Grant No. 31570183; 31529001) and UK-China partnering award from BBSRC of UK (Grant No BB/H531419).	Abramson M, 2010, PLANT SCI, V178, P61, DOI 10.1016/j.plantsci.2009.11.003; Arsovski AA, 2009, PLANT PHYSIOL, V150, P1219, DOI 10.1104/pp.109.138388; Bartley LE, 2013, PLANT PHYSIOL, V161, P1615, DOI 10.1104/pp.112.208694; BEFFA RS, 1993, P NATL ACAD SCI USA, V90, P8792, DOI 10.1073/pnas.90.19.8792; Bi YuYun, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P211; Buanafina MMDO, 2008, PLANT BIOTECHNOL J, V6, P264, DOI 10.1111/j.1467-7652.2007.00317.x; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Cao GL, 2008, CHINESE SCI BULL, V53, P784, DOI 10.1007/s11434-008-0145-4; Cao PJ, 2008, MOL PLANT, V1, P858, DOI 10.1093/mp/ssn052; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Christopher LP, 2014, FRONT ENERGY RES, DOI 10.3389/fenrg.2014.00012; CONDIT CM, 1987, MOL CELL BIOL, V7, P4273, DOI 10.1128/MCB.7.12.4273; d'Yvoire MB, 2013, PLANT J, V73, P496, DOI 10.1111/tpj.12053; DeMartini JD, 2013, ENERG ENVIRON SCI, V6, P898, DOI 10.1039/c3ee23801f; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Gadde B, 2009, BIOMASS BIOENERG, V33, P1532, DOI 10.1016/j.biombioe.2009.07.018; Gadde B, 2009, ENVIRON POLLUT, V157, P1554, DOI 10.1016/j.envpol.2009.01.004; GOLD MH, 1989, ACS SYM SER, V389, P127; Gomez LD, 2008, NEW PHYTOL, V178, P473, DOI 10.1111/j.1469-8137.2008.02422.x; Gomez LD, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-23; Gou JY, 2012, PLANT CELL, V24, P50, DOI 10.1105/tpc.111.092411; HALL LN, 1993, PLANT J, V3, P121, DOI 10.1111/j.1365-313X.1993.tb00015.x; Harris D, 2010, PLANT BIOTECHNOL J, V8, P244, DOI 10.1111/j.1467-7652.2009.00481.x; Harris D, 2009, GCB BIOENERGY, V1, P51, DOI 10.1111/j.1757-1707.2009.01000.x; Hazen SP, 2002, PLANT PHYSIOL, V128, P336, DOI 10.1104/pp.010875; Itai A, 2003, J EXP BOT, V54, P2615, DOI 10.1093/jxb/erg291; Jackson LA, 2008, BIOENERG RES, V1, P180, DOI 10.1007/s12155-008-9020-z; Kavousi B, 2010, PHYTOCHEMISTRY, V71, P531, DOI 10.1016/j.phytochem.2010.01.008; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; LAZAN H, 1995, PHYSIOL PLANTARUM, V95, P106, DOI 10.1034/j.1399-3054.1995.950116.x; Lin CC, 2001, J PLANT PHYSIOL, V158, P667, DOI 10.1078/0176-1617-00245; Liu ZZ, 2003, PLANTA, V216, P824, DOI 10.1007/s00425-002-0934-y; Mansfield SD, 2012, NEW PHYTOL, V194, P91, DOI 10.1111/j.1469-8137.2011.04031.x; Marriott PE, 2016, NEW PHYTOL, V209, P1366, DOI 10.1111/nph.13684; Marriott PE, 2014, P NATL ACAD SCI USA, V111, P14601, DOI 10.1073/pnas.1414020111; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Mewalal R, 2014, PLANT CELL PHYSIOL, V55, P1031, DOI 10.1093/pcp/pcu050; Mika Angela, 2004, Phytochemistry Reviews, V3, P173, DOI 10.1023/B:PHYT.0000047806.21626.49; Min DY, 2012, APPL BIOCHEM BIOTECH, V168, P947, DOI 10.1007/s12010-012-9833-2; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Newman LJ, 2004, PLANT J, V37, P239, DOI 10.1046/j.1365-313X.2003.01953.x; Penning BW, 2014, PLANT PHYSIOL, V165, P1475, DOI 10.1104/pp.114.242446; Sahoo DK, 2013, PLANT BIOTECHNOL J, V11, P362, DOI 10.1111/pbi.12024; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Sonbol FM, 2009, PLANT MOL BIOL, V70, P283, DOI 10.1007/s11103-009-9473-2; Van Acker R, 2014, P NATL ACAD SCI USA, V111, P845, DOI 10.1073/pnas.1321673111; Vercauteren I, 2002, MOL PLANT MICROBE IN, V15, P404, DOI 10.1094/MPMI.2002.15.4.404; Wan LL, 2011, PLANTA, V233, P309, DOI 10.1007/s00425-010-1301-z; Wang LQ, 2010, BMC PLANT BIOL, V10; XU DP, 1995, PLANT MOL BIOL, V28, P455, DOI 10.1007/BF00020394; Zhang FT, 2015, SCI REP-UK, V5, DOI 10.1038/srep10298; Zhang HF, 2008, ATMOS ENVIRON, V42, P8432, DOI 10.1016/j.atmosenv.2008.08.015; Zhao QA, 2010, PLANT J, V63, P100, DOI 10.1111/j.1365-313X.2010.04223.x; Zheng BS, 2003, THEOR APPL GENET, V107, P1505, DOI 10.1007/s00122-003-1390-1; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2015, PLANT CELL PHYSIOL, V56, P195, DOI 10.1093/pcp/pcu140; Zhong RQ, 2011, PLANT CELL PHYSIOL, V52, P1856, DOI 10.1093/pcp/pcr123; Zhong RQ, 2010, PLANT SIGNAL BEHAV, V5, P469, DOI 10.4161/psb.5.4.11400; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321; Zhou YH, 2009, PLANT J, V57, P446, DOI 10.1111/j.1365-313X.2008.03703.x	66	6	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159117	10.1371/journal.pone.0159117	http://dx.doi.org/10.1371/journal.pone.0159117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415441	gold, Green Published, Green Accepted			2022-12-27	WOS:000379579500080
J	Sarcina, C; Tinelli, C; Ferrario, F; Visciano, B; Pani, A; De Silvestri, A; De Simone, I; Del Vecchio, L; Terraneo, V; Furiani, S; Santagostino, G; Corghi, E; Pozzi, C				Sarcina, Cristina; Tinelli, Carmine; Ferrario, Francesca; Visciano, Bianca; Pani, Antonello; De Silvestri, Annalisa; De Simone, Ilaria; Del Vecchio, Lucia; Terraneo, Veronica; Furiani, Silvia; Santagostino, Gaia; Corghi, Enzo; Pozzi, Claudio			Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CONVERTING ENZYME-INHIBITORS; TERM-FOLLOW-UP; OXFORD CLASSIFICATION; PROGNOSTIC-FACTORS; NATURAL-HISTORY; PROGRESSION; GLOMERULONEPHRITIS; THERAPY; AZATHIOPRINE	The clinical course of IgA nephropathy (IgAN) and its outcome are extremely variable. Proteinuria at baseline has been considered one of the most important risk factors. More recently, mean proteinuria of follow-up (time-average proteinuria: TAp) was described as a stronger marker of renal survival, suggesting to consider it as a marker of disease activity and response to treatment. We evaluated predictors of renal survival in IgAN patients with different degrees of renal dysfunction and histological lesions, focusing on the role of the therapy in influencing TAp. We performed a retrospective analysis of three prospective, randomized, clinical trials enrolling 325 IgAN patients from 1989 to 2005. Patients were divided into 5 categories according to TAp. The primary endpoint of the 100% increase of serum creatinine occurred in 54 patients (16.6%) and renal survival was much better in groups having lower TAp. The median follow up was 66.6 months (range 12 to 144). The primary endpoint of the 100% increase of serum creatinine occurred in 54 patients (16,6%) and renal survival was much better in groups having lower TA proteinuria. At univariate analysis plasma creatinine and 24h proteinuria, systolic (SBP) and diastolic (DBP) blood pressure during follow-up and treatment with either steroid (CS) or steroid plus azathioprine (CS+A) were the main factors associated with lower TAp and renal survival. At multivariate analysis, female gender, treatment with S or S+A, lower baseline proteinuria and SBP during followup remained as the only variables independently influencing TAp. In conclusion, TA-proteinuria is confirmed as one of the best outcome indicators, also in patients with a severe renal insufficiency. A 6-month course of corticosteroids seems the most effective therapy to reduce TAp.	[Sarcina, Cristina; Ferrario, Francesca; Visciano, Bianca; De Simone, Ilaria; Terraneo, Veronica; Furiani, Silvia; Santagostino, Gaia; Corghi, Enzo; Pozzi, Claudio] E Bassini Hosp, Dept Nephrol & Dialysis, Milan, Italy; [Tinelli, Carmine; De Silvestri, Annalisa] Policlin San Matteo, Biometry & Clin Epidemiol Unit, Pavia, Italy; [Pani, Antonello] G Brotzu Hosp, Dept Nephrol & Dialysis, Cagliari, Italy; [Del Vecchio, Lucia] Dialysis & Renal Transplant A Manzoni Hosp, Dept Nephrol, Lecce, Italy	IRCCS Fondazione San Matteo	Sarcina, C (corresponding author), E Bassini Hosp, Dept Nephrol & Dialysis, Milan, Italy.	cristina.sarcina@gmail.com	Pani, Antonello/HDN-3366-2022; De Silvestri, Annalisa/I-6024-2014; del vecchio, lucia/AAG-7073-2019; Del Vecchio, Lucia/AAH-3140-2019	De Silvestri, Annalisa/0000-0003-3128-8441; Tinelli, Carmine/0000-0002-8749-1978				ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8; Barbour SJ, 2015, KIDNEY INT, V88, P1392, DOI 10.1038/ki.2015.241; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Coppo R, 2007, J AM SOC NEPHROL, V18, P1880, DOI 10.1681/ASN.2006040347; Coppo R, 2014, KIDNEY INT, V86, P828, DOI 10.1038/ki.2014.63; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; IBELS LS, 1994, MEDICINE, V73, P79, DOI 10.1097/00005792-199403000-00002; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; JOHNSTON PA, 1992, Q J MED, V84, P619; Kanno Y, 2000, CLIN NEPHROL, V54, P360; KATAFUCHI R, 1994, CLIN NEPHROL, V41, P191; KDIGO, 2012, KIDNEY INT SUPPL, V2, pS209; Lv JC, 2012, J AM SOC NEPHROL, V23, P1108, DOI 10.1681/ASN.2011111112; Lv JC, 2009, AM J KIDNEY DIS, V53, P26, DOI 10.1053/j.ajkd.2008.07.029; Maisonneuve P, 2000, AM J KIDNEY DIS, V35, P157, DOI 10.1016/S0272-6386(00)70316-7; Manno C, 2009, NEPHROL DIAL TRANSPL, V24, P3694, DOI 10.1093/ndt/gfp356; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Pozzi C, 2013, J NEPHROL, V26, P86, DOI 10.5301/jn.5000110; Pozzi C, 2010, J AM SOC NEPHROL, V21, P1783, DOI 10.1681/ASN.2010010117; Rauen T, 2015, NEW ENGL J MED, V373, P2225, DOI 10.1056/NEJMoa1415463; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Sarafidis PA, 2007, AM J KIDNEY DIS, V49, P12, DOI 10.1053/j.ajkd.2006.10.014; Sobin LH, 1992, RENAL DIS CLASSIFICA; Tesar V, 2015, J AM SOC NEPHROL	27	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158584	10.1371/journal.pone.0158584	http://dx.doi.org/10.1371/journal.pone.0158584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416024	gold, Green Submitted, Green Published			2022-12-27	WOS:000379579500025
J	Song, G; Shao, XX; Wu, QP; Xu, ZG; Liu, YL; Guo, ZY				Song, Ge; Shao, Xiao-Xia; Wu, Qing-Ping; Xu, Zeng-Guang; Liu, Ya-Li; Guo, Zhan-Yun			Novel Bioluminescent Binding Assays for Ligand-Receptor Interaction Studies of the Fibroblast Growth Factor Family	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CELLS; HORMONES; NANOLUCIFERASE; IDENTIFICATION; PROTEIN; DIMERIZATION; SPECIFICITY; EXPRESSION; PEPTIDE	We recently developed novel bioluminescent binding assays for several protein/peptide hormones to study their interactions with receptors using the so far brightest NanoLuc reporter. To validate the novel bioluminescent binding assay using a variety of protein/peptide hormones, in the present work we applied it to the fibroblast growth factor (FGF) family using the prototype member FGF2 as an example. A fully active recombinant FGF2 retaining a unique exposed cysteine (Cys) residue was chemically conjugated with an engineered NanoLuc carrying a unique exposed Cys residue at the C-terminus via formation of an intermolecular disulfide linkage. The NanoLuc-conjugated FGF2 (FGF2-Luc) retained high binding affinity to the overexpressed FGFR1 and the endogenous FGF receptor with the calculated dissociation constants of 161 +/- 21 pM (n = 3) and 25 +/- 4 pM(n = 3), respectively. In competition binding assays using FGF2-Luc as a tracer, receptor-binding potencies of wild-type or mutant FGF2s were accurately quantified. Thus, FGF2-Luc represents a novel non-radioactive tracer for the quantitative measurement of ligand-receptor interactions in the FGF family. These data suggest that the novel bioluminescent binding assay can be applied to a variety of protein/peptide hormones for ligand-receptor interaction studies.	[Song, Ge; Shao, Xiao-Xia; Wu, Qing-Ping; Xu, Zeng-Guang; Liu, Ya-Li; Guo, Zhan-Yun] Tongji Univ, Coll Life Sci & Technol, Res Ctr Translat Med, East Hosp, Shanghai, Peoples R China	Tongji University	Liu, YL; Guo, ZY (corresponding author), Tongji Univ, Coll Life Sci & Technol, Res Ctr Translat Med, East Hosp, Shanghai, Peoples R China.	yaliliuliu@163.com; zhan-yun.guo@tongji.edu.cn			National Natural Science Foundation of China [31470767, 31270824]; Fundamental Research Funds for the Central Universities [2000219098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31470767, 31270824) and the Fundamental Research Funds for the Central Universities (2000219098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; AGO H, 1991, J BIOCHEM-TOKYO, V110, P360, DOI 10.1093/oxfordjournals.jbchem.a123586; ARMELIN HA, 1973, P NATL ACAD SCI USA, V70, P2702, DOI 10.1073/pnas.70.9.2702; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; Fernandes-Freitas I, 2015, CURR OPIN PHARMACOL, V25, P30, DOI 10.1016/j.coph.2015.09.014; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; GOSPODAROWICZ D, 1974, NATURE, V249, P123, DOI 10.1038/249123a0; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; He SX, 2014, BIOCHIMIE, V106, P140, DOI 10.1016/j.biochi.2014.08.012; Hu MJ, 2016, AMINO ACIDS, V48, P2227, DOI 10.1007/s00726-016-2260-x; Itoh N, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00154; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; KROIHER M, 1995, BBA-PROTEIN STRUCT M, V1250, P29, DOI 10.1016/0167-4838(95)00060-8; KUROKAWA T, 1987, FEBS LETT, V213, P189, DOI 10.1016/0014-5793(87)81489-8; La Venuta G, 2015, J BIOL CHEM, V290, P27015, DOI 10.1074/jbc.R115.689257; Liu YL, 2016, AMINO ACIDS, V48, P1151, DOI 10.1007/s00726-016-2220-5; Liu Y, 2015, AMINO ACIDS, V47, P2237, DOI 10.1007/s00726-015-2009-y; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; NEUFELD G, 1985, J BIOL CHEM, V260, P3860; OLWIN BB, 1986, BIOCHEMISTRY-US, V25, P3487, DOI 10.1021/bi00360a001; OLWIN BB, 1989, J CELL BIOCHEM, V39, P443, DOI 10.1002/jcb.240390410; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SHARMA A, 1988, BIOMED BIOCHIM ACTA, V47, P975; Song G, 2015, J PHOTOCH PHOTOBIO B, V153, P311, DOI 10.1016/j.jphotobiol.2015.10.014; SQUIRES CH, 1988, J BIOL CHEM, V263, P16297; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wu QP, 2016, AMINO ACIDS, V48, P1099, DOI 10.1007/s00726-015-2146-3; Zhang L, 2013, BIOCHIMIE, V95, P2454, DOI 10.1016/j.biochi.2013.09.008; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	35	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159263	10.1371/journal.pone.0159263	http://dx.doi.org/10.1371/journal.pone.0159263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414797	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500114
J	Spaan, M; Hullegie, SJ; Beudeker, BJB; Kreefft, K; van Oord, GW; Groothuismink, ZMA; van Tilborg, M; Rijnders, B; de Knegt, RJ; Claassen, MAA; Boonstra, A				Spaan, Michelle; Hullegie, Sebastiaan J.; Beudeker, Boris J. B.; Kreefft, Kim; van Oord, Gertine W.; Groothuismink, Zwier M. A.; van Tilborg, Marjolein; Rijnders, Bart; de Knegt, Robert J.; Claassen, Mark A. A.; Boonstra, Andre			Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy	PLOS ONE			English	Article							INVARIANT T-CELLS; HEPATITIS-C; NK CELLS; RESPONSES; INTERFERON; ACTIVATION; EXHAUSTION; INDUCTION; INFECTION; ROLES	Objective Mucosal-associated invariant T (MAIT) cells comprise a subpopulation of T cells that can be activated by bacterial products and cytokines to produce IFN-gamma Since little is known on MAIT cells during HCV infection, we compared their phenotype and function in comparison to HIV and HCV/HIV co-infected patients, and determined the effect of IFN-alpha-based and direct-acting antiviral therapy on MAIT cells of HCV patients. Methods Blood samples from patients with chronic HCV (CHCV), virologically suppressed HIV, acute HCV/HIV co-infection (AHCV/HIV) and healthy individuals were examined by flowcytometry for phenotype and function of MAIT and NK cells. Results and Conclusions Compared to healthy individuals, the frequency of CD161(+)V alpha 7.2(+) MAIT cells was significantly decreased in patients with CHCV, HIV and AHCV/HIV co-infection. CD38 expression on MAIT cells was increased in AHCV/HIV patients. MAIT cells were responsive to IFN-alpha in vitro as evidenced by enhanced frequencies of IFN-gamma producing cells. IFN-alpha-based therapy for CHCV decreased the frequency of IFN-gamma(+) MAIT cells, which was still observed 24 weeks after successful therapy. Importantly, even after successful IFN-alpha-based as well as IFN-alpha-free therapy for CHCV, decreased frequencies of MAIT cells persisted. We show that the frequencies of MAIT cells are reduced in blood of patients with CHCV, HIV and in AHCV/HIV co-infection compared to healthy individuals. Successful therapy for CHCV did not normalize MAIT cell frequencies at 24 weeks follow up. The impact of HIV and HCV infection on the numbers and function of MAIT cells warrant further studies on the impact of viral infections and the antimicrobial function of MAIT cells.	[Spaan, Michelle; Beudeker, Boris J. B.; Kreefft, Kim; van Oord, Gertine W.; Groothuismink, Zwier M. A.; van Tilborg, Marjolein; de Knegt, Robert J.; Boonstra, Andre] Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Hullegie, Sebastiaan J.; Rijnders, Bart; Claassen, Mark A. A.] Univ Med Ctr, Infect Dis Sect Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Boonstra, A (corresponding author), Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	p.a.boonstra@erasmusmc.nl	rijnders, bart ja/V-7527-2018; De Knegt, Robert/X-4629-2019; rijnders, bart/AAB-2868-2019	De Knegt, Robert/0000-0003-0934-6975; rijnders, bart/0000-0003-3343-9610; Boonstra, Andre/0000-0001-8607-1616	Virgo consortium - Dutch government [FES0908]	Virgo consortium - Dutch government	This study was supported by the Virgo consortium, funded by the Dutch government project number FES0908. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barathan M, 2016, EUR J CLIN INVEST, V46, P170, DOI 10.1111/eci.12581; Bosinger SE, 2015, CURR HIV-AIDS REP, V12, P41, DOI 10.1007/s11904-014-0244-6; Chua WJ, 2010, IMMUNOL CELL BIOL, V88, P767, DOI 10.1038/icb.2010.104; Claassen MAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049389; Cook KD, 2013, J IMMUNOL, V190, P641, DOI 10.4049/jimmunol.1202448; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Eberhard JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111323; Fernandez CS, 2015, IMMUNOL CELL BIOL, V93, P177, DOI 10.1038/icb.2014.91; Gapin L, 2014, J IMMUNOL, V192, P4475, DOI 10.4049/jimmunol.1400119; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Golden-Mason L, 2013, IMMUNOL REV, V255, P68, DOI 10.1111/imr.12090; Gonzalez VD, 2010, CLIN IMMUNOL, V135, P12, DOI 10.1016/j.clim.2009.12.005; Hengst J, 2016, EUR J IMMUNOL, V46, P2204, DOI 10.1002/eji.201646447; Hotho DM, 2013, ANTIVIR RES, V97, P347, DOI 10.1016/j.antiviral.2012.12.025; Hullegie SJ, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.03.026; Iannello A, 2008, J LEUKOCYTE BIOL, V84, P1, DOI 10.1189/jlb.0907650; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Li YJ, 2014, REV MED VIROL, V24, P332, DOI 10.1002/rmv.1795; Lunemann S, 2012, DIGEST DIS, V30, P48, DOI 10.1159/000341680; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Saeidi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124659; Spaan M, 2012, BEST PRACT RES CLIN, V26, P1049; Spaan M, 2016, J INFECT DIS, V213, P216, DOI 10.1093/infdis/jiv391; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Ussher JE, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001134; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; Vinton C, 2016, J VIROL, V90, P4520, DOI 10.1128/JVI.02876-15; Wong EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083474	33	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159243	10.1371/journal.pone.0159243	http://dx.doi.org/10.1371/journal.pone.0159243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416100	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500108
J	Szarmach, A; Luczkiewicz, P; Skotarczak, M; Kaszubowski, M; Winklewski, PJ; Dzierzanowski, J; Piskunowicz, M; Szurowska, E; Baczkowski, B				Szarmach, Arkadiusz; Luczkiewicz, Piotr; Skotarczak, Monika; Kaszubowski, Mariusz; Winklewski, Pawel J.; Dzierzanowski, Jaroslaw; Piskunowicz, Maciej; Szurowska, Edyta; Baczkowski, Boguslaw			Assessment of the Relationship between the Shape of the Lateral Meniscus and the Risk of Extrusion Based on MRI Examination of the Knee Joint	PLOS ONE			English	Article							CARTILAGE LOSS; ARTICULAR-CARTILAGE; MEDIAL MENISCUS; OSTEOARTHRITIS; CONTACT; DAMAGE; TEARS	Background Meniscus extrusion is a serious and relatively frequent clinical problem. For this reason the role of different risk factors for this pathology is still the subject of debate. The goal of this study was to verify the results of previous theoretical work, based on the mathematical models, regarding a relationship between the cross-section shape of the meniscus and the risk of its extrusion. Materials and Methods Knee MRI examination was performed in 77 subjects (43 men and 34 women), mean age 34.99 years (range: 18-49 years), complaining of knee pain. Patients with osteoarthritic changes (grade 3 and 4 to Kellgren classification), varus or valgus deformity and past injuries of the knee were excluded from the study. A 3-Tesla MR device was used to study the relationship between the shape of the lateral meniscus (using slope angle, meniscus-cartilage height and meniscus-bone angle) and the risk of extrusion. Results Analysis revealed that with values of slope angle and meniscus-bone angle increasing by one degree, the risk of meniscus extrusion raises by 1.157 and 1.078 respectively. Also, an increase in meniscus-cartilage height by 1 mm significantly elevates the risk of extrusion. At the same time it was demonstrated that for meniscus-bone angle values over 42 degrees and slope angle over 37 degrees the risk of extrusion increases significantly. Conclusions This was the first study to demonstrate a tight correlation between slope angle, meniscusbone angle and meniscus-cartilage height values in the assessment of the risk of lateral meniscus extrusion. Insertion of the above parameters to the radiological assessment of the knee joint allows identification of patients characterized by an elevated risk of development of this pathology.	[Szarmach, Arkadiusz; Skotarczak, Monika; Szurowska, Edyta] Med Univ Gdansk, Dept Radiol 2, Gdansk, Poland; [Luczkiewicz, Piotr; Baczkowski, Boguslaw] Med Univ Gdansk, Clin Orthopaed & Kinet Organ Traumatol 2, Gdansk, Poland; [Kaszubowski, Mariusz] Gdansk Univ Technol, Fac Econ & Management, Dept Econ Sci, Gdansk, Poland; [Winklewski, Pawel J.] Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland; [Dzierzanowski, Jaroslaw] Med Univ Gdansk, Dept Neurosurg, Gdansk, Poland; [Piskunowicz, Maciej] Med Univ Gdansk, Dept Radiol 1, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Winklewski, PJ (corresponding author), Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland.	pawelwinklewski@wp.pl	Luczkiewicz, Piotr/AAC-2970-2020	Luczkiewicz, Piotr/0000-0001-8988-1251; Piskunowicz, Maciej/0000-0002-3154-5463; Szarmach, Arkadiusz/0000-0003-3118-014X; Szurowska, Edyta/0000-0002-7042-4381; Winklewski, Pawel/0000-0002-1671-2163	Medical University of Gdansk	Medical University of Gdansk(Medical University Gdansk)	AS received funding from Medical University of Gdansk. The other authors received no specific funding for this work.	[Anonymous], PRACTICAL RELIABILIT; Arno S, 2012, KNEE, V19, P896, DOI 10.1016/j.knee.2012.04.005; Basu B, 2009, CERAM INT, V35, P237, DOI 10.1016/j.ceramint.2007.10.003; Bloecker K, 2015, ARTHRIT CARE RES, V67, P1545, DOI 10.1002/acr.22615; Chan WP, 2008, SKELETAL RADIOL, V37, P917, DOI 10.1007/s00256-008-0530-8; Costa CR, 2004, AM J ROENTGENOL, V183, P17, DOI 10.2214/ajr.183.1.1830017; Englund M, 2007, ARTHRITIS RHEUM, V56, P4048, DOI 10.1002/art.23071; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Gale DR, 1999, OSTEOARTHR CARTILAGE, V7, P526, DOI 10.1053/joca.1999.0256; Hudek R, 2011, CLIN ORTHOP RELAT R, V469, P2377, DOI 10.1007/s11999-011-1802-5; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P2488, DOI 10.1002/art.22016; Hwang SH, 2012, OSTEOARTHR CARTILAGE, V20, P110, DOI 10.1016/j.joca.2011.11.005; Jang SH, 2011, ARTHROSCOPY, V27, DOI 10.1016/j.arthro.2011.02.017; Khan N, 2014, SKELETAL RADIOL, V43, P955, DOI 10.1007/s00256-014-1867-9; Lee BS, 2015, ARTHROSCOPY, V31, P699, DOI 10.1016/j.arthro.2014.10.016; Lee DH, 2011, KNEE SURG SPORT TR A, V19, P222, DOI 10.1007/s00167-010-1274-2; Luczkiewicz P, 2015, J BIOMECH, V48, P1356, DOI 10.1016/j.jbiomech.2015.03.002; Nakamura N, 2006, MAGNETIC RESONANCE I, V24, P1143; Pollard ME, 1995, ARTHROSCOPY, V11, P684, DOI 10.1016/0749-8063(95)90110-8; Raynauld JP, 2006, ARTHRITIS RES THER, V8, P21; Rennie WJ, 2006, AM J ROENTGENOL, V186, P791, DOI 10.2214/AJR.04.1181; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Sharma L, 2008, ARTHRITIS RHEUM-US, V58, P1716, DOI 10.1002/art.23462; Sturnick DR, 2014, J ORTHOP RES, V32, P1487, DOI 10.1002/jor.22702; Sugita T, 2001, CLIN ORTHOP RELAT R, P171; Wenger A, 2013, ARTHRITIS RHEUM-US, V65, P1804, DOI 10.1002/art.37947; Wenger A, 2012, EUR RADIOL, V22, P211, DOI 10.1007/s00330-011-2234-z	27	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159156	10.1371/journal.pone.0159156	http://dx.doi.org/10.1371/journal.pone.0159156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415422	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500092
J	Daskalaki, E; Diem, P; Mougiakakou, SG				Daskalaki, Elena; Diem, Peter; Mougiakakou, Stavroula G.			Model-Free Machine Learning in Biomedicine: Feasibility Study in Type 1 Diabetes	PLOS ONE			English	Article							ARTIFICIAL PANCREAS SYSTEMS; ACTOR-CRITIC ALGORITHMS; CLOSED-LOOP CONTROL; RANDOMIZED CROSSOVER; GLUCOSE REGULATION; ADULTS; CHALLENGES; PREDICTION	Although reinforcement learning (RL) is suitable for highly uncertain systems, the applicability of this class of algorithms to medical treatment may be limited by the patient variability which dictates individualised tuning for their usually multiple algorithmic parameters. This study explores the feasibility of RL in the framework of artificial pancreas development for type 1 diabetes (T1D). In this approach, an Actor-Critic (AC) learning algorithm is designed and developed for the optimisation of insulin infusion for personalised glucose regulation. AC optimises the daily basal insulin rate and insulin: carbohydrate ratio for each patient, on the basis of his/her measured glucose profile. Automatic, personalised tuning of AC is based on the estimation of information transfer (IT) from insulin to glucose signals. Insulin-to-glucose IT is linked to patient-specific characteristics related to total daily insulin needs and insulin sensitivity (SI). The AC algorithm is evaluated using an FDA-accepted T1D simulator on a large patient database under a complex meal protocol, meal uncertainty and diurnal SI variation. The results showed that 95.66% of time was spent in normoglycaemia in the presence of meal uncertainty and 93.02% when meal uncertainty and SI variation were simultaneously considered. The time spent in hypoglycaemia was 0.27% in both cases. The novel tuning method reduced the risk of severe hypoglycaemia, especially in patients with low SI.	[Daskalaki, Elena; Mougiakakou, Stavroula G.] Univ Bern, ARTORG Ctr Biomed Engn Res, Diabet Technol Res Grp, Murtenstr 50, CH-3008 Bern, Switzerland; [Diem, Peter; Mougiakakou, Stavroula G.] Bern Univ Hosp Inselspital, Div Endocrinol Diabet & Clin Nutr, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Mougiakakou, SG (corresponding author), Univ Bern, ARTORG Ctr Biomed Engn Res, Diabet Technol Res Grp, Murtenstr 50, CH-3008 Bern, Switzerland.; Mougiakakou, SG (corresponding author), Bern Univ Hosp Inselspital, Div Endocrinol Diabet & Clin Nutr, CH-3010 Bern, Switzerland.	stavroula.mougiakakou@artorg.unibe.ch	Diem, Peter/A-7650-2008	Diem, Peter/0000-0002-1190-9880				Agianniotis Aristotelis, 2015, J Diabetes Sci Technol, V9, P549, DOI 10.1177/1932296815583333; [Anonymous], 1996, NEURO DYNAMIC PROGRA; Bequette BW, 2012, ANNU REV CONTROL, V36, P255, DOI 10.1016/j.arcontrol.2012.09.007; Bhatnagar S, 2009, AUTOMATICA, V45, P2471, DOI 10.1016/j.automatica.2009.07.008; Bothe MK, 2013, EXPERT REV MED DEVIC, V10, P661, DOI 10.1586/17434440.2013.827515; Butte A. J., 2000, PAC S BIOCOMPUT, P418, DOI [DOI 10.1142/9789814447331_, DOI 10.1142/9789814447331_0040]; Byrd RJ, 2014, INT J MED INFORM, V83, P983, DOI 10.1016/j.ijmedinf.2012.12.005; Cameron F, 2012, J PROCESS CONTR, V22, P1422, DOI 10.1016/j.jprocont.2012.05.014; Cameron Fraser, 2011, J Diabetes Sci Technol, V5, P368; Das S, 2013, IEEE T POWER SYST, V28, P669, DOI 10.1109/TPWRS.2012.2207466; Daskalaki E, 2013, P 35 IEEE ENG MED BI; Daskalaki E, 2013, COMPUT METH PROG BIO, V109, P116, DOI 10.1016/j.cmpb.2012.03.002; Daskalaki E, 2012, DIABETES TECHNOL THE, V14, P168, DOI 10.1089/dia.2011.0093; Dauber A, 2013, DIABETES CARE, V36, P222, DOI 10.2337/dc12-1079; De Paula M, 2015, EXPERT SYST APPL, V42, P2234, DOI 10.1016/j.eswa.2014.10.038; Donsa K, INSMART HLTH 2015, P237; Doyle FJ, 2014, DIABETES CARE, V37, P1191, DOI 10.2337/dc13-2108; Dyrba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064925; Elleri D, 2013, DIABETES CARE, V36, P838, DOI 10.2337/dc12-0816; Greensmith E, 2004, J MACH LEARN RES, V5, P1471; Grondman I, 2012, IEEE T SYST MAN CY C, V42, P1291, DOI 10.1109/TSMCC.2012.2218595; Hu L, 2014, MED PHYS, V41, P276; Jacobs PG, 2014, IEEE T BIO-MED ENG, V61, P2569, DOI 10.1109/TBME.2014.2323248; Kober J, 2013, INT J ROBOT RES, V32, P1238, DOI 10.1177/0278364913495721; Konda VR, 2003, SIAM J CONTROL OPTIM, V42, P1143, DOI 10.1137/S0363012901385691; Kovatchev BP, 2014, DIABETES CARE, V37, P1789, DOI 10.2337/dc13-2076; Kovatchev Boris P, 2009, J Diabetes Sci Technol, V3, P44; Kovatchev BP, 1998, DIABETES CARE, V21, P1870, DOI 10.2337/diacare.21.11.1870; Kudva YC, 2014, DIABETES CARE, V37, P1184, DOI 10.2337/dc13-2066; Lee Hyunjin, 2009, J Diabetes Sci Technol, V3, P1082; Lee JM, 2004, KOREAN J CHEM ENG, V21, P338, DOI 10.1007/BF02705417; Luijf YM, 2013, DIABETES CARE, V36, P3882, DOI 10.2337/dc12-1956; Marbach P, 2001, IEEE T AUTOMAT CONTR, V46, P191, DOI 10.1109/9.905687; Messori M., 2014, PROC 19 WORLD CONG I; Miller S, 2011, DIABETES TECHNOL THE, V13, P983, DOI 10.1089/dia.2010.0216; Modayil J, 2014, ADAPT BEHAV, V22, P146, DOI 10.1177/1059712313511648; Moore BL, 2014, J MACH LEARN RES, V15, P655; Nimri R, 2014, PEDIATR DIABETES, V15, P91, DOI 10.1111/pedi.12071; Patek Stephen D, 2009, J Diabetes Sci Technol, V3, P269; Rana R, 2015, EXPERT SYST APPL, V42, P426, DOI 10.1016/j.eswa.2014.07.007; Reddy M, 2014, DIABETES TECHNOL THE, V16, P550, DOI 10.1089/dia.2014.0009; Rosenstein M.T., 2004, SUPERVISED ACTOR CRI, P359; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Schiavon M, 2014, DIABETES CARE, V37, P1216, DOI 10.2337/dc13-1120; Shortreed SM, 2011, MACH LEARN, V84, P109, DOI 10.1007/s10994-010-5229-0; Song R, 2015, STAT, V4, P59, DOI 10.1002/sta4.78; Soru P, 2012, ANNU REV CONTROL, V36, P118, DOI 10.1016/j.arcontrol.2012.03.009; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1007/BF00115009; Szepesv?ri, 2010, SYNTHESIS LECT ARTIF, V4, DOI [10.2200/S00268ED1V01Y201005AIM009, DOI 10.2200/S00268ED1V01Y201005AIM009]; Thabit H, 2014, LANCET DIABETES ENDO, V2, P701, DOI 10.1016/S2213-8587(14)70114-7; Tsitsiklis JN, 1997, IEEE T AUTOMAT CONTR, V42, P674, DOI 10.1109/9.580874; Turksoy K, 2014, J HEALTHC ENG, V5, P1, DOI 10.1260/2040-2295.5.1.1; Walsh John, 2010, J Diabetes Sci Technol, V4, P1174; Williams P. L., 2011, ARXIV11021507; Zakim D, 2015, TRENDS PHARMACOL SCI, V36, P68, DOI 10.1016/j.tips.2014.11.002	57	26	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158722	10.1371/journal.pone.0158722	http://dx.doi.org/10.1371/journal.pone.0158722			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441367	gold, Green Published, Green Submitted			2022-12-27	WOS:000380797500021
J	Rhodes, D; Di Luca, M				Rhodes, Darren; Di Luca, Massimiliano			Temporal Regularity of the Environment Drives Time Perception	PLOS ONE			English	Article							WORKING-MEMORY; INTERNAL CLOCK; NEURAL-NETWORK; JUDGED LONGER; INTERVAL; MODEL; DISCRIMINATION; REPRESENTATION; BEAT; OSCILLATIONS	It's reasonable to assume that a regularly paced sequence should be perceived as regular, but here we show that perceived regularity depends on the context in which the sequence is embedded. We presented one group of participants with perceptually regularly paced sequences, and another group of participants with mostly irregularly paced sequences (75% irregular, 25% regular). The timing of the final stimulus in each sequence could be varied. In one experiment, we asked whether the last stimulus was regular or not. We found that participants exposed to an irregular environment frequently reported perfectly regularly paced stimuli to be irregular. In a second experiment, we asked participants to judge whether the final stimulus was presented before or after a flash. In this way, we were able to determine distortions in temporal perception as changes in the timing necessary for the sound and the flash to be perceived synchronous. We found that within a regular context, the perceived timing of deviant last stimuli changed so that the relative anisochrony appeared to be perceptually decreased. In the irregular context, the perceived timing of irregular stimuli following a regular sequence was not affected. These observations suggest that humans use temporal expectations to evaluate the regularity of sequences and that expectations are combined with sensory stimuli to adapt perceived timing to follow the statistics of the environment. Expectations can be seen as a-priori probabilities on which perceived timing of stimuli depend.	[Rhodes, Darren; Di Luca, Massimiliano] Univ Birmingham, Sch Psychol, Ctr Computat Neurosci & Cognit Robot, Birmingham, W Midlands, England; [Rhodes, Darren] Univ Sussex, Sch Engn & Informat, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England	University of Birmingham; University of Sussex	Di Luca, M (corresponding author), Univ Birmingham, Sch Psychol, Ctr Computat Neurosci & Cognit Robot, Birmingham, W Midlands, England.	m.diluca@bham.ac.uk	Di Luca, Massimiliano/A-7850-2012	Di Luca, Massimiliano/0000-0003-3085-7251; Rhodes, Darren/0000-0001-5859-4567	Marie Curie Grant [CIG 304235]	Marie Curie Grant(European Commission)	MDL and DR were supported by a Marie Curie Grant: CIG 304235 'TICS'. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ninja Katja Horr for comments on a previous version of the manuscript. This research was funded by Marie Curie CIG 304235 'TICS' for DR and MDL.	Acerbi L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002771; BADDELEY A, 1992, J COGNITIVE NEUROSCI, V4, P281, DOI 10.1162/jocn.1992.4.3.281; Barlow H. B., 1961, CURRENT PROBLEMS ANI, P330; Bateson M, 1997, ANIM BEHAV, V53, P1129, DOI 10.1006/anbe.1996.0388; Brady TF, 2009, J EXP PSYCHOL GEN, V138, P487, DOI 10.1037/a0016797; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brochard R, 2013, COGNITION, V127, P214, DOI 10.1016/j.cognition.2013.01.007; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buhusi CV, 2002, J COMP PSYCHOL, V116, P381, DOI 10.1037//0735-7036.116.4.381; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Chopin A, 2012, CURR BIOL, V22, P622, DOI 10.1016/j.cub.2012.02.021; Cicchini GM, 2012, J NEUROSCI, V32, P1056, DOI 10.1523/JNEUROSCI.3411-11.2012; Correa A, 2005, PSYCHON B REV, V12, P328, DOI 10.3758/BF03196380; Cravo AM, 2013, J NEUROSCI, V33, P4002, DOI 10.1523/JNEUROSCI.4675-12.2013; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; Dyjas O, 2014, Q J EXP PSYCHOL, V67, P1121, DOI 10.1080/17470218.2013.847968; Elliott MT, 2014, P ROY SOC LOND B BIO, V281; Escoffier N, 2010, ACTA PSYCHOL, V135, P12, DOI 10.1016/j.actpsy.2010.04.005; Estes KG, 2007, PSYCHOL SCI, V18, P254, DOI 10.1111/j.1467-9280.2007.01885.x; Freestone DM, 2016, CURR OPIN BEHAV SCI, V8, P276, DOI 10.1016/j.cobeha.2016.02.031; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gallistel CR, 2004, J EXP PSYCHOL ANIM B, V30, P3, DOI 10.1037/0097-7403.30.1.3; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; GOLDSTON.S, 1974, PERCEPT MOTOR SKILL, V39, P63, DOI 10.2466/pms.1974.39.1.63; Grahn JA, 2013, CEREB CORTEX, V23, P913, DOI 10.1093/cercor/bhs083; Greville WJ, 2010, J EXP PSYCHOL GEN, V139, P756, DOI 10.1037/a0020976; Gribova A, 2002, EXP BRAIN RES, V146, P322, DOI 10.1007/s00221-002-1174-x; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; HELSON H, 1947, AM J PSYCHOL, V60, P1, DOI 10.2307/1417326; Helson H, 1964, ADAPTATION LEVEL THE; Henderson J, 2006, CURR BIOL, V16, P512, DOI 10.1016/j.cub.2006.01.054; Honing H, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P369, DOI 10.1016/B978-0-12-381460-9.00009-2; Horr NK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00114; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Jazayeri M, 2015, CURR BIOL, V25, P2599, DOI 10.1016/j.cub.2015.08.038; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Kersten D, 2003, CURR OPIN NEUROBIOL, V13, P150, DOI 10.1016/S0959-4388(03)00042-4; Knill DC, 1996, PERCEPTION BAYESIAN; Kosem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040936; Kusnir F, 2011, CONSCIOUS COGN, V20, P1201, DOI 10.1016/j.concog.2011.01.012; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Li MS., 2016, TIMING TIME PERCEPT, V4, P123, DOI [10.1163/22134468-00002057, DOI 10.1163/22134468-00002057]; Mamassian P, 2002, NEU INF PRO, P13; Manning F, 2013, PSYCHON B REV, V20, P1133, DOI 10.3758/s13423-013-0439-7; McNeill W. H., 1995, KEEPING TOGETHER TIM; Meck WH, 2005, BRAIN COGNITION, V58, P1, DOI 10.1016/j.bandc.2004.09.004; Merchant H, 2015, PHIL T R SOC LOND B, V370; Merker BH, 2009, CORTEX, V45, P4, DOI 10.1016/j.cortex.2008.06.011; Miall C, 1989, NEURAL COMPUT, V1, P359, DOI 10.1162/neco.1989.1.3.359; Miller J, 2001, PERCEPT PSYCHOPHYS, V63, P1399, DOI 10.3758/BF03194551; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petzschner FH, 2015, TRENDS COGN SCI, V19, P285, DOI 10.1016/j.tics.2015.03.002; Petzschner FH, 2011, J NEUROSCI, V31, P17220, DOI 10.1523/JNEUROSCI.2028-11.2011; POVEL DJ, 1984, PSYCHOL RES-PSYCH FO, V45, P315, DOI 10.1007/BF00309709; POVEL DJ, 1981, J EXP PSYCHOL HUMAN, V7, P3, DOI 10.1037/0096-1523.7.1.3; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Rohenkohl G, 2014, J VISION, V14, DOI 10.1167/14.4.8; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; SCHIFFMAN HR, 1977, AM J PSYCHOL, V90, P85, DOI 10.2307/1421643; SCHULZE HH, 1989, PERCEPT PSYCHOPHYS, V45, P291, DOI 10.3758/BF03204943; Shi ZH, 2016, CURR OPIN BEHAV SCI, V8, P200, DOI [10.1016/j.cobeha.2016.02.014, 10.1163/9789004307339_002]; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Sternberg S., 1973, ATTENTION PERFORM, VIV, P629; Sternberg S, 1971, PRIOR ENTRY REEXAMIN; Su YH, 2012, PSYCHOL RES-PSYCH FO, V76, P373, DOI 10.1007/s00426-011-0346-3; Teki S, 2011, FRONTIERS INTEGRATIV, P5; Ten Hoopen G, 2011, ATTEN PERCEPT PSYCHO, V73, P2249, DOI 10.3758/s13414-011-0171-1; TENHOOPEN G, 1995, PERCEPTION, V24, P577, DOI 10.1068/p240577; THOMAS EAC, 1974, PERCEPT PSYCHOPHYS, V16, P449, DOI 10.3758/BF03198571; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Turk-Browne NB, 2010, J NEUROSCI, V30, P11177, DOI 10.1523/JNEUROSCI.0858-10.2010; Umemoto A, 2010, J EXP PSYCHOL HUMAN, V36, P1419, DOI 10.1037/a0019324; Van der Burg E, 2013, J NEUROSCI, V33, P14633, DOI 10.1523/JNEUROSCI.1182-13.2013; van Rijn H, 2014, ADV EXP MED BIOL, V829, P75, DOI 10.1007/978-1-4939-1782-2_5; VanRullen R., 2011, FRONT PSYCHOL, V2, P1, DOI DOI 10.3389/FPSYG.2011.00365; Wackermann J, 2006, J THEOR BIOL, V239, P482, DOI 10.1016/j.jtbi.2005.08.024; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wearden JH, 2006, Q J EXP PSYCHOL, V59, P1709, DOI 10.1080/17470210500314729; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; Wearden JH, 2007, J EXP PSYCHOL HUMAN, V33, P716, DOI 10.1037/0096-1523.33.3.716; Wei XX, 2015, NAT NEUROSCI, V18, P1509, DOI 10.1038/nn.4105; Wei XX, 2012, EFFICIENT CODING PRO, P1313; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Yamamoto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040379; Yarrow K, 2011, CONSCIOUS COGN, V20, P1518, DOI 10.1016/j.concog.2011.07.003	97	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159842	10.1371/journal.pone.0159842	http://dx.doi.org/10.1371/journal.pone.0159842			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS5CG	27441686	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000380797500145
J	Spinella, G; Britti, D; Loprete, G; Musella, V; Romagnoli, N; Vilar, JM; Valentini, S				Spinella, Giuseppe; Britti, Domenico; Loprete, Giovanni; Musella, Vincenzo; Romagnoli, Noemi; Vilar, Jose M.; Valentini, Simona			Relative Echogenicity of Tendons and Ligaments of the Palmar Metacarpal Region in Foals from Birth to 4 Months of Age: A Longitudinal Study	PLOS ONE			English	Article							DIGITAL FLEXOR TENDONS; CROSS-SECTIONAL AREA; ULTRASONOGRAPHIC TISSUE CHARACTERIZATION; MEAN ECHOGENICITY; EQUINE TENDONS; HORSES; ADULT; LEVEL; DOGS	The objective of this study was to evaluate relative echogenicity of superficial and deep digital flexor tendons, the accessory ligament of the deep digital flexor tendon and interosseous muscle of the metacarpal region in foals ages 1 week to 4 months; and assess the association between echogenicity and sex or side/laterality. Seven Standardbred trotter foals were examined. Right and left metacarpal regions (palmar surface) were ultrasonographically investigated, and four regions of interest were assessed. A significant increase in echogenicity was seen in superficial and deep digital flexor tendons, accessory ligament of deep digital flexor tendon, and interosseous muscle during growth from 1 week to 4 months of age. Echogenicity of examined tendons and ligaments was not influenced by gender nor laterality. Reference values for tendon and ligament echogenicity could function as a tool to discriminate between physiological and abnormal conditions such as congenital contractural conditions.	[Spinella, Giuseppe; Romagnoli, Noemi; Valentini, Simona] Univ Bologna, Dept Vet Med Sci, Ozzano Dellemilia, BO, Italy; [Britti, Domenico; Loprete, Giovanni; Musella, Vincenzo] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Germaneto, CZ, Italy; [Vilar, Jose M.] Univ Palmas Gran Canaria, Fac Vet Med, Dept Anim Pathol, Trasmontana S-N, Arucas, Las Palmas, Spain	University of Bologna; Magna Graecia University of Catanzaro; Universidad de Las Palmas de Gran Canaria	Spinella, G (corresponding author), Univ Bologna, Dept Vet Med Sci, Ozzano Dellemilia, BO, Italy.	giuseppe.spinella@unibo.it	Vilar, José Manuel/AAA-7925-2019	Vilar, José Manuel/0000-0002-2060-2274; SPINELLA, GIUSEPPE/0000-0003-2346-0168; Musella, Vincenzo/0000-0002-4448-8832				Agut A, 2009, VET J, V180, P377, DOI 10.1016/j.tvjl.2008.01.012; Crevier-Denoix N, 1998, AM J VET RES, V59, P969; Dakin SG, 2011, EQUINE VET J, V43, P418, DOI 10.1111/j.2042-3306.2010.00303.x; Dowling BA, 2005, VET J, V170, P184, DOI 10.1016/j.tvjl.2004.03.021; Dyce K. M., 2010, TXB VET ANATOMY, P604; GILLIS C, 1995, AM J VET RES, V56, P1265; Gillis C, 1997, AM J VET RES, V58, P425; Micklethwaite L, 2001, AM J VET RES, V62, P1320, DOI 10.2460/ajvr.2001.62.1320; O'Grady SE, 2012, EQUINE VET EDUC, V24, P260, DOI 10.1111/j.2042-3292.2011.00375.x; Padilla NF, 2009, ULTRASOUND MED BIOL, V35, P1421, DOI 10.1016/j.ultrasmedbio.2009.04.014; Sande RD, 1998, EQUINE DIAGNOSTIC ULTRASONOGRAPHY, P103; Spinella G, 2015, RES VET SCI, V101, P11, DOI 10.1016/j.rvsc.2015.05.011; Spinella G, 2013, VET COMP ORTHOPAED, V26, P366, DOI 10.3415/VCOT-12-11-0144; Spinella G, 2007, POINT VET, V38, P31; Trumble TN, 2005, VET CLIN N AM-EQUINE, V21, P357, DOI 10.1016/j.cveq.2005.04.008; Van Heel MC, 2006, EQUINE VET J, V38, P373; van Schie HTM, 2000, AM J VET RES, V61, P210, DOI 10.2460/ajvr.2000.61.210; van Schie HTM, 2003, AM J VET RES, V64, P366, DOI 10.2460/ajvr.2003.64.366; van Schie JTM, 1999, VET RADIOL ULTRASOUN, V40, P151, DOI 10.1111/j.1740-8261.1999.tb01901.x; Vergari C, 2012, ULTRASOUND MED BIOL, V38, P162, DOI 10.1016/j.ultrasmedbio.2011.10.008; Vilar JM, 2011, EQUINE VET J, V43, P235, DOI 10.1111/j.2042-3306.2010.00141.x; WILSON DA, 1991, AM J VET RES, V52, P133	22	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159953	10.1371/journal.pone.0159953	http://dx.doi.org/10.1371/journal.pone.0159953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441630	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500155
J	Burrell, M; Henderson, SJ; Ravnefjord, A; Schweikart, F; Fowler, SB; Witt, S; Hansson, KM; Webster, CI				Burrell, Matthew; Henderson, Simon J.; Ravnefjord, Anna; Schweikart, Fritz; Fowler, Susan B.; Witt, Susanne; Hansson, Kenny M.; Webster, Carl I.			Neprilysin Inhibits Coagulation through Proteolytic Inactivation of Fibrinogen	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; APP TRANSGENIC MICE; ALZHEIMERS-DISEASE; HEART-FAILURE; GENE-TRANSFER; BETA; THROMBIN; BINDING; PHOSPHORAMIDON; SPECIFICITY	Neprilysin (NEP) is an endogenous protease that degrades a wide range of peptides including amyloid beta (A beta), the main pathological component of Alzheimer's disease (AD). We have engineered NEP as a potential therapeutic for AD but found in pre-clinical safety testing that this variant increased prothrombin time (PT) and activated partial thromboplastin time (APTT). The objective of the current study was to investigate the effect of wild type NEP and the engineered variant on coagulation and define the mechanism by which this effect is mediated. PT and APTT were measured in cynomolgus monkeys and rats dosed with a human serum albumin fusion with an engineered variant of NEP (HSA-NEPv) as well as in control plasma spiked with wild type or variant enzyme. The coagulation factor targeted by NEP was determined using in vitro prothrombinase, calibrated automated thrombogram (CAT) and fibrin formation assays as well as N-terminal sequencing of fibrinogen treated with the enzyme. We demonstrate that HSA-NEP wild type and HSA-NEPv unexpectedly impaired coagulation, increasing PT and APTT in plasma samples and abolishing fibrin formation from fibrinogen. This effect was mediated through cleavage of the N-termini of the A alpha- and B beta-chains of fibrinogen thereby significantly impairing initiation of fibrin formation by thrombin. Fibrinogen has therefore been identified for the first time as a substrate for NEP wild type suggesting that the enzyme may have a role in regulating fibrin formation. Reductions in NEP levels observed in AD and cerebral amyloid angiopathy may contribute to neurovascular degeneration observed in these conditions.	[Burrell, Matthew; Fowler, Susan B.; Witt, Susanne; Webster, Carl I.] MedImmune, Antibody Discovery & Prot Engn, Milstein Bldg,Granta Pk, Cambridge, England; [Henderson, Simon J.] MedImmune, Biol Safety Assessment, Aaron Klug Bldg,Granta Pk, Cambridge, England; [Ravnefjord, Anna; Hansson, Kenny M.] AstraZeneca R&D, Cardiovasc & Metab Dis iMed, SE-43183 Molndal, Sweden; [Schweikart, Fritz] AstraZeneca R&D, Pharmaceut Dev, SE-43183 Molndal, Sweden	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; AstraZeneca	Webster, CI (corresponding author), MedImmune, Antibody Discovery & Prot Engn, Milstein Bldg,Granta Pk, Cambridge, England.	websterc@medimmune.com	Schweikart, Fritz/M-6486-2019; Schweikart, Fritz/O-4560-2019	Schweikart, Fritz/0000-0002-2201-7896	MedImmune; AstraZeneca	MedImmune(AstraZenecaMedimmune); AstraZeneca(AstraZeneca)	All work was funded by MedImmune and AstraZeneca. The funders provided support in the form of salaries for authors MB, SH, AR, FS, SBF, SW, KMH, and CIW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; BALE MD, 1985, P NATL ACAD SCI USA, V82, P1410, DOI 10.1073/pnas.82.5.1410; Bowley SR, 2009, BLOOD, V113, P4425, DOI 10.1182/blood-2008-09-178178; Carpentier M, 2002, J NEUROPATH EXP NEUR, V61, P849, DOI 10.1093/jnen/61.10.849; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Galli A, 2014, NEW ENGL J MED, V371, P2335, DOI 10.1056/NEJMc1412654; Geer CB, 2007, J THROMB HAEMOST, V5, P2344, DOI 10.1111/j.1538-7836.2007.02774.x; Goodman OB, 2006, J BIOL CHEM, V281, P33597, DOI 10.1074/jbc.M602490200; Hardy J, 2007, NEUROCHEM RES, V32, P833, DOI 10.1007/s11064-006-9221-9; Henderson SJ, 2014, BRAIN, V137, P553, DOI 10.1093/brain/awt308; Hultman K, 2013, J CEREBR BLOOD F MET, V33, P1251, DOI 10.1038/jcbfm.2013.76; Klohs J, 2012, J NEUROSCI, V32, P1705, DOI 10.1523/JNEUROSCI.5626-11.2012; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Marr RA, 2003, J NEUROSCI, V23, P1992; MARSH HC, 1982, BIOCHEMISTRY-US, V21, P6167, DOI 10.1021/bi00267a022; Marsh Jr HC, 1983, BIOCHEMISTRY-US, P22; MATSAS R, 1984, BIOCHEM J, V223, P433, DOI 10.1042/bj2230433; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Miners JS, 2006, J NEUROPATH EXP NEUR, V65, P1012, DOI 10.1097/01.jnen.0000240463.87886.9a; Miners JS, 2011, BRAIN PATHOL, V21, P594, DOI 10.1111/j.1750-3639.2011.00486.x; Morisaki N, 2010, J BIOL CHEM, V285, P39819, DOI 10.1074/jbc.M110.161547; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; Takaki Y, 2000, J BIOCHEM-TOKYO, V128, P897, DOI 10.1093/oxfordjournals.jbchem.a022839; Tsiang M, 1996, BIOCHEMISTRY-US, V35, P16449, DOI 10.1021/bi9616108; Webster CI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104001; WEISEL JW, 1986, BIOPHYS J, V50, P1079, DOI 10.1016/S0006-3495(86)83552-4; Yang Z, 2001, BIOCHEMISTRY-US, V40, P12515, DOI 10.1021/bi011394p; Zamolodchikov D, 2012, BLOOD, V119, P3342, DOI 10.1182/blood-2011-11-389668	34	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158114	10.1371/journal.pone.0158114	http://dx.doi.org/10.1371/journal.pone.0158114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437944	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100006
J	Dan, S; Yuan, Y; Wang, YS; Chen, C; Gao, CX; Yu, S; Liu, Y; Song, W; Asan; Zhu, HM; Yang, L; Deng, HM; Su, Y; Yi, X				Dan, Shan; Yuan, Yuan; Wang, Yaoshen; Chen, Chao; Gao, Changxin; Yu, Song; Liu, Yan; Song, Wei; Asan; Zhu, Hongmei; Yang, Ling; Deng, Hongmei; Su, Yue; Yi, Xin			Non-Invasive Prenatal Diagnosis of Lethal Skeletal Dysplasia by Targeted Capture Sequencing of Maternal Plasma	PLOS ONE			English	Article							RARE MUTATIONS; DNA; ACHONDROPLASIA; ACCURATE	Background Since the discovery of cell-free foetal DNA in the plasma of pregnant women, many non-invasive prenatal testing assays have been developed. In the area of skeletal dysplasia diagnosis, some PCR-based non-invasive prenatal testing assays have been developed to facilitate the ultrasound diagnosis of skeletal dysplasias that are caused by de novo mutations. However, skeletal dysplasias are a group of heterogeneous genetic diseases, the PCR-based method is hard to detect multiple gene or loci simultaneously, and the diagnosis rate is highly dependent on the accuracy of the ultrasound diagnosis. In this study, we investigated the feasibility of using targeted capture sequencing to detect foetal de novo pathogenic mutations responsible for skeletal dysplasia. Methodology/Principal Findings Three families whose foetuses were affected by skeletal dysplasia and two control families whose foetuses were affected by other single gene diseases were included in this study. Sixteen genes related to some common lethal skeletal dysplasias were selected for analysis, and probes were designed to capture the coding regions of these genes. Targeted capture sequencing was performed on the maternal plasma DNA, the maternal genomic DNA, and the paternal genomic DNA. The de novo pathogenic variants in the plasma DNA data were identified using a bioinformatical process developed for low frequency mutation detection and a strict variant interpretation strategy. The causal variants could be specifically identified in the plasma, and the results were identical to those obtained by sequencing amniotic fluid samples. Furthermore, a mean of 97% foetal specific alleles, which are alleles that are not shared by maternal genomic DNA and amniotic fluid DNA, were identified successfully in plasma samples. Conclusions/Significance Our study shows that capture sequencing of maternal plasma DNA can be used to non-invasive detection of de novo pathogenic variants. This method has the potential to be used to facilitate the prenatal diagnosis of skeletal dysplasia.	[Dan, Shan; Yu, Song; Liu, Yan; Song, Wei; Deng, Hongmei; Su, Yue] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Perinatal Med, Beijing, Peoples R China; [Yuan, Yuan; Wang, Yaoshen; Chen, Chao; Gao, Changxin; Asan; Zhu, Hongmei; Yang, Ling; Yi, Xin] BGI Shenzhen, BGI Tianjin, Binhai Genom Inst, Tianjin, Peoples R China; [Yuan, Yuan; Wang, Yaoshen; Chen, Chao; Gao, Changxin; Asan; Zhu, Hongmei; Yang, Ling; Yi, Xin] BGI Shenzhen, BGI Tianjin, Tianjin Translat Genom Ctr, Tianjin, Peoples R China; [Yuan, Yuan; Wang, Yaoshen; Chen, Chao; Gao, Changxin; Asan; Zhu, Hongmei; Yang, Ling; Yi, Xin] BGI Shenzhen, Shenzhen, Peoples R China; [Yi, Xin] BGI Shenzhen, BGI Guangzhou, Guangzhou Key Lab Canc Trans Omics Res GZ2012, NO348, Guangzhou, Peoples R China	Capital Medical University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI)	Dan, S; Su, Y (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Perinatal Med, Beijing, Peoples R China.	sd_bao@sina.com; yusong_bogh@sina.com		Wang, Yaoshen/0000-0003-2034-3855	Tianjin Municipal Science and Technology Special Funds for Enterprise Development [14ZXLJSY00320]; Capital Public Health Project [Z131100004013022]	Tianjin Municipal Science and Technology Special Funds for Enterprise Development; Capital Public Health Project	This work was supported by Tianjin Municipal Science and Technology Special Funds for Enterprise Development (NO. 14ZXLJSY00320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was also supported by the Capital Public Health Project(NO. Z131100004013022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Bartsch O, 2010, AM J MED GENET A, V152A, P181, DOI 10.1002/ajmg.a.33153; broadinstitute, PIC; Chen CP, 2013, TAIWAN J OBSTET GYNE, V52, P580, DOI 10.1016/j.tjog.2013.10.023; Chen SP, 2013, GENOME MED, V5, DOI 10.1186/gm422; Chen SP, 2013, PRENATAL DIAG, V33, P584, DOI 10.1002/pd.4110; Chitty LS, 2013, PRENATAL DIAG, V33, P416, DOI 10.1002/pd.4066; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Goncalves LF, 2004, ULTRASOUND OBST GYN, V24, P115, DOI 10.1002/uog.1712; Jiang FM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-57; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Lau TK, 2012, J MATERN-FETAL NEO M, V25, P1370, DOI 10.3109/14767058.2011.635730; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2004, PRENATAL DIAG, V24, P896, DOI 10.1002/pd.1030; Lim JH, 2011, J ASSIST REPROD GEN, V28, P167, DOI 10.1007/s10815-010-9489-1; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Ma DY, 2014, GENE, V544, P252, DOI 10.1016/j.gene.2014.04.055; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Noel AE, 2014, INT J WOMENS HEALTH, V6, P489, DOI 10.2147/IJWH.S47073; ROSE NJ, 1994, HUM GENET, V94, P497, DOI 10.1007/BF00211014; Saito H, 2000, LANCET, V356, P1170, DOI 10.1016/S0140-6736(00)02767-7; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; You YQ, 2014, GENET MED, V16, P594, DOI 10.1038/gim.2013.197	27	11	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159355	10.1371/journal.pone.0159355	http://dx.doi.org/10.1371/journal.pone.0159355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433940	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600050
J	Kreinest, M; Reisig, G; Strobel, P; Dinter, D; Attenberger, U; Lipp, P; Schwarz, M				Kreinest, Michael; Reisig, Gregor; Stroebel, Philipp; Dinter, Dietmar; Attenberger, Ulrike; Lipp, Peter; Schwarz, Markus			A Porcine Animal Model for Early Meniscal Degeneration - Analysis of Histology, Gene Expression and Magnetic Resonance Imaging Six Months after Resection of the Anterior Cruciate Ligament	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; CANINE MENISCUS; MESSENGER-RNA; KNEE-JOINT; COLLAGEN; OSTEOARTHRITIS; CHONDROCYTES; PROFILES; STIMULATION; ARTHROSCOPY	Background/Objective The menisci of the mammalian knee joint balance the incongruence between femoral condyle and tibial plateau and thus menisci absorb and distribute high loads. Degeneration processes of the menisci lead to pain syndromes in the knee joint. The origin of such degenerative processes on meniscal tissue is rarely understood and may be described best as an imbalance of anabolic and catabolic metabolism. A standardized animal model of meniscal degeneration is needed for further studies. The aim of the current study was to develop a porcine animal model with early meniscal degeneration. Material and Methods Resection of the anterior cruciate ligament (ACLR) was performed on the left knee joints of eight Gottingen minipigs. A sham operation was carried out on the right knee joint. The grade of degeneration was determined 26 weeks after the operation using histology and magnetic resonance imaging (MRI). Furthermore, the expression of 14 genes which code for extracellular matrix proteins, catabolic matrix metalloproteinases and inflammation mediators were analyzed. Results Degenerative changes were detected by a histological analysis of the medial meniscus after ACLR. These changes were not detected by MRI. In terms of their gene expression profile, these degenerated medial menisci showed a significantly increased expression of COL1A1. Conclusion This paper describes a new animal model for early secondary meniscal degeneration in the Gottingen minipig. Histopathological evidence of the degenerative changes could be described. This early degenerative changes could not be seen by NMR imaging.	[Kreinest, Michael; Reisig, Gregor; Schwarz, Markus] Heidelberg Univ, Med Fac Mannheim, Dept Expt Orthoped & Trauma Surg, Mannheim, Germany; [Stroebel, Philipp] Univ Med Ctr Gottingen, Dept Pathol, Gottingen, Germany; [Dinter, Dietmar; Attenberger, Ulrike] Heidelberg Univ, Med Fac Mannheim, Dept Radiol, Mannheim, Germany; [Kreinest, Michael; Lipp, Peter] Univ Saarland, Univ Med Ctr Homburg, Dept Mol Cell Biol, Homburg, Germany; [Kreinest, Michael] BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthoped Surg, Ludwigshafen, Germany	Ruprecht Karls University Heidelberg; University of Gottingen; Ruprecht Karls University Heidelberg; Saarland University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kreinest, M (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Expt Orthoped & Trauma Surg, Mannheim, Germany.; Kreinest, M (corresponding author), Univ Saarland, Univ Med Ctr Homburg, Dept Mol Cell Biol, Homburg, Germany.; Kreinest, M (corresponding author), BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthoped Surg, Ludwigshafen, Germany.	michael.kreinest@bgu-ludwigshafen.de	Attenberger, Ulrike/HDN-2286-2022; Kreinest, Michael/ABI-7282-2020; Attenberger, Ulrike/ABD-8541-2020	Attenberger, Ulrike/0000-0002-8123-5447; Attenberger, Ulrike/0000-0002-8123-5447	Medical Faculty Mannheim, Heidelberg University	Medical Faculty Mannheim, Heidelberg University	The study was financially supported by Medical Faculty Mannheim, Heidelberg University. The funding was received by MK and MS.	Aigner T, 2006, EUR CELLS MATER, V12, P49, DOI 10.22203/eCM.v012a06; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; ASPDEN RM, 1985, J ANAT, V140, P371; Biau DJ, 2008, CLIN ORTHOP RELAT R, V466, P2282, DOI 10.1007/s11999-008-0346-9; Bollen P, 1997, PHARMACOL TOXICOL, V80, P3, DOI 10.1111/j.1600-0773.1997.tb01980.x; Bydder M, 2007, J MAGN RESON IMAGING, V25, P290, DOI 10.1002/jmri.20850; Cerejo R, 2002, ARTHRITIS RHEUM, V46, P2632, DOI 10.1002/art.10530; Curt A, 2012, LEITLINIEN DIAGNOSTI; Dankof A, 2006, VIRCHOWS ARCH, V449, P230, DOI 10.1007/s00428-006-0221-6; Fan ZY, 2005, ARTHRITIS RHEUM-US, V52, P136, DOI 10.1002/art.20725; FERRERROCA O, 1980, CLIN ORTHOP RELAT R, P289; FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19; Gotterbarm T, 2008, LAB ANIM-UK, V42, P71, DOI 10.1258/la.2007.06029e; Guehring T, 2005, SPINE, V30, P2510, DOI 10.1097/01.brs.0000186591.17114.e9; Guehring T, 2009, ARTHRITIS RHEUM-US, V60, P1026, DOI 10.1002/art.24407; HARING F, 1963, ZBL BAKT PARASIT, V189, P521; Hauger O, 2000, RADIOLOGY, V217, P193, DOI 10.1148/radiology.217.1.r00se36193; Hsieh YS, 2004, ARTHROSCOPY, V20, P482, DOI 10.1016/j.arthro.2004.03.010; Jones ARC, 2007, EUR CELLS MATER, V13, P40, DOI 10.22203/eCM.v013a04; Jones ARC, 2009, ARTHRITIS RHEUM-US, V60, P133, DOI 10.1002/art.24143; Kaab MJ, 1998, J ANAT, V193, P23, DOI 10.1046/j.1469-7580.1998.19310023.x; Kambic HE, 2005, J ORTHOP RES, V23, P142, DOI 10.1016/j.orthres.2004.06.016; Kiapour AM, 2015, CLIN ORTHOP RELAT R, V473, P639, DOI 10.1007/s11999-014-3974-2; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KREINEST M, 2015, COMP MED IN PRESS; Krenn V, 2010, Z RHEUMATOL, V69, P644, DOI 10.1007/s00393-010-0609-1; Krenn V, 2010, ORTHOPADE, V39, P475, DOI 10.1007/s00132-010-1606-4; Lasch P, 2001, J BIOL CHEM, V276, P9492, DOI 10.1074/jbc.M008528200; Libicher M, 2005, EUR RADIOL, V15, P390, DOI 10.1007/s00330-004-2486-y; Lin Z, 2008, J ORTHOP RES, V26, P1230, DOI 10.1002/jor.20523; Lorenz H, 2005, ARTHRITIS RES THER, V7, pR156, DOI 10.1186/ar1471; McAlinden A, 2001, OSTEOARTHR CARTILAGE, V9, P33, DOI 10.1053/joca.2000.0347; Melrose J, 2005, HISTOCHEM CELL BIOL, V124, P225, DOI 10.1007/s00418-005-0005-0; Nawata K, 1999, KNEE SURG SPORT TR A, V7, P274, DOI 10.1007/s001670050163; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Ochi K, 2003, J HUM GENET, V48, P177, DOI 10.1007/s10038-003-0004-8; Papageorgiou CD, 2001, AM J SPORT MED, V29, P226, DOI 10.1177/03635465010290021801; Pond M J, 1973, Ann Rheum Dis, V32, P387, DOI 10.1136/ard.32.4.387; RAUNEST J, 1994, ARTHROSCOPY, V10, P634, DOI 10.1016/S0749-8063(05)80061-1; Schumacher BL, 2005, J ORTHOP RES, V23, P562, DOI 10.1016/j.orthres.2004.11.011; Schwarz ML, 2010, SCAND J LAB ANIM SCI, V37, P13; Stoker Aaron M, 2006, J Orthop Surg Res, V1, P8, DOI 10.1186/1749-799X-1-8; Sun YB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2968; von Engelhardt LV, 2008, ARCH ORTHOP TRAUM SU, V128, P451, DOI 10.1007/s00402-007-0485-6; Wang QG, 2009, BIOCHEM BIOPH RES CO, V379, P738, DOI 10.1016/j.bbrc.2008.12.111; Wildey GM, 2001, J ORTHOP RES, V19, P650, DOI 10.1016/S0736-0266(00)00053-X; Wimmer MA, 2007, ARTHRITIS RHEUM-US, V56, P3511, DOI 10.1002/art.22973; Wojtys Edward M, 2005, Instr Course Lect, V54, P323; Zarins ZA, 2010, OSTEOARTHR CARTILAGE, V18, P1408, DOI 10.1016/j.joca.2010.07.012	49	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159331	10.1371/journal.pone.0159331	http://dx.doi.org/10.1371/journal.pone.0159331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434644	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600048
J	Thakur, J; Dwivedi, MD; Sourabh, P; Uniyal, PL; Pandey, AK				Thakur, Julie; Dwivedi, Mayank D.; Sourabh, Pragya; Uniyal, Prem L.; Pandey, Arun K.			Genetic Homogeneity Revealed Using SCoT, ISSR and RAPD Markers in Micropropagated Pittosporum eriocarpum Royle- An Endemic and Endangered Medicinal Plant	PLOS ONE			English	Article							IN-VITRO PROPAGATION; IMPROVEMENT; STABILITY; CULTURES; INDIA; RARE; TREE	Pittosporum eriocarpum Royle, a medicinally important taxon, is endemic to Uttarakhand region of Himalaya. It has become endangered due to over-collection and the loss of habitats. As raising plants through seeds in this plant is problematic, a reliable protocol for micro-propagation using nodal explants has been developed. High shoot regeneration (95%) occurred in MS medium augmented with BA 0.4mg/l in combination IBA 0.6mg/l. In vitro regenerated shoots were rooted in MS medium supplemented with three auxins, of which 0.6 mg/l indole butyric acid proved to be the best for rooting (90%) with maximum number of roots per shoot. Thereafter, rooted plants were hardened and nearly 73% of rooted shoots were successfully acclimatized and established in the field. Start codon targeted (SCoT), inter simple sequence repeats (ISSR) and random amplified polymorphic DNA (RAPD) markers were used to validate the genetic homogeneity amongst nine in vitro raised plantlets with mother plant. DNA fingerprints of in vitro regenerated plantlets displayed monomorphic bands similar to mother plant, indicating homogeneity among the micropropagated plants with donor mother plant. The similarity values were calculated based on SCoT, ISSR and RAPD profiles which ranged from 0.89 to 1.00, 0.91 to 1.00 and 0.95 to 1.00 respectively. The dendrograms generated through Unweighted Pair Group Method with arithmetic mean (UPGMA) analysis revealed 97% similarity amongst micropropagated plants with donor mother plant, thus confirming genetic homogeneity of micropropagated clones. This is the first report on micropropagation and genetic homogeneity assessment of P. eriocarpum. The protocol would be useful for the conservation and large scale production of P. eriocarpum to meet the demand for medicinal formulations and also for the re-introduction of in vitro grown plants in the suitable natural habitats to restore the populations.	[Thakur, Julie; Dwivedi, Mayank D.; Sourabh, Pragya; Uniyal, Prem L.; Pandey, Arun K.] Univ Delhi, Dept Bot, Delhi, India	University of Delhi	Pandey, AK (corresponding author), Univ Delhi, Dept Bot, Delhi, India.	arunkpandey@botany.du.ac.in	Dwivedi, Mayank/V-8220-2019	Thakur, Julie/0000-0003-1077-1565	Department of Biotechnology, Government of India [BT/Env/BC/01/2010/23.3.2012]; Department of Biotechnology, Government of India, New Delhi [BT/Env/BC/01/2010/23.3.2012]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	Grant support from Department of Biotechnology (# BT/Env/BC/01/2010/23.3.2012), Government of India, was provided to AKP.; Grant support (# BT/Env/BC/01/2010/23.3.2012) from Department of Biotechnology, Government of India, New Delhi, is thankfully acknowledged. We thank Prof. Mala Mazumdar, CPGS Jain University, Bangalore and an anonymous reviewer for their valuable comments. We are grateful to Prof Shailendra Goel, University of Delhi for help in molecular analysis and Dr GP Sharma and Dr Pooja Jha Maity for help in statistical analysis. The authors warmly thank Dr. Randall P. Niedz for critically reading the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], PLANT BIOTECHNOL; Benmahioul B, 2012, PLANT CELL TISS ORG, V108, P353, DOI 10.1007/s11240-011-0040-6; Chalupa V, 1987, CELL TISSUE CULTURE, P224; Chandra S, 2010, BIOTECHNOL LETT, V32, P1199, DOI 10.1007/s10529-010-0290-0; Collard BCY, 2009, PLANT MOL BIOL REP, V27, P86, DOI 10.1007/s11105-008-0060-5; Conover CA, 1963, FLORIDA STATE HORTIC, V1781, P480; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; Dhan Singh, 1999, Annals of Forestry, V7, P185; Dhar U, 2000, PLANT CELL TISS ORG, V63, P231, DOI 10.1023/A:1010610603893; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Gaur R., 1999, FLORA DISTRICT GARHW; Gupta AK, 2014, APPL BIOCHEM BIOTECH, V173, P1481, DOI 10.1007/s12010-014-0920-4; Gupta PK, 2002, PLANT CELL TISS ORG, V70, P229, DOI 10.1023/A:1016597404454; Harish, 2014, GENE, V535, P266, DOI 10.1016/j.gene.2013.11.018; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Lakshmanan V, 2007, ELECTRON J BIOTECHN, V10, P106, DOI 10.2225/vol10-issue1-fulltext-12; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Mathur A, 2008, AFR J BIOTECHNOL, V7, P1046; McNaughton S.J., 1989, P109; Mishra J, 2011, PLANT CELL TISS ORG, V104, P181, DOI 10.1007/s11240-010-9816-3; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nayar M.P., 1987, RED DATA BOOK INDIAN, V1; Padalia H, 2010, J INDIAN SOC REMOT, V38, P513, DOI 10.1007/s12524-010-0036-4; Patel AK, 2014, SCI HORTIC-AMSTERDAM, V165, P175, DOI 10.1016/j.scienta.2013.10.039; Phulwaria M, 2012, ACTA PHYSIOL PLANT, V34, P299, DOI 10.1007/s11738-011-0828-3; Rai MK, 2012, PLANT CELL TISS ORG, V111, P259, DOI 10.1007/s11240-012-0190-1; Rathore NS, 2014, ACTA PHYSIOL PLANT, V36, P555, DOI 10.1007/s11738-013-1429-0; Rawat JM, 2013, ACTA PHYSIOL PLANT, V35, P2589, DOI 10.1007/s11738-013-1294-x; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; Semwal P, 2013, BTI, V6, P25; Tripathi M, 2010, ACTA PHYSIOL PLANT, V32, P1011, DOI 10.1007/s11738-010-0484-z; Velayutham P., 2006, J AGR TECHNOL, V2, P287; Wu K, PLOS ONE, V9, P1; Xiong FQ, 2011, MOL BIOL REP, V38, P3487, DOI 10.1007/s11033-010-0459-6; Yokawa K, 2013, TRENDS PLANT SCI, V18, P117, DOI 10.1016/j.tplants.2013.01.002; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460	40	42	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159050	10.1371/journal.pone.0159050	http://dx.doi.org/10.1371/journal.pone.0159050			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434060	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600031
J	Hung, YC; Cheng, YC; Muo, CH; Chiu, HE; Liu, CT; Hu, WL				Hung, Yu-Chiang; Cheng, Yu-Chen; Muo, Chih-Hsin; Chiu, Hsienhsueh Elley; Liu, Chun-Ting; Hu, Wen-Long			Adjuvant Chinese Herbal Products for Preventing Ischemic Stroke in Patients with Atrial Fibrillation	PLOS ONE			English	Article							SALVIA-MILTIORRHIZA; RISK-FACTORS; WARFARIN; DANSHEN; ANTIOXIDANT; THERAPEUTICS; MEDICINE; ESTROGEN; TAIWAN; CELLS	Objective Chinese herbal products (CHPs) are widely used for atrial fibrillation (AF) in Taiwan. We investigated the effect of adjuvant CHPs in preventing ischemic stroke in patients with AF. Methods Taiwanese patients in the Health Insurance Database newly diagnosed with AF during 2000-2011 were enrolled. Medication treatment with/without CHPs was administered within 7 days after the AF diagnosis. The clinical endpoint was an ischemic stroke. The Chi-square test, Fisher's exact test, and Student t test were used to examine differences between the traditional Chinese medicine (TCM) and non-TCM cohorts. Cox proportional hazard regression was used to assess the risk for ischemic stroke between two cohorts. Results Three hundred and eleven patients underwent TCM treatment and 1715 patients did not. Compared to non-TCM users, TCM users had a lower incidence of stroke (12.59% vs. 1.93%, respectively) and lower risk of stroke [CHA(2)DS(2)-VASc score = 0-2 (hazard ratio = 0.20; 95% confidence interval = 0.06-0.65)]. Compared to non-TCM users, the stroke risk was significantly lower in TCM users with AF who were female or younger than 65 years, but not in males, people more than 65 years old, or people with comorbidities. Compared to TCM users, non-TCM users who received conventional treatment had a higher ischemic stroke risk. The risk for AF-related hospitalization was significantly lower in TCM users (0.64%) than in non-TCM users (38.1%). Conclusions Users of TCM with AF have a lower risk of new-onset ischemic stroke. Therefore, adjuvant CHP therapy may have a protective effect and may be used in AF patients to prevent ischemic stroke.	[Hung, Yu-Chiang; Cheng, Yu-Chen; Liu, Chun-Ting; Hu, Wen-Long] Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung, Taiwan; [Hung, Yu-Chiang; Cheng, Yu-Chen; Liu, Chun-Ting; Hu, Wen-Long] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Hung, Yu-Chiang; Chiu, Hsienhsueh Elley] I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Hu, Wen-Long] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Hu, Wen-Long] Fooyin Univ, Coll Nursing, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; I Shou University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Fooyin University	Hung, YC; Hu, WL (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung, Taiwan.; Hung, YC; Hu, WL (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Hung, YC (corresponding author), I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan.; Hu, WL (corresponding author), Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan.; Hu, WL (corresponding author), Fooyin Univ, Coll Nursing, Kaohsiung, Taiwan.	hungyuchiang@gmail.com; oolonghu@gmail.com	Hu, Wen-Long/N-1660-2014; Liu, Chun-Ting/GWM-4693-2022; Hung, yu-chiang/ABE-7636-2020	Hu, Wen-Long/0000-0001-9549-6202; 	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW) [105TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW); China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	The use of National Health Insurance Research Database (NHIRD) was supported by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All of the authors' contributions were independent from the study sponsors.	Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; [Anonymous], 2010, CHINESE PHARMACOPOEI, V1, P236; [Anonymous], 2008, TAIWAN J CLIN CHINES, V14, P308; Bonaccini L, 2015, PLANTA MED, V81, P1003, DOI 10.1055/s-0035-1546196; Cai Y, 2004, J AGR FOOD CHEM, V52, P7884, DOI 10.1021/jf0489116; Chan TYK, 2001, ANN PHARMACOTHER, V35, P501, DOI 10.1345/aph.19029; Chao TF, 2012, STROKE, V43, P2551, DOI 10.1161/STROKEAHA.112.667865; Chen Fen-yan, 2015, Zhongguo Zhong Yao Za Zhi, V40, P1649; Chen LC, 2010, INT J GYNECOL OBSTET, V109, P63, DOI 10.1016/j.ijgo.2009.10.014; Chen LY, 2001, CHINESE TRADITIONAL, V32, P134; Chen Q., 1998, PHARM CLIN BASIS REN, P382; Chen WG, 2010, J TRADIT CHIN MED, V30, P47, DOI 10.1016/S0254-6272(10)60012-X; Cheng EY, 2016, AM J CARDIOL, V117, P1021, DOI 10.1016/j.amjcard.2015.12.040; Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004; Cheng TO, 2006, INT J CARDIOL, V113, P437, DOI 10.1016/j.ijcard.2005.10.026; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Chien KL, 2010, INT J CARDIOL, V139, P173, DOI 10.1016/j.ijcard.2008.10.045; Chinese Materia Medical Compiling Committee of the National Administration Bureau of Traditional Chinese Medicine, 1998, RAD SALV MILT, P1654; Chiu HE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086351; Chu FY, 2010, CHIN J INTEGR MED, V16, P399, DOI 10.1007/s11655-010-9999-9; Chua YT, 2015, SINGAP MED J, V56, P11, DOI 10.11622/smedj.2015004; Chung JWY, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/819871; Covel CL, 2014, THROMB HAEMOSTASIS, V111, P385, DOI 10.1160/TH13-04-0347; Ge BK, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/957362; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hung YC, 2010, BBA-PROTEINS PROTEOM, V1804, P1310, DOI 10.1016/j.bbapap.2010.02.001; Hung YC, 2009, J ETHNOPHARMACOL, V124, P463, DOI 10.1016/j.jep.2009.05.020; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Koellhoffer EC, 2013, TRANSL STROKE RES, V4, P390, DOI 10.1007/s12975-012-0230-5; Lee JJ, 2011, J ETHNOPHARMACOL, V134, P824, DOI 10.1016/j.jep.2011.01.033; Lee S, 2010, AUTON NEUROSCI-BASIC, V155, P5, DOI 10.1016/j.autneu.2010.02.003; Li J, 2009, J LIAONING U TCM, V11, P83, DOI [10.13194/ j. jlunivtcm. 2009.06.84. lij. 037, DOI 10.13194/J.JLUNIVTCM.2009.06.84.LIJ.037]; Li JL, 2000, RES TRADITIONAL CHIN, V16, P57; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Liu P, 2010, PHYTOMEDICINE, V17, P794, DOI 10.1016/j.phymed.2010.01.004; Liu R, 2013, BRAIN RES, V1514, P83, DOI 10.1016/j.brainres.2013.01.023; Liu S. J., 2015, J PRACTICAL TRADITIO, V29, P7; Liu W, 2015, COMPLEMENT THER MED, V23, P100, DOI 10.1016/j.ctim.2014.12.008; Lomuscio A, 2011, J CARDIOVASC ELECTR, V22, P241, DOI 10.1111/j.1540-8167.2010.01878.x; Lu Li, 2015, Zhong Yao Cai, V38, P781; Marchlinski F, 2012, HARRISONS PRINCIPLES; Michaud GF, 2015, HARRISONS PRINCIPLES; Nagajyothi PC, 2015, J PHOTOCH PHOTOBIO B, V146, P10, DOI 10.1016/j.jphotobiol.2015.02.008; Nutescu EA, 2006, EXPERT OPIN DRUG SAF, V5, P433, DOI 10.1517/14740338.5.3.433; Pellman J, 2015, COMPR PHYSIOL, V5, P649, DOI 10.1002/cphy.c140047; Qin RA, 2014, J ETHNOPHARMACOL, V156, P190, DOI 10.1016/j.jep.2014.08.023; Qin RA, 2012, J TRADIT CHIN MED, V32, P63, DOI 10.1016/S0254-6272(12)60033-8; Qiu Zhong-xia, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P787; Shia CS, 2011, J ETHNOPHARMACOL, V137, P1388, DOI 10.1016/j.jep.2011.08.003; Sim Y, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0922-y; Smith W, 2012, HARRISONS PRINCIPLES; Sohrabji F, 2013, NEUROCHEM INT, V63, P291, DOI 10.1016/j.neuint.2013.06.013; Sze FKH, 2005, ACTA NEUROL SCAND, V111, P118, DOI 10.1111/j.1600-0404.2004.00369.x; Tang Jian-yang, 2012, Xiamen Daxue Xuebao (Ziran Kexue Ban), V51, P789; Tian HL, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/782635; Tsai CF, 2015, INT J STROKE, V10, P485, DOI 10.1111/ijs.12508; Tsai DS, 2014, J ETHNOPHARMACOL, V155, P1534, DOI 10.1016/j.jep.2014.07.047; Tsai HH, 2013, EUR J CLIN PHARMACOL, V69, P629, DOI 10.1007/s00228-012-1359-6; Wang B, 2013, J PRACT TRADIT CHIN, V29, P168; Wu Bing, 2007, Asian Journal of Ecotoxicology, V2, P18; Wu B, 2007, STROKE, V38, P1973, DOI 10.1161/STROKEAHA.106.473165; Wu CC, 2011, EXP DIABETES RES, DOI 10.1155/2011/514738; Xiao Y, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/936459; Xu Hong-Ke, 2007, Zhongguo Zhen Jiu, V27, P96; Xu KD, 2015, SCI REP-UK, V5, DOI 10.1038/srep08823; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304; Zhang DY, 2013, CARBOHYD POLYM, V95, P114, DOI 10.1016/j.carbpol.2013.03.015; Zhou W, 2014, J ETHNOPHARMACOL, V151, P66, DOI 10.1016/j.jep.2013.11.007; Zhou X., 2015, CHINESE MED MODERN D, V12, P50	69	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159333	10.1371/journal.pone.0159333	http://dx.doi.org/10.1371/journal.pone.0159333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428543	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300052
J	Liang, WZ; Xu, JW; Yuan, WS; Song, X; Zhang, JY; Wei, W; Yu, XF; Yang, Y				Liang, Weizi; Xu, Jiwei; Yuan, Wensu; Song, Xuan; Zhang, Jianyong; Wei, Wei; Yu, Xiao-Fang; Yang, Ying			APOBEC3DE Inhibits LINE-1 Retrotransposition by Interacting with ORF1p and Influencing LINE Reverse Transcriptase Activity	PLOS ONE			English	Article							HIV-1 VIF; L1 RETROTRANSPOSITION; DEAMINASE APOBEC3G; ENZYME APOBEC3G; SVA ELEMENTS; 7SL RNA; PROTEINS; RESTRICTION; DISEASE; VIRUS	Human long interspersed elements 1 (LINE-1 or L1) is the only autonomous non-LTR retroelement in humans and has been associated with genome instability, inherited genetic diseases, and the development of cancer. Certain human APOBEC3 family proteins are known to have LINE-1 restriction activity. The mechanisms by which APOBEC3 affects LINE-1 retrotransposition are not all well characterized; here, we confirm that both A3B and A3DE have a strong ability to inhibit LINE-1 retrotransposition. A3DE interacts with LINE-1 ORF1p to target LINE-1 ribonucleoprotein particles in an RNA-dependent manner. Moreover, A3DE binds to LINE-1 RNA and ORF1 protein in cell culture system. Fluorescence microscopy demonstrated that A3DE co-localizes with ORF1p in cytoplasm. Furthermore, A3DE inhibits LINE-1 reverse transcriptase activity in LINE-1 ribonucleoprotein particles in a cytidine deaminase-independent manner. In contrast, A3B has less inhibitory effects on LINE-1 reverse transcriptase activity despite its strong inhibition of LINE-1 retrotransposition. This study demonstrates that different A3 proteins have been evolved to inhibit LINE-1 activity through distinct mechanisms.	[Liang, Weizi; Xu, Jiwei; Yuan, Wensu; Song, Xuan; Zhang, Jianyong; Yu, Xiao-Fang; Yang, Ying] Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China; [Wei, Wei] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Wei, Wei; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, 615 N Wolfe St, Baltimore, MD 21205 USA	Tianjin University; Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yu, XF; Yang, Y (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China.; Wei, W (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.; Wei, W; Yu, XF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, 615 N Wolfe St, Baltimore, MD 21205 USA.	wwei6@jlu.edu.cn; xyu2@jhu.edu; yangyingcn2002@163.com	Wei, Wei/ABG-9776-2021	Wei, Wei/0000-0003-4456-840X	Tianjin Municipal Science and Technology Commission [13JCYBJC40800]	Tianjin Municipal Science and Technology Commission	This work was supported by Tianjin Municipal Science and Technology Commission, Grant number: 13JCYBJC40800 (http://www.tstc.gov.cn/) to YY. The Tianjin Municipal Science and Technology Commission provided the funding for materials.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2006, P NATL ACAD SCI USA, P103; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Cullen BR, 2003, MOL THER, V8, P525, DOI 10.1016/j.ymthe.2003.08.010; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Duggal NK, 2011, J VIROL, V85, P11361, DOI 10.1128/JVI.05046-11; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Goodier JL, 2013, NUCLEIC ACIDS RES, V41, P7401, DOI 10.1093/nar/gkt512; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Horn AV, 2014, NUCLEIC ACIDS RES, V42, P396, DOI 10.1093/nar/gkt898; Hu SQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005367; Khazina E, 2011, NAT STRUCT MOL BIOL, V18, P1006, DOI 10.1038/nsmb.2097; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lander ES, 2001, NATURE, P409; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Li XY, 2013, J BIOL CHEM, V288, P21148, DOI 10.1074/jbc.M113.465856; Lovsin N, 2009, ANN NY ACAD SCI, V1178, P268, DOI 10.1111/j.1749-6632.2009.05006.x; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Malim MH, 2006, CR BIOL, V329, P871, DOI 10.1016/j.crvi.2006.01.012; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Moldovan JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005121; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schumann GG, 2010, INT REV CEL MOL BIO, V285, P115, DOI 10.1016/S1937-6448(10)85003-8; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Wang T, 2008, J MOL BIOL, V375, P1098, DOI 10.1016/j.jmb.2007.11.017; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhao K, 2013, CELL REP, V4, P1108, DOI 10.1016/j.celrep.2013.08.019; Zhen AJ, 2010, J VIROL, V84, P1902, DOI 10.1128/JVI.01509-09	51	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0157220	10.1371/journal.pone.0157220	http://dx.doi.org/10.1371/journal.pone.0157220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428332	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169300002
J	Li, CZ; Zhao, LH; Sun, PS; Zhao, FZ; Kang, D; Yang, GH; Han, XH; Feng, YZ; Ren, GX				Li, Changzhen; Zhao, Luhong; Sun, Pingsheng; Zhao, Fazhu; Kang, Di; Yang, Gaihe; Han, Xinhui; Feng, Yongzhong; Ren, Guangxin			Deep Soil C, N, and P Stocks and Stoichiometry in Response to Land Use Patterns in the Loess Hilly Region of China	PLOS ONE			English	Article							ORGANIC-CARBON; STORAGE; NITROGEN; AFFORESTATION; PLATEAU; CONVERSION; THRESHOLD; FOREST; SEQUESTRATION; DEGRADATION	In the Loess Hilly Region of China, the widespread conversion of cropland to forestland and grassland has resulted in great increased in organic carbon (C), nitrogen (N) and phosphorus (P) stocks in the shallow soil layers. However, knowledge regarding changes in C, N, and P in deep soil is still limited. To elucidate the responses of deep soil C, N, and P stocks and stoichiometry in response to changes in land use, the soil from a 0-200 cm soil profile was collected from the following three typical land use patterns in the heartland of the region: forestland, grassland, and cropland. Compared with cropland, forestland and grassland had improved soil organic carbon (SOC) and total nitrogen (TN) contents and stocks at most soil depths but decreased total phosphorus (TP) contents and stocks. At soil depths of 0-200 cm in the forestland and grassland, the cumulative SOC stocks were improved by 34.97% and 7.61%, respectively, and the TN stocks were improved by 54.54% and 12.47%, respectively. The forestland had higher SOC, TN and TP contents and stocks compared to the grassland in almost all soil layers. The soil depths of 100-200 cm contained the highest percentages of SOC, TN and TP stocks (47.80%-49.93%, 46.08%-50.05% and 49.09%-52.98%, respectively). Additionally, the forestland and grassland showed enhanced soil C:P, N:P and C:N:P ratios, and the forestland had higher C:P, N:P and C:N:P ratios compared to the grassland. Furthermore, the SOC and TN stocks had significant impacts on the soil C:N, C:P and N:P ratios. It was concluded that afforestation was the best choice for soil nutrient restoration of degraded land, and deep soil provided an extremely important resource for evaluating soil C, N and P pools and cycling.	[Li, Changzhen; Sun, Pingsheng; Yang, Gaihe; Han, Xinhui; Feng, Yongzhong; Ren, Guangxin] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Li, Changzhen; Zhao, Luhong; Sun, Pingsheng; Kang, Di; Yang, Gaihe; Han, Xinhui; Feng, Yongzhong; Ren, Guangxin] Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China; [Zhao, Luhong; Kang, Di] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Zhao, Fazhu] Northwest Univ, Coll Urban & Environm Sci, Xian, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest University Xi'an	Yang, GH; Han, XH (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.; Yang, GH; Han, XH (corresponding author), Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China.	ygh@nwsuaf.edu.cn; hanxinhui@nwsuaf.edu.cn	Feng, Yongzhong/F-5090-2012; Zhao, Fazhu/CAG-5988-2022; Ren, Chengjie/CAF-2259-2022	Feng, Yongzhong/0000-0002-5202-4368; Zhao, Fazhu/0000-0003-4758-3277; Kang, Di/0000-0003-4255-8689	National Natural Science Foundation of China [41301601, 41571501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by National Natural Science Foundation of China (No. 41301601 and No. 41571501) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte C, 2010, BIOGEOCHEMISTRY, V101, P77, DOI 10.1007/s10533-010-9418-5; Bai ZG, 2009, AMBIO, V38, P150, DOI 10.1579/0044-7447-38.3.150; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Cao SX, 2009, P NATL ACAD SCI USA, V106, P10712, DOI 10.1073/pnas.0900197106; Chang RY, 2011, ENVIRON MANAGE, V48, P1158, DOI 10.1007/s00267-011-9682-8; Chen LD, 2007, ECOL RES, V22, P641, DOI 10.1007/s11284-006-0065-1; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Deng J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151446; Deng L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07039; Deng L, 2014, GLOBAL CHANGE BIOL, V20, P3544, DOI 10.1111/gcb.12508; Deng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071923; Deng L, 2013, CATENA, V110, P1, DOI 10.1016/j.catena.2013.06.016; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; Fan HB, 2015, PLANT SOIL, V392, P127, DOI 10.1007/s11104-015-2444-2; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; FU BJ, 1989, SOIL USE MANAGE, V5, P76, DOI 10.1111/j.1475-2743.1989.tb00765.x; Fu BJ, 2000, CATENA, V39, P69, DOI 10.1016/S0341-8162(99)00084-3; Fu XL, 2010, GEODERMA, V155, P31, DOI 10.1016/j.geoderma.2009.11.020; Gao Y, 2014, ECOL ENG, V67, P171, DOI 10.1016/j.ecoleng.2014.03.013; Gao Y, 2013, ECOL ENG, V57, P366, DOI 10.1016/j.ecoleng.2013.04.011; Gao Y, 2012, ENVIRON SCI TECHNOL, V46, P4687, DOI 10.1021/es301163u; Gao Y, 2011, J APPL ECOL, V48, P1145, DOI 10.1111/j.1365-2664.2011.02011.x; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; He Jin-Sheng, 2010, Chinese Journal of Plant Ecology, V34, P2, DOI 10.3773/j.issn.1005-264x.2010.01.002; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; Jiao Y, 2012, J ARID LAND, V4, P420, DOI 10.3724/SP.J.1227.2012.00420; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li Y, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004399; Liao CZ, 2012, GLOBAL ECOL BIOGEOGR, V21, P318, DOI 10.1111/j.1466-8238.2011.00690.x; Michaels AF, 2003, SCIENCE, V300, P906, DOI 10.1126/science.1083140; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Paul EA., 2006, SOIL MICROBIOLOGY EC, V3rd; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Saikh H, 1998, PLANT SOIL, V198, P137, DOI 10.1023/A:1004391615003; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Scott NA, 2006, AUST J SOIL RES, V44, P85, DOI 10.1071/SR05013; Shi SW, 2013, FOREST ECOL MANAG, V296, P53, DOI 10.1016/j.foreco.2013.01.026; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Wang W, 2014, GEODERMA, V232, P459, DOI 10.1016/j.geoderma.2014.06.004; Wang YF, 2010, QUATERNARY RES, V73, P70, DOI 10.1016/j.yqres.2008.11.006; Wei XR, 2009, BIOGEOCHEMISTRY, V96, P149, DOI 10.1007/s10533-009-9350-8; Wu HB, 2003, GLOBAL CHANGE BIOL, V9, P305, DOI 10.1046/j.1365-2486.2003.00590.x; Yimer F, 2007, FOREST ECOL MANAG, V242, P337, DOI 10.1016/j.foreco.2007.01.087; Zeng DeHui, 2005, Acta Phytoecologica Sinica, V29, P1007; Zhang C, 2013, EUR J SOIL BIOL, V54, P16, DOI 10.1016/j.ejsobi.2012.10.007; Zhang DJ, 2014, PLANT SOIL, V376, P307, DOI 10.1007/s11104-013-1954-z; Zhang ZH, 2013, J SOIL SEDIMENT, V13, P140, DOI [10.1007/s11368-012-0571-4, 10.1007/s11368-013-0693-3]; Zhao FZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10195; Zhao FZ, 2015, ECOL ENG, V74, P415, DOI 10.1016/j.ecoleng.2014.11.010; Zhao FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099657	55	73	78	11	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159075	10.1371/journal.pone.0159075	http://dx.doi.org/10.1371/journal.pone.0159075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415785	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500070
J	Liu, HT; Gao, Y; Hu, ZY; Lin, LH; Yin, XY; Wang, J; Chen, DY; Chen, F; Jiang, H; Ren, JH; Wang, W				Liu, Hongtai; Gao, Ya; Hu, Zhiyang; Lin, Linhua; Yin, Xuyang; Wang, Jun; Chen, Dayang; Chen, Fang; Jiang, Hui; Ren, Jinghui; Wang, Wei			Performance Evaluation of NIPT in Detection of Chromosomal Copy Number Variants Using Low-Coverage Whole-Genome Sequencing of Plasma DNA	PLOS ONE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; MICRODELETION	Objectives The aim of this study was to assess the performance of noninvasively prenatal testing (NIPT) for fetal copy number variants (CNVs) in clinical samples, using a whole-genome sequencing method. Method A total of 919 archived maternal plasma samples with karyotyping/microarray results, including 33 CNVs samples and 886 normal samples from September 1, 2011 to May 31, 2013, were enrolled in this study. The samples were randomly rearranged and blindly sequenced by low-coverage (about 7M reads) whole-genome sequencing of plasma DNA. Fetal CNVs were detected by Fetal Copy-number Analysis through Maternal Plasma Sequencing (FCAPS) to compare to the karyotyping/microarray results. Sensitivity, specificity and were evaluated. Results 33 samples with deletions/duplications ranging from 1 to 129 Mb were detected with the consistent CNV size and location to karyotyping/microarray results in the study. Ten false positive results and two false negative results were obtained. The sensitivity and specificity of detection deletions/duplications were 84.21% and 98.42%, respectively. Conclusion Whole-genome sequencing-based NIPT has high performance in detecting genome-wide CNVs, in particular > 10Mb CNVs using the current FCAPS algorithm. It is possible to implement the current method in NIPT to prenatally screening for fetal CNVs.	[Liu, Hongtai; Chen, Dayang] Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen 518083, Peoples R China; [Liu, Hongtai; Gao, Ya; Yin, Xuyang; Wang, Jun; Chen, Dayang; Chen, Fang; Jiang, Hui; Wang, Wei] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Hu, Zhiyang; Lin, Linhua; Ren, Jinghui] Jinan Univ, Sch Clin Med 2, Shenzhen Peoples Hosp, Shenzhen 518020, Peoples R China; [Chen, Fang] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sect Mol Dis Biol, DK-2200 Copenhagen N, Denmark	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Jinan University; University of Copenhagen	Wang, W (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangw@genomics.cn		Gao, Ya/0000-0002-5094-9842	Science and Technology Plan of Guangdong Province [2013B022000005]; Guangdong Enterprise Key Laboratory of Human Disease Genomics [2011A060906007]; Shenzhen Engineering Laboratory for Birth Defects Screening [[2011]861]	Science and Technology Plan of Guangdong Province; Guangdong Enterprise Key Laboratory of Human Disease Genomics; Shenzhen Engineering Laboratory for Birth Defects Screening	The work is supported by Science and Technology Plan of Guangdong Province (no. 2013B022000005), the Guangdong Enterprise Key Laboratory of Human Disease Genomics (no. 2011A060906007), and Shenzhen Engineering Laboratory for Birth Defects Screening (no. [2011]861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai-Hua Y, 2015, P NATL ACAD SCI, V112; American College of Obstetricians and Gynecologists Committee on Genetics, 2013, Obstet Gynecol, V122, P1374, DOI 10.1097/01.AOG.0000438962.16108.d1; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Brady P, 2015, CLIN GENETICS; Chen SP, 2013, PRENATAL DIAG, V33, P584, DOI 10.1002/pd.4110; Dong Z, 2016, GENET MED; Hardisty EE, 2014, CURR OPIN PEDIATR, V26, P634, DOI 10.1097/MOP.0000000000000145; Li XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085096; Litton C, 2009, MT SINAI J MED, V76, P521, DOI 10.1002/msj.20153; Lo KK, 2015, AM J HUMAN GENETICS; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; Minear MA, 2015, PRENATAL DIAG, V35, P959, DOI 10.1002/pd.4637; Nevado J, 2014, GENET MOL BIOL, V37, P210, DOI 10.1590/S1415-47572014000200007; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; South ST, 2013, GENET MED, V15, P901, DOI 10.1038/gim.2013.129; Srinivasan A, 2013, AM J HUM GENET, V92, P167, DOI 10.1016/j.ajhg.2012.12.006; Straver R, 2014, NUCLEIC ACIDS RES, V42, P1635; Wapner RJ, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.041; Wapner RJ, 2012, PRENATAL DIAG, V32, P396, DOI 10.1002/pd.3863; Weise A, 2012, J HISTOCHEM CYTOCHEM, V60, P346, DOI 10.1369/0022155412440001; Yao H, 2012, PRENATAL DIAG, V32, P1114, DOI 10.1002/pd.3946; Yu SC, 2013, PLOS ONE, V8, P392; Zhang H, 2015, ULTRASOUND OBST GYN, V45, P530, DOI 10.1002/uog.14792; Zhou Y, 2015, REPROD SCI	26	28	40	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159233	10.1371/journal.pone.0159233	http://dx.doi.org/10.1371/journal.pone.0159233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415003	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500103
J	Park, SD; Moon, J; Kwon, SW; Suh, YJ; Kim, TH; Jang, HJ; Suh, J; Park, HW; Oh, PC; Shin, SH; Woo, SI; Kim, DH; Kwan, J; Kang, W				Park, Sang-Don; Moon, Jeonggeun; Kwon, Sung Woo; Suh, Young Ju; Kim, Tae-Hoon; Jang, Ho-Jun; Suh, Jon; Park, Hyun Woo; Oh, Pyung Chun; Shin, Sung-Hee; Woo, Seong-Il; Kim, Dae-Hyeok; Kwan, Jun; Kang, WoongChol			Prognostic Impact of Combined Contrast-Induced Acute Kidney Injury and Hypoxic Liver Injury in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results from INTERSTELLAR Registry	PLOS ONE			English	Article							PRIMARY ANGIOPLASTY; KOREAN PATIENTS; HEART-FAILURE; CARE UNIT; OUTCOMES; MORTALITY; HEPATITIS; TRENDS	Background Besides contrast-induced acute kidney injury(CI-AKI), adscititious vital organ damage such as hypoxic liver injury(HLI) may affect the survival in patients with ST-elevation myocardial infarction (STEMI). We sought to evaluate the prognostic impact of CI-AKI and HLI in STEMI patients who underwent primary percutaneous coronary intervention (PCI). Methods A total of 668 consecutive patients (77.2% male, mean age 61.3 +/- 13.3 years) from the INTERSTELLAR STEMI registry who underwent primary PCI were analyzed. CI-AKI was defined as an increase of >= 0.5 mg/dL in serum creatinine level or 25% relative increase, within 48h after the index procedure. HLI was defined as >= 2-fold increase in serum aspartate transaminase above the upper normal limit on admission. Patients were divided into four groups according to their CI-AKI and HLI states. Major adverse cardiovascular and cerebrovascular events (MACCE) defined as a composite of all-cause mortality, non-fatal MI, non-fatal stroke, ischemia-driven target lesion revascularization and target vessel revascularization were recorded. Results Over a mean follow-up period of 2.2 +/- 1.6 years, 94 MACCEs occurred with an event rate of 14.1%. The rates of MACCE and all-cause mortality were 9.7% and 5.2%, respectively, in the no organ damage group; 21.3% and 21.3% in CI-AKI group; 18.5% and 14.6% in HLI group; and 57.7% and 50.0% in combined CI-AKI and HLI group. Survival probability plots of composite MACCE and all-cause mortality revealed that the combined CI-AKI and HLI group was associated with the worst prognosis (p<0.0001 for both). Conclusion Combined CI-AKI after index procedure and HLI on admission is associated with poor clinical outcomes in patients with STEMI who underwent primary PCI.	[Park, Sang-Don; Kwon, Sung Woo; Shin, Sung-Hee; Woo, Seong-Il; Kim, Dae-Hyeok; Kwan, Jun] Inha Univ Hosp, Dept Cardiol, Incheon, South Korea; [Moon, Jeonggeun; Oh, Pyung Chun; Kang, WoongChol] Gachon Univ, Gil Med Ctr, Dept Cardiol, Incheon, South Korea; [Suh, Young Ju] Inha Univ, Sch Med, Dept Biomed Sci, Incheon, South Korea; [Kim, Tae-Hoon; Jang, Ho-Jun] Sejong Gen Hosp, Dept Cardiol, Bucheon, South Korea; [Suh, Jon; Park, Hyun Woo] Soon Chun Hyang Univ, Bucheon Hosp, Dept Cardiol, Bucheon, South Korea	Inha University; Inha University Hospital; Gachon University; Inha University; Sejong General Hospital; Soonchunhyang University	Kwon, SW (corresponding author), Inha Univ Hosp, Dept Cardiol, Incheon, South Korea.; Kang, W (corresponding author), Gachon Univ, Gil Med Ctr, Dept Cardiol, Incheon, South Korea.	kwonswdr@gmail.com; kangwch@gilhospital.com	Kim, Tae-Hoon/AAG-3292-2021; Suh, Young Ju/AAD-5737-2021; Moon, James C/F-1031-2014; Moon, James/AAA-9905-2020	Moon, James C/0000-0001-8071-1491; Moon, James/0000-0001-8071-1491; Kwon, Sung Woo/0000-0002-0679-1523; Kim, Tae-Hoon/0000-0002-4032-1285	INHA UNIVERSITY Research Grant [INHA-51457]	INHA UNIVERSITY Research Grant	This work was supported by INHA UNIVERSITY Research Grant (INHA-51457). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the INHA UNIVERSITY Research Grant (INHA-51457).	Ando G, 2014, CIRC-CARDIOVASC INTE, V7, P465, DOI 10.1161/CIRCINTERVENTIONS.114.001545; BYNUM TE, 1979, DIGEST DIS SCI, V24, P129, DOI 10.1007/BF01324740; COHEN JA, 1978, GASTROENTEROLOGY, V74, P583; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Ebert EC, 2006, MAYO CLIN PROC, V81, P1232, DOI 10.4065/81.9.1232; Fuhrmann V, 2011, INTENS CARE MED, V37, P1302, DOI 10.1007/s00134-011-2248-7; Giacoppo D, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002475; Goldberg RJ, 2009, CIRCULATION, V119, P1211, DOI 10.1161/CIRCULATIONAHA.108.814947; HENRION J, 1994, J HEPATOL, V21, P696, DOI 10.1016/S0168-8278(94)80226-2; Kavoliuniene A, 2013, INT J CARDIOL, V166, P554, DOI 10.1016/j.ijcard.2012.05.003; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Kostis WJ, 2010, CIRC-CARDIOVASC QUAL, V3, P581, DOI 10.1161/CIRCOUTCOMES.110.957803; Kwon SW, 2016, KOREAN CIRC J, V46, P154, DOI 10.4070/kcj.2016.46.2.154; Mamas MA, 2014, EUR HEART J, V35, P3004, DOI 10.1093/eurheartj/ehu303; Marenzi G, 2004, J AM COLL CARDIOL, V44, P1780, DOI 10.1016/j.jacc.2004.07.043; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Moon J, 2016, AM J CARDIOL, V118, P177, DOI 10.1016/j.amjcard.2016.04.046; Moon J, 2014, INT J CARDIOL, V177, P442, DOI 10.1016/j.ijcard.2014.09.002; Narula A, 2014, EUR HEART J, V35, P1533, DOI 10.1093/eurheartj/ehu063; Naschitz JE, 2000, AM HEART J, V140, P111, DOI 10.1067/mhj.2000.107177; Roger VL, 2010, CIRCULATION, V121, P863, DOI 10.1161/CIRCULATIONAHA.109.897249; Sadeghi HM, 2003, CIRCULATION, V108, P2769, DOI 10.1161/01.CIR.0000103623.63687.21; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tsai TT, 2014, JACC-CARDIOVASC INTE, V7, P1, DOI 10.1016/j.jcin.2013.06.016; Westfall P.H., 1993, RESAMPLING BASED MUL, V279	27	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159416	10.1371/journal.pone.0159416	http://dx.doi.org/10.1371/journal.pone.0159416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415006	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500127
J	Udommethaporn, S; Tencomnao, T; McGowan, EM; Boonyaratanakornkit, V				Udommethaporn, Sutthirat; Tencomnao, Tewin; McGowan, Eileen M.; Boonyaratanakornkit, Viroj			Assessment of Anti-TNF-alpha Activities in Keratinocytes Expressing Inducible TNF-alpha: A Novel Tool for Anti-TNF-alpha Drug Screening	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; PSORIATIC SKIN; HACAT CELLS; IN-VITRO; INFLAMMATION; ACTIVATION; RECEPTORS; APOPTOSIS; CANCER	Tumor necrosis factor alpha (TNF-alpha) is a pro-inflammatory cytokine important in normal and pathological biological processes. Newly synthesized pro-TNF-alpha is expressed on the plasma membrane and cleaved to release soluble TNF-alpha protein: both are biologically active. Secreted TNF-alpha signals through TNF receptors and the membrane-bound TNF-alpha acts by cell contact-dependent signaling. Anti-TNF-alpha antibodies have been used effectively for treatment of chronic inflammation, however with adverse side effects. Thus, there is a need for new anti-TNF-alpha small molecule compounds. Anti-TNF-alpha activity assays involve treatment of keratinocytes with exogenous TNF-alpha before or after anti-TNF-alpha incubation. However, this model fails to address the dual signaling of TNF-alpha. Here we describe a Doxycycline (Dox)-inducible TNF-alpha (HaCaT-TNF-alpha) expression system in keratinocytes. Using this in-vitro model, we show cell inhibition and induced expression of pro-inflammatory cytokines and markers, including IL-1 beta, IL-6, IL-8, NF-kappa B1, and KRT-16, similar to cells treated with exogenous TNF-alpha. Sufficient secreted TNF-a produced also activated IL-1 beta and IL-8 expression in wt HaCaT cells. Importantly, stimulated expression of IL-1 beta and IL-8 in HaCaT-TNF-alpha were blocked by Quercetin, a flavanol shown to possess anti-TNF-alpha activities. This novel in vitro cell model provides an efficient tool to investigate the dual signaling of TNF-alpha. Importantly, this model provides an effective, fast, and simple screening for compounds with anti-TNF-alpha activities for chronic inflammatory disease therapies.	[Udommethaporn, Sutthirat; Tencomnao, Tewin; Boonyaratanakornkit, Viroj] Chulalongkorn Univ, Fac Allied Hlth Sci, Grad Program Clin Biochem & Mol Med, Bangkok 10330, Thailand; [Tencomnao, Tewin; Boonyaratanakornkit, Viroj] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Bangkok 10330, Thailand; [McGowan, Eileen M.] Univ Technol Sydney, Chron Dis Solut Team, Sch Life Sci, Sydney, NSW 2007, Australia	Chulalongkorn University; Chulalongkorn University; University of Technology Sydney	Boonyaratanakornkit, V (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Grad Program Clin Biochem & Mol Med, Bangkok 10330, Thailand.; Boonyaratanakornkit, V (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Bangkok 10330, Thailand.	Viroj.b@chula.ac.th		Boonyaratanakornkit, Viroj/0000-0003-1800-7836; McGowan, Eileen/0000-0001-6371-3751; Tencomnao, Tewin/0000-0003-4177-2165	Korea Foundation for Advanced Studies [009/2556]; Chulalongkorn University 90th Anniversary Fund [GCUGR11255725107M]; Chulalongkorn University 90th Anniversary Fund (Ratchadaphiseksomphot Endowment Fund) [GCUGR11255725107M]	Korea Foundation for Advanced Studies; Chulalongkorn University 90th Anniversary Fund(Chulalongkorn University); Chulalongkorn University 90th Anniversary Fund (Ratchadaphiseksomphot Endowment Fund)	This work was supported by grant from Korea Foundation for Advanced Studies (009/2556) and the Chulalongkorn University 90th Anniversary Fund (GCUGR11255725107M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant from Korea Foundation for Advanced Studies (009/2556) to V.B., and the Chulalongkorn University 90th Anniversary Fund (Ratchadaphiseksomphot Endowment Fund) (GCUGR11255725107M) to S.U.	Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; Ardestani S, 2013, CANCER RES, V73, P3938, DOI 10.1158/0008-5472.CAN-13-0002; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Barroso E, 2011, BIOCHEM PHARMACOL, V81, P534, DOI 10.1016/j.bcp.2010.12.004; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Boonyaratanakornkit V, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/140196; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Chan Chung-Yin Stanley, 2008, Dermatol Online J, V14, P12; CHENG J, 1992, GENE DEV, V6, P1444, DOI 10.1101/gad.6.8.1444; Cho JW, 2007, INT J MOL MED, V19, P469; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Corazza N, 2004, GASTROENTEROLOGY, V127, P816, DOI 10.1053/j.gastro.2004.06.036; Mackey AC, 2007, J PEDIATR GASTR NUTR, V44, P265, DOI 10.1097/MPG.0b013e31802f6424; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; ETTEHADI P, 1994, CLIN EXP IMMUNOL, V96, P146, DOI 10.1111/j.1365-2249.1994.tb06244.x; Ganguly S, 2009, AM J CLIN DERMATOL, V10, P125, DOI 10.2165/00128071-200910020-00005; Ghazizadeh R, 2010, INT J MED SCI, V7, P284; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang Z, 2012, ONCOGENE, V31, P3709, DOI 10.1038/onc.2011.529; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kaplan MJ, 2008, VASC HEALTH RISK MAN, V4, P1229, DOI 10.2147/VHRM.S3461; Kim HH, 2008, BIOCHEM BIOPH RES CO, V368, P343, DOI 10.1016/j.bbrc.2008.01.062; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; KRISTENSEN M, 1993, CLIN EXP IMMUNOL, V94, P354; Kwon DJ, 2011, BIOCHEM BIOPH RES CO, V409, P780, DOI 10.1016/j.bbrc.2011.05.088; Leverkus M, 2000, CANCER RES, V60, P553; Lisby S, 2007, BIOCHEM PHARMACOL, V73, P526, DOI 10.1016/j.bcp.2006.11.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makol Ashima, 2008, Cases J, V1, P287, DOI 10.1186/1757-1626-1-287; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mounach A, 2008, CLIN EXP RHEUMATOL, V26, P1116; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Paul C, 1996, BRIT J DERMATOL, V134, P710, DOI 10.1111/j.1365-2133.1996.tb06976.x; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Reinartz J, 1996, EXP CELL RES, V228, P334, DOI 10.1006/excr.1996.0333; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; Saelee C, 2011, MOLECULES, V16, P3908, DOI 10.3390/molecules16053908; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Silva LCR, 2010, IMMUNOTHERAPY-UK, V2, P817, DOI [10.2217/imt.10.67, 10.2217/IMT.10.67]; Vijayalakshmi A., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P269, DOI 10.1016/S2221-1691(12)60021-5; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Wermuth J, 2009, CLIN GASTROENTEROL H, V7, pXXVIII, DOI 10.1016/j.cgh.2008.08.009; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0	50	13	17	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159151	10.1371/journal.pone.0159151	http://dx.doi.org/10.1371/journal.pone.0159151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415000	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500091
J	Zhang, L; Wu, LH; Tian, F; Wang, Z				Zhang, Li; Wu, Lihua; Tian, Feng; Wang, Zheng			Retrospection-Simulation-Revision: Approach to the Analysis of the Composition and Characteristics of Medical Waste at a Disaster Relief Site	PLOS ONE			English	Article							MANAGEMENT; GENERATION; INCINERATION	A large amount of medical waste is produced during disaster relief, posing a potential hazard to the habitat and the environment. A comprehensive understanding of the composition and characteristics of medical waste that requires management is one of the most basic steps in the development of a plan for medical waste management. Unfortunately, limited reliable information is available in the open literature on the characteristics of the medical waste that is generated at disaster relief sites. This paper discusses the analysis of the composition and characteristics of medical waste at a disaster relief site using the retrospection-simulation-revision method. For this study, we obtained 35 medical relief records of the Wenchuan Earthquake, Sichuan, May 2008 from a field cabin hospital. We first present a retrospective analysis of the relief medical records, and then, we simulate the medical waste generated in the affected areas. We ultimately determine the composition and characteristics of medical waste in the affected areas using untreated medical waste to revise the composition of the simulated medical waste. The results from 35 cases showed that the medical waste generated from disaster relief consists of the following: plastic (43.2%), biomass (26.3%), synthetic fiber (15.3%), rubber (6.6%), liquid (6.6%), inorganic salts (0.3%) and metals (1.7%). The bulk density of medical relief waste is 249 kg/m(3), and the moisture content is 44.75%. The data should be provided to assist the collection, segregation, storage, transportation, disposal and contamination control of medical waste in affected areas. In this paper, we wish to introduce this research method of restoring the medical waste generated in disaster relief to readers and researchers. In addition, we hope more disaster relief agencies will become aware of the significance of medical case recording and storing. This may be very important for the environmental evaluation of medical waste in disaster areas, as well as for medical waste management and disposal.	[Zhang, Li; Wu, Lihua; Tian, Feng; Wang, Zheng] Acad Mil Med Sci, Inst Med Equipment, Tianjin, Peoples R China; [Zhang, Li] Chinese Peoples Armed Police Forces, Logist Univ, Basic Courses Dept, Tianjin, Peoples R China	Academy of Military Medical Sciences - China	Wang, Z (corresponding author), Acad Mil Med Sci, Inst Med Equipment, Tianjin, Peoples R China.	wangzheng62037@163.com			National Major Projects of Infectious Diseases [2012ZX10004-801]	National Major Projects of Infectious Diseases	The work was supported by the Special Fund of National Major Projects of Infectious Diseases (2012ZX10004-801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was financially supported by the Special Fund of National Major Projects of Infectious Diseases (2012ZX10004-801). The authors thank Dr. Fan Li and Dr. Song Lin and Dr. Maoti Wei for their assistance in improving the quality of this paper. Due to confidentiality, we cannot mention the names of the staff members working at People's Liberation Army Hospital. However, we express our appreciation to the hospitals and physicians who helped with this study.	Beigl P, 2008, WASTE MANAGE, V28, P200, DOI 10.1016/j.wasman.2006.12.011; Bernstad A, 2012, WASTE MANAGE RES, V30, P200, DOI 10.1177/0734242X11410113; Caniato M, 2015, J ENVIRON MANAGE, V153, P93, DOI 10.1016/j.jenvman.2015.01.039; Carraro E, 2016, J ENVIRON MANAGE, V168, P185, DOI 10.1016/j.jenvman.2015.11.021; Cetin S, 2004, WASTE MANAGE, V24, P183, DOI 10.1016/j.wasman.2003.07.002; Chen Y, 2013, WASTE MANAGE, V33, P1165, DOI 10.1016/j.wasman.2013.01.011; Coker A, 2009, WASTE MANAGE, V29, P804, DOI 10.1016/j.wasman.2008.06.040; Diaz LF, 2008, WASTE MANAGE, V28, P1219, DOI 10.1016/j.wasman.2007.04.010; Edjabou ME, 2015, WASTE MANAGE, V36, P12, DOI 10.1016/j.wasman.2014.11.009; Gao Y, 2003, ENG ENV SANIT, V12, P77; Gautam AK, 2007, J ENVIRON MANAGE, V83, P298, DOI 10.1016/j.jenvman.2006.03.009; Hossain MS, 2011, WASTE MANAGE, V31, P754, DOI 10.1016/j.wasman.2010.11.008; [蒋旭光 JIANG Xuguang], 2009, [环境科学学报, Acta Scientiae Circumstantiae], V29, P1226; Komilis D, 2012, WASTE MANAGE, V32, P1434, DOI 10.1016/j.wasman.2012.02.015; Lee CC, 1996, J HAZARD MATER, V48, P1, DOI 10.1016/0304-3894(95)00153-0; Li YX, 2002, CHINA PREV MED, V3, P344; Ministry of Housing and Rural-Urban Development (CN), 2009, 3132009 CJT CN MIN H; Mohee R, 2005, WASTE MANAGE, V25, P575, DOI 10.1016/j.wasman.2004.10.003; Park H, 2009, J ENVIRON SCI HEAL A, V44, P995, DOI 10.1080/10934520902996898; Rajor A, 2012, J ENVIRON MANAGE, V108, P36, DOI 10.1016/j.jenvman.2012.04.031; Tan XD, 2002, CHIN HOSP MANAG, V22, P19; Townend WK, 1999, SAFE MANAGEMENT WAST, P171; Windfeld ES, 2015, J ENVIRON MANAGE, V163, P98, DOI 10.1016/j.jenvman.2015.08.013; Xin YT, 2015, J CLEAN PROD, V100, P202, DOI 10.1016/j.jclepro.2015.03.056; Zhang J, 2008, AGROENVIRONMENT DEV, V25, P41; Zhang Y, 2009, WASTE MANAGE, V29, P1376, DOI 10.1016/j.wasman.2008.10.023; Zhao LJ, 2010, J HAZARD MATER, V173, P181, DOI 10.1016/j.jhazmat.2009.08.066	27	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159261	10.1371/journal.pone.0159261	http://dx.doi.org/10.1371/journal.pone.0159261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414649	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500113
J	Jain, S; Chittem, K; Brueggeman, R; Osorno, JM; Richards, J; Nelson, BD				Jain, Shalu; Chittem, Kishore; Brueggeman, Robert; Osorno, Juan M.; Richards, Jonathan; Nelson, Berlin D., Jr.			Comparative Transcriptome Analysis of Resistant and Susceptible Common Bean Genotypes in Response to Soybean Cyst Nematode Infection	PLOS ONE			English	Article							PATHOGENESIS-RELATED GENES; GLYCINE-MAX ROOTS; NBS-LRR GENES; HETERODERA-GLYCINES; RNA-SEQ; DISEASE RESISTANCE; EXPRESSION ANALYSIS; PHASEOLUS-VULGARIS; GENOME; STRESS	Soybean cyst nematode (SCN; Heterodera glycines Ichinohe) reproduces on the roots of common bean (Phaseolus vulgaris L.) and can cause reductions in plant growth and seed yield. The molecular changes in common bean roots caused by SCN infection are unknown. Identification of genetic factors associated with SCN resistance could help in development of improved bean varieties with high SCN resistance. Gene expression profiling was conducted on common bean roots infected by SCN HG type 0 using next generation RNA sequencing technology. Two pinto bean genotypes, PI533561 and GTS-900, resistant and susceptible to SCN infection, respectively, were used as RNA sources eight days post inoculation. Total reads generated ranged between similar to 3.2 and 5.7 million per library and were mapped to the common bean reference genome. Approximately 70-90% of filtered RNA-seq reads uniquely mapped to the reference genome. In the inoculated roots of resistant genotype PI533561, a total of 353 genes were differentially expressed with 154 up-regulated genes and 199 down-regulated genes when compared to the transcriptome of noninoculated roots. On the other hand, 990 genes were differentially expressed in SCN-inoculated roots of susceptible genotype GTS-900 with 406 up-regulated and 584 down-regulated genes when compared to non-inoculated roots. Genes encoding nucleotide-binding site leucine-rich repeat resistance (NLR) proteins, WRKY transcription factors, pathogenesis- related (PR) proteins and heat shock proteins involved in diverse biological processes were differentially expressed in both resistant and susceptible genotypes. Overall, suppression of the photosystem was observed in both the responses. Furthermore, RNA-seq results were validated through quantitative real time PCR. This is the first report describing genes/transcripts involved in SCN-common bean interaction and the results will have important implications for further characterization of SCN resistance genes in common bean.	[Jain, Shalu; Chittem, Kishore; Brueggeman, Robert; Richards, Jonathan; Nelson, Berlin D., Jr.] North Dakota State Univ, Dept Plant Pathol, Fargo, ND 58108 USA; [Osorno, Juan M.] North Dakota State Univ, Dept Plant Sci, Fargo, ND 58108 USA	North Dakota State University Fargo; North Dakota State University Fargo	Jain, S (corresponding author), North Dakota State Univ, Dept Plant Pathol, Fargo, ND 58108 USA.	shalu.jain@ndsu.edu	Osorno, Juan M/C-6971-2009; Chittem, Kishore/W-1282-2017	Chittem, Kishore/0000-0003-0318-5517; Richards, Jonathan/0000-0001-9342-3595	Specialty Crop Grant Northarvest Bean Grower association	Specialty Crop Grant Northarvest Bean Grower association	This work was supported by the Specialty Crop Grant Northarvest Bean Grower association. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold DL, 2011, MOL PLANT PATHOL, V12, P617, DOI [10.1111/j.1364-3703.2010.00697.x, 10.1111/J.1364-3703.2010.00697.X]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayyappan V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132176; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Bohlmann H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00089; Brosche M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004112; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cook DE, 2014, PLANT PHYSIOL, V165, P630, DOI 10.1104/pp.114.235952; Donald PA, 2006, J NEMATOL, V38, P76; Dong K, 1997, J NEMATOL, V29, P509; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Garcia AV, 2012, CELL MOL LIFE SCI, V69, P3259, DOI 10.1007/s00018-012-1093-3; Hamamouch N, 2011, MOL PLANT PATHOL, V12, P355, DOI 10.1111/j.1364-3703.2010.00675.x; Han YP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1800-1; Hernandez G, 2007, PLANT PHYSIOL, V144, P752, DOI 10.1104/pp.107.096958; Hirao T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-13; Hiz MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092598; Hosseini P, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0300-9; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Ibrahim HMM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-220; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Jain S, 2012, PLANT CELL TISS ORG, V109, P19, DOI 10.1007/s11240-011-0069-6; Kandoth PK, 2011, PLANT PHYSIOL, V155, P1960, DOI 10.1104/pp.110.167536; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Klink VP, 2007, PLANTA, V226, P1389, DOI 10.1007/s00425-007-0581-4; Klink VP, 2010, PLANT PHYSIOL BIOCH, V48, P176, DOI 10.1016/j.plaphy.2009.12.003; Klink VP, 2009, PLANT PHYSIOL, V151, P1017, DOI 10.1104/pp.109.144006; Klink VP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-111; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039650; Li XY, 2011, CHINESE SCI BULL, V56, P1904, DOI 10.1007/s11434-011-4510-3; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Liu XH, 2011, FUNCT INTEGR GENOMIC, V11, P539, DOI 10.1007/s10142-011-0225-4; Lopez CE, 2003, PHYTOPATHOLOGY, V93, P88, DOI 10.1094/PHYTO.2003.93.1.88; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; Martin LBB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00066; McClean PE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-184; McConnell M, 2010, THEOR APPL GENET, V121, P1103, DOI 10.1007/s00122-010-1375-9; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meksem K, 2001, THEOR APPL GENET, V103, P710, DOI 10.1007/s001220100597; Molinari S, 2014, MOL PLANT PATHOL, V15, P255, DOI 10.1111/mpp.12085; Niblack TL, 2005, PLANT DIS, V89, P1020, DOI 10.1094/PD-89-1020; Oblessuc PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043161; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Poromarto SH, 2012, PHYTOPATHOLOGY, V102, P93; Poromarto SH, 2010, PLANT DIS, V94, P1299, DOI 10.1094/PDIS-05-10-0326; Poromarto SH, 2009, PLANT DIS, V93, P507, DOI 10.1094/PDIS-93-5-0507; Schlueter J. A., 2008, Tropical Plant Biology, V1, P40, DOI 10.1007/s12042-007-9003-9; SCHMITT DP, 1992, CROP SCI, V32, P275, DOI 10.2135/cropsci1992.0011183X003200010056x; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Smith JR, 2003, J NEMATOL, V35, P23; Tenhaken R, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00771; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TYLKA GL, 2014, PLANT HLTH PROGR, V15, P13, DOI DOI 10.1094/PHP-BR-14-0006; van der Vossen EAG, 2000, PLANT J, V23, P567, DOI 10.1046/j.1365-313x.2000.00814.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Voss I, 2013, PLANT BIOLOGY, V15, P713, DOI 10.1111/j.1438-8677.2012.00710.x; Wan JR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1316-8; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wrather JA, 2001, CAN J PLANT PATHOL, V23, P115; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Xue RF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127698; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	67	35	36	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159338	10.1371/journal.pone.0159338	http://dx.doi.org/10.1371/journal.pone.0159338			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441552	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500055
J	Aspillaga, E; Bartumeus, F; Linares, C; Starr, RM; Lopez-Sanz, A; Diaz, D; Zabala, M; Hereu, B				Aspillaga, Eneko; Bartumeus, Frederic; Linares, Cristina; Starr, Richard M.; Lopez-Sanz, Angel; Diaz, David; Zabala, Mikel; Hereu, Bernat			Ordinary and Extraordinary Movement Behaviour of Small Resident Fish within a Mediterranean Marine Protected Area	PLOS ONE			English	Article							GROUPER EPINEPHELUS-MARGINATUS; WHITE SEA BREAM; HOME-RANGE; DIPLODUS-SARGUS; SPAWNING AGGREGATIONS; DIEL ACTIVITY; HABITAT USE; REPRODUCTIVE-BIOLOGY; FISHERIES MANAGEMENT; COMMUNITY STRUCTURE	It is important to account for the movement behaviour of fishes when designing effective marine protected areas (MPAs). Fish movements occur across different spatial and temporal scales and understanding the variety of movements is essential to make correct management decisions. This study describes in detail the movement patterns of an economically and commercially important species, Diplodus sargus, within a well-enforced Mediterranean MPA. We monitored horizontal and vertical movements of 41 adult individuals using passive acoustic telemetry for up to one year. We applied novel analysis and visualization techniques to get a comprehensive view of a wide range of movements. D. sargus individuals were highly territorial, moving within small home ranges(< 1 km(2)), inside which they displayed repetitive diel activity patterns. Extraordinary movements beyond the ordinary home range were observed under two specific conditions. First, during stormy events D. sargus presented a sheltering behaviour, moving to more protected places to avoid the disturbance. Second, during the spawning season they made excursions to deep areas (> 50 m), where they aggregated to spawn. This study advances our understanding about the functioning of an established MPA and provides important insights into the biology and management of a small sedentary species, suggesting the relevance of rare but important fish behaviours.	[Aspillaga, Eneko; Linares, Cristina; Zabala, Mikel; Hereu, Bernat] Univ Barcelona, Dept Ecol, Barcelona, Spain; [Aspillaga, Eneko] Ctr Estudis Avancats Blanes CEAB CSIC, Girona, Spain; [Bartumeus, Frederic] CREAF, Cerdanyola Del Valles, Spain; [Bartumeus, Frederic] ICREA, Barcelona, Spain; [Starr, Richard M.] Univ Calif, Sea Grant Extens Program, Moss Landing Marine Labs, Moss Landing, CA USA; [Lopez-Sanz, Angel] Inst Ciencies Mar ICM CSIC, Barcelona, Spain; [Diaz, David] Inst Espanol Oceanog, Ctr Oceanog Balears, Palma de Mallorca, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); ICREA; Moss Landing Marine Laboratories; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Spanish Institute of Oceanography	Aspillaga, E (corresponding author), Univ Barcelona, Dept Ecol, Barcelona, Spain.	aspillaga@ub.edu	Linares, Cristina/A-5244-2018; Hereu, Bernat/K-9150-2015; Aspillaga, Eneko/AAH-8613-2019; DIAZ, DAVID/AAS-8722-2021	Linares, Cristina/0000-0003-3855-2743; Hereu, Bernat/0000-0001-6247-7638; Aspillaga, Eneko/0000-0002-8888-8731; DIAZ, DAVID/0000-0003-0611-2516	Spanish Ministry of Science [CGL2005-05238/BOS]; Generalitat de Catalunya [AG-2014-654]; Spanish Ministry of Education (FPU) [AP2012-0141]; ICREA Funding Source: Custom	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministry of Education (FPU)(Spanish Government); ICREA(ICREA)	This research was funded by the Spanish Ministry of Science (CGL2005-05238/BOS) and the Generalitat de Catalunya (AG-2014-654). EA was supported by the Spanish Ministry of Education (FPU scholarship No. AP2012-0141). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Abecasis D, 2013, ESTUAR COAST SHELF S, V118, P80, DOI 10.1016/j.ecss.2012.12.014; Abecasis D, 2015, MAR ECOL PROG SER, V518, P255, DOI 10.3354/meps11054; Abecasis D, 2009, ESTUAR COAST SHELF S, V85, P525, DOI 10.1016/j.ecss.2009.09.001; Afonso P, 2008, MAR ECOL PROG SER, V359, P215, DOI 10.3354/meps07272; Aguzzi J, 2013, MAR ECOL PROG SER, V486, P223, DOI 10.3354/meps10399; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Burger J, 2001, ENVIRON MONIT ASSESS, V66, P23, DOI 10.1023/A:1026476030728; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chapman MR, 2000, ENVIRON BIOL FISH, V57, P11, DOI 10.1023/A:1004545724503; Claydon J, 2004, OCEANOGR MAR BIOL, V42, P265; D'Anna G, 2011, ITAL J ZOOL, V78, P255, DOI 10.1080/11250000903464059; DeMitcheson YS, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4; Denny CM, 2004, BIOL CONSERV, V116, P119, DOI 10.1016/S0006-3207(03)00183-6; Di Lorenzo M, 2016, MAR ENVIRON RES, V116, P1, DOI 10.1016/j.marenvres.2016.02.007; Di Lorenzo M, 2014, MAR ECOL PROG SER, V502, P245, DOI 10.3354/meps10723; Domeier ML, 1997, B MAR SCI, V60, P698; FAO, 2014, FAO SPEC FACT SHEETS; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Figueiredo M, 2005, FISH RES, V75, P107, DOI 10.1016/j.fishres.2005.04.013; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Garcia-Rubies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073922; Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155; Grothues TM, 2009, REV-METHODS TECHNOL, V9, P77, DOI 10.1007/978-1-4020-9640-2_5; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; HARMELINVIVIEN ML, 1995, HYDROBIOLOGIA, V300, P309, DOI 10.1007/BF00024471; Hereu B, 2005, MAR BIOL, V146, P293, DOI 10.1007/s00227-004-1439-y; Hereu B., 2012, FONS MARI ILLES MEDE, P35; Hereu B, 2008, ECOLOGY, V89, P3423, DOI 10.1890/07-0613.1; Hereu B, 2006, MAR ECOL PROG SER, V325, P187, DOI 10.3354/meps325187; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Jadot C, 2002, AQUAT LIVING RESOUR, V15, P343, DOI 10.1016/S0990-7440(02)01193-2; Koeck B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069303; Koeck B, 2013, J EXP MAR BIOL ECOL, V440, P1, DOI 10.1016/j.jembe.2012.11.014; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; LETOURNEUR Y, 1993, ENVIRON BIOL FISH, V37, P109, DOI 10.1007/BF00000586; Lino PG, 2009, REV-METHODS TECHNOL, V9, P23, DOI 10.1007/978-14020-9640-2_2; Lloret J, 2008, OCEAN COAST MANAGE, V51, P749, DOI 10.1016/j.ocecoaman.2008.07.001; Macpherson E, 1997, MAR ECOL PROG SER, V160, P135, DOI 10.3354/meps160135; March D, 2010, MAR ECOL PROG SER, V400, P195, DOI 10.3354/meps08410; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Meyer CG, 2010, MAR BIOL, V157, P1499, DOI 10.1007/s00227-010-1424-6; Moffitt EA, 2009, ECOL APPL, V19, P1835, DOI 10.1890/08-1101.1; Morato T, 2003, J FISH BIOL, V63, P59, DOI 10.1046/j.1095-8649.2003.00129.x; Mouine N, 2007, SCI MAR, V71, P461, DOI 10.3989/scimar.2007.71n3461; Nielson R. M., 2013, BBMM BROWNIAN BRIDGE; Oksanen J, 2013, PACKAGE VEGAN COMMUN, DOI [10.4135/9781412971874.n145, DOI 10.4135/9781412971874.N145]; Pages JF, 2013, MAR ECOL PROG SER, V492, P199, DOI 10.3354/meps10494; Pages JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062719; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; Pascual J, 2012, FONS MARI ILLES MEDE; Payne NL, 2010, MAR ECOL PROG SER, V419, P295, DOI 10.3354/meps08864; R Core Team, 2013, R LANG ENV STAT COMP; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; Sala E, 1996, MAR ECOL PROG SER, V140, P71, DOI 10.3354/meps140071; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Sala E, 2001, FISHERIES, V26, P23, DOI 10.1577/1548-8446(2001)026<0023:RDONGS>2.0.CO;2; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Walsh W.J., 1983, Coral Reefs, V2, P49, DOI 10.1007/BF00304732; Welsh JQ, 2012, CORAL REEFS, V31, P693, DOI 10.1007/s00338-012-0892-1; Williams ID, 2009, BIOL CONSERV, V142, P1066, DOI 10.1016/j.biocon.2008.12.029; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zabala M, 1997, SCI MAR, V61, P65	67	33	33	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159813	10.1371/journal.pone.0159813	http://dx.doi.org/10.1371/journal.pone.0159813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437692	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100075
J	Golz, G; Alter, T; Bereswill, S; Heimesaat, MM				Goelz, Greta; Alter, Thomas; Bereswill, Stefan; Heimesaat, Markus M.			The Immunopathogenic Potential of Arcobacter butzleri - Lessons from a Meta-Analysis of Murine Infection Studies	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; IMMUNE-RESPONSES; EPITHELIAL-CELLS; SPP.; ADHERENCE; MICE; OUTBREAK; ETIOLOGY; INVASION; DIARRHEA	Background Only limited information is available about the immunopathogenic properties of Arcobacter infection in vivo. Therefore, we performed a meta-analysis of published data in murine infection models to compare the pathogenic potential of Arcobacter butzleri with Campylobacter jejuni and commensal Escherichia coli as pathogenic and harmless reference bacteria, respectively. Methodology / Principal Findings Gnotobiotic IL-10(-/-) mice generated by broad-spectrum antibiotic compounds were perorally infected with A. butzleri (strains CCUG 30485 or C1), C. jejuni (strain 81-176) or a commensal intestinal E. coli strain. Either strain stably colonized the murine intestines upon infection. At day 6 postinfection (p.i.), C. jejuni infected mice only displayed severe clinical sequelae such as wasting bloody diarrhea. Gross disease was accompanied by increased numbers of colonic apoptotic cells and distinct immune cell populations including macrophages and monocytes, T and B cells as well as regulatory T cells upon pathogenic infection. Whereas A. butzleri and E. coli infected mice were clinically unaffected, respective colonic immune cell numbers increased in the former, but not in the latter, and more distinctly upon A. butzleri strain CCUG 30485 as compared to C1 strain infection. Both, A. butzleri and C. jejuni induced increased secretion of pro-inflammatory cytokines such as IFN-gamma, TNF, IL-6 and MCP-1 in large, but also small intestines. Remarkably, even though viable bacteria did not translocate from the intestines to extra-intestinal compartments, systemic immune responses were induced in C. jejuni, but also A. butzleri infected mice as indicated by increased respective pro-inflammatory cytokine concentrations in serum samples at day 6 p.i. Conclusion / Significance A. butzleri induce less distinct pro-inflammatory sequelae as compared to C. jejuni, but more pronounced local and systemic immune responses than commensal E. coli in a strain-dependent manner. Hence, data point towards that A. butzleri is more than a commensal in vertebrate hosts.	[Goelz, Greta; Alter, Thomas] Free Univ Berlin, Inst Food Hyg, Berlin, Germany; [Bereswill, Stefan; Heimesaat, Markus M.] Charite, Dept Microbiol & Hyg, Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Golz, G (corresponding author), Free Univ Berlin, Inst Food Hyg, Berlin, Germany.	greta.goelz@fu-berlin.de	Alter, Thomas/J-4810-2014	Heimesaat, Markus/0000-0001-6399-651X; Alter, Thomas/0000-0002-6048-5666	German Research Foundation (DFG) [SFB633]; German Federal Ministery of Education and Research (BMBF)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministery of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foundation (DFG) to SB and MMH (SFB633, TP A7 and B6, respectively), and from the German Federal Ministery of Education and Research (BMBF) to SB (TP1.1).	Adesiji YO, 2009, SIERRA LEONE J BIOME, V1, P6; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Bucker R, 2009, J INFECT DIS, V200, P756, DOI 10.1086/600868; Carbone M, 2003, FOOD MICROBIOL, V20, P611, DOI 10.1016/S0740-0020(02)00172-7; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Fernandez H, 2013, REV ARGENT MICROBIOL, V45, P75, DOI 10.1016/S0325-7541(13)70002-6; Ferreira S, 2015, CRIT REV MICROBIOL, P1; Golz G, 2015, EUR J MICROBIOL IMMU, V5, P321, DOI 10.1556/1886.2015.00043; Golz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139402; Golla SC, 2002, J FOOD PROTECT, V65, P1849, DOI 10.4315/0362-028X-65.12.1849; Gugliandolo C, 2008, MAR POLLUT BULL, V56, P600, DOI 10.1016/j.marpolbul.2007.12.001; Haag LM, 2012, EUR J MICROBIOL IMMU, V2, P2, DOI 10.1556/EuJMI.2.2012.1.2; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2015, EUR J MICROBIOL IMMU, V5, P333, DOI 10.1556/1886.2015.00042; Heimesaat MM, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0075-z; Heimesaat MM, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00077; Heimesaat MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090148; Ho HTK, 2007, FEMS IMMUNOL MED MIC, V50, P51, DOI 10.1111/j.1574-695X.2007.00230.x; Ho HTK, 2006, VET MICROBIOL, V115, P1, DOI 10.1016/j.vetmic.2006.03.004; ICMSF, 2002, MICR TEST FOOD SAF M; Jansen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-143; Jiang ZD, 2010, J CLIN MICROBIOL, V48, P1417, DOI 10.1128/JCM.01709-09; Karadas G, 2016, J APPL MICROBIOL, V120, P218, DOI 10.1111/jam.12979; Karadas G, 2013, J APPL MICROBIOL, V115, P583, DOI 10.1111/jam.12245; Lappi V, 2013, FOODBORNE PATHOG DIS, V10, P250, DOI 10.1089/fpd.2012.1307; Levican A, 2013, APPL ENVIRON MICROB, V79, P4951, DOI 10.1128/AEM.01073-13; Mandisodza O, 2012, NEW ZEAL MED J, V125, P40; Musmanno RA, 1997, MICROBIOLOGICA, V20, P63; Prouzet-Mauleon V, 2006, EMERG INFECT DIS, V12, P307; Silipo A, 2010, CARBOHYD RES, V345, P850, DOI 10.1016/j.carres.2010.01.012; TAYLOR DN, 1991, J INFECT DIS, V163, P1062, DOI 10.1093/infdis/163.5.1062; Van den Abeele AM, 2014, EMERG INFECT DIS, V20, P1731, DOI 10.3201/eid2010.140433; VANDAMME P, 1992, J CLIN MICROBIOL, V30, P2335, DOI 10.1128/JCM.30.9.2335-2337.1992; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Villarruel-Lopez A, 2003, J FOOD PROTECT, V66, P1374, DOI 10.4315/0362-028X-66.8.1374; Webb AL, 2016, J CLIN MICROBIOL, V54, P1082, DOI 10.1128/JCM.03202-15; Wesley IV, 1999, POULTRY SCI, V78, P536, DOI 10.1093/ps/78.4.536; zur Bruegge J, 2014, INT J MED MICROBIOL, V304, P1209, DOI 10.1016/j.ijmm.2014.08.017	39	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159685	10.1371/journal.pone.0159685	http://dx.doi.org/10.1371/journal.pone.0159685			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438014	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100068
J	Jaffar, N; Ishikawa, Y; Mizuno, K; Okinaga, T; Maeda, T				Jaffar, Norzawani; Ishikawa, Yuya; Mizuno, Kouhei; Okinaga, Toshinori; Maeda, Toshinari			Mature Biofilm Degradation by Potential Probiotics: Aggregatibacter actinomycetemcomitans versus Lactobacillus spp.	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; HUMAN PERIODONTAL-DISEASE; LOCALIZED JUVENILE PERIODONTITIS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ORAL-HEALTH; ACTINOMYCES-NAESLUNDII; STRAINS; BACTERIA; SUSCEPTIBILITY; MACROPHAGES	The biofilm degradation of Aggregatibacter actinomycetemcomitans is essential as a complete periodontal disease therapy, and here we show the effects of potential probiotic bacteria such as Lactobacillus spp. for the biofilm of several serotypes of A. actinomycetemcomitans strains. Eight of the 13 species showed the competent biofilm degradation of >= 90% reduction in biofilm values in A. actinomycetemcomitans Y4 (serotype b) as well as four of the seven species for the biofilm of A. actinomycetemcomitans OMZ 534 (serotype e). In contrast, the probiotic bacteria did not have a big impact for the degradation of A. actinomycetemcomitans SUNY 75 (serotype a) biofilm. The dispersed A. actinomycetemcomitans Y4 cells through the biofilm detachment were still viable and plausible factors for the biofilm degradation were not due to the lactic acid and low pH conditions. The three enzymes, protease, lipase, and amylase may be responsible for the biofilm degradation; in particular, lipase was the most effective enzyme for the biofilm degradation of A. actinomycetemcomitans Y4 along with the protease activity which should be also important for the other serotypes. Remarkable lipase enzyme activities were detected from some of the potential probiotics and a supporting result using a lipase inhibitor presented corroborating evidence that lipase activity is one of the contributing factors for biofilm degradation outside of the protease which is also another possible factor for the biofilm of the other serotype of A. actinomycetemcomitans strains. On the other hand, the biofilm of A. actinomycetemcomitans SUNY 75 (serotype a) was not powerfully degraded by the lipase enzyme because the lipase inhibitor was slightly functional for only two of potential probiotics.	[Jaffar, Norzawani; Ishikawa, Yuya; Maeda, Toshinari] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Dept Biol Funct Engn, Wakamatsu Ku, Kitakyushu, Fukuoka, Japan; [Jaffar, Norzawani] Univ Sultan Zainal Abidin UniSZA, Fac Hlth Sci, Gong Badak Campus, Kuala Terengganu, Terengganu Daru, Malaysia; [Mizuno, Kouhei] Kitakyushu Natl Coll Technol, Dept Mat Sci & Chem Engn, Kitakyushu, Fukuoka, Japan; [Okinaga, Toshinori] Kyushu Dent Univ, Sch Oral Hlth Sci, Fac Dent, Kitakyushu, Fukuoka, Japan; [Maeda, Toshinari] Kyushu Inst Technol, Res Ctr Adv Ecofitting Technol, Kitakyushu, Fukuoka, Japan	Kyushu Institute of Technology; Universiti Sultan Zainal Abidin; Kyushu Dental University; Kyushu Institute of Technology	Maeda, T (corresponding author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Dept Biol Funct Engn, Wakamatsu Ku, Kitakyushu, Fukuoka, Japan.; Maeda, T (corresponding author), Kyushu Inst Technol, Res Ctr Adv Ecofitting Technol, Kitakyushu, Fukuoka, Japan.	toshi.maeda@life.kyutech.ac.jp	Jaffar, Norzawani/AAP-6357-2021; Maeda, Toshinari/G-3302-2017	Jaffar, Norzawani/0000-0003-4560-7116; Maeda, Toshinari/0000-0002-6219-9110; Mizuno, Kouhei/0000-0002-2070-8669	Pfizer Health Research Foundation; University of Sultan Zainal Abidin (UniSZA); Grants-in-Aid for Scientific Research [15K11083] Funding Source: KAKEN	Pfizer Health Research Foundation; University of Sultan Zainal Abidin (UniSZA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Pfizer Health Research Foundation. NJ received a scholarship from the University of Sultan Zainal Abidin (UniSZA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg CH, 2015, VIRULENCE, V6, P188, DOI 10.4161/21505594.2014.982428; Amarasinghe JJ, 2009, INFECT IMMUN, V77, P2896, DOI 10.1128/IAI.00126-09; [Anonymous], 2002, EMERGING INFECT DIS, V8; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; BAKER PJ, 1995, ANTIMICROB AGENTS CH, V39, P406, DOI 10.1128/AAC.39.2.406; Boesze-Battaglia K, 2015, INFECT IMMUN, V83, P4042, DOI 10.1128/IAI.00788-15; Brown SA, 2007, J BACTERIOL, V189, P6407, DOI 10.1128/JB.00554-07; Caglar E, 2005, ORAL DIS, V11, P131, DOI 10.1111/j.1601-0825.2005.01109.x; Chise S, 2013, JARQ, V47, P249; Collado MC, 2007, J MICROBIOL METH, V71, P71, DOI 10.1016/j.mimet.2007.07.005; Collado MC, 2008, EUR FOOD RES TECHNOL, V226, P1065, DOI 10.1007/s00217-007-0632-x; de Toledo A, 2012, MOL ORAL MICROBIOL, V27, P295, DOI 10.1111/j.2041-1014.2012.00646.x; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; DIRIENZO JM, 1994, INFECT IMMUN, V62, P3058, DOI 10.1128/IAI.62.8.3058-3065.1994; Fine DH, 2001, J CLIN PERIODONTOL, V28, P697, DOI 10.1034/j.1600-051x.2001.028007697.x; Fine DH, 1999, ARCH ORAL BIOL, V44, P1063, DOI 10.1016/S0003-9969(99)00089-8; Free RH, 2001, ANN OTO RHINOL LARYN, V110, P946, DOI 10.1177/000348940111001010; Gilan I, 2013, FEMS MICROBIOL LETT, V342, P18, DOI 10.1111/1574-6968.12114; Haase EM, 2006, ARCH ORAL BIOL, V51, P299, DOI 10.1016/j.archoralbio.2005.09.002; Habil N, 2011, BENEF MICROBES, V2, P283, DOI 10.3920/BM2011.0027; HANDLEY PS, 1987, J GEN MICROBIOL, V133, P3207; Hansch GM, 2012, ISRN IMMUNOLOGY, V2012, P17, DOI [10.5402/2012/853123, DOI 10.5402/2012/853123]; Health ECoEo Bacteria NPoPiFiPMwLLA, 2001, HLTH NUTR PROP PROB; HOOVER CI, 1988, J DENT RES, V67, P574, DOI 10.1177/00220345880670030901; INOUYE T, 1990, FEMS MICROBIOL LETT, V69, P13, DOI 10.1016/0378-1097(90)90405-F; Ivec M, 2007, ANTIVIR RES, V75, P266, DOI 10.1016/j.antiviral.2007.03.013; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005; Kang MS, 2006, J CLIN PERIODONTOL, V33, P226, DOI 10.1111/j.1600-051X.2006.00893.x; Kaplan JB, 2002, J CLIN MICROBIOL, V40, P1181, DOI 10.1128/JCm.40.4.1181-1187.2002; Kaplan JB, 2003, J BACTERIOL, V185, P1399, DOI 10.1128/JB.185.4.1399-1404.2003; Karched M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0439-z; Kim JY, 2013, MOL CELLS, V35, P115, DOI 10.1007/s10059-013-2190-3; Kimizuka Ryuta, 2009, Bull Tokyo Dent Coll, V50, P23; Korhonen R, 2001, INFLAMMATION, V25, P223, DOI 10.1023/A:1010971703271; Krasse P, 2006, SWED DENT J, V30, P55; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Matangkasombut O, 2010, INFECT IMMUN, V78, P783, DOI 10.1128/IAI.00857-09; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259-266.2003; Morou-Bermudez E, 1999, INFECT IMMUN, V67, P504, DOI 10.1128/IAI.67.2.504-512.1999; Nikawa H, 2004, INT J FOOD MICROBIOL, V95, P219, DOI 10.1016/j.ijfoodmicro.2004.03.006; NORDSTEDT C, 1994, J BIOL CHEM, V269, P30773; Norskov-Lauritsen N, 2006, INT J SYST EVOL MICR, V56, P2135, DOI 10.1099/ijs.0.64207-0; Paju S, 2000, J CLIN MICROBIOL, V38, P79; Paturel L, 2004, CLIN MICROBIOL INFEC, V10, P98, DOI 10.1111/j.1469-0691.2004.00794.x; Paul-Satyaseela M, 2006, J MED MICROBIOL, V55, P931, DOI 10.1099/jmm.0.46470-0; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Saha S, 2012, EXPERT OPIN BIOL TH, V12, P1207, DOI 10.1517/14712598.2012.693474; Saito Takayuki, 2010, Bull Tokyo Dent Coll, V51, P145; Samot J, 2013, ANAEROBE, V19, P34, DOI 10.1016/j.anaerobe.2012.11.007; Sashihara T, 2006, J DAIRY SCI, V89, P2846, DOI 10.3168/jds.S0022-0302(06)72557-7; Shenker BJ, 2004, J IMMUNOL, V172, P410, DOI 10.4049/jimmunol.172.1.410; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Shenker BJ, 1999, J IMMUNOLOGY; Singh V, 2015, MICROBIOLOGY+, V84, P59, DOI 10.1134/S0026261715010130; SLOTS J, 1984, J DENT RES, V63, P412, DOI 10.1177/00220345840630031101; Sol A, 2013, INFECT IMMUN, V81, P3577, DOI 10.1128/IAI.01288-12; Takahashi N, 2007, J ANTIMICROB CHEMOTH, V59, P59, DOI 10.1093/jac/dkl452; Wang CY, 2010, J MICROBIOL IMMUNOL, V43, P491, DOI 10.1016/S1684-1182(10)60076-X; Wang PL, 2001, ORAL DIS, V7, P233, DOI 10.1034/j.1601-0825.2001.70406.x; Wilkinson SG, 1996, PROG LIPID RES, V35, P283, DOI 10.1016/S0163-7827(96)00004-5; Yusoff MZM, 2012, INT J HYDROGEN ENERG, V37, P17778, DOI 10.1016/j.ijhydene.2012.08.115; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x; ZAMBON JJ, 1983, INFECT IMMUN, V41, P19, DOI 10.1128/IAI.41.1.19-27.1983; Zhang YH, 2009, J MICROBIOL BIOTECHN, V19, P888, DOI 10.4014/jmb.0812.695; Zijnge V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041662	68	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159466	10.1371/journal.pone.0159466	http://dx.doi.org/10.1371/journal.pone.0159466			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438340	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100049
J	Posada, IMD; Serulla, M; Zhou, Y; Oetken-Lindholm, C; Abankwa, D; Lectez, B				Posada, Itziar M. D.; Serulla, Marc; Zhou, Yong; Oetken-Lindholm, Christina; Abankwa, Daniel; Lectez, Benoit			ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold	PLOS ONE			English	Article							H-RAS; K-RAS; MEMBRANE ORIENTATION; TUMOR-SUPPRESSOR; ACTIVATE RAF-1; STEM-CELLS; P53; PROTEINS; GALECTIN-1; CANCER	Ras-induced senescence mediated through ASPP2 represents a barrier to tumour formation. It is initiated by ASPP2's interaction with Ras at the plasma membrane, which stimulates the Raf/MEK/ERK signaling cascade. Ras to Raf signalling requires Ras to be organized in nanoscale signalling complexes, called nanocluster. We therefore wanted to investigate whether ASPP2 affects Ras nanoclustering. Here we show that ASPP2 increases the nanoscale clustering of all oncogenic Ras isoforms, H-ras, K-ras and N-ras. Structure-function analysis with ASPP2 truncation mutants suggests that the nanocluster scaffolding activity of ASPP2 converges on its alpha-helical domain. While ASPP2 increased effector recruitment and stimulated ERK and AKT phosphorylation, it did not increase colony formation of RasG12V transformed NIH/3T3 cells. By contrast, ASPP2 was able to suppress the transformation enhancing ability of the nanocluster scaffold Gal-1, by competing with the specific effect of Gal-1 on H-rasG12V- and K-rasG12V-nanoclustering, thus imposing ASPP2's ERK and AKT signalling signature. Similarly, ASPP2 robustly induced senescence and strongly abrogated mammosphere formation irrespective of whether it was expressed alone or together with Gal-1, which by itself showed the opposite effect in Ras wt or H-ras mutant breast cancer cells. Our results suggest that Gal-1 and ASPP2 functionally compete in nanocluster for active Ras on the plasma membrane. ASPP2 dominates the biological outcome, thus switching from a Gal-1 supported growth-promoting setting to a senescence inducing and stemness suppressive program in cancer cells. Our results support Ras nanocluster as major integrators of tumour fate decision events.	[Posada, Itziar M. D.; Serulla, Marc; Oetken-Lindholm, Christina; Abankwa, Daniel; Lectez, Benoit] Abo Akad Univ, Turku Ctr Biotechnol, Tykistokatu 6B, FIN-20520 Turku, Finland; [Zhou, Yong] Univ Texas Hlth Sci Ctr Houston, Sch Med, Houston, TX 77030 USA	Abo Akademi University; University of Texas System; University of Texas Health Science Center Houston	Abankwa, D (corresponding author), Abo Akad Univ, Turku Ctr Biotechnol, Tykistokatu 6B, FIN-20520 Turku, Finland.	daniel.abankwa@btk.fi		Zhou, Yong/0000-0002-0214-8151; Lectez, Benoit/0000-0001-9796-1606; Abankwa, Daniel/0000-0003-2769-0745; Serulla, Marc/0000-0002-4166-1556	Academy of Finland [252381, 256440, 281497]; Sigrid Juselius Foundation; Cancer Society of Finland; Marie-Curie Reintegration Grant; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Marie-Curie Reintegration Grant(European Commission); Jane and Aatos Erkko Foundation	This work was supported by the Academy of Finland fellowship grant ("Targeting a new Switch in oncogenic small GTPases"; #252381, 256440, 281497), the Sigrid Juselius Foundation, the Cancer Society of Finland, the Marie-Curie Reintegration Grant and the Jane and Aatos Erkko Foundation grants to D.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Amir AI, 2015, SCI REP-UK, V5, DOI 10.1038/srep11629; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Blazevits O, 2016, SCI REP-UK, V6, DOI 10.1038/srep24165; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ehrhardt A, 2004, MOL CELL BIOL, V24, P6311, DOI 10.1128/MCB.24.14.6311-6323.2004; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Godin-Heymann N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082022; Guzman C, 2014, J BIOL CHEM, V289, P9519, DOI 10.1074/jbc.M113.537001; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Inder KL, 2009, J BIOL CHEM, V284, P28410, DOI 10.1074/jbc.M109.001537; Jang H, 2016, BIOCHEM J, V473, P1719, DOI 10.1042/BCJ20160031; Kampa KM, 2009, CELL CYCLE, V8, P2871, DOI 10.4161/cc.8.18.9474; Kampa KM, 2009, P NATL ACAD SCI USA, V106, P4390, DOI 10.1073/pnas.0809080106; Kohnke M, 2012, CHEM BIOL, V19, P866, DOI 10.1016/j.chembiol.2012.05.019; Najumudeen AK, 2016, ONCOGENE, V35, P5248, DOI 10.1038/onc.2016.59; Najurnudeen AK, 2015, BIOCHEMISTRY-US, V54, P7212, DOI 10.1021/acs.biochem.5b00724; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior Ian A, 2003, Sci STKE, V2003, pPL9, DOI 10.1126/stke.2003.177.pl9; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Rotem S, 2008, J BIOL CHEM, V283, P18990, DOI 10.1074/jbc.M708717200; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Solman M, 2015, ELIFE, V4, DOI 10.7554/eLife.08905; Tidow H, 2007, J MOL BIOL, V371, P948, DOI 10.1016/j.jmb.2007.05.024; Tordella L, 2013, P NATL ACAD SCI USA, V110, P17969, DOI 10.1073/pnas.1309362110; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Wang MT, 2015, CELL, V163, P1237, DOI 10.1016/j.cell.2015.10.041; Wang Y, 2013, CELL DEATH DIFFER, V20, P525, DOI 10.1038/cdd.2013.3; Wang YH, 2012, P NATL ACAD SCI USA, V109, P13325, DOI 10.1073/pnas.1120193109; Wang ZP, 2013, P NATL ACAD SCI USA, V110, P312, DOI 10.1073/pnas.1201514110; Yamashita M, 2015, CELL STEM CELL, V17, P23, DOI 10.1016/j.stem.2015.05.013; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Zhou Y, 2014, MOL CELL BIOL, V34, P862, DOI 10.1128/MCB.01227-13	48	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159677	10.1371/journal.pone.0159677	http://dx.doi.org/10.1371/journal.pone.0159677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437940	Green Submitted, Green Published, gold			2022-12-27	WOS:000380170100066
J	van Beek, FE; Kuling, IA; Brenner, E; Tiest, WMB; Kappers, AML				van Beek, Femke E.; Kuling, Irene A.; Brenner, Eli; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.			Correcting for Visuo-Haptic Biases in 3D Haptic Guidance	PLOS ONE			English	Article							SPACE; DISTANCE; HAND; POSITION; TARGETS	Visuo-haptic biases are observed when bringing your unseen hand to a visual target. The biases are different between, but consistent within participants. We investigated the usefulness of adjusting haptic guidance to these user-specific biases in aligning haptic and visual perception. By adjusting haptic guidance according to the biases, we aimed to reduce the conflict between the modalities. We first measured the biases using an adaptive procedure. Next, we measured performance in a pointing task using three conditions: 1) visual images that were adjusted to user-specific biases, without haptic guidance, 2) veridical visual images combined with haptic guidance, and 3) shifted visual images combined with haptic guidance. Adding haptic guidance increased precision. Combining haptic guidance with user-specific visual information yielded the highest accuracy and the lowest level of conflict with the guidance at the end point. These results show the potential of correcting for user-specific perceptual biases when designing haptic guidance.	[van Beek, Femke E.; Kuling, Irene A.; Brenner, Eli; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Beek, FE (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	f.e.van.beek@vu.nl	Kuling, Irene/ABC-4022-2021	Kuling, Irene/0000-0003-3556-0393; van Beek, Femke/0000-0003-4741-6196; Brenner, Eli/0000-0002-3611-2843; Kappers, Astrid/0000-0003-4101-7717	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs, Agriculture and Innovation [12157]	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs, Agriculture and Innovation	This work was supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO) and partly funded by the Ministry of Economic Affairs, Agriculture and Innovation, under grant number 12157.	Abbink DA, 2012, COGN TECHNOL WORK, V14, P19, DOI 10.1007/s10111-011-0192-5; Adamovich SV, 1998, J NEUROPHYSIOL, V79, P2833, DOI 10.1152/jn.1998.79.6.2833; Brenner E, 2000, VISION RES, V40, P1649, DOI 10.1016/S0042-6989(00)00062-6; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; Gentaz E, 2004, PSYCHON B REV, V11, P31, DOI 10.3758/BF03206457; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; Hayward V., 2004, Sensor Review, V24, P16, DOI 10.1108/02602280410515770; Kuling IA, 2015, EXP BRAIN RES, V233, P61, DOI 10.1007/s00221-014-4086-7; Kuling IA, ADJUSTING HAPT UNPUB; Kuling IA, ERRORS VISUO H UNPUB; Kuling IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074236; Mon-Williams M, 1999, PERCEPTION, V28, P167, DOI 10.1068/p2737; Mugge W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150912; Pierce RM, 2012, P IEEE RAS-EMBS INT, P169, DOI 10.1109/BioRob.2012.6290927; Rincon-Gonzalez L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025214; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; Sousa R, 2010, VISION RES, V50, P1786, DOI 10.1016/j.visres.2010.05.035; Sousa R, 2012, J VISION, V12, DOI 10.1167/12.10.6; TILLERY SIH, 1994, NEUROREPORT, V6, P177; van Beek FE, 2014, LECT NOTES COMPUT SC, V8618, P48, DOI 10.1007/978-3-662-44193-0_7; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van der Kooij K, 2013, J NEUROPHYSIOL, V109, P1890, DOI 10.1152/jn.00845.2012; van der Linde RQ, 2003, IND ROBOT, V30, P515, DOI 10.1108/01439910310506783	25	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158709	10.1371/journal.pone.0158709	http://dx.doi.org/10.1371/journal.pone.0158709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438009	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100018
J	Zhang, L; Wang, W; Gao, Y; Lan, J; Xie, LX				Zhang, Lu; Wang, Wen; Gao, Yan; Lan, Jie; Xie, Lixin			The Efficacy and Safety of Current Treatments in Diabetic Macular Edema: A Systematic Review and Network Meta-Analysis	PLOS ONE			English	Review							GRID LASER PHOTOCOAGULATION; INTRAVITREAL BEVACIZUMAB; RANIBIZUMAB-MONOTHERAPY; RANDOMIZED-TRIAL; TRIAMCINOLONE; VEGF; DEXAMETHASONE; AFLIBERCEPT; MANAGEMENT	Purpose To compare the efficacy and safety of current treatments in diabetic macular edema (DME). Methods PubMed, Embase and CENTRAL were systematically reviewed for randomized controlled trials of current treatments in DME through August 2015. Data on the mean change of best-corrected visual acuity (BCVA) and central macular thickness (CMT) were extracted, and adverse events (AEs) were collected. Results A total of 21 trials were included in our network meta-analysis. Intravitreal ranibizumab improved BCVA most significantly (OR: +7.01 95% CI (2.56 to 11.39)) in 6 months and intravitreal aflibercept (+8.19 (5.07 to 11.96)) in 12 months. Intravitreal triamcinolone combined with LASER decreased CMT most significantly (-111.34 (-254.61 to 37.93)) in 6 months and intravitreal aflibercept (-110.83 (-190.25 to -35.27)) in 12 months. Compared with the relatively high rate of ocular AEs in the groups with administration of steroids, systematic AEs occurred more frequently in the groups with vascular endothelial growth factor inhibitors involved. Conclusions Our analysis confirms that intravitreal aflibercept is most favorable with both BCVA improvement and CMT decrease than other current therapies in the management of DME within 12 months. Vascular endothelial growth factor inhibitors for DME should be used with caution due to systematic AEs. Combined intravitreal triamcinolone with LASER has a stronger efficacy in decreasing CMT than the other interventions in the early stage after injection. More high-quality randomized controlled trials will be necessary.	[Zhang, Lu] Shandong Univ, Sch Med, Dept Ophthalmol, Jinan, Peoples R China; [Zhang, Lu; Gao, Yan; Lan, Jie; Xie, Lixin] Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Peoples R China; [Wang, Wen] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Soochow University - China	Xie, LX (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Peoples R China.	lixin_xie@hotmail.com	Xie, li/HGE-6052-2022		National Natural Science Foundation of China [81570820]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was partly supported by a grant from the National Natural Science Foundation of China (81570820).	Agarwal A, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0652-z; Ahmadieh H, 2008, GRAEF ARCH CLIN EXP, V246, P483, DOI 10.1007/s00417-007-0688-0; Arevalo JF, 2013, RETINA-J RET VIT DIS, V33, P403, DOI 10.1097/IAE.0b013e3182695b83; Audren F, 2006, ACTA OPHTHALMOL SCAN, V84, P624, DOI 10.1111/j.1600-0420.2006.00700.x; Behl T, 2015, PHARMACOL RES, V99, P137, DOI 10.1016/j.phrs.2015.05.013; Berger A, 2013, CAN J DIABETES, V37, pS48; Berger A, 2015, CAN J OPHTHALMOL, V50, P209, DOI 10.1016/j.jcjo.2014.12.014; Bhatnagar Nidhi, 2014, Perspect Clin Res, V5, P154, DOI 10.4103/2229-3485.140550; Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034; Callanan DG, 2013, OPHTHALMOLOGY, V120, P1843, DOI 10.1016/j.ophtha.2013.02.018; Campa C, 2011, CURR DRUG TARGETS, V12, P173, DOI 10.2174/138945011794182674; Comyn O, 2014, AM J OPHTHALMOL, V157, P960, DOI 10.1016/j.ajo.2014.02.019; Das A, 2015, OPHTHALMOLOGY, V122, P1375, DOI 10.1016/j.ophtha.2015.03.024; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dowler JGF, 2003, J ROY SOC MED, V96, P277, DOI 10.1258/jrsm.96.6.277; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Ford JA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002269; Funatsu H, 2009, OPHTHALMOLOGY, V116, P73, DOI 10.1016/j.ophtha.2008.09.037; Gillies MC, 2014, OPHTHALMOLOGY, V121, P2473, DOI 10.1016/j.ophtha.2014.07.002; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishibashi T, 2015, OPHTHALMOLOGY, V122, P1402, DOI 10.1016/j.ophtha.2015.02.006; Ishida S, 2003, INVEST OPHTH VIS SCI, V44, P2155, DOI 10.1167/iovs.02-0807; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; Korobelnik JF, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0035-x; Korobelnik JF, 2014, OPHTHALMOLOGY, V121, P2247, DOI 10.1016/j.ophtha.2014.05.006; Kriechbaum K, 2014, EYE, V28, P9, DOI 10.1038/eye.2013.242; Lam DSC, 2007, OPHTHALMOLOGY, V114, P2162, DOI 10.1016/j.ophtha.2007.02.006; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Nepomuceno AB, 2013, AM J OPHTHALMOL, V156, P502, DOI 10.1016/j.ajo.2013.04.026; Ozaki H, 1997, EXP EYE RES, V64, P505, DOI 10.1006/exer.1996.0239; Pappas GD, 2008, TRIAMCINOLONE GRID L; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016; Regnier SA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007527; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; SCHATZ H, 1991, ARCH OPHTHALMOL-CHIC, V109, P1549, DOI 10.1001/archopht.1991.01080110085041; Scott IU, 2007, OPHTHALMOLOGY, V114, P1860, DOI 10.1016/j.ophtha.2007.05.062; Shoeibi Nasser, 2013, J Ophthalmic Vis Res, V8, P99; Soheilian M, 2012, RETINA-J RET VIT DIS, V32, P314, DOI 10.1097/IAE.0b013e31822f55de; Sultan MB, 2011, OPHTHALMOLOGY, V118, P1107, DOI 10.1016/j.ophtha.2011.02.045; Synek S, 2011, COLLEGIUM ANTROPOL, V35, P841; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Williams R, 2004, EYE, V18, P963, DOI 10.1038/sj.eye.6701476; Zhang XL, 2013, INT J OPHTHALMOL-CHI, V6, P546, DOI 10.3980/j.issn.2222-3959.2013.04.26	49	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159553	10.1371/journal.pone.0159553	http://dx.doi.org/10.1371/journal.pone.0159553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434498	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169600069
J	Pereira-Simon, S; Rubio, GA; Xia, XM; Cai, WJ; Choi, R; Striker, GE; Elliot, SJ				Pereira-Simon, Simone; Rubio, Gustavo A.; Xia, Xiaomei; Cai, Weijing; Choi, Rhea; Striker, Gary E.; Elliot, Sharon J.			Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor a Expression in Aged Female Mice	PLOS ONE			English	Article							TYPE-2 DIABETIC-NEPHROPATHY; ER-ALPHA EXPRESSION; BREAST-CANCER CELLS; GROWTH-FACTOR-BETA; OXIDATIVE STRESS; TGF-BETA; OXIDANT STRESS; KAPPA-B; INFLAMMATORY RESPONSE; SIRT1 DEACETYLASE	Age-related increases in oxidant stress (OS) play a role in regulation of estrogen receptor (ER) expression in the kidneys. In this study, we establish that in vivo 17 beta-estradiol (E-2) replacement can no longer upregulate glomerular ER expression by 21 months of age in female mice (anestrous). We hypothesized that advanced glycation end product (AGE) accumulation, an important source of oxidant stress, contributes to these glomerular ER expression alterations. We treated 19-month old ovariectomized female mice with pyridoxamine (Pyr), a potent AGE inhibitor, in the presence or absence of E-2 replacement. Glomerular ER alpha mRNA expression was upregulated in mice treated with both Pyr and E-2 replacement and TGF beta mRNA expression decreased compared to controls. Histological sections of kidneys demonstrated decreased type IV collagen deposition in mice receiving Pyr and E-2 compared to placebo control mice. In addition, anti-AGE defenses Sirtuin1 (SIRT1) and advanced glycation receptor 1 (AGER1) were also upregulated in glomeruli following treatment with Pyr and E-2. Mesangial cells isolated from all groups of mice demonstrated similar ER alpha, SIRT1, and AGER1 expression changes to those of whole glomeruli. To demonstrate that AGE accumulation contributes to the observed age-related changes in the glomeruli of aged female mice, we treated mesangial cells from young female mice with AGE-BSA and found similar downregulation of ER alpha, SIRT1, and AGER1 expression. These results suggest that inhibition of intracellular AGE accumulation with pyridoxamine may protect glomeruli against age-related oxidant stress by preventing an increase of TGF beta production and by regulation of the estrogen receptor.	[Pereira-Simon, Simone; Rubio, Gustavo A.; Xia, Xiaomei; Elliot, Sharon J.] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Cai, Weijing; Striker, Gary E.] Mt Sinai Sch Med, Dept Geriatr & Palliat Care, Div Expt Diabet & Aging, 1 Gustave Levy Pl, New York, NY USA; [Choi, Rhea] Univ Miami, Miller Sch Med, Dept Med, Miami, FL USA	University of Miami; Icahn School of Medicine at Mount Sinai; University of Miami	Elliot, SJ (corresponding author), Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA.	selliot@med.miami.edu		Choi, Rhea/0000-0002-3173-9890	National Institute of Aging grant [RR01 AG17170-13]	National Institute of Aging grant	Author SJE was supported by the National Institute of Aging grant RR01 AG17170-13 (https://www.nia.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson NL, 2003, KIDNEY INT, V63, P2123, DOI 10.1046/j.1523-1755.2003.00027.x; Alderson NL, 2004, DIABETOLOGIA, V47, P1385, DOI 10.1007/s00125-004-1474-8; Blush J, 2004, KIDNEY INT, V66, P2148, DOI 10.1111/j.1523-1755.2004.66005.x; Brands CMJ, 2000, J AGR FOOD CHEM, V48, P2271, DOI 10.1021/jf9907586; Cai W, 2012, P NATLACADSCIUSA; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Cai WJ, 2006, P NATL ACAD SCI USA, V103, P13801, DOI 10.1073/pnas.0600362103; Cai WJ, 2002, MOL MED, V8, P337, DOI 10.1007/BF03402014; Casalena G, 2012, SEMIN NEPHROL, V32, P295, DOI 10.1016/j.semnephrol.2012.04.009; Cohen MP, 1998, EXP NEPHROL, V6, P226; Doublier S, 2009, KIDNEY INT, V75, P1194, DOI [10.1038/ki.2009.69, DOI 10.1038/KI.2009.69]; Eikmans M, 2001, KIDNEY INT, V60, P974, DOI 10.1046/j.1523-1755.2001.060003974.x; Elliot SJ, 2007, KIDNEY INT, V72, P464, DOI 10.1038/sj.ki.5002328; Elliot SJ, 2006, J AM SOC NEPHROL, V17, P3315, DOI 10.1681/ASN.2006070799; ELLIOT SJ, 1993, ENDOCRINOLOGY, V133, P1783, DOI 10.1210/en.133.4.1783; Finot PA, 2005, ANN NY ACAD SCI, V1043, P1, DOI 10.1196/annals.1333.001; Goldberg T, 2004, J AM DIET ASSOC, V104, P1287, DOI 10.1016/j.jada.2004.05.214; Goldfarb S, 2001, Trans Am Clin Climatol Assoc, V112, P27; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Helmersson J, 2002, CLIN SCI, V102, P39, DOI 10.1042/CS20010179; Holloway JN, 2004, MOL ENDOCRINOL, V18, P1396, DOI 10.1210/me.2004-0048; KALANT N, 1977, CAN J BIOCHEM CELL B, V55, P1197, DOI 10.1139/o77-179; Kang Z, 2006, AMINO ACIDS, V30, P55, DOI 10.1007/s00726-005-0209-6; Karl M, 2006, AM J PATHOL, V169, P351, DOI 10.2353/ajpath.2006.051255; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kosch M, 2003, NEPHROL DIAL TRANSPL, V18, P1370, DOI 10.1093/ndt/gfg169; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; Kovacic P, 2011, J RECEPT SIG TRANSD, V31, P332, DOI 10.3109/10799893.2011.607171; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Lee HC, 2007, EXP BIOL MED, V232, P592; Lewis EJ, 2001, AM J KIDNEY DIS, V38, pS191, DOI 10.1053/ajkd.2001.27442; LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241; Lu CY, 2004, P NATL ACAD SCI USA, V101, P11767, DOI 10.1073/pnas.0401588101; MACKAY K, 1988, KIDNEY INT, V33, P677, DOI 10.1038/ki.1988.53; Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010; Moore RL, 2012, J ENDOCRINOL, V213, P37, DOI 10.1530/JOE-11-0217; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Oh AS, 2001, MOL ENDOCRINOL, V15, P1344, DOI 10.1210/me.15.8.1344; Pereira-Simon S, 2012, ENDOCRINOLOGY, V153, P5491, DOI 10.1210/en.2012-1379; Poncelet AC, 1998, AM J PHYSIOL-RENAL, V275, pF458; Potier M, 2002, AM J PATHOL, V160, P1877, DOI 10.1016/S0002-9440(10)61134-0; Potier M, 2001, JAMSOCNEPHROL, V12; Pouillart P, 2008, ANN NY ACAD SCI, V1126, P173, DOI 10.1196/annals.1433.040; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Tanimoto M, 2007, METABOLISM, V56, P160, DOI 10.1016/j.metabol.2006.08.026; Turgut F, 2010, AM J KIDNEY DIS, V55, P928, DOI 10.1053/j.ajkd.2009.11.021; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Uribarri J, 2006, CLIN J AM SOC NEPHRO, V1, P1293, DOI 10.2215/CJN.01270406; Uribarri J, 2014, AMINO ACIDS, V46, P301, DOI 10.1007/s00726-013-1502-4; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Vlassara H, 2009, J CLIN ENDOCR METAB, V94, P4483, DOI 10.1210/jc.2009-0089; Wharton W, BRAIN RES; Williams ME, 2007, AM J NEPHROL, V27, P605, DOI 10.1159/000108104; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu M, 2011, J AM SOC NEPHROLOGY; Zheng F, 2004, AM J PATHOL, V165, P1789, DOI 10.1016/S0002-9440(10)63434-7; Zheng F, 2003, AM J PATHOL, V162, P1339, DOI 10.1016/S0002-9440(10)63929-6	61	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159666	10.1371/journal.pone.0159666	http://dx.doi.org/10.1371/journal.pone.0159666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428057	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300080
J	Wu, W; Zhao, L; Yang, P; Zhou, W; Li, BB; Moorhead, JF; Varghese, Z; Ruan, XZ; Chen, YX				Wu, Wei; Zhao, Lei; Yang, Ping; Zhou, Wei; Li, Beibei; Moorhead, John F.; Varghese, Zac; Ruan, Xiong Z.; Chen, Yaxi			Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/- Mice	PLOS ONE			English	Article							HIGH-FAT DIET; OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS; MITOCHONDRIAL DYSFUNCTION; METABOLIC-DISORDERS; LIPID-PEROXIDATION; NRF2-NULL MICE; KNOCKOUT MICE; IN-VIVO; HEPATOTOXICITY	Statins, which are revolutionized cholesterol-lowing agents, have been reported to have unfavorable effects on the liver. Inflammatory stress is a susceptibility factor for drug-induced liver injury. This study investigated whether inflammatory stress sensitized the liver to statin-induced toxicity in mice and explored the underlying mechanisms. We used casein injection in ApoE-/- mice to induce inflammatory stress. Half of the mice were orally administered atorvastatin (10mg/kg/d) for 8 weeks. The results showed that casein injection increased the levels of serum pro-inflammatory cytokines (IL-6 and TNF alpha). Atorvastatin treatment increased serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in casein injection mice. Moreover, atorvastatin treatment exacerbated hepatic steatosis, inflammation and fibrosis, as well as increased hepatic reactive oxygen species (ROS) and malondialdehyde in casein injection mice. However, above changes were not observed in atorvastatin treated alone mice. The protein expression of liver nuclear factor erythroid 2-related factor 2 (Nrf2) and the mRNA expressions of Nrf2 target genes were increased, together with the enhancement of activities of hepatic catalase and superoxide dismutase in atorvastatin treated alone mice, but these antioxidant responses were lost in mice treated with atorvastatin under inflammatory stress. This study demonstrates that atorvastatin exacerbates the liver injury under inflammatory stress, which may be associated with the loss of adaptive antioxidant response mediated by Nrf2.	[Wu, Wei; Zhao, Lei; Yang, Ping; Zhou, Wei; Li, Beibei; Ruan, Xiong Z.; Chen, Yaxi] Chongqing Med Univ, Ctr Lipid Res, Chongqing, Peoples R China; [Wu, Wei; Zhao, Lei; Yang, Ping; Zhou, Wei; Li, Beibei; Ruan, Xiong Z.; Chen, Yaxi] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Inst Viral Hepatitis,Dept Infect Dis,Affiliated H, Chongqing, Peoples R China; [Ruan, Xiong Z.] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Moorhead, John F.; Varghese, Zac; Ruan, Xiong Z.] UCL, Sch Med, John Moorhead Res Lab, Ctr Nephrol, Royal Free Campus, London, England	Chongqing Medical University; Chongqing Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; University of London; University College London; UCL Medical School	Ruan, XZ; Chen, YX (corresponding author), Chongqing Med Univ, Ctr Lipid Res, Chongqing, Peoples R China.; Ruan, XZ; Chen, YX (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Inst Viral Hepatitis,Dept Infect Dis,Affiliated H, Chongqing, Peoples R China.; Ruan, XZ (corresponding author), UCL, Sch Med, John Moorhead Res Lab, Ctr Nephrol, Royal Free Campus, London, England.	x.ruan@ucl.ac.uk; chenyaxi@cqmu.edu.cn	Moorhead, John/M-7404-2014; Ruan, Xiong Zhong/GZA-5963-2022	Ruan, Xiong Zhong/0000-0001-5199-4971	Major State Basic Research Development Program of China (973 Program) [2012CB517700, 2012CB517500]; National Natural Science Foundation of China [81270789, 81390354, 81570517, 81270493]; Chongqing Research Program of Basic Research and Frontier Technology [cstc2015jcyjBX0044]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Research Program of Basic Research and Frontier Technology	Major State Basic Research Development Program of China (973 Program, NO. 2012CB517700), http://www.most.gov.cn/, XZR received the funding; Major State Basic Research Development Program of China (973 Program, NO. 2012CB517500), http://www.most.gov.cn/, YC received the funding; National Natural Science Foundation of China (81270789, 81390354), http://www.nsfc.gov.cn/, XZR received the funding; National Natural Science Foundation of China (81570517, 81270493), http://www.nsfc.gov.cn/, YC received the funding; Chongqing Research Program of Basic Research and Frontier Technology (No. cstc2015jcyjBX0044), http://www.cstc.gov.cn/, YC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2014, FREE RADICAL BIO MED, V75, pS40, DOI 10.1016/j.freeradbiomed.2014.10.790; Aminzadeh MA, 2013, NEPHROL DIAL TRANSPL, V28, P2038, DOI 10.1093/ndt/gft022; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Berson A, 1998, GASTROENTEROLOGY, V114, P764, DOI 10.1016/S0016-5085(98)70590-6; Bjornsson E, 2012, J HEPATOL, V56, P374, DOI [10.1016/j.jhep.2011.08.016, 10.1016/j.jhep.2011.07.023]; Bouitbir J, 2016, ANTIOXID REDOX SIGN, V24, P84, DOI 10.1089/ars.2014.6190; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Chen YX, 2014, NEPHROL DIAL TRANSPL, V29, P1864, DOI 10.1093/ndt/gfu203; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Clarke AT, 2006, DIGEST LIVER DIS, V38, P772, DOI 10.1016/j.dld.2006.04.013; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Copple Ian M, 2010, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-642-00663-0_9; Deng XM, 2009, PHARMACOL REV, V61, P262, DOI 10.1124/pr.109.001727; Dworski R, 2011, FREE RADICAL BIO MED, V51, P516, DOI 10.1016/j.freeradbiomed.2011.04.040; Engelhardt JF, 1999, ANTIOXID REDOX SIGN, V1, P5, DOI 10.1089/ars.1999.1.1-5; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Ganey PE, 2004, CHEM-BIOL INTERACT, V150, P35, DOI 10.1016/j.cbi.2004.09.002; Han D, 2013, TRENDS PHARMACOL SCI, V34, P243, DOI 10.1016/j.tips.2013.01.009; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Labbe G, 2008, FUND CLIN PHARMACOL, V22, P335, DOI 10.1111/j.1472-8206.2008.00608.x; Lee J, 2015, BIOCHEM BIOPH RES CO, V464, P229, DOI 10.1016/j.bbrc.2015.06.121; Leonarduzzi G, 1997, FASEB J, V11, P851, DOI 10.1096/fasebj.11.11.9285483; Liu F, 2010, TOXICOL SCI, V115, P596, DOI 10.1093/toxsci/kfq075; Liu J, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/305861; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Meakin PJ, 2014, MOL CELL BIOL, V34, P3305, DOI [10.1128/MCB.00677-14, 10.1128/MCB.00677-1]; Nieto N, 2002, HEPATOLOGY, V35, P62, DOI 10.1053/jhep.2002.30362; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Okada K, 2013, J GASTROENTEROL, V48, P620, DOI 10.1007/s00535-012-0659-z; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; Pereira CV, 2012, EXPERT OPIN DRUG MET, V8, P219, DOI 10.1517/17425255.2012.645536; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Rieber N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/252460; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Tariq Z, 2014, LIVER INT, V34, pE180, DOI 10.1111/liv.12523; Wu Y, 2013, J ENDOCRINOL, V219, P195, DOI 10.1530/JOE-13-0160; Yuan LY, 2013, CLIN LIVER DIS, V17, P507, DOI 10.1016/j.cld.2013.07.002; Zhao L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10222; Zhao L, 2011, J GASTROEN HEPATOL, V26, P875, DOI 10.1111/j.1440-1746.2010.06560.x; Zou HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040432	43	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159512	10.1371/journal.pone.0159512	http://dx.doi.org/10.1371/journal.pone.0159512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428373	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300073
J	Cameron, EZ; Ryan, SJ				Cameron, Elissa Z.; Ryan, Sadie J.			Welfare at Multiple Scales: Importance of Zoo Elephant Population Welfare in a World of Declining Wild Populations	PLOS ONE			English	Editorial Material							RELATEDNESS; IMPACTS; RISK		[Cameron, Elissa Z.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Cameron, Elissa Z.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Ryan, Sadie J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA	University of Canterbury; University of Tasmania; State University System of Florida; University of Florida	Cameron, EZ (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand.; Cameron, EZ (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	elissa.cameron@canterbury.ac.nz	Ryan, Sadie Jane/H-7488-2019; Cameron, Elissa/B-8053-2014	Ryan, Sadie Jane/0000-0002-4308-6321; Cameron, Elissa/0000-0002-9243-0547				baLLou J. d., 1995, POPULATION MANAGEMEN; Bennett EL, 2015, CONSERV BIOL, V29, P54, DOI 10.1111/cobi.12377; Breuer T, 2016, CONSERV BIOL; Brown JL, 2016, PLOS ONE; Bunting E, 2013, LAND-BASEL, V2, P225, DOI 10.3390/land2020225; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; de Boer WF, 2013, BIOL CONSERV, V159, P468, DOI 10.1016/j.biocon.2012.10.015; Fiona Harvey, 2016, GUARDIAN; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Greco BJ, 2016, PLOS ONE; Holdgate MR, 2016, PLOS ONE; Ihwagi FW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139079; [IUCN T UNEP C], 2013, EL DUST THE AFR EL C; Jachowski DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031818; Jathanna D, 2015, BIOL CONSERV, V187, P212, DOI 10.1016/j.biocon.2015.04.030; Jeffery Gettleman, 2016, NY TIMES; Kerley GIH, 2006, S AFR J SCI, V102, P395; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Mackenzie CA, 2012, ECOL ECON, V75, P72, DOI 10.1016/j.ecolecon.2011.12.018; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Malhi Y, 2016, P NATL ACAD SCI USA, V113, P838, DOI 10.1073/pnas.1502540113; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; Meehan C, PLOS ONE IN PRESS; Meehan CL, 2016, PLOS ONE; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; MILNERGULLAND EJ, 1993, P ROY SOC B-BIOL SCI, V252, P29, DOI 10.1098/rspb.1993.0042; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Mumby HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep13946; Nyhus P, 2004, AGR ECOSYST ENVIRON, V104, P87, DOI 10.1016/j.agee.2004.01.009; Prado-Oviedo NA, 2016, PLOS ONE; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Rutina LP, 2005, WILDLIFE BIOL, V11, P207, DOI 10.2981/0909-6396(2005)11[207:ELADWC]2.0.CO;2; Ryan SJ, 2006, CONSERV BIOL, V20, P1321, DOI 10.1111/j.1523-1739.2006.00347.x; Ryan SJ, 2001, ZOO BIOL, V20, P89, DOI 10.1002/zoo.1009; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Shannon G, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-62; Sukumar R., 1992, ASIAN ELEPHANT ECOLO; Suprahman H, 1986, ECOLOGY ELEPHANT ELE; Thitaram C, 2015, APPL ANIM BEHAV SCI, V172, P52, DOI 10.1016/j.applanim.2015.09.002; van Aarde RJ, 2006, S AFR J SCI, V102, P385; Wasser SK, 2015, SCIENCE, V349, P84, DOI 10.1126/science.aaa2457; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111	42	5	5	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158701	10.1371/journal.pone.0158701	http://dx.doi.org/10.1371/journal.pone.0158701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415004	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500031
J	Greco, BJ; Meehan, CL; Miller, LJ; Shepherdson, DJ; Morfeld, KA; Andrews, J; Baker, AM; Carlstead, K; Mench, JA				Greco, Brian J.; Meehan, Cheryl L.; Miller, Lance J.; Shepherdson, David J.; Morfeld, Kari A.; Andrews, Jeff; Baker, Anne M.; Carlstead, Kathy; Mench, Joy A.			Elephant Management in North American Zoos: Environmental Enrichment, Feeding, Exercise, and Training	PLOS ONE			English	Article							POSITIVE REINFORCEMENT; STEREOTYPIC BEHAVIOR; NOCTURNAL BEHAVIOR; WELFARE; CHILDREN; OBESITY; BONE; RATS	The management of African (Loxodonta africana) and Asian (Elephas maximus) elephants in zoos involves a range of practices including feeding, exercise, training, and environmental enrichment. These practices are necessary to meet the elephants' nutritional, healthcare, and husbandry needs. However, these practices are not standardized, resulting in likely variation among zoos as well as differences in the way they are applied to individual elephants within a zoo. To characterize elephant management in North America, we collected survey data from zoos accredited by the Association of Zoos and Aquariums, developed 26 variables, generated population level descriptive statistics, and analyzed them to identify differences attributable to sex and species. Sixty-seven zoos submitted surveys describing the management of 224 elephants and the training experiences of 227 elephants. Asian elephants spent more time managed (defined as interacting directly with staff) than Africans (mean time managed: Asians = 56.9%; Africans = 48.6%; p<0.001), and managed time increased by 20.2% for every year of age for both species. Enrichment, feeding, and exercise programs were evaluated using diversity indices, with mean scores across zoos in the midrange for these measures. There were an average of 7.2 feedings every 24-hour period, with only 1.2 occurring during the nighttime. Feeding schedules were predictable at 47.5% of zoos. We also calculated the relative use of rewarding and aversive techniques employed during training interactions. The population median was seven on a scale from one (representing only aversive stimuli) to nine (representing only rewarding stimuli). The results of our study provide essential information for understanding management variation that could be relevant to welfare. Furthermore, the variables we created have been used in subsequent elephant welfare analyses.	[Greco, Brian J.; Mench, Joy A.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Greco, Brian J.; Mench, Joy A.] Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA; [Greco, Brian J.; Meehan, Cheryl L.] AWARE Inst, Portland, OR USA; [Miller, Lance J.] Chicago Zool Soc, Brookfield Zoo, Brookfield, IL USA; [Shepherdson, David J.] Oregon Zoo, Portland, OR USA; [Morfeld, Kari A.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Baker, Anne M.] CBSG North America, Apple Valley, ME USA; [Andrews, Jeff] Busch Gardens, Tampa, FL USA; [Carlstead, Kathy] Honolulu Zoo, Honolulu, HI USA	University of California System; University of California Davis; University of California System; University of California Davis; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Greco, BJ (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.; Greco, BJ (corresponding author), Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA.; Greco, BJ (corresponding author), AWARE Inst, Portland, OR USA.	bjgreco@ucdavis.edu			Institute of Museum and Library Services [LG-25-10-0033-10]; Oregon Zoo; Chicago Zoological Society-Brookfield Zoo; Busch Gardens; Lincoln Children's Zoo; Smithsonian's National Zoo; Honolulu Zoo; IMLS; AWARE Institute	Institute of Museum and Library Services; Oregon Zoo; Chicago Zoological Society-Brookfield Zoo; Busch Gardens; Lincoln Children's Zoo; Smithsonian's National Zoo; Honolulu Zoo; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. Employers provided financial support in the form of authors' salaries as follows: Oregon Zoo (DS); Chicago Zoological Society-Brookfield Zoo (LM); Busch Gardens (JA); Lincoln Children's Zoo and Smithsonian's National Zoo (KM); Honolulu Zoo (KC). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquariums AoZa, 2011, STAND EL MAN CAR; Atlantis E, 2006, INT J OBESITY, V30, P1027, DOI 10.1038/sj.ijo.0803286; Bashaw MJ, 2001, APPL ANIM BEHAV SCI, V73, P235, DOI 10.1016/S0168-1591(01)00137-X; Bassett L, 2007, APPL ANIM BEHAV SCI, V102, P223, DOI 10.1016/j.applanim.2006.05.029; BELL RR, 1995, J NUTR, V125, P2356, DOI 10.1093/jn/125.9.2356; Bennett C, 2015, J APPL ANIM WELF SCI, V18, pS43, DOI 10.1080/10888705.2015.1075835; Bollen K, 1997, J ELEPHANT MANAGERS, V8, P51; Bradshaw G. A., 2009, ELEPHANTS EDGE WHAT; Brockett RC, 1999, ZOO BIOL, V18, P101, DOI 10.1002/(SICI)1098-2361(1999)18:2&lt;101::AID-ZOO2&gt;3.0.CO;2-4; Brown JL, 2016, PLOS ONE; Buchanan-Smith HM, 2012, APPL ANIM BEHAV SCI, V137, P166, DOI 10.1016/j.applanim.2011.07.002; Butterworth A., 2011, Animal welfare, P200, DOI 10.1079/9781845936594.0200; Carlstead K, 2000, BIOLOGY OF ANIMAL STRESS, P337, DOI 10.1079/9780851993591.0337; CHANCE P, 1988, LEARNING BEHAV; Christen Catherine A., 2008, ELEPHANTS ETHICS MOR; Cohen J., 2003, APPL MULTIPLE REGRES; Degeling C, 2012, CAN J VET RES, V76, P235; DEJONG TM, 1975, OIKOS, V26, P222, DOI 10.2307/3543712; FORSYTHE WA, 1981, ATHEROSCLEROSIS, V38, P327, DOI 10.1016/0021-9150(81)90049-6; FRANKLIN CW, 1972, PSYCHOL REP, V30, P655, DOI 10.2466/pr0.1972.30.2.655; Gerber B, 2014, LEARN MEMORY, V21, P232, DOI 10.1101/lm.032995.113; Greco BJ, 2016, PLOS ONE; Green C, 1993, SHAPE ENRICHMENT, V2, P5; Greene LM, 2013, JAVMA-J AM VET MED A, V242, P1528, DOI 10.2460/javma.242.11.1528; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Henriksen EJ, 2002, J APPL PHYSIOL, V93, P778; Hiby EF, 2004, ANIM WELFARE, V13, P63; Hockenhull J, 2013, J VET BEHAV, V8, P245, DOI 10.1016/j.jveb.2012.06.002; Holdgate MR, 2016, PLOS ONE; Honda A, 2003, J APPL PHYSIOL, V95, P1032, DOI 10.1152/japplphysiol.00781.2002; Hoy JM, 2010, ZOO BIOL, V29, P303, DOI 10.1002/zoo.20254; Lambeth SP, 2006, AM J PRIMATOL, V68, P245, DOI 10.1002/ajp.20148; Laule Gail, 1998, P302; Lehnhardt John, 2008, P167; Leotti LA, 2010, TRENDS COGN SCI, V14, P457, DOI 10.1016/j.tics.2010.08.001; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lockhart J, 2013, APPL ANIM BEHAV SCI, V143, P128, DOI 10.1016/j.applanim.2012.10.011; Marlow AG, 1997, CHILD FAM BEHAV THER, V19, P1, DOI 10.1300/J019v19n02_01; Mason GJ, 2010, ZOO BIOL, V29, P237, DOI 10.1002/zoo.20256; Meehan CL, 2007, APPL ANIM BEHAV SCI, V102, P246, DOI 10.1016/j.applanim.2006.05.031; Meehan CL, 2016, PLOS ONE; Melfi VA, 2009, ZOO BIOL, V28, P574, DOI 10.1002/zoo.20288; Mellen J, 2001, ZOO BIOL, V20, P211, DOI 10.1002/zoo.1021; Metsios GS, 2008, RHEUMATOLOGY, V47, P239, DOI 10.1093/rheumatology/kem260; Mikota S.K., 1994, W BLOOMFIELD; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Muths E, 1996, COMP BIOCHEM PHYS A, V114, P355, DOI 10.1016/0300-9629(96)00025-4; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Prado-Oviedo NA, 2016, PLOS ONE; Rees PA, 2009, ZOO BIOL, V28, P79, DOI 10.1002/Zoo.20200; REYNOLDS GS, 1975, PRIMER OPERANT CONDI; ROLLS BJ, 1979, PHYSIOL BEHAV, V23, P241, DOI 10.1016/0031-9384(79)90361-5; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; Sambrook TD, 1997, ANIM WELFARE, V6, P207; Schneider JD, 2007, J ANIM SCI, V85, P3462, DOI 10.2527/jas.2007-0345; Shepherdson D, 2013, APPL ANIM BEHAV SCI, V147, P268, DOI 10.1016/j.applanim.2013.01.001; SHEPHERDSON DJ, 1993, ZOO BIOL, V12, P203, DOI 10.1002/zoo.1430120206; Shyne A, 2006, ZOO BIOL, V25, P317, DOI 10.1002/zoo.20091; Skinner BF., 1976, BEHAVIORISM; Spinage C.A., 1994, ELEPHANTS; Stoinski TS, 2000, ZOO BIOL, V19, P485, DOI 10.1002/1098-2361(2000)19:6&lt;485::AID-ZOO1&gt;3.0.CO;2-5; Sukumar R., 2003, LIVING ELEPHANTS EVO; Swaisgood R, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P256, DOI 10.1079/9780851990040.0256; Under D, 2014, VET CLIN N AM-SMALL, V44, P789, DOI 10.1016/j.cvsm.2014.03.004; Veasey J., 2006, International Zoo Yearbook, V40, P63, DOI 10.1111/j.1748-1090.2006.00063.x; Walsmith J, 2002, INT J CARDIOL, V85, P89, DOI 10.1016/S0167-5273(02)00237-1; Whittaker M, 2009, ELEPHANT ROOM SCI WE; Wiedenmayer C, 1998, APPL ANIM BEHAV SCI, V56, P77, DOI 10.1016/S0168-1591(97)00091-9; Wilson ML, 2006, ZOO BIOL, V25, P173, DOI 10.1002/zoo.20084; Young RJ, 2003, ENV ENRICHMENT CAPTI, DOI DOI 10.1002/9780470751046; Zeligs JA., 2014, ANIMAL TRAINING 101	75	30	30	6	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0152490	10.1371/journal.pone.0152490	http://dx.doi.org/10.1371/journal.pone.0152490			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414654	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500005
J	Pollock, LM; Gupta, N; Chen, X; Luna, EJ; McDermott, BM				Pollock, Lana M.; Gupta, Nilay; Chen, Xi; Luna, Elizabeth J.; McDermott, Brian M., Jr.			Supervillin Is a Component of the Hair Cell's Cuticular Plate and the Head Plates of Organ of Corti Supporting Cells	PLOS ONE			English	Article							MYOSIN-II; F-ACTIN; INTERCELLULAR-JUNCTIONS; MEMBRANE SKELETON; RETICULAR LAMINA; CATION CONTENTS; GENE; COCHLEA; BINDING; PROTEIN	The organ of Corti has evolved a panoply of cells with extraordinary morphological specializations to harness, direct, and transduce mechanical energy into electrical signals. Among the cells with prominent apical specializations are hair cells and nearby supporting cells. At the apical surface of each hair cell is a mechanosensitive hair bundle of filamentous actin (F-actin)-based stereocilia, which insert rootlets into the F-actin meshwork of the underlying cuticular plate, a rigid organelle considered to hold the stereocilia in place. Little is known about the protein composition and development of the cuticular plate or the apicolateral specializations of organ of Corti supporting cells. We show that supervillin, an F-actin cross-linking protein, localizes to cuticular plates in hair cells of the mouse cochlea and vestibule and zebrafish sensory epithelia. Moreover, supervillin localizes near the apicolateral margins within the head plates of Deiters' cells and outer pillar cells, and proximal to the apicolateral margins of inner phalangeal cells, adjacent to the junctions with neighboring hair cells. Overall, supervillin localization suggests this protein may shape the surface structure of the organ of Corti.	[Pollock, Lana M.; Gupta, Nilay; Chen, Xi; McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Pollock, Lana M.; McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Gupta, Nilay; Chen, Xi; McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44016 USA; [Luna, Elizabeth J.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA; [Chen, Xi] Loyola Univ Chicago, Stritch Sch Med, 2160 South First Ave, Maywood, IL 60153 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Massachusetts System; University of Massachusetts Worcester; Loyola University Chicago	McDermott, BM (corresponding author), Case Western Reserve Univ, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA.; McDermott, BM (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.; McDermott, BM (corresponding author), Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.; McDermott, BM (corresponding author), Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44016 USA.	bmm30@case.edu			National Institutes of Health Office of Research Infrastructure Programs [S10RR017980, S10OD016164]; Center for Clinical Research and Technology at University Hospitals Case Medical Center; National Institutes of Health (NIH) [DC009437, GM008056-28]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; Center for Clinical Research and Technology at University Hospitals Case Medical Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Images were generated at the Imaging Core Facility, Department of Genetics and Genome Sciences, Case Western Reserve University, supported by the National Institutes of Health Office of Research Infrastructure Programs under award numbers S10RR017980 and S10OD016164. This research was supported by the Center for Clinical Research and Technology at University Hospitals Case Medical Center (BMM) and National Institutes of Health (NIH) Grant DC009437 (BMM). LMP was supported by National Institutes of Health Training Grant GM008056-28. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Antonellis PJ, 2014, J NEUROSCI, V34, P305, DOI 10.1523/JNEUROSCI.1880-13.2014; Anttonen T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00978; Basch ML, 2016, J ANAT, V228, P233, DOI 10.1111/joa.12314; Bhuwania R, 2012, J CELL SCI, V125, P2300, DOI 10.1242/jcs.100032; Burns JC, 2013, J COMP NEUROL, V521, P1430, DOI 10.1002/cne.23250; Chan DK, 2005, BIOPHYS J, V89, P4382, DOI 10.1529/biophysj.105.070474; Chen Y, 2003, J BIOL CHEM, V278, P46094, DOI 10.1074/jbc.M305311200; Chou SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014807; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; DRENCKHAHN D, 1991, J CELL BIOL, V112, P641, DOI 10.1083/jcb.112.4.641; DUVALL AJ, 1967, ANN OTO RHINOL LARYN, V76, P688, DOI 10.1177/000348946707600312; Etournay R, 2010, DEVELOPMENT, V137, P1373, DOI 10.1242/dev.045138; Fedechkin SO, 2013, J BIOMOL STRUCT DYN, V31, P1150, DOI 10.1080/07391102.2012.726531; Fridberger A, 2002, J NEUROSCI, V22, P9850; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; GULLEY RL, 1976, J NEUROCYTOL, V5, P479, DOI 10.1007/BF01181652; HIROKAWA N, 1982, J CELL BIOL, V95, P249, DOI 10.1083/jcb.95.1.249; HIROKAWA N, 1986, HEARING RES, V22, P41, DOI 10.1016/0378-5955(86)90076-6; Hordichok AJ, 2007, HEARING RES, V232, P1, DOI 10.1016/j.heares.2007.06.011; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; Hwang P, 2015, CELL REP, V13, P1287, DOI 10.1016/j.celrep.2015.10.003; Kachar B, 1997, HEARING RES, V107, P102, DOI 10.1016/S0378-5955(97)00027-0; KONISHI T, 1973, ACTA OTO-LARYNGOL, V76, P410, DOI 10.3109/00016487309121529; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Lee JY, 2012, CURR BIOL, V22, P956, DOI 10.1016/j.cub.2012.03.068; Leonova EV, 1997, HEARING RES, V113, P14, DOI 10.1016/S0378-5955(97)00130-5; MARCUS DC, 1981, HEARING RES, V4, P149, DOI 10.1016/0378-5955(81)90002-2; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Oh SW, 2003, J CELL SCI, V116, P2261, DOI 10.1242/jcs.00422; Parker Mark, 2010, J Vis Exp, DOI 10.3791/1685; Pestonjamasp KN, 1997, J CELL BIOL, V139, P1255, DOI 10.1083/jcb.139.5.1255; Pollock LM, 2015, BIRTH DEFECTS RES C, V105, P126, DOI 10.1002/bdrc.21098; Raphael Y, 2003, BRAIN RES BULL, V60, P397, DOI 10.1016/S0361-9230(03)00047-9; RAPHAEL Y, 1994, HEARING RES, V76, P173, DOI 10.1016/0378-5955(94)90098-1; Robinson-Rechavi M, 2001, GENOME RES, V11, P781, DOI 10.1101/gr.165601; Smith TC, 2013, MOL BIOL CELL, V24, P3603, DOI 10.1091/mbc.E12-10-0714; Smith TC, 2010, CYTOSKELETON, V67, P346, DOI 10.1002/cm.20449; STOSSEL TP, 1981, COLD SPRING HARB SYM, V46, P569, DOI 10.1101/SQB.1982.046.01.053; Szarama KB, 2012, DEVELOPMENT, V139, P2187, DOI 10.1242/dev.073734; Takizawa N, 2007, J CELL SCI, V120, P3792, DOI 10.1242/jcs.008219; TILNEY LG, 1980, J CELL BIOL, V86, P244, DOI 10.1083/jcb.86.1.244; Trinh LA, 2011, GENE DEV, V25, P2306, DOI 10.1101/gad.174037.111; Wulfkuhle JD, 1999, J CELL SCI, V112, P2125; Yamamoto N, 2009, DEVELOPMENT, V136, P1977, DOI 10.1242/dev.030718	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158349	10.1371/journal.pone.0158349	http://dx.doi.org/10.1371/journal.pone.0158349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415442	Green Published, gold			2022-12-27	WOS:000379579500020
J	Wang, X; Xie, H; Cotton, AS; Duval, ER; Tamburrino, MB; Brickman, KR; Elhai, JD; Ho, SS; McLean, SA; Ferguson, EJ; Liberzon, I				Wang, Xin; Xie, Hong; Cotton, Andrew S.; Duval, Elizabeth R.; Tamburrino, Marijo B.; Brickman, Kristopher R.; Elhai, Jon D.; Ho, S. Shaun; McLean, Samuel A.; Ferguson, Eric J.; Liberzon, Israel			Preliminary Study of Acute Changes in Emotion Processing in Trauma Survivors with PTSD Symptoms	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PREFRONTAL CORTEX; BRAIN; ACTIVATION; ANXIETY; CONNECTIVITY; METAANALYSIS; EARTHQUAKE; RISK	Accumulating evidence suggests traumatic experience can rapidly alter brain activation associated with emotion processing. However, little is known about acute changes in emotion neurocircuits that underlie PTSD symptom development. To examine acute alterations in emotion circuit activation and structure that may be linked to PTSD symptoms, thirty-eight subjects performed a task of appraisal of emotional faces as their brains were functionally and structurally studied with MRI at both two weeks and three months after motor vehicle collision (MVC). As determined by symptoms reported in the PTSD Checklist at three months, sixteen survivors developed probable PTSD, whereas the remaining 22 did not meet criteria for PTSD diagnosis (non-PTSD). The probable PTSD group had greater activation than the non-PTSD group in dorsal and ventral medial prefrontal cortex (dmPFC and vmPFC) while appraising fearful faces within two weeks after MVC and in left insular cortex (IC) three months after MVC. dmPFC activation at two weeks significantly positively correlated with PTSD symptom severity at two weeks (R = 0.462, P = 0.006) and three months (R = 0.418, p = 0.012). Changes over time in dmPFC activation and in PTSD symptom severity were also significantly positively correlated in the probable PTSD group (R = 0.641, P = 0.018). A significant time by group interaction was found for volume changes in left superior frontal gyrus (SFG, F = 6.048, p = 0.019) that partially overlapped dmPFC active region. Between two weeks and three months, left SFG volume decreased in probable PTSD survivors. These findings identify alterations in frontal cortical activity and structure during the early post-trauma period that appear to be associated with development of PTSD symptoms.	[Wang, Xin; Cotton, Andrew S.; Tamburrino, Marijo B.] Univ Toledo, Dept Psychiat, 2801 W Bancroft St, Toledo, OH 43606 USA; [Xie, Hong] Univ Toledo, Dept Neurosci, Toledo, OH USA; [Duval, Elizabeth R.; Ho, S. Shaun; Liberzon, Israel] Univ Michigan, Dept Psychiat, Ann Arbor, MI USA; [Brickman, Kristopher R.] Univ Toledo, Dept Emergency Med, Toledo, OH USA; [Elhai, Jon D.] Univ Toledo, Dept Psychol, Toledo, OH USA; [McLean, Samuel A.] Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC USA; [Ferguson, Eric J.] ProMed Toledo Hosp, Dept Trauma Serv, Toledo, OH USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Michigan System; University of Michigan; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of North Carolina; University of North Carolina Chapel Hill	Wang, X (corresponding author), Univ Toledo, Dept Psychiat, 2801 W Bancroft St, Toledo, OH 43606 USA.	xin.wang2@utoledo.edu	McLean, Samuel/GPT-1213-2022; Elhai, Jon D/U-1901-2017; Duval, Elizabeth/X-3376-2019	McLean, Samuel/0000-0001-9482-3582; Elhai, Jon D/0000-0001-5205-9010; Duval, Elizabeth/0000-0002-3883-863X; Ho, Shao-Hsuan/0000-0003-2617-1628	National Institutes of Health [R21MH098198-01]; ProMedica Translational Research Stimulation Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ProMedica Translational Research Stimulation Award	The work is funded by National Institutes of Health R21MH098198-01 and by a ProMedica Translational Research Stimulation Award to XW.	Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Burgmer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071289; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Cwik JC, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00049; Dickstein BD, 2015, ASSESSMENT, V22, P289, DOI 10.1177/1073191114548683; Du MY, 2015, SOC COGN AFFECT NEUR, V10, P1497, DOI 10.1093/scan/nsv040; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Felmingham KL, 2012, BIOL PSYCHOL, V90, P224, DOI 10.1016/j.biopsycho.2012.03.011; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Galatzer-Levy IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070084; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [DOI 10.1097/00001199-199309000-00010, 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00009]; Ke J, 2016, ACTA RADIOL, V57, P1387, DOI 10.1177/0284185115585848; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; Klumpp H, 2011, DEPRESS ANXIETY, V28, P194, DOI 10.1002/da.20802; Li L, 2014, NEUROSCI BIOBEHAV R, V43, P163, DOI 10.1016/j.neubiorev.2014.04.003; Liberzon I, 2015, SOC COGN AFFECT NEUR, V10, P1596, DOI 10.1093/scan/nsv045; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; McEwen BS, 2013, NEURON, V79, P16, DOI 10.1016/j.neuron.2013.06.028; Mylle J, 2004, J AFFECT DISORDERS, V78, P37, DOI 10.1016/S0165-0327(02)00218-5; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Osuch EA, 2008, BIOL PSYCHIAT, V64, P327, DOI 10.1016/j.biopsych.2008.03.010; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Radley JJ, 2011, STRESS, V14, P481, DOI 10.3109/10253890.2011.604751; Ramage AE, 2013, HUM BRAIN MAPP, V34, P3392, DOI 10.1002/hbm.22155; Reynolds K, 2016, AM J GERIAT PSYCHIAT, V24, P81, DOI 10.1016/j.jagp.2015.11.001; Schmidt U, 2015, PSYCHONEUROENDOCRINO, V51, P444, DOI 10.1016/j.psyneuen.2014.08.020; Sekiguchi A, 2013, MOL PSYCHIATR, V18, P618, DOI 10.1038/mp.2012.51; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sripada RK, 2013, BIOL PSYCHIAT, V73, P1045, DOI 10.1016/j.biopsych.2012.12.008; Stark EA, 2015, NEUROSCI BIOBEHAV R, V56, P207, DOI 10.1016/j.neubiorev.2015.07.007; Sun YW, 2015, J AFFECT DISORDERS, V188, P80, DOI 10.1016/j.jad.2015.08.021; Sun YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083473; Sussman D, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0247-x; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Wang X, 2010, CEREB CORTEX, V20, P1513, DOI 10.1093/cercor/bhp226; Wang X, 2010, NEUROIMAGE, V49, P3075, DOI 10.1016/j.neuroimage.2009.11.018; Wolf EJ, 2009, J NERV MENT DIS, V197, P419, DOI 10.1097/NMD.0b013e3181a61c68; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046833; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	48	23	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159065	10.1371/journal.pone.0159065	http://dx.doi.org/10.1371/journal.pone.0159065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27415431	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500068
J	Courtney, R; Browning, S; Northfield, T; Seymour, J				Courtney, Robert; Browning, Sally; Northfield, Tobin; Seymour, Jamie			Thermal and Osmotic Tolerance of 'Irukandji' Polyps: Cubozoa; Carukia barnesi	PLOS ONE			English	Article							MORBAKKA-VIRULENTA KISHINOUYE; CARYBDEA-MARSUPIALIS LINNAEUS; TRIPEDALIA-CYSTOPHORA CUBOZOA; CNIDARIA CUBOZOA; BOX JELLYFISH; LIFE-CYCLE; METAMORPHOSIS; GROWTH	This research explores the thermal and osmotic tolerance of the polyp stage of the Irukandji jellyfish Carukia barnesi, which provides new insights into potential polyp habitat suitability. The research also targets temperature, salinity, feeding frequency, and combinations thereof, as cues for synchronous medusae production. Primary findings revealed 100% survivorship in osmotic treatments between 19 and 46 parts per thousand, with the highest proliferation at 26 parts per thousand. As salinity levels of 26 parts per thousand do not occur within the waters of the Great Barrier Reef or Coral Sea, we conclude that the polyp stage of C. barnesi is probably found in estuarine environments, where these lower salinity conditions commonly occur, in comparison to the medusa stage, which is oceanic. Population stability was achieved at temperatures between 18 and 31 degrees C, with an optimum temperature of 22.9 degrees C. We surmise that C. barnesi polyps may be restricted to warmer estuarine areas where water temperatures do not drop below 18 degrees C. Asexual reproduction was also positively correlated with feeding frequency. Temperature, salinity, feeding frequency, and combinations thereof did not induce medusae production, suggesting that this species may use a different cue, possibly photoperiod, to initiate medusae production.	[Courtney, Robert; Browning, Sally; Seymour, Jamie] James Cook Univ, Div Trop Hlth & Med, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia; [Northfield, Tobin] James Cook Univ, Coll Sci & Engn, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia	James Cook University; James Cook University	Courtney, R (corresponding author), James Cook Univ, Div Trop Hlth & Med, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia.	Robert.Courtney@my.jcu.edu.au	Northfield, Tobin/I-2323-2013	Northfield, Tobin/0000-0002-0563-485X; Courtney, Robert/0000-0002-3914-1551	Australian Post Graduate Award; Australian Lions Foundation for Scientific and Medical Research on Marine Species Dangerous to Humans	Australian Post Graduate Award(Australian Government); Australian Lions Foundation for Scientific and Medical Research on Marine Species Dangerous to Humans	This study was partially funded by the Australian Post Graduate Award (scholarship) for RC, and a student grant provided by The Australian Lions Foundation for Scientific and Medical Research on Marine Species Dangerous to Humans, also for RC. The Australian Lions Foundation did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Acevedo MJ, 2013, J EXP MAR BIOL ECOL, V439, P84, DOI 10.1016/j.jembe.2012.10.007; Arai M.N.A.., 1997, FUNCTIONAL BIOL SCYP; Arneson A. C., 1976, COELENTERATE ECOLOGY, P227, DOI [10.1007/978-1-4757-9724-4_24, DOI 10.1007/978-1-4757-9724-4_24]; Bentlage B, 2012, J NAT HIST, V46, P2595, DOI 10.1080/00222933.2012.717645; Canepa A, 2014, J PLANKTON RES, V36, P585, DOI 10.1093/plankt/fbt124; Carrette T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084377; Carrette TJ, 2013, DIVING HYPERB MED, V43, P9; Carrette TJ, 2012, DIVING HYPERB MED, V42, P214; Courtney R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151197; Courtney R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069369; Cutress C. E., 1973, P ASS ISLAND MARINE, V9, P25; Feng S, 2017, CHIN J OCEANOL LIMN, V35, P153, DOI 10.1007/s00343-016-5230-y; Fenner J, 2006, QJM-INT J MED, V99, P802, DOI 10.1093/qjmed/hcl104; Fischer AB, 2004, HYDROBIOLOGIA, V530, P331, DOI 10.1007/s10750-004-2658-4; Gordon M, 2004, HYDROBIOLOGIA, V530, P339, DOI 10.1007/s10750-004-2655-7; Gordon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031277; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P171, DOI 10.1007/BF00026459; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P181, DOI 10.1007/BF00026460; Jacups SP, 2010, ECOHEALTH, V7, P14, DOI 10.1007/s10393-010-0306-1; Kingsford MJ, 2012, HYDROBIOLOGIA, V690, P257, DOI 10.1007/s10750-012-1041-0; Klein SG, 2014, GLOBAL CHANGE BIOL, V20, P28, DOI 10.1111/gcb.12408; LASKAMEHNERT G, 1985, HELGOLANDER MEERESUN, V39, P129, DOI 10.1007/BF01997447; Little M, 2003, ANAESTH INTENS CARE, V31, P642, DOI 10.1177/0310057X0303100605; Nickson CP, 2009, ANN EMERG MED, V54, P395, DOI 10.1016/j.annemergmed.2009.03.022; Nittrouer CA, 1995, GEO-MAR LETT, V15, P121, DOI 10.1007/BF01204452; Pereira P, 2010, CLIN TOXICOL, V48, P390, DOI 10.3109/15563651003662675; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Sommer S, 2016, J LIMNOL, V75, P30, DOI 10.4081/jlimnol.2016.1292; SOUTHCOTT R. V., 1967, AUST J ZOOL, V15, P651, DOI 10.1071/ZO9670651; Stangl K, 2002, VIE MILIEU, V52, P131; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Straehler-Pohl I, 2011, ZOOTAXA, P36; Suchy KD, 2016, MAR ECOL PROG SER, V545, P77, DOI 10.3354/meps11637; Toshino S, 2015, EVOL DEV, V17, P231, DOI 10.1111/ede.12127; Toshino Sho, 2014, Plankton & Benthos Research, V9, P32; Toshino Sho, 2013, Plankton & Benthos Research, V8, P1; Underwood AH, 2007, TOXICON, V49, P1073, DOI 10.1016/j.toxicon.2007.01.014; WERNER B, 1983, HELGOLANDER MEERESUN, V36, P257, DOI 10.1007/BF01983630; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0; Williamson J.A., 1996, VENOMOUS POISONOUS M; Yamaguchi M., 1980, P11; [No title captured]	43	4	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159380	10.1371/journal.pone.0159380	http://dx.doi.org/10.1371/journal.pone.0159380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441693	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000380797500068
J	Martin, K; Staiano, W; Menaspa, P; Hennessey, T; Marcora, S; Keegan, R; Thompson, KG; Martin, D; Halson, S; Rattray, B				Martin, Kristy; Staiano, Walter; Menaspa, Paolo; Hennessey, Tom; Marcora, Samuele; Keegan, Richard; Thompson, Kevin G.; Martin, David; Halson, Shona; Rattray, Ben			Superior Inhibitory Control and Resistance to Mental Fatigue in Professional Road Cyclists	PLOS ONE			English	Article							SELF-REGULATION; INDIVIDUAL-DIFFERENCES; PHYSICAL PERFORMANCE; COGNITIVE CONTROL; EXERCISE; ACTIVATION; MECHANISMS; FITNESS; DELAY	Purpose Given the important role of the brain in regulating endurance performance, this comparative study sought to determine whether professional road cyclists have superior inhibitory control and resistance to mental fatigue compared to recreational road cyclists. Methods After preliminary testing and familiarization, eleven professional and nine recreational road cyclists visited the lab on two occasions to complete a modified incongruent colour-word Stroop task (a cognitive task requiring inhibitory control) for 30 min (mental exertion condition), or an easy cognitive task for 10 min (control condition) in a randomized, counterbalanced cross-over order. After each cognitive task, participants completed a 20-min time trial on a cycle ergometer. During the time trial, heart rate, blood lactate concentration, and rating of perceived exertion (RPE) were recorded. Results The professional cyclists completed more correct responses during the Stroop task than the recreational cyclists (705 +/- 68 vs 576 +/- 74, p = 0.001). During the time trial, the recreational cyclists produced a lower mean power output in the mental exertion condition compared to the control condition (216 +/- 33 vs 226 +/- 25 W, p = 0.014). There was no difference between conditions for the professional cyclists (323 +/- 42 vs 326 +/- 35 W, p = 0.502). Heart rate, blood lactate concentration, and RPE were not significantly different between the mental exertion and control conditions in both groups. Conclusion The professional cyclists exhibited superior performance during the Stroop task which is indicative of stronger inhibitory control than the recreational cyclists. The professional cyclists also displayed a greater resistance to the negative effects of mental fatigue as demonstrated by no significant differences in perception of effort and time trial performance between the mental exertion and control conditions. These findings suggest that inhibitory control and resistance to mental fatigue may contribute to successful road cycling performance. These psychobiological characteristics may be either genetic and/or developed through the training and lifestyle of professional road cyclists.	[Martin, Kristy; Hennessey, Tom; Keegan, Richard; Thompson, Kevin G.; Rattray, Ben] Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT, Australia; [Staiano, Walter] Danish Elite Sport Inst, Team Danmark, Brondby, Denmark; [Menaspa, Paolo] Edith Cowan Univ, Sch Exercise & Hlth Sci, Perth, WA, Australia; [Marcora, Samuele] Univ Kent, Sch Sport & Exercise Sci, Endurance Res Grp, Canterbury, Kent, England; [Martin, David; Halson, Shona] Australian Inst Sport, Physiol, Canberra, ACT, Australia	University of Canberra; Edith Cowan University; University of Kent; Australian Institute of Sport	Marcora, S (corresponding author), Univ Kent, Sch Sport & Exercise Sci, Endurance Res Grp, Canterbury, Kent, England.	s.m.marcora@kent.ac.uk	Staiano, Walter/AAB-3246-2019; Keegan, Richard/V-1752-2019; Marcora, Samuele/W-4284-2019; Keegan, Richard/E-9498-2013; Menaspà, Paolo/D-1542-2015	Staiano, Walter/0000-0002-1269-0016; Keegan, Richard/0000-0003-4253-4492; Marcora, Samuele/0000-0002-1570-7936; Keegan, Richard/0000-0003-4253-4492; Menaspà, Paolo/0000-0002-0094-9596; Thompson, Kevin/0000-0003-3985-1622; Halson, Shona/0000-0002-1047-3878; Rattray, Ben/0000-0002-1652-7726; Martin, Kristy/0000-0003-0953-7595				Anokhin AP, 2004, NEUROSCI LETT, V368, P314, DOI 10.1016/j.neulet.2004.07.036; Ayduk O, 2000, J PERS SOC PSYCHOL, V79, P776, DOI 10.1037/0022-3514.79.5.776; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Cona G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132943; De Pauw K, 2013, INT J SPORT PHYSIOL, V8, P111, DOI 10.1123/ijspp.8.2.111; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Gruber SA, 2002, NEUROIMAGE, V16, P349, DOI 10.1006/nimg.2002.1089; Hoonakker Peter, 2011, IIE Trans Healthc Syst Eng, V1, P131; Huelsman TJ, 1998, EDUC PSYCHOL MEAS, V58, P804, DOI 10.1177/0013164498058005006; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Lorist MM, 2003, BRAIN COGNITION, V53, P82, DOI 10.1016/S0278-2626(03)00206-9; MacMahon C, 2014, J SPORT EXERCISE PSY, V36, P375, DOI 10.1123/jsep.2013-0249; Marcora S, 2009, J APPL PHYSIOL, V106, P2060, DOI 10.1152/japplphysiol.90378.2008; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; Marcora SM., ENCY PERCEPTION, V2010, P380, DOI DOI 10.4135/9781412972000.N119; Marcora SM, 2015, 62 ANN M AM COLL SPO; MISCHEL W, 1972, J PERS SOC PSYCHOL, V21, P204, DOI 10.1037/h0032198; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Muraven M, 1999, J SOC PSYCHOL, V139, P446, DOI 10.1080/00224549909598404; Noble B., 1996, PERCEIVED EXERTION; Pageaux B, 2014, EUR J APPL PHYSL, V114, P1; Purvis D, 2010, PM&R, V2, P442, DOI 10.1016/j.pmrj.2010.03.025; Retey JV, 2006, J NEUROSCI, V26, P10472, DOI 10.1523/JNEUROSCI.1538-06.2006; Schlam TR, 2013, J PEDIATR-US, V162, P90, DOI 10.1016/j.jpeds.2012.06.049; Smith MR, 2015, MED SCI SPORT EXER, V47, P1682, DOI 10.1249/MSS.0000000000000592; Whelan R, 2008, PSYCHOL REC, V58, P475, DOI 10.1007/BF03395630; Williamson JW, 2001, J APPL PHYSIOL, V90, P1392, DOI 10.1152/jappl.2001.90.4.1392; Wong CN, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00154	38	117	121	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159907	10.1371/journal.pone.0159907	http://dx.doi.org/10.1371/journal.pone.0159907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441380	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000380797500153
J	Nishiuchi, H; Taguri, M; Ishikawa, Y				Nishiuchi, Hiromu; Taguri, Masataka; Ishikawa, Yoshiki			Using a Marginal Structural Model to Design a Theory-Based Mass Media Campaign	PLOS ONE			English	Article							PREVENTION; INFERENCE; BEHAVIOR	Background The essential first step in the development of mass media health campaigns is to identify specific beliefs of the target audience. The challenge is to prioritize suitable beliefs derived from behavioral theory. The purpose of this study was to identify suitable beliefs to target in a mass media campaign to change behavior using a new method to estimate the possible effect size of a small set of beliefs. Methods Data were drawn from the 2010 Japanese Young Female Smoker Survey (n = 500), conducted by the Japanese Ministry of Health, Labor and Welfare. Survey measures included intention to quit smoking, psychological beliefs (attitude, norms, and perceived control) based on the theory of planned behavior and socioeconomic status (age, education, household income, and marital status). To identify suitable candidate beliefs for a mass media health campaign, we estimated the possible effect size required to change the intention to quit smoking among the population of young Japanese women using the population attributable fraction from a marginal structural model. Results Thirteen percent of study participants intended to quit smoking. The marginal structural model estimated a population attributable fraction of 47 psychological beliefs (21 attitudes, 6 norms, and 19 perceived controls) after controlling for socioeconomic status. The belief, "I could quit smoking if my husband or significant other recommended it" suggested a promising target for a mass media campaign (population attributable fraction = 0.12, 95% CI = 0.02-0.23). Messages targeting this belief could possibly improve intention rates by up to 12% among this population. The analysis also suggested the potential for regulatory action. Conclusions This study proposed a method by which campaign planners can develop theory-based mass communication strategies to change health behaviors at the population level. This method might contribute to improving the quality of future mass health communication strategies and further research is needed.	[Nishiuchi, Hiromu] Univ Tokyo, Policy Alternat Res Inst, Bunkyo Ku, Tokyo, Japan; [Taguri, Masataka] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa, Japan; [Ishikawa, Yoshiki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Yokohama City University; University of Tokyo	Nishiuchi, H (corresponding author), Univ Tokyo, Policy Alternat Res Inst, Bunkyo Ku, Tokyo, Japan.	h-nishiuchi@umin.ac.jp			Grants-in-Aid for Scientific Research [15K16502] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Brumback BA, 2004, STAT MED, V23, P749, DOI 10.1002/sim.1657; Cho HY, 2007, J COMMUN, V57, P293, DOI 10.1111/j.1460-2466.2007.00344.x; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Farrelly MC, 2002, AM J PUBLIC HEALTH, V92, P901, DOI 10.2105/AJPH.92.6.901; Fishbein M, 2000, AIDS CARE, V12, P273, DOI 10.1080/09540120050042918; Fishbein M, 2006, J COMMUN, V56, pS1, DOI 10.1111/j.1460-2466.2006.00280.x; Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; Gollwitzer P.M., 1993, EUR REV SOC PSYCHOL, V4, DOI [10.1080/14792779343000059, DOI 10.1080/14792779343000059]; Guide to Community Preventive Services, HLTH COMM SOC MARK; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Hornik R, 1995, SOC MAR Q, V2, P24; Hornik R, 2008, AM J PUBLIC HEALTH, V98, P2229, DOI 10.2105/AJPH.2007.125849; Institute of Medicine, 2002, SPEAK HLTH ASS HLTH; Montano DE., 2015, HLTH BEHAV THEORY RE, V5th, P95; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Sheeran P., 2002, EUR REV SOC PSYCHOL, P1, DOI DOI 10.1080/14792772143000003; Sjolander A, 2011, STAT METHODS MED RES, V20, P415, DOI 10.1177/0962280209349880; Taguri M, 2012, BIOSTATISTICS, V13, P455, DOI 10.1093/biostatistics/kxr038; Wakefield M, 2006, AM J PUBLIC HEALTH, V96, P2154, DOI 10.2105/AJPH.2005.083352; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4	22	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158328	10.1371/journal.pone.0158328	http://dx.doi.org/10.1371/journal.pone.0158328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS5CG	27441626	gold, Green Published, Green Submitted			2022-12-27	WOS:000380797500012
J	Ayer, R; Kikuchi, K; Ghimire, M; Shibanuma, A; Pant, MR; Poudel, KC; Jimba, M				Ayer, Rakesh; Kikuchi, Kimiyo; Ghimire, Mamata; Shibanuma, Akira; Pant, Madhab Raj; Poudel, Krishna C.; Jimba, Masamine			Clinic Attendance for Antiretroviral Pills Pick-Up among HIV-Positive People in Nepal: Roles of Perceived Family Support and Associated Factors	PLOS ONE			English	Article							HEALTH-RELATED KNOWLEDGE; SELF-RATED HEALTH; INFECTED PATIENTS; MEDICATION ADHERENCE; SOCIAL SUPPORT; THERAPY; RETENTION; LITERACY; DISPARITIES; PREDICTORS	Introduction HIV-positive people's clinic attendance for medication pick-up is critical for successful HIV treatment. However, limited evidence exists on it especially in low-income settings such as Nepal. Moreover, the role of family support in clinic attendance remains under-explored. Therefore, this study was conducted to examine the association between perceived family support and regular clinic attendance and to assess factors associated with regular clinic attendance for antiretroviral pills pick-up among HIV-positive individuals in Nepal. Methods A cross-sectional study was conducted among 423 HIV-positive people in three districts of Nepal. Clinic attendance was assessed retrospectively for the period of 12 months. To assess the factors associated, an interview survey was conducted using a semi-structured questionnaire from July to August, 2015. Multiple logistic regression models were used to assess the factors associated with regular clinic attendance. Results Of 423 HIV-positive people, only 32.6% attended the clinics regularly. They were more likely to attend them regularly when they received high family support (AOR = 3.98, 95% CI = 2.29, 6.92), participated in support programs (AOR = 1.68, 95% CI = 1.00, 2.82), and had knowledge on the benefits of antiretroviral therapy (AOR = 2.62, 95% CI = 1.15, 5.99). In contrast, they were less likely to attend them regularly when they commuted more than 60 minutes to the clinics (AOR = 0.53, 95% CI = 0.30, 0.93), when they self-rated their health status as being very good (AOR = 0.13, 95% CI = 0.04, 0.44), good (AOR = 0.14, 95% CI = 0.04, 0.46), and fair (AOR = 0.21, 95% CI = 0.06, 0.70). Conclusion HIV-positive individuals are more likely to attend the clinics regularly when they receive high family support, know the benefits of antiretroviral therapy, and participate in support programs. To improve clinic attendance, family support should be incorporated with HIV care programs in resource limited settings. Service providers should also consider educating them about the benefits of antiretroviral therapy.	[Ayer, Rakesh; Kikuchi, Kimiyo; Shibanuma, Akira; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Ghimire, Mamata] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Hlth Care Policy & Management, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3018577, Japan; [Pant, Madhab Raj] Tribhuvan Univ Teaching Hosp, Antiretroviral Therapy Clin, Kathmandu, Nepal; [Poudel, Krishna C.] Univ Massachusetts, Dept Hlth Promot & Policy, Sch Publ Hlth & Hlth Sci, 316 Arnold House,715 North Pleasant St, Amherst, MA 01003 USA	University of Tokyo; University of Tsukuba; Tribhuvan University; Institute of Medicine (IoM) - Nepal; University of Massachusetts System; University of Massachusetts Amherst	Kikuchi, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kimiyo@m.u-tokyo.ac.jp	Shibanuma, Akira/C-7652-2016; Jimba, Masamine/AAF-5630-2020	Shibanuma, Akira/0000-0003-2058-1722; 	Asian Development Bank Japan Scholarship Program	Asian Development Bank Japan Scholarship Program	This study was supported by Asian Development Bank Japan Scholarship Program (http://www.adb.org/site/careers/japan-scholarship-program/main). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSTAR, 2010, AD ADH TREATM RET CA; Amiya RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090959; Armstrong WS, 2014, CLIN INFECT DIS, V59, P1480, DOI 10.1093/cid/ciu607; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bateganya MH, 2015, JAIDS-J ACQ IMM DEF, V68, pS368, DOI 10.1097/QAI.0000000000000519; Bennett IM, 2009, ANN FAM MED, V7, P204, DOI 10.1370/afm.940; Bhatta L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-604; Catz SL, 1999, AIDS CARE, V11, P361, DOI 10.1080/09540129947983; Cauldbeck MB, 2009, AIDS RES THER, V6, P7, DOI DOI 10.1186/1742-6405-6-7; CBS, 2012, NAT POP HOUS CENS 20; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Daigle GT, 2015, AIDS CARE, V27, P836, DOI 10.1080/09540121.2015.1024098; Do TN, 2012, CLIN INFECT DIS, V54, pS306, DOI 10.1093/cid/cir1045; Dyrehave C, 2015, J INT ASS PROVID AID; Havlir D, 2012, NEW ENGL J MED, V367, P685, DOI 10.1056/NEJMp1207138; Hirnschall GW., 2015, LEARNING B IMPLICATI; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; IDRE, 2015, REGR STAT; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Kalichman SC, 2000, AM J PREV MED, V18, P325, DOI 10.1016/S0749-3797(00)00121-5; Kalichman SC, 2000, J ACQ IMMUN DEF SYND, V25, P337, DOI 10.1097/00126334-200012010-00007; Kalichman Seth C, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P317, DOI 10.1177/1545109708328130; Kohrt BA, 2009, POLITICAL VIOLENCE M; Kunutsor S, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/872396; Kunutsor S, 2011, AIDS BEHAV, V15, P1795, DOI 10.1007/s10461-011-9927-9; Ministry of Health and Population (MoHP) [Nepal] New ERA ICF International Inc., 2011, NEPAL DEMOGRAPHIC AN; Mitiku Habtamu, 2013, ISRN AIDS, V2013, P960954, DOI 10.1155/2013/960954; MoHSW, 2007, ART TREATM LITR COUR; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P100, DOI 10.1097/QAI.0b013e31818d5c37; Murray C. J. L., 2013, LANCET; National Center for AIDS and STDs Control (NCASC), 2011, INT BIOL BEH SURV IB; National Centre for AIDS and STD Control (NCASC) & Ministry of Health and Population, 2015, COUNTR PROGR REP NEP; Ncama BP, 2008, INT J NURS STUD, V45, P1757, DOI 10.1016/j.ijnurstu.2008.06.006; NCASC, 2014, FACTSH 6 ANT THER CA; NCASC, 2012, NAT ANT THER GUID; NCASC, 2015, ART SERV SIT; NCASC, 2014, NAT CONS GUID TREAT; Nolan S, 2014, LANCET INFECT DIS, V14, P258, DOI 10.1016/S1473-3099(13)70329-3; O'Brien ME, 2003, JAIDS-J ACQ IMM DEF, V34, P407, DOI 10.1097/00126334-200312010-00008; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Poudel KC, 2015, INT Q COMMUNITY HLTH; Reda AA, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/574656; Rivero-Mendez M, 2015, P R HEALTH SCI J, V34, P31; Robbins GK, 2010, CLIN INFECT DIS, V50, P779, DOI 10.1086/650537; Sharma S, 2013, Kathmandu Univ Med J (KUMJ), V11, P50; Shigdel R, 2014, HIV AIDS-RES PALLIAT, V6, P109, DOI 10.2147/HIV.S55816; Shrestha Sadhana, 2014, J Int Assoc Provid AIDS Care, V13, P214, DOI 10.1177/1545109712456741; Simoni JA, 2006, HEALTH PSYCHOL, V25, P74, DOI 10.1037/0278-6133.25.1.74; Taiwo BO, 2010, JAIDS-J ACQ IMM DEF, V54, P85, DOI 10.1097/01.qai.0000371678.25873.1c; Talam N C, 2008, East Afr J Public Health, V5, P74; Tas U, 2007, BRIT J GEN PRACT, V57, P319; Thapa R, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0056-9; UNAIDS, 2015, 15 15 GLOB TARG ACH; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Wasti SP, 2012, TROP MED INT HEALTH, V17, P71, DOI 10.1111/j.1365-3156.2011.02888.x; Wasti Sharada Prasad, 2009, Kathmandu Univ Med J (KUMJ), V7, P306; WHO, 2011, RET HIV PROGR DEF CH; WHO, 2011, ASS WHO HIV DRUG RES; World Health Organization, 2016, CONS GUID US ANT DRU; Wringe A, 2009, AIDS CARE, V21, P632, DOI 10.1080/09540120802385629; Yehia BR, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0990-0; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	63	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159382	10.1371/journal.pone.0159382	http://dx.doi.org/10.1371/journal.pone.0159382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27438024	gold, Green Published, Green Submitted			2022-12-27	WOS:000380170100039
J	Smolinski, A; Howaniec, N				Smolinski, Adam; Howaniec, Natalia			Quantitative Modelling of Trace Elements in Hard Coal	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; MULTIVARIATE CALIBRATION; OUTLIER DETECTION; REGRESSION; GASIFICATION; ELIMINATION; COMPONENTS; BIOMASS	The significance of coal in the world economy remains unquestionable for decades. It is also expected to be the dominant fossil fuel in the foreseeable future. The increased awareness of sustainable development reflected in the relevant regulations implies, however, the need for the development and implementation of clean coal technologies on the one hand, and adequate analytical tools on the other. The paper presents the application of the quantitative Partial Least Squares method in modeling the concentrations of trace elements (As, Ba, Cd, Co, Cr, Cu, Mn, Ni, Pb, Rb, Sr, V and Zn) in hard coal based on the physical and chemical parameters of coal, and coal ash components. The study was focused on trace elements potentially hazardous to the environment when emitted from coal processing systems. The studied data included 24 parameters determined for 132 coal samples provided by 17 coal mines of the Upper Silesian Coal Basin, Poland. Since the data set contained outliers, the construction of robust Partial Least Squares models for contaminated data set and the correct identification of outlying objects based on the robust scales were required. These enabled the development of the correct Partial Least Squares models, characterized by good fit and prediction abilities. The root mean square error was below 10% for all except for one the final Partial Least Squares models constructed, and the prediction error (root mean square error of cross-validation) exceeded 10% only for three models constructed. The study is of both cognitive and applicative importance. It presents the unique application of the chemometric methods of data exploration in modeling the content of trace elements in coal. In this way it contributes to the development of useful tools of coal quality assessment.	[Smolinski, Adam; Howaniec, Natalia] Cent Min Inst, Dept Energy Saving & Air Protect, Katowice, Poland	Central Mining Institute (GIG)	Smolinski, A (corresponding author), Cent Min Inst, Dept Energy Saving & Air Protect, Katowice, Poland.	smolin@gig.katowice.pl	Smolinski, Adam/P-5333-2018	Smolinski, Adam/0000-0002-4901-7546; Howaniec, Natalia/0000-0003-4625-8464	Ministry of Science and Higher Education, Poland [11310046]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education, Poland, under Grant No. 11310046 (AS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeyo KH, 2010, APPL RADIAT ISOTOPES, V70, P2596; Bell DA, 2011, COAL GASIFICATION AND ITS APPLICATIONS, P1; Bridgwater AV, 1997, DEV THERMOCHEMICAL B; Centner V, 1996, ANAL CHEM, V68, P3851, DOI 10.1021/ac960321m; Chi QH, 2014, CONTROL ENG PRACT, V22, P181, DOI 10.1016/j.conengprac.2013.02.010; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Howaniec N, 2014, ENERGY, V78, P814, DOI 10.1016/j.energy.2014.10.076; Howaniec N, 2014, FUEL, V128, P442, DOI 10.1016/j.fuel.2014.03.036; Howaniec N, 2013, INT J HYDROGEN ENERG, V38, P16152, DOI 10.1016/j.ijhydene.2013.10.019; Joliffe IT, 1982, J ROYAL STAT SOC C, V31, P300; Jureczka J, 1995, PAPERS POLISH GEOLOG, P164; Koshoubu J, 2001, ANAL SCI, V17, P319, DOI 10.2116/analsci.17.319; LUCASIUS CB, 1993, CHEMOMETR INTELL LAB, V19, P1, DOI 10.1016/0169-7439(93)80079-W; Martens H., 1987, NEAR INFRARED TECHNO; Martens H., 1992, MULTIVARIATE CALIBRA; MASSART DL, 1986, ANAL CHIM ACTA, V187, P171, DOI 10.1016/S0003-2670(00)82910-4; Massart DL, 1997, HDB CHEMOMETRICS Q A; Mayfield DB, 2013, 2013 WORLD COAL ASH, P22; Michalewicz Z, 1992, GENETIC ALGORITHMS D; Peng J, 2010, J OPER MANAG, V30, P467; Peng JT, 2012, ANAL CHIM ACTA, V719, P24, DOI 10.1016/j.aca.2011.12.058; Rouhollah K, 2013, FOOD ANAL METHOD, V6, P386; Rousseeuw P. J., 1987, ROBUST REGRESSION OU; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; RUPPERT D, 1980, J AM STAT ASSOC, V75, P828, DOI 10.2307/2287169; Seredin VV, 2012, INT J COAL GEOL, V94, P67, DOI 10.1016/j.coal.2011.11.001; SIEGEL AF, 1982, BIOMETRIKA, V69, P242, DOI 10.1093/biomet/69.1.242; Smolinski A, 2003, ANAL LETT, V36, P2317, DOI 10.1081/AL-120023722; Smolinski A., 2014, J SUST MIN, V13, P7; Smolinski A, 2014, THESCIENTIFICWORLDJO, V2014, DOI [10.1155/2014/234204, DOI 10.1155/2014/234204]; Smolinski A, 2009, CHEMOSPHERE, V76, P565, DOI 10.1016/j.chemosphere.2009.02.057; US Energy Information Administration, ANN EN OUTL 2015 PRO; WALCZAK B, 1995, CHEMOMETR INTELL LAB, V29, P63, DOI 10.1016/0169-7439(95)00009-L; WALCZAK B, 1995, CHEMOMETR INTELL LAB, V28, P259, DOI 10.1016/0169-7439(94)00077-V; WALCZAK B, 1995, CHEMOMETR INTELL LAB, V27, P41, DOI 10.1016/0169-7439(94)00059-R; Wold H., 1981, SYSTEMS INDIRECT OBS; Wold S, 1983, LECT NOTES MATH	38	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159265	10.1371/journal.pone.0159265	http://dx.doi.org/10.1371/journal.pone.0159265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438794	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100034
J	Tian, WJ; Huang, ML; Qin, QF; Chen, Q; Fang, K; Wang, PL				Tian, Wei-Jie; Huang, Miao-Ling; Qin, Qing-Feng; Chen, Qing; Fang, Kun; Wang, Ping-Ling			Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL-CARCINOMA; PHASE-II TRIAL; UTERINE CERVIX; LUNG-CANCER; CATHEPSIN-D; EGFR; EXPRESSION; RECURRENT; CYCLOOXYGENASE-2; ERLOTINIB	Clinical trials have provided conflicting results regarding whether epidermal growth factor receptor (EGFR) overexpression predicts poor survival in cervical cancer patients. In this study, we perform a meta-analysis of the association between EGFR expression and survival in cervical cancer patients. We searched clinical studies in the Medline, PubMed, Embase, and Web of Science databases. A total of 22 studies with 2,505 patients were included, and pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated for each study. Heterogeneity was assessed using Higgins I-2 to select a Mantel-Haenszel fixed effects model (I-2 <= 50%) or a DerSimonian-Laird random effects model (I2 >= 50%). High EGFR levels predicted poor overall survival (OS) (HR: 1.40, 95% CI: 1.10-1.78) and disease-free survival (DFS) (HR: 1.84, 95% CI: 1.51-2.24). Stratified analyses showed that EGFR overexpression was significantly related to poor DFS in patients treated with chemoradiation or surgery. Moreover, the pooled odds ratios (ORs) revealed associations between EGFR expression and clinicopathological features, such as lymph node metastasis (OR: 1.72, 95% CI: 1.23-2.40) and tumor size >= 4 cm (OR: 1.64, 95% CI: 1.20-2.23). This meta-analysis demonstrates that EGFR overexpression is closely associated with reduced survival in patients with cervical cancer. These results may facilitate the individualized management of clinical decisions for anti-EGFR therapies in cervical cancer patients.	[Tian, Wei-Jie; Qin, Qing-Feng; Fang, Kun; Wang, Ping-Ling] Guizhou Prov Peoples Hosp, Dept Obstet & Gynecol, Guiyang, Guizhou, Peoples R China; [Huang, Miao-Ling; Chen, Qing] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Wang, PL (corresponding author), Guizhou Prov Peoples Hosp, Dept Obstet & Gynecol, Guiyang, Guizhou, Peoples R China.	ajie666@foxmail.com			Guangdong Province Medical Science Technology Grant [B2013118]; Guangdong Pharmaceutical Association Fund [2012D04]	Guangdong Province Medical Science Technology Grant; Guangdong Pharmaceutical Association Fund	This work was funded by B2013118 (http://kyjj.gdwskj.cn/), Guangdong Province Medical Science Technology Grant (to MLH); and 2012D04 (http://www.sinopharmacy.com.cn/), Guangdong Pharmaceutical Association Fund (to MLH).	Alberts DS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008285; Arias-Pulido H, 2008, INT J GYNECOL CANCER, V18, P749, DOI 10.1111/j.1525-1438.2007.01111.x; Baltazar F, 2007, INT J GYNECOL PATHOL, V26, P235, DOI 10.1097/pgp.0b013e31802f1996; Bodner K, 2011, ARCH GYNECOL OBSTET, V283, P611, DOI 10.1007/s00404-010-1464-7; Cho NH, 2003, GYNECOL ONCOL, V91, P346, DOI 10.1016/S0090-8258(03)00504-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eijsink JJH, 2010, HUM PATHOL, V41, P1735, DOI 10.1016/j.humpath.2010.04.017; Farley J, 2011, GYNECOL ONCOL, V121, P303, DOI 10.1016/j.ygyno.2011.01.030; Fuchs I, 2007, ANTICANCER RES, V27, P959; Gaffney DK, 2003, INT J RADIAT ONCOL, V56, P922, DOI 10.1016/S0360-3016(03)00209-8; Giordano G, 2011, INT J GYNECOL CANCER, V21, P337, DOI 10.1097/IGC.0b013e31820864b7; Goncalves A, 2008, GYNECOL ONCOL, V108, P42, DOI 10.1016/j.ygyno.2007.07.057; Halle C, 2011, CLIN CANCER RES, V17, P5501, DOI 10.1158/1078-0432.CCR-11-0297; Hayes DF, 1996, JNCI-J NATL CANCER I, V88, P1456, DOI 10.1093/jnci/88.20.1456; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Iida K, 2011, BRIT J CANCER, V105, P420, DOI 10.1038/bjc.2011.222; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson JR, 2005, CLIN CANCER RES, V11, P6414, DOI 10.1158/1078-0432.CCR-05-0790; Kersemaekers AMF, 1999, CLIN CANCER RES, V5, P577; Kim GE, 2004, CLIN CANCER RES, V10, P1366, DOI 10.1158/1078-0432.CCR-0497-03; Kim YT, 2002, GYNECOL ONCOL, V87, P84, DOI 10.1006/gyno.2002.6803; Kristensen GB, 1996, CANCER, V78, P433; Lee CM, 2005, GYNECOL ONCOL, V99, P415, DOI 10.1016/j.ygyno.2005.05.045; Lee CM, 2004, GYNECOL ONCOL, V93, P209, DOI 10.1016/j.ygyno.2004.01.006; MANTEL N, 1959, J NATL CANCER I, V22, P719; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Nagai N, 2000, ONCOL REP, V7, P551; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nogueira-Rodrigues A, 2014, CANCER-AM CANCER SOC, V120, P1187, DOI 10.1002/cncr.28471; Noordhuis MG, 2009, CLIN CANCER RES, V15, P7389, DOI 10.1158/1078-0432.CCR-09-1149; Oh MJ, 2004, CANCER LETT, V203, P107, DOI 10.1016/j.canlet.2003.09.025; Oka K, 1997, INT J GYNECOL CANCER, V7, P122, DOI 10.1046/j.1525-1438.1997.00431.x; Perez-Regadera J, 2011, AM J CLIN ONCOL-CANC, V34, P395, DOI 10.1097/COC.0b013e3181e84634; Rivera F, 2009, EXPERT REV ANTICANC, V9, P1421, DOI [10.1586/era.09.113, 10.1586/ERA.09.113]; Roengvoraphoj M, 2013, CANCER TREAT REV, V39, P839, DOI 10.1016/j.ctrv.2013.05.001; Santin AD, 2011, GYNECOL ONCOL, V122, P495, DOI 10.1016/j.ygyno.2011.05.040; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Scambia G, 1998, CANCER LETT, V123, P135, DOI 10.1016/S0304-3835(97)00421-7; Schilder RJ, 2009, INT J GYNECOL CANCER, V19, P929, DOI 10.1111/IGC.0b013e3181a83467; Sharma DN, 2013, INT J GYNECOL CANCER, V23, P705, DOI 10.1097/IGC.0b013e31828b1699; Skomedal H, 1999, GYNECOL ONCOL, V73, P223, DOI 10.1006/gyno.1999.5346; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; Sonobe M, 2007, J SURG ONCOL, V95, P63, DOI 10.1002/jso.20547; Soonthornthum T, 2011, ANN ONCOL, V22, P2166, DOI 10.1093/annonc/mdq723; Tangjitgamol S, 2005, INT J GYNECOL CANCER, V15, P646, DOI 10.1111/j.1525-1438.2005.00121.x; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Vosmik M, 2014, PATHOL ONCOL RES, V20, P131, DOI 10.1007/s12253-013-9674-5; Yamashita H, 2009, INT J RADIAT ONCOL, V74, P1165, DOI 10.1016/j.ijrobp.2008.09.005	49	22	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158787	10.1371/journal.pone.0158787	http://dx.doi.org/10.1371/journal.pone.0158787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438047	gold, Green Submitted, Green Published			2022-12-27	WOS:000380170100020
J	Zhu, LJ; Liu, JK; Cong, L; Ma, WM; Ma, W; Zhang, ZM				Zhu, Lijuan; Liu, Jiakai; Cong, Ling; Ma, Wenmei; Ma, Wu; Zhang, Zhenming			Spatiotemporal Characteristics of Particulate Matter and Dry Deposition Flux in the Cuihu Wetland of Beijing	PLOS ONE			English	Article							AIR-POLLUTION; ATMOSPHERIC AEROSOL; PM2.5; PARTICLES; URBAN; PM10; POLLUTANTS; SHANGHAI; FOREST; SITES	In recent years, the rapid development of industrialization and urbanization has caused serious environmental pollution, especially particulate pollution. As the "Earth's kidneys," wet-land plays a significant role in improving the environmental quality and adjusting the climate. To study how wetlands work in this aspect, from the early autumn of 2014 to 2015, we implemented a study to measure the PM concentration and chemical composition at three heights (1.5, 6, and 10 m) during different periods (dry, normal water, and wet periods) in the Cuihu wetland park in Beijing for analyzing the dry deposition flux and the effect of meteorological factors on the concentration. Results indicated that (1) the diurnal variations of the PM2.5 and PM10 concentrations at the three heights were similar in that the highest concentration occurred at night and the lowest occurred at noon, and the daytime concentration was lower than that at night; (2) the PM2.5 and PM10 concentrations also varied between different periods that wet period > normal water period > wet period, and the concentration at different heights during different periods varied. In general, the lowest concentration occurred at 10 m during the dry and normal water periods, and the highest concentration occurred at 1.5 m during the wet period. (3) SO42-, NO3-, and Cl- are the dominant constituents of PM2.5, accounting for 42.22, 12.6, and 21.56%, respectively; (4) the dry depositions of PM2.5 and PM10 at 10 m were higher than those at 6 m, and the deposition during the dry period was higher than those during the wet and normal water periods. In addition, the deposition during the night-time was higher than that during the daytime. Moreover, meteorological factors affected the deposition, the temperature and wind speed being negatively correlated with the deposition flux and the humidity being positively correlated. (5) The PM10 and PM2.5 concentrations were influenced by meteorological factors. The PM2.5 and PM10 concentrations were negatively correlated with temperature and wind speed but positively correlated with relative humidity.	[Zhu, Lijuan; Liu, Jiakai; Cong, Ling; Ma, Wenmei; Zhang, Zhenming] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Ma, Wu] West Virginia Univ, Sch Nat Resources, Morgantown, WV USA	Beijing Forestry University; West Virginia University	Zhang, ZM (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	zhenmingzhang@bjfu.edu.cn	Liu, Jiakai/L-9946-2014; cong, ling/GQG-9582-2022	Liu, Jiakai/0000-0002-3337-1962; 	Fundamental Research Funds for the Central Universities [2016JX05]; Forestry Public Welfare Projects Special Fund of China [201304301]; Beijing Municipal Science and Technology Project [Z141100006014031]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Forestry Public Welfare Projects Special Fund of China; Beijing Municipal Science and Technology Project	This work was supported by the Fundamental Research Funds for the Central Universities (2016JX05), Forestry Public Welfare Projects Special Fund of China (201304301), and Beijing Municipal Science and Technology Project (Z141100006014031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Fundamental Research Funds for the Central Universities (2016JX05), Forestry Public Welfare Projects Special Fund of China (201304301), and Beijing Municipal Science and Technology Project (Z141100006014031). The authors acknowledge the constructive comments provided by both the reviewers and editors.	Aldrin M, 2005, ATMOS ENVIRON, V39, P2145, DOI 10.1016/j.atmosenv.2004.12.020; [Anonymous], 2002, MDHS143 HLTH SAF EX; Balestrini R, 2007, ATMOS ENVIRON, V41, P745, DOI 10.1016/j.atmosenv.2006.09.002; Borja-Aburto VH, 1998, ENVIRON HEALTH PERSP, V106, P849, DOI 10.2307/3434129; Cao JJ, 2009, AEROSOL AIR QUAL RES, V9, P277; Chen JG, 2015, ATMOSPHERE-BASEL, V6, P650, DOI 10.3390/atmos6050650; Correia AW, 2013, EPIDEMIOLOGY, V24, P23, DOI 10.1097/EDE.0b013e3182770237; Dzierzanowski K, 2011, INT J PHYTOREMEDIAT, V13, P1037, DOI 10.1080/15226514.2011.552929; Eskeland GS, 1997, AM J AGR ECON, V79, P1636, DOI 10.2307/1244395; Fang GC, 2014, TOXICOL IND HEALTH, V30, P728, DOI 10.1177/0748233712462474; Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x; [郭建超 Guo Jianchao], 2014, [水土保持学报, Journal of Soil and Water Conservation], V28, P88; Guo S, 2012, ENVIRON SCI TECHNOL, V46, P9846, DOI [10.1021/es20425641, 10.1021/es2042564]; [郝立生 HAO Lisheng], 2008, [南京气象学院学报, Journal of Nanjing Institute of Meteorology], V31, P109; Harrison RM, 2001, ATMOS ENVIRON, V35, P3667, DOI 10.1016/S1352-2310(00)00526-4; He KB, 2001, ATMOS ENVIRON, V35, P4959, DOI 10.1016/S1352-2310(01)00301-6; Hu M, 2002, ATMOS ENVIRON, V36, P5853, DOI 10.1016/S1352-2310(02)00581-2; Jeremy A, 2001, NEW ENGL J MED, V344, P1251; Khan FI, 2000, ENVIRON MONIT ASSESS, V64, P457, DOI 10.1023/A:1006278000352; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu JK, 2016, ATMOS ENVIRON, V125, P178, DOI 10.1016/j.atmosenv.2015.11.023; [刘建华 Liu Jianhua], 2003, [物探与化探, Geophysical and Geochemical Exploration], V27, P490; Liu J, 2015, INFORM FUSION, V23, P1, DOI 10.1016/j.inffus.2014.08.001; Marcazzan GM, 2001, ATMOS ENVIRON, V35, P4639, DOI 10.1016/S1352-2310(01)00124-8; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Park SS, 2004, ATMOS ENVIRON, V38, P1459, DOI 10.1016/j.atmosenv.2003.12.004; Pateraki S, 2012, SCI TOTAL ENVIRON, V419, P124, DOI 10.1016/j.scitotenv.2011.12.064; Peng GL, 2011, J ENVIRON MONITOR, V13, P1927, DOI 10.1039/c0em00776e; Petroff A, 2008, ATMOS ENVIRON, V42, P3625, DOI 10.1016/j.atmosenv.2007.09.043; Powe NA, 2004, J ENVIRON MANAGE, V70, P119, DOI 10.1016/j.jenvman.2003.11.003; Qiu DD, 2015, J ENVIRON SCI, V36, P93, DOI 10.1016/j.jes.2015.04.016; Shen ZX, 2008, J AIR WASTE MANAGE, V58, P1560, DOI 10.3155/1047-3289.58.12.1560; SLINN SA, 1980, ATMOS ENVIRON, V14, P1013, DOI 10.1016/0004-6981(80)90032-3; Spindler G, 2010, ATMOS ENVIRON, V44, P164, DOI 10.1016/j.atmosenv.2009.10.015; Sun FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097723; Nguyen T, 2015, J ENVIRON SCI, V27, P33, DOI 10.1016/j.jes.2014.04.019; Wang J, 2015, INT J ENV RES PUB HE, V12, P9089, DOI 10.3390/ijerph120809089; Wang Y, 2005, ATMOS ENVIRON, V39, P3771, DOI 10.1016/j.atmosenv.2005.03.013; Weinbruch S, 2014, ATMOS ENVIRON, V99, P175, DOI 10.1016/j.atmosenv.2014.09.075; Wu Z. P., 2007, J TSINGHUA U SCI TEC, V47, P2152; Yao XH, 2002, ATMOS ENVIRON, V36, P4223, DOI 10.1016/S1352-2310(02)00342-4; Ye BM, 2003, ATMOS ENVIRON, V37, P499, DOI 10.1016/S1352-2310(02)00918-4; Zhang LM, 2001, ATMOS ENVIRON, V35, P549, DOI 10.1016/S1352-2310(00)00326-5; Zhang XY, 2002, ATMOS ENVIRON, V36, P4189, DOI 10.1016/S1352-2310(02)00347-3; Zheng M, 2005, ATMOS ENVIRON, V39, P3967, DOI 10.1016/j.atmosenv.2005.03.036	45	24	26	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158616	10.1371/journal.pone.0158616	http://dx.doi.org/10.1371/journal.pone.0158616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437688	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100015
J	Connan, M; Hofmeyr, GJG; Pistorius, PA				Connan, Maelle; Hofmeyr, G. J. Greg; Pistorius, Pierre A.			Reappraisal of the Trophic Ecology of One of the World's Most Threatened Spheniscids, the African Penguin	PLOS ONE			English	Article							CARBON STABLE-ISOTOPES; JACKASS PENGUINS; SOUTH-AFRICA; PRIOR INFORMATION; GENTOO PENGUIN; MIXING MODELS; CHOKKA SQUID; AVIAN BLOOD; BAY-REGION; ALGOA-BAY	Many species of seabirds, including the only penguin species breeding on the African continent, are threatened with extinction. The world population of the endangered African penguin Spheniscus demersus has decreased from more than 1.5 million individuals in the early 1900s to c.a. 23 000 pairs in 2013. Determining the trophic interactions of species, especially those of conservation concern, is important when declining numbers are thought to be driven by food limitation. By and large, African penguin dietary studies have relied on the identification of prey remains from stomach contents. Despite all the advantages of this method, it has well known biases. We therefore assessed the African penguin's diet, using stable isotopes, at two colonies in Algoa Bay (south-east coast of South Africa). These represent over 50% of the world population. Various samples (blood, feathers, egg membranes) were collected for carbon and nitrogen stable isotope analyses. Results indicate that the trophic ecology of African penguins is influenced by colony, season and age class, but not adult sex. Isotopic niches identified by standard Bayesian ellipse areas and convex hulls, highlighted differences among groups and variability among individual penguins. Using Bayesian mixing models it was for the first time shown that adults target chokka squid Loligo reynaudii for self-provisioning during particular stages of their annual cycle, while concurrently feeding their chicks primarily with small pelagic fish. This has important ramifications and means that not only pelagic fish, but also squid stocks, need to be carefully managed in order to allow population recovery of African penguin.	[Connan, Maelle; Pistorius, Pierre A.] Nelson Mandela Metropolitan Univ, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, Dept Zool, ZA-6031 Port Elizabeth, South Africa; [Hofmeyr, G. J. Greg] Nelson Mandela Metropolitan Univ, Dept Zool, ZA-6031 Port Elizabeth, South Africa; [Hofmeyr, G. J. Greg] Port Elizabeth Museum Bayworld, ZA-6013 Port Elizabeth, South Africa	National Research Foundation - South Africa; Nelson Mandela University; Nelson Mandela University	Connan, M (corresponding author), Nelson Mandela Metropolitan Univ, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, Dept Zool, ZA-6031 Port Elizabeth, South Africa.	maelle.connan@gmail.com		Pistorius, Pierre/0000-0001-6561-7069; Connan, Maelle/0000-0002-1308-9118	Department of Science and Technology- National Research Foundation Centre of Excellence grant; Nelson Mandela Metropolitan University	Department of Science and Technology- National Research Foundation Centre of Excellence grant; Nelson Mandela Metropolitan University	This research was funded by the Department of Science and Technology- National Research Foundation Centre of Excellence grant to the Percy FitzPatrick Institute of African Ornithology at the University of Cape Town, http://www.fitzpatrick.uct.ac.za/. MC was supported by the Nelson Mandela Metropolitan University through a post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALMELLI M, 1994, S AFR J MARINE SCI, V14, P151; Barange M, 1999, S AFR J MARINE SCI, V21, P367; Barham PJ, 2008, BIRD CONSERV INT, V18, P144, DOI 10.1017/S0959270908000142; Barquete V, 2012, USING STABLE ISOTOPE; Barquete V, 2013, J EXP MAR BIOL ECOL, V448, P121, DOI 10.1016/j.jembe.2013.06.021; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Bearhop S, 2000, AUK, V117, P504, DOI 10.1642/0004-8038(2000)117[0504:IOLAUA]2.0.CO;2; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; BirdLife International, 2015, SPHEN DEM IUCN RED L; Brinker DF, 2007, WATERBIRDS, V30, P93, DOI 10.1675/1524-4695(2007)030[0093:CSITCB]2.0.CO;2; Browne T, 2011, AUSTRAL ECOL, V36, P99, DOI 10.1111/j.1442-9993.2010.02125.x; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; COOPER J, 1977, Zoologica Africana, V12, P201; Cooper J., 1984, P217; Cooper J., 1978, International Zoo Yearbook, V18, P22, DOI 10.1111/j.1748-1090.1978.tb00211.x; Crawford RJM, 2011, AFR J MAR SCI, V33, P139, DOI 10.2989/1814232X.2011.572377; Crawford R.J.M., 1981, P15; CRAWFORD RJM, 1995, IBIS, V137, P329, DOI 10.1111/j.1474-919X.1995.tb08029.x; Crawford RJM., 1985, S AFR J MARINE SCI, V3, P215, DOI [https://doi.org/10.2989/025776185784461252, DOI 10.2989/025776185784461252]; Crawford RJM., 2006, ACTA ZOOL SINICA, V52, P444; Crawford RJM, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00010; Crawford RJM, 2014, OSTRICH, V85, P111, DOI 10.2989/00306525.2014.955141; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; CROXALL JP, 1982, J ANIM ECOL, V51, P177, DOI 10.2307/4318; Davies DH, 1956, S AFRICAN PILCHARD S, V23, P1; Davies DH, 1955, INVESTIGATIONAL REPO, V18, P1; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DUFFY DC, 1987, NATL GEOGR RES, V3, P480; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; GHEBREMESKEL K, 1991, COMP BIOCHEM PHYS A, V99, P245, DOI 10.1016/0300-9629(91)90267-G; Green DB, 2015, ICES J MAR SCI, V72, P771, DOI 10.1093/icesjms/fsu203; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HEATH RGM, 1985, J ZOOL, V205, P91; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hobson KA, 2011, J ORNITHOL, V152, P49, DOI 10.1007/s10336-011-0653-x; International BirdLife, IUCN RED LIST BIRDS; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jaquemet S, 2008, MAR BIOL, V155, P505, DOI 10.1007/s00227-008-1049-1; Jaquemet S, 2008, ESTUAR COAST SHELF S, V80, P374, DOI 10.1016/j.ecss.2008.08.019; Kohler SA, 2011, MAR ECOL PROG SER, V435, P235, DOI 10.3354/meps09215; LAUGKSCH RC, 1993, S AFR J MARINE SCI, V13, P295, DOI 10.2989/025776193784287275; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lescroel A, 2005, MAR ECOL PROG SER, V302, P245, DOI 10.3354/meps302245; Ludynia K, 2010, AFR J MAR SCI, V32, P563, DOI 10.2989/1814232X.2010.538151; Matthews JP, 1961, INVESTIGATIONAL REPO; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; Meijer T, 1999, IBIS, V141, P399, DOI 10.1111/j.1474-919X.1999.tb04409.x; Michalik A, 2010, RAPID COMMUN MASS SP, V24, P875, DOI 10.1002/rcm.4462; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; MIZUTANI H, 1990, AUK, V107, P400, DOI 10.2307/4087626; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; O'Brien JK, 2016, GEN COMP ENDOCR, V225, P81, DOI 10.1016/j.ygcen.2015.09.013; O'Donoghue SH, 2010, AFR J MAR SCI, V32, P361, DOI 10.2989/1814232X.2010.502640; Ogden LJE, 2004, AUK, V121, P170, DOI 10.1642/0004-8038(2004)121[0170:BICANT]2.0.CO;2; Oppel S, 2009, J ORNITHOL, V150, P109, DOI 10.1007/s10336-008-0325-7; Parnell AC, 2013, ENVIRONMETRICS, V24, P387, DOI 10.1002/env.2221; Petersen SL, 2006, IBIS, V148, P14, DOI 10.1111/j.1474-919X.2006.00459.x; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1; Pichegru L, 2013, ENDANGER SPECIES RES, V19, P255, DOI 10.3354/esr00477; Pichegru L, 2012, BIOL CONSERV, V156, P117, DOI 10.1016/j.biocon.2011.12.013; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Pichegru L, BIRD CONSERVATION IN; Polito MJ, 2009, J EXP MAR BIOL ECOL, V372, P106, DOI 10.1016/j.jembe.2009.02.014; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Quillfeldt P, 2015, RAPID COMMUN MASS SP, V29, P667, DOI 10.1002/rcm.7145; Quillfeldt P, 2009, RAPID COMMUN MASS SP, V23, P3632, DOI 10.1002/rcm.4286; Ralph M., 2008, THESIS N MANDELA MET; Ramirez F, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00297.1; Rand R. W., 1960, INVESTIGATIONAL REPO, V41, P1; RANDALL RM, 1986, BIOL CONSERV, V37, P119, DOI 10.1016/0006-3207(86)90087-X; RANDALL RM, 1981, S AFR J ZOOL, V16, P163; Randall RM, 1983, BIOL JACKASS PENGUIN; Ricklefs R. E., 1983, STUD AVIAN BIOL, V8, P84; Rishworth GM, 2014, AFR ZOOL, V49, P107, DOI 10.3377/004.049.0115; Roberts MJ, 2012, ICES J MAR SCI, V69, P563, DOI 10.1093/icesjms/fss023; Roy C, 2007, AFR J MAR SCI, V29, P309, DOI 10.2989/AJMS.2007.29.3.1.331; Saraux C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020407; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Sears J, 2009, OECOLOGIA, V159, P41, DOI 10.1007/s00442-008-1199-3; SEDDON PJ, 1993, OSTRICH, V64, P8, DOI 10.1080/00306525.1993.9634188; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Shannon L. J., 1999, Marine Ornithology, V27, P119; Shelton PA, 1984, S AFRICAN J MARINE S, V2, P217, DOI DOI 10.2989/02577618409504370; Sherley RB, 2013, MAR ECOL PROG SER, V473, P291, DOI 10.3354/meps10070; Smale MJ, 2001, MAR BIOL, V139, P1095; Smith JA, 2013, METHODS ECOL EVOL, V4, P612, DOI 10.1111/2041-210X.12048; Stock B., 2015, MIXSIAR USER MANUAL; Team RDC, 2015, LANG ENV STAT COMP; van der Lingen CD, 2010, AFR J MAR SCI, V32, P271, DOI 10.2989/1814232X.2010.501581; VANHEEZIK Y, 1989, J FIELD ORNITHOL, V60, P451; Voogt NM, 2014, DIETARY ASPECTS ESTA; Ward EJ, 2010, ENVIRON SCI TECHNOL, V44, P4645, DOI 10.1021/es100053v; Weller F, 2016, ECOL MODEL, V327, P44, DOI 10.1016/j.ecolmodel.2016.01.011; Weller F, 2014, ECOL MODEL, V277, P38, DOI 10.1016/j.ecolmodel.2014.01.013; Williams CT, 2007, OECOLOGIA, V153, P11, DOI 10.1007/s00442-007-0717-z; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; WILSON RP, 1985, MAR ECOL PROG SER, V25, P219, DOI 10.3354/meps025219; WILSON RP, 1985, J ORNITHOL, V126, P53, DOI 10.1007/BF01640442; WILSON RP, 1985, ORNIS SCAND, V16, P77, DOI 10.2307/3676580	104	13	13	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159402	10.1371/journal.pone.0159402	http://dx.doi.org/10.1371/journal.pone.0159402			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434061	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600052
J	Ponsuksili, S; Reyer, H; Trakooljul, N; Murani, E; Wimmers, K				Ponsuksili, Siriluck; Reyer, Henry; Trakooljul, Nares; Murani, Eduard; Wimmers, Klaus			Single- and Bayesian Multi-Marker Genome-Wide Association for Haematological Parameters in Pigs	PLOS ONE			English	Article							CLINICAL-CHEMICAL TRAITS; GROWTH-FACTOR SYSTEM; KOREAN NATIVE PIGS; BLOOD-CELL; BRANGUS HEIFERS; F-2 INTERCROSS; QTL ANALYSIS; COAT COLOR; POPULATION; HEMATOPOIESIS	Haematological traits are important traits that show associations with immune and metabolic status, as well as diseases in humans and animals. Mapping genome regions that affect the blood cell traits can contribute to the identification of genomic features useable as biomarkers for immune, disease and metabolic status. A genome-wide association study (GWAS) was conducted using PorcineSNP60 BeadChips. Single-marker and Bayesian multi-marker approaches were integrated to identify genomic regions and corresponding genes overlapping for both methods. GWAS was performed for haematological traits of 591 German Landrace pig. Heritability estimates for haematological traits were medium to high. In total 252 single SNPs associated with 12 haematological traits were identified (NegLog10 of p-value > 5). The Bayesian multi-marker approach revealed 102 QTL regions across the genome, indicated by 1-Mb windows with contribution to additive genetic variance above 0.5%. The integration of both methods resulted in 24 overlapping QTL regions. This study identified overlapping QTL regions from single-and multi-marker approaches for haematological traits. Identifying candidate genes that affect blood cell traits provides the first step towards the understanding of the molecular basis of haematological phenotypes.	[Ponsuksili, Siriluck] Leibniz Inst Farm Anim Biol FBN, Res Unit Funct Genome Anal, Inst Genome Biol, Wilhelm Stahl Allee 2, D-18196 Dummerstorf, Germany; [Reyer, Henry; Trakooljul, Nares; Murani, Eduard; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Res Unit Genom, Inst Genome Biol, Wilhelm Stahl Allee 2, D-18196 Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Wimmers, K (corresponding author), Leibniz Inst Farm Anim Biol FBN, Res Unit Genom, Inst Genome Biol, Wilhelm Stahl Allee 2, D-18196 Dummerstorf, Germany.	wimmers@fbn-dummertorf.de	Wimmers, Klaus/AAF-9434-2020	Trakooljul, Nares/0000-0002-3214-2498; Wimmers, Klaus/0000-0002-9523-6790	project AgroClustEr PHAENOMICS [FKZ 0315536G]; German Federal Ministry of Education and Research; Leibniz Institute for Farm Animal Biology (FBN); Leibniz Association	project AgroClustEr PHAENOMICS; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Leibniz Institute for Farm Animal Biology (FBN); Leibniz Association	This study was part of the project AgroClustEr PHAENOMICS (FKZ 0315536G), which was funded by the German Federal Ministry of Education and Research. The Leibniz Institute for Farm Animal Biology (FBN) provided its own matched funding. The publication of this article was funded by the open access funds of the Leibniz Association and the Leibniz Institute for Farm Animal Biology (FBN).	Amati-Bonneau P, 2009, INT J BIOCHEM CELL B, V41, P1855, DOI 10.1016/j.biocel.2009.04.012; Boddicker N, 2012, J ANIM SCI, V90, P1733, DOI 10.2527/jas.2011-4464; Bode G, 2010, J PHARMACOL TOX MET, V62, P196, DOI 10.1016/j.vascn.2010.05.009; Bustos RI, 2013, BIOCHEM BIOPH RES CO, V437, P426, DOI 10.1016/j.bbrc.2013.06.095; Chen YN, 2011, EXP BIOL MED, V236, P477, DOI 10.1258/ebm.2011.010283; Cho IC, 2011, ANIM GENET, V42, P621, DOI 10.1111/j.1365-2052.2011.02204.x; Clapperton M, 2008, ANIMAL, V2, P1575, DOI 10.1017/S1751731108002929; Dayyani F, 2008, BLOOD, V111, P4338, DOI 10.1182/blood-2007-07-103291; El-Kordi A, 2013, BEHAV BRAIN RES, V251, P41, DOI 10.1016/j.bbr.2012.11.016; Evstatiev R, 2014, AM J HEMATOL, V89, P524, DOI 10.1002/ajh.23682; Fernando RL, 2008, GENSEL USER MANUAL P; Fesus L, 2005, J ANIM BREED GENET, V122, P127, DOI 10.1111/j.1439-0388.2005.00504.x; Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606; Gong YF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-56; Haase B, 2010, VET J, V184, P315, DOI 10.1016/j.tvjl.2009.02.017; Johansson A, 2005, ANIM GENET, V36, P288, DOI 10.1111/j.1365-2052.2005.01320.x; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kuang SQ, 2010, BLOOD, V115, P2412, DOI 10.1182/blood-2009-05-222208; Lee S, 2011, BIOMETRICS, V67, P967, DOI 10.1111/j.1541-0420.2010.01520.x; Luo WZ, 2012, INT J BIOL SCI, V8, P870, DOI 10.7150/ijbs.4027; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Moore SF, 2015, CARDIOVASC RES, V107, P9, DOI 10.1093/cvr/cvv132; Mpetile Z, 2015, J ANIM SCI, V93, P892, DOI 10.2527/jas.2014-8132; Okada Y, 2011, HUM MOL GENET, V20, P1224, DOI 10.1093/hmg/ddq551; Peters SO, 2013, J ANIM SCI, V91, P605, DOI 10.2527/jas.2012-5580; Peters SO, 2012, J ANIM SCI, V90, P3398, DOI [10.2527/jas.2011-4507, 10.2527/jas.2012-4507]; Pielberg G, 2002, GENETICS, V160, P305; Reiner G, 2009, ANIM GENET, V40, P57, DOI 10.1111/j.1365-2052.2008.01804.x; Reiner G, 2007, ANIM GENET, V38, P447, DOI 10.1111/j.1365-2052.2007.01629.x; Sandahl JD, 2014, HAEMATOLOGICA, V99, P865, DOI 10.3324/haematol.2013.098517; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Shi LL, 2013, HUM MOL GENET, V22, P3749, DOI 10.1093/hmg/ddt226; SHIMON I, 1995, LEUKEMIA RES, V19, P233, DOI 10.1016/0145-2126(94)00133-U; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Vong QP, 2014, BLOOD, V124, P3905, DOI 10.1182/blood-2014-06-582965; Wheat JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105557; Wu ZH, 2012, J BIOL CHEM, V287, P15557, DOI 10.1074/jbc.M112.340869; Yoo CK, 2012, PHYSIOL GENOMICS, V44, P657, DOI 10.1152/physiolgenomics.00172.2011; Yu G, 2004, J BIOL CHEM, V279, P55531, DOI 10.1074/jbc.M410814200; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-41; Zhang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063665; Zhao HQ, 2009, GENET EPIDEMIOL, V33, P679, DOI 10.1002/gepi.20419; Zhu J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1240-y; Zumkeller W, 1999, BLOOD, V94, P3653, DOI 10.1182/blood.V94.11.3653.423k42_3653_3657	46	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159212	10.1371/journal.pone.0159212	http://dx.doi.org/10.1371/journal.pone.0159212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434032	Green Submitted, gold, Green Published			2022-12-27	WOS:000380169600040
J	Pycinski, B; Czajkowska, J; Badura, P; Juszczyk, J; Pietka, E				Pycinski, Bartlomiej; Czajkowska, Joanna; Badura, Pawel; Juszczyk, Jan; Pietka, Ewa			Time-Of-Flight Camera, Optical Tracker and Computed Tomography in Pairwise Data Registration	PLOS ONE			English	Article							SURFACE REGISTRATION; NAVIGATION; SURGERY; SEGMENTATION; SELECTION; SYSTEM	Purpose A growing number of medical applications, including minimal invasive surgery, depends on multi-modal or multi-sensors data processing. Fast and accurate 3D scene analysis, comprising data registration, seems to be crucial for the development of computer aided diagnosis and therapy. The advancement of surface tracking system based on optical trackers already plays an important role in surgical procedures planning. However, new modalities, like the time-of-flight (ToF) sensors, widely explored in non-medical fields are powerful and have the potential to become a part of computer aided surgery set-up. Connection of different acquisition systems promises to provide a valuable support for operating room procedures. Therefore, the detailed analysis of the accuracy of such multi-sensors positioning systems is needed. Methods We present the system combining pre-operative CT series with intra-operative ToF-sensor and optical tracker point clouds. The methodology contains: optical sensor set-up and the ToF-camera calibration procedures, data pre-processing algorithms, and registration technique. The data pre-processing yields a surface, in case of CT, and point clouds for ToF-sensor and marker-driven optical tracker representation of an object of interest. An applied registration technique is based on Iterative Closest Point algorithm. Results The experiments validate the registration of each pair of modalities/sensors involving phantoms of four various human organs in terms of Hausdorff distance and mean absolute distance metrics. The best surface alignment was obtained for CT and optical tracker combination, whereas the worst for experiments involving ToF-camera. Conclusion The obtained accuracies encourage to further develop the multi-sensors systems. The presented substantive discussion concerning the system limitations and possible improvements mainly related to the depth information produced by the ToF-sensor is useful for computer aided surgery developers.	[Pycinski, Bartlomiej; Czajkowska, Joanna; Badura, Pawel; Juszczyk, Jan; Pietka, Ewa] Silesian Tech Univ, Fac Biomed Engn, Zabrze, Poland	Silesian University of Technology	Pycinski, B (corresponding author), Silesian Tech Univ, Fac Biomed Engn, Zabrze, Poland.	bartlomiej.pycinski@polsl.pl	Czajkowska, Joanna/AAB-2097-2019; Czajkowska, Joanna/AAC-9634-2022; Pyciński, Bartłomiej/G-7989-2015; Badura, Pawel/O-4990-2014; Juszczyk, Jan/T-7381-2018	Czajkowska, Joanna/0000-0002-6237-1793; Pyciński, Bartłomiej/0000-0002-6634-4127; Badura, Pawel/0000-0002-3941-4927; Juszczyk, Jan/0000-0003-1645-144X	Polish National Centre for Research and Development (Narodowe Centrum Badan i Rozwoju) [STRATEGMED2/267398/4/NCBR/2015]	Polish National Centre for Research and Development (Narodowe Centrum Badan i Rozwoju)	This research was supported by the Polish National Centre for Research and Development (Narodowe Centrum Badan i Rozwoju) grant No. STRATEGMED2/267398/4/NCBR/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, INT C MEDICAL IMAGE, DOI DOI 10.1007/3-540-45468-3_62; ARUN KS, 1987, IEEE T PATTERN ANAL, V9, P699, DOI 10.1109/TPAMI.1987.4767965; Audette MA, 2000, MED IMAGE ANAL, V4, P201, DOI 10.1016/S1361-8415(00)00014-1; Babalola KO, 2009, NEUROIMAGE, V47, P1435, DOI 10.1016/j.neuroimage.2009.05.029; Badura P, 2007, ADV INTEL SOFT COMPU, V45, P679; Baumhauer M, 2008, INT J COMPUT ASS RAD, V3, P307, DOI 10.1007/s11548-008-0216-7; BENTLEY JL, 1975, COMMUN ACM, V18, P509, DOI 10.1145/361002.361007; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bohm W., 1984, Computer-Aided Geometric Design, V1, P1, DOI 10.1016/0167-8396(84)90003-7; Cash DM, 2005, IEEE T MED IMAGING, V24, P1479, DOI 10.1109/TMI.2005.855434; CHEN Y, 1991, 1991 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-3, P2724, DOI 10.1109/ROBOT.1991.132043; Czajkowska J, 2015, IEEE ENG MED BIO, P6326, DOI 10.1109/EMBC.2015.7319839; Czajkowska J, 2015, COMPUT MED IMAG GRAP, V46, P142, DOI 10.1016/j.compmedimag.2015.05.001; Czajkowska J, 2010, ADV INTEL SOFT COMPU, V69, P91; dos Santos TR, 2014, MED IMAGE ANAL, V18, P1101, DOI 10.1016/j.media.2014.06.002; Dumpuri P, 2010, PROG BIOPHYS MOL BIO, V103, P197, DOI 10.1016/j.pbiomolbio.2010.09.014; Feuerstein M, 2008, IEEE T MED IMAGING, V27, P355, DOI 10.1109/TMI.2007.907327; Gelfand N., 2005, P 3 EUR S GEOM PROC, P197; Groch A, 2011, PROC SPIE, V7964, DOI 10.1117/12.878354; Guo CY, 2015, BIOMED SIGNAL PROCES, V18, P303, DOI 10.1016/j.bspc.2015.02.007; Haase S, 2012, BILDVERARBEITUNG MED, P111; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Juszczyk J, 2015, COMPUT MED IMAG GRAP, V46, P121, DOI 10.1016/j.compmedimag.2015.03.002; Juszczyk J, 2015, IEEE ENG MED BIO, P2908, DOI 10.1109/EMBC.2015.7319000; Kawa J, 2014, ADV INTELL SYST, V284, P69, DOI 10.1007/978-3-319-06596-0_7; Kolb A, 2010, COMPUT GRAPH FORUM, V29, P141, DOI 10.1111/j.1467-8659.2009.01583.x; Kumar SN, 2014, INT C INF COMM EMB S; Lago MA, 2012, P IEEE RAS-EMBS INT, P1161, DOI 10.1109/BioRob.2012.6290683; Langmann B, 2013, COMPUT IND, V64, P1090, DOI 10.1016/j.compind.2013.06.006; Lango T, 2012, INT J COMPUT ASS RAD, V7, P585, DOI 10.1007/s11548-011-0656-3; Lepetit V, 2009, INT J COMPUT VISION, V81, P155, DOI 10.1007/s11263-008-0152-6; Lin HH, 2015, J FORMOS MED ASSOC, V114, P300, DOI 10.1016/j.jfma.2015.01.017; Maier-Hein L, 2008, MED PHYS, V35, P5385, DOI 10.1118/1.3002315; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Markelj P, 2012, MED IMAGE ANAL, V16, P642, DOI 10.1016/j.media.2010.03.005; Maurer CR, 1997, IEEE T MED IMAGING, V16, P447, DOI 10.1109/42.611354; Mersmann S, 2013, MED PHYS, V40, DOI 10.1118/1.4812889; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pietka E, 2011, EUR J RADIOL, V78, P225, DOI 10.1016/j.ejrad.2009.08.015; Placht S, 2012, MED PHYS, V39, P4, DOI 10.1118/1.3664006; Pomerleau F, 2013, AUTON ROBOT, V34, P133, DOI 10.1007/s10514-013-9327-2; Pycinski B, 2014, ADV INTELL SYST COMP, V284, P25, DOI 10.1007/978-3-319-06596-0_3; Rucker DC, 2014, IEEE T MED IMAGING, V33, P147, DOI 10.1109/TMI.2013.2283016; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Shahriari N, 2015, INT J COMPUT ASS RAD, V10, P1845, DOI 10.1007/s11548-015-1176-3; Sindram D, 2010, HPB, V12, P709, DOI 10.1111/j.1477-2574.2010.00244.x; Song Y, 2015, INT J COMPUT ASS RAD, V10, P1951, DOI 10.1007/s11548-015-1236-8; Sorger H, 2016, INT J COMPUT ASS RAD, V11, P1431, DOI 10.1007/s11548-015-1326-7; Spinczyk D., 2015, EMERGING TRENDS IMAG, P489; Spinczyk D, 2014, COMPUT AIDED SURG, V19, P34, DOI 10.3109/10929088.2014.891657; Spinczyk D, 2013, VIDEOSURGERY MINIINV, V8, P80, DOI 10.5114/wiitm.2011.32809; Su LM, 2009, UROLOGY, V73, P896, DOI 10.1016/j.urology.2008.11.040; Wieclawek W, 2008, ADV INTEL SOFT COMPU, V47, P93; Wood BJ, 2010, J VASC INTERV RADIOL, V21, pS257, DOI 10.1016/j.jvir.2010.05.003; Zarychta P, 2006, Proceedings of the International Conference Mixed Design of Integrated Circuits and Systems, P741, DOI 10.1109/MIXDES.2006.1706684; Zarychta P, 2009, IFAC WORKSHOP ON PROGRAMMABLE DEVICES AND EMBEDDED SYSTEMS (PDES 2009), PROCEEDINGS, P260; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718	58	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159493	10.1371/journal.pone.0159493	http://dx.doi.org/10.1371/journal.pone.0159493			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434396	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169600057
J	Sagata, K; Gibb, H				Sagata, Katayo; Gibb, Heloise			The Effect of Temperature Increases on an Ant-Hemiptera-Plant Interaction	PLOS ONE			English	Article							SCALE INSECTS; ELEVATED CO2; EUCALYPTUS-CAMALDULENSIS; ECOLOGICAL CONSEQUENCES; CLIMATE-CHANGE; WOOD DENSITY; HONEYDEW; GROWTH; NECTAR; RANGE	Global temperature increases are significantly altering species distributions and the structure of ecological communities. However, the impact of temperature increases on multi-species interactions is poorly understood. We used an ant-Hemiptera-plant interaction to examine the potential outcomes of predicted temperature increases for each partner and for the availability of honeydew, a keystone resource in many forest ecosystems. We re-created this interaction in growth cabinets using predicted mean summer temperatures for Melbourne, Australia, for the years 2011 (23 degrees C), 2050 (25 degrees C) and 2100 (29 degrees C), respectively, under an unmitigated greenhouse gas emission scenario. Plant growth and ant foraging activities increased, while scale insect growth, abundance and size, honeydew standing crop per tree and harvesting by ants decreased at 29 degrees C, relative to lower temperatures (23 and 25 degrees C). This led to decreased scale insect infestations of plants and reduced honeydew standing crop per tree at the highest temperature. At all temperatures, honeydew standing crop was lower when ants harvested the honeydew from scale insects, but the impact of ant harvesting was particularly significant at 29 degrees C, where combined effects of temperature and ants reduced honeydew standing crop to below detectable levels. Although temperature increases in the next 35 years will have limited effects on this system, by the end of this century, warmer temperatures may cause the availability of honeydew to decline. Decline of honeydew may have far-reaching trophic effects on honeydew and ant-mediated interactions. However, field-based studies that consider the full complexity of ecosystems may be required to elucidate these impacts.	[Sagata, Katayo; Gibb, Heloise] La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia; [Sagata, Katayo] Papua New Guinea Inst Biol Res, Goroka, Eastern Highlan, Papua N Guinea	La Trobe University	Sagata, K (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia.; Sagata, K (corresponding author), Papua New Guinea Inst Biol Res, Goroka, Eastern Highlan, Papua N Guinea.	ksagata@students.latrobe.edu.au	Gibb, Heloise/B-8338-2013	Gibb, Heloise/0000-0001-7194-0620	La Trobe University Full Fee Research Scholarship; La Trobe University Postgraduate Research Scholarship; Australian Research Council Discovery Project [DP0985886, DP120100781]	La Trobe University Full Fee Research Scholarship; La Trobe University Postgraduate Research Scholarship; Australian Research Council Discovery Project(Australian Research Council)	The study was funded by a La Trobe University Full Fee Research Scholarship, a La Trobe University Postgraduate Research Scholarship and Australian Research Council Discovery Project grants DP0985886 to HG (and D. I. Warton and N. R. Andrew) and DP120100781 to HG (and C. L. Parr, N. J. Sanders, and R. R. Dunn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, beyond their initial decision to grant funding to the project.	Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Beggs J, 2001, BIOL CONSERV, V99, P17, DOI 10.1016/S0006-3207(00)00185-3; Beggs JR, 2005, NEW ZEAL J ECOL, V29, P105; Bernardo AL, 1998, FOREST ECOL MANAG, V104, P1, DOI 10.1016/S0378-1127(97)00199-0; Bluthgen N, 2004, AUSTRAL ECOL, V29, P418, DOI 10.1111/j.1442-9993.2004.01380.x; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; BOND W, 1984, ECOLOGY, V65, P1031, DOI 10.2307/1938311; BRISTOW CM, 1991, OECOLOGIA, V87, P514, DOI 10.1007/BF00320414; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cotrufo MF, 1998, GLOBAL CHANGE BIOL, V4, P43, DOI 10.1046/j.1365-2486.1998.00101.x; Crozier L, 2004, ECOLOGY, V85, P231, DOI 10.1890/02-0607; CSIRO and Australian Bureau of Meteorology, 2007, CLIM CHANG AUSTR; Davies ZG, 2006, J ANIM ECOL, V75, P247, DOI 10.1111/j.1365-2656.2006.01044.x; DEGEN AA, 1986, INSECT SOC, V33, P211, DOI 10.1007/BF02224599; Diamond SE, 2013, INTEGR COMP BIOL, V53, P965, DOI 10.1093/icb/ict085; Dungan RJ, 2004, NEW ZEAL J ECOL, V28, P283; Dungan RJ, 2007, ECOL ENTOMOL, V32, P338, DOI 10.1111/j.1365-2311.2007.00871.x; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; Flynn DFB, 2006, ENVIRON EXP BOT, V56, P10, DOI 10.1016/j.envexpbot.2004.12.001; Gibb H, 2009, INSECT SOC, V56, P405, DOI 10.1007/s00040-009-0038-9; Gough N, 1975, THESIS; GREENBERG R, 1993, OIKOS, V68, P519, DOI 10.2307/3544920; Gullan P. J., 1991, General and Applied Entomology, V23, P21; Hazell SP, 2010, J INSECT PHYSIOL, V56, P123, DOI 10.1016/j.jinsphys.2009.08.022; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Hellmann JJ, 2008, OECOLOGIA, V157, P583, DOI 10.1007/s00442-008-1112-0; Heterick BE, 2011, ZOOTAXA, P1; Hill JK, 1999, OECOLOGIA, V121, P165, DOI 10.1007/s004420050918; Holldobler B., 1990, pi; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Johns CV, 2002, GLOBAL CHANGE BIOL, V8, P142, DOI 10.1046/j.1365-2486.2002.00462.x; Kaspari M, 2015, GLOBAL CHANGE BIOL, V21, P1092, DOI 10.1111/gcb.12750; KISS A, 1981, OIKOS, V37, P382, DOI 10.2307/3544132; LARSEN KJ, 1992, J INSECT BEHAV, V5, P109, DOI 10.1007/BF01049162; LINCOLN DE, 1984, ENVIRON ENTOMOL, V13, P1527, DOI 10.1093/ee/13.6.1527; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Marquis M, 2014, ECOLOGY, V95, P9, DOI 10.1890/13-0760.1; Nano CEM, 2013, AUSTRAL ECOL, V38, P741, DOI 10.1111/aec.12036; PATEL J D, 1971, Journal of the Australian Entomological Society, V10, P43, DOI 10.1111/j.1440-6055.1971.tb00009.x; Piyaphongkul J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029409; R Core Team, 2012, R LANG ENV STAT COMP; Reynolds JF, 2004, OECOLOGIA, V141, P194, DOI 10.1007/s00442-004-1524-4; Robinet C, 2010, INTEGR ZOOL, V5, P132, DOI 10.1111/j.1749-4877.2010.00196.x; Roderick ML, 2001, NEW PHYTOL, V149, P473, DOI 10.1046/j.1469-8137.2001.00054.x; ROTH SK, 1995, GLOBAL CHANGE BIOL, V1, P173, DOI 10.1111/j.1365-2486.1995.tb00019.x; Salvucci ME, 1999, J INSECT PHYSIOL, V45, P21, DOI 10.1016/S0022-1910(98)00105-X; Seeger J, 2008, EUR J SOIL BIOL, V44, P483, DOI 10.1016/j.ejsobi.2008.07.008; Stadler B, 1998, ECOLOGY, V79, P1514, DOI 10.1890/0012-9658(1998)079[1514:LAEWNF]2.0.CO;2; Stiling P, 1999, ECOL APPL, V9, P240, DOI 10.1890/1051-0761(1999)009[0240:DLMAIE]2.0.CO;2; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Subchan W, 2002, THESIS; Thomas DS, 2004, FOREST ECOL MANAG, V193, P157, DOI 10.1016/j.foreco.2004.01.028; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Vranjic JA, 1997, J ECOL, V85, P143, DOI 10.2307/2960646; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Watson R.T., 2001, CLIMATE CHANGE 2001, P388; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515	59	11	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0155131	10.1371/journal.pone.0155131	http://dx.doi.org/10.1371/journal.pone.0155131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434232	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600001
J	Waltman, PH; Guo, J; Reistetter, EN; Purvine, S; Ansong, CK; van Baren, MJ; Wong, CH; Wei, CL; Smith, RD; Callister, SJ; Stuart, JM; Worden, AZ				Waltman, Peter H.; Guo, Jian; Reistetter, Emily Nahas; Purvine, Samuel; Ansong, Charles K.; van Baren, Marijke J.; Wong, Chee-Hong; Wei, Chia-Lin; Smith, Richard D.; Callister, Stephen J.; Stuart, Joshua M.; Worden, Alexandra Z.			Identifying Aspects of the Post-Transcriptional Program Governing the Proteome of the Green Alga Micromonas pusilla	PLOS ONE			English	Article							MESSENGER-RNA DEGRADATION; AU-RICH ELEMENTS; SACCHAROMYCES-CEREVISIAE; INTEGRATIVE ANALYSIS; UNTRANSLATED REGION; CIRCADIAN-RHYTHMS; SOFTWARE PACKAGE; GENE-FUNCTION; LAND PLANTS; EXPRESSION	Micromonas is a unicellular motile alga within the Prasinophyceae, a green algal group that is related to land plants. This picoeukaryote (<2 mu m diameter) is widespread in the marine environment but is not well understood at the cellular level. Here, we examine shifts in mRNA and protein expression over the course of the day-night cycle using triplicated mid-exponential, nutrient replete cultures of Micromonas pusilla CCMP1545. Samples were collected at key transition points during the diel cycle for evaluation using high-throughput LC-MS proteomics. In conjunction, matched mRNA samples from the same time points were sequenced using pair-ended directional Illumina RNA-Seq to investigate the dynamics and relationship between the mRNA and protein expression programs of M. pusilla. Similar to a prior study of the marine cyanobacterium Prochlorococcus, we found significant divergence in the mRNA and proteomics expression dynamics in response to the light: dark cycle. Additionally, expressional responses of genes and the proteins they encoded could also be variable within the same metabolic pathway, such as we observed in the oxygenic photosynthesis pathway. A regression framework was used to predict protein levels from both mRNA expression and gene-specific sequence-based features. Several features in the genome sequence were found to influence protein abundance including codon usage as well as 3' UTR length and structure. Collectively, our studies provide insights into the regulation of the proteome over a diel cycle as well as the relationships between transcriptional and translational programs in the widespread marine green alga Micromonas.	[Waltman, Peter H.; Stuart, Joshua M.] Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA; [Guo, Jian; Reistetter, Emily Nahas; van Baren, Marijke J.; Worden, Alexandra Z.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Purvine, Samuel; Ansong, Charles K.; Smith, Richard D.; Callister, Stephen J.] Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Wong, Chee-Hong; Wei, Chia-Lin] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Worden, Alexandra Z.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Worden, Alexandra Z.] Canadian Inst Adv Res, Integrated Microbial Biodivers Program, Toronto, ON M5G 1Z8, Canada	University of California System; University of California Santa Cruz; Monterey Bay Aquarium Research Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Santa Cruz; Canadian Institute for Advanced Research (CIFAR)	Stuart, JM (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA.; Worden, AZ (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.; Callister, SJ (corresponding author), Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA.; Worden, AZ (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.; Worden, AZ (corresponding author), Canadian Inst Adv Res, Integrated Microbial Biodivers Program, Toronto, ON M5G 1Z8, Canada.	stephen.callister@pnnl.gov; jstuart@ucsc.edu; azworden@mbari.org	Worden, Alexandra Z./AAD-6567-2019; Smith, Richard D/J-3664-2012; Purvine, Samuel O/O-3358-2017	Smith, Richard D/0000-0002-2381-2349; Purvine, Samuel O/0000-0002-2257-2400; Stuart, Joshua/0000-0002-2171-565X; Worden, Alexandra/0000-0002-9888-9324; Wong, Chee Hong/0000-0003-4546-4979	DOE's Office of Biological and Environmental Research Pan-omics program; Environmental Molecular Sciences Laboratory located at Pacific Northwest National Laboratory for the DOE [DE-AC05-76RL01830]; David and Lucile Packard Foundation; U.S. DOE [DE-AC02-05CH11231]; U.S. Department of Energy (DOE) [DOE-DE-SC0004765]; GBMF Investigator Award [3788];  [NSF-IOS0843119]	DOE's Office of Biological and Environmental Research Pan-omics program; Environmental Molecular Sciences Laboratory located at Pacific Northwest National Laboratory for the DOE; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); U.S. DOE(United States Department of Energy (DOE)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); GBMF Investigator Award; 	Partial support for this research was provided by the DOE's Office of Biological and Environmental Research Pan-omics program, and the Environmental Molecular Sciences Laboratory located at Pacific Northwest National Laboratory operated by Battelle for the DOE under contract DE-AC05-76RL01830. Additional funds came from the David and Lucile Packard Foundation, a GBMF Investigator Award (3788) and NSF-IOS0843119 to AZW and for JGI under U.S. DOE Contract No. DE-AC02-05CH11231. Major funds for this research collaboration were from grant DOE-DE-SC0004765 from the U.S. Department of Energy (DOE) to RDS, SJC, JMS and AZW.	Aryal UK, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-194; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Ben-Hur A, 2010, METHODS MOL BIOL, V609, P223, DOI 10.1007/978-1-60327-241-4_13; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Boudiere L, 2014, BBA-BIOENERGETICS, V1837, P470, DOI 10.1016/j.bbabio.2013.09.007; Bourquin F, 2010, STRUCTURE, V18, P1054, DOI 10.1016/j.str.2010.05.011; Breiman L., 1998, USING CONVEX PSEUDOD; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Buhlmann P, 2007, STAT SCI, V22, P477, DOI 10.1214/07-STS242; Callister SJ, 2010, ENVIRON SCI TECHNOL, V44, P8897, DOI 10.1021/es101029f; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cenik C, 2015, GENOME RES, V25, P1610, DOI 10.1101/gr.193342.115; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Duanmu DQ, 2014, P NATL ACAD SCI USA, V111, P15827, DOI 10.1073/pnas.1416751111; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FONAGY A, 1993, J CELL PHYSIOL, V154, P16, DOI 10.1002/jcp.1041540104; Fonagy A, 1989, Cancer Commun, V1, P243; Foulon E, 2008, ENVIRON MICROBIOL, V10, P2433, DOI 10.1111/j.1462-2920.2008.01673.x; Fournier ML, 2010, MOL CELL PROTEOMICS, V9, P271, DOI 10.1074/mcp.M900415-MCP200; Friedman J H, 1995, Stat Methods Med Res, V4, P197, DOI 10.1177/096228029500400303; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guerreiro ACL, 2014, MOL CELL PROTEOMICS, V13, P2042, DOI 10.1074/mcp.M113.035840; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3., 10.1007/978-1-4615-8714-9_3]; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hastie T., 2009, UNSUPERVISED LEARNIN; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kaufman L., 1987, CLUSTERING MEANS MED; Kim S., 2012, PPCOR PARTIAL SEMIPA; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kind B, 2009, BIOCHEM BIOPH RES CO, V390, P205, DOI 10.1016/j.bbrc.2009.09.080; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Matallana-Surget S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099076; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Milborrow S., 2013, EARTH MULTIVARIATE A; Mitchell CJ, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0225-4; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakahara K, 2003, PLANT CELL PHYSIOL, V44, P326, DOI 10.1093/pcp/pcg044; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Pillai B, 2009, J MOL BIOL, V385, P580, DOI 10.1016/j.jmb.2008.10.072; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Robidart J, 2013, ENVIRON SCI TECHNOL, V47, P4399, DOI 10.1021/es3037302; Schmid AK, 2007, GENOME RES, V17, P1399, DOI 10.1101/gr.6728007; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Smyth R.D., 1982, Progress in Clinical and Biological Research, V80, P211; STAYTON MM, 1989, PLANT PHYSIOL, V89, P776, DOI 10.1104/pp.89.3.776; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanguay RL, 1996, MOL CELL BIOL, V16, P146; Martinez-Pastor MT, 2013, INT J MOL SCI, V14, P15785, DOI 10.3390/ijms140815785; Torres-Garcia W, 2009, BIOINFORMATICS, V25, P1905, DOI 10.1093/bioinformatics/btp325; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Baren MJ, BMC GENOMICS UNPUB; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogel C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009217; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Waldbauer JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043432; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Wilkerson M., 2013, PACKAGE CONSENSUSCLU; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Wu G, 2008, CURR MICROBIOL, V57, P18, DOI 10.1007/s00284-008-9145-5; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	93	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0155839	10.1371/journal.pone.0155839	http://dx.doi.org/10.1371/journal.pone.0155839			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434306	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000380169600002
J	Qi, LX; Fang, Q; Zhao, L; Xia, H; Zhou, YX; Xiao, JH; Li, K; Ye, GY				Qi, Lixing; Fang, Qi; Zhao, Lei; Xia, Hao; Zhou, Yuxun; Xiao, Junhua; Li, Kai; Ye, Gongyin			De Novo Assembly and Developmental Transcriptome Analysis of the Small White Butterfly Pieris rapae	PLOS ONE			English	Article							SHOCK-PROTEIN GENES; MANDUCA-SEXTA; EXPRESSION; EVOLUTIONARY; TOOL; PROPHENOLOXIDASE; RECOGNITION; GENERATION; ONTOLOGY; CLONING	The small white butterfly Pieris rapae is one of the most destructive pests of Brassicaceae. Yet little is understood about its genes involved in development. To facilitate research on P. rapae, we sequenced the transcriptome of P. rapae during six developmental stages, including the egg, three larval stages, the pupa, and the adult. In total, 240 million high-quality reads were obtained. De novo assembly generated 96,069 unigenes with an average length of 1353 nt. Of these, 31,629 unigenes had homologs as determined by a blastx search against the NR database with a cut-off e-value of 10(-5). Clusters of Orthologous Groups of proteins (COG), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were conducted to functionally annotate those genes. Then, 849 genes involved in seven canonical development signaling pathway were identified, including dozens of key genes such as Hippo, Notch, and JAK2. A total of 21,883 differentially expressed (cut-off of 2-fold) unigenes were detected across the developmental stages, most of which were found between the egg and first larval stages. Interestingly, only 34 differentially expressed unigenes, most of which are cuticle protein related genes, were detected with a cut-off of 2(10)-fold. Furthermore, we identified 32 heat shock protein (Hsp) genes that were expressed with complete open reading frames. Based on phylogenetic trees of the Hsp genes, we found that Hsp genes with close evolutionary relationships had similar expression pattern. Additionally, partial pattern recognition receptors genes were found to be developmental regulated. This study provides comprehensive sequence resources for P. rapae and numerous differential expressed genes, and these findings will lay the foundation for future functional genomics studies on this species.	[Qi, Lixing; Zhao, Lei; Xia, Hao; Zhou, Yuxun; Xiao, Junhua; Li, Kai] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China; [Fang, Qi; Ye, Gongyin] Zhejiang Univ, Inst Insect Sci, Minist Agr, State Key Lab Rice Biol,Key Lab Mol Biol Crop Pat, Hangzhou, Zhejiang, Peoples R China	Donghua University; Ministry of Agriculture & Rural Affairs; Zhejiang University	Li, K (corresponding author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.; Ye, GY (corresponding author), Zhejiang Univ, Inst Insect Sci, Minist Agr, State Key Lab Rice Biol,Key Lab Mol Biol Crop Pat, Hangzhou, Zhejiang, Peoples R China.	likai@dhu.edu.cn; chu@zju.edu.cn			Key Project of Science & Technology Commission of Shanghai Municipality [13140900300]; National Science Foundation of China [31171199]; Fundamental Research Funds for the Central Universities [2232013A3-06]; DHU Distinguished Young Professor Program [B201308]	Key Project of Science & Technology Commission of Shanghai Municipality; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); DHU Distinguished Young Professor Program	This work was supported by 1) National Science Foundation of China (No. 31171199, http://www.nsfc.gov.cn/): Data analysis; 2) Fundamental Research Funds for the Central Universities (No. 2232013A3-06, http://www.dhu.edu.cn/): sample collection and study design; 3) DHU Distinguished Young Professor Program (B201308, http://www.dhu.edu.cn/): data analysis, preparation of the manuscript; and 4) Key Project of Science & Technology Commission of Shanghai Municipality (No. 13140900300, http://www.stcsm.gov.cn/): sample collection.	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao YY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-160; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Chen SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015633; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Gu J, 2013, INSECT BIOCHEM MOLEC, V43, P794, DOI 10.1016/j.ibmb.2013.06.001; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Heikkila JJ, 2004, J CELL BIOCHEM, V93, P672, DOI 10.1002/jcb.20237; Huang LH, 2009, J INSECT PHYSIOL, V55, P279, DOI 10.1016/j.jinsphys.2008.12.004; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073911; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; MacCallum RM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-620; Mao Zeng-Hui, 2010, Acta Entomologica Sinica, V53, P1295; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mun S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10484; Oppenheim SJ, 2015, INSECT MOL BIOL, V24, P139, DOI 10.1111/imb.12154; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Qi YX, 2014, J NEUROCHEM, V131, P767, DOI 10.1111/jnc.12940; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roxstrom-Lindquist K, 2005, INSECT MOL BIOL, V14, P645, DOI 10.1111/j.1365-2583.2005.00593.x; Shi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059721; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Vogel H, 2014, INSECT MOL BIOL, V23, P98, DOI 10.1111/imb.12067; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wu SF, 2013, DEV COMP IMMUNOL, V41, P1, DOI 10.1016/j.dci.2013.04.006; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin JianLi, 2010, Plant Diseases and Pests, V1, P21; Yu XQ, 1999, ARCH INSECT BIOCHEM, V42, P198, DOI 10.1002/(SICI)1520-6327(199911)42:3&lt;198::AID-ARCH4&gt;3.0.CO;2-G; Zeng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061479; Zhang XF, 2015, INSECT BIOCHEM MOLEC, V62, P38, DOI 10.1016/j.ibmb.2015.02.001; Zhu JY, 2013, INSECT SCI, V20, P183, DOI 10.1111/j.1744-7917.2011.01494.x; Zhu JY, 2011, J ZHEJIANG UNIV-SC B, V12, P103, DOI 10.1631/jzus.B1000275	49	21	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159258	10.1371/journal.pone.0159258	http://dx.doi.org/10.1371/journal.pone.0159258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428371	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300042
J	Zhang, L; Zhang, J; Han, W; Gao, J; He, L; Yang, YL; Yin, P; Xie, MX; Ge, SP				Zhang, Li; Zhang, Jing; Han, Wei; Gao, Jun; He, Lin; Yang, Yali; Yin, Ping; Xie, Mingxing; Ge, Shuping			Three-Dimensional Rotation, Twist and Torsion Analyses Using Real-Time 3D Speckle Tracking Imaging: Feasibility, Reproducibility, and Normal Ranges in Pediatric Population	PLOS ONE			English	Article							LEFT-VENTRICULAR TWIST; AGE-RELATED-CHANGES; APICAL ROTATION; ECHOCARDIOGRAPHY; MECHANICS; STRAIN; ASSOCIATION; GUIDELINES; STANDARDS; CHILDREN	Background and Objective The specific aim of this study was to evaluate the feasibility, reproducibility and maturational changes of LV rotation, twist and torsion variables by real-time 3D speckle-tracking echocardiography (RT3DSTE) in children. Methods A prospective study was conducted in 347 consecutive healthy subjects (181 males/156 females, mean age 7.12 +/- 5.3 years, and range from birth to 18-years) using RT 3D echocardiography (3DE). The LV rotation, twist and torsion measurements were made off-line using TomTec software. Manual landmark selection and endocardial border editing were performed in 3 planes (apical "2"-, "4"-, and "3"-chamber views) and semi-automated tracking yielded LV rotation, twist and torsion measurements. LV rotation, twist and torsion analysis by RT 3DSTE were feasible in 307 out of 347 subjects (88.5%). Results There was no correlation between rotation or twist and age, height, weight, BSA or heart rate, respectively. However, there was statistically significant, but very modest correlation between LV torsion and age (R-2 = 0.036, P<0.001). The normal ranges were defined for rotation and twist in this cohort, and for torsion for each age group. The intra-observer and inter-observer variabilities for apical and basal rotation, twist and torsion ranged from 7.3% +/- 3.8% to 12.3% +/- 8.8% and from 8.8% +/- 4.6% to 15.7% +/- 10.1%, respectively. Conclusions We conclude that analysis of LV rotation, twist and torsion by this new RT3D STE is feasible and reproducible in pediatric population. There is no maturational change in rotation and twist, but torsion decreases with age in this cohort. Further refinement is warranted to validate the utility of this new methodology in more sensitive and quantitative evaluation of congenital and acquired heart diseases in children.	[Zhang, Li; Zhang, Jing; Han, Wei; Gao, Jun; He, Lin; Yang, Yali; Xie, Mingxing] Huazhong Univ Sci & Technol, Dept Ultrasound, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China; [Gao, Jun] Wuhan Women & Children Med Ctr, Dept Ultrasound, Wuhan, Peoples R China; [Yin, Ping] Huazhong Univ Sci & Technol, Epidemiol & Hlth Stat, Wuhan, Peoples R China; [Zhang, Li; Ge, Shuping] Drexel Univ, Coll Med, Ctr Heart, St Christophers Hosp Children, Philadelphia, PA 19104 USA; [Ge, Shuping] Deborah Heart & Lung Ctr, Browns Mills, NJ 08015 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Drexel University	Xie, MX (corresponding author), Huazhong Univ Sci & Technol, Dept Ultrasound, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China.; Ge, SP (corresponding author), Drexel Univ, Coll Med, Ctr Heart, St Christophers Hosp Children, Philadelphia, PA 19104 USA.; Ge, SP (corresponding author), Deborah Heart & Lung Ctr, Browns Mills, NJ 08015 USA.	xiemx64@126.com; shuping.ge@drexelmed.edu	Zhang, L/ABG-4378-2020; Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022; Yang, Ya-Li/GYU-4320-2022; Zhang, L/A-8465-2019	Zhang, L/0000-0003-1620-1512; Zhang, L/0000-0003-1620-1512				Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; Ashraf M, 2012, J AM SOC ECHOCARDIOG, V25, P121, DOI 10.1016/j.echo.2011.09.001; Boissiere J, 2013, J AM SOC ECHOCARDIOG, V26, P1298, DOI 10.1016/j.echo.2013.07.007; Di Maria MV, 2014, J AM SOC ECHOCARDIOG, V27, P1336, DOI 10.1016/j.echo.2014.07.016; Dong LL, 2009, INT J CARDIOVAS IMAG, V25, P479, DOI 10.1007/s10554-009-9458-x; Forsey J, 2014, J AM SOC ECHOCARDIOG, V27, P215, DOI 10.1016/j.echo.2013.10.012; Gayat E, 2011, J AM SOC ECHOCARDIOG, V24, P878, DOI 10.1016/j.echo.2011.04.016; Goffinet C, 2009, EUR HEART J, V30, P608, DOI 10.1093/eurheartj/ehn511; Hui L, 2007, J AM SOC ECHOCARDIOG, V20, P486, DOI 10.1016/j.echo.2006.10.012; Kim WJ, 2009, CIRC-CARDIOVASC IMAG, V2, P123, DOI 10.1161/CIRCIMAGING.108.794719; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Laser KT, 2009, J AM SOC ECHOCARDIOG, V22, P1121, DOI 10.1016/j.echo.2009.06.014; Lorch SM, 2008, J AM SOC ECHOCARDIOG, V21, P1207, DOI 10.1016/j.echo.2008.08.011; Marcus KA, 2011, J AM SOC ECHOCARDIOG, V24, P625, DOI 10.1016/j.echo.2011.01.021; Mor-Avi V, 2004, CIRCULATION, V110, P1814, DOI 10.1161/01.CIR.0000142670.65971.5F; Nadal-Ginard B, 2003, CIRC RES, V92, P139, DOI 10.1161/01.RES.0000053618.86362.DF; Natori S, 2006, AM J ROENTGENOL, V186, pS357, DOI 10.2214/AJR.04.1868; Notomi Y, 2006, CIRCULATION, V113, P2534, DOI 10.1161/CIRCULATIONAHA.105.537639; Parikh NI, 2012, AM HEART J, V163, P470, DOI 10.1016/j.ahj.2011.12.011; Sengupta PP, 2007, J AM SOC ECHOCARDIOG, V20, P539, DOI 10.1016/j.echo.2006.10.013; Sengupta PP, 2006, J AM COLL CARDIOL, V48, P1988, DOI 10.1016/j.jacc.2006.08.030; Takahashi K, 2010, J AM SOC ECHOCARDIOG, V23, P286, DOI 10.1016/j.echo.2009.11.018; Tavakoli V, 2013, J ULTRAS MED, V32, P1435, DOI 10.7863/ultra.32.8.1435; Tejman-Yarden S, 2016, PEDIATR CARDIOL, V37, P106, DOI 10.1007/s00246-015-1246-x; van Dalen BM, 2009, HEART, V95, P657, DOI 10.1136/hrt.2008.152777; Wang JW, 2007, CIRCULATION, V116, P2580, DOI 10.1161/CIRCULATIONAHA.107.706770; Xie MX, 2013, INT J CARDIOL, V168, P4631, DOI 10.1016/j.ijcard.2013.07.194; Young AA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-49; Zhang L, 2007, J HUAZHONG U SCI-MED, V27, P691, DOI 10.1007/s11596-007-0619-7; Zhang L, 2013, J AM SOC ECHOCARDIOG, V26, P853, DOI 10.1016/j.echo.2013.05.002	32	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158679	10.1371/journal.pone.0158679	http://dx.doi.org/10.1371/journal.pone.0158679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427968	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300018
J	Matsumoto, Y; Yamagishi, T; Li, Y; Kiyonari, T				Matsumoto, Yoshie; Yamagishi, Toshio; Li, Yang; Kiyonari, Toko			Prosocial Behavior Increases with Age across Five Economic Games	PLOS ONE			English	Article							SOCIAL VALUE ORIENTATION; UNFAIR OFFERS; COOPERATION; DILEMMAS; CHILDREN; ADOLESCENCE; RECIPROCITY; REJECTION; EXCHANGE; FAIRNESS	Ontogenic studies of human prosociality generally agree on that human prosociality increases from early childhood through early adulthood; however, it has not been established if prosociality increases beyond early adulthood. We examined a sample of 408 non-student residents from Tokyo, Japan, who were evenly distributed across age (20-59) and sex. Participants played five economic games each separated by a few months. We demonstrated that prosocial behavior increased with age beyond early adulthood and this effect was shown across all five economic games. A similar, but weaker, age-related trend was found in one of three social value orientation measures of prosocial preferences. We measured participants' belief that manipulating others is a wise strategy for social success, and found that this belief declined with age. Participants' satisfaction with the unilateral exploitation outcome of the prisoner's dilemma games also declined with age. These two factors-satisfaction with the DC outcome in the prisoner's dilemma games and belief in manipulation-mediated the age effect on both attitudinal and behavioral prosociality. Participants' age-related socio-demographic traits such as marriage, having children, and owning a house weakly mediated the age effect on prosociality through their relationships with satisfaction with the DC outcome and belief in manipulation.	[Matsumoto, Yoshie; Yamagishi, Toshio; Li, Yang] Tamagawa Univ, Brain Sci Inst, 6-1-1 Tamagawagakuen, Machida, Tokyo, Japan; [Yamagishi, Toshio] Hitotsubashi Univ, Grad Sch Int Corp Strategy, Tokyo, Japan; [Kiyonari, Toko] Aoyama Gakuin Univ, Sch Social Informat, Sagamihara, Kanagawa, Japan	Hitotsubashi University; Aoyama Gakuin University	Yamagishi, T (corresponding author), Tamagawa Univ, Brain Sci Inst, 6-1-1 Tamagawagakuen, Machida, Tokyo, Japan.; Yamagishi, T (corresponding author), Hitotsubashi Univ, Grad Sch Int Corp Strategy, Tokyo, Japan.	yamagishitoshio@gmail.com	Li, Yang/V-1465-2019	Li, Yang/0000-0002-8239-3279	Japan Society for the Promotion of Science [23223003, 15H05730]; Grants-in-Aid for Scientific Research [15H05730] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	23223003 and 15H05730, Japan Society for the Promotion of Science, https://www.jsps.go.jp/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balliet D, 2009, GROUP PROCESS INTERG, V12, P533, DOI 10.1177/1368430209105040; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Blake PR, 2015, NATURE, V528, P258, DOI 10.1038/nature15703; Eisenberg N., 1991, PROSOCIAL BEHAV, P34; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Gutierrez-Roig M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5362; Harbaugh WT, 2000, ECON INQ, V38, P95, DOI 10.1093/ei/38.1.95; Kanacri BPL, 2013, J PERS, V81, P302, DOI 10.1111/jopy.12001; Kelley H. H, 1978, INTERPERSONAL RELATI; Kiyonari T, 2000, EVOL HUM BEHAV, V21, P411, DOI 10.1016/S1090-5138(00)00055-6; KNIGHT GP, 1984, J RES PERS, V18, P372, DOI 10.1016/0092-6566(84)90021-7; LIEBRAND WBG, 1985, J EXP SOC PSYCHOL, V21, P86, DOI 10.1016/0022-1031(85)90008-3; LIEBRAND WBG, 1984, EUR J SOC PSYCHOL, V14, P239, DOI 10.1002/ejsp.2420140302; McAuliffe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080966; McClintock CG, 1978, J RES DEV EDUC, V12, P121; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Murphy RO, 2014, PERS SOC PSYCHOL REV, V18, P13, DOI 10.1177/1088868313501745; Murphy RO, 2011, JUDGM DECIS MAK, V6, P771; Nishina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137089; PRUITT DG, 1977, ANNU REV PSYCHOL, V28, P363, DOI 10.1146/annurev.ps.28.020177.002051; RUSHTON JP, 1975, J PERS SOC PSYCHOL, V31, P459, DOI 10.1037/h0076466; Skyrms B, 1987, STAG HUNT EVOLUTION; Sutter M, 2007, J ECON PSYCHOL, V28, P69, DOI 10.1016/j.joep.2006.09.001; Takagishi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108462; Takagishi H, 2010, J EXP CHILD PSYCHOL, V105, P130, DOI 10.1016/j.jecp.2009.09.005; Taylor M., 1987, POSSIBILITY COOPERAT; van den Assem MJ, 2012, MANAGE SCI, V58, P2, DOI 10.1287/mnsc.1110.1413; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Yamagishi T, 2007, RATION SOC, V19, P259, DOI 10.1177/1043463107080449; Yamagishi T, 2016, P NATL ACAD SCI USA, V113, P5582, DOI 10.1073/pnas.1523940113; Yamagishi T, 2015, SOC COGNITION, V33, P436, DOI 10.1521/soco.2015.33.5.436; Yamagishi T, 2014, PSYCHOL SCI, V25, P1699, DOI 10.1177/0956797614538065; Yamagishi T, 2012, P NATL ACAD SCI USA, V109, P20364, DOI 10.1073/pnas.1212126109; Yamagishi T, 2009, P NATL ACAD SCI USA, V106, P11520, DOI 10.1073/pnas.0900636106	36	41	42	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158671	10.1371/journal.pone.0158671	http://dx.doi.org/10.1371/journal.pone.0158671			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414803	Green Published, gold			2022-12-27	WOS:000379579500030
J	Ittenbach, RF; Huang, G; Foss, KDB; Hewett, TE; Myer, GD				Ittenbach, Richard F.; Huang, Guixia; Foss, Kim D. Barber; Hewett, Timothy E.; Myer, Gregory D.			Reliability and Validity of the Anterior Knee Pain Scale: Applications for Use as an Epidemiologic Screener	PLOS ONE			English	Article							PATELLOFEMORAL PAIN; OUTCOME MEASURES; TRANSLATION; VALIDATION	A screening instrument's ability to provide clinicians with consistent and reproducible information is crucial to intervention. Despite widespread acceptance and clinical use of the Kujala Anterior Knee Pain Scale (AKPS) in orthopedics and sports medicine, few studies have reported on its reliability and no such studies have concentrated on child or adolescent samples exclusively, segments of the population for which this instrument is often used. The purpose of the current study was to describe and report on the reliability and validity of the AKPS for use with high school female athletes participating in interscholastic athletics. The study was a secondary analysis of prospective epidemiologic data using established scale validation methods. The records of 414 female athletes 11.0 to 18.1 years of age (Mean 13.9 yrs, SD = 1.7 yrs) were used for analysis. Four different approaches to scoring and scale reduction of the AKPS were evaluated, including the original, ordinal 13-item form, a modified, ordinal 6-item form, a modified, dichotomous 13-item form, and a modified, dichotomous 6-item form. Three different types of reliability (internal consistency, equivalence across forms, standard error of measurement) and one type of validity (criterion-related) were estimated for the AKPS in the current sample. The four scoring formats of the AKPS scale were found to have high internal consistency (alpha(coef) = 0.83 to 0.91), equivalence across the short and long forms (r = 0.98), acceptable standard errors of measurement (0.82 to 3.00), and moderate to high criterion related validity-as determined by physican's diagnosis: 0.92 (13-item form), 0.90 (6-item form). The Kujala AKPS is a valid and reliable measure of anterior knee pain and appropriate for use as an epidemiologic screening tool with adolescent female athletes.	[Ittenbach, Richard F.; Huang, Guixia] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Ittenbach, Richard F.; Huang, Guixia] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Foss, Kim D. Barber; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Sports Med, Cincinnati, OH 45229 USA; [Hewett, Timothy E.] Mayo Clin, Biomechan Labs, Rochester, MN USA; [Hewett, Timothy E.] Mayo Sports Med Ctr, Rochester, MN USA; [Hewett, Timothy E.] Mayo Clin, Biomechan Lab, Minneapolis, MN USA; [Hewett, Timothy E.] Mayo Sports Med Ctr, Minneapolis, MN USA; [Myer, Gregory D.] Univ Cincinnati, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Ohio State Univ, Sports Hlth & Performance Inst, Columbus, OH 43210 USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Mayo Clinic; Mayo Clinic; Mayo Clinic; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University	Ittenbach, RF (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA.; Ittenbach, RF (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	richard.ittenbach@cchmc.org	Hewett, Timothy Edwin/GLT-1556-2022; Myer, Gregory/H-6572-2016	Myer, Gregory/0000-0002-9983-8422	National Institutes of Health/NIAMS Grants [1R21AR065068-01A1, R01-AR055563, 1R21AR065068]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR065068, R01AR055563] Funding Source: NIH RePORTER	National Institutes of Health/NIAMS Grants; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors acknowledge funding support from the National Institutes of Health/NIAMS Grants 1R21AR065068-01A1 (GDM) and R01-AR055563 (TEH).; The authors acknowledge funding support from National Institutes of Health/NIAMS Grants 1R21AR065068 (GDM) and R01-AR055563 (TEH).	Bennell K., 2000, PHYS THER SPORT, V1, P32, DOI [DOI 10.1054/PTSP.2000.0009, 10.1054/ptsp.2000.0009]; Cheung RTH, 2012, DISABIL REHABIL, V34, P510, DOI 10.3109/09638288.2011.610494; Crossley KM, 2004, ARCH PHYS MED REHAB, V85, P815, DOI 10.1016/S0003-9993(03)00613-0; Green A, 2014, MANUAL THER, V19, P517, DOI 10.1016/j.math.2014.05.013; Kievit AJ, 2013, KNEE SURG SPORT TR A, V21, P2647, DOI 10.1007/s00167-013-2635-4; KUJALA UM, 1993, ARTHROSCOPY, V9, P159, DOI 10.1016/S0749-8063(05)80366-4; Myer GD, 2016, KNEE SURG SPORT TR A, V24, P653, DOI 10.1007/s00167-014-3004-7	7	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159204	10.1371/journal.pone.0159204	http://dx.doi.org/10.1371/journal.pone.0159204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441381	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500043
J	Seehusen, F; Al-Azreg, SA; Raddatz, BB; Haist, V; Puff, C; Spitzbarth, I; Ulrich, R; Baumgartner, W				Seehusen, Frauke; Al-Azreg, Seham A.; Raddatz, Barbara B.; Haist, Verena; Puff, Christina; Spitzbarth, Ingo; Ulrich, Reiner; Baumgaertner, Wolfgang			Accumulation of Extracellular Matrix in Advanced Lesions of Canine Distemper Demyelinating Encephalitis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SULFATE PROTEOGLYCANS NEUROCAN; BASEMENT-MEMBRANE PROTEINS; MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD LESIONS; CHONDROITIN SULFATE; ADULT-RAT; DIFFERENTIAL EXPRESSION; VIRUS-INFECTION	In demyelinating diseases, changes in the quality and quantity of the extracellular matrix (ECM) may contribute to demyelination and failure of myelin repair and axonal sprouting, especially in chronic lesions. To characterize changes in the ECM in canine distemper demyelinating leukoencephalitis (DL), histochemical and immunohistochemical investigations of formalin-fixed paraffin-embedded cerebella using azan, picrosirius red and Gomori's silver stain as well as antibodies directed against aggrecan, type I and IV collagen, fibronectin, laminin and phosphacan showed alterations of the ECM in CDV-infected dogs. A significantly increased amount of aggrecan was detected in early and late white matter lesions. In addition, the positive signal for collagens I and IV as well as fibronectin was significantly increased in late lesions. Conversely, the expression of phosphacan was significantly decreased in early and more pronounced in late lesions compared to controls. Furthermore, a set of genes involved in ECM was extracted from a publically available microarray data set and was analyzed for differential gene expression. Gene expression of ECM molecules, their biosynthesis pathways, and pro-fibrotic factors was mildly up-regulated whereas expression of matrix remodeling enzymes was up-regulated to a relatively higher extent. Summarized, the observed findings indicate that changes in the quality and content of ECM molecules represent important, mainly post-transcriptional features in advanced canine distemper lesions. Considering the insufficiency of morphological regeneration in chronic distemper lesions, the accumulated ECM seems to play a crucial role upon regenerative processes and may explain the relatively small regenerative potential in late stages of this disease.	[Seehusen, Frauke; Al-Azreg, Seham A.; Raddatz, Barbara B.; Haist, Verena; Puff, Christina; Spitzbarth, Ingo; Ulrich, Reiner; Baumgaertner, Wolfgang] Univ Vet Med, Dept Pathol, Hannover, Germany; [Haist, Verena] Boehringer Ingelheim Vet Res Ctr GmbH & Co KG, Hannover, Germany; [Ulrich, Reiner] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany	University of Veterinary Medicine Hannover, Foundation; Boehringer Ingelheim; Friedrich Loeffler Institute	Baumgartner, W (corresponding author), Univ Vet Med, Dept Pathol, Hannover, Germany.	wolfgang.baumgaertner@tiho-hannover.de	Seehusen, Frauke/Q-8192-2018	Seehusen, Frauke/0000-0001-6701-7868	Deutsche Forschungsgemeinschaft (DFG) [BA 815/6-1, BA 815/6-2]; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; Boehringer Ingelheim Pharma GmbHCo KG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; Boehringer Ingelheim Pharma GmbHCo KG(Boehringer Ingelheim)	This study was in part supported by Deutsche Forschungsgemeinschaft (DFG; www.dfg.de; grant number: BA 815/6-1, BA 815/6-2) and by Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany. Boehringer Ingelheim Pharma GmbH&Co KG provided support in the form of salaries for authors [VH]. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059367; Alldinger S, 2000, ACTA NEUROPATHOL, V99, P138, DOI 10.1007/PL00007417; Althoff GEM, 2010, AM J PATHOL, V177, P840, DOI 10.2353/ajpath.2010.090918; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; Baron D, 2011, BIOINFORMATICS, V27, P725, DOI 10.1093/bioinformatics/btq710; BARTSCH S, 1992, J NEUROSCI, V12, P736; Beggah AT, 2005, NEUROSCIENCE, V133, P749, DOI 10.1016/j.neuroscience.2005.03.005; Beineke A, 2009, VET IMMUNOL IMMUNOP, V127, P1, DOI 10.1016/j.vetimm.2008.09.023; Beineke A, 2008, VIRAL IMMUNOL, V21, P401, DOI 10.1089/vim.2008.0043; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Buss A, 2007, BRAIN, V130, P940, DOI 10.1093/brain/awl374; CHOI BH, 1994, MICROSC RES TECHNIQ, V28, P193, DOI 10.1002/jemt.1070280304; DALCANTO MC, 1982, ANN NEUROL, V11, P109, DOI 10.1002/ana.410110202; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Deller T, 1997, NEUROSCIENCE, V81, P829, DOI 10.1016/S0306-4522(97)00194-2; Dyck SM, 2015, EXP NEUROL, V269, P169, DOI 10.1016/j.expneurol.2015.04.006; ESIRI MM, 1991, J NEUROL SCI, V101, P59, DOI 10.1016/0022-510X(91)90018-3; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Frisk AL, 1999, J NEUROIMMUNOL, V97, P102, DOI 10.1016/S0165-5728(99)00055-7; Furusho M, 2015, GLIA, V63, P1714, DOI 10.1002/glia.22838; Gaedke K, 1997, J VET MED B, V44, P329, DOI 10.1111/j.1439-0450.1997.tb00983.x; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Grone A, 2000, J NEUROIMMUNOL, V110, P20, DOI 10.1016/S0165-5728(00)00332-5; Groters S, 2005, ACTA NEUROPATHOL, V110, P369, DOI 10.1007/s00401-005-1055-z; Gruber HE, 2002, BIOTECH HISTOCHEM, V77, P81, DOI 10.1080/714028181; Haist V, 2012, BRAIN PATHOL, V22, P188, DOI 10.1111/j.1750-3639.2011.00518.x; Hermanns S, 2001, RESTOR NEUROL NEUROS, V19, P139; HIGGINS RJ, 1982, AM J VET RES, V43, P1820; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Imbschweiler I, 2012, GLIA, V60, P358, DOI 10.1002/glia.22270; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Ji Z, 2014, J IMMUNOL, V193, P2157, DOI 10.4049/jimmunol.1302702; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Kappler J, 1998, BRAIN RES, V793, P328, DOI 10.1016/S0006-8993(98)00260-1; Kim RY, 2014, J NEUROIMMUNOL, V274, P53, DOI 10.1016/j.jneuroim.2014.06.009; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; KRAKOWKA S, 1976, J INFECT DIS, V134, P629, DOI 10.1093/infdis/134.6.629; Lempp C, 2014, VIRUSES-BASEL, V6, P2571, DOI 10.3390/v6072571; Liesi P, 2002, EXP NEUROL, V173, P31, DOI 10.1006/exnr.2001.7800; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Margolis RK, 1996, PERSPECT DEV NEUROBI, V3, P273; Matsui F, 2002, NEUROSCIENCE, V112, P773, DOI 10.1016/S0306-4522(02)00136-7; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Messersmith DJ, 2000, J NEUROSCI RES, V62, P241, DOI 10.1002/1097-4547(20001015)62:2<241::AID-JNR9>3.0.CO;2-D; MEYERPUTTLITZ B, 1995, J NEUROCHEM, V65, P2327; Miao Q, 2003, ACTA NEUROPATHOL, V106, P486, DOI 10.1007/s00401-003-0754-6; Milev P, 1998, BIOCHEM BIOPH RES CO, V247, P207, DOI 10.1006/bbrc.1998.8759; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Mohan H, 2010, BRAIN PATHOL, V20, P966, DOI 10.1111/j.1750-3639.2010.00399.x; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; MORI S, 1992, HISTOCHEMISTRY, V97, P237, DOI 10.1007/BF00267633; Moyon S, 2015, J NEUROSCI, V35, P4, DOI 10.1523/JNEUROSCI.0849-14.2015; Nasu-Tada K, 2006, GLIA, V53, P769, DOI 10.1002/glia.20339; Niquet J, 1996, DEV BRAIN RES, V95, P227, DOI 10.1016/S0165-3806(96)00089-2; Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; Puff C, 2009, VET J, V182, P100, DOI 10.1016/j.tvjl.2008.03.026; RISLING M, 1993, BRAIN RES BULL, V30, P405, DOI 10.1016/0361-9230(93)90272-D; Ryu JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9164; Satoh JI, 2009, MULT SCLER J, V15, P531, DOI 10.1177/1352458508101943; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Seehusen F, 2010, BRAIN PATHOL, V20, P551, DOI 10.1111/j.1750-3639.2009.00332.x; Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/j.tins.2007.11.001; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Snyder SE, 1996, MOL BRAIN RES, V40, P79; SOBEL RA, 1989, AM J PATHOL, V135, P161; Sobel RA, 2001, J NEUROPATH EXP NEUR, V60, P1198, DOI 10.1093/jnen/60.12.1198; Sobel RA, 1998, J NEUROPATH EXP NEUR, V57, P205, DOI 10.1097/00005072-199803000-00001; Spitzbarth I, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.472; Stichel CC, 1999, EUR J NEUROSCI, V11, P632, DOI 10.1046/j.1460-9568.1999.00466.x; Stichel CC, 1995, BRAIN RES, V704, P263, DOI 10.1016/0006-8993(95)01131-5; Stoffels JMJ, 2015, GLIA, V63, P242, DOI 10.1002/glia.22748; Stoffels JMJ, 2013, BRAIN, V136, P116, DOI 10.1093/brain/aws313; SUMMERS BA, 1979, ACTA NEUROPATHOL, V46, P1, DOI 10.1007/BF00684797; SUMMERS BA, 1987, J NEUROCYTOL, V16, P871; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; Ulrich R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095917; Ulrich R, 2010, J CELL MOL MED, V14, P434, DOI 10.1111/j.1582-4934.2008.00646.x; van Horssen J, 2005, J NEUROPATH EXP NEUR, V64, P722, DOI 10.1097/01.jnen.0000173894.09553.13; Horssen J, 2007, J NEUROCHEM, V103, P1293, DOI 10.1111/j.1471-4159.2007.04897.x; van Horssen J, 2006, NEUROBIOL DIS, V24, P484, DOI 10.1016/j.nbd.2006.08.005; Vandevelde M, 2005, ACTA NEUROPATHOL, V109, P56, DOI 10.1007/s00401-004-0958-4; VANDEVELDE M, 1982, ACTA NEUROPATHOL, V56, P285, DOI 10.1007/BF00691260; VANDEVELDE M, 1985, ACTA NEUROPATHOL, V67, P211, DOI 10.1007/BF00687803; Vitellaro-Zuccarello L, 2007, CELL TISSUE RES, V327, P433, DOI 10.1007/s00441-006-0289-y; WEBERSINKE G, 1992, BIOCHEM BIOPH RES CO, V189, P877, DOI 10.1016/0006-291X(92)92285-6; Webster JD, 2009, J HISTOCHEM CYTOCHEM, V57, P753, DOI 10.1369/jhc.2009.953877; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Wunschmann A, 1999, VET IMMUNOL IMMUNOP, V67, P101, DOI 10.1016/S0165-2427(98)00216-5; Wurmbach E, 2003, METHODS, V31, P306, DOI 10.1016/S1046-2023(03)00161-0; Yamaguchi Y, 1996, PERSPECT DEV NEUROBI, V3, P307; Zhou YX, 2006, GLIA, V54, P578, DOI 10.1002/glia.20410	98	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159752	10.1371/journal.pone.0159752	http://dx.doi.org/10.1371/journal.pone.0159752			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441688	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500134
J	Wu, ZZ; Zhang, H; Bin, SY; Chen, L; Han, QX; Lin, JT				Wu, Zhongzhen; Zhang, He; Bin, Shuying; Chen, Lei; Han, Qunxin; Lin, Jintian			Antennal and Abdominal Transcriptomes Reveal Chemosensory Genes in the Asian Citrus Psyllid, Diaphorina citri	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; CARBON-DIOXIDE DETECTION; RNA-SEQ DATA; DIFFERENTIAL EXPRESSION; AEDES-AEGYPTI; PHEROMONE DETECTION; GENOME ANNOTATION; ANOPHELES-GAMBIAE; ALDEHYDE OXIDASE; MAXILLARY PALP	The Asian citrus psyllid, Diaphorina citri is the principal vector of the highly destructive citrus disease called Huanglongbing (HLB) or citrus greening, which is a major threat to citrus cultivation worldwide. More effective pest control strategies against this pest entail the identification of potential chemosensory proteins that could be used in the development of attractants or repellents. However, the molecular basis of olfaction in the Asian citrus psyllid is not completely understood. Therefore, we performed this study to analyze the antennal and abdominal transcriptome of the Asian citrus psyllid. We identified a large number of transcripts belonging to nine chemoreception-related gene families and compared their expression in male and female adult antennae and terminal abdomen. In total, 9 odorant binding proteins (OBPs), 12 chemosensory proteins (CSPs), 46 odorant receptors (ORs), 20 gustatory receptors (GRs), 35 ionotropic receptors (IRs), 4 sensory neuron membrane proteins (SNMPs) and 4 different gene families encoding odorant-degrading enzymes (ODEs): 80 cytochrome P450s (CYPs), 12 esterase (ESTs), and 5 aldehyde dehydrogenases (ADE) were annotated in the D. citri antennal and abdominal transcriptomes. Our results revealed that a large proportion of chemosensory genes exhibited no distinct differences in their expression patterns in the antennae and terminal abdominal tissues. Notably, RNA sequencing (RNA-seq) data and quantitative real time-PCR (qPCR) analyses showed that 4 DictOBPs, 4 DictCSPs, 4 DictIRs, 1 DictSNMP, and 2 DictCYPs were upregulated in the antennae relative to that in terminal abdominal tissues. Furthermore, 2 DictOBPs (DictOBP8 and DictOBP9), 2 DictCSPs (DictOBP8 and DictOBP12), 4 DictIRs (DictIR3, DictIR6, DictIR10, and DictIR35), and 1 DictCYP (DictCYP57) were expressed at higher levels in the male antennae than in the female antennae. Our study provides the first insights into the molecular basis of chemoreception in this insect pest. Further studies on the identified differentially expressed genes would facilitate the understanding of insect olfaction and their role in the interactions between olfactory system and biological processes.	[Wu, Zhongzhen; Zhang, He; Bin, Shuying; Chen, Lei; Han, Qunxin; Lin, Jintian] Zhongkai Univ Agr & Engn, Inst Management Invas Alien Species, Guangzhou, Guangdong, Peoples R China	Zhongkai University of Agriculture & Engineering	Lin, JT (corresponding author), Zhongkai Univ Agr & Engn, Inst Management Invas Alien Species, Guangzhou, Guangdong, Peoples R China.	linjtian@163.com			scientific and technological development of Guangdong Province, China [2016B020202009, 2016A040403118]; Guangzhou scientific and technological project [201510010141]	scientific and technological development of Guangdong Province, China; Guangzhou scientific and technological project	This work was supported financially by the special funds of scientific and technological development of Guangdong Province in 2016, China (Grant No. 2016B020202009 and 2016A040403118), and the Guangzhou scientific and technological project (Grant No. 201510010141)	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Andersson MN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-501; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Boyle SM, 2013, ELIFE, V2, DOI 10.7554/eLife.01120; Cao DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101187; Cheng DF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09245; Costa-da-Silva AL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-364; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103420; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073524; Gu SH, 2013, INSECT BIOCHEM MOLEC, V43, P237, DOI 10.1016/j.ibmb.2012.12.009; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Hull JJ, 2014, INSECT MOL BIOL, V23, P78, DOI 10.1111/imb.12064; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keeling CI, 2013, INSECT BIOCHEM MOLEC, V43, P1142, DOI 10.1016/j.ibmb.2013.10.001; Koh TW, 2014, NEURON, V83, P850, DOI 10.1016/j.neuron.2014.07.012; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2013, P NATL ACAD SCI USA, V110, P18704, DOI 10.1073/pnas.1316059110; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MF, 2013, INSECT BIOCHEM MOLEC, V43, P417, DOI 10.1016/j.ibmb.2013.02.004; Maibeche-Coisne M, 2004, P NATL ACAD SCI USA, V101, P11459, DOI 10.1073/pnas.0403537101; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Marinotti O, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-15; Menuz K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004810; Merlin C, 2005, BIOCHEM BIOPH RES CO, V332, P4, DOI 10.1016/j.bbrc.2005.04.084; Missbach C, 2014, ELIFE, V3, DOI 10.7554/eLife.02115; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Omondi BA, 2015, J EXP BIOL, V218, P2482, DOI 10.1242/jeb.116798; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Pitts RJ, 2014, P NATL ACAD SCI USA, V111, P2566, DOI 10.1073/pnas.1322923111; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Potter CJ, 2014, CELL, V156, P878, DOI 10.1016/j.cell.2014.02.003; Pottier MA, 2012, INSECT MOL BIOL, V21, P568, DOI 10.1111/j.1365-2583.2012.01160.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; RYBCZYNSKI R, 1990, J BIOL CHEM, V265, P19712; RYBCZYNSKI R, 1989, J NEUROSCI, V9, P1341; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shi L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15581; Smadja C, 2009, MOL BIOL EVOL, V26, P2073, DOI 10.1093/molbev/msp116; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Stewart S, 2015, P NATL ACAD SCI USA, V112, P4195, DOI 10.1073/pnas.1503292112; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tauxe GM, 2013, CELL, V155, P1365, DOI 10.1016/j.cell.2013.11.013; Tiwari S, 2011, INSECT MOL BIOL, V20, P733, DOI 10.1111/j.1365-2583.2011.01103.x; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Tiwari S, 2011, PEST MANAG SCI, V67, P94, DOI 10.1002/ps.2038; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wenninger EJ, 2007, FLA ENTOMOL, V90, P715, DOI 10.1653/0015-4040(2007)90[715:DTOMAA]2.0.CO;2; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yasuda K, 1997, J APPL ENTOMOL ZOOL, P146; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Younus F, 2014, INSECT BIOCHEM MOLEC, V53, P30, DOI 10.1016/j.ibmb.2014.07.003; Zhang YN, 2014, GENE, V536, P279, DOI 10.1016/j.gene.2013.12.011; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou SS, 2014, COMP BIOCHEM PHYS D, V9, P31, DOI 10.1016/j.cbd.2013.12.002; Zhou XH, 2013, BIOL CHEM, V394, P43, DOI 10.1515/hsz-2012-0114	96	22	27	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159372	10.1371/journal.pone.0159372	http://dx.doi.org/10.1371/journal.pone.0159372			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441376	gold, Green Submitted, Green Published			2022-12-27	WOS:000380797500065
J	Yang, G; Xu, HQ; Zhang, HP; Yu, Q; Wu, YH; Shi, JP; Rao, WW; You, YY; Kou, CG; Yu, YQ				Yang, Guang; Xu, Hongqin; Zhang, Huiping; Yu, Qiong; Wu, Yanhua; Shi, Jieping; Rao, Wenwang; You, Yueyue; Kou, Changgui; Yu, Yaqin			Association between PLA2G12A Polymorphisms and Schizophrenia in a Han Chinese Population from Northeast China	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE-A2 GENE; PTGS2/PLA2G4A LOCUS; COMMON VARIANTS; A(2) ACTIVITY; SAMPLES; CPLA2	Objective The purpose of this study was to explore the association between single nucleotide polymorphisms (SNPs) in the phospholipase A2 (PLA2), group XIIA gene (PLA2G12A) and schizophrenia. Methods This study included 1,063 schizophrenia patients and 1,103 healthy controls from a Han Chinese Population in Northeast China. Four tagSNPs (rs11728699 in intron 1, synonymous rs2285714 in exon 3, rs3087494 in the 3' UTR, and rs7694620 in the downstream region) in PLA2G12A were selected, and they were genotyped by the MALDI-TOF-MS technology. The Chi-square (chi(2)) test and haplotype analysis were performed to analyze the association of PLA2G12A SNPs and schizophrenia using the software packages SPSS 16.0 and Haploview 4.2. Results Among the four tagSNPs, only SNP rs3087494 in the 3' UTR of PLA2G12A showed significant differences in both allele frequencies (chi(2) = 20.136, P<0.001) compared to healthy controls. The minor allele G of SNP rs3087494 is potentially a predictive factor for schizophrenia (OR = 0.753, 95% CI: 0.665-0.882). The frequency distribution of haplotypes consisting of specific alleles of two SNPs (rs7694620-rs3087494 or rs3087494-rs2285714), three SNPs (rs7694620-rs3087494-rs2285714 or rs3087494-rs2285714-rs11728699), or all four SNPs (rs7694620-rs3087494-rs2285714-rs11728699) was significantly different between schizophrenia patients and control subjects (P<0.001). Conclusions Our study demonstrated that PLA2G12A SNPs or haplotypes might influence the susceptibility to schizophrenia in the Han Chinese population from Northeast China.	[Yang, Guang; Xu, Hongqin; Yu, Qiong; Shi, Jieping; Rao, Wenwang; You, Yueyue; Kou, Changgui; Yu, Yaqin] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1163 Xinmin St, Changchun 130021, Jilin Province, Peoples R China; [Xu, Hongqin] Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130021, Jilin, Peoples R China; [Zhang, Huiping] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Zhang, Huiping] VA Connecticut Healthcare Syst, VA Med Ctr, West Haven, CT USA; [Wu, Yanhua] Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130021, Jilin, Peoples R China	Jilin University; Jilin University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Jilin University	Kou, CG; Yu, YQ (corresponding author), Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1163 Xinmin St, Changchun 130021, Jilin Province, Peoples R China.	koucg@jlu.edu.cn; yuyq@jlu.edu.cn	Yu, Qiong/M-1175-2018; SHI, JIE/GXG-3394-2022	Rao, Wenwang/0000-0002-3514-3082; Zhang, Huiping/0000-0002-4902-0104; Yu, Qiong/0000-0003-1143-1749; Yang, Guang/0000-0002-4335-2618; Kou, Changgui/0000-0001-9544-4066	National Natural Science Foundation of China [30972536]; First Hospital of Jilin University; Sixth Hospital of Changchun	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); First Hospital of Jilin University; Sixth Hospital of Changchun	This research was totally supported by the National Natural Science Foundation of China (30972536). The funding source had no role in the design of this study, the collection, analysis and interpretation of data, the writing of the paper, or the decision or submit the paper for publication.; We are grateful to the First Hospital of Jilin University and the Sixth Hospital of Changchun for supporting our project.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Arias B, 2002, NEUROTOX RES, V4, P523, DOI 10.1080/1029842021000022106; Chowdari KV, 2001, PSYCHIATR GENET, V11, P207, DOI 10.1097/00041444-200112000-00005; Eckert GP, 2011, PHARMACOPSYCHIATRY, V44, P161, DOI 10.1055/s-0031-1279731; Frieboes RM, 2001, AM J MED GENET, V105, P246, DOI 10.1002/ajmg.1262; GATTAZ WF, 1995, SCHIZOPHR RES, V16, P1, DOI 10.1016/0920-9964(94)00060-L; GATTAZ WF, 1990, BIOL PSYCHIAT, V28, P495; [寇长贵 KOU Changgui], 2006, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V32, P448; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Monti JM, 2013, PROG NEURO-PSYCHOPH, V43, P209, DOI 10.1016/j.pnpbp.2012.12.021; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Pae CU, 2004, PROG NEURO-PSYCHOPH, V28, P739, DOI 10.1016/j.pnpbp.2004.05.009; Price SA, 1997, PSYCHIATR GENET, V7, P111, DOI 10.1097/00041444-199723000-00004; Ross BM, 1997, ARCH GEN PSYCHIAT, V54, P487; Rybakowski JK, 2003, NEUROPSYCHOBIOLOGY, V47, P115, DOI 10.1159/000070578; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Smesny S, 2010, NEUROIMAGE, V52, P1314, DOI 10.1016/j.neuroimage.2010.05.009; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Talib LL, 2015, EUR ARCH PSY CLIN N, V265, P701, DOI 10.1007/s00406-015-0600-6; Tao R, 2005, AM J MED GENET B, V137B, P56, DOI 10.1002/ajmg.b.30210; Tao R, 2010, PSYCHIAT GENET, V20, P46, DOI 10.1097/YPG.0b013e328335117f; Tavares H, 2003, SCHIZOPHR RES, V61, P1, DOI 10.1016/S0920-9964(02)00281-5; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Wei J, 2004, PROSTAG LEUKOTR ESS, V70, P413, DOI 10.1016/j.plefa.2003.12.018; Wei J, 1998, MOL PSYCHIATR, V3, P480, DOI 10.1038/sj.mp.4000445; [俞琼 Yu Qiong], 2010, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V36, P938; Yu YQ, 2005, PROSTAG LEUKOTR ESS, V73, P351, DOI 10.1016/j.plefa.2005.07.003; Yu YQ, 2004, PROSTAG LEUKOTR ESS, V71, P405, DOI 10.1016/j.plefa.2004.09.001	28	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159584	10.1371/journal.pone.0159584	http://dx.doi.org/10.1371/journal.pone.0159584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434078	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600075
J	Zeiner, CA; Purvine, SO; Zink, EM; Pasa-Tolic, L; Chaput, DL; Haridas, S; Wu, S; LaButti, K; Grigoriev, IV; Henrissat, B; Santelli, CM; Hansel, CM				Zeiner, Carolyn A.; Purvine, Samuel O.; Zink, Erika M.; Pasa-Tolic, Ljiljana; Chaput, Dominique L.; Haridas, Sajeet; Wu, Si; LaButti, Kurt; Grigoriev, Igor V.; Henrissat, Bernard; Santelli, Cara M.; Hansel, Colleen M.			Comparative Analysis of Secretome Profiles of Manganese(II)-Oxidizing Ascomycete Fungi	PLOS ONE			English	Article							COAL-MINE DRAINAGE; ASPERGILLUS-NIGER; MN(II) OXIDATION; PHANEROCHAETE-CHRYSOSPORIUM; EXTRACELLULAR PROTEOME; TREATMENT SYSTEMS; PROTEINS; DATABASE; PEROXIDASE; DIVERSITY	Fungal secretomes contain a wide range of hydrolytic and oxidative enzymes, including cellulases, hemicellulases, pectinases, and lignin-degrading accessory enzymes, that synergistically drive litter decomposition in the environment. While secretome studies of model organisms such as Phanerochaete chrysosporium and Aspergillus species have greatly expanded our knowledge of these enzymes, few have extended secretome characterization to environmental isolates or conducted side-by-side comparisons of diverse species. Thus, the mechanisms of carbon degradation by many ubiquitous soil fungi remain poorly understood. Here we use a combination of LC-MS/MS, genomic, and bioinformatic analyses to characterize and compare the protein composition of the secretomes of four recently isolated, cosmopolitan, Mn(II)-oxidizing Ascomycetes (Alternaria alternata SRC1lrK2f, Stagonospora sp. SRC1lsM3a, Pyrenochaeta sp. DS3sAY3a, and Paraconiothyrium sporulosum AP3s5-JAC2a). We demonstrate that the organisms produce a rich yet functionally similar suite of extracellular enzymes, with species-specific differences in secretome composition arising from unique amino acid sequences rather than overall protein function. Furthermore, we identify not only a wide range of carbohydrate-active enzymes that can directly oxidize recalcitrant carbon, but also an impressive suite of redox-active accessory enzymes that suggests a role for Fenton-based hydroxyl radical formation in indirect, non-specific lignocellulose attack. Our findings highlight the diverse oxidative capacity of these environmental isolates and enhance our understanding of the role of filamentous Ascomycetes in carbon turnover in the environment.	[Zeiner, Carolyn A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Purvine, Samuel O.; Pasa-Tolic, Ljiljana; Wu, Si] Pacific Northwest Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Zink, Erika M.] Pacific Northwest Natl Lab, Biol Sci Lab, Richland, WA 99352 USA; [Chaput, Dominique L.] Smithsonian Inst, Dept Mineral Sci, Natl Museum Nat Hist, Washington, DC 20560 USA; [Haridas, Sajeet; LaButti, Kurt; Grigoriev, Igor V.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Henrissat, Bernard] CNRS, Architecture & Fonct Macromol Biol, UMR7257, F-13288 Marseille 9, France; [Henrissat, Bernard] Aix Marseille Univ, F-13288 Marseille 9, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, POB 80203, Jeddah 21589, Saudi Arabia; [Santelli, Cara M.] Univ Minnesota, Dept Earth Sci, Minneapolis, MN USA; [Hansel, Colleen M.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Zeiner, Carolyn A.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Wu, Si] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	Harvard University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University; University of Minnesota System; University of Minnesota Twin Cities; Woods Hole Oceanographic Institution; Boston University; University of Oklahoma System; University of Oklahoma - Norman	Hansel, CM (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	chansel@whoi.edu	Santelli, Cara/AAG-2453-2019; Purvine, Samuel O/O-3358-2017; Henrissat, Bernard/J-2475-2012; Haridas, Sajeet/H-4018-2019	Santelli, Cara/0000-0001-8617-0008; Purvine, Samuel O/0000-0002-2257-2400; Henrissat, Bernard/0000-0002-3434-8588; Haridas, Sajeet/0000-0002-0229-0975; Chaput, Dominique/0000-0002-9736-2619; Grigoriev, Igor/0000-0002-3136-8903; Zeiner, Carolyn/0000-0002-4847-4673	National Science Foundation [EAR-1249489, CBET-1336496]; Office of Biological and Environmental Research [DE-AC02-05CH11231, DE-AC05-76RL01830]; Harvard University; Ford Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1743046] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Harvard University; Ford Foundation; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation (www.nsf.gov), grant numbers EAR-1249489 and CBET-1336496, both awarded to CMH. Personal support for CAZ was also provided by Harvard University (www.harvard.edu) and by a Ford Foundation (www.fordfoundation.org) Predoctoral Fellowship administered by the National Academies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was performed under the Facilities Integrating Collaborations for User Science (FICUS) exploratory effort and used resources at the DOE Joint Genome Institute and the Environmental Molecular Sciences Laboratory, which are DOE Office of Science User Facilities. Both facilities are sponsored by the Office of Biological and Environmental Research and operated under Contract Nos. DE-AC02-05CH11231 (JGI) and DE-AC05-76RL01830 (EMSL). Part of this research was performed at the Bauer Core Facility of the FAS Center for Systems Biology at Harvard University. A portion of the bioinformatics analysis was performed at Harvard's FAS Research Computing facility.	Acumedia, 2011, YEAST EXTR 7184 PROD; Adav SS, 2010, J PROTEOME RES, V9, P3932, DOI 10.1021/pr100148j; Antelmann H, 2001, GENOME RES, V11, P1484, DOI 10.1101/gr.182801; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; BERGBAUER M, 1992, BIOTECHNOL LETT, V14, P317, DOI 10.1007/BF01022331; Callister SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001542; Dashtban Mehdi, 2010, Int J Biochem Mol Biol, V1, P36; Garcia-Molina MD, 2014, IUBMB LIFE, V66, P122, DOI 10.1002/iub.1250; Domsch KH, 2007, COMPENDIUM SOIL FUNG; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ferrer C, 2009, J CLIN MICROBIOL, V47, P1596, DOI 10.1128/JCM.01912-08; Finch-Savage WE, 2003, EUR J PLANT PATHOL, V109, P615, DOI 10.1023/A:1024784831972; Girard V, 2013, PROTEOMICS, V13, P597, DOI 10.1002/pmic.201200282; GLENN JK, 1986, ARCH BIOCHEM BIOPHYS, V251, P688, DOI 10.1016/0003-9861(86)90378-4; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Grigoriev IV, 2006, APPL MYCOL BIOTECH, V6, P123; HAIDER K, 1969, ARCH MIKROBIOL, V64, P338, DOI 10.1007/BF00417015; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; Hatakka A, 2010, MYCOTA, V10, P319; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Hofer C, 1999, FEBS LETT, V451, P186, DOI 10.1016/S0014-5793(99)00566-9; Hori C, 2014, APPL ENVIRON MICROB, V80, P2062, DOI 10.1128/AEM.03652-13; HUDSON HJ, 1968, NEW PHYTOL, V67, P837, DOI 10.1111/j.1469-8137.1968.tb06399.x; Jensen KA, 2001, APPL ENVIRON MICROB, V67, P2705, DOI 10.1128/AEM.67.6.2705-2711.2001; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kersten P, 2014, FUNGAL GENET BIOL, V72, P124, DOI 10.1016/j.fgb.2014.05.011; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Krijger JJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-722; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Levic J, 2012, ROM AGRIC RES, V29, P339; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liang LM, 2013, APPL MICROBIOL BIOT, V97, P8683, DOI 10.1007/s00253-013-5178-1; Liu DY, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-149; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lu X, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-23; Luan FB, 2012, APPL GEOCHEM, V27, P1567, DOI 10.1016/j.apgeochem.2012.03.010; Maiolica A, 2005, PROTEOMICS, V5, P3847, DOI 10.1002/pmic.200402010; Mayampurath AM, 2008, BIOINFORMATICS, V24, P1021, DOI 10.1093/bioinformatics/btn063; Medina ML, 2004, FUNGAL GENET BIOL, V41, P327, DOI 10.1016/j.fgb.2003.11.014; Munoz-Gomez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112179; Nilsson T, 1973, STUD FOR SUEC, V104, P5; Nitsche BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-380; Perez J., 2002, International Microbiology, V5, P53, DOI 10.1007/s10123-002-0062-3; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phalip V, 2005, CURR GENET, V48, P366, DOI 10.1007/s00294-005-0040-3; Przybyl K, 2002, FOREST PATHOL, V32, P387, DOI 10.1046/j.1439-0329.2002.00301.x; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; RIEBLE S, 1994, J BACTERIOL, V176, P4838, DOI 10.1128/jb.176.16.4838-4844.1994; Rohr CO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081033; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Santelli CM, 2014, GEOMICROBIOL J, V31, P605, DOI 10.1080/01490451.2013.875605; Santelli CM, 2010, APPL ENVIRON MICROB, V76, P4871, DOI 10.1128/AEM.03029-09; Saykhedkar S, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-52; Schlosser D, 2002, APPL ENVIRON MICROB, V68, P3514, DOI 10.1128/AEM.68.7.3514-3521.2002; Schoch CL, 2015, MYCOTA COMPREHENSIVE, VVII; Shi JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085532; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Solomon PS, 2006, MOL PLANT PATHOL, V7, P147, DOI [10.1111/j.1364-3703.2006.00326.x, 10.1111/J.1364-3703.2006.00326.X]; Timmer LW, 2000, COMPENDIUM CITRUS DI, P20; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; Whittaker MM, 1996, J BIOL CHEM, V271, P681, DOI 10.1074/jbc.271.2.681; Wlodawer A, 2003, ACTA BIOCHIM POL, V50, P81; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	71	35	35	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0157844	10.1371/journal.pone.0157844	http://dx.doi.org/10.1371/journal.pone.0157844			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434633	Green Published, gold			2022-12-27	WOS:000380169600004
J	Helmfors, L; Bergkvist, L; Brorsson, AC				Helmfors, Linda; Bergkvist, Liza; Brorsson, Ann-Christin			Serum Amyloid P Component Ameliorates Neurological Damage Caused by Expressing a Lysozyme Variant in the Central Nervous System of Drosophila melanogaster	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ALZHEIMERS-DISEASE; MODEL; NEURODEGENERATION; APOPTOSIS; FAMILY; BETA	Lysozyme amyloidosis is a hereditary disease in which mutations in the gene coding for lysozyme leads to misfolding and consequently accumulation of amyloid material. To improve understanding of the processes involved we expressed human wild type (WT) lysozyme and the disease-associated variant F57I in the central nervous system (CNS) of a Drosophila melanogaster model of lysozyme amyloidosis, with and without co-expression of serum amyloid p component (SAP). SAP is known to be a universal constituent of amyloid deposits and to associate with lysozyme fibrils. There are clear indications that SAP may play an important role in lysozyme amyloidosis, which requires further elucidation. We found that flies expressing the amyloidogenic variant F57I in the CNS have a shorter lifespan than flies expressing WT lysozyme. We also identified apoptotic cells in the brains of F57I flies demonstrating that the flies' neurological functions are impaired when F57I is expressed in the nerve cells. However, co-expression of SAP in the CNS prevented cell death and restored the F57I flies' lifespan. Thus, SAP has the apparent ability to protect nerve cells from damage caused by F57I. Furthermore, it was found that co-expression of SAP prevented accumulation of insoluble forms of lysozyme in both WT- and F57I-expressing flies. Our findings suggest that the F57I mutation affects the aggregation process of lysozyme resulting in the formation of cytotoxic species and that SAP is able to prevent cell death in the F57I flies by preventing accumulation of toxic F57I structures.	[Helmfors, Linda; Bergkvist, Liza; Brorsson, Ann-Christin] Linkoping Univ, Dept Phys Chem & Biol, Div Mol Biotechnol, Linkoping, Sweden	Linkoping University	Brorsson, AC (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Div Mol Biotechnol, Linkoping, Sweden.	anki@ifm.liu.se		Bergkvist, Liza/0000-0001-7433-2647; Brorsson, Ann-Christin/0000-0001-7651-3556	Swedish Research Council; Soderberg foundation [M26/11]; Linkoping University Neurobiology Center	Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg foundation; Linkoping University Neurobiology Center	This work was supported in part by the Swedish Research Council www.vr.se and the Soderberg foundation M26/11 www.torstensoderbergsstiftelse.se (A.-C.B.) and by the Linkoping University Neurobiology Center (L.H.). L.H. was enrolled in the multidisciplinary graduate school Forum Scientium at Linkoping University.	Andersson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055766; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; BRAND AH, 1993, DEVELOPMENT, V118, P401; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Coker AR, 2000, FEBS LETT, V473, P199, DOI 10.1016/S0014-5793(00)01530-1; Crowther DC, 2006, METHOD ENZYMOL, V412, P234, DOI 10.1016/S0076-6879(06)12015-7; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; de Haas CJC, 1999, FEMS IMMUNOL MED MIC, V26, P197, DOI 10.1016/S0928-8244(99)00148-0; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Gillmore JD, 1999, NEPHROL DIAL TRANSPL, V14, P2639, DOI 10.1093/ndt/14.11.2639; Girnius S, 2012, AMYLOID, V19, P182, DOI 10.3109/13506129.2012.723074; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Jonson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133272; Kamada Y, 2015, BBA-GEN SUBJECTS, V1850, P1107, DOI 10.1016/j.bbagen.2015.01.018; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; Kumita JR, 2012, FASEB J, V26, P192, DOI 10.1096/fj.11-185983; Loewen CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013084; Lu JH, 2012, IMMUNOL REV, V250, P230, DOI 10.1111/j.1600-065X.2012.01162.x; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Nilsberth C, 2001, ARCTIC APP MUTATION, P18; Noursadeghi M, 2000, P NATL ACAD SCI USA, V97, P14584, DOI 10.1073/pnas.97.26.14584; PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001	31	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159294	10.1371/journal.pone.0159294	http://dx.doi.org/10.1371/journal.pone.0159294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428539	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300043
J	Caballero, IC; Bates, JM; Hennen, M; Ashley, MV				Caballero, Isabel C.; Bates, John M.; Hennen, Mary; Ashley, Mary V.			Sex in the City: Breeding Behavior of Urban Peregrine Falcons in the Midwestern US	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; NEST-SITE FIDELITY; COMPUTER-PROGRAM; PARENTAL GENOTYPES; PROGENY ARRAYS; DISPERSAL; BIRDS; FERTILIZATIONS; RECONSTRUCTION; POPULATION	Peregrine falcons (Falco peregrinus) were extirpated from most of the continental United States by widespread use of the pesticide DDT in the 1960s. Populations have rebounded with banning of the pesticide and successful implementation of captive breeding and hacking programs. An essentially new population of Midwestern peregrines now exists that is comprised almost entirely of urban-nesting birds. The new population is considered to be of mixed ancestry, occurs at relatively high densities, and has nest sites in close proximity, factors that could influence breeding behaviors including mate fidelity, nest-site fidelity, extrapair paternity, and natal dispersal. We investigated these behaviors using a combination of field observations and DNA microsatellite genotyping. Data for eleven microsatellite DNA markers, including eight newly developed for the species, were analyzed from a total of 350 birds from nine Midwestern cities, representing 149 broods collected at 20 nest sites. To document breeding behavior, parentage was inferred by likelihood techniques when both parents were sampled and by parental genotype reconstruction when only one parent was sampled. In cases where neither parent was sampled, a sibship reconstruction approach was used. We found high mate fidelity and nest-site fidelity in urban peregrines; in 122 nesting attempts made by long-term breeders, only 12 (9.8%) mate changes and six (4.9%) nest-site changes occurred. Only one brood (of 35 tested) revealed extra-pair paternity and involved a male tending two offspring of a recently acquired mate. Natal dispersal patterns indicated that female peregrines dispersed on average 226 km, almost twice the distance of males (average 124 km). Despite the novel environment of cities, our results suggest that monogamous breeding, nest fidelity, and female natal dispersal are high in urban peregrines, not unlike other raptors living in non-urban habitats.	[Caballero, Isabel C.; Ashley, Mary V.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Caballero, Isabel C.] Texas A&M Univ, Dept Biol, College Stn, TX USA; [Bates, John M.] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL USA; [Hennen, Mary] Field Museum Nat Hist, Gantz Family Collect Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Texas A&M University System; Texas A&M University College Station; Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago)	Caballero, IC (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.; Caballero, IC (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX USA.	icabal@tamu.edu		, Isabel/0000-0002-1373-3436	Donald L. Bleitz Award; Dean Amadon Grant; TIOF Grant; Pritzker Foundation; American Ornithologist's Union	Donald L. Bleitz Award; Dean Amadon Grant; TIOF Grant; Pritzker Foundation; American Ornithologist's Union	This work was supported by Donald L. Bleitz Award, American Ornithologist's Union (awarded to ICC) http://americanornithology.org/content/student-postdoctoral-research-awards, the Dean Amadon Grant (awarded to ICC) http://www.raptorresearchfoundation.org/grants-and-awards/grants/dean-amadon-grant, and the TIOF Grant (awarded to ICC) http://www.ospreys.com/styled-4/index.html. This work was completed in partial fulfillment of the requirements for the doctoral degree (to ICC) from the Graduate College, University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Microsatellite development by ICC and laboratory work was carried out in the Ashley Laboratory at UIC and the Pritzker Laboratory for Molecular Systematics and Evolution operated with support from the Pritzker Foundation. We thank Kevin A. Feldheim for helping in the development of microsatellites. We are grateful to the curators, collections managers, and their institutions that kindly provided materials for this study: David Willard, Field Museum of Natural History, Robert M. Zink and Mike Westberg, Bell Museum of Natural History. Special thanks go to the Chicago Peregrine Program members Matt Gies and Stephanie Ware. This work was supported by Donald L. Bleitz Award, American Ornithologist's Union (awarded to ICC) http://americanornithology.org/content/student-postdoctoral-research-awards, the Dean Amadon Grant (awarded to ICC) http://www.raptorresearchfoundation.org/grants-and-awards/grants/dean-amadon-grant, and the TIOF Grant (awarded to ICC) http://www.ospreys.com/styled-4/index.html. This work was completed in partial fulfillment of the requirements for the doctoral degree (to ICC) from the Graduate College, University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2005, IBIS, V147, P608, DOI 10.1111/j.1474-919x.2005.00429.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berger DD, 1969, PEREGRINE FALCON POP; Booms TL, 2011, CONDOR, V113, P768, DOI 10.1525/cond.2011.100178; Burnham W, 2003, CONDOR, V105, P327, DOI 10.1650/0010-5422(2003)105[0327:PFEESH]2.0.CO;2; Dennhardt AJ, 2013, J RAPTOR RES, V47, P262; Faccio SD, 2013, J RAPTOR RES, V47, P246; Fuller MR, 1998, J AVIAN BIOL, V29, P433, DOI 10.2307/3677162; Gahbauer MA, 2015, J WILDLIFE MANAGE, V79, P10, DOI 10.1002/jwmg.803; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HICKEY JJ, 1968, SCIENCE, V162, P271, DOI 10.1126/science.162.3850.271; JENKINS JM, 1993, CONDOR, V95, P1053, DOI 10.2307/1369447; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones AG, 2001, MOL ECOL NOTES, V1, P215, DOI 10.1046/j.1471-8278.2001.00062.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McKay C., 2006, USDI FISH WILDLIFE S, V71, P60563; Mougeot F, 2004, ANIM BEHAV, V67, P1067, DOI 10.1016/j.anbehav.2003.10.011; Negro JJ, 1996, ANIM BEHAV, V51, P935, DOI 10.1006/anbe.1996.0097; Nesje M, 2000, MOL ECOL, V9, P53, DOI 10.1046/j.1365-294x.2000.00834.x; R Core Team, 2021, R LANGUAGE ENV STAT; RATCLIFF.DA, 1967, NATURE, V215, P208, DOI 10.1038/215208a0; Ratcliffe Derek A., 1980, PEREGRINE FALCON; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REDIG P. T., 1999, LOON, V71, P182; Redig PT, 2008, MIDWEST PEREGRINE FA; Redig PT, 2007, MIDWEST PEREGRINE FA; Rejt Lukasz, 2001, Acta Ornithologica (Warsaw), V36, P165; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenfield RN, 2015, J FIELD ORNITHOL, V86, P144, DOI 10.1111/jofo.12097; Rousset F, 1997, GENETICS, V145, P1219; Santure AW, 2009, GENETICS, V181, P259, DOI [10.1534/genetics.108.097998, 10.1534/genetics.108.100214]; SODHI NS, 1991, CONDOR, V93, P433, DOI 10.2307/1368960; Steenhof K, 2009, WILSON J ORNITHOL, V121, P12, DOI 10.1676/07-177.1; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Tordoff H.B., 1993, Loon, V65, P107; Tordoff HB, 1997, J RAPTOR RES, V31, P339; Tordoff HB, 2001, CONSERV BIOL, V15, P528, DOI 10.1046/j.1523-1739.2001.015002528.x; Villarroel M, 1998, ANIM BEHAV, V56, P289, DOI 10.1006/anbe.1998.0788; Wakamiya SM, 2009, BIOL CONSERV, V142, P1767, DOI 10.1016/j.biocon.2009.03.015; WARKENTIN IG, 1994, MOL ECOL, V3, P229, DOI 10.1111/j.1365-294X.1994.tb00056.x; White C. M., 1994, HDB BIRDS WORLD, V2, P216; Zuberogoitia I, 2015, J ZOOL, V296, P6, DOI 10.1111/jzo.12221; Zuberogoitia I, 2009, J ORNITHOL, V150, P95, DOI 10.1007/s10336-008-0321-y	46	9	10	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0159054	10.1371/journal.pone.0159054	http://dx.doi.org/10.1371/journal.pone.0159054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420915	Green Submitted, Green Published, gold			2022-12-27	WOS:000379662300008
J	Assaf, D; Amar, E; Marwan, N; Neuman, Y; Salai, M; Rath, E				Assaf, Dan; Amar, Eyal; Marwan, Norbert; Neuman, Yair; Salai, Moshe; Rath, Ehud			Dynamic Patterns of Expertise: The Case of Orthopedic Medical Diagnosis	PLOS ONE			English	Article							RECURRENCE PLOTS; EXPERIENCE; EDUCATION	The aim of this study was to analyze dynamic patterns for scanning femoroacetabular impingement (FAI) radiographs in orthopedics, in order to better understand the nature of expertise in radiography. Seven orthopedics residents with at least two years of expertise and seven board-certified orthopedists participated in the study. The participants were asked to diagnose 15 anteroposterior (AP) pelvis radiographs of 15 surgical patients, diagnosed with FAI syndrome. Eye tracking data were recorded using the SMI desk-mounted tracker and were analyzed using advanced measures and methodologies, mainly recurrence quantification analysis. The expert orthopedists presented a less predictable pattern of scanning the radiographs although there was no difference between experts and non-experts in the deterministic nature of their scan path. In addition, the experts presented a higher percentage of correct areas of focus and more quickly made their first comparison between symmetric regions of the pelvis. We contribute to the understanding of experts' process of diagnosis by showing that experts are qualitatively different from residents in their scanning patterns. The dynamic pattern of scanning that characterizes the experts was found to have a more complex and less predictable signature, meaning that experts' scanning is simultaneously both structured (i.e. deterministic) and unpredictable.	[Assaf, Dan; Amar, Eyal; Salai, Moshe; Rath, Ehud] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Amar, Eyal; Salai, Moshe; Rath, Ehud] Tel Aviv Sourasky Med Ctr, Orthoped Div, 6 Weizmann St, Tel Aviv, Israel; [Marwan, Norbert] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Neuman, Yair] Ben Gurion Univ Negev, Ctr Study Convers & Interreligious Encounters, Homeland Secur Inst, Dept Educ, Beer Sheva, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Potsdam Institut fur Klimafolgenforschung; Ben Gurion University	Neuman, Y (corresponding author), Ben Gurion Univ Negev, Ctr Study Convers & Interreligious Encounters, Homeland Secur Inst, Dept Educ, Beer Sheva, Israel.	yneuman@bgu.ac.il	Amar, Eyal/ABF-1838-2020; Rath, Ehud/HDN-1358-2022; Marwan, Norbert/D-9576-2011	Marwan, Norbert/0000-0003-1437-7039				[Anonymous], 2005, TUTORIALS CONT NONLI; Avila GMR, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0623; Donges JF, 2011, P NATL ACAD SCI USA, V108, P20422, DOI 10.1073/pnas.1117052108; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Eng J, 2000, AM J ROENTGENOL, V175, P1233, DOI 10.2214/ajr.175.5.1751233; Feldhoff JH, 2012, PHYS LETT A, V376, P3504, DOI 10.1016/j.physleta.2012.10.008; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20052; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Krupinski EA, 2006, HUM PATHOL, V37, P1543, DOI 10.1016/j.humpath.2006.08.024; Kundel HL, 2007, RADIOLOGY, V242, P396, DOI 10.1148/radiol.2422051997; Leunig M, 2009, CLIN ORTHOP RELAT R, V467, P616, DOI 10.1007/s11999-008-0646-0; Litchfield D, 2010, J EXP PSYCHOL-APPL, V16, P251, DOI 10.1037/a0020082; Manning D, 2006, RADIOGRAPHY, V12, P134, DOI 10.1016/j.radi.2005.02.003; Marwan N, 2004, INT J BIFURCAT CHAOS, V14, P761, DOI 10.1142/S0218127404009454; Marwan N, 2008, EUR PHYS J-SPEC TOP, V164, P3, DOI 10.1140/epjst/e2008-00829-1; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Neuman Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101014; Nodine CF, 2001, RADIOLOGY, V221, P122, DOI 10.1148/radiol.2211001507; Norman G, 2007, MED EDUC, V41, P1140, DOI 10.1111/j.1365-2923.2007.02914.x; Pusic M, 2011, ACAD MED, V86, P731, DOI 10.1097/ACM.0b013e3182178c3c; Reingold EM, 2011, OXFORD HDB EYE MOVEM, P528, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0029; Tannast M, 2007, AM J ROENTGENOL, V188, P1540, DOI 10.2214/AJR.06.0921; van Beek EJR, 2007, RADIOLOGY, V243, P633, DOI 10.1148/radiol.2433051098; Webber C., 2014, RECURRENCE QUANTIFIC; Webber CL, 2009, PHYS LETT A, V373, P3753, DOI 10.1016/j.physleta.2009.08.052; Zbilut JP, 2002, MED ENG PHYS, V24, P53, DOI 10.1016/S1350-4533(01)00112-6	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158820	10.1371/journal.pone.0158820	http://dx.doi.org/10.1371/journal.pone.0158820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414794	Green Published, gold			2022-12-27	WOS:000379579500042
J	Butler, JM; Field, KE; Maruska, KP				Butler, Julie M.; Field, Karen E.; Maruska, Karen P.			Cobalt Chloride Treatment Used to Ablate the Lateral Line System Also Impairs the Olfactory System in Three Freshwater Fishes	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; AFRICAN CICHLID FISH; RAINBOW-TROUT; MECHANOSENSORY SYSTEM; HAPLOCHROMIS-BURTONI; SPAWNING READINESS; SENSORY BASIS; CRYPT CELLS; TIME-COURSE; COPPER	Fishes use multimodal signals during both inter-and intra-sexual displays to convey information about their sex, reproductive state, and social status. These complex behavioral displays can include visual, auditory, olfactory, tactile, and hydrodynamic signals, and the relative role of each sensory channel in these complex multi-sensory interactions is a common focus of neuroethology. The mechanosensory lateral line system of fishes detects near-body water movements and is implicated in a variety of behaviors including schooling, rheotaxis, social communication, and prey detection. Cobalt chloride is commonly used to chemically ablate lateral line neuromasts, thereby eliminating water-movement cues to test for mechanosensory-mediated behavioral functions. However, cobalt acts as a nonspecific calcium channel antagonist and could potentially disrupt function of all superficially located sensory receptor cells, including those for chemosensing. Here, we examined whether CoCl2 treatment used to ablate the lateral line system also impairs olfaction in three freshwater fishes, the African cichlid fish Astatotilapia burtoni, goldfish Carassius auratus, and the Mexican blind cavefish Astyanax mexicanus. To examine the impact of CoCl2 on the activity of peripheral receptors, we quantified DASPEI fluorescence intensity of the olfactory epithelium from fish exposed to control and CoCl2 solutions. In addition, we examined brain activation in olfactory processing regions of A. burtoni immersed in either control or cobalt solutions. All three species exposed to CoCl2 had decreased DASPEI staining of the olfactory epithelium, and in A. burtoni, cobalt treatment caused reduced neural activation in olfactory processing regions of the brain. To our knowledge this is the first empirical evidence demonstrating that the same CoCl2 treatment used to ablate the lateral line system also impairs olfactory function. These data have important implications for the use of CoCl2 in future research and suggest that previous studies using CoCl2 should be reinterpreted in the context of both impaired mechanoreception and olfaction.	[Butler, Julie M.; Field, Karen E.; Maruska, Karen P.] Louisiana State Univ, Dept Biol Sci, 107 Life Sci Bldg, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Butler, JM (corresponding author), Louisiana State Univ, Dept Biol Sci, 107 Life Sci Bldg, Baton Rouge, LA 70803 USA.	jbutl48@lsu.edu			College of Science and Department of Biological Sciences at Louisiana State University; Louisiana Board of Regents RCS Grant; Powe Faculty Enhancement Award from ORAU; National Science Foundation [IOS-1456004, IOS-1456558]; Louisiana Board of Regents Graduate Fellowship; National Science Foundation Graduate Research Fellowship	College of Science and Department of Biological Sciences at Louisiana State University; Louisiana Board of Regents RCS Grant; Powe Faculty Enhancement Award from ORAU; National Science Foundation(National Science Foundation (NSF)); Louisiana Board of Regents Graduate Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	Support was provided by startup funds from the College of Science and Department of Biological Sciences at Louisiana State University (KPM), Louisiana Board of Regents RCS Grant (KPM; http://www.regents.la.gov/), Powe Faculty Enhancement Award from ORAU (KPM; http://www.orau.org/university-partnership/faculty-studentprograms/powe/), and National Science Foundation (IOS-1456004 and IOS-1456558 to KPM; http://www.nsf.gov/div/index.jsp?div=IOS). JMB was supported by a Louisiana Board of Regents Graduate Fellowship and National Science Foundation Graduate Research Fellowship (https://www.nsfgrfp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts J. R., 1976, MAMMALIAN OLFACTION, P67; Almeida OG, 2005, CHEM SENSES, V30, pI309, DOI 10.1093/chemse/bjh238; Gayoso JA, 2011, J COMP NEUROL, V519, P247, DOI 10.1002/cne.22518; Appelt CW, 2007, ANIM BEHAV, V74, P1329, DOI 10.1016/j.anbehav.2007.02.032; Appelt Christopher W., 1999, P247; Aronson LR, 1949, AN ANALYSIS OF REPRO; Baker CF, 1999, J COMP PHYSIOL A, V184, P519, DOI 10.1007/s003590050351; Barata EN, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-54; Barata EN, 2008, J CHEM ECOL, V34, P438, DOI 10.1007/s10886-008-9458-7; Barata EN, 2008, ANIM BEHAV, V75, P379, DOI 10.1016/j.anbehav.2007.05.018; Barlow GW, 2002, CICHILD FISHES NATUR; Bazaes A, 2012, J EXP BIOL, V215, P1740, DOI 10.1242/jeb.067264; BECERRA M, 1994, J COMP NEUROL, V342, P131, DOI 10.1002/cne.903420112; BEREITERHAHN J, 1976, BIOCHIM BIOPHYS ACTA, V423, P1, DOI 10.1016/0005-2728(76)90096-7; Bireg WJ, 1980, OIL SHAL S SAMPL AN; BLAUSTEIN AR, 1981, AM NAT, V117, P1006, DOI 10.1086/283786; BLECKMANN H, 1991, J COMP PHYSIOL A, V168, P749; Brown AD, 2011, HEARING RES, V272, P1, DOI 10.1016/j.heares.2010.10.014; Brown SB, 1982, CHEMORECEPTION FISHE; Burghardt G. M., 1970, COMMUNICATION CHEM S, P241; Burghardt G.M., 1980, CHEM SIGNALS, P275; Butler JM, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00093; Butler JM, 2015, J EXP BIOL, V218, P3284, DOI 10.1242/jeb.125948; CAPRIO J, 1975, COMP BIOCHEM PHYS A, V52, P247, DOI 10.1016/S0300-9629(75)80160-5; Coffin AB, 2014, J EXP BIOL, V217, P2078, DOI 10.1242/jeb.093831; Coombs S, 1996, J COMP PHYSIOL A, V178, P359; COOMBS S, 1994, J EXP BIOL, V190, P109; Coombs S, 2009, J COMP PHYSIOL A, V195, P279, DOI 10.1007/s00359-008-0405-4; Corrado AP, 1988, ACTA PHYSL LAT AM, V39, P419; Curtis B, 1939, GILL B AMNH, V76; D'Aniello B, 2015, MICROSC RES TECHNIQ, V78, P268, DOI 10.1002/jemt.22471; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; Doty R, 2012, MAMMALIAN OLFACTION; DULKA JG, 1987, NATURE, V325, P251, DOI 10.1038/325251a0; DULON D, 1989, J NEUROSCI RES, V24, P338, DOI 10.1002/jnr.490240226; Enger P.S., 1989, P575; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1977, ANIM BEHAV, V25, P643, DOI 10.1016/0003-3472(77)90115-4; FERNALD RD, 1985, J COMP NEUROL, V238, P202, DOI 10.1002/cne.902380207; Gerlach G, 2006, ANIM BEHAV, V72, P1119, DOI 10.1016/j.anbehav.2006.03.009; Gire DH, 2012, J NEUROSCI, V32, P2964, DOI 10.1523/JNEUROSCI.5580-11.2012; Grone BP, 2015, J COMP NEUROL, V523, P1125, DOI 10.1002/cne.23729; GuevaraGuzman R, 1997, BRAIN RES BULL, V44, P141, DOI 10.1016/S0361-9230(97)00103-2; Hamdani EH, 2007, PROG NEUROBIOL, V82, P80, DOI 10.1016/j.pneurobio.2007.02.007; Hansen JA, 1999, ENVIRON TOXICOL CHEM, V18, P1979, DOI [10.1897/1551-5028(1999)018&lt;1979:CSOTAR&gt;2.3.CO;2, 10.1002/etc.5620180917]; Hansen JA, 1999, ENVIRON TOXICOL CHEM, V18, P1972, DOI [10.1897/1551-5028(1999)018&lt;1972:DINROC&gt;2.3.CO;2, 10.1002/etc.5620180916]; Hara TJ, 2006, J FISH BIOL, V68, P810, DOI 10.1111/j.1095.8649.2006.00967.x; HARA TJ, 1994, ACTA PHYSIOL SCAND, V152, P207, DOI 10.1111/j.1748-1716.1994.tb09800.x; Hara TJ, 1992, FISH CHEMORECEPTION, P199; Hiermes M, 2015, ANIM COGN, V18, P839, DOI 10.1007/s10071-015-0850-8; Janssen J, 2000, J COMP PHYSIOL A, V186, P957, DOI 10.1007/s003590000148; Julliard AK, 1996, TISSUE CELL, V28, P367, DOI 10.1016/S0040-8166(96)80023-1; KARLSEN HE, 1987, J EXP BIOL, V133, P249; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kermen F, 2014, FRONT NEURAL CIRCUIT; KOTRSCHAL K, 1992, ENVIRON BIOL FISH, V35, P273, DOI 10.1007/BF00001894; Kotrschal K, 2000, PFLUG ARCH EUR J PHY, V439, pR178, DOI 10.1007/s004240000137; Kulpa M, 2015, J EXP BIOL, V218, P1603, DOI 10.1242/jeb.119537; Lamb CF, 2000, FOOD INTAKE IN FISH, P108; Levy F, 2004, HORM BEHAV, V46, P284, DOI 10.1016/j.yhbeh.2004.02.005; Linbo TL, 2006, ENVIRON TOXICOL CHEM, V25, P597, DOI 10.1897/05-241R.1; MACKERETH RW, 1993, CAN J ZOOL, V71, P960, DOI 10.1139/z93-126; Marr JCA, 1998, AQUAT TOXICOL, V43, P225, DOI 10.1016/S0166-445X(98)00061-7; Medina LM, 2013, BEHAV PROCESS, V100, P163, DOI 10.1016/j.beproc.2013.09.007; Maruska KP, 2012, J COMP NEUROL, V520, P3471, DOI 10.1002/cne.23100; Maruska KP, 2012, J EXP BIOL, V215, P68, DOI 10.1242/jeb.062794; McHenry MJ, 2014, SPRINGER HANDB AUDIT, V48, P73, DOI 10.1007/2506_2013_13; Meyers JR, 2003, J NEUROSCI, V23, P4054; Michel William C., 2006, P471; Mirjany M, 2011, J EXP BIOL, V214, P3358, DOI 10.1242/jeb.052894; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Montgomery J, 2014, SPRINGER HANDB AUDIT, V48, P121, DOI 10.1007/2506_2013_17; Munchrath LA, 2010, J COMP NEUROL, V518, P3302, DOI 10.1002/cne.22401; MUNRO AD, 1985, HORM BEHAV, V19, P353, DOI 10.1016/0018-506X(85)90034-0; Oka Y, 1982, CHEMORECEPTION FISHE, P61; Olsen K. Hakan, 1992, Fish and Fisheries Series, V6, P229; PARADELIS AG, 1980, METHOD FIND EXP CLIN, V2, P45; Persson E, 2003, TOXICOL LETT, V145, P19, DOI 10.1016/S0378-4274(03)00266-2; PITCHER TJ, 1976, SCIENCE, V194, P963, DOI 10.1126/science.982056; Pohlmann K, 2004, J EXP BIOL, V207, P2971, DOI 10.1242/jeb.01129; Repass JJ, 2001, HEARING RES, V154, P98, DOI 10.1016/S0378-5955(01)00226-X; Roper TJ, 1999, ADV STUD BEHAV, V28, P247, DOI 10.1016/S0065-3454(08)60219-3; Rosenthal GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016994; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Ruschenbaum S, 2013, ETHOLOGY, V119, P368, DOI 10.1111/eth.12072; SAND O, 1975, J COMP PHYSIOL, V102, P27, DOI 10.1007/BF00657483; Sandahl JF, 2006, CAN J FISH AQUAT SCI, V63, P1840, DOI 10.1139/F06-074; SATOU M, 1994, J COMP PHYSIOL A, V174, P539; SAUCIER D, 1995, COMP BIOCHEM PHYS A, V112, P273, DOI 10.1016/0300-9629(95)00098-4; Schmachtenberg O, 2006, J COMP NEUROL, V495, P113, DOI 10.1002/cne.20847; SCHNEIDER D, 1969, SCIENCE, V163, P1031, DOI 10.1126/science.163.3871.1031; Schwalbe MAB, 2016, J EXP BIOL, V219, P1050, DOI 10.1242/jeb.136150; Schwalbe MAB, 2014, ZOOLOGY, V117, P112, DOI 10.1016/j.zool.2013.09.003; Schwalbe MAB, 2012, J EXP BIOL, V215, P2060, DOI 10.1242/jeb.065920; SORENSEN PW, 1992, BIOL BULL, V183, P173, DOI 10.2307/1542420; Stabell Ole B., 1992, Fish and Fisheries Series, V6, P249; Stacey N, 2015, FISH PHEROMONES AND RELATED CUES, P33; Stefansson SO., 2000, P 6 INT S REPR PHYS, P125; Stewart WJ, 2014, J EXP BIOL, V217, P4328, DOI 10.1242/jeb.111773; Stewart WJ, 2013, J EXP BIOL, V216, P388, DOI 10.1242/jeb.072751; STOVNER J, 1960, ACTA PHARMACOL TOX, V16, P235; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Stripling RMB, 1998, RESPONSE MODULATION; Sunderman FW, 2001, ANN CLIN LAB SCI, V31, P3; Tierney KB, 2010, AQUAT TOXICOL, V96, P2, DOI 10.1016/j.aquatox.2009.09.019; TONOSAKI K, 1985, COMP BIOCHEM PHYS C, V80, P361; TYRER NM, 1974, BRAIN RES, V73, P151, DOI 10.1016/0006-8993(74)91014-2; Webb JF, 2014, SPRINGER HANDB AUDIT, V48, P17, DOI 10.1007/2506_2013_12; WEBB JF, 1989, BRAIN BEHAV EVOLUT, V33, P34, DOI 10.1159/000115896; Wenzel B.M., 1971, P432; Whitear Mary, 1992, Fish and Fisheries Series, V6, P103; Yamamoto M., 1982, CHEMORECEPTION FISHE, P39; Yasuoka A, 2009, CHEMOSENSORY SYSTEMS, P97; YOSHII K, 1983, BRAIN RES, V274, P239, DOI 10.1016/0006-8993(83)90701-1; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017; Zeiske E., 1992, FISH CHEMORECEPTION, P13, DOI [10.1007/978-94-011-2332-7_2, DOI 10.1007/978-94-011-2332-7_2]	116	7	7	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159521	10.1371/journal.pone.0159521	http://dx.doi.org/10.1371/journal.pone.0159521			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416112	Green Published, gold			2022-12-27	WOS:000379579500134
J	Chen, CC; Lin, MW; Liang, CJ; Wang, SH				Chen, Chin-Chaun; Lin, Ming-Wei; Liang, Chan-Jung; Wang, Shu-Huei			The Anti-Inflammatory Effects and Mechanisms of Eupafolin in Lipopolysaccharide-Induced Inflammatory Responses in RAW264.7 Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; LUNG EPITHELIAL-CELLS; RAW 264.7 MACROPHAGES; NITRIC-OXIDE; SIGNALING PATHWAYS; GENE-EXPRESSION; ACTIVATION; MAPK; L.; NEUROTOXICITY	Eupafolin is a flavone isolated from Artemisia princeps Pampanini (family Asteraceae). The aim of this study was to examine the anti-inflammatory effects of eupafolin in lipopolysaccharide (LPS)-treated RAW264.7 macrophages and LPS-induced mouse skin and lung inflammation models and to identify the mechanism underlying these effects. Eupafolin decreased the LPS-induced release of inflammatory mediators (iNOS, COX-2 and NO) and proinflammatory cytokines (IL-6 and TNF-alpha) from the RAW264.7 macrophages. Eupafolin inhibited the LPS-induced phosphorylation of p38 MAPK, ERK1/2, JNK, AKT and p65 and the nuclear translocation of p65 and c-fos. These effects were mainly mediated by the inhibition of JNK. In the mouse paw and lung models, eupafolin effectively suppressed the LPS-induced edema formation and down-regulated iNOS and COX-2 expression. These results demonstrated that eupafolin exhibits anti-inflammatory properties and suggested that eupafolin can be developed as an anti-inflammatory agent.	[Chen, Chin-Chaun] Chang Gung Univ, Grad Inst Nat Prod, Taoyuan, Taiwan; [Chen, Chin-Chaun] Chang Gung Univ, Hlth Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan; [Chen, Chin-Chaun] Chang Gung Mem Hosp, Tissue Bank, Taoyuan, Taiwan; [Liang, Chan-Jung] Kaohsiung Med Univ, CLGR, Kaohsiung, Taiwan; [Liang, Chan-Jung] Kaohsiung Med Univ Hosp, CLB, Kaohsiung, Taiwan; [Lin, Ming-Wei; Wang, Shu-Huei] Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan University	Wang, SH (corresponding author), Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan.	shwang@ntu.edu.tw	Chen, Chin-Chuan/G-3094-2013	Chen, Chin-Chuan/0000-0002-8938-3209; WANG, SHU-HUEI/0000-0002-9208-3135	National Science Council [NSC103-2320-B-002-017]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council (NSC103-2320-B-002-017).	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Boje KMK, 2004, FRONT BIOSCI-LANDMRK, V9, P763, DOI 10.2741/1268; Boots AW, 2012, BBA-MOL CELL RES, V1823, P1151, DOI 10.1016/j.bbamcr.2012.04.012; Bosca L, 2005, TOXICOLOGY, V208, P249, DOI 10.1016/j.tox.2004.11.035; Choudhari AS, 2013, J ETHNOPHARMACOL, V150, P215, DOI 10.1016/j.jep.2013.08.025; Chung KS, 2010, MOL NUTR FOOD RES, V54, P1318, DOI 10.1002/mnfr.200900305; Esser N, 2015, EXPERT OPIN INV DRUG, V24, P283, DOI 10.1517/13543784.2015.974804; Faffe DS, 2000, EUR RESPIR J, V15, P85, DOI 10.1183/09031936.00.15108500; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Ha VT, 2014, MEDIAT INFLAMM, V2014, DOI [10.1155/2014/354843, DOI 10.1155/2014/354843]; Hensel A, 2011, J ETHNOPHARMACOL, V138, P641, DOI 10.1016/j.jep.2011.10.002; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim HG, 2007, J ETHNOPHARMACOL, V114, P307, DOI 10.1016/j.jep.2007.08.011; Kim HR, 2015, MOL IMMUNOL, V63, P355, DOI 10.1016/j.molimm.2014.09.003; Ko HH, 2014, J ETHNOPHARMACOL, V151, P386, DOI 10.1016/j.jep.2013.10.054; Koyama S, 1999, EUR RESPIR J, V14, P545, DOI 10.1034/j.1399-3003.1999.14c11.x; Kwon DJ, 2014, BMB REP, V47, P318, DOI 10.5483/BMBRep.2014.47.6.200; Kwon DJ, 2013, FOOD CHEM TOXICOL, V58, P479, DOI 10.1016/j.fct.2013.05.031; Lahti A, 2003, MOL PHARMACOL, V64, P308, DOI 10.1124/mol.64.2.308; Ma CH, 2015, J ETHNOPHARMACOL, V168, P349, DOI 10.1016/j.jep.2015.03.068; Maas M, 2011, J ETHNOPHARMACOL, V137, P371, DOI 10.1016/j.jep.2011.05.040; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Miura K, 2002, J AGR FOOD CHEM, V50, P1845, DOI 10.1021/jf011314o; Park HJ, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-7; Shi QH, 2014, INT IMMUNOPHARMACOL, V20, P298, DOI 10.1016/j.intimp.2014.04.004; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Sung HC, 2015, J ETHNOPHARMACOL, V170, P136, DOI 10.1016/j.jep.2015.04.058; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253	34	39	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158662	10.1371/journal.pone.0158662	http://dx.doi.org/10.1371/journal.pone.0158662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414646	Green Submitted, gold, Green Published			2022-12-27	WOS:000379579500029
J	Czapla, J; Matuszczak, S; Wisniewska, E; Jarosz-Biej, M; Smolarczyk, R; Cichon, T; Glowala-Kosinska, M; Sliwka, J; Garbacz, M; Szczypior, M; Jazwiec, T; Langrzyk, A; Zembala, M; Szala, S				Czapla, Justyna; Matuszczak, Sybilla; Wisniewska, Ewa; Jarosz-Biej, Magdalena; Smolarczyk, Ryszard; Cichon, Tomasz; Glowala-Kosinska, Magdalena; Sliwka, Joanna; Garbacz, Marcin; Szczypior, Mateusz; Jazwiec, Tomasz; Langrzyk, Agnieszka; Zembala, Michal; Szala, Stanislaw			Human Cardiac Mesenchymal Stromal Cells with CD105(+)CD34(-) Phenotype Enhance the Function of Post-Infarction Heart in Mice	PLOS ONE			English	Article							STEM-CELLS; BONE-MARROW; STEM/STROMAL CELLS; THERAPY; REPAIR; INTERLEUKIN-6; ANGIOGENESIS; POLARIZATION; HYPERTROPHY; MEDIATE	Aims The aim of the present study was to isolate mesenchymal stromal cells (MSC) with CD105(+)CD34(-) phenotype from human hearts, and to investigate their therapeutic potential in a mouse model of hindlimb ischemia and myocardial infarction (MI). The study aimed also to investigate the feasibility of xenogeneic MSCs implantation. Methods and Results MSC isolated from human hearts were multipotent cells. Separation of MSC with CD105(+)CD34(-) phenotype limited the heterogeneity of the originally isolated cell population. MSC secreted a number of anti-inflammatory and proangiogenic cytokines (mainly IL-6, IL-8, and GRO). Human MSC were transplanted into C57Bl/6NCrl mice. Using the mouse model of hindlimb ischemia it was shown that human MSC treated mice demonstrated a higher capillary density 14 days after injury. It was also presented that MSC administrated into the ischemic muscle facilitated fast wound healing (functional recovery by ischemic limb). MSC transplanted into an infarcted myocardium reduced the post-infarction scar, fibrosis, and increased the number of blood vessels both in the border area, and within the post-infarction scar. The improvement of left ventricular ejection fraction was also observed. Conclusion In two murine models (hindlimb ischemia and MI) we did not observe the xenotransplant rejection. Indeed, we have shown that human cardiac mesenchymal stromal cells with CD105(+)CD34(-) phenotype exhibit therapeutic potential. It seems that M2 macrophages are essential for healing and repair of the post-infarcted heart.	[Czapla, Justyna; Matuszczak, Sybilla; Jarosz-Biej, Magdalena; Smolarczyk, Ryszard; Cichon, Tomasz; Glowala-Kosinska, Magdalena; Langrzyk, Agnieszka; Szala, Stanislaw] Maria Sklodowska Curie Mem Canc Ctr, Ctr Translat Res & Mol Biol Canc, Gliwice, Poland; [Czapla, Justyna; Matuszczak, Sybilla; Jarosz-Biej, Magdalena; Smolarczyk, Ryszard; Cichon, Tomasz; Glowala-Kosinska, Magdalena; Langrzyk, Agnieszka; Szala, Stanislaw] Inst Oncol, Gliwice Branch, Gliwice, Poland; [Wisniewska, Ewa; Sliwka, Joanna; Garbacz, Marcin; Szczypior, Mateusz; Jazwiec, Tomasz; Zembala, Michal] Silesian Ctr Heart Dis, Dept Cardiac Surg & Transplantol, Zabrze, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Silesian Center for Heart Diseases	Szala, S (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Ctr Translat Res & Mol Biol Canc, Gliwice, Poland.; Szala, S (corresponding author), Inst Oncol, Gliwice Branch, Gliwice, Poland.	sszala@io.gliwice.pl	Smolarczyk, Ryszard/AAL-8683-2021; Zembala, Michal/GNP-2971-2022; Jarosz-Biej, Magdalena/AAR-2783-2021; Sliwka, Joanna/HDM-3585-2022	Jarosz-Biej, Magdalena/0000-0003-4023-6782; Sliwka, Joanna/0000-0001-7231-0743; Smolarczyk, Ryszard/0000-0002-1131-289X; Matuszczak, Sybilla/0000-0001-6359-2582; Glowala-Kosinska, Magdalena/0000-0002-6455-7794; Czapla, Justyna/0000-0001-5402-8461; Cichon, Tomasz/0000-0002-3009-7080	Innovative Economy Operational Programme [POIG.01.03.01-00 169/09]; European Regional Development Fund within the framework of Innovative Economy Operational Programme (axis: Investments in Innovative Undertakings); European Regional Development Fund within the framework of Innovative Economy Operational Programme	Innovative Economy Operational Programme; European Regional Development Fund within the framework of Innovative Economy Operational Programme (axis: Investments in Innovative Undertakings); European Regional Development Fund within the framework of Innovative Economy Operational Programme	This work was supported by the Innovative Economy Operational Programme POIG.01.03.01-00 169/09. The study has been co-financed by European Regional Development Fund within the framework of Innovative Economy Operational Programme (axis: Investments in Innovative Undertakings). This work was supported by equipment bought for the purposes of the Project: "Silesian BIO-FARMA. Center for Biotechnology, Bioengineering, and Bioinformatics" cofinanced by European Regional Development Fund within the framework of Innovative Economy Operational Programme 2007-2013.	Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Ben-Mordechai T, 2013, J AM COLL CARDIOL, V62, P1890, DOI 10.1016/j.jacc.2013.07.057; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Brenes RA, 2012, J VASC SURG, V56, P1669, DOI 10.1016/j.jvs.2012.04.067; Caidahl K, 2010, ARTERIOSCL THROM VAS, V30, P1684, DOI 10.1161/ATVBAHA.110.208843; Chen PW, 2013, INT REV CEL MOL BIO, V301, P1, DOI 10.1016/B978-0-12-407704-1.00001-4; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; de Couto G, 2015, J CLIN INVEST, V125, P3147, DOI 10.1172/JCI81321; de Girolamo L, 2013, CURR PHARM DESIGN, V19, P2459, DOI 10.2174/1381612811319130015; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Eggenhofer E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-12; Fredj S, 2005, J CELL PHYSIOL, V204, P428, DOI 10.1002/jcp.20307; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gaebel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015652; Gao S, 2014, EXP BIOL MED, V239, P366, DOI 10.1177/1535370213518169; GEISER T, 1993, J BIOL CHEM, V268, P15419; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002; Hoogduijn MJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0596-3; Horwitz EM, 2008, CYTOTHERAPY, V10, P771, DOI 10.1080/14653240802618085; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; MacDonald DJ, 2005, J THORAC CARDIOV SUR, V130, P1114, DOI 10.1016/j.jtcvs.2005.04.033; Matuszczak S, 2014, CLIN RES CARDIOL, V103, P711, DOI 10.1007/s00392-014-0705-3; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; OWEN M, 1988, CIBA F SYMP, V136, P42, DOI 10.1002/9780470513637.ch4; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Qazi BS, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/908468; Rahman MM, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00402; Rossini A, 2011, CARDIOVASC RES, V89, P650, DOI 10.1093/cvr/cvq290; Saito T, 2002, ANN THORAC SURG, V74, P19, DOI 10.1016/S0003-4975(02)03591-9; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Sharma RR, 2014, TRANSFUSION, V54, P1418, DOI 10.1111/trf.12421; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Stoff A, 2009, EXP DERMATOL, V18, P362, DOI 10.1111/j.1600-0625.2008.00792.x; Uchibori R, 2014, INT J HEMATOL, V99, P377, DOI 10.1007/s12185-014-1537-7; Wang X, 2013, INT ORTHOP, V37, P2491, DOI 10.1007/s00264-013-2059-2; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Watt SM, 2013, BRIT MED BULL, V108, P25, DOI 10.1093/bmb/ldt031; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zheng GP, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/989473	51	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158745	10.1371/journal.pone.0158745	http://dx.doi.org/10.1371/journal.pone.0158745			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415778	gold, Green Published, Green Submitted			2022-12-27	WOS:000379579500035
J	McDougall, C; Woodcroft, BJ; Degnan, BM				McDougall, Carmel; Woodcroft, Ben J.; Degnan, Bernard M.			The Widespread Prevalence and Functional Significance of Silk-Like Structural Proteins in Metazoan Biological Materials	PLOS ONE			English	Article							SPIDER DRAGLINE SILK; SEA-URCHIN; MATRIX PROTEIN; MECHANICAL-PROPERTIES; ORGANIC MATRIX; NACREOUS LAYER; MUSSEL BYSSUS; PEARL OYSTER; BOMBYX-MORI; GENE FAMILY	In nature, numerous mechanisms have evolved by which organisms fabricate biological structures with an impressive array of physical characteristics. Some examples of metazoan biological materials include the highly elastic byssal threads by which bivalves attach themselves to rocks, biomineralized structures that form the skeletons of various animals, and spider silks that are renowned for their exceptional strength and elasticity. The remarkable properties of silks, which are perhaps the best studied biological materials, are the result of the highly repetitive, modular, and biased amino acid composition of the proteins that compose them. Interestingly, similar levels of modularity/repetitiveness and similar bias in amino acid compositions have been reported in proteins that are components of structural materials in other organisms, however the exact nature and extent of this similarity, and its functional and evolutionary relevance, is unknown. Here, we investigate this similarity and use sequence features common to silks and other known structural proteins to develop a bioinformatics-based method to identify similar proteins from large-scale transcriptome and whole-genome datasets. We show that a large number of proteins identified using this method have roles in biological material formation throughout the animal kingdom. Despite the similarity in sequence characteristics, most of the silk-like structural proteins (SLSPs) identified in this study appear to have evolved independently and are restricted to a particular animal lineage. Although the exact function of many of these SLSPs is unknown, the apparent independent evolution of proteins with similar sequence characteristics in divergent lineages suggests that these features are important for the assembly of biological materials. The identification of these characteristics enable the generation of testable hypotheses regarding the mechanisms by which these proteins assemble and direct the construction of biological materials with diverse morphologies. The SilkSlider predictor software developed here is available at https://github.com/wwood/SilkSlider.	[McDougall, Carmel; Degnan, Bernard M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Woodcroft, Ben J.] Univ Queensland, Australian Ctr Ecogen, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Degnan, BM (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	b.degnan@uq.edu.au	McDougall, Carmel/G-3512-2010	McDougall, Carmel/0000-0002-2116-5651; Woodcroft, Ben/0000-0003-0670-7480; Degnan, Bernard/0000-0001-7573-8518	Australian Research Council [LP0990280]; BRAEMBL/NCISF in St Lucia, QLD, Australia	Australian Research Council(Australian Research Council); BRAEMBL/NCISF in St Lucia, QLD, Australia	This work was funded by Australian Research Council grant LP0990280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Fred Wilt for kindly providing S. purpuratus material, protocols and helpful advice, William Hatleberg for generating the line art in Fig 2, Felipe Aguilera, Selene Fernandez-Valverde and Marie E. A. Gauthier for bioinformatics assistance, and staff at Heron Island Research Station for assistance with animal maintenance. We acknowledge the support of the BRAEMBL/NCISF in St Lucia, QLD, Australia and the use of the High Performance Computing Cluster "Barrine" to complete this research.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; [Anonymous], 2014, R LANG ENV STAT COMP; Aspock G, 1999, GENOME RES, V9, P909, DOI 10.1101/gr.9.10.909; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Beckmann A, 2015, BMC BIOL, V13, DOI 10.1186/s12915-014-0113-1; Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043; Bonnal RJP, 2012, BIOINFORMATICS, V28, P1035, DOI 10.1093/bioinformatics/bts080; Buckley KM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-68; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cameron CB, 2012, P ROY SOC B-BIOL SCI, V279, P3041, DOI 10.1098/rspb.2012.0335; Cao QP, 1997, CURR BIOL, V7, pR677, DOI 10.1016/S0960-9822(06)00353-8; Chang YS, 2002, MOL REPROD DEV, V62, P397, DOI 10.1002/mrd.10125; Chen CM, 2013, BIOINFORMATICS, V29, P2808, DOI 10.1093/bioinformatics/btt484; Cheng C, 2008, ADV FUNCT MATER, V18, P2172, DOI 10.1002/adfm.200701130; Cheng SM, 2010, BIOPHYS J, V99, P3863, DOI 10.1016/j.bpj.2010.10.011; Coyne KJ, 1997, SCIENCE, V277, P1830, DOI 10.1126/science.277.5333.1830; Craig CL, 2002, COMP BIOCHEM PHYS B, V133, P493, DOI 10.1016/S1096-4959(02)00095-7; David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Degens E T, 1976, Top Curr Chem, V64, P1, DOI 10.1007/BFb0045698; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Evans JS, 2012, BIOINFORMATICS, V28, P3182, DOI 10.1093/bioinformatics/bts604; FANG RX, 1991, PLANT MOL BIOL, V17, P1255, DOI 10.1007/BF00028742; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GAGE LP, 1980, J BIOL CHEM, V255, P9444; Goto N, 2010, BIOINFORMATICS, V26, P2617, DOI 10.1093/bioinformatics/btq475; Harrington MJ, 2007, J EXP BIOL, V210, P4307, DOI 10.1242/jeb.009753; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; HIBNER BL, 1991, GENETICS, V128, P595; Hinman VF, 2000, DEV GENES EVOL, V210, P129, DOI 10.1007/s004270050019; HOHL D, 1991, J BIOL CHEM, V266, P6626; Hronska M, 2004, BIOMACROMOLECULES, V5, P834, DOI 10.1021/bm0343904; Huang XW, 2014, J BIOMED MATER RES B, V102, P1720, DOI 10.1002/jbm.b.33157; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hwang JS, 2010, P NATL ACAD SCI USA, V107, P18539, DOI 10.1073/pnas.1003256107; IATROU K, 1982, J MOL BIOL, V157, P417, DOI 10.1016/0022-2836(82)90469-7; Iconomidou VA, 2006, J STRUCT BIOL, V156, P480, DOI 10.1016/j.jsb.2006.08.011; Innamorati G, 2006, CELL SIGNAL, V18, P761, DOI 10.1016/j.cellsig.2005.11.004; Ioannidou ZS, 2014, INSECT BIOCHEM MOLEC, V52, P51, DOI 10.1016/j.ibmb.2014.06.004; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Jackson D, 2005, MAR BIOL, V147, P681, DOI 10.1007/s00227-005-1603-z; Jackson DJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-160; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Kalmar L, 2012, BONE, V51, P528, DOI 10.1016/j.bone.2012.05.009; KELLER B, 1988, EMBO J, V7, P3625, DOI 10.1002/j.1460-2075.1988.tb03243.x; Killian CE, 2008, CHEM REV, V108, P4463, DOI 10.1021/cr0782630; Killian CE, 2010, GENE EXPR PATTERNS, V10, P135, DOI 10.1016/j.gep.2010.01.002; Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007; KUNZ W, 1987, NUCLEIC ACIDS RES, V15, P5894, DOI 10.1093/nar/15.14.5894; Liu XJ, 2015, GENE, V555, P217, DOI 10.1016/j.gene.2014.11.006; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; Lucas JM, 2002, J EXP BIOL, V205, P1807; Mann K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-249; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-33; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-22; Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 2013, RECENT ADV PEARL RES; McDougall C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0041; McDougall C, 2011, CELLS TISSUES ORGANS, V194, P103, DOI 10.1159/000324213; MITA K, 1994, J MOL EVOL, V38, P583; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Nudelman F, 2008, J STRUCT BIOL, V162, P290, DOI 10.1016/j.jsb.2008.01.008; Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qin XX, 1997, J BIOL CHEM, V272, P32623, DOI 10.1074/jbc.272.51.32623; Rafiq K, 2014, DEVELOPMENT, V141, P950, DOI 10.1242/dev.105585; Ransick A, 2004, METHOD CELL BIOL, V74, P601; ROBSON P, 1993, J BIOL CHEM, V268, P1440; Rose MLH, 2009, CELL MOL LIFE SCI, V66, P2707, DOI 10.1007/s00018-009-0046-y; Ruangsittichai J, 2006, INT J PARASITOL, V36, P1329, DOI 10.1016/j.ijpara.2006.06.012; Scheffel A, 2011, P NATL ACAD SCI USA, V108, P3175, DOI 10.1073/pnas.1012842108; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; Takahashi J, 2012, GENE, V499, P130, DOI 10.1016/j.gene.2011.11.057; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; WEINER S, 1980, FEBS LETT, V111, P311, DOI 10.1016/0014-5793(80)80817-9; Wilt F, 2013, J STRUCT BIOL, V183, P199, DOI 10.1016/j.jsb.2013.04.001; Woodcroft BJ, 2011, ORF FINDER RB; Woodcroft BJ, 2014, SILKSLIDER; Woodcroft BJ, 2012, GLY SLIDING WINDOW R; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Yang YJ, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2013.19; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200; Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413	97	13	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159128	10.1371/journal.pone.0159128	http://dx.doi.org/10.1371/journal.pone.0159128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415783	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500083
J	Meehan, CL; Mench, JA; Carlstead, K; Hogan, JN				Meehan, Cheryl L.; Mench, Joy A.; Carlstead, Kathy; Hogan, Jennifer N.			Determining Connections between the Daily Lives of Zoo Elephants and Their Welfare: An Epidemiological Approach	PLOS ONE			English	Article							ANIMAL-WELFARE; BEHAVIOR	Concerns about animal welfare increasingly shape people's views about the acceptability of keeping animals for food production, biomedical research, and in zoos. The field of animal welfare science has developed over the past 50 years as a method of investigating these concerns via research that assesses how living in human-controlled environments influences the behavior, health and affective states of animals. Initially, animal welfare research focused on animals in agricultural settings, but the field has expanded to zoos because good animal welfare is essential to zoos' mission of promoting connections between animals and visitors and raising awareness of conservation issues. A particular challenge for zoos is ensuring good animal welfare for long-lived, highly social species like elephants. Our main goal in conducting an epidemiological study of African (Loxodonta africana) and Asian (Elephas maximus) elephant welfare in 68 accredited North American zoos was to understand the prevalence of welfare indicators in the population and determine the aspects of an elephant's zoo environment, social life and management that are most important to prevent and reduce a variety of welfare problems. In this overview, we provide a summary of the findings of the nine papers in the collection titled: Epidemiological Investigations of North American Zoo Elephant Welfare with a focus on the life history, social, housing, and management factors found to be associated with particular aspects of elephant welfare, including the performance of abnormal behavior, foot and joint problems, recumbence, walking rates, and reproductive health issues. Social and management factors were found to be important for multiple indicators of welfare, while exhibit space was found to be less influential than expected. This body of work results from the largest prospective zoo-based animal welfare study conducted to date and sets in motion the process of using science-based welfare benchmarks to optimize care of zoo elephants.	[Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA; [Mench, Joy A.] Univ Calif Davis, Ctr Anim Welf, Davis, CA USA; [Mench, Joy A.] Univ Calif Davis, Dept Anim Sci, Davis, CA USA; [Carlstead, Kathy] Honolulu Zoo Soc, Honolulu, HI USA	University of California System; University of California Davis; University of California System; University of California Davis	Meehan, CL (corresponding author), AWARE Inst, Portland, OR USA.	Cheryl.meehan@aware.institute			Institute of Museum and Library Services [LG-25-10-0033-10]; IMLS; AWARE Institute	Institute of Museum and Library Services; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. Employers provided financial support in the form of authors' salaries as follows: Honolulu Zoo (KC). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1965, REPORT TECHNICAL COM; Appleby M.C, 2011, ANIMAL WELFARE; Barber JCE, 2009, ELEPHANT ROOM SCI WE; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Botreau R, 2009, ANIM WELFARE, V18, P363; Brown JL, 2004, GEN COMP ENDOCR, V136, P360, DOI 10.1016/j.ygcen.2004.01.013; Brown JL, 2016, PLOS ONE; Carlstead K, 1999, ZOO BIOL, V18, P17, DOI 10.1002/(SICI)1098-2361(1999)18:1&lt;17::AID-ZOO4&gt;3.0.CO;2-K; Carlstead K, 1999, ZOO BIOL, V18, P35, DOI 10.1002/(SICI)1098-2361(1999)18:1&lt;35::AID-ZOO5&gt;3.0.CO;2-L; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Carlstead K, 2009, ZOO BIOL, V28, P589, DOI 10.1002/zoo.20289; CHAMOVE AS, 1988, ZOO BIOL, V7, P359, DOI 10.1002/zoo.1430070407; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; Davey G, 2007, J APPL ANIM WELF SCI, V10, P169, DOI 10.1080/10888700701313595; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; Fowler M, 2006, BIOL MED SURG ELEPHA; Fraser D, 2011, UNDERSTANDING ANIMAL; Fraser D, 2013, VET J, V198, P19, DOI 10.1016/j.tvjl.2013.06.028; Galindo F., 2011, Animal welfare, P228, DOI 10.1079/9781845936594.0228; Gartner MC, 2013, APPL ANIM BEHAV SCI, V144, P1, DOI 10.1016/j.applanim.2012.11.010; Gosling SD, 2010, PSYCHOL BULL, V127, P54; Grandin T., 2010, IMPROVING ANIMAL WEL; Greco BJ, 2016, PLOS ONE; Harrison R., 1964, ANIMAL MACHINES; Holdgate MR, 2016, PLOS ONE; Hosey G, 2008, APPL ANIM BEHAV SCI, V109, P105, DOI 10.1016/j.applanim.2007.04.013; Hutchins M, 2008, ZOO BIOL, V27, P488, DOI 10.1002/zoo.20167; Mason G., 2008, STEREOTYPIC ANIMAL B; Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]; Meehan CL, 2016, PLOS ONE; Melfi VA, 2009, ZOO BIOL, V28, P574, DOI 10.1002/zoo.20288; Mellor D, 2009, SCI ANIMAL WELFARE; Mench J., 2004, Measuring and auditing broiler welfare, P3, DOI 10.1079/9780851998053.0003; Mench JA, 2016, J ANIM SCI, V94, P1296, DOI 10.2527/jas.2015-9680; Mikota S.K., 1994, W BLOOMFIELD; Mikota SK, 2001, J ZOO WILDLIFE MED, V32, P1, DOI 10.1638/1042-7260(2001)032[0001:EADOMT]2.0.CO;2; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Millman ST, 2009, J APPL ANIM WELF SCI, V12, P83, DOI 10.1080/10888700902719542; Moberg G.P., 2000, BIOL ANIMAL STRESS B, V1st; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Morfeld KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093802; Muller DWH, 2010, AM J VET RES, V71, P275, DOI 10.2460/ajvr.71.3.275; Olsson IAS, 2007, APPL ANIM BEHAV SCI, V103, P229, DOI 10.1016/j.applanim.2006.05.022; Prado-Oviedo NA, 2016, PLOS ONE; Price EE, 2007, APPL ANIM BEHAV SCI, V103, P255, DOI 10.1016/j.applanim.2006.05.021; Proctor CM, 2010, ZOO BIOL, V29, P127, DOI 10.1002/zoo.20238; Ralph CR, 2016, J ANIM SCI, V94, P457, DOI 10.2527/jas.2015-9645; Rault JL, 2012, APPL ANIM BEHAV SCI, V136, P1, DOI 10.1016/j.applanim.2011.10.002; Roberts M., 1989, P129; Rushen J, 2003, APPL ANIM BEHAV SCI, V81, P199, DOI 10.1016/S0168-1591(02)00281-2; Ryan SJ, 2001, ZOO BIOL, V20, P89, DOI 10.1002/zoo.1009; Shepherdson D, 2013, APPL ANIM BEHAV SCI, V147, P268, DOI 10.1016/j.applanim.2013.01.001; Shepherdson David, 2010, P62; Swaisgood RR, 2005, ZOO BIOL, V24, P499, DOI 10.1002/zoo.20066; van Keulen-Kromhout G., 1978, International Zoo Yearbook, V18, P177; Walker M., 2014, INT J COMP PSYCHOL, V27, P80, DOI [10.46867/ijcp.2014.27.01.03, DOI 10.46867/IJCP.2014.27.01.03]; Ward SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140237; Ward SJ, 2013, APPL ANIM BEHAV SCI, V147, P179, DOI 10.1016/j.applanim.2013.05.008; Watters JV, 2009, ZOO BIOL, V28, P501, DOI 10.1002/zoo.20287; Weiss A, 2011, BIOL LET        0715; Whitham JC, 2009, ZOO BIOL, V28, P545, DOI 10.1002/zoo.20281; Wielebnowski NC, 2002, ZOO BIOL, V21, P77, DOI 10.1002/zoo.10005; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Yeates JW, 2008, VET J, V175, P293, DOI 10.1016/j.tvjl.2007.05.009	65	40	43	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158124	10.1371/journal.pone.0158124	http://dx.doi.org/10.1371/journal.pone.0158124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414416	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500016
J	Zhu, WN; Drewes, J; Melcher, D				Zhu, Weina; Drewes, Jan; Melcher, David			Time for Awareness: The Influence of Temporal Properties of the Mask on Continuous Flash Suppression Effectiveness	PLOS ONE			English	Article							THRESHOLD TACTILE STIMULI; MOTION-INDUCED BLINDNESS; INTEROCULAR SUPPRESSION; VISUAL AWARENESS; BINOCULAR-RIVALRY; GLOBAL WORKSPACE; PHASE RESET; THETA-BAND; EEG ALPHA; LOW-LEVEL	Visual processing is not instantaneous, but instead our conscious perception depends on the integration of sensory input over time. In the case of Continuous Flash Suppression (CFS), masks are flashed to one eye, suppressing awareness of stimuli presented to the other eye. One potential explanation of CFS is that it depends, at least in part, on the flashing mask continually interrupting visual processing before the stimulus reaches awareness. We investigated the temporal features of masks in two ways. First, we measured the suppression effectiveness of a wide range of masking frequencies (0-32Hz), using both complex (faces/houses) and simple (closed/open geometric shapes) stimuli. Second, we varied whether the different frequencies were interleaved within blocks or separated in homogenous blocks, in order to see if suppression was stronger or weaker when the frequency remained constant across trials. We found that break-through contrast differed dramatically between masking frequencies, with mask effectiveness following a skewed-normal curve peaking around 6Hz and little or no masking for low and high temporal frequencies. Peak frequency was similar for trial-randomized and block randomized conditions. In terms of type of stimulus, we found no significant difference in peak frequency between the stimulus groups (complex/simple, face/house, closed/open). These findings suggest that temporal factors play a critical role in perceptual awareness, perhaps due to interactions between mask frequency and the time frame of visual processing.	[Zhu, Weina] Yunnan Univ, Sch Informat Sci, Kunming, Peoples R China; [Zhu, Weina; Drewes, Jan; Melcher, David] Univ Trento, Ctr Mind Brain Sci CIMeC, Rovereto, Italy; [Zhu, Weina] Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China	Yunnan University; University of Trento; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhu, WN (corresponding author), Yunnan Univ, Sch Informat Sci, Kunming, Peoples R China.; Zhu, WN (corresponding author), Univ Trento, Ctr Mind Brain Sci CIMeC, Rovereto, Italy.; Zhu, WN (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China.	zhuweina.cn@gmail.com	Melcher, David/D-1775-2010	Melcher, David/0000-0003-0926-585X	European Research Council (ERC) grant [313658]; National Natural Science Foundation of China [61005087, 61263042, 61563056]; Key Science Project of the Department of Education, Yunnan Province, China [2015Z010]; High-level Foreign Expert Grant [GDT20155300084]	European Research Council (ERC) grant(European Research Council (ERC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science Project of the Department of Education, Yunnan Province, China; High-level Foreign Expert Grant	This work was supported by a European Research Council (ERC) grant (Grant Agreement No. 313658), the National Natural Science Foundation of China (61005087, 61263042, 61563056), a Key Science Project of the Department of Education, Yunnan Province, China (2015Z010) and a High-level Foreign Expert Grant (GDT20155300084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2007, VISION RES, V47, P269, DOI 10.1016/j.visres.2006.09.003; Aller M, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00016; Alsius A, 2013, PSYCHOL SCI, V24, P423, DOI 10.1177/0956797612457378; Bahrami B, 2008, J VISION, V8, DOI 10.1167/8.3.12; BRADDICK OJ, 1980, PHILOS T ROY SOC B, V290, P137, DOI 10.1098/rstb.1980.0087; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brandt ME, 1997, INT J PSYCHOPHYSIOL, V26, P285, DOI 10.1016/S0167-8760(97)00771-X; Breitmeyer B., 2006, VISUAL MASKING; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Chen L, 2003, P NATL ACAD SCI USA, V100, P6884, DOI 10.1073/pnas.0732090100; Cohen MA, 2015, J COGNITIVE NEUROSCI, V27, P2240, DOI 10.1162/jocn_a_00855; Costello P, 2009, CONSCIOUS COGN, V18, P375, DOI 10.1016/j.concog.2009.02.003; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Dijksterhuis A, 2003, PSYCHOL SCI, V14, P14, DOI 10.1111/1467-9280.t01-1-01412; Drewes J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16290; Dugue L, 2015, P NATL ACAD SCI USA, V112, P15214, DOI 10.1073/pnas.1511331112; Dugue L, 2015, J COGNITIVE NEUROSCI, V27, P945, DOI 10.1162/jocn_a_00755; Enns James T, 2008, Adv Cogn Psychol, V3, P211, DOI 10.2478/v10053-008-0026-z; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Fiebelkorn IC, 2013, CURR BIOL, V23, P2553, DOI 10.1016/j.cub.2013.10.063; Fiebelkorn IC, 2011, J NEUROSCI, V31, P9971, DOI 10.1523/JNEUROSCI.1338-11.2011; Fogelson SV, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00601; Gaillard R, 2006, P NATL ACAD SCI USA, V103, P7524, DOI 10.1073/pnas.0600584103; Goodhew SC, 2013, PSYCHON B REV, V20, P859, DOI 10.3758/s13423-013-0400-9; Hamada Y, 2001, CLIN NEUROPHYSIOL, V112, P1326, DOI 10.1016/S1388-2457(01)00542-9; Henry MJ, 2014, P NATL ACAD SCI USA, V111, P14935, DOI 10.1073/pnas.1408741111; Hong SW, 2015, EMOT SCI, V392, DOI [10.3389/fpsyq.2015.00392, DOI 10.3389/FPSYQ.2015.00392]; Huang Y, 2015, J NEUROSCI, V35, P2830, DOI 10.1523/JNEUROSCI.4294-14.2015; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Jiang Y, 2009, NEUROIMAGE, V44, P1171, DOI 10.1016/j.neuroimage.2008.09.038; Kafaligonul H, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00279; Kang MS, 2011, J NEUROSCI, V31, P13535, DOI 10.1523/JNEUROSCI.1691-11.2011; Kaunitz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060787; Kaunitz L, 2011, J VISION, V11, DOI 10.1167/11.13.10; Kaunitz LN, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00804; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Landau AN, 2012, CURR BIOL, V22, P1000, DOI 10.1016/j.cub.2012.03.054; Levelt JWM, 1965, BINOCULAR RIVALRY; Lin ZC, 2014, PSYCHOL SCI, V25, P296, DOI 10.1177/0956797613504964; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; Loffler G, 2005, VISION RES, V45, P2287, DOI 10.1016/j.visres.2005.02.009; Mach E., 1865, UNTERSUCHUNGEN ZEITS; Mathewson KE, 2012, J COGNITIVE NEUROSCI, V24, P2321, DOI 10.1162/jocn_a_00288; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Meng QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033053; MERZENICH MM, 1993, ANN NY ACAD SCI, V682, P1; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Mitroff SR, 2005, VISION RES, V45, P961, DOI 10.1016/j.visres.2004.09.044; Montaser-Kouhsari L, 2004, PERCEPTION, V33, P249, DOI 10.1068/p5174; Moors P, 2015, I-PERCEPTION, V6, P48, DOI 10.1068/i0678; Mudrik L, 2014, TRENDS COGN SCI, V18, P488, DOI 10.1016/j.tics.2014.04.009; Mudrik L, 2011, PSYCHOL SCI, V22, P764, DOI 10.1177/0956797611408736; Newman J, 1997, NEURAL NETWORKS, V10, P1195, DOI 10.1016/S0893-6080(97)00060-9; Ng BSW, 2012, J NEUROSCI, V32, P12268, DOI 10.1523/JNEUROSCI.1877-12.2012; Occelli V, 2011, NEUROSCI BIOBEHAV R, V35, P589, DOI 10.1016/j.neubiorev.2010.07.004; OYAMA T, 1983, PSYCHOL RES-PSYCH FO, V45, P303, DOI 10.1007/BF00308709; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Poppel E, 2009, PHILOS T R SOC B, V364, P1887, DOI 10.1098/rstb.2009.0015; Smith ML, 2012, CEREB CORTEX, V22, P1748, DOI 10.1093/cercor/bhr250; Smith ML, 2006, P NATL ACAD SCI USA, V103, P5626, DOI 10.1073/pnas.0508972103; Song K, 2014, J NEUROSCI, V34, P4837, DOI 10.1523/JNEUROSCI.4856-13.2014; Stein T, 2016, J EXP PSYCHOL HUMAN, V42, P788, DOI 10.1037/xhp0000188; Stein T, 2012, EMOTION, V12, P988, DOI 10.1037/a0026944; Stein T, 2012, COGNITION, V125, P64, DOI 10.1016/j.cognition.2012.06.005; Stein T, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00167; Stein T, 2011, J VISION, V11, DOI 10.1167/11.8.5; Stein T, 2011, COGNITION, V119, P307, DOI 10.1016/j.cognition.2011.01.008; Sterzer P, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00453; Sterzer P, 2008, J VISION, V8, DOI 10.1167/8.15.10; Sterzer P, 2009, NEUROIMAGE, V46, P803, DOI 10.1016/j.neuroimage.2009.02.046; Thut G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00170; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; van Boxtel JJA, 2010, P NATL ACAD SCI USA, V107, P8883, DOI 10.1073/pnas.0913292107; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00060; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; WALTER WG, 1946, NATURE, V158, P540, DOI 10.1038/158540a0; Wertheimer Max, 1912, EXPT STUDIEN SEHEN B; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wikstrom H, 1996, EVOKED POTENTIAL, V100, P479; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671; Wuhle A, 2011, EUR J NEUROSCI, V34, P641, DOI 10.1111/j.1460-9568.2011.07770.x; Wuhle A, 2010, PSYCHOPHYSIOLOGY, V47, P523, DOI 10.1111/j.1469-8986.2010.00964.x; Wutz A., 2014, J VISION, V14, P584, DOI DOI 10.1167/14.10.584; Wutz A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00952; Wutz A, 2014, J NEUROSCI, V34, P1554, DOI 10.1523/JNEUROSCI.3187-13.2014; Wutz A, 2013, ATTEN PERCEPT PSYCHO, V75, P921, DOI 10.3758/s13414-013-0454-9; Yabe H, 1998, PSYCHOPHYSIOLOGY, V35, P615, DOI 10.1017/S0048577298000183; Yang E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00724; Yang E, 2012, J VISION, V12, DOI 10.1167/12.3.8; Yang E, 2010, J VISION, V10, DOI 10.1167/10.12.24; Zhou GM, 2010, CONSCIOUS COGN, V19, P408, DOI 10.1016/j.concog.2009.12.009	94	28	28	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159206	10.1371/journal.pone.0159206	http://dx.doi.org/10.1371/journal.pone.0159206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27416317	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500097
J	Astakhova, L; Ngara, M; Babich, O; Prosekov, A; Asyakina, L; Dyshlyuk, L; Midtvedt, T; Zhou, XY; Ernberg, I; Matskova, L				Astakhova, Lidiia; Ngara, Mtakai; Babich, Olga; Prosekov, Aleksandr; Asyakina, Lyudmila; Dyshlyuk, Lyubov; Midtvedt, Tore; Zhou, Xiaoying; Ernberg, Ingemar; Matskova, Liudmila			Short Chain Fatty Acids (SCFA) Reprogram Gene Expression in Human Malignant Epithelial and Lymphoid Cells	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NETWORK ENRICHMENT ANALYSIS; NASOPHARYNGEAL CARCINOMA; HISTONE DEACETYLASES; SODIUM-BUTYRATE; HUMAN COLON; IN-VITRO; INDUCTION; MIGRATION; POLYSACCHARIDES	The effect of short chain fatty acids (SCFAs) on gene expression in human, malignant cell lines was investigated, with a focus on signaling pathways. The commensal microbial flora produce high levels of SCFAs with established physiologic effects in humans. The most abundant SCFA metabolite in the human microflora is n-butyric acid. It is well known to activate endogenous latent Epstein-Barr virus (EBV), that was used as a reference read out system and extended to EBV+ epithelial cancer cell lines. N-butyric acid and its salt induced inflammatory and apoptotic responses in tumor cells of epithelial and lymphoid origin. Epithelial cell migration was inhibited. The n-butyric gene activation was reduced by knockdown of the cell membrane transporters MCT-1 and -4 by siRNA. N-butyric acid show biologically significant effects on several important cellular functions, also with relevance for tumor cell phenotype.	[Astakhova, Lidiia; Babich, Olga; Prosekov, Aleksandr; Asyakina, Lyudmila; Dyshlyuk, Lyubov] Inst Food Sci & Technol, Kemerovo, Russia; [Ngara, Mtakai] Karolinska Inst, Ludwig Inst Canc Res, Dept Cell & Mol Biol CMB, Stockholm, Sweden; [Astakhova, Lidiia; Midtvedt, Tore; Zhou, Xiaoying; Ernberg, Ingemar; Matskova, Liudmila] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden	Kemerovo State University; Karolinska Institutet; Ludwig Institute for Cancer Research; Karolinska Institutet	Ernberg, I (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	ingemar.ernberg@ki.se	Lyubov, Dyshlyuk/C-7941-2014; Matskova, Liudmila/J-3843-2017; Prosekov, Alexander/C-7606-2014; Matskova, Liudmila/AAF-4201-2020; Lidiia, Astakhova/AAT-5780-2021; Babich, Olga/D-4720-2014; Astakhova, Lidiia/I-4820-2014; Asyakina, Ludmila K/B-8192-2018	Lyubov, Dyshlyuk/0000-0002-7333-8411; Matskova, Liudmila/0000-0002-3174-1560; Prosekov, Alexander/0000-0002-5630-3196; Matskova, Liudmila/0000-0002-3174-1560; Lidiia, Astakhova/0000-0002-0270-8390; Babich, Olga/0000-0002-4921-8997; Asyakina, Ludmila K/0000-0003-4988-8197; Tuyen, Pham Van/0000-0001-8885-5713; Luu, Thien/0000-0002-1467-1767; Ngara, Mtakai/0000-0001-5018-4387	Ministry of Education and Science of the Russian Federation [14.586.21.0002]; Swedish Cancer Society [150017]; Radiumhemmets Forskningsfonder [121063]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Swedish Cancer Society(Swedish Cancer Society); Radiumhemmets Forskningsfonder	This work was supported by The Ministry of Education and Science of the Russian Federation in the framework of the state contract No. 14.586.21.0002, http://government.ru/en/department/33/events/ (IE); The Swedish Cancer Society (IE), grant no. 150017, https://www.cancerfonden.se/forskning; Radiumhemmets Forskningsfonder grant no. 121063 (IE), http://www.rahfo.se/.	Alexeyenko A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-226; Andrews S., 2010, FASTQC QUALITY CONTR; BARRANCO SC, 1983, CANCER RES, V43, P1703; Binne UK, 1996, J VIROL, V70, P3894; BLAZAR B, 1980, J EXP MED, V151, P614, DOI 10.1084/jem.151.3.614; Blottiere HM, 2003, P NUTR SOC, V62, P101, DOI 10.1079/PNS2002215; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; CUMMINGS JH, 1984, P NUTR SOC, V43, P35, DOI 10.1079/PNS19840025; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; De Saedeleer CJ, 2014, ONCOGENE, V33, P4060, DOI 10.1038/onc.2013.454; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; EPSTEIN MA, 1966, J NATL CANCER I, V37, P547; EPSTEIN MA, 1965, J NATL CANCER I, V34, P231, DOI 10.1093/jnci/34.2.231; Feng WH, 2004, J VIROL, V78, P1893, DOI 10.1128/JVI.78.4.1893-1902.2004; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Gallagher SM, 2009, AM J PHYSIOL-CELL PH, V296, pC414, DOI 10.1152/ajpcell.00430.2008; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; HILL MJ, 1995, EUR J CANCER PREV, V4, P353, DOI 10.1097/00008469-199510000-00004; Holzapfel WH, 1998, INT J FOOD MICROBIOL, V41, P85, DOI 10.1016/S0168-1605(98)00044-0; Hsu CH, 2002, ANTICANCER RES, V22, P4065; Hui KF, 2016, INT J CANCER, V138, P125, DOI 10.1002/ijc.29698; Imai K, 2012, BIOCHIMIE, V94, P839, DOI 10.1016/j.biochi.2011.12.001; Kanauchi O, 1999, INT J MOL MED, V3, P175; KRAUSE AW, 1984, J HISTOCHEM CYTOCHEM, V32, P1084, DOI 10.1177/32.10.6090533; Layden BT, 2013, TRANSL RES, V161, P131, DOI 10.1016/j.trsl.2012.10.007; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Mentzer S J, 2001, Transpl Infect Dis, V3, P177, DOI 10.1034/j.1399-3062.2001.003003177.x; Merid SK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-308; Natarajan N, 2014, AM J PHYSIOL-CELL PH, V307, pC979, DOI 10.1152/ajpcell.00228.2014; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; QUINLIVAN EB, 1993, NUCLEIC ACIDS RES, V21, P1999, DOI 10.1093/nar/21.8.1999; Ruemmele FM, 2003, GUT, V52, P94, DOI 10.1136/gut.52.1.94; SAKATA T, 1984, Q J EXP PHYSIOL CMS, V69, P639, DOI 10.1113/expphysiol.1984.sp002850; SALYERS AA, 1977, APPL ENVIRON MICROB, V34, P529, DOI 10.1128/AEM.34.5.529-533.1977; Sandberg R., 2015, RPKM CALCULATIONS PR; Shaw A, 2014, NAT METHODS, V11, P841, DOI [10.1038/NMETH.3025, 10.1038/nmeth.3025]; Smith JG, 1998, CRIT REV FOOD SCI, V38, P259, DOI 10.1080/10408699891274200; Stoker SD, 2015, J CANCER RES CLIN, V141, P1845, DOI 10.1007/s00432-015-1969-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Tuohy KM, 2005, CURR PHARM DESIGN, V11, P75, DOI 10.2174/1381612053382331; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Westphal EM, 2000, CANCER RES, V60, P5781; WOLF H, 1993, INTERVIROLOGY, V35, P26, DOI 10.1159/000150293; YAO K, 1990, INT J CANCER, V45, P83, DOI 10.1002/ijc.2910450116; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509; Zhang YG, 2001, J VIROL, V75, P9571, DOI 10.1128/JVI.75.20.9571-9578.2001; Zhou X, 2015, ONCOGENE, V34, P4491, DOI 10.1038/onc.2014.380	54	27	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0154102	10.1371/journal.pone.0154102	http://dx.doi.org/10.1371/journal.pone.0154102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441625	gold, Green Published, Green Submitted			2022-12-27	WOS:000380797500001
J	Gallego-Llamas, J; Timms, AE; Pitstick, R; Peters, J; Carlson, GA; Beier, DR				Gallego-Llamas, Jabier; Timms, Andrew E.; Pitstick, Rose; Peters, Janet; Carlson, George A.; Beier, David R.			Improvement of ENU Mutagenesis Efficiency Using Serial Injection and Mismatch Repair Deficiency Mice	PLOS ONE			English	Article							ETHYL-N-NITROSOUREA; SEQUENCING DATA; MOUSE; GENERATION; MUTATIONS; AGENTS; DAMAGE; CELLS	ENU mutagenesis is a powerful method for generating novel lines of mice that are informative with respect to both fundamental biological processes and human disease. Rapid developments in genomic technology have made the task of identifying causal mutations by positional cloning remarkably efficient. One limitation of this approach remains the mutation frequency achievable using standard treatment protocols, which currently generate approximately 1-2 sequence changes per megabase when optimized. In this study we used two strategies to attempt to increase the number of mutations induced by ENU treatment. One approach employed mice carrying a mutation in the DNA repair enzyme Msh6. The second strategy involved injection of ENU to successive generations of mice. To evaluate the number of ENU-induced mutations, single mice or pooled samples were analyzed using whole exome sequencing. The results showed that there is considerable variability in the induced mutation frequency using these approaches, but an overall increase in ENU-induced variants from one generation to another was observed. The analysis of the mice deficient for Msh6 also showed an increase in the ENU-induced variants compared to the wild-type ENU-treated mice. However, in both cases the increase in ENU-induced mutation frequency was modest.	[Gallego-Llamas, Jabier; Timms, Andrew E.; Beier, David R.] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98105 USA; [Gallego-Llamas, Jabier; Beier, David R.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Pitstick, Rose; Peters, Janet; Carlson, George A.] McLaughlin Res Inst, Great Falls, MT USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; McLaughlin Research Institute for Biomedical Sciences, Inc.	Beier, DR (corresponding author), Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98105 USA.; Beier, DR (corresponding author), Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA.	david.beier@seattlechildrens.org		Beier, David/0000-0002-0325-8520	NIH [R01NS41997, R01MH081187, R01HD36404]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081187] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants R01NS41997, R01MH081187 and R01HD36404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120061; Arnold Carrie N, 2012, BMC Res Notes, V5, P577, DOI 10.1186/1756-0500-5-577; Augustin M, 2005, MAMM GENOME, V16, P405, DOI 10.1007/s00335-004-3028-2; Beutler B, 2007, NAT IMMUNOL, V8, P659, DOI 10.1038/ni0707-659; BHANOT OS, 1992, NUCLEIC ACIDS RES, V20, P587, DOI 10.1093/nar/20.3.587; Claij N, 2003, CANCER RES, V63, P2062; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Feitsma H, 2008, MUTAGENESIS, V23, P325, DOI 10.1093/mutage/gen019; Fishel R, 2015, J BIOL CHEM, V290, P26395, DOI 10.1074/jbc.R115.660142; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Justice MJ, 2000, MAMM GENOME, V11, P484, DOI 10.1007/s003350010094; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; KLEIN JC, 1990, NUCLEIC ACIDS RES, V18, P4131, DOI 10.1093/nar/18.14.4131; Li GM, 2014, DNA REPAIR, V19, P48, DOI 10.1016/j.dnarep.2014.03.027; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nhung N, 2011, AM J PHYSIOL-GASTR L, V300, pG1, DOI 10.1152/ajpgi.00343.2010; Noveroske JK, 2000, MAMM GENOME, V11, P478, DOI 10.1007/s003350010093; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sakuraba Y, 2005, BIOCHEM BIOPH RES CO, V336, P609, DOI 10.1016/j.bbrc.2005.08.134; SHIBUYA T, 1993, MUTAT RES, V290, P273, DOI 10.1016/0027-5107(93)90168-F; Spies M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a022657; Stottmann Rolf, 2014, Curr Protoc Mouse Biol, V4, P25, DOI 10.1002/9780470942390.mo140029; Stottmann RW, 2010, METHOD ENZYMOL, V477, P329, DOI 10.1016/S0076-6879(10)77017-8; Takahasi KR, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-52; Tosal L, 2001, MOL GENET GENOMICS, V265, P327, DOI 10.1007/s004380000419; van Boxtel R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-460; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	35	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159377	10.1371/journal.pone.0159377	http://dx.doi.org/10.1371/journal.pone.0159377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441645	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500067
J	Kripke, K; Njeuhmeli, E; Samuelson, J; Schnure, M; Dalal, S; Farley, T; Hankins, C; Thomas, AG; Reed, J; Stegman, P; Bock, N				Kripke, Katharine; Njeuhmeli, Emmanuel; Samuelson, Julia; Schnure, Melissa; Dalal, Shona; Farley, Timothy; Hankins, Catherine; Thomas, Anne G.; Reed, Jason; Stegman, Peter; Bock, Naomi			Assessing Progress, Impact, and Next Steps in Rolling Out Voluntary Medical Male Circumcision for HIV Prevention in 14 Priority Countries in Eastern and Southern Africa through 2014	PLOS ONE			English	Article							COSTS	Background In 2007, the World Health Organization and the Joint United Nations Programme on HIV/AIDS (UNAIDS) identified 14 priority countries across eastern and southern Africa for scaling up voluntary medical male circumcision (VMMC) services. Several years into this effort, we reflect on progress. Methods Using the Decision Makers' Program Planning Tool (DMPPT) 2.1, we assessed age-specific impact, cost-effectiveness, and coverage attributable to circumcisions performed through 2014. We also compared impact of actual progress to that of achieving 80% coverage among men ages 15-49 in 12 VMMC priority countries and Nyanza Province, Kenya. We populated the models with age-disaggregated VMMC service statistics and with population, mortality, and HIV incidence and prevalence projections exported from country-specific Spectrum/Goals files. We assumed each country achieved UNAIDS' 90-90-90 treatment targets. Results More than 9 million VMMCs were conducted through 2014: 43% of the estimated 20.9 million VMMCs required to reach 80% coverage by the end of 2015. The model assumed each country reaches the UNAIDS targets, and projected that VMMCs conducted through 2014 will avert 240,000 infections by the end of 2025, compared to 1.1 million if each country had reached 80% coverage by the end of 2015. The median estimated cost per HIV infection averted was $4,400. Nyanza Province in Kenya, the 11 priority regions in Tanzania, and Uganda have reached or are approaching MC coverage targets among males ages 15-24, while coverage in other age groups is lower. Across all countries modeled, more than half of the projected HIV infections averted were attributable to circumcising 10- to 19-year-olds. Conclusions The priority countries have made considerable progress in VMMC scale-up, and VMMC remains a cost-effective strategy for epidemic impact, even assuming near-universal HIV diagnosis, treatment coverage, and viral suppression. Examining circumcision coverage by five-year age groups will inform countries' decisions about next steps.	[Kripke, Katharine; Stegman, Peter] Avenir Hlth, Project SOAR, Washington, DC USA; [Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC USA; [Samuelson, Julia; Dalal, Shona] WHO, Geneva, Switzerland; [Schnure, Melissa] Project SOAR, Palladium Grp, Washington, DC USA; [Farley, Timothy] Sigma3 Serv, Nyon, Switzerland; [Hankins, Catherine] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Thomas, Anne G.] US Dept Def, Naval Hlth Res Ctr, San Diego, CA USA; [Reed, Jason] Jhpiego, Washington, DC USA; [Bock, Naomi] US Ctr Dis Control & Prevent, Atlanta, GA USA	United States Agency for International Development (USAID); World Health Organization; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Jhpiego; Centers for Disease Control & Prevention - USA	Njeuhmeli, E (corresponding author), US Agcy Int Dev, Washington, DC USA.	enjeuhmeli@usaid.gov	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577; Hankins, Catherine/0000-0002-1642-8592	American people through the United States President's Emergency Plan for AIDS Relief (PEPFAR); United States Agency for International Development (USAID) [AID-OAA-14-00026, AIDOAA-A-14-00046]	American people through the United States President's Emergency Plan for AIDS Relief (PEPFAR); United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This manuscript is made possible by the generous support of the American people through the United States President's Emergency Plan for AIDS Relief (PEPFAR) with the United States Agency for International Development (USAID) under the Cooperative Agreement Project SOAR(Supporting Operational AIDS Research), number AID-OAA-14-00026, and Cooperative Agreement Strengthening High Impact Interventions for an AIDS-free Generation, number AIDOAA-A-14-00046. The information provided does not necessarily reflect the official position of USAID, PEPFAR, WHO, CDC, DoD, or the United States Government, and the contents of this article are the sole responsibility of Projects SOAR and AIDSFree, the Population Council, and the authors. E. Njeuhmeli played a substantial role in study design and manuscript preparation.	[Anonymous], 2008, SWAZ DEM HLTH SURV 2; [Anonymous], 2012, UG DEM HLTH SURV 201; Avenir Health, 2011, GOALS MAN MOD EST EF; Barnighausen T, 2012, P NATL ACAD SCI; Bertrand JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027562; Botswana Central Statistics Office, 2008, BOTSW HIV AIDS IMP S; Central Statistical Office (CSO), 2007, ZAMB DEM HLTH SURV 2; Farnham PG, 2013, JAIDS-J ACQ IMM DEF, V64, pE15, DOI 10.1097/QAI.0b013e3182a5c8d4; Forsythe S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S4; Gopalappa C, 2014, AIDS, V28, pS5, DOI 10.1097/QAD.0000000000000083; Guaraldi G, 2013, CLINICOECONOMIC OUTC, V5, P481, DOI 10.2147/CEOR.S40607; ICF Macro, 2009, LES DEM HLTH SURV 20; ICF Macro, 2006, NAM DEM HLTH SURV 20; Instituto Nacional de Estatistica, 2011, INQ DEM SAUD 2011; International AIDS Vaccine Initiative (IAVI), 2012, AIDS VACC EXPL POT C; Kenya National Bureau of Statistics ICF Macro, 2008, KEN DEM HLTH SURV; Kripke K, 2016, PLOS ONE; Kripke K, 2016, PLOS ONE IN PRESS; Meyer-Rath G, 2013, JAIDS-J ACQ IMM DEF, V62, P322, DOI 10.1097/QAI.0b013e31827e8785; National Institute of Statistics Rwanda, 2010, RWAND DEM HLTH SURV; National Statistical Office (NSO), 2011, ICF MACR MAL DEM HLT; Njeuhmeli E, 2015, PLOS ONE IN PRESS; Njeuhmeli E, 2016, GLOB HLTH SCI PRACT; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; South Africa Department of Health OrcMacro MRC, 2007, S AFR DEM HLTH SURV; Stover J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111956; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Tchuenche M, 2016, PLOS ONE IN PRESS; The World Bank, 2015, GNI CAP PPP CURR INT; Thomas AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027561; U.S. President's Emergency Plan for AIDS Relief (PEPFAR), 2012, REP PIL EXP AN PEPFA; UNAIDS/ WHO/ SACEMA expert group on modelling the impact and cost of male circumcision for HIV prevention, 2009, PLOS MED, V6; WHO, 2015, VOLUNT MED MAL CIRC; World Health Organization and UNAIDS, 2011, PROGR SCAL UP MAL CI; World Health Organization (WHO), 2012, WHO REG OFF AFR PROG; Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) ICF International Inc, 2012, TANZ HIV AIDS MAL IN; Zimbabwe National Statistics Agency, 2010, ZIMB DEM HLTH SURV 2	37	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158767	10.1371/journal.pone.0158767	http://dx.doi.org/10.1371/journal.pone.0158767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441648	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500024
J	Maglietta, A; Maglietta, R; Staiano, T; Bertoni, R; Ancona, N; Marra, G; Resta, L				Maglietta, Antonella; Maglietta, Rosalia; Staiano, Teresa; Bertoni, Ramona; Ancona, Nicola; Marra, Giancarlo; Resta, Leonardo			The Immune Landscapes of Polypoid and Nonpolypoid Precancerous Colorectal Lesions	PLOS ONE			English	Article							ADENOMA-CARCINOMA SEQUENCE; REGULATORY T-CELLS; TUMOR MICROENVIRONMENT; NEOPLASTIC LESIONS; HUMAN CANCER; FLAT; RISK; SURVEILLANCE; INFILTRATION; PROGRESSION	Little is known about the immunoediting process in precancerous lesions. We explored this aspect of benign colorectal adenomas with a descriptive analysis of the immune pathways and immune cells whose regulation is linked to the morphology and size of these lesions. Two series of polypoid and nonpolypoid colorectal adenomas were used in this study: 1) 84 samples (42 lesions, each with matched samples of normal mucosa) whose gene expression data were used to quantify the tumor morphology-and size-related dysregulation of immune pathways collected in the Molecular Signature Database, using Gene Set Enrichment Analysis; 2) 40 other lesions examined with immunohistochemistry to quantify the presence of immune cells in the stromal compartment. In the analysis of transcriptomic data, 429 immune pathways displayed significant differential regulation in neoplasms of different morphology and size. Most pathways were significantly upregulated or downregulated in polypoid lesions versus nonpolypoid lesions (regardless of size). Differential pathway regulation associated with lesion size was observed only in polypoid neoplasms. These findings were mirrored by tissue immunostaining with CD4, CD8, FOXP3, MHC-I, CD68, and CD163 antibodies: stromal immune cell counts (mainly T lymphocytes and macrophages) were significantly higher in polypoid lesions. Certain markers displayed significant size-related differences regardless of lesion morphology. Multivariate analysis of variance showed that the marker panel clearly discriminated between precancerous lesions of different morphologies and sizes. Statistical analysis of immunostained cell counts fully support the results of the transcriptomic data analysis: the density of infiltration of most immune cells in the stroma of polypoid precancerous lesions was significantly higher than that observed in nonpolypoid lesions. Large neoplasms also have more immune cells in their stroma than small lesions. Immunoediting in precancerous colorectal tumors may vary with lesion morphology and stage of development, and this variability could influence a given lesion's trajectory to cancer.	[Maglietta, Antonella; Resta, Leonardo] Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy; [Maglietta, Rosalia; Ancona, Nicola] CNR ISSIA, Natl Res Council, Inst Intelligent Syst Automat, Bari, Italy; [Staiano, Teresa] Hosp Cremona, Endoscopy & Gastroenterol Unit, Cremona, Italy; [Bertoni, Ramona] Hosp Cremona, Dept Pathol, Cremona, Italy; [Marra, Giancarlo] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Studi sui Sistemi Intelligenti per l'Automazione (ISSIA-CNR); University of Zurich	Maglietta, R (corresponding author), CNR ISSIA, Natl Res Council, Inst Intelligent Syst Automat, Bari, Italy.	maglietta@ba.issia.cnr.it	Maglietta, Rosalia/AAE-8546-2020; Ancona, Nicola/AAD-4772-2022	Maglietta, Rosalia/0000-0001-8580-4806; 	Swiss National Science Foundation [31003A_141225]; Regione Puglia [FIRB RBAP11B2SX, 44, 2009 RF/2009-1471624]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Regione Puglia(Regione Puglia)	The research was partially supported by a grant of the Swiss National Science Foundation to GM (no. 31003A_141225), of Regione Puglia to NA (PO FESR 2007-2013 Progetto BISIMANE Cod. n. 44, Progetto FIRB RBAP11B2SX, Progetto di Ricerca Finalizzata 2009 RF/2009-1471624). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axon A, 2005, ENDOSCOPY, V37, P570, DOI 10.1055/s-2005-861352; Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Bettington M, 2013, HISTOPATHOLOGY, V62, P367, DOI 10.1111/his.12055; Bianco MA, 2010, ENDOSCOPY, V42, P279, DOI 10.1055/s-0029-1244020; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Cattaneo E, 2011, EMBO MOL MED, V3, P334, DOI 10.1002/emmm.201100141; Cattaneo E, 2011, PRE-INVASIVE DISEASE: PATHOGENESIS AND CLINICAL MANAGEMENT, P369, DOI 10.1007/978-1-4419-6694-0_18; Chia WK, 2012, NAT REV CLIN ONCOL, V9, P561, DOI 10.1038/nrclinonc.2012.137; Cui GL, 2012, SCAND J GASTROENTERO, V47, P367, DOI 10.3109/00365521.2011.648950; Cui GL, 2009, HISTOPATHOLOGY, V54, P550, DOI 10.1111/j.1365-2559.2009.03273.x; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Gallimore A, 2008, IMMUNOLOGY, V123, P157, DOI 10.1111/j.1365-2567.2007.02748.x; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grizzi F, 2013, WORLD J GASTROENTERO, V19, P174, DOI 10.3748/wjg.v19.i2.174; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Jang TJ, 2013, KOREAN J PATHOL, V47, P443, DOI 10.4132/KoreanJPathol.2013.47.5.443; Krzanowski W. J., 1988, PRINCIPLES MULTIVARI; Kudo SE, 2008, GASTROINTEST ENDOSC, V68, pS3, DOI 10.1016/j.gie.2008.07.052; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; Laghi L, 2009, LANCET ONCOL, V10, P877, DOI 10.1016/S1470-2045(09)70186-X; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Maglietta R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-608; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mariani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054488; McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366; Menon AG, 2004, LAB INVEST, V84, P493, DOI 10.1038/labinvest.3700055; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Naito Y, 1998, CANCER RES, V58, P3491; O'Brien MJ, 2004, CLIN GASTROENTEROL H, V2, P905, DOI 10.1016/S1542-3565(04)00392-1; Okada K, 2004, PATHOL INT, V54, P490, DOI 10.1111/j.1440-1827.2004.01650.x; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Park DH, 2008, DIS COLON RECTUM, V51, P43, DOI 10.1007/s10350-007-9091-5; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Schenk M, 2008, BEST PRACT RES CL GA, V22, P391, DOI 10.1016/j.bpg.2007.11.002; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Simpson JAD, 2010, GUT, V59, P926, DOI 10.1136/gut.2009.194472; Soetikno RM, 2008, JAMA-J AM MED ASSOC, V299, P1027, DOI 10.1001/jama.299.9.1027; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Voorham QJM, 2013, AM J GASTROENTEROL, V108, P1042, DOI 10.1038/ajg.2013.126; Whiteside TL, 2014, CANCER IMMUNOL IMMUN, V63, P67, DOI 10.1007/s00262-013-1490-y; Yuan AP, 2008, APMIS, V116, P445, DOI 10.1111/j.1600-0463.2008.00879.x	51	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159373	10.1371/journal.pone.0159373	http://dx.doi.org/10.1371/journal.pone.0159373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441558	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000380797500066
J	Mahale, SP; Sharma, A; Mylavarapu, SVS				Mahale, Sagar P.; Sharma, Amit; Mylavarapu, Sivaram V. S.			Dynein Light Intermediate Chain 2 Facilitates the Metaphase to Anaphase Transition by Inactivating the Spindle Assembly Checkpoint	PLOS ONE			English	Article							PLANAR CELL POLARITY; MITOTIC SPINDLE; MICROTUBULE ATTACHMENT; CYTOPLASMIC DYNEIN; CHROMOSOME SEGREGATION; KINETOCHORES; PROTEINS; MOTOR; ORIENTATION; TRANSPORT	The multi-functional molecular motor cytoplasmic dynein performs diverse essential roles during mitosis. The mechanistic importance of the dynein Light Intermediate Chain homologs, LIC1 and LIC2 is unappreciated, especially in the context of mitosis. LIC1 and LIC2 are believed to exist in distinct cytoplasmic dynein complexes as obligate subunits. LIC1 had earlier been reported to be required for metaphase to anaphase progression by inactivating the kinetochore-microtubule attachment-sensing arm of the spindle assembly checkpoint (SAC). However, the functional importance of LIC2 during mitosis remains elusive. Here we report prominent novel roles for the LIC2 subunit of cytoplasmic dynein in regulating the spindle assembly checkpoint. LIC2 depletion in mammalian cells led to prolonged metaphase arrest in the presence of an active SAC and also to stretched kinetochores, thus implicating it in SAC inactivation. Quantitative fluorescence microscopy of SAC components revealed accumulation of both attachment- and tension-sensing checkpoint proteins at metaphase kinetochores upon LIC2 depletion. These observations support a stronger and more diverse role in checkpoint inactivation for LIC2 in comparison to its close homolog LIC1. Our study uncovers a novel functional hierarchy during mitotic checkpoint inactivation between the closely related but homologous LIC subunits of cytoplasmic dynein. These subtle functional distinctions between dynein subpopulations could be exploited to study specific aspects of the spindle assembly checkpoint, which is a key mediator of fidelity in eukaryotic cell division.	[Mahale, Sagar P.; Sharma, Amit; Mylavarapu, Sivaram V. S.] Natl Capital Reg Biotech Sci Cluster, Reg Ctr Biotechnol, Lab Cellular Dynam, Faridabad, Haryana, India; [Mahale, Sagar P.; Sharma, Amit; Mylavarapu, Sivaram V. S.] Manipal Univ, Manipal, Karnataka, India	Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Manipal Academy of Higher Education (MAHE)	Mylavarapu, SVS (corresponding author), Natl Capital Reg Biotech Sci Cluster, Reg Ctr Biotechnol, Lab Cellular Dynam, Faridabad, Haryana, India.; Mylavarapu, SVS (corresponding author), Manipal Univ, Manipal, Karnataka, India.	sivaram@rcb.res.in		Sharma, Amit/0000-0002-6340-2950	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR6420/GBD/27/435/2012]; Regional Centre for Biotechnology, Faridabad; Indian Council of Medical Research	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Regional Centre for Biotechnology, Faridabad(Department of Biotechnology (DBT) India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by Rapid Grant for Young Investigators (RGYI no. BT/PR6420/GBD/27/435/2012) from the Department of Biotechnology, Ministry of Science and Technology, Government of India (SVSM); Regional Centre for Biotechnology, Faridabad (intramural funds) (SVSM); and Indian Council of Medical Research (research fellowship) (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacallao RL, 2009, CLIN GENET, V75, P107, DOI 10.1111/j.1399-0004.2008.01148.x; Bhabha G, 2014, CELL, V159, P857, DOI 10.1016/j.cell.2014.10.018; Biggins S, 2003, CURR BIOL, V13, pR449, DOI 10.1016/S0960-9822(03)00369-5; Bomont P, 2005, EMBO J, V24, P3927, DOI 10.1038/sj.emboj.7600848; Castanon I, 2011, CURR OPIN CELL BIOL, V23, P697, DOI 10.1016/j.ceb.2011.09.009; Cheerambathur DK, 2013, SCIENCE, V342, P1239, DOI 10.1126/science.1246232; Cheeseman Iain M, 2005, Sci STKE, V2005, ppl1, DOI 10.1126/stke.2662005pl1; Ciliberto A, 2009, EMBO J, V28, P2162, DOI 10.1038/emboj.2009.186; Domanski Michal, 2012, Biotechniques, V0, P1, DOI 10.2144/000113864; Famulski JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016494; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Hehnly H, 2014, DEV CELL, V28, P497, DOI 10.1016/j.devcel.2014.01.014; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Horgan CP, 2011, CELL BIOL INT, V35, P171, DOI 10.1042/CBI20100284; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Jones LA, 2014, J CELL BIOL, V207, P499, DOI 10.1083/jcb.201408025; Kapoor TM, 2004, CURR BIOL, V14, pR1011, DOI 10.1016/j.cub.2004.11.026; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Logarinho E, 2004, J CELL SCI, V117, P1757, DOI 10.1242/jcs.01033; Logarinho E, 2008, CELL CYCLE, V7, P1763, DOI 10.4161/cc.7.12.6180; Ma HH, 2012, MOL CELL PROTEOMICS, V11, P501, DOI 10.1074/mcp.O111.016246; Mische S, 2008, MOL BIOL CELL, V19, P4918, DOI 10.1091/mbc.E08-05-0483; Mora-Bermudez F, 2014, ELIFE, V3, DOI 10.7554/eLife.02875; Murray AW, 2011, NAT CELL BIOL, V13, P1178, DOI 10.1038/ncb2348; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Palmer KJ, 2009, MOL BIOL CELL, V20, P2885, DOI 10.1091/mbc.E08-12-1160; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Raaijmakers JA, 2013, J CELL BIOL, V201, P201, DOI 10.1083/jcb.201208098; Scherer J, 2014, J CELL BIOL, V205, P163, DOI 10.1083/jcb.201307116; Schroeder CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03351; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Silva PMA, 2014, FEBS LETT, V588, P3265, DOI 10.1016/j.febslet.2014.07.011; Sivaram MVS, 2009, EMBO J, V28, P902, DOI 10.1038/emboj.2009.38; Tan SC, 2011, MOL BIOL CELL, V22, P467, DOI 10.1091/mbc.E10-02-0129; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Varma D, 2008, J CELL BIOL, V182, P1045, DOI 10.1083/jcb.200710106; Varma D, 2013, J CELL BIOL, V202, P735, DOI 10.1083/jcb.201304197; Yamashita YM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001313	44	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159646	10.1371/journal.pone.0159646	http://dx.doi.org/10.1371/journal.pone.0159646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441562	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500110
J	Yang, Y; Tullberg, M; Mehlig, K; Rosengren, A; Toren, K; Zetterberg, H; Wikkelso, C				Yang, Yi; Tullberg, Mats; Mehlig, Kirsten; Rosengren, Annika; Toren, Kjell; Zetterberg, Henrik; Wikkelso, Carsten			The APOE Genotype in Idiopathic Normal Pressure Hydrocephalus	PLOS ONE			English	Article							CORTICAL BRAIN BIOPSY; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; ASSOCIATION; COMORBIDITY; PREVALENCE; BETA	Introduction Amyloid plaque has been reported in brain biopsies from patients with idiopathic normal-pressure hydrocephalus (iNPH) and proposed as a significant feature of the pathophysiology. Presence of the apolipoprotein E epsilon 4 (APOE epsilon 4) allele is associated with increased risk of Alzheimer's disease (AD). Aims To compare the distribution of APOE genotype in iNPH patients with an age-matched population- based control group and with Alzheimer's disease (AD) patients. Methods APOE genotype frequencies were determined in 77 iNPH patients (50 men and 27 women, mean age 71.7 years) diagnosed with iNPH, a sample of 691 AD patients and 638 agematched population controls (299 men and 339 women) from the INTERGENE cohort. Results The APOE distribution did not differ significantly between the iNPH patients and the control population. The per e4-allele odds-ratio (OR) of iNPH was given by OR = 0.90, 95% confidence interval (CI) = (0.50, 1.60) that was considerably smaller than the per-allele OR of AD, OR = 5.34 (4.10, 7.00). Conclusion The results suggest that the APOE-related risk of AD in patients with iNPH is not higher than in the general population.	[Yang, Yi; Tullberg, Mats; Wikkelso, Carsten] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Mehlig, Kirsten] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Toren, Kjell] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Sect Occupat & Environm Med, Gothenburg, Sweden; [Toren, Kjell] Univ Perugia, Occupat Med Resp Dis & Toxicol, Perugia, Italy; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Queen Sq, London, England	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Perugia; University of Gothenburg; University of London; University College London	Yang, Y (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden.	mats.tullberg@neuro.gu.se	Mehlig, Kirsten/AAT-3468-2020	Tullberg, Mats/0000-0003-4997-5266				Agren-Wilsson A, 2007, ACTA NEUROL SCAND, V116, P333, DOI 10.1111/j.1600-0404.2007.00890.x; Bech-Azeddine R, 2007, J NEUROL NEUROSUR PS, V78, P157, DOI 10.1136/jnnp.2006.095117; Blennow K, 2000, J NEURAL TRANSM, V107, P1065, DOI 10.1007/s007020070052; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; DelBigio MR, 1997, CAN J NEUROL SCI, V24, P121, DOI 10.1017/S0317167100021442; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Golomb J, 2000, J NEUROL NEUROSUR PS, V68, P778, DOI 10.1136/jnnp.68.6.778; Hellstrom P, 2012, ACTA NEUROL SCAND, V126, P229, DOI 10.1111/j.1600-0404.2012.01677.x; Jeppsson A, 2013, NEUROLOGY, V80, P1385, DOI 10.1212/WNL.0b013e31828c2fda; Leinonen V, 2010, ANN NEUROL, V68, P446, DOI 10.1002/ana.22100; POLVIKOSKI T, 1995, NEW ENGL J MED, V333, P1242, DOI 10.1056/NEJM199511093331902; Pyykko OT, 2012, J NEUROL NEUROSUR PS, V83, P1119, DOI [10.1136/jnnp-2012-303849, 10.1136/jnnp-2011-303849]; Relkin Norman, 2005, Neurosurgery, V57, pS4; Savolainen S, 1999, ACTA NEUROCHIR, V141, P849, DOI 10.1007/s007010050386; Silverberg GD, 2008, NEUROLOGY, V71, P202, DOI 10.1212/01.wnl.0000316197.04157.6f; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Strandhagen E, 2010, EUR J EPIDEMIOL, V25, P163, DOI 10.1007/s10654-010-9427-7; Tarnaris A, 2006, CEREBROSPINAL FLUID, V3; Toma AK, 2013, ACTA NEUROCHIR, V155, P1977, DOI 10.1007/s00701-013-1835-5; Zetterberg M, 2008, AM J MED GENET B, V147B, P720, DOI 10.1002/ajmg.b.30668	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158985	10.1371/journal.pone.0158985	http://dx.doi.org/10.1371/journal.pone.0158985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441602	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500034
J	Bordag, N; Janakiraman, V; Nachtigall, J; Maldonado, SG; Bethan, B; Laine, JP; Fux, E				Bordag, Natalie; Janakiraman, Vijay; Nachtigall, Jonny; Maldonado, Sandra Gonzlez; Bethan, Bianca; Laine, Jean-Philippe; Fux, Elie			Fast Filtration of Bacterial or Mammalian Suspension Cell Cultures for Optimal Metabolomics Results	PLOS ONE			English	Article							SAMPLE PREPARATION; MASS-SPECTROMETRY; STAPHYLOCOCCUS-AUREUS; METABOLISM; YEAST; ADENYLATE; APOPTOSIS; PROTOCOL	The metabolome offers real time detection of the adaptive, multi-parametric response of the organisms to environmental changes, pathophysiological stimuli or genetic modifications and thus rationalizes the optimization of cell cultures in bioprocessing. In bioprocessing the measurement of physiological intracellular metabolite levels is imperative for successful applications. However, a sampling method applicable to all cell types with little to no validation effort which simultaneously offers high recovery rates, high metabolite coverage and sufficient removal of extracellular contaminations is still missing. Here, quenching, centrifugation and fast filtration were compared and fast filtration in combination with a stabilizing washing solution was identified as the most promising sampling method. Different influencing factors such as filter type, vacuum pressure, washing solutions were comprehensively tested. The improved fast filtration method (MxP (R) FastQuench) followed by routine lipid/polar extraction delivers a broad metabolite coverage and recovery reflecting well physiological intracellular metabolite levels for different cell types, such as bacteria (Escherichia coli) as well as mammalian cells chinese hamster ovary (CHO) and mouse myeloma cells (NS0). The proposed MxP (R) FastQuench allows sampling, i.e. separation of cells from medium with washing and quenching, in less than 30 seconds and is robustly designed to be applicable to all cell types. The washing solution contains the carbon source respectively the C-13-labeled carbon source to avoid nutritional stress during sampling. This method is also compatible with automation which would further reduce sampling times and the variability of metabolite profiling data.	[Bordag, Natalie; Nachtigall, Jonny; Maldonado, Sandra Gonzlez; Bethan, Bianca; Fux, Elie] Metanomics GmbH, Berlin, Germany; [Janakiraman, Vijay] Biogen Idec Inc, Raleigh, NC USA; [Laine, Jean-Philippe] Metan Hlth GmbH, Berlin, Germany	Biogen	Fux, E (corresponding author), Metanomics GmbH, Berlin, Germany.	elie.fux@metanomics.de	Bordag, Natalie/M-7957-2013	Bordag, Natalie/0000-0002-9505-6271	Metanomics Health GmbH; metanomics GmbH; Biogen Idec Inc.	Metanomics Health GmbH; metanomics GmbH; Biogen Idec Inc.(Biogen)	The authors received no specific funding for this work. Natalie Bordag, Jonny Nachtigall, Sandra Gonzalez Maldonado, Bianca Bethan and Elie Fux are employed by metanomics GmbH. Vijay Janakiraman is employed by Biogen Idec Inc. Jean-Philippe Laine is employed by Metanomics Health GmbH. metanomics GmbH, Biogen Idec Inc. and Metanomics Health GmbH provided support in the form of salaries for authors Natalie Bordag, Jonny Nachtigall, Sandra Gonzalez Maldonado, Bianca Bethan, Elie Fux, Vijay Janakiraman and Jean-Philippe Laine and also materials, reagents and publication fees but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Balcke G, 2011, METHODS ANAL POLAR M; Balcke GU, 2011, TOXICOL LETT, V203, P200, DOI 10.1016/j.toxlet.2011.03.013; Bolten CJ, 2008, BIOTECHNOL LETT, V30, P1993, DOI 10.1007/s10529-008-9789-z; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Dietmair S, 2010, ANAL BIOCHEM, V404, P155, DOI 10.1016/j.ab.2010.04.031; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; Foley G, 2006, J MEMBRANE SCI, V274, P38, DOI 10.1016/j.memsci.2005.12.008; Grossmann K, 2010, WEED SCI, V58, P1, DOI 10.1614/WS-D-09-00004.1; Kamlage B, 2014, CLIN CHEM, V60, P399, DOI 10.1373/clinchem.2013.211979; Kim S, 2013, ANAL CHEM, V85, P2169, DOI 10.1021/ac302881e; Leon Z, 2013, ELECTROPHORESIS, V34, P2762, DOI 10.1002/elps.201200605; Liu X, 2012, BIOTECHNOL LETT, V34, P2275, DOI 10.1007/s10529-012-1030-4; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Ma NN, 2009, BIOTECHNOL PROGR, V25, P1353, DOI 10.1002/btpr.238; Mattes WB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/202497; Mellert W, 2011, TOXICOL LETT, V207, P173, DOI 10.1016/j.toxlet.2011.08.013; Meyer H, 2010, ANAL BIOCHEM, V401, P250, DOI 10.1016/j.ab.2010.03.003; Mutch DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007905; Padberg I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085082; Pinheiro J, R PACKAGE VERSION; R Development Core Team, 2014, R LANG ENV STAT COMP; ROTHMAN LB, 1969, BIOCHEMISTRY-US, V8, P3332, DOI 10.1021/bi00836a030; SAEZ MJ, 1976, MOL CELL BIOCHEM, V13, P73, DOI 10.1007/BF01837056; Sellick CA, 2011, BIOTECHNOL BIOENG, V108, P3025, DOI 10.1002/bit.23269; Sellick CA, 2009, ANAL CHEM, V81, P174, DOI 10.1021/ac8016899; Shin MH, 2010, ANAL CHEM, V82, P6660, DOI 10.1021/ac1012656; Singh D, 2013, INT J BIOL SCI, V9, P521, DOI 10.7150/ijbs.4962; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Taymaz-Nikerel H, 2009, ANAL BIOCHEM, V386, P9, DOI 10.1016/j.ab.2008.11.018; Thevissen K, 2006, MINI-REV MED CHEM, V6, P699, DOI 10.2174/138955706777435643; van Gulik WM, 2010, CURR OPIN BIOTECH, V21, P27, DOI 10.1016/j.copbio.2010.01.008; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; Volmer M, 2011, BIOTECHNOL LETT, V33, P495, DOI 10.1007/s10529-010-0466-7; Vuckovic D, 2012, ANAL BIOANAL CHEM, V403, P1523, DOI 10.1007/s00216-012-6039-y; Walk T. B., 2003, Patent Application, Patent No. [PCT/ EP2003/ 001274, WO2003073464, 2003001274]; Walk T.B., 2003, Mass spectrometry method for analysing mixtures of substances, Patent No. 2003073464; Walk TB, 2003, Patent No. [US7196323 B2, 71962323]; WEIBEL KE, 1974, ANAL BIOCHEM, V58, P208, DOI 10.1016/0003-2697(74)90459-X; WHITFORD W, 2003, BIOPROCESS INT   DEC, P36; Wittmann C, 2004, ANAL BIOCHEM, V327, P135, DOI 10.1016/j.ab.2004.01.002; Wu XH, 2010, BIOTECHNOL J, V5, P75, DOI 10.1002/biot.200900038; Xu YJ, 2014, TRAC-TREND ANAL CHEM, V56, P37, DOI 10.1016/j.trac.2013.12.009	45	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159389	10.1371/journal.pone.0159389	http://dx.doi.org/10.1371/journal.pone.0159389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438065	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100040
J	Kim, S; Feinberg, B; Kant, R; Chui, B; Goldman, K; Park, J; Moses, W; Blaha, C; Iqbal, Z; Chow, C; Wright, N; Fissell, WH; Zydney, A; Roy, S				Kim, Steven; Feinberg, Benjamin; Kant, Rishi; Chui, Benjamin; Goldman, Ken; Park, Jaehyun; Moses, Willieford; Blaha, Charles; Iqbal, Zohora; Chow, Clarence; Wright, Nathan; Fissell, William H.; Zydney, Andrew; Roy, Shuvo			Diffusive Silicon Nanopore Membranes for Hemodialysis Applications	PLOS ONE			English	Article							WEARABLE ARTIFICIAL-KIDNEY; QUALITY-OF-LIFE; HEMOFILTRATION MEMBRANES; PREDICT MORTALITY; DIALYSIS PATIENTS; TRANSPORT; ULTRAFILTRATION; PERFORMANCE; DISEASE; SYSTEMS	Hemodialysis using hollow-fiber membranes provides life-sustaining treatment for nearly 2 million patients worldwide with end stage renal disease (ESRD). However, patients on hemodialysis have worse long-term outcomes compared to kidney transplant or other chronic illnesses. Additionally, the underlying membrane technology of polymer hollow-fiber membranes has not fundamentally changed in over four decades. Therefore, we have proposed a fundamentally different approach using microelectromechanical systems (MEMS) fabrication techniques to create thin-flat sheets of silicon-based membranes for implantable or portable hemodialysis applications. The silicon nanopore membranes (SNM) have biomimetic slit-pore geometry and uniform pores size distribution that allow for exceptional permeability and selectivity. A quantitative diffusion model identified structural limits to diffusive solute transport and motivated a new microfabrication technique to create SNM with enhanced diffusive transport. We performed in vitro testing and extracorporeal testing in pigs on prototype membranes with an effective surface area of 2.52 cm(2) and 2.02 cm(2), respectively. The diffusive clearance was a two-fold improvement in with the new microfabrication technique and was consistent with our mathematical model. These results establish the feasibility of using SNM for hemodialysis applications with additional scale-up.	[Kim, Steven] Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA; [Feinberg, Benjamin; Kant, Rishi; Park, Jaehyun; Blaha, Charles; Iqbal, Zohora; Chow, Clarence; Wright, Nathan; Roy, Shuvo] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Chui, Benjamin] Ben Chui Consulting, Sunnyvale, CA USA; [Goldman, Ken] H Cubed, Olmsted Falls, OH USA; [Moses, Willieford] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Blaha, Charles; Wright, Nathan; Fissell, William H.; Roy, Shuvo] Silicon Kidney LLC, San Francisco, CA 94122 USA; [Fissell, William H.] Vanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, Nashville, TN USA; [Zydney, Andrew] Penn State Univ, Dept Chem Engn, State Coll, PA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Roy, S (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Roy, S (corresponding author), Silicon Kidney LLC, San Francisco, CA 94122 USA.	Shuvo.roy@ucsf.edu		Fissell, William/0000-0002-3960-3998	American Society of Nephrology Ben J. Lipps Research Fellowship; National Institute of Diabetes, and Digestive, and Kidney Diseases of the National Institutes of Health [F32 DK103468]; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [R01 EB014315, U01EB021214]; Wildwood Foundation; John and Marcia Goldman Foundation; H-Cubed; Ben Chui Consulting; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021214, R01EB014315] Funding Source: NIH RePORTER	American Society of Nephrology Ben J. Lipps Research Fellowship; National Institute of Diabetes, and Digestive, and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Wildwood Foundation; John and Marcia Goldman Foundation; H-Cubed; Ben Chui Consulting; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the American Society of Nephrology Ben J. Lipps Research Fellowship, National Institute of Diabetes, and Digestive, and Kidney Diseases of the National Institutes of Health under the Award Number F32 DK103468, National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under Award Numbers R01 EB014315 and U01EB021214, Wildwood Foundation and the John and Marcia Goldman Foundation. The funders, H-Cubed and Ben Chui Consulting, provided support in the form of salaries for authors BC and KG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2011, FRESENIUS OPTIFLUX D; Buoncristiani U, 1998, NEPHROL DIAL TRANSPL, V13, P148, DOI 10.1093/ndt/13.suppl_6.148; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Conlisk AT, 2009, ANN BIOMED ENG, V37, P722, DOI 10.1007/s10439-009-9642-0; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; Daugirdas JT, 2012, KIDNEY INT, V82, P147, DOI 10.1038/ki.2012.130; Daugirdas JT., 2007, HDB DIALYSIS; Dechadilok P, 2006, IND ENG CHEM RES, V45, P6953, DOI 10.1021/ie051387n; Del Vecchio L, 2011, SEMIN DIALYSIS, V24, P56, DOI 10.1111/j.1525-139X.2010.00819.x; Finkelstein FO, 2012, KIDNEY INT, V82, P561, DOI 10.1038/ki.2012.168; Fissell WH, 2006, ASAIO J, V52, P221, DOI 10.1097/01.mat.0000205228.30516.9c; Fissell WH, 2009, J MEMBRANE SCI, V326, P58, DOI 10.1016/j.memsci.2008.09.039; Gura V, 2009, CLIN J AM SOC NEPHRO, V4, P1441, DOI 10.2215/CJN.02790409; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Johnson DG, 2013, ADV CHRONIC KIDNEY D, V20, P508, DOI 10.1053/j.ackd.2013.08.001; Kanani DM, 2010, J MEMBRANE SCI, V349, P405, DOI 10.1016/j.memsci.2009.12.003; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Kim S, 2013, ADV CHRONIC KIDNEY D, V20, P516, DOI 10.1053/j.ackd.2013.08.006; Kimmel PL, 2000, KIDNEY INT, V57, P2093, DOI 10.1046/j.1523-1755.2000.00059.x; Langsdorf LJ, 1994, TRANSPORT PROPERTIES; Lee DBN, 2008, CLIN EXP NEPHROL, V12, P171, DOI 10.1007/s10157-008-0050-9; LI L, 2010, J BIOMATER SCI POLYM; Muthusubramaniam L, 2011, ANN BIOMED ENG, V39, P1296, DOI 10.1007/s10439-011-0256-y; OPONG WS, 1991, AICHE J, V37, P1497, DOI 10.1002/aic.690371007; Papra A, 2001, LANGMUIR, V17, P1457, DOI 10.1021/la000609d; Popat KC, 2004, BIOSENS BIOELECTRON, V19, P1037, DOI 10.1016/j.bios.2003.10.007; PORTER MC, 1972, IND ENG CHEM PROD RD, V11, P234, DOI 10.1021/i360043a002; Randoux C, 2001, KIDNEY INT, V60, P1571, DOI 10.1046/j.1523-1755.2001.00970.x; Ronco C, 2001, BLOOD PURIFICAT, V19, P347, DOI 10.1159/000046964; Saran R, 2006, KIDNEY INT, V69, P1222, DOI 10.1038/sj.ki.5000186; Smith RA, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/4/045802; Twardowski ZJ, 2008, HEMODIAL INT, V12, P173, DOI 10.1111/j.1542-4758.2008.00253.x; Tzamaloukas AH, 1998, KIDNEY INT, V53, P1405, DOI 10.1046/j.1523-1755.1998.00896.x; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; US Department of Health and Human Services, 2013, OPTN DAT ORG PROC TR; Zhu JM, 2006, BIOMACROMOLECULES, V7, P1036, DOI 10.1021/bm050611p	37	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159526	10.1371/journal.pone.0159526	http://dx.doi.org/10.1371/journal.pone.0159526			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438878	Green Published, gold			2022-12-27	WOS:000380170100053
J	Parpouchi, M; Moniruzzaman, A; Russolillo, A; Somers, JM				Parpouchi, Milad; Moniruzzaman, Akm; Russolillo, Angela; Somers, Julian M.			Food Insecurity among Homeless Adults with Mental Illness	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; MARGINALLY HOUSED INDIVIDUALS; NONNORMAL REGRESSION-MODELS; HIV-INFECTED INDIVIDUALS; 3RD NATIONAL-HEALTH; SAN-FRANCISCO; MEAL PROGRAMS; LOS-ANGELES; TORONTO; CARE	Background The prevalence of food insecurity and food insufficiency is high among homeless people. We investigated the prevalence and correlates of food insecurity among a cohort of homeless adults with mental illness in Vancouver, British Columbia, Canada. Methods Data collected from baseline questionnaires in the Vancouver At Home study were analysed to calculate the prevalence of food insecurity within the sample (n = 421). A modified version of the U.S. Department of Agriculture's Adult Food Security Survey Module was used to ascertain food insecurity. Univariable and multivariable logistic regression were used to examine potential correlates of food insecurity. Results The prevalence of food insecurity was 64%. In the multivariable model, food insecurity was significantly associated with age (adjusted odds ratio [ aOR] = 0.97; 95% CI: 0.95-0.99), less than high school completion (aOR = 0.57; 95% CI: 0.35-0.93), needing health care but not receiving it (aOR = 1.65; 95% CI: 1.00-2.72), subjective mental health (aOR = 0.97; 95% CI: 0.96-0.99), having spent over $500 for drugs and alcohol in the past month (aOR = 2.25; 95% CI: 1.16-4.36), HIV/AIDS (aOR = 4.20; 95% CI: 1.36-12.96), heart disease (aOR = 0.39; 95% CI: 0.16-0.97) and having gone to a drop-in centre, community meal centre or program/food bank (aOR = 1.65; 95% CI: 1.01-2.68). Conclusions The prevalence of food insecurity was extremely high in a cohort with long-standing homelessness and serious mental illness. Younger age, needing health care but not receiving it, poorer subjective mental health, having spent over $500 for drugs and alcohol in the past month, HIV/AIDS and having gone to a drop-in centre, community meal centre or program/food bank each increased odds of food insecurity, while less than high school completion and heart disease each decreased odds of food insecurity. Interventions to reduce food insecurity in this population are urgently needed.	[Parpouchi, Milad; Moniruzzaman, Akm; Russolillo, Angela; Somers, Julian M.] Simon Fraser Univ, Somers Res Grp, Fac Hlth Sci, Burnaby, BC, Canada	Simon Fraser University	Parpouchi, M (corresponding author), Simon Fraser Univ, Somers Res Grp, Fac Hlth Sci, Burnaby, BC, Canada.	spa16@sfu.ca			Mental Health Commission of Canada [2009s0124]	Mental Health Commission of Canada	This work was supported by the Mental Health Commission of Canada, Grant Number: 2009s0124, URL: http://www.mentalhealthcommission.ca, Recipient: JMS. The funder required an experimental design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Adair CE, 2012, J URBAN HEALTH, V89, P36, DOI 10.1007/s11524-011-9632-z; Alaimo K, 1998, AM J PUBLIC HEALTH, V88, P419, DOI 10.2105/AJPH.88.3.419; ANDERSON SA, 1990, J NUTR, V120, P1559, DOI 10.1093/jn/120.suppl_11.1555; Anema Aranka, 2009, Curr HIV/AIDS Rep, V6, P224, DOI 10.1007/s11904-009-0030-z; Baggett TP, 2011, J GEN INTERN MED, V26, P627, DOI 10.1007/s11606-011-1638-4; Baggett TP, 2010, AM J PUBLIC HEALTH, V100, P1326, DOI 10.2105/AJPH.2009.180109; Bickel G., 2000, J COOK GUIDE MEASURI; BRIEFEL RR, 1992, J NUTR EDUC, V24, pS24; Che J, 2001, Health Rep, V12, P11; Dachner N, 2002, SOC SCI MED, V54, P1039, DOI 10.1016/S0277-9536(01)00079-X; Dachner N, 2009, J HEALTH CARE POOR U, V20, P846, DOI 10.1353/hpu.0.0167; Dennis ML, 2006, AM J ADDICTION, V15, P80, DOI 10.1080/10550490601006055; Furness BW, 2004, PUBLIC HEALTH NUTR, V7, P791, DOI 10.1079/PHN2004608; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; Gelberg L, 1997, AM J PUBLIC HEALTH, V87, P217, DOI 10.2105/AJPH.87.2.217; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; Hamelin A.-M., 2009, CANADIAN J URBAN RES, V18, P1; Hanson KL, 2014, AM J CLIN NUTR, V100, P684, DOI 10.3945/ajcn.114.084525; Holland AC, 2011, PUBLIC HEALTH NUTR, V14, P2254, DOI 10.1017/S1368980011001327; Irving SM, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140190; Johnson Lesley J., 2003, Journal of Nutrition for the Elderly, V23, P1, DOI 10.1300/J052v23n01_01; Larson CO, 2002, HEALTH SERV RES, V37, P733, DOI 10.1111/1475-6773.00046; LAWLESS JF, 1978, BIOMETRICS, V34, P318, DOI 10.2307/2530022; Lee BA, 2008, J HEALTH SOC BEHAV, V49, P3, DOI 10.1177/002214650804900102; Lindsey C, 2015, STATA J, V15, P1046, DOI 10.1177/1536867X1501500406; Marsden J, 1998, ADDICTION, V93, P1857, DOI 10.1046/j.1360-0443.1998.9312185711.x; Menard S., 2002, APPL LOGISTIC REGRES; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Myers R., 1990, CLASSICAL MODERN REG; Normen L, 2005, J NUTR, V135, P820, DOI 10.1093/jn/135.4.820; Palepu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075133; Richards R, 2006, J NUTR EDUC BEHAV, V38, P96, DOI 10.1016/j.jneb.2005.11.031; Roshanafshar S, 2015, FOOD INSECURITY CANA; Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sissonand LG, 2011, J HUNGER ENVIRON NUT, V6, P312, DOI 10.1080/19320248.2011.597832; Smith C, 2010, AGR HUM VALUES, V27, P141, DOI 10.1007/s10460-009-9191-z; Somers JM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-365; Sprake EF, 2014, J HUM NUTR DIET, V27, P242, DOI 10.1111/jhn.12130; Stuff JE, 2004, J NUTR, V134, P2330, DOI 10.1093/jn/134.9.2330; Sullivan G, 2000, PSYCHIATR SERV, V51, P1135, DOI 10.1176/appi.ps.51.9.1135; Tarasuk V, 2009, PUBLIC HEALTH NUTR, V12, P1437, DOI 10.1017/S1368980008004291; Tse C, 2008, PUBLIC HEALTH NUTR, V11, P1296, DOI 10.1017/S1368980008002577; United States Department of Agriculture (USDA), 2008, USDA ADULT FOOD SECU; Vogenthaler NS, 2010, PUBLIC HEALTH NUTR, V13, P1478, DOI 10.1017/S1368980009993181; Weiser SD, 2013, AIDS, V27, P2953, DOI 10.1097/01.aids.0000432538.70088.a3; Weiser SD, 2013, J GEN INTERN MED, V28, P91, DOI 10.1007/s11606-012-2176-4; Weiser SD, 2009, AIDS BEHAV, V13, P841, DOI 10.1007/s10461-009-9597-z; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5; White BM, 2015, J PRIM CARE COMMUNIT, V6, P77, DOI 10.1177/2150131914556122; Wicks R, 2006, J AM DIET ASSOC, V106, P921, DOI 10.1016/j.jada.2006.03.006; WIECHA JL, 1991, PUBLIC HEALTH REP, V106, P364	52	28	28	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159334	10.1371/journal.pone.0159334	http://dx.doi.org/10.1371/journal.pone.0159334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27437937	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100036
J	Schalet, BD; Tang, TZ; DeRubeis, RJ; Hollon, SD; Amsterdam, JD; Shelton, RC				Schalet, Benjamin D.; Tang, Tony Z.; DeRubeis, Robert J.; Hollon, Steven D.; Amsterdam, Jay D.; Shelton, Richard C.			Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; RATING-SCALE; ANTIDEPRESSANT MEDICATION; SELECTIVE ALTERATION; PARTIAL RESPONDERS; HAMILTON; PERSONALITY; ANXIETY; DISORDER; NEUROTICISM	Background Meta-analyses of placebo-controlled trials of SSRIs suggest that only a small portion of the observable change in depression may be attributed to "true" pharmacological effects. But depression is a multidimensional construct, so treatment effects may differ by symptom cluster. We tested the hypothesis that SSRIs uniquely alter psychological rather than somatic symptoms of depression and anxiety. Method Outpatients with moderate to severe MDD were randomly assigned to receive paroxetine (n = 120) or placebo (n = 60). Results Paroxetine significantly outperformed placebo on all psychological subscales of the syndrome measures, but not on any of the somatic subscales. The difference in score reduction between paroxetine and placebo was more than twice as great for the psychological symptoms compared to the somatic symptoms. Conclusions Paroxetine appears to have a "true" pharmacological effect on the psychological but not on the somatic symptoms of depression and anxiety. Paroxetine's influence on somatic symptoms appears to be mostly duplicated by placebo.	[Schalet, Benjamin D.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Tang, Tony Z.; DeRubeis, Robert J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Hollon, Steven D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Amsterdam, Jay D.] Univ Penn, Perelman Sch Med, Depress Res Unit, Philadelphia, PA 19104 USA; [Shelton, Richard C.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	Northwestern University; Feinberg School of Medicine; University of Pennsylvania; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Birmingham	Schalet, BD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA.	b-schalet@northwestern.edu		DeRubeis, Robert/0000-0003-3129-0277	National Institute of Mental Health, Bethesda, MD [MH50129(R10), MH55875(R10), MH01697(K02)]	National Institute of Mental Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The dataset for this study came from a clinical trial supported by grants MH50129(R10), MH55875(R10), MH01697(K02) from the National Institute of Mental Health, Bethesda, MD. Authors who received funding include RD SH JA RS. GlaxoSmithKline, Brentford, Middlesex, United Kingdom, provided medications and pill placebos for the trial. The authors received no funding to support their work on the specific study detailed in this PLOS ONE manuscript, which comprises secondary data analysis and writing. The funders of the original clinical trial had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKISKAL HS, 1983, AM J PSYCHIAT, V140, P11; Bagby RM, 1999, PSYCHIAT RES, V86, P211, DOI 10.1016/S0165-1781(99)00041-4; Baguley T, 2009, BRIT J PSYCHOL, V100, P603, DOI 10.1348/000712608X377117; Baldwin DS, 2006, J CLIN PSYCHIAT, V67, P9; Ballesteros J, 2007, J AFFECT DISORDERS, V102, P93, DOI 10.1016/j.jad.2006.12.015; BECH P, 1981, ACTA PSYCHIAT SCAND, V63, P290, DOI 10.1111/j.1600-0447.1981.tb00676.x; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bodkin JA, 1997, J CLIN PSYCHIAT, V58, P137, DOI 10.4088/JCP.v58n0401; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen JC, 2003, LS APPL MULTIPLE REG; Cohen P, 1999, MULTIVAR BEHAV RES, V34, P315, DOI 10.1207/S15327906MBR3403_2; Costa P. T., 2009, OXFORD HDB PERSONALI, P299, DOI [10.1093/oxfordhb/9780195366877.013.0016, DOI 10.1093/OXFORDHB/9780195366877.013.0016]; Costa PT, 2007, REVISED NEO PERSONAL; de Beurs E, 2007, BEHAV RES THER, V45, P1609, DOI 10.1016/j.brat.2006.07.004; Delgado PL, 2004, J CLIN PSYCHIAT, V65, P16; Demyttenaere K, 2005, INT J NEUROPSYCHOPH, V8, P93, DOI 10.1017/S1461145704004729; Demyttenaere K, 2003, PSYCHOTHER PSYCHOSOM, V72, P61, DOI 10.1159/000068690; Depue R A, 1986, Ann N Y Acad Sci, V487, P47, DOI 10.1111/j.1749-6632.1986.tb27885.x; DeRubeis RJ, 1999, AM J PSYCHIAT, V156, P1007; Enns MW, 2000, J AFFECT DISORDERS, V60, P33, DOI 10.1016/S0165-0327(99)00156-1; Entsuah R, 2002, J PSYCHIATR RES, V36, P437, DOI 10.1016/S0022-3956(02)00024-9; Evans KR, 2004, J PSYCHIATR RES, V38, P275, DOI 10.1016/j.jpsychires.2003.11.003; Faries D, 2000, J PSYCHIATR RES, V34, P3, DOI 10.1016/S0022-3956(99)00037-0; Fava M, 2005, J CLIN PSYCHIAT, V66, P85, DOI 10.4088/JCP.v66n0112; Feinstein JS, 2010, P NATL ACAD SCI USA, V107, P7674, DOI 10.1073/pnas.0914054107; Flament MF, 2012, INT J NEUROPSYCHOPH, V15, P189, DOI 10.1017/S1461145711000381; Fournier JC, 2013, BEHAV RES THER, V51, P392, DOI 10.1016/j.brat.2013.03.010; GIBBONS RD, 1993, J PSYCHIATR RES, V27, P259, DOI 10.1016/0022-3956(93)90037-3; Griffith JW, 2010, PSYCHOL MED, V40, P1125, DOI 10.1017/S0033291709991449; Gwadz MV, 2008, ADDICT RES THEORY, V16, P47, DOI 10.1080/16066350701651214; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hollon SD, 2005, ARCH GEN PSYCHIAT, V62, P417, DOI 10.1001/archpsyc.62.4.417; Judge R, 2000, J CLIN PSYCHOPHARM, V20, P666, DOI 10.1097/00004714-200012000-00013; Kang EH, 2009, PSYCHIAT RES, V169, P118, DOI 10.1016/j.psychres.2008.06.021; Kirsch I., 2002, PREV TREAT, V5, P23, DOI [DOI 10.1037/1522-3736.5.1.523A, 10.1037/1522-3736.5.1.523a]; Kirsch I., 1998, PREVENTION TREATMENT, V1, DOI 10.1037/1522-3736.1.1.12a; Knutson B, 1998, AM J PSYCHIAT, V155, P373, DOI 10.1176/ajp.155.3.373; MAIER W, 1985, ACTA PSYCHIAT SCAND, V72, P239, DOI 10.1111/j.1600-0447.1985.tb02601.x; Mallinckrodt CH, 2007, NEUROPSYCHOBIOLOGY, V56, P73, DOI 10.1159/000111537; McCrae RR., 1999, HDB PERSONALITY THEO, V2nd, P139, DOI DOI 10.1016/S0191-8869(97)81000-8; McIntyre R, 2002, J PSYCHIATR NEUROSCI, V27, P235; Mendenhall AN, 2009, J CONSULT CLIN PSYCH, V77, P463, DOI 10.1037/a0014527; Ormel J, 2012, CLIN PSYCHOL REV, V32, P71, DOI 10.1016/j.cpr.2011.10.004; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; Palacios JM, 2016, BRAIN RES, V1645, P46, DOI 10.1016/j.brainres.2015.12.042; Papakostas GI, 2007, BIOL PSYCHIAT, V62, P1217, DOI 10.1016/j.biopsych.2007.03.027; Algorta GP, 2011, BIPOLAR DISORD, V13, P76, DOI 10.1111/j.1399-5618.2010.00886.x; Pincus HA, 2000, HDB PSYCHIAT MEASURE; Quilty LC, 2008, J AFFECT DISORDERS, V111, P67, DOI 10.1016/j.jad.2008.02.006; Rainnie DG, 1999, J NEUROPHYSIOL, V82, P69, DOI 10.1152/jn.1999.82.1.69; Rapaport MH, 2001, J CLIN PSYCHIAT, V62, P6; Reimherr FW, 1998, AM J PSYCHIAT, V155, P1247, DOI 10.1176/ajp.155.9.1247; Rinne T, 2002, AM J PSYCHIAT, V159, P2048, DOI 10.1176/appi.ajp.159.12.2048; Ripoll LH, 2011, INT J NEUROPSYCHOPH, V14, P1257, DOI 10.1017/S1461145711000071; Santor DA, 2008, DEPRESS ANXIETY, V25, P774, DOI 10.1002/da.20351; Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Shelton RC, 2007, INT CLIN PSYCHOPHARM, V22, P348, DOI 10.1097/YIC.0b013e32821c6189; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; Stahl SM, 2003, J CLIN PSYCHIAT, V64, P6; Tang TZ, 2009, ARCH GEN PSYCHIAT, V66, P1322, DOI 10.1001/archgenpsychiatry.2009.166; Vaswani M, 2003, PROG NEURO-PSYCHOPH, V27, P85, DOI 10.1016/S0278-5846(02)00338-X; Watson D, 2008, PSYCHOL ASSESSMENT, V20, P248, DOI 10.1037/a0012570; Watson D, 2007, PSYCHOL ASSESSMENT, V19, P253, DOI 10.1037/1040-3590.19.3.253; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Zohar J, 2000, OBSESSIVE COMPULSIVE, P43	68	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159647	10.1371/journal.pone.0159647	http://dx.doi.org/10.1371/journal.pone.0159647			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438078	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100060
J	Segev, A; Curtis, D; Jung, S; Chae, S				Segev, Aviv; Curtis, Dorothy; Jung, Sukhwan; Chae, Suhyun			Invisible Brain: Knowledge in Research Works and Neuron Activity	PLOS ONE			English	Article							DYNAMICS; CALCIUM; INTERNET; SYNCHRONIZATION; POPULATION; NETWORKS; SYSTEMS	If the market has an invisible hand, does knowledge creation and representation have an "invisible brain"? While knowledge is viewed as a product of neuron activity in the brain, can we identify knowledge that is outside the brain but reflects the activity of neurons in the brain? This work suggests that the patterns of neuron activity in the brain can be seen in the representation of knowledge-related activity. Here we show that the neuron activity mechanism seems to represent much of the knowledge learned in the past decades based on published articles, in what can be viewed as an "invisible brain" or collective hidden neural networks. Similar results appear when analyzing knowledge activity in patents. Our work also tries to characterize knowledge increase as neuron network activity growth. The results propose that knowledge-related activity can be seen outside of the neuron activity mechanism. Consequently, knowledge might exist as an independent mechanism.	[Segev, Aviv; Jung, Sukhwan; Chae, Suhyun] Korea Adv Inst Sci & Technol, Grad Sch Knowledge Serv Engn, 291 Daehak Ro, Daejeon, South Korea; [Segev, Aviv] Korea Adv Inst Sci & Technol, Sch Comp, 291 Daehak Ro, Taejon 305701, South Korea; [Curtis, Dorothy] MIT, CSAIL, 32 Vassar St, Cambridge, MA 02139 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Massachusetts Institute of Technology (MIT)	Segev, A (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Knowledge Serv Engn, 291 Daehak Ro, Daejeon, South Korea.; Segev, A (corresponding author), Korea Adv Inst Sci & Technol, Sch Comp, 291 Daehak Ro, Taejon 305701, South Korea.	aviv@kaist.edu	Segev, Aviv/C-2060-2011		IT R&D program of MSIP/KEIT [10044494]; National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2016R1A2B4011694]	IT R&D program of MSIP/KEIT; National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the IT R&D program of MSIP/KEIT [10044494, WiseKB: Big data based self-evolving knowledge base and reasoning platform]. It was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) 2016R1A2B4011694.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Aggarwal C, 2014, ACM COMPUT SURV, V47, DOI 10.1145/2601412; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; [Anonymous], 2006, P 12 ACM SIGKDD INT, DOI DOI 10.1145/1150402.1150467; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Battaglia D, 2013, PLOS COMPUTATIONAL B, V8, P1; Berger-Wolf TY, 2006, P 12 ACM SIGKDD INT, P523, DOI [10.1145/1150402.1150462, DOI 10.1145/1150402.1150462]; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Dal Maschio M, 2012, ADV EXP MED BIOL, V740, P83, DOI 10.1007/978-94-007-2888-2_4; Dayan P., 2005, THEORETICAL NEUROSCI; De Carlos JA, 2007, BRAIN RES REV, V55, P8, DOI 10.1016/j.brainresrev.2007.03.010; Dowdy S., 1983, STAT RES; Eckmann JP, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015011; Eppler Jochen Martin, 2008, Front Neuroinform, V2, P12, DOI 10.3389/neuro.11.012.2008; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Fodor J. A, 2001, MIND DOESNT WORK WAY; FODOR JA, 1988, COGNITION, V28, P3, DOI 10.1016/0010-0277(88)90031-5; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gewaltig MO, NEST NEURAL SIMULATI; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Herman I, 2000, IEEE T VIS COMPUT GR, V6, P24, DOI 10.1109/2945.841119; HOLLAND PW, 1971, COMP GROUP STUD, V2, P107, DOI 10.1177/104649647100200201; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jowett Benjamin, 2008, THEAETETUS; Jung S, 2014, KNOWL-BASED SYST, V69, P34, DOI 10.1016/j.knosys.2014.04.036; Katona G, 2012, NAT METHODS, V9, P201, DOI [10.1038/NMETH.1851, 10.1038/nmeth.1851]; Leal B, 2010, INTERNET OF THINGS-BOOK, P3, DOI 10.1007/978-1-4419-1674-7_1; MacKay D. J. C., 2003, INFORM THEORY INFERE; Marre O, 2012, J NEUROSCI, V32, P14859, DOI 10.1523/JNEUROSCI.0723-12.2012; Mishchenko Y, 2011, ANN APPL STAT, V5, P1229, DOI 10.1214/09-AOAS303; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Orlandi JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098842; Plato, 2008, TIMAEUS; Ruan Y., 2013, WWW, P1089, DOI 10.1145/2488388.2488483; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubner Y, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P59, DOI 10.1109/ICCV.1998.710701; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Smith Adam, 1761, THEORY MORAL SENTIME; Song T, 2013, INFORM SCIENCES, V219, P197, DOI 10.1016/j.ins.2012.07.023; Steinmetz PN, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056019; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Tsodyks M, 2000, J NEUROSCI, V20; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	54	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158590	10.1371/journal.pone.0158590	http://dx.doi.org/10.1371/journal.pone.0158590			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27439199	gold, Green Published, Green Submitted			2022-12-27	WOS:000380170100014
J	Van Acker, H; Gielis, J; Acke, M; Cools, F; Cos, P; Coenye, T				Van Acker, Heleen; Gielis, Jan; Acke, Marloes; Cools, Freya; Cos, Paul; Coenye, Tom			The Role of Reactive Oxygen Species in Antibiotic-Induced Cell Death in Burkholderia cepacia Complex Bacteria	PLOS ONE			English	Article							OXIDATIVE STRESS; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; CIPROFLOXACIN; RESISTANCE; CEFTAZIDIME; INVOLVEMENT; MECHANISMS; BIOFILM	It was recently proposed that bactericidal antibiotics, besides through specific drug-target interactions, kill bacteria by a common mechanism involving the production of reactive oxygen species (ROS). However, this mechanism involving the production of hydroxyl radicals has become the subject of a lot of debate. Since the contribution of ROS to antibiotic mediated killing most likely depends on the conditions, differences in experimental procedures are expected to be at the basis of the conflicting results. In the present study different methods (ROS specific stainings, gene-expression analyses, electron paramagnetic resonance, genetic and phenotypic experiments, detection of protein carbonylation and DNA oxidation) to measure the production of ROS upon antibiotic treatment in Burkholderia cepacia complex (Bcc) bacteria were compared. Different classes of antibiotics (tobramycin, ciprofloxacin, meropenem) were included, and both planktonic and biofilm cultures were studied. Our results indicate that some of the methods investigated were not sensitive enough to measure antibiotic induced production of ROS, including the spectrophotometric detection of protein carbonylation. Secondly, other methods were found to be useful only in specific conditions. For example, an increase in the expression of OxyR was measured in Burkholderia cenocepacia K56-2 after treatment with ciprofloxacin or meropenem (both in biofilms and planktonic cultures) but not after treatment with tobramycin. In addition results vary with the experimental conditions and the species tested. Nevertheless our data strongly suggest that ROS contribute to antibiotic mediated killing in Bcc species and that enhancing ROS production or interfering with the protection against ROS may form a novel strategy to improve antibiotic treatment.	[Van Acker, Heleen; Acke, Marloes; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, Ghent, Belgium; [Gielis, Jan] Univ Antwerp, Antwerp Surg Training & Anat Res Ctr, Dept Thorac Surg, Antwerp, Belgium; [Gielis, Jan; Cools, Freya; Cos, Paul] Univ Antwerp, Lab Microbiol Parasitol & Hyg, Antwerp, Belgium	Ghent University; University of Antwerp	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, Ghent, Belgium.	Tom.coenye@ugent.be	Cos, Paul/L-9717-2015; Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014; cos, paul/AAU-3896-2020	Cos, Paul/0000-0003-4361-8911; Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; cos, paul/0000-0003-4361-8911; Cools, Freya/0000-0003-1891-4102	FWO-Vlaanderen	FWO-Vlaanderen(FWO)	This work was financially supported by FWO-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by FWO-Vlaanderen. We thank prof. Miguel Valvano for providing us with the B. cenocepacia K56-2 oxyR::lux fusion strain, B. cenocepacia C524 and the B. cenocepacia MDL2 mutant strain, prof. Giovanni Riccardi for the B. cenocepacia triple quorum sensing deletion mutant.	Aiassa V, 2010, BIOCHEM BIOPH RES CO, V393, P84, DOI 10.1016/j.bbrc.2010.01.083; Albesa I, 2004, BIOCHEM BIOPH RES CO, V317, P605, DOI 10.1016/j.bbrc.2004.03.085; Battan PC, 2004, LUMINESCENCE, V19, P265, DOI 10.1002/bio.779; Cardona ST, 2006, APPL ENVIRON MICROB, V72, P2547, DOI 10.1128/AEM.72.4.2547-2555.2006; Dhamdhere G, 2010, ANTIMICROB AGENTS CH, V54, P5366, DOI 10.1128/AAC.00719-10; Dridi B, 2015, ANTIMICROB AGENTS CH; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; El-Halfawy OM, 2014, ANTIMICROB AGENTS CH, V58, P4162, DOI 10.1128/AAC.02649-14; EUCAST, 2003, CLIN MICROBIOL INFEC, V6, P509; Fang FC, 2013, NAT BIOTECHNOL, V31, P415, DOI 10.1038/nbt.2574; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Gielis JF, 2015, EUR J CARDIO-THORAC, V48, P622, DOI 10.1093/ejcts/ezu518; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; IMLAY JA, 1991, FREE RADICAL RES COM, V12-3, P59, DOI 10.3109/10715769109145768; Imlay JA, 2015, CURR OPIN MICROBIOL, V24, P124, DOI 10.1016/j.mib.2015.01.004; Jo I, 2015, P NATL ACAD SCI USA, V112, P6443, DOI 10.1073/pnas.1424495112; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kolodkin-Gal I, 2008, PLOS BIOL, V6, P2774, DOI 10.1371/journal.pbio.0060319; Paez PL, 2010, FUND CLIN PHARMACOL, V24, P771, DOI 10.1111/j.1472-8206.2009.00806.x; Lefebre MD, 2005, MICROBIOL-SGM, V151, P1975, DOI 10.1099/mic.0.27704-0; Liu YL, 2012, ANTIMICROB AGENTS CH, V56, P6048, DOI 10.1128/AAC.00754-12; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Neeley WL, 2006, CHEM RES TOXICOL, V19, P491, DOI 10.1021/tx0600043; Paulander W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092231; Peeters C, 2013, SYST APPL MICROBIOL, V36, P483, DOI 10.1016/j.syapm.2013.06.003; Peeters E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-90; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Renggli S, 2013, J BACTERIOL, V195, P4067, DOI 10.1128/JB.00393-13; Tavernier S, 2015, PEERJ, V3, DOI 10.7717/peerj.787; Thomas VC, 2013, MBIO, V4, DOI 10.1128/mBio.00437-13; Udine C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055112; Van Acker H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058943; Wang JH, 2014, ANTIMICROB AGENTS CH, V58, P5964, DOI 10.1128/AAC.03683-14; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Wang Y, 2015, APPL ENVIRON MICROB, V81, P6393, DOI 10.1128/AEM.01199-15; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Wright GD, 2013, NAT MED, V19, P544, DOI 10.1038/nm.3198	39	50	52	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159837	10.1371/journal.pone.0159837	http://dx.doi.org/10.1371/journal.pone.0159837			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438061	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100077
J	Qin, XL; Zheng, HP; Xue, YH; Ren, XQ; Yang, B; Huang, JM; Huang, SJ; Wu, XZ; Zeng, WY; Ou, JL; Lan, YY; Tang, SM				Qin, Xiaolin; Zheng, Heping; Xue, Yaohua; Ren, Xuqi; Yang, Bin; Huang, Jinmei; Huang, Shujie; Wu, Xingzhong; Zeng, Weiying; Ou, Jiangli; Lan, Yinyuan; Tang, Sanmei			Prevalence of Chlamydia trachomatis Genotypes in Men Who Have Sex with Men and Men Who Have Sex with Women Using Multilocus VNTR Analysis-ompA Typing in Guangzhou, China	PLOS ONE			English	Article							INFECTION	Background Chlamydia trachomatis is one of the most prevalent bacterial sexually transmitted infection in China. Although C. trachomatis genotypes can be discriminated by outer membrane protein gene (ompA) sequencing, currently available methods have limited resolutions. This study used a high-resolution genotypingmethod, namely, multilocus variable number tandem-repeat analysis with ompA sequencing (MLVA)-ompA, to investigate the local epidemiology of C. trachomatis infections among men who have sex with men (MSM) and men who have sex with women (MSW) attending a sexually transmitted diseases (STD) clinic in Guangzhou, China. Methods Rectal specimens from MSM and urethral specimens from MSW were collected between January 2013 and July 2014 at the Guangdong Provincial Center STD clinic. The specimens were sent to the laboratory for analyses. All specimens that were tested positive for C. trachomatis by the commercial nucleic acid amplification tests were genotyped by MLVA-ompA. Results Fifty-one rectal specimens from MSM and 96 urethral specimens from MSW were identified with C. trachomatis. One hundred and forty-four of the 147 specimens were fully genotyped by MLVA-ompA. Rectal specimens from MSM were divided into four ompA genotypes and urethral specimens from MSW into nine genotypes. No mixed infections were found among all specimens. The most frequent genotypes were D, G, J, E and F. All specimens were further divided into 46 types after ompA genotyping was combined with MLVA. Genotypes D-8.7.1 and G-3.4a.3 were the most frequent among MSM, whereas genotypes D-3.4a.4, E-8.5.1, F-8.5.1, and J-3.4a.2 were the most frequent subtypes among MSW. The discriminatory index D was 0.90 for MLVA, 0.85 for ompA, and 0.95 for MLVA-ompA. Conclusions The most prevalent MLVA-ompA genotypes were significantly different between MSM and MSW from Guangzhou, China. Moreover, MLVA-ompA represented a more favorable degree of discrimination than ompA and could be a reliable complement for ompA for the routine subtypes of C. trachomatis.	[Qin, Xiaolin; Zheng, Heping; Xue, Yaohua; Ren, Xuqi; Yang, Bin; Huang, Jinmei; Huang, Shujie; Wu, Xingzhong; Zeng, Weiying; Ou, Jiangli; Lan, Yinyuan; Tang, Sanmei] Guangdong Prov Ctr Skin Dis & STIs Control & Prev, Guangzhou, Guangdong, Peoples R China; [Xue, Yaohua] Southern Med Univ, Dept Lab Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Zheng, HP (corresponding author), Guangdong Prov Ctr Skin Dis & STIs Control & Prev, Guangzhou, Guangdong, Peoples R China.	zhhpf@hotmail.com	Ren, Xu-Qi/GRX-4131-2022		Medical Science and Technology Research Fundation of Guangdong Province [B2013050]; Guangdong Province Science Funds [2013B021800169]; Natural Science Foundation of Guangdong Province [2015A030313895]	Medical Science and Technology Research Fundation of Guangdong Province; Guangdong Province Science Funds; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the Medical Science and Technology Research Fundation of Guangdong Province (No. B2013050), Guangdong Province Science Funds (No. 2013B021800169), and the Natural Science Foundation of Guangdong Province (No. 2015A030313895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bom RJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053869; Bom RJ, 2011, J CLIN MICROBIOL; Chen L, 2015, MED IMAGE ANAL, V23, P1, DOI 10.1016/j.media.2015.03.004; Chen XS, 2013, LANCET INFECT DIS, V13, P13, DOI 10.1016/S1473-3099(12)70298-0; Chen XS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-111; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Han Y, 2013, JPN J INFECT DIS, V66, P69, DOI 10.7883/yoken.66.69; Hong X., 2014, J DIAGN THER DERMATO, V21, P65, DOI 10.3969/j.issn.1674-8468.2014.01.023; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; Klint M, 2006, J CLIN MICROBIOL, V44, P4066, DOI 10.1128/JCM.00574-06; Labiran C, 2015, SEXUALLY TRANSMITTED; Labiran C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00068; Li JH, 2011, JPN J INFECT DIS, V64, P143; Liu JJ, 2014, UROLOGY, V83, P795, DOI 10.1016/j.urology.2013.11.009; Marrazzo J, 2014, F1000PRIME REPORTS, V6; Mejuto P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002330; Pedersen LN, 2008, CLIN MICROBIOL INFEC, V14, P644, DOI 10.1111/j.1469-0691.2008.02011.x; Peuchant O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031538; Satoh M, 2014, J INFECT CHEMOTHER, V20, P656, DOI 10.1016/j.jiac.2014.06.010; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016971; Yang B, 2010, JPN J INFECT DIS, V63, P342	23	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159658	10.1371/journal.pone.0159658	http://dx.doi.org/10.1371/journal.pone.0159658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434536	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600080
J	Rodriguez-Nieves, JA; Patalano, SC; Almanza, D; Gharaee-Kermani, M; Macoska, JA				Rodriguez-Nieves, Jose A.; Patalano, Susan C.; Almanza, Diego; Gharaee-Kermani, Mehrnaz; Macoska, Jill A.			CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; URINARY-TRACT SYMPTOMS; UP-REGULATING CXCR4; SURGICAL THERAPY; LUNG FIBROBLASTS; TISSUE-REPAIR; TGF-BETA; HYPERPLASIA; EXPRESSION; DISEASE	Benign prostate hyperplasia (BPH), an enlargement of the prostate common in aging in men, is associated with urinary voiding dysfunction manifest as Lower Urinary Tract Symptoms (LUTS). Although inflammation and abnormal smooth muscle contractions are known to play key roles in the development of LUTS, tissue fibrosis may also be an important and previously unrecognized contributing factor. Tissue fibrosis arises from the unregulated differentiation of fibroblasts or other precursor cell types into myofibroblasts, which is usually accomplished by activation of the TGF beta/TGF beta R axis. Previously we reported that the CXC-type chemokines, CXCL5, CXCL8 and CXCL12, which are up-regulated in the aging in the prostate, can drive this differentiation process as well in the absence of TGF beta. Based on this data we sought to elucidate the molecular mechanisms employed by CXCL12, and its receptor CXCR4, during prostate myofibroblast phenoconversion. The results of these studies suggest that CXCL12/CXCR4-mediated signaling events in prostate myofibroblast phenoconversion may proceed through non-canonical pathways that do not depend on TGF beta/TGF beta R axis activation or Smad signaling. Here we report that CXCL12/CXCR4 axis activation promotes signaling through the EGFR and downstream MEK/ERK and PI3K/A kappa t pathways during myofibroblast phenoconversion, but not through TGF beta/TGF beta R and downstream Smad signaling, in prostate fibroblasts undergoing myofibroblast phenoconversion. We document that EGFR transactivation is required for CXCL12-mediated signaling and expression of genes associate with myofibroblast phenoconversion (alpha-SMA, COL1a1). Our study successfully identified TGF beta/TGF beta R-independent molecular mechanisms that promote CXCL12/CXCR4-induced myofibroblast phenoconversion. This information may be crucial for the development of novel therapies and potential biomarkers for prostatic fibrosis.	[Macoska, Jill A.] Univ Massachusetts, Ctr Personalized Canc Therapy, Boston, MA 02125 USA; Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston	Macoska, JA (corresponding author), Univ Massachusetts, Ctr Personalized Canc Therapy, Boston, MA 02125 USA.	Jill.Macoska@umb.edu		Almanza, Diego/0000-0003-1222-9366	National Institute of Diabetes and Digestive and Kidney Diseases [U54104310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK104310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315, R25GM076321] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases U54104310 to JAM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Bautista OM, 2003, CONTROL CLIN TRIALS, V24, P224, DOI 10.1016/S0197-2456(02)00263-5; Begley L, 2005, AGING CELL, V4, P291, DOI 10.1111/j.1474-9726.2005.00173.x; Begley LA, 2008, CYTOKINE, V43, P194, DOI 10.1016/j.cyto.2008.05.012; Chen S, 2005, IMMUNOLOGY, V114, P565, DOI 10.1111/j.1365-2567.2004.02110.x; Delongchamps NB, 2008, J UROLOGY, V179, P1736, DOI 10.1016/j.juro.2008.01.034; Dincses E, 2015, EUR J GASTROEN HEPAT, V27, P1149, DOI 10.1097/MEG.0000000000000409; Feng YF, 2014, MOL CELL BIOCHEM, V397, P131, DOI 10.1007/s11010-014-2180-6; Franitza S, 2002, EUR J IMMUNOL, V32, P193, DOI 10.1002/1521-4141(200201)32:1<193::AID-IMMU193>3.0.CO;2-H; Gharaee-Kermani M, 2014, AM J PATHOL, V184, P732, DOI 10.1016/j.ajpath.2013.11.024; Gharaee-Kermani M, 2013, CURR UROL REP, V14, P628, DOI 10.1007/s11934-013-0368-z; Gharaee-Kermani M, 2013, PROSTATE, V73, P1123, DOI 10.1002/pros.22662; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; GUESS HA, 1992, EPIDEMIOL REV, V14, P131, DOI 10.1093/oxfordjournals.epirev.a036083; Hardie WD, 2008, AM J PHYSIOL-LUNG C, V294, pL1217, DOI 10.1152/ajplung.00020.2008; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2013, PERIODONTOL 2000, V63, P14, DOI 10.1111/prd.12030; Hosokawa Y, 2005, CLIN EXP IMMUNOL, V141, P467, DOI 10.1111/j.1365-2249.2005.02852.x; Kasabova M, 2014, J BIOL CHEM, V289, P16239, DOI 10.1074/jbc.M113.542407; Kasina S, 2009, CELL PROLIFERAT, V42, P799, DOI 10.1111/j.1365-2184.2009.00645.x; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Laborde Eric E, 2009, Rev Urol, V11, pS19; Ma JJ, 2012, J UROLOGY, V188, P1375, DOI 10.1016/j.juro.2012.06.007; Macoska JA, 2004, CANCER GENET CYTOGEN, V154, P36, DOI 10.1016/j.cancergencyto.2004.02.013; Madala SK, 2012, AM J RESP CELL MOL, V46, P380, DOI 10.1165/rcmb.2011-0237OC; Malaeb BS, 2012, UROLOGY, V79, P1111, DOI 10.1016/j.urology.2011.11.084; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Meigs JB, 2001, J CLIN EPIDEMIOL, V54, P935, DOI 10.1016/S0895-4356(01)00351-1; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Robert G, 2009, PROSTATE, V69, P1774, DOI 10.1002/pros.21027; Rodriguez-Nieves JA, 2013, NAT REV UROL, V10, P546, DOI 10.1038/nrurol.2013.149; St Sauver Jennifer L, 2008, Curr Prostate Rep, V6, P67, DOI 10.1007/s11918-008-0011-5; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yu XH, 2008, J UROLOGY, V180, P241, DOI 10.1016/j.juro.2008.03.039	38	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159490	10.1371/journal.pone.0159490	http://dx.doi.org/10.1371/journal.pone.0159490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434301	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600056
J	Bang, OY; Chung, JW; Lee, MJ; Kim, SJ; Cho, YH; Kim, GM; Chung, CS; Lee, KH; Ahn, MJ; Moon, GJ				Bang, Oh Young; Chung, Jong-Won; Lee, Mi Ji; Kim, Suk Jae; Cho, Yeon Hee; Kim, Gyeong-Moon; Chung, Chin-Sang; Lee, Kwang Ho; Ahn, Myung-Ju; Moon, Gyeong Joon			Cancer Cell-Derived Extracellular Vesicles Are Associated with Coagulopathy Causing Ischemic Stroke via Tissue Factor-Independent Way: The OASIS-CANCER Study	PLOS ONE			English	Article							COLORECTAL-CANCER; FACTOR EXPRESSION; P-SELECTIN; MICROPARTICLES; TUMOR; MICROVESICLES; COAGULATION; ACTIVATION; EPCAM; RISK	Background Cancer and stroke, which are known to be associated with one another, are the most common causes of death in the elderly. However, the pathomechanisms that lead to stroke in cancer patients are not well known. Circulating extracellular vesicles (EVs) play a role in cancer-associated thrombosis and tumor progression. Therefore, we hypothesized that cancer cell-derived EVs cause cancer-related coagulopathy resulting in ischemic stroke. Methods Serum levels of D-dimer and EVs expressing markers for cancer cells (epithelial cell adhesion molecule [CD326]), tissue factor (TF [CD142]), endothelial cells (CD31+CD42b-), and platelets (CD62P) were measured using flow cytometry in (a) 155 patients with ischemic stroke and active cancer (116 - cancer-related, 39 - conventional stroke mechanisms), (b) 25 patients with ischemic stroke without cancer, (c) 32 cancer patients without stroke, and (d) 101 healthy subjects. Results The levels of cancer cell-derived EVs correlated with the levels of D-dimer and TF+ EVs. The levels of cancer cell-derived EVs (CD326+ and CD326+ CD142+) were higher in cancer- related stroke than in other groups (P<0.05 in all the cases). Path analysis showed that cancer cell-derived EVs are related to stroke via coagulopathy as measured by D-dimer levels. Poor correlation was observed between TF+ EV and D-dimer, and path analysis demonstrated that cancer cell-derived EVs may cause cancer-related coagulopathy independent of the levels of TF+EVs. Conclusions Our findings suggest that cancer cell-derived EVs mediate coagulopathy resulting in ischemic stroke via TF-independent mechanisms.	[Bang, Oh Young; Chung, Jong-Won; Lee, Mi Ji; Kim, Suk Jae; Kim, Gyeong-Moon; Chung, Chin-Sang; Lee, Kwang Ho] Sungkyunkwan Univ, Sch Med, Dept Neurol, Samsung Med Ctr, Seoul, South Korea; [Bang, Oh Young; Chung, Jong-Won; Cho, Yeon Hee; Moon, Gyeong Joon] Samsung Med Ctr, Translat & Stem Cell Res Lab Stroke, Seoul, South Korea; [Cho, Yeon Hee; Moon, Gyeong Joon] Samsung Biomed Res Inst, Clin Res Ctr, Seoul, South Korea; [Ahn, Myung-Ju] Sungkyunkwan Univ, Sch Med, Dept Hematooncol, Samsung Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Bang, OY (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Neurol, Samsung Med Ctr, Seoul, South Korea.; Bang, OY (corresponding author), Samsung Med Ctr, Translat & Stem Cell Res Lab Stroke, Seoul, South Korea.	ohyoung.bang@samsung.com	Moon, Gyeong Joon/P-7878-2019	Moon, Gyeong Joon/0000-0002-2851-9563; Lee, Mi Ji/0000-0003-1364-1969; Chung, Jong-Won/0000-0002-9200-8899	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C16240000]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C16240000).; This study was supported by the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C16240000).	Bang OY, 2014, STROKE, V45, P1186, DOI 10.1161/STROKEAHA.113.003720; Bang OY, 2011, J CLIN NEUROL, V7, P53, DOI 10.3988/jcn.2011.7.2.53; Bick RL, 2003, NEW ENGL J MED, V349, P109, DOI 10.1056/NEJMp030086; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Castellana D, 2010, THROMB RES, V125, pS84, DOI 10.1016/S0049-3848(10)70021-9; Cestari DM, 2004, NEUROLOGY, V62, P2025, DOI 10.1212/01.WNL.0000129912.56486.2B; Chen PC, 2011, STROKE, V42, P3034, DOI 10.1161/STROKEAHA.111.615534; Chen WX, 2014, TUMOR BIOL, V35, P2883, DOI 10.1007/s13277-013-1417-4; Date K, 2013, THROMB RES, V131, P109, DOI 10.1016/j.thromres.2012.11.013; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Erichsen R, 2013, CANCER EPIDEM BIOMAR, V22, P1994, DOI 10.1158/1055-9965.EPI-13-0444; FALANGA A, 1985, BIOCHEMISTRY-US, V24, P5558, DOI 10.1021/bi00341a041; Fujita Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/486413; Geddings JE, 2016, J THROMB HAEMOST, V14, P153, DOI 10.1111/jth.13181; Goubran HA, 2013, EUR J INTERN MED, V24, P393, DOI 10.1016/j.ejim.2013.01.017; GRAUS F, 1985, MEDICINE, V64, P16, DOI 10.1097/00005792-198501000-00002; Gyorgy B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049726; Hron G, 2007, THROMB HAEMOSTASIS, V97, P119, DOI 10.1160/TH06-03-0141; Kim SG, 2010, STROKE, V41, P798, DOI 10.1161/STROKEAHA.109.571356; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044959; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037036; Kim Y, 2009, ANTICANCER RES, V29, P1817; Kuderer NM, 2009, J CLIN ONCOL, V27, P4902, DOI 10.1200/JCO.2009.22.4584; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Lima LG, 2013, BIOSCIENCE REP, V33, P701, DOI 10.1042/BSR20130057; Lima LG, 2011, THROMB HAEMOSTASIS, V106, P712, DOI 10.1160/TH11-03-0143; Mezouar S, 2015, INT J CANCER, V136, P462, DOI 10.1002/ijc.28997; Mostefai HA, 2008, PHYSIOL RES, V57, P311, DOI 10.33549/physiolres.931533; Navi BB, 2015, ANN NEUROL, V77, P291, DOI 10.1002/ana.24325; Nickel KF, 2015, BLOOD, V126, P1379, DOI 10.1182/blood-2015-01-622811; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Rautou PE, 2013, EXPERT REV HEMATOL, V6, P91, DOI [10.1586/ehm.12.74, 10.1586/EHM.12.74]; Rickles FR, 2003, CHEST, V124, p58S, DOI 10.1378/chest.124.3_suppl.58S; Sancho-Bru P, 2012, HEPATOLOGY, V55, P1931, DOI 10.1002/hep.25614; Schnell U, 2013, BBA-BIOMEMBRANES, V1828, P1989, DOI 10.1016/j.bbamem.2013.04.018; Seok JM, 2012, EUR NEUROL, V68, P368, DOI 10.1159/000341147; Seok JM, 2010, ANN NEUROL, V68, P213, DOI 10.1002/ana.22050; Sousou T, 2009, ARTERIOSCL THROM VAS, V29, P316, DOI 10.1161/ATVBAHA.108.182196; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P587, DOI 10.1074/mcp.M112.021303; Thaler J, 2012, J THROMB HAEMOST, V10, P1363, DOI 10.1111/j.1538-7836.2012.04754.x; Thalin C, 2016, THROMB RES, V139, P56, DOI 10.1016/j.thromres.2016.01.009; Thomas GM, 2009, J EXP MED, V206, P1913, DOI 10.1084/jem.20082297; Trzpis M, 2008, J PATHOL, V216, P201, DOI 10.1002/path.2396; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Yu JL, 2005, BLOOD, V105, P1734, DOI 10.1182/blood-2004-05-2042; Yu JL, 2004, J THROMB HAEMOST, V2, P2065, DOI 10.1111/j.1538-7836.2004.00972.x; Zoller B, 2012, EUR J CANCER, V48, P1875, DOI 10.1016/j.ejca.2012.01.005	48	28	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159170	10.1371/journal.pone.0159170	http://dx.doi.org/10.1371/journal.pone.0159170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427978	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300038
J	Ito, S; Murphy, CG; Doubrovina, E; Jasin, M; Moynahan, ME				Ito, Shuhei; Murphy, Conleth G.; Doubrovina, Ekaterina; Jasin, Maria; Moynahan, Mary Ellen			PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells	PLOS ONE			English	Article							SISTER-CHROMATID EXCHANGES; HOMOLOGY-DIRECTED REPAIR; DNA-DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; BLOOMS-SYNDROME; CHROMOSOME STABILITY; RECOMBINATION; MUTATION; CANCER; BRCA1	Poly(ADP-ribose) polymerases (PARPs) are the first proteins involved in cellular DNA repair pathways to be targeted by specific inhibitors for clinical benefit. Tumors harboring genetic defects in homologous recombination (HR), a DNA double-strand break (DSB) repair pathway, are hypersensitive to PARP inhibitors (PARPi). Early phase clinical trials with PARPi have been promising in patients with advanced BRCA1 or BRCA2-associated breast, ovary and prostate cancer and have led to limited approval for treatment of BRCA-deficient ovary cancer. Unlike HR-defective cells, HR-proficient cells manifest very low cytotoxicity when exposed to PARPi, although they mount a DNA damage response. However, the genotoxic effects on normal human cells when agents including PARPi disturb proficient cellular repair processes have not been substantially investigated. We quantified cytogenetic alterations of human cells, including primary lymphoid cells and non-tumorigenic and tumorigenic epithelial cell lines, exposed to PARPi at clinically relevant doses by both sister chromatid exchange (SCE) assays and chromosome spreading. As expected, both olaparib and veliparib effectively inhibited poly-ADP-ribosylation (PAR), and caused marked hypersensitivity in HR-deficient cells. Significant dose- dependent increases in SCEs were observed in normal and non-tumorigenic cells with minimal residual PAR activity. Clinically relevant doses of the FDA-approved olaparib led to a marked increase of SCEs (5-10-fold) and chromatid aberrations (2-6-fold). Furthermore, olaparib potentiated SCE induction by cisplatin in normal human cells. Our data have important implications for therapies with regard to sustained genotoxicity to normal cells. Genomic instability arising from PARPi warrants consideration, especially if these agents will be used in people with early stage cancers, in prevention strategies or for non-oncologic indications.	[Ito, Shuhei; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA; [Murphy, Conleth G.; Moynahan, Mary Ellen] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Doubrovina, Ekaterina] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Ito, Shuhei] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka, Japan; [Murphy, Conleth G.] Bon Secours Hosp, Dept Med Oncol, Cork, Ireland	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Kyushu University	Moynahan, ME (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	moynaham@mskcc.org			Hecksher Foundation for Children (MEM); National Institutes for Health [P01CA94060]; Memorial Sloan Kettering Cancer Center [P30 CA008748]; Sumitomo Life Social Welfare Services Foundation; Uehara Memorial Foundation; Fukuoka Foundation for Sound Health Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Hecksher Foundation for Children (MEM); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center; Sumitomo Life Social Welfare Services Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Fukuoka Foundation for Sound Health Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Hecksher Foundation for Children (MEM), National Institutes for Health grants P01CA94060 (MEM and MJ), The Memorial Sloan Kettering Cancer Center Support/CoreGrant (P30 CA008748), Sumitomo Life Social Welfare Services Foundation (SI), The Uehara Memorial Foundation (SI) and Fukuoka Foundation for Sound Health Cancer Research Fund (SI). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2014, ONCOLOGIC DRUGS ADVI; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Barker JN, 2010, BLOOD, V116, P5045, DOI 10.1182/blood-2010-04-281873; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; CARRANO AV, 1978, NATURE, V271, P551, DOI 10.1038/271551a0; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; De Soto JA, 2006, INT J BIOL SCI, V2, P179; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng FY, 2015, MOL CELL, V58, P925, DOI 10.1016/j.molcel.2015.04.016; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gallmeier E, 2005, CANCER BIOL THER, V4, P703, DOI 10.4161/cbt.4.7.1909; GERMAN J, 1977, AM J HUM GENET, V29, P248; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Haikarainen T, 2014, ACS MED CHEM LETT, V5, P18, DOI 10.1021/ml400292s; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; KATO H, 1974, NATURE, V251, P70, DOI 10.1038/251070a0; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; LANGLOIS RG, 1989, P NATL ACAD SCI USA, V86, P670, DOI 10.1073/pnas.86.2.670; LaRocque JR, 2011, P NATL ACAD SCI USA, V108, P11971, DOI 10.1073/pnas.1104421108; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Livraghi L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0425-1; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Masutani M, 1999, MOL CELL BIOCHEM, V193, P149; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Morimatsu M, 1998, CANCER RES, V58, P3441; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 2001, CANCER RES, V61, P4842; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Neumann R, 2010, P NATL ACAD SCI USA, V107, P8304, DOI 10.1073/pnas.1003634107; NISHI Y, 1984, CANCER RES, V44, P3270; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Patel AG, 2012, CLIN CANCER RES, V18, P1655, DOI 10.1158/1078-0432.CCR-11-2890; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; She QB, 2003, CLIN CANCER RES, V9, P4340; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Tentori L, 2002, CANCER CHEMOTH PHARM, V49, P217, DOI 10.1007/s00280-001-0409-z; Tong WM, 2007, ONCOGENE, V26, P3857, DOI 10.1038/sj.onc.1210156; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Westermark UK, 2003, MOL CELL BIOL, V23, P7926, DOI 10.1128/MCB.23.21.7926-7936.2003; Wilson DM, 2007, MUTAT RES-FUND MOL M, V616, P11, DOI 10.1016/j.mrfmmm.2006.11.017; Yelamos J, 2006, EMBO J, V25, P4350, DOI 10.1038/sj.emboj.7601301; Yusa K, 2004, NATURE, V429, P896, DOI 10.1038/nature02646; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	53	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159341	10.1371/journal.pone.0159341	http://dx.doi.org/10.1371/journal.pone.0159341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428646	gold, Green Submitted, Green Published			2022-12-27	WOS:000380169300053
J	Yue, QX; Zhen, H; Huang, M; Zheng, X; Feng, LX; Jiang, BH; Yang, M; Wu, WY; Liu, X; Guo, D				Yue, Qingxi; Zhen, Hong; Huang, Ming; Zheng, Xi; Feng, Lixing; Jiang, Baohong; Yang, Min; Wu, Wanying; Liu, Xuan; Guo, Dean			Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells	PLOS ONE			English	Article							NA+/K+-ATPASE; HEPATOCELLULAR-CARCINOMA; CARDIAC-GLYCOSIDES; TOAD VENOM; CARDIOTONIC STEROIDS; GLIOBLASTOMA CELLS; CANCER-TREATMENT; CYCLE ARREST; LUNG-CANCER; APOPTOSIS	Although the possibility of developing cardiac steroids/ cardiac glycosides as novel cancer therapeutic agents has been recognized, the mechanism of their anticancer activity is still not clear enough. Toad venom extract containing bufadienolides, which belong to cardiac steroids, has actually long been used as traditional Chinese medicine in clinic for cancer therapy in China. The cytotoxicity of arenobufagin, a bufadienolide isolated from toad venom, on human cervical carcinoma HeLa cells was checked. And, the protein expression profile of control HeLa cells and HeLa cells treated with arenobufagin for 48 h was analyzed using two-dimensional electrophoresis, respectively. Differently expressed proteins in HeLa cells treated with arenobufagin were identified and the pathways related to these proteins were mapped from KEGG database. Computational molecular docking was performed to verify the binding of arenobufagin and Na, K-ATPase. The effects of arenobufagin on Na, K-ATPase activity and proteasome activity of HeLa cells were checked. The protein-protein interaction network between Na, K-ATPase and proteasome was constructed and the expression of possible intermediate proteins ataxin-1 and translationally-controlled tumor protein in HeLa cells treated with arenobufagin was then checked. Arenobufagin induced apoptosis and G2/M cell cycle arrest in HeLa cells. The cytotoxic effect of arenobufagin was associated with 25 differently expressed proteins including proteasome-related proteins, calcium ion binding-related proteins, oxidative stress-related proteins, metabolism-related enzymes and others. The results of computational molecular docking revealed that arenobufagin was bound in the cavity formed by the transmembrane alpha subunits of Na, K-ATPase, which blocked the pathway of extracellular Na+/K+ cation exchange and inhibited the function of ion exchange. Arenobufagin inhibited the activity of Na, K-ATPase and proteasome, decreased the expression of Na, K-ATPase alpha 1 and alpha 3 subunits and increased the expression of WEE1 in HeLa cells. Antibodies against Na, K-ATPase alpha 1 and alpha 3 subunits alone or combinated with arenobufagin also inhibited the activity of proteasome. Furthermore, the expression of the possible intermediate proteins ataxin-1 and translationally-controlled tumor protein was increased in HeLa cells treated with arenobufagin by flow cytometry analysis, respectively. These results indicated that arenobufagin might directly bind with Na, K-ATPase alpha 1 and alpha 3 subunits and the inhibitive effect of arenobufagin on proteasomal activity of HeLa cells might be related to its binding with Na, K-ATPase.	[Yue, Qingxi; Zhen, Hong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Inst Oncol, Shanghai 201999, Peoples R China; [Yue, Qingxi; Feng, Lixing; Jiang, Baohong; Yang, Min; Wu, Wanying; Liu, Xuan; Guo, Dean] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai 201203, Peoples R China; [Huang, Ming] Rutgers State Univ, Ctr Integrat Prote Res, BioMaPS Inst, Piscataway, NJ 08854 USA; [Huang, Ming] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Zheng, Xi] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Yue, QX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Inst Oncol, Shanghai 201999, Peoples R China.; Yue, QX; Liu, X; Guo, D (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai 201203, Peoples R China.	qxyue@sibs.ac.cn; xuanliu@simm.ac.cn; daguo@simm.ac.cn	zhou, ju/M-3255-2017; Liu, Xuan/AAR-5093-2020	Liu, Xuan/0000-0002-7356-7898	Twelfth Five-Year National Science & Technology Support Program [2012BAI29B06]; Shanghai Science & Technology Support Program [13431900401]; China Postdoctoral Science Foundation funded project [2012M510907]; Shanghai Postdoctoral Scientific Program [13R21417800]; Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012KIP516]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program; National Nature Science Foundation [81302809, 81373964]; Research Program of Shanghai Municipal Commission of Health and Family Planning [20154Y0149]; grant constructed multi-disciplinary team for oncology in No. 3 People's Hospital, School of Medicine, Shanghai Jiaotong University;  [syzrc2014-001];  [syz2014-005];  [YG2015MS24]	Twelfth Five-Year National Science & Technology Support Program; Shanghai Science & Technology Support Program; China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation); Shanghai Postdoctoral Scientific Program; Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Research Program of Shanghai Municipal Commission of Health and Family Planning; grant constructed multi-disciplinary team for oncology in No. 3 People's Hospital, School of Medicine, Shanghai Jiaotong University; ; ; 	This work was supported in part by grants from the Twelfth Five-Year National Science & Technology Support Program (2012BAI29B06), Shanghai Science & Technology Support Program (13431900401), China Postdoctoral Science Foundation funded project (2012M510907), Shanghai Postdoctoral Scientific Program (13R21417800), the Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2012KIP516), the Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program, the National Nature Science Foundation (81302809, 81373964), the Research Program of Shanghai Municipal Commission of Health and Family Planning (20154Y0149), the fund (syzrc2014-001, syz2014-005, YG2015MS24) and the grant constructed multi-disciplinary team for oncology in No. 3 People's Hospital, School of Medicine, Shanghai Jiaotong University. The authors would like to thank Scientific Creation (Shanghai) Bio-Tech Co. Limited for technology support and helpful advice.; This work was supported in part by grants from the Twelfth Five-Year National Science & Technology Support Program (2012BAI29B06), Shanghai Science & Technology Support Program (13431900401), China Postdoctoral Science Foundation funded project (2012M510907), Shanghai Postdoctoral Scientific Program (13R21417800), the Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2012KIP516), the Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program, the National Nature Science Foundation (81302809, 81373964), the Research Program of Shanghai Municipal Commission of Health and Family Planning (20154Y0149), the fund (syzrc2014-001, syz2014-005, YG2015MS24) and the grant constructed multi-disciplinary team for oncology in No. 3 People's Hospital, School of Medicine, Shanghai Jiaotong University. We would like to thank Scientific Creation(Shanghai) Bio-Tech Co. Limited for technology support and helpful advice.	Acunzo J, 2014, CANCER TREAT REV, V40, P760, DOI 10.1016/j.ctrv.2014.02.007; Adams J, 1999, CANCER RES, V59, P2615; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babula P, 2013, ANTI-CANCER AGENT ME, V13, P1069, DOI 10.2174/18715206113139990304; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Cerella C, 2013, MITOCHONDRION, V13, P225, DOI 10.1016/j.mito.2012.06.003; Chen AL, 2009, BIOTECHNOL LETT, V31, P487, DOI 10.1007/s10529-008-9888-x; Chen DD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-716; Chen Z, 2012, CHIN J INTEGR MED, V18, P339, DOI 10.1007/s11655-012-1083-1; Contreras RG, 1999, J CELL SCI, V112, P4223; CRUZ JD, 1994, EUR J PHARM-MOLEC PH, V266, P317; CRUZ JD, 1993, EUR J PHARMACOL, V239, P223; de Chiara C, 2014, TRENDS NEUROSCI, V37, P211, DOI 10.1016/j.tins.2014.02.003; de Pril R, 2007, MOL CELL NEUROSCI, V34, P10, DOI 10.1016/j.mcn.2006.09.006; Deng LJ, 2015, ONCOTARGET, V6, P34258, DOI 10.18632/oncotarget.5545; Dou QP, 1999, DRUG RESIST UPDATE, V2, P215, DOI 10.1054/drup.1999.0095; Durlacher CT, 2015, CLIN EXP PHARMACOL P, V42, P427, DOI 10.1111/1440-1681.12385; Feldmann T, 2007, AM J PHYSIOL-CELL PH, V293, pC885, DOI 10.1152/ajpcell.00602.2006; Feng L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.222; Forrest MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051169; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Gomes A, 2010, INDIAN J EXP BIOL, V48, P93; Hashimoto O, 2003, MOL CARCINOGEN, V36, P171, DOI 10.1002/mc.10111; Jaitovich AA, 2006, SEMIN NEPHROL, V26, P386, DOI 10.1016/j.semnephrol.2006.07.002; JING YK, 1994, ANTICANCER RES, V14, P1193; Juel C, 2013, AM J PHYSIOL-REG I, V304, pR1161, DOI 10.1152/ajpregu.00591.2012; Kawazoe N, 1999, J BIOCHEM-TOKYO, V126, P278, DOI 10.1093/oxfordjournals.jbchem.a022446; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Lagalwar Sarita, 2013, Methods Mol Biol, V1010, P201, DOI 10.1007/978-1-62703-411-1_13; Laursen M, 2015, P NATL ACAD SCI USA, V112, P1755, DOI 10.1073/pnas.1422997112; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Lee DY, 1996, LIFE SCI, V60, P127, DOI 10.1016/S0024-3205(96)00602-9; Lefranc F, 2008, NEUROSURGERY, V62, P211, DOI 10.1227/01.NEU.0000311080.43024.0E; Li D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141681; Li MM, 2012, BIOCHEM PHARMACOL, V83, P1251, DOI 10.1016/j.bcp.2012.01.023; Liu X, 1999, MOL BRAIN RES, V71, P210, DOI 10.1016/S0169-328X(99)00186-2; Lopez-Lazaro M, 2007, EXPERT OPIN THER TAR, V11, P1043, DOI 10.1517/14728222.11.8.1043; Luo HL, 2003, AM J PATHOL, V163, P381, DOI 10.1016/S0002-9440(10)63667-X; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Meng ZQ, 2009, CANCER-AM CANCER SOC, V115, P5309, DOI 10.1002/cncr.24602; Mijatovic T, 2012, CURR MED CHEM, V19, P627, DOI 10.2174/092986712798992075; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; N'Diaye EN, 2008, MOL BIOL CELL, V19, P1252, DOI 10.1091/mbc.E07-08-0775; Newman RA, 2006, J EXP THER ONCOL, V5, P167; Paul D, 2014, J NEUROL SCI, V340, P139, DOI 10.1016/j.jns.2014.03.012; PAUL RJ, 1979, SCIENCE, V206, P1414, DOI 10.1126/science.505014; Cordova WHP, 2016, TOXICON, V110, P27, DOI 10.1016/j.toxicon.2015.11.015; Piccioni F, 2004, HUM MOL GENET, V13, P437, DOI 10.1093/hmg/ddh045; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Qi FH, 2010, BIOSCI TRENDS, V4, P297; Qi FH, 2011, INT IMMUNOPHARMACOL, V11, P342, DOI 10.1016/j.intimp.2010.12.007; Qin TJ, 2008, WORLD J GASTROENTERO, V14, P5210, DOI 10.3748/wjg.14.5210; Qiu J, 2008, BBA-PROTEINS PROTEOM, V1784, P1857, DOI 10.1016/j.bbapap.2008.07.006; Raghavendra PB, 2007, MOL IMMUNOL, V44, P2292, DOI 10.1016/j.molimm.2006.11.009; Sakai H, 2004, FEBS LETT, V563, P151, DOI 10.1016/S0014-5793(04)00292-3; Slingerland M, 2013, INVEST NEW DRUG, V31, P1087, DOI 10.1007/s10637-013-9984-1; Sun T, 2014, BIOSCI TRENDS, V8, P235, DOI 10.5582/bst.2014.01073; Sunol M, 2011, ANTICANCER RES, V31, P953; TANAHASHI N, 1993, ENZYME PROTEIN, V47, P241, DOI 10.1159/000468683; Tian J, 2003, MOL CELL BIOCHEM, V242, P181, DOI 10.1023/A:1021114501561; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Webster KA, 2012, FUTUR CARDIOL, V8, P863, DOI [10.2217/FCA.12.58, 10.2217/fca.12.58]; Woo AL, 2000, J BIOL CHEM, V275, P20693, DOI 10.1074/jbc.M002323200; Wu T, 2014, J CANCER RES THER, V10, P60, DOI 10.4103/0973-1482.139763; Xie XF, 2013, MED HYPOTHESES, V81, P243, DOI 10.1016/j.mehy.2013.04.038; Xie ZJ, 2003, ANN NY ACAD SCI, V986, P497, DOI 10.1111/j.1749-6632.2003.tb07234.x; Ye M, 2006, J CHROMATOGR B, V838, P86, DOI 10.1016/j.jchromb.2006.04.042; Yi YJ, 2007, BIOL REPROD, V77, P780, DOI 10.1095/biolreprod.107.061275; Yin JQ, 2007, ACTA PHARMACOL SIN, V28, P712, DOI 10.1111/j.1745-7254.2007.00559.x; Yu SP, 2003, BIOCHEM PHARMACOL, V66, P1601, DOI 10.1016/S0006-2952(03)00531-8; Yue QX, 2010, PHYTOMEDICINE, V17, P606, DOI 10.1016/j.phymed.2009.12.013; Yue QX, 2008, CANCER SCI, V99, P1461, DOI 10.1111/j.1349-7006.2008.00824.x; Yue QX, 2008, MOL CELL PROTEOMICS, V7, P949, DOI 10.1074/mcp.M700259-MCP200; Yue QX, 2012, J ETHNOPHARMACOL, V141, P659, DOI 10.1016/j.jep.2011.08.044; Yue QX, 2016, MOL CELL PROTEOMICS, V15, P26, DOI 10.1074/mcp.M115.053272; Zhang DW, 2009, J NEUROSCI, V29, P4498, DOI 10.1523/JNEUROSCI.6094-08.2009; Zhang DM, 2013, CARCINOGENESIS, V34, P1331, DOI 10.1093/carcin/bgt060; Zhao QF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/231351; Zhou B, 2015, EVID-BASED COMPL ALT, V2015	80	15	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159034	10.1371/journal.pone.0159034	http://dx.doi.org/10.1371/journal.pone.0159034			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428326	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169300031
J	Barnard, S; Calderara, S; Pistocchi, S; Cucchiara, R; Podaliri-Vulpiani, M; Messori, S; Ferri, N				Barnard, Shanis; Calderara, Simone; Pistocchi, Simone; Cucchiara, Rita; Podaliri-Vulpiani, Michele; Messori, Stefano; Ferri, Nicola			Quick, Accurate, Smart: 3D Computer Vision Technology Helps Assessing Confined Animals' Behaviour	PLOS ONE			English	Article							VIDEO TRACKING SYSTEM; KENNELED DOGS; AUTOMATIC IDENTIFICATION; PHYSIOLOGICAL-RESPONSES; SHELTER; PIGS; TEMPERAMENT; VALIDATION; VALIDITY; STRESS	Mankind directly controls the environment and lifestyles of several domestic species for purposes ranging from production and research to conservation and companionship. These environments and lifestyles may not offer these animals the best quality of life. Behaviour is a direct reflection of how the animal is coping with its environment. Behavioural indicators are thus among the preferred parameters to assess welfare. However, behavioural recording (usually from video) can be very time consuming and the accuracy and reliability of the output rely on the experience and background of the observers. The outburst of new video technology and computer image processing gives the basis for promising solutions. In this pilot study, we present a new prototype software able to automatically infer the behaviour of dogs housed in kennels from 3D visual data and through structured machine learning frameworks. Depth information acquired through 3D features, body part detection and training are the key elements that allow the machine to recognise postures, trajectories inside the kennel and patterns of movement that can be later labelled at convenience. The main innovation of the software is its ability to automatically cluster frequently observed temporal patterns of movement without any pre-set ethogram. Conversely, when common patterns are defined through training, a deviation from normal behaviour in time or between individuals could be assessed. The software accuracy in correctly detecting the dogs' behaviour was checked through a validation process. An automatic behaviour recognition system, independent from human subjectivity, could add scientific knowledge on animals' quality of life in confinement as well as saving time and resources. This 3D framework was designed to be invariant to the dog's shape and size and could be extended to farm, laboratory and zoo quadrupeds in artificial housing. The computer vision technique applied to this software is innovative in non-human animal behaviour science. Further improvements and validation are needed, and future applications and limitations are discussed.	[Barnard, Shanis; Podaliri-Vulpiani, Michele; Messori, Stefano; Ferri, Nicola] Ist Zooprofilatt Sperimentale Abruzzo & Molise, Teramo, Italy; [Calderara, Simone; Pistocchi, Simone; Cucchiara, Rita] Univ Modena & Reggio Emilia, Engn Dept Enzo Ferrari, Modena, Italy; [Barnard, Shanis] Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland	IZS Dell'abruzzo E Del Molise Giuseppe Caporale; Universita di Modena e Reggio Emilia; Queens University Belfast	Barnard, S (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise, Teramo, Italy.; Barnard, S (corresponding author), Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland.	shanis.barnard@gmail.com	ferri, nicola/AAJ-8630-2021; Vulpiani, Michele Podaliri/P-6132-2015; Calderara, Simone/M-6932-2015; Cucchiara, Rita/L-3006-2015; Barnard, Shanis/J-7151-2012	ferri, nicola/0000-0003-1454-1687; Vulpiani, Michele Podaliri/0000-0001-8958-0424; Calderara, Simone/0000-0001-9056-1538; Cucchiara, Rita/0000-0002-2239-283X; Barnard, Shanis/0000-0001-9521-8122; Messori, Stefano/0000-0002-6988-7960	Italian Ministry of Health [IZS AM 01/11 RC]	Italian Ministry of Health(Ministry of Health, Italy)	This study was funded by the Italian Ministry of Health on the project IZS AM 01/11 RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrendt P, 2011, COMPUT ELECTRON AGR, V76, P169, DOI 10.1016/j.compag.2011.01.011; Aydin A, 2013, T ASABE, V56, P1123; Barnard S, 2012, APPL ANIM BEHAV SCI, V138, P79, DOI 10.1016/j.applanim.2012.02.017; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Beerda B, 2000, ANIM WELFARE, V9, P49; Berckmans D, 2014, REV SCI TECH OIE, V33, P189, DOI 10.20506/rst.33.1.2273; Bertelli L., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2153, DOI 10.1109/CVPR.2011.5995597; Bordes A., 2007, P 24 INT C MACH LEAR, P89; Calderara S, 2011, COMPUT VIS IMAGE UND, V115, P1099, DOI 10.1016/j.cviu.2011.03.003; Calderara S, 2011, IEEE T CIRC SYST VID, V21, P457, DOI 10.1109/TCSVT.2011.2125550; Cangar O, 2008, COMPUT ELECTRON AGR, V64, P53, DOI 10.1016/j.compag.2008.05.014; Chen K, 2011, COMP VIS WORKSH ICCV, P846, DOI [. doi: 10.1109/ ICCVW. 2011.6130340, DOI 10.1109/ICCVW.2011.6130340]; Clarke N, 2016, APPL ANIM BEHAV SCI, V174, P99, DOI 10.1016/j.applanim.2015.11.019; Cucchiara R, 2008, MONDO DIGITALE, V3, P38; Dalla Villa P, 2010, PREV VET MED, V97, P58, DOI 10.1016/j.prevetmed.2010.07.001; Dalla Villa P, 2013, VET ITAL, V49, P231, DOI 10.12834/VetIt.2013.492.231.241; Dawkins MS, 2004, ANIM WELFARE, V13, pS3; Delcourt J, 2013, FISH FISH, V14, P186, DOI 10.1111/j.1467-2979.2012.00462.x; Diesel G, 2008, APPL ANIM BEHAV SCI, V115, P171, DOI 10.1016/j.applanim.2008.05.005; Eichner M., 2009, BRIT MACH VIS C, P5; Frost AR, 1997, COMPUT ELECTRON AGR, V17, P139, DOI 10.1016/S0168-1699(96)01301-4; Garde E., 2012, 1 INT C DOG POP MAN; Gerencser L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077814; Hare S, 2011, IEEE I CONF COMP VIS, P263, DOI 10.1109/ICCV.2011.6126251; Hiby EF, 2006, PHYSIOL BEHAV, V89, P385, DOI 10.1016/j.physbeh.2006.07.012; HUBRECHT RC, 1992, APPL ANIM BEHAV SCI, V34, P365, DOI 10.1016/S0168-1591(05)80096-6; Kashiha M, 2013, COMPUT ELECTRON AGR, V93, P111, DOI 10.1016/j.compag.2013.01.013; Kiddie JL, 2014, APPL ANIM BEHAV SCI, V158, P57, DOI 10.1016/j.applanim.2014.05.008; Kulikov VA, 2014, J NEUROSCI METH, V235, P219, DOI 10.1016/j.jneumeth.2014.07.012; Leroy T, 2006, T ASABE, V49, P795, DOI 10.13031/2013.20462; Lind NM, 2005, J NEUROSCI METH, V143, P123, DOI 10.1016/j.jneumeth.2004.09.019; Mason GJ, 2004, ANIM WELFARE, V13, pS57; Matsumoto J, 2014, BEHAV BRAIN RES, V272, P16, DOI 10.1016/j.bbr.2014.06.047; Matsumoto J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078460; Mertens PA, 1996, ANTHROZOOS, V9, P40, DOI 10.2752/089279396787001662; Natoli E, 2009, J VET BEHAV, V4, P79; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Oczak M, 2013, COMPUT ELECTRON AGR, V99, P209, DOI 10.1016/j.compag.2013.09.015; Ott S, 2014, LIVEST SCI, V160, P132, DOI 10.1016/j.livsci.2013.12.011; Park HS, 2009, EXPERT SYST APPL, V36, P3336, DOI 10.1016/j.eswa.2008.01.039; Pistocchi S, 2014, INT C PATT RECOG, P1993, DOI 10.1109/ICPR.2014.348; Preston T, 2012, RES VET SCI, V93, P412, DOI 10.1016/j.rvsc.2011.08.005; Publicover NG, 2009, J NEUROSCI METH, V182, P34, DOI 10.1016/j.jneumeth.2009.05.016; Spangenberg EMF, 2006, APPL ANIM BEHAV SCI, V98, P260, DOI 10.1016/j.applanim.2005.09.004; Stephen JM, 2006, PHYSIOL BEHAV, V87, P911, DOI 10.1016/j.physbeh.2006.02.015; Tillett RD, 1997, COMPUT ELECTRON AGR, V17, P249, DOI 10.1016/S0168-1699(96)01308-7; Valsecchi P, 2011, J VET BEHAV, V6, P161, DOI 10.1016/j.jveb.2011.01.002; Wathes CM, 2008, COMPUT ELECTRON AGR, V64, P2, DOI 10.1016/j.compag.2008.05.005; Wells DL, 2000, APPL ANIM BEHAV SCI, V68, P151, DOI 10.1016/S0168-1591(00)00100-3; Wells DL, 2002, ANIM WELFARE, V11, P317; Wu JH, 2004, COMPUT ELECTRON AGR, V44, P203, DOI 10.1016/j.compag.2004.05.003	52	18	18	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158748	10.1371/journal.pone.0158748	http://dx.doi.org/10.1371/journal.pone.0158748			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415814	Green Published, gold			2022-12-27	WOS:000379579500036
J	Greco, BJ; Meehan, CL; Hogan, JN; Leighty, KA; Mellen, J; Mason, GJ; Mench, JA				Greco, Brian J.; Meehan, Cheryl L.; Hogan, Jen N.; Leighty, Katherine A.; Mellen, Jill; Mason, Georgia J.; Mench, Joy A.			The Days and Nights of Zoo Elephants: Using Epidemiology to Better Understand Stereotypic Behavior of African Elephants (Loxodonta africana) and Asian Elephants (Elephas maximus) in North American Zoos	PLOS ONE			English	Article							ANIMAL-WELFARE; STRESS; CHOICE; POISSON; PARROTS	Stereotypic behavior is an important indicator of compromised welfare. Zoo elephants are documented to perform stereotypic behavior, but the factors that contribute to performance have not been systematically assessed. We collected behavioral data on 89 elephants (47 African [Loxodonta africana], 42 Asian [Elephas maximus]) at 39 North American zoos during the summer and winter. Elephants were videoed for a median of 12 daytime hours per season. A subset of 32 elephants (19 African, 13 Asian) was also observed live for a median of 10.5 nighttime hours. Percentages of visible behavior scans were calculated from five minute instantaneous samples. Stereotypic behavior was the second most commonly performed behavior (after feeding), making up 15.5% of observations during the daytime and 24.8% at nighttime. Negative binomial regression models fitted with generalized estimating equations were used to determine which social, housing, management, life history, and demographic variables were associated with daytime and nighttime stereotypic behavior rates. Species was a significant risk factor in both models, with Asian elephants at greater risk (daytime: p<0.001, Risk Ratio = 4.087; nighttime: p<0.001, Risk Ratio = 8.015). For both species, spending time housed separately (p<0.001, Risk Ratio = 1.009), and having experienced inter-zoo transfers (p<0.001, Risk Ratio = 1.175), increased the risk of performing higher rates of stereotypy during the day, while spending more time with juvenile elephants (p<0.001, Risk Ratio = 0.985), and engaging with zoo staff reduced this risk (p = 0.018, Risk Ratio = 0.988). At night, spending more time in environments with both indoor and outdoor areas (p = 0.013, Risk Ratio = 0.987) and in larger social groups (p = 0.039, Risk Ratio = 0.752) corresponded with reduced risk of performing higher rates of stereotypy, while having experienced inter-zoo transfers (p = 0.033, Risk Ratio = 1.115) increased this risk. Overall, our results indicate that factors related to the social environment are most influential in predicting elephant stereotypic behavior rates.	[Greco, Brian J.; Mench, Joy A.] Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA; [Greco, Brian J.; Mench, Joy A.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Greco, Brian J.; Meehan, Cheryl L.; Hogan, Jen N.] AWARE Inst, Portland, OR USA; [Leighty, Katherine A.; Mellen, Jill] Disneys Anim Kingdom, Lake Buena Vista, FL USA; [Mason, Georgia J.] Univ Guelph, Dept Anim Sci, Guelph, ON, Canada	University of California System; University of California Davis; University of California System; University of California Davis; Walt Disney Company; University of Guelph	Greco, BJ (corresponding author), Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA.; Greco, BJ (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.; Greco, BJ (corresponding author), AWARE Inst, Portland, OR USA.	bjgreco@ucdavis.edu			Institute of Museum and Library Services [LG-25-10-0033-10]; UC Davis' Jastro-Shields Research Scholarship; Disney's Animal Kingdom; IMLS	Institute of Museum and Library Services; UC Davis' Jastro-Shields Research Scholarship; Disney's Animal Kingdom; IMLS	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. Funding was also provided by UC Davis' Jastro-Shields Research Scholarship (BJG). Employers provided financial support in the form of authors' salaries as follows: Disney's Animal Kingdom (KAL, JM). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquariums AoZa, 2011, STAND EL MAN CAR; Bassett L, 2007, APPL ANIM BEHAV SCI, V102, P223, DOI 10.1016/j.applanim.2006.05.029; Birkett LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020101; Byrne RW, 2007, CURR BIOL, V17, pR714, DOI 10.1016/j.cub.2007.05.069; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; CHAMOVE AS, 1988, ZOO BIOL, V7, P359, DOI 10.1002/zoo.1430070407; Claxton AM, 2011, APPL ANIM BEHAV SCI, V133, P1, DOI 10.1016/j.applanim.2011.03.002; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; Cohen J., 2003, APPL MULTIPLE REGRES; Coleman K, 2010, APPL ANIM BEHAV SCI, V124, P142, DOI 10.1016/j.applanim.2010.02.008; Cook RD, 1982, RESIDUALS INFLUENCE; Dehnhard M, 2007, GEN COMP ENDOCR, V151, P274, DOI 10.1016/j.ygcen.2007.01.001; Dembiec DP, 2004, ZOO BIOL, V23, P335, DOI 10.1002/zoo.20012; Friend TH, 1999, APPL ANIM BEHAV SCI, V64, P213, DOI 10.1016/S0168-1591(99)00039-8; Friend TH, 1999, APPL ANIM BEHAV SCI, V62, P73, DOI 10.1016/S0168-1591(98)00210-X; Garai Marion E., 2006, Zeitschrift des Koelner Zoo, V49, P85; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Garner JP, 2006, APPL ANIM BEHAV SCI, V96, P153, DOI 10.1016/j.applanim.2005.09.009; Garner JP, 2003, BEHAV BRAIN RES, V145, P125, DOI 10.1016/S0166-4328(03)00115-3; Gottlieb DH, 2013, AM J PRIMATOL, V75, P995, DOI 10.1002/ajp.22161; Greco BJ, 2016, PLOS ONE; Gruber TM, 2000, ZOO BIOL, V19, P209, DOI 10.1002/1098-2361(2000)19:3&lt;209::AID-ZOO4&gt;3.0.CO;2-7; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Harris M., 2008, WELFARE HOUSING HUSB; Haspeslagh M, 2013, ANIM WELFARE, V22, P437, DOI 10.7120/09627286.22.4.437; Hemsworth PH, 2003, APPL ANIM BEHAV SCI, V81, P185, DOI 10.1016/S0168-1591(02)00280-0; Hosey G, 2008, APPL ANIM BEHAV SCI, V109, P105, DOI 10.1016/j.applanim.2007.04.013; Hutchins Michael, 2008, P285; Kay R, 2009, APPL ANIM BEHAV SCI, V116, P237, DOI 10.1016/j.applanim.2008.08.013; KURT F, 2001, INT EL RHIN RES S VI; Kurtycz LM, 2014, J APPL ANIM WELF SCI, V17, P185, DOI 10.1080/10888705.2014.896213; Laule Gail E., 2003, Journal of Applied Animal Welfare Science, V6, P163, DOI 10.1207/S15327604JAWS0603_02; Laws N, 2007, J APPL ANIM WELF SCI, V10, P349, DOI 10.1080/10888700701555600; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0000; Mason G., 2006, STEREOTYPIC ANIMAL B, P196; Mason GJ, 2010, TRENDS ECOL EVOL, V25, P713, DOI 10.1016/j.tree.2010.08.011; Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]; MASON GJ, 1993, BEHAVIOUR, V127, P191, DOI 10.1163/156853993X00029; Meehan CL, 2016, PLOS ONE; Millman ST, 2009, J APPL ANIM WELF SCI, V12, P83, DOI 10.1080/10888700902719542; Novak MA, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P153, DOI 10.1079/9780851990040.0153; Olsson IAS, 2007, APPL ANIM BEHAV SCI, V103, P229, DOI 10.1016/j.applanim.2006.05.022; Owen MA, 2005, ZOO BIOL, V24, P475, DOI 10.1002/zoo.20064; Ozminkowski RJ, 2002, J OCCUP ENVIRON MED, V44, P21, DOI 10.1097/00043764-200201000-00005; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pomerantz O, 2009, AM J PRIMATOL, V71, P687, DOI 10.1002/ajp.20703; Poole JH, 2009, ELEPHANT ROOM SCI WE; Prado-Oviedo NA, 2016, PLOS ONE; Rault JL, 2012, APPL ANIM BEHAV SCI, V136, P1, DOI 10.1016/j.applanim.2011.10.002; Rees PA, 2004, J THERM BIOL, V29, P37, DOI 10.1016/j.jtherbio.2003.10.004; Rees PA, 2009, ZOO BIOL, V28, P79, DOI 10.1002/Zoo.20200; Rohland N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000564; Ross SR, 2006, BEHAV PROCESS, V73, P117, DOI 10.1016/j.beproc.2006.04.003; Rushen J, 2003, APPL ANIM BEHAV SCI, V81, P199, DOI 10.1016/S0168-1591(02)00281-2; SCHMID J, 1995, ANIM WELFARE, V4, P87; Schmid J, 2001, ANIM WELFARE, V10, P357; Spinage C.A., 1994, ELEPHANTS; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889; Swaisgood R, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P256, DOI 10.1079/9780851990040.0256; Vickery S, 2004, ZOO BIOL, V23, P409, DOI 10.1002/zoo.20027; Wilson ML, 2006, ZOO BIOL, V25, P173, DOI 10.1002/zoo.20084; Wilson ML, 2004, ANIM WELFARE, V13, P39; Wurbel H, 1996, ETHOLOGY, V102, P371; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	66	49	51	4	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0144276	10.1371/journal.pone.0144276	http://dx.doi.org/10.1371/journal.pone.0144276			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416071	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500001
J	Rodrigues, JFM; Coelho, MTP				Mota Rodrigues, Joao Fabricio; Pacheco Coelho, Marco Tulio			Differences in Movement Pattern and Detectability between Males and Females Influence How Common Sampling Methods Estimate Sex Ratio	PLOS ONE			English	Article							FOREST; BATS	Sampling the biodiversity is an essential step for conservation, and understanding the efficiency of sampling methods allows us to estimate the quality of our biodiversity data. Sex ratio is an important population characteristic, but until now, no study has evaluated how efficient are the sampling methods commonly used in biodiversity surveys in estimating the sex ratio of populations. We used a virtual ecologist approach to investigate whether active and passive capture methods are able to accurately sample a population's sex ratio and whether differences in movement pattern and detectability between males and females produce biased estimates of sex-ratios when using these methods. Our simulation allowed the recognition of individuals, similar to mark-recapture studies. We found that differences in both movement patterns and detectability between males and females produce biased estimates of sex ratios. However, increasing the sampling effort or the number of sampling days improves the ability of passive or active capture methods to properly sample sex ratio. Thus, prior knowledge regarding movement patterns and detectability for species is important information to guide field studies aiming to understand sex ratio related patterns.	[Mota Rodrigues, Joao Fabricio; Pacheco Coelho, Marco Tulio] Univ Fed Goias, Dept Ecol, Programa Posgrad Ecol & Evol, Goiania, Go, Brazil	Universidade Federal de Goias	Rodrigues, JFM (corresponding author), Univ Fed Goias, Dept Ecol, Programa Posgrad Ecol & Evol, Goiania, Go, Brazil.	fabriciorodrigues303@gmail.com	RODRIGUES, JOÃO/AAC-6993-2019; Coelho, Marco Túlio Pacheco/U-7747-2017; Rodrigues, João/GVU-7735-2022	Coelho, Marco Túlio Pacheco/0000-0002-7831-3053; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq.)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq.)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JFMR and MTPC are supported by a graduate fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq.), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many ideas presented in this paper came from the computer modelling course taught by Dr. Paulo de Marco at the Universidade Federal de Goias. JFMR and MTPC are supported by a graduate fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq.), respectively.	Anjos L, 2007, ARARAJUBA, V15, P239; Austin MP, 2006, ECOL MODEL, V199, P197, DOI 10.1016/j.ecolmodel.2006.05.023; Cechin Sonia Zanini, 2000, Revista Brasileira de Zoologia, V17, P729, DOI 10.1590/S0101-81752000000300017; Ellis MV, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00078.1; FRANCIS CM, 1989, J MAMMAL, V70, P865, DOI 10.2307/1381730; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; GLIWICZ J, 1970, Acta Theriologica, V15, P15; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Harrel JB, 1996, AM MIDL NAT, V135, P60, DOI 10.2307/2426872; Heithaus MR, 2006, J ANIM ECOL, V75, P666, DOI 10.1111/j.1365-2656.2006.01087.x; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Larsen RJ, 2007, ACTA CHIROPTEROL, V9, P423, DOI 10.3161/1733-5329(2007)9[423:MNBSAC]2.0.CO;2; Mendes DM, 2015, NAT CONSERVACAO, V13, P60, DOI 10.1016/j.ncon.2015.05.002; Merilaita S, 1997, ANIM BEHAV, V54, P769, DOI 10.1006/anbe.1996.0490; Mesquita PCMD, 2013, AN ACAD BRAS CIENC, V85, P1127, DOI 10.1590/S0001-37652013005000040; Newson SE, 2008, J APPL ECOL, V45, P1330, DOI 10.1111/j.1365-2664.2008.01480.x; Ribeiro MA, 2011, ZOOLOGIA-CURITIBA, V28, P80, DOI 10.1590/S1984-46702011000100012; Ribeiro MA, 2008, J HERPETOL, V42, P733, DOI 10.1670/07-097R3.1; Swannack TM, 2007, SOUTHWEST NAT, V52, P386, DOI 10.1894/0038-4909(2007)52[386:PCFTSD]2.0.CO;2; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Waldez Fabiano, 2011, South American Journal of Herpetology, V6, P119; Zurell D, 2010, OIKOS, V119, P622, DOI 10.1111/j.1600-0706.2009.18284.x	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159736	10.1371/journal.pone.0159736	http://dx.doi.org/10.1371/journal.pone.0159736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441554	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500132
J	Smith, AP; Bailey, AR; Chow, JJ; Beckmann, JS; Zentall, TR				Smith, Aaron P.; Bailey, Alexandria R.; Chow, Jonathan J.; Beckmann, Joshua S.; Zentall, Thomas R.			Suboptimal Choice in Pigeons: Stimulus Value Predicts Choice over Frequencies	PLOS ONE			English	Article							CONDITIONED REINFORCER RATHER; PREFERENCE; BEHAVIOR; DELAY	Pigeons have shown suboptimal gambling-like behavior when preferring a stimulus that infrequently signals reliable reinforcement over alternatives that provide greater reinforcement overall. As a mechanism for this behavior, recent research proposed that the stimulus value of alternatives with more reliable signals for reinforcement will be preferred relatively independently of their frequencies. The present study tested this hypothesis using a simplified design of a Discriminative alternative that, 50% of the time, led to either a signal for 100% reinforcement or a blackout period indicative of 0% reinforcement against a Nondiscriminative alternative that always led to a signal that predicted 50% reinforcement. Pigeons showed a strong preference for the Discriminative alternative that remained despite reducing the frequency of the signal for reinforcement in subsequent phases to 25% and then 12.5%. In Experiment 2, using the original design of Experiment 1, the stimulus following choice of the Nondiscriminative alternative was increased to 75% and then to 100%. Results showed that preference for the Discriminative alternative decreased only when the signals for reinforcement for the two alternatives predicted the same probability of reinforcement. The ability of several models to predict this behavior are discussed, but the terminal link stimulus value offers the most parsimonious account of this suboptimal behavior.	[Smith, Aaron P.; Bailey, Alexandria R.; Chow, Jonathan J.; Beckmann, Joshua S.; Zentall, Thomas R.] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA	University of Kentucky	Smith, AP (corresponding author), Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA.	aarsmith.aps@uky.edu		Chow, Jonathan/0000-0001-5999-145X; Zentall, Thomas/0000-0003-0359-9082	Oswald Research and Creativity Award	Oswald Research and Creativity Award	Alexandria R. Bailey was supported by an Oswald Research and Creativity Award.	BAUM WM, 1974, J EXP ANAL BEHAV, V22, P231, DOI 10.1901/jeab.1974.22-231; BELKE TW, 1994, J EXP ANAL BEHAV, V62, P353, DOI 10.1901/jeab.1994.62-353; DUNN R, 1990, J EXP ANAL BEHAV, V53, P201, DOI 10.1901/jeab.1990.53-201; Gipson CD, 2009, LEARN BEHAV, V37, P289, DOI 10.3758/LB.37.4.289; GRACE RC, 1994, J EXP ANAL BEHAV, V61, P113, DOI 10.1901/jeab.1994.61-113; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Hursh SR, 2008, PSYCHOL REV, V115, P186, DOI 10.1037/0033-295X.115.1.186; KENDALL SB, 1974, J EXP ANAL BEHAV, V21, P463, DOI 10.1901/jeab.1974.21-463; Laude JR, 2014, J EXP PSYCHOL-ANIM L, V40, P12, DOI 10.1037/xan0000010; LESIEUR HR, 1992, SOCIETY, V29, P43, DOI 10.1007/BF02695311; Mazur J. E., 1993, CURRENT DIRECTIONS P, V2, P70, DOI DOI 10.1111/1467-8721.EP10770907; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; Mazur JE, 1996, J EXP ANAL BEHAV, V66, P63, DOI 10.1901/jeab.1996.66-63; McDevitt MA, 1997, J EXP ANAL BEHAV, V68, P317, DOI 10.1901/jeab.1997.68-317; McDevitt MA, 2016, J EXP ANAL BEHAV, V105, P23, DOI 10.1002/jeab.192; Molet M, 2012, LEARN BEHAV, V40, P439, DOI 10.3758/s13420-012-0065-7; Pisklak JM, 2015, J EXP ANAL BEHAV, V104, P241, DOI 10.1002/jeab.177; Shapiro MS, 2008, J EXP PSYCHOL-ANIM B, V34, P75, DOI 10.1037/0097-7403.34.1.75; Smith A, 2015, THESIS; Smith AP, 2016, J EXP PSYCHOL-ANIM L, V42, P212, DOI 10.1037/xan0000092; SPETCH ML, 1990, J EXP ANAL BEHAV, V53, P219, DOI 10.1901/jeab.1990.53-219; Stagner JP, 2012, J EXP PSYCHOL-ANIM B, V38, P446, DOI 10.1037/a0030321; Stagner JP, 2011, LEARN MOTIV, V42, P282, DOI 10.1016/j.lmot.2011.09.001; Stagner JP, 2010, PSYCHON B REV, V17, P412, DOI 10.3758/PBR.17.3.412; Stephens D.W., 1986, pi; TATHAM TA, 1989, BEHAV RES METH INSTR, V21, P294, DOI 10.3758/BF03205598; Trujano RE, 2015, BEHAV PROCESS, V119, P22, DOI 10.1016/j.beproc.2015.07.010; van Holst RJ, 2012, BIOL PSYCHIAT, V71, P741, DOI 10.1016/j.biopsych.2011.12.030; van Holst RJ, 2010, NEUROSCI BIOBEHAV R, V34, P87, DOI 10.1016/j.neubiorev.2009.07.007; Vasconcelos M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13874; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; VILLIERS PAD, 1976, PSYCHOL BULL, V83, P1131, DOI 10.1037/0033-2909.83.6.1131; WILLIAMS BA, 1991, J EXP ANAL BEHAV, V55, P37, DOI 10.1901/jeab.1991.55-37; Zentall TR, 2016, J EXP PSYCHOL-ANIM L, V42, P1, DOI 10.1037/xan0000085; Zentall TR, 2015, PSYCHOL REC, V65, P223, DOI 10.1007/s40732-015-0119-2; Zentall TR, 2011, LEARN MOTIV, V42, P245, DOI 10.1016/j.lmot.2011.03.002; Zentall TR, 2011, P ROY SOC B-BIOL SCI, V278, P1203, DOI 10.1098/rspb.2010.1607; Zentall TR, 2011, BEHAV PROCESS, V87, P50, DOI 10.1016/j.beproc.2010.12.017	38	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159336	10.1371/journal.pone.0159336	http://dx.doi.org/10.1371/journal.pone.0159336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441394	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500054
J	Asano, R; Ito, K; Yoshida, T				Asano, Ryosuke; Ito, Kenichi; Yoshida, Toshikazu			Shared Relationship Efficacy of Dyad Can Increase Life Satisfaction in Close Relationships: Multilevel Study	PLOS ONE			English	Article							ROMANTIC RELATIONSHIPS; RELATIONSHIP SCIENCE; SELF-ESTEEM; PERSPECTIVE; ATTACHMENT; MODEL; COMMITMENT; SOCIOMETER; SUPPORT; PEOPLE	Characteristics of relationship itself play an important role in determining well-being of individuals who participate in the relationship. We used efficacy expectations mutually shared between close friends or romantic partners as a characteristic of relationship and investigated its impact on their life satisfaction. In Study 1, we conducted a cross-sectional study among 137 pairs of close same-sex friends to test whether the efficacy expectations shared between friends are associated with levels of life satisfaction. In Study 2, we conducted a longitudinal study among 114 heterosexual romantic couples to test predictive validity of the efficacy expectations shared between couples predict levels of life satisfaction 2 month later. In both studies we found a consistent result that as degrees of the efficacy expectations shared between individuals in a relationship increased, the degree of their life satisfaction also increased. Underlying mechanisms that explain how characteristics of relationship itself increase life satisfaction are discussed.	[Asano, Ryosuke] Kurume Univ, Dept Literature, Kurume, Fukuoka, Japan; [Ito, Kenichi] Nanyang Technol Univ, Div Psychol, Singapore, Singapore; [Ito, Kenichi] Inst Asian Consumer Insight, Singapore, Singapore; [Yoshida, Toshikazu] Gifu Shotoku Gakuen Univ, Dept Educ, Gifu, Japan	Kurume University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Asano, R (corresponding author), Kurume Univ, Dept Literature, Kurume, Fukuoka, Japan.	asano_ryousuke@kurume-u.ac.jp	Ito, Kenichi/A-5364-2019	Ito, Kenichi/0000-0001-6936-4468; Asano, Ryosuke/0000-0001-5812-5859	JSPS [23-2815]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by JSPS Research Fellowships for Young Scientists (23-2815) to RA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acitelli LK, 2000, SOCIAL PSYCHOL PERSO, P215; Agnew CR, 1998, J PERS SOC PSYCHOL, V74, P939, DOI 10.1037/0022-3514.74.4.939; Asano R, 2015, JAPANESE J PSYCHOL, V86, P481; Asano R, 2011, JAPANESE J SOC PSYCH, V27, P41; Asano R, 2011, JAPANESE J PSYCHOL, V82, P175; Asano R, 2009, JAPANESE J INTERPERS, V9, P121; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Ben-Ari A, 2005, AM J ORTHOPSYCHIAT, V75, P621, DOI 10.1037/0002-9432.75.4.621; BERSCHEID E, 1989, J PERS SOC PSYCHOL, V57, P792, DOI 10.1037/0022-3514.57.5.792; Berscheid E, 1999, AM PSYCHOL, V54, P260, DOI 10.1037/0003-066X.54.4.260; Bolger N, 2000, J PERS SOC PSYCHOL, V79, P953, DOI 10.1037//0022-3514.79.6.953; Campbell L, 2012, SCIENCE OF THE COUPLE: THE ONTARIO SYMPOSIUM, VOL 12, P1; CLARK MS, 1979, J PERS SOC PSYCHOL, V37, P12, DOI 10.1037/0022-3514.37.1.12; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Diener E, 2013, SOC INDIC RES, V112, P497, DOI 10.1007/s11205-012-0076-y; DOHERTY WJ, 1981, AM J FAM THER, V9, P35, DOI 10.1080/01926188108250395; Feeney BC, 2015, PERS SOC PSYCHOL REV, V19, P113, DOI 10.1177/1088868314544222; Fincham FD, 2000, J FAM PSYCHOL, V14, P267, DOI 10.1037/0893-3200.14.2.267; Gable SL, 2010, ADV EXP SOC PSYCHOL, V42, P195, DOI 10.1016/S0065-2601(10)42004-3; Gonzaga GC, 2007, J PERS SOC PSYCHOL, V93, P34, DOI 10.1037/0022-3514.93.1.34; Gonzalez R, 2000, SOCIAL PSYCHOL PERSO, P181; Huta V, 2014, J HAPPINESS STUD, V15, P1425, DOI 10.1007/s10902-013-9485-0; Ickes W, 2004, HANDBOOK OF CLOSENESS AND INTIMACY, P357; Kahneman D., 1999, WELL BEING FDN HEDON; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; Kenny D. A., 2006, DYADIC DATA ANAL; KENNY DA, 1985, J PERS SOC PSYCHOL, V48, P339, DOI 10.1037/0022-3514.48.2.339; Kubo M, 1993, JAPANESE J EXPT SOCI, V33, P1; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; Ledermann T, 2012, J FAM PSYCHOL, V26, P140, DOI 10.1037/a0026624; Lewin K, 1947, HUM RELAT, V1, P143, DOI 10.1177/001872674700100201; Ludtke O, 2008, PSYCHOL METHODS, V13, P203, DOI 10.1037/a0012869; Ludtke O, 2011, PSYCHOL METHODS, V16, P444, DOI 10.1037/a0024376; Murray SL, 2006, PSYCHOL BULL, V132, P641, DOI 10.1037/0033-2909.132.5.641; Murray SL, 2009, J EXP SOC PSYCHOL, V45, P1180, DOI 10.1016/j.jesp.2009.07.001; Murray SL, 1997, PERS SOC PSYCHOL B, V23, P586, DOI 10.1177/0146167297236003; Muthen B., 2011, HDB ADV MULTILEVEL A, P15, DOI DOI 10.4324/9780203848852.CH2; Muthen L.K., 2012, MPLUS USERS GUIDE ST, V7th; Oishi S., 2009, DOING SCI HAPPINESS; Oishi S, 2007, PERSPECT PSYCHOL SCI, V2, P346, DOI 10.1111/j.1745-6916.2007.00048.x; Oishi S, 2009, PERS SOC PSYCHOL REV, V13, P334, DOI 10.1177/1088868309347835; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Reis HT, 2013, PERSPECT PSYCHOL SCI, V8, P558, DOI 10.1177/1745691613497966; Reis HT, 2004, HANDBOOK OF CLOSENESS AND INTIMACY, P201; Rusbult CE, 2009, CURR DIR PSYCHOL SCI, V18, P305, DOI 10.1111/j.1467-8721.2009.01657.x; RUSBULT CE, 1983, J PERS SOC PSYCHOL, V45, P101, DOI 10.1037/0022-3514.45.1.101; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Schimmack U, 2003, J RES PERS, V37, P100, DOI 10.1016/S0092-6566(02)00532-9; Simpson JA, 2007, J PERS SOC PSYCHOL, V92, P355, DOI 10.1037/0022-3514.92.2.355; Srivastava S, 2005, J PERS SOC PSYCHOL, V89, P966, DOI 10.1037/0022-3514.89.6.966; Sternberg RJ, 1997, EUR J SOC PSYCHOL, V27, P313, DOI 10.1002/(SICI)1099-0992(199705)27:3<313::AID-EJSP824>3.3.CO;2-W; Watson CB, 2001, PERS SOC PSYCHOL B, V27, P1057, DOI 10.1177/0146167201278012; Zaccaro S., 1995, SELF EFFICACY ADAPTA, P305, DOI [DOI 10.1007/978-1-4419-6868-5_11, 10.1007/978-1-4419-6868-5_11]	57	3	3	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159822	10.1371/journal.pone.0159822	http://dx.doi.org/10.1371/journal.pone.0159822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27437946	gold, Green Published			2022-12-27	WOS:000380170100076
J	Walworth, K; Bodas, M; Campbell, RJ; Swanson, D; Sharma, A; Vij, N				Walworth, Kyla; Bodas, Manish; Campbell, Ryan John; Swanson, Doug; Sharma, Ajit; Vij, Neeraj			Dendrimer-Based Selective Proteostasis-Inhibition Strategy to Control NSCLC Growth and Progression	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; CANCER-THERAPY; LUNG-CANCER; CELL-DEATH; ATPASE; P97; NANOPARTICLE; DEGRADATION; APOPTOSIS; FIBROSIS	Elevated valosin containing protein (VCP/p97) levels promote the progression of non-small cell lung carcinoma (NSCLC). Although many VCP inhibitors are available, most of these therapeutic compounds have low specificity for targeted tumor cell delivery. Hence, the primary aim of this study was to evaluate the in vitro efficacy of dendrimer-encapsulated potent VCP-inhibitor drug in controlling non-small cell lung carcinoma (NSCLC) progression. The VCP inhibitor(s) (either in their pure form or encapsulated in generation-4 PAMAM-dendrimer with hydroxyl surface) were tested for their in vitro efficacy in modulating H1299 (NSCLC cells) proliferation, migration, invasion, apoptosis and cell cycle progression. Our results show that VCP inhibition by DBeQ was significantly more potent than NMS-873 as evident by decreased cell proliferation (p<0.0001, MTT-assay) and migration (p<0.05; scratch-assay), and increased apoptosis (p<0.05; caspase-3/7-assay) as compared to untreated control cells. Next, we found that dendrimer-encapsulated DBeQ (DDNDBeQ) treatment increased ubiquitinated-protein accumulation in soluble protein-fraction (immunoblotting) of H1299 cells as compared to DDN-control, implying the effectiveness of DBeQ in proteostasis-inhibition. We verified by immunostaining that DDNDBeQ treatment increases accumulation of ubiquitinated-proteins that co-localizes with an ER-marker, KDEL. We observed that proteostasis-inhibition with DDNDBeQ, significantly decreased cell migration rate (scratch-assay and transwell-invasion) as compared to the control-DDN treatment (p<0.05). Moreover, DDNDBeQ treatment showed a significant decrease in cell proliferation (p<0.01, MTT-assay) and increased caspase-3/7 mediated apoptotic cell death (p<0.05) as compared to DDN-control. This was further verified by cell cycle analysis (propidium-iodide-staining) that demonstrated significant cell cycle arrest in the G2/M-phase (p<0.001) by DDNDBeQ treatment as compared to control-DDN. Moreover, we confirmed by clonogenic-assay that DDNDBeQ treatment significantly (p<0.001) inhibits H1299 colony-formation as compared to control/DDN. Overall, encapsulation of potent VCP-inhibitor DBeQ into a dendrimer allows selective VCP-mediated proteostasis-inhibition for controlling NSCLC-tumor growth and progression to allow tumor-targeted sustained drug delivery.	[Walworth, Kyla; Bodas, Manish; Campbell, Ryan John; Vij, Neeraj] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA; [Vij, Neeraj] Johns Hopkins Sch Med, Dept Pediat Resp Sci, Baltimore, MD 21205 USA; [Swanson, Doug; Sharma, Ajit] Cent Michigan Univ, Dept Chem & Biochem, Mt Pleasant, MI 48859 USA	Central Michigan University; Johns Hopkins University; Johns Hopkins Medicine; Central Michigan University	Vij, N (corresponding author), Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA.; Vij, N (corresponding author), Johns Hopkins Sch Med, Dept Pediat Resp Sci, Baltimore, MD 21205 USA.	neeraj.vij@cmich.edu	Bodas, Manish/AAE-4016-2020	Bodas, Manish/0000-0002-1046-9799	FAMRI [YCSA_082131]; NIH [U54CA141868]	FAMRI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by FAMRI (YCSA_082131) and NIH (U54CA141868) grants to NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auner HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074415; Barthelme D, 2016, J MOL BIOL, V428, P1861, DOI 10.1016/j.jmb.2015.11.015; Bisht Savita, 2007, Journal of Nanobiotechnology, V5, P3, DOI 10.1186/1477-3155-5-3; Bodas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015480; Chou TF, 2014, J MOL BIOL, V426, P2886, DOI 10.1016/j.jmb.2014.05.022; Chou TF, 2011, AUTOPHAGY, V7, P1091, DOI 10.4161/auto.7.9.16489; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Duong HQ, 2012, INT J ONCOL, V41, P2227, DOI 10.3892/ijo.2012.1672; Fang CJ, 2015, CHEMMEDCHEM, V10, P52, DOI 10.1002/cmdc.201402420; Fessart D, 2013, CANCER LETT, V337, P26, DOI 10.1016/j.canlet.2013.05.030; Gogineni VR, 2011, CANCER LETT, V313, P64, DOI 10.1016/j.canlet.2011.08.022; Kobes JE, 2016, PANCREAS, V45, P1158, DOI 10.1097/MPA.0000000000000607; Liu JF, 2011, INT J NANOMED, V6, P59, DOI 10.2147/IJN.S14601; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Pan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013298; Parzych K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.373; Pourianazar NT, 2016, BIOMED PHARMACOTHER, V78, P81, DOI 10.1016/j.biopha.2016.01.002; Roy I, 2010, NANOMED-NANOTECHNOL, V6, P237, DOI 10.1016/j.nano.2009.07.001; Shah PP, 2015, ONCOTARGET, V6, P17725, DOI 10.18632/oncotarget.3918; Shivalingappa PC, 2016, ANTIOXID REDOX SIGN, V24, P186, DOI 10.1089/ars.2015.6367; Upadhaya SK, 2014, ANAL BIOANAL CHEM, V406, P455, DOI 10.1007/s00216-013-7458-0; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Vij Neeraj, 2010, Journal of Nanobiotechnology, V8, P22, DOI 10.1186/1477-3155-8-22; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yang H, 2016, NANOMED-NANOTECHNOL, V12, P309, DOI 10.1016/j.nano.2015.11.012; Yoon AR, 2016, J CONTROL RELEASE, V231, P2, DOI 10.1016/j.jconrel.2016.02.046; Zheng YL, 2010, INT J CANCER, V126, P2199, DOI 10.1002/ijc.24771	32	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158507	10.1371/journal.pone.0158507	http://dx.doi.org/10.1371/journal.pone.0158507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434122	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600009
J	Zakostelska, Z; Malkova, J; Klimesova, K; Rossmann, P; Hornova, M; Novosadova, I; Stehlikova, Z; Kostovcik, M; Hudcovic, T; Stepankova, R; Juzlova, K; Hercogova, J; Tlaskalova-Hogenova, H; Kverka, M				Zakostelska, Zuzana; Malkova, Jana; Klimesova, Klara; Rossmann, Pavel; Hornova, Michaela; Novosadova, Iva; Stehlikova, Zuzana; Kostovcik, Martin; Hudcovic, Tomas; Stepankova, Renata; Juzlova, Katerina; Hercogova, Jana; Tlaskalova-Hogenova, Helena; Kverka, Miloslav			Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response	PLOS ONE			English	Article							ALTERED GUT MICROBIOTA; BACTERIAL OVERGROWTH; MUCOSAL BARRIER; GERM-FREE; T-CELLS; PROBIOTICS; DIET; MANIFESTATIONS; DISEASE; ROSACEA	Psoriasis is a chronic inflammatory skin disease in which Th17 cells play a crucial role. Since indigenous gut microbiota influences the development and reactivity of immune cells, we analyzed the link among microbiota, T cells and the formation of psoriatic lesions in the imiquimod-induced murine model of psoriasis. To explore the role of microbiota, we induced skin inflammation in germ-free (GF), broad-spectrum antibiotic (ATB)-treated or conventional (CV) BALB/c and C57BL/6 mice. We found that both mice reared in GF conditions for several generations and CV mice treated with ATB were more resistant to imiquimod-induced skin inflammation than CV mice. The ATB treatment dramatically changed the diversity of gut bacteria, which remained stable after subsequent imiquimod application; ATB treatment resulted in a substantial increase in the order Lactobacillales and a significant decrease in Coriobacteriales and Clostridiales. Moreover, as compared to CV mice, imiquimod induced a lower degree of local and systemic Th17 activation in both GF and ATB-treated mice. These findings suggest that gut microbiota control imiquimod-induced skin inflammation by altering the T cell response.	[Zakostelska, Zuzana; Malkova, Jana; Klimesova, Klara; Rossmann, Pavel; Hornova, Michaela; Novosadova, Iva; Stehlikova, Zuzana; Kostovcik, Martin; Tlaskalova-Hogenova, Helena; Kverka, Miloslav] Czech Acad Sci, Inst Microbiol, Vvi, Prague, Czech Republic; [Klimesova, Klara] Czech Acad Sci, Inst Mol Genet, Vvi, Prague, Czech Republic; [Hudcovic, Tomas; Stepankova, Renata] Czech Acad Sci, Inst Microbiol, Vvi, Novy Hradek, Czech Republic; [Juzlova, Katerina; Hercogova, Jana] Charles Univ Prague, Fac Med 2, Dept Dermatol, Prague, Czech Republic; [Juzlova, Katerina; Hercogova, Jana] Bulovka Hosp, Prague, Czech Republic; [Kverka, Miloslav] Czech Acad Sci, Inst Expt Med, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Bulovka University Hospital; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Kverka, M (corresponding author), Czech Acad Sci, Inst Microbiol, Vvi, Prague, Czech Republic.; Kverka, M (corresponding author), Czech Acad Sci, Inst Expt Med, Vvi, Prague, Czech Republic.	kverka@biomed.cas.cz	Hudcovic, Tomas/H-7917-2014; Zákostelská, Zuzana/ABB-9807-2021; stepankova, renata/J-9735-2014; Stehlikova, Zuzana/AAR-2775-2021; Kverka, Miloslav/H-2507-2014; Kostovcikova, Klara/J-6851-2014	Hudcovic, Tomas/0000-0002-4761-5040; stepankova, renata/0000-0001-7504-6300; Stehlikova, Zuzana/0000-0002-2420-3289; Kverka, Miloslav/0000-0002-1335-5252; Kostovcikova, Klara/0000-0003-1821-398X; Zakostelska, Zuzana/0000-0002-6695-8188	Ministry of Health of the Czech Republic [15-30782A]; Czech Science Foundation [P303/12/0535]; Institutional Research Concept [RVO: 61388971]; European Regional Development Fund BIOCEV [CZ.1.05/1.1.00/02.0109]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Institutional Research Concept; European Regional Development Fund BIOCEV	This work was supported by Ministry of Health of the Czech Republic (15-30782A; http://www.azvcr.cz/; JH), by Czech Science Foundation (P303/12/0535; https://gacr.cz/; MKv), by Institutional Research Concept (RVO: 61388971) and by European Regional Development Fund BIOCEV (CZ.1.05/1.1.00/02.0109; www.biocev.eu; MKo). All rights reserved. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-31; Arck P, 2010, EXP DERMATOL, V19, P401, DOI 10.1111/j.1600-0625.2009.01060.x; Bhatia BK, 2014, J AM ACAD DERMATOL, V71, P350, DOI 10.1016/j.jaad.2014.03.017; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Bowe WP, 2014, BENEF MICROBES, V5, P185, DOI 10.3920/BM2012.0060; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardone M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114516; Chen LL, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/909514; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Debbaneh M, 2014, J AM ACAD DERMATOL, V71, P133, DOI 10.1016/j.jaad.2014.02.012; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Di Meglio P, 2014, IMMUNITY, V40, P989, DOI 10.1016/j.immuni.2014.04.019; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Fry L, 2013, BRIT J DERMATOL, V169, P47, DOI 10.1111/bjd.12322; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Huang BL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00013; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansen C, 2015, P NATL ACAD SCI USA, V112, pE5825, DOI 10.1073/pnas.1509971112; Klimesova K, 2013, INFLAMM BOWEL DIS, V19, P1266, DOI 10.1097/MIB.0b013e318281330a; Leffler DA, 2015, NAT REV GASTRO HEPAT, V12, P561, DOI 10.1038/nrgastro.2015.131; Majamaa H, 1997, J ALLERGY CLIN IMMUN, V99, P179, DOI 10.1016/S0091-6749(97)70093-9; Majamaa H, 1996, J ALLERGY CLIN IMMUN, V97, P985, DOI 10.1016/S0091-6749(96)80074-1; McFadden JP, 2009, BRIT J DERMATOL, V160, P929, DOI 10.1111/j.1365-2133.2009.09102.x; Naldi L, 2001, J AM ACAD DERMATOL, V44, P433, DOI 10.1067/mjd.2001.110876; NOAH PW, 1990, SEMIN DERMATOL, V9, P269; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Parodi A, 2008, CLIN GASTROENTEROL H, V6, P759, DOI 10.1016/j.cgh.2008.02.054; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Viljanen M, 2005, ALLERGY, V60, P494, DOI 10.1111/j.1398-9995.2004.00514.x; Weinstock LB, 2013, J AM ACAD DERMATOL, V68, P875, DOI 10.1016/j.jaad.2012.11.038; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Zakostelska Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027961; Zanvit P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9424	42	85	89	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159539	10.1371/journal.pone.0159539	http://dx.doi.org/10.1371/journal.pone.0159539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434104	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169600065
J	Ashinsky, BG; Fishbein, KW; Carter, EM; Lin, PC; Pleshko, N; Raggio, CL; Spencer, RG				Ashinsky, Beth G.; Fishbein, Kenneth W.; Carter, Erin M.; Lin, Ping-Chang; Pleshko, Nancy; Raggio, Cathleen L.; Spencer, Richard G.			Multiparametric Classification of Skin from Osteogenesis Imperfecta Patients and Controls by Quantitative Magnetic Resonance Microimaging	PLOS ONE			English	Article							IN-VIVO; RELAXATION-TIMES; COLLAGEN; CARTILAGE; MRI; T2	The purpose of this study is to evaluate the ability of quantitative magnetic resonance imaging (MRI) to discriminate between skin biopsies from individuals with osteogenesis imperfecta (OI) and skin biopsies from individuals without OI. Skin biopsies from nine controls (unaffected) and nine OI patients were imaged to generate maps of five separate MR parameters, T-1, T-2, k(m), MTR and ADC. Parameter values were calculated over the dermal region and used for univariate and multiparametric classification analysis. A substantial degree of overlap of individual MR parameters was observed between control and OI groups, which limited the sensitivity and specificity of univariate classification. Classification accuracies ranging between 39% and 67% were found depending on the variable of investigation, with T-2 yielding the best accuracy of 67%. When several MR parameters were considered simultaneously in a multivariate analysis, the classification accuracies improved up to 89% for specific combinations, including the combination of T-2 and k(m). These results indicate that multiparametric classification by quantitative MRI is able to detect differences between the skin of OI patients and of unaffected individuals, which motivates further study of quantitative MRI for the clinical diagnosis of OI.	[Ashinsky, Beth G.; Fishbein, Kenneth W.; Spencer, Richard G.] NIA, Lab Clin Invest, Magnet Resonance Imaging & Spect Sect, NIH, Baltimore, MD 21224 USA; [Carter, Erin M.; Raggio, Cathleen L.] Hosp Special Surg, Kathryn O & Alan C Greenberg Ctr Skeletal Dysplas, 535 E 70th St, New York, NY 10021 USA; [Lin, Ping-Chang] Augusta Univ, GRU Canc Ctr, Core Imaging Facil Small Anim, Augusta, GA USA; [Pleshko, Nancy] Temple Univ, Coll Engn, Dept Bioengn, Philadelphia, PA 19122 USA; [Raggio, Cathleen L.] Hosp Special Surg, Dept Orthopaed, 535 E 70th St, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Georgia; Augusta University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Spencer, RG (corresponding author), NIA, Lab Clin Invest, Magnet Resonance Imaging & Spect Sect, NIH, Baltimore, MD 21224 USA.	spencer@helix.nih.gov	Fishbein, Kenneth/AAN-2595-2021	Fishbein, Kenneth/0000-0002-6353-4603; Lin, Ping-Chang/0000-0003-0918-4072	Pediatric Society of North America; National Institute on Aging, National Institutes of Health, Intramural Research Program; NATIONAL INSTITUTE ON AGING [ZIAAG000922] Funding Source: NIH RePORTER	Pediatric Society of North America; National Institute on Aging, National Institutes of Health, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Pediatric Society of North America (https://posna.org/) Grant to CLR, "Identification of Skin Abnormalities in OI Patients by MR Imaging" and the National Institute on Aging, National Institutes of Health, Intramural Research Program (RGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablin DS, 1997, PEDIATR RADIOL, V27, P111, DOI 10.1007/s002470050079; Adur J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069186; Balasubramanian M, 2015, CLIN DYSMORPHOL, V24, P45, DOI 10.1097/MCD.0000000000000066; BITTOUN J, 1990, RADIOLOGY, V176, P457, DOI 10.1148/radiology.176.2.2367660; Bittoun J, 2006, NMR BIOMED, V19, P723, DOI 10.1002/nbm.1101; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; Braun Hillary J, 2011, Imaging Med, V3, P541; Burstein D, 2000, INVEST RADIOL, V35, P622, DOI 10.1097/00004424-200010000-00008; Canuto HC, 2012, NMR BIOMED, V25, P169, DOI 10.1002/nbm.1732; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheung MS, 2008, REV ENDOCR METAB DIS, V9, P153, DOI 10.1007/s11154-008-9074-4; Choi JA, 2011, MAGN RESON IMAGING C, V19, P249, DOI 10.1016/j.mric.2011.02.010; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; Dimitriadou E, 2008, R PACKAGE, V1, P5; Fishbein KW, 2007, MAGN RESON MED, V57, P1000, DOI 10.1002/mrm.21216; FRANCIS MJO, 1974, BRIT MED J, V1, P421, DOI 10.1136/bmj.1.5905.421; HAJNAL JV, 1992, J COMPUT ASSIST TOMO, V16, P7, DOI 10.1097/00004728-199201000-00003; Hansen B, 2002, ARCH DERMATOL, V138, P909, DOI 10.1001/archderm.138.7.909; Hastie T, 1996, J ROY STAT SOC B MET, V58, P155; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; HOLBROOK KA, 1989, AM J MED GENET, V34, P105, DOI 10.1002/ajmg.1320340118; Laistler E, 2015, J MAGN RESON IMAGING, V41, P496, DOI 10.1002/jmri.24549; Lin PC, 2012, MAGN RESON MED, V67, P1815, DOI 10.1002/mrm.23189; Lin PC, 2009, MAGN RESON MED, V62, P1311, DOI 10.1002/mrm.22110; Lin PC, 2009, J MAGN RESON, V201, P61, DOI 10.1016/j.jmr.2009.08.001; Lukas VA, 2015, J ORTHOP RES, V33, P640, DOI 10.1002/jor.22810; Marini JC, 2014, CURR OPIN PEDIATR, V26, P500, DOI 10.1097/MOP.0000000000000117; Mirrashed F, 2004, SKIN RES TECHNOL, V10, P149, DOI 10.1111/j.1600-0846.2004.00071.x; Mosher Timothy J, 2006, Magn Reson Imaging Clin N Am, V14, P63, DOI 10.1016/j.mric.2005.12.002; Mosher TJ, 2004, ARTHRITIS RHEUM-US, V50, P2820, DOI 10.1002/art.20473; RENOU JP, 1994, BIOPOLYMERS, V34, P1615, DOI 10.1002/bip.360341206; RICHARD S, 1993, J INVEST DERMATOL, V100, P705, DOI 10.1111/1523-1747.ep12472356; Schwenzer NF, 2009, J MAGN RESON IMAGING, V29, P1346, DOI 10.1002/jmri.21789; Shapiro L, 2012, J MAGN RESON IMAGING, V36, P775, DOI 10.1002/jmri.23629; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SMITH R, 1975, Q J MED, V44, P555; Song HK, 1997, MAGNET RESON MED, V37, P185, DOI 10.1002/mrm.1910370207; Spencer RG, 2013, J AM ACAD ORTHOP SUR, V21, P438, DOI 10.5435/JAAOS-21-07-438; Van Dijk FS, 2014, AM J MED GENET A, V164, P1470, DOI 10.1002/ajmg.a.36545; Wirth W, 2014, OSTEOARTHR CARTILAGE, V22, P1554, DOI 10.1016/j.joca.2014.06.003	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0157891	10.1371/journal.pone.0157891	http://dx.doi.org/10.1371/journal.pone.0157891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416032	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500014
J	Garcia-Lopez, R; de la Morena-Barrio, ME; Alsina, L; Perez-Duenas, B; Jaeken, J; Serrano, M; Casado, M; Hernandez-Caselles, T				Garcia-Lopez, Roberto; Eugenia de la Morena-Barrio, Maria; Alsina, Laia; Perez-Duenas, Belen; Jaeken, Jaak; Serrano, Mercedes; Casado, Mercedes; Hernandez-Caselles, Trinidad			Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG)	PLOS ONE			English	Article							NK-CELLS; CONGENITAL DISORDERS; GLYCOSYLATION; EXPRESSION; BINDING; ICAM-1; SUSCEPTIBILITY; IDENTIFICATION; DEGRANULATION; LYMPHOCYTES	Background PMM2-CDG is the most common N-glycosylation defect and shows an increased risk of recurrent and/or severe, sometimes fatal, infections in early life. We hypothesized that natural killer (NK) cells, as important mediators of the immune response against microbial pathogens and regulators of adaptive immunity, might be affected in this genetic disorder. Objective To evaluate possible defects on PMM2-CDG NK peripheral blood cell number, killing activity and expression of membrane receptors. Methods We studied fresh and activated NK cells from twelve PMM2-CDG cells. The number and expression of lymphoid surface receptors were studied by flow cytometry. The NK responsiveness (frequency of degranulated NK cells) and killing activity against K562 target cells was determined in the NK cytotoxicity assay. Results We found an increase of blood NK cells in three patients with a severe phenotype. Two of them, who had suffered from moderate/severe viral infections during their first year of life, also had reduced T lymphocyte numbers. Patient activated NK cells showed increased expression of CD54 adhesion molecule and NKG2D and NKp46 activating receptors. NKp46 and 2B4 expression was inversely correlated with the expression of NKG2D in activated PMM2-CDG cells. Maximal NK activity against K562 target cells was similar in control and PMM2-CDG cells. Interestingly, the NK cell responsiveness was higher in patient cells. NKG2D and specially CD54 increased surface expression significantly correlated with the increased NK cell cytolytic activity according to the modulation of the killer activity by expression of triggering receptors and adhesion molecules. Conclusions Our results indicate that hypoglycosylation in PMM2-CDG altered NK cell reactivity against target cells and the expression of CD54 and NKG2D, NKp46 and 2B4 activating receptors during NK cell activation. This suggests a defective control of NK cell killing activity and the overall anti-viral immune response in PMM2-CDG patients. The present work improves our understanding of the immunological functions in PMM2-CDG and possibly in other CDG-I types.	[Garcia-Lopez, Roberto; Hernandez-Caselles, Trinidad] IMIB Univ Murcia, Fac Med, Dept Bioquim Biol Mol & Inmunol B, Murcia, Spain; [Eugenia de la Morena-Barrio, Maria] Hosp Univ Morales Meseguer, IMIB Arrixaca, Serv Hematol & Oncol Med, Ctr Reg Hemodonac, Murcia, Spain; [Eugenia de la Morena-Barrio, Maria] CIBERER, Valencia, Spain; [Alsina, Laia] Hosp St Joan de Deu, Secc Alergia & Inmunol Clin, Barcelona, Spain; [Perez-Duenas, Belen; Serrano, Mercedes] Hosp St Joan de Deu, Dept Neurol Infantil, Barcelona, Spain; [Jaeken, Jaak] KULeuven, Univ Ziekenhuis Gasthuisberg, Ctr Metab Dis, Leuven, Belgium; [Casado, Mercedes] Hosp St Joan de Deu CIBERER ISCIII, Dept Bioquim Clin & Neuropediat, Barcelona, Spain	University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; Meseguer General University Hospital Morales; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona; KU Leuven; University Hospital Leuven; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Hernandez-Caselles, T (corresponding author), IMIB Univ Murcia, Fac Med, Dept Bioquim Biol Mol & Inmunol B, Murcia, Spain.	trini@um.es	de la Morena-Barrio, ME/AAG-5103-2021; Perez-Duenas, Belen/AAG-9054-2019; Alsina, Laia/AID-4372-2022; Hernandez-Caselles, Trinidad/R-1065-2018; Alsina, Laia/GQI-3516-2022	de la Morena-Barrio, ME/0000-0001-7426-4947; Hernandez-Caselles, Trinidad/0000-0001-6727-8320; Alsina, Laia/0000-0002-3559-0018; Serrano, Mercedes/0000-0002-2056-2428	Ministerio de Economia y Competitividad	Ministerio de Economia y Competitividad(Spanish Government)	RG-L is a postgraduate student from the University of Murcia. MEM-B is a holder of a postdoctoral research grant from Ministerio de Economia y Competitividad.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Benson V, 2010, INT IMMUNOL, V22, P167, DOI 10.1093/intimm/dxp123; Bergmann M, 1998, GLYCOBIOLOGY, V8, P963, DOI 10.1093/glycob/8.10.963; Blank C, 2006, J INHERIT METAB DIS, V29, P592, DOI 10.1007/s10545-006-0275-2; Bowles JA, 2005, J IMMUNOL METHODS, V304, P88, DOI 10.1016/j.jim.2005.06.018; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Cohnen A, 2013, BLOOD, V122, P1411, DOI 10.1182/blood-2012-07-441832; Crome SQ, 2013, TRENDS IMMUNOL, V34, P342, DOI 10.1016/j.it.2013.03.002; de la Morena-Barrio ME, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-170; Della Chiesa M, 2006, BLOOD, V108, P4118, DOI 10.1182/blood-2006-06-006700; Drescher B, 2003, IMMUNOLOGY, V110, P335, DOI 10.1046/j.1365-2567.2003.01743.x; Duske H, 2011, HUM IMMUNOL, V72, P1007, DOI 10.1016/j.humimm.2011.08.006; Enqvist M, 2015, J IMMUNOL, V194, P4518, DOI 10.4049/jimmunol.1401972; ERKELLERYUKSEL FM, 1992, J PEDIATR-US, V120, P216, DOI 10.1016/S0022-3476(05)80430-5; Freeze H. H., 2009, ESSENTIALS GLYCOBIOL; GALUSTIAN C, 1994, IMMUNOPHARMACOLOGY, V27, P165, DOI 10.1016/0162-3109(94)90051-5; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; He P, 2014, GLYCOBIOLOGY, V24, P392, DOI 10.1093/glycob/cwu006; He P, 2012, J BIOL CHEM, V287, P18210, DOI 10.1074/jbc.M112.355677; Hernandez-Caselles T, 2006, J LEUKOCYTE BIOL, V79, P46, DOI 10.1189/jlb.0205096; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kjaergaard S, 2001, ARCH DIS CHILD, V85, P236, DOI 10.1136/adc.85.3.236; Konjevic G, 2007, CLIN EXP METASTAS, V24, P1, DOI 10.1007/s10585-006-9043-9; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Long EO, 2011, J IMMUNOL, V186, P5021, DOI 10.4049/jimmunol.1100646; Margraf-Schonfeld S, 2011, J BIOL CHEM, V286, P24142, DOI 10.1074/jbc.M111.225334; Mason LH, 2003, J IMMUNOL, V171, P4235, DOI 10.4049/jimmunol.171.8.4235; Murugin VV, 2011, CLIN VACCINE IMMUNOL, V18, P1410, DOI 10.1128/CVI.05084-11; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Nielsen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031959; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Poggi A, 2006, CLIN DEV IMMUNOL, V13, P325, DOI 10.1080/17402520600578194; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Soderquest K, 2011, J IMMUNOL, V186, P3304, DOI 10.4049/jimmunol.1004122; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; WANG P, 1990, CELL IMMUNOL, V131, P366, DOI 10.1016/0008-8749(90)90261-O; Watzl Carsten, 2014, F1000Prime Rep, V6, P87, DOI 10.12703/P6-87	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158863	10.1371/journal.pone.0158863	http://dx.doi.org/10.1371/journal.pone.0158863			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415628	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500045
J	Haubrich, C; Czosnyka, M; Diehl, R; Smielewski, P; Czosnyka, Z				Haubrich, Christina; Czosnyka, Marek; Diehl, Rolf; Smielewski, Peter; Czosnyka, Zofia			Ventricular Volume Load Reveals the Mechanoelastic Impact of Communicating Hydrocephalus on Dynamic Cerebral Autoregulation	PLOS ONE			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; CEREBROSPINAL COMPENSATORY RESERVE; BLOOD-FLOW VELOCITY; INTRACRANIAL-PRESSURE; FLUID DYNAMICS; STENOSIS; DISEASE; CSF	Several studies have shown that the progression of communicating hydrocephalus is associated with diminished cerebral perfusion and microangiopathy. If communicating hydrocephalus similarly alters the cerebrospinal fluid circulation and cerebral blood flow, both may be related to intracranial mechanoelastic properties as, for instance, the volume pressure compliance. Twenty-three shunted patients with communicating hydrocephalus underwent intraventricular constant-flow infusion with Hartmann's solution. The monitoring included transcranial Doppler (TCD) flow velocities (FV) in the middle (MCA) and posterior cerebral arteries (PCA), intracranial pressure (ICP), and systemic arterial blood pressure (ABP). The analysis covered cerebral perfusion pressure (CPP), the index of pressure-volume compensatory reserve (RAP), and phase shift angles between Mayer waves (3 to 9 cpm) in ABP and MCA-FV or PCA-FV. Due to intraventricular infusion, the pressure-volume reserve was exhausted (RAP) 0.84+/-0.1 and ICP was increased from baseline 11.5+/-5.6 to plateau levels of 20.7+/-6.4 mmHg. The ratio dRAP/dICP distinguished patients with large 0.1+/-0.01, medium 0.05+/-0.02, and small 0.02+/-0.01 intracranial volume compliances. Both M wave phase shift angles (r = 0.64; p<0.01) and CPP (r = 0.36; p<0.05) displayed a gradual decline with decreasing dRAP/dICP gradients. This study showed that in communicating hydrocephalus, CPP and dynamic cerebral autoregulation in particular, depend on the volume-pressure compliance. The results suggested that the alteration of mechanoelastic characteristics contributes to a reduced cerebral perfusion and a loss of autonomy of cerebral blood flow regulation. Results warrant a prospective TCD follow-up to verify whether the alteration of dynamic cerebral autoregulation may indicate a progression of communicating hydrocephalus.	[Haubrich, Christina; Czosnyka, Marek; Smielewski, Peter; Czosnyka, Zofia] Addenbrookes Hosp, Dept Acad Neurosurg, Cambridge, England; [Haubrich, Christina] Univ Hosp Aachen, Dept Neurol, Aachen, Germany; [Diehl, Rolf] Alfried Krupp Hosp, Dept Neurol, Essen, Germany	Addenbrooke's Hospital; University of Cambridge; RWTH Aachen University; RWTH Aachen University Hospital; Alfried Krupp Hospital	Haubrich, C (corresponding author), Addenbrookes Hosp, Dept Acad Neurosurg, Cambridge, England.; Haubrich, C (corresponding author), Univ Hosp Aachen, Dept Neurol, Aachen, Germany.	ch723@cam.ac.uk		Smielewski, Peter/0000-0001-5096-3938	Alexander-von-Humboldt foundation; Cambridge Enterprise Ltd, UK	Alexander-von-Humboldt foundation(Alexander von Humboldt Foundation); Cambridge Enterprise Ltd, UK	CH received a research fellowship of the Alexander-von-Humboldt foundation. Cambridge Enterprise Ltd, UK, a commercial company, provided support in the form of ICM+ software licensing fees for authors PS and MC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bateman GA, 2000, AM J NEURORADIOL, V21, P1574; BRADLEY WG, 1991, AM J NEURORADIOL, V12, P31; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2004, PHYSIOL MEAS, V25, pR51, DOI 10.1088/0967-3334/25/5/R01; Czosnyka M, 1996, J NEUROL NEUROSUR PS, V60, P549, DOI 10.1136/jnnp.60.5.549; Czosnyka ZH, 2002, NEUROSURGERY, V50, P526, DOI 10.1097/00006123-200203000-00018; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; EKSTEDT J, 1984, HYDROCEPHALUS; Freimann FB, 2012, NEURORADIOLOGY, V54, P189, DOI 10.1007/s00234-011-0871-1; GREITZ TVB, 1969, J NEUROSURG, V31, P644, DOI 10.3171/jns.1969.31.6.0644; Hakim S, 1976, Surg Neurol, V5, P187; Haubrich C, 2004, ACTA NEUROL SCAND, V109, P210, DOI 10.1034/j.1600-0404.2003.00210.x; Haubrich C, 2003, STROKE, V34, P1881, DOI 10.1161/01.STR.0000080936.36601.34; Haubrich C, 2013, ULTRASOUND MED BIOL; Haubrich C, 2007, STROKE, V38, P2677, DOI 10.1161/STROKEAHA.107.485847; Haubrich C, 2015, MED ENG PHYS, V37, P175, DOI 10.1016/j.medengphy.2014.11.009; Hertel F, 2003, J NEUROL NEUROSUR PS, V74, P479, DOI 10.1136/jnnp.74.4.479; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kim DJ, 2009, NEUROSURGERY, V64, P494, DOI 10.1227/01.NEU.0000338434.59141.89; Kim HG, 2015, ALTERNAT MED, P1, DOI DOI 10.3171/2014.11.JNS141382; Krauss JK, 1996, STROKE, V27, P24, DOI 10.1161/01.STR.27.1.24; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Mase M, 2005, ACT NEUR S, V95, P303; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Momjian S, 2004, BRAIN, V127, P965, DOI 10.1093/brain/awh131; Monro A, 1823, OBSERVATIONS STRUCTU, V5; Mori K, 2002, ACTA NEUROCHIR, V144, P255, DOI 10.1007/s007010200033; Owler BK, 2001, ACTA NEUROL SCAND, V104, P325, DOI 10.1034/j.1600-0404.2001.00092.x; Paulsen KD, 2011, P INT SOC MAG RESON, V19, P41; Pena A, 2002, ACT NEUR S, V81, P59; Piper IR, 1997, SEVERE CLOSED HEAD I, P102; Reinhard M, 2004, STROKE, V35, P1381, DOI 10.1161/01.STR.0000127533.46914.31; Schuhmann MU, 2008, PEDIATR NEUROSURG, V44, P269, DOI 10.1159/000131675; Steiner LA, 2005, ACTA NEUROCHIR, V147, P477, DOI 10.1007/s00701-005-0510-x; Tisell M, 2004, EUR J NEUROL, V11, P17, DOI 10.1046/j.1351-5101.2003.00698.x; Tullberg M, 2001, AM J NEURORADIOL, V22, P1665	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158506	10.1371/journal.pone.0158506	http://dx.doi.org/10.1371/journal.pone.0158506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415784	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500023
J	Kurita, T; Sakurai, K; Takeda, Y; Horinouchi, T; Kusumi, I				Kurita, Tsugiko; Sakurai, Kotaro; Takeda, Youji; Horinouchi, Toru; Kusumi, Ichiro			Very Long-Term Outcome of Non-Surgically Treated Patients with Temporal Lobe Epilepsy with Hippocampal Sclerosis: A Retrospective Study	PLOS ONE			English	Article							PHARMACORESISTANT EPILEPSY; MRI EVIDENCE; SURGERY; PROGNOSIS; SEIZURES; TRIAL	Objective Surgical intervention can result in complete seizure remission rates of up to 80% in patients with temporal lobe epilepsy with hippocampal sclerosis (TLE-HS). However, certain patients cannot be treated surgically for various reasons. We analyzed the very long-term clinical outcomes of patients with TLE-HS who could not be treated surgically. Methods Subjects were selected from among patients with TLE-HS who were actively followed up for > 10 years and treated with medication without surgical treatment. Patient medical records were used to retrospectively study seizure frequency, various clinical factors, and social adjustment. Patients who were seizure-free or had only aura were classified into Group 1; the others were classified into Group 2. Clinical factors including both patient and disease-specific factors were compared between the two groups. Current social adjustment, including the education, work, and economic status of each patient, was also investigated. Results Forty-one (41) subjects met the criteria for analysis, of which 12 (29%) were classified into Group 1. The average age of patients in Group 1 was higher than that of Group 2 (p = 0.0468). Group 2 included a significantly higher rate of patients who had more than one seizure per week at the onset (p = 0.0328), as well as a greater mean number of anti-epileptic drugs taken (p = 0.0024). Regarding social adjustment, Group 2 contained significantly fewer current jobholders than Group 1 (p = 0.0288). Conclusions After very long-term follow-up periods, 29% of patients with TLE-HS had a good outcome through treatment with anticonvulsant medications. Older patients tended to have fewer seizures, and seizure frequency at the onset was the only factor that predicted outcome.	[Kurita, Tsugiko; Sakurai, Kotaro; Takeda, Youji; Horinouchi, Toru; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat & Neurol, Sapporo, Hokkaido, Japan	Hokkaido University	Kurita, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Psychiat & Neurol, Sapporo, Hokkaido, Japan.	tsugiko@med.hokudai.ac.jp						Aldenkamp AP, 2003, SEIZURE-EUR J EPILEP, V12, P101, DOI 10.1016/S1059131102002546; Cohen-Gadol AA, 2006, J NEUROSURG, V104, P513, DOI 10.3171/jns.2006.104.4.513; Cohen-Gadol AA, 2005, J NEUROSURG, V102, P902, DOI 10.3171/jns.2005.102.5.0902; Elsharkawy AE, 2009, EPILEPSY RES, V86, P191, DOI 10.1016/j.eplepsyres.2009.06.008; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; Kim WJ, 1999, EPILEPSIA, V40, P290, DOI 10.1111/j.1528-1157.1999.tb00706.x; Kumlien E, 2002, SEIZURE-EUR J EPILEP, V11, P413, DOI 10.1053/seiz.2001.0614; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Labate A, 2006, NEUROLOGY, V66, P562, DOI 10.1212/01.wnl.0000198208.59347.96; Loscher W, 2010, EPILEPSIA, V51, P89, DOI 10.1111/j.1528-1167.2009.02183.x; Olafsson E, 2005, LANCET NEUROL, V4, P627, DOI 10.1016/S1474-4422(05)70172-1; Raz N, 2007, ANN NY ACAD SCI, V1097, P84, DOI 10.1196/annals.1379.018; Salanova V, 1999, EPILEPSIA, V40, P1417, DOI 10.1111/j.1528-1157.1999.tb02014.x; Sandok EK, 2000, EPILEPSIA, V41, P1315, DOI 10.1111/j.1528-1157.2000.tb04611.x; Selwa LM, 2003, EPILEPSIA, V44, P1568, DOI 10.1111/j.0013-9580.2003.15003.x; Seymour N, 2012, EPILEPSIA, V53, P267, DOI 10.1111/j.1528-1167.2011.03343.x; Shackleton DP, 2003, NEUROLOGY, V61, P64, DOI 10.1212/01.WNL.0000073543.63457.0A; Spencer SS, 2002, LANCET NEUROL, V1, P375, DOI 10.1016/S1474-4422(02)00163-1; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Yasuda CL, 2006, SEIZURE-EUR J EPILEP, V15, P35, DOI 10.1016/j.seizure.2005.10.005; Yu AH, 2008, EUR J RADIOL, V65, P86, DOI 10.1016/j.ejrad.2007.04.011	23	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159464	10.1371/journal.pone.0159464	http://dx.doi.org/10.1371/journal.pone.0159464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415827	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500131
J	Shih, HI; Hsu, HC; Wu, CJ; Lin, CH; Chang, CM; Tu, YF; Hsieh, CC; Chi, CH; Sung, TC				Shih, Hsin-I; Hsu, Hsiang-Chin; Wu, Chi-Jung; Lin, Chih-Hao; Chang, Chia-Ming; Tu, Yi-Fang; Hsieh, Chih-Chia; Chi, Chih-Hsien; Sung, Tzu-Ching			Applications of a Rapid and Sensitive Dengue DUO Rapid Immunochromatographic Test Kit as a Diagnostic Strategy during a Dengue Type 2 Epidemic in an Urban City	PLOS ONE			English	Article								Dengue infection is a major health problem in tropical and subtropical countries. A prospective observational study in a university-affiliated hospital was conducted between August 2015 and September 2015. Patients who visited the emergency department (ED) with a presentation of any symptoms of dengue were eligible for the dengue non-structural protein 1 (NS1), IgM/IgG rapid immunochromatographic tests and real-time polymerase chain reaction (RT-PCR) to evaluate the performance of the rapid tests. Considering the RT-PCR as the gold standard for the dengue diagnosis, the ideal primary results of sensitivity (80-100%), specificity (60-84%), positive predicted value(75%-95%), and negative predicted value (70-100%) suggested that the NS1-based test with or without a combination of IgM and IgG tests have good diagnostic performances in detecting dengue infections, even in the afebrile or elderly populations.	[Shih, Hsin-I; Hsu, Hsiang-Chin; Lin, Chih-Hao; Hsieh, Chih-Chia; Chi, Chih-Hsien] Natl Cheng Kung Univ Tainan, Natl Cheng Kung Univ Hosp, Dept Emergency Med, Tainan, Taiwan; [Shih, Hsin-I; Lin, Chih-Hao; Chi, Chih-Hsien] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Emergency Med, Tainan, Taiwan; [Wu, Chi-Jung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Shih, Hsin-I] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Publ Hlth, Tainan, Taiwan; [Chang, Chia-Ming] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Geriatr, Tainan, Taiwan; [Chang, Chia-Ming] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med,Div Geriatr, Tainan, Taiwan; [Tu, Yi-Fang] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Pediat, Tainan, Taiwan; [Sung, Tzu-Ching] Univ Kang Ning, Dept Hlth Care Management, Tainan, Taiwan; [Shih, Hsin-I; Wu, Chi-Jung] Natl Hlth Res Inst, Natl Mosquito Borne Dis Control Res Ctr, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan	Sung, TC (corresponding author), Univ Kang Ning, Dept Hlth Care Management, Tainan, Taiwan.	tisung@ukn.edu.tw			Ministry of Science and Technology (MOST), R.O.C. [MOST 102-2314-B-426-001]; Department of Emergency Medicine, National Cheng Kung University Hospital [NCKUH-10506016]	Ministry of Science and Technology (MOST), R.O.C.; Department of Emergency Medicine, National Cheng Kung University Hospital	This work was supported in part by a grant MOST 102-2314-B-426-001-from the Ministry of Science and Technology (MOST), R.O.C., and by a grant NCKUH-10506016 from the Department of Emergency Medicine, National Cheng Kung University Hospital.	Alahmadi YM, 2011, J HOSP INFECT, V77, P233, DOI 10.1016/j.jhin.2010.09.033; Bessoff K, 2010, CLIN VACCINE IMMUNOL, V17, P949, DOI 10.1128/CVI.00041-10; Carayon P, 2008, ADV PATIENT SAFETY; Center of Disease Control, TAIW NAT INF DIS STA; [Department of Health Kaohsiung City Government Disease Control Division], 2015, DENG FEV CONTR KAOHS; Diagnostics S, 2016, KYONGG DO; Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244; Fusco FM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-27; Gan VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090037; Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Halverson S, 2013, J CLIN MICROBIOL, V51, P1721, DOI 10.1128/JCM.03422-12; Huang CH, 2013, J MICROBIOL IMMUNOL, V46, P358, DOI 10.1016/j.jmii.2012.07.011; Kosasih H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080891; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Shu PY, 2009, CLIN VACCINE IMMUNOL, V16, P589, DOI 10.1128/CVI.00475-08; Solem RC, 2015, AM J ORTHOD DENTOFAC, V148, P205, DOI 10.1016/j.ajodo.2015.05.006; Sung SF, 2013, EMERG MED J, V30, P454, DOI 10.1136/emermed-2012-201423; Unnikrishnan Rahul, 2015, J Family Med Prim Care, V4, P369, DOI 10.4103/2249-4863.161323; Wang SF, 2016, AM J TROP MED HYG, V94, P193, DOI 10.4269/ajtmh.15-0422; Wang SF, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.46; World Health Organization, 2012, HDB CLIN MAN DENG; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2012, GLOB STRAT DENG PREV	24	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158437	10.1371/journal.pone.0158437	http://dx.doi.org/10.1371/journal.pone.0158437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415767	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500022
J	Shimada, H; Makizako, H; Doi, T; Tsutsumimoto, K; Lee, S; Suzuki, T				Shimada, Hiroyuki; Makizako, Hyuma; Doi, Takehiko; Tsutsumimoto, Kota; Lee, Sangyoon; Suzuki, Takao			Cognitive Impairment and Disability in Older Japanese Adults	PLOS ONE			English	Article							MINI-MENTAL-STATE; GERIATRIC DEPRESSION SCALE; VASCULAR RISK-FACTORS; TERM-CARE INSURANCE; FUNCTIONAL DECLINE; INSTRUMENTAL ACTIVITIES; SCREENING-TEST; FOLLOW-UP; COMMUNITY; DEMENTIA	The prevalence of disability is increasing due to an expanding aging population and an increasing incidence of chronic health problems. Cognitive impairment may predict the development of disability in older adults. Therefore, we examined the association of mild cognitive impairment (MCI) and/or general cognitive impairment (GCI, defined as a Mini Mental State Examination [MMSE] score of 20-23) with the development of disability in a cohort of Japanese community-dwelling older adults. A total of 4290 participants (aged >= 65 years) enrolled in the Obu Study of Health Promotion for the Elderly were classified according to the presence and degree of cognitive impairment as follows: cognitively healthy, GCI, MCI single domain (MCIs), MCIs with GCI, MCI multiple domain (MCIm), and MCIm with GCI. MMSE scores, risk factors for dementia, and incidences of new disability were recorded. After an average of 29.5 months, 205 participants (4.8%) experienced a new onset of disability. All subtypes of cognitive impairment showed significant relationships with disability except for GCI alone. The following hazard ratios (HRs) were determined: MCIs (HR, 2.04; 95% CI, 1.39-3.00), MCIs with GCI (HR, 2.10; 95% CI, 1.21-3.62), MCIm (HR, 2.32; 95% CI, 1.39-3.85), and MCIm with GCI (HR, 4.23; 95% CI, 2.73-6.57). These results indicate that cognitive impairment may be related to an increased risk for the development of disability. Healthcare providers should implement global cognitive assessments to identify MCI and GCI and consider preventive interventions for disability, especially in older persons.	[Shimada, Hiroyuki; Makizako, Hyuma; Doi, Takehiko; Tsutsumimoto, Kota; Lee, Sangyoon] Natl Ctr Geriatr & Gerontol, Dept Prevent Gerontol, Ctr Gerontol & Social Sci, Obu, Japan; [Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Obu, Japan; [Suzuki, Takao] JF Oberlin Univ, Dept Gerontol, Grad Sch, Tokyo, Japan	National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology	Shimada, H (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Prevent Gerontol, Ctr Gerontol & Social Sci, Obu, Japan.	shimada@ncgg.go.jp			Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health) [23300205]; MEXT; Ministry of Education, Culture, Sports, Science and Technology [S1511017]; National Center for Geriatrics and Gerontology, Japan [22-16]	Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Geriatrics and Gerontology, Japan	This work was supported by grants from Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health), a Grant-in-Aid for Scientific Research (B) (grant number 23300205); MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2015-2019 from the Ministry of Education, Culture, Sports, Science and Technology (S1511017); and Research Funding for Longevity Sciences (22-16) from the National Center for Geriatrics and Gerontology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIKOFF H, 1987, J CLIN EXP NEUROPSYC, V9, P435, DOI 10.1080/01688638708405063; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; ANTHONY JC, 1982, PSYCHOL MED, V12, P397, DOI 10.1017/S0033291700046730; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Belle SH, 1996, NEUROEPIDEMIOLOGY, V15, P321, DOI 10.1159/000109922; Bischkopf J, 2002, ACTA PSYCHIAT SCAND, V106, P403, DOI 10.1034/j.1600-0447.2002.01417.x; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; De Vriendt P, 2013, J NUTR HEALTH AGING, V17, P64, DOI 10.1007/s12603-012-0381-9; Di Carlo A, 2000, J AM GERIATR SOC, V48, P775, DOI 10.1111/j.1532-5415.2000.tb04752.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freidl W, 1996, J CLIN EPIDEMIOL, V49, P73, DOI 10.1016/0895-4356(95)00541-2; Friedman B, 2005, J AM GERIATR SOC, V53, P1570, DOI 10.1111/j.1532-5415.2005.53461.x; Fukutomi E, 2015, GERIATR GERONTOL INT, V15, P864, DOI 10.1111/ggi.12360; Hanninen T, 2002, ACTA NEUROL SCAND, V106, P148, DOI 10.1034/j.1600-0404.2002.01225.x; Ishizaki T, 2000, J AM GERIATR SOC, V48, P1424, DOI 10.1111/j.1532-5415.2000.tb02632.x; Ishizaki T, 2006, ARCH GERONTOL GERIAT, V42, P47, DOI 10.1016/j.archger.2005.06.001; Jungwirth S, 2005, INT J GERIATR PSYCH, V20, P452, DOI 10.1002/gps.1311; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; Makizako H, 2015, J AM GERIATR SOC, V63, P1959, DOI 10.1111/jgs.13623; Makizako H, 2013, GERIATR GERONTOL INT, V13, P860, DOI 10.1111/ggi.12014; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Rait G, 2005, AGE AGEING, V34, P242, DOI 10.1093/ageing/afi039; Rajan KB, 2013, J GERONTOL A-BIOL, V68, P624, DOI 10.1093/gerona/gls208; Raji MA, 2005, J AM GERIATR SOC, V53, P1462, DOI 10.1111/j.1532-5415.2005.53457.x; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; UHLMANN RF, 1991, J AM GERIATR SOC, V39, P876, DOI 10.1111/j.1532-5415.1991.tb04454.x; Wadley VG, 2008, AM J GERIAT PSYCHIAT, V16, P416, DOI 10.1097/JGP.0b013e31816b7303; World Health Organization, 2014, DIS HLTH; Yaffe K, 2011, ARCH NEUROL-CHICAGO, V68, P631, DOI 10.1001/archneurol.2011.82; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709	35	40	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158720	10.1371/journal.pone.0158720	http://dx.doi.org/10.1371/journal.pone.0158720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27415430	gold, Green Submitted, Green Published			2022-12-27	WOS:000379579500032
J	Vergara, PM; Soto, GE; Moreira-Arce, D; Rodewald, AD; Meneses, LO; Perez-Hernandez, CG				Vergara, Pablo M.; Soto, Gerardo E.; Moreira-Arce, Dario; Rodewald, Amanda D.; Meneses, Luis O.; Perez-Hernandez, Christian G.			Foraging Behaviour in Magellanic Woodpeckers Is Consistent with a Multi-Scale Assessment of Tree Quality	PLOS ONE			English	Article							BROWNIAN BRIDGE MOVEMENT; INDIVIDUAL-BASED MODEL; TIERRA-DEL-FUEGO; INCOMPLETE INFORMATION; HABITAT SELECTION; ANIMAL MOVEMENT; SPATIAL MEMORY; SPACE-USE; LANDSCAPES; ABUNDANCE	Theoretical models predict that animals should make foraging decisions after assessing the quality of available habitat, but most models fail to consider the spatio-temporal scales at which animals perceive habitat availability. We tested three foraging strategies that explain how Magellanic woodpeckers (Campephilus magellanicus) assess the relative quality of trees: 1) Woodpeckers with local knowledge select trees based on the available trees in the immediate vicinity. 2) Woodpeckers lacking local knowledge select trees based on their availability at previously visited locations. 3) Woodpeckers using information from long-term memory select trees based on knowledge about trees available within the entire landscape. We observed foraging woodpeckers and used a Brownian Bridge Movement Model to identify trees available to woodpeckers along foraging routes. Woodpeckers selected trees with a later decay stage than available trees. Selection models indicated that preferences of Magellanic woodpeckers were based on clusters of trees near the most recently visited trees, thus suggesting that woodpeckers use visual cues from neighboring trees. In a second analysis, Cox's proportional hazards models showed that woodpeckers used information consolidated across broader spatial scales to adjust tree residence times. Specifically, woodpeckers spent more time at trees with larger diameters and in a more advanced stage of decay than trees available along their routes. These results suggest that Magellanic woodpeckers make foraging decisions based on the relative quality of trees that they perceive and memorize information at different spatio-temporal scales.	[Vergara, Pablo M.; Soto, Gerardo E.; Meneses, Luis O.; Perez-Hernandez, Christian G.] Univ Santiago Chile, Lab Ecol & Conservac, Dept Gest Arg, Santiago 3363, Chile; [Soto, Gerardo E.; Rodewald, Amanda D.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Soto, Gerardo E.; Rodewald, Amanda D.] Dept Nat Resources, Ithaca, NY USA; [Moreira-Arce, Dario] Univ Chile, Fac Ciencias, Lab Conservac, Dept Ciencias Ecol, Santiago, Chile	Universidad de Santiago de Chile; Cornell University; Universidad de Chile	Vergara, PM (corresponding author), Univ Santiago Chile, Lab Ecol & Conservac, Dept Gest Arg, Santiago 3363, Chile.	pablo.vergara@usach.cl	Rodewald, Amanda D/I-6308-2016; Vergara, Pablo M/F-2519-2010; Moreira-Arce, Dario/ABG-2898-2021	Rodewald, Amanda D/0000-0002-6719-6306; Vergara, Pablo M/0000-0002-0024-1678; Moreira-Arce, Dario/0000-0002-1188-496X; Soto, Gerardo/0000-0002-9706-6588	FONDECYT (Comision Nacional de Investigacion Cientifica y Tecnologica) [1131133]; FONDECYT [1131133]	FONDECYT (Comision Nacional de Investigacion Cientifica y Tecnologica); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was funded by FONDECYT (Comision Nacional de Investigacion Cientifica y Tecnologica) Grant #1131133, http://w1.conicyt.cl/bases/fondecyt/personas/4/0/40146.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by FONDECYT grant No1131133. We appreciate the help of Alejandro Canto, Daniela Cortes, Maria Donoso, Marlene Lizama, Ninoska Gajardo, Paola Diaz, and Ashley Smiley who helped in data collection. GES acknowledges Wesley Hochachka from the Cornell Lab of Ornithology and Mario Nazar for his technical support. We thank two anonymous reviewers for their helpful suggestions	Amano T, 2006, ECOL MONOGR, V76, P601, DOI 10.1890/0012-9615(2006)076[0601:DIGFWI]2.0.CO;2; Anderson CB, 2009, MAMMAL REV, V39, P33, DOI 10.1111/j.1365-2907.2008.00136.x; Avgar T, 2013, ECOL MODEL, V251, P158, DOI 10.1016/j.ecolmodel.2012.12.002; Azevedo JCM, 2000, FOREST ECOL MANAG, V127, P271, DOI 10.1016/S0378-1127(99)00136-X; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Beauchesne D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077514; BENHAMOU S, 1994, ANIM BEHAV, V47, P1423, DOI 10.1006/anbe.1994.1189; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Boyer D, 2010, PHILOS T R SOC A, V368, P5645, DOI 10.1098/rsta.2010.0275; Briscoe BK, 2002, B MATH BIOL, V64, P261, DOI 10.1006/bulm.2001.0273; Brooks RP, 1997, WILDLIFE SOC B, V25, P163; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Byrne ME, 2014, J ANIM ECOL, V83, P1234, DOI 10.1111/1365-2656.12205; Calenge C., 2011, HOME RANGE ESTIMATIO; Cardador L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092790; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chazarreta L, 2012, ORNITOL NEOTROP, V23, P529; COWIE RJ, 1977, NATURE, V268, P137, DOI 10.1038/268137a0; COX DR, 1972, J R STAT SOC B, V34, P187; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; DAVIES NB, 1981, J ANIM ECOL, V50, P157, DOI 10.2307/4038; DUCHATEAU L, 2008, THE FRAILTY MODEL; Edwards W, 2006, J ECOL, V94, P687, DOI 10.1111/j.1365-2745.2006.01116.x; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Flaxman SM, 2009, J THEOR BIOL, V256, P187, DOI 10.1016/j.jtbi.2008.09.024; Fletcher RJ, 2007, J ANIM ECOL, V76, P598, DOI 10.1111/j.1365-2656.2007.01230.x; Forsman A, 2008, ECOLOGY, V89, P34, DOI 10.1890/07-0572.1; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fritz H, 2003, P ROY SOC B-BIOL SCI, V270, P1143, DOI 10.1098/rspb.2003.2350; FRYXELL JM, 1991, CAN J ZOOL, V69, P1308, DOI 10.1139/z91-184; Gautestad AO, 2005, AM NAT, V165, P44, DOI 10.1086/426673; Gautestad AO, 2010, ECOL COMPLEX, V7, P458, DOI 10.1016/j.ecocom.2009.11.005; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hamel S, 2007, CAN J ZOOL, V85, P933, DOI 10.1139/Z07-080; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Houston AI, 2011, ECOL LETT, V14, P1101, DOI 10.1111/j.1461-0248.2011.01678.x; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Klaassen RHG, 2006, THEOR POPUL BIOL, V70, P452, DOI 10.1016/j.tpb.2006.04.002; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Kristan WB, 2006, CONDOR, V108, P5, DOI 10.1650/0010-5422(2006)108[0005:SAEFHS]2.0.CO;2; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; LIMA SL, 1984, ECOLOGY, V65, P166, DOI 10.2307/1939468; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; McKellar AE, 2015, ANIMAL CONSERVATION, DOI 10.111; McNamara JM, 2006, OIKOS, V112, P243, DOI 10.1111/j.0030-1299.2006.14228.x; MCNAMARA JM, 1987, J THEOR BIOL, V125, P385, DOI 10.1016/S0022-5193(87)80209-6; MCQUILLAN PB, 1993, BIOL J LINN SOC, V49, P317, DOI 10.1111/j.1095-8312.1993.tb00910.x; Meinel G., 2004, INT ARCH PHOTOGRAM B, V35, P1097, DOI DOI 10.3390/RS6042912; Merzlyak MN, 1999, PHYSIOL PLANTARUM, V106, P135, DOI 10.1034/j.1399-3054.1999.106119.x; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Morrissey CA, 2008, ECOL APPL, V18, P172, DOI 10.1890/07-0015.1; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Ohashi K, 2005, BEHAV ECOL, V16, P592, DOI 10.1093/beheco/ari031; Ojeda VS, 2006, WILSON J ORNITHOL, V118, P251, DOI 10.1676/05-014.1; Olsson O, 1999, OIKOS, V87, P264, DOI 10.2307/3546741; Olsson O, 2006, OIKOS, V112, P260, DOI 10.1111/j.0030-1299.2006.13548.x; Olsson O, 2001, OECOLOGIA, V127, P435, DOI 10.1007/s004420000596; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; Pancel L, 2002, AGENTES DE DANO EN E; Patenaude-Monette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102162; Prevedello JA, 2010, J ANIM ECOL, V79, P1315, DOI 10.1111/j.1365-2656.2010.01736.x; Roman I, 2013, 98 ANN EC SOC AM M M; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Rota CT, 2014, FOREST ECOL MANAG, V313, P161, DOI 10.1016/j.foreco.2013.10.048; Santos MJ, 2010, REMOTE SENS ENVIRON, V114, P1242, DOI 10.1016/j.rse.2010.01.009; Schlatter RP, 2005, J ORNITHOL, V146, P188, DOI 10.1007/s10336-004-0069-y; SHORT LL, 1970, WILSON BULL, V82, P115; Soto GE, THE WILSON JOURNAL O; Soto GE, 2012, BOSQUE, V33, P271, DOI 10.4067/S0717-92002012000300007; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Stephens D.W., 1986, pi; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Tingley MW, 2014, CONDOR, V116, P325, DOI 10.1650/CONDOR-13-140.1; VALONE TJ, 1989, ECOLOGY, V70, P1800, DOI 10.2307/1938113; Van Moorter B, 2009, OECOLOGIA, V159, P669, DOI 10.1007/s00442-008-1245-1; Vergara P, 2004, J ORNITHOL, V145, P343, DOI 10.1007/s10336-004-0052-7; Vergara PM, 2015, ECOL MODEL, V300, P114, DOI 10.1016/j.ecolmodel.2015.01.006; Wells AG, 2014, ECOL MODEL, V273, P242, DOI 10.1016/j.ecolmodel.2013.11.008; White G.C., 1990, ANAL WILDLIFE RADIO; Wiens J.A., 1991, FISH WILDLIFE RES, P1; Yang X, 2014, J GEOPHYS RES-BIOGEO, V119, P181, DOI 10.1002/2013JG002460; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035; Zollner PA, 2000, LANDSCAPE ECOL, V15, P523, DOI 10.1023/A:1008154532512	88	22	22	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159096	10.1371/journal.pone.0159096	http://dx.doi.org/10.1371/journal.pone.0159096			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416115	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500074
J	Zhao, C; Zhang, C; Chen, B; Shi, YH; Quan, YP; Nie, ZM; Zhang, YZ; Yu, W				Zhao, Cui; Zhang, Chen; Chen, Bin; Shi, Yanghui; Quan, Yanping; Nie, Zuoming; Zhang, Yaozhou; Yu, Wei			A DNA Binding Protein Is Required for Viral Replication and Transcription in Bombyx mori Nucleopolyhedrovirus	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; ESCHERICHIA-COLI; GENE; RECOMBINATION; SEQUENCE; GENOME; IDENTIFICATION; BACULOVIRUS; CLONING	A DNA-binding protein (DBP) [GenBank accession number: M63416] of Bombyx mori nuclear polyhedrosis virus (BmNPV) has been reported to be a regulatory factor in BmNPV, but its detailed functions remain unknown. In order to study the regulatory mechanism of DBP on viral proliferation, genome replication, and gene transcription, a BmNPV dbp gene knockout virus dbp-ko-Bacmid was generated by the means of Red recombination system. In addition, dbp-repaired virus dbp-re-Bacmid was constructed by the means of the Bac to Bac system. Then, the Bacmids were transfected into BmN cells. The results of this viral titer experiment revealed that the TCID50 of the dbp-ko-Bacmid was 0; however, the dbp-re-Bacmid was similar to the wtBacmid (p>0.05), indicating that the dbp-deficient would lead to failure in the assembly of virus particles. In the next step, Real-Time PCR was used to analyze the transcriptional phases of dbp gene in BmN cells, which had been infected with BmNPV. The results of the latter experiment revealed that the transcript of dbp gene was first detected at 3 h post-infection. Furthermore, the replication level of virus genome and the transcriptional level of virus early, late, and very late genes in BmN cells, which had been transfected with 3 kinds of Bacmids, were analyzed by Real-Time PCR. The demonstrating that the replication level of genome was lower than that of wtBacmid and dbp-re-Bacmid (p<0.01). The transcriptional level of dbp-ko-Bacmid early gene lef-3, ie-1, dnapol, late gene vp39 and very late gene p10 were statistically significantly lower than dbp-re-Bacmid and wtBacmid (p<0.01). The results presented are based on Western blot analysis, which indicated that the lack of dbp gene would lead to low expressions of lef3, vp39, and p10. In conclusion, dbp was not only essential for early viral replication, but also a viral gene that has a significant impact on transcription and expression during all periods of baculovirus life cycle.	[Zhao, Cui; Zhang, Chen; Chen, Bin; Shi, Yanghui; Quan, Yanping; Nie, Zuoming; Zhang, Yaozhou; Yu, Wei] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China; [Zhao, Cui; Zhang, Chen; Chen, Bin; Shi, Yanghui; Quan, Yanping; Nie, Zuoming; Zhang, Yaozhou; Yu, Wei] Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou 310018, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Yu, W (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China.; Yu, W (corresponding author), Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou 310018, Zhejiang, Peoples R China.	mikkyu@163.com			National High-tech R&D program (863 Program) [2011AA100603]; Project Grants 521 Talents Cultivation of Zhejiang Sci-Tech University [11610132521506]	National High-tech R&D program (863 Program); Project Grants 521 Talents Cultivation of Zhejiang Sci-Tech University	This work was supported by the National High-tech R&D program (863 Program) (No. 2011AA100603) and the Project Grants 521 Talents Cultivation of Zhejiang Sci-Tech University (No. 11610132521506).	Argaud O, 1998, J GEN VIROL, V79, P931, DOI 10.1099/0022-1317-79-4-931; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Du MF, 2006, J BIOCHEM MOL BIOL, V39, P737; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; Hamajima R, 2015, VIROLOGY, V485, P244, DOI 10.1016/j.virol.2015.08.008; Han YY, 2014, CURR MICROBIOL, V69, P56, DOI 10.1007/s00284-014-0551-6; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Innami K, 2016, J VIROL METHODS, V229, P24, DOI 10.1016/j.jviromet.2015.12.002; KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212; Li A, 2015, J VIROL, V89, P7646, DOI 10.1128/JVI.00333-15; Lin GY, 2002, J VIROL, V76, P5503, DOI 10.1128/JVI.76.11.5503-5514.2002; MAEDA S, 1990, J GEN VIROL, V71, P1851, DOI 10.1099/0022-1317-71-8-1851; MAEDA S, 1993, J VIROL, V67, P6234, DOI 10.1128/JVI.67.10.6234-6238.1993; MAEDA S, 1991, VIROLOGY, V180, P807, DOI 10.1016/0042-6822(91)90096-T; MONTALVO EA, 1985, J VIROL, V53, P761, DOI 10.1128/JVI.53.3.761-770.1985; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; SUGAWARA K, 1986, VIRUS RES, V6, P27; Xiang XW, 2013, J GEN VIROL, V94, P1669, DOI 10.1099/vir.0.050583-0; Yamamoto Y, 2014, INFLAMMATION, V37, P1806, DOI 10.1007/s10753-014-9911-4; Yang JJ, 2015, BIOTECHNOL LETT, V37, P2011, DOI 10.1007/s10529-015-1878-1; Yang ZN, 2008, VIRUS RES, V135, P220, DOI 10.1016/j.virusres.2008.03.016; Yu W, 2013, VIRUS RES, V175, P45, DOI 10.1016/j.virusres.2013.03.022; Yu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-90; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	26	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159149	10.1371/journal.pone.0159149	http://dx.doi.org/10.1371/journal.pone.0159149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414795	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500090
J	Sun, JJ; Ray, R				Sun, Jenny J.; Ray, Russell			Generation of Two Noradrenergic-Specific Dopamine-Beta-Hydroxylase-FLPo Knock-In Mice Using CRISPR/Cas9-Mediated Targeting in Embryonic Stem Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DBH GENE; NOREPINEPHRINE; MEMORY; NORADRENALINE; POLYMORPHISM; NEURONS; ZYGOTES; LOCUS; CONSOLIDATION	CRISPR/Cas9 mediated DNA double strand cutting is emerging as a powerful approach to increase rates of homologous recombination of large targeting vectors, but the optimization of parameters, equipment and expertise required remain barriers to successful mouse generation by single-step zygote injection. Here, we sought to apply CRISPR/Cas9 methods to traditional embryonic stem (ES) cell targeting followed by blastocyst injection to overcome the common issues of difficult vector construction and low targeting efficiency. To facilitate the study of noradrenergic function, which is implicated in myriad behavioral and physiological processes, we generated two different mouse lines that express FLPo recombinase under control of the noradrenergic-specific Dopamine-Beta-Hydroxylase (DBH) gene. We found that by co-electroporating a circular vector expressing Cas9 and a locus-specific sgRNA, we could target FLPo to the DBH locus in ES cells with shortened 1 kb homology arms. Two different sites in the DBH gene were targeted; the translational start codon with 6-8% targeting efficiency, and the translational stop codon with 75% targeting efficiency. Using this approach, we established two mouse lines with DBH-specific expression of FLPo in brainstem catecholaminergic populations that are publically available on MMRRC (MMRRC_041575-UCD and MMRRC_041577-UCD). Altogether, this study supports simplified, high-efficiency Cas9/CRISPR-mediated targeting in embryonic stem cells for production of knock-in mouse lines in a wider variety of contexts than zygote injection alone.	[Sun, Jenny J.; Ray, Russell] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Ray, Russell] Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Ray, R (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Ray, R (corresponding author), Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA.	russell.ray@bcm.edu		Sun, Jenny/0000-0001-9951-7680; Ray, Russell/0000-0001-9610-2703	National Heart Lung Blood Institute [1R01HL130249-01]; March of Dimes [5-FY15-48]; Parker B. Francis Foundation; McNair Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130249] Funding Source: NIH RePORTER	National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); March of Dimes(March of Dimes); Parker B. Francis Foundation; McNair Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by 1R01HL130249-01, National Heart Lung Blood Institute, http://www.nhlbi.nih.gov; #5-FY15-48, March of Dimes, http://www.marchofdimes.org; Parker B. Francis Foundation, http://www.francisfellowships.org; and the McNair Medical Institute, https://www.bcm.edu/about-us/leadership/office-of-the-president/initiatives/mcnair-medical-institute-scholars/home.	Aston-Jone G, 2008, BIOL PSYCHIAT, V63, P1005, DOI 10.1016/j.biopsych.2008.03.016; Bang SJ, 2012, EUR J NEUROSCI, V35, P85, DOI 10.1111/j.1460-9568.2011.07936.x; Barsegyan A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00160; Bhaduri N, 2010, CELL MOL NEUROBIOL, V30, P265, DOI 10.1007/s10571-009-9448-5; Biancardi V, 2008, PFLUG ARCH EUR J PHY, V455, P1119, DOI 10.1007/s00424-007-0338-8; Buttenschon HN, 2011, J NEURAL TRANSM, V118, P969, DOI 10.1007/s00702-011-0624-7; Chai N, 2014, NEUROPSYCHOPHARMACOL, V39, P1933, DOI 10.1038/npp.2014.42; Chalermpalanupap T, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt175; Chen CC, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00035; Chen YQ, 2010, J HYPERTENS, V28, P76, DOI 10.1097/HJH.0b013e328332bc87; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Clem RL, 2013, J NEUROSCI, V33, P11825, DOI 10.1523/JNEUROSCI.3317-12.2013; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; Fernandez F, 2006, J NEUROL SCI, V251, P118, DOI 10.1016/j.jns.2006.09.013; Ghosh J, 2013, NEUROMOL MED, V15, P61, DOI 10.1007/s12017-012-8195-9; Gibbs ME, 2010, NEUROSCIENCE, V170, P1209, DOI 10.1016/j.neuroscience.2010.07.052; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GUYENET PG, 1993, AM J PHYSIOL, V264, pR1035, DOI 10.1152/ajpregu.1993.264.6.R1035; Hasegawa Y, 2016, EXP ANIM; Kalk NJ, 2011, J PSYCHOPHARMACOL, V25, P3, DOI 10.1177/0269881110367448; Kieling C, 2008, AM J MED GENET B, V147B, P485, DOI 10.1002/ajmg.b.30636; Mustapic M, 2007, AM J MED GENET B, V144B, P1087, DOI 10.1002/ajmg.b.30526; Preuss UW, 2013, DRUG ALCOHOL DEPEN, V133, P459, DOI 10.1016/j.drugalcdep.2013.07.002; Robertson SD, 2013, NAT NEUROSCI, V16, P1016, DOI 10.1038/nn.3458; Sofuoglu M, 2009, ADDICT BIOL, V14, P119, DOI 10.1111/j.1369-1600.2008.00138.x; Szot P, 2012, EPILEPSIA, V53, P61, DOI 10.1111/j.1528-1167.2012.03476.x; Taxini CL, 2011, NEUROSCIENCE, V199, P177, DOI 10.1016/j.neuroscience.2011.09.068; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Thomas SA, 1997, BEHAV NEUROSCI, V111, P579, DOI 10.1037/0735-7044.111.3.579; Thomas SA, 1997, CELL, V91, P583, DOI 10.1016/S0092-8674(00)80446-8; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wang BM, 2015, BIOTECHNIQUES, V59, P201, DOI 10.2144/000114339; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396	39	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159474	10.1371/journal.pone.0159474	http://dx.doi.org/10.1371/journal.pone.0159474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441631	gold, Green Submitted, Green Published			2022-12-27	WOS:000380797500078
J	Goudarzi, S; Hassan, WH; Hashim, AHA; Soleymani, SA; Anisi, MH; Zakaria, OM				Goudarzi, Shidrokh; Hassan, Wan Haslina; Hashim, Aisha-Hassan Abdalla; Soleymani, Seyed Ahmad; Anisi, Mohammad Hossein; Zakaria, Omar M.			A Novel RSSI Prediction Using Imperialist Competition Algorithm (ICA), Radial Basis Function (RBF) and Firefly Algorithm (FFA) in Wireless Networks	PLOS ONE			English	Article							VERTICAL HANDOFF ALGORITHM; SERVICE; QUALITY; DESIGN	This study aims to design a vertical handover prediction method to minimize unnecessary handovers for a mobile node (MN) during the vertical handover process. This relies on a novel method for the prediction of a received signal strength indicator (RSSI) referred to as IRBF-FFA, which is designed by utilizing the imperialist competition algorithm (ICA) to train the radial basis function (RBF), and by hybridizing with the firefly algorithm (FFA) to predict the optimal solution. The prediction accuracy of the proposed IRBF-FFA model was validated by comparing it to support vector machines (SVMs) and multilayer perceptron (MLP) models. In order to assess the model's performance, we measured the coefficient of determination (R-2), correlation coefficient (r), root mean square error (RMSE) and mean absolute percentage error (MAPE). The achieved results indicate that the IRBF-FFA model provides more precise predictions compared to different ANNs, namely, support vector machines (SVMs) and multilayer perceptron (MLP). The performance of the proposed model is analyzed through simulated and real-time RSSI measurements. The results also suggest that the IRBF-FFA model can be applied as an efficient technique for the accurate prediction of vertical handover.	[Goudarzi, Shidrokh; Hassan, Wan Haslina; Zakaria, Omar M.] Univ Teknol Malaysia, MJIIT, Commun Syst & Network iKohza Res Grp, Jalan Semarak, Kuala Lumpur 54100, Malaysia; [Hashim, Aisha-Hassan Abdalla] Int Islamic Univ Malaysia Kuala Lumpur, Fac Elect & Comp Engn, Kuala Lumpur, Malaysia; [Soleymani, Seyed Ahmad] Univ Teknol Malaysia, Fac Comp, Utm Johor Bahru 81310, Johor, Malaysia; [Anisi, Mohammad Hossein] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Comp Syst & Technol, Kuala Lumpur 50603, Malaysia	Universiti Teknologi Malaysia; International Islamic University Malaysia; Universiti Teknologi Malaysia; Universiti Malaya	Goudarzi, S (corresponding author), Univ Teknol Malaysia, MJIIT, Commun Syst & Network iKohza Res Grp, Jalan Semarak, Kuala Lumpur 54100, Malaysia.	gshidrokh2@live.utm.my	Hashim, Aisha/A-2921-2019; Hassan, Wan H/AAM-1570-2020; Goudarzi, Shidrokh/P-9642-2019; Anisi, Mohammad Hossein/L-3718-2016; Soleymani, Ahmad/AAN-1522-2021; Goudarzi, Shidrokh/AAH-3237-2019; Goudarzi, Shidrokh/AAA-4570-2021	Hashim, Aisha/0000-0001-6331-1373; Goudarzi, Shidrokh/0000-0003-0383-3553; Anisi, Mohammad Hossein/0000-0001-8414-2708; 	Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, International Islamic University Malaysia (IIUM)	Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, International Islamic University Malaysia (IIUM)	Authors acknowledge the support from Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, International Islamic University Malaysia (IIUM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors acknowledge the support from Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, International Islamic University Malaysia (IIUM). Authors acknowledge support from Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, International Islamic University Malaysia (IIUM).	Ahmed A, 2014, IEEE COMMUN SURV TUT, V16, P776, DOI 10.1109/SURV.2013.082713.00141; Anisi MH, 2012, SENSORS-BASEL, V12, P3964, DOI 10.3390/s120403964; Ansong MO, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/376931; Atashpaz-Gargari E, 2007, IEEE C EVOL COMPUTAT, P4661, DOI 10.1109/CEC.2007.4425083; Becvar Z, 2011, COMPUT NETW, V55, P3759, DOI 10.1016/j.comnet.2011.03.020; Biabangard-Oskouyi A, 2009, INT J ENG SIMUL, V10, P11; Calhan A, 2013, WIRELESS PERS COMMUN, V71, P2399, DOI 10.1007/s11277-012-0944-4; Calhan A, 2013, COMPUT STAND INTER, V35, P170, DOI 10.1016/j.csi.2012.06.002; Chang BJ, 2008, IEEE T VEH TECHNOL, V57, P3679, DOI 10.1109/TVT.2008.921619; Chang BJ., 2009, WIR COMM NETW C WCNC, P1, DOI DOI 10.1109/WCNC.2009.4917802; Datta RS, 2010, ECON THEOR, V42, P55, DOI 10.1007/s00199-009-0447-z; Foody GM, 2004, INT J REMOTE SENS, V25, P3091, DOI 10.1080/01431160310001648019; Gargari EA, 2008, INT J INTELL COMPUT, V1, P337, DOI 10.1108/17563780810893446; Goudarzi S, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/620658; JORGENSEN M, 1995, IEEE T SOFTWARE ENG, V21, P674, DOI 10.1109/32.403791; Kordos M, 2004, Proceedings of the Eighth IASTED International Conference on Artificial Intelligence and Soft Computing, P215; Lam KF, 2001, COMPUT OPER RES, V28, P1141, DOI 10.1016/S0305-0548(00)00026-5; Lera G, 2002, IEEE T NEURAL NETWOR, V13, P1200, DOI 10.1109/TNN.2002.1031951; Lin CP, 2012, COMPUT ELECTR ENG, V38, P681, DOI 10.1016/j.compeleceng.2012.02.013; LITOVSKI VB, 1992, ELECTRON LETT, V28, P1766, DOI 10.1049/el:19921124; Liu Xia, 2008, 2008 International Conference on Neural Networks and Signal Processing, P550, DOI 10.1109/ICNNSP.2008.4590411; Liu Xia, 2012, Journal of Shanghai Jiaotong University (Science), V17, P25, DOI 10.1007/s12204-011-1137-0; Lukasik S, 2009, LECT NOTES ARTIF INT, V5796, P97; Mohanty S, 2006, IEEE T MOBILE COMPUT, V5, P1347, DOI 10.1109/TMC.2006.142; Movahedi Z, 2012, IEEE COMMUN SURV TUT, V14, P464, DOI 10.1109/SURV.2011.042711.00078; Pawar P, 2008, APPLIED COMPUTING 2008, VOLS 1-3, P481; Perkins CE, 2001, IEEE PERS COMMUN, V8, P16, DOI 10.1109/98.904895; Rajabioun R, 2008, LECT NOTES COMPUT SC, V5073, P680; Rakovic V, 2010, NOVEL RAT SELECTION, P210; Rehan M, 2009, IFIP ADV INF COMM TE, V308, P359; Sadiq AS, 2014, INT J COMMUN SYST, V27, P969, DOI 10.1002/dac.2386; Salcic Z, 2000, WIRELESS PERS COMMUN, V14, P235, DOI 10.1023/A:1008917401129; Shabanzadeh P, 2015, J IND ENG CHEM, V24, P42, DOI 10.1016/j.jiec.2014.09.007; Shen XM, 2000, WIREL NETW, V6, P363, DOI 10.1023/A:1019166304306; Singhrova A, 2012, IET COMMUN, V6, P211, DOI 10.1049/iet-com.2010.0820; TalebiFard P, 2010, COMPUT NETW, V54, P545, DOI 10.1016/j.comnet.2009.08.017; Wang N, 2011, PROCEDIA ENVIRON SCI, V11, P55, DOI 10.1016/j.proenv.2011.12.010; Xia L, 2007, IEEE ICC, P5665, DOI 10.1109/ICC.2007.939; Yan XH, 2008, IEEE COMMUN LETT, V12, P14, DOI 10.1109/LCOMM.2008.071430; Yang XS, 2010, INT J BIO-INSPIR COM, V2, P78, DOI 10.1504/IJBIC.2010.032124; Ylianttila M, 2005, COMPUT NETW, V47, P185, DOI 10.1016/j.comnet.2004.07.004; Yu H, 2011, IEEE T IND ELECTRON, V58, P5438, DOI 10.1109/TIE.2011.2164773	42	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0151355	10.1371/journal.pone.0151355	http://dx.doi.org/10.1371/journal.pone.0151355			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438600	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000380170100001
J	Hu, HH; Hori, A; Nishiura, C; Sasaki, N; Okazaki, H; Nakagawa, T; Honda, T; Yamamoto, S; Tomita, K; Miyamoto, T; Nagahama, S; Uehara, A; Yamamoto, M; Murakami, T; Shimizu, C; Shimizu, M; Eguchi, M; Kochi, T; Imai, T; Okino, A; Kuwahara, K; Kashino, I; Akter, S; Kurotani, K; Nanri, A; Kabe, I; Mizoue, T; Kunugita, N; Dohi, S				Hu, Huanhuan; Hori, Ai; Nishiura, Chihiro; Sasaki, Naoko; Okazaki, Hiroko; Nakagawa, Tohru; Honda, Toru; Yamamoto, Shuichiro; Tomita, Kentaro; Miyamoto, Toshiaki; Nagahama, Satsue; Uehara, Akihiko; Yamamoto, Makoto; Murakami, Taizo; Shimizu, Chii; Shimizu, Makiko; Eguchi, Masafumi; Kochi, Takeshi; Imai, Teppei; Okino, Akiko; Kuwahara, Keisuke; Kashino, Ikuko; Akter, Shamima; Kurotani, Kayo; Nanri, Akiko; Kabe, Isamu; Mizoue, Tetsuya; Kunugita, Naoki; Dohi, Seitaro		Japan Epidemiology Collaboration	Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study	PLOS ONE			English	Article							POORER GLYCEMIC CONTROL; MULTIFACTORIAL INTERVENTION; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; CIGARETTE-SMOKING; TYPE-2; RISK; ADULTS; CARE; COMPLICATIONS	Aims The control of blood glucose levels, blood pressure (BP), and low-density lipoprotein cholesterol (LDL-C) levels reduces the risk of diabetes complications; however, data are scarce on control status of these factors among workers with diabetes. The present study aimed to estimate the prevalence of participants with diabetes who meet glycated hemoglobin (HbA1c), BP, and LDL-C recommendations, and to investigate correlates of poor glycemic control in a large working population in Japan. Methods The Japan Epidemiology Collaboration on Occupational Health (J-ECOH) Study is an ongoing cohort investigation, consisting mainly of employees in large manufacturing companies. We conducted a cross-sectional analysis of 3,070 employees with diabetes (2,854 men and 216 women) aged 20-69 years who attended periodic health examinations. BP was measured and recorded using different company protocols. Risk factor targets were defined using both American Diabetes Association (ADA) guidelines (HbA1c < 7.0%, BP < 140/90 mmHg, and LDL-C < 100 mg/dL) and Japan Diabetes Society (JDS) guidelines (HbA1c < 7.0%, BP < 130/80 mmHg, and LDL-C < 120 mg/dL). Logistic regression models were used to explore correlates of poor glycemic control (defined as HbA1c >= 8.0%). Results The percentages of participants who met ADA (and JDS) targets were 44.9%(44.9%) for HbA1c, 76.6% (36.3%) for BP, 27.1%(56.2%) for LDL-C, and 11.2%(10.8%) for simultaneous control of all three risk factors. Younger age, obesity, smoking, and uncontrolled dyslipidemia were associated with poor glycemic control. The adjusted odds ratio of poor glycemic control was 0.58 (95% confidence interval, 0.46-0.73) for participants with treated but uncontrolled hypertension, and 0.47 (0.33-0.66) for participants with treated and controlled hypertension, as compared with participants without hypertension. There was no significant difference in HbA1c levels between participants with treated but uncontrolled hypertension and those with treated and controlled hypertension. Conclusion Data from a large working population, predominantly composed of men, suggest that achievement of HbA1c, BP, and LDL-C targets was less than optimal, especially in younger participants. Uncontrolled dyslipidemia was associated with poor glycemic control. Participants not receiving antihypertensive treatment had higher HbA1c levels.	[Hu, Huanhuan; Kuwahara, Keisuke; Kashino, Ikuko; Akter, Shamima; Kurotani, Kayo; Nanri, Akiko; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Hori, Ai; Nishiura, Chihiro] Tokyo Gas Co Ltd, Tokyo, Japan; [Sasaki, Naoko] Mitsubishi Fuso Truck & Bus Corp, Kawasaki, Kanagawa, Japan; [Okazaki, Hiroko; Dohi, Seitaro] Mitsui Chem Inc, Tokyo, Japan; [Nakagawa, Tohru; Honda, Toru; Yamamoto, Shuichiro] Hitachi Ltd, Ibaraki, Japan; [Tomita, Kentaro] Mitsubishi Plast Inc, Tokyo, Japan; [Miyamoto, Toshiaki] Nippon Steel & Sumitomo Met Corp Kimitsu Works, Chiba, Japan; [Nagahama, Satsue] All Japan Labour Welf Fdn, Tokyo, Japan; [Uehara, Akihiko; Yamamoto, Makoto] YAMAHA Corp, Shizuoka, Japan; [Murakami, Taizo; Shimizu, Chii; Shimizu, Makiko] Keihin Occupat Hlth Ctr, Mizue Med Clin, Kawasaki, Kanagawa, Japan; [Eguchi, Masafumi; Kochi, Takeshi; Kabe, Isamu] Furukawa Elect Corp Ltd, Tokyo, Japan; [Imai, Teppei; Okino, Akiko] Azbil Corp, Tokyo, Japan; [Kuwahara, Keisuke] Teikyo Univ, Grad Sch Publ Hlth, Tokyo, Japan; [Kunugita, Naoki] Natl Inst Publ Hlth, Saitama, Japan	National Center for Global Health & Medicine - Japan; Daimler AG; Mitsui Chemicals; Hitachi Limited; Nippon Steel & Sumitomo Metal Corporation; Yamaha; Furukawa Electric; Teikyo University; National Institute of Public Health - Japan	Hu, HH (corresponding author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan.	huhuanhuan@ri.ncgm.go.jp	Okino, Akitoshi/O-1804-2013; Nishiura, Chihiro/Q-7938-2019; Nishiura, Chihiro/C-4132-2017; Hori, Ai/G-5277-2019; KASHINO, IKUKO/AAS-4008-2020	Okino, Akitoshi/0000-0002-8949-294X; Nishiura, Chihiro/0000-0002-8850-5446; Nishiura, Chihiro/0000-0002-8850-5446; Hori, Ai/0000-0002-0191-5996; Kuwahara, Keisuke/0000-0002-7503-1333; Kochi, Takeshi/0000-0002-3411-1070; Kunugita, Naoki/0000-0002-6516-8379	Industrial Health Foundation; Industrial Disease Clinical Research Grants [140202-01, 150903-01]; Tokyo Gas Co., Ltd.; Mitsubishi Fuso Truck and Bus Corporation; Mitsui Chemicals, Inc.; Hitachi, Ltd.; Mitsubishi Plastics, Inc.; Nippon Steel & Sumitomo Metal Corporation Kimitsu Works; YAMAHA CORPORATION; Furukawa Electric Co., Ltd.; Azbil Corporation	Industrial Health Foundation; Industrial Disease Clinical Research Grants; Tokyo Gas Co., Ltd.; Mitsubishi Fuso Truck and Bus Corporation; Mitsui Chemicals, Inc.; Hitachi, Ltd.; Mitsubishi Plastics, Inc.; Nippon Steel & Sumitomo Metal Corporation Kimitsu Works; YAMAHA CORPORATION; Furukawa Electric Co., Ltd.; Azbil Corporation	This study was supported by the Industrial Health Foundation and Industrial Disease Clinical Research Grants (140202-01, 150903-01). "Tokyo Gas Co., Ltd.", "Mitsubishi Fuso Truck and Bus Corporation", "Mitsui Chemicals, Inc.", "Hitachi, Ltd.", "Mitsubishi Plastics, Inc.", "Nippon Steel & Sumitomo Metal Corporation Kimitsu Works", "YAMAHA CORPORATION", "Furukawa Electric Co., Ltd." and "Azbil Corporation" provided support in the form of salaries for authors [A. Hori, C. Nishiura, N. Sasaki, H. Okazaki, S. Dohi, T. Nakagawa, T. Honda, S. Yamamoto, K. Tomita, T. Miyamoto, A. Uehara, M. Yamamoto, M. Eguchi, T. Kochi, I. Kabe, T. Imai, and A. Okino], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali MK, 2014, ANN INTERN MED, V161, P681, DOI 10.7326/M14-0019; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Arai K, 2009, DIABETES RES CLIN PR, V83, P397, DOI 10.1016/j.diabres.2008.11.036; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258; Cederberg H, 2015, DIABETOLOGIA, V58, P1109, DOI 10.1007/s00125-015-3528-5; Chan WB, 2005, DIABETES-METAB RES, V21, P183, DOI 10.1002/dmrr.497; Collins R, 2003, LANCET, V361, P2005; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gillespie EL, 2005, DIABETES CARE, V28, P2261, DOI 10.2337/diacare.28.9.2261; Guideline committee of the Japan Diabetes Society, 2013, TREATM GUID DIAB 201; Gunton JE, 2002, DIABETES CARE, V25, P796, DOI 10.2337/diacare.25.4.796-a; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Holmes VA, 2011, DIABETES CARE, V34, P1683, DOI 10.2337/dc11-0244; Hori A, 2014, CIRC J, V78, P1160, DOI 10.1253/circj.CJ-13-1067; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Iso H, 2008, CIRCULATION, V118, P2725, DOI 10.1161/CIRCULATIONAHA.107.750117; Janghorbani M, 2015, J DIABETES INVEST, V6, P716, DOI 10.1111/jdi.12349; Juarez DT, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120065; Kemp TM, 2005, DIABETES CARE, V28, P1490, DOI 10.2337/diacare.28.6.1490; Liew SM, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-53; MacIsaac RJ, 2009, INTERN MED J, V39, P512, DOI 10.1111/j.1445-5994.2008.01821.x; Matsushita Y, 2010, OBESITY, V18, P2374, DOI 10.1038/oby.2010.33; Mullugeta Y, 2012, INDIAN J CLIN BIOCHE, V27, P363, DOI 10.1007/s12291-012-0225-8; Quah JHM, 2011, ANN ACAD MED SINGAP, V40, P276; Quah JHM, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-18; Rizos CV, 2014, WORLD J CARDIOL, V6, P517, DOI 10.4330/wjc.v6.i7.517; Ronnemaa T, 1996, DIABETES CARE, V19, P1229, DOI 10.2337/diacare.19.11.1229; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; So WY, 2011, J DIABETES, V3, P109, DOI 10.1111/j.1753-0407.2011.00115.x; Spoelstra JA, 2003, THESIS; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Takahashi E, 2014, INTERNAL MED, V53, P1491, DOI 10.2169/internalmedicine.53.1876; Targher G, 1997, J CLIN ENDOCR METAB, V82, P3619, DOI 10.1210/jc.82.11.3619; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; The Ministry of Health Labour and Welfare Ministry of Education Culture Sports Science and Technology, 2002, ETH GUID EP RES; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Uehara A, 2014, DIABETES RES CLIN PR, V106, P118, DOI 10.1016/j.diabres.2014.07.013; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yokoyama H, 2007, DIABETES CARE, V30, P989, DOI 10.2337/dc06-1859; Yu SH, 2013, J DIABETES INVEST, V4, P460, DOI 10.1111/jdi.12077	43	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159071	10.1371/journal.pone.0159071	http://dx.doi.org/10.1371/journal.pone.0159071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437997	gold, Green Published, Green Submitted			2022-12-27	WOS:000380170100027
J	Wu, J; Huang, Q; Meng, DD; Huang, MY; Li, CW; Qin, TZ				Wu, Jun; Huang, Qun; Meng, Dongdong; Huang, Minyu; Li, Chaowen; Qin, Tianzi			A Functional rs353293 Polymorphism in the Promoter of miR-143/145 Is Associated with a Reduced Risk of Bladder Cancer	PLOS ONE			English	Article							MICRORNA-145; EXPRESSION; INVASION; SURVIVAL; SMOKING; GROWTH; CELLS; GENE	Background and Objectives MicroRNA (miR)-143/145, known as tumor suppressors, can promote cell apoptosis and differentiation, and suppress cell proliferation, invasion and migration. We performed a case-control study to investigate the association of rs353293 in the promoter region of miR-143/145 with bladder cancer risk. Methods In total, 869 subjects including 333 cases and 536 controls were enrolled in this study, and the rs353293 polymorphism was genotyped by using a Taqman assay. The promoter activity was measured by the Dual-Luciferase Assay System. Results We calculated an adjusted odds ratio of 0.64 for the presence of either AA/AG genotypes (95% CI 0.46-0.90) and 0.64 (95% CI 0.47-0.87) for carrying at least one A allele in bladder cancer. Stratified analyses showed that the AA/AG genotypes and the A allele were less prevalent in patients with low grade tumors, compared to those harboring higher grade bladder cancers (adjusted OR = 0.53, 95% CI, 0.30-0.94, P = 0.03 and adjusted OR = 0.54, 95% CI, 0.32-0.92, P = 0.02, respectively). In vitro luciferase reporter analysis showed that rs353293A allele had a lower activity compared with the rs353293G allele (P < 0.001). Conclusion These findings suggest that the functional rs353293 polymorphism may be a useful biomarker to predict the risk of bladder cancer.	[Wu, Jun; Huang, Qun; Meng, Dongdong; Huang, Minyu; Li, Chaowen; Qin, Tianzi] Youjiang Med Coll Nationalities, Affiliated Hosp, Dept Urinary Surg, Baise 533000, Guangxi, Peoples R China	Youjiang Medical University for Nationalities	Wu, J (corresponding author), Youjiang Med Coll Nationalities, Affiliated Hosp, Dept Urinary Surg, Baise 533000, Guangxi, Peoples R China.	984136322@qq.com			Health and Family Planning Commission of Guangxi [Z2015085]	Health and Family Planning Commission of Guangxi	This work was supported by Health and Family Planning Commission of Guangxi (No. Z2015085).	Aben KKH, 2002, INT J CANCER, V98, P274, DOI 10.1002/ijc.10191; Avgeris M, 2015, CARCINOGENESIS, V36, P528, DOI 10.1093/carcin/bgv024; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Chu HY, 2016, ARCH TOXICOL, V90, P403, DOI 10.1007/s00204-014-1396-2; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Fujii T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1846-0; Gautam KA, 2016, CYTOKINE, V77, P152, DOI 10.1016/j.cyto.2015.11.008; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iio A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-136; Inamoto T, 2015, ONCOTARGET, V6, P21628, DOI 10.18632/oncotarget.4129; Kou B, 2014, UROL ONCOL-SEMIN ORI, V32, P846, DOI 10.1016/j.urolonc.2014.01.003; Leppert JT, 2006, EUR UROL, V49, P226, DOI 10.1016/j.eururo.2005.12.011; Li LJ, 2013, HUM IMMUNOL, V74, P993, DOI 10.1016/j.humimm.2013.04.019; Li X, 2015, CANC BIOMARKERS A; Liang YD, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001289; Liu LP, 2012, MOL MED REP, V5, P753, DOI 10.3892/mmr.2011.696; Michael MZ, 2003, MOL CANCER RES, V1, P882; Noguchi S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.11; Noguchi S, 2013, CANCER LETT, V328, P353, DOI 10.1016/j.canlet.2012.10.017; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song T, 2010, ASIAN PAC J CANCER P, V11, P905; Su JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114420; Villadsen SB, 2012, BRIT J CANCER, V106, P366, DOI 10.1038/bjc.2011.520; Volanisa D, 2010, TOXICOL LETT, V193, P131, DOI 10.1016/j.toxlet.2009.12.018; Wang Y, 2014, DNA CELL BIOL, V33, P205, DOI 10.1089/dna.2013.2100; Wu DY, 2013, MOL MED REP, V8, P626, DOI 10.3892/mmr.2013.1501; Yan X, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-220; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Zeegers MPA, 2000, CANCER-AM CANCER SOC, V89, P630, DOI 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q; Zeegers MPA, 2002, CANCER CAUSE CONTROL, V13, P83, DOI 10.1023/A:1013954932343; Zhai L, 2015, MOL CARCINOG; Zhou H, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0167-0; Zhu ZW, 2014, FEBS LETT, V588, P3180, DOI 10.1016/j.febslet.2014.06.059	36	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159115	10.1371/journal.pone.0159115	http://dx.doi.org/10.1371/journal.pone.0159115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438131	Green Published, gold, Green Submitted			2022-12-27	WOS:000380170100029
J	Chen, L; Chu, C; Zhang, YH; Zhu, CM; Kong, XY; Huang, T; Cai, YD				Chen, Lei; Chu, Chen; Zhang, Yu-Hang; Zhu, Changming; Kong, Xiangyin; Huang, Tao; Cai, Yu-Dong			Analysis of Gene Expression Profiles in the Human Brain Stem, Cerebellum and Cerebral Cortex	PLOS ONE			English	Article							AMINO-ACID OXIDASE; METABOLIC PATHWAY; SMO ALGORITHM; PREDICTION; EVOLUTION; DELETION; PROTEIN; CONVERGENCE; INFORMATION; DENSIN-180	The human brain is one of the most mysterious tissues in the body. Our knowledge of the human brain is limited due to the complexity of its structure and the microscopic nature of connections between brain regions and other tissues in the body. In this study, we analyzed the gene expression profiles of three brain regions-the brain stem, cerebellum and cerebral cortex-to identify genes that are differentially expressed among these different brain regions in humans and to obtain a list of robust, region-specific, differentially expressed genes by comparing the expression signatures from different individuals. Feature selection methods, specifically minimum redundancy maximum relevance and incremental feature selection, were employed to analyze the gene expression profiles. Sequential minimal optimization, a machine-learning algorithm, was employed to examine the utility of selected genes. We also performed a literature search, and we discuss the experimental evidence for the important physiological functions of several highly ranked genes, including NR2E1, DAO, and LRRC7, and we give our analyses on a gene (TFAP2B) that have not been investigated or experimentally validated. As a whole, the results of our study will improve our ability to predict and understand genes related to brain regionalization and function.	[Chen, Lei; Cai, Yu-Dong] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China; [Chen, Lei; Zhu, Changming] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China; [Chu, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Zhang, Yu-Hang; Kong, Xiangyin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cai, YD (corresponding author), Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China.; Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China.	tohuangtao@126.com; cai_yud@126.com	Chen, Lei/A-2275-2011; Chu, Chen/J-6527-2019; Zhang, Yu-Hang/AAQ-9012-2021; Zhang, Yu-Hang/O-9774-2015	Chen, Lei/0000-0003-3068-1583; Chu, Chen/0000-0001-8084-0867; Zhang, Yu-Hang/0000-0003-3825-0796; Zhang, Yu-Hang/0000-0003-3825-0796; cai, yudong/0000-0001-5664-7979	National Natural Science Foundation of China [61202021, 31371335]; Shanghai Natural Science Foundation [16ZR1414500]; Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) [2016245]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS)	This study was supported by the National Natural Science Foundation of China (61202021, 31371335), Shanghai Natural Science Foundation (16ZR1414500), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (61202021, 31371335), Shanghai Natural Science Foundation (16ZR1414500), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245).	[Anonymous], 2014, LANCET NEUROL, V13, P855, DOI 10.1016/S1474-4422(14)70181-4; Apperson ML, 1996, J NEUROSCI, V16, P6839; Bauernfeind AL, 2015, GENOME BIOL EVOL, V7, P2276, DOI 10.1093/gbe/evv132; Carlisle HJ, 2011, J NEUROSCI, V31, P16194, DOI 10.1523/JNEUROSCI.5877-10.2011; Chang CC, 2000, IEEE T NEURAL NETWOR, V11, P1003, DOI 10.1109/72.857780; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen L, 2015, PLOS ONE, V10, DOI [10.1371/ journal. pone. 0126492, DOI 10.1371/J0URNAL.P0NE.0126492]; Chen L, 2016, COMB CHEM HIGH T SCR, V19, P136, DOI 10.2174/1386207319666151110122453; Chen L, 2015, AMINO ACIDS, V47, P1485, DOI 10.1007/s00726-015-1974-5; Chen L, 2013, CURR BIOINFORM, V8, P200, DOI 10.2174/1574893611308020008; Christie BR, 2006, NEUROSCIENCE, V137, P1031, DOI 10.1016/j.neuroscience.2005.08.091; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Fernandez-Irigoyen J, 2015, J PROTEOMICS, V127, P395, DOI 10.1016/j.jprot.2015.03.032; Foletta VC, 2002, MOL BRAIN RES, V107, P65, DOI 10.1016/S0169-328X(02)00448-5; Giger T, 2010, GENOME BIOL EVOL, V2, P284, DOI 10.1093/gbe/evq018; Gofflot F, 2007, CELL, V131, P405, DOI 10.1016/j.cell.2007.09.012; Gui TT, 2015, J COMPUT BIOL, V22, P63, DOI 10.1089/cmb.2014.0122; Hastie T, 1998, ADV NEUR IN, V10, P507; HORIIKE K, 1994, BRAIN RES, V652, P297, DOI 10.1016/0006-8993(94)90240-2; Joven A, 2013, J COMP NEUROL, V521, P3913, DOI 10.1002/cne.23385; Keerthi SS, 2002, MACH LEARN, V46, P351, DOI 10.1023/A:1012431217818; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; KRUMLAUF R, 1987, DEVELOPMENT, V99, P603; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043927; Lin CJ, 2001, IEEE T NEURAL NETWOR, V12, P1288, DOI 10.1109/72.963765; Lingaiah Kusuma, 2011, Indian J Med Res, V134, P621, DOI 10.4103/0971-5916.90986; Liu T, 2015, INT J SYST SCI, V46, P919, DOI 10.1080/00207721.2013.801096; Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002; Mahfouz A, 2015, METHODS, V73, P79, DOI 10.1016/j.ymeth.2014.10.004; Matsunaga E, 2001, DEVELOPMENT, V128, P4069; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohn AR, 1997, MOL CELL NEUROSCI, V9, P63, DOI 10.1006/mcne.1997.0606; Moreno S, 1999, J NEUROCYTOL, V28, P169, DOI 10.1023/A:1007064504007; Myers EM, 2015, METHODS, V73, P54, DOI 10.1016/j.ymeth.2014.12.010; NAGATA Y, 1992, EXPERIENTIA, V48, P753, DOI 10.1007/BF02124295; O'Loghlen A, 2015, ONCOGENE, V34, P4069, DOI 10.1038/onc.2014.335; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Reichert H, 2010, ADV EXP MED BIOL, V689, P145; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Shen EH, 2012, TRENDS NEUROSCI, V35, P711, DOI 10.1016/j.tins.2012.09.005; Stenman J, 2003, DEVELOPMENT, V130, P1113, DOI 10.1242/dev.00328; Stenman JM, 2003, J NEUROSCI, V23, P10568; Strick CA, 2011, NEUROPHARMACOLOGY, V61, P1001, DOI 10.1016/j.neuropharm.2011.06.029; Torii Y, 2009, NEUROCOMPUTING, V72, P973, DOI 10.1016/j.neucom.2008.04.008; Witten I.H., 2005, DATA MINING PRACTICA; Wu H, 2007, DNA SEQUENCE, V18, P73, DOI 10.1080/10425170500511271; Xiong F, 2013, CARDIOVASC PATHOL, V22, P141, DOI 10.1016/j.carpath.2012.07.001; Xu ZB, 2009, IEEE T SYST MAN CY B, V39, P1292, DOI 10.1109/TSMCB.2009.2015672; Yamanaka M, 2012, AMINO ACIDS, V43, P1811, DOI 10.1007/s00726-012-1384-x; Young KA, 2002, BEHAV BRAIN RES, V132, P145, DOI 10.1016/S0166-4328(01)00413-2; Zhang P., 2015, J SENSORS, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0133137	59	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159395	10.1371/journal.pone.0159395	http://dx.doi.org/10.1371/journal.pone.0159395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434030	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600051
J	Nunes, HEG; Goncalves, ECD; Vieira, JAJ; Silva, DAS				Gimenes Nunes, Heloyse Elaine; de Andrade Goncalves, Eliane Cristina; Jesus Vieira, Jessika Aparecida; Santos Silva, Diego Augusto			Clustering of Risk Factors for Non-Communicable Diseases among Adolescents from Southern Brazil	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BEHAVIORS; ASSOCIATIONS; PREVALENCE	Introduction The aim of this study was to investigate the simultaneous presence of risk factors for non-communicable diseases and the association of these risk factors with demographic and economic factors among adolescents from southern Brazil. Methods The study included 916 students (14-19 years old) enrolled in the 2014 school year at state schools in Sao Jose, Santa Catarina, Brazil. Risk factors related to lifestyle (i.e., physical inactivity, excessive alcohol consumption, smoking, sedentary behaviour and unhealthy diet), demographic variables (sex, age and skin colour) and economic variables (school shift and economic level) were assessed through a questionnaire. Simultaneous behaviours were assessed by the ratio between observed and expected prevalences of risk factors for non-communicable diseases. The clustering of risk factors was analysed by multinomial logistic regression. The clusters of risk factors that showed a higher prevalence were analysed by binary logistic regression. Results The clustering of two, three, four, and five risk factors were found in 22.2%, 49.3%, 21.7% and 3.1% of adolescents, respectively. Subgroups that were more likely to have both behaviours of physical inactivity and unhealthy diet simultaneously were mostly composed of girls (OR = 3.03, 95% CI = 1.57-5.85) and those with lower socioeconomic status (OR = 1.83, 95% CI = 1.05-3.21); simultaneous physical inactivity, excessive alcohol consumption, sedentary behaviour and unhealthy diet were mainly observed among older adolescents (OR = 1.49, 95% CI = 1.05-2.12). Subgroups less likely to have both behaviours of sedentary behaviour and unhealthy diet were mostly composed of girls (OR = 0.58, 95% CI = 0.38-0.89); simultaneous physical inactivity, sedentary behaviour and unhealthy diet were mainly observed among older individuals (OR = 0.66, 95% CI = 0.49-0.87) and those of the night shift (OR = 0.59, 95% CI = 0.43-0.82). Conclusion Adolescents had a high prevalence of simultaneous risk factors for NCDs. Demographic (gender and age) and economic (school shift) variables were associated with the most prevalent simultaneous behaviours among adolescents.	[Gimenes Nunes, Heloyse Elaine; de Andrade Goncalves, Eliane Cristina; Jesus Vieira, Jessika Aparecida; Santos Silva, Diego Augusto] Univ Fed Santa Catarina, Res Ctr Kinanthropometry & Human Performance, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Silva, DAS (corresponding author), Univ Fed Santa Catarina, Res Ctr Kinanthropometry & Human Performance, Florianopolis, SC, Brazil.	diegoaugustoss@yahoo.com.br	Silva, Diego/GRF-5446-2022; Silva, Diego Augusto Santos/AAB-9249-2020	Silva, Diego Augusto Santos/0000-0002-0489-7906	UNIEDU	UNIEDU	The author (HEGN) thanks the UNIEDU for the scholarship.	Alamian A, 2009, PREV MED, V48, P493, DOI 10.1016/j.ypmed.2009.02.015; [Anonymous], 2015, WHO REP GLOB TOB EP; Brazilian Association of Research Companies, 2012, EC CLASS CRIT BRAZ; Brazilian Institute of Geography and Statistics, 2013, POP CENS 2010; Brazilian Institute of Geography and Statistics, 2013, NAT HLTH SURV SCH 20; Busch V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1118; Council on Foreign Relations, 2011, POL DECL HIGH LEV M; Cureau FV, 2014, J PHYS ACT HEALTH, V11, P942, DOI 10.1123/jpah.2012-0247; Currie C, 2008, INEQUALITES YOUNG PE; da Silva KS, 2009, CAD SAUDE PUBLICA, V25, P2187, DOI 10.1590/S0102-311X2009001000010; Pedrosa AAD, 2011, CAD SAUDE PUBLICA, V27, P1611, DOI 10.1590/S0102-311X2011000800016; Drewnowski A, 2010, AM J CLIN NUTR, V92, P1181, DOI 10.3945/ajcn.2010.29300; Costa Filipe Ferreira da, 2013, Rev. bras. epidemiol., V16, P398, DOI 10.1590/S1415-790X2013000200015; de Moraes ACF, 2009, REV ASSOC MED BRAS, V55, P523, DOI 10.1590/S0104-42302009000500013; de Moraes ACF, 2009, CAD SAUDE PUBLICA, V25, P1195, DOI 10.1590/S0102-311X2009000600002; Goncalves EC, 2015, REV PAUL PEDIAT; Guedes Dartagnan Pinto, 2010, Rev. Saúde Pública, V44, P840, DOI 10.1590/S0034-89102010000500009; Pavon DJ, 2010, NUTR HOSP, V25, P311, DOI 10.3305/nh.2010.25.2.4596; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Kuhnen Mirian, 2009, Rev. bras. epidemiol., V12, P615, DOI 10.1590/S1415-790X2009000400011; Kuntsche E, 2006, ADDICT BEHAV, V31, P1844, DOI 10.1016/j.addbeh.2005.12.028; Luiz R., 2000, CAD SAUDE COLET, V8, P9; Malta DC, 2013, EPIDEMIOL SERV SAUDE, V22; Ng C, 2010, PUBLIC HEALTH NUTR, V13, P1430, DOI 10.1017/S1368980010000832; Pechansky Flavio, 2004, Rev. Bras. Psiquiatr., V26, P14, DOI 10.1590/S1516-44462004000500005; Pronk NP, 2004, AM J PREV MED, V27; Rehm J, 2004, COMP QUANTIFICATION, P959; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Anez CRR, 2008, ARQ BRAS CARDIOL, V91, P102; Sanchez A, 2007, AM J PREV MED, V32, P124, DOI 10.1016/j.amepre.2006.10.012; Silva DAS, 2016, PEDIATR EXERC SCI, V28, P312, DOI 10.1123/pes.2015-0172; Silva DAS, 2012, J COMMUN HEALTH, V37, P591, DOI 10.1007/s10900-011-9489-9; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; Silva K. S., 2012, REV PAUL PEDIATR, V30, P338, DOI DOI 10.1590/S0103-05822012000300006; Sousa SZ, 2008, EDUC REV-CURITIBA, P53, DOI 10.1590/S0104-40602008000100005; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Taylor RM, 2008, J CLIN NURS, V17, P3083, DOI 10.1111/j.1365-2702.2008.02629.x; Vereecken CA, 2006, PUBLIC HEALTH NUTR, V9, P244, DOI 10.1079/PHN2005847; WHO, 2013, HANDBOOK ON HEALTH INEQUALITY MONITORING: WITH A SPECIAL FOCUS ON LOW- AND MIDDLE-INCOME COUNTRIES, P1; WHO, 2015, GLOB STRAT DIET PHYS, P3	40	21	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159037	10.1371/journal.pone.0159037	http://dx.doi.org/10.1371/journal.pone.0159037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434023	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600029
J	Hoare, R; Thompson, KD; Herath, T; Collet, B; Bron, JE; Adams, A				Hoare, R.; Thompson, K. D.; Herath, T.; Collet, B.; Bron, J. E.; Adams, A.			Development, Characterisation and Application of Monoclonal Antibodies for the Detection and Quantification of Infectious Salmon Anaemia Virus in Plasma Samples Using Luminex Bead Array Technology	PLOS ONE			English	Article							MULTIPLEX FLOW IMMUNOASSAY; ATLANTIC SALMON; IDENTIFICATION; ASSAY; ISA; NUCLEOPROTEIN; CYTOKINES; PROTEINS; VACCINE; ELISA	Infectious salmon anaemia virus (ISAV) is an orthomyxovirus that has had a significant economic impact on Atlantic salmon farming in Europe, North America and Chile. Monoclonal antibodies (mAbs) were developed against Segment 3 (encoding the viral nucleoprotein, NP) of the virus. Six of the mAbs were shown to be specific to ISAV and recognised all isolates from Scotland, Norway and Canada. They reacted with ISAV in enzyme-linked immunosorbent assay (ELISA), indirect fluorescent antibody technique (IFAT) and western blotting. They were also used to develop a novel detection method based on Luminex (BioPlex) bead-based flow cytometric technology for the detection of ISAV in the plasma of Atlantic salmon (Salmo salar L.) smolts experimentally infected with ISAV. Fish were challenged by intraperitoneal (i.p.) injection of virus at 50% Tissue Culture Infective Dose (TCID50) = 2.8 x10(6) per animal. Virus present in plasma of infected fish, collected at 0, 4, 8, 12, 16, 21 and 28 days post infection using a non-lethal sampling method (n = 12 at each time point), was quantified using the optimised Bio-Plex assay. The results obtained with this assay were compared with absolute quantification of the virus by RT-qPCR using SYBR Green I and TaqMan chemistries. The Bio-Plex assay developed using the NP mAbs appears to be a rapid, sensitive method for detecting and quantifying ISAV in small volumes of fish plasma and has the potential to be multiplexed for the detection of other fish pathogens (e.g. during co-infections). To our knowledge this is the first report of the use of Luminex (Bio-Plex) technology for the detection of a fish pathogen.	[Hoare, R.; Thompson, K. D.; Bron, J. E.; Adams, A.] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Thompson, K. D.] Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland; [Herath, T.] Harper Adams Univ, Dept Anim Prod Welf & Vet Sci, Newport TF10 8NB, Shrops, England; [Collet, B.] Marine Lab, Marine Scotland, 375 Victoria Rd, Aberdeen AB11 9PA, Scotland	University of Stirling; Moredun Research Institute; Marine Scotland Science (MSS)	Hoare, R (corresponding author), Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland.	rh30@stir.ac.uk	Thompson, Kim/GLU-8547-2022; Bron, James E/B-6231-2018; Thompson, Kim/O-7707-2015; Collet, Bertrand/C-1113-2012	Bron, James E/0000-0003-3544-0519; Hoare, Rowena/0000-0002-9298-4275; Thompson, Kim/0000-0003-3550-4842; Collet, Bertrand/0000-0003-2795-2653; Adams, Alexandra/0000-0002-2469-3310	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [G1100675]	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs))	This work was funded by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs, grant G1100675). The web page of the project is located at https://www.nc3rs.org.uk/development-non-lethalsampling-method-monitor-immune-response-anddisease-progression-salmonid-fish: BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamelfot M, 2014, J FISH DIS, V37, P291, DOI 10.1111/jfd.12225; ADAMS A, 1995, FISH SHELLFISH IMMUN, V5, P537, DOI 10.1016/S1050-4648(95)80040-9; Ahn S.-B., 2014, EUPA OPEN PROTEOM, V3, P78; Aspehaug V, 2004, VIRUS RES, V106, P51, DOI 10.1016/j.virusres.2004.06.001; Binnicker MJ, 2008, CLIN VACCINE IMMUNOL, V15, P1410, DOI 10.1128/CVI.00082-08; Caraguel C, 2012, PREV VET MED, V104, P165, DOI 10.1016/j.prevetmed.2011.10.006; CASWELLRENO P, 1989, J CLIN MICROBIOL, V27, P1924, DOI 10.1128/JCM.27.9.1924-1929.1989; Christiansen DH, 2011, J GEN VIROL, V92, P909, DOI 10.1099/vir.0.027094-0; Christopher-Hennings J, 2013, J VET DIAGN INVEST, V25, P671, DOI 10.1177/1040638713507256; Collet B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137767; Costa JZ, 2007, J FISH DIS, V30, P419, DOI 10.1111/j.1365-2761.2007.00824.x; DANNEVIG BH, 1995, J GEN VIROL, V76, P1353, DOI 10.1099/0022-1317-76-6-1353; DANNEVIG BH, 1995, VET RES, V26, P438; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Falk K, 2004, J VIROL, V78, P3063, DOI 10.1128/JVI.78.6.3063-3071.2004; Falk K, 1998, DIS AQUAT ORGAN, V34, P77, DOI 10.3354/dao034077; Falk K, 1997, J VIROL, V71, P9016, DOI 10.1128/JVI.71.12.9016-9023.1997; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Fronhoffs S, 2002, MOL CELL PROBE, V16, P99, DOI 10.1006/mcpr.2002.0405; Goic B, 2008, VIROLOGY, V379, P55, DOI 10.1016/j.virol.2008.05.036; Gomez E, 2010, CLIN VACCINE IMMUNOL, V17, P966, DOI 10.1128/CVI.00086-10; Gorgoglione B., 2013, DAFINET WORKSH 2013; Kawaoka Y., 2005, 8 INT COMM TAX VIR, P681; Kuller L, 2005, DIAGN MICR INFEC DIS, V53, P185, DOI 10.1016/j.diagmicrobio.2005.05.012; Lawson S, 2010, VACCINE, V28, P5356, DOI 10.1016/j.vaccine.2010.05.016; Mardones FO, 2014, PREV VET MED, V114, P37, DOI 10.1016/j.prevetmed.2014.01.012; Munir K, 2004, J VIROL METHODS, V117, P37, DOI 10.1016/j.jviromet.2003.11.020; Murray AG, 2002, EMERG INFECT DIS, V8, P1, DOI 10.3201/eid0801.010144; NEELAM B, 1995, DIS AQUAT ORGAN, V21, P201, DOI 10.3354/dao021201; OIE, 2014, AN OIE MAN DIAGN TES; Lhorente JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095397; Pauly D, 2009, ANALYST, V134, P2028, DOI 10.1039/b911525k; Snow M, 2006, DEV BIOLOGICALS, V126, P133; Tallent SM, 2013, APPL ENVIRON MICROB, V79, P1422, DOI 10.1128/AEM.02743-12; Thorud K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P109; Valdes-Donoso P, 2013, J FISH DIS, V36, P353, DOI 10.1111/jfd.12070; Wolf A, 2014, FISH SHELLFISH IMMUN, V36, P383, DOI 10.1016/j.fsi.2013.12.018; Workenhe ST, 2008, J VIROL METHODS, V154, P128, DOI 10.1016/j.jviromet.2008.08.007; Zubach V, 2012, J CLIN MICROBIOL, V50, P460, DOI 10.1128/JCM.06090-11	40	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159155	10.1371/journal.pone.0159155	http://dx.doi.org/10.1371/journal.pone.0159155			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434377	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000380169600036
J	Katsoulieris, EN; Drossopoulou, GI; Kotsopoulou, ES; Vlahakos, DV; Lianos, EA; Tsilibary, EC				Katsoulieris, Elias N.; Drossopoulou, Garyfalia I.; Kotsopoulou, Eleni S.; Vlahakos, Dimitrios V.; Lianos, Elias A.; Tsilibary, Effie C.			High Glucose Impairs Insulin Signaling in the Glomerulus: An In Vitro and Ex Vivo Approach	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; SERINE/THREONINE PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; RECEPTOR SUBSTRATE-1; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; PODOCALYXIN EXPRESSION; ENDOPLASMIC-RETICULUM; NUTRIENT HOMEOSTASIS; SKELETAL-MUSCLE	Objective Chronic hyperglycaemia, as seen in type II diabetes, results in both morphological and functional impairments of podocytes in the kidney. We investigated the effects of high glucose (HG) on the insulin signaling pathway, focusing on cell survival and apoptotic markers, in immortalized human glomerular cells (HGEC; podocytes) and isolated glomeruli from healthy rats. Methods and Findings HGEC and isolated glomeruli were cultured for various time intervals under HG concentrations in the presence or absence of insulin. Our findings indicated that exposure of HGEC to HG led to downregulation of all insulin signaling markers tested (IR, p-IR, IRS-1, p-Akt, p-Fox01,03), as well as to increased sensitivity to apoptosis (as seen by increased PARP cleavage, Casp3 activation and DNA fragmentation). Short insulin pulse caused upregulation of insulin signaling markers (IR, p-IR, p-Akt, p-Fox01,03) in a greater extent in normoglycaemic cells compared to hyperglycaemic cells and for the case of p-Akt, in a PI3K-dependent manner. IRS-1 phosphorylation of HG-treated podocytes was negatively regulated, favoring serine versus tyrosine residues. Prolonged insulin treatment caused a significant decrease of IR levels, while alterations in glucose concentrations for various time intervals demonstrated changes of IR, p-IR and p-Akt levels, suggesting that the IR signaling pathway is regulated by glucose levels. Finally, HG exerted similar effects in isolated glomeruli. Conclusions These results suggest that HG compromises the insulin signaling pathway in the glomerulus, promoting a proapoptotic environment, with a possible critical step for this malfunction lying at the level of IRS-1 phosphorylation; thus we herein demonstrate glomerular insulin signaling as another target for investigation for the prevention and/or treatment of diabetic nephropathy.	[Katsoulieris, Elias N.; Drossopoulou, Garyfalia I.; Kotsopoulou, Eleni S.; Tsilibary, Effie C.] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece; [Vlahakos, Dimitrios V.] Attikon Univ Hosp, Dept Propaedeut Med 2, Athens, Greece; [Lianos, Elias A.] Univ Athens, Sch Med, Dept Pathol, Athens, Greece	National Centre of Scientific Research "Demokritos"; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens	Drossopoulou, GI; Tsilibary, EC (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece.	gdross@bio.demokritos.gr; effie@bio.demokritos.gr			European Social Fund NSRF EXCELLENCE (ARISTEIA) [DIABETAL-164]; Operational Programme Education and Lifelong learning, Ministry of Education Lifelong Learning and Religious Affiairs	European Social Fund NSRF EXCELLENCE (ARISTEIA); Operational Programme Education and Lifelong learning, Ministry of Education Lifelong Learning and Religious Affiairs	ENK's work was part of European Social Fund NSRF EXCELLENCE (ARISTEIA) DIABETAL-164 "Common Pathogenetic Mechanisms and Pathways of the Matrix-related Diseases of Diabetes and Alzheimer Resulting in Apoptotic Cell Death". The project was further supported by the Operational Programme Education and Lifelong learning, Ministry of Education Lifelong Learning and Religious Affiairs, and by receiving the honorary 1st award in the Panhellenic Medical Conference, 2014, Athens, Greece. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Benigni A, 2004, KIDNEY INT, V65, P2193, DOI 10.1111/j.1523-1755.2004.00636.x; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Catalano C, 1997, DIABETES, V46, P868, DOI 10.2337/diabetes.46.5.868; Chen C, 2009, NEPHRON EXP NEPHROL, V113, pE26, DOI 10.1159/000228080; Chuang PY, 2007, KIDNEY INT, V72, P965, DOI 10.1038/sj.ki.5002456; Cleveland-Donovan K, 2010, ENDOCRINOLOGY, V151, P3752, DOI 10.1210/en.2010-0043; Coward RJM, 2005, DIABETES, V54, P3095, DOI 10.2337/diabetes.54.11.3095; DAgati V, 2010, TRENDS ENDOCRIN MET, V21, P50, DOI 10.1016/j.tem.2009.07.003; Dalla Vestra M, 2003, DIABETES, V52, P1031, DOI 10.2337/diabetes.52.4.1031; DELARUE F, 1991, KIDNEY INT, V40, P906, DOI 10.1038/ki.1991.292; Ding GH, 2002, AM J PHYSIOL-RENAL, V283, pF173, DOI 10.1152/ajprenal.00240.2001; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Drapeau N, 2013, AM J PHYSIOL-ENDOC M, V304, pE1188, DOI 10.1152/ajpendo.00560.2012; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Drossopoulou GI, 2009, AM J PHYSIOL-RENAL, V297, pF594, DOI 10.1152/ajprenal.00203.2009; Durvasula RV, 2008, AM J PHYSIOL-RENAL, V294, pF830, DOI 10.1152/ajprenal.00266.2007; Economou CG, 2004, J CELL SCI, V117, P3281, DOI 10.1242/jcs.01163; Gatica R, 2013, J CELL BIOCHEM, V114, P639, DOI 10.1002/jcb.24406; GROOP L, 1993, DIABETOLOGIA, V36, P642, DOI 10.1007/BF00404074; Guo S, 2009, MOL CELL BIOL, V29, P5070, DOI 10.1128/MCB.00138-09; Hilgers KF, 2005, J AM SOC NEPHROL, V16, P574, DOI 10.1681/ASN.2005010083; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; IDE R, 1994, BIOCHEM BIOPH RES CO, V201, P71, DOI 10.1006/bbrc.1994.1670; Iwakami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027401; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Katsoulieris E, 2010, FREE RADICAL BIO MED, V48, P1654, DOI 10.1016/j.freeradbiomed.2010.03.021; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Lewko B, 2009, J CELL PHYSIOL, V221, P288, DOI 10.1002/jcp.21856; Li B, 2011, CELL SIGNAL, V23, P35, DOI 10.1016/j.cellsig.2010.07.019; Liu Y, 2014, J DIABETES COMPLICAT, V28, P265, DOI 10.1016/j.jdiacomp.2014.02.001; Meyer C, 2005, DIABETIC MED, V22, P453, DOI 10.1111/j.1464-5491.2005.01440.x; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Mima A, 2011, KIDNEY INT, V79, P883, DOI 10.1038/ki.2010.526; MOGENSEN CE, 1971, SCAND J CLIN LAB INV, V28, P91, DOI 10.3109/00365517109090667; Musso C, 2006, CLIN J AM SOC NEPHRO, V1, P616, DOI 10.2215/CJN.01271005; Orchard TJ, 2002, KIDNEY INT, V62, P963, DOI 10.1046/j.1523-1755.2002.00507.x; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Patari A, 2003, DIABETES, V52, P2969, DOI 10.2337/diabetes.52.12.2969; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Pillay TS, 1996, J CLIN INVEST, V97, P613, DOI 10.1172/JCI118457; Qi YJ, 2013, DIABETES, V62, P3887, DOI 10.2337/db13-0095; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; ROTHENBERG PL, 1995, DIABETES, V44, P802, DOI 10.2337/diabetes.44.7.802; Sharma M, 2009, AM J PHYSIOL-RENAL, V296, pF1386, DOI 10.1152/ajprenal.90369.2008; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Simon-Szabo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097868; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Tang SG, 2001, DIABETES, V50, P83, DOI 10.2337/diabetes.50.1.83; TANTI JF, 1994, J BIOL CHEM, V269, P6051; Tejada T, 2008, KIDNEY INT, V73, P1385, DOI 10.1038/ki.2008.109; Tiwari S, 2007, J AM SOC NEPHROL, V18, P2661, DOI 10.1681/ASN.2006121410; Tsotakos NE, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-28; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Wu MS, 2014, MOL CARCINOGEN, V53, pE119, DOI 10.1002/mc.22053; Yu MS, 2006, INT J MOL MED, V17, P1157; Zdychova J, 2008, EXP BIOL MED, V233, P1231, DOI 10.3181/0801-RM-29	65	17	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158873	10.1371/journal.pone.0158873	http://dx.doi.org/10.1371/journal.pone.0158873			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434075	Green Submitted, gold, Green Published			2022-12-27	WOS:000380169600020
J	Takahashi, Y; Kitaguchi, Y; Nakakura, S; Mito, H; Kimura, A; Kakizaki, H				Takahashi, Yasuhiro; Kitaguchi, Yoshiyuki; Nakakura, Shunsuke; Mito, Hidenori; Kimura, Akiko; Kakizaki, Hirohiko			Correction of Excyclotropia by Surgery on the Inferior Rectus Muscle in Patients with Thyroid Eye Disease: A Retrospective, Observational Study	PLOS ONE			English	Article							SUPERIOR OBLIQUE PALSY; GRAVES OPHTHALMOPATHY; STRABISMUS SURGERY; VERTICAL STRABISMUS; ORBITOPATHY; RECESSION; CYCLODEVIATION; OUTCOMES	Purpose To examine the characteristics of excyclotropia correction through surgery on the inferior rectus muscle in patients with thyroid eye disease. Methods This was a retrospective, observational study at a single institution. We reviewed 36 patients who had undergone unilateral inferior rectus muscle recession, with or without nasal inferior rectus muscle transposition. The following factors were investigated as possibly influencing excyclotropia correction: inferior rectus muscle thickness, degree of adipose change in the inferior rectus muscle, smoking status, history of orbital radiotherapy, and the amount of inferior rectus muscle recession. Using T1-weighted coronal magnetic resonance imaging, we measured the cross-sectional area of the inferior rectus muscle at its largest point, as well as the bright-signal area of the inferior rectus muscle, which reflects intermuscular adipose change. We then calculated the percentage internal bright-signal area at the point of the largest inferior rectus muscle cross-sectional area. The history of orbital radiotherapy was graded using a binary system. We evaluated correlations among excyclotropia correction, the amount of nasal inferior rectus muscle transposition, and the possible influencing factors listed, using stepwise multiple regression analyses. Results The multiple regression model demonstrated a significant relationship among excyclotropia correction, amount of nasal inferior rectus muscle transposition, and the amount of inferior rectus muscle recession (Y-CORRECTION = 8.546X(TENDON WIDTH) + 0.405X(RECESSION)-0.908; r = 0.844; adjusted r(2) = 0.695; P < 0.001). Conclusions Excyclotropia correction was correlated with the amount of nasal inferior rectus muscle transposition and the amount of inferior rectus muscle recession, but not with the other factors. The regression model presented in this study will enable us to determine more precisely the amount of nasal inferior rectus muscle transposition in patients with excyclotropia of various angles.	[Takahashi, Yasuhiro; Kitaguchi, Yoshiyuki; Mito, Hidenori; Kakizaki, Hirohiko] Aichi Med Univ Hosp, Dept Oculoplast Orbital & Lacrimal Surg, Nagakute, Aichi, Japan; [Nakakura, Shunsuke] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Mito, Hidenori] Ide Eye Hosp, Yamagata, Japan; [Kimura, Akiko] Hyogo Coll Med, Dept Ophthalmol, Nishinomiya, Hyogo, Japan	Aichi Medical University; Hyogo College of Medicine	Kakizaki, H (corresponding author), Aichi Med Univ Hosp, Dept Oculoplast Orbital & Lacrimal Surg, Nagakute, Aichi, Japan.	cosme@d1.dion.ne.jp						CAYGILL WM, 1972, AM J OPHTHALMOL, V73, P437, DOI 10.1016/0002-9394(72)90073-6; Chen VM, 2008, J NEURO-OPHTHALMOL, V28, P302, DOI 10.1097/WNO.0b013e31818f133e; De Hoog J, 2010, EYE, V24, P1011, DOI 10.1038/eye.2009.267; Dutton JJ, 2011, ATLAS CLIN SURG ORBI, P29; Gilbert J, 2005, J AAPOS, V9, P26, DOI 10.1016/j.jaapos.2004.10.004; Jellema HM, 2012, OPHTHAL PLAST RECONS, V28, P268, DOI 10.1097/IOP.0b013e3182565c26; Kahaly GJ, 2001, EUR J ENDOCRINOL, V145, P107, DOI 10.1530/eje.0.1450107; Kimura A, 2013, RINSHO GANKA, V67, P1452; Kimura A, 2013, RINSHO GANKA, V67, P1630; Kose S, 2002, J PEDIAT OPHTH STRAB, V39, P331, DOI 10.3928/0191-3913-20021101-06; Kubota M, 2008, JAPANESE ORTHOPTIC J, V37, P91; Kushner BJ, 2013, JAMA OPHTHALMOL, V131, P190, DOI 10.1001/2013.jamaophthalmol.199; MOURITS MP, 1989, BRIT J OPHTHALMOL, V73, P639, DOI 10.1136/bjo.73.8.639; MOURITS MP, 1990, BRIT J OPHTHALMOL, V74, P481, DOI 10.1136/bjo.74.8.481; Mourits MP, 2007, GRAVES ORBITOPATHY M, P66; Nardi M, 2009, ORBIT, V28, P245, DOI 10.1080/01676830903104603; Nardi M., 2007, GRAVES ORBITOPATHY M, P176; Nassar MM, 2009, J AAPOS, V13, P236, DOI 10.1016/j.jaapos.2008.11.007; Okamoto M, 2015, CLIN OPHTHALMOL, V9, P691, DOI 10.2147/OPTH.S79482; Peragallo JH, 2013, STRABISMUS, V21, P23, DOI 10.3109/09273972.2012.762533; Pitz S, 2005, ORBIT, V24, P173, DOI 10.1080/01676830500182705; Prendiville P, 2000, OPHTHALMOLOGY, V107, P545, DOI 10.1016/S0161-6420(99)00145-1; Schittkowski M, 2004, KLIN MONATSBL AUGENH, V221, P941, DOI 10.1055/s-2004-813752; Skrivanek S, USE DUMMY VARIABLES; Takahashi Y, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/703671; TROBE JD, 1984, ARCH OPHTHALMOL-CHIC, V102, P717; Von Noorden G., 2002, BINOCULAR VISION OCU, V6th ed, P52; von Noorden G K, 1990, J Pediatr Ophthalmol Strabismus, V27, P291; Woo SJ, 2005, EYE, V19, P873, DOI 10.1038/sj.eye.6701675; Yoo SH, 2013, J AAPOS, V17, P9, DOI 10.1016/j.jaapos.2012.09.018	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159562	10.1371/journal.pone.0159562	http://dx.doi.org/10.1371/journal.pone.0159562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434022	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600073
J	Tohya, M; Watanabe, T; Maruyama, F; Arai, S; Ota, A; Athey, TBT; Fittipaldi, N; Nakagawa, I; Sekizaki, T				Tohya, Mari; Watanabe, Takayasu; Maruyama, Fumito; Arai, Sakura; Ota, Atsushi; Athey, Taryn B. T.; Fittipaldi, Nahuel; Nakagawa, Ichiro; Sekizaki, Tsutomu			Comparative Genome Analyses of Streptococcus suis Isolates from Endocarditis Demonstrate Persistence of Dual Phenotypic Clones	PLOS ONE			English	Article							HAEMOPHILUS-INFLUENZAE DISEASE; PYLORI GENETIC DIVERSITY; MULTIPLEX PCR ASSAY; POLYSACCHARIDE CAPSULE; PORCINE ENDOCARDITIS; CPS LOCUS; PATHOGEN; SEROTYPE-2; PHAGOCYTOSIS; VIRULENCE	Many bacterial species coexist in the same niche as heterogeneous clones with different phenotypes; however, understanding of infectious diseases by polyphenotypic bacteria is still limited. In the present study, encapsulation in isolates of the porcine pathogen Streptococcus suis from persistent endocarditis lesions was examined. Coexistence of both encapsulated and unencapsulated S. suis isolates was found in 26 out of 59 endocarditis samples. The isolates were serotype 2, and belonged to two different sequence types (STs), ST1 and ST28. The genomes of each of the 26 pairs of encapsulated and unencapsulated isolates from the 26 samples were sequenced. The data showed that each pair of isolates had one or more unique nonsynonymous mutations in the cps gene, and the encapsulated and unencapsulated isolates from the same samples were closest to each other. Pairwise comparisons of the sequences of cps genes in 7 pairs of encapsulated and unencapsulated isolates identified insertion/deletions (indels) ranging from one to 104 bp in different cps genes of unencapsulated isolates. Capsule expression was restored in a subset of unencapsulated isolates by complementation in trans with cps expression vectors. Examination of gene content common to isolates indicated that mutation frequency was higher in ST28 pairs than in ST1 pairs. Genes within mobile genetic elements were mutation hot spots among ST28 isolates. Taken all together, our results demonstrate the coexistence of dual phenotype (encapsulated and unencapsulated) bacterial clones and suggest that the dual phenotypes arose independently in each farm by means of spontaneous mutations in cps genes.	[Tohya, Mari; Watanabe, Takayasu; Arai, Sakura; Sekizaki, Tsutomu] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Bunkyo Ku, Tokyo, Japan; [Maruyama, Fumito; Ota, Atsushi; Nakagawa, Ichiro] Kyoto Univ, Dept Microbiol, Grad Sch Med, Kyoto, Kyoto, Japan; [Athey, Taryn B. T.; Fittipaldi, Nahuel] Publ Hlth Ontario, Toronto, ON, Canada; [Fittipaldi, Nahuel] Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, Toronto, ON, Canada	University of Tokyo; Kyoto University; University of Toronto	Sekizaki, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Bunkyo Ku, Tokyo, Japan.; Maruyama, F (corresponding author), Kyoto Univ, Dept Microbiol, Grad Sch Med, Kyoto, Kyoto, Japan.	maruyama.fumito.5e@kyoto-u.ac.jp; asekizak@mail.ecc.u-tokyo.ac.jp	Maruyama, Fumito/F-6875-2016; Maruyama, Fumito/AAK-5928-2020; Tohya, Mari/V-1505-2017; Sekizaki, Tsutomu/AAB-1816-2021	Maruyama, Fumito/0000-0003-2347-616X; Tohya, Mari/0000-0002-8590-4396; Sekizaki, Tsutomu/0000-0002-8899-2504; Watanabe, Takayasu/0000-0001-5487-8191; Fittipaldi, Nahuel/0000-0001-9553-3798	JSPS KAKENHI Grant [15K15675, 25713060, 24117508, 25305013, 15J10486, 26861544, 16K08015, 26660226, 15H02651, 16K15037]; Grants-in-Aid for Scientific Research [15J10486] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 15K15675, 25713060, 24117508 (to FM), 25305013 (to IN), 15J10486 (to SA), 26861544, 16K08015 (to TW), 26660226, 15H02651 and 16K15037 (to TS).	Sanchez-Romero MA, 2014, P NATL ACAD SCI USA, V111, P355, DOI 10.1073/pnas.1316084111; Ashish A, 2013, J CYST FIBROS, V12, P790, DOI 10.1016/j.jcf.2013.04.003; Athey TBT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137760; Bellais S, 2012, J INFECT DIS, V206, P1745, DOI 10.1093/infdis/jis605; Benga L, 2004, CELL MICROBIOL, V6, P867, DOI 10.1111/j.1462-5822.2004.00409.x; Benga L, 2008, VET MICROBIOL, V132, P211, DOI 10.1016/j.vetmic.2008.05.005; Blaser MJ, 2001, J CLIN INVEST, V107, P767, DOI 10.1172/JCI12672; BLOUIN C, 1994, CAN J VET RES, V58, P49; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Darch SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep07649; Davies MR, 2015, NAT GENET, V47, P84, DOI 10.1038/ng.3147; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Dworkin MS, 2007, CLIN INFECT DIS, V44, P810, DOI 10.1086/511861; ELLIOTT SD, 1978, J EXP MED, V148, P1699, DOI 10.1084/jem.148.6.1699; FARLEY MM, 1992, ANN INTERN MED, V116, P806, DOI 10.7326/0003-4819-116-10-806; Ferrando ML, 2015, J INFECT DIS, V212, P95, DOI 10.1093/infdis/jiu813; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Flores AR, 2012, MBIO, V3, DOI 10.1128/mBio.00413-12; Gardner SN, 2015, BIOINFORMATICS, V31, P2877, DOI 10.1093/bioinformatics/btv271; Gottschalk M., 2012, DIS SWINE, P841; Griffiths AJ, 2000, INTRO GENETIC ANAL, V7th; Hanage WP, 2006, J CLIN MICROBIOL, V44, P743, DOI 10.1128/JCM.44.3.743-749.2006; Harris SR, 2015, GENOME RES, V25, P1360, DOI 10.1101/gr.189803.115; Hilty M, 2014, GENOME BIOL EVOL, V6, P3281, DOI 10.1093/gbe/evu263; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; HOLT ME, 1988, RES VET SCI, V45, P349, DOI 10.1016/S0034-5288(18)30963-9; HOLT ME, 1989, J COMP PATHOL, V100, P435, DOI 10.1016/0021-9975(89)90009-1; Houde M, 2012, INFECT IMMUN, V80, P506, DOI 10.1128/IAI.05734-11; Ishida S, 2014, J MICROBIOL METH, V107, P66, DOI 10.1016/j.mimet.2014.09.003; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Lakkitjaroen N, 2014, FEMS MICROBIOL LETT, V354, P46, DOI 10.1111/1574-6968.12428; Lakkitjaroen N, 2011, J MED MICROBIOL, V60, P1669, DOI 10.1099/jmm.0.034686-0; Lam TT, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.09.027; Lee GT, 2008, EMERG INFECT DIS, V14, P183, DOI 10.3201/eid1401.070930; Magistrali C, 2008, RES VET SCI, V85, P204, DOI 10.1016/j.rvsc.2007.12.002; Marois C, 2004, J CLIN MICROBIOL, V42, P3169, DOI 10.1128/JCM.42.7.3169-3175.2004; McLean JS, 2013, GENOME RES, V23, P867, DOI 10.1101/gr.150433.112; MOGOLLON JD, 1990, J CLIN MICROBIOL, V28, P2462, DOI 10.1128/JCM.28.11.2462-2466.1990; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Okura M, 2014, J CLIN MICROBIOL, V52, P1714, DOI 10.1128/JCM.03411-13; Okura M, 2013, APPL ENVIRON MICROB, V79, P2796, DOI 10.1128/AEM.03742-12; Okura M, 2011, J BACTERIOL, V193, P822, DOI 10.1128/JB.01555-09; Onishi H, 2012, J VET MED SCI, V74, P1681, DOI 10.1292/jvms.12-0301; Palmieri C, 2012, ANTIMICROB AGENTS CH, V56, P4697, DOI 10.1128/AAC.00629-12; ROMLING U, 1994, J INFECT DIS, V170, P1616, DOI 10.1093/infdis/170.6.1616; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Segura M, 2004, INFECT IMMUN, V72, P5322, DOI 10.1128/IAI.72.9.5322-5330.2004; Sheppard SK, 2013, P NATL ACAD SCI USA, V110, P11923, DOI 10.1073/pnas.1305559110; Smith HE, 2000, MICROB PATHOGENESIS, V29, P127, DOI 10.1006/mpat.2000.0372; Smith HE, 1999, INFECT IMMUN, V67, P1750; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Steward KF, 2016, MOL BIOSYST, V12, P1194, DOI 10.1039/c5mb00780a; Suzuki S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6792; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe SI, 2010, CAN J VET RES, V74, P65; Temime L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003244; Tenenbaum T, 2009, CELL MICROBIOL, V11, P323, DOI 10.1111/j.1462-5822.2008.01255.x; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Turner CE, 2015, MBIO, V6, DOI 10.1128/mBio.00622-15; Van Calsteren MR, 2010, BIOCHEM CELL BIOL, V88, P513, DOI [10.1139/O09-170, 10.1139/o09-170]; Van Eldere J, 2000, CLIN INFECT DIS, V31, P24, DOI 10.1086/313915; Wang SJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00173; Weinert LA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7740; Willenborg J, 2011, MICROBIOL-SGM, V157, P1823, DOI 10.1099/mic.0.046417-0; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	71	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159558	10.1371/journal.pone.0159558	http://dx.doi.org/10.1371/journal.pone.0159558			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433935	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600072
J	Zhao, Q; Zhu, Y; Best, LG; Umans, JG; Uppal, K; Tran, VT; Jones, DP; Lee, ET; Howard, BV; Zhao, JY				Zhao, Qi; Zhu, Yun; Best, Lyle G.; Umans, Jason G.; Uppal, Karan; Tran, ViLinh T.; Jones, Dean P.; Lee, Elisa T.; Howard, Barbara V.; Zhao, Jinying			Metabolic Profiles of Obesity in American Indians: The Strong Heart Family Study	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; PHYTANIC ACID; INSULIN-RESISTANCE; MASS-SPECTROMETRY; INFLAMMATORY CYTOKINES; CARDIOVASCULAR-DISEASE; ABDOMINAL OBESITY; LIPID-METABOLISM; PRISTANIC ACID; PPAR-ALPHA	Obesity is a typical metabolic disorder resulting from the imbalance between energy intake and expenditure. American Indians suffer disproportionately high rates of obesity and diabetes. The goal of this study is to identify metabolic profiles of obesity in 431 normoglycemic American Indians participating in the Strong Heart Family Study. Using an untargeted liquid chromatography-mass spectrometry, we detected 1,364 distinct m/z features matched to known compounds in the current metabolomics databases. We conducted multivariate analysis to identify metabolic profiles for obesity, adjusting for standard obesity indicators. After adjusting for covariates and multiple testing, five metabolites were associated with body mass index and seven were associated with waist circumference. Of them, three were associated with both. Majority of the obesity-related metabolites belongs to lipids, e.g., fatty amides, sphingolipids, prenol lipids, and steroid derivatives. Other identified metabolites are amino acids or peptides. Of the nine identified metabolites, five metabolites (oleoylethanolamide, mannosyl-diinositol-phosphorylceramide, pristanic acid, glutamate, and kynurenine) have been previously implicated in obesity or its related pathways. Future studies are warranted to replicate these findings in larger populations or other ethnic groups.	[Zhao, Qi; Zhu, Yun; Zhao, Jinying] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; [Best, Lyle G.] Missouri Breaks Ind Res Inc, Timber Lake, SD USA; [Umans, Jason G.] MedStar Hlth Res Inst, Hyattsville, MD USA; [Uppal, Karan; Tran, ViLinh T.; Jones, Dean P.] Emory Univ, Sch Med, Div Pulm Med, Atlanta, GA 30322 USA; [Lee, Elisa T.] Univ Oklahoma, Hlth Sci Ctr, Ctr Amer Indian Hlth Res, Oklahoma City, OK USA; [Howard, Barbara V.] Medstar Res Inst, Washington, DC USA; [Howard, Barbara V.] Georgetown & Howard Univ, Ctr Translat Sci, Washington, DC USA	Tulane University; MedStar Health Research Institute; Emory University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhao, JY (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.	jzhao5@tulane.edu	Zhao, Qi/Y-9866-2019	Uppal, Karan/0000-0001-5985-1668	National Institute of Health (NIH) [R01DK091369, K01AG034259, R21HL092363, P20HL113451, R01AG038746, U01HL65520, U01HL41642, U01HL41652, U01HL41654, U01HL65521]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institute of Health [K12HD043451]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001409] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109319, R01HL109284] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institute of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institute of Health (NIH) grants R01DK091369, K01AG034259, R21HL092363, P20HL113451, R01AG038746 and cooperative agreement grants U01HL65520, U01HL41642, U01HL41652, U01HL41654, and U01HL65521. Dr. Qi Zhao is a Tulane University Building Interdisciplinary Research Careers in Women's Health (BIRCWH) scholar supported by Award K12HD043451 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institute of Health. The funder provided support in the form of salaries for authors [QZ, YZ, LGB, JGU, KU, VTT, DPJ, ETL, BVH, and JZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barnes PM, 2010, 20 CDCP; Bogl LH, 2016, METABOLISM, V65, P111, DOI 10.1016/j.metabol.2015.10.027; Brandacher G, 2007, CURR DRUG METAB, V8, P289, DOI 10.2174/138920007780362590; BROWN PJ, 1993, J HUM NUTR DIET, V6, P295, DOI 10.1111/j.1365-277X.1993.tb00375.x; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Contreras AV, 2013, ADV NUTR, V4, P439, DOI 10.3945/an.113.003798; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Despres JP, 2006, EUR HEART J SUPPL, V8, pB4, DOI 10.1093/eurheartj/sul002; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; Favennec M, 2015, OBESITY, V23, P2066, DOI 10.1002/oby.21199; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Go YM, 2015, TOXICOL SCI, V148, P531, DOI 10.1093/toxsci/kfv198; Grosshans M, 2014, JAMA PSYCHIAT, V71, P1254, DOI 10.1001/jamapsychiatry.2014.1215; Hanamatsu H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.38; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; He K, 2011, AM J CLIN NUTR, V93, P1328, DOI 10.3945/ajcn.110.008870; Hermanussen M, 2006, EUR J CLIN NUTR, V60, P25, DOI 10.1038/sj.ejcn.1602263; Hermanussen M, 2003, J PEDIATR ENDOCR MET, V16, P965; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Hughes G, 2014, BIOINFORMATICS, V30, P133, DOI 10.1093/bioinformatics/btt589; Izzo AA, 2010, OBESITY, V18, P55, DOI 10.1038/oby.2009.186; Johnson JM, 2010, ANALYST, V135, P2864, DOI 10.1039/c0an00333f; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim HY, 2014, NUTRITION, V30, P1433, DOI 10.1016/j.nut.2014.04.013; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757; Levian Candace, 2014, Yale Journal of Biology and Medicine, V87, P113; Mangge H, 2014, OBESITY, V22, P195, DOI 10.1002/oby.20491; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Morris C, 2012, P NUTR SOC, V71, P634, DOI 10.1017/S0029665112000699; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; North KE, 2003, AM J EPIDEMIOL, V157, P303, DOI 10.1093/aje/kwf208; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Osborn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072737; Panel N, 1998, 984083 NAT HEART LUN; Park YH, 2012, TOXICOLOGY, V295, P47, DOI 10.1016/j.tox.2012.02.007; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Proulx K, 2005, AM J PHYSIOL-REG I, V289, pR729, DOI 10.1152/ajpregu.00029.2005; Schirra HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002764; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105; Services USDohaH, 2012, 256 CDCP SERV USDOHA; Sigruener A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085724; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Soltow QA, 2013, METABOLOMICS, V9, pS132, DOI 10.1007/s11306-011-0332-1; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8; van den Brink DM, 2006, CELL MOL LIFE SCI, V63, P1752, DOI 10.1007/s00018-005-5463-y; Verhoeven NM, 2001, PROG LIPID RES, V40, P453, DOI 10.1016/S0163-7827(01)00011-X; Walker D.I., 2016, METABOLIC PHENOTYPIN; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Willet W., 1998, NUTR EPIDEMIOLOGY, P74, DOI DOI 10.1093/ACPROF:OSO/9780195122978.001.0001; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wolowczuk I., 2012, AM J PHYSIOL-REG I, V303, pR135, DOI DOI 10.1152/ajpregu.00373.2011; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Yu TW, 2013, J PROTEOME RES, V12, P1419, DOI 10.1021/pr301053d; Zhao JY, 2015, DIABETES CARE, V38, P220, DOI 10.2337/dc14-2033; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zomer AWM, 2000, J LIPID RES, V41, P1801	65	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159548	10.1371/journal.pone.0159548	http://dx.doi.org/10.1371/journal.pone.0159548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434237	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169600067
J	Jongwe, TI; Chapman, R; Douglass, N; Chetty, S; Chege, G; Williamson, AL				Jongwe, Tsungai Ivai; Chapman, Ros; Douglass, Nicola; Chetty, Shivan; Chege, Gerald; Williamson, Anna-Lise			HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MYCOBACTERIUM-BOVIS BCG; RECOMBINANT VACCINIA VIRUS; HIGHLY PATHOGENIC SIV; RHESUS-MONKEYS; DISCORDANT ASSOCIATIONS; INTRACELLULAR BACTERIA; PANTOTHENATE AUXOTROPH; LYMPHOCYTE RESPONSES; IMMUNE-RESPONSES	Over 90% of HIV/AIDS positive individuals in sub-Saharan Africa are infected with highly heterogeneous HIV-1 subtype C (HIV-1C) viruses. One of the best ways to reduce the burden of this disease is the development of an affordable and effective prophylactic vaccine. Mosaic immunogens are computationally designed to overcome the hurdle of HIV diversity by maximizing the expression of potential T cell epitopes. Mycobacterium bovis BCG Delta panCD auxotroph and modified vaccinia Ankara (MVA) vaccines expressing HIV-1C mosaic Gag (Gag(M)) were tested in a prime-boost regimen to demonstrate immunogenicity in a mouse study. The BCG-Gag(M) vaccine was stable and persisted 11.5 weeks post vaccination in BALB/c mice. Priming with BCG-Gag(M) and boosting with MVA-Gag(M) elicited higher Gag-specific IFN-gamma ELISPOT responses than the BCG-Gag(M) only and MVA-Gag(M) only homologous vaccination regimens. The heterologous vaccination also generated a more balanced and persistent CD4(+) and CD8(+) T cell Gag-specific IFN-gamma ELISPOT response with a predominant effector memory phenotype. A Th1 bias was induced by the vaccines as determined by the predominant secretion of IFN-gamma, TNF-alpha, and IL-2. This study shows that a low dose of MVA (10(4) pfu) can effectively boost a BCG prime expressing the same mosaic immunogen, generating strong, cellular immune responses against Gag in mice. Our data warrants further evaluation in non-human primates. A low dose vaccine would be an advantage in the resource limited countries of sub-Saharan Africa and India (where the predominating virus is HIV-1 subtype C).	[Jongwe, Tsungai Ivai; Chapman, Ros; Douglass, Nicola; Chetty, Shivan; Chege, Gerald; Williamson, Anna-Lise] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Jongwe, Tsungai Ivai; Chapman, Ros; Douglass, Nicola; Chetty, Shivan; Chege, Gerald; Williamson, Anna-Lise] Univ Cape Town, Div Med Virol, Dept Pathol, Fac Hlth Sci, Cape Town, South Africa; [Williamson, Anna-Lise] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Chapman, R (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa.; Chapman, R (corresponding author), Univ Cape Town, Div Med Virol, Dept Pathol, Fac Hlth Sci, Cape Town, South Africa.	Ros.Chapman@uct.ac.za	Chege, Gerald/HIK-1573-2022; Chapman, Rosamund/AAJ-6490-2020	Chege, Gerald/0000-0003-3986-9638; Chapman, Rosamund/0000-0001-9162-2099; Williamson, Anna-Lise/0000-0002-5467-1200; Douglass, Nicola/0000-0002-8929-6279	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Schlumberger Foundation; Oppenheimer Memorial Trust; Poliomyelitis Research Foundation	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Schlumberger Foundation(Schlumberger); Oppenheimer Memorial Trust; Poliomyelitis Research Foundation	This work is also based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation. Tsungai Jongwe received bursaries from the Schlumberger Foundation, the Oppenheimer Memorial Trust and the Poliomyelitis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zarouni M, 2002, TUBERCULOSIS, V82, P283, DOI 10.1054/tube.2002.0374; Alcalde R, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-156; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Borsuk S, 2007, TUBERCULOSIS, V87, P474, DOI 10.1016/j.tube.2007.07.006; Boyle D.B., 2007, POXVIRUSES BIRKH USE; Bredell H, 2007, AIDS RES HUM RETROV, V23, P477, DOI 10.1089/aid.2006.0232; Burgers WA, 2006, J GEN VIROL, V87, P399, DOI 10.1099/vir.0.81379-0; Burgers WA, 2008, AIDS RES HUM RETROV, V24, P195, DOI 10.1089/aid.2007.0205; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Chapman R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103314; Chapman R, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071601, 10.1371/journal.pone.0076584]; Chapman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032769; Chapman R, 2010, CURR HIV RES, V8, P282, DOI 10.2174/157016210791208686; Chege GK, 2013, J VIROL, V87, P5151, DOI 10.1128/JVI.03178-12; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Columb MO, 2006, CURR ANAESTH CRIT CA, V17, P233, DOI DOI 10.1016/J.CACC.2006.03.005; Esparza J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00124; Excler JL, 2015, VACCINE; Fenimore PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044769; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; GHEORGHIU M, 1988, J BIOL STAND, V16, P15, DOI 10.1016/0092-1157(88)90025-X; Goulder PJR, 1997, J EXP MED, V185, P1423, DOI 10.1084/jem.185.8.1423; Graf T, 2013, VIROLOGY, V435, P170, DOI 10.1016/j.virol.2012.08.048; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Guevara H, 2000, J ACQ IMMUN DEF SYND, V25, P390, DOI 10.1097/00126334-200012150-00002; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hatherill M, 2011, ARCH DIS CHILD, V96, P851, DOI 10.1136/adc.2011.214494; Haynes BF, 2015, CURR OPIN IMMUNOL, V35, P39, DOI 10.1016/j.coi.2015.05.007; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hess J, 2000, ADV IMMUNOL, V75, P1, DOI 10.1016/S0065-2776(00)75001-2; Hulot SL, 2015, J VIROL, V89, P6462, DOI 10.1128/JVI.00383-15; Im EJ, 2007, J VIROL, V81, P9408, DOI 10.1128/JVI.00707-07; Johansen P, 2004, EUR J IMMUNOL, V34, P91, DOI 10.1002/eji.200324231; Kemball CC, 2007, J IMMUNOL, V179, P1113, DOI 10.4049/jimmunol.179.2.1113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kong WP, 2009, J VIROL, V83, P2201, DOI 10.1128/JVI.02256-08; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mann JK, 2015, VIROL J, V12; Matsuo Kazuhiro, 2011, Tuberc Res Treat, V2011, P574591, DOI 10.1155/2011/574591; MCADAM RA, 1995, INFECT IMMUN, V63, P1004, DOI 10.1128/IAI.63.3.1004-1012.1995; McShane H, 2011, PHILOS T R SOC B, V366, P2782, DOI 10.1098/rstb.2011.0097; Murphy K. M., 2011, JANEWAYS IMMUNOBIOLO; Nkolola JP, 2014, J VIROL, V88, P9538, DOI 10.1128/JVI.01739-14; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Parish T, 2001, MYCOBACTERIA PROTOCO; Prendergast A, 2011, AIDS, V25, P1329, DOI 10.1097/QAD.0b013e3283478575; Price PJR, 2013, VACCINE, V31, P4231, DOI 10.1016/j.vaccine.2013.03.017; Ramsburg EA, 2007, J IMMUNOL, V178, P6350, DOI 10.4049/jimmunol.178.10.6350; Ranasinghe S, 2012, J VIROL, V86, P277, DOI 10.1128/JVI.05577-11; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sampson SL, 2004, INFECT IMMUN, V72, P3031, DOI 10.1128/IAI.72.5.3031-3037.2004; Santra S, 2012, VIROLOGY, V428, P121, DOI 10.1016/j.virol.2012.03.012; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Saubi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042559; Shedlock DJ, 2013, MOL THER, V21, P1432, DOI 10.1038/mt.2013.61; Shen Y. J., 2010, INVESTIGATION USE LU; Someya K, 2004, J VIROL, V78, P9842, DOI 10.1128/JVI.78.18.9842-9853.2004; Tatt ID, 2004, JAIDS-J ACQ IMM DEF, V36, P1092, DOI 10.1097/00126334-200408150-00013; Tongo M, 2014, VIRUSES-BASEL, V6, P3968, DOI 10.3390/v6103968; UNAIDS, GLOB FACT SHEET JUL; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; Van Harmelen JH, 1999, AIDS RES HUM RETROV, V15, P395; Wong YC, 2011, J VIROL METHODS, V171, P295, DOI 10.1016/j.jviromet.2010.11.003; Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09; Zheng YQ, 2015, EXPERT REV VACCINES, V14, P1255, DOI 10.1586/14760584.2015.1068124; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	74	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159141	10.1371/journal.pone.0159141	http://dx.doi.org/10.1371/journal.pone.0159141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427967	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169300037
J	Koli, K; Sutinen, E; Ronty, M; Rantakari, P; Fortino, V; Pulkkinen, V; Greco, D; Sipila, P; Myllarniemi, M				Koli, Katri; Sutinen, Eva; Ronty, Mikko; Rantakari, Pia; Fortino, Vittorio; Pulkkinen, Ville; Greco, Dario; Sipila, Petra; Myllarniemi, Marjukka			Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment - A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; MIGRATION INHIBITORY FACTOR; TO-MESENCHYMAL TRANSITION; GENE-EXPRESSION PATTERNS; TRANSGENIC MICE; IN-VIVO; ANTAGONIST; GROWTH; RECOMBINATION; INFLAMMATION	Idiopathic pulmonary fibrosis (IPF) is characterized by activation and injury of epithelial cells, the accumulation of connective tissue and changes in the inflammatory microenvironment. The bone morphogenetic protein (BMP) inhibitor protein gremlin-1 is associated with the progression of fibrosis both in human and mouse lung. We generated a transgenic mouse model expressing gremlin-1 in type II lung epithelial cells using the surfactant protein C (SPC) promoter and the Cre-LoxP system. Gremlin-1 protein expression was detected specifically in the lung after birth and did not result in any signs of respiratory insufficiency. Exposure to silicon dioxide resulted in reduced amounts of lymphocyte aggregates in transgenic lungs while no alteration in the fibrotic response was observed. Microarray gene expression profiling and analyses of bronchoalveolar lavage fluid cytokines indicated a reduced lymphocytic response and a downregulation of interferon-induced gene program. Consistent with reduced Th1 response, there was a downregulation of the mRNA and protein expression of the anti-fibrotic chemokine CXCL10, which has been linked to IPF. In human IPF patient samples we also established a strong negative correlation in the mRNA expression levels of gremlin-1 and CXCL10. Our results suggest that in addition to regulation of epithelial-mesenchymal crosstalk during tissue injury, gremlin-1 modulates inflammatory cell recruitment and anti-fibrotic chemokine production in the lung.	[Koli, Katri] Univ Helsinki, Translat Canc Biol, Res Programs Unit, Helsinki, Finland; [Koli, Katri; Sutinen, Eva; Myllarniemi, Marjukka] Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki, Finland; [Sutinen, Eva; Pulkkinen, Ville; Myllarniemi, Marjukka] Univ Helsinki, Helsinki, Finland; [Sutinen, Eva; Pulkkinen, Ville; Myllarniemi, Marjukka] Helsinki Univ Hosp, Heart & Lung Ctr, Dept Pulm Med, Helsinki, Finland; [Ronty, Mikko] Univ Helsinki, Dept Pathol, Tampere, Finland; [Ronty, Mikko] Fimlab Labs, Pathol, Tampere, Finland; [Rantakari, Pia] Univ Turku, MediCity Res Lab, Turku, Finland; [Fortino, Vittorio; Greco, Dario] FIOH, Unit Syst Toxicol, Helsinki, Finland; [Fortino, Vittorio; Greco, Dario] FIOH, Nanosafety Ctr, Helsinki, Finland; [Sipila, Petra] Univ Turku, Dept Physiol, Inst Biomed, Turku, Finland; [Sipila, Petra] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Turku; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Turku; University of Turku	Koli, K (corresponding author), Univ Helsinki, Translat Canc Biol, Res Programs Unit, Helsinki, Finland.; Koli, K (corresponding author), Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki, Finland.	katri.koli@helsinki.fi	Sipilä, Petra/GYE-3323-2022; Greco, Dario/T-7113-2019	Greco, Dario/0000-0001-9195-9003; Sipila, Petra/0000-0001-8187-7143; Myllarniemi, L Marjukka/0000-0001-9343-0867; Sutinen, Eva/0000-0002-9169-7178; Rantakari, Pia/0000-0003-1638-5075	Jane and Aatos Erkko foundation; Sigrid Juselius Foundation; University of Helsinki Research Fund; Magnus Ehrnrooth foundation; Helsinki University Hospital Research Fund; Academy of Finland [275151, 292307]; European Commission [FP7-309329]	Jane and Aatos Erkko foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki Research Fund; Magnus Ehrnrooth foundation; Helsinki University Hospital Research Fund; Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre)	KK and MM are supported by the Jane and Aatos Erkko foundation, the Sigrid Juselius Foundation and the University of Helsinki Research Fund. KK is supported by the Magnus Ehrnrooth foundation. MM is supported by the Helsinki University Hospital Research Fund. VP is supported by the Sigrid Juselius Foundation. DG is supported by the Academy of Finland (grant number 275151 and 292307) and the European Commission, under grant agreement FP7-309329 (NANOSOLUTIONS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beamer CA, 2010, J LEUKOCYTE BIOL, V88, P547, DOI 10.1189/jlb.0210108; Boers W, 2006, J BIOL CHEM, V281, P16289, DOI 10.1074/jbc.M600711200; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; Chambers Rachel C, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS16, DOI 10.1513/AnnalsATS.201410-448MG; Chen B, 2004, J IMMUNOL, V173, P5914, DOI 10.4049/jimmunol.173.10.5914; Church RH, 2015, BIOCHEM J, V466, P55, DOI 10.1042/BJ20140771; Corsini M, 2014, ARTERIOSCL THROM VAS, V34, P136, DOI 10.1161/ATVBAHA.113.302517; D'Ambrosio D, 2001, AM J RESP CRIT CARE, V164, P1266, DOI 10.1164/ajrccm.164.7.2103011; Droguett A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101879; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farkas L, 2011, AM J RESP CELL MOL, V44, P870, DOI 10.1165/rcmb.2010-0070OC; Fortino V, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0477-4; Harari S, 2010, ALLERGY, V65, P537, DOI 10.1111/j.1398-9995.2009.02305.x; Jiang DH, 2010, J CLIN INVEST, V120, P2049, DOI 10.1172/JCI38644; Kalderen C, 2014, INT IMMUNOPHARMACOL, V20, P66, DOI 10.1016/j.intimp.2014.02.020; Karagiannis GS, 2015, BIOL CHEM, V396, P163, DOI 10.1515/hsz-2014-0221; Keane MP, 1997, J IMMUNOL, V159, P1437; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lavoz C, 2015, J PATHOL, V236, P407, DOI 10.1002/path.4537; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Lepparanta O, 2013, AM J RESP CELL MOL, V48, P448, DOI 10.1165/rcmb.2012-0201OC; Lepparanta O, 2012, CELL TISSUE RES, V348, P491, DOI 10.1007/s00441-012-1385-9; Lindahl GE, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-80; Lu MM, 2001, DEV DYNAM, V222, P667, DOI 10.1002/dvdy.1231; Marchant V, 2015, AM J PHYSIOL-RENAL, V309, pF559, DOI 10.1152/ajprenal.00023.2015; Meyringer R, 2007, J RHEUMATOL, V34, P747; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Muller I, 2013, J BIOL CHEM, V288, P31635, DOI 10.1074/jbc.M113.477745; Muller II, 2014, INT J CARDIOL, V176, P923, DOI 10.1016/j.ijcard.2014.08.051; Mueller KAL, 2013, J CARD FAIL, V19, P678, DOI 10.1016/j.cardfail.2013.09.001; Mulvihill MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042264; Myllarniemi M, 2008, J PATHOL, V214, P456, DOI 10.1002/path.2300; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; Myllarniemi M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-170; Namkoong H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-74; Pignatti P, 2006, AM J RESP CRIT CARE, V173, P310, DOI 10.1164/rccm.200502-244OC; Pulkkinen V, 2010, FASEB J, V24, P1167, DOI 10.1096/fj.09-138545; Smyth G, 2005, LIMMA LINEAR MODELS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-165; Sundar IK, 2015, AM J RESP CELL MOL B; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Tamminen JA, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.29; Team RC, 2012, R LANG ENV STAT COMP; Topol LZ, 2000, J BIOL CHEM, V275, P8785, DOI 10.1074/jbc.275.12.8785; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; Yeung CYC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05183; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	53	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159010	10.1371/journal.pone.0159010	http://dx.doi.org/10.1371/journal.pone.0159010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428020	gold, Green Submitted, Green Published			2022-12-27	WOS:000380169300029
J	Wei, XH; Sun, BY; Cui, JX; Xu, GC				Wei, Xiaohui; Sun, Bingyi; Cui, Jiaxu; Xu, Gaochao			A Multi-Objective Compounded Local Mobile Cloud Architecture Using Priority Queues to Process Multiple Jobs	PLOS ONE			English	Article								As a result of the greatly increased use of mobile devices, the disadvantages of portable devices have gradually begun to emerge. To solve these problems, the use of mobile cloud computing assisted by cloud data centers has been proposed. However, cloud data centers are always very far from the mobile requesters. In this paper, we propose an improved multi-objective local mobile cloud model: Compounded Local Mobile Cloud Architecture with Dynamic Priority Queues (LMCpri). This new architecture could briefly store jobs that arrive simultaneously at the cloudlet in different priority positions according to the result of auction processing, and then execute partitioning tasks on capable helpers. In the Scheduling Module, NSGA-II is employed as the scheduling algorithm to shorten processing time and decrease requester cost relative to PSO and sequential scheduling. The simulation results show that the number of iteration times that is defined to 30 is the best choice of the system. In addition, comparing with LMCque, LMCpri is able to effectively accommodate a requester who would like his job to be executed in advance and shorten execution time. Finally, we make a comparing experiment between LMCpri and cloud assisting architecture, and the results reveal that LMCpri presents a better performance advantage than cloud assisting architecture.	[Wei, Xiaohui; Sun, Bingyi; Xu, Gaochao] Jilin Univ, Coll Comp Sci & Technol, Changchun, Peoples R China; [Cui, Jiaxu] Jilin Univ, Coll Software, Changchun, Peoples R China; [Wei, Xiaohui; Xu, Gaochao] Jilin Univ, Symbol Computat & Knowledge Engn Minist Educ, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University	Xu, GC (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun, Peoples R China.; Xu, GC (corresponding author), Jilin Univ, Symbol Computat & Knowledge Engn Minist Educ, Changchun, Peoples R China.	lvxf@jlu.edu.cn			National Natural Science Foundation of China [61170004]; Jilin Provincial key science and technology project [20140204013GX]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Provincial key science and technology project	This work is supported by the National Natural Science Foundation of China (grant 61170004 to Prof Xiaohui Wei) and Jilin Provincial key science and technology project (grant 20140204013GX to Prof Xiaohui Wei). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahtovski A, 2014, PROCEDIA ENGINEER, V69, P704, DOI 10.1016/j.proeng.2014.03.045; Calheiros RN, 2011, SOFTWARE PRACT EXPER, V41, P23, DOI 10.1002/spe.995; Chun BG, 2011, EUROSYS 11: PROCEEDINGS OF THE EUROSYS 2011 CONFERENCE, P301; Conti M, 2011, COMPUT COMMUN, V34, P2115, DOI 10.1016/j.comcom.2011.09.001; Cuervo E., 2010, P 8 INT C MOB SYST A, P49, DOI [10.1145/1814433.1814441, DOI 10.1145/1814433.1814441]; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Dijiang Huang, 2010, 2010 Fifth International Symposium on Service Oriented System Engineering (SOSE 2010), P27, DOI 10.1109/SOSE.2010.20; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Eric J, 2010, P 1 ACM WORKSH MOB C, P2, DOI 10.1145/1810931.1810933; HAJELA P, 1992, STRUCT OPTIMIZATION, V4, P99, DOI 10.1007/BF01759923; Huang D., 2011, IEEE COMSOC MULTIMED, V6, P27; Khan KA, 2014, PROC SPIE, V9139, DOI 10.1117/12.2052474; Krishna V, 2009, AUCTION THEORY, P12; Lei Yang, 2012, 2012 IEEE 5th International Conference on Cloud Computing (CLOUD), P794, DOI 10.1109/CLOUD.2012.97; Li Z., 2001, P 2001 INT C COMP AR, P238, DOI DOI 10.1145/502217.502257; Nasseri M, 2013, IEEE INT CONF CL NET, P123, DOI 10.1109/CloudNet.2013.6710566; Nir M, 2014, IEEE CONF COMPUT, P404, DOI 10.1109/INFCOMW.2014.6849266; Park SW, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/929380; Satyanarayanan M, 2009, IEEE PERVAS COMPUT, V8, P14, DOI 10.1109/MPRV.2009.82; Srinivas N., 1994, Evolutionary Computation, V2, P221, DOI 10.1162/evco.1994.2.3.221; Varshney U, 2007, MOBILE NETW APPL, V12, P113, DOI 10.1007/s11036-007-0017-1; Verbelen Tim, 2012, P 3 ACM WORKSHOP MOB, P29; Xiaoyan Yang, 2010, 2010 3rd IEEE International Conference on Ubi-Media Computing (U-Media 2010), P198, DOI 10.1109/UMEDIA.2010.5544470; Zhao S., 2012, P 2012 8 INT C WIR C, P1, DOI [DOI 10.1109/WICOM.2012.6478580, DOI 10.1109/WIC0M.2012.6478580]	24	1	1	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0158491	10.1371/journal.pone.0158491	http://dx.doi.org/10.1371/journal.pone.0158491			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27419854	Green Published, Green Submitted, gold			2022-12-27	WOS:000379662300003
J	Martinez-Nava, GA; Fernandez-Nino, JA; Madrid-Marina, V; Torres-Poveda, K				Martinez-Nava, Gabriela A.; Fernandez-Nino, Julian A.; Madrid-Marina, Vicente; Torres-Poveda, Kirvis			Cervical Cancer Genetic Susceptibility: A Systematic Review and Meta-Analyses of Recent Evidence	PLOS ONE			English	Review							P21 SER31ARG POLYMORPHISM; RISK; ASSOCIATION; REVEALS; BRIP1	Introduction Cervical cancer (CC) has one of the highest mortality rates among women worldwide. Several efforts have been made to identify the genetic susceptibility factors underlying CC development. However, only a few polymorphisms have shown consistency among studies. Materials and Methods We conducted a systematic review of all recent case-control studies focused on the evaluation of single nucleotide polymorphisms (SNPs) and CC risk, stringently following the "PRISMA" statement recommendations. The MEDLINE data base was used for the search. A total of 100 case-control studies were included in the meta-analysis. Polymorphisms that had more than two reports were meta-analyzed by fixed or random models according to the heterogeneity presented among studies. Results We found significant negative association between the dominant inheritance model of p21 rs1801270 polymorphism (C/A+A/A) and CC (pooled OR = 0.76; 95%CI: 0.63-0.91; p<0.01). We also found a negative association with the rs2048718 BRIP1 polymorphism dominant inheritance model (T/C+C/C) and CC (pooled OR = 0.83; 95%CI: 0.70-0.98; p = 0.03), as well as with the rs11079454 BRIP1 polymorphism recessive inheritance model and CC (pooled OR = 0.79; 95%CI: 0.63-0.99; p = 0.04). Interestingly, we observed a strong tendency of the meta-analyzed studies to be of Asiatic origin (67%). We also found a significant low representation of African populations (4%). Conclusions Our results provide evidence of the negative association of p21 rs1801270 polymorphism, as well as BRIP1 rs2048718 and rs11079454 polymorphisms, with CC risk. This study suggests the urgent need for more replication studies focused on GWAS identified CC susceptibility variants, in order to reveal the most informative genetic susceptibility markers for CC across different populations.	[Martinez-Nava, Gabriela A.] Inst Nacl Rehabil Luis Guillermo Ibarra INR LGII, Synovial Fluid Lab, Mexico City, DF, Mexico; [Fernandez-Nino, Julian A.] Univ Ind Santander, Sch Med, Dept Publ Hlth, Bucaramanga, Colombia; [Fernandez-Nino, Julian A.] Univ Manuela Beltran, Bucaramanga, Colombia; [Madrid-Marina, Vicente; Torres-Poveda, Kirvis] Inst Nacl Salud Publ, Ctr Res Infect Dis, Chron Infect Dis & Canc Div, Cuernavaca, Morelos, Mexico; [Torres-Poveda, Kirvis] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico	Universidad Industrial de Santander; Universidad Manuela Beltran - UMB; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Torres-Poveda, K (corresponding author), Inst Nacl Salud Publ, Ctr Res Infect Dis, Chron Infect Dis & Canc Div, Cuernavaca, Morelos, Mexico.; Torres-Poveda, K (corresponding author), Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico.	kjtorres@insp.mx	Martínez-Nava, Gabriela Angelica/AAT-6660-2021; Fernández-Niño, Julián Alfredo/AHE-6038-2022; Martínez-Nava, Gabriela A/P-3914-2014	Martínez-Nava, Gabriela Angelica/0000-0001-9857-3840; Fernández-Niño, Julián Alfredo/0000-0002-8948-8481; Martínez-Nava, Gabriela A/0000-0001-9857-3840; TORRES-POVEDA, KIRVIS/0000-0001-9608-9617	Instituto Nacional de Salud Publica, Mexico; Consejo Nacional de Ciencia y Tecnologia (MX) (CONACYT) Fondo E0013 APOYO COMPLEMENTARIO [CATEDRAS-2014-C01-245520]; CONACyT-FONSEC, Mexico [SSA/IMSS/ISSSTE-2014-C01-234149]	Instituto Nacional de Salud Publica, Mexico; Consejo Nacional de Ciencia y Tecnologia (MX) (CONACYT) Fondo E0013 APOYO COMPLEMENTARIO(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT-FONSEC, Mexico	This work was supported by the Instituto Nacional de Salud Publica, Mexico, and grants from Consejo Nacional de Ciencia y Tecnologia (MX) (CONACYT) Fondo E0013 APOYO COMPLEMENTARIO CATEDRAS-2014-C01-245520 and CONACyT-FONSEC SSA/IMSS/ISSSTE-2014-C01-234149, Mexico.	Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Audirac-Chalifour A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153274; Balacescu O, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-246; Bedi U, 2011, J CLIN HYPERTENS, V13, P492, DOI 10.1111/j.1751-7176.2011.00428.x; Bosch FX, 2011, EXPERT OPIN PHARMACO, V12, P2189, DOI 10.1517/14656566.2011.596527; CHEDID M, 1994, ONCOGENE, V9, P3021; Dong Y, 2015, TECHNOL CANCER RES T, V14, P627, DOI 10.7785/tcrtexpress.2013.500422; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fotedar R, 2004, CELL CYCLE, V3, P134; Gelman A, 2013, EPIDEMIOLOGY, V24, P69, DOI 10.1097/EDE.0b013e31827886f7; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; IARC/WHO, 2012, GLOBOCAN 2012 EST CA; Li GJ, 2005, CARCINOGENESIS, V26, P1596, DOI 10.1093/carcin/bgi105; Li Y, 2011, INT J GYNECOL CANCER, V21, P445, DOI 10.1097/IGC.0b013e31820da58b; Liu HL, 2016, TUMOR BIOL, V37, P8057, DOI 10.1007/s13277-015-4682-6; Ma XD, 2013, GENE, V524, P208, DOI 10.1016/j.gene.2013.04.025; Ma XD, 2013, BIOCHEM BIOPH RES CO, V433, P232, DOI 10.1016/j.bbrc.2013.02.089; Ma YC, 2013, TUMOR BIOL, V34, P3887, DOI 10.1007/s13277-013-0976-8; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Norquist BM, 2016, JAMA ONCOL, V2, P482, DOI 10.1001/jamaoncol.2015.5495; Ouhtit Allal, 2016, Front Biosci (Elite Ed), V8, P289; Pabalan N, 2013, BREAST CANCER RES TR, V137, P553, DOI 10.1007/s10549-012-2364-2; Qiu LX, 2010, BREAST CANCER RES TR, V124, P475, DOI 10.1007/s10549-010-0858-3; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; [Secretaria de Salud de Mexico Direccion General de Epidemiologia], AN MORB 1984 2014; Secretaria de Salud de Mexico, NOM014SSA21994 SECR; Shao CS, 2009, MUTAT RES-FUND MOL M, V670, P103, DOI 10.1016/j.mrfmmm.2009.09.001; Song D, 2015, ONCOL LETT, V10, P600, DOI 10.3892/ol.2015.3295; Stanley MA, 2014, CURR PROBL DERMATOL, V45, P58, DOI 10.1159/000355964; Sterne JAC, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P75, DOI 10.1002/0470870168.ch5; Sun Y, CANC EPIDEMIOL BIOMA, V4, P261; Torres-Poveda K, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2364-4; Torres-Poveda K, 2014, GAC MEX ONCOL, V13, P4; Torres-Poveda K, 2014, WORLD J CLIN ONCOL, V5, P753, DOI 10.5306/wjco.v5.i4.753; Wang N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-589; Wang SS, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0168-z; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang X, 2014, BJOG-INT J OBSTET GY, V121, P664, DOI 10.1111/1471-0528.12638	42	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0157344	10.1371/journal.pone.0157344	http://dx.doi.org/10.1371/journal.pone.0157344			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415837	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500013
J	Mohammed, KA; Boakye, EA; Ismail, HA; Geneus, CJ; Tobo, BB; Buchanan, PM; Zelicoff, AP				Mohammed, Kahee A.; Boakye, Eric Adjei; Ismail, Honer A.; Geneus, Christian J.; Tobo, Betelihem B.; Buchanan, Paula M.; Zelicoff, Alan P.			Pineal Gland Calcification in Kurdistan: A Cross-Sectional Study of 480 Roentgenograms	PLOS ONE			English	Article							AGE-RELATED INCIDENCE; COMPUTED-TOMOGRAPHY; ALZHEIMERS-DISEASE; MELATONIN; PREVALENCE; CHILDREN; SYSTEM; RHYTHM; FILMS	Objective The goal of this study was to compare the incidence of Pineal Gland Calcification (PGC) by age group and gender among the populations living in the Kurdistan Region-Iraq. Methods This prospective study examined skull X-rays of 480 patients between the ages of 3 and 89 years who sought care at a large teaching public hospital in Duhok, Iraq from June 2014 to November 2014. Descriptive statistics and a binary logistic regression were used for analysis. Results The overall incidence rate of PGC among the study population was 26.9% with the 51-60 age group and males having the highest incidence. PGC incidence increased after the first decade and remained steady until the age of 60. Thereafter the incidence began to decrease. Logistic regression analysis revealed that both age and gender significantly affected the risk of PGC. After adjusting for age, males were 1.94 (95% CI, 1.26-2.99) times more likely to have PGC compared to females. In addition, a one year increase in age increases the odds of developing PGC by 1.02 (95% CI, 1.01-1.03) units after controlling for the effects of gender. Conclusion Our analysis demonstrated a close relationship between PGC and age and gender, supporting a link between the development of PGC and these factors. This study provides a basis for future researchers to further investigate the nature and mechanisms underlying pineal gland calcification.	[Mohammed, Kahee A.; Tobo, Betelihem B.] St Louis Univ, Dept Epidemiol, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA; [Boakye, Eric Adjei; Buchanan, Paula M.] St Louis Univ, Ctr Outcomes Res SLUCOR, St Louis, MO 63103 USA; [Mohammed, Kahee A.; Ismail, Honer A.] Univ Duhok, Sch Med, Dept Radiol, Duhok, Kurdistan, Iraq; [Geneus, Christian J.; Zelicoff, Alan P.] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Environm & Occupat Hlth, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University; University of Duhok; Saint Louis University	Boakye, EA (corresponding author), St Louis Univ, Ctr Outcomes Res SLUCOR, St Louis, MO 63103 USA.	adjeiboakyee@slu.edu	Adjei Boakye, Eric/D-4448-2015; Mohammed, Kahee/B-6344-2016	Adjei Boakye, Eric/0000-0001-9163-8103; Mohammed, Kahee/0000-0001-6765-3194				ADELOYE A, 1974, AM J ROENTGENOL, V122, P503, DOI 10.2214/ajr.122.3.503; Admassie Daniel, 2009, Ethiop Med J, V47, P55; Afgin AE, 2012, J ALZHEIMERS DIS, V29, P431, DOI 10.3233/JAD-2011-111667; Akano A, 2003, CLIN RADIOL, V58, P336, DOI 10.1016/S0009-9260(02)00510-X; Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002; Bersani G, 1999, EUR PSYCHIAT, V14, P163, DOI 10.1016/S0924-9338(99)80735-4; Bhatti I H, 1977, J Pak Med Assoc, V27, P310; Butler P., 1999, APPL RADIOLOGICAL AN; Chiba M, 1948, PSYCHIAT CLIN NEUROS, V2; DARAMOLA GF, 1972, NEUROENDOCRINOLOGY, V9, P41, DOI 10.1159/000122036; Dyke CG, 1930, AM J ROENTGENOL, V23; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Gurvit H, 2008, AM J ALZHEIMERS DIS, V23, P67, DOI 10.1177/1533317507310570; Hardeland R, 2012, J PINEAL RES, V52, P139, DOI 10.1111/j.1600-079X.2011.00934.x; Khaleghipour S, 2012, SAO PAULO MED J, V130, P167, DOI 10.1590/S1516-31802012000300006; KOHLI N, 1992, INDIAN J MED RES-B, V96, P139; Korkmaz A, 2009, MOL MED, V15, P43, DOI 10.2119/molmed.2008.00117; Kunz D, 1998, PSYCHIAT RES-NEUROIM, V82, P187, DOI 10.1016/S0925-4927(98)00013-4; Macchi MM, 2004, FRONT NEUROENDOCRIN, V25, P177, DOI 10.1016/j.yfrne.2004.08.001; MACPHERSON P, 1979, NEURORADIOLOGY, V18, P67, DOI 10.1007/BF00344824; Mahlberg R, 2006, PSYCHONEUROENDOCRINO, V31, P634, DOI 10.1016/j.psyneuen.2006.01.009; Mahlberg R, 2008, NEUROBIOL AGING, V29, P203, DOI 10.1016/j.neurobiolaging.2006.10.003; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; Mayo JC, 2005, ENDOCRINE, V27, P169, DOI 10.1385/ENDO:27:2:169; MCKAY RT, 1973, T ROY SOC TROP MED H, V67, P214, DOI 10.1016/0035-9203(73)90147-8; MUGONDI SG, 1976, BRIT J RADIOL, V49, P594, DOI 10.1259/0007-1285-49-583-594; OON CL, 1964, AMER J ROENTGENOL RA, V92, P1242; Reiter RJ, 2007, J PHYSIOL PHARMACOL, V58, P5; Ritzenthaler T, 2009, J PINEAL RES, V46, P349, DOI 10.1111/j.1600-079X.2009.00670.x; SANDYK R, 1994, INT J NEUROSCI, V79, P75, DOI 10.3109/00207459408986069; SANDYK R, 1992, INT J NEUROSCI, V62, P89; SILMAN RE, 1979, NATURE, V282, P301, DOI 10.1038/282301a0; Skene DJ, 2003, EXP GERONTOL, V38, P199, DOI 10.1016/S0531-5565(02)00198-5; Tan DX, 2000, BIOL SIGNAL RECEPT, V9, P137; Turgut Ahmet Tuncay, 2008, Pathophysiology, V15, P41, DOI 10.1016/j.pathophys.2008.02.001; Uberos J, 2011, J PINEAL RES, V50, P192, DOI 10.1111/j.1600-079X.2010.00828.x; Vastine JH, 1927, AM J ROENTGENOLOGY, V17; Vijayalaxmi, 2002, J CLIN ONCOL, V20, P2575, DOI 10.1200/JCO.2002.11.004; Wang X, 2009, STROKE, V40, P1877, DOI 10.1161/STROKEAHA.108.540765; WINKLER P, 1987, J PINEAL RES, V4, P247, DOI 10.1111/j.1600-079X.1987.tb00862.x; WURTMAN RJ, 1964, J CLIN ENDOCR METAB, V24, P299, DOI 10.1210/jcem-24-3-299; Zhou JN, 2003, J PINEAL RES, V34, P11, DOI 10.1034/j.1600-079X.2003.01897.x; ZIMMERMAN RA, 1982, RADIOLOGY, V142, P659, DOI 10.1148/radiology.142.3.7063680	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159239	10.1371/journal.pone.0159239	http://dx.doi.org/10.1371/journal.pone.0159239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415622	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500105
J	Plaete, J; De Bourdeaudhuij, I; Crombez, G; Steenhuyzen, S; Dejaegere, L; Vanhauwaert, E; Verloigne, M				Plaete, Jolien; De Bourdeaudhuij, Ilse; Crombez, Geert; Steenhuyzen, Saidja; Dejaegere, Liesbet; Vanhauwaert, Erika; Verloigne, Maite			The Reliability and Validity of Short Online Questionnaires to Measure Fruit and Vegetable Intake in Adults: The Fruit Test and Vegetable Test	PLOS ONE			English	Article							TAILORED PHYSICAL-ACTIVITY; FOOD-FREQUENCY QUESTIONNAIRES; ACTIVITY INTERVENTION; RELATIVE VALIDITY; VALIDATION; INSTRUMENTS; AGREEMENT; BEHAVIOR; REPRODUCIBILITY; ACCEPTABILITY	The first aim of this study was to investigate the stability of the Fruit Test and Vegetable Test over time and whether the Fruit Test and Vegetable Test are capable of measuring fruit and vegetable intake with consistency. Second, the study aimed to examine criterion (concurrent) validity of the Fruit Test and Vegetable Test by testing their agreement with 7-day food diary-derived measures of fruit and vegetable intake. In total 58 adults (31% male, mean age = 30.0 +/- 12.09y) completed the Flemish Fruit and Vegetable test by indicating the frequency of days that they ate fruit and vegetables and the number of portions during the past week. Validity was tested by using a 7-day food diary as a golden standard. Adults were asked to register their fruit and vegetable intake daily in a diary during one week. Spearman correlations were measured to compare total intake reported in the Fruit and Vegetable Test and in the 7-day diary. Agreement plots were used to illustrate absolute agreement. Test-retest reliability was evaluated by having participants completing the Fruit Test and Vegetable Test twice. The Fruit Test (ICC = 0.81) and Vegetable Test (ICC = 0.78) showed excellent and substantial reliability. The Fruit Test (rho = 0.73) and Vegetable Test showed good validity. Agreement plots showed modest variability in differences between vegetable and fruit intake as measured by the Vegetable and Fruit Test and the 7-day food diary. Also a small underestimation of fruit intake in the Fruit test and vegetable intake in the Vegetable test against the 7-day food diary was shown. Based on the results, it is suggested to include portion size pictures and consumption of mixed vegetables to prevent underestimation. To prevent overestimation, it is concluded to add a moderate number of representative fruit and vegetable items, questions on portion size, household sizes with sufficient detail and food items highly tailored to the dietary behaviors and local food items of the population surveyed. The questionnaires can easily be adapted for the use in other diets (e.g. Asian diet), but reliability and validity should then be examined again. Also, validity remains to be tested in other population groups (i.e. low socio economic status groups, other age groups).	[Plaete, Jolien; De Bourdeaudhuij, Ilse; Verloigne, Maite] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium; [Crombez, Geert] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium; [Steenhuyzen, Saidja; Dejaegere, Liesbet] Flemish Inst Hlth Promot & Dis Prevent VIGeZ, Brussels, Belgium; [Vanhauwaert, Erika] Univ Coll Leuven Limburg, Knowledge & Innovat Ctr FOOD, Leuven, Belgium	Ghent University; Ghent University	Plaete, J (corresponding author), Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium.	Jolien.Plaete@UGent.be	De+Bourdeaudhuij, Ilse/AAC-5528-2019	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597	Ministry of the Flemish Community, Department of Welfare, Public Health and Family; Research Foundation Flanders (FWO) [FWO13/PDO/191]	Ministry of the Flemish Community, Department of Welfare, Public Health and Family; Research Foundation Flanders (FWO)(FWO)	The study was commissioned, financed and steered by the Ministry of the Flemish Community, Department of Welfare, Public Health and Family. Maite Verloigne is supported by the Research Foundation Flanders (FWO) (postdoctoral research fellowship: FWO13/PDO/191).	Albar SA, 2016, BRIT J NUTR, V115, P1678, DOI 10.1017/S0007114516000593; Alcantara I, 2015, PUBLIC HEALTH NUTR, V18, P1932, DOI 10.1017/S1368980014002547; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123; Broekhuizen K, 2012, ANN BEHAV MED, V44, P259, DOI 10.1007/s12160-012-9384-3; Brouwer W, 2009, HEALTH EDUC, V109, P460, DOI 10.1108/09654280911001149; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; Cade JE, 2004, NUTR RES REV, V17, P5, DOI 10.1079/NRR200370; Cerin E, 2016, MED SCI SPORT EXER, V48, P1075, DOI 10.1249/MSS.0000000000000870; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Keyzer Willem, 2011, Food Nutr Res, V55, DOI 10.3402/fnr.v55i0.7307; Drieskens S., 2014, GEZONDHEIDSENQUETE 2; European food information council (EUFIC), 2012, FRUIT VEG CONS EUR D; Gezondheidsraad Hoge [Belgian Superior Health council], 2009, VOED BELG; GLOVER JA, 1989, J EDUC PSYCHOL, V81, P392, DOI 10.1037/0022-0663.81.3.392; Greene GW, 2008, J NUTR, V138, p200S, DOI 10.1093/jn/138.1.200S; Haerens L, 2007, PATIENT EDUC COUNS, V66, P303, DOI 10.1016/j.pec.2007.01.003; Johnson B, 2001, J HUM NUTR DIET, V14, P457, DOI 10.1046/j.1365-277X.2001.00320.x; Kim DJ, 2003, PREV MED, V36, P440, DOI 10.1016/S0091-7435(02)00040-3; Kristjansdottir AG, 2006, EUR J CLIN NUTR, V60, P408, DOI 10.1038/sj.ejcn.1602332; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laviolle B, 2005, EUR J CARDIOV PREV R, V12, P587, DOI 10.1097/00149831-200512000-00012; Lean MEJ, 2003, EUR J CLIN NUTR, V57, P667, DOI 10.1038/sj.ejcn.1601596; Mainvil LA, 2011, APPETITE, V56, P111, DOI 10.1016/j.appet.2010.09.008; Mayne ST, 2003, J NUTR, V133, p933S, DOI 10.1093/jn/133.3.933S; Natarajan L, 2006, AM J EPIDEMIOL, V163, P770, DOI 10.1093/aje/kwj082; NUBEL vzw, 2004, BELG VOED; Plaete J, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4835; Portney L., 2009, FDN CLIN RES, V(3rd ed.); Rangan AM, 2016, BRIT J NUTR, V115, P2219, DOI 10.1017/S0007114516001525; Resnicow K, 2000, AM J EPIDEMIOL, V152, P1072, DOI 10.1093/aje/152.11.1072; Thompson FE, 2004, PUBLIC HEALTH NUTR, V7, P1097, DOI 10.1079/PHN2004642; Van Holle V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1785-3; Vandelanotte C, 2003, HEALTH EDUC RES, V18, P304, DOI 10.1093/her/cyf027; Vandelanotte C., 2005, J PHYS ACT HEALTH, V2, P63, DOI DOI 10.1123/JPAH.2.1.63; Vandevijvere S, 2009, PUBLIC HEALTH NUTR, V12, P423, DOI 10.1017/S1368980008002164; Vanhauwaert E, 2012, ACTIEVE VOEDINGSDRIE; VIGeZ, 2016, VOED PRAKT VOED; WHO, 2003, WHO TECH REP SER, V916, P1; Yaroch AL, 2012, J ACAD NUTR DIET, V112, P1570, DOI 10.1016/j.jand.2012.06.002	41	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159834	10.1371/journal.pone.0159834	http://dx.doi.org/10.1371/journal.pone.0159834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS5CG	27441632	Green Published, gold, Green Submitted			2022-12-27	WOS:000380797500144
J	Chen, X; Yang, YE; Shi, ZP; Gao, MQ; Zhang, Y				Chen, Xin; Yang, Yange; Shi, Zhaopeng; Gao, Ming-Qing; Zhang, Yong			Effects of Genetically Modified Milk Containing Human Beta-Defensin-3 on Gastrointestinal Health of Mice	PLOS ONE			English	Article							SAFETY ASSESSMENT; RISK-ASSESSMENT; FOOD ALLERGENS; CATTLE; DIGESTION; MEAT; STABILITY; ANIMALS; PEPTIDE; PROTEIN	This study was performed to investigate the effects of genetically modified (GM) milk containing human beta-defensin-3 (HBD3) on mice by a 90-day feeding study. The examined parameters included the digestibility of GM milk, general physical examination, gastric emptying function, intestinal permeability, intestinal microflora composition of mice, and the possibility of horizontal gene transfer (HGT). The emphasis was placed on the effects on gastrointestinal (GI) tract due to the fact that GI tract was the first site contacting with food and played crucial roles in metabolic reactions, nutrition absorption and immunity regulation in the host. However, the traditional methods for analyzing the potential toxicological risk of GM product pay little attention on GI health. In this study, the results showed GM milk was easy to be digested in simulated gastric fluid, and it did not have adverse effects on general and GI health compared to conventional milk. And there is little possibility of HGT. This study may enrich the safety assessment of GM product on GI health.	[Chen, Xin; Yang, Yange; Shi, Zhaopeng; Gao, Ming-Qing; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Gao, Ming-Qing; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Gao, MQ; Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.; Gao, MQ; Zhang, Y (corresponding author), Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China.	gaomingqing@nwsuaf.edu.cn; zhangyong1956@nwsuaf.edu.cn	chen, xiner/GVU-3933-2022		National Major Project for Production of Transgenic Breeding [2013ZX08007-004]	National Major Project for Production of Transgenic Breeding	This work was supported by the National Major Project for Production of Transgenic Breeding (No. 2013ZX08007-004), http://www.moa.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaas H, 2006, INT DAIRY J, V16, P961, DOI 10.1016/j.idairyj.2005.10.029; Astwood JD, 1996, NAT BIOTECHNOL, V14, P1269, DOI 10.1038/nbt1096-1269; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Cinova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016169; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Einspanier R, 2001, EUR FOOD RES TECHNOL, V212, P129, DOI 10.1007/s002170000248; Fu TJ, 2002, ANN NY ACAD SCI, V964, P99; Fu TT, 2002, J AGR FOOD CHEM, V50, P7154, DOI 10.1021/jf020599h; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Golovan SP, 2001, NAT BIOTECHNOL, V19, P741, DOI 10.1038/90788; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guillen I, 1999, MAR BIOTECHNOL, V1, P2, DOI 10.1007/PL00011746; Guttman JA, 2006, CELL MICROBIOL, V8, P634, DOI 10.1111/j.1462-5822.2005.00656.x; Hammond B, 2004, FOOD CHEM TOXICOL, V42, P1003, DOI 10.1016/j.fct.2004.02.013; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hu WP, 2012, BIOCHEM CELL BIOL, V90, P485, DOI [10.1139/o2012-003, 10.1139/O2012-003]; Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P978, DOI 10.1016/j.fct.2008.06.012; Kleter GA, 2010, ANIM SCI PAP REP, V28, P105; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu S, 2013, FOOD CHEM TOXICOL, V57, P314, DOI 10.1016/j.fct.2013.04.003; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; Malatesta M, 2008, HISTOCHEM CELL BIOL, V130, P967, DOI 10.1007/s00418-008-0476-x; Mihara H, 2010, J NEUROSCI, V30, P16536, DOI 10.1523/JNEUROSCI.4426-10.2010; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tang MX, 2012, TRANSGENIC RES, V21, P499, DOI 10.1007/s11248-011-9550-6; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vantrappen G, 1986, DIG DIS SCI; Wheeler MB, 2010, TRANSGENIC RES, V19, P136; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Xu JX, 2011, TRANSGENIC RES, V20, P1043, DOI 10.1007/s11248-010-9477-3; Yamaguchi M, 2007, THERIOGENOLOGY, V67, P152, DOI 10.1016/j.theriogenology.2006.09.010; Yang XZ, 2007, NAT BIOTECHNOL, V25, P77, DOI 10.1038/nbt1276; Yu Y, 2013, PLOS ONE, V8; Yuan YF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01962; Zhang Q, 2010, MICROB PATHOGENESIS, V48, P28, DOI 10.1016/j.micpath.2009.10.002; Zhang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049697; Zhou C, 2011, DRUG CHEM TOXICOL, V34, P359, DOI 10.3109/01480545.2010.542465	40	7	7	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159700	10.1371/journal.pone.0159700	http://dx.doi.org/10.1371/journal.pone.0159700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438026	Green Published, Green Submitted, gold			2022-12-27	WOS:000380170100069
J	Liu, L; Jiang, YD; Steinle, JJ				Liu, Li; Jiang, Youde; Steinle, Jena J.			Compound 49b Restores Retinal Thickness and Reduces Degenerate Capillaries in the Rat Retina following Ischemia/Reperfusion	PLOS ONE			English	Article							OXYGEN-INDUCED RETINOPATHY; ISCHEMIA-REPERFUSION INJURY; BETA-ADRENERGIC-RECEPTOR; VASCULAR-PERMEABILITY; CELL APOPTOSIS; MOUSE MODEL; HYPOXIA; IGFBP-3; EXPRESSION; GROWTH	We have recently reported that Compound 49b, a novel beta-adrenergic receptor agonist, can significantly reduce VEGF levels in retinal endothelial cells (REC) grown in diabetic-like conditions. In this study, we investigated whether Compound 49b could protect the retina under hypoxic conditions using the ischemia-reperfusion (I/R)-induced model in rats, as well REC cultured in hypoxic conditions. Some rats received 1mM topical Compound 49b for the 2 (5 rats each group) or 10 (4 rats in each group) days post-I/R. Analyses for retinal thickness and cell loss in the ganglion cell layer was done at 2 days post-I/R, while numbers of degenerate capillaries and pericyte ghosts were measured at 10 days post-I/R. Additionally, REC were cultured in normal oxygen or hypoxia (5% O-2) only or treated with 50 nM Compound 49b for 12 hours. Twelve hours after Compound 49b exposure, cells were collected and analyzed for protein levels of insulin-like growth factor binding protein 3 (IGFBP3), vascular endothelial cell growth factor (VEGF) and its receptor (KDR), angiopoietin 1 and its receptor Tie2 for Western blotting. Data indicate that exposure to I/R significantly decreased retinal thickness, with increasing numbers of degenerate capillaries and pericyte ghosts. Compound 49b treatment inhibited these retinal changes. In REC cultured in hypoxia, levels of IGFBP-3 were reduced, which were significantly increased by Compound 49b. Hypoxia significantly increased protein levels of VEGF, KDR, Angiopoiein 1, and Tie2, which were reduced following Compound 49b treatment. These data strongly suggested that Compound 49b protected the retina against I/R-induced injury. This provides additional support for a role of beta-adrenergic receptor actions in the retina.	[Liu, Li; Jiang, Youde; Steinle, Jena J.] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Steinle, Jena J.] Wayne State Univ, Dept Ophthalmol, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Steinle, JJ (corresponding author), Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48201 USA.; Steinle, JJ (corresponding author), Wayne State Univ, Dept Ophthalmol, Detroit, MI 48201 USA.	jsteinle@med.wayne.edu		Steinle, Jena/0000-0002-7539-2892	Research to Prevent Blindness;  [R01EY022045];  [P30EY04068]; NATIONAL EYE INSTITUTE [P30EY004068, R01EY022045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01EY022045 (JJS), P30EY04068 (PI: Hazlett) and an Unrestricted Grant to the Department of Ophthalmology from Research to Prevent Blindness (Kresge Eye Institute).	Abcouwer SF, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-149; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Chang RL, 2015, GROWTH FACTORS, V33, P275, DOI 10.3109/08977194.2015.1077824; Chen J, 2012, INVEST OPHTH VIS SCI, V53, P2968, DOI 10.1167/iovs.12-9691; Dal Monte M, 2013, EXP EYE RES, V111, P27, DOI 10.1016/j.exer.2013.03.013; Dal Monte M, 2012, INVEST OPHTH VIS SCI, V53, P2181, DOI 10.1167/iovs.11-9408; Hsieh DJY, 2015, CELL PHYSIOL BIOCHEM, V36, P274, DOI 10.1159/000374070; Jiang YD, 2015, GROWTH FACTORS, V33, P192, DOI 10.3109/08977194.2015.1054990; Jiang YD, 2010, EXP EYE RES, V91, P171, DOI 10.1016/j.exer.2010.04.014; Kielczewski JL, 2011, AM J PATHOL, V178, P1517, DOI 10.1016/j.ajpath.2010.12.031; Kielczewski JL, 2009, CIRCULATION, P9022; Kociok N, 2007, GRAEF ARCH CLIN EXP, V245, P258, DOI 10.1007/s00417-006-0355-x; Muthusamy A, 2014, J CEREBR BLOOD F MET, V34, P522, DOI 10.1038/jcbfm.2013.230; Natsuizaka M, 2014, AM J CANCER RES, V4, P29; Park SY, 2011, INT J CANCER, V128, P2306, DOI 10.1002/ijc.25589; Park YS, 2003, MICROVASC RES, V65, P125, DOI 10.1016/S0026-2862(02)00035-3; Ristori C, 2011, INVEST OPHTH VIS SCI, V52, P155, DOI 10.1167/iovs.10-5536; Steinle JJ, 2009, EXP EYE RES, V88, P1014, DOI 10.1016/j.exer.2008.12.015; Veenstra Alexander, 2015, Curr Protoc Mouse Biol, V5, P247, DOI 10.1002/9780470942390.mo140190; Wiley LA, 2006, INVEST OPHTH VIS SCI, V47, P439, DOI 10.1167/iovs.05-0656; Yang EV, 2009, BRAIN BEHAV IMMUN, V23, P267, DOI 10.1016/j.bbi.2008.10.005; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P5376, DOI 10.1167/iovs.13-12497; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779	23	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159532	10.1371/journal.pone.0159532	http://dx.doi.org/10.1371/journal.pone.0159532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27439004	gold, Green Published, Green Submitted			2022-12-27	WOS:000380170100054
J	Tiadi, A; Seassau, M; Gerard, CL; Bucci, MP				Tiadi, Aime; Seassau, Magali; Gerard, Christophe-Loic; Bucci, Maria Pia			Differences between Dyslexic and Non-Dyslexic Children in the Performance of Phonological Visual-Auditory Recognition Tasks: An Eye-Tracking Study	PLOS ONE			English	Article							SPOKEN WORD RECOGNITION; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; SPEECH-PERCEPTION; PARIETAL CORTEX; MOVEMENTS; AWARENESS; SACCADES; DEFICIT; EYETRACKING	The object of this study was to explore further phonological visual-auditory recognition tasks in a group of fifty-six healthy children (mean age: 9.9 +/- 0.3) and to compare these data to those recorded in twenty-six age-matched dyslexic children (mean age: 9.8 +/- 0.2). Eye movements from both eyes were recorded using an infrared video-oculography system (MobileEBT (R) e(y)e BRAIN). The recognition task was performed under four conditions in which the target object was displayed either with phonologically unrelated objects (baseline condition), or with cohort or rhyme objects (cohort and rhyme conditions, respectively), or both together (rhyme + cohort condition). The percentage of the total time spent on the targets and the latency of the first saccade on the target were measured. Results in healthy children showed that the percentage of the total time spent in the baseline condition was significantly longer than in the other conditions, and that the latency of the first saccade in the cohort condition was significantly longer than in the other conditions; interestingly, the latency decreased significantly with the increasing age of the children. The developmental trend of phonological awareness was also observed in healthy children only. In contrast, we observed that for dyslexic children the total time spent on the target was similar in all four conditions tested, and also that they had similar latency values in both cohort and rhyme conditions. These findings suggest a different sensitivity to the phonological competitors between dyslexic and non-dyslexic children. Also, the eye-tracking technique provides online information about phonological awareness capabilities in children.	[Tiadi, Aime; Bucci, Maria Pia] Robert Debre Hosp, Inst Natl Sante & Rech Med Paris Diderot, UMR 1141, Paris, France; [Seassau, Magali] Eye Brain, Ivry, France; [Gerard, Christophe-Loic] Robert Debre Hosp, Child & Adolescent Psychiat Dept, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Tiadi, A (corresponding author), Robert Debre Hosp, Inst Natl Sante & Rech Med Paris Diderot, UMR 1141, Paris, France.	bi-kuyami-guy-aime.tiadi@inserm.fr			e(ye)BRAIN company	e(ye)BRAIN company	These authors have no support or funding to report. The e(ye)BRAIN company provided support in the form of salaries for authors [Magali Seassau], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; BENTIN S, 1991, PSYCHOL SCI, V2, P271, DOI 10.1111/j.1467-9280.1991.tb00148.x; Berninger VW, 2010, J PSYCHOLINGUIST RES, V39, P141, DOI 10.1007/s10936-009-9130-6; BRADLEY L, 1983, NATURE, V301, P419, DOI 10.1038/301419a0; BRADY S, 1983, J EXP CHILD PSYCHOL, V35, P345, DOI 10.1016/0022-0965(83)90087-5; BRUCK M, 1992, DEV PSYCHOL, V28, P874, DOI 10.1037/0012-1649.28.5.874; Bucci MP, 2014, RES DEV DISABIL, V35, P1292, DOI 10.1016/j.ridd.2014.03.029; Bucci MP, 2014, EXP BRAIN RES, V232, P927, DOI 10.1007/s00221-013-3805-9; Bucci MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077920; Bucci MP, 2013, RES DEV DISABIL, V34, P3727, DOI 10.1016/j.ridd.2013.07.032; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Bucci MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033458; CARRILLO M, 1994, READ WRIT, V6, P279, DOI 10.1007/BF01027086; Chevrie-Muller C, 1997, BATTERIE LANGAGE ORA; Clark KA, 2014, BRAIN, V137, P3136, DOI 10.1093/brain/awu229; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Demont E., 2004, ENFANCE, V3, P245; Desroches AS, 2006, COGNITION, V100, pB32, DOI 10.1016/j.cognition.2005.09.001; Ehri LC, 1991, DYSLEXIA INTEGRATING, P63; Fukushima J, 2000, BRAIN DEV-JPN, V22, P173, DOI 10.1016/S0387-7604(00)00101-7; Gorges F, 2013, ACTA PSYCHOL, V143, P168, DOI 10.1016/j.actpsy.2013.03.006; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gombert J.-E, 2007, ACQUISITION LANGAGE, P47; Goswami U, 2005, J EXP CHILD PSYCHOL, V92, P345, DOI 10.1016/j.jecp.2005.06.002; Goswami U, 2000, Dyslexia, V6, P133, DOI 10.1002/(SICI)1099-0909(200004/06)6:2<133::AID-DYS160>3.0.CO;2-A; Goswani U, 1990, PHONOLOGICAL SKILLS, P166; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Jones MW, 2010, COGNITION, V116, P56, DOI 10.1016/j.cognition.2010.03.015; Jones MW, 2008, COGNITION, V109, P389, DOI 10.1016/j.cognition.2008.10.005; KIRTLEY C, 1989, J EXP CHILD PSYCHOL, V48, P224, DOI 10.1016/0022-0965(89)90004-0; Lions C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083972; Lions C, 2013, INVEST OPHTH VIS SCI, V54, P620, DOI 10.1167/iovs.12-10526; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; McSorley E, 2012, VISION RES, V60, P61, DOI 10.1016/j.visres.2012.03.007; Meyer AS, 2007, PSYCHON B REV, V14, P710, DOI 10.3758/BF03196826; Miller B, 2013, SCHOOL PSYCHOL REV, V42, P123; Nystrom M, 2010, BEHAV RES METHODS, V42, P188, DOI 10.3758/BRM.42.1.188; O'Regan J K, 1990, Rev Oculomot Res, V4, P395; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; RACK JP, 1992, READ RES QUART, V27, P28, DOI 10.2307/747832; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Ruffino M, 2010, NEUROPSYCHOLOGIA, V48, P3793, DOI 10.1016/j.neuropsychologia.2010.09.002; Salman MS, 2006, VISION RES, V46, P1432, DOI 10.1016/j.visres.2005.06.011; Sekerina IA, 2007, J EXP CHILD PSYCHOL, V98, P20, DOI 10.1016/j.jecp.2007.04.005; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Snowling M.J., 1995, J RES READ, V18, P132, DOI DOI 10.1111/J.1467-9817.1995.TB00079.X; Sprenger-Charolles L, 2003, J EXP CHILD PSYCHOL, V84, P194, DOI 10.1016/S0022-0965(03)00024-9; Sprenger-Charolles L, 2006, READING ACQUISITION; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Szczepanski SM, 2010, J NEUROSCI, V30, P148, DOI 10.1523/JNEUROSCI.3862-09.2010; TALLAL P, 1980, TRENDS NEUROSCI, V3, P309; Tiadi A, 2014, RES DEV DISABIL, V35, P3175, DOI 10.1016/j.ridd.2014.07.057; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; Wimmer H, 1996, J EXP CHILD PSYCHOL, V61, P80, DOI 10.1006/jecp.1996.0004; Zagar D, 1992, PSYCHOL COGNITIVE LE	57	7	7	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159190	10.1371/journal.pone.0159190	http://dx.doi.org/10.1371/journal.pone.0159190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27438352	gold, Green Published, Green Submitted			2022-12-27	WOS:000380170100030
J	Aziz, SGG; Pashaei-Asl, F; Fardyazar, Z; Pashaiasl, M				Aziz, Shiva Gholizadeh-Ghaleh; Pashaei-Asl, Fatima; Fardyazar, Zahra; Pashaiasl, Maryam			Isolation, Characterization, Cryopreservation of Human Amniotic Stem Cells and Differentiation to Osteogenic and Adipogenic Cells	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; FETAL MEMBRANES; FLUID CELLS; IN-VITRO; MOUSE; MIR-302; CULTURE; LINES; PLURIPOTENCY; EXPRESSION	Human stem cells and progenitor cells can be used to treat cancer and replace dysfunctional cells within a tissue or organ. The objective of this study was to identify the appropriate cells type in regenerative medicine and targeted therapy. As an alternative to embryonic and bone marrow stem cells, we examined human amniotic fluid stem cells (hAFSCs), one of the potential source of multipotent stem cells isolated from both cell pellet (using single-stage method), and supernatant of human amniotic fluid. Source of isolation and unique property of the cells emphasize that these cells are one of the promising new tools in therapeutic field. Double sources for isolation and availability of the left over samples in diagnostic laboratory at the same time have less legal and ethical concerns compared with embryonic stem cell studies. Cells were isolated, cultured for 18th passage for 6 months and characterized using qPCR and flow cytometry. Cells showed good proliferative ability in culture condition. The cells successfully differentiated into the adipogenic and osteogenic lineages. Based on these findings, amniotic fluid can be considered as an appropriate and convenient source of human amniotic fluid stem cells. These cells provide potential tools for therapeutic applications in the field of regenerative medicine. To get a better understanding of crosstalk between Oct4/NANOG with osteogenesis and adipogenesis, we used network analysis based on Common Targets algorithm and Common Regulators algorithm as well as subnetwork discovery based on gene set enrichment. Network analysis highlighted the possible role of MIR 302A and MIR let-7g. We demonstrated the high expression of MIR 302A and low expression of MIR let7g in hAFSCs by qPCR.	[Aziz, Shiva Gholizadeh-Ghaleh; Fardyazar, Zahra; Pashaiasl, Maryam] Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Tabriz, Iran; [Pashaei-Asl, Fatima] Tabriz Univ Med Sci, Mol Biol Lab, Biotechnol Res Ctr, Tabriz, Iran; [Aziz, Shiva Gholizadeh-Ghaleh; Fardyazar, Zahra] Tabriz Univ Med Sci, Sch Adv Med Sci, Dept Mol Med, Tabriz, Iran; [Pashaiasl, Maryam] Tabriz Univ Med Sci, Fac Med, Dept Anat Sci, Tabriz, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Pashaiasl, M (corresponding author), Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Tabriz, Iran.; Pashaiasl, M (corresponding author), Tabriz Univ Med Sci, Fac Med, Dept Anat Sci, Tabriz, Iran.	pashaim@tbzmed.ac.ir	Fardiazar, Zahra/M-5603-2017; az, Shiva Gholizadeh-Ghaleh/G-8254-2017; Pashaiasl, Maryam/M-4676-2017	az, Shiva Gholizadeh-Ghaleh/0000-0003-1949-4381; Pashaiasl, Maryam/0000-0002-4490-6627	Women's Reproductive Health Research Center of Medical Sciences Tabriz, Iran; Training Center-Al-Zahra Hospital of Tabriz University of Medical Sciences Grant [93/4-10/2]; Department of Molecular Medicine, Faculty of Advanced Medical Science of Tabriz University	Women's Reproductive Health Research Center of Medical Sciences Tabriz, Iran; Training Center-Al-Zahra Hospital of Tabriz University of Medical Sciences Grant; Department of Molecular Medicine, Faculty of Advanced Medical Science of Tabriz University	This work is funded by the 2015 Women's Reproductive Health Research Center of Medical Sciences Tabriz, Iran, Training Center-Al-Zahra Hospital of Tabriz University of Medical Sciences Grant (Study ID: 93/4-10/2).; The authors thank the Department of Molecular Medicine, Faculty of Advanced Medical Science of Tabriz University, for all support provided. This work is funded by the 2015 Women's Reproductive Health Research Center of Medical Sciences Tabriz, Iran, Training Center-AlZahra Hospital of Tabriz University of Medical Sciences Grant (Study ID: 93/4-10/2). We would like to thank Dr. Manijeh Mohammadidehcheshmeh, The University of Adelaide, for the assistance in network construction using Pathway Studio Web (version 11.0.5).	Alanazi I, 2013, APOPTOSIS, V18, P1291, DOI 10.1007/s10495-013-0887-6; Alanazi IO, 2016, MOL BIOTECHNOL, P1; Alisoltani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096320; Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bhatti I, 2009, J GASTROINTEST SURG, V13, P1379, DOI 10.1007/s11605-009-0887-6; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Csermely P, 2015, SEMINARS CANC BIOL; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Diecke S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08081; Ebrahimie E, 2016, J ALZHEIMERS DIS, P1; Ebrahimie E, 2015, MOL BIOL REP, V42, P1377, DOI 10.1007/s11033-015-3916-4; Ebrahimie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090885; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Fruzangohar M, 2014, BIORXIV; Fruzangohar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058759; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Gholizadeh-Ghalehaziz S, 2015, INT J STEM CELLS, V8, P115, DOI 10.15283/ijsc.2015.8.2.115; GOSDEN CM, 1983, BRIT MED BULL, V39, P348, DOI 10.1093/oxfordjournals.bmb.a071847; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Hauser PV, 2010, AM J PATHOL, V177, P2011, DOI 10.2353/ajpath.2010.091245; Hendy GN, 2000, HUM MUTAT, V16, P281, DOI 10.1002/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO;2-A; HOEHN H, 1982, METHOD CELL BIOL, V26, P11; Hosseinpour B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049931; Huskey NE, 2015, STEM CELL REP, V4, P374, DOI 10.1016/j.stemcr.2015.01.019; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Kaviani A, 2001, J PEDIATR SURG, V36, P1662, DOI 10.1053/jpsu.2001.27945; Klemmt PAB, 2011, EXPERT OPIN BIOL TH, V11, P1297, DOI 10.1517/14712598.2011.587800; Lee Young Jin, 2016, Cell Regen, V5, P2, DOI 10.1186/s13619-016-0028-0; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Li L, 2015, CHARACTERISTICS HUMA; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ludlow J, 2015, FASEB J, V29; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Menasche P, 2015, EUROPEAN HEART J; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; NICOLAIDES K, 1994, LANCET, V344, P435, DOI 10.1016/S0140-6736(94)91769-8; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Novichkova S, 2003, BIOINFORMATICS, V19, P1699, DOI 10.1093/bioinformatics/btg207; Pashaiasl M, 2016, GENE, V578, P194, DOI 10.1016/j.gene.2015.12.023; Pashaiasl M, 2013, REPROD FERT DEVELOP, V25, P707, DOI 10.1071/RD12018; Perin L, 2008, METHOD CELL BIOL, V86, P85, DOI 10.1016/S0091-679X(08)00005-8; Phermthai T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-79; POLGAR K, 1989, AM J HUM GENET, V45, P786; Pozzobon M, 2014, CELL TISSUE BANK, V15, P199, DOI 10.1007/s10561-014-9428-y; PRIEST RE, 1978, LAB INVEST, V39, P106; Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Rossant J, 2015, DEVELOPMENT, V142, P9, DOI 10.1242/dev.115451; Rossi B, 2014, STEM CELL REV REP, V10, P712, DOI 10.1007/s12015-014-9525-0; Roubelakis MG, 2011, J CELL MOL MED, V15, P1896, DOI 10.1111/j.1582-4934.2010.01180.x; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; Sartore S, 2005, EUR J CARDIO-THORAC, V28, P677, DOI 10.1016/j.ejcts.2005.07.019; Stocum DL, 2001, WOUND REPAIR REGEN, V9, P429, DOI 10.1046/j.1524-475x.2001.00429.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takahashi Kazutoshi, 2006, V329, P449; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Turner JD, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09207; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Vidal DO, 2013, PEDIATR HEMAT ONCOL, V30, P367, DOI 10.3109/08880018.2013.783890; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; You Q, 2008, INT J GYNECOL OBSTET, V103, P149, DOI 10.1016/j.ijgo.2008.06.012; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	77	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158281	10.1371/journal.pone.0158281	http://dx.doi.org/10.1371/journal.pone.0158281			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434028	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600007
J	Colvin, RA; Jin, QL; Lai, B; Kiedrowski, L				Colvin, Robert A.; Jin, Qiaoling; Lai, Barry; Kiedrowski, Lech			Visualizing Metal Content and Intracellular Distribution in Primary Hippocampal Neurons with Synchrotron X-Ray Fluorescence	PLOS ONE			English	Article							PLASMA-MASS SPECTROMETRY; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; CORTICAL-NEURONS; DOPAMINERGIC-NEURONS; SYNAPTIC VESICLES; SUBSTANTIA-NIGRA; IRON-METABOLISM; NERVOUS-SYSTEM; ZINC	Increasing evidence suggests that metal dyshomeostasis plays an important role in human neurodegenerative diseases. Although distinctive metal distributions are described for mature hippocampus and cortex, much less is known about metal levels and intracellular distribution in individual hippocampal neuronal somata. To solve this problem, we conducted quantitative metal analyses utilizing synchrotron radiation X-Ray fluorescence on frozen hydrated primary cultured neurons derived from rat embryonic cortex (CTX) and two regions of the hippocampus: dentate gyrus (DG) and CA1. Comparing average metal contents showed that the most abundant metals were calcium, iron, and zinc, whereas metals such as copper and manganese were less than 10% of zinc. Average metal contents were generally similar when compared across neurons cultured from CTX, DG, and CA1, except for manganese that was larger in CA1. However, each metal showed a characteristic spatial distribution in individual neuronal somata. Zinc was uniformly distributed throughout the cytosol, with no evidence for the existence of previously identified zinc-enriched organelles, zincosomes. Calcium showed a peri-nuclear distribution consistent with accumulation in endoplasmic reticulum and/or mitochondria. Iron showed 2-3 distinct highly concentrated puncta only in peri-nuclear locations. Notwithstanding the small sample size, these analyses demonstrate that primary cultured neurons show characteristic metal signatures. The iron puncta probably represent iron-accumulating organelles, siderosomes. Thus, the metal distributions observed in mature brain structures are likely the result of both intrinsic neuronal factors that control cellular metal content and extrinsic factors related to the synaptic organization, function, and contacts formed and maintained in each region.	[Colvin, Robert A.] Ohio Univ, Dept Biol Sci, Interdisciplinary Grad Program Mol & Cellular Bio, Neurosci Program, Athens, OH 45701 USA; [Jin, Qiaoling] Northwestern Univ, Dept Phys & Astron, Evanston, IL USA; [Lai, Barry] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Lemont, IL USA; [Kiedrowski, Lech] Univ Illinois, Dept Psychiat, Inst Psychiat, Chicago, IL 60612 USA; [Kiedrowski, Lech] Univ Illinois, Dept Pharmacol, Chicago, IL USA	University System of Ohio; Ohio University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colvin, RA (corresponding author), Ohio Univ, Dept Biol Sci, Interdisciplinary Grad Program Mol & Cellular Bio, Neurosci Program, Athens, OH 45701 USA.	colvin@ohio.edu			DOE Office of Science [DE-AC02-06CH11357]; National Institute of General Medical Sciences [1R01GM104530]; National Institutes of Health [1R21NS082786]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104530] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research used resources of the Advanced Photon Source (B.L.), a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Q. J. was supported by the National Institute of General Medical Sciences under Grant 1R01GM104530 awarded to Chris Jacobsen at Argonne National Laboratory and Northwestern University. L. K. was supported by National Institutes of Health Grant 1R21NS082786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The authors wish to thank Benjamin A. Colvin for art work.	ANDRASI E, 1995, ARCH GERONTOL GERIAT, V21, P89, DOI 10.1016/0167-4943(95)00643-Y; Antharam V, 2012, NEUROIMAGE, V59, P1249, DOI 10.1016/j.neuroimage.2011.08.019; Barnham KJ, 2014, CHEM SOC REV, V43, P6727, DOI 10.1039/c4cs00138a; Bourassa MW, 2012, METALLOMICS, V4, P721, DOI 10.1039/c2mt20052j; Bozym R, 2008, METHOD ENZYMOL, V450, P287, DOI 10.1016/S0076-6879(08)03414-9; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Carmona A, 2010, ACS CHEM NEUROSCI, V1, P194, DOI 10.1021/cn900021z; CASSELL MD, 1984, J COMP NEUROL, V222, P461, DOI 10.1002/cne.902220311; Cerchiaro G, 2013, METALLOMICS, V5, P1336, DOI 10.1039/c3mt00136a; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; Chwiej J, 2014, J BIOL INORG CHEM, V19, P1209, DOI 10.1007/s00775-014-1177-7; Chwiej J, 2012, J BIOL INORG CHEM, V17, P731, DOI 10.1007/s00775-012-0892-1; Ciccotosto GD, 2014, METALLOMICS, V6, P1894, DOI 10.1039/c4mt00176a; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Colvin R.A., 2012, METAL ION STROKE, P227, DOI [10.1007/978-1-4419-9663-3_10, DOI 10.1007/978-1-4419-9663-3_10]; Colvin RA, 2002, AM J PHYSIOL-CELL PH, V282, pC317, DOI 10.1152/ajpcell.00143.2001; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Colvin RA, 2006, BRAIN RES, V1085, P1, DOI 10.1016/j.brainres.2006.02.043; Colvin RA, 2015, METALLOMICS, V7, P1111, DOI 10.1039/c5mt00084j; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; Danscher G, 1997, J NEUROSCI METH, V76, P53, DOI 10.1016/S0165-0270(97)00079-4; Daoust A, 2014, HIPPOCAMPUS, V24, P598, DOI 10.1002/hipo.22252; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Ducic T, 2015, ACS CHEM NEUROSCI, V6, P1769, DOI 10.1021/acschemneuro.5b00093; Ducic T, 2013, J NEUROCHEM, V124, P250, DOI 10.1111/jnc.12073; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Fahrni CJ, 2007, CURR OPIN CHEM BIOL, V11, P121, DOI 10.1016/j.cbpa.2007.02.039; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Ghadially FN, 1997, ULTRASTRUCT PATHOL, P668; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Hare DJ, 2013, METALLOMICS, V5, P1656, DOI 10.1039/c3mt00227f; Hare DJ, 2012, ANAL CHEM, V84, P3990, DOI 10.1021/ac300374x; Hare DJ, 2010, METALLOMICS, V2, P745, DOI 10.1039/c0mt00039f; Haug F M, 1975, J Hirnforsch, V16, P151; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Jin QL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117437; KEMP K, 1979, HISTOCHEMISTRY, V59, P167, DOI 10.1007/BF00495664; Kiedrowski L, 2015, J NEUROCHEM, V135, P777, DOI 10.1111/jnc.13282; Kiedrowski L, 2014, J NEUROCHEM, V130, P87, DOI 10.1111/jnc.12712; Kosior E, 2012, J STRUCT BIOL, V177, P239, DOI 10.1016/j.jsb.2011.12.005; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Lane DJR, 2015, BBA-MOL CELL RES, V1853, P1130, DOI 10.1016/j.bbamcr.2015.01.021; Lavenex P, 2012, CLIN NEUROBIOLOGY HI, P10, DOI [DOI 10.1093/ACPROF:OSO/9780199592388.003.0002, DOI 10.1038/s41380-019-0392-6]; Lear J, 2012, ANAL CHEM, V84, P6707, DOI 10.1021/ac301156f; Leskovjan AC, 2011, NEUROIMAGE, V55, P32, DOI 10.1016/j.neuroimage.2010.11.073; Maret Wolfgang, 2013, Met Ions Life Sci, V13, P389, DOI 10.1007/978-94-007-7500-8_12; de Lima MNM, 2008, NEUROBIOL AGING, V29, P1052, DOI 10.1016/j.neurobiolaging.2007.02.006; McRae R, 2009, CHEM REV, V109, P4780, DOI 10.1021/cr900223a; Michaelis EK, 2012, CLIN NEUROBIOLOGY HI, P55; Ortega R, 2016, MOL NEUROBIOL, V53, P1925, DOI 10.1007/s12035-015-9146-x; Ortega R, 2009, J R SOC INTERFACE, V6, pS649, DOI 10.1098/rsif.2009.0166.focus; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Pivovarova NB, 2014, J NEUROCHEM, V128, P592, DOI 10.1111/jnc.12489; Prasad A, 1993, BIOCH ELEMENTS, V11, P149; Qin ZY, 2011, METALLOMICS, V3, P823, DOI 10.1039/c1mt00033k; Ranaldi G, 2002, AM J PHYSIOL-RENAL, V283, DOI DOI 10.1111/JNC.12073; Raven EP, 2013, J ALZHEIMERS DIS, V37, P127, DOI 10.3233/JAD-130209; Robison G, 2015, METALLOMICS, V7, P748, DOI 10.1039/c5mt00023h; Robison G, 2013, METALLOMICS, V5, P1554, DOI 10.1039/c3mt00133d; Robison G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048899; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; SATO S, 1981, J INVEST DERMATOL, V77, P264, DOI 10.1111/1523-1747.ep12482449; Schroder N, 2013, J ALZHEIMERS DIS, V34, P797, DOI 10.3233/JAD-121996; Sekler I, 2012, GLIA, V60, P843, DOI 10.1002/glia.22286; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; Wegst-Uhrich SR, 2015, BIOMETALS, V28, P187, DOI 10.1007/s10534-014-9814-8; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676	72	15	15	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159582	10.1371/journal.pone.0159582	http://dx.doi.org/10.1371/journal.pone.0159582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434052	Green Published, gold			2022-12-27	WOS:000380169600074
J	Lv, YB; Wang, Y; Ma, WG; Yan, DY; Zheng, WL; Chu, C; Guo, TS; Yuan, ZY; Mu, JJ				Lv, Yong-Bo; Wang, Yang; Ma, Wang-Ge; Yan, Ding-Yi; Zheng, Wen-Ling; Chu, Chao; Guo, Tong-Shuai; Yuan, Zu-Yi; Mu, Jian-Jun			Association of Renalase SNPs rs2296545 and rs2576178 with the Risk of Hypertension: A Meta-Analysis	PLOS ONE			English	Article							GENE POLYMORPHISM; OXIDASE	Background/Aims Two renalase single nucleotide polymorphisms (SNPs) rs2296545 and rs2576178 have been reported to be associated with the susceptibility to hypertension (HT). Given the inconsistent results, we conducted a meta-analysis to assess the association between these two SNPs and the risk of HT. Methods Electronic databases were systematically searched to find relevant studies. Subgroup analysis was conducted according to the different concomitant diseases and ethnicities in the study population. Pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated using fixed-effect or random-effect models. Results A total of six case-control studies on rs2296545 and six studies on rs2576178 were included. In the combined analysis, results showed a significant association between SNP rs2296545 and risk of HT in all genetic models (dominant model CG+CC/GG: OR = 1.43, 95% CI = 1.24-1.65; recessive model CC/CG+GG: OR = 1.36, 95% CI = 1.09-1.69; codominant model CC/GG: OR = 1.63, 95% CI = 1.20-2.20, CG/GG: OR = 1.30, 95% CI = 1.12-1.52; allelic model C/G: OR = 1.29, 95% CI = 1.10-1.51). In subgroup analysis, we observed a significant association between rs2296545 and risk of essential HT. Although we did not observe an association between rs2576178 polymorphism and HT in the combined analysis, an increased risk was observed in the essential HT patients versus healthy controls (subgroup 1) analysis under the dominant, recessive, and codominant genetic models. Conclusions Renalase gene rs2296545 polymorphism is significantly associated with increased risk of HT, whereas rs2576178 polymorphism may not be associated with the susceptibility to HT.	[Lv, Yong-Bo; Wang, Yang; Ma, Wang-Ge; Yan, Ding-Yi; Zheng, Wen-Ling; Chu, Chao; Guo, Tong-Shuai; Yuan, Zu-Yi; Mu, Jian-Jun] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Cardiol, Xian, Peoples R China; [Lv, Yong-Bo; Wang, Yang; Ma, Wang-Ge; Yan, Ding-Yi; Zheng, Wen-Ling; Chu, Chao; Guo, Tong-Shuai; Yuan, Zu-Yi; Mu, Jian-Jun] Key Lab Mol Cardiol Shaanxi Prov, Xian, Peoples R China	Xi'an Jiaotong University	Mu, JJ (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Cardiol, Xian, Peoples R China.; Mu, JJ (corresponding author), Key Lab Mol Cardiol Shaanxi Prov, Xian, Peoples R China.	mujjun@163.com		Yuan, Zuyi/0000-0002-4141-0298	China Scholarship Council [201506280092]; National Basic Research Program (973 Program) of China [2012CB517804]; National Natural Science Foundation of China [81370357, 81570381]; Clinical Research Award of the First Affiliated Hospital of Xi'an Jiangtong University of China [XJTU1AF-CRF-2015-006]	China Scholarship Council(China Scholarship Council); National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Research Award of the First Affiliated Hospital of Xi'an Jiangtong University of China	Y.W. is grateful to the China Scholarship Council (No. 201506280092) for a PhD fellowship. This work was supported by the grants: the National Basic Research Program (also called 973 Program) of China (No. 2012CB517804), the National Natural Science Foundation of China (No. 81370357 and No. 81570381), the Clinical Research Award of the First Affiliated Hospital of Xi'an Jiangtong University of China (No. XJTU1AF-CRF-2015-006). The sponsor or funding organization had no role in the design or conduct of this research.; Y.W. is grateful to the China Scholarship Council (No. 201506280092) for a PhD fellowship. We would particular like to thank Dr. Robert Safirstein (Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA) for his language editing. This work was supported by the grants: the National Basic Research Program (also called 973 Program) of China (No. 2012CB517804), the National Natural Science Foundation of China (No. 81370357 and No. 81570381), the Clinical Research Award of the First Affiliated Hospital of Xi'an Jiangtong University of China (No. XJTU1AF-CRF-2015-006). The sponsor or funding organization had no role in the design or conduct of this research.	Baroni S, 2013, CURR PHARM DESIGN, V19, P2540, DOI 10.2174/1381612811319140005; Beaupre BA, 2015, ARCH BIOCHEM BIOPHYS, V579, P62, DOI 10.1016/j.abb.2015.05.016; Buraczynska M, 2011, NEUROMOL MED, V13, P321, DOI 10.1007/s12017-011-8158-6; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Chen S, 2014, SPINE J, V14, P2968, DOI 10.1016/j.spinee.2014.05.019; Desir GV, 2014, NEPHROL DIAL TRANSPL, V29, P22, DOI 10.1093/ndt/gft083; Desir GV, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002634; Desir GV, 2012, J AM SOC HYPERTENS, V6, P417, DOI 10.1016/j.jash.2012.09.002; Fava C, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-57; He BH, 2014, PAK J MED SCI, V30, P963, DOI 10.12669/pjms.305.5286; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Li XG, 2014, KIDNEY BLOOD PRESS R, V39, P9, DOI 10.1159/000355771; Maciorkowska D, 2015, J AM SOC HYPERTENS, V9, P855, DOI 10.1016/j.jash.2015.08.002; Malyszko J, 2012, RENAL FAILURE, V34, P727, DOI 10.3109/0886022X.2012.681534; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Newhouse SJ, 2005, HUM MOL GENET, V14, P1805, DOI 10.1093/hmg/ddi187; Rezk NA, 2015, APPL BIOCHEM BIOTECH, V175, P2309, DOI 10.1007/s12010-014-1433-x; Shi WB, 2015, INT J CLIN EXP MED, V8, P9505; Staessen JA, 2003, LANCET, V361, P1629, DOI 10.1016/S0140-6736(03)13302-8; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stec A, 2012, NEPHROL DIAL TRANSPL, V27, P4162, DOI 10.1093/ndt/gfr293; Wang F, 2014, RENAL FAILURE, V36, P552, DOI 10.3109/0886022X.2013.876352; Wang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122932; Wang L, 2014, J AM SOC NEPHROL, V25, P1226, DOI 10.1681/ASN.2013060665; Wang Y, 2014, KIDNEY BLOOD PRESS R, V39, P497, DOI 10.1159/000368460; Wu YL, 2011, KIDNEY INT, V79, P853, DOI 10.1038/ki.2010.488; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Yu K, 2015, CHINESE J HYPERTENSI, P365; [张荣 Zhang Rong], 2015, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V35, P1141; Zhang RY, 2013, NEUROMOL MED, V15, P396, DOI 10.1007/s12017-013-8227-0; Zhao Q, 2007, J MOL MED, V85, P877, DOI 10.1007/s00109-006-0151-4	31	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158880	10.1371/journal.pone.0158880	http://dx.doi.org/10.1371/journal.pone.0158880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434211	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600022
J	Sieswerda, E; Font-Gonzalez, A; Reitsma, JB; Dijkgraaf, MGW; Heinen, RC; Jaspers, MW; van der Pal, HJ; van Leeuwen, FE; Caron, HN; Geskus, RB; Kremer, LC				Sieswerda, Elske; Font-Gonzalez, Anna; Reitsma, Johannes B.; Dijkgraaf, Marcel G. W.; Heinen, Richard C.; Jaspers, Monique W.; van der Pal, Helena J.; van Leeuwen, Flora E.; Caron, Huib N.; Geskus, Ronald B.; Kremer, Leontien C.			High Hospitalization Rates in Survivors of Childhood Cancer: A Longitudinal Follow-Up Study Using Medical Record Linkage	PLOS ONE			English	Article							LONG-TERM SURVIVORS; QUALITY-OF-LIFE; ADULT SURVIVORS; CARDIAC-FUNCTION; HEALTH OUTCOMES; HEART-FAILURE; BRAIN-TUMORS; COHORT; POPULATION; NEOPLASMS	Hospitalization rates over time of childhood cancer survivors (CCS) provide insight into the burden of unfavorable health conditions on CCS and health care resources. The objective of our study was to examine trends in hospitalizations of CCS and risk factors in comparison with the general population. We performed a medical record linkage study of a cohort of 1564 >= five-year CCS with national registers. We obtained a random sample of the general population matched on year of birth, gender and calendar year per CCS retrieved. We quantified and compared hospitalization rates of CCS and reference persons from 1995 until 2005, and we analyzed risk factors for hospitalization within the CCS cohort with multivariable Poisson models. We retrieved hospitalization information from 1382 CCS and 25583 reference persons. The overall relative hospitalization rate (RHR) was 2.2 (95% CI: 1.9-2.5) for CCS compared to reference persons. CCS with central nervous system and solid tumors had highest RHRs. Hospitalization rates in CCS were increased compared to reference persons up to at least 30 years after primary diagnosis, with highest rates 5-10 and 20-30 years after primary cancer. RHRs were highest for hospitalizations due to neoplasms (10.7; 95% CI: 7.1-16.3) and endocrine/nutritional/metabolic disorders (7.3; 95% CI: 4.6-11.7). Female gender (P<0.001), radiotherapy to head and/or neck (P<0.001) or thorax and/or abdomen (P = 0.03) and surgery (P = 0.01) were associated with higher hospitalization rates in CCS. In conclusion, CCS have increased hospitalization rates compared to the general population, up to at least 30 years after primary cancer treatment. These findings imply a high and long-term burden of unfavorable health conditions after childhood cancer on survivors and health care resources.	[Sieswerda, Elske; Font-Gonzalez, Anna; Heinen, Richard C.; van der Pal, Helena J.; Caron, Huib N.; Kremer, Leontien C.] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands; [Reitsma, Johannes B.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Dijkgraaf, Marcel G. W.] Acad Med Ctr, Clin Res Unit, Amsterdam, Netherlands; [Jaspers, Monique W.] Acad Med Ctr, Dept Med Informat, Ctr Human Factors Engn Hlth Informat Technol HITl, Amsterdam, Netherlands; [van der Pal, Helena J.] Acad Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Geskus, Ronald B.] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam	Sieswerda, E (corresponding author), Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands.	e.sieswerda@amc.uva.nl	Geskus, Ronald B/H-3684-2019	Geskus, Ronald B/0000-0002-2740-3155; Kremer, Leontien/0000-0001-7422-3248; kremer, leontien/0000-0002-7619-7845; Reitsma, Johannes/0000-0003-4026-4345	Stichting Kinderen Kankervrij (KiKa) [84]	Stichting Kinderen Kankervrij (KiKa)	This work was supported by Stichting Kinderen Kankervrij (KiKa), Project 84, https://www.kika.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, SURVIVORS CHILDHOOD; Armstrong GT, 2007, J CLIN ONCOL, V25, P4477, DOI 10.1200/JCO.2007.11.2003; Armstrong GT, 2010, RADIAT RES, V174, P840, DOI 10.1667/RR1903.1; Bradley NME, 2010, EUR J CANCER, V46, P2441, DOI 10.1016/j.ejca.2010.05.001; Brewster DH, 2013, EUR J CANCER, V110, P1342, DOI DOI 10.1038/BJC.2013.788; Cohen JW, 2003, HEALTH AFFAIR, V22, P129, DOI 10.1377/hlthaff.22.2.129; Curry HL, 2006, EUR J CANCER, V42, P501, DOI 10.1016/j.ejca.2005.11.003; desBruin A., 2004, STAT J UN EC COMM EU, V21, P23; Dijkgraaf MGW, 1996, HEALTH POLICY, V35, P13, DOI 10.1016/0168-8510(95)00772-5; Gatta G, 2009, EUR J CANCER, V45, P992, DOI 10.1016/j.ejca.2008.11.042; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Gudmundsdottir T, 2015, INT J CANCER, V137, P1176, DOI 10.1002/ijc.29468; Gunn ME, 2015, NEURO-ONCOLOGY, V17, P747, DOI 10.1093/neuonc/nou321; Gurney JG, 2006, CANCER-AM CANCER SOC, V107, P1303, DOI 10.1002/cncr.22120; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; Holmqvist AS, 2014, EUR J CANCER, V50, P1169, DOI 10.1016/j.ejca.2014.01.014; Howards PP, 2007, AM J EPIDEMIOL, V165, P444, DOI 10.1093/aje/kwk027; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Kilian R, 2001, CLIN PSYCHOL PSYCHOT, V8, P206, DOI 10.1002/cpp.277; Kirchhoff AC, 2014, CANCER EPIDEM BIOMAR, V23, P1280, DOI 10.1158/1055-9965.EPI-13-1090; Kurt BA, 2012, PEDIATR BLOOD CANCER, V59, P126, DOI 10.1002/pbc.24017; Licht SD, 2014, LANCET, V383, P1981, DOI 10.1016/S0140-6736(13)62564-7; Lorenzi MF, 2011, INT J CANCER, V128, P1624, DOI 10.1002/ijc.25751; Lund LW, 2013, LANCET ONCOL, V14, P971, DOI 10.1016/S1470-2045(13)70351-6; Meadows AT, 2009, J CLIN ONCOL, V27, P2356, DOI 10.1200/JCO.2008.21.1920; Metcalfe C, 2003, EUR HEART J, V24, P105, DOI 10.1016/S0195-668X(02)00384-6; Mulder RL, 2009, CANCER TREAT REV, V35, P616, DOI 10.1016/j.ctrv.2009.06.004; MULROONEY DA, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4606; Mulrooney DA, 2008, CURR TREAT OPTION ON, V9, P51, DOI 10.1007/s11864-008-0054-4; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Oeffinger KC, 2010, HEMATOL ONCOL CLIN N, V24, P129, DOI 10.1016/j.hoc.2009.11.013; Olsen M, 2014, AM J EPIDEMIOL, V180, P120, DOI 10.1093/aje/kwu144; Paas G, 2002, RES VALIDITY LMR; Poutanen T, 2003, J CLIN ONCOL, V21, P2349, DOI 10.1200/JCO.2003.08.050; Punyko JA, 2005, PEDIATR BLOOD CANCER, V44, P643, DOI 10.1002/pbc.20310; Rebholz CE, 2011, J CLIN ONCOL, V29, P4181, DOI 10.1200/JCO.2011.36.5619; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Reynolds MR, 2010, AM HEART J, V160, P752, DOI 10.1016/j.ahj.2010.06.034; Ross L, 2003, NEW ENGL J MED, V349, P650, DOI 10.1056/NEJMoa022672; Sieswerda E, 2013, J CANCER SURVIV, V7, P439, DOI 10.1007/s11764-013-0283-9; Sieswerda E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132444; Steliarova-Foucher E, 2004, LANCET, V364, P2097, DOI 10.1016/S0140-6736(04)17550-8; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Stichting Medische Registratie, 1980, CLASS DIS 1980 BAS I; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; van der Pal HJ, 2010, ARCH INTERN MED, V170, P1247, DOI 10.1001/archinternmed.2010.233; Wallace WH, 2004, LATE EFFECTS CHILDHO; Whelan KF, 2010, PEDIATR BLOOD CANCER, V54, P103, DOI 10.1002/pbc.22277	48	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159518	10.1371/journal.pone.0159518	http://dx.doi.org/10.1371/journal.pone.0159518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27433937	Green Submitted, gold, Green Published			2022-12-27	WOS:000380169600061
J	Zhao, J; Hakvoort, TBM; Willemsen, AM; Jongejan, A; Sokolovic, M; Bradley, EJ; de Boer, VCJ; Baas, F; van Kampen, AHC; Lamers, WH				Zhao, Jing; Hakvoort, Theodorus B. M.; Willemsen, A. Marcel; Jongejan, Aldo; Sokolovic, Milka; Bradley, Edward J.; de Boer, Vincent C. J.; Baas, Frank; van Kampen, Antoine H. C.; Lamers, Wouter H.			Effect of Hyperglycemia on Gene Expression during Early Organogenesis in Mice	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; GLUCOSE-TRANSPORTER EXPRESSION; DIABETES-MELLITUS; VISCEROATRIAL HETEROTAXY; EMBRYONIC MALFORMATIONS; ACTIN DYNAMICS; MOUSE EMBRYO; METABOLISM; PREGNANCY; STRESS	Background Cardiovascular and neural malformations are common sequels of diabetic pregnancies, but the underlying molecular mechanisms remain unknown. We hypothesized that maternal hyperglycemia would affect the embryos most shortly after the glucose-sensitive time window at embryonic day (ED) 7.5 in mice. Methods Mice were made diabetic with streptozotocin, treated with slow-release insulin implants and mated. Pregnancy aggravated hyperglycemia. Gene expression profiles were determined in ED8.5 and ED9.5 embryos from diabetic and control mice using Serial Analysis of Gene Expression and deep sequencing. Results Maternal hyperglycemia induced differential regulation of 1,024 and 2,148 unique functional genes on ED8.5 and ED9.5, respectively, mostly in downward direction. Pathway analysis showed that ED8.5 embryos suffered mainly from impaired cell proliferation, and ED9.5 embryos from impaired cytoskeletal remodeling and oxidative phosphorylation (all P <= E-5). A query of the Mouse Genome Database showed that 20-25% of the differentially expressed genes were caused by cardiovascular and/or neural malformations, if deficient. Despite high glucose levels in embryos with maternal hyperglycemia and a similar to 150-fold higher rate of ATP production from glycolysis than from oxidative phosphorylation on ED9.5, ATP production from both glycolysis and oxidative phosphorylation was reduced to similar to 70% of controls, implying a shortage of energy production in hyperglycemic embryos. Conclusion Maternal hyperglycemia suppressed cell proliferation during gastrulation and cytoskeletal remodeling during early organogenesis. 20-25% of the genes that were differentially regulated by hyperglycemia were associated with relevant congenital malformations. Unexpectedly, maternal hyperglycemia also endangered the energy supply of the embryo by suppressing its glycolytic capacity.	[Zhao, Jing; Hakvoort, Theodorus B. M.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [Willemsen, A. Marcel; Jongejan, Aldo; van Kampen, Antoine H. C.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Dept Bioinformat, Amsterdam, Netherlands; [Sokolovic, Milka] Univ Amsterdam, Acad Med Ctr, Dept Biochem, Amsterdam, Netherlands; [Bradley, Edward J.; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Amsterdam, Netherlands; [de Boer, Vincent C. J.] Univ Amsterdam, Acad Med Ctr, Dept Lab Genet Metab Dis, Amsterdam, Netherlands; [van Kampen, Antoine H. C.] Univ Amsterdam, Biosyst Data Anal Grp, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	Lamers, WH (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands.	w.h.lamers@amc.uva.nl	Sokolovic, Milka/AAY-1618-2020; de Boer, Vincent CJ/L-2196-2016; Lamers, Wouter H./D-2965-2012; Baas, Frank/F-9574-2010	Sokolovic, Milka/0000-0002-3957-4656; de Boer, Vincent CJ/0000-0001-9928-1698; Baas, Frank/0000-0003-3912-5428	EU Seventh Framework Programme [HEALTH-F2-2008-223040]	EU Seventh Framework Programme	The work was supported by EU Seventh Framework Programme (HEALTH-F2-2008-223040), http://ec.europa.eu/research/health/medical-research/cardiovasculardiseases/projects/chearted_en.html.	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; BECERRA JE, 1990, PEDIATRICS, V85, P1; Berkopec A, 2007, J DISCRETE ALGORITHM, P5; Bracero LA, 1996, GYNECOL OBSTET INVES, V41, P10, DOI 10.1159/000292026; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brozinick JT, 2007, CURR DIABETES REV, V3, P111, DOI 10.2174/157339907780598199; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Charron MJ, 1998, MOL CELL BIOCHEM, V182, P143, DOI 10.1023/A:1006809611658; Cheng CH, 2009, CARDIOVASC RES, V81, P381, DOI 10.1093/cvr/cvn319; Chiu TT, 2010, MOL BIOL CELL, V21, P3529, DOI 10.1091/mbc.E10-04-0316; Christodoulou DC, 2011, CURR PROTOC MOL BIOL, p25B; CLOUGH JR, 1983, J EMBRYOL EXP MORPH, V74, P133; Dawson PA, 2001, MOL GENET METAB, V74, P186, DOI 10.1006/mgme.2001.3212; DEUCHAR EM, 1977, J EMBRYOL EXP MORPH, V41, P93; Di Ciano-Oliveira C, 2006, ACTA PHYSIOL, V187, P257, DOI 10.1111/j.1748-1716.2006.01535.x; Ekins S, 2005, DRUG METAB DISPOS, V33, P474, DOI 10.1124/dmd.104.002717; ELHAGE S, 1990, DEV GENET, V11, P149, DOI 10.1002/dvg.1020110205; ERIKSSON UJ, 1993, DIABETES, V42, P411, DOI 10.2337/diabetes.42.3.411; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Fine EL, 1999, DIABETES, V48, P2454, DOI 10.2337/diabetes.48.12.2454; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Fraseri RB, 2007, HUM REPROD, V22, P3059, DOI 10.1093/humrep/dem318; Fu J, 2006, DIABETOLOGIA, V49, P1027, DOI 10.1007/s00125-006-0153-3; GIAVINI E, 1986, TERATOLOGY, V34, P81, DOI 10.1002/tera.1420340111; GITTES GK, 1992, P NATL ACAD SCI USA, V89, P1128, DOI 10.1073/pnas.89.3.1128; GOODNER CJ, 1961, DIABETES, V10, P383, DOI 10.2337/diab.10.5.383; Harris MJ, 2005, BIRTH DEFECTS RES A, V73, P532, DOI 10.1002/bdra.20170; Horal M, 2004, BIRTH DEFECTS RES A, V70, P519, DOI 10.1002/bdra.20056; Houghton FD, 1996, MOL REPROD DEV, V44, P476, DOI 10.1002/(SICI)1098-2795(199608)44:4&lt;476::AID-MRD7&gt;3.0.CO;2-I; Innes KE, 1999, ACTA OBSTET GYN SCAN, V78, P263, DOI 10.1034/j.1600-0412.1999.780401.x; Ishibashi F, 2008, DIABETES RES CLIN PR, V80, P24, DOI 10.1016/j.diabres.2007.11.004; Jiang B, 2008, J NEUROSCI RES, V86, P3481, DOI 10.1002/jnr.21800; Jorstad TS, 2007, TRENDS PLANT SCI, V12, P46, DOI 10.1016/j.tplants.2007.01.001; Jungheim ES, 2008, SEMIN REPROD MED, V26, P186, DOI 10.1055/s-2008-1042957; Kappen C, 2011, REPROD TOXICOL, V31, P41, DOI 10.1016/j.reprotox.2010.09.002; KARUNANAYAKE EH, 1976, DIABETOLOGIA, V12, P483, DOI 10.1007/BF01219512; Kaufman M.H., 1992, ATLAS MOUSE DEV; Korgun ET, 2001, BIOL REPROD, V65, P1364, DOI 10.1095/biolreprod65.5.1364; Kowluru A, 2010, ENDOCR REV, V31, P52, DOI 10.1210/er.2009-0022; Kucera J, 1965, Ger Med Mon, V10, P393; KUCERA J, 1971, J REPROD MED, V7, P73; Lambert JF, 2000, J NEUROSCI METH, V95, P127, DOI 10.1016/S0165-0270(99)00157-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li R, 2007, DIABETOLOGIA, V50, P682, DOI 10.1007/s00125-006-0579-7; Lian QZ, 2004, J NEUROSCI RES, V75, P554, DOI 10.1002/jnr.20006; Loeken MR, 2005, AM J MED GENET C, V135C, P77, DOI 10.1002/ajmg.c.30056; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MACKLER B, 1971, ARCH BIOCHEM BIOPHYS, V144, P603, DOI 10.1016/0003-9861(71)90367-5; MACKLER B, 1973, ARCH BIOCHEM BIOPHYS, V158, P662, DOI 10.1016/0003-9861(73)90558-4; Maksimovic-Ivanic D, 2002, CLIN EXP IMMUNOL, V129, P214, DOI 10.1046/j.1365-2249.2002.02001.x; Matsumura Hideo, 2012, Methods Mol Biol, V883, P1, DOI 10.1007/978-1-61779-839-9_1; Membrez M, 2006, MOL CELL BIOL, V26, P4268, DOI 10.1128/MCB.00081-06; Morgan SC, 2008, BIRTH DEFECTS RES A, V82, P453, DOI 10.1002/bdra.20457; MORISHIMA M, 1991, TERATOLOGY, V44, P91, DOI 10.1002/tera.1420440113; Morishima M, 1996, TERATOLOGY, V54, P183, DOI 10.1002/(SICI)1096-9926(199610)54:4<183::AID-TERA2>3.0.CO;2-2; MORITA Y, 1992, BIOCHEM BIOPH RES CO, V188, P8, DOI 10.1016/0006-291X(92)92342-U; MORITA Y, 1994, BIOCHEM BIOPH RES CO, V199, P1525, DOI 10.1006/bbrc.1994.1404; Narchi H, 2000, Images Paediatr Cardiol, V2, P17; Nikolsky Y, 2005, DRUG DISCOV TODAY, V10, P653, DOI 10.1016/S1359-6446(05)03420-3; PASSARGE E, 1966, PEDIATRICS, V37, P672; Pavlinkova G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-274; Phelan SA, 1997, DIABETES, V46, P1189, DOI 10.2337/diabetes.46.7.1189; Reed JC, 2015, NAT REV ENDOCRINOL, V11, P308, DOI 10.1038/nrendo.2014.236; Salbaum JM, 2010, BIRTH DEFECTS RES A, V88, P601, DOI 10.1002/bdra.20680; Savagner P, 2015, CURR TOP DEV BIOL, V112, P273, DOI 10.1016/bs.ctdb.2014.11.021; Schmidt S, 2009, J ENDOCRINOL, V200, P23, DOI 10.1677/JOE-08-0262; Scott-Drechsel DE, 2013, DIABETES, V62, P234, DOI 10.2337/db12-0161; Sheffield JS, 2002, OBSTET GYNECOL, V100, P925, DOI 10.1016/S0029-7844(02)02242-1; Shen XH, 2009, J REPROD DEVELOP, V55, P534, DOI 10.1262/jrd.20231; Shepard TH, 1998, ANAT REC, V252, P383, DOI 10.1002/(SICI)1097-0185(199811)252:3<383::AID-AR6>3.0.CO;2-Z; SMITH DE, 1992, DEVELOPMENT, V116, P555; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; STYRUD J, 1995, PEDIATR RES, V37, P343, DOI 10.1203/00006450-199503000-00015; TAKAO Y, 1993, DIABETOLOGIA, V36, P696, DOI 10.1007/BF00401139; Teng Beina, 2012, Int J Cell Biol, V2012, P320531, DOI 10.1155/2012/320531; Thirone ACP, 2009, AM J PHYSIOL-CELL PH, V296, pC463, DOI 10.1152/ajpcell.00467.2008; TROCINO RA, 1994, ENDOCRINOLOGY, V134, P869, DOI 10.1210/en.134.2.869; Uenishi E, 2013, J BIOL CHEM, V288, P25851, DOI 10.1074/jbc.M113.464420; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vannucci SJ, 2000, DEV NEUROSCI-BASEL, V22, P274, DOI 10.1159/000017451; Veld RAGHI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029002; Vijaya M, 2013, GENE, V516, P218, DOI 10.1016/j.gene.2012.12.071; Wu YQ, 2015, DIABETES, V64, P2526, DOI 10.2337/db14-1683; YANG XL, 1995, ANAT RECORD, V241, P255, DOI 10.1002/ar.1092410212	85	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158035	10.1371/journal.pone.0158035	http://dx.doi.org/10.1371/journal.pone.0158035			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433804	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600005
J	Cartagena, CM; Mountney, A; Hwang, H; Swiercz, A; Rammelkamp, Z; Boutte, AM; Shear, DA; Tortella, FC; Schmid, KE				Cartagena, Casandra M.; Mountney, Andrea; Hwang, Hye; Swiercz, Adam; Rammelkamp, Zoe; Boutte, Angela M.; Shear, Deborah A.; Tortella, Frank C.; Schmid, Kara E.			Subacute Changes in Cleavage Processing of Amyloid Precursor Protein and Tau following Penetrating Traumatic Brain Injury	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; BETA ACCUMULATION; CASPASE CLEAVAGE; PROGENITOR CELLS; HEAD-INJURY; PROLIFERATION; MITOCHONDRIA; AGGREGATION; FRAGMENT	Traumatic brain injury (TBI) is an established risk factor for the development of Alzheimer's disease (AD). Here the effects of severe penetrating TBI on APP and tau cleavage processing were investigated in a rodent model of penetrating ballistic-like brain injury (PBBI). PBBI was induced by stereotactically inserting a perforated steel probe through the right frontal cortex of the anesthetized rat and rapidly inflating/deflating the probe's elastic tubing into an elliptical shaped balloon to 10% of total rat brain volume causing temporary cavitation injury. Separate animals underwent probe injury (PrI) alone without balloon inflation. Shams underwent craniectomy. Brain tissue was collected acutely (4h, 24h, 3d) and subacutely (7d) post-injury and analyzed by immunoblot for full length APP (APP-FL) and APP beta c-terminal fragments (beta CTFs), full length tau (tau-FL) and tau truncation fragments and at 7d for cytotoxic Beta amyloid (A beta) peptides A beta 40 and A beta 42 analysis. APP-FL was significantly decreased at 3d and 7d following PBBI whereas APP beta CTFs were significantly elevated by 4h post-injury and remained elevated through 7d post-injury. Effects on beta CTFs were mirrored with PrI, albeit to a lesser extent. A beta 40 and A beta 42 were significantly elevated at 7d following PBBI and PrI. Tau-FL decreased substantially 3d and 7d post-PBBI and PrI. Importantly, a 22 kDa tau fragment (tau22), similar to that found in AD, was significantly elevated by 4h and remained elevated through 7d post-injury. Thus both APP and tau cleavage was dramatically altered in the acute and subacute periods post-injury. As cleavage of these proteins has also been implicated in AD, TBI pathology shown here may set the stage for the later development of AD or other tauopathies.	[Cartagena, Casandra M.; Mountney, Andrea; Hwang, Hye; Swiercz, Adam; Rammelkamp, Zoe; Boutte, Angela M.; Shear, Deborah A.; Tortella, Frank C.; Schmid, Kara E.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Cartagena, CM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA.	casandra.m.cartagena@gmail.com			U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program	U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program	This research was funded by the U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Rebecca Pedersen and Weihong Yang for their excellent technical assistance. This research was funded by the U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program. This material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or reflecting true views of the Department of the Army or the Department of Defense.	Amadoro G, 2014, NEUROBIOL DIS, V62, P489, DOI 10.1016/j.nbd.2013.10.018; Amadoro G, 2014, J ALZHEIMERS DIS, V42, P211, DOI 10.3233/JAD-140267; Amadoro G, 2010, J ALZHEIMERS DIS, V21, P445, DOI 10.3233/JAD-2010-100120; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Baratchi S, 2012, HIPPOCAMPUS, V22, P1517, DOI 10.1002/hipo.20988; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Berry RW, 2003, BIOCHEMISTRY-US, V42, P8325, DOI 10.1021/bi027348m; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Demars MP, 2013, NEUROBIOL AGING, V34, P2431, DOI 10.1016/j.neurobiolaging.2013.04.016; Demars MP, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt77; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hill T., 2006, STAT METHODS APPL CO; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Koike MA, 2011, NEUROSCI LETT, V495, P55, DOI 10.1016/j.neulet.2011.03.034; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Li RN, 2013, LIFE SCI, V92, P747, DOI 10.1016/j.lfs.2013.02.014; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Muller K. E., 2002, REGRESSION ANOVA INT; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Reddy PH, 2011, BRAIN RES, V1415, P136, DOI 10.1016/j.brainres.2011.07.052; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zilka N, 2012, BIOCHEM SOC T, V40, P681, DOI 10.1042/BST20120015	44	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158576	10.1371/journal.pone.0158576	http://dx.doi.org/10.1371/journal.pone.0158576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428544	gold, Green Submitted, Green Published			2022-12-27	WOS:000380169300013
J	Davies, GF; Greenhough, BJ; Hobson-West, P; Kirk, RGW; Applebee, K; Bellingan, LC; Berdoy, M; Buller, H; Cassaday, HJ; Davies, K; Diefenbacher, D; Druglitro, T; Escobar, MP; Friese, C; Herrmann, K; Hinterberger, A; Jarrett, WJ; Jayne, K; Johnson, AM; Johnson, ER; Konold, T; Leach, MC; Leonelli, S; Lewis, DI; Lilley, EJ; Longridge, ER; McLeod, CM; Miele, M; Nelson, NC; Ormandy, EH; Pallett, H; Poort, L; Pound, P; Ramsden, E; Roe, E; Scalway, H; Schrader, A; Scotton, CJ; Scudamore, CL; Smith, JA; Whitfield, L; Wolfensohn, S				Davies, Gail F.; Greenhough, Beth J.; Hobson-West, Pru; Kirk, Robert G. W.; Applebee, Ken; Bellingan, Laura C.; Berdoy, Manuel; Buller, Henry; Cassaday, Helen J.; Davies, Keith; Diefenbacher, Daniela; Druglitro, Tone; Escobar, Maria Paula; Friese, Carrie; Herrmann, Kathrin; Hinterberger, Amy; Jarrett, Wendy J.; Jayne, Kimberley; Johnson, Adam M.; Johnson, Elizabeth R.; Konold, Timm; Leach, Matthew C.; Leonelli, Sabina; Lewis, David I.; Lilley, Elliot J.; Longridge, Emma R.; McLeod, Carmen M.; Miele, Mara; Nelson, Nicole C.; Ormandy, Elisabeth H.; Pallett, Helen; Poort, Lonneke; Pound, Pandora; Ramsden, Edmund; Roe, Emma; Scalway, Helen; Schrader, Astrid; Scotton, Chris J.; Scudamore, Cheryl L.; Smith, Jane A.; Whitfield, Lucy; Wolfensohn, Sarah			Developing a Collaborative Agenda for Humanities and Social Scientific Research on Laboratory Animal Science and Welfare	PLOS ONE			English	Article							QUESTIONS; MEDICINE; SUPPORT; MODELS; ETHICS; CARE; 3RS	Improving laboratory animal science and welfare requires both new scientific research and insights from research in the humanities and social sciences. Whilst scientific research provides evidence to replace, reduce and refine procedures involving laboratory animals (the '3Rs'), work in the humanities and social sciences can help understand the social, economic and cultural processes that enhance or impede humane ways of knowing and working with laboratory animals. However, communication across these disciplinary perspectives is currently limited, and they design research programmes, generate results, engage users, and seek to influence policy in different ways. To facilitate dialogue and future research at this interface, we convened an interdisciplinary group of 45 life scientists, social scientists, humanities scholars, non-governmental organisations and policy-makers to generate a collaborative research agenda. This drew on methods employed by other agenda-setting exercises in science policy, using a collaborative and deliberative approach for the identification of research priorities. Participants were recruited from across the community, invited to submit research questions and vote on their priorities. They then met at an interactive workshop in the UK, discussed all 136 questions submitted, and collectively defined the 30 most important issues for the group. The output is a collaborative future agenda for research in the humanities and social sciences on laboratory animal science and welfare. The questions indicate a demand for new research in the humanities and social sciences to inform emerging discussions and priorities on the governance and practice of laboratory animal research, including on issues around: international harmonisation, openness and public engagement, 'cultures of care', harm-benefit analysis and the future of the 3Rs. The process outlined below underlines the value of interdisciplinary exchange for improving communication across different research cultures and identifies ways of enhancing the effectiveness of future research at the interface between the humanities, social sciences, science and science policy.	[Davies, Gail F.] Univ Exeter, Coll Life & Environm Sci, Dept Geog, Exeter, Devon, England; [Greenhough, Beth J.] Univ Oxford, Sch Geog & Environm, Oxford, England; [Greenhough, Beth J.] Univ Oxford, Keble Coll, Oxford, England; [Hobson-West, Pru] Univ Nottingham, Sch Vet Med & Sci, Ctr Appl Bioeth, Nottingham NG7 2RD, Leics, England; [Kirk, Robert G. W.] Univ Manchester, Fac Life Sci, CHSTM, Manchester, Lancs, England; [Applebee, Ken] Kings Coll London, Hlth Sch, Biol Serv, London, England; [Bellingan, Laura C.; Diefenbacher, Daniela] Soc Biol, Charles Darwin House, London, England; [Berdoy, Manuel] Univ Oxford, Biomed Serv, Oxford, England; [Cassaday, Helen J.] Univ Nottingham, Sch Psychol, Univ Pk, Nottingham, England; [Davies, Keith] Cardiff Univ, Coll Biomed & Life Sci, Joint Biol Serv, Cardiff, S Glam, Wales; [Druglitro, Tone] Univ Oslo, Fac Social Sci, TIK Ctr Technol Innovat & Culture, Oslo, Norway; [Escobar, Maria Paula] Kings Coll London, Dept Geog, London, England; [Friese, Carrie] London Sch Econ, Dept Sociol, London, England; [Herrmann, Kathrin] Free Univ Berlin, Inst Pharmacol, Berlin, Germany; [Herrmann, Kathrin] Free Univ Berlin, Toxicol Dept Vet Med, Berlin, Germany; [Hinterberger, Amy] Univ Warwick, Dept Sociol, Coventry, W Midlands, England; [Jarrett, Wendy J.] Understanding Anim Res, London, England; [Jayne, Kimberley] Univ Exeter, Ctr Res Anim Behav, Psychol, Exeter, Devon, England; [Johnson, Adam M.] Univ Manchester, Fac Life Sci, BSF, Manchester, Lancs, England; [Johnson, Elizabeth R.] Hobart & William Smith Coll, Dept Environm Studies, Geneva, NY 14456 USA; [Konold, Timm] Anim & Plant Hlth Agency Weybridge, Anim Sci Unit, Addlestone, Surrey, England; [Leach, Matthew C.] Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne, Tyne & Wear, England; [Leonelli, Sabina] Univ Exeter, Exeter Ctr Study Life Sci Egen, Exeter, Devon, England; [Leonelli, Sabina] Univ Exeter, Dept Sociol Philosophy & Anthropol, Exeter, Devon, England; [Lewis, David I.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England; [Lilley, Elliot J.] RSPCA, Sci Grp, Res Anim Dept, Wilberforce Way, Southwater, W Sussex, England; [Longridge, Emma R.] BBSRC, Swindon, Wilts, England; [McLeod, Carmen M.] Univ Nottingham, Fac Med & Hlth Sci, Nottingham NG7 2RD, Leics, England; [Miele, Mara] Cardiff Univ, Coll Art Human & Social Sci, Sch Planning & Geog, Cardiff, Wales; [Nelson, Nicole C.] Univ Wisconsin, Dept Hist Sci, Madison, WI USA; [Ormandy, Elisabeth H.] UBC Anim Welfare Program, Vancouver, BC, Canada; [Pallett, Helen] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England; [Poort, Lonneke] Vrije Univ Amsterdam, Fac Law, Amsterdam, Netherlands; [Pound, Pandora] Univ Bristol, Sch Social & Commun Med, Bristol, Avon, England; [Ramsden, Edmund] Queen Mary Univ London, Sch Hist, London, England; [Roe, Emma] Univ Southampton, Dept Geog & Environm, Southampton, Hants, England; [Scalway, Helen] Univ London Royal Holloway & Bedford New Coll, Dept Geog, Honorary Res Associate, London, England; [Schrader, Astrid] Univ Exeter, Dept Sociol Philosophy & Anthropol, Exeter, Devon, England; [Scotton, Chris J.] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [Scudamore, Cheryl L.] MRC Harwell, Mary Lyon Ctr, Harwell, Berks, England; [Smith, Jane A.] Open Univ, Fac Sci, Milton Keynes, Bucks, England; [Whitfield, Lucy] Royal Vet Coll, Named Vet Surg Grp, London, England; [Wolfensohn, Sarah] Univ Surrey, Sch Vet Med, Guildford, Surrey, England	University of Exeter; University of Oxford; University of Oxford; University of Nottingham; University of Manchester; University of London; King's College London; University of Oxford; University of Nottingham; Cardiff University; University of Oslo; University of London; King's College London; University of London; London School Economics & Political Science; Free University of Berlin; Free University of Berlin; University of Warwick; University of Exeter; University of Manchester; Newcastle University - UK; University of Exeter; University of Exeter; University of Leeds; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); University of Nottingham; Cardiff University; University of Wisconsin System; University of Wisconsin Madison; University of East Anglia; Vrije Universiteit Amsterdam; University of Bristol; University of London; Queen Mary University London; University of Southampton; University of London; Royal Holloway University London; University of Exeter; University of Exeter; MRC Harwell; Open University - UK; University of London; University of London Royal Veterinary College; University of Surrey	Davies, GF (corresponding author), Univ Exeter, Coll Life & Environm Sci, Dept Geog, Exeter, Devon, England.	g.f.davies@exeter.ac.uk	Wolfensohn, Sarah/ABB-5408-2020; Miele, Mara/AAH-9160-2019; Escobar, Maria Paula/L-4630-2016; Konold, Timm/C-6498-2011	Wolfensohn, Sarah/0000-0002-0985-3603; Escobar, Maria Paula/0000-0002-0856-114X; Scudamore, Cheryl/0000-0002-7101-1714; Lilley, Elliot/0000-0001-8770-2432; Davies, Gail/0000-0002-6811-0885; McLeod, Carmen/0000-0003-2005-3778; Leonelli, Sabina/0000-0002-7815-6609; Kirk, Robert G W/0000-0002-6541-5915; Hobson-West, Pru/0000-0001-6105-0747; Nelson, Nicole/0000-0001-9492-9766	Small Grant in Society and Ethics from the Wellcome Trust [104339/Z/14/Z]; MRC [G0901338, MC_UP_1502/1] Funding Source: UKRI; Medical Research Council [MC_UP_1502/1, G0901338] Funding Source: researchfish	Small Grant in Society and Ethics from the Wellcome Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by a Small Grant in Society and Ethics for GFD from the Wellcome Trust (104339/Z/14/Z) http://www.wellcome.ac.uk/Funding/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, NATURE, V517, P5, DOI 10.1038/517005a; Avey MT, 2015, J AM ASSOC LAB ANIM, V54, P153; Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; Barry A, 2008, ECON SOC, V37, P20, DOI 10.1080/03085140701760841; Buller H, 2014, J RURAL STUD, V33, P141, DOI 10.1016/j.jrurstud.2013.01.005; Buller H, 2009, AREA, V41, P395, DOI 10.1111/j.1475-4762.2008.00856.x; Burgess J, 2007, PUBLIC UNDERST SCI, V16, P299, DOI 10.1177/0963662507077510; Davies G, 2006, ECON SOC, V35, P232, DOI 10.1080/03085140600635722; Davies G, 2013, BIOSOCIETIES, V8, P386, DOI 10.1057/biosoc.2013.26; Davies G, 2012, ENVIRON PLANN D, V30, P623, DOI 10.1068/d3211; Davies G, 2012, BODY SOC, V18, P126, DOI 10.1177/1357034X12446378; Davies K, 2010, ANIM TECHNOL WELFARE, V9, P1; Donovan Josephine, 2007, FEMINIST CARE TRADIT; Doubleday R, 2007, AREA, V39, P166, DOI 10.1111/j.1475-4762.2007.00742.x; Ferdowsian HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024059; Franco Nuno Henrique, 2013, Animals (Basel), V3, P238, DOI 10.3390/ani3010238; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Friese C, 2013, CURR ANTHROPOL, V54, pS129, DOI 10.1086/670805; Gibbons M, 1994, NEW PRODUCTION KNOWL; Graham ML, 2015, EUR J PHARMACOL, V759, P19, DOI 10.1016/j.ejphar.2015.03.040; Greenhough B, 2011, PROG HUM GEOG, V35, P153, DOI 10.1177/0309132510376258; Greenhough B, 2011, ENVIRON PLANN D, V29, P47, DOI 10.1068/d17109; Guerrini Anita, 2003, EXPT HUMANS ANIMALS; Hobson-West P, 2010, J MED ETHICS, V36, P46, DOI 10.1136/jme.2009.030817; Hobson-West P, 2012, SOCIOLOGY, V46, P649, DOI 10.1177/0038038511435058; Hobson-West P, 2009, ATLA-ALTERN LAB ANIM, V37, P95, DOI 10.1177/026119290903702S11; Holmberg T, 2012, PUBLIC UNDERST SCI, V21, P354, DOI 10.1177/0963662510372584; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Jasanoff S., 2005, DESIGNS NATURE SCI D; Kilkenny C, 2013, ARRIVE GUIDELINES AN; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Kirk Robert., 2014, STRESS SHOCK ADAPTAT, P241; Kirk RGW, 2010, ISIS, V101, P62, DOI 10.1086/652689; Kirk RGW, 2009, MED HIST, V53, P513, DOI 10.1017/S0025727300000533; Klein HJ, 2007, ILAR J, V48, P3, DOI 10.1093/ilar.48.1.3; MacArthur Clark JA, 2007, ALTEX S, V14, P735; Macleod MR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002273; Mak IWY, 2014, AM J TRANSL RES, V6, P114; McLeod C, 2016, PUBLIC UNDERST SCI, V25, P791, DOI 10.1177/0963662515586320; Mori Ipsos, ATT AN RES 2014; Olsson A., 2012, ALTEX, V1, p333?336; Ormandy Elisabeth H, 2014, Animals (Basel), V4, P391, DOI 10.3390/ani4030391; Pallett H, 2015, PROG HUM GEOG, V39, P146, DOI 10.1177/0309132513518831; Parker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096480; Rose M, 2013, LAB ANIM-UK, V47, P146, DOI 10.1177/0023677213479338; RUDACILLE D, 2000, SCALPEL BUTTERFLY WA; RUSSELL W. M. S., 1959; Schuppli CA, 2011, ANTHROZOOS, V24, P409, DOI 10.2752/175303711X13159027359980; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Sutherland WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031824; Sutherland WJ, 2011, METHODS ECOL EVOL, V2, P238, DOI 10.1111/j.2041-210X.2010.00083.x; Turner PV, 2015, J AM ASSOC LAB ANIM, V54, P174; Wells D, 2015, DIS MODEL MECH, V8, P1175, DOI 10.1242/dmm.022616; Yeates JW, 2015, J MED ETHICS, V41, P504, DOI 10.1136/medethics-2015-102939	56	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158791	10.1371/journal.pone.0158791	http://dx.doi.org/10.1371/journal.pone.0158791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27428071	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300021
J	Eghdam, A; Bartfai, A; Oldenburg, C; Koch, S				Eghdam, Aboozar; Bartfai, Aniko; Oldenburg, Christian; Koch, Sabine			How Do Persons with Mild Acquired Cognitive Impairment Use Information and Communication Technology and E-Services? Results from a Swedish National Survey	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; FAILURES QUESTIONNAIRE; PROFILE; HEALTH; DIMENSIONALITY; ASSOCIATION; DEFICITS; MEMORY; STROKE	Introduction Mild acquired cognitive impairment is a term used to describe a sub-group of persons with mild cognitive impairment who are expected to reach a stable cognitive level over time. One tactic that can be considered for further developing treatment for this group is the use of information and communication technology and e-services. The purpose of this study was to investigate the current use of regular e-services and social media by this group as well as their user experiences. Methods and Materials Data were collected through a self-administered survey and analyzed using quantitative methods. The questionnaire included questions regarding the participants' use of and experience with e-services. Categorization of e-services was based on and cross-validated with the International Classification of Functioning, Disability and Health (ICF). To estimate participants' degree and type of impairment, the Cognitive Failure Questionnaire (CFQ), measuring cognitive difficulties in performing everyday tasks, was added. Results In total, 282 persons with acquired brain injury participated in the survey. The participants' CFQ scores showed that they were suffering from mild to moderate cognitive impairments, most often acquired from traumatic brain injuries (40%). The majority (89%) used e-services in different categories whereof the most popular and essential ones were communication services (59%) and banking (39%) services. Participants with higher total CFQ scores (>58) used more e-services in most of the categories compared to participants with lower scores (<31). Although participants were interested in social media, they were annoyed by advertisements and the Internet speed in general. Some participants reported privacy concerns and addictive behavior. However, they mostly considered e-services to be trustworthy and supportive in different contexts. The usage of electronic devices decreased by age with the exception of electronic tablets that were used by older participants approximately as frequently as by other age groups. Conclusions Although persons with mild to moderate acquired brain injury used various e-services that are not customized for them, very few participants used self-care health services (apps) and readers (e-readers). Further studies are needed on utilizing these identified aspects for this group to support them with their chronic condition.	[Eghdam, Aboozar; Koch, Sabine] Karolinska Inst, Hlth Informat Ctr, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden; [Bartfai, Aniko; Oldenburg, Christian] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Rehabil Med, Stockholm, Sweden	Karolinska Institutet; Danderyds Hospital; Karolinska Institutet	Eghdam, A (corresponding author), Karolinska Inst, Hlth Informat Ctr, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden.	aboozar.eghdam@ki.se	Koch, Sabine/F-8020-2010; Eghdam, Aboozar/D-8561-2013; Eqdam, James Abbott/H-5975-2016	Koch, Sabine/0000-0001-7144-8740; Oldenburg, Christian/0000-0003-4647-9136; Eqdam, James Abbott/0000-0001-8690-8594	Strategic Research Area in Care Sciences (SFO-V) at Karolinska Institutet through the Swedish Research Council; VINNOVA-Swedish Agency for Innovation Systems	Strategic Research Area in Care Sciences (SFO-V) at Karolinska Institutet through the Swedish Research Council; VINNOVA-Swedish Agency for Innovation Systems(Vinnova)	Strategic Research Area in Care Sciences (SFO-V) at Karolinska Institutet through the Swedish Research Council and VINNOVA-Swedish Agency for Innovation Systems supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994; Bartfai A., 2014, TECHNOL DISABIL, V26, P11, DOI 10.3233/TAD-140400; Bridger RS, 2013, ERGONOMICS, V56, P1515, DOI 10.1080/00140139.2013.821172; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cotten SR, 2004, SOC SCI MED, V59, P1795, DOI 10.1016/j.socscimed.2004.02.020; De Silva TM, 2016, CELL MOL NEUROBIOL, V36, P241, DOI 10.1007/s10571-015-0308-1; DiMaggio P, 2001, ANNU REV SOCIOL, V27, P307, DOI 10.1146/annurev.soc.27.1.307; Dobransky K., 2006, Information Communication & Society, V9, P313, DOI 10.1080/13691180600751298; Eghdam A, 2012, J MED INTERNET RES, V14, P4, DOI 10.2196/jmir.2275; Eurostat, INF SOC STAT HOUS IN; HIRSCHHEIM R, 1988, COMPUT J, V31, P398, DOI 10.1093/comjnl/31.5.398; Hofer S, 2008, HDB COGNITIVE AGING; Jaillard A, 2009, STROKE, V40, P2473, DOI 10.1161/STROKEAHA.108.541144; Larson GE, 1997, BRIT J PSYCHOL, V88, P29, DOI 10.1111/j.2044-8295.1997.tb02618.x; Lazar J, 2011, ISSUES SCI TECHNOL, V27, P69; Lindberg B, 2013, INT J TELEMED APPL, V2013, DOI 10.1155/2013/461829; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1394, DOI 10.1001/archneur.60.10.1394; Lundberg N, 2013, STUD HEALTH TECHNOL, V192, P687, DOI 10.3233/978-1-61499-289-9-687; MATTHEWS G, 1990, J PSYCHOPATHOL BEHAV, V12, P49, DOI 10.1007/BF00960453; Mayo Clinic Staff, 2012, MILD COGN IMP MAYO C; Meijer WJ, 2007, ST HEAL T, V127, P199; Nilsson C, 2011, DISABIL REHABIL, V33, P969, DOI 10.3109/09638288.2010.528141; Ojo O, 2015, INT J ENV RES PUB HE, V12, P8281, DOI 10.3390/ijerph120708281; Petersen RC, 2009, CURR ALZHEIMER RES, V6, P324, DOI 10.2174/156720509788929237; POLLINA LK, 1992, BRIT J PSYCHOL, V83, P305, DOI 10.1111/j.2044-8295.1992.tb02443.x; Prigatano G.P., 2010, STUDY ANOSOGNOSIA; Rast P, 2009, ASSESSMENT, V16, P145, DOI 10.1177/1073191108324440; Rowley J, 2006, INTERNET RES, V16, P339, DOI 10.1108/10662240610673736; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Sandberg Karl W, 2005, Work, V24, P229; Tun PA, 2010, PSYCHOL AGING, V25, P560, DOI 10.1037/a0019543; van Rijsbergen MWA, 2015, J STROKE CEREBROVASC, V24, P1823, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.017; Wallace JC, 2004, PERS INDIV DIFFER, V37, P307, DOI 10.1016/j.paid.2003.09.005; WHO, WHO GLOB STAT REP RO; Whyte E, 2011, PM&R, V3, pS45, DOI 10.1016/j.pmrj.2011.05.007; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; World Health Organization, WHO INT CLASS FUNCT; Zhu FX, 2002, INT J SERV IND MANAG, V13, P69, DOI 10.1108/09564230210421164; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015	41	4	4	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159362	10.1371/journal.pone.0159362	http://dx.doi.org/10.1371/journal.pone.0159362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27427947	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300056
J	Jonas, BA; Johnson, C; Gratzinger, D; Majeti, R				Jonas, Brian A.; Johnson, Carl; Gratzinger, Dita; Majeti, Ravindra			Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell Activity	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; MYELODYSPLASTIC SYNDROMES; BETHESDA PROPOSALS; INITIATING CELLS; MICE; EXPRESSION; MUTATIONS; CLASSIFICATION; IDENTIFICATION; HETEROGENEITY	Acute myeloid leukemia (AML) is a heterogeneous group of aggressive bone marrow cancers arising from transformed hematopoietic stem and progenitor cells (HSPC). Therapy-related AML and MDS (t-AML/MDS) comprise a subset of AML cases occurring after exposure to alkylating chemotherapy and/or radiation and are associated with a very poor prognosis. Less is known about the pathogenesis and disease-initiating/leukemia stem cell (LSC) subpopulations of t-AML/MDS compared to their de novo counterparts. Here, we report the development of mouse models of t-AML/MDS. First, we modeled alkylator-induced t-AML/MDS by exposing wild type adult mice to N-ethyl-N-nitrosurea (ENU), resulting in several models of AML and MDS that have clinical and pathologic characteristics consistent with human t-AML/MDS including cytopenia, myelodysplasia, and shortened overall survival. These models were limited by their inability to transplant clinically aggressive disease. Second, we established three patient-derived xenograft models of human t-AML. These models led to rapidly fatal disease in recipient immunodeficient xenografted mice. LSC activity was identified in multiple HSPC subpopulations suggesting there is no canonical LSC immunophenotype in human t-AML. Overall, we report several new t-AML/MDS mouse models that could potentially be used to further define disease pathogenesis and test novel therapeutics.	[Jonas, Brian A.] Univ Calif Davis, Sch Med, Ctr Comprehens Canc, Dept Internal Med,Div Hematol & Oncol, Sacramento, CA 95817 USA; [Johnson, Carl; Majeti, Ravindra] Stanford Univ, Sch Med, Dept Med, Div Hematol,Canc Inst, Stanford, CA 94305 USA; [Johnson, Carl; Majeti, Ravindra] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Gratzinger, Dita] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	University of California System; University of California Davis; Stanford University; Stanford University; Stanford University	Majeti, R (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Hematol,Canc Inst, Stanford, CA 94305 USA.	rmajeti@stanford.edu	Jonas, Brian/AAS-3639-2020	Jonas, Brian/0000-0002-4921-5809; Majeti, Ravindra/0000-0002-5814-0984; Gratzinger, Dita/0000-0002-9182-8123	Leukemia & Lymphoma Society (LLS) [4698-13]; Stanford Training Program in Investigative Oncology [T32CA00927-35]; National Institutes of Health Paul Calabresi K12 Clinical Oncology Career Development Award [K12 CA138464]; California Institute for Regenerative Medicine Bridges Grant [TB1-01194]; Burroughs Welcome Fund; New York Stem Cell Foundation Robertson Investigator; Department of Defense (DOD) [CA093573]	Leukemia & Lymphoma Society (LLS)(Leukemia and Lymphoma Society); Stanford Training Program in Investigative Oncology; National Institutes of Health Paul Calabresi K12 Clinical Oncology Career Development Award; California Institute for Regenerative Medicine Bridges Grant; Burroughs Welcome Fund(Burroughs Wellcome Fund); New York Stem Cell Foundation Robertson Investigator; Department of Defense (DOD)(United States Department of Defense)	This work was funded by a Special Fellow in Clinical Research award from the Leukemia & Lymphoma Society (LLS 4698-13; https://www.lls.org/research/career-development-program), Stanford Training Program in Investigative Oncology (T32CA00927-35; https://researchtraining.nih.gov/programs/training-grants/T32), and National Institutes of Health Paul Calabresi K12 Clinical Oncology Career Development Award (K12 CA138464; http://www.cancer.gov/grants-training/training/funding/K12) [BAJ]; California Institute for Regenerative Medicine Bridges Grant (TB1-01194; https://www.cirm.ca.gov/our-funding/research-rfas/bridges) [CJ]; and Career Award for Medical Scientists from the Burroughs Welcome Fund (http://www.bwfund.org/grantprograms/biomedicalsciences/career-awards-medical-scientists), New York Stem Cell Foundation Robertson Investigator (http://www.nyscf.org/grants/nyscf-robertson-prize), and Department of Defense (DOD CA093573; http://cdmrp.army.mil/funding/) [RM]. DG received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Beachy SH, 2010, HEMATOL ONCOL CLIN N, V24, P361, DOI 10.1016/j.hoc.2010.02.002; Beurlet S, 2013, HAEMATOLOGICA, V98, P10, DOI 10.3324/haematol.2012.069385; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Chao RC, 2005, CANCER CELL, V8, P337, DOI 10.1016/j.ccr.2005.08.011; Churpek JE, 2013, BEST PRACT RES CL HA, V26, P309, DOI 10.1016/j.beha.2013.09.001; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Cordes SP, 2005, MICROBIOL MOL BIOL R, V69, P426, DOI 10.1128/MMBR.69.3.426-439.2005; Davis AP, 1998, GENETICS, V148, P7; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fenske TS, 2006, CANCER RES, V66, P5029, DOI 10.1158/0008-5472.CAN-05-3404; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Godley LA, 2008, SEMIN ONCOL, V35, P418, DOI 10.1053/j.seminoncol.2008.04.012; Goyama S, 2015, BLOOD, V125, P2630, DOI 10.1182/blood-2014-11-570218; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Janke MR, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.59; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Lu EP, 2014, BLOOD, V124, P3887, DOI 10.1182/blood-2014-06-582551; Mahgoub N, 1999, BLOOD, V93, P3617, DOI 10.1182/blood.V93.11.3617.411a49_3617_3623; Majeti R, 2011, ONCOGENE, V30, P1009, DOI 10.1038/onc.2010.511; MAJOR IR, 1978, NATURE, V272, P455, DOI 10.1038/272455a0; Mallardo M, 2013, LEUKEMIA, V27, P2248, DOI 10.1038/leu.2013.114; Matsuura S, 2012, BLOOD, V120, P4028, DOI 10.1182/blood-2012-01-404533; Mc Cormack E, 2005, LEUKEMIA, V19, P687, DOI 10.1038/sj.leu.2403670; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Nilsson L, 2002, BLOOD, V100, P259, DOI 10.1182/blood-2001-12-0188; Nilsson L, 2007, BLOOD, V110, P3005, DOI 10.1182/blood-2007-03-079368; Ok CY, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0139-z; Ok CY, 2015, LEUKEMIA RES, V39, P348, DOI 10.1016/j.leukres.2014.12.006; Olme CH, 2013, LEUKEMIA RES, V37, P1374, DOI 10.1016/j.leukres.2013.05.019; Ornstein MC, 2014, AM J HEMATOL, V89, P168, DOI 10.1002/ajh.23605; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Schulz E, 2015, ANN HEMATOL, V94, P527, DOI 10.1007/s00277-014-2191-0; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Smith SM, 2003, BLOOD, V102, P43, DOI 10.1182/blood-2002-11-3343; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Thanopoulou E, 2004, BLOOD, V103, P4285, DOI 10.1182/blood-2003-09-3192; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wegrzyn J, 2011, LEUKEMIA RES, V35, P853, DOI 10.1016/j.leukres.2011.03.007; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; Woll PS, 2014, CANCER CELL, V25, P794, DOI 10.1016/j.ccr.2014.03.036; Wong TN, 2015, NATURE, V518, P552, DOI 10.1038/nature13968; Yuan YZ, 2001, P NATL ACAD SCI USA, V98, P10398, DOI 10.1073/pnas.171321298	54	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159189	10.1371/journal.pone.0159189	http://dx.doi.org/10.1371/journal.pone.0159189			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428079	Green Published, gold			2022-12-27	WOS:000380169300040
J	Li, XH; Lu, J; Wang, Y; Huo, XY; Li, ZK; Zhang, SY; Li, CL; Guo, M; Du, XY; Chen, ZW				Li, Xiaohong; Lu, Jing; Wang, Ying; Huo, Xueyun; Li, Zhenkun; Zhang, Shuangyue; Li, Changlong; Guo, Meng; Du, Xiaoyan; Chen, Zhenwen			Establishment and Characterization of a Newly Established Diabetic Gerbil Line	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ANIMAL-MODELS; TYPE-2; OBESITY; MELLITUS; ASSOCIATION	Objectives We aimed to selectively breed a spontaneous diabetic gerbil when a sub-line of inbred gerbil showed increased blood glucose levels was found recently. Then we investigated the characteristics including the serum insulin, triglyceride, cholesterol, leptin, adiponectin and explored the underlying molecular mechanism for the diabetic phenotype. Methods The spontaneous diabetic line of gerbils was selectively inbreed the sub-line of gerbil by monitoring blood glucose of each animal. The serum insulin, adiponectin, and leptin levels were tested using an ELISA kit. The expression levels of GLUT4, Akt, leptin, adiponectin, and calpain 10 (CAPN10) were tested by western blot and Quantitative Real-time PCR (qPCR) in liver, skeletal muscle, and white adipose. Results Our results show that the percentages of animals with FPG >= 5.2 (mmol/l), PG2h >= 6.8 (mmol/l) and both FPG >= 5.2 and PG2h >= 6.8 (mmol/l) were increased with the number of breeding generations from F0 (21.33%) to F6 (38.46%). These diabetic gerbils exhibited insulin resistance and leptin resistance as well as decreased adiponectin level in the serum. We also observed decreased expression of adiponectin and increased expression of leptin in the skeletal muscle, respectively. Conclusions These results indicate that we have primarily established a spontaneous diabetic gerbil line, and the diabetic phenotypes may have been accounted for by altered expression of leptin and adiponectin.	[Li, Xiaohong; Lu, Jing; Wang, Ying; Huo, Xueyun; Li, Zhenkun; Zhang, Shuangyue; Li, Changlong; Guo, Meng; Du, Xiaoyan; Chen, Zhenwen] Capital Med Univ, Sch Basic Med Sci, Beijing Key Lab Canc Invas & Metastasis Res, Beijing 100069, Peoples R China	Capital Medical University	Du, XY; Chen, ZW (corresponding author), Capital Med Univ, Sch Basic Med Sci, Beijing Key Lab Canc Invas & Metastasis Res, Beijing 100069, Peoples R China.	duduyan@ccmu.edu.cn; czwen@ccmu.edu.cn	Du, Xiaoyan/ABD-3167-2021; li, xiao/GSN-6181-2022; Li, Changlong/AAJ-4483-2020	Du, Xiaoyan/0000-0002-4030-7299; 	National Science Foundation of China [31272393, 31572341]; Key Projects in the National Science & Technology Pillar Program [2015BAI09B01]; Beijing Natural Science Foundation [7141002]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was funded by the National Science Foundation of China Nos. 31272393 and 31572341 Xiaoyan Du, the website is http://www.nsfc.gov.cn/Portal0/default152.htm, Key Projects in the National Science & Technology Pillar Program (No. 2015BAI09B01) and the Beijing Natural Science Foundation (No. 7141002), the website is http://www.bjnsf.org.	Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243; Black BL, 1998, METABOLISM, V47, P1354, DOI 10.1016/S0026-0495(98)90304-3; BOQUIST L, 1972, DIABETOLOGIA, V8, P274, DOI 10.1007/BF01225571; Cefalu WT, 2006, ILAR J, V47, P186, DOI 10.1093/ilar.47.3.186; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Govers R, 2014, ADV CLIN CHEM, V66, P173, DOI 10.1016/B978-0-12-801401-1.00006-2; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Henry ML, 2008, BLOOD COAGUL FIBRIN, V19, P124, DOI 10.1097/MBC.0b013e3282f41e56; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Ikeda Y, 2001, DIABETES, V50, P584, DOI 10.2337/diabetes.50.3.584; Liu Y, 2014, BEST PRACT RES CL EN, V28, P33, DOI 10.1016/j.beem.2013.08.003; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Miura T, 2001, EUR J ENDOCRINOL, V145, P785, DOI 10.1530/eje.0.1450785; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; NAKAMA K, 1977, ENDOCRINOL JAPON, V24, P421; Narayan KMV, 2000, DIABETES RES CLIN PR, V50, pS77; Nishigaki R, 1999, Nihon Ika Daigaku Zasshi, V66, P166, DOI 10.1272/jnms.66.166; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Segre AV, 2015, DIABETES, V64, P1470, DOI 10.2337/db14-0703; Shafrir E, 2010, WORLD J DIABETES, V1, P137, DOI 10.4239/wjd.v1.i5.137; Shafrir E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1450, DOI 10.1152/ajpendo.00113.2009; Siitonen N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-5; Swellam M, 2012, IUBMB LIFE, V64, P180, DOI 10.1002/iub.597; Tsuchiya T, 2006, MOL GENET METAB, V89, P174, DOI 10.1016/j.ymgme.2006.05.013; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang J, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/106206; Yang XL, 2001, MOL GENET METAB, V73, P111, DOI 10.1006/mgme.2001.3171	31	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159420	10.1371/journal.pone.0159420	http://dx.doi.org/10.1371/journal.pone.0159420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427908	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169300065
J	Paillamanque, J; Madrid, C; Carmona, EM; Osses, N; Moreno, RD; Oresti, GM; Pino, JA; Reyes, JG				Paillamanque, Joaquin; Madrid, Cristian; Carmona, Emerson M.; Osses, Nelson; Moreno, Ricardo D.; Oresti, Gerardo M.; Pino, Jose A.; Reyes, Juan G.			Effects of Fatty Acids on Intracellular [Ca2+], Mitochondrial Uncoupling and Apoptosis in Rat Pachytene Spermatocytes and Round Spermatids	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; MOUSE SPERMATOGENIC CELLS; SERTOLI-CELLS; GERM-CELLS; ARACHIDONIC-ACID; LACTATE PRODUCTION; SPECIES PRODUCTION; GENE-EXPRESSION; IN-VITRO; GLUCOSE	The aim of this work was to explore the ability of free arachidonic acid, palmitic acid and the unsaturated fatty acids oleic acid and docosahexaenoic acid to modify calcium homeostasis and mitochondrial function in rat pachytene spermatocytes and round spermatids. In contrast to palmitic acid, unsaturated fatty acids produced significant increases in intracellular calcium concentrations ([Ca2+](i)) in both cell types. Increases were fatty acid specific, dose-dependent and different for each cell type. The arachidonic acid effects on [Ca2+](i) were higher in spermatids than in spermatocytes and persisted when residual extracellular Ca2+ was chelated by EGTA, indicating that the increase in [Ca2+](i) originated from release of intracellular calcium stores. At the concentrations required for these increases, unsaturated fatty acids produced no significant changes in the plasma membrane potential of or nonspecific permeability in spermatogenic cells. For the case of arachidonic acid, the [Ca2+](i) increases were not caused by its metabolic conversion to eicosanoids or anandamide; thus we attribute this effect to the fatty acid itself. As estimated with fluorescent probes, unsaturated fatty acids did not affect the intracellular pH but were able to induce a progressive decrease in the mitochondrial membrane potential. The association of this decrease with reduced reactive oxygen species (ROS) production strongly suggests that unsaturated fatty acids induced mitochondrial uncoupling. This effect was stronger in spermatids than in spermatocytes. As a late event, arachidonic acid induced caspase 3 activation in a dose-dependent manner both in the absence and presence of external Ca2+. The concurrent but differential effects of unsaturated fatty acids on [Ca2+](i) and mitochondrial functions are additional manifestations of the metabolic changes that germ cells undergo during their differentiation.	[Paillamanque, Joaquin; Madrid, Cristian; Carmona, Emerson M.; Osses, Nelson; Pino, Jose A.; Reyes, Juan G.] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile; [Moreno, Ricardo D.] Pontificia Univ Catolica Chile, Dept Fisiol, Santiago, Chile; [Oresti, Gerardo M.] INIBIBB, Bahia Blanca, Buenos Aires, Argentina	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Chile	Reyes, JG (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile.	juan.reyes@pucv.cl	Osses, Nelson/V-9065-2019; Pino, José/AAF-4359-2021	Osses, Nelson/0000-0003-0974-1051; Pino, José/0000-0002-1542-0660; Moreno, Ricardo/0000-0002-7499-5501; Carmona, Emerson/0000-0003-1332-0372	Fondo Nacional de Investigacion en Ciencia Y Tecnologia (Fondecyt) [1110267, 1140758]; Pontificia Universidad Catolica de Valparaiso (PUCV-VRIEA) grant [125.726]	Fondo Nacional de Investigacion en Ciencia Y Tecnologia (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Pontificia Universidad Catolica de Valparaiso (PUCV-VRIEA) grant	This work was supported by Fondo Nacional de Investigacion en Ciencia Y Tecnologia (Fondecyt) grant numbers 1110267 and 1140758 to JGR, and by the Pontificia Universidad Catolica de Valparaiso (PUCV-VRIEA) grant 125.726 to JGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artwohl M, 2009, ATHEROSCLEROSIS, V202, P351, DOI 10.1016/j.atherosclerosis.2008.05.030; Balnave CD, 2000, J PHYSIOL-LONDON, V528, P25, DOI 10.1111/j.1469-7793.2000.00025.x; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bustamante-Marin X, 2012, APOPTOSIS, V17, P539, DOI 10.1007/s10495-012-0709-2; Carrillo C, 2011, CELL PHYSIOL BIOCHEM, V28, P329, DOI 10.1159/000331749; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Chiarella P, 2004, J CELL SCI, V117, P4127, DOI 10.1242/jcs.01283; CHO H, 1991, J MED CHEM, V34, P1503, DOI 10.1021/jm00108a039; Di PM, 2006, BIOCHIM BIOPHYS ACTA, V1757, P1330; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Glass R, 2001, CELLS TISSUES ORGANS, V169, P377, DOI 10.1159/000047905; GOETZL EJ, 1980, IMMUNOLOGY, V40, P709; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALL PF, 1984, BIOL REPROD, V31, P863, DOI 10.1095/biolreprod31.5.863; Herrera E, 2000, BIOL CELL, V92, P429, DOI 10.1016/S0248-4900(00)01082-0; Huleihel M, 2007, GROWTH FACTORS, V25, P236, DOI 10.1080/08977190701783400; JANNINI EA, 1994, BIOL REPROD, V51, P140, DOI 10.1095/biolreprod51.1.140; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; Konrad L, 2006, APOPTOSIS, V11, P739, DOI 10.1007/s10495-006-5542-z; LAPPIN DF, 1982, CLIN EXP IMMUNOL, V49, P623; Le GF, 1983, ARCH ANDROLOGY, V10, P149; Lee JH, 2006, ARCH ANDROLOGY, V52, P311, DOI 10.1080/01485010600664024; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Liu WH, 2009, TOXICOL LETT, V191, P140, DOI 10.1016/j.toxlet.2009.08.016; Lizama C, 2007, APOPTOSIS, V12, P499, DOI 10.1007/s10495-006-0012-1; LYMAN GE, 1967, ANAL BIOCHEM, V21, P435, DOI 10.1016/0003-2697(67)90318-1; MACDONALD ML, 1984, J NUTR, V114, P719, DOI 10.1093/jn/114.4.719; Mahaut-Smith MP, 2008, TRENDS PHARMACOL SCI, V29, P421, DOI 10.1016/j.tips.2008.05.007; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Meinhardt A, 2000, MOL CELL ENDOCRINOL, V168, P111, DOI 10.1016/S0303-7207(00)00308-7; Meroni SB, 2003, INT J ANDROL, V26, P310, DOI 10.1046/j.1365-2605.2003.00432.x; Mishra DP, 2006, J BIOL CHEM, V281, P2133, DOI 10.1074/jbc.M508648200; MITA M, 1982, ENDOCRINOLOGY, V110, P1535, DOI 10.1210/endo-110-5-1535; Okamura Y, 2009, J PHYSIOL-LONDON, V587, P513, DOI 10.1113/jphysiol.2008.163097; Oresti GM, 2010, J LIPID RES, V51, P2909, DOI 10.1194/jlr.M006429; Pino JA, 2013, REPRODUCTION, V145, P203, DOI 10.1530/REP-12-0330; Pointis Georges, 2011, Spermatogenesis, V1, P303; REYES J, 1984, MEMBRANE BIOCHEM, V5, P243, DOI 10.3109/09687688409150281; REYES JG, 1994, J REPROD FERTIL, V102, P313, DOI 10.1530/jrf.0.1020313; Reyes JG, 2002, REPRODUCTION, V123, P701, DOI 10.1530/reprod/123.5.701; Reyes JG, 1997, BIOL CELL, V89, P53, DOI 10.1016/S0248-4900(99)80081-1; Reyes JG, 2010, FEBS LETT, V584, P3111, DOI 10.1016/j.febslet.2010.05.051; Riera MF, 2001, GEN COMP ENDOCR, V122, P88, DOI 10.1006/gcen.2001.7619; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; ROBINSON R, 1981, BIOL REPROD, V24, P1032, DOI 10.1095/biolreprod24.5.1032; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; ROUSSEAU E, 1990, PFLUG ARCH EUR J PHY, V415, P645, DOI 10.1007/BF02583520; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Sofikitis N, 2008, J STEROID BIOCHEM, V109, P323, DOI 10.1016/j.jsbmb.2008.03.004; Sokal RR., 1979, BIOMETRIA PRINCIPIOS; TSURUTA JK, 1995, BIOL REPROD, V53, P1454, DOI 10.1095/biolreprod53.6.1454; Turmel P, 2011, MOL REPROD DEV, V78, P124, DOI 10.1002/mrd.21280; TURNER TT, 1983, FERTIL STERIL, V40, P530; Ulisse S, 2000, CELL DEATH DIFFER, V7, P916, DOI 10.1038/sj.cdd.4400716; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Yeung-Yam-Wah V, 2012, CELL CALCIUM, V51, P140, DOI 10.1016/j.ceca.2011.11.012; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06	61	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158518	10.1371/journal.pone.0158518	http://dx.doi.org/10.1371/journal.pone.0158518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428262	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300010
J	Rowe, PC; Fontaine, KR; Lauver, M; Jasion, SE; Marden, CL; Moni, M; Thompson, CB; Violand, RL				Rowe, Peter C.; Fontaine, Kevin R.; Lauver, Megan; Jasion, Samantha E.; Marden, Colleen L.; Moni, Malini; Thompson, Carol B.; Violand, Richard L.			Neuromuscular Strain Increases Symptom Intensity in Chronic Fatigue Syndrome	PLOS ONE			English	Article							NEURALLY-MEDIATED HYPOTENSION; POSTURAL TACHYCARDIA SYNDROME; RANDOMIZED CONTROLLED-TRIAL; LEG RAISE TESTS; BLOOD-FLOW; SPINAL-CORD; FIBROMYALGIA SYNDROME; GENERAL-POPULATION; PERIPHERAL-NERVES; MAST-CELLS	Chronic fatigue syndrome (CFS) is a complex, multisystem disorder that can be disabling. CFS symptoms can be provoked by increased physical or cognitive activity, and by orthostatic stress. In preliminary work, we noted that CFS symptoms also could be provoked by application of longitudinal neural and soft tissue strain to the limbs and spine of affected individuals. In this study we measured the responses to a straight leg raise neuromuscular strain maneuver in individuals with CFS and healthy controls. We randomly assigned 60 individuals with CFS and 20 healthy controls to either a 15 minute period of passive supine straight leg raise (true neuromuscular strain) or a sham straight leg raise. The primary outcome measure was the symptom intensity difference between the scores during and 24 hours after the study maneuver compared to baseline. Fatigue, body pain, lightheadedness, concentration difficulties, and headache scores were measured individually on a 0-10 scale, and summed to create a composite symptom score. Compared to individuals with CFS in the sham strain group, those with CFS in the true strain group reported significantly increased body pain (P = 0.04) and concentration difficulties (P = 0.02) as well as increased composite symptom scores (all P = 0.03) during the maneuver. After 24 hours, the symptom intensity differences were significantly greater for the CFS true strain group for the individual symptom of lightheadedness (P = 0.001) and for the composite symptom score (P = 0.005). During and 24 hours after the exposure to the true strain maneuver, those with CFS had significantly higher individual and composite symptom intensity changes compared to the healthy controls. We conclude that a longitudinal strain applied to the nerves and soft tissues of the lower limb is capable of increasing symptom intensity in individuals with CFS for up to 24 hours. These findings support our preliminary observations that increased mechanical sensitivity may be a contributor to the provocation of symptoms in this disorder.	[Rowe, Peter C.; Lauver, Megan; Jasion, Samantha E.; Marden, Colleen L.; Moni, Malini] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Fontaine, Kevin R.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Hlth Behav, Birmingham, AL 35294 USA; [Thompson, Carol B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Violand, Richard L.] Rick Violand PT LLC, Ellicott City, MD USA	Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Rowe, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	prowe@jhmi.edu	Moni, Mohammad Ali/ABG-3606-2020		Solve ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) Initiative; Blaustein Pain Foundation at the Johns Hopkins University School of Medicine; Sunshine Natural Wellbeing Foundation Professorship in Chronic Fatigue and Related Disorders; Antoine Lavoisier Endowed Professor of Energetics and Health Lifestyles, School of Public Health, University of Alabama at Birmingham; National Center for Research Resources; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [1UL1TR001079]	Solve ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) Initiative; Blaustein Pain Foundation at the Johns Hopkins University School of Medicine; Sunshine Natural Wellbeing Foundation Professorship in Chronic Fatigue and Related Disorders; Antoine Lavoisier Endowed Professor of Energetics and Health Lifestyles, School of Public Health, University of Alabama at Birmingham; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by Solve ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) Initiative, PCR, no grant number assigned [http://solvecfs.org/] and. Blaustein Pain Foundation at the Johns Hopkins University School of Medicine, KLF, no grant number assigned. Dr. Rowe's work is supported by the Sunshine Natural Wellbeing Foundation Professorship in Chronic Fatigue and Related Disorders. Dr. Fontaine is supported by the Antoine Lavoisier Endowed Professor of Energetics and Health Lifestyles, School of Public Health, University of Alabama at Birmingham. The authors would like to acknowledge partial support for the statistical analysis from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through Grant Number 1UL1TR001079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A., 1993, BECK ANXIETY INVENTO; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; BENTALL RP, 1993, BRIT J CLIN PSYCHOL, V32, P375, DOI 10.1111/j.2044-8260.1993.tb01070.x; Biswal B, 2011, J NEUROL SCI, V301, P9, DOI 10.1016/j.jns.2010.11.018; BOUHOLAIGAH I, 1995, JAMA-J AM MED ASSOC, V274, P961, DOI 10.1001/jama.274.12.961; BRIEG A, 1979, SPINE, V4, P242; Brieg A., 1978, ADVERSE MECH TENSION; Brown Molly M, 2007, Dyn Med, V6, P6, DOI 10.1186/1476-5918-6-6; Butler DS, 1999, MOBILISATION NERVOUS; Cockshell SJ, 2014, NEUROPSYCHOLOGY, V28, P394, DOI 10.1037/neu0000025; De-La-Llave-Rincon AI, 2009, J ORTHOP SPORT PHYS, V39, P658, DOI 10.2519/jospt.2009.3058; DOLAN EJ, 1980, J NEUROSURG, V53, P756, DOI 10.3171/jns.1980.53.6.0756; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Henderson FC, 2005, NEUROSURGERY, V56, P1101, DOI 10.1227/01.NEU.0000157929.85251.7C; Herrington L, 2008, MANUAL THER, V13, P289, DOI 10.1016/j.math.2007.01.013; Hu KK, 2014, IMMUNOL RES, V58, P211, DOI 10.1007/s12026-014-8510-7; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Keech A, 2015, J PSYCHOSOM RES, V79, P537, DOI 10.1016/j.jpsychores.2015.08.008; Kobayashi S, 2003, SPINE, V28, P1427, DOI 10.1097/00007632-200307010-00014; Komaroff AL, 1996, AM J MED, V101, P281, DOI 10.1016/S0002-9343(96)00174-X; Lamanca John J., 1998, American Journal of Medicine, V105, p59S, DOI 10.1016/S0002-9343(98)00171-5; Lew P. C., 1997, Man Ther, V2, P98, DOI 10.1054/math.1997.0291; Light AR, 2009, J PAIN, V10, P1099, DOI 10.1016/j.jpain.2009.06.003; LOUIS R, 1981, ANAT CLIN, V3, P1, DOI 10.1007/BF01557969; Lyons JJ, 2014, J ALLERGY CLIN IMMUN, V133, P1471, DOI 10.1016/j.jaci.2013.11.039; Murrough JW, 2010, NMR BIOMED, V23, P643, DOI 10.1002/nbm.1512; Nakatomi Y, 2014, J NUCL MED, V55, P945, DOI 10.2967/jnumed.113.131045; NATHAN H, 1987, SPINE, V12, P527, DOI 10.1097/00007632-198707000-00003; Nijs J, 2012, EUR J CLIN INVEST, V42, P203, DOI 10.1111/j.1365-2362.2011.02575.x; Ocon AJ, 2012, CLIN SCI, V122, P227, DOI 10.1042/CS20110241; Rade M, 2015, SPINE, V40, P935, DOI 10.1097/BRS.0000000000000914; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rempel D, 1999, J BONE JOINT SURG AM, V81A, P1600, DOI 10.2106/00004623-199911000-00013; Torres JR, 2015, ARCH PHYS MED REHAB, V96, P1771, DOI 10.1016/j.apmr.2015.06.008; Rowe PC, 1999, J PEDIATR-US, V135, P494, DOI 10.1016/S0022-3476(99)70173-3; Rowe PC, 2001, JAMA-J AM MED ASSOC, V285, P52, DOI 10.1001/jama.285.1.52; Rowe PC, 2014, J PEDIATR-US, V165, P360, DOI 10.1016/j.jpeds.2014.04.051; Rowe PC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00115; Shacklock M., 1995, NEURODYNAMICS PHYSIO, V81, P9, DOI [10.1016/S0031-9406(05)67024-1, DOI 10.1016/S0031-9406(05)67024-1]; Shibao C, 2005, HYPERTENSION, V45, P385, DOI 10.1161/01.HYP.0000158259.68614.40; Skaper SD, 2014, IMMUNOLOGY, V141, P314, DOI 10.1111/imm.12170; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; SMITH CG, 1956, RADIOLOGY, V66, P259, DOI 10.1148/66.2.259; SMITH SA, 1993, SPINE, V18, P992, DOI 10.1097/00007632-199306150-00007; STRAUS SE, 1988, NEW ENGL J MED, V319, P1692, DOI 10.1056/NEJM198812293192602; Sunderland S., 1978, NERVES NERVE INJURIE; Tesarz J, 2011, NEUROSCIENCE, V194, P302, DOI 10.1016/j.neuroscience.2011.07.066; Theoharides TC, 2005, J CLIN PSYCHOPHARM, V25, P515, DOI 10.1097/01.jcp.0000193483.89260.a7; Topp KS, 2006, PHYS THER, V86, P92, DOI 10.1093/ptj/86.1.92; VanNess JM, 2010, J WOMENS HEALTH, V19, P239, DOI 10.1089/jwh.2009.1507; White KP, 2000, SCAND J RHEUMATOL, V29, P44; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wyller VB, 2015, TIDSSKR NORSKE LAEGE, V135, P2172, DOI 10.4045/tidsskr.15.1180; YAMADA S, 1981, J NEUROSURG, V54, P494, DOI 10.3171/jns.1981.54.4.0494; Yoshiuchi K, 2006, CLIN PHYSIOL FUNCT I, V26, P83, DOI 10.1111/j.1475-097X.2006.00649.x	55	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159386	10.1371/journal.pone.0159386	http://dx.doi.org/10.1371/journal.pone.0159386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428358	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300060
J	Rieger, A; Kemter, E; Kumar, S; Popper, B; Aigner, B; Wolf, E; Wanke, R; Blutke, A				Rieger, Alexandra; Kemter, Elisabeth; Kumar, Sudhir; Popper, Bastian; Aigner, Bernhard; Wolf, Eckhard; Wanke, Ruediger; Blutke, Andreas			Missense Mutation of POU Domain Class 3 Transcription Factor 3 in Pou3f3(L423P) Mice Causes Reduced Nephron Number and Impaired Development of the Thick Ascending Limb of the Loop of Henle	PLOS ONE			English	Article							RENAL-DISEASE; GLOMERULAR HYPERTROPHY; KIDNEY-DISEASE; CRUCIAL ROLES; UROMODULIN; GROWTH; HYPERTENSION; PRESSURE; WEIGHT; EXCESS	During nephrogenesis, POU domain class 3 transcription factor 3 (POU3F3 aka BRN1) is critically involved in development of distinct nephron segments, including the thick ascending limb of the loop of Henle (TAL). Deficiency of POU3F3 in knock-out mice leads to underdevelopment of the TAL, lack of differentiation of TAL cells, and perinatal death due to renal failure. Pou3f3(L423P) mutant mice, which were established in the Munich ENU Mouse Mutagenesis Project, carry a recessive point mutation in the homeobox domain of POU3F3. Homozygous Pou3f3(L423P) mutants are viable and fertile. The present study used functional, as well as qualitative and quantitative morphological analyses to characterize the renal phenotype of juvenile (12 days) and aged (60 weeks) homo-and heterozygous Pou3f3(L423P) mutant mice and age-matched wild-type controls. In both age groups, homozygous mutants vs. control mice displayed significantly smaller kidney volumes, decreased nephron numbers and mean glomerular volumes, smaller TAL volumes, as well as lower volume densities of the TAL in the kidney. No histological or ultrastructural lesions of TAL cells or glomerular cells were observed in homozygous mutant mice. Aged homozygous mutants displayed increased serum urea concentrations and reduced specific urine gravity, but no evidence of glomerular dysfunction. These results confirm the role of POU3F3 in development and function of the TAL and provide new evidence for its involvement in regulation of the nephron number in the kidney. Therefore, Pou3f3(L423P) mutant mice represent a valuable research model for further analyses of POU3F3 functions, or for nephrological studies examining the role of congenital low nephron numbers.	[Rieger, Alexandra; Wanke, Ruediger; Blutke, Andreas] Univ Munich, Ctr Clin Vet Med, Inst Vet Pathol, Munich, Germany; [Kemter, Elisabeth; Kumar, Sudhir; Aigner, Bernhard; Wolf, Eckhard] Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Kemter, Elisabeth; Kumar, Sudhir; Aigner, Bernhard; Wolf, Eckhard] Univ Munich, Gene Ctr, Lab Funct Genome Anal, Munich, Germany; [Popper, Bastian] Univ Munich, Biomed Ctr, Dept Anat & Cell Biol, Munich, Germany; [Wolf, Eckhard] Helmholtz Zentrum Munche, German Ctr Diabet Res DZD, Neuherberg, Germany	University of Munich; University of Munich; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Blutke, A (corresponding author), Univ Munich, Ctr Clin Vet Med, Inst Vet Pathol, Munich, Germany.	blutke@patho.vetmed.uni-muenchen.de	Wolf, Eckhard/AAT-7500-2021	Wolf, Eckhard/0000-0002-0430-9510; Popper, Bastian/0000-0003-1517-695X; Kemter, Elisabeth/0000-0001-7785-7502	Hanns-Seidel-Stiftung e. V., Munich, Germany	Hanns-Seidel-Stiftung e. V., Munich, Germany	AR recieved a PhD scholarship from the Hanns-Seidel-Stiftung e. V., Munich, Germany.	Aigner B, 2007, AM J PHYSIOL-RENAL, V292, pF1560, DOI 10.1152/ajprenal.00213.2006; Albl B, 2016, TOXICOL PATHOL, V44, P414, DOI 10.1177/0192623316631023; Amann Kerstin, 2011, Klin Padiatr, V223 Suppl 1, pS18, DOI 10.1055/s-0030-1255880; [Anonymous], 1979, STEREOLOGICAL METHOD; Benz K, 2011, AM J PHYSIOL-RENAL, V300, pF521, DOI 10.1152/ajprenal.00490.2009; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; Blutke A, 2014, MOL CELL ENDOCRINOL, V394, P88, DOI 10.1016/j.mce.2014.07.002; Blutke A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12709; Boyce RW, 2010, TOXICOL PATHOL, V38, P1011, DOI 10.1177/0192623310385140; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; BURG MB, 1982, KIDNEY INT, V22, P454, DOI 10.1038/ki.1982.198; Cohen CD, 2003, METH MOLEC MED, V86, P285; Cullen-McEwen L, 2016, HUMAN KIDNEY PARALLE, P27; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Douglas-Denton Rebecca N, 2006, Ethn Dis, V16, pS2; El-Aouni C, 2006, J AM SOC NEPHROL, V17, P1334, DOI 10.1681/ASN.2005090921; El-Dahr SS, 2008, AM J PHYSIOL-RENAL, V294, pF1273, DOI 10.1152/ajprenal.00562.2007; FOGO A, 1989, SEMIN NEPHROL, V9, P329; FOGO A, 1991, AM J KIDNEY DIS, V17, P666, DOI 10.1016/S0272-6386(12)80347-7; Fogo AB, 2000, KIDNEY INT, V57, pS15, DOI 10.1046/j.1523-1755.2000.07505.x; Friedrich RP, 2005, MOL CELL BIOL, V25, P1821, DOI 10.1128/MCB.25.5.1821-1829.2005; Graham LA, 2014, HYPERTENSION, V63, P551, DOI 10.1161/HYPERTENSIONAHA.113.01423; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Herbach N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022814; Herbach N, 2009, AM J PHYSIOL-RENAL, V296, pF819, DOI 10.1152/ajprenal.90665.2008; HERMANNS W, 1981, HISTOCHEMISTRY, V73, P439, DOI 10.1007/BF00495658; Hoeflich A, 2002, FASEB J, V16, P1721, DOI 10.1096/fj.02-0349com; Howard V., 2004, UNBIASED STEREOLOGY; Hoy WE, 2006, KIDNEY INT, V70, P104, DOI 10.1038/sj.ki.5000397; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; Hoy WE, 2008, CURR OPIN NEPHROL HY, V17, P258, DOI 10.1097/MNH.0b013e3282f9b1a5; Hughson M, 2006, KIDNEY INT, V69, P671, DOI 10.1038/sj.ki.5000041; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; KRIZ W, 1974, Z ANAT ENTWICKLUNGS, V144, P137, DOI 10.1007/BF00519771; KRIZ W, 1988, ANAT EMBRYOL, V178, pN1; Kumar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150472; Lechner MS, 1997, MECH DEVELOP, V62, P105, DOI 10.1016/S0925-4773(97)00667-9; Little MH, 2015, CURR OPIN GENET DEV, V32, P135, DOI 10.1016/j.gde.2015.03.001; Luyckx VA, 2010, J AM SOC NEPHROL, V21, P898, DOI 10.1681/ASN.2009121248; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Massa F, 2013, DEVELOPMENT, V140, P886, DOI 10.1242/dev.086546; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Mount DB, 2014, CLIN J AM SOC NEPHRO, V9, P1974, DOI 10.2215/CJN.04480413; Murawski IJ, 2010, ORGANOGENESIS, V6, P189, DOI 10.4161/org.6.3.12125; Nakai S, 2003, DEVELOPMENT, V130, P4751, DOI 10.1242/dev.00666; Nyengaard JR, 1999, J AM SOC NEPHROL, V10, P1100; NYENGAARD JR, 1993, DIABETOLOGIA, V36, P189, DOI 10.1007/BF00399948; O'Brien LL, 2014, SEMIN CELL DEV BIOL, V36, P31, DOI 10.1016/j.semcdb.2014.08.014; PENNICA D, 1987, SCIENCE, V236, P83, DOI 10.1126/science.3453112; Ramage IJ, 2002, KIDNEY INT, V62, P895, DOI 10.1046/j.1523-1755.2002.00527.x; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Siner JM, 2007, FASEB J, V21, P1422, DOI 10.1096/fj.06-6661com; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song S, 2009, NEPHROL DIAL TRANSPL, V24, P1157, DOI 10.1093/ndt/gfn626; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; TAMM I, 1950, P SOC EXP BIOL MED, V74, P108, DOI 10.3181/00379727-74-17825; Wang QR, 2005, DEV BIOL, V288, P582, DOI 10.1016/j.ydbio.2005.09.024; Wanke R, 2001, VERH DEUT G, V85, P250; Weiner ID, 2015, CLIN J AM SOC NEPHRO, V10, P1444, DOI 10.2215/CJN.10311013; Zhong JY, 2012, PEDIATR RES, V72, P241, DOI 10.1038/pr.2012.81	65	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0158977	10.1371/journal.pone.0158977	http://dx.doi.org/10.1371/journal.pone.0158977			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420727	gold, Green Published, Green Submitted			2022-12-27	WOS:000379662300007
J	Wann, GT; Aldridge, CL; Braun, CE				Wann, Gregory T.; Aldridge, Cameron L.; Braun, Clait E.			Effects of Seasonal Weather on Breeding Phenology and Reproductive Success of Alpine Ptarmigan in Colorado	PLOS ONE			English	Article							WHITE-TAILED PTARMIGAN; CLIMATE-CHANGE; WILLOW PTARMIGAN; LAGOPUS-LEUCURUS; BODY-MASS; POPULATION; SELECTION; SURVIVAL; HISTORY; GROWTH	Animal populations occurring at high elevations are often assumed to be in peril of extinctions or local extirpations due to elevational-dispersal limitations and thermoregulatory constraints as habitats change and warm. However, long-term monitoring of high-elevation populations is uncommon relative to those occurring at lower elevations, and evidence supporting this assumption is limited. We analyzed 45 years of reproductive data for two Colorado populations of white-tailed ptarmigan (Lagopus leucura), an alpine-endemic species with restricted distribution in western North America. Seasonal temperatures measured by the number of growing degree days warmed significantly at our study sites for pre-nesting, nesting, and brood-rearing seasonal periods (mean advance of 8 growing degree days per decade), and both populations advanced their reproductive phenology over the study period based on median hatch dates (median advance of 3.7 and 1.9 days per decade for the northern and southern sites, respectively). Reproductive performance measured by the number of chicks per hen declined significantly at one study site but not the other, and differences between sites may have been due to habitat degradation at one study area. Annual variability in chicks per hen was large at both sites but only weakly related to seasonal weather. An index of precipitation and temperature during the brood-rearing period was the best predictor for reproductive success with warm and dry conditions relating positively to number of chicks per hen. Our results provide evidence for two alpine ptarmigan populations that are remarkably invariant to fluctuations in seasonal weather with respect to reproductive success as measured by number of chicks per hen in the breeding population. These results are surprising given the general perception of alpine animal populations as being highly sensitive to warming temperatures.	[Wann, Gregory T.] Colorado State Univ, Dept Ecosyst Sci, 1231 East Dr, Ft Collins, CO 80523 USA; [Wann, Gregory T.] Colorado State Univ, Nat Resource Ecol Lab, 1231 East Dr, Ft Collins, CO 80523 USA; [Aldridge, Cameron L.] Colorado State Univ, US Geol Survey, Ft Collins Sci Ctr, Dept Ecosyst Sci, 2150 Ctr Ave,Bldg C, Ft Collins, CO 80526 USA; [Aldridge, Cameron L.] Colorado State Univ, US Geol Survey, Ft Collins Sci Ctr, Nat Resource Ecol Lab, 2150 Ctr Ave,Bldg C, Ft Collins, CO 80526 USA; [Braun, Clait E.] Grouse Inc, 5572 North Ventana Vista Rd, Tucson, AZ 85750 USA	Colorado State University; Colorado State University; Colorado State University; United States Department of the Interior; United States Geological Survey; Colorado State University; United States Department of the Interior; United States Geological Survey	Wann, GT (corresponding author), Colorado State Univ, Dept Ecosyst Sci, 1231 East Dr, Ft Collins, CO 80523 USA.; Wann, GT (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, 1231 East Dr, Ft Collins, CO 80523 USA.	greg.wann@colostate.edu	Aldridge, Cameron L/F-4025-2011	Aldridge, Cameron L/0000-0003-3926-6941	National Science Foundation; Colorado Division of Wildlife through Federal Aid in Wildlife Restoration Project [W-37-R]; Grouse Inc.; United States Geological Survey; Colorado State University; Rocky Mountain Conservancy through the Leslie Bailey Charitable Trust Fellowship; U.S. Geological Survey	National Science Foundation(National Science Foundation (NSF)); Colorado Division of Wildlife through Federal Aid in Wildlife Restoration Project; Grouse Inc.; United States Geological Survey(United States Geological Survey); Colorado State University; Rocky Mountain Conservancy through the Leslie Bailey Charitable Trust Fellowship; U.S. Geological Survey(United States Geological Survey)	This work was supported by the National Science Foundation (1966-1969; www.nsf.gov) through graduate support to CB through a NSF Traineeship, and also in the 1970s through the Tundra Biome Program. This work was also supported by the Colorado Division of Wildlife (1970-1999; http://cpw.state.co.us/) through Federal Aid in Wildlife Restoration Project W-37-R, Grouse Inc. (2000-2008), the United States Geological Survey (2007-2012; http://www.usgs.gov/), and Colorado State University (2008-2012; www.colostate.edu). GW was partially supported by the Rocky Mountain Conservancy through the Leslie Bailey Charitable Trust Fellowship. The U.S. Geological Survey and Colorado State University provided support in the form of salaries for authors GW and CA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The long-term studies benefited from field support provided by R Schmidt Jr., T May, B Poley, and R Ryder in the 1960s, K Giesen and R Hoffman in the late 1970s through the 1990s at RM, and K Martin in the late 1980s and early 1990s at ME. Early administrative support in RM was provided by Chief Naturalists T Thomas and G Gallison through housing and permits. Field work at ME was facilitated by housing provided courtesy of M Monahan of University of Denver. G Rogers and W Sandfort of the Colorado Division of Wildlife provided administrative and financial support to initiate the studies at both sites. The National Science Foundation provided graduate support to CEB through a NSF Traineeship during 1966-1969 and also in the 1970s through the Tundra Biome Program. Work at both sites was supported by the Colorado Division of Wildlife through Federal Aid in Wildlife Restoration Project W-37-R and the United States Geological Survey. GTW was partially supported by the Rocky Mountain Conservancy through the Leslie Bailey Charitable Trust Fellowship. Weather data were provided by the National Science Foundation supported Niwot Ridge Long-Term Ecological Research project and the University of Colorado Mountain Research Station. This manuscript was improved by an anonymous reviewer and academic editor. We thank all of those that were afield with us.	Aldridge CL, 2008, ISR J ECOL EVOL, V54, P389, DOI 10.1560/IJEE.54.3-4.389; Aublet JF, 2009, OECOLOGIA, V159, P237, DOI 10.1007/s00442-008-1198-4; Badyaev AV, 2001, ECOLOGY, V82, P2948, DOI 10.1890/0012-9658(2001)082[2948:EOLHAE]2.0.CO;2; Barton K., 2014, MUMIN MULTIMODEL INF; BOAG DA, 1966, CAN J ZOOLOG, V44, P799, DOI 10.1139/z66-081; Bowman W. D., 2001, STRUCTURE FUNCTION A; BRAUN CE, 1973, J WILDLIFE MANAGE, V37, P90, DOI 10.2307/3799744; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Camfield AF, 2010, J AVIAN BIOL, V41, P273, DOI 10.1111/j.1600-048X.2009.04816.x; CaraDonna PJ, 2014, P NATL ACAD SCI USA, V111, P4916, DOI 10.1073/pnas.1323073111; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; CLARKE JA, 1992, CONDOR, V94, P622, DOI 10.2307/1369247; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Dirnbock T, 2003, J BIOGEOGR, V30, P401, DOI 10.1046/j.1365-2699.2003.00839.x; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; Elsen PR, 2015, NAT CLIM CHANGE, V5, P772, DOI [10.1038/nclimate2656, 10.1038/NCLIMATE2656]; ERIKSTAD KE, 1983, ORNIS SCAND, V14, P249, DOI 10.2307/3676311; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; GIESEN KM, 1979, J WILDLIFE MANAGE, V43, P508, DOI 10.2307/3800362; GIESEN KM, 1980, WILSON BULL, V92, P188; Giraudoux P., 2013, PGIRMESS DATA ANAL E; Grayson DK, 2005, J BIOGEOGR, V32, P2103, DOI 10.1111/j.1365-2699.2005.01341.x; HANNON SJ, 1988, AUK, V105, P330, DOI 10.2307/4087498; HOFFMAN RW, 2006, WHITE TAILED PTARMIG; Hussell DJT, 2003, AUK, V120, P607, DOI 10.1642/0004-8038(2003)120[0607:CCSTAT]2.0.CO;2; Jackson MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142110; Keller F, 2003, ARCT ANTARCT ALP RES, V35, P361, DOI 10.1657/1523-0430(2003)035[0361:TROPIA]2.0.CO;2; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Ludwig GX, 2006, P ROY SOC B-BIOL SCI, V273, P2009, DOI 10.1098/rspb.2006.3538; Marcstrom V., 1960, VILTREVY, V2, P1; Martin K, 2004, INTEGR COMP BIOL, V44, P177, DOI 10.1093/icb/44.2.177; Martin K, 2000, CONDOR, V102, P503, DOI 10.1650/0010-5422(2000)102[0503:RDADRI]2.0.CO;2; Martin K, 2015, BIRDS N AM; Martin M, 2009, J FIELD ORNITHOL, V80, P253, DOI 10.1111/j.1557-9263.2009.00228.x; Mason THE, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0069-6; MAY TA, 1972, J WILDLIFE MANAGE, V36, P1180, DOI 10.2307/3799246; May TA, 1970, THESIS; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; Moss R, 2001, J ANIM ECOL, V70, P47, DOI 10.1046/j.1365-2656.2001.00473.x; Novoa C, 2008, IBIS, V150, P270, DOI 10.1111/j.1474-919X.2007.00771.x; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PEDERSEN HC, 1979, ORNIS SCAND, V10, P17, DOI 10.2307/3676339; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; R Core Team, 2021, R LANGUAGE ENV STAT; Sandercock BK, 2005, ECOLOGY, V86, P2176, DOI 10.1890/04-0563; SMITH AT, 1974, ECOLOGY, V55, P1368, DOI 10.2307/1935464; Thompson LG, 2000, QUATERNARY SCI REV, V19, P19, DOI 10.1016/S0277-3791(99)00052-9; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wang GM, 2002, CLIM RES, V23, P81, DOI 10.3354/cr023081; Wann GT, 2014, POPUL ECOL, V56, P555, DOI 10.1007/s10144-014-0452-3; Wiebe KL, 1998, IBIS, V140, P14, DOI 10.1111/j.1474-919X.1998.tb04536.x; Wilkening JL, 2009, QUATERN INT, V235, P77; Wilson S, 2010, J AVIAN BIOL, V41, P319, DOI 10.1111/j.1600-048X.2009.04945.x; Wilson SD, 2009, GLOBAL CHANGE BIOL, V15, P1676, DOI 10.1111/j.1365-2486.2009.01896.x; Wong MML, 2009, WILSON J ORNITHOL, V121, P638, DOI 10.1676/08-029.1; Yee TW, 2010, J STAT SOFTW, V32, P1; Zeigenfuss LC, 2006, 20061122 US GEOL SUR; [No title captured]	63	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0158913	10.1371/journal.pone.0158913	http://dx.doi.org/10.1371/journal.pone.0158913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420478	Green Published, Green Submitted, gold			2022-12-27	WOS:000379662300006
J	Ahonen, L; Cowley, B; Torniainen, J; Ukkonen, A; Vihavainen, A; Puolamaki, K				Ahonen, Lauri; Cowley, Benjamin; Torniainen, Jari; Ukkonen, Antti; Vihavainen, Arto; Puolamaki, Kai			Cognitive Collaboration Found in Cardiac Physiology: Study in Classroom Environment	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; MECHANISMS; INDEXES	It is known that periods of intense social interaction result in shared patterns in collaborators' physiological signals. However, applied quantitative research on collaboration is hindered due to scarcity of objective metrics of teamwork effectiveness. Indeed, especially in the domain of productive, ecologically-valid activity such as programming, there is a lack of evidence for the most effective, affordable and reliable measures of collaboration quality. In this study we investigate synchrony in physiological signals between collaborating computer science students performing pair-programming exercises in a class room environment. We recorded electrocardiography over the course of a 60 minute programming session, using lightweight physiological sensors. We employ correlation of heart-rate variability features to study social psychophysiological compliance of the collaborating students. We found evident physiological compliance in collaborating dyads' heart-rate variability signals. Furthermore, dyads' self-reported workload was associated with the physiological compliance. Our results show viability of a novel approach to field measurement using lightweight devices in an uncontrolled environment, and suggest that self-reported collaboration quality can be assessed via physiological signals.	[Ahonen, Lauri; Cowley, Benjamin; Torniainen, Jari; Ukkonen, Antti; Puolamaki, Kai] Finnish Inst Occupat Hlth, Helsinki, Finland; [Vihavainen, Arto] Univ Helsinki, Dept Comp Sci, Helsinki, Finland; [Cowley, Benjamin] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland	Finnish Institute of Occupational Health; University of Helsinki; University of Helsinki	Ahonen, L (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	lauri.ahonen@ttl.fi	Puolamäki, Kai/C-9016-2017; Cowley, Benjamin Ultan/A-6271-2019; Ukkonen, Antti/E-8512-2013	Puolamäki, Kai/0000-0003-1819-1047; Cowley, Benjamin Ultan/0000-0001-8828-2994; Ahonen, Lauri/0000-0001-9957-4263; Torniainen, Jari/0000-0003-4953-4508	Tekes (The Finnish Funding Agency for Innovation, Revolution of Knowledge Work project) [5159/31/2014]	Tekes (The Finnish Funding Agency for Innovation, Revolution of Knowledge Work project)	This work was supported by Tekes (The Finnish Funding Agency for Innovation, Revolution of Knowledge Work project), http://www.tekes.fi/en/funding/research_organisations/strategic-researchopenings/, 5159/31/2014.; Authors wish to thank Andreas Henelius, Jussi Korpela, and Kristian Lukander for technical contributions, and Tekes (The Finnish Funding Agency for Innovation, Revolution of Knowledge Work project) for funding.	Ackerman MS, 2000, HUM-COMPUT INTERACT, V15, P179, DOI 10.1207/S15327051HCI1523_5; Akgun AE, 2015, INFORM MANAGE-AMSTER, V52, P247, DOI 10.1016/j.im.2014.11.004; [Anonymous], 2016, GITHUB; Balocchi R, 2006, BIOMED TECH, V51, P190, DOI 10.1515/BMT.2006.034; Bani-Salameh H, 2014, INT J COMPUT APPL T, V49, P89, DOI 10.1504/IJCAT.2014.060520; Bartel CA, 2000, ADMIN SCI QUART, V45, P197, DOI 10.2307/2667070; Begel A, 2008, ESEM'08: PROCEEDINGS OF THE 2008 ACM-IEEE INTERNATIONAL SYMPOSIUM ON EMPIRICAL SOFTWARE ENGINEERING AND MEASUREMENT, P120; Call J., 1994, Human Evolution, V9, P297, DOI 10.1007/BF02435516; Camm AJ, 1996, EUR HEART J, V17, P354; Chanel G, 2012, INTERACT COMPUT, V24, P306, DOI 10.1016/j.intcom.2012.04.012; Chaparro Edgar Acosta, 2005, P 17 WORKSH PSYCH PR, P5; Chenes C., 2013, SOCIAL MEDIA RETRIEV, P217; Choi KS, 2008, INFORM SOFTWARE TECH, V50, P1114, DOI 10.1016/j.infsof.2007.11.002; Elkins AN, 2009, APPL ERGON, V40, P997, DOI 10.1016/j.apergo.2009.02.002; Goldberger JJ, 1999, AM J PHYSIOL-HEART C, V276, pH1273, DOI 10.1152/ajpheart.1999.276.4.H1273; Good P, 2004, PERMUTATION TESTS PR; GOTTMAN JM, 1979, PSYCHOL BULL, V86, P338, DOI 10.1037/0033-2909.86.2.338; HART S G, 1988, P139; Henelius A, 2009, IEEE ENG MED BIO, P1836; Henning RA, 2009, APPL ERGON, V40, P1004, DOI 10.1016/j.apergo.2009.04.009; Henning RA, 2001, INT J PSYCHOPHYSIOL, V40, P221, DOI 10.1016/S0167-8760(00)00190-2; Hjortskov N, 2004, EUR J APPL PHYSIOL, V92, P84, DOI 10.1007/s00421-004-1055-z; Judd CM, 2000, HANDBOOK OF RESEARCH; Jung M., 2012, P SIGCHI C HUM FACT, P829, DOI [10.1145/2207676.2208523, DOI 10.1145/2207676.2208523]; Katira N., 2004, SIGCSE Bulletin, V36, P7, DOI 10.1145/1028174.971307; Kristiansen J, 2009, INT ARCH OCC ENV HEA, V82, P631, DOI 10.1007/s00420-008-0367-4; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; LEVENSON RW, 1983, J PERS SOC PSYCHOL, V45, P587, DOI 10.1037/0022-3514.45.3.587; Lovallo WR, 2005, INT J PSYCHOPHYSIOL, V58, P119, DOI 10.1016/j.ijpsycho.2004.11.007; Massen C, 2009, PHILOS T R SOC B, V364, P2349, DOI 10.1098/rstb.2009.0059; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Nagappan N., 2003, SIGCSE Bulletin, V35, P359, DOI 10.1145/792548.612006; R Core Team, 2016, R LANG ENV STAT COMP; Skibniewski FW, 2015, AEROSP MED HUM PERF, V86, P518, DOI 10.3357/AMHP.4087.2015; Smith AL, 2013, J CLIN MONIT COMPUT, V27, P569, DOI 10.1007/s10877-013-9471-4; Smith T.J., 1987, HDB HUMAN FACTORS, P251; Smith TJ, 1994, DESIGN WORK DEV PERS, P273; Spape MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078795; Suthers DD, 2005, CSCL 2005: COMPUTER SUPPORTED COLLABORATIVE LEARNING 2005: THE NEXT 10 YEARS, PROCEEDINGS, P662; Ter Horst GJ, 1999, EUR J MORPHOL, V37, P257, DOI 10.1076/ejom.37.4.257.4722; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Van Leeuwen P, 2009, P NATL ACAD SCI USA, V106, P13661, DOI 10.1073/pnas.0901049106; vanSchaik CP, 1996, NATURWISSENSCHAFTEN, V83, P186, DOI 10.1007/s001140050271; Vihavainen Arto, 2013, P 18 ACM C INNOVATIO, P117, DOI DOI 10.1145/2462476.2462501; Wang HM, 2012, MOD SIMUL ENG, V2012, DOI 10.1155/2012/931943; Williams L, 2000, IEEE SOFTWARE, V17, P19, DOI 10.1109/52.854064; Williams L., 2002, PAIR PROGRAMMING ILL; Zhang HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133148	48	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159178	10.1371/journal.pone.0159178	http://dx.doi.org/10.1371/journal.pone.0159178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27416036	Green Submitted, Green Published, gold			2022-12-27	WOS:000379579500095
J	Endendijk, JJ; Groeneveld, MG; Bakermans-Kranenburg, MJ; Mesman, J				Endendijk, Joyce J.; Groeneveld, Marleen G.; Bakermans-Kranenburg, Marian J.; Mesman, Judi			Gender-Differentiated Parenting Revisited: Meta-Analysis Reveals Very Few Differences in Parental Control of Boys and Girls	PLOS ONE			English	Article							MOTHER-CHILD INTERACTION; SEX-DIFFERENCES; MATERNAL CONTROL; PSYCHOLOGICAL CONTROL; CORPORAL PUNISHMENT; BEHAVIOR PROBLEMS; PUBLICATION BIAS; SELF-REGULATION; TRANSACTIONAL-ANALYSIS; CONFIDENCE-INTERVALS	Although various theories describe mechanisms leading to differential parenting of boys and girls, there is no consensus about the extent to which parents do treat their sons and daughters differently. The last meta-analyses on the subject were conducted more than fifteen years ago, and changes in gender-specific child rearing in the past decade are quite plausible. In the current set of meta-analyses, based on 126 observational studies (15,034 families), we examined mothers' and fathers' differential use of autonomy-supportive and controlling strategies with boys and girls, and the role of moderators related to the decade in which the study was conducted, the observational context, and sample characteristics. Databases of Web of Science, ERIC, PsychInfo, Online Contents, Picarta, and Proquest were searched for studies examining differences in observed parental control of boys and girls between the ages of 0 and 18 years. Few differences were found in parents' use of control with boys and girls. Parents were slightly more controlling with boys than with girls, but the effect size was negligible (d = 0.08). The effect was larger, but still small, in normative groups and in samples with younger children. No overall effect for gender-differentiated autonomy-supportive strategies was found (d = 0.03). A significant effect of time emerged: studies published in the 1970s and 1980s reported more autonomy-supportive strategies with boys than toward girls, but from 1990 onwards parents showed somewhat more autonomy-supportive strategies with girls than toward boys. Taking into account parents' gender stereotypes might uncover subgroups of families where gender-differentiated control is salient, but based on our systematic review of the currently available large data base we conclude that in general the differences between parenting of boys versus girls are minimal.	[Endendijk, Joyce J.; Groeneveld, Marleen G.; Bakermans-Kranenburg, Marian J.; Mesman, Judi] Leiden Univ, Ctr Child & Family Studies, Leiden, Netherlands; [Endendijk, Joyce J.] Univ Utrecht, Child & Adolescent Studies, Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Utrecht University	Mesman, J (corresponding author), Leiden Univ, Ctr Child & Family Studies, Leiden, Netherlands.	mesmanj@fsw.leidenuniv.nl	Endendijk, Joyce/AAB-2184-2021; Bakermans-Kranenburg, Marian/AAF-7746-2020	Bakermans-Kranenburg, Marian/0000-0001-7763-0711	European Research Council [240885]; Netherlands Organization for Scientific Research [453-09-003]	European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by a European Research Council (https://erc.europa.eu/) Starting Grant awarded to JM (project # 240885). MJBK was supported by the Netherlands Organization for Scientific Research (http://www.nwo.nl/en; VICI Grant 453-09-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahl RE, 2013, INFANT BEHAV DEV, V36, P199, DOI 10.1016/j.infbeh.2013.01.005; Ainsworth M., 1978, PATTERNS ATTACHMENT; Alink LRA, 2006, CHILD DEV, V77, P954, DOI 10.1111/j.1467-8624.2006.00912.x; Andersson G, 2006, DEMOGRAPHY, V43, P255, DOI 10.1353/dem.2006.0010; [Anonymous], 2013, GLOBAL GENDER GAP RE; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Arnold F., 1984, J COMP FAM STUD, V15, P299, DOI DOI 10.3138/JCFS.15.2.299; Baillargeon RH, 2007, DEV PSYCHOL, V43, P13, DOI 10.1037/0012-1649.43.1.13; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Barber BK, 1996, CHILD DEV, V67, P3296, DOI 10.2307/1131780; BARBER BK, 1994, CHILD DEV, V65, P1120, DOI 10.2307/1131309; Barber BK., 2002, INTRUSIVE PARENTING, P262, DOI [10.1037/10422-000, DOI 10.1037/10422-009]; BARKLEY RA, 1989, J CHILD PSYCHOL PSYC, V30, P379, DOI 10.1111/j.1469-7610.1989.tb00253.x; Barnett D, 1998, CHILD DEV, V69, P1657, DOI 10.1111/j.1467-8624.1998.tb06183.x; Basow S.A., 1999, APPEARANCE NEW LOOK, P25, DOI [DOI 10.1037/10325-001, 10.1037/10325-001]; BAUMRIND D, 1971, DEV PSYCHOL, V4, P1, DOI 10.1037/h0030372; BEFERA MS, 1985, J CHILD PSYCHOL PSYC, V26, P439, DOI 10.1111/j.1469-7610.1985.tb01945.x; Belden AC, 2007, ATTACH HUM DEV, V9, P239, DOI 10.1080/14616730701455395; BELLINGER DC, 1982, SEX ROLES, V8, P1123, DOI 10.1007/BF00290968; BEM SL, 1981, PSYCHOL REV, V88, P354, DOI 10.1037/0033-295X.88.4.354; BEM SL, 1983, SIGNS, V8, P598, DOI 10.1086/493998; Bender HL, 2007, DEV PSYCHOPATHOL, V19, P227, DOI 10.1017/S0954579407070125; Bernstein VJ, 2005, J APPL DEV PSYCHOL, V26, P241, DOI 10.1016/j.appdev.2005.02.002; BEZIRGANIAN S, 1992, J AM ACAD CHILD PSY, V31, P790, DOI 10.1097/00004583-199209000-00004; BLACKWELDER DE, 1986, J PERS SOC PSYCHOL, V50, P80; Block JH, 1979, PSYCHOL WOMEN FUTURE, P29; Boeldt DL, 2012, INFANT CHILD DEV, V21, P85, DOI 10.1002/icd.764; Borenstein M., 2009, INTRO METAANALYSIS; BOWLBY J, 1969, ATTACHMENT LOSS, DOI DOI 10.1177/000306518403200125; BraungartRieker U, 1997, J APPL DEV PSYCHOL, V18, P411; BRIGHT MC, 1984, J GENET PSYCHOL, V144, P219, DOI 10.1080/00221325.1984.9923428; BRODY GH, 1985, BEHAV RES THER, V23, P291, DOI 10.1016/0005-7967(85)90007-5; BRODY GH, 1992, CHILD DEV, V63, P82, DOI 10.2307/1130903; BRODY GH, 1986, DEV PSYCHOL, V22, P291, DOI 10.1037/0012-1649.22.3.291; BRONSTEIN P, 1984, DEV PSYCHOL, V20, P995, DOI 10.1037/0012-1649.20.6.995; Bronstein P, 2007, SEX ROLES, V56, P661, DOI 10.1007/s11199-007-9182-8; Buckholtz JW, 2008, MOL PSYCHIATR, V13, P313, DOI 10.1038/sj.mp.4002020; Bumpus MF, 2001, DEV PSYCHOL, V37, P163, DOI 10.1037/0012-1649.37.2.163; Cabrera NJ, 2000, CHILD DEV, V71, P127, DOI 10.1111/1467-8624.00126; CALDERA YM, 1989, CHILD DEV, V60, P70, DOI 10.2307/1131072; Calkins SD, 1998, SOC DEV, V7, P350, DOI 10.1111/1467-9507.00072; Campbell JJ., 1999, THESIS; CAMPBELL SB, 1986, J ABNORM CHILD PSYCH, V14, P425, DOI 10.1007/BF00915436; Celano M, 2008, FAM PROCESS, V47, P7, DOI 10.1111/j.1545-5300.2008.00236.x; Chaplin TM, 2005, EMOTION, V5, P80, DOI 10.1037/1528-3542.5.1.80; Chen XY, 2001, PARENT-SCI PRACT, V1, P159, DOI 10.1207/S15327922PAR0103_01; Chen XY, 2000, INT J BEHAV DEV, V24, P119, DOI 10.1080/016502500383557; CHERRY L, 1976, DEV PSYCHOL, V12, P278, DOI 10.1037/0012-1649.12.4.278; Christopoulou C, 1988, THESIS; Ciarrocchi JW., 1983, THESIS; Cipriano EA, 2010, J APPL DEV PSYCHOL, V31, P221, DOI 10.1016/j.appdev.2010.02.004; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; COPELAND AP, 1984, J DIVORCE, V8, P17; Coulson SL., 2001, THESIS; CROCKENBERG S, 1990, DEV PSYCHOL, V26, P961, DOI 10.1037/0012-1649.26.6.961; CULP RE, 1983, SEX ROLES, V9, P475, DOI 10.1007/BF00289787; Cyr M, 2014, CHILD PSYCHIAT HUM D, V45, P555, DOI 10.1007/s10578-013-0424-4; Das Eiden R, 2001, ALCOHOL CLIN EXP RES, V25, P1621, DOI 10.1097/00000374-200111000-00010; Deater-Deckard K, 2000, CHILD DEV, V71, P468, DOI 10.1111/1467-8624.00158; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; DECI EL, 1994, J PERS, V62, P119, DOI 10.1111/j.1467-6494.1994.tb00797.x; DEKOVIC M, 1992, J MARRIAGE FAM, V54, P675, DOI 10.2307/353253; Dennis T, 2006, DEV PSYCHOL, V42, P84, DOI 10.1037/0012-1649.42.1.84; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; Dodson TA, 2006, CAREER DEV Q, V54, P283, DOI 10.1002/j.2161-0045.2006.tb00194.x; Donovan WL, 2000, DEV PSYCHOL, V36, P402, DOI 10.1037/0012-1649.36.3.402; DUMAS JE, 1995, J ABNORM PSYCHOL, V104, P104, DOI 10.1037/0021-843X.104.1.104; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Eddy JM, 2001, AGGRESSIVE BEHAV, V27, P14, DOI 10.1002/1098-2337(20010101/31)27:1<14::AID-AB2>3.0.CO;2-2; Eley TC, 2010, J CHILD PSYCHOL PSYC, V51, P772, DOI 10.1111/j.1469-7610.2010.02227.x; Else-Quest NM, 2006, PSYCHOL BULL, V132, P33, DOI 10.1037/0033-2909.132.1.33; EMBER CR, 1994, J CONFLICT RESOLUT, V38, P620, DOI 10.1177/0022002794038004002; Emmons Y. D., 2001, THESIS; Endendijk JJ, 2016, CHILD DEV; Endendijk JJ, 2014, PARENT-SCI PRACT, V14, P141, DOI 10.1080/15295192.2014.972753; Ex CTGM, 1998, SEX ROLES, V38, P171; FAGOT BI, 1993, CHILD DEV, V64, P258, DOI 10.2307/1131450; Fagot BI, 1996, J SOC PERS RELAT, V13, P295, DOI 10.1177/0265407596132008; FAGOT BI, 1985, SEX ROLES, V12, P471, DOI 10.1007/BF00288169; FAGOT BI, 1985, SEX ROLES, V12, P341, DOI 10.1007/BF00287600; FALENDER CA, 1975, DEV PSYCHOL, V11, P830, DOI 10.1037/0012-1649.11.6.830; Feldman R, 2003, DEV PSYCHOL, V39, P680, DOI 10.1037/0012-1649.39.4.680; FELDMAN SS, 1986, MERRILL PALMER QUART, V32, P365; Fisher P. A., 1993, J FAMILY PSYCHOL, V7, P250, DOI DOI 10.1037/0893-3200.7.2.250; Flynn CP, 1999, J MARRIAGE FAM, V61, P971, DOI 10.2307/354017; Frampton K. L., 2012, THESIS; FRANKEL MT, 1983, DEV PSYCHOL, V19, P694; Frodi A., 1985, INFANT MENT HEALTH J, V6, P60, DOI DOI 10.1002/1097-0355(198522)6:2<60::AID-; Fuligni AJ, 1998, DEV PSYCHOL, V34, P782, DOI 10.1037/0012-1649.34.4.782; Gaertner BM, 2008, INFANT CHILD DEV, V17, P339, DOI 10.1002/ICD.580; Gardner F, 2000, Clin Child Fam Psychol Rev, V3, P185, DOI 10.1023/A:1009503409699; Gershoff ET, 2002, PSYCHOL BULL, V128, P539, DOI 10.1037//0033-2909.128.4.539; Gjerde PF, J RES ADOLESC, V1, P63; GOLDSTEIN H, 1995, J ROY STAT SOC A STA, V158, P175, DOI 10.2307/2983411; GOLINKOFF RM, 1979, CHILD DEV, V50, P28, DOI 10.2307/1129037; GORDON BN, 1983, CHILD PSYCHIAT HUM D, V13, P153, DOI 10.1007/BF00705856; Grolnick WS, 2013, PSYCHOL PARENTAL CON; Gross D, 2009, PREV SCI, V10, P54, DOI 10.1007/s11121-008-0116-7; Gunnoe ML, 1999, J EARLY ADOLESCENCE, V19, P199, DOI 10.1177/0272431699019002004; Gustafsson HC, 2012, J FAM PSYCHOL, V26, P115, DOI 10.1037/a0026283; Hank K., 2000, DEMOGR RES, V2, DOI [https://doi.org/10.4054/DemRes.2000.2.1, DOI 10.4054/DEMRES.2000.2.1]; Harris RJ, 1998, SEX ROLES, V38, P239, DOI 10.1023/A:1018785100469; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Henderson S. A., 2007, THESIS; HESS RD, 1984, CHILD DEV, V55, P2017, DOI 10.1111/j.1467-8624.1984.tb03899.x; Higgins KN, 2008, THESIS; Holt EC., 2007, THESIS; Huang CY, 2014, J CROSS CULT PSYCHOL, V45, P507, DOI 10.1177/0022022113513652; Huerta Maria., 2013, OECD SOCIAL EMPLOYME, V140, DOI [10.1787/5k4dlw9w6czq-en, DOI 10.1787/5K4DLW9W6CZQ-EN]; Hughes C, 1999, SOC DEV, V8, P143, DOI 10.1111/1467-9507.00088; HYDE JS, 1984, DEV PSYCHOL, V20, P722, DOI 10.1037/0012-1649.20.4.722; Infa Lloyd CA., 2010, THESIS; Inglehart R., 2003, RISING TIDE GENDER E; Inoff-Germain G., 1988, J EARLY ADOLESCENCE, V8, P17, DOI [10.1177/0272431688081002, DOI 10.1177/0272431688081002]; Jaffee SR, 2004, DEV PSYCHOL, V40, P1047, DOI 10.1037/0012-1649.40.6.1047; Janssens JMAM, 1997, INT J BEHAV DEV, V20, P509, DOI 10.1080/016502597385252; Joosen KJ, 2012, ATTACH HUM DEV, V14, P101, DOI 10.1080/14616734.2012.661217; Julious SA, 2004, PHARM STAT, V3, P217, DOI 10.1002/pst.126; JURICH AP, 1976, PSYCHOL REP, V38, P883, DOI 10.2466/pr0.1976.38.3.883; KAGAN J, 1963, CHILD DEV, V34, P899, DOI 10.1111/j.1467-8624.1963.tb05162.x; Kalpidou MD, 1998, J GENET PSYCHOL, V159, P103, DOI 10.1080/00221329809596138; Kapungu CT, 2006, J YOUTH ADOLESCENCE, V35, P787, DOI 10.1007/s10964-006-9102-1; Karreman A, 2006, INFANT CHILD DEV, V15, P561, DOI 10.1002/icd.478; Kauffman CM, 1985, THESIS; Kawabata Y, 2011, DEV REV, V31, P240, DOI 10.1016/j.dr.2011.08.001; Keenan K, 1997, PSYCHOL BULL, V121, P95, DOI 10.1037/0033-2909.121.1.95; Kenney-Benson GA, 2005, J PERS, V73, P23, DOI 10.1111/j.1467-6494.2004.00303.x; KERIG PK, 1993, DEV PSYCHOL, V29, P931, DOI 10.1037/0012-1649.29.6.931; Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851; Kochanska G, 2001, CHILD DEV, V72, P1091, DOI 10.1111/1467-8624.00336; KOCHANSKA G, 1995, CHILD DEV, V66, P597, DOI 10.2307/1131937; Kochanska G, 2003, DEV PSYCHOL, V39, P949, DOI 10.1037/0012-1649.39.6.949; Kochanska G, 2009, CHILD DEV, V80, P1288, DOI 10.1111/j.1467-8624.2009.01332.x; Kok R, 2013, DEV PSYCHOBIOL, V55, P451, DOI 10.1002/dev.21049; KUCZYNSKI L, 1984, DEV PSYCHOL, V20, P1061, DOI 10.1037/0012-1649.20.6.1061; Kuczynski L., 1994, PARENTING CHILDRENS, P78; LAFRENIERE PJ, 1992, DEV PSYCHOPATHOL, V4, P385, DOI 10.1017/S0954579400000857; Lamb M.E., 2010, ROLE FATHER CHILD DE; LAOSA LM, 1978, CHILD DEV, V49, P1129, DOI 10.1111/j.1467-8624.1978.tb04081.x; Larsson H, 2008, J ABNORM CHILD PSYCH, V36, P633, DOI 10.1007/s10802-007-9151-2; Leaper C, 1998, DEV PSYCHOL, V34, P3, DOI 10.1037/0012-1649.34.1.3; Lee IC, 2011, PSYCHOL BULL, V137, P1029, DOI 10.1037/a0025410; Lengua LJ, 2007, J APPL DEV PSYCHOL, V28, P40, DOI 10.1016/j.appdev.2006.10.001; Lengua LJ, 2014, SOC DEV, V23, P631, DOI 10.1111/sode.12071; Li JJ, 2013, J CLIN CHILD ADOLESC, V42, P174, DOI 10.1080/15374416.2012.736355; Lindsey EW, 2005, INFANT BEHAV DEV, V28, P165, DOI 10.1016/j.infbeh.2005.02.004; Linver MR, 2002, DEV PSYCHOL, V38, P719, DOI 10.1037//0012-1649.38.5.719; Liu MW, 2010, SCAND J PSYCHOL, V51, P109, DOI 10.1111/j.1467-9450.2009.00795.x; LOEB RC, 1980, MERRILL PALMER QUART, V26, P205; Loeber R, 2013, BRAIN RES FDN S SERI, V1, P137, DOI [10.1007/978-1-4614-7557-6_6, DOI 10.1007/978-1-4614-7557-6_6]; Longeway KP., 1983, THESIS; Lundberg S, 2005, OXFORD REV ECON POL, V21, P340, DOI 10.1093/oxrep/gri020; LYTTON H, 1991, PSYCHOL BULL, V109, P267, DOI 10.1037/0033-2909.109.2.267; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, V2; MACCOBY EE, 1984, DEV PSYCHOL, V20, P459, DOI 10.1037/0012-1649.20.3.459; Mandara J, 2012, FAM RELAT, V61, P129, DOI 10.1111/j.1741-3729.2011.00688.x; MARGOLIN G, 1975, DEV PSYCHOL, V11, P537, DOI 10.1037/h0076682; MARTINEZ EA, 1988, FAM RELAT, V37, P275, DOI 10.2307/584562; McFadyenKetchum SA, 1996, CHILD DEV, V67, P2417, DOI 10.1111/j.1467-8624.1996.tb01865.x; McHale SM, 2003, SOC DEV, V12, P125, DOI 10.1111/1467-9507.00225; MCLAUGHLIN B, 1983, DEV PSYCHOL, V19, P667; MCLAUGHLIN B, 1980, CHILD DEV, V51, P580; Mills RSL, 1998, CAN J BEHAV SCI, V30, P132, DOI 10.1037/h0085803; MINTON C, 1971, CHILD DEV, V42, P1873, DOI 10.1111/j.1467-8624.1971.tb03777.x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Morrell J, 2003, J CHILD PSYCHOL PSYC, V44, P489, DOI 10.1111/1469-7610.t01-1-00139; Morsbach SK, 2006, CLIN CHILD FAM PSYCH, V9, P1, DOI 10.1007/s10567-006-0001-5; MULLIS RL, 1985, PERCEPT MOTOR SKILL, V60, P567, DOI 10.2466/pms.1985.60.2.567; Mulvaney MK, 2007, J FAM PSYCHOL, V21, P389, DOI 10.1037/0893-3200.21.3.389; Nelson D. A., 2002, INTRUSIVE PARENTING, P161, DOI DOI 10.1037/10422-006; Nelson DA, 2013, J APPL DEV PSYCHOL, V34, P1, DOI 10.1016/j.appdev.2012.07.003; Neppl TK, 2009, DEV PSYCHOL, V45, P1241, DOI 10.1037/a0014850; OBRIEN M, 1987, J CHILD LANG, V14, P269, DOI 10.1017/S0305000900012927; OLDERSHAW L, 1986, CHILD DEV, V57, P722; Huber MO, 2012, REV LAT AM PSICOL, V44, P75; Patterson J., 2017, DEEP LEARNING PRACTI; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Pettit GS, 2001, CHILD DEV, V72, P583, DOI 10.1111/1467-8624.00298; Pierce CA, 2008, ORGAN RES METHODS, V11, P188, DOI 10.1177/1094428106296641; POMERLEAU A, 1990, SEX ROLES, V22, P359, DOI 10.1007/BF00288339; POWER TG, 1985, CHILD DEV, V56, P1514; Roberts WL., 1983, FAMILY INTERATIONS C; ROBINSON EA, 1981, J CONSULT CLIN PSYCH, V49, P245, DOI 10.1037/0022-006X.49.2.245; Rodriguez MMD, 2009, FAM PROCESS, V48, P195, DOI 10.1111/j.1545-5300.2009.01277.x; ROTHBAUM F, 1994, PSYCHOL BULL, V116, P55, DOI 10.1037/0033-2909.116.1.55; Russell A, 1996, INT J BEHAV DEV, V19, P291, DOI 10.1080/016502596385794; Scaramella LV, 2008, SOC DEV, V17, P578, DOI 10.1111/j.1467-9507.2007.00439.x; SCHAEFER ES, 1965, CHILD DEV, V36, P413, DOI 10.1111/j.1467-8624.1965.tb05305.x; SERBIN LA, 1990, SEX ROLES, V23, P613, DOI 10.1007/BF00289251; Shaw DS, 1998, J ABNORM CHILD PSYCH, V26, P95, DOI 10.1023/A:1022665704584; Silverman IW, 1995, J APPL DEV PSYCHOL, V16, P569, DOI 10.1016/0193-3973(95)90005-5; Smith CL, 2004, DEV PSYCHOL, V40, P29, DOI 10.1037/0012-1649.40.1.29; Smith CL, 2010, PARENT-SCI PRACT, V10, P1, DOI 10.1080/15295190903014588; Smith JR, 1997, ARCH PEDIAT ADOL MED, V151, P777, DOI 10.1001/archpedi.1997.02170450027004; SMITH PK, 1977, CHILD DEV, V48, P1250, DOI 10.1111/j.1467-8624.1977.tb03929.x; Soenens B, 2007, DEV PSYCHOL, V43, P633, DOI 10.1037/0012-1649.43.3.633; Soenens B, 2010, DEV REV, V30, P74, DOI 10.1016/j.dr.2009.11.001; Stormshak EA, 2000, J CLIN CHILD PSYCHOL, V29, P17, DOI 10.1207/S15374424jccp2901_3; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; SWIM JK, 1995, J PERS SOC PSYCHOL, V68, P199, DOI 10.1037/0022-3514.68.2.199; Tabachnick B, 2001, USING MULTIVARIATE A; Tam VCW, 2004, MARRIAGE FAM REV, V35, P45, DOI [10.1300/J002v35n03_04, DOI 10.1300/J002V35N03_04]; Tamis-LeMonda CS, 2009, J APPL DEV PSYCHOL, V30, P321, DOI 10.1016/j.appdev.2008.12.018; The Fatherhood Institute, 2010, FATH REP 2010 11 FAI; Thomson RM, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-247; Trautmann-Villalba P, 2006, PRAX KINDERPSYCHOL K, V55, P169; Tulananda O, 2001, J FAM PSYCHOL, V15, P676, DOI 10.1037//0893-3200.15.4.676; U.S. Department of Labor Bureau of Labor Statistics, 2012, 1038 US DEP LAB BUR; van Ijzendoorn MH, 2005, PSYCHOL BULL, V131, P301, DOI 10.1037/0033-2909.131.2.301; Van Zeijl J, 2007, J FAM PSYCHOL, V21, P626, DOI 10.1037/0893-3200.21.4.626; Van Zeijl J, 2006, J CONSULT CLIN PSYCH, V74, P994, DOI 10.1037/0022-006X.74.6.994; Webster-Stratton C, 1999, J CHILD PSYCHOL PSYC, V40, P917, DOI 10.1017/S0021963099004199; Whipple EE, 1997, CHILD ABUSE NEGLECT, V21, P431, DOI 10.1016/S0145-2134(97)00004-5; Williamson N.E., 1976, SONS DAUGHTERS CROSS; Wilson EC., 1980, THESIS; Wood W, 2002, PSYCHOL BULL, V128, P699, DOI 10.1037//0033-2909.128.5.699; Wood W, 2012, ADV EXP SOC PSYCHOL, V46, P55, DOI 10.1016/B978-0-12-394281-4.00002-7; Yagmur S, 2014, ATTACH HUM DEV, V16, P371, DOI 10.1080/14616734.2014.912489; Yaman A, 2010, J CHILD FAM STUD, V19, P617, DOI 10.1007/s10826-009-9346-y; Zahn-Waxler C, 2008, ANNU REV CLIN PSYCHO, V4, P275, DOI 10.1146/annurev.clinpsy.3.022806.091358; Zevalkink J, 2001, INT J BEHAV DEV, V25, P167, DOI 10.1080/01650250042000113	222	127	128	6	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159193	10.1371/journal.pone.0159193	http://dx.doi.org/10.1371/journal.pone.0159193			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27416099	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500096
J	Kazama, T; Toriyama, K				Kazama, Tomohiko; Toriyama, Kinya			Whole Mitochondrial Genome Sequencing and Re-Examination of a Cytoplasmic Male Sterility-Associated Gene in Boro-Taichung-Type Cytoplasmic Male Sterile Rice	PLOS ONE			English	Article							REPEAT-CONTAINING GENE; RESTORES FERTILITY; ATP6 RNA; PROTEIN; EVOLUTION; UNCOVER	Nuclear genome substitutions between subspecies can lead to cytoplasmic male sterility (CMS) through incompatibility between nuclear and mitochondrial genomes. Boro-Taichung (BT)-type CMS rice was obtained by substituting the nuclear genome of Oryza sativa subsp. indica cultivar Chinsurah Boro II with that of Oryza sativa subsp. japonica cultivar Taichung 65. In BT-type CMS rice, the mitochondrial gene orf79 is associated with male sterility. A complete sequence of the Boro-type mitochondrial genome responsible for BT-type CMS has not been determined to date. Here, we used pyrosequencing to construct the Boro-type mitochondrial genome. The contiguous sequences were assembled into five circular DNA molecules, four of which could be connected into a single circle. The two resulting subgenomic circles were unable to form a reliable master circle, as recombination between them was scarcely detected. We also found an unequal abundance of DNA molecules for the two loci of atp6. These results indicate the presence of multi-partite DNA molecules in the Borotype mitochondrial genome. Expression patterns were investigated for Boro-type mitochondria- specific orfs, which were not found in the mitochondria from the standard japonica cultivar Nipponbare. Restorer of fertility 1 (RF1)-dependent RNA processing has been observed in orf79-containing RNA but was not detected in other Boro-type mitochondria-specific orfs, supporting the conclusion that orf79 is a unique CMS-associated gene in Boro-type mitochondria.	[Kazama, Tomohiko; Toriyama, Kinya] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi, Japan	Tohoku University	Toriyama, K (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi, Japan.	torikin@m.tohoku.ac.jp		Kazama, Tomohiko/0000-0003-3808-3991	Ministry of Education, Culture, Sports, Science and Technology, Japan [24117502]; Japan Society for the Promotion of Science [23380002, 26292002, 16H06182]; Ministry of Agriculture Forestry and Fishery, Japan (Technology Research Promotion Program for the Agriculture, Forestry, Fisheries and Food Industry) [26010A]; Council for Science, Technology and Innovation (Cross-ministerial Strategic Innovation Promotion Program (SIP) "Technologies for creating next-generation agricult; Grants-in-Aid for Scientific Research [26292002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture Forestry and Fishery, Japan (Technology Research Promotion Program for the Agriculture, Forestry, Fisheries and Food Industry); Council for Science, Technology and Innovation (Cross-ministerial Strategic Innovation Promotion Program (SIP) "Technologies for creating next-generation agricult; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/english/, grant number 24117502 to K.T.), Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html, grant numbers 23380002, 26292002 to K.T. and 16H06182 to T.K.), the Ministry of Agriculture Forestry and Fishery, Japan (http://www.maff.go.jp/e/index.html, Technology Research Promotion Program for the Agriculture, Forestry, Fisheries and Food Industry, grant number 26010A to K.T.), and Council for Science, Technology and Innovation (http://www8.cao.go.jp/cstp/english/, Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO; http://www.naro.affrc.go.jp/english/brain/) to K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI H, 1994, CURR GENET, V25, P52, DOI 10.1007/BF00712968; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Bentolila S, 2012, PLANT PHYSIOL, V158, P996, DOI 10.1104/pp.111.190231; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Fujii S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-209; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Huang JZ, 2014, RICE, V7, DOI 10.1186/s12284-014-0013-6; Igarashi K, 2013, PLANT CELL PHYSIOL, V54, P237, DOI 10.1093/pcp/pcs177; Itabashi E, 2009, PLANT CELL REP, V28, P233, DOI 10.1007/s00299-008-0625-7; IWABUCHI M, 1993, EMBO J, V12, P1437, DOI 10.1002/j.1460-2075.1993.tb05787.x; Kazama T, 2003, FEBS LETT, V544, P99, DOI 10.1016/S0014-5793(03)00480-0; Kazama T, 2008, PLANT J, V55, P619, DOI 10.1111/j.1365-313X.2008.03529.x; Kazama T, 2016, PLANT J, V85, P707, DOI 10.1111/tpj.13135; Koizuka N, 2003, PLANT J, V34, P407, DOI 10.1046/j.1365-313X.2003.01735.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Okazaki M, 2013, PLANT CELL PHYSIOL, V54, P1560, DOI 10.1093/pcp/pct102; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Tsushiya T, 2002, HYBRID RICE FOOD SEC, P53; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; Yi P, 2002, CHINESE SCI BULL, V47, P744, DOI 10.1360/02tb9168; Zeltz P, 1996, PLANT MOL BIOL, V31, P647, DOI 10.1007/BF00042236; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042041	29	12	13	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159379	10.1371/journal.pone.0159379	http://dx.doi.org/10.1371/journal.pone.0159379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414645	Green Published, Green Submitted, gold			2022-12-27	WOS:000379579500125
J	Li, Z; An, XK; Liu, YD; Hou, ML				Li, Zhen; An, Xing-Kui; Liu, Yu-Di; Hou, Mao-Lin			Transcriptomic and Expression Analysis of the Salivary Glands in White-Backed Planthoppers, Sogatella furcifera	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; PROTEIN-KINASE-II; ALKALINE-PHOSPHATASE; MOLECULAR CHARACTERIZATION; BROWN PLANTHOPPER; NILAPARVATA-LUGENS; TREHALASE ACTIVITY; GENE-EXPRESSION; RUSSIAN WHEAT; RICE	The white-backed planthopper (WBPH), Sogatella furcifera (Horvath), is one of the serious rice pests because of its destructive feeding. The salivary glands of the WBPH play an important role in the feeding behaviour. Currently, however, very little is known about the salivary glands at the molecular level. We sequenced the salivary gland transcriptome (sialotranscripome) of adult WBPHs using the Illumina sequencing. A total of 65,595 transcripts and 51,842 unigenes were obtained from salivary glands. According to annotations against the Nr database, many of the unigenes identified were associated with the most studied enzymes in hemipteran saliva. In the present study, we identified 32 salivary protein genes from the WBPH sialotranscripome, which were categorized as those involved in sugar metabolism, detoxification, suppression of plant defense responses, immunity-related responses, general digestion, and other phytophagy processes. Tissue expression profiles analysis revealed that four of 32 salivary protein genes (multicopper oxidase 4, multicopper oxidase 6, carboxylesterase and uridine phosphorylase 1 isform X2) were primarily expressed in the salivary gland, suggesting that they played putative role in insect-rice interactions. 13 of 32 salivary protein genes were primarily expressed in gut, which might play putative role in digestive and detoxify mechanism. Development expression profiles analysis revealed that the expression level of 26 of 32 salivary protein genes had no significant difference, suggesting that they may play roles in every developmental stages of salivary gland of WBPH. The other six genes have a high expression level in the salivary gland of adult. 31 of 32 genes (except putative acetylcholinesterase 1) have no significant difference in male and female adult, suggesting that their expression level have no difference between sexes. This report analysis of the sialotranscripome for the WBPH, and the transcriptome provides a foundational list of the genes involved in feeding. Our data will be useful to investigate the mechanisms of interaction between the WBPH and the host plant.	[Li, Zhen; An, Xing-Kui; Liu, Yu-Di; Hou, Mao-Lin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, 2 West Yuan Ming Yuan Rd, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Liu, YD (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, 2 West Yuan Ming Yuan Rd, Beijing 100193, Peoples R China.	ydliu@ippcaas.cn	An, Xingkui/AAJ-7484-2020		National Natural Science Foundation of China [31370439]; EuropeAid project [DCIFood/2010/230-238]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EuropeAid project	This work was supported by the National Natural Science Foundation of China (31370439) and a EuropeAid project (DCIFood/2010/230-238).	An XK, 2016, J ECON ENTOMOL, V109, P879, DOI 10.1093/jee/tov333; Bansal R, 2013, B ENTOMOL RES, V103, P286, DOI 10.1017/S0007485312000697; Bao YY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-507; Bao YY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-160; Blanc S, 2011, CURR OPIN MICROBIOL, V14, P483, DOI 10.1016/j.mib.2011.07.008; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Burkert P, 2006, EUR J NEUROSCI, V23, P335, DOI 10.1111/j.1460-9568.2005.04562.x; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; CHANG WS, 1993, DEVELOPMENT, V118, P651; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010133; CLEGG JS, 1961, SCIENCE, V134, P54, DOI 10.1126/science.134.3471.54; COHEN P, 1978, FEBS LETT, V92, P287, DOI 10.1016/0014-5793(78)80772-8; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; Dai LL, 2015, INSECT BIOCHEM MOLEC, V65, P35, DOI 10.1016/j.ibmb.2015.08.004; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; Fujita D, 2013, CRIT REV PLANT SCI, V32, P162, DOI 10.1080/07352689.2012.735986; Gasper Raphael, 2010, Small GTPases, V1, P133, DOI 10.4161/sgtp.1.3.14742; Ge LQ, 2011, PESTIC BIOCHEM PHYS, V100, P172, DOI 10.1016/j.pestbp.2011.03.007; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Inagaki S, 1998, COMP BIOCHEM PHYS C, V120, P225, DOI 10.1016/S0742-8413(98)00044-9; Isaac RE, 2007, PEPTIDES, V28, P153, DOI 10.1016/j.peptides.2006.08.029; Isaac RE, 1998, BIOCHEM J, V330, P61, DOI 10.1042/bj3300061; Ji R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079612; Jiang XJ, 2009, BIOCHEM BIOPH RES CO, V378, P269, DOI 10.1016/j.bbrc.2008.11.046; Kamikouchi A, 2000, J COMP NEUROL, V417, P501, DOI 10.1002/(SICI)1096-9861(20000221)417:4&lt;501::AID-CNE8&gt;3.0.CO;2-4; KUCERA M, 1974, ACTA ENTOMOL BOHEMOS, V71, P289; Kucharski R, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0007; Lamango NS, 1997, PEPTIDES, V18, P47, DOI 10.1016/S0196-9781(96)00232-X; Lemeire E, 2008, INSECT BIOCHEM MOLEC, V38, P166, DOI 10.1016/j.ibmb.2007.10.004; Li BL, 2012, PESTIC BIOCHEM PHYS, V102, P198, DOI 10.1016/j.pestbp.2012.01.004; Liu S, 2015, PEST MANAG SCI, V71, P32, DOI 10.1002/ps.3760; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071970; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr C, 2007, CELL TISSUE RES, V327, P189, DOI 10.1007/s00441-006-0249-6; Marshall SDG, 2003, J MOL EVOL, V57, P487, DOI 10.1007/s00239-003-2492-8; Matsukura K, 2013, PHYTOPATHOLOGY, V103, P509, DOI 10.1094/PHYTO-10-12-0261-R; Matsumoto Y, 2014, J INSECT PHYSIOL, V71, P170, DOI 10.1016/j.jinsphys.2014.10.010; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Miao YG, 2002, J APPL ENTOMOL, V126, P138, DOI 10.1046/j.1439-0418.2002.00625.x; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; MUTA T, 1993, J BIOL CHEM, V268, P21384; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; OHSAKO S, 1993, J BIOL CHEM, V268, P2052; Otuka A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00309; Paine M.J.I., 2005, CYTOCHROME P450 STRU, P115, DOI DOI 10.1007/0-387-27447-2_4; Peng ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111344; Petrova A, 2014, INSECT MOL BIOL, V23, P13, DOI 10.1111/imb.12058; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Piao S, 2005, BBA-PROTEINS PROTEOM, V1752, P103, DOI 10.1016/j.bbapap.2005.05.008; Quan GX, 2001, INSECT BIOCHEM MOLEC, V31, P97, DOI 10.1016/S0965-1748(00)00112-0; Ramzi S, 2010, J ASIA-PAC ENTOMOL, V13, P215, DOI 10.1016/j.aspen.2010.03.009; Sharma A, 2014, B ENTOMOL RES, V104, P117, DOI 10.1017/S0007485313000618; Silva MCP, 2009, INSECT MOL BIOL, V18, P769, DOI 10.1111/j.1365-2583.2009.00920.x; Siviter RJ, 2002, BIOCHEM J, V367, P187, DOI 10.1042/BJ20020567; Su YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039303; SUJAK P, 1978, J INVERTEBR PATHOL, V31, P4, DOI 10.1016/0022-2011(78)90101-5; Sukhanova MZ, 1996, J INSECT PHYSIOL, V42, P161, DOI 10.1016/0022-1910(95)00070-4; Sun ZX, 2015, MOL ECOL, V24, P771, DOI 10.1111/mec.13069; Taillebois E, 2013, ARCH INSECT BIOCHEM, V83, P138, DOI 10.1002/arch.21102; Tatun N, 2008, INSECT BIOCHEM MOLEC, V38, P788, DOI 10.1016/j.ibmb.2008.05.003; Tatun N, 2008, J INSECT PHYSIOL, V54, P351, DOI 10.1016/j.jinsphys.2007.10.006; TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2; Wang J, 2014, ARCH INSECT BIOCHEM, V85, P216, DOI 10.1002/arch.21155; Wang ZX, 2011, ARCH INSECT BIOCHEM, V78, P30, DOI 10.1002/arch.20437; Will T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00336; XU XM, 1994, J BIOL CHEM, V269, P23569; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye YX, 2015, INSECT BIOCHEM MOLEC, V63, P124, DOI 10.1016/j.ibmb.2015.06.010; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-553; Zhao W, 2016, INSECT BIOCHEM MOLEC, V70, P60, DOI 10.1016/j.ibmb.2015.11.009	74	15	17	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159393	10.1371/journal.pone.0159393	http://dx.doi.org/10.1371/journal.pone.0159393			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414796	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500126
J	Zimering, JH; Dong, YL; Fang, F; Huang, LN; Zhang, YY; Xie, ZC				Zimering, Jeffrey H.; Dong, Yuanlin; Fang, Fang; Huang, Lining; Zhang, Yiying; Xie, Zhongcong			Anesthetic Sevoflurane Causes Rho-Dependent Filopodial Shortening in Mouse Neurons	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; DENDRITIC SPINE; ELECTRICAL-ACTIVITY; NEONATAL EXPOSURE; F-ACTIN; DREBRIN; ACTIVATION; NEUROTOXICITY; DISAPPEARANCE; PLASTICITY	Early postnatal anesthesia causes long-lasting learning and memory impairment in rodents, however, evidence for a specific neurotoxic effect on early synaptogenesis has not been demonstrated. Drebrin A is an actin binding protein whose localization in dendritic protrusions serves an important role in dendritic spine morphogenesis, and is a marker for early synaptogenesis. We therefore set out to investigate whether clinically-relevant concentrations of anesthetic sevoflurane, widely-used in infants and children, alters dendritic morphology in cultured fetal day 16 mouse hippocampal neurons. After 7 days in vitro, mouse hippocampal neurons were exposed to four hours of 3% sevoflurane in 95% air/5% CO2 or control condition (95% air/5% CO2). Neurons were fixed in 4% paraformaldehyde and stained with Alexa Fluor555-Phalloidin, and/or rabbit anti-mouse drebrin A/E antibodies which permitted subcellular localization of filamentous (F)-actin and/or drebrin immunoreactivity, respectively. Sevoflurane caused acute significant length-shortening in filopodia and thin dendritic spines in days-in-vitro 7 neurons, an effect which was completely rescued by co-incubating neurons with ten micromolar concentrations of the selective Rho kinase inhibitor Y27632. Filopodia and thin spine recovered in length two days after sevoflurane exposure. Yet cluster-type filopodia (a precursor to synaptic filopodia) were persistently significantly decreased in number on day-in-vitro 9, in part owing to preferential localization of drebrin immunoreactivity to dendritic shafts versus filopodial stalks. These data suggest that sevoflurane induces F-actin depolymerization leading to acute, reversible length-shortening in dendritic protrusions through a mechanism involving (in part) activation of RhoA/Rho kinase signaling and impairs localization of drebrin A to filopodia required for early excitatory synapse formation.	[Zimering, Jeffrey H.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Zimering, Jeffrey H.; Dong, Yuanlin; Fang, Fang; Huang, Lining; Zhang, Yiying; Xie, Zhongcong] Massachusetts Gen Hosp, Geriatr Anesthesia Res Unit, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA 02129 USA; [Zimering, Jeffrey H.; Dong, Yuanlin; Fang, Fang; Huang, Lining; Zhang, Yiying; Xie, Zhongcong] Harvard Med Sch, Charlestown, MA 02129 USA; [Zimering, Jeffrey H.] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA USA; [Fang, Fang] Fudan Univ, Dept Anesthesiol, Zhongshan Hosp, Shanghai, Peoples R China; [Huang, Lining] Hebei Med Univ, Hosp 2, Dept Anesthesiol, Shijiazhuang, Hebei Province, Peoples R China	University of Rochester; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Fudan University; Hebei Medical University	Xie, ZC (corresponding author), Massachusetts Gen Hosp, Geriatr Anesthesia Res Unit, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA 02129 USA.; Xie, ZC (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	zxie@mgh.harvard.edu		Dong, Yuanlin/0000-0002-4760-0519	Howard Hughes Medical Institute Medical Research Fellowship, Chevy Chase, Maryland; Harvard Medical School, Boston, Massachusetts; National Institutes of Health, Bethesda, Maryland [R01 GM088801, R01 AG041274]; Alzheimer's Association, Chicago, Illinois; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD086977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041274] Funding Source: NIH RePORTER	Howard Hughes Medical Institute Medical Research Fellowship, Chevy Chase, Maryland; Harvard Medical School, Boston, Massachusetts; National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association, Chicago, Illinois(Alzheimer's Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by Howard Hughes Medical Institute Medical Research Fellowship, Chevy Chase, Maryland and Harvard Medical School, Boston, Massachusetts to JHZ. This research was supported by R01 GM088801 and R01 AG041274 from National Institutes of Health, Bethesda, Maryland, Investigator-initiated Research grant from Alzheimer's Association, Chicago, Illinois to ZX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castaneda P, 2015, J NEUROSCI RES, V93, P1476, DOI 10.1002/jnr.23602; Chen KE, 2013, NEURAL REGEN RES, V8, P3027, DOI 10.3969/j.issn.1673-5374.2013.32.006; Davidson AJ, 2015, LANCET; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Feinerman O, 2005, J NEUROPHYSIOL, V94, P3406, DOI 10.1152/jn.00264.2005; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Ivanov Anton, 2009, Commun Integr Biol, V2, P268; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Ji MH, 2015, J MOL NEUROSCI, V57, P358, DOI 10.1007/s12031-015-0627-1; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Lee BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105340; Lemkuil BP, 2011, ANESTHESIOLOGY, V114, P49, DOI 10.1097/ALN.0b013e318201dcb3; Lu Y, 2010, ANESTHESIOLOGY, V112, P1404, DOI 10.1097/ALN.0b013e3181d94de1; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; MARTIN DC, 1995, BIOCHEM PHARMACOL, V49, P809, DOI 10.1016/0006-2952(94)00519-R; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Merriam EB, 2013, J NEUROSCI, V33, P16471, DOI 10.1523/JNEUROSCI.0661-13.2013; Penzes P, 2012, CYTOSKELETON, V69, P426, DOI 10.1002/cm.21015; Platholi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102978; Pozueta J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2927; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Sekino Y, 2006, MOL CELL NEUROSCI, V31, P493, DOI 10.1016/j.mcn.2005.11.003; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Sudarov A, 2013, EMBO MOL MED, V5, P591, DOI 10.1002/emmm.201202106; Takahashi H, 2003, J NEUROSCI, V23, P6586; Takahashi H, 2009, J CELL SCI, V122, P1211, DOI 10.1242/jcs.043729; Tao GR, 2014, ANESTHESIOLOGY, V121, P510, DOI 10.1097/ALN.0000000000000278; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Wang SQ, 2013, EUR REV MED PHARMACO, V17, P941; Zhang MQ, 2015, BRIT J ANAESTH, V115, P752, DOI 10.1093/bja/aev339; Zhen Y, 2009, ANESTHESIOLOGY, V111, P741, DOI 10.1097/ALN.0b013e3181b27fd4; Zhou LS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11145	40	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0159637	10.1371/journal.pone.0159637	http://dx.doi.org/10.1371/journal.pone.0159637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27441369	Green Published, Green Submitted, gold			2022-12-27	WOS:000380797500109
J	Mahjourimajd, S; Taylor, J; Rengel, Z; Khabaz-Saberi, H; Kuchel, H; Okamoto, M; Langridge, P				Mahjourimajd, Saba; Taylor, Julian; Rengel, Zed; Khabaz-Saberi, Hossein; Kuchel, Haydn; Okamoto, Mamoru; Langridge, Peter			The Genetic Control of Grain Protein Content under Variable Nitrogen Supply in an Australian Wheat Mapping Population	PLOS ONE			English	Article							USE EFFICIENCY; NEGATIVE RELATIONSHIP; BREAD WHEAT; YIELD; DISSECTION; PHOSPHORUS; DEVIATION; VARIETY; TRAITS; WEIGHT	Genetic variation has been observed in both protein concentration in wheat grain and total protein content (protein yield). Here we describe the genetic analysis of variation for grain protein in response to nitrogen (N) supply and locate significant genomic regions controlling grain protein components in a spring wheat population. In total, six N use efficiency (NUE) field trials were carried out for the target traits in a sub-population of doubled haploid lines derived from a cross between two Australian varieties, RAC875 and Kukri, in Southern and Western Australia from 2011 to 2013. Twenty-four putative Quantitative Trait Loci (QTL) for protein-related traits were identified at high and low N supply and ten QTL were identified for the response to N for the traits studied. These loci accounted for a significant proportion of the overall effect of N supply. Several of the regions were co-localised with grain yield QTL and are promising targets for further investigation and selection in breeding programs.	[Mahjourimajd, Saba; Okamoto, Mamoru] Univ Adelaide, Australian Ctr Plant Funct Genom, PMB1, Glen Osmond, SA 5064, Australia; [Kuchel, Haydn] Australian Grain Technol, PMB1, Glen Osmond, SA 5064, Australia; [Taylor, Julian; Kuchel, Haydn; Langridge, Peter] Univ Adelaide, Sch Agr Food & Wine, Waite Res Inst, PMB 1, Glen Osmond, SA 5064, Australia; [Rengel, Zed; Khabaz-Saberi, Hossein] Univ Western Australia, Sch Earth & Environm, Soil Sci & Plant Nutr M087, 35 Stirling Highway, Crawley, WA 6009, Australia	University of Adelaide; University of Adelaide; University of Western Australia	Okamoto, M (corresponding author), Univ Adelaide, Australian Ctr Plant Funct Genom, PMB1, Glen Osmond, SA 5064, Australia.; Langridge, P (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Waite Res Inst, PMB 1, Glen Osmond, SA 5064, Australia.	mamoru.okamoto@acpfg.com.au; peter.langridge@adelaide.edu.au	Okamoto, Mamoru/AAF-4265-2019; Langridge, Peter/G-5864-2010; Taylor, Julian/AAO-6302-2020	Okamoto, Mamoru/0000-0002-2989-607X; Langridge, Peter/0000-0001-9494-400X; Taylor, Julian/0000-0002-9145-052X	Australian Grain Technologies; University of Adelaide	Australian Grain Technologies; University of Adelaide	One of the authors, HK, is employed by the wheat breeding company, Australian Grain Technologies (AGT) and several questions were asked about the potential role of this commercial relationship. HK also holds the status as an affiliate of the University of Adelaide and his role in the project was as one of the supervisors of SM during her PhD studies. The authors can confirm that "Australian Grain Technologies provided support in the form of salaries for authors [HK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bennett D, 2012, THEOR APPL GENET, V125, P255, DOI 10.1007/s00122-012-1831-9; Bogard M, 2011, J EXP BOT, V62, P3621, DOI 10.1093/jxb/err061; Bogard M, 2010, J EXP BOT, V61, P4303, DOI 10.1093/jxb/erq238; Butler D.G., 2009, TECHNICAL REPORT; Charmet G, 2005, THEOR APPL GENET, V111, P540, DOI 10.1007/s00122-005-2045-1; Cormier F, 2014, THEOR APPL GENET, V127, P2679, DOI 10.1007/s00122-014-2407-7; Cormier F, 2013, THEOR APPL GENET, V126, P3035, DOI 10.1007/s00122-013-2191-9; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; Fontaine JX, 2009, THEOR APPL GENET, V119, P645, DOI 10.1007/s00122-009-1076-4; Gelli M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-015-0696-x; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Habash DZ, 2007, THEOR APPL GENET, V114, P403, DOI 10.1007/s00122-006-0429-5; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Laperche A, 2007, THEOR APPL GENET, V115, P399, DOI 10.1007/s00122-007-0575-4; Liu ZY, 2016, FUNCT INTEGR GENOMIC, V16, P323, DOI 10.1007/s10142-016-0486-z; Mahjourimajd S, 2015, THESIS; Maurer A, 2016, J EXP BOT, V67, P2507, DOI 10.1093/jxb/erw070; McDonald G, 2015, CROP PASTURE SCI, V66, P430, DOI 10.1071/CP14191; Monaghan JM, 2001, EUPHYTICA, V122, P309, DOI 10.1023/A:1012961703208; Oury FX, 2007, EUPHYTICA, V157, P45, DOI 10.1007/s10681-007-9395-5; Payne R.W., 2009, STAT, V1, P255, DOI DOI 10.1002/WICS.32; Smith A, 2001, BIOMETRICS, V57, P1138, DOI 10.1111/j.0006-341X.2001.01138.x; Smith AB, 2005, J AGR SCI-CAMBRIDGE, V143, P449, DOI 10.1017/S0021859605005587; SOSULSKI FW, 1990, J AGR FOOD CHEM, V38, P1351, DOI 10.1021/jf00096a011; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S., 2007, WINDOWS QTL CARTOGRA; Xu YF, 2014, THEOR APPL GENET, V127, P59, DOI 10.1007/s00122-013-2201-y	27	14	14	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159371	10.1371/journal.pone.0159371	http://dx.doi.org/10.1371/journal.pone.0159371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438012	gold, Green Submitted, Green Published			2022-12-27	WOS:000380170100038
J	Connelly, SJ; Stoeckel, JA; Gitzen, RA; Williamson, CE; Gonzalez, MJ				Connelly, Sandra J.; Stoeckel, James A.; Gitzen, Robert A.; Williamson, Craig E.; Gonzalez, Maria J.			Effect of Clonal Selection on Daphnia Tolerance to Dark Experimental Conditions	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; ULTRAVIOLET-RADIATION; UV-RADIATION; LIFE-HISTORY; WATER; ZOOPLANKTON; COMPETITION; PREDATION; WINBUGS	Recent studies have demonstrated substantial effects of environmental stress that vary among clones. Exposure to ultraviolet radiation (UV) is an important abiotic stressor that is highly variable in aquatic ecosystems due to diel and seasonal variations in incident sunlight as well as to differences in the UV transparency of water among water bodies, the depth distribution of organisms, and the ability of organisms to detect and respond to UV. In contrast to the convention that all UV is damaging, evidence is accumulating for the beneficial effects of exposure to low levels of UV radiation. Whereas UV has been frequently observed as the primary light-related stressor, herein we present evidence that dark conditions may be similarly "stressful" (reduction of overall fitness), and stress responses vary among clones of the freshwater crustacean Daphnia parvula. We have identified a significant relationship between survivorship and reduced fecundity of clones maintained in dark conditions, but no correlation between tolerance of the clones to dark and UV radiation. Low tolerance to dark conditions can have negative effects not only on accumulated stresses in organisms (e.g. the repair of UV-induced damage in organisms with photolyase), but potentially on the overall physiology and fitness of organisms. Our results support recent evidence of the beneficial effects of low-level UV exposure for some organisms.	[Connelly, Sandra J.] Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA; [Stoeckel, James A.] Auburn Univ, Coll Agr, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA; [Stoeckel, James A.; Williamson, Craig E.; Gonzalez, Maria J.] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Gitzen, Robert A.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA	Rochester Institute of Technology; Auburn University System; Auburn University; University System of Ohio; Miami University; Auburn University System; Auburn University	Connelly, SJ (corresponding author), Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA.	Sandra.Connelly@rit.edu		Gitzen, Robert/0000-0001-8507-8197				Agra AR, 2011, ECOTOXICOLOGY, V20, P552, DOI 10.1007/s10646-011-0621-5; Auld SKJR, 2014, AM NAT, V184, pS77, DOI 10.1086/676927; Barata C, 2002, ENVIRON TOXICOL CHEM, V21, P1058, DOI [10.1897/1551-5028(2002)021<1058:AAWPVI>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1058:AAWPVI&gt;2.0.CO;2]; Boeing WJ, 2006, ARCH HYDROBIOL, V166, P241, DOI 10.1127/0003-9136/2006/0166-0241; Connelly SJ, 2009, PHOTOCHEM PHOTOBIOL, V85, P144, DOI 10.1111/j.1751-1097.2008.00408.x; Cooke SL, 2006, J PLANKTON RES, V28, P171, DOI 10.1093/plankt/fbi108; Dominoni DM, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0015; Effertz C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3250; Fischer JM, 2006, HYDROBIOLOGIA, V563, P217, DOI 10.1007/s10750-005-0007-x; Fischer JM, 2006, PHOTOCHEM PHOTOBIOL, V82, P547, DOI 10.1562/2005-08-30-RA-664; Gadgil A, 1998, ANNU REV ENERG ENV, V23, P253, DOI 10.1146/annurev.energy.23.1.253; Gerrish GA, 2003, FRESHWATER BIOL, V48, P1971, DOI 10.1046/j.1365-2427.2003.01136.x; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hader DP, 2015, PHOTOCH PHOTOBIO SCI, V14, P108, DOI 10.1039/c4pp90035a; Jansen M, 2013, ECOTOXICOLOGY, V22, P900, DOI 10.1007/s10646-013-1072-y; KARENTZ S, 1991, NATURE, V350, P28, DOI 10.1038/350028b0; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MACISAAC HJ, 1991, FRESHWATER BIOL, V25, P189, DOI 10.1111/j.1365-2427.1991.tb00484.x; Maguire SE, 2014, J BIOL RHYTHM, V29, P167, DOI 10.1177/0748730414537801; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; Meyer-Rochow V B, 2000, Int J Circumpolar Health, V59, P38; Miner BE, 2015, MOL ECOL, V24, P6177, DOI 10.1111/mec.13460; Mitchell David L., 1993, P345; Overholt EP, 2016, J PLANKTON RES, V38, P16, DOI 10.1093/plankt/fbv113; Overholt EP, 2012, ECOL LETT, V15, P47, DOI 10.1111/j.1461-0248.2011.01707.x; Paull SH, 2014, ECOL LETT, V17, P445, DOI 10.1111/ele.12244; Riessen HP, 1999, CAN J FISH AQUAT SCI, V56, P2487, DOI 10.1139/cjfas-56-12-2487; SPITZE K, 1992, AM NAT, V139, P229, DOI 10.1086/285325; Stoeckel JA, 2008, ENVIRON TOXICOL CHEM, V27, P2352, DOI 10.1897/07-564.1; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; United States Environmental Protection Agency Office of Research and Development, 1990, METH MEAS AC TOX EFF; Williamson CE, 2001, ECOL APPL, V11, P1843, DOI 10.1890/1051-0761(2001)011[1843:BADEOU]2.0.CO;2; Williamson CE, 2014, NAT CLIM CHANGE, V4, P434, DOI [10.1038/nclimate2225, 10.1038/NCLIMATE2225]; Williamson CE, 2011, LIMNOL OCEANOGR, V56, P1603, DOI 10.4319/lo.2011.56.5.1603	35	3	3	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159628	10.1371/journal.pone.0159628	http://dx.doi.org/10.1371/journal.pone.0159628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434210	gold, Green Published, Green Submitted			2022-12-27	WOS:000380169600077
J	Gao, F; Liu, XX; Wang, XZ; Chen, SH; Shi, JH; Zhang, Y; Wu, SL; Cai, J				Gao, Fei; Liu, Xiaoxue; Wang, Xizhu; Chen, Shouhua; Shi, Jihong; Zhang, Ying; Wu, Shouling; Cai, Jun			Changes in Cardiovascular Health Status and the Risk of New-Onset Hypertension in Kailuan Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; URIC-ACID LEVELS; ASSOCIATION; PREVALENCE; INFLAMMATION; POPULATION; MORTALITY; METRICS; IMPACT	American Heart Association cardiovascular health metrics are intimately related to cardiovascular diseases. Acting as a key independent risk factor for high morbidity and mortality of cardiovascular diseases, hypertension and its relationship between health status get urgent attention. While the influence of individual health status changes and the future risk of new-onset hypertension is rarely understood, the present study applied this construct to assess the changes of cardiovascular health status and the morbidity of hypertension in Kailuan cohort study in north China. The Cardiovascular Health Score (CHS) was evaluated by the follow-ups of 2006-2007, 2008-2009, 2010-2011 and 2012-2013. The study population (n = 19381) was divided into 5 groups based on the changes in their CHS score between the first two follow-ups (Delta CHS) of 2006-2007 and 2008-2009 (<=-2, -1, 0, 1, >= 2). The morbidity of hypertension was collected during 2010-2011 and 2012-2013 follow-ups. Data analysis showed that during a median follow-up of 3.79 +/- 0.96 years, morbidity of hypertension had a graded relationship with Delta CHS. As Delta CHS scored from low to high, the standardized morbidity of hypertension for all participants were 81.40, 75.47, 68.37, 71.43 and 83.13 per 1000 person-year, respectively. An increased Delta CHS score of 1 was associated with a 10% decrease in the future risk of new-onset hypertension(HR: 0.90, 95% CI: 0.88-0.92). In conclusion, there was a strong inverse relationship between the incidence of new-onset hypertension and elevation of cardiovascular health metrics. Population-wide prevention, especially the promotion of lifestyle improvements, is critical to reducing the morbidity of new-onset hypertension.	[Gao, Fei] Univ Hong Kong, LKS Fac Med, Dept Opthalmol, Hong Kong, Hong Kong, Peoples R China; [Liu, Xiaoxue; Wang, Xizhu] North China Univ Sci & Technol, Tangshan Peoples Hosp, Dept Cardiol, Tangshan, Peoples R China; [Chen, Shouhua] North China Univ Sci & Technol, Kailuan Hosp, Dept Hlth Care Ctr, Tangshan, Peoples R China; [Shi, Jihong; Wu, Shouling] North China Univ Sci & Technol, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China; [Zhang, Ying] North China Univ Sci & Technol, Hosp, Dept Ultrasonog, Tangshan, Peoples R China; [Cai, Jun] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Dept Hyertens, Beijing, Peoples R China; [Cai, Jun] Peking Union Med Coll, Beijing, Peoples R China	University of Hong Kong; North China University of Science & Technology; North China University of Science & Technology; North China University of Science & Technology; North China University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, SL (corresponding author), North China Univ Sci & Technol, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.; Cai, J (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Dept Hyertens, Beijing, Peoples R China.; Cai, J (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	drwusl@163.com; caijun@fuwaihospital.org			National Basic Research Program of China [2014CB542302]; International S&T Cooperation Program of China [2013DFB30310]; Natural Science Foundation of China [811170244, 81222001, 81470541]	National Basic Research Program of China(National Basic Research Program of China); International S&T Cooperation Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Basic Research Program of China (2014CB542302) http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm, International S&T Cooperation Program of China (2013DFB30310), http://www.istcp.org.cn/, Natural Science Foundation of China (811170244, 81222001, 81470541) http://www.nsfc.gov.cn/publish/portal1/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatola H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000532; Crichton GE, 2014, J HUM HYPERTENS, V28, P444, DOI 10.1038/jhh.2013.131; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Dong CH, 2012, CIRCULATION, V125, P2975, DOI 10.1161/CIRCULATIONAHA.111.081083; Du TT, 2014, EUR J INTERN MED, V25, P388, DOI 10.1016/j.ejim.2014.03.004; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Gao JS, 2015, CLIN EXP HYPERTENS, V37, P650, DOI 10.3109/10641963.2015.1047938; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Huffman MD, 2013, CIRCULATION, V127, P2477, DOI 10.1161/CIRCULATIONAHA.112.000769; Huffman MD, 2012, CIRCULATION, V125, P2595, DOI 10.1161/CIRCULATIONAHA.111.070722; Kim Ji Young, 2013, J Prev Med Public Health, V46, P319, DOI 10.3961/jpmph.2013.46.6.319; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Kulshreshtha A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000282; Lachman S, 2016, EUR J PREV CARDIOL, V23, P986, DOI 10.1177/2047487315602015; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Laitinen TT, 2012, CIRCULATION, V125, P1971, DOI 10.1161/CIRCULATIONAHA.111.073585; Li ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep11564; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu XF, 2014, HYPERTENS RES, V37, P685, DOI 10.1038/hr.2014.58; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Maclagan LC, 2015, CURR OPIN CARDIOL, V30, P518, DOI 10.1097/HCO.0000000000000210; Ogagarue ER, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000430; Pahkala K, 2013, CIRCULATION, V127, P2088, DOI 10.1161/CIRCULATIONAHA.112.000761; Qin L, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-26; Rasmussen-Torvik LJ, 2013, CIRCULATION, V127, P1270, DOI 10.1161/CIRCULATIONAHA.112.001183; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Sandberg K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-7; Still CH, 2015, J AM GERIATR SOC, V63, P2130, DOI 10.1111/jgs.13672; Wang F, 2009, NUTR METAB CARDIOVAS, V19, P542, DOI 10.1016/j.numecd.2008.11.006; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Xue H, 2014, CLIN CHEM LAB MED, V52, P1379, DOI 10.1515/cclm-2013-0657; Xue H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081597; Yanes LL, 2011, CURR TOP MED CHEM, V11, P1736; Ye CL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1230; Zhang Q, 2013, STROKE, V44, P2451, DOI 10.1161/STROKEAHA.113.678839; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]	40	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158869	10.1371/journal.pone.0158869	http://dx.doi.org/10.1371/journal.pone.0158869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434049	gold, Green Submitted, Green Published			2022-12-27	WOS:000380169600019
J	Goldman, N; Glei, DA; Weinstein, M				Goldman, Noreen; Glei, Dana A.; Weinstein, Maxine			What Matters Most for Predicting Survival? A Multinational Population-Based Cohort Study	PLOS ONE			English	Article							MULTIPLE IMPUTATION; PHYSICIANS; HEALTH	Despite myriad efforts among social scientists, epidemiologists, and clinicians to identify variables with strong linkages to mortality, few researchers have evaluated statistically the relative strength of a comprehensive set of predictors of survival. Here, we determine the strongest predictors of five-year mortality in four national, prospective studies of older adults. We analyze nationally representative surveys of older adults in four countries with similar levels of life expectancy: England (n = 6113, ages 52+), the US (n = 2023, ages 50+), Costa Rica (n = 2694, ages 60+), and Taiwan (n = 1032, ages 53+). Each survey includes a broad set of demographic, social, health, and biological variables that have been shown previously to predict mortality. We rank 57 predictors, 25 of which are available in all four countries, net of age and sex. We use the area under the receiver operating characteristic curve and assess robustness with additional discrimination measures. We demonstrate consistent findings across four countries with different cultural traditions, levels of economic development, and epidemiological transitions. Self-reported measures of instrumental activities of daily living limitations, mobility limitations, and overall self-assessed health are among the top predictors in all four samples. C-reactive protein, additional inflammatory markers, homocysteine, serum albumin, three performance assessments (gait speed, grip strength, and chair stands), and exercise frequency also discriminate well between decedents and survivors when these measures are available. We identify several promising candidates that could improve mortality prediction for both population-based and clinical populations. Better prognostic tools are likely to provide researchers with new insights into the behavioral and biological pathways that underlie social stratification in health and may allow physicians to have more informed discussions with patients about end-of-life treatment and priorities.	[Goldman, Noreen] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Glei, Dana A.; Weinstein, Maxine] Georgetown Univ, Ctr Populat & Hlth, Washington, DC 20057 USA	Princeton University; Georgetown University	Glei, DA (corresponding author), Georgetown Univ, Ctr Populat & Hlth, Washington, DC 20057 USA.	dag77@georgetown.edu		Goldman, Noreen/0000-0003-2865-9491	National Institute on Aging [R01AG16790, R01AG16661]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P2CHD047879]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016790] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (www.nia.nih.gov) [grant numbers R01AG16790 (Princeton University, N.G. as PI), R01AG16661 (Georgetown University, M.W. as PI)] and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov) [grant number P2CHD047879]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; [Anonymous], 1999, DEATH FORETOLD PROPH; Belloc NB, 1973, PREV MED, V2, P67; CALKINS DR, 1991, ANN INTERN MED, V114, P451, DOI 10.7326/0003-4819-114-6-451; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Crimmins E, 2010, DEMOGRAPHY, V47, pS41, DOI 10.1353/dem.2010.0005; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Hurd MD, 2001, THEMES EC AGING, P171; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Pantell M, 2013, AM J PUBLIC HEALTH, V103, P2056, DOI 10.2105/AJPH.2013.301261; PARKES CM, 1972, BRIT MED J, V2, P29, DOI 10.1136/bmj.2.5804.29; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; The World Bank, LIF EXP BIRTH TOT YE; Todd MA, 2013, EPIDEMIOLOGY, V24, P913, DOI 10.1097/EDE.0b013e3182a713a8; University of California, HUMAN MORTALITY DATA; Weinstein M, 2007, BIOSOCIAL SURVEYS; WINSHIP C, 1994, SOCIOL METHOD RES, V23, P230, DOI 10.1177/0049124194023002004; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	22	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159273	10.1371/journal.pone.0159273	http://dx.doi.org/10.1371/journal.pone.0159273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434271	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169600045
J	Rodrigues-de-Souza, DP; Palacios-Cena, D; Moro-Gutierrez, L; Camargo, PR; Salvini, TF; Alburquerque-Sendin, F				Priscila Rodrigues-de-Souza, Daiana; Palacios-Cena, Domingo; Moro-Gutierrez, Lourdes; Camargo, Paula Rezende; Salvini, Tania Fatima; Alburquerque-Sendin, Francisco			Socio-Cultural Factors and Experience of Chronic Low Back Pain: a Spanish and Brazilian Patients' Perspective. A Qualitative Study	PLOS ONE			English	Article							PRIMARY-CARE; HEALTH; BELIEFS; MANAGEMENT; IMPACT; DISABILITY; NECK; POPULATIONS; PERCEPTIONS; INTERVIEWS	Background Low back pain (LBP) could be influenced by socio-cultural factors. Pain narratives are important to understand the influence of environment on patients with chronic LBP. There are few studies that have explored the experience of patients with chronic LBP in different socio-cultural environments. The aim of this study was to describe the experience of patients with chronic LBP in Spain and Brazil. Methods A qualitative phenomenology approach was implemented. Chronic LBP patients from the University Hospital of Salamanca (Spain), and/or Federal University of Sao Carlos (Brazil) were included, using purposeful sampling. Data were collected from 22 Spanish and 26 Brazilian patients during in-depth interviews and using researchers' field notes and patients' personal diaries and letters. A thematic analysis was performed and the guidelines for reporting qualitative research were applied. Results Forty-eight patients with a mean age of 50.7 years (SD: +/- 13.1 years) were included in the study. The themes identified included: a) ways of perceiving and expressing pain-the participants focused constantly on their pain and anything outside it was considered secondary; b) the socio-familial environment as a modulator of pain-most participants stated that no one was able to understand the pain they were experiencing; c) religion as a modulator of pain-all Brazilian patients stated that religious belief affected the experience of pain; and d) socio-economic and educational status as a modulator of pain-the study reported that economic factors influenced the experience of pain. Conclusions The influences of LBP can be determined based on the how a patient defines pain. Religion can be considered as a possible mechanism for patients to manage pain and as a form of solace.	[Priscila Rodrigues-de-Souza, Daiana] Catholic Univ Avila, Dept Phys Therapy, Avila, Spain; [Palacios-Cena, Domingo] Rey Juan Carlos Univ, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Madrid, Spain; [Moro-Gutierrez, Lourdes] Univ Salamanca, Dept Social Psychol & Anthropol, Salamanca, Spain; [Camargo, Paula Rezende; Salvini, Tania Fatima] Univ Fed Sao Carlos, Dept Phys Therapy, Sao Paulo, Brazil; [Alburquerque-Sendin, Francisco] Univ Salamanca, Dept Nursing & Phys Therapy, Biomed Res Inst Salamanca IBSAL, Salamanca, Spain	Santa Teresa Jesus Catholic University of Avila; Universidad Rey Juan Carlos; University of Salamanca; Universidade Federal de Sao Carlos; University of Salamanca	Alburquerque-Sendin, F (corresponding author), Univ Salamanca, Dept Nursing & Phys Therapy, Biomed Res Inst Salamanca IBSAL, Salamanca, Spain.	pacoalbu@usal.es	PALACIOS-CEÑA, DOMINGO/B-6944-2015; Salvini, Tania F/G-4349-2012; Rodrigues-de-Souza, Daiana Priscila/AAO-7843-2021; Camargo, Paula R/G-8782-2012; Moro, Lourdes/AAQ-7019-2021; Alburquerque-Sendín, Francisco/L-1539-2016	PALACIOS-CEÑA, DOMINGO/0000-0003-0669-6339; Salvini, Tania F/0000-0002-6353-6393; Rodrigues-de-Souza, Daiana Priscila/0000-0002-3651-3276; Camargo, Paula R/0000-0002-8961-4353; Alburquerque-Sendín, Francisco/0000-0002-3892-8440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) SP, Brazil [2015/50303-5]; University of Salamanca, Spain [8247/463AB08]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) SP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Salamanca, Spain	The study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP/Processes: 2015/50303-5) SP, Brazil and the University of Salamanca (process: 8247/463AB08), Spain.	Abasolo L, 2012, RHEUMATOL INT, V32, P3831, DOI 10.1007/s00296-011-2264-5; Arcanjo GN, 2007, CIENC SAUDE COLETIVA, V12, P389, DOI 10.1590/S1413-81232007000200015; Baetz M, 2008, PAIN RES MANAG, V13, P383, DOI 10.1155/2008/263751; Bailly F, 2015, JOINT BONE SPINE, V82, P437, DOI 10.1016/j.jbspin.2015.02.019; Montekio VB, 2011, SALUD PUBLICA MEXICO, V53, pS120; Bishop FL, 2015, SPINE, V40, P1842, DOI 10.1097/BRS.0000000000001215; Borrego PS, 2005, FISIOTERAPIA, V27, P250; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Briggs AM, 2010, PAIN, V150, P275, DOI 10.1016/j.pain.2010.04.031; Buchbinder R, 2013, BEST PRACT RES CL RH, V27, P575, DOI 10.1016/j.berh.2013.10.007; Cano A, 2014, DISABIL REHABIL, V36, P1713, DOI 10.3109/09638288.2013.869625; Chen HY, 2010, J CLIN NURS, V19, P234, DOI 10.1111/j.1365-2702.2009.02896.x; Coggon D, 2013, PAIN, V154, P856, DOI 10.1016/j.pain.2013.02.008; Cohen DJ, 2008, ANN FAM MED, V6, P331, DOI 10.1370/afm.818; Coyle N, 2007, PAIN MED, V8, P205, DOI 10.1111/j.1526-4637.2007.00303.x; Darlow B, 2012, EUR J PAIN, V16, P3, DOI 10.1016/j.ejpain.2011.06.006; Darlow B, 2015, SPINE, V40, P842, DOI 10.1097/BRS.0000000000000901; Darlow B, 2014, FAM PRACT, V31, P723, DOI 10.1093/fampra/cmu051; De Souza L, 2011, DISABIL REHABIL, V33, P310, DOI 10.3109/09638288.2010.490865; Dean SG, 2011, J OCCUP REHABIL, V21, P395, DOI 10.1007/s10926-010-9275-z; Dezutter J, 2010, PAIN MED, V11, P765, DOI 10.1111/j.1526-4637.2010.00827.x; Dezutter J, 2009, INT J PSYCHIAT MED, V39, P393, DOI 10.2190/PM.39.4.d; Dima A, 2013, BRIT J GEN PRACT, V63, pE490, DOI 10.3399/bjgp13X669211; Duggleby Wendy, 2003, Home Healthc Nurse, V21, P174, DOI 10.1097/00004045-200303000-00013; Eaves ER, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0531-9; Fernandez-de-las-Penas C, 2013, SPINE J, V13, P1069, DOI 10.1016/j.spinee.2013.02.064; Fernandez-de-las-Penas C, 2011, SPINE, V36, pE213, DOI 10.1097/BRS.0b013e3181d952c2; Froud R, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-50; Haanstra TM, 2013, EUR SPINE J, V22, P1986, DOI 10.1007/s00586-013-2803-8; Hestbaek L, 2008, EUR SPINE J, V17, P1727, DOI 10.1007/s00586-008-0796-5; Heuch I, 2013, J PHYSIOTHER, V59, P127, DOI 10.1016/S1836-9553(13)70166-8; Holmberg SAC, 2010, ANN AGR ENV MED, V17, P251; Holt N, 2015, BRIT J GEN PRACT, V65, pE692, DOI 10.3399/bjgp15X686953; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Jones RK, 2000, QUAL HEALTH RES, V10, P555, DOI 10.1177/104973200129118543; Kligler B, 2015, J ALTERN COMPLEM MED, V21, P713, DOI 10.1089/acm.2014.0376; Langridge N, 2015, MANUAL THER, V20, P745, DOI 10.1016/j.math.2015.01.005; Larsen EL, 2013, DISABIL REHABIL, V35, P819, DOI 10.3109/09638288.2012.709302; Lin IB, 2012, EUR J PAIN, V16, P1331, DOI 10.1002/j.1532-2149.2012.00128.x; MacNeela P, 2015, HEALTH PSYCHOL REV, V9, P63, DOI 10.1080/17437199.2013.840951; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Matthias MS, 2012, PAIN MED, V13, P1018, DOI 10.1111/j.1526-4637.2012.01433.x; Costa LDM, 2012, CAN MED ASSOC J, V184, pE613, DOI 10.1503/cmaj.111271; Meucci RD, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-155; Ministerio de Sanidad Servicios Sociales e Igualdad, 2012, SIST NAC SAL; Mullersdorf M, 2011, SCAND J CARING SCI, V25, P637, DOI 10.1111/j.1471-6712.2011.00872.x; Murray SA, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3702; Myburgh C, 2015, J REHABIL MED, V47, P741, DOI 10.2340/16501977-1987; Perez-Agote A., 2012, CAMBIO RELIG ESPANA; Rainville J, 2011, SPINE J, V11, P895, DOI 10.1016/j.spinee.2011.08.006; Rippentrop AE, 2005, PAIN, V116, P311, DOI 10.1016/j.pain.2005.05.008; Scheermesser M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-5; Shaw WS, 2013, BEST PRACT RES CL RH, V27, P637, DOI 10.1016/j.berh.2013.09.012; Shipton EA, 2013, NEW ZEAL MED J, V126, P7; Sloots M, 2010, J REHABIL MED, V42, P566, DOI 10.2340/16501977-0536; Snelgrove S, 2013, CHRONIC ILLN, V9, P283, DOI 10.1177/1742395313476901; Stisen DB, 2016, DISABIL REHABIL, V38, P307, DOI 10.3109/09638288.2015.1037465; Suto, 2008, QUALITATIVE RES OCCU; Tavafian SS, 2008, HEALTH CARE WOMEN IN, V29, P339, DOI 10.1080/07399330701876356; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Urquhart DM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-148; van Nes F, 2010, EUR J AGEING, V7, P313, DOI 10.1007/s10433-010-0168-y; Vianin M, 2008, J CHIROPR MED, V7, P161, DOI 10.1016/j.jcm.2008.07.001; Vigatto R, 2007, SPINE, V32, P481, DOI 10.1097/01.brs.0000255075.11496.47; Wachholtz AB, 2009, CURR PAIN HEADACHE R, V13, P127, DOI 10.1007/s11916-009-0022-0; Webster LR, 2013, PAIN MED, V14, P1811, DOI 10.1111/pme.12291	67	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159554	10.1371/journal.pone.0159554	http://dx.doi.org/10.1371/journal.pone.0159554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434594	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600070
J	Raggi, A; Corso, B; Minicuci, N; Quintas, R; Sattin, D; De Torres, L; Chatterji, S; Frisoni, GB; Haro, JM; Koskinen, S; Martinuzzi, A; Miret, M; Tobiasz-Adamczyk, B; Leonardi, M				Raggi, Alberto; Corso, Barbara; Minicuci, Nadia; Quintas, Rui; Sattin, Davide; De Torres, Laura; Chatterji, Somnath; Frisoni, Giovanni Battista; Haro, Josep Maria; Koskinen, Seppo; Martinuzzi, Andrea; Miret, Marta; Tobiasz-Adamczyk, Beata; Leonardi, Matilde			Determinants of Quality of Life in Ageing Populations: Results from a Cross-Sectional Study in Finland, Poland and Spain	PLOS ONE			English	Article							OLDER-ADULTS; PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; COLLABORATIVE RESEARCH; ELDERLY POPULATION; VISUAL IMPAIRMENT; CHRONIC DISEASES; SOCIAL NETWORK; HEALTH-STATUS; IMPACT	Purpose To comprehensively identify the determinants of quality of life (QoL) in a population study sample of persons aged 18-50 and 50+. Methods In this observational, cross-sectional study, QoL was measured with the WHOQOL-AGE, a brief instrument designed to measure QoL in older adults. Eight hierarchical regression models were performed to identify determinants of QoL. Variables were entered in the following order: Sociodemographic; Health Habits; Chronic Conditions; Health State description; Vision and Hearing; Social Networks; Built Environment. In the final model, significant variables were retained. The final model was re-run using data from the three countries separately. Results Complete data were available for 5639 participants, mean age 46.3 (SD 18.4). The final model accounted for 45% of QoL variation and the most relevant contribution was given by sociodemographic data (particularly age, education level and living in Finland: 17.9% explained QoL variation), chronic conditions (particularly depression: 4.6%) and a wide and rich social network (4.6%). Other determinants were presence of disabling pain, learning difficulties and visual problems, and living in usable house that is perceived as non-risky. Some variables were specifically associated to QoL in single countries: age in Poland, alcohol consumption in Spain, angina in Finland, depression in Spain, and self-reported sadness both in Finland and Poland, but not in Spain. Other were commonly associated to QoL: smoking status, bodily aches, being emotionally affected by health problems, good social network and home characteristics. Conclusions Our results highlight the importance of modifiable determinants of QoL, and provide public health indications that could support concrete actions at country level. In particular, smoking cessation, increasing the level of physical activity, improving social network ties and applying universal design approach to houses and environmental infrastructures could potentially increase QoL of ageing population.	[Raggi, Alberto; Quintas, Rui; Sattin, Davide; De Torres, Laura; Leonardi, Matilde] Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, Milan, Italy; [Corso, Barbara; Minicuci, Nadia] CNR, Inst Neurosci, Padua, Italy; [Chatterji, Somnath] WHO, Informat Evidence & Res Unit, Geneva, Switzerland; [Frisoni, Giovanni Battista] IRCCS Ist Ctr San Giovanni Dio Fatebenefratelli, Lab Alzheimers Neuroimaging & Epidemiol, Brescia, Italy; [Frisoni, Giovanni Battista] Univ Hosp, Memory Clin, Geneva, Switzerland; [Frisoni, Giovanni Battista] Univ Hosp, LANVIE, Geneva, Switzerland; [Frisoni, Giovanni Battista] Univ Geneva, Geneva, Switzerland; [Haro, Josep Maria] Univ Barcelona, CIBERSAM, Parc Sanitari St Joan Deu, Barcelona, Spain; [Koskinen, Seppo] Natl Inst Hlth & Welf, Populat Hlth Res Unit, Helsinki, Finland; [Martinuzzi, Andrea] E Medea Sci Inst, Conegliano Pieve Soligo Res Ctr, Conegliano, Italy; [Miret, Marta] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain; [Haro, Josep Maria; Miret, Marta] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, CIBERSAM, Madrid, Spain; [Miret, Marta] Hosp Univ Princesa, Inst Invest Sanitaria Princesa IP, Dept Psychiat, Madrid, Spain; [Tobiasz-Adamczyk, Beata] Jagiellonian Univ, Coll Med, Dept Med Sociol, Chair Epidemiol & Prevent Med, Krakow, Poland	Consiglio Nazionale delle Ricerche (CNR); World Health Organization; IRCCS Fatebenefratelli; University of Geneva; University of Geneva; University of Geneva; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Finland National Institute for Health & Welfare; IRCCS Eugenio Medea; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Jagiellonian University; Collegium Medicum Jagiellonian University	Raggi, A (corresponding author), Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, Milan, Italy.	alberto.raggi@istituto-besta.it	Sattin, Davide/K-5963-2016; Haro, Josep Maria/D-1423-2011; Miret, Marta/C-6103-2019; leonardi, matilde/J-9997-2018; CHATTERJI, Somnath/ABE-6832-2020; MINICUCI, NADIA/D-5237-2016; Raggi, Alberto/K-5787-2016; Frisoni, Giovanni B./K-1360-2016; Corso, Barbara/P-1796-2018; Quintas, Rui/AAJ-6630-2021; Martinuzzi, Andrea/K-3887-2016	Sattin, Davide/0000-0001-7736-4337; Haro, Josep Maria/0000-0002-3984-277X; Miret, Marta/0000-0003-3252-854X; leonardi, matilde/0000-0003-0552-8923; MINICUCI, NADIA/0000-0002-0970-6531; Raggi, Alberto/0000-0002-7433-7779; Frisoni, Giovanni B./0000-0002-6419-1753; Corso, Barbara/0000-0002-0684-9078; Quintas, Rui/0000-0002-9985-334X; Martinuzzi, Andrea/0000-0002-0319-3579	European Commission [HEALTH-F2-2009-223071]; Commission's Seventh Framework Programme under REA grant [316795]	European Commission(European CommissionEuropean Commission Joint Research Centre); Commission's Seventh Framework Programme under REA grant	The authors acknowledge funding from the European Commission's Seventh Framework Programme, project no HEALTH-F2-2009-223071 (COURAGE in Europe), and from the Commission's Seventh Framework Programme under REA grant agreement no 316795 (MARATONE). AR takes full responsibility for the data, the analysis, the interpretation, and the conduct of the research. AR has full access to all of the data. All authors report no conflicts of interest. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this paper are those of the authors, and do not necessarily represent the views or policies of the World Health Organization.	Allen J, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-140; Araya R, 2007, BRIT J PSYCHIAT, V190, P394, DOI 10.1192/bjp.bp.106.024596; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Bernfort L, 2015, PAIN, V156, P521, DOI 10.1097/01.j.pain.0000460336.31600.01; Bookwala J, 2011, J GERONTOL B-PSYCHOL, V66, P605, DOI 10.1093/geronb/gbr091; Borglin G, 2006, HEALTH SOC CARE COMM, V14, P136, DOI 10.1111/j.1365-2524.2006.00603.x; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Carta Mauro Giovanni, 2012, Clin Pract Epidemiol Ment Health, V8, P169, DOI 10.2174/1745017901208010169; Cash SW, 2013, QUAL LIFE RES, V22, P2381, DOI 10.1007/s11136-013-0389-6; Chia EM, 2004, INVEST OPHTH VIS SCI, V45, P71, DOI 10.1167/iovs.03-0661; Dale CE, 2013, AGE AGEING, V42, P312, DOI 10.1093/ageing/aft029; Dey M, 2014, QUAL LIFE RES, V23, P1009, DOI 10.1007/s11136-013-0524-4; du Toit R, 2010, OPHTHALMOLOGY, V117, P2308, DOI 10.1016/j.ophtha.2010.03.041; Caballero FF, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-177; Fernandez-Martinez B, 2012, REV SAUDE PUBL, V46, P310, DOI 10.1590/S0034-89102012000200013; Finger RP, 2011, INVEST OPHTH VIS SCI, V52, P3613, DOI 10.1167/iovs.10-7127; Garcia EL, 2005, QUAL LIFE RES, V14, P511, DOI 10.1007/s11136-004-5329-z; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111498; Garin Noe, 2014, Clin Pract Epidemiol Ment Health, V10, P103, DOI 10.2174/1745017901410010103; Georgellis Y, 2009, SOC INDIC RES, V91, P329, DOI 10.1007/s11205-008-9344-2; Gill Diane L, 2013, J Prev Med Public Health, V46 Suppl 1, pS28, DOI 10.3961/jpmph.2013.46.S.S28; Goldenberg M, 2014, AM J ADDICTION, V23, P540, DOI 10.1111/j.1521-0391.2014.12148.x; Gureje O, 2007, CURR OPIN PSYCHIATR, V20, P42, DOI 10.1097/YCO.0b013e328010ddf4; Han KT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0109-0; Herman KM, 2012, MED SCI SPORT EXER, V44, P625, DOI 10.1249/MSS.0b013e31823a90ae; Hider SL, 2015, EUR SPINE J, V24, P444, DOI 10.1007/s00586-014-3355-2; Hunger M, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-53; Jespersen L, 2013, CLIN RES CARDIOL, V102, P571, DOI 10.1007/s00392-013-0568-z; Jivraj S, 2014, QUAL LIFE RES, V23, P2545, DOI 10.1007/s11136-014-0694-8; Jurschik P, 2012, ARCH GERONTOL GERIAT, V55, P625, DOI 10.1016/j.archger.2012.07.002; Kim SY, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-68; Konnopka A, 2009, VALUE HEALTH, V12, P253, DOI 10.1111/j.1524-4733.2008.00444.x; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Lacey RJ, 2014, RHEUMATOLOGY, V53, P2071, DOI 10.1093/rheumatology/keu240; Layte R, 2013, J AM GERIATR SOC, V61, pS299, DOI 10.1111/jgs.12198; Leonardi M, 2014, CLIN PSYCHOL PSYCHOT, V21, P193, DOI 10.1002/cpp.1856; Lin CH, 2014, J AFFECT DISORDERS, V166, P173, DOI 10.1016/j.jad.2014.03.039; Lopez D, 2011, MATURITAS, V69, P359, DOI 10.1016/j.maturitas.2011.05.006; Low G, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-146; Luthy C, 2015, QUAL LIFE RES, V24, P1687, DOI 10.1007/s11136-014-0894-2; Mielck A, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-58; Netuveli G, 2006, J EPIDEMIOL COMMUN H, V60, P357, DOI 10.1136/jech.2005.040071; Ohayon MM, 2010, J PSYCHIATR RES, V44, P454, DOI 10.1016/j.jpsychires.2009.10.013; Organization WH, 2015, SUMM WORLD REP AG HL; Parker L, 2014, FAM PRACT, V31, P557, DOI 10.1093/fampra/cmu035; Parra DC, 2010, SOC SCI MED, V70, P1070, DOI 10.1016/j.socscimed.2009.12.024; Perales F, 2014, QUAL LIFE RES, V23, P1921, DOI 10.1007/s11136-014-0645-4; Raggi A, 2014, CLIN PSYCHOL PSYCHOT, V21, P215, DOI 10.1002/cpp.1859; Raggi A, 2014, QUAL LIFE RES, V23, P1273, DOI 10.1007/s11136-013-0556-9; Renalds A, 2010, FAM COMMUNITY HEALTH, V33, P68, DOI 10.1097/FCH.0b013e3181c4e2e5; Rosenkranz RR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1071; Saatcioglu O, 2008, DRUG ALCOHOL REV, V27, P83, DOI 10.1080/09595230701711140; Seland JH, 2011, ACTA OPHTHALMOL, V89, P608, DOI 10.1111/j.1755-3768.2009.01794.x; Soulet D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053942; Strine TW, 2008, J COMMUN HEALTH, V33, P40, DOI 10.1007/s10900-007-9066-4; Subramanian SV, 2006, J GERONTOL B-PSYCHOL, V61, pS153, DOI 10.1093/geronb/61.3.S153; Switaj P, 2012, TRANSCULT PSYCHIATRY, V49, P51, DOI 10.1177/1363461511433143; Thompson WW, 2012, AM J PUBLIC HEALTH, V102, P496, DOI 10.2105/AJPH.2011.300500; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POPULATION AGE; Ustun T.B., 2005, HOUSEHOLD SAMPLE SUR, P199; Valencia-Martin JL, 2013, PREV MED, V57, P703, DOI 10.1016/j.ypmed.2013.09.007; Van Dijk AP, 2004, J STUD ALCOHOL, V65, P241, DOI 10.15288/jsa.2004.65.241; Vogl M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-203; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; *WHO, 2002, INT GUID MON ALC CON; World Health Organization, 2015, WHO GUID TRANSL AD I, P4; World Health Organization (WHO), 2015, PHYS ACTIVITY; World Health Organization (WHO), 2011, WAIST CIRCUMFERENCE; Zawisza K, 2014, CLIN PSYCHOL PSYCHOT, V21, P227, DOI 10.1002/cpp.1860	70	49	50	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159293	10.1371/journal.pone.0159293	http://dx.doi.org/10.1371/journal.pone.0159293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434374	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169600046
J	Urbanek, K; De Angelis, A; Spaziano, G; Piegari, E; Matteis, M; Cappetta, D; Esposito, G; Russo, R; Tartaglione, G; De Palma, R; Rossi, F; D'Agostino, B				Urbanek, Konrad; De Angelis, Antonella; Spaziano, Giuseppe; Piegari, Elena; Matteis, Maria; Cappetta, Donato; Esposito, Grazia; Russo, Rosa; Tartaglione, Gioia; De Palma, Raffaele; Rossi, Francesco; D'Agostino, Bruno			Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model	PLOS ONE			English	Article							ACUTE LUNG INJURY; STROMAL CELLS; BONE-MARROW; RECEPTOR ANTAGONIST; INDUCED BRONCHOCONSTRICTION; ASTHMATIC-PATIENTS; ALLERGIC-ASTHMA; T-LYMPHOCYTES; MURINE MODEL; IFN-GAMMA	Background The need for new options for chronic lung diseases promotes the research on stem cells for lung repair. Bone marrow-derived mesenchymal stem cells (MSCs) can modulate lung inflammation, but the data on cellular processes involved in early airway remodeling and the potential involvement of neuropeptides are scarce. Objectives To elucidate the mechanisms by which local administration of MSCs interferes with pathophysiological features of airway hyperresponsiveness in an animal model. Methods GFP-tagged mouse MSCs were intratracheally delivered in the ovalbumin mouse model with subsequent functional tests, the analysis of cytokine levels, neuropeptide expression and histological evaluation of MSCs fate and airway pathology. Additionally, MSCs were exposed to pro-inflammatory factors in vitro. Results Functional improvement was observed after MSC administration. Although MSCs did not adopt lung cell phenotypes, cell therapy positively affected airway remodeling reducing the hyperplastic phase of the gain in bronchial smooth muscle mass, decreasing the proliferation of epithelium in which mucus metaplasia was also lowered. Decrease of interleukin-4, interleukin-5, interleukin-13 and increase of interleukin-10 in bronchoalveolar lavage was also observed. Exposed to pro-inflammatory cytokines, MSCs upregulated indoleamine 2,3-dioxygenase. Moreover, asthma-related in vivo upregulation of pro-inflammatory neurokinin 1 and neurokinin 2 receptors was counteracted by MSCs that also determined a partial restoration of VIP, a neuropeptide with anti-inflammatory properties. Conclusion Intratracheally administered MSCs positively modulate airway remodeling, reduce inflammation and improve function, demonstrating their ability to promote tissue homeostasis in the course of experimental allergic asthma. Because of a limited tissue retention, the functional impact of MSCs may be attributed to their immunomodulatory response combined with the interference of neuropeptide system activation and tissue remodeling.	[Urbanek, Konrad; De Angelis, Antonella; Spaziano, Giuseppe; Piegari, Elena; Matteis, Maria; Cappetta, Donato; Esposito, Grazia; Russo, Rosa; Tartaglione, Gioia; Rossi, Francesco; D'Agostino, Bruno] Univ Naples 2, Pharmacol Sect, Dept Expt Med, Naples, Italy; [De Palma, Raffaele] Univ Naples 2, Dept Clin & Expt Med, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	De Angelis, A; D'Agostino, B (corresponding author), Univ Naples 2, Pharmacol Sect, Dept Expt Med, Naples, Italy.	antonella.deangelis@unina2.it; bruno.dagostino@unina2.it	SPAZIANO, GIUSEPPE/H-9202-2016; Piegari, Elena/ABG-7510-2020	SPAZIANO, GIUSEPPE/0000-0002-1906-5109; D'AGOSTINO, Bruno/0000-0002-7220-7962	Scientific Publications Fund of SUN [5 14.06.16]	Scientific Publications Fund of SUN	This work was supported by Scientific Publications Fund of SUN n. 5 14.06.16.	Abreu SC, 2013, RESP PHYSIOL NEUROBI, V187, P190, DOI 10.1016/j.resp.2013.03.014; BAI TR, 1995, AM J PHYSIOL-LUNG C, V269, pL309, DOI 10.1152/ajplung.1995.269.3.L309; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bonfield TL, 2010, AM J PHYSIOL-LUNG C, V299, pL760, DOI 10.1152/ajplung.00182.2009; Burian Bernhard, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P344; Cohen L, 2007, AM J RESP CRIT CARE, V176, P138, DOI 10.1164/rccm.200607-1062OC; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Crescenzi E, 2011, ONCOGENE, V30, P2707, DOI 10.1038/onc.2011.1; D'Agostino B, 2002, CLIN EXP ALLERGY, V32, P472, DOI 10.1046/j.1365-2222.2002.01328.x; D'Agostino B, 2010, EXPERT OPIN BIOL TH, V10, P681, DOI 10.1517/14712591003610614; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Duong KM, 2015, AM J RESP CELL MOL, V53, P615, DOI 10.1165/rcmb.2014-0431OC; FAHY JV, 1995, AM J RESP CRIT CARE, V152, P879, DOI 10.1164/ajrccm.152.3.7663799; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Firinci F, 2011, INT IMMUNOPHARMACOL, V11, P1120, DOI 10.1016/j.intimp.2011.03.009; Gallelli L, 2003, LIFE SCI, V72, P1135, DOI 10.1016/S0024-3205(02)02372-X; Garbacki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016509; Goodwin M, 2011, STEM CELLS, V29, P1137, DOI 10.1002/stem.656; Groneberg DA, 2004, ALLERGY, V59, P1139, DOI 10.1111/j.1398-9995.2004.00665.x; Guan CX, 2006, PEPTIDES, V27, P3107, DOI 10.1016/j.peptides.2006.08.004; Guan XJ, 2013, J CELL BIOCHEM, V114, P323, DOI 10.1002/jcb.24377; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hoffman AM, 2011, STEM CELLS DEV, V20, P1779, DOI 10.1089/scd.2011.0105; Ichinose M, 1996, AM J RESP CRIT CARE, V153, P936, DOI 10.1164/ajrccm.153.3.8630576; ICHINOSE M, 1992, LANCET, V340, P1248, DOI 10.1016/0140-6736(92)92948-F; Ionescu L, 2012, AM J PHYSIOL-LUNG C, V303, pL967, DOI 10.1152/ajplung.00144.2011; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; JAMES AL, 1988, AM REV RESPIR DIS, V138, P136, DOI 10.1164/ajrccm/138.1.136; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Joos GF, 2000, ALLERGY, V55, P321, DOI 10.1034/j.1398-9995.2000.00112.x; Kanki-Horimoto S, 2006, CIRCULATION, V114, pI181, DOI 10.1161/CIRCULATIONAHA.105.001487; Kobayashi M, 2012, EUR J IMMUNOL, V42, P393, DOI 10.1002/eji.201141845; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kraneveld AD, 2001, INT IMMUNOPHARMACOL, V1, P1629, DOI 10.1016/S1567-5769(01)00099-6; Lau AN, 2012, MOL THER, V20, P1116, DOI 10.1038/mt.2012.37; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Lynch EL, 2003, CYTOKINE GROWTH F R, V14, P489, DOI 10.1016/S1359-6101(03)00056-X; Mathias LJ, 2013, J IMMUNOL, V191, P5914, DOI 10.4049/jimmunol.1300667; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Oslund KL, 2009, TOXICOL PATHOL, V37, P805, DOI 10.1177/0192623309345691; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Ramalho R, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-41; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Raza K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109034; Reynolds SD, 2010, INT J BIOCHEM CELL B, V42, P1, DOI 10.1016/j.biocel.2009.09.002; Royce SG, 2015, STEM CELL RES, V15, P495, DOI 10.1016/j.scr.2015.09.007; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Shiomi T, 2014, FASEB J, V28, P5242, DOI 10.1096/fj.13-242735; Sinclair K, 2013, RESPIROLOGY, V18, P397, DOI 10.1111/resp.12050; Song LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082367; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Squillaro T, 2015, CELL TRANSP IN PRESS; Sullo N, 2013, AM J PHYSIOL-LUNG C, V304, pL657, DOI 10.1152/ajplung.00358.2012; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Temelkovski J, 1998, THORAX, V53, P849, DOI 10.1136/thx.53.10.849; Trevor JL, 2014, ALLERGY, V69, P817, DOI 10.1111/all.12412; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Vignola AM, 2000, J ALLERGY CLIN IMMUN, V105, P1041, DOI 10.1067/mai.2000.107195; Visweswaran M, 2015, INT J BIOCHEM CELL B, V68, P139, DOI 10.1016/j.biocel.2015.09.008; Walters MS, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-135; Weiss Daniel J, 2011, Proc Am Thorac Soc, V8, P223, DOI 10.1513/pats.201012-071DW; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Yao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129164; Zhen GH, 2010, CYTOTHERAPY, V12, P605, DOI 10.3109/14653241003745888; Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504	76	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158746	10.1371/journal.pone.0158746	http://dx.doi.org/10.1371/journal.pone.0158746			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434719	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169600015
J	Fok, PW				Fok, Pak-Wing			Multi-Layer Mechanical Model of Glagov Remodeling in Coronary Arteries: Differences between In-Vivo and Ex-Vivo Measurements	PLOS ONE			English	Article							COMPENSATORY ENLARGEMENT; ATHEROSCLEROSIS; COLLAGEN; FLOW; WALL	When blood vessels undergo remodeling because of the buildup of atherosclerotic plaque, it is thought that they first undergo compensatory or outward remodeling, followed by inward remodeling: the lumen area stays roughly constant or increases slightly and then decreases rapidly. The second phase of remodeling is supposed to start after the plaque burden exceeds about 40%. These changes in the vessel were first observed by S. Glagov who examined cross-sections of coronary arteries at different stages of the disease. In this paper, we use a mathematical model based on growth and elasticity theory to verify the main aspects of Glagov's result. However, both our model and curve-fitting to the data suggest that the critical stenosis is around 20% rather than 40%. Our model and data from the PROSPECT trial also show that Glagov remodeling is qualitatively different depending on whether measurements are taken ex-vivo or in-vivo. Our results suggest that the first outward phase of "Glagov remodeling" is largely absent for in-vivo measurements: that is, the lumen area always decreases as plaque builds up. We advocate that care must be taken when infering how in-vivo vessels remodel from ex-vivo data.	[Fok, Pak-Wing] Univ Delaware, Dept Math Sci, Newark, DE 19716 USA	University of Delaware	Fok, PW (corresponding author), Univ Delaware, Dept Math Sci, Newark, DE 19716 USA.	pakwing@udel.edu			Simons Foundation [282579]	Simons Foundation	This work was supported by Simons Foundation Grant 282579 (https://www.simonsfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya RU, 2012, J MED SYST, V36, P1861, DOI 10.1007/s10916-010-9645-2; Akyildiz AC, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-25; Born G. V., 1990, PATHOBIOLOGY HUMAN A, P413; Fok PW, 2015, MATH MED BIOL; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Goriely A, 2009, LECT NOTES LES HOUCH, V92, P153, DOI [10.1093/acprof:oso/9780199605835.003.0006, DOI 10.1093/ACPROF:OSO/9780199605835.003.0006]; Hanke M, 2001, AM MATH MON, V108, P512, DOI 10.2307/2695705; Holzapfel GA, 2005, AM J PHYSIOL-HEART C, V289, pH2048, DOI 10.1152/ajpheart.00934.2004; Holzapfel GA, 2004, J BIOMECH ENG-T ASME, V126, P657, DOI 10.1115/1.1800557; Inaba S, 2014, CORONARY ARTERY DIS, V25, P98, DOI 10.1097/MCA.0000000000000074; KAMIYA A, 1980, AM J PHYSIOL, V239, pH14, DOI 10.1152/ajpheart.1980.239.1.H14; Korshunov VA, 2004, CIRCULATION, V110, P220, DOI 10.1161/01.CIR.0000134958.88379.2E; LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Mulvany MJ, 2012, BASIC CLIN PHARMACOL, V110, P49, DOI 10.1111/j.1742-7843.2011.00758.x; Pijls NHJ, 2000, CIRCULATION, V102, P2371, DOI 10.1161/01.CIR.102.19.2371; SHEKHONIN BV, 1985, COLLAGEN REL RES, V5, P355; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Vandiver RM, 2015, J THEOR BIOL, V371, P1, DOI 10.1016/j.jtbi.2015.01.039; Vandiver RM., 2009, MORPHOELASTICITY MEC; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186	23	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159304	10.1371/journal.pone.0159304	http://dx.doi.org/10.1371/journal.pone.0159304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427954	Green Submitted, Green Published, gold			2022-12-27	WOS:000380169300046
J	Liu, JB; Li, W; Deng, M; Liu, DC; Ma, QY; Feng, XS				Liu, Jiangbo; Li, Wei; Deng, Miao; Liu, Dechun; Ma, Qingyong; Feng, Xiaoshan			Immunohistochemical Determination of p53 Protein Overexpression for Predicting p53 Gene Mutations in Hepatocellular Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; B-VIRUS INFECTION; HEPATITIS-B; AFLATOXIN B-1; CODON 249; EXPRESSION; ASSOCIATION; CHINA; DNA; GUANGXI	Background Whether increased expression of the tumor suppressor protein p53 indicates a p53 gene mutation in hepatocellular carcinoma (HCC) remains unclear. We conducted a meta-analysis to determine whether p53 protein overexpression detected by immunohistochemistry (IHC) offers a diagnostic prediction for p53 gene mutations in HCC patients. Methods Systematic literature searches were conducted with an end date of December 2015. A meta-analysis was performed to estimate the diagnostic accuracy of IHC-determined p53 protein overexpression in the prediction of p53 gene mutations in HCC. Sensitivity, subgroup, and publication bias analyses were also conducted. Results Thirty-six studies were included in the meta-analysis. The results showed that the overall sensitivity and specificity for IHC-determined p53 overexpression in the diagnostic prediction of p53 mutations in HCC were 0.83 (95% CI: 0.80-0.86) and 0.74 (95% CI: 0.71-0.76), respectively. The summary positive likelihood ratio (PLR) and negative likelihood ratio (NLR) were 2.65 (95% CI: 2.21-3.18) and 0.36 (95% CI: 0.26-0.50), respectively. The diagnostic odds ratio (DOR) of IHC-determined p53 overexpression in predicting p53 mutations ranged from 0.56 to 105.00 (pooled, 9.77; 95% CI: 6.35-15.02), with significant heterogeneity between the included studies (I-2 = 40.7%, P = 0.0067). Moreover, subgroup and sensitivity analyses did not alter the results of the meta-analysis. However, potential publication bias was present in the current meta-analysis. Conclusion The upregulation of the tumor suppressor protein p53 was indeed linked to p53 gene mutations. IHC determination of p53 overexpression can predict p53 gene mutations in HCC patients.	[Liu, Jiangbo; Deng, Miao; Liu, Dechun] Henan Univ Sci & Technol, Affiliated Hosp 1, Coll Clin Med, Dept Gen Surg, Luoyang, Henan, Peoples R China; [Liu, Jiangbo; Li, Wei; Ma, Qingyong] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China; [Feng, Xiaoshan] Henan Univ Sci & Technol, Affiliated Hosp 1, Coll Clin Med, Inst Canc,Henan Key Lab Canc Epigenet, Luoyang, Henan, Peoples R China	Henan University of Science & Technology; Xi'an Jiaotong University; Henan University of Science & Technology	Liu, JB (corresponding author), Henan Univ Sci & Technol, Affiliated Hosp 1, Coll Clin Med, Dept Gen Surg, Luoyang, Henan, Peoples R China.; Liu, JB (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China.; Feng, XS (corresponding author), Henan Univ Sci & Technol, Affiliated Hosp 1, Coll Clin Med, Inst Canc,Henan Key Lab Canc Epigenet, Luoyang, Henan, Peoples R China.	jiangboliuxing@163.com; samfeng@163.com		Deng, Miao/0000-0001-7146-0619	Scientific Research Foundation for Medical Doctors First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology [2014-0801]	Scientific Research Foundation for Medical Doctors First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology	Support was provided by 2014-0801 [http://yfy.haust.edu.cn/] from the Scientific Research Foundation for Medical Doctors First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, JL.	An FQ, 2001, INT J CANCER, V93, P468, DOI 10.1002/ijc.1367; ANDERSSON M, 1995, CANCER EPIDEM BIOMAR, V4, P765; Anzola M, 2004, J VIRAL HEPATITIS, V11, P502, DOI 10.1111/j.1365-2893.2004.00541.x; Boix-Ferrero J, 1999, VIRCHOWS ARCH, V434, P497, DOI 10.1007/s004280050374; BOURDON JC, 1995, GASTROENTEROLOGY, V108, P1176, DOI 10.1016/0016-5085(95)90217-1; Cabelguenne A, 2000, J CLIN ONCOL, V18, P1465, DOI 10.1200/JCO.2000.18.7.1465; CHALLEN C, 1992, HEPATOLOGY, V16, P1362, DOI 10.1002/hep.1840160610; Chen GG, 2003, AM J PATHOL, V162, P1823, DOI 10.1016/S0002-9440(10)64317-9; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheung ST, 2006, ONCOL REP, V15, P1507; DeBenedetti VMG, 1996, CARCINOGENESIS, V17, P145, DOI 10.1093/carcin/17.1.145; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Greenblatt MS, 1997, CANCER RES, V57, P426; Gross-Goupil M, 2003, INT J CANCER, V104, P745, DOI 10.1002/ijc.11017; Hsia CC, 2000, ONCOL REP, V7, P353; HSU HC, 1993, CANCER RES, V53, P4691; Jablkowski M, 2005, J EXP CLIN CANC RES, V24, P117; Kang YK, 1998, VIRCHOWS ARCH, V432, P27, DOI 10.1007/s004280050130; KUBICKA S, 1995, J HEPATOL, V23, P412, DOI 10.1016/0168-8278(95)80199-5; Lee SN, 2002, J KOREAN MED SCI, V17, P801, DOI 10.3346/jkms.2002.17.6.801; Lim SO, 2011, HEPATOLOGY, V53, P1352, DOI 10.1002/hep.24208; Liu JB, 2012, EUR J CANCER, V48, P2328, DOI 10.1016/j.ejca.2012.03.001; Lunn RM, 1997, CANCER RES, V57, P3471; Luo Yu-lin, 2001, Hunan Yike Daxue Xuebao, V26, P13; Midgley CA, 1997, ONCOGENE, V15, P1179, DOI 10.1038/sj.onc.1201459; Mitsumoto Y, 2004, HUM PATHOL, V35, P350, DOI 10.1016/j.humpath.2003.09.014; Mohamed WS, 2008, INT J HEALTH SCI-IJH, V2, P27; Okada T, 2003, FEBS LETT, V555, P583, DOI 10.1016/S0014-5793(03)01345-0; Otsuka M, 2000, J BIOL CHEM, V275, P34122, DOI 10.1074/jbc.M000578200; Park NH, 2001, J CLIN GASTROENTEROL, V33, P397, DOI 10.1097/00004836-200111000-00011; Peng XM, 1998, WORLD J GASTROENTERO, V4, P125; Qi LN, 2015, LIVER INT, V35, P999, DOI 10.1111/liv.12460; Qin LF, 1998, INT J CANCER, V79, P424, DOI 10.1002/(SICI)1097-0215(19980821)79:4<424::AID-IJC19>3.0.CO;2-4; Rashid A, 1999, BRIT J CANCER, V80, P59, DOI 10.1038/sj.bjc.6690321; Ryder SD, 1996, J CLIN PATHOL, V49, P295, DOI 10.1136/jcp.49.4.295; Sanefuji K, 2010, ONCOLOGY-BASEL, V79, P229, DOI 10.1159/000322374; SHIEH YSC, 1993, INT J CANCER, V54, P558; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soini Y, 1996, CARCINOGENESIS, V17, P1007, DOI 10.1093/carcin/17.5.1007; Stern MC, 2001, CANCER EPIDEM BIOMAR, V10, P617; Szymanska K, 2004, INT J CANCER, V110, P374, DOI 10.1002/ijc.20103; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Volkmann M, 2001, J MOL MED-JMM, V79, P594, DOI 10.1007/s001090100244; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yuan RH, 2006, J PATHOL, V209, P549, DOI 10.1002/path.2011; Zekri Abdel Rahman N, 2006, J Egypt Natl Canc Inst, V18, P17; Zhang YJ, 2006, INT J CANCER, V119, P985, DOI 10.1002/ijc.21699; Zhou F, 1997, Hua Xi Yi Ke Da Xue Xue Bao, V28, P50	48	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159636	10.1371/journal.pone.0159636	http://dx.doi.org/10.1371/journal.pone.0159636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428001	Green Published, gold, Green Submitted			2022-12-27	WOS:000380169300079
J	Mendiratta, S; Bhatia, S; Jain, S; Kaur, T; Brahmachari, V				Mendiratta, Shweta; Bhatia, Shipra; Jain, Shruti; Kaur, Taniya; Brahmachari, Vani			Interaction of the Chromatin Remodeling Protein hINO80 with DNA	PLOS ONE			English	Article							ACTIN-RELATED PROTEINS; STRAND BREAK REPAIR; POLYCOMB RECRUITMENT; BINDING DOMAIN; INO80 COMPLEX; TRANSCRIPTION; DROSOPHILA; YY1; CHD1; CHROMODOMAIN	The presence of a highly conserved DNA binding domain in INO80 subfamily predicted that INO80 directly interacts with DNA and we demonstrated its DNA binding activity in vitro. Here we report the consensus motif recognized by the DBINO domain identified by SELEX method and demonstrate the specific interaction of INO80 with the consensus motif. We show that INO80 significantly down regulates the reporter gene expression through its binding motif, and the repression is dependent on the presence of INO80 but not YY1 in the cell. The interaction is lost if specific residues within the consensus motif are altered. We identify a large number of potential target sites of INO80 in the human genome through in silico analysis that can grouped into three classes; sites that contain the recognition sequence for INO80 and YY1, only YY1 and only INO80. We demonstrate the binding of INO80 to a representative set of sites in HEK cells and the correlated repressive histone modifications around the binding motif. In the light of the role of INO80 in homeotic gene regulation in Drosophila as an Enhancer of trithorax and polycomb protein (ETP) that can modify the effect of both repressive complexes like polycomb as well as the activating complex like trithorax, it remains to be seen if INO80 can act as a recruiter of chromatin modifying complexes.	[Mendiratta, Shweta; Bhatia, Shipra; Jain, Shruti; Kaur, Taniya; Brahmachari, Vani] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi, India; [Bhatia, Shipra] Univ Edinburgh, Inst Genet & Mol Med, Human Genet Unit, MRC, Edinburgh, Midlothian, Scotland	University of Delhi; University of Edinburgh	Brahmachari, V (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi, India.	vbrahmachari@acbr.du.ac.in		Kaur, Taniya/0000-0001-8061-0391	Council for Scientific and Industrial Research, Government of India (CSIR) [60(0102)/12/EMR-II, EpiHeD: BSC0118/2012-17]; CSIR	Council for Scientific and Industrial Research, Government of India (CSIR); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council for Scientific and Industrial Research, Government of India (CSIR, No. 60(0102)/12/EMR-II and EpiHeD: BSC0118/2012-17 to VB). SM, SB and SJ are supported by a fellowship from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Debasis Das and Singh G.P. for help with bioinformatics, D. Bharadwaj for SELEX oligos and Animal Research facility at Dr. B.R. Ambedkar Centre for Biomedical Research, University of Delhi for help with antibody generation. VB thanks Council for Scientific and Industrial Research, Govt India (CSIR, No. 60(0102)/12/EMR-II) and (EpiHeD: BSC0118/2012-17) for financial support through research grant. SM, SB and SJ thank CSIR for fellowship.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bakshi R, 2006, BIOCHEM BIOPH RES CO, V339, P313, DOI 10.1016/j.bbrc.2005.10.206; Bakshi R, 2004, BIOCHEM BIOPH RES CO, V320, P197, DOI 10.1016/j.bbrc.2004.05.147; Basu A, 2014, NUCLEIC ACIDS RES, V42, P2208, DOI 10.1093/nar/gkt1187; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhatia S, 2010, GENES CELLS, V15, P725, DOI 10.1111/j.1365-2443.2010.01416.x; Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018; DELMAS V, 1993, P NATL ACAD SCI USA, V90, P2414, DOI 10.1073/pnas.90.6.2414; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gerhold CB, 2014, TRENDS CELL BIOL; Ghasemi M, 2015, MECH DEV, V4; Gospodinov A, 2011, MOL CELL BIOL, V31, P4735, DOI 10.1128/MCB.06182-11; Hogan CJ, 2010, MOL CELL BIOL, V30, P657, DOI 10.1128/MCB.01117-09; Hur SK, 2010, CELL MOL LIFE SCI, V67, P2283, DOI 10.1007/s00018-010-0337-3; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Johnson CN, 2005, BIOCHEM CELL BIOL, V83, P405, DOI 10.1139/O05-115; Kato D, 2012, BIOCHEM BIOPH RES CO, V417, P433, DOI 10.1016/j.bbrc.2011.11.134; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Luo RX, 1999, J NATL CANCER I, V91, P1288, DOI 10.1093/jnci/91.15.1288; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Moshkin YM, 2012, MOL CELL BIOL, V32, P675, DOI 10.1128/MCB.06365-11; Neuman SD, 2014, DEV BIOL, V387, P229, DOI 10.1016/j.ydbio.2014.01.006; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Park EJ, 2010, BIOCHEM J, V431, P179, DOI 10.1042/BJ20100988; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Sharma A, 2011, J BIOL CHEM, V286, P42099, DOI 10.1074/jbc.C111.294462; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; STOKES DG, 1995, MOL CELL BIOL, V15, P2745; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Vassileva I, 2014, NUCLEIC ACIDS RES, V42, P9074, DOI 10.1093/nar/gku605; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang L, 2014, CELL STEM CELL, V14, P575, DOI 10.1016/j.stem.2014.02.013; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Xue Y, 2015, GENE DEV, V29, P350, DOI 10.1101/gad.256255.114	49	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159370	10.1371/journal.pone.0159370	http://dx.doi.org/10.1371/journal.pone.0159370			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428271	gold, Green Submitted, Green Published			2022-12-27	WOS:000380169300059
J	Now, H; Yoo, JY				Now, Hesung; Yoo, Joo-Yeon			AG490 and PF431396 Sensitive Tyrosine Kinase Control the Population Heterogeneity of Basal STAT1 Activity in Ube1l Deficient Cells	PLOS ONE			English	Article							PHENOTYPIC DIVERSITY; PROTEIN ISGYLATION; GENE-EXPRESSION; FOCAL ADHESION; GROWTH-FACTOR; CANCER-CELLS; STEM-CELLS; IDENTIFICATION; INHIBITOR; MIGRATION	A population often contains distinct sub-populations, thereby increasing the complexity of the overall heterogeneity. However, the cellular origin and biological relevance of sub-populations in cell population have not been clearly identified. Here we demonstrated the novel roles of ISGylation, which is an IFN-induced post-translational modification, controlling heterogeneity at the population level in cultured adherent cells. Without UBE1L, an E1 enzyme of ISGylation, mouse embryonic fibroblasts (MEF) exhibited low viral resistance despite high STAT1 and ISG expression compared with the wild-type MEF. We observe that Ube1l(-/-) MEF populations consist of two behaviorally distinguishable sub-populations with distinct basal STAT1 activity, while wild-type MEF populations are unimodal. This population heterogeneity in Ube1l knock-out cells was perturbed by tyrosine kinase inhibitors, AG490 and PF431396. In contrast, the neutralization of type I IFN did not affect population heterogeneity. Based on these results, we concluded that UBE1L functions to adjust basal immunological states with the regulation of population heterogeneity.	[Now, Hesung; Yoo, Joo-Yeon] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang 37673, South Korea	Pohang University of Science & Technology (POSTECH)	Yoo, JY (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang 37673, South Korea.	jyoo@postech.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2012R1A4A1028200, NRF-2015R1A2A1A10054957]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (no. NRF-2012R1A4A1028200 and no. NRF-2015R1A2A1A10054957).	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bolnick DI, 2004, EVOLUTION, V58, P608, DOI 10.1111/j.0014-3820.2004.tb01683.x; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chapman A, 2014, CELL REP, V8, P688, DOI 10.1016/j.celrep.2014.06.045; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; GAZIT A, 1991, J MED CHEM, V34, P1896, DOI 10.1021/jm00110a022; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Han S, 2009, J BIOL CHEM, V284, P13193, DOI 10.1074/jbc.M809038200; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Heng HHQ, 2006, J CELL PHYSIOL, V208, P461, DOI 10.1002/jcp.20685; Heng HHQ, 2009, J CELL PHYSIOL, V220, P538, DOI 10.1002/jcp.21799; Hwang SY, 2013, J IMMUNOL, V190, P1192, DOI 10.4049/jimmunol.1202326; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; Kingsolver JG, 2007, BIOSCIENCE, V57, P561, DOI 10.1641/B570706; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lai C, 2009, J VIROL, V83, P1147, DOI 10.1128/JVI.00105-08; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Martin RA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-136; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Overton KW, 2014, P NATL ACAD SCI USA, V111, pE4386, DOI 10.1073/pnas.1409797111; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Skinner MK, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0153-y; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xia L, 2002, J BIOL CHEM, V277, P30716, DOI 10.1074/jbc.M202823200; Xie B, 2001, J BIOL CHEM, V276, P19512, DOI 10.1074/jbc.M009063200; Yoo HS, 2014, J IMMUNOL, V192, P1440, DOI 10.4049/jimmunol.1201952; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; ZAWATZKY R, 1985, P NATL ACAD SCI USA, V82, P1136, DOI 10.1073/pnas.82.4.1136; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249	48	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159453	10.1371/journal.pone.0159453	http://dx.doi.org/10.1371/journal.pone.0159453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427993	Green Published, Green Submitted, gold			2022-12-27	WOS:000380169300069
J	Chung, HS; Lee, S; Park, SJ				Chung, Hye-Shin; Lee, Sunbae; Park, Soon Jae			Oxidation Protection in Metal-Binding Peptide Motif and Its Application to Antibody for Site-Selective Conjugation	PLOS ONE			English	Article							DISULFIDE BOND; ZINC; COORDINATION; PROTEIN; IDENTIFICATION; MODULATION; REACTIVITY; STABILITY; CHEMISTRY; STRATEGY	Here, we demonstrate that a metal ion binding motif could serve as an efficient and robust tool for site-specific conjugation strategy. Cysteine-containing metal binding motifs were constructed as single repeat or tandem repeat peptides and their metal binding characteristics were investigated. The tandem repeats of the Cysteine-Glycine-Histidine (CGH) metal ion binding motif exhibited concerted binding to Co(II) ions, suggesting that conformational transition of peptide was triggered by the sequential metal ion binding. Evaluation of the free thiol content after reduction by reducing reagent showed that metal-ion binding elicited strong retardation of cysteine oxidation in the order of Zn(II)>Ni(II)>Co(II). The CGH metal ion binding motif was then introduced to the C-terminus of antibody heavy chain and the metal ion-dependent characteristics of oxidation kinetics were investigated. As in the case of peptides, CGH-motif-introduced antibody exhibited strong dependence on metal ion binding to protect against oxidation. Zn(II)-saturated antibody with tandem repeat of CGH motif retains the cysteine reactivity as long as 22 hour even with saturating O-2 condition. Metal-ion dependent fluorophore labeling clearly indicated that metal binding motifs could be employed as an efficient tool for site-specific conjugation. Whereas Trastuzumab without a metal ion binding site exhibited site-nonspecific dye conjugation, Zn(II) ion binding to antibody with a tandem repeat of CGH motif showed that fluorophores were site-specifically conjugated to the heavy chain of antibody. We believe that this strong metal ion dependence on oxidation protection and the resulting site-selective conjugation could be exploited further to develop a highly site-specific conjugation strategy for proteins that contain multiple intrinsic cysteine residues, including monoclonal antibodies.	[Chung, Hye-Shin] Hannam Univ, Coll Life Sci & Nano Technol, Dept Biol Sci & Biotechnol, 1646 Yuseong Daero, Daejeon, South Korea; [Chung, Hye-Shin; Lee, Sunbae; Park, Soon Jae] Alteogen Inc, Yuseong Daero 62, Daejeon, South Korea	Hannam University	Park, SJ (corresponding author), Alteogen Inc, Yuseong Daero 62, Daejeon, South Korea.	park@alteogen.com			Ministry of Trade, Industry and Energy, Republic of Korea [10040057]; Alteogen Inc.	Ministry of Trade, Industry and Energy, Republic of Korea; Alteogen Inc.	This work was supported by the Ministry of Trade, Industry and Energy, Republic of Korea (http://english.motie.go.kr/) Grant No.: 10040057. Alteogen Inc. provided support in the form of authors' salary [HSC, SL, and SJP] and research materials/instruments but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barok M, 2011, CANCER LETT, V306, P171, DOI 10.1016/j.canlet.2011.03.002; Brautigam L, 2013, BIOCHEM BIOPH RES CO, V436, P491, DOI 10.1016/j.bbrc.2013.05.132; Bullock TL, 2008, P NATL ACAD SCI USA, V105, P7428, DOI 10.1073/pnas.0711812105; Drake PM, 2014, BIOCONJUGATE CHEM, V25, P1331, DOI 10.1021/bc500189z; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Gasymov OK, 2014, BIOCHEM BIOPH RES CO, V452, P1004, DOI 10.1016/j.bbrc.2014.09.029; Griep MA, 1997, BIOCHEMISTRY-US, V36, P544, DOI 10.1021/bi9612778; HANAS JS, 1983, J BIOL CHEM, V258, P4120; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Ismail NF, 2016, SCI REP, V19, P1; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Kalia J, 2010, CURR ORG CHEM, V14, P138, DOI 10.2174/138527210790069839; Kassim R, 2013, J BIOL INORG CHEM, V18, P333, DOI 10.1007/s00775-013-0977-5; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Lee S, 2006, J AM CHEM SOC, V128, P1937, DOI 10.1021/ja0546828; Lewis MR, 2001, BIOCONJUGATE CHEM, V12, P320, DOI 10.1021/bc0000886; Li L, 2002, BIOCONJUGATE CHEM, V13, P985, DOI 10.1021/bc025565u; Liu YJ, 2013, J NUCL MED, V54, P1135, DOI 10.2967/jnumed.112.114777; Lu HR, 2016, TALANTA, V146, P477, DOI 10.1016/j.talanta.2015.09.014; MCMILLIN DR, 1974, P NATL ACAD SCI USA, V71, P4760, DOI 10.1073/pnas.71.12.4760; Nies DH, 1997, CH MICROBIOL SER, P77; Ohrvik H, 2015, INT J MOL SCI, V16, P16728, DOI 10.3390/ijms160816728; Peacock AFA, 2009, DALTON T, P2271, DOI 10.1039/b818306f; Plegaria JS, 2015, BIOCHEMISTRY-US, V54, P2858, DOI 10.1021/acs.biochem.5b00064; Shein SA, 2015, B EXP BIOL MED+, V158, P371, DOI 10.1007/s10517-015-2765-4; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Singh VK, 1999, MOL MICROBIOL, V33, P200, DOI 10.1046/j.1365-2958.1999.01466.x; Smith MEB, 2010, J AM CHEM SOC, V132, P1960, DOI 10.1021/ja908610s; Stanyon HF, 2014, FEBS J, V281, P3945, DOI 10.1111/febs.12934; Strop P, 2013, CHEM BIOL, V20, P161, DOI 10.1016/j.chembiol.2013.01.010; URADE Y, 1995, J BIOL CHEM, V270, P1422, DOI 10.1074/jbc.270.3.1422; Van Horn JD, 2003, J BIOL INORG CHEM, V8, P601, DOI 10.1007/s00775-003-0454-7; Wang H, 2008, BIOMACROMOLECULES, V9, P3223, DOI 10.1021/bm800801b; Wang L, 2014, BIOCONJUGATE CHEM, V25, P1252, DOI 10.1021/bc5000934; Watanabe M, 2015, FEBS LETT, V589, P1200, DOI 10.1016/j.febslet.2015.03.020; Wen B, 2006, ARCH BIOCHEM BIOPHYS, V454, P42, DOI 10.1016/j.abb.2006.08.003; Xie F, 2010, J INORG BIOCHEM, V104, P261, DOI 10.1016/j.jinorgbio.2009.12.005; Zhang ZW, 2003, BIOCHEMISTRY-US, V42, P6735, DOI 10.1021/bi0300231; Zinzani PL, 2015, ONCOLOGIST, V20, P1413, DOI 10.1634/theoncologist.2015-0227	40	1	1	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0159451	10.1371/journal.pone.0159451	http://dx.doi.org/10.1371/journal.pone.0159451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420328	Green Published, Green Submitted, gold			2022-12-27	WOS:000379662300013
J	Bai, YL; Zhu, WB; Hu, XC; Sun, CC; Li, YL; Wang, DD; Wang, QH; Pei, GL; Zhang, YF; Guo, AG; Zhao, HX; Lu, HB; Mu, XQ; Hu, JJ; Zhou, XN; Xie, CG				Bai, Yili; Zhu, Wenbo; Hu, Xiaochen; Sun, Congcong; Li, Yanlin; Wang, Dandan; Wang, Qinhu; Pei, Guoliang; Zhang, Yanfeng; Guo, Aiguang; Zhao, Huixian; Lu, Haibin; Mu, Xiaoqian; Hu, Jingjiang; Zhou, Xiaona; Xie, Chang Gen			Genome-Wide Analysis of the bZIP Gene Family Identifies Two ABI5-Like bZIP Transcription Factors, BrABI5a and BrABI5b, as Positive Modulators of ABA Signalling in Chinese Cabbage	PLOS ONE			English	Article							ALTERNATIVE SPLICING PRODUCTS; DROUGHT STRESS TOLERANCE; REGULATES ABSCISIC-ACID; BRASSICA-OLERACEA; SEED-GERMINATION; E3 LIGASE; EXPRESSION ANALYSIS; BINDING FACTOR; ABI5; ARABIDOPSIS	bZIP (basic leucine zipper) transcription factors coordinate plant growth and development and control responses to environmental stimuli. The genome of Chinese cabbage (Brassica rapa) encodes 136 putative bZIP transcription factors. The bZIP transcription factors in Brassica rapa (BrbZIP) are classified into 10 subfamilies. Phylogenetic relationship analysis reveals that subfamily A consists of 23 BrbZIPs. Two BrbZIPs within subfamily A, Bra005287 and Bra017251, display high similarity to ABI5 (ABA Insensitive 5). Expression of subfamily A BrbZIPs, like BrABI5a (Bra005287/BrbZIP14) and BrABI5b (Bra017251/BrbZIP13), are significantly induced by the plant hormone ABA. Subcellular localization assay reveal that both BrABI5a and BrABI5b have a nuclear localization. BrABI5a and BrABI5b could directly stimulate ABA Responsive Element-driven HIS (a HIS3 reporter gene, which confers His prototrophy) or LUC (LUCIFERASE) expression in yeast and Arabidopsis protoplast. Deletion of the bZIP motif abolished BrABI5a and BrABI5b transcriptional activity. The ABA insensitive phenotype of Arabidopsis abi5-1 is completely suppressed in transgenic lines expressing BrABI5a or BrABI5b. Overall, these results suggest that ABI5 orthologs, BrABI5a and BrABI5b, have key roles in ABA signalling in Chinese cabbage.	[Bai, Yili; Zhu, Wenbo; Hu, Xiaochen; Sun, Congcong; Li, Yanlin; Wang, Dandan; Wang, Qinhu; Pei, Guoliang; Guo, Aiguang; Zhao, Huixian; Mu, Xiaoqian; Hu, Jingjiang; Zhou, Xiaona; Xie, Chang Gen] Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Yanfeng] Hybrid Rapeseed Res Ctr Shaanxi Prov, Yangling 712100, Shaanxi, Peoples R China; [Lu, Haibin] Northwest A&F Univ, Coll Agron, Yangling 712100, Shaanxi, Peoples R China; [Xie, Chang Gen] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	Northwest A&F University - China; Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Xie, CG (corresponding author), Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Xie, CG (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	changen.xie@nwsuaf.edu.cn	Wang, Qinhu/AAD-4793-2021; Wang, Qinhu/I-6274-2012	Wang, Qinhu/0000-0003-1251-073X; Wang, Qinhu/0000-0003-1251-073X	National Natural Science Foundation of China [31201630]; China Scholarship Council [201506305025]; Young Faculty Study Abroad Program by Northwest AF University; Fundamental Research Funds for Science and Technology Innovation Program of the Central Universities by Northwest AF University [2452015216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Young Faculty Study Abroad Program by Northwest AF University; Fundamental Research Funds for Science and Technology Innovation Program of the Central Universities by Northwest AF University	This work was supported by grants from National Natural Science Foundation of China to Zhou Xiaona (31201630), grants from the State Scholarship Fund to Dr. Xie Chang Gen by China Scholarship Council (201506305025), and grants from the Young Faculty Study Abroad Program and the Fundamental Research Funds for Science and Technology Innovation Program of the Central Universities (2452015216) to Dr. Xie Chang Gen by Northwest A&F University.	Albertos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9669; Baloglu MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096014; Bensmihen S, 2005, J EXP BOT, V56, P597, DOI 10.1093/jxb/eri050; Bensmihen S, 2002, PLANT CELL, V14, P1391, DOI 10.1105/tpc.000869; Casaretto J, 2003, PLANT CELL, V15, P271, DOI 10.1105/tpc.007096; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Dong X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130451; Farinati S, 2010, NEW PHYTOL, V185, P964, DOI 10.1111/j.1469-8137.2009.03132.x; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Hossain MA, 2010, J PLANT PHYSIOL, V167, P1512, DOI 10.1016/j.jplph.2010.05.008; Hossain MA, 2010, PLANT MOL BIOL, V72, P557, DOI 10.1007/s11103-009-9592-9; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hwang I, 2014, GENOMICS, V104, P194, DOI 10.1016/j.ygeno.2014.07.008; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jin ZW, 2014, PLANTA, V239, P299, DOI 10.1007/s00425-013-1979-9; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Lee JH, 2010, PLANT CELL, V22, P1716, DOI 10.1105/tpc.109.073783; Liu HX, 2010, PLANT CELL, V22, P2630, DOI 10.1105/tpc.110.076075; Liu JY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-281; Liu S, 2014, NAT PROD COMMUN, V9, P7, DOI 10.1038/ncomms4930; Liu X, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1457-9; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Lopez-Molina L, 2003, GENE DEV, V17, P410, DOI 10.1101/gad.1055803; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Miura K, 2009, P NATL ACAD SCI USA, V106, P5418, DOI 10.1073/pnas.0811088106; Nicolas P, 2014, PLANT PHYSIOL, V164, P365, DOI 10.1104/pp.113.231977; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Pourabed E, 2015, MOL BIOTECHNOL, V57, P12, DOI 10.1007/s12033-014-9797-2; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Waldmuller S, 1995, PLANT MOL BIOL, V29, P507, DOI 10.1007/BF00020981; Waldmuller S, 1996, PLANT MOL BIOL, V32, P631, DOI 10.1007/BF00020204; Wang JZ, 2011, J INTEGR PLANT BIOL, V53, P212, DOI 10.1111/j.1744-7909.2010.01017.x; Wang MY, 2013, BIOCHEM BIOPH RES CO, V442, P214, DOI 10.1016/j.bbrc.2013.11.032; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang YP, 2013, J EXP BOT, V64, P675, DOI 10.1093/jxb/ers361; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Wycliffe P, 2005, PLANT J, V44, P1, DOI 10.1111/j.1365-313X.2005.02482.x; Yang X, 2011, PLANT PHYSIOL, V156, P1397, DOI 10.1104/pp.111.173427; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Yu JY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-664; Yuan FF, 2013, BIOCHEM BIOPH RES CO, V442, P202, DOI 10.1016/j.bbrc.2013.11.035; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhou B, 2009, BIOTECHNOL LETT, V31, P1811, DOI 10.1007/s10529-009-0080-8; Zhou XN, 2015, PLANT PHYSIOL, V168, P659, DOI 10.1104/pp.114.255455; Zhou XN, 2013, BIOCHEM BIOPH RES CO, V430, P1140, DOI 10.1016/j.bbrc.2012.12.023; Zou MJ, 2008, PLANT MOL BIOL, V66, P675, DOI 10.1007/s11103-008-9298-4; Zou MJ, 2007, BIOCHEM BIOPH RES CO, V360, P307, DOI 10.1016/j.bbrc.2007.05.226	59	18	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158966	10.1371/journal.pone.0158966	http://dx.doi.org/10.1371/journal.pone.0158966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414644	Green Submitted, gold, Green Published			2022-12-27	WOS:000379579500053
J	Davenport, EP; Harris, DF; Origanti, S; Antony, E				Davenport, Eric Parker; Harris, Derek F.; Origanti, Sofia; Antony, Edwin			Rad51 Nucleoprotein Filament Disassembly Captured Using Fluorescent Plasmodium falciparum SSB as a Reporter for Single-Stranded DNA	PLOS ONE			English	Article							PROTEIN-OLIGONUCLEOTIDE INTERACTIONS; C-TERMINAL TAILS; BINDING-PROTEIN; HOMOLOGOUS RECOMBINATION; NEGATIVE COOPERATIVITY; LABELED NUCLEOTIDES; CRYSTAL-STRUCTURE; HELICASE ACTIVITY; NUCLEIC-ACIDS; SRS2 HELICASE	Single-stranded DNA binding (SSB) proteins coordinate DNA replication, repair, and recombination and are critical for maintaining genomic integrity. SSB binds to single-stranded DNA (ssDNA) rapidly and with very high affinity making it a useful molecular tool to detect free ssDNA in solution. We have labeled SSB from Plasmodium falciparum (Pf-SSB) with the MDCC (7-diethylamino-3-((((2-maleimidyl) ethyl)amino)-carbonyl)coumarin) fluorophore which yields a four-fold increase in fluorescence upon binding to ssDNA. Pf-SSBMDCC binding to DNA is unaffected by NaCl or Mg2+ concentration and does not display salt-dependent changes in DNA binding modes or cooperative binding on long DNA substrates. These features are unique to Pf-SSB, making it an ideal tool to probe the presence of free ssDNA in any biochemical reaction. Using this Pf-SSBMDCC probe as a sensor for free ssDNA, we have investigated the clearing of preformed yeast Rad51 nucleoprotein filaments by the Srs2 helicase during HR. Our studies provide a rate for the disassembly of the Rad51 filament by full length Srs2 on long ssDNA substrates. Mutations in the conserved 2B domain in the homologous bacterial UvrD, Rep and PcrA helicases show an enhancement of DNA unwinding activity, but similar mutations in Srs2 do not affect its DNA unwinding or Rad51 clearing properties. These studies showcase the utility of the Pf-SSB probe in mechanistic investigation of enzymes that function in DNA metabolism.	[Davenport, Eric Parker; Harris, Derek F.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Davenport, Eric Parker; Origanti, Sofia; Antony, Edwin] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	Utah System of Higher Education; Utah State University; Marquette University	Antony, E (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	edwin.antony@mu.edu	Antony, Edwin/AAA-3596-2021	Origanti, Sofia/0000-0002-6953-0160	NIH-NIGMS [R15GM110671]; Marquette University; Undergraduate Research and Creative Opportunities (URCO) grant from Utah State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110671] Funding Source: NIH RePORTER	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Marquette University; Undergraduate Research and Creative Opportunities (URCO) grant from Utah State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the NIH-NIGMS (R15GM110671) and start-up support from Marquette University to EA. EPD was supported by an Undergraduate Research and Creative Opportunities (URCO) grant from Utah State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a grant from the NIH-NIGMS (R15GM110671) and start-up support from Marquette University to EA. EPD was supported by an Undergraduate Research and Creative Opportunities (URCO) grant from Utah State University. We thank Tawny Moss for generation of the Srs2<SUP>DK-AA</SUP> mutation and undergraduate students-Mark Soffe, Cason Worley, Danny Morris and Jeff VonGermeten for their assistance with protein purification. We also acknowledge the members of the Antony Lab for critical reading of the manuscript and sharing ideas for using the Pf-SSB probe.	Antony E, 2013, J MOL BIOL, V425, P4802, DOI 10.1016/j.jmb.2013.08.021; Antony E, 2012, J MOL BIOL, V420, P284, DOI 10.1016/j.jmb.2012.04.022; Antony E, 2012, J MOL BIOL, V420, P269, DOI 10.1016/j.jmb.2012.04.021; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Balci H, 2011, BIOPHYS J, V101, P976, DOI 10.1016/j.bpj.2011.07.010; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Bianco P R, 1998, Front Biosci, V3, pD570; Bianco Piero R, 2012, Methods Mol Biol, V922, P235, DOI 10.1007/978-1-62703-032-8_18; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; BUJALOWSKI W, 1989, J MOL BIOL, V207, P269, DOI 10.1016/0022-2836(89)90455-5; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; BUJALOWSKI W, 1989, J MOL BIOL, V207, P249, DOI 10.1016/0022-2836(89)90454-3; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; BUJALOWSKI W, 1987, J MOL BIOL, V195, P897, DOI 10.1016/0022-2836(87)90493-1; Centore RC, 2009, J BACTERIOL, V191, P1429, DOI 10.1128/JB.01415-08; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Daley JM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a017954; EGGLESTON AK, 1991, BIOCHIMIE, V73, P163, DOI 10.1016/0300-9084(91)90199-B; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Green M, 2014, BIOSENS BIOELECTRON, V61, P579, DOI 10.1016/j.bios.2014.06.011; Heyer WD, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016501; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Korolev S, 1998, PROTEIN SCI, V7, P605, DOI 10.1002/pro.5560070309; KOWALCZYKOWSKI SC, 1987, P NATL ACAD SCI USA, V84, P3127, DOI 10.1073/pnas.84.10.3127; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P11611, DOI 10.1021/bi020361m; Kozlov AG, 2015, J MOL BIOL, V427, P763, DOI 10.1016/j.jmb.2014.12.020; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Kunzelmann S, 2009, J BIOL CHEM, V284, P33130, DOI 10.1074/jbc.M109.047118; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Liu J, 2011, CRIT REV BIOCHEM MOL, V46, P240, DOI 10.3109/10409238.2011.576007; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; LOHMAN TM, 1988, TRENDS BIOCHEM SCI, V13, P250; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Lytle AK, 2014, J MOL BIOL, V426, P1883, DOI 10.1016/j.jmb.2014.02.014; Macris MA, 2005, BIOCHEM SOC T, V33, P1447, DOI 10.1042/BST0331447; Meiners MJ, 2014, J BIOL CHEM, V289, P17100, DOI 10.1074/jbc.M114.565309; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Modesti M, 2007, STRUCTURE, V15, P599, DOI 10.1016/j.str.2007.04.003; OVERMAN LB, 1988, BIOCHEMISTRY-US, V27, P456, DOI 10.1021/bi00401a067; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Prusty D, 2010, NUCLEIC ACIDS RES, V38, P7037, DOI 10.1093/nar/gkq565; Qiu YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3281; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; Ristic D, 2005, NUCLEIC ACIDS RES, V33, P3292, DOI 10.1093/nar/gki640; Robertson RB, 2009, J MOL BIOL, V388, P703, DOI 10.1016/j.jmb.2009.03.049; RONG L, 1993, J BIOL CHEM, V268, P1252; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Saikrishnan K, 2005, ACTA CRYSTALLOGR D, V61, P1140, DOI 10.1107/S0907444905016896; Saikrishnan K, 2003, J MOL BIOL, V331, P385, DOI 10.1016/S0022-2836(03)00729-0; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Tomko EJ, 2010, EMBO J, V29, P3826, DOI 10.1038/emboj.2010.242; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Walsh MT, 2015, BIOCHEMISTRY-US, V54, P4019, DOI 10.1021/acs.biochem.5b00269; Webb MR, 2001, BIOPHYS J, V81, P1562, DOI 10.1016/S0006-3495(01)75810-9; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907; Zhang G, 1998, J BACTERIOL, V180, P377, DOI 10.1128/JB.180.2.377-387.1998; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	69	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159242	10.1371/journal.pone.0159242	http://dx.doi.org/10.1371/journal.pone.0159242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416037	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500107
J	Lin, MV; Sise, ME; Pavlakis, M; Amundsen, BM; Chute, D; Rutherford, AE; Chung, RT; Curry, MP; Hanifi, JM; Gabardi, S; Chandraker, A; Heher, EC; Elias, N; Riella, LV				Lin, Ming V.; Sise, Meghan E.; Pavlakis, Martha; Amundsen, Beth M.; Chute, Donald; Rutherford, Anna E.; Chung, Raymond T.; Curry, Michael P.; Hanifi, Jasmine M.; Gabardi, Steve; Chandraker, Anil; Heher, Eliot C.; Elias, Nahel; Riella, Leonardo V.			Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							RENAL-REPLACEMENT THERAPY; GENOTYPE 1; DISEASE; IMPACT; SOFOSBUVIR; SURVIVAL; METAANALYSIS; SIMEPREVIR; HIV; HCV	The prevalence of Hepatitis C Virus (HCV) infection is significantly higher in patients with end-stage renal disease compared to the general population and poses important clinical challenges in patients who undergo kidney transplantation. Historically, interferon-based treatment options have been limited by low rates of efficacy and significant side effects, including risk of precipitating rejection. Limited data exist on the use of all-oral, interferon-free direct-acting antiviral (DAA) therapies in kidney transplant recipients. In this study, we performed a retrospective chart review with prospective clinical follow-up of post-kidney transplant patients treated with DAA therapies at three major hospitals in Boston, MA. A total of 24 kidney recipients with HCV infection received all-oral DAA therapy post-transplant. Patients were predominantly male (79%) with a median age of 60 years (range 34-70 years), median creatinine of 1.2 mg/dL (0.66-1.76), and 42% had advanced fibrosis or cirrhosis. The majority had HCV genotype 1a infection (58%). All patients received full-dose sofosbuvir; it was paired with simeprevir (9 patients without and 3 patients with ribavirin), ledipasvir (7 patients without and 1 patient with ribavirin) or ribavirin alone (4 patients). The overall sustained virologic response (SVR12) was 91% (21 out of 23 patients). One patient achieved SVR4 but demised prior to SVR12 check point due to treatment unrelated cause. Two treatment failures were successfully retreated with alternative DAA regimens and achieved SVR. Both initials failures occurred in patients with advanced fibrosis or cirrhosis, with genotype 1a infection, and prior HCV treatment failure. Adverse events were reported in 11 patients (46%) and were managed clinically without discontinuation of therapy. Calcineurin inhibitor trough levels did not significantly change during therapy. In this multi-center series of patients, all-oral DAA therapy appears to be safe and effective in post-kidney transplant patients with chronic HCV infection.	[Lin, Ming V.; Rutherford, Anna E.] Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Sise, Meghan E.; Heher, Eliot C.] Harvard Med Sch, Massachusetts Gen Hosp, Div Nephrol, Boston, MA USA; [Pavlakis, Martha] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA USA; [Amundsen, Beth M.; Heher, Eliot C.; Elias, Nahel] Harvard Med Sch, Massachusetts Gen Hosp, Div Transplant Surg, Boston, MA USA; [Chute, Donald; Chung, Raymond T.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Liver, Div Gastroenterol, Boston, MA USA; [Curry, Michael P.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA USA; [Hanifi, Jasmine M.] Harvard Med Sch, Brigham & Womens Hosp, Dept Internal Med, Boston, MA USA; [Gabardi, Steve; Chandraker, Anil; Riella, Leonardo V.] Harvard Med Sch, Brigham & Womens Hosp, Div Renal, Transplantat Res Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lin, MV (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA.; Riella, LV (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Renal, Transplantat Res Ctr, Boston, MA USA.	mvlin@partners.org; lriella@bwh.harvard.edu	Riella, Leonardo V./AAD-5246-2019; Elias, Nahel/AAO-8344-2020; Chandraker, Anil/L-3908-2019; Riella, Leonardo V./AAC-8182-2019	Elias, Nahel/0000-0001-6466-7347; Riella, Leonardo V./0000-0002-7636-3196; Gabardi, Steven/0000-0001-8022-2751				Adinolfi LE, 2014, WORLD J GASTROENTERO, V20, P3410, DOI 10.3748/wjg.v20.i13.3410; Berdichevski RH, 2010, CLIN KIDNEY J, V3, P564, DOI 10.1093/ndtplus/sfq155; Bruchfeld A, 2004, TRANSPLANTATION, V78, P745, DOI 10.1097/01.TP.0000131948.29742.24; Burgess S, 2015, ANN PHARMACOTHER, V49, P674, DOI 10.1177/1060028015576180; Caillard S, 2006, TRANSPLANTATION, V81, P888, DOI 10.1097/01.tp.0000203554.54242.56; Caillard S, 2006, AM J TRANSPLANT, V6, P2735, DOI 10.1111/j.1600-6143.2006.01540.x; Fabrizi F, 2006, ALIMENT PHARM THER, V24, P1413, DOI 10.1111/j.1365-2036.2006.03151.x; Fabrizi F, 2014, J VIRAL HEPATITIS, V21, P314, DOI 10.1111/jvh.12148; Fabrizi F, 2011, J VIRAL HEPATITIS, V18, pE263, DOI 10.1111/j.1365-2893.2010.01405.x; Fabrizi F, 2014, J MED VIROL, V86, P933, DOI 10.1002/jmv.23919; Fabrizi F, 2013, KIDNEY INT, V84, P874, DOI 10.1038/ki.2013.264; Gutierrez JA, 2015, LIVER TRANSPLANT, V21, P823, DOI 10.1002/lt.24126; Ingsathit A, 2013, TRANSPLANTATION, V95, P943, DOI 10.1097/TP.0b013e3182848de2; Kamar N, 2015, AM J TRANSPLANT; Kanungo S, 2010, INT UROL NEPHROL, V42, P219, DOI 10.1007/s11255-009-9594-1; Kidney Disease: Improving Global Outcomes (KDIGO), 2008, Kidney Int Suppl, pS1, DOI 10.1038/ki.2008.81; Lawitz E, 2015, HEPATOLOGY; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Mahmoud IM, 2004, AM J KIDNEY DIS, V43, P131, DOI 10.1053/j.ajkd.2003.09.018; Markowitz GS, 2010, CLIN J AM SOC NEPHRO, V5, P607, DOI 10.2215/CJN.07311009; Pawlotsky JM, 2014, SEMIN LIVER DIS, V34, P22, DOI 10.1055/s-0034-1371007; Pungpapong S, 2015, HEPATOLOGY, V61, P1880, DOI 10.1002/hep.27770; Roth D, 1996, TRANSPLANTATION, V61, P886, DOI 10.1097/00007890-199603270-00007; Roth D, 2015, LANCET, V386, P1537, DOI 10.1016/S0140-6736(15)00349-9; Roth D, 2011, J AM SOC NEPHROL, V22, P1152, DOI 10.1681/ASN.2010060668; Santos L, 2009, TRANSPL P, V41, P880, DOI 10.1016/j.transproceed.2009.01.074; Sawinski D, 2015, AM J TRANSPLANT; Scott DR, 2010, TRANSPLANTATION, V90, P1165, DOI 10.1097/TP.0b013e3181f92548; Trotter JF, 2005, ALIMENT PHARM THERAP, V22, P37, DOI 10.1111/j.1365-2036.2005.02502.x; Wessler JD, 2013, J AM COLL CARDIOL, V61, P2495, DOI 10.1016/j.jacc.2013.02.058; Xia Y, 2014, AM J TRANSPLANT, V14, P2037, DOI 10.1111/ajt.12847; Yoshida EM, 2015, HEPATOLOGY, V61, P41, DOI 10.1002/hep.27366	33	85	91	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158431	10.1371/journal.pone.0158431	http://dx.doi.org/10.1371/journal.pone.0158431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415632	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500021
J	Therkelsen, SP; Hetland, G; Lyberg, T; Lygren, I; Johnson, E				Therkelsen, Stig Palm; Hetland, Geir; Lyberg, Torstein; Lygren, Idar; Johnson, Egil			Effect of the Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan (TM), on Symptoms, Fatigue and Quality of Life in Patients with Crohn's Disease in a Randomized Single-Blinded Placebo Controlled Study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; ADHESION MOLECULES; ANTITUMOR-ACTIVITY; FRUITING BODIES; HUMAN MONOCYTES; NORMATIVE DATA; EXPRESSION; CYTOKINES; MURRILL	Background Ingestion of AndoSan (TM), based on the mushroom Agaricus blazei Murill, has previously shown an anti-inflammatory effect through reduction of pro-inflammatory cytokines in healthy individuals and patients with Crohn's disease (CD). In this randomized single-blinded placebo-controlled study we examined whether intake of AndoSan (TM) also resulted in clinical effects. Methods and Findings 50 patients with symptomatic CD were randomized for oral daily consumption of AndoSan (TM) or placebo for a 21-day experimental period, in this per-protocol study. Patients reported validated scores for symptoms, fatigue and health related quality of life (HRQoL) at days 0, 14 and 21. Fecal calprotectin and general blood parameters were also analyzed. In the AndoSan (TM) group (n = 25) symptoms improved from baseline (day 0) to days 14 and 21, with respective mean scores (95% CI) of 5.52 (4.64-6.40), 4.48 (3.69-5.27) and 4.08 (3.22-4.94) (p<0,001). We found significant improvements in symptom score for both genders in the AndoSan (TM) group, and no significant changes in the placebo (n = 25) group. There were however no significant differences between the groups (p = 0.106), although a marginal effect in symptom score for men (p = 0.054). There were comparable improvements in physical, mental and total fatigue for both groups. HRQoL versus baseline were at day 21 improved for bodily pain and vitality in the AndoSan (TM) group and for vitality and social functioning in the placebo group. No crucial changes in general blood samples and fecal calprotectin were detected. Conclusions The results from this single-blinded randomized clinical trial shows significant improvement on symptoms, for both genders, in the AndoSan (TM) group, but no significant differences between the study groups. The results on fatigue, HRQoL, fecal calprotectin and blood samples were quite similar compared with placebo. The patients did not report any harms or unintended effects of AndoSan (TM). CD patients with mild to moderate symptoms may have beneficiary effects of AndoSan (TM) as a safe supplement in addition to conventional medication.	[Therkelsen, Stig Palm; Johnson, Egil] Oslo Univ Hosp, Dept Gastrointestinal & Pediat Surg, Oslo, Norway; [Hetland, Geir] Oslo Univ Hosp, Immunol & Transfus Med, Oslo, Norway; [Lyberg, Torstein] Oslo Univ Hosp, Med Biochem, Oslo, Norway; [Lygren, Idar] Oslo Univ Hosp, Med, Oslo, Norway; [Johnson, Egil] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Therkelsen, SP (corresponding author), Oslo Univ Hosp, Dept Gastrointestinal & Pediat Surg, Oslo, Norway.	stig.therkelsen@ous-hf.no		Therkelsen, Stig Palm/0000-0001-7104-0403	Faculty of Medicine, University of Oslo	Faculty of Medicine, University of Oslo	This work was supported by grants from the Faculty of Medicine, University of Oslo.	ADACHI Y, 1994, BIOL PHARM BULL, V17, P1554, DOI 10.1248/bpb.17.1554; Ahn WS, 2004, INT J GYNECOL CANCER, V14, P589, DOI 10.1111/j.1048-891X.2004.14403.x; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Bernardshaw S, 2005, INFLAMMATION, V29, P147, DOI 10.1007/s10753-006-9010-2; Berven L, 2015, J MED FOOD, V18, P429, DOI 10.1089/jmf.2014.0018; Ellertsen Linda K, 2009, Clin Mol Allergy, V7, P6, DOI 10.1186/1476-7961-7-6; Endo M, 2010, BBA-GEN SUBJECTS, V1800, P669, DOI 10.1016/j.bbagen.2010.03.016; Engdal S, 2008, XENOBIOTICA, V38, P559, DOI [10.1080/00498250801986969, 10.1080/00498250801986969 ]; Engdal S, 2009, PHYTOTHER RES, V23, P906, DOI 10.1002/ptr.2750; Fagerland MW, 2009, CONTEMP CLIN TRIALS, V30, P490, DOI 10.1016/j.cct.2009.06.007; Firenzuoli F, 2008, EVID-BASED COMPL ALT, V5, P3, DOI 10.1093/ecam/nem007; Forland DT, 2011, SCAND J IMMUNOL, V73, P66, DOI 10.1111/j.1365-3083.2010.02477.x; Forland DT, 2010, CYTOKINE, V49, P245, DOI 10.1016/j.cyto.2009.09.002; Fujimiya Y, 1999, ANTICANCER RES, V19, P113; Grinde B, 2006, INT IMMUNOPHARMACOL, V6, P1311, DOI 10.1016/j.intimp.2006.04.005; HARVEY RF, 1980, LANCET, V1, P514; Hetland G, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/157015; Hsu CH, 2008, J ALTERN COMPLEM MED, V14, P299, DOI 10.1089/acm.2006.6344; IKUZAWA M, 1988, INT J IMMUNOPHARMACO, V10, P415; Izawa S, 2004, APPL MICROBIOL BIOT, V64, P537, DOI 10.1007/s00253-003-1467-4; Johnson E, 2009, SCAND J IMMUNOL, V69, P242, DOI 10.1111/j.1365-3083.2008.02218.x; Johnson E, 2012, SCAND J GASTROENTERO, V47, P984, DOI 10.3109/00365521.2012.660544; KAWAGISHI H, 1990, CARBOHYD POLYM, V12, P393, DOI 10.1016/0144-8617(90)90089-B; KAWAGISHI H, 1988, CARBOHYD RES, V183, P150, DOI 10.1016/0008-6215(88)80057-0; Korolkova OY, 2015, CLIN MED INSIGHTS-GA, V8, P29, DOI 10.4137/CGast.S20612; Lee EW, 2000, BIOSCI BIOTECH BIOCH, V64, P2402, DOI 10.1271/bbb.64.2402; Lee JG, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060336; Lee JS, 2010, EXP MOL MED, V42, P143, DOI 10.3858/emm.2010.42.2.016; Lima CUJO, 2012, SCAND J IMMUNOL, V75, P336, DOI 10.1111/j.1365-3083.2011.02656.x; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; Loge JH, 1998, SCAND J SOC MED, V26, P250; MAHIDA YR, 1989, GUT, V30, P835, DOI 10.1136/gut.30.6.835; McClane SJ, 1999, JPEN-PARENTER ENTER, V23, pS20, DOI 10.1177/014860719902300506; Mukai H, 2006, JPN J CLIN ONCOL, V36, P808, DOI 10.1093/jjco/hyl108; MURCH SH, 1991, GUT, V32, P913, DOI 10.1136/gut.32.8.913; Niwa A, 2011, J CLIN BIOCHEM NUTR, V48, P194, DOI 10.3164/jcbn.10-78; O'Neill LAJ, 2008, SCIENCE, V320, P619, DOI 10.1126/science.1158398; Oh TW, 2010, J AGR FOOD CHEM, V58, P4113, DOI 10.1021/jf9036672; Ohno S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/192381; Padilha MM, 2009, J MED FOOD, V12, P359, DOI 10.1089/jmf.2008.0177; Pelizon AC, 2005, PHYSIOL RES, V54, P557, DOI 10.33549/physiolres.930686; Rice PJ, 2005, J PHARMACOL EXP THER, V314, P1079, DOI 10.1124/jpet.105.085415; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; SAKURAI T, 1992, INT J IMMUNOPHARMACO, V14, P821, DOI 10.1016/0192-0561(92)90080-5; Skog O, 2013, CURR OPIN ENDOCRINOL, V20, P118, DOI 10.1097/MED.0b013e32835edb89; Takaku T, 2001, J NUTR, V131, P1409, DOI 10.1093/jn/131.5.1409; Tangen JM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/718539; Therkelsen SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150191; Tsai WJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/435916; Wang P, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/164817; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; Woywodt A, 1999, EUR J GASTROEN HEPAT, V11, P267, DOI 10.1097/00042737-199903000-00010; Yatawara L, 2009, KOREAN J PARASITOL, V47, P345, DOI 10.3347/kjp.2009.47.4.345	53	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159288	10.1371/journal.pone.0159288	http://dx.doi.org/10.1371/journal.pone.0159288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415795	Green Published, gold, Green Submitted			2022-12-27	WOS:000379579500120
